/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;


INSERT INTO `orpha_classification_levels` (`id`, `name`) VALUES
(1, 'Disorder'),
(2, 'Subtype of disorder'),
(3, 'Group of disorders');

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(1, 'ORPHA:10', '48,XXYY syndrome', 1),
(2, 'ORPHA:100', 'Ataxia-telangiectasia', 1),
(3, 'ORPHA:100', 'Louis-Bar syndrome', 1),
(4, 'ORPHA:1000', 'Ocular albinism with late-onset sensorineural deafness', 1),
(5, 'ORPHA:1000', 'Ocular albinism with late-onset sensorineural hearing loss', 1),
(6, 'ORPHA:100000', 'Reticular perineurioma', 2),
(7, 'ORPHA:100001', 'Sclerosing perineurioma', 2),
(8, 'ORPHA:100002', 'Extraneural perineurioma', 1),
(9, 'ORPHA:100002', 'Soft tissue perineurioma', 1),
(10, 'ORPHA:100003', 'Intraneural perineurioma', 1),
(11, 'ORPHA:100006', 'ABeta amyloidosis, Dutch type', 2),
(12, 'ORPHA:100006', 'ABetaE22Q amyloidosis', 2),
(13, 'ORPHA:100006', 'HCHWA, Dutch type', 2),
(14, 'ORPHA:100006', 'HCHWA-D', 2),
(15, 'ORPHA:100006', 'Hereditary cerebral hemorrhage with amyloidosis, Dutch type', 2),
(16, 'ORPHA:100008', 'ACys amyloidosis', 2),
(17, 'ORPHA:100008', 'CST3-related amyloidosis', 2),
(18, 'ORPHA:100008', 'Cystatin amyloidosis', 2),
(19, 'ORPHA:100008', 'HCHWA, Icelandic type', 2),
(20, 'ORPHA:100008', 'Hereditary cerebral hemorrhage with amyloidosis, Icelandic type', 2),
(21, 'ORPHA:100008', 'Hereditary cystatin C amyloid angiopathy', 2),
(22, 'ORPHA:100011', 'Lissencephaly with cerebellar hypoplasia type A', 1),
(23, 'ORPHA:100012', 'Lissencephaly with cerebellar hypoplasia type B', 1),
(24, 'ORPHA:100013', 'Lissencephaly with cerebellar hypoplasia type C', 1),
(25, 'ORPHA:100014', 'Lissencephaly with cerebellar hypoplasia type D', 1),
(26, 'ORPHA:100015', 'Lissencephaly with cerebellar hypoplasia type E', 1),
(27, 'ORPHA:100016', 'Lissencephaly with cerebellar hypoplasia type F', 1),
(28, 'ORPHA:100019', 'RAEB-1', 2),
(29, 'ORPHA:100019', 'Refractory anemia with excess blasts type 1', 2),
(30, 'ORPHA:100020', 'RAEB-2', 2),
(31, 'ORPHA:100020', 'Refractory anemia with excess blasts type 2', 2),
(32, 'ORPHA:100021', 'Primary plasmacytoma of the bone', 2),
(33, 'ORPHA:100022', 'Extramedullary soft tissue plasmacytoma', 2),
(34, 'ORPHA:100024', 'Mu-heavy chain disease', 2),
(35, 'ORPHA:100024', 'mu-HCD', 2),
(36, 'ORPHA:100025', 'Alpha-HCD', 2),
(37, 'ORPHA:100025', 'Alpha-heavy chain disease', 2),
(38, 'ORPHA:100025', 'IPSID', 2),
(39, 'ORPHA:100025', 'Immunoproliferative small intestinal disease', 2),
(40, 'ORPHA:100025', 'Mediterranean lymphoma', 2),
(41, 'ORPHA:100026', 'Franklin disease', 2),
(42, 'ORPHA:100026', 'Gamma-HCD', 2),
(43, 'ORPHA:100026', 'Gamma-heavy chain disease', 2),
(44, 'ORPHA:100031', 'Amelogenesis imperfecta type 1', 2),
(45, 'ORPHA:100031', 'Hypoplastic amelogenesis imperfecta', 2),
(46, 'ORPHA:100032', 'Amelogenesis imperfecta type 3', 2),
(47, 'ORPHA:100032', 'Hypocalcified amelogenesis imperfecta', 2),
(48, 'ORPHA:100033', 'Amelogenesis imperfecta type 2', 2),
(49, 'ORPHA:100033', 'Hypomaturation amelogenesis imperfecta', 2),
(50, 'ORPHA:100034', 'Amelogenesis imperfecta type 4', 2),
(51, 'ORPHA:100034', 'Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism', 2),
(52, 'ORPHA:100035', 'Hepatic solitary necrotic nodule', 1),
(53, 'ORPHA:100035', 'Solitary necrotic nodule of the liver', 1),
(54, 'ORPHA:100043', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type A', 1),
(55, 'ORPHA:100043', 'CMTDIA', 1),
(56, 'ORPHA:100044', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type B', 1),
(57, 'ORPHA:100044', 'CMTDIB', 1),
(58, 'ORPHA:100045', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type C', 1),
(59, 'ORPHA:100045', 'CMTDIC', 1),
(60, 'ORPHA:100046', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type D', 1),
(61, 'ORPHA:100046', 'CMTDID', 1),
(62, 'ORPHA:100047', 'Esophageal duplication cyst', 1),
(63, 'ORPHA:100048', 'Tubular duplication of the esophagus', 1),
(64, 'ORPHA:100049', 'Primary ILD specific to childhood due to pulmonary surfactant protein anomalies', 3),
(65, 'ORPHA:100049', 'Primary interstitial lung disease specific to childhood due to pulmonary surfactant protein anomalies', 3),
(66, 'ORPHA:100050', 'HAE 1', 2),
(67, 'ORPHA:100050', 'HAE-I', 2),
(68, 'ORPHA:100050', 'Hereditary angioedema type 1', 2),
(69, 'ORPHA:100050', 'Hereditary angioneurotic edema type 1', 2),
(70, 'ORPHA:100051', 'HAE 2', 2),
(71, 'ORPHA:100051', 'HAE-II', 2),
(72, 'ORPHA:100051', 'Hereditary angioedema type 2', 2),
(73, 'ORPHA:100051', 'Hereditary angioneurotic edema type 2', 2),
(74, 'ORPHA:100054', 'F12-related HAE with normal C1 inhibitor', 2),
(75, 'ORPHA:100054', 'F12-related hereditary angioedema with normal C1Inh', 2),
(76, 'ORPHA:100054', 'HAE 3', 2),
(77, 'ORPHA:100054', 'HAE-III', 2),
(78, 'ORPHA:100054', 'Hereditary angioedema type 3', 2),
(79, 'ORPHA:100054', 'Hereditary angioneurotic edema type 3', 2),
(80, 'ORPHA:100054', 'Inherited estrogen-associated angioedema', 2),
(81, 'ORPHA:100054', 'Inherited estrogen-associated angioneurotic edema', 2),
(82, 'ORPHA:100054', 'Inherited estrogen-dependent angioedema', 2),
(83, 'ORPHA:100054', 'Inherited estrogen-dependent angioneurotic edema', 2),
(84, 'ORPHA:100055', 'AAE 2', 2),
(85, 'ORPHA:100055', 'AAE II', 2),
(86, 'ORPHA:100055', 'Acquired angioedema type 2', 2),
(87, 'ORPHA:100055', 'Acquired angioneurotic edema type 2', 2),
(88, 'ORPHA:100056', 'Acquired angioedema type 1', 2),
(89, 'ORPHA:100056', 'Acquired angioneurotic edema type 1', 2),
(90, 'ORPHA:100057', 'ACE inhibitor-related acquired angioedema', 1),
(91, 'ORPHA:100057', 'ACEI-related acquired angioedema', 1),
(92, 'ORPHA:100057', 'Acquired angioedema with normal C1 inhibitor', 1),
(93, 'ORPHA:100057', 'Acquired angioedema with normal C1INH', 1),
(94, 'ORPHA:100057', 'RAAS-blocker-induced angioedema', 1),
(95, 'ORPHA:100057', 'RAAS-blocker-induced angioneurotic edema', 1),
(96, 'ORPHA:100057', 'RAE', 1),
(97, 'ORPHA:100057', 'Renin-angiotensin-aldosterone system-blocker-induced angioedema', 1),
(98, 'ORPHA:100057', 'Renin-angiotensin-aldosterone system-blocker-induced angioneurotic edema', 1),
(99, 'ORPHA:100067', 'Waterhouse-Friderichsen syndrome', 2),
(100, 'ORPHA:100069', 'Semantic dementia', 1),
(101, 'ORPHA:100069', 'Semantic primary progressive aphasia', 1),
(102, 'ORPHA:100069', 'Semantic variant PPA', 1),
(103, 'ORPHA:100070', 'Agramatic variant of PPA', 1),
(104, 'ORPHA:100070', 'Agramatic variant of primary progressive aphasia', 1),
(105, 'ORPHA:100070', 'Non-fluent variant PPA', 1),
(106, 'ORPHA:100070', 'Progressive non-fluent aphasia', 1),
(107, 'ORPHA:100071', 'Mosaic trisomy 3', 1),
(108, 'ORPHA:100071', 'Mosaic trisomy chromosome 3', 1),
(109, 'ORPHA:100071', 'Trisomy 3 mosaicism', 1),
(110, 'ORPHA:100073', 'NTOS', 2),
(111, 'ORPHA:100073', 'Neurogenic TOS', 2),
(112, 'ORPHA:100073', 'Neurogenic cervical rib syndrome', 2),
(113, 'ORPHA:100073', 'Neurogenic costoclavicular syndrome', 2),
(114, 'ORPHA:100073', 'Neurogenic thoracic outlet compression syndrome', 2),
(115, 'ORPHA:100073', 'Neurogenic thoracic outlet syndrome', 2),
(116, 'ORPHA:100075', 'GNET', 1),
(117, 'ORPHA:100075', 'Gastric NET', 1),
(118, 'ORPHA:100075', 'Gastric neuroendocrine tumor', 1),
(119, 'ORPHA:100075', 'NET of stomach', 1),
(120, 'ORPHA:100075', 'Neuroendocrine tumor of stomach', 1),
(121, 'ORPHA:100076', 'Duodenal neuroendocrine tumor', 3),
(122, 'ORPHA:100077', 'Jejunal neuroendocrine neoplasm', 3),
(123, 'ORPHA:100077', 'Jejunal neuroendocrine tumor', 3),
(124, 'ORPHA:100078', 'Ileal neuroendocrine neoplasm', 1),
(125, 'ORPHA:100078', 'Ileal neuroendocrine tumor', 1),
(126, 'ORPHA:100079', 'Appendiceal NEN', 1),
(127, 'ORPHA:100079', 'Appendiceal neuroendocrine neoplasm', 1),
(128, 'ORPHA:100079', 'NEN of appendix', 1),
(129, 'ORPHA:100079', 'Neuroendocrine neoplasm of appendix', 1),
(130, 'ORPHA:100080', 'Colonic NET', 1),
(131, 'ORPHA:100080', 'NET of the colon', 1),
(132, 'ORPHA:100080', 'Neuroendocrine neoplasm of the colon', 1),
(133, 'ORPHA:100080', 'Neuroendocrine tumor of the colon', 1),
(134, 'ORPHA:100081', 'NET of the rectum', 1),
(135, 'ORPHA:100081', 'Neuroendocrine tumor of the rectum', 1),
(136, 'ORPHA:100081', 'Rectal NET', 1),
(137, 'ORPHA:100081', 'Rectal neuroendocrine tumor', 1),
(138, 'ORPHA:100082', 'NET of anal canal', 1),
(139, 'ORPHA:100082', 'Neuroendocrine tumor of anal canal', 1),
(140, 'ORPHA:100083', 'Laryngeal neuroendocrine tumor', 1),
(141, 'ORPHA:100084', 'Middle ear neuroendocrine tumor', 1),
(142, 'ORPHA:100085', 'Primary hepatic neuroendocrine carcinoma', 1),
(143, 'ORPHA:100086', 'Gallbladder neuroendocrine tumor', 1),
(144, 'ORPHA:100087', 'Thyroid tumor', 3),
(145, 'ORPHA:100088', 'Thyroid carcinoma', 3),
(146, 'ORPHA:100090', 'Rare parathyroid tumor', 3),
(147, 'ORPHA:100091', 'Adrenal/paraganglial tumor', 3),
(148, 'ORPHA:100092', 'GEP-NEN', 3),
(149, 'ORPHA:100092', 'Gastroenteropancreatic neuroendocrine neoplasm', 3),
(150, 'ORPHA:100093', 'Carcinoid syndrome', 1),
(151, 'ORPHA:100093', 'Malignant carcinoid syndrome', 1),
(152, 'ORPHA:100094', 'Multiple polyglandular tumor', 3),
(153, 'ORPHA:1001', '2q37 microdeletion syndrome', 1),
(154, 'ORPHA:1001', 'Albright hereditary osteodystrophy type 3', 1),
(155, 'ORPHA:1001', 'Albright hereditary osteodystrophy-like syndrome', 1),
(156, 'ORPHA:1001', 'Brachydactyly-intellectual disability syndrome', 1),
(157, 'ORPHA:1001', 'Del(2)(q37)', 1),
(158, 'ORPHA:1001', 'Deletion 2q37', 1),
(159, 'ORPHA:1001', 'Monosomy 2q37qter', 1),
(160, 'ORPHA:100100', 'Thymic tumor', 3),
(161, 'ORPHA:100101', 'Neuroendocrine tumor with other location', 3),
(162, 'ORPHA:1003', 'Scalp defects-postaxial polydactyly syndrome', 1),
(163, 'ORPHA:1005', 'ACD-intellectual disability syndrome', 1),
(164, 'ORPHA:1005', 'Alopecia-contractures-dwarfism-intellectual disability syndrome', 1),
(165, 'ORPHA:1006', 'Alopecia antibody deficiency', 1),
(166, 'ORPHA:1006', 'Ipp-Gelfand syndrome', 1),
(167, 'ORPHA:1008', 'Alopecia-epilepsy-pyorrhea-intellectual disability syndrome', 1),
(168, 'ORPHA:1008', 'Shokeir syndrome', 1),
(169, 'ORPHA:100924', 'ALAD porphyria', 1),
(170, 'ORPHA:100924', 'Porphyria due to ALA dehydratase deficiency', 1),
(171, 'ORPHA:100924', 'Porphyria due to ALAD deficiency', 1),
(172, 'ORPHA:100924', 'Porphyria due to delta-aminolevulinate dehydratase deficiency', 1),
(173, 'ORPHA:100924', 'Porphyria of Doss', 1),
(174, 'ORPHA:100973', 'FRAXE intellectual disability', 1),
(175, 'ORPHA:100973', 'Intellectual disability associated with fragile site FRAXE', 1),
(176, 'ORPHA:100974', 'FRAXF syndrome', 1),
(177, 'ORPHA:100976', 'BSI', 1),
(178, 'ORPHA:100976', 'Bathing suit ichthyosis', 1),
(179, 'ORPHA:100978', 'Benallegue-Lacete syndrome', 1),
(180, 'ORPHA:100978', 'Cloverleaf skull-asphyxiating thoracic dysplasia syndrome', 1),
(181, 'ORPHA:100979', 'Autosomal dominant complex HSP', 3),
(182, 'ORPHA:100979', 'Autosomal dominant complex SPG', 3),
(183, 'ORPHA:100979', 'Autosomal dominant complex spastic paraplegia', 3),
(184, 'ORPHA:100979', 'Autosomal dominant complicated HSP', 3),
(185, 'ORPHA:100979', 'Autosomal dominant complicated SPG', 3),
(186, 'ORPHA:100979', 'Autosomal dominant complicated spastic paraplegia', 3),
(187, 'ORPHA:100980', 'Autosomal dominant pure HSP', 3),
(188, 'ORPHA:100980', 'Autosomal dominant pure SPG', 3),
(189, 'ORPHA:100980', 'Autosomal dominant pure spastic paraplegia', 3),
(190, 'ORPHA:100980', 'Autosomal dominant uncomplicated HSP', 3),
(191, 'ORPHA:100980', 'Autosomal dominant uncomplicated SPG', 3),
(192, 'ORPHA:100980', 'Autosomal dominant uncomplicated spastic paraplegia', 3),
(193, 'ORPHA:100981', 'Autosomal recessive complex HSP', 3),
(194, 'ORPHA:100981', 'Autosomal recessive complex SPG', 3),
(195, 'ORPHA:100981', 'Autosomal recessive complex spastic paraplegia', 3),
(196, 'ORPHA:100981', 'Autosomal recessive complicated HSP', 3),
(197, 'ORPHA:100981', 'Autosomal recessive complicated SPG', 3),
(198, 'ORPHA:100981', 'Autosomal recessive complicated spastic paraplegia', 3),
(199, 'ORPHA:100982', 'Autosomal recessive pure HSP', 3),
(200, 'ORPHA:100982', 'Autosomal recessive pure SPG', 3),
(201, 'ORPHA:100982', 'Autosomal recessive pure spastic paraplegia', 3),
(202, 'ORPHA:100982', 'Autosomal recessive uncomplicated HSP', 3),
(203, 'ORPHA:100982', 'Autosomal recessive uncomplicated SPG', 3),
(204, 'ORPHA:100982', 'Autosomal recessive uncomplicated spastic paraplegia', 3),
(205, 'ORPHA:100984', 'Autosomal dominant spastic paraplegia type 3', 1),
(206, 'ORPHA:100984', 'Strümpell disease', 1),
(207, 'ORPHA:100985', 'Autosomal dominant spastic paraplegia type 4', 1),
(208, 'ORPHA:100985', 'SPG4', 1),
(209, 'ORPHA:100986', 'Autosomal recessive spastic paraplegia type 5A', 1),
(210, 'ORPHA:100986', 'SPG5A', 1),
(211, 'ORPHA:100988', 'Autosomal dominant spastic paraplegia type 6', 1),
(212, 'ORPHA:100988', 'SPG6', 1),
(213, 'ORPHA:100989', 'Autosomal dominant spastic paraplegia type 8', 1),
(214, 'ORPHA:100989', 'SPG8', 1),
(215, 'ORPHA:100991', 'Autosomal dominant spastic paraplegia type 10', 1),
(216, 'ORPHA:100991', 'SPG10', 1),
(217, 'ORPHA:100993', 'Autosomal dominant spastic paraplegia type 12', 1),
(218, 'ORPHA:100993', 'SPG12', 1),
(219, 'ORPHA:100994', 'Autosomal dominant spastic paraplegia type 13', 1),
(220, 'ORPHA:100994', 'SPG13', 1),
(221, 'ORPHA:100995', 'Autosomal recessive spastic paraplegia type 14', 1),
(222, 'ORPHA:100995', 'SPG14', 1),
(223, 'ORPHA:100996', 'Autosomal recessive spastic paraplegia type 15', 1),
(224, 'ORPHA:100996', 'Hereditary spastic paraparesis type 15', 1),
(225, 'ORPHA:100996', 'Kjellin syndrome', 1),
(226, 'ORPHA:100996', 'SPG15', 1),
(227, 'ORPHA:100996', 'Spastic paraplegia-retinal degeneration syndrome', 1),
(228, 'ORPHA:100997', 'SPG16', 1),
(229, 'ORPHA:100997', 'X-linked spastic paraplegia type 16', 1),
(230, 'ORPHA:100998', 'Autosomal dominant spastic paraplegia type 17', 1),
(231, 'ORPHA:100998', 'SPG17', 1),
(232, 'ORPHA:100998', 'Silver syndrome', 1),
(233, 'ORPHA:100998', 'Spastic paraplegia-amyotrophy of hands and feet', 1),
(234, 'ORPHA:100999', 'Autosomal dominant spastic paraplegia type 19', 1),
(235, 'ORPHA:100999', 'SPG19', 1),
(236, 'ORPHA:101', 'DRPLA', 1),
(237, 'ORPHA:101', 'Dentatorubral pallidoluysian atrophy', 1),
(238, 'ORPHA:101', 'Dentatorubropallidoluysian atrophy', 1),
(239, 'ORPHA:101', 'Naito-Oyanagi disease', 1),
(240, 'ORPHA:1010', 'Autosomal dominant palmoplantar hyperkeratosis and congenital alopecia', 1),
(241, 'ORPHA:1010', 'Autosomal dominant palmoplantar keratoderma and congenital alopecia', 1),
(242, 'ORPHA:1010', 'PPK-CA, Stevanovic type', 1),
(243, 'ORPHA:1010', 'Palmoplantar keratoderma and congenital alopecia, Stevanovic type', 1),
(244, 'ORPHA:101000', 'Autosomal recessive spastic paraplegia type 20', 1),
(245, 'ORPHA:101000', 'Childhood-onset spastic paraparesis-distal muscle wasting syndrome', 1),
(246, 'ORPHA:101000', 'SPG20', 1),
(247, 'ORPHA:101000', 'Troyer syndrome', 1),
(248, 'ORPHA:101001', 'Autosomal recessive spastic paraplegia type 21', 1),
(249, 'ORPHA:101001', 'Mast syndrome', 1),
(250, 'ORPHA:101001', 'SPG21', 1),
(251, 'ORPHA:101003', 'Autosomal recessive spastic paraplegia type 23', 1),
(252, 'ORPHA:101003', 'Lison syndrome', 1),
(253, 'ORPHA:101003', 'SPG23', 1),
(254, 'ORPHA:101003', 'Spastic paraparesis-vitiligo-premature graying-characteristic facies syndrome', 1),
(255, 'ORPHA:101004', 'Autosomal recessive spastic paraplegia type 24', 1),
(256, 'ORPHA:101004', 'SPG24', 1),
(257, 'ORPHA:101005', 'Autosomal recessive spastic paraplegia type 25', 1),
(258, 'ORPHA:101005', 'Autosomal recessive spastic paraplegia-disc herniation syndrome', 1),
(259, 'ORPHA:101005', 'SPG25', 1),
(260, 'ORPHA:101006', 'Autosomal recessive spastic paraplegia type 26', 1),
(261, 'ORPHA:101006', 'GM2 synthase deficiency', 1),
(262, 'ORPHA:101006', 'SPG26', 1),
(263, 'ORPHA:101007', 'Autosomal recessive spastic paraplegia type 27', 1),
(264, 'ORPHA:101007', 'SPG27', 1),
(265, 'ORPHA:101008', 'Autosomal recessive spastic paraplegia type 28', 1),
(266, 'ORPHA:101008', 'SPG28', 1),
(267, 'ORPHA:101009', 'Autosomal dominant spastic paraplegia type 29', 1),
(268, 'ORPHA:101009', 'SPG29', 1),
(269, 'ORPHA:101010', 'Autosomal spastic paraplegia type 30', 1),
(270, 'ORPHA:101010', 'SPG30', 1),
(271, 'ORPHA:101011', 'Autosomal dominant spastic paraplegia type 31', 1),
(272, 'ORPHA:101011', 'SPG31', 1),
(273, 'ORPHA:101016', 'Romano-Ward long QT syndrome', 1),
(274, 'ORPHA:101016', 'Romano-Ward syndrome', 1),
(275, 'ORPHA:101023', 'Cleft hard palate', 1),
(276, 'ORPHA:101028', 'TALDO deficiency', 1),
(277, 'ORPHA:101028', 'Transaldolase deficiency', 1),
(278, 'ORPHA:101029', 'Sub-cortical nodular heterotopia', 2),
(279, 'ORPHA:101030', 'Subependymal nodular heterotopia', 2),
(280, 'ORPHA:101039', 'EFMR', 1),
(281, 'ORPHA:101039', 'Female restricted epilepsy with intellectual disability', 1),
(282, 'ORPHA:101039', 'Juberg-Hellman syndrome', 1),
(283, 'ORPHA:101041', 'Familial hypofibrinogenemia', 2),
(284, 'ORPHA:101043', 'Congenital aortic valve dysplasia', 2),
(285, 'ORPHA:101046', 'ADEAF', 1),
(286, 'ORPHA:101046', 'ADLTE', 1),
(287, 'ORPHA:101046', 'ADPEAF', 1),
(288, 'ORPHA:101046', 'Autosomal dominant epilepsy with auditory features', 1),
(289, 'ORPHA:101046', 'Autosomal dominant lateral temporal lobe epilepsy', 1),
(290, 'ORPHA:101046', 'Partial epilepsy with auditory aura', 1),
(291, 'ORPHA:101046', 'Partial epilepsy with auditory features', 1),
(292, 'ORPHA:101049', 'FHH type 2', 2),
(293, 'ORPHA:101049', 'Familial hypocalciuric hypercalcemia type 2', 2),
(294, 'ORPHA:101050', 'FHH type 3', 2),
(295, 'ORPHA:101050', 'Familial hypocalciuric hypercalcemia type 3', 2),
(296, 'ORPHA:101063', 'Complete situs inversus', 1),
(297, 'ORPHA:101063', 'Complete situs inversus viscerum', 1),
(298, 'ORPHA:101063', 'Situs inversus', 1),
(299, 'ORPHA:101063', 'Situs inversus totalis', 1),
(300, 'ORPHA:101068', 'CSCD', 1),
(301, 'ORPHA:101068', 'Congenital hereditary stromal dystrophy', 1),
(302, 'ORPHA:101068', 'Congenital stromal corneal dystrophy', 1),
(303, 'ORPHA:101068', 'Witschel dystrophy', 1),
(304, 'ORPHA:101070', 'Bilateral frontoparietal polymicrogyria', 2),
(305, 'ORPHA:101071', 'Unilateral hemispheric polymicrogyria', 2),
(306, 'ORPHA:101075', 'CMT1X', 1),
(307, 'ORPHA:101075', 'CMTX1', 1),
(308, 'ORPHA:101075', 'X-linked Charcot-Marie-Tooth disease type 1', 1),
(309, 'ORPHA:101076', 'CMTX2', 1),
(310, 'ORPHA:101076', 'X-linked Charcot-Marie-Tooth disease type 2', 1),
(311, 'ORPHA:101077', 'CMT3X', 1),
(312, 'ORPHA:101077', 'CMTX3', 1),
(313, 'ORPHA:101077', 'X-linked Charcot-Marie-Tooth disease type 3', 1),
(314, 'ORPHA:101078', 'CMT4X', 1),
(315, 'ORPHA:101078', 'CMTX4', 1),
(316, 'ORPHA:101078', 'Cowchock syndrome', 1),
(317, 'ORPHA:101078', 'X-linked Charcot-Marie-Tooth disease type 4', 1),
(318, 'ORPHA:101081', 'CMT1A', 1),
(319, 'ORPHA:101081', 'Charcot-Marie-Tooth disease type 1A', 1),
(320, 'ORPHA:101081', 'Microduplication 17p12', 1),
(321, 'ORPHA:101082', 'CMT1B', 1),
(322, 'ORPHA:101082', 'Charcot-Marie-Tooth disease type 1B', 1),
(323, 'ORPHA:101083', 'CMT1C', 1),
(324, 'ORPHA:101083', 'Charcot-Marie-Tooth disease type 1C', 1),
(325, 'ORPHA:101084', 'CMT1D', 1),
(326, 'ORPHA:101084', 'Charcot-Marie-Tooth disease type 1D', 1),
(327, 'ORPHA:101085', 'CMT1F', 1),
(328, 'ORPHA:101085', 'Charcot-Marie-Tooth disease type 1F', 1),
(329, 'ORPHA:101088', 'HIGM1', 2),
(330, 'ORPHA:101088', 'Hyper-IgM syndrome due to CD40 ligand deficiency', 2),
(331, 'ORPHA:101088', 'Hyper-IgM syndrome due to CD40L deficiency', 2),
(332, 'ORPHA:101088', 'Hyper-IgM syndrome type 1', 2),
(333, 'ORPHA:101088', 'X-linked hyper-IgM syndrome', 2),
(334, 'ORPHA:101088', 'XHIGM', 2),
(335, 'ORPHA:101089', 'AID deficiency', 2),
(336, 'ORPHA:101089', 'Activation-induced cytidine deaminase deficiency', 2),
(337, 'ORPHA:101089', 'HIGM2', 2),
(338, 'ORPHA:101089', 'Hyper-IgM syndrome type 2', 2),
(339, 'ORPHA:101090', 'HIGM3', 2),
(340, 'ORPHA:101090', 'Hyper-IgM syndrome due to CD40 deficiency', 2),
(341, 'ORPHA:101090', 'Hyper-IgM syndrome type 3', 2),
(342, 'ORPHA:101091', 'HIGM4', 2),
(343, 'ORPHA:101091', 'Hyper-IgM syndrome type 4', 2),
(344, 'ORPHA:101092', 'HIGM5', 2),
(345, 'ORPHA:101092', 'Hyper-IgM syndrome due to UNG deficiency', 2),
(346, 'ORPHA:101092', 'Hyper-IgM syndrome due to uracil N-glycosylase', 2),
(347, 'ORPHA:101092', 'Hyper-IgM syndrome type 5', 2),
(348, 'ORPHA:101096', 'Aregenerative anemia', 1),
(349, 'ORPHA:101097', 'ARCMT2K', 1),
(350, 'ORPHA:101097', 'Autosomal recessive Charcot-Marie-Tooth disease with hoarseness', 1),
(351, 'ORPHA:101097', 'Autosomal recessive axonal CMT4C4', 1),
(352, 'ORPHA:101097', 'Autosomal recessive axonal Charcot-Marie-Tooth disease type 2K', 1),
(353, 'ORPHA:101101', 'AR-CMT2B2', 1),
(354, 'ORPHA:101101', 'Autosomal recessive axonal CMT4C3', 1),
(355, 'ORPHA:101101', 'Autosomal recessive axonal Charcot-Marie-Tooth disease type 2B2', 1),
(356, 'ORPHA:101101', 'Charcot-Marie-Tooth disease type 2B2', 1),
(357, 'ORPHA:101102', 'AR-CMT2C', 1),
(358, 'ORPHA:101102', 'Autosomal recessive axonal CMT4C2', 1),
(359, 'ORPHA:101102', 'Axonal Charcot-Marie-Tooth disease with pyramidal involvement', 1),
(360, 'ORPHA:101102', 'CMT2H', 1),
(361, 'ORPHA:101102', 'Charcot-Marie-Tooth disease type 2H', 1),
(362, 'ORPHA:101104', 'Marin-Amat syndrome', 2),
(363, 'ORPHA:101108', 'SCA23', 1),
(364, 'ORPHA:101108', 'Spinocerebellar ataxia type 23', 1),
(365, 'ORPHA:101109', 'SCA28', 1),
(366, 'ORPHA:101109', 'Spinocerebellar ataxia type 28', 1),
(367, 'ORPHA:101110', 'SCA20', 1),
(368, 'ORPHA:101110', 'Spinocerebellar ataxia type 20', 1),
(369, 'ORPHA:101111', 'SCA25', 1),
(370, 'ORPHA:101111', 'Spinocerebellar ataxia type 25', 1),
(371, 'ORPHA:101112', 'SCA26', 1),
(372, 'ORPHA:101112', 'Spinocerebellar ataxia type 26', 1),
(373, 'ORPHA:101150', 'Autosomal recessive Segawa syndrome', 1),
(374, 'ORPHA:101150', 'Autosomal recessive dopa-responsive dystonia', 1),
(375, 'ORPHA:101150', 'DYT5b', 1),
(376, 'ORPHA:101150', 'Tyrosine hydroxylase deficiency', 1),
(377, 'ORPHA:101150', 'Tyrosine hydroxylase-deficient dopa-responsive dystonia', 1),
(378, 'ORPHA:101206', 'APV/ADA, Fallot type', 1),
(379, 'ORPHA:101206', 'Absence of pulmonary valve-Fallot tetralogy-absence of ductus arteriosus syndrome', 1),
(380, 'ORPHA:101206', 'PVA/ADA, Fallot type', 1),
(381, 'ORPHA:101206', 'Pulmonary valve agenesis-tetralogy of Fallot-absence of ductus arteriosus syndrome', 1),
(382, 'ORPHA:101330', 'PCT', 1),
(383, 'ORPHA:101330', 'Porphyria cutanea tarda', 1),
(384, 'ORPHA:101334', 'African tick typhus', 1),
(385, 'ORPHA:101351', 'Familial isolated congenital asplenia', 1),
(386, 'ORPHA:1014', 'Alopecia-intellectual disability-hypergonadotropic hypogonadism syndrome', 1),
(387, 'ORPHA:1014', 'Devriendt-Vandenberghe-Fryns syndrome', 1),
(388, 'ORPHA:101433', 'Rare urogenital disease', 3),
(389, 'ORPHA:101435', 'Rare genetic eye disease', 3),
(390, 'ORPHA:101435', 'Rare genetic ophthalmologic disease', 3),
(391, 'ORPHA:101685', 'Rare NSID', 1),
(392, 'ORPHA:101685', 'Rare non-syndromic intellectual disability', 1),
(393, 'ORPHA:1018', 'X-linked Alport syndrome-diffuse leiomyomatosis', 2),
(394, 'ORPHA:1018', 'Xq22.3 microdeletion syndrome', 2),
(395, 'ORPHA:101932', 'Anomaly of the mitral subvalvular apparatus', 1),
(396, 'ORPHA:101934', 'Genetic cardiac rhythm disease', 3),
(397, 'ORPHA:101936', 'Rare gastroesophageal disease', 3),
(398, 'ORPHA:101937', 'Rare pancreatic disease', 3),
(399, 'ORPHA:101938', 'Rare vascular liver disease', 3),
(400, 'ORPHA:101939', 'Rare parenchymal liver disease', 3),
(401, 'ORPHA:101940', 'Rare metabolic liver disease', 3),
(402, 'ORPHA:101941', 'Rare biliary tract disease', 3),
(403, 'ORPHA:101943', 'Rare hepatic and biliary tract tumor', 3),
(404, 'ORPHA:101944', 'Rare pulmonary disease', 3),
(405, 'ORPHA:101945', 'Rare bronchopulmonary tumor', 3),
(406, 'ORPHA:101950', 'Rare eye tumor', 3),
(407, 'ORPHA:101952', 'Rare diabetes mellitus', 3),
(408, 'ORPHA:101953', 'Rare dyslipidemia', 3),
(409, 'ORPHA:101954', 'Rare adrenal disease', 3),
(410, 'ORPHA:101955', 'Rare thyroid disease', 3),
(411, 'ORPHA:101956', 'Polyendocrinopathy', 3),
(412, 'ORPHA:101957', 'Pituitary deficiency', 3),
(413, 'ORPHA:101958', 'Primary adrenal insufficiency', 3),
(414, 'ORPHA:101959', 'CPAI', 3),
(415, 'ORPHA:101959', 'Chronic adrenocorticoid insufficiency', 3),
(416, 'ORPHA:101959', 'Chronic primary adrenal insufficiency', 3),
(417, 'ORPHA:101960', 'Genetic chronic primary adrenal insufficiency', 3),
(418, 'ORPHA:101963', 'Acquired chronic primary adrenal insufficiency', 3),
(419, 'ORPHA:101972', 'Combined T and B cell immunodeficiency', 3),
(420, 'ORPHA:101977', 'Immunodeficiency predominantly affecting antibody production', 3),
(421, 'ORPHA:101985', 'Quantitative and/or qualitative congenital phagocyte defect', 3),
(422, 'ORPHA:101987', 'Constitutional neutropenia', 3),
(423, 'ORPHA:101988', 'Primary immunodeficiency due to a defect in innate immunity', 3),
(424, 'ORPHA:101992', 'Immunodeficiency due to a complement cascade protein anomaly', 3),
(425, 'ORPHA:101995', 'Periodic fever syndrome', 3),
(426, 'ORPHA:101997', 'Primary immunodeficiency', 3),
(427, 'ORPHA:101998', 'Rare epilepsy', 3),
(428, 'ORPHA:102', 'MSA', 1),
(429, 'ORPHA:102', 'Multiple system atrophy', 1),
(430, 'ORPHA:102', 'Multisystem atrophy', 1),
(431, 'ORPHA:1020', 'EOFAD', 1),
(432, 'ORPHA:1020', 'Early-onset autosomal dominant Alzheimer disease', 1),
(433, 'ORPHA:1020', 'Early-onset familial autosomal dominant Alzheimer disease', 1),
(434, 'ORPHA:1020', 'Familial Alzheimer disease', 1),
(435, 'ORPHA:102000', 'Medullar disease', 3),
(436, 'ORPHA:102002', 'Rare ataxia', 3),
(437, 'ORPHA:102003', 'Rare movement disorder', 3),
(438, 'ORPHA:102005', 'Brain inflammatory disease', 3),
(439, 'ORPHA:102006', 'Neurovascular malformation', 3),
(440, 'ORPHA:102009', 'Classic lissencephaly', 3),
(441, 'ORPHA:102009', 'Lissencephaly type 1', 3),
(442, 'ORPHA:102010', 'Other syndrome with lissencephaly as a major feature', 3),
(443, 'ORPHA:102011', 'Lissencephaly type 3', 3),
(444, 'ORPHA:102012', 'Pure HSP', 3),
(445, 'ORPHA:102012', 'Pure SPG', 3),
(446, 'ORPHA:102012', 'Pure familial spastic paraplegia', 3),
(447, 'ORPHA:102012', 'Pure hereditary spastic paraplegia', 3),
(448, 'ORPHA:102012', 'Uncomplicated HSP', 3),
(449, 'ORPHA:102012', 'Uncomplicated SPG', 3),
(450, 'ORPHA:102012', 'Uncomplicated familial spastic paraplegia', 3),
(451, 'ORPHA:102012', 'Uncomplicated hereditary spastic paraplegia', 3),
(452, 'ORPHA:102013', 'Complex HSP', 3),
(453, 'ORPHA:102013', 'Complex SPG', 3),
(454, 'ORPHA:102013', 'Complex familial spastic paraplegia', 3),
(455, 'ORPHA:102013', 'Complex hereditary spastic paraplegia', 3),
(456, 'ORPHA:102013', 'Complicated HSP', 3),
(457, 'ORPHA:102013', 'Complicated SPG', 3),
(458, 'ORPHA:102013', 'Complicated familial spastic paraplegia', 3),
(459, 'ORPHA:102013', 'Complicated hereditary spastic paraplegia', 3),
(460, 'ORPHA:102014', 'Autosomal dominant limb-girdle muscular dystrophy', 3),
(461, 'ORPHA:102015', 'Autosomal recessive limb-girdle muscular dystrophy', 3),
(462, 'ORPHA:102020', 'Autosomal deletion', 3),
(463, 'ORPHA:102020', 'Autosomal monosomy', 3),
(464, 'ORPHA:102021', 'Rickettsiae disease', 3),
(465, 'ORPHA:102021', 'Rickettsial disease', 3),
(466, 'ORPHA:102022', 'Spotted fever rickettsiae disease', 3),
(467, 'ORPHA:102022', 'Spotted fever rickettsiosis', 3),
(468, 'ORPHA:102023', 'Typhus-group rickettsiae disease', 3),
(469, 'ORPHA:102023', 'Typhus-group rickettsiosis', 3),
(470, 'ORPHA:102024', 'HHV-8-related disorder', 3),
(471, 'ORPHA:102024', 'Human herpesvirus 8-related disorder', 3),
(472, 'ORPHA:1021', 'Amaurosis-hypertrichosis syndrome', 1),
(473, 'ORPHA:102237', 'Unexplained periodic fever syndrome', 3),
(474, 'ORPHA:102283', 'MCA/MR', 3),
(475, 'ORPHA:102283', 'Multiple congenital anomalies-intellectual disability with or without dysmorphism', 3),
(476, 'ORPHA:102283', 'Multiple congenital anomalies/dysmorphic syndrome-intellectual disability', 3),
(477, 'ORPHA:102284', 'MCA/variable MR', 3),
(478, 'ORPHA:102284', 'Multiple congenital anomalies-variable intellectual disability with or without dysmorphism syndrome', 3),
(479, 'ORPHA:102284', 'Multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome', 3),
(480, 'ORPHA:102285', 'MCA without intellectual disability', 3),
(481, 'ORPHA:102285', 'Multiple congenital anomalies without intellectual disability with or without dysmorphism', 3),
(482, 'ORPHA:102285', 'Multiple congenital anomalies/dysmorphic syndrome without intellectual disability', 3),
(483, 'ORPHA:1023', 'Ambras syndrome', 2),
(484, 'ORPHA:1023', 'Congenital generalized hypertrichosis, Ambras type', 2),
(485, 'ORPHA:102369', 'Rare syndromic intellectual disability', 3),
(486, 'ORPHA:102379', 'AML and myelodysplastic syndromes related to alkylating agent', 1),
(487, 'ORPHA:102379', 'Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent', 1),
(488, 'ORPHA:102381', 'AML and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 1),
(489, 'ORPHA:102381', 'Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor', 1),
(490, 'ORPHA:1027', 'Autosomal recessive amelia', 1),
(491, 'ORPHA:102724', 'AML with t(8;21)(q22;q22) translocation', 1),
(492, 'ORPHA:102724', 'Acute myeloid leukemia with t(8;21)(q22;q22) translocation', 1),
(493, 'ORPHA:1028', 'Amelo-onycho-hypohidrotic syndrome', 1),
(494, 'ORPHA:1028', 'Ameloonychohypohidrotic ectodermal dysplasia', 1),
(495, 'ORPHA:1028', 'Ameloonychohypohidrotic syndrome', 1),
(496, 'ORPHA:1031', 'Amelogenesis imperfecta-nephrocalcinosis syndrome', 1),
(497, 'ORPHA:1031', 'Enamel-renal syndrome', 1),
(498, 'ORPHA:1035', '3-mercaptopyruvate sulfurtransferase deficiency', 1),
(499, 'ORPHA:1035', 'Ampola syndrome', 1),
(500, 'ORPHA:1035', 'Beta-mercaptolactate cysteine disulfiduria', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(501, 'ORPHA:1035', 'MCDU', 1),
(502, 'ORPHA:1037', 'AMC', 3),
(503, 'ORPHA:1037', 'Arthrogryposis multiplex congenita', 3),
(504, 'ORPHA:1037', 'Multiple congenital arthrogryposis', 3),
(505, 'ORPHA:103907', 'Chronic diarrhea due to glucoamylase deficiency', 1),
(506, 'ORPHA:103907', 'Maltase-glucoamylase deficiency', 1),
(507, 'ORPHA:103908', 'Congenital sodium diarrhea', 1),
(508, 'ORPHA:103908', 'Na-H exchange deficiency', 1),
(509, 'ORPHA:103908', 'Non-syndromic congenital sodium diarrhea', 1),
(510, 'ORPHA:103909', 'Isolated trehalose intolerance', 1),
(511, 'ORPHA:103909', 'Trehalase deficiency', 1),
(512, 'ORPHA:103910', 'Congenital enterocyte heparan sulfate deficiency', 1),
(513, 'ORPHA:103918', 'TCP', 1),
(514, 'ORPHA:103918', 'Tropical calcific chronic pancreatitis', 1),
(515, 'ORPHA:103918', 'Tropical pancreatitis', 1),
(516, 'ORPHA:103919', 'AIP', 1),
(517, 'ORPHA:103919', 'Autoimmune pancreatitis', 1),
(518, 'ORPHA:103920', 'Undetermined colitis', 1),
(519, 'ORPHA:104', 'LHON', 1),
(520, 'ORPHA:104', 'Leber hereditary optic neuropathy', 1),
(521, 'ORPHA:104', 'Leber optic atrophy', 1),
(522, 'ORPHA:1040', 'Maroteaux-Verloes-Stanescu syndrome', 1),
(523, 'ORPHA:1040', 'Metaphyseal anadysplasia', 1),
(524, 'ORPHA:1040', 'Regressive metaphyseal dysplasia', 1),
(525, 'ORPHA:104003', 'Congenital intestinal transport defect', 3),
(526, 'ORPHA:104004', 'Intestinal disease due to vitamin absorption anomaly', 3),
(527, 'ORPHA:104005', 'Intestinal disease due to fat malabsorption', 3),
(528, 'ORPHA:104006', 'Congenital intestinal disease due to an enzymatic defect', 3),
(529, 'ORPHA:104007', 'Congenital enteropathy involving intestinal mucosa development', 3),
(530, 'ORPHA:104008', 'Short bowel syndrome', 3),
(531, 'ORPHA:104009', 'Rare disease involving intestinal motility', 3),
(532, 'ORPHA:104010', 'Intestinal polyposis syndrome', 3),
(533, 'ORPHA:104011', 'Rare intestinal tumor', 3),
(534, 'ORPHA:104011', 'Rare tumor of bowel', 3),
(535, 'ORPHA:104011', 'Rare tumor of intestine', 3),
(536, 'ORPHA:104012', 'Rare inflammatory bowel disease', 3),
(537, 'ORPHA:104013', 'Metabolic disease with intestinal involvement', 3),
(538, 'ORPHA:104075', 'Adenocarcinoma of the small bowel', 1),
(539, 'ORPHA:104075', 'Adenocarcinoma of the small intestine', 1),
(540, 'ORPHA:104076', 'Leiomyosarcoma of small intestine', 1),
(541, 'ORPHA:104077', 'Myopathic intestinal pseudoobstruction', 2),
(542, 'ORPHA:104078', 'Unclassified intestinal pseudoobstruction', 2),
(543, 'ORPHA:1041', 'Fetal anasarca', 1),
(544, 'ORPHA:1041', 'Fetal hydrops', 1),
(545, 'ORPHA:1041', 'Generalized fetal edema', 1),
(546, 'ORPHA:1041', 'HF', 1),
(547, 'ORPHA:1041', 'Hydrops fetalis', 1),
(548, 'ORPHA:1046', 'Lethal hemolytic anemia-genital anomalies syndrome', 1),
(549, 'ORPHA:1046', 'Water-West syndrome', 1),
(550, 'ORPHA:1047', 'Sideroblastic anemia', 3),
(551, 'ORPHA:1048', 'Isolated anencephaly/exencephaly', 1),
(552, 'ORPHA:105', 'Atresia of urethra', 1),
(553, 'ORPHA:105', 'Urethral atresia', 1),
(554, 'ORPHA:1051', 'Corneal anesthesia-deafness-intellectual disability syndrome', 1),
(555, 'ORPHA:1051', 'Corneal anesthesia-hearing loss-intellectual disability syndrome', 1),
(556, 'ORPHA:1051', 'Ramos-Arroyo syndrome', 1),
(557, 'ORPHA:1052', 'Mosaic variegated aneuploidy syndrome', 1),
(558, 'ORPHA:1052', 'Warburton-Anyane-Yeboa syndrome', 1),
(559, 'ORPHA:1053', 'Vein of Galen aneurysmal malformation', 1),
(560, 'ORPHA:1053', 'Vein of Galen arteriovenous malformations', 1),
(561, 'ORPHA:1054', 'Aneurysm of sinus of Valsalva', 1),
(562, 'ORPHA:1055', 'Congenital left ventricular aneurysm', 1),
(563, 'ORPHA:1059', 'BRBN', 1),
(564, 'ORPHA:1059', 'Bean syndrome', 1),
(565, 'ORPHA:1059', 'Blue rubber bleb nevus', 1),
(566, 'ORPHA:1062', 'Hereditary neurocutaneous malformation', 1),
(567, 'ORPHA:1063', 'Nakagawa angioblastoma', 1),
(568, 'ORPHA:1063', 'Tufted angioma', 1),
(569, 'ORPHA:1064', 'Aniridia-renal agenesis-psychomotor retardation syndrome', 1),
(570, 'ORPHA:1064', 'Sommer-Rathbun-Battles syndrome', 1),
(571, 'ORPHA:1065', 'Aniridia-cerebellar ataxia-intellectual disability syndrome', 1),
(572, 'ORPHA:1065', 'Gillespie syndrome', 1),
(573, 'ORPHA:1067', 'Aniridia-ptosis-intellectual disability-familial obesity syndrome', 1),
(574, 'ORPHA:1068', 'Aniridia-intellectual disability syndrome', 1),
(575, 'ORPHA:1068', 'Walker-Dyson syndrome', 1),
(576, 'ORPHA:1069', 'Aniridia-absent patella syndrome', 1),
(577, 'ORPHA:107', 'BOR syndrome', 1),
(578, 'ORPHA:107', 'Branchiootorenal syndrome', 1),
(579, 'ORPHA:1070', 'Anisakiasis', 1),
(580, 'ORPHA:1071', 'AEC syndrome', 1),
(581, 'ORPHA:1071', 'Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome', 1),
(582, 'ORPHA:1071', 'Hay-Wells syndrome', 1),
(583, 'ORPHA:1072', 'Ankyloblepharon filiforme adnatum-cleft palate syndrome', 2),
(584, 'ORPHA:1074', 'Ankyloblepharon filiforme adnatum-imperforate anus syndrome', 2),
(585, 'ORPHA:1074', 'Aughton-Hufnagle syndrome', 2),
(586, 'ORPHA:1077', 'Ankylosis of teeth', 1),
(587, 'ORPHA:1077', 'Dental ankylosis', 1),
(588, 'ORPHA:1078', 'Piussan-Lenaerts-Mathieu syndrome', 1),
(589, 'ORPHA:1078', 'Thumb stiffness-brachydactyly-intellectual disability syndrome', 1),
(590, 'ORPHA:108', 'Babesiosis', 1),
(591, 'ORPHA:1081', 'Coronary artery congenital malformation', 3),
(592, 'ORPHA:1083', 'Microlissencephaly', 1),
(593, 'ORPHA:1084', 'Isolated lissencephaly type 1 without known genetic defects', 1),
(594, 'ORPHA:108959', 'Non-syndromic esophageal malformation', 3),
(595, 'ORPHA:108961', 'Syndromic esophageal malformation', 3),
(596, 'ORPHA:108963', 'Non-syndromic gastroduodenal malformation', 3),
(597, 'ORPHA:108965', 'Syndromic gastroduodenal malformation', 3),
(598, 'ORPHA:108967', 'Non-syndromic intestinal malformation', 3),
(599, 'ORPHA:108969', 'Syndromic intestinal malformation', 3),
(600, 'ORPHA:108971', 'Non-syndromic visceral malformation', 3),
(601, 'ORPHA:108973', 'Syndromic visceral malformation', 3),
(602, 'ORPHA:108977', 'Non-syndromic diaphragmatic or abdominal wall malformation', 3),
(603, 'ORPHA:108979', 'Syndromic diaphragmatic or abdominal wall malformation', 3),
(604, 'ORPHA:108989', 'Non-syndromic central nervous system malformation', 3),
(605, 'ORPHA:108991', 'Syndrome with a central nervous system malformation as a major feature', 3),
(606, 'ORPHA:108993', 'Non-syndromic respiratory or mediastinal malformation', 3),
(607, 'ORPHA:108995', 'Syndromic respiratory or mediastinal malformation', 3),
(608, 'ORPHA:108997', 'Rare anemia', 3),
(609, 'ORPHA:108999', 'Rare disorder due to toxic effects', 3),
(610, 'ORPHA:109', 'BRRS', 1),
(611, 'ORPHA:109', 'Bannayan-Riley-Ruvalcaba syndrome', 1),
(612, 'ORPHA:109', 'Myhre-Riley-Smith syndrome', 1),
(613, 'ORPHA:109007', 'Arthrogryposis syndrome', 3),
(614, 'ORPHA:109009', 'Syndrome with limb malformations as a major feature', 3),
(615, 'ORPHA:109011', 'Non-syndromic limb malformation', 3),
(616, 'ORPHA:1094', 'Anonychia-microcephaly syndrome', 1),
(617, 'ORPHA:1094', 'Teebi-Kaurah syndrome', 1),
(618, 'ORPHA:11', '49,XXXXX syndrome', 1),
(619, 'ORPHA:11', 'Penta-X', 1),
(620, 'ORPHA:11', 'Pentasomy X', 1),
(621, 'ORPHA:11', 'Poly-X', 1),
(622, 'ORPHA:110', 'BBS', 1),
(623, 'ORPHA:110', 'Bardet-Biedl syndrome', 1),
(624, 'ORPHA:1101', 'Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome', 1),
(625, 'ORPHA:1101', 'Cassia Stocco dos Santos syndrome', 1),
(626, 'ORPHA:1104', 'Anophthalmia plus syndrome', 1),
(627, 'ORPHA:1104', 'Fryns microphthalmia syndrome', 1),
(628, 'ORPHA:1104', 'Microphthalmia with facial clefting', 1),
(629, 'ORPHA:1106', 'Anophthalmia-syndactyly syndrome', 1),
(630, 'ORPHA:1106', 'Microphthalmia with limb anomalies', 1),
(631, 'ORPHA:1106', 'OAS', 1),
(632, 'ORPHA:1106', 'Ophthalmoacromelic syndrome', 1),
(633, 'ORPHA:1106', 'Waardenburg anophthalmia syndrome', 1),
(634, 'ORPHA:111', '3-methylglutaconic aciduria type 2', 1),
(635, 'ORPHA:111', 'BTHS', 1),
(636, 'ORPHA:111', 'Barth syndrome', 1),
(637, 'ORPHA:111', 'Cardioskeletal myopathy with neutropenia and abnormal mitochondria', 1),
(638, 'ORPHA:111', 'Cardioskeletal myopathy-neutropenia syndrome', 1),
(639, 'ORPHA:111', 'MGA2', 1),
(640, 'ORPHA:111', 'X-linked cardioskeletal myopathy and neutropenia', 1),
(641, 'ORPHA:1110', 'Aortic arch anomaly-facial dysmorphism-intellectual disability syndrome', 1),
(642, 'ORPHA:1112', 'Aphalangy-hemivertebrae-urogenital-intestinal dysgenesis syndrome', 1),
(643, 'ORPHA:1112', 'Johnson-Munson syndrome', 1),
(644, 'ORPHA:1113', 'Aphalangy-syndactyly-microcephaly syndrome', 1),
(645, 'ORPHA:1114', 'Aplasia cutis congenita', 1),
(646, 'ORPHA:1116', 'Aplasia cutis congenita-intestinal lymphangiectasia syndrome', 1),
(647, 'ORPHA:1116', 'Bronspiegel-Zelnick syndrome', 1),
(648, 'ORPHA:1117', 'Aplasia cutis-myopia syndrome', 1),
(649, 'ORPHA:1117', 'Gershoni-Baruch-Leibo syndrome', 1),
(650, 'ORPHA:1118', 'Fibular aplasia-ectrodactyly syndrome', 1),
(651, 'ORPHA:112', 'Bartter syndrome', 1),
(652, 'ORPHA:112', 'Renal tubular normotensive hypokalemic alkalosis with hypercalciuria', 1),
(653, 'ORPHA:112', 'Salt-losing tubular disorder, Henle\'s loop type', 1),
(654, 'ORPHA:112', 'Salt-wasting tubulopathy, Henle\'s loop type', 1),
(655, 'ORPHA:1120', 'Lung agenesis-heart defect-thumb anomalies syndrome', 1),
(656, 'ORPHA:1120', 'Mardini-Nyhan syndrome', 1),
(657, 'ORPHA:1121', 'Radial deficiency-tibial hypoplasia syndrome', 1),
(658, 'ORPHA:1122', 'Ulnar hypoplasia-lobster-claw deformity of feet syndrome', 1),
(659, 'ORPHA:1122', 'Ulnar hypoplasia-split foot syndrome', 1),
(660, 'ORPHA:1122', 'Van den Berghe-Dequecker syndrome', 1),
(661, 'ORPHA:1123', 'Caudal appendage-deafness syndrome', 1),
(662, 'ORPHA:1123', 'Caudal appendage-hearing loss syndrome', 1),
(663, 'ORPHA:1123', 'Lynch-Lee-Murday syndrome', 1),
(664, 'ORPHA:1125', 'Ocular motor apraxia, Cogan type', 1),
(665, 'ORPHA:1125', 'Oculomotor apraxia, Cogan type', 1),
(666, 'ORPHA:1126', 'Aprosencephaly cerebellar dysgenesis', 1),
(667, 'ORPHA:1129', 'Arachnodactyly-abnormal ossification-intellectual disability syndrome', 1),
(668, 'ORPHA:1129', 'Kosztolanyi syndrome', 1),
(669, 'ORPHA:113', 'BDCS', 1),
(670, 'ORPHA:113', 'Bazex-Dupré-Christol syndrome', 1),
(671, 'ORPHA:113', 'Follicular atrophoderma and basal cell carcinomas', 1),
(672, 'ORPHA:1130', 'Arachnodactyly-intellectual disability-dysmorphism syndrome', 1),
(673, 'ORPHA:1130', 'De Die-Smulders-Vles-Fryns syndrome', 1),
(674, 'ORPHA:1131', 'Mandibulofacial dysostosis, Toriello type', 1),
(675, 'ORPHA:1131', 'X-linked branchial arch syndrome', 1),
(676, 'ORPHA:1131', 'X-linked mandibulofacial dysostosis', 1),
(677, 'ORPHA:1131', 'X-linked mandibulofacial dysostosis with limb anomalies', 1),
(678, 'ORPHA:1132', 'Aortic arch defects', 3),
(679, 'ORPHA:1133', 'AREDYLD syndrome', 1),
(680, 'ORPHA:1133', 'Acrorenal defect-ectodermal dysplasia-diabetes syndrome', 1),
(681, 'ORPHA:1134', 'Isolated arrhinia', 1),
(682, 'ORPHA:1134', 'Isolated nose agenesis', 1),
(683, 'ORPHA:1135', 'Arrhinia-choanal atresia-microphthalmia syndrome', 1),
(684, 'ORPHA:1136', 'Arnold-Chiari malformation type 2', 1),
(685, 'ORPHA:1136', 'Arnold-Chiari malformation type II', 1),
(686, 'ORPHA:1136', 'Chiari malformation type 2', 1),
(687, 'ORPHA:1136', 'Chiari malformation type II', 1),
(688, 'ORPHA:1138', 'Abnormal origin of the pulmonary artery', 3),
(689, 'ORPHA:114', 'Auriculoosteodysplasia', 1),
(690, 'ORPHA:1143', 'Neurogenic arthrogryposis multiplex congenita', 1),
(691, 'ORPHA:1144', 'Arthrogryposis-like hand anomaly-sensorineural deafness syndrome', 1),
(692, 'ORPHA:1144', 'Arthrogryposis-like hand anomaly-sensorineural hearing loss syndrome', 1),
(693, 'ORPHA:1144', 'Distal arthrogryposis type 6', 1),
(694, 'ORPHA:1145', 'Infantile-onset X-linked spinal muscular atrophy', 1),
(695, 'ORPHA:1145', 'SMAX2', 1),
(696, 'ORPHA:1145', 'Spinal muscular atrophy with arthrogryposis', 1),
(697, 'ORPHA:1145', 'X-linked distal arthrogryposis multiplex congenita', 1),
(698, 'ORPHA:1145', 'X-linked spinal muscular atrophy type 2', 1),
(699, 'ORPHA:1146', 'DA1', 1),
(700, 'ORPHA:1146', 'Digitotalar dysmorphism', 1),
(701, 'ORPHA:1146', 'Distal arthrogryposis type 1', 1),
(702, 'ORPHA:1147', 'Distal arthrogryposis type 2B', 1),
(703, 'ORPHA:1147', 'Freeman-Sheldon syndrome variant', 1),
(704, 'ORPHA:1147', 'Sheldon-Hall syndrome', 1),
(705, 'ORPHA:1149', 'Arthrogryposis-like syndrome', 1),
(706, 'ORPHA:1149', 'Kuskokwim disease', 1),
(707, 'ORPHA:1149', 'Kuskokwim syndrome', 1),
(708, 'ORPHA:115', 'Beals syndrome', 1),
(709, 'ORPHA:115', 'Beals-Hecht syndrome', 1),
(710, 'ORPHA:115', 'CCA syndrome', 1),
(711, 'ORPHA:115', 'Congenital contractural arachnodactyly', 1),
(712, 'ORPHA:115', 'Distal arthrogryposis type 9', 1),
(713, 'ORPHA:1150', 'Arthrogryposis multiplex congenita-whistling face syndrome', 1),
(714, 'ORPHA:1150', 'Illum syndrome', 1),
(715, 'ORPHA:1154', 'Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome', 1),
(716, 'ORPHA:1154', 'Distal arthrogryposis type 5', 1),
(717, 'ORPHA:1154', 'Distal arthrogryposis type IIB', 1),
(718, 'ORPHA:1154', 'Distal arthrogryposis with ophthalmoplegia', 1),
(719, 'ORPHA:1154', 'Oculomelic amyoplasia', 1),
(720, 'ORPHA:1159', 'Progressive pseudorheumatoid arthropathy of childhood', 1),
(721, 'ORPHA:1159', 'Spondyloepiphyseal dysplasia tarda-progressive arthropathy syndrome', 1),
(722, 'ORPHA:116', 'BWS', 1),
(723, 'ORPHA:116', 'Beckwith-Wiedemann syndrome', 1),
(724, 'ORPHA:116', 'Exomphalos-macroglossia-gigantism syndrome', 1),
(725, 'ORPHA:116', 'Wiedemann-Beckwith syndrome', 1),
(726, 'ORPHA:1160', 'Chylous ascites', 1),
(727, 'ORPHA:1163', 'Aspergillosis', 1),
(728, 'ORPHA:1164', 'ABPA', 1),
(729, 'ORPHA:1164', 'Allergic aspergillosis', 1),
(730, 'ORPHA:1164', 'Allergic bronchopulmonary aspergillosis', 1),
(731, 'ORPHA:1164', 'Hinson-Pepys disease', 1),
(732, 'ORPHA:1166', 'Congenital unilateral hypoplasia of depressor anguli oris', 1),
(733, 'ORPHA:1166', 'Isolated asymmetric crying facies', 1),
(734, 'ORPHA:1168', 'AOA1', 1),
(735, 'ORPHA:1168', 'Ataxia-oculomotor apraxia type 1', 1),
(736, 'ORPHA:117', 'Behçet disease', 1),
(737, 'ORPHA:1170', 'Autosomal recessive cerebelloparenchymal disorder type 3', 1),
(738, 'ORPHA:1170', 'Autosomal recessive spinocerebellar ataxia type 2', 1),
(739, 'ORPHA:1170', 'SCAR2', 1),
(740, 'ORPHA:1171', 'CAPOS syndrome', 1),
(741, 'ORPHA:1171', 'Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural deafness syndrome', 1),
(742, 'ORPHA:1171', 'Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome', 1),
(743, 'ORPHA:1172', 'ARCA', 3),
(744, 'ORPHA:1172', 'Autosomal recessive cerebellar ataxia', 3),
(745, 'ORPHA:1173', 'Cerebellar ataxia-hypogonadism syndrome', 1),
(746, 'ORPHA:1173', 'Gordon-Holmes syndrome', 1),
(747, 'ORPHA:1173', 'Luteinizing hormone-releasing hormone deficiency with ataxia', 1),
(748, 'ORPHA:1174', 'Cerebellar ataxia-ectodermal dysplasia syndrome', 1),
(749, 'ORPHA:1175', 'X-linked progressive cerebellar ataxia', 1),
(750, 'ORPHA:117569', 'Rare intestinal disease', 3),
(751, 'ORPHA:117573', 'Syndromic anorectal malformation', 3),
(752, 'ORPHA:1177', 'EOCA', 1),
(753, 'ORPHA:1177', 'EOCARR', 1),
(754, 'ORPHA:1177', 'Early-onset cerebellar ataxia with retained tendon reflexes', 1),
(755, 'ORPHA:1177', 'Harding ataxia', 1),
(756, 'ORPHA:1178', 'Ataxia-tapetoretinal degeneration syndrome', 1),
(757, 'ORPHA:1179', 'Benign paroxysmal tonic upgaze of childhood with ataxia', 1),
(758, 'ORPHA:1179', 'Ouvrier-Billson syndrome', 1),
(759, 'ORPHA:118', 'Beta-mannosidase deficiency', 1),
(760, 'ORPHA:118', 'Beta-mannosidosis', 1),
(761, 'ORPHA:1180', 'Ataxia-hypogonadism-choroidal dystrophy syndrome', 1),
(762, 'ORPHA:1180', 'Boucher-Neuhäuser syndrome', 1),
(763, 'ORPHA:1182', 'Autosomal dominant spastic ataxia type 7', 1),
(764, 'ORPHA:1182', 'SPAX7', 1),
(765, 'ORPHA:1182', 'Spastic ataxia with congenital miosis', 1),
(766, 'ORPHA:1183', 'Ataxo-opso-myoclonus syndrome', 1),
(767, 'ORPHA:1183', 'Dancing eye syndrome', 1),
(768, 'ORPHA:1183', 'Dancing eye-dancing feet syndrome', 1),
(769, 'ORPHA:1183', 'Kinsbourne syndrome', 1),
(770, 'ORPHA:1183', 'OMA syndrome', 1),
(771, 'ORPHA:1183', 'OMS', 1),
(772, 'ORPHA:1183', 'Opsoclonus-myoclonus syndrome', 1),
(773, 'ORPHA:1183', 'Opsoclonus-myoclonus-ataxia syndrome', 1),
(774, 'ORPHA:1183', 'POMA syndrome', 1),
(775, 'ORPHA:1183', 'Paraneoplastic opsoclonus-myoclonus', 1),
(776, 'ORPHA:1183', 'Paraneoplastic opsoclonus-myoclonus-ataxia syndrome', 1),
(777, 'ORPHA:1184', 'Ataxia-photosensitivity-short stature syndrome', 1),
(778, 'ORPHA:1184', 'Fenton-Wilkinson-Toselano syndrome', 1),
(779, 'ORPHA:1185', 'Spinocerebellar ataxia-dysmorphism syndrome', 1),
(780, 'ORPHA:1186', 'IOSCA', 1),
(781, 'ORPHA:1186', 'Infantile-onset spinocerebellar ataxia', 1),
(782, 'ORPHA:1186', 'Ohaha syndrome', 1),
(783, 'ORPHA:1186', 'Ophthalmoplegia-hypotonia-ataxia-hypoacusis-athetosis syndrome', 1),
(784, 'ORPHA:1187', 'Arts syndrome', 1),
(785, 'ORPHA:1187', 'Lethal ataxia with deafness and optic atrophy', 1),
(786, 'ORPHA:1187', 'Lethal ataxia with hearing loss and optic atrophy', 1),
(787, 'ORPHA:1188', 'Ataxia-deafness-intellectual disability syndrome', 1),
(788, 'ORPHA:1188', 'Ataxia-hearing loss-intellectual disability syndrome', 1),
(789, 'ORPHA:1188', 'Reardon-Baraitser syndrome', 1),
(790, 'ORPHA:119', 'Autosomal recessive limb-girdle muscular dystrophy type 2E', 1),
(791, 'ORPHA:119', 'Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4', 1),
(792, 'ORPHA:119', 'Beta-sarcoglycan-related LGMD R4', 1),
(793, 'ORPHA:119', 'Beta-sarcoglycanopathy', 1),
(794, 'ORPHA:119', 'LGMD due to beta-sarcoglycan deficiency', 1),
(795, 'ORPHA:119', 'LGMD type 2E', 1),
(796, 'ORPHA:119', 'LGMD2E', 1),
(797, 'ORPHA:119', 'Limb-girdle muscular dystrophy due to beta-sarcoglycan deficiency', 1),
(798, 'ORPHA:119', 'Limb-girdle muscular dystrophy type 2E', 1),
(799, 'ORPHA:1190', 'AO1', 1),
(800, 'ORPHA:1190', 'AOI', 1),
(801, 'ORPHA:1190', 'Atelosteogenesis type 1', 1),
(802, 'ORPHA:1190', 'Atelosteogenesis type I', 1),
(803, 'ORPHA:1190', 'Giant cell chondrodysplasia', 1),
(804, 'ORPHA:1190', 'Spondylo-humero-femoral dysplasia', 1),
(805, 'ORPHA:1192', 'Atherosclerosis-deafness-diabetes-epilepsy-nephropathy syndrome', 1),
(806, 'ORPHA:1192', 'Atherosclerosis-hearing loss-diabetes-epilepsy-nephropathy syndrome', 1),
(807, 'ORPHA:1192', 'Feigenbaum-Bergeron-Richardson syndrome', 1),
(808, 'ORPHA:1193', 'Atkin-Flaitz syndrome', 1),
(809, 'ORPHA:1193', 'X-linked intellectual disability, Atkin type', 1),
(810, 'ORPHA:1194', 'Mitochondrial encephalo-cardio-myopathy due to F1Fo ATPase deficiency', 1),
(811, 'ORPHA:1194', 'Mitochondrial encephalo-cardio-myopathy due to isolated ATP synthase deficiency', 1),
(812, 'ORPHA:1194', 'Mitochondrial encephalo-cardio-myopathy due to isolated mitochondrial respiratory chain complex V deficiency', 1),
(813, 'ORPHA:1194', 'TMEM70-related mitochondrial encephalo-cardio-myopathy', 1),
(814, 'ORPHA:1195', 'Congenital atransferrinemia', 1),
(815, 'ORPHA:1195', 'Congenital hypotransferrinemia', 1),
(816, 'ORPHA:1198', 'Colonic atresia', 1),
(817, 'ORPHA:1199', 'Esophageal atresia', 1),
(818, 'ORPHA:1200', 'Burn-McKeown syndrome', 1),
(819, 'ORPHA:1200', 'Choanal atresia-hearing loss-cardiac defects-craniofacial dysmorphism syndrome', 1),
(820, 'ORPHA:1201', 'Apple peel syndrome', 1),
(821, 'ORPHA:1201', 'Atresia of small intestine', 1),
(822, 'ORPHA:1201', 'Intestinal atresia type IIIb', 1),
(823, 'ORPHA:1201', 'Jejunal atresia', 1),
(824, 'ORPHA:1201', 'Jejunoileal atresia', 1),
(825, 'ORPHA:1201', 'Small intestinal atresia', 1),
(826, 'ORPHA:1202', 'Larynx atresia', 1),
(827, 'ORPHA:1203', 'Duodenal atresia', 1),
(828, 'ORPHA:1205', 'Mitral atresia', 1),
(829, 'ORPHA:1207', 'Pulmonary atresia with ventricular septal defect', 1),
(830, 'ORPHA:1208', 'Pulmonary atresia-intact ventricular septum syndrome', 1),
(831, 'ORPHA:1209', 'Tricuspid atresia', 1),
(832, 'ORPHA:1214', 'Hemifacial atrophy', 1),
(833, 'ORPHA:1214', 'PHA', 1),
(834, 'ORPHA:1214', 'Parry-Romberg syndrome', 1),
(835, 'ORPHA:1214', 'Progressive facial hemiatrophy', 1),
(836, 'ORPHA:1214', 'Progressive hemifacial atrophy', 1),
(837, 'ORPHA:1214', 'Romberg syndrome', 1),
(838, 'ORPHA:1215', 'Autosomal dominant optic atrophy plus syndrome', 1),
(839, 'ORPHA:1215', 'DOA+', 1),
(840, 'ORPHA:1215', 'Optic atrophy-deafness-polyneuropathy-myopathy syndrome', 1),
(841, 'ORPHA:1215', 'Optic atrophy-hearing loss-polyneuropathy-myopathy syndrome', 1),
(842, 'ORPHA:1216', 'Autosomal dominant benign distal spinal muscular atrophy', 1),
(843, 'ORPHA:1216', 'Autosomal dominant congenital benign spinal muscular atrophy', 1),
(844, 'ORPHA:1216', 'Congenital benign spinal muscular atrophy with contractures', 1),
(845, 'ORPHA:1216', 'Congenital nonprogressive spinal muscular atrophy', 1),
(846, 'ORPHA:1217', 'Hamano-Tsukamoto syndrome', 1),
(847, 'ORPHA:1217', 'Spinal atrophy-ophthalmoplegia-pyramidal syndrome', 1),
(848, 'ORPHA:122', 'Birt-Hogg-Dubé syndrome', 1),
(849, 'ORPHA:122', 'Fibrofolliculomas with trichodiscomas and acrochordons', 1),
(850, 'ORPHA:1221', 'Cheilitis glandularis', 1),
(851, 'ORPHA:1223', 'Balantidiasis', 1),
(852, 'ORPHA:1223', 'Balantidiosis', 1),
(853, 'ORPHA:1223', 'Ciliary dysentery', 1),
(854, 'ORPHA:1225', 'Baller-Gerold syndrome', 1),
(855, 'ORPHA:1226', 'Athyroidal hypothyroidism-spiky hair-cleft palate syndrome', 1),
(856, 'ORPHA:1226', 'Bamforth syndrome', 1),
(857, 'ORPHA:1226', 'Bamforth-Lazarus syndrome', 1),
(858, 'ORPHA:1226', 'Hypothyroidism-cleft palate syndrome', 1),
(859, 'ORPHA:1227', 'Ataxia-diabetes-goiter-gonadal insufficiency syndrome', 1),
(860, 'ORPHA:1227', 'Bangstad syndrome', 1),
(861, 'ORPHA:1228', 'Banki syndrome', 1),
(862, 'ORPHA:1229', 'BLC-PMG', 1),
(863, 'ORPHA:1229', 'Baraitser-Brett-Piesowicz syndrome', 1),
(864, 'ORPHA:1229', 'Baraitser-Reardon syndrome', 1),
(865, 'ORPHA:1229', 'Bilateral band-like calcification with polymicrogyria', 1),
(866, 'ORPHA:1229', 'Congenital intrauterine infection-like syndrome', 1),
(867, 'ORPHA:1229', 'Microcephaly-intracranial calcification-intellectual disability syndrome', 1),
(868, 'ORPHA:1229', 'Pseudo-TORCH syndrome', 1),
(869, 'ORPHA:123', 'Björnstad syndrome', 1),
(870, 'ORPHA:123', 'Deafness-pili torti-hypogonadism syndrome', 1),
(871, 'ORPHA:123', 'Hearing loss-pili torti-hypogonadism syndrome', 1),
(872, 'ORPHA:1231', 'Barber-Say syndrome', 1),
(873, 'ORPHA:1231', 'Hypertrichosis-atrophic skin-ectropion-macrostomia syndrome', 1),
(874, 'ORPHA:1234', 'Autosomal recessive popliteal pterygium syndrome', 1),
(875, 'ORPHA:1234', 'Bartsocas-Papas syndrome', 1),
(876, 'ORPHA:1234', 'Lethal popliteal pterygium syndrome', 1),
(877, 'ORPHA:1236', 'Severe microbrachycephaly-intellectual disability-athetoid cerebral palsy syndrome', 1),
(878, 'ORPHA:1237', 'Beemer-Ertbruggen syndrome', 1),
(879, 'ORPHA:1237', 'Lethal hydrocephalus-cardiac malformation-dense bones syndrome', 1),
(880, 'ORPHA:124', 'Aase syndrome', 1),
(881, 'ORPHA:124', 'Aase-Smith II syndrome', 1),
(882, 'ORPHA:124', 'Blackfan-Diamond anemia', 1),
(883, 'ORPHA:124', 'Congenital PRCA', 1),
(884, 'ORPHA:124', 'Congenital hypoplastic anemia, Blackfan-Diamond type', 1),
(885, 'ORPHA:124', 'Congenital pure red cell aplasia', 1),
(886, 'ORPHA:124', 'Diamond-Blackfan anemia', 1),
(887, 'ORPHA:1240', 'Bellini syndrome', 1),
(888, 'ORPHA:1240', 'Intellectual disability-short stature-wedge-shaped epiphyses of knees syndrome', 1),
(889, 'ORPHA:1240', 'Metaphyseal acroscyphodysplasia', 1),
(890, 'ORPHA:1241', 'Bencze syndrome', 1),
(891, 'ORPHA:1241', 'Hemifacial hyperplasia-strabismus syndrome', 1),
(892, 'ORPHA:1243', 'BMD', 1),
(893, 'ORPHA:1243', 'BVMD', 1),
(894, 'ORPHA:1243', 'Best disease', 1),
(895, 'ORPHA:1243', 'Best macular dystrophy', 1),
(896, 'ORPHA:1243', 'Best vitelliform macular dystrophy', 1),
(897, 'ORPHA:1243', 'Early-onset vitelliform macular dystrophy', 1),
(898, 'ORPHA:1243', 'Juvenile-onset vitelliform macular dystrophy', 1),
(899, 'ORPHA:1243', 'Polymorphic vitelline macular degeneration', 1),
(900, 'ORPHA:1243', 'Vitelliform macular dystrophy type 2', 1),
(901, 'ORPHA:1246', 'Biemond syndrome', 1),
(902, 'ORPHA:1246', 'Brachydactyly-nystagmus-cerebellar ataxia syndrome', 1),
(903, 'ORPHA:1247', 'Bilharziasis', 1),
(904, 'ORPHA:1247', 'Schistosomiasis', 1),
(905, 'ORPHA:1248', 'Binder syndrome', 1),
(906, 'ORPHA:1248', 'Maxillonasal dysostosis', 1),
(907, 'ORPHA:1248', 'Maxillonasal dysplasia', 1),
(908, 'ORPHA:125', 'BSyn', 1),
(909, 'ORPHA:125', 'Bloom syndrome', 1),
(910, 'ORPHA:1252', 'Blepharonasofacial malformation syndrome', 1),
(911, 'ORPHA:1252', 'Pashayan syndrome', 1),
(912, 'ORPHA:1252', 'Pashayan-Pruzansky syndrome', 1),
(913, 'ORPHA:1253', 'Ascher syndrome', 1),
(914, 'ORPHA:1253', 'Blepharochalasis-double lip syndrome', 1),
(915, 'ORPHA:1259', 'Blepharoptosis-myopia-ectopia lentis syndrome', 1),
(916, 'ORPHA:126', 'BPES', 1),
(917, 'ORPHA:126', 'Blepharophimosis-ptosis-epicanthus inversus syndrome', 1),
(918, 'ORPHA:1261', 'Bonnemann-Meinecke-Reich syndrome', 1),
(919, 'ORPHA:1261', 'Encephalopathy-intracerebral calcification-retinal degeneration syndrome', 1),
(920, 'ORPHA:1262', 'Böök syndrome', 1),
(921, 'ORPHA:1263', 'Boomerang dysplasia', 1),
(922, 'ORPHA:1264', 'Bork syndrome', 1),
(923, 'ORPHA:1264', 'Tricho-retino-dento-digital syndrome', 1),
(924, 'ORPHA:1264', 'Uncombable hair-retinal pigmentary dystrophy-dental anomalies-brachydactyly syndrome', 1),
(925, 'ORPHA:1267', 'Botulism', 1),
(926, 'ORPHA:127', 'BFLS', 1),
(927, 'ORPHA:127', 'Borjeson-Forssman-Lehmann syndrome', 1),
(928, 'ORPHA:127', 'Intellectual disability-epilepsy-endocrine disorders syndrome', 1),
(929, 'ORPHA:1270', 'Bowen syndrome, Hutterite type', 1),
(930, 'ORPHA:1270', 'Bowen-Conradi syndrome', 1),
(931, 'ORPHA:1272', 'Aymé-Gripp syndrome', 1),
(932, 'ORPHA:1272', 'Brachycephaly-deafness-cataract-intellectual disability syndrome', 1),
(933, 'ORPHA:1272', 'Brachycephaly-hearing loss-cataract-intellectual disability syndrome', 1),
(934, 'ORPHA:1272', 'Fine-Lubinsky syndrome', 1),
(935, 'ORPHA:1275', 'Brachydactyly-elbow wrist dysplasia syndrome', 1),
(936, 'ORPHA:1275', 'Brachydactyly-joint dysplasia syndrome', 1),
(937, 'ORPHA:1275', 'Liebenberg syndrome', 1),
(938, 'ORPHA:1276', 'Bilginturan brachydactyly', 1),
(939, 'ORPHA:1276', 'Bilginturan syndrome', 1),
(940, 'ORPHA:1276', 'Brachydactyly type E, with short stature and hypertension', 1),
(941, 'ORPHA:1276', 'Brachydactyly-arterial hypertension syndrome', 1),
(942, 'ORPHA:1277', 'Brachydactyly-mesomelia-intellectual disability-heart defects syndrome', 1),
(943, 'ORPHA:1277', 'Stratton-Garcia-Young syndrome', 1),
(944, 'ORPHA:1278', 'Brachydactyly-preaxial hallux varus syndrome', 1),
(945, 'ORPHA:128', 'Bothriocephalosis', 1),
(946, 'ORPHA:128', 'Diphyllobothriasis', 1),
(947, 'ORPHA:129', 'Pseudopelade of Brocq', 1),
(948, 'ORPHA:1292', 'BOD syndrome', 1),
(949, 'ORPHA:1292', 'Brachymorphism-onychodysplasia-dysphalangism syndrome', 1),
(950, 'ORPHA:1292', 'Senior syndrome', 1),
(951, 'ORPHA:1293', 'Brachyolmia', 3),
(952, 'ORPHA:1295', 'Brachytelephalangy-dysmorphism-Kallmann syndrome', 1),
(953, 'ORPHA:1296', 'Branchial dysplasia-intellectual disability-inguinal hernia syndrome', 1),
(954, 'ORPHA:1296', 'Lambert syndrome', 1),
(955, 'ORPHA:1297', 'BOFS', 1),
(956, 'ORPHA:1297', 'Branchio-oculo-facial syndrome', 1),
(957, 'ORPHA:1299', 'BSG syndrome', 1),
(958, 'ORPHA:1299', 'Branchioskeletogenital syndrome', 1),
(959, 'ORPHA:1299', 'Elsahy-Waters syndrome', 1),
(960, 'ORPHA:13', '6-pyruvoyl-tetrahydropterin synthase deficiency', 2),
(961, 'ORPHA:13', 'Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency', 2),
(962, 'ORPHA:130', 'Brugada syndrome', 1),
(963, 'ORPHA:130', 'Idiopathic ventricular fibrillation, Brugada type', 1),
(964, 'ORPHA:1300', 'Autosomal dominant popliteal pterygium syndrome', 1),
(965, 'ORPHA:1300', 'Facio-genito-popliteal syndrome', 1),
(966, 'ORPHA:1300', 'Popliteal web syndrome', 1),
(967, 'ORPHA:1302', 'BOOP', 1),
(968, 'ORPHA:1302', 'Bronchiolitis obliterans organizing pneumonia', 1),
(969, 'ORPHA:1302', 'COP', 1),
(970, 'ORPHA:1302', 'Cryptogenic organizing pneumonia', 1),
(971, 'ORPHA:1303', 'Bronchiolitis obliterans with obstructive pulmonary disease', 1),
(972, 'ORPHA:1303', 'Constrictive bronchiolitis', 1),
(973, 'ORPHA:1303', 'Obliterative bronchiolitis', 1),
(974, 'ORPHA:1304', 'Brucellosis', 1),
(975, 'ORPHA:1305', 'Brunner-Winter syndrome', 1),
(976, 'ORPHA:1305', 'Digital anomalies with short palpebral fissures and atresia of esophagus or duodenum', 1),
(977, 'ORPHA:1305', 'FGLDS', 1),
(978, 'ORPHA:1305', 'FS', 1),
(979, 'ORPHA:1305', 'Feingold syndrome', 1),
(980, 'ORPHA:1305', 'MMT', 1),
(981, 'ORPHA:1305', 'MODED syndrome', 1),
(982, 'ORPHA:1305', 'Microcephaly-digital anomalies-normal intelligence syndrome', 1),
(983, 'ORPHA:1305', 'Microcephaly-intellectual disability-tracheoesophageal fistula syndrome', 1),
(984, 'ORPHA:1305', 'Microcephaly-oculo-digito-esophageal-duodenal syndrome syndrome', 1),
(985, 'ORPHA:1305', 'ODED syndrome', 1),
(986, 'ORPHA:1305', 'Oculo-digito-esophageal-duodenal syndrome', 1),
(987, 'ORPHA:1306', 'Buschke-Ollendorff syndrome', 1),
(988, 'ORPHA:1306', 'Disseminated dermatofibrosis with osteopoikilosis', 1),
(989, 'ORPHA:1307', '10q24 microduplication syndrome', 1),
(990, 'ORPHA:1307', 'Buttiens-Fryns syndrome', 1),
(991, 'ORPHA:1307', 'Distal limb deficiencies-micrognathia syndrome', 1),
(992, 'ORPHA:1308', 'C syndrome', 1),
(993, 'ORPHA:1308', 'OTCS', 1),
(994, 'ORPHA:1308', 'Opitz C trigonocephaly', 1),
(995, 'ORPHA:1308', 'Opitz trigonocephaly C syndrome', 1),
(996, 'ORPHA:1308', 'Opitz trigonocephaly syndrome', 1),
(997, 'ORPHA:1308', 'Trigonocephaly C syndrome', 1),
(998, 'ORPHA:1309', 'Cacchi-Ricci disease', 1),
(999, 'ORPHA:1309', 'MSK', 1),
(1000, 'ORPHA:1309', 'Medullary sponge kidney', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(1001, 'ORPHA:1309', 'Precalicial canalicular ectasia', 1),
(1002, 'ORPHA:131', 'Budd-Chiari syndrome', 1),
(1003, 'ORPHA:1310', 'Caffey disease', 1),
(1004, 'ORPHA:1310', 'Infantile cortical hyperostosis', 1),
(1005, 'ORPHA:1313', 'Infantile choroidocerebral calcification syndrome', 1),
(1006, 'ORPHA:1314', 'Bilateral symmetrical thalamic gliosis', 1),
(1007, 'ORPHA:1314', 'Symmetrical thalamic calcifications', 1),
(1008, 'ORPHA:1318', 'Campomelia, Cumming type', 1),
(1009, 'ORPHA:1319', 'Camptobrachydactyly', 1),
(1010, 'ORPHA:132', 'Butyrylcholinesterase deficiency', 1),
(1011, 'ORPHA:132', 'Pseudocholinesterase deficiency', 1),
(1012, 'ORPHA:1320', 'Idiopathic camptocormia', 1),
(1013, 'ORPHA:1320', 'Idiopathic camptocormism', 1),
(1014, 'ORPHA:1320', 'Idiopathic progressive lumbar kyphosis', 1),
(1015, 'ORPHA:1321', 'Camptodactyly-fibrous tissue hyperplasia-skeletal dysplasia syndrome', 1),
(1016, 'ORPHA:1321', 'Goodman camptodactyly', 1),
(1017, 'ORPHA:1323', 'Camptodactyly-joint contractures-facial skeletal defects syndrome', 1),
(1018, 'ORPHA:1323', 'Rozin-Hertz-Goodman syndrome', 1),
(1019, 'ORPHA:1323', 'Rozin-camptodactyly syndrome', 1),
(1020, 'ORPHA:1325', 'Camptodactyly-taurinuria syndrome', 1),
(1021, 'ORPHA:1325', 'Familial streblodactyly with amino-aciduria', 1),
(1022, 'ORPHA:1326', 'Camptodactyly syndrome, Guadalajara type 2', 1),
(1023, 'ORPHA:1327', 'Camptodactyly syndrome, Guadalajara type 1', 1),
(1024, 'ORPHA:1328', 'Camurati-Engelmann disease', 1),
(1025, 'ORPHA:1328', 'Progressive diaphyseal dysplasia', 1),
(1026, 'ORPHA:1329', 'CAVC', 1),
(1027, 'ORPHA:1329', 'Complete AVSD', 1),
(1028, 'ORPHA:1329', 'Complete atrioventricular canal', 1),
(1029, 'ORPHA:1329', 'Complete atrioventricular canal defect', 1),
(1030, 'ORPHA:1329', 'Complete atrioventricular septal defect', 1),
(1031, 'ORPHA:1329', 'Complete atrioventricular septal defect with atrial and ventricular components', 1),
(1032, 'ORPHA:133', 'Berylliosis', 1),
(1033, 'ORPHA:133', 'Chronic berylliosis', 1),
(1034, 'ORPHA:133', 'Chronic beryllium disease', 1),
(1035, 'ORPHA:133', 'Chronic beryllium lung disease', 1),
(1036, 'ORPHA:1330', 'PAVC', 1),
(1037, 'ORPHA:1330', 'Partial AVSD', 1),
(1038, 'ORPHA:1330', 'Partial atrioventricular canal defect', 1),
(1039, 'ORPHA:1330', 'Partial atrioventricular septal defect', 1),
(1040, 'ORPHA:1331', 'Familial prostate cancer', 1),
(1041, 'ORPHA:1332', 'MTC', 1),
(1042, 'ORPHA:1332', 'Medullary thyroid carcinoma', 1),
(1043, 'ORPHA:1333', 'Familial pancreatic cancer', 1),
(1044, 'ORPHA:1333', 'Familial pancreatic carcinoma', 1),
(1045, 'ORPHA:1334', 'CMC', 1),
(1046, 'ORPHA:1334', 'Chronic mucocutaneous candidiasis', 1),
(1047, 'ORPHA:1335', 'Cantrell deformity', 1),
(1048, 'ORPHA:1335', 'Cantrell syndrome', 1),
(1049, 'ORPHA:1335', 'Pentalogy of Cantrell', 1),
(1050, 'ORPHA:1335', 'Thoraco-abdominal syndrome', 1),
(1051, 'ORPHA:1336', 'Hyperkeratosis-hyperpigmentation syndrome', 1),
(1052, 'ORPHA:1338', 'Heart defect-tongue hamartoma-polysyndactyly syndrome', 1),
(1053, 'ORPHA:1338', 'Ostravik-Lindemann-Solberg syndrome', 1),
(1054, 'ORPHA:134', '3-ketothiolase deficiency', 1),
(1055, 'ORPHA:134', '3-oxothiolase deficiency', 1),
(1056, 'ORPHA:134', 'Alpha methylacetoacetic aciduria', 1),
(1057, 'ORPHA:134', 'Alpha-methyl-acetoacetyl-CoA thiolase deficiency', 1),
(1058, 'ORPHA:134', 'Beta-ketothiolase deficiency', 1),
(1059, 'ORPHA:134', 'Mitochondrial acetoacetyl-coenzyme A thiolase deficiency', 1),
(1060, 'ORPHA:134', 'T2 deficiency', 1),
(1061, 'ORPHA:1340', 'CFC syndrome', 1),
(1062, 'ORPHA:1340', 'Cardiofaciocutaneous syndrome', 1),
(1063, 'ORPHA:1342', 'Atriodigital dysplasia type 3', 1),
(1064, 'ORPHA:1342', 'Cardiomelic syndrome type 3', 1),
(1065, 'ORPHA:1342', 'Heart-hand syndrome type 3', 1),
(1066, 'ORPHA:1342', 'Heart-hand syndrome, Spanish type', 1),
(1067, 'ORPHA:1342', 'Heart-limb syndrome type 3', 1),
(1068, 'ORPHA:1344', 'Atrial cardiomyopathy with heart block', 1),
(1069, 'ORPHA:1344', 'Atrial standstill', 1),
(1070, 'ORPHA:1345', 'Cardiomyopathy-cataract-hip spine disease syndrome', 1),
(1071, 'ORPHA:1345', 'Krasnow-Qazi syndrome', 1),
(1072, 'ORPHA:1349', 'Maternally-inherited cardiomyopathy and deafness', 1),
(1073, 'ORPHA:1349', 'Mitochondrial DNA-related cardiomyopathy and hearing loss', 1),
(1074, 'ORPHA:1349', 'mtDNA-related cardiomyopathy and deafness', 1),
(1075, 'ORPHA:1349', 'mtDNA-related cardiomyopathy and hearing loss', 1),
(1076, 'ORPHA:1349', 'tRNA-LYS-related cardiomyopathy-hearing loss syndrome', 1),
(1077, 'ORPHA:135', 'CACH syndrome', 1),
(1078, 'ORPHA:135', 'Childhood ataxia with diffuse central nervous system hypomyelination', 1),
(1079, 'ORPHA:135', 'Leukoencephalopathy with vanishing white matter', 1),
(1080, 'ORPHA:135', 'Myelinosis centralis diffusa', 1),
(1081, 'ORPHA:1350', 'Atriodigital dysplasia type 2', 1),
(1082, 'ORPHA:1350', 'Heart-hand syndrome type 2', 1),
(1083, 'ORPHA:1350', 'Tabatznik syndrome', 1),
(1084, 'ORPHA:1352', 'Atrioventricular defect-blepharophimosis-radial and anal defect syndrome', 1),
(1085, 'ORPHA:1352', 'Houlston-Ironton-Temple syndrome', 1),
(1086, 'ORPHA:1354', 'Heart defects-limb shortening syndrome', 1),
(1087, 'ORPHA:1355', 'Congenital heart defect-round face-developmental delay syndrome', 1),
(1088, 'ORPHA:1355', 'Sonoda syndrome', 1),
(1089, 'ORPHA:1358', 'Carey-Fineman-Ziter syndrome', 1),
(1090, 'ORPHA:1358', 'Myopathy-Moebius-Robin syndrome', 1),
(1091, 'ORPHA:1359', 'Carney complex', 1),
(1092, 'ORPHA:1359', 'Carney syndrome', 1),
(1093, 'ORPHA:1359', 'Myxoma-spotty pigmentation-endocrine overactivity syndrome', 1),
(1094, 'ORPHA:136', 'CADASIL', 1),
(1095, 'ORPHA:136', 'Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy', 1),
(1096, 'ORPHA:136', 'Hereditary multi-infarct dementia', 1),
(1097, 'ORPHA:1361', 'Carnosinase deficiency', 1),
(1098, 'ORPHA:1366', 'Autosomal recessive palmoplantar hyperkeratosis and congenital alopecia', 1),
(1099, 'ORPHA:1366', 'Autosomal recessive palmoplantar keratoderma and congenital alopecia', 1),
(1100, 'ORPHA:1366', 'Cataract-alopecia-sclerodactyly syndrome', 1),
(1101, 'ORPHA:1366', 'PPK-CA, Wallis type', 1),
(1102, 'ORPHA:1366', 'Palmoplantar keratoderma and congenital alopecia, Wallis type', 1),
(1103, 'ORPHA:1368', 'Cataract-ataxia-deafness syndrome', 1),
(1104, 'ORPHA:1368', 'Cataract-ataxia-hearing loss syndrome', 1),
(1105, 'ORPHA:1369', 'Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome', 1),
(1106, 'ORPHA:1369', 'Sengers syndrome', 1),
(1107, 'ORPHA:137', 'CDG', 3),
(1108, 'ORPHA:137', 'Carbohydrate deficient glycoprotein syndrome', 3),
(1109, 'ORPHA:137', 'Congenital disorder of glycosylation', 3),
(1110, 'ORPHA:1373', 'Cataract-aberrant oral frenula-growth delay syndrome', 1),
(1111, 'ORPHA:1373', 'Wellesley-Carman-French syndrome', 1),
(1112, 'ORPHA:1375', 'CAHMR syndrome', 1),
(1113, 'ORPHA:1375', 'Cataract-hypertrichosis-intellectual disability syndrome', 1),
(1114, 'ORPHA:137577', 'HIE', 1),
(1115, 'ORPHA:137577', 'Hypoxic and ischemic brain injury in the newborn', 1),
(1116, 'ORPHA:137577', 'Hypoxic-ischemic encephalopathy', 1),
(1117, 'ORPHA:137577', 'Neonatal hypoxic and ischemic brain injury', 1),
(1118, 'ORPHA:137577', 'Perinatal asphyxia', 1),
(1119, 'ORPHA:137577', 'Perinatal hypoxia', 1),
(1120, 'ORPHA:137583', 'VIN', 1),
(1121, 'ORPHA:137583', 'Vulvar intraepithelial neoplasia', 1),
(1122, 'ORPHA:137583', 'Vulvar intraepithelial tumor', 1),
(1123, 'ORPHA:137593', 'Infectious epithelial keratitis', 1),
(1124, 'ORPHA:137596', 'Neurotrophic keratitis', 1),
(1125, 'ORPHA:137596', 'Neurotrophic keratopathy', 1),
(1126, 'ORPHA:137599', 'Herpes simplex virus stromal keratitis', 1),
(1127, 'ORPHA:137602', 'Endotheliitis', 1),
(1128, 'ORPHA:137605', 'Legius syndrome', 1),
(1129, 'ORPHA:137605', 'NF1-like syndrome', 1),
(1130, 'ORPHA:137605', 'Neurofibromatosis 1-like syndrome', 1),
(1131, 'ORPHA:137608', 'SOLAMEN syndrome', 1),
(1132, 'ORPHA:137608', 'Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome', 1),
(1133, 'ORPHA:137617', 'Nephrogenic fibrosing dermopathy', 1),
(1134, 'ORPHA:137617', 'Nephrogenic systemic fibrosis', 1),
(1135, 'ORPHA:137622', 'Intractable diarrhea-choanal atresia-eye anomalies syndrome', 1),
(1136, 'ORPHA:137625', 'GSD due to muscle and heart glycogen synthase deficiency', 1),
(1137, 'ORPHA:137625', 'GSD type 0b', 1),
(1138, 'ORPHA:137625', 'Glycogen storage disease due to muscle and heart glycogen synthase deficiency', 1),
(1139, 'ORPHA:137625', 'Glycogen storage disease type 0b', 1),
(1140, 'ORPHA:137625', 'Glycogenosis due to muscle and heart glycogen synthase deficiency', 1),
(1141, 'ORPHA:137625', 'Glycogenosis type 0b', 1),
(1142, 'ORPHA:137628', 'Cardiac anomalies-heterotaxy syndrome', 1),
(1143, 'ORPHA:137631', 'Lung fibrosis-immunodeficiency-46,XX gonadal dysgenesis syndrome', 1),
(1144, 'ORPHA:137634', 'Overgrowth-macrocephaly-facial dysmorphism syndrome', 1),
(1145, 'ORPHA:137639', 'Ataxia-delayed dentition-hypomyelination syndrome', 2),
(1146, 'ORPHA:137639', 'Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome', 2),
(1147, 'ORPHA:137667', 'CM-AVM', 1),
(1148, 'ORPHA:137667', 'Capillary malformation-arteriovenous malformation', 1),
(1149, 'ORPHA:137672', 'Pellucid marginal degeneration', 1),
(1150, 'ORPHA:137675', 'Foamy myocardial transformation of infancy', 1),
(1151, 'ORPHA:137675', 'Histiocytoid cardiomyopathy', 1),
(1152, 'ORPHA:137675', 'Infantile cardiomyopathy with histiocytoid change', 1),
(1153, 'ORPHA:137675', 'Infantile xanthomatous cardiomyopathy', 1),
(1154, 'ORPHA:137675', 'Oncocytic cardiomyopathy', 1),
(1155, 'ORPHA:137678', 'Czech dysplasia, metatarsal type', 1),
(1156, 'ORPHA:137678', 'SED with metatarsal shortening', 1),
(1157, 'ORPHA:137678', 'Spondyloepiphyseal dysplasia with metatarsal shortening', 1),
(1158, 'ORPHA:137681', 'Hepatoencephalopathy due to COXPD1', 1),
(1159, 'ORPHA:137681', 'Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1', 1),
(1160, 'ORPHA:137686', 'Asherman syndrome', 1),
(1161, 'ORPHA:137698', 'CMV disease in patients with impaired cell mediated immunity deemed at risk', 1),
(1162, 'ORPHA:137698', 'Cytomegalovirus disease in patients with impaired cell mediated immunity deemed at risk', 1),
(1163, 'ORPHA:1377', 'Cataract-microcornea syndrome', 1),
(1164, 'ORPHA:137754', 'ACY1D', 1),
(1165, 'ORPHA:137754', 'N-acyl-L-amino acid amidohydrolase deficiency', 1),
(1166, 'ORPHA:137754', 'Neurological conditions associated with aminoacylase 1 deficiency', 1),
(1167, 'ORPHA:137776', 'LCCS2', 1),
(1168, 'ORPHA:137776', 'Lethal congenital contracture syndrome type 2', 1),
(1169, 'ORPHA:137776', 'Multiple contracture syndrome, Israeli-Bedouin type', 1),
(1170, 'ORPHA:137783', 'LCCS3', 1),
(1171, 'ORPHA:137783', 'Lethal congenital contracture syndrome type 3', 1),
(1172, 'ORPHA:137807', 'PLCA', 3),
(1173, 'ORPHA:137807', 'Primary cutaneous amyloidosis', 3),
(1174, 'ORPHA:137807', 'Primary localized cutaneous amyloidosis', 3),
(1175, 'ORPHA:137810', 'Nodular cutaneous amyloidosis', 1),
(1176, 'ORPHA:137810', 'PLCNA', 1),
(1177, 'ORPHA:137810', 'Primary localized cutaneous nodular amyloidosis', 1),
(1178, 'ORPHA:137814', 'Macular amyloidosis', 1),
(1179, 'ORPHA:137817', 'Adhesive arachnoiditis', 1),
(1180, 'ORPHA:137817', 'Arachnoiditis', 1),
(1181, 'ORPHA:137817', 'Chronic arachnoiditis', 1),
(1182, 'ORPHA:137820', 'Endometriosis outside pelvis', 1),
(1183, 'ORPHA:137820', 'Extrapelvic endometriosis', 1),
(1184, 'ORPHA:137831', 'OPHN1 syndrome', 1),
(1185, 'ORPHA:137831', 'Oligophrenin-1 syndrome', 1),
(1186, 'ORPHA:137831', 'X-linked intellectual disability-cerebellar hypoplasia syndrome', 1),
(1187, 'ORPHA:137834', 'Frank-Ter Haar syndrome', 1),
(1188, 'ORPHA:137834', 'Ter Haar syndrome', 1),
(1189, 'ORPHA:137839', 'Lemierre postanginal sepsis', 1),
(1190, 'ORPHA:137839', 'Lemierre syndrome', 1),
(1191, 'ORPHA:137839', 'Postanginal sepsis secondary to orophyngeal infection', 1),
(1192, 'ORPHA:137839', 'Septic phlebitis of the internal jugular vein', 1),
(1193, 'ORPHA:137867', 'MMND', 1),
(1194, 'ORPHA:137867', 'Madras motor neuron disease', 1),
(1195, 'ORPHA:137888', 'Auriculocondylar syndrome', 1),
(1196, 'ORPHA:137888', 'Question mark ear syndrome', 1),
(1197, 'ORPHA:137893', 'Macrocephalic sperm head syndrome', 2),
(1198, 'ORPHA:137893', 'Male infertility due to large-headed multiflagellar polyploid spermatozoa', 2),
(1199, 'ORPHA:137893', 'Male infertility due to macrozoospermia', 2),
(1200, 'ORPHA:137898', 'LBSL', 1),
(1201, 'ORPHA:137898', 'Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome', 1),
(1202, 'ORPHA:137898', 'Leukoencephalopathy with brain stem and spinal cord involvement-lactate elevation syndrome', 1),
(1203, 'ORPHA:137902', 'Isolated optic nerve hypoplasia/aplasia', 1),
(1204, 'ORPHA:137905', 'Syndromic optic nerve hypoplasia', 3),
(1205, 'ORPHA:137908', 'COXPD5', 1),
(1206, 'ORPHA:137908', 'Combined oxidative phosphorylation defect type 5', 1),
(1207, 'ORPHA:137908', 'Hypotonia with lactic acidemia and hyperammonemia', 1),
(1208, 'ORPHA:137911', 'Autism-facial port-wine stain syndrome', 1),
(1209, 'ORPHA:137914', 'Choanal atresia', 1),
(1210, 'ORPHA:137917', 'Choanal atresia, unilateral', 2),
(1211, 'ORPHA:137920', 'Choanal atresia, bilateral', 2),
(1212, 'ORPHA:137926', 'Primary laryngeal lymphangioma', 1),
(1213, 'ORPHA:137929', 'Neonatal brainstem dysfunction', 1),
(1214, 'ORPHA:137932', 'Congenital laryngeal palsy', 1),
(1215, 'ORPHA:137932', 'Congenital vocal cord paralysis', 1),
(1216, 'ORPHA:137935', 'Laryngotracheal angioma', 1),
(1217, 'ORPHA:138', 'CHARGE association', 1),
(1218, 'ORPHA:138', 'CHARGE syndrome', 1),
(1219, 'ORPHA:138', 'Coloboma-heart defects-atresia choanae-retardation of growth and development-genitourinary problems-ear abnormalities syndrome', 1),
(1220, 'ORPHA:138', 'Hall-Hittner syndrome', 1),
(1221, 'ORPHA:1380', 'Cataract-nephropathy-encephalopathy syndrome', 1),
(1222, 'ORPHA:1380', 'Crome syndrome', 1),
(1223, 'ORPHA:138041', 'Pierre Robin sequence associated with collagen disease', 3),
(1224, 'ORPHA:138041', 'Pierre Robin syndrome associated with collagen disease', 3),
(1225, 'ORPHA:138044', 'Rare disease with Pierre Robin syndrome', 3),
(1226, 'ORPHA:138047', 'Pierre Robin sequence associated with a chromosomal anomaly', 3),
(1227, 'ORPHA:138047', 'Pierre Robin syndrome associated with a chromosomal anomaly', 3),
(1228, 'ORPHA:138050', 'Pierre Robin sequence associated with branchial archs anomalies', 3),
(1229, 'ORPHA:138050', 'Pierre Robin syndrome associated with branchial archs anomalies', 3),
(1230, 'ORPHA:138055', 'Pierre Robin sequence associated with bone disease', 3),
(1231, 'ORPHA:138055', 'Pierre Robin syndrome associated with bone disease', 3),
(1232, 'ORPHA:138059', 'Teratogenic Pierre Robin sequence', 3),
(1233, 'ORPHA:138059', 'Teratogenic Pierre Robin syndrome', 3),
(1234, 'ORPHA:138069', 'Sucking/swallowing disorder not related with Pierre Robin sequence', 3),
(1235, 'ORPHA:138069', 'Sucking/swallowing disorder not related with Pierre Robin syndrome', 3),
(1236, 'ORPHA:138072', 'Sucking/swallowing disorder associated with an identified syndrome', 3),
(1237, 'ORPHA:138076', 'Sucking/swallowing disorder associated to a chromosomal anomaly', 3),
(1238, 'ORPHA:138080', 'Syndromic sucking/swallowing disorder with unidentifyed syndrome', 3),
(1239, 'ORPHA:138084', 'Sucking/swallowing disorder associated to cervicofacial or esophageal malformation', 3),
(1240, 'ORPHA:138095', 'Sucking/swallowing disorder associated with neurologic anomalies', 3),
(1241, 'ORPHA:1381', 'Cataract-intellectual disability-anal atresia-urinary defects syndrome', 1),
(1242, 'ORPHA:1381', 'Karandikar-Maria-Kamble syndrome', 1),
(1243, 'ORPHA:138101', 'Sucking/swallowing disorder associated with suprabulbar anomalies', 3),
(1244, 'ORPHA:138104', 'Sucking/swallowing disorder associated with basal ganglia anomalies', 3),
(1245, 'ORPHA:138109', 'Sucking/swallowing disorder associated with posterior fossa anomalies', 3),
(1246, 'ORPHA:138112', 'Sucking/swallowing disorder associated with cerebellar anomalies', 3),
(1247, 'ORPHA:138115', 'Sucking/swallowing disorder associated with a neuromuscular disease', 3),
(1248, 'ORPHA:138221', 'Rare sucking/swallowing disorder', 3),
(1249, 'ORPHA:1383', 'Cataract-deafness-hypogonadism syndrome', 1),
(1250, 'ORPHA:1383', 'Cataract-hearing loss-hypogonadism syndrome', 1),
(1251, 'ORPHA:1383', 'Schaap-Taylor-Baraitser syndrome', 1),
(1252, 'ORPHA:1387', 'Cataract-intellectual disability-hypogonadism syndrome', 1),
(1253, 'ORPHA:1387', 'Martsolf syndrome', 1),
(1254, 'ORPHA:1388', 'Catel-Manzke syndrome', 1),
(1255, 'ORPHA:1388', 'Hyperphalangy-clinodactyly of index finger with Pierre Robin syndrome', 1),
(1256, 'ORPHA:1388', 'Index finger anomaly-Pierre Robin syndrome', 1),
(1257, 'ORPHA:1388', 'Micrognathia digital syndrome', 1),
(1258, 'ORPHA:1388', 'Palatodigital syndrome, Catel-Manzke type', 1),
(1259, 'ORPHA:1388', 'Pierre Robin sequence-hyperphalangy-clinodactyly syndrome', 1),
(1260, 'ORPHA:1388', 'Pierre Robin syndrome-hyperphalangy-clinodactyly syndrome', 1),
(1261, 'ORPHA:1389', 'Cortical blindness-intellectual disability-polydactyly syndrome', 1),
(1262, 'ORPHA:139', 'CHILD nevus', 1),
(1263, 'ORPHA:139', 'CHILD syndrome', 1),
(1264, 'ORPHA:139', 'Congenital hemidysplasia with ichthyosiform nevus and limbs defects', 1),
(1265, 'ORPHA:1390', 'Hunter-Thompson-Reed syndrome', 1),
(1266, 'ORPHA:1390', 'Night blindness-skeletal anomalies-dysmorphism syndrome', 1),
(1267, 'ORPHA:139009', 'Developmental anomaly of metabolic origin', 3),
(1268, 'ORPHA:139012', 'Rare bone development disorder', 3),
(1269, 'ORPHA:139012', 'Rare skeletal development disorder', 3),
(1270, 'ORPHA:139021', 'Malformation syndrome with short stature', 3),
(1271, 'ORPHA:139024', 'Overgrowth/obesity syndrome', 3),
(1272, 'ORPHA:139027', 'Rare developmental defect with skin/mucosae involvement', 3),
(1273, 'ORPHA:139030', 'Rare developmental defect with connective tissue involvement', 3),
(1274, 'ORPHA:139033', 'Progeroid syndrome', 3),
(1275, 'ORPHA:139036', 'Branchial arch or oral-acral syndrome', 3),
(1276, 'ORPHA:139039', 'Orofacial clefting syndrome', 3),
(1277, 'ORPHA:139042', 'Malformation syndrome with odontal and/or periodontal component', 3),
(1278, 'ORPHA:1393', 'Cerebrocostomandibular syndrome', 1),
(1279, 'ORPHA:139390', 'Isolated craniosynostosis', 3),
(1280, 'ORPHA:139393', 'Syndromic craniosynostosis', 3),
(1281, 'ORPHA:139396', 'X-CALD', 2),
(1282, 'ORPHA:139396', 'X-linked cerebral adrenoleukodystrophy', 2),
(1283, 'ORPHA:139399', 'Adrenomyeloneuropathy', 2),
(1284, 'ORPHA:1394', 'Cerebrofaciothoracic dysplasia', 1),
(1285, 'ORPHA:1394', 'Pascual-Castroviejo syndrome type 1', 1),
(1286, 'ORPHA:139402', 'DRESS syndrome', 1),
(1287, 'ORPHA:139402', 'Drug rash with eosinophilia and systemic symptoms', 1),
(1288, 'ORPHA:139402', 'Drug reaction eosinophilic systemic syndrome', 1),
(1289, 'ORPHA:139406', 'Combined prosaposin deficiency', 1),
(1290, 'ORPHA:139406', 'Encephalopathy due to prosaposin deficiency', 1),
(1291, 'ORPHA:139411', 'Carney triad', 1),
(1292, 'ORPHA:139414', 'Congenital panfollicular nevus', 1),
(1293, 'ORPHA:139417', 'Acute transverse myelitis', 1),
(1294, 'ORPHA:139420', 'Disease-associated transverse myelitis', 2),
(1295, 'ORPHA:139420', 'Secondary acute transverse myelitis', 2),
(1296, 'ORPHA:139423', 'ATM/TM', 2),
(1297, 'ORPHA:139423', 'Idiopathic acute transverse myelitis', 2),
(1298, 'ORPHA:139426', 'POMA', 1),
(1299, 'ORPHA:139426', 'Perioral myoclonia with absences', 1),
(1300, 'ORPHA:139431', 'EMEA', 1),
(1301, 'ORPHA:139431', 'Eyelid myoclonia with and without absences', 1),
(1302, 'ORPHA:139431', 'Jeavons syndrome', 1),
(1303, 'ORPHA:139436', 'Giant cell histiocytomatosis', 1),
(1304, 'ORPHA:139436', 'Lipoid dermatoarthritis', 1),
(1305, 'ORPHA:139436', 'Multicentric reticulohistiocytosis', 1),
(1306, 'ORPHA:139441', 'H-ABC', 1),
(1307, 'ORPHA:139441', 'Hypomyelination with atrophy of basal ganglia and cerebellum', 1),
(1308, 'ORPHA:139444', 'Leukoencephalopathy with bilateral anterior temporal lobe cysts', 1),
(1309, 'ORPHA:139447', 'Progressive cavitating leukoencephalopathy', 1),
(1310, 'ORPHA:139450', 'Balikova-Vermeesch syndrome', 1),
(1311, 'ORPHA:139450', 'Microtia-eye coloboma-imperforation of the nasolacrimal duct syndrome', 1),
(1312, 'ORPHA:139455', 'Autosomal recessive bestrophinopathy', 1),
(1313, 'ORPHA:139455', 'Retinopathy, Burgess-Black type', 1),
(1314, 'ORPHA:139466', 'SERKAL syndrome', 1),
(1315, 'ORPHA:139466', 'Sex reversion-kidneys, adrenal and lung dysgenesis syndrome', 1),
(1316, 'ORPHA:139471', 'Bakrania-Ragge syndrome', 1),
(1317, 'ORPHA:139471', 'MCOPS6', 1),
(1318, 'ORPHA:139471', 'Microphthalmia with brain and digit anomalies', 1),
(1319, 'ORPHA:139471', 'Syndromic microphthalmia type 6', 1),
(1320, 'ORPHA:139474', '17q11.2 microduplication syndrome', 1),
(1321, 'ORPHA:139474', 'Dup(17)(q11.2)', 1),
(1322, 'ORPHA:139474', 'Grisart-Destrée syndrome', 1),
(1323, 'ORPHA:139474', 'Trisomy 17q11.2', 1),
(1324, 'ORPHA:139480', 'Autosomal recessive spastic paraplegia type 39', 1),
(1325, 'ORPHA:139480', 'SPG39', 1),
(1326, 'ORPHA:139480', 'Spastic paraplegia due to NTE mutation', 1),
(1327, 'ORPHA:139480', 'Spastic paraplegia due to neuropathy target esterase mutation', 1),
(1328, 'ORPHA:139485', 'ARCA2', 1),
(1329, 'ORPHA:139485', 'Autosomal recessive ataxia due to coenzyme Q10 deficiency', 1),
(1330, 'ORPHA:139485', 'Autosomal recessive ataxia due to ubiquinone deficiency', 1),
(1331, 'ORPHA:139485', 'Autosomal recessive cerebellar ataxia type 2', 1),
(1332, 'ORPHA:139485', 'Autosomal recessive spinocerebellar ataxia type 9', 1),
(1333, 'ORPHA:139485', 'SCAR9', 1),
(1334, 'ORPHA:139491', 'Autosomal dominant hereditary hemochromatosis', 1),
(1335, 'ORPHA:139491', 'Ferroportin disease', 1),
(1336, 'ORPHA:139491', 'Hemochromatosis due to defect in ferroportin', 1),
(1337, 'ORPHA:139491', 'Hemochromatosis type 4', 1),
(1338, 'ORPHA:139507', 'African iron overload', 1),
(1339, 'ORPHA:139507', 'Bantu siderosis', 1),
(1340, 'ORPHA:139512', 'Neuropathy with hearing impairment', 1),
(1341, 'ORPHA:139515', 'CMT4J', 1),
(1342, 'ORPHA:139515', 'Charcot-Marie-Tooth disease type 4J', 1),
(1343, 'ORPHA:139518', 'Autosomal dominant distal juvenile spinal muscular atrophy type 1', 1),
(1344, 'ORPHA:139518', 'Distal hereditary motor neuropathy type 1', 1),
(1345, 'ORPHA:139518', 'dHMN1', 1),
(1346, 'ORPHA:139525', 'Distal hereditary motor neuropathy type 2', 1),
(1347, 'ORPHA:139525', 'Distal spinal muscular atrophy type 2', 1),
(1348, 'ORPHA:139525', 'dHMN2', 1),
(1349, 'ORPHA:139525', 'dSMA2', 1),
(1350, 'ORPHA:139536', 'Distal HMN V', 1),
(1351, 'ORPHA:139536', 'Distal hereditary motor neuropathy type 5', 1),
(1352, 'ORPHA:139536', 'Distal hereditary motor neuropathy type V', 1),
(1353, 'ORPHA:139536', 'Distal spinal muscular atrophy type 5', 1),
(1354, 'ORPHA:139536', 'dHMN5', 1),
(1355, 'ORPHA:139547', 'Autosomal recessive distal spinal muscular atrophy type 3', 1),
(1356, 'ORPHA:139547', 'Distal hereditary motor neuropathy type 3 and type 4', 1),
(1357, 'ORPHA:139547', 'Distal spinal muscular atrophy type 3', 1),
(1358, 'ORPHA:139547', 'dHMN3 and dHMN4', 1),
(1359, 'ORPHA:139547', 'dSMA3', 1),
(1360, 'ORPHA:139552', 'Autosomal recessive distal spinal muscular atrophy type 2', 1),
(1361, 'ORPHA:139552', 'Distal hereditary motor neuropathy, Jerash type', 1),
(1362, 'ORPHA:139552', 'dHMNJ', 1),
(1363, 'ORPHA:139557', 'ATP7A-related distal motor neuropathy', 1),
(1364, 'ORPHA:139557', 'DSMAX', 1),
(1365, 'ORPHA:139557', 'SMAX3', 1),
(1366, 'ORPHA:139557', 'X-linked dHMN3', 1),
(1367, 'ORPHA:139557', 'X-linked dSMA3', 1),
(1368, 'ORPHA:139557', 'X-linked distal hereditary motor neuropathy type 3', 1),
(1369, 'ORPHA:139557', 'X-linked distal spinal muscular atrophy type 3', 1),
(1370, 'ORPHA:139564', 'HSAN with cough and gastroesophageal reflux', 1),
(1371, 'ORPHA:139564', 'HSAN1B', 1),
(1372, 'ORPHA:139564', 'Hereditary sensory and autonomic neuropathy type 1 with cough and gastroesophageal reflux', 1),
(1373, 'ORPHA:139564', 'Hereditary sensory and autonomic neuropathy type 1B', 1),
(1374, 'ORPHA:139564', 'Hereditary sensory and autonomic neuropathy type IB', 1),
(1375, 'ORPHA:139573', 'HSAN with deafness and global delay', 1),
(1376, 'ORPHA:139573', 'HSAN with hearing loss and global delay', 1),
(1377, 'ORPHA:139573', 'Hereditary sensory and autonomic neuropathy with deafness and global delay', 1),
(1378, 'ORPHA:139573', 'Hereditary sensory and autonomic neuropathy with hearing loss and global delay', 1),
(1379, 'ORPHA:139578', 'Mutilating HSAN with spastic paraplegia', 1),
(1380, 'ORPHA:139578', 'Mutilating hereditary sensory neuropathy with spastic paraplegia', 1),
(1381, 'ORPHA:139583', 'X-linked HSAN with deafness', 1),
(1382, 'ORPHA:139583', 'X-linked HSAN with hearing loss', 1),
(1383, 'ORPHA:139583', 'X-linked auditory neuropathy with peripheral sensory neuropathy type 1', 1),
(1384, 'ORPHA:139583', 'X-linked hereditary sensory and autonomic neuropathy with deafness', 1),
(1385, 'ORPHA:139583', 'X-linked hereditary sensory and autonomic neuropathy with hearing loss', 1),
(1386, 'ORPHA:139589', 'Distal hereditary motor neuropathy type 7', 1),
(1387, 'ORPHA:139589', 'Distal spinal muscular atrophy with vocal cord paralysis', 1),
(1388, 'ORPHA:139589', 'dHMN7', 1),
(1389, 'ORPHA:1397', 'Hydrocephaly-cerebellar agenesis syndrome', 1),
(1390, 'ORPHA:1398', 'Isolated cerebellar agenesis', 1),
(1391, 'ORPHA:1398', 'Near total absence of cerebellum', 1),
(1392, 'ORPHA:1398', 'Subtotal absence of cerebellum', 1),
(1393, 'ORPHA:1399', 'Ketoaciduria-intellectual disability-ataxia-deafness syndrome', 1),
(1394, 'ORPHA:1399', 'Ketoaciduria-intellectual disability-ataxia-hearing loss syndrome', 1),
(1395, 'ORPHA:1399', 'Richards-Rundle syndrome', 1),
(1396, 'ORPHA:14', 'Abetalipoproteinemia', 1),
(1397, 'ORPHA:14', 'Bassen-Kornzweig disease', 1),
(1398, 'ORPHA:14', 'Homozygous familial hypobetalipoproteinemia', 1),
(1399, 'ORPHA:140', 'Campomelic dwarfism', 1),
(1400, 'ORPHA:140', 'Campomelic dysplasia', 1),
(1401, 'ORPHA:1401', 'Baughman syndrome', 1),
(1402, 'ORPHA:1401', 'CHAND syndrome', 1),
(1403, 'ORPHA:1401', 'CHANDS', 1),
(1404, 'ORPHA:1401', 'Curly hair-ankyloblepharon-nail dysplasia syndrome', 1),
(1405, 'ORPHA:140162', 'Inherited cancer-predisposing syndrome', 3),
(1406, 'ORPHA:140286', 'Secondary hypoparathyroidism due to impaired parathormon secretion', 1),
(1407, 'ORPHA:140436', 'Intraosseous hemangioma', 1),
(1408, 'ORPHA:140436', 'Osseous venous malformation', 1),
(1409, 'ORPHA:140436', 'Primary intraosseous venous malformation', 1),
(1410, 'ORPHA:140453', 'Autosomal dominant hereditary demyelinating motor and sensory neuropathy', 3),
(1411, 'ORPHA:140456', 'Autosomal dominant hereditary axonal motor and sensory neuropathy', 3),
(1412, 'ORPHA:140459', 'Autosomal recessive hereditary demyelinating motor and sensory neuropathy', 3),
(1413, 'ORPHA:140465', 'Autosomal dominant dHMN', 3),
(1414, 'ORPHA:140465', 'Autosomal dominant distal hereditary motor neuropathy', 3),
(1415, 'ORPHA:140465', 'Autosomal dominant distal spinal muscular atrophy', 3),
(1416, 'ORPHA:140468', 'Autosomal recessive dHMN', 3),
(1417, 'ORPHA:140468', 'Autosomal recessive dSMA', 3),
(1418, 'ORPHA:140468', 'Autosomal recessive distal hereditary motor neuropathy', 3),
(1419, 'ORPHA:140468', 'Autosomal recessive distal spinal muscular atrophy', 3),
(1420, 'ORPHA:140471', 'HSAN', 3),
(1421, 'ORPHA:140471', 'Hereditary sensory and autonomic neuropathy', 3),
(1422, 'ORPHA:140474', 'Autosomal dominant hereditary sensory and autonomic neuropathy', 3),
(1423, 'ORPHA:140477', 'Autosomal recessive hereditary sensory and autonomic neuropathy', 3),
(1424, 'ORPHA:140481', 'Autosomal dominant slowed nerve conduction velocity', 1),
(1425, 'ORPHA:1406', 'Charlie M syndrome', 1),
(1426, 'ORPHA:140653', 'Neuro-ophthalmological disease', 3),
(1427, 'ORPHA:140874', 'JSRD', 3),
(1428, 'ORPHA:140874', 'Joubert syndrome and related disorders', 3),
(1429, 'ORPHA:140896', 'SARS', 1),
(1430, 'ORPHA:140896', 'SARS-1', 1),
(1431, 'ORPHA:140896', 'Severe acute respiratory syndrome', 1),
(1432, 'ORPHA:140905', 'Hyperlipidemia due to HL deficiency', 1),
(1433, 'ORPHA:140905', 'Hyperlipidemia due to HTGL deficiency', 1),
(1434, 'ORPHA:140905', 'Hyperlipidemia due to hepatic lipase deficiency', 1),
(1435, 'ORPHA:140905', 'Hyperlipidemia due to hepatic triacylglycerol lipase deficiency', 1),
(1436, 'ORPHA:140905', 'Hyperlipidemia due to hepatic triglyceride lipase deficiency', 1),
(1437, 'ORPHA:140908', 'Brachydactyly type B2', 2),
(1438, 'ORPHA:140917', 'Stapes ankylosis with broad thumbs and toes', 1),
(1439, 'ORPHA:140917', 'Teunissen-Cremers syndrome', 1),
(1440, 'ORPHA:140922', 'Autosomal recessive limb-girdle muscular dystrophy type 2J', 1),
(1441, 'ORPHA:140922', 'LGMD type 2J', 1),
(1442, 'ORPHA:140922', 'LGMD2J', 1),
(1443, 'ORPHA:140922', 'Limb-girdle muscular dystrophy type 2J', 1),
(1444, 'ORPHA:140922', 'Titin-related  limb-girdle muscular dystrophy R10', 1),
(1445, 'ORPHA:140922', 'Titin-related LGMD R10', 1),
(1446, 'ORPHA:140927', 'BFNIS', 1),
(1447, 'ORPHA:140927', 'Benign familial neonatal-infantile seizures', 1),
(1448, 'ORPHA:140927', 'Benign neonatal-infantile epilepsy', 1),
(1449, 'ORPHA:140933', 'Linear atrophoderma of Moulin', 1),
(1450, 'ORPHA:140936', 'Ectodermal dysplasia-acanthosis nigricans syndrome', 1),
(1451, 'ORPHA:140936', 'Lelis syndrome', 1),
(1452, 'ORPHA:140941', 'Short stature due to primary acid-labile subunit deficiency', 1),
(1453, 'ORPHA:140944', 'CLOVES syndrome', 1),
(1454, 'ORPHA:140944', 'Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-skeletal anomaly syndrome', 1),
(1455, 'ORPHA:140944', 'Congenital lipomatous overgrowth-vascular malformation-epidermal nevi-spinal anomaly syndrome', 1),
(1456, 'ORPHA:140949', 'Low-flow priapism', 1),
(1457, 'ORPHA:140952', 'STAR syndrome', 1),
(1458, 'ORPHA:140952', 'Syndactyly-telecanthus-anogenital and renal malformations syndrome', 1),
(1459, 'ORPHA:140957', 'Autosomal dominant macrothrombocytopenia', 1),
(1460, 'ORPHA:140963', 'Bilateral microtia-deafness-cleft palate syndrome', 1),
(1461, 'ORPHA:140963', 'Bilateral microtia-hearing loss-cleft palate syndrome', 1),
(1462, 'ORPHA:140966', 'PPK, Nagashima type', 1),
(1463, 'ORPHA:140966', 'Palmoplantar hyperkeratosis, Nagashima type', 1),
(1464, 'ORPHA:140966', 'Palmoplantar keratoderma, Nagashima type', 1),
(1465, 'ORPHA:140969', 'Conorenal syndrome', 1),
(1466, 'ORPHA:140969', 'Renal dysplasia-retinal pigmentary dystrophy-cerebellar ataxia-skeletal dysplasia syndrome', 1),
(1467, 'ORPHA:140969', 'Saldino-Mainzer syndrome', 1),
(1468, 'ORPHA:140976', 'RHYNS syndrome', 1),
(1469, 'ORPHA:140976', 'Retinitis pigmentosa-hypopituitarism-nephronophthisis-skeletal dysplasia syndrome', 1),
(1470, 'ORPHA:140989', 'Isolated angiitis of the central nervous system', 1),
(1471, 'ORPHA:140989', 'PACNS', 1),
(1472, 'ORPHA:140989', 'PCNSV', 1),
(1473, 'ORPHA:140989', 'Primary angiitis of the central nervous system', 1),
(1474, 'ORPHA:140989', 'Primary central nervous system vasculitis', 1),
(1475, 'ORPHA:140989', 'Primary vasculitis of the central nervous system', 1),
(1476, 'ORPHA:140997', 'OFD', 3),
(1477, 'ORPHA:140997', 'Oral-facial-digital syndrome', 3),
(1478, 'ORPHA:140997', 'Orofaciodigital syndrome', 3),
(1479, 'ORPHA:141', 'ACY2 deficiency', 1),
(1480, 'ORPHA:141', 'Aminoacylase 2 deficiency', 1),
(1481, 'ORPHA:141', 'Aspartoacylase deficiency', 1),
(1482, 'ORPHA:141', 'Canavan disease', 1),
(1483, 'ORPHA:141', 'Spongy degeneration of the brain', 1),
(1484, 'ORPHA:1410', 'Pili trianguli et canaliculi', 1),
(1485, 'ORPHA:1410', 'Uncombable hair syndrome', 1),
(1486, 'ORPHA:141000', 'OFD11', 1),
(1487, 'ORPHA:141000', 'Oral-facial-digital syndrome type 11', 1),
(1488, 'ORPHA:141000', 'Oral-facial-digital syndrome, Gabrielli type', 1),
(1489, 'ORPHA:141000', 'Orofaciodigital syndrome type 11', 1),
(1490, 'ORPHA:141000', 'Orofaciodigital syndrome, Gabrielli type', 1),
(1491, 'ORPHA:141007', 'OFD9', 1),
(1492, 'ORPHA:141007', 'Oral-facial-digital syndrome type 9', 1),
(1493, 'ORPHA:141007', 'Oral-facial-digital syndrome with retinal abnormalities', 1),
(1494, 'ORPHA:141007', 'Orofaciodigital syndrome type 9', 1),
(1495, 'ORPHA:141007', 'Orofaciodigital syndrome with retinal abnormalities', 1),
(1496, 'ORPHA:141013', 'First branchial cleft anomaly', 1),
(1497, 'ORPHA:141013', 'First branchial cleft cyst', 1),
(1498, 'ORPHA:141013', 'First branchial cleft fistula', 1),
(1499, 'ORPHA:141022', 'Second branchial cleft anomaly', 1),
(1500, 'ORPHA:141022', 'Second branchial cleft cyst', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(1501, 'ORPHA:141022', 'Second branchial cleft fistula', 1),
(1502, 'ORPHA:141030', 'Third branchial cleft anomaly', 1),
(1503, 'ORPHA:141030', 'Third branchial cleft cyst', 1),
(1504, 'ORPHA:141030', 'Third branchial cleft fistula', 1),
(1505, 'ORPHA:141037', 'Fourth branchial cleft anomaly', 1),
(1506, 'ORPHA:141037', 'Fourth branchial cleft cyst', 1),
(1507, 'ORPHA:141037', 'Fourth branchial cleft fistula', 1),
(1508, 'ORPHA:141046', 'Cervical dermoid cyst', 1),
(1509, 'ORPHA:141046', 'Dermoid cyst of the neck', 1),
(1510, 'ORPHA:141051', 'Dermoid cyst of the face', 1),
(1511, 'ORPHA:141051', 'Facial dermoid cyst', 1),
(1512, 'ORPHA:141061', 'Commissural lip fistula', 1),
(1513, 'ORPHA:141064', 'Lower lip fistula', 1),
(1514, 'ORPHA:141067', 'Cervicofacial fibrochondroma', 1),
(1515, 'ORPHA:141071', 'Digestive duplication cyst of the tongue', 1),
(1516, 'ORPHA:141071', 'Enteric duplication cyst of the tongue', 1),
(1517, 'ORPHA:141071', 'Foregut duplication cyst of the tongue', 1),
(1518, 'ORPHA:141071', 'Gastric duplication cyst of the tongue', 1),
(1519, 'ORPHA:141074', 'External auditory canal aplasia/hypoplasia', 1),
(1520, 'ORPHA:141074', 'External auditory canal stenosis/atresia', 1),
(1521, 'ORPHA:141077', 'Epignathus', 2),
(1522, 'ORPHA:141077', 'Oropharyngeal teratoma', 2),
(1523, 'ORPHA:141083', 'Dacryocele', 1),
(1524, 'ORPHA:141083', 'Dacryocystocele', 1),
(1525, 'ORPHA:141083', 'Nasolacrimal duct cyst', 1),
(1526, 'ORPHA:141083', 'Nasolacrimal mucocele', 1),
(1527, 'ORPHA:141091', 'Double nose', 1),
(1528, 'ORPHA:141091', 'Polyrhinia', 1),
(1529, 'ORPHA:141091', 'Polyrrhinia', 1),
(1530, 'ORPHA:141096', 'Accessory nostril', 1),
(1531, 'ORPHA:141096', 'Supernumerary nostril', 1),
(1532, 'ORPHA:141099', 'Congenital tubular nose', 1),
(1533, 'ORPHA:141099', 'Proboscis lateralis', 1),
(1534, 'ORPHA:141103', 'Nasal dermoid cyst', 1),
(1535, 'ORPHA:141103', 'Nasal dermoid sinus cyst', 1),
(1536, 'ORPHA:141107', 'Nasopharyngeal teratoma', 2),
(1537, 'ORPHA:141107', 'Teratoma of the nasopharynx', 2),
(1538, 'ORPHA:141112', 'Nasal glial heterotopia', 1),
(1539, 'ORPHA:141112', 'Nasal glioma', 1),
(1540, 'ORPHA:141115', 'Nasal ganglioglioma', 2),
(1541, 'ORPHA:141118', 'Nasal encephalocele', 2),
(1542, 'ORPHA:141121', 'Congenital subglottic stenosis', 1),
(1543, 'ORPHA:141124', 'Congenital laryngeal cyst', 1),
(1544, 'ORPHA:141127', 'Congenital tracheal stenosis', 1),
(1545, 'ORPHA:141132', 'OAV spectrum', 1),
(1546, 'ORPHA:141132', 'Oculo-auriculo-vertebral spectrum', 1),
(1547, 'ORPHA:141132', 'Oculoauriculovertebral spectrum', 1),
(1548, 'ORPHA:141145', 'Hemifacial hyperplasia', 1),
(1549, 'ORPHA:141145', 'Hemifacial hypertrophy', 1),
(1550, 'ORPHA:141148', 'Hemifacial myohyperplasia', 1),
(1551, 'ORPHA:141152', 'Isolated congenital hypoglossia/aglossia', 1),
(1552, 'ORPHA:141163', 'Cosack syndrome', 1),
(1553, 'ORPHA:141163', 'Glossopalatine ankylosis', 1),
(1554, 'ORPHA:141168', 'Frontonasal arteriovenous malformation', 1),
(1555, 'ORPHA:141171', 'Arteriovenous malformation of maxilla', 1),
(1556, 'ORPHA:141171', 'Maxillary arteriovenous malformation', 1),
(1557, 'ORPHA:141174', 'Arteriovenous malformation of mandible', 1),
(1558, 'ORPHA:141174', 'Mandibular arteriovenous malformation', 1),
(1559, 'ORPHA:141179', 'NICH', 1),
(1560, 'ORPHA:141179', 'Non-involuting congenital hemangioma', 1),
(1561, 'ORPHA:141184', 'RICH', 1),
(1562, 'ORPHA:141184', 'Rapidly involuting congenital hemangioma', 1),
(1563, 'ORPHA:141189', 'CAMS', 3),
(1564, 'ORPHA:141189', 'Cerebrofacial arteriovenous metameric syndrome', 3),
(1565, 'ORPHA:141194', 'CAMS1', 1),
(1566, 'ORPHA:141194', 'Cerebrofacial arteriovenous metameric syndrome type 1', 1),
(1567, 'ORPHA:141199', 'CAMS3', 1),
(1568, 'ORPHA:141199', 'Cerebrofacial arteriovenous metameric syndrome type 3', 1),
(1569, 'ORPHA:1412', 'Tarsal-carpal coalition syndrome', 1),
(1570, 'ORPHA:141209', 'Diffuse lymphangioma', 1),
(1571, 'ORPHA:141209', 'Diffuse lymphangiomatosis', 1),
(1572, 'ORPHA:141209', 'Diffuse lymphatic malformation', 1),
(1573, 'ORPHA:141209', 'Disseminated lymphangioma', 1),
(1574, 'ORPHA:141209', 'Disseminated lymphangiomatosis', 1),
(1575, 'ORPHA:141209', 'Disseminated lymphatic malformation', 1),
(1576, 'ORPHA:141209', 'GLA', 1),
(1577, 'ORPHA:141209', 'Generalized lymphatic anomaly', 1),
(1578, 'ORPHA:141214', 'Isolated congenital maxillomandibular fusion', 1),
(1579, 'ORPHA:141214', 'Isolated congenital syngnathia', 1),
(1580, 'ORPHA:141219', 'Nasal dorsum fistula', 1),
(1581, 'ORPHA:141229', 'Craniofacial cleft', 3),
(1582, 'ORPHA:141229', 'Facial cleft', 3),
(1583, 'ORPHA:141234', 'Median facial cleft', 3),
(1584, 'ORPHA:141234', 'Midline facial cleft', 3),
(1585, 'ORPHA:141234', 'Tessier number 0-14 and 30 facial cleft', 3),
(1586, 'ORPHA:141239', 'Median cleft of the upper lip and maxilla', 1),
(1587, 'ORPHA:141242', 'Alar cleft', 1),
(1588, 'ORPHA:141242', 'Alar rim cleft', 1),
(1589, 'ORPHA:141242', 'Cleft nose', 1),
(1590, 'ORPHA:141242', 'Isolated cleft of the ala nasi', 1),
(1591, 'ORPHA:141242', 'Isolated coloboma of the nose', 1),
(1592, 'ORPHA:141242', 'Paramedian nasal cleft', 1),
(1593, 'ORPHA:141242', 'Tessier number 1 cleft', 1),
(1594, 'ORPHA:141253', 'Oblique facial cleft', 3),
(1595, 'ORPHA:141253', 'Orbitofacial cleft', 3),
(1596, 'ORPHA:141258', 'Tessier number 4 facial cleft', 1),
(1597, 'ORPHA:141261', 'Tessier number 5 facial cleft', 1),
(1598, 'ORPHA:141265', 'Tessier number 6 facial cleft', 1),
(1599, 'ORPHA:141269', 'Lateral facial cleft', 3),
(1600, 'ORPHA:141276', 'Commissural facial cleft', 1),
(1601, 'ORPHA:141276', 'Macrostomia', 1),
(1602, 'ORPHA:141276', 'Tessier number 7 facial cleft', 1),
(1603, 'ORPHA:141276', 'Transverse facial cleft', 1),
(1604, 'ORPHA:141288', 'Midline cervical cleft', 1),
(1605, 'ORPHA:141291', 'Cleft lip and alveolus', 1),
(1606, 'ORPHA:141327', 'Moran-Barroso syndrome', 1),
(1607, 'ORPHA:141327', 'OFD12', 1),
(1608, 'ORPHA:141327', 'Oral-facial-digital syndrome type 12', 1),
(1609, 'ORPHA:141327', 'Orofaciodigital syndrome type 12', 1),
(1610, 'ORPHA:141330', 'Degner syndrome', 1),
(1611, 'ORPHA:141330', 'OFD13', 1),
(1612, 'ORPHA:141330', 'Oral-facial-digital syndrome type 13', 1),
(1613, 'ORPHA:141330', 'Orofaciodigital syndrome type 13', 1),
(1614, 'ORPHA:141333', 'Biemond syndrome type 2', 1),
(1615, 'ORPHA:141333', 'Hypogonadism-short stature-coloboma-preaxial polydactyly syndrome', 1),
(1616, 'ORPHA:1414', 'Aagenaes syndrome', 1),
(1617, 'ORPHA:1414', 'Cholestasis-lymphedema syndrome', 1),
(1618, 'ORPHA:1415', 'Cholestasis-pigmentary retinopathy-cleft palate syndrome', 1),
(1619, 'ORPHA:1415', 'Hardikar syndrome', 1),
(1620, 'ORPHA:1416', 'Calcium pyrophosphate dihydrate crystal deposition disease', 1),
(1621, 'ORPHA:1416', 'Familial CC', 1),
(1622, 'ORPHA:1416', 'Familial CPPD', 1),
(1623, 'ORPHA:1416', 'Familial articular chondrocalcinosis', 1),
(1624, 'ORPHA:1416', 'Familial calcium pyrophosphate deposition', 1),
(1625, 'ORPHA:1416', 'Hereditary CC', 1),
(1626, 'ORPHA:1416', 'Hereditary articular chondrocalcinosis', 1),
(1627, 'ORPHA:1416', 'Hereditary calcium pyrophosphate deposition', 1),
(1628, 'ORPHA:142', 'Anaplastic thyroid carcinoma', 1),
(1629, 'ORPHA:1422', 'Chondrodysplasia-disorder of sex development syndrome', 1),
(1630, 'ORPHA:1422', 'Nivelon-Nivelon-Mabille syndrome', 1),
(1631, 'ORPHA:1423', 'Lethal recessive chondrodysplasia', 1),
(1632, 'ORPHA:1423', 'Maroteaux-Stanescu-Cousin syndrome', 1),
(1633, 'ORPHA:1425', 'DBQD', 1),
(1634, 'ORPHA:1425', 'Desbuquois dysplasia', 1),
(1635, 'ORPHA:1425', 'Desbuquois syndrome', 1),
(1636, 'ORPHA:1426', 'Greenberg dysplasia', 1),
(1637, 'ORPHA:1426', 'HEM dysplasia', 1),
(1638, 'ORPHA:1426', 'Hydrops-ectopic calcification-motheaten syndrome', 1),
(1639, 'ORPHA:1426', 'Skeletal dysplasia, Greenberg type', 1),
(1640, 'ORPHA:1427', 'OSMED', 1),
(1641, 'ORPHA:1427', 'Otospondylomegaepiphyseal dysplasia', 1),
(1642, 'ORPHA:1428', 'Familial chondromalacia patellae', 1),
(1643, 'ORPHA:1429', 'BHC', 1),
(1644, 'ORPHA:1429', 'Benign familial chorea', 1),
(1645, 'ORPHA:1429', 'Benign hereditary chorea', 1),
(1646, 'ORPHA:143', 'Parathyroid carcinoma', 1),
(1647, 'ORPHA:1431', 'Paroxysmal choreoathetosis', 3),
(1648, 'ORPHA:1431', 'Paroxysmal dyskinesia', 3),
(1649, 'ORPHA:1431', 'Paroxysmal dystonic choreoathetosis', 3),
(1650, 'ORPHA:1433', 'Choroidal atrophy-alopecia syndrome', 1),
(1651, 'ORPHA:1433', 'Moloney syndrome', 1),
(1652, 'ORPHA:1433', 'Regional choroidal atrophy and alopecia', 1),
(1653, 'ORPHA:1435', 'Ayazi syndrome', 1),
(1654, 'ORPHA:1435', 'Del(X)(q21)', 1),
(1655, 'ORPHA:1435', 'Monosomy Xq21', 1),
(1656, 'ORPHA:1435', 'Xq21 microdeletion syndrome', 1),
(1657, 'ORPHA:1436', 'Christian syndrome', 1),
(1658, 'ORPHA:1436', 'X-linked skeletal dysplasia-intellectual disability syndrome', 1),
(1659, 'ORPHA:1437', 'Ring 1', 1),
(1660, 'ORPHA:1437', 'Ring chromosome 1', 1),
(1661, 'ORPHA:1437', 'Ring chromosome 1 syndrome', 1),
(1662, 'ORPHA:1437', 'r(1) syndrome', 1),
(1663, 'ORPHA:1438', 'Ring 10', 1),
(1664, 'ORPHA:1438', 'Ring chromosome 10', 1),
(1665, 'ORPHA:1438', 'Ring chromosome 10 syndrome', 1),
(1666, 'ORPHA:1439', 'Ring 12', 1),
(1667, 'ORPHA:1439', 'Ring chromosome 12', 1),
(1668, 'ORPHA:1439', 'Ring chromosome 12 syndrome', 1),
(1669, 'ORPHA:144', 'Lynch syndrome', 1),
(1670, 'ORPHA:1440', 'Ring 14', 1),
(1671, 'ORPHA:1440', 'Ring chromosome 14', 1),
(1672, 'ORPHA:1440', 'Ring chromosome 14 syndrome', 1),
(1673, 'ORPHA:1441', 'Ring 17', 1),
(1674, 'ORPHA:1441', 'Ring chromosome 17', 1),
(1675, 'ORPHA:1441', 'Ring chromosome 17 syndrome', 1),
(1676, 'ORPHA:1442', 'Ring 18', 1),
(1677, 'ORPHA:1442', 'Ring chromosome 18', 1),
(1678, 'ORPHA:1442', 'Ring chromosome 18 syndrome', 1),
(1679, 'ORPHA:1443', 'Ring 19', 1),
(1680, 'ORPHA:1443', 'Ring chromosome 19', 1),
(1681, 'ORPHA:1443', 'Ring chromosome 19 syndrome', 1),
(1682, 'ORPHA:1444', 'Ring 20', 1),
(1683, 'ORPHA:1444', 'Ring chromosome 20', 1),
(1684, 'ORPHA:1444', 'Ring chromosome 20 syndrome', 1),
(1685, 'ORPHA:1445', 'Ring chromosome 21 syndrome', 1),
(1686, 'ORPHA:1446', 'Ring 22', 1),
(1687, 'ORPHA:1446', 'Ring chromosome 22', 1),
(1688, 'ORPHA:1446', 'Ring chromosome 22 syndrome', 1),
(1689, 'ORPHA:1446', 'r(22) syndrome', 1),
(1690, 'ORPHA:1447', 'Ring 4', 1),
(1691, 'ORPHA:1447', 'Ring chromosome 4', 1),
(1692, 'ORPHA:1447', 'Ring chromosome 4 syndrome', 1),
(1693, 'ORPHA:1447', 'Syndrome r(4)', 1),
(1694, 'ORPHA:1447', 'r(4) syndrome', 1),
(1695, 'ORPHA:1448', 'Ring 6', 1),
(1696, 'ORPHA:1448', 'Ring chromosome 6', 1),
(1697, 'ORPHA:1448', 'Ring chromosome 6 syndrome', 1),
(1698, 'ORPHA:1449', 'Ring 7', 1),
(1699, 'ORPHA:1449', 'Ring chromosome 7', 1),
(1700, 'ORPHA:1449', 'Ring chromosome 7 syndrome', 1),
(1701, 'ORPHA:145', 'Hereditary breast and ovarian cancer syndrome', 1),
(1702, 'ORPHA:1450', 'Ring 8', 1),
(1703, 'ORPHA:1450', 'Ring chromosome 8', 1),
(1704, 'ORPHA:1450', 'Ring chromosome 8 syndrome', 1),
(1705, 'ORPHA:1450', 'r(8) syndrome', 1),
(1706, 'ORPHA:1451', 'CINCA syndrome', 1),
(1707, 'ORPHA:1451', 'Chronic infantile neurological cutaneous and articular syndrome', 1),
(1708, 'ORPHA:1451', 'IOMID syndrome', 1),
(1709, 'ORPHA:1451', 'Infantile-onset multisystem inflammatory disease', 1),
(1710, 'ORPHA:1451', 'NOMID syndrome', 1),
(1711, 'ORPHA:1451', 'Neonatal-onset multisystem inflammatory disease', 1),
(1712, 'ORPHA:1451', 'Prieur-Griscelli syndrome', 1),
(1713, 'ORPHA:1452', 'Cleidocranial dysostosis', 1),
(1714, 'ORPHA:1452', 'Cleidocranial dysplasia', 1),
(1715, 'ORPHA:1453', 'Cleidorhizomelic syndrome', 1),
(1716, 'ORPHA:1453', 'Rhizomelic shortness with clavicular defect', 1),
(1717, 'ORPHA:1453', 'Wallis-Zieff-Goldblatt syndrome', 1),
(1718, 'ORPHA:1454', 'COACH syndrome', 1),
(1719, 'ORPHA:1454', 'Cerebellar vermis hypoplasia-oligophrenia-congenital ataxia-coloboma-hepatic fibrosis', 1),
(1720, 'ORPHA:1454', 'Gentile syndrome', 1),
(1721, 'ORPHA:1454', 'JS-H', 1),
(1722, 'ORPHA:1454', 'Joubert syndrome with congenital hepatic fibrosis', 1),
(1723, 'ORPHA:1454', 'Joubert syndrome with hepatic defect', 1),
(1724, 'ORPHA:1455', 'Autosomal dominant coarctation of aorta', 2),
(1725, 'ORPHA:1456', 'Atypical coarctation of aorta', 2),
(1726, 'ORPHA:1456', 'Coarctation of the abdominal aorta', 2),
(1727, 'ORPHA:1456', 'Mid-aortic dysplastic syndrome', 2),
(1728, 'ORPHA:1456', 'Mid-aortic syndrome', 2),
(1729, 'ORPHA:1456', 'Midaortic syndrome', 2),
(1730, 'ORPHA:1456', 'Middle aortic syndrome', 2),
(1731, 'ORPHA:1457', 'Aorta coarctation', 1),
(1732, 'ORPHA:1458', 'CODAS syndrome', 1),
(1733, 'ORPHA:1458', 'Cerebrooculodentoauriculoskeletal syndrome', 1),
(1734, 'ORPHA:1459', 'CEC', 1),
(1735, 'ORPHA:1459', 'Celiac disease-epilepsy-cerebral calcification syndrome', 1),
(1736, 'ORPHA:146', 'Differentiated thyroid carcinoma', 1),
(1737, 'ORPHA:146', 'Papillary or follicular thyroid carcinoma', 1),
(1738, 'ORPHA:146', 'Well-differentiated thyroid carcinoma', 1),
(1739, 'ORPHA:1460', 'Isolated CoQ-cytochrome C reductase deficiency', 1),
(1740, 'ORPHA:1460', 'Isolated coenzyme Q-cytochrome C reductase deficiency', 1),
(1741, 'ORPHA:1460', 'Isolated complex III deficiency', 1),
(1742, 'ORPHA:1460', 'Isolated mitochondrial respiratory chain complex III deficiency', 1),
(1743, 'ORPHA:1460', 'Isolated ubiquinone-cytochrome C reductase deficiency', 1),
(1744, 'ORPHA:1461', 'Criss-cross atrioventricular relationships', 1),
(1745, 'ORPHA:1461', 'Criss-cross heart', 1),
(1746, 'ORPHA:1461', 'Superoinferior ventricles', 1),
(1747, 'ORPHA:1461', 'Twisted atrioventricular connections', 1),
(1748, 'ORPHA:1463', 'Cor triatriatum', 3),
(1749, 'ORPHA:1463', 'Triatrial heart', 3),
(1750, 'ORPHA:1464', 'Double inlet left ventricle', 1),
(1751, 'ORPHA:1464', 'Univentricular heart', 1),
(1752, 'ORPHA:1465', 'CSS', 1),
(1753, 'ORPHA:1465', 'Coffin-Siris syndrome', 1),
(1754, 'ORPHA:1466', 'COFS syndrome', 2),
(1755, 'ORPHA:1466', 'Cerebrooculofacioskeletal syndrome', 2),
(1756, 'ORPHA:1466', 'Pena-Shokeir syndrome type 2', 2),
(1757, 'ORPHA:1467', 'Cogan syndrome', 1),
(1758, 'ORPHA:147', 'CPS1 deficiency', 1),
(1759, 'ORPHA:147', 'CPS1D', 1),
(1760, 'ORPHA:147', 'Carbamoyl-phosphate synthetase 1 deficiency', 1),
(1761, 'ORPHA:147', 'Carbamoyl-phosphate synthetase I deficiency', 1),
(1762, 'ORPHA:147', 'Carbamoyl-phosphate synthetase deficiency', 1),
(1763, 'ORPHA:1471', 'Coloboma of macula-brachydactyly type B syndrome', 1),
(1764, 'ORPHA:1471', 'Sorsby syndrome', 1),
(1765, 'ORPHA:1473', 'Uveal coloboma-cleft lip and palate-intellectual disability', 1),
(1766, 'ORPHA:1475', 'Coloboma of optic nerve with renal disease', 1),
(1767, 'ORPHA:1475', 'Papillo-renal syndrome', 1),
(1768, 'ORPHA:1475', 'Renal coloboma syndrome', 1),
(1769, 'ORPHA:1478', 'ASD', 1),
(1770, 'ORPHA:1478', 'Atrial septal defect', 1),
(1771, 'ORPHA:1478', 'Interatrial communication', 1),
(1772, 'ORPHA:1478', 'Interauricular communication', 1),
(1773, 'ORPHA:1479', 'Atrial septal defect-atrioventricular conduction defects syndrome', 1),
(1774, 'ORPHA:148', 'MCD', 3),
(1775, 'ORPHA:148', 'Multiple carboxylase deficiency', 3),
(1776, 'ORPHA:1482', 'Gonococcal conjunctivitis', 1),
(1777, 'ORPHA:1484', 'Contractures-ectodermal dysplasia-cleft lip/palate syndrome', 1),
(1778, 'ORPHA:1484', 'Ladda-Zonana-Ramer syndrome', 1),
(1779, 'ORPHA:1485', 'Arthrogryposis-hyperkeratosis syndrome, lethal form', 1),
(1780, 'ORPHA:1485', 'Johnston-Aarons-Schelley syndrome', 1),
(1781, 'ORPHA:1486', 'Herva disease', 1),
(1782, 'ORPHA:1486', 'LCCS1', 1),
(1783, 'ORPHA:1486', 'Lethal congenital contracture syndrome type 1', 1),
(1784, 'ORPHA:1486', 'Multiple contracture syndrome, Finnish type', 1),
(1785, 'ORPHA:1487', 'Anonychia-onychodystrophy with hypoplasia or absence of distal phalanges syndrome', 1),
(1786, 'ORPHA:1487', 'Cooks syndrome', 1),
(1787, 'ORPHA:1487', 'ODP', 1),
(1788, 'ORPHA:1488', 'Aural atresia-multiple congenital anomalies-intellectual disability syndrome', 1),
(1789, 'ORPHA:1488', 'Cooper-Jabs syndrome', 1),
(1790, 'ORPHA:1489', 'Pertussis', 1),
(1791, 'ORPHA:1489', 'Whooping cough', 1),
(1792, 'ORPHA:1490', 'CDPD', 1),
(1793, 'ORPHA:1490', 'Corneal dystrophy with progressive deafness', 1),
(1794, 'ORPHA:1490', 'Corneal dystrophy with progressive hearing loss', 1),
(1795, 'ORPHA:1490', 'Corneal dystrophy-perceptive deafness syndrome', 1),
(1796, 'ORPHA:1490', 'Corneal dystrophy-perceptive hearing loss syndrome', 1),
(1797, 'ORPHA:1490', 'Harboyan syndrome', 1),
(1798, 'ORPHA:1493', 'Corpus callosum agenesis-cataract-immunodeficiency syndrome', 1),
(1799, 'ORPHA:1493', 'Dionisi-Vici-Sabetta-Gambarara syndrome', 1),
(1800, 'ORPHA:1493', 'Vici syndrome', 1),
(1801, 'ORPHA:1495', 'Da Silva syndrome', 1),
(1802, 'ORPHA:1495', 'Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome', 1),
(1803, 'ORPHA:1496', 'Andermann syndrome', 1),
(1804, 'ORPHA:1496', 'Charlevoix disease', 1),
(1805, 'ORPHA:1496', 'Corpus callosum agenesis-neuronopathy syndrome', 1),
(1806, 'ORPHA:1497', 'X-linked complicated corpus callosum dysgenesis', 2),
(1807, 'ORPHA:15', 'Achondroplasia', 1),
(1808, 'ORPHA:150', 'Nasopharyngeal carcinoma', 1),
(1809, 'ORPHA:150', 'Squamous cell carcinoma of the nasopharynx', 1),
(1810, 'ORPHA:1501', 'Adrenocortical carcinoma', 1),
(1811, 'ORPHA:1505', 'Short rib-polydactyly syndrome', 3),
(1812, 'ORPHA:1506', 'Sharma-Kapoor-Ramji syndrome', 1),
(1813, 'ORPHA:1506', 'Thin ribs-tubular bones-dysmorphism syndrome', 1),
(1814, 'ORPHA:1507', 'Autosomal recessive Robinow syndrome', 2),
(1815, 'ORPHA:1507', 'COVESDEM syndrome', 2),
(1816, 'ORPHA:1507', 'Costovertebral segmentation defect-mesomelia syndrome', 2),
(1817, 'ORPHA:1507', 'RRS', 2),
(1818, 'ORPHA:1508', 'Coxoauricular syndrome', 1),
(1819, 'ORPHA:1509', 'Coxopodopatellar syndrome', 1),
(1820, 'ORPHA:1509', 'Ischiopatellar dysplasia', 1),
(1821, 'ORPHA:1509', 'SPS', 1),
(1822, 'ORPHA:1509', 'Scott-Taor syndrome', 1),
(1823, 'ORPHA:1509', 'Small patella syndrome', 1),
(1824, 'ORPHA:1512', 'Crane-Heise syndrome', 1),
(1825, 'ORPHA:1513', 'Craniodiaphyseal dysplasia', 1),
(1826, 'ORPHA:1514', 'Craniodigital-intellectual disability syndrome', 1),
(1827, 'ORPHA:1514', 'Scott craniodigital syndrome', 1),
(1828, 'ORPHA:1514', 'Scott-Bryant-Graham syndrome', 1),
(1829, 'ORPHA:1515', 'CED', 1),
(1830, 'ORPHA:1515', 'Cranioectodermal dysplasia', 1),
(1831, 'ORPHA:1515', 'Sensenbrenner syndrome', 1),
(1832, 'ORPHA:1516', 'BLSS', 1),
(1833, 'ORPHA:1516', 'Bilateral lambdoid and sagittal synostosis', 1),
(1834, 'ORPHA:1516', 'Craniofacial dyssynostosis', 1),
(1835, 'ORPHA:1517', 'Hypertrichotic osteochondrodysplasia, Cantu type', 1),
(1836, 'ORPHA:1519', 'Brachycephalofrontonasal dysplasia', 1),
(1837, 'ORPHA:1519', 'Craniofrontonasal dysplasia, Teebi type', 1),
(1838, 'ORPHA:1519', 'Hypertelorism, Teebi type', 1),
(1839, 'ORPHA:1519', 'Teebi hypertelorism syndrome', 1),
(1840, 'ORPHA:1519', 'Teebi syndrome', 1),
(1841, 'ORPHA:1520', 'CFND', 1),
(1842, 'ORPHA:1520', 'CFNS', 1),
(1843, 'ORPHA:1520', 'Craniofrontonasal dysplasia', 1),
(1844, 'ORPHA:1520', 'Craniofrontonasal syndrome', 1),
(1845, 'ORPHA:1521', 'Craniofrontonasal dysplasia-Poland anomaly syndrome', 1),
(1846, 'ORPHA:1521', 'Webster-Deming syndrome', 1),
(1847, 'ORPHA:1522', 'Craniometaphyseal dysplasia', 1),
(1848, 'ORPHA:1524', 'Craniomicromelic syndrome', 1),
(1849, 'ORPHA:1525', 'Cranio-osteoarthropathy', 1),
(1850, 'ORPHA:1525', 'Currarino disease', 1),
(1851, 'ORPHA:1525', 'Currarino idiopathic osteoarthropathy', 1),
(1852, 'ORPHA:1525', 'Reginato-Schiapachasse syndrome', 1),
(1853, 'ORPHA:1527', 'Craniosynostosis, Philadelphia type', 1),
(1854, 'ORPHA:1528', 'Craniotelencephalic dysplasia', 1),
(1855, 'ORPHA:1529', 'CDHS', 1),
(1856, 'ORPHA:1529', 'Craniofacial-deafness-hand syndrome', 1),
(1857, 'ORPHA:1529', 'Craniofacial-hearing loss-hand syndrome', 1),
(1858, 'ORPHA:1529', 'Sommer-Young-Wee-Frye syndrome', 1),
(1859, 'ORPHA:1531', 'Craniosynostosis', 3),
(1860, 'ORPHA:1532', 'Cerebellotrigeminal-dermal dysplasia syndrome', 1),
(1861, 'ORPHA:1532', 'Craniosynostosis-alopecia-brain defect syndrome', 1),
(1862, 'ORPHA:1532', 'Gómez-López-Hernández syndrome', 1),
(1863, 'ORPHA:1533', 'Craniosynostosis-fibular aplasia syndrome', 1),
(1864, 'ORPHA:1533', 'Lowry syndrome', 1),
(1865, 'ORPHA:1538', 'Braddock-Jones-Superneau syndrome', 1),
(1866, 'ORPHA:1538', 'Craniosynostosis-Dandy-Walker malformation-hydrocephalus syndrome', 1),
(1867, 'ORPHA:154', 'Familial isolated dilated cardiomyopathy', 1),
(1868, 'ORPHA:154', 'Familial or idiopathic dilated cardiomyopathy', 1),
(1869, 'ORPHA:1540', 'Craniosynostosis-midfacial hypoplasia-foot abnormalities syndrome', 1),
(1870, 'ORPHA:1540', 'JWS', 1),
(1871, 'ORPHA:1540', 'Jackson-Weiss syndrome', 1),
(1872, 'ORPHA:1541', 'Craniosynostosis, Boston type', 1),
(1873, 'ORPHA:1541', 'Craniosynostosis, Warman type', 1),
(1874, 'ORPHA:1541', 'Warman-Mulliken-Hayward syndrome', 1),
(1875, 'ORPHA:1544', 'Adolescent benign focal crisis', 1),
(1876, 'ORPHA:1544', 'Benign focal seizures of adolescence', 1),
(1877, 'ORPHA:1545', 'Crisponi syndrome', 1),
(1878, 'ORPHA:1546', 'Cryptococcosis', 1),
(1879, 'ORPHA:1547', 'Cryptomicrotia-brachydactyly syndrome', 1),
(1880, 'ORPHA:1547', 'Cryptomicrotia-brachydactyly-excess fingertip arch syndrome', 1),
(1881, 'ORPHA:1547', 'Tonoki-Ohura-Niikawa syndrome', 1),
(1882, 'ORPHA:1548', 'Cryptorchidism-arachnodactyly-intellectual disability syndrome', 1),
(1883, 'ORPHA:1548', 'Van Benthem-Driessen-Hanveld syndrome', 1),
(1884, 'ORPHA:1549', 'Cryptosporidiosis', 1),
(1885, 'ORPHA:1551', 'Familial benign copper deficiency', 1),
(1886, 'ORPHA:1551', 'Familial benign hypocupremia', 1),
(1887, 'ORPHA:1552', 'Currarino syndrome', 1),
(1888, 'ORPHA:1552', 'Currarino triad', 1),
(1889, 'ORPHA:1553', 'Corpus callosum agenesis-polysyndactyly syndrome', 1),
(1890, 'ORPHA:1553', 'Curry-Jones syndrome', 1),
(1891, 'ORPHA:1555', 'Beare-Stevenson cutis gyrata syndrome', 1),
(1892, 'ORPHA:1555', 'Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome', 1),
(1893, 'ORPHA:1556', 'CMTC', 1),
(1894, 'ORPHA:1556', 'Cutis marmorata telangiectatica congenita', 1),
(1895, 'ORPHA:155832', 'Rare head and neck malformation', 3),
(1896, 'ORPHA:155835', 'Cysts and fistulae of the face and oral cavity', 3),
(1897, 'ORPHA:155838', 'Pinnae fistula or cyst', 1),
(1898, 'ORPHA:155867', 'Paramedian facial cleft', 3),
(1899, 'ORPHA:155867', 'Tessier number 1-1 and 2-12 facial cleft', 3),
(1900, 'ORPHA:155878', 'Submucosal cleft palate', 1),
(1901, 'ORPHA:155884', 'Coloboma of superior eyelid', 1),
(1902, 'ORPHA:155884', 'Superior palpebral coloboma', 1),
(1903, 'ORPHA:155889', 'Coloboma of inferior eyelid', 1),
(1904, 'ORPHA:155889', 'Inferior palpebral coloboma', 1),
(1905, 'ORPHA:155896', 'Otomandibular dysplasia', 3),
(1906, 'ORPHA:155899', 'Bilateral and symmetric oto-mandibular dysplasia', 3),
(1907, 'ORPHA:155899', 'Mandibulofacial dysostosis', 3),
(1908, 'ORPHA:156', 'CPT1A deficiency', 1),
(1909, 'ORPHA:156', 'Carnitine palmitoyl transferase 1A deficiency', 1),
(1910, 'ORPHA:156', 'Carnitine palmitoyl transferase IA deficiency', 1),
(1911, 'ORPHA:156', 'Hepatic carnitine palmitoyl transferase 1 deficiency', 1),
(1912, 'ORPHA:156', 'Hepatic carnitine palmitoyl transferase I deficiency', 1),
(1913, 'ORPHA:156', 'L-CPT1 deficiency', 1),
(1914, 'ORPHA:156', 'L-CPTI deficiency', 1),
(1915, 'ORPHA:1560', 'Cysticercosis', 1),
(1916, 'ORPHA:156005', 'Primary early-onset glaucoma', 3),
(1917, 'ORPHA:1561', 'Fatal infantile COX deficiency', 1),
(1918, 'ORPHA:1561', 'Fatal infantile cardioencephalomyopathy due to cytochrome C oxidase deficiency', 1),
(1919, 'ORPHA:1561', 'Fatal infantile cytochrome C oxidase deficiency', 1),
(1920, 'ORPHA:156140', 'Predominantly large-vessel vasculitis', 3),
(1921, 'ORPHA:156143', 'Predominantly medium-vessel vasculitis', 3),
(1922, 'ORPHA:156146', 'Predominantly small-vessel vasculitis', 3),
(1923, 'ORPHA:156149', 'Immune complex mediated vasculitis', 3),
(1924, 'ORPHA:156152', 'AAV', 3),
(1925, 'ORPHA:156152', 'ANCA-associated vasculitis', 3),
(1926, 'ORPHA:156152', 'Anti-neutrophil cytoplasmic antibody-associated vasculitis', 3),
(1927, 'ORPHA:156152', 'Antineutrophil cytoplasmic antibody-associated vasculitis', 3),
(1928, 'ORPHA:156159', 'Isolated dystonia', 3),
(1929, 'ORPHA:156159', 'Pure dystonia', 3),
(1930, 'ORPHA:156162', 'Nephropathy-associated ciliopathy', 3),
(1931, 'ORPHA:156165', 'Retinal ciliopathy', 3),
(1932, 'ORPHA:156168', 'Retinal ciliopathy due to mutation in RP1 gene', 3),
(1933, 'ORPHA:156168', 'Retinal ciliopathy due to mutation in the retinitis pigmentosa-1 gene', 3),
(1934, 'ORPHA:156171', 'Retinal ciliopathy due to mutation in the RPGR gene', 3),
(1935, 'ORPHA:156174', 'Retinal ciliopathy due to mutation in the RPGRIP gene', 3),
(1936, 'ORPHA:156177', 'Retinal ciliopathy due to mutation in Usher gene', 3),
(1937, 'ORPHA:156180', 'Retinal ciliopathy due to mutation in nephronophthisis gene', 3),
(1938, 'ORPHA:156183', 'Retinal ciliopathy due to mutation in Bardet-Biedl gene', 3),
(1939, 'ORPHA:1562', 'Dacryocystitis-osteopoikilosis syndrome', 1),
(1940, 'ORPHA:1562', 'Gunal-Seber-Basaran syndrome', 1),
(1941, 'ORPHA:156202', 'Otomandibular dysplasia associated with monogenic syndromes', 3),
(1942, 'ORPHA:156207', 'Macroglossia', 3),
(1943, 'ORPHA:156212', 'Hypoglossia/aglossia', 3),
(1944, 'ORPHA:156215', 'Oromandibular-limb anomalies syndrome', 3),
(1945, 'ORPHA:156224', 'Paralytic facial malformation', 3),
(1946, 'ORPHA:156230', 'Facial arteriovenous malformation', 3),
(1947, 'ORPHA:156237', 'Syndrome or malformation associated with head and neck malformations', 3),
(1948, 'ORPHA:156243', 'Pinnae and external auditory canal anomaly', 3),
(1949, 'ORPHA:156246', 'Nose and cavum anomaly', 3),
(1950, 'ORPHA:156249', 'Larynx anomaly', 3),
(1951, 'ORPHA:156252', 'Tracheal anomaly', 3),
(1952, 'ORPHA:1563', 'Dahlberg syndrome', 1),
(1953, 'ORPHA:1563', 'Dahlberg-Borer-Newcomer syndrome', 1),
(1954, 'ORPHA:1563', 'Lymphedema-hypoparathyroidism syndrome', 1),
(1955, 'ORPHA:156532', 'Rare syndrome with cardiac malformations', 3),
(1956, 'ORPHA:1566', 'DWM with postaxial polydactyly', 1),
(1957, 'ORPHA:1566', 'Dandy-Walker malformation-postaxial polydactyly syndrome', 1),
(1958, 'ORPHA:1566', 'Pierquin syndrome', 1),
(1959, 'ORPHA:156601', 'Rare genetic hepatic disease', 3),
(1960, 'ORPHA:156604', 'Genetic parenchymatous liver disease', 3),
(1961, 'ORPHA:156607', 'Genetic biliary tract disease', 3),
(1962, 'ORPHA:156610', 'Rare genetic respiratory disease', 3),
(1963, 'ORPHA:156619', 'Rare genetic urogenital disease', 3),
(1964, 'ORPHA:156622', 'Genetic urogenital tract malformation', 3),
(1965, 'ORPHA:156629', 'Rare genetic cause of hypertension', 3),
(1966, 'ORPHA:156638', 'Rare genetic endocrine disease', 3),
(1967, 'ORPHA:156643', 'Genetic endocrine growth disease', 3),
(1968, 'ORPHA:156728', 'SEMD, MATN3-related', 1),
(1969, 'ORPHA:156728', 'SEMD, matrilin-3 type', 1),
(1970, 'ORPHA:156728', 'Spondyloepimetaphyseal dysplasia, matrilin-3 type', 1),
(1971, 'ORPHA:156731', 'Dyssegmental dysplasia, Rolland-Desbuquois type', 1),
(1972, 'ORPHA:1568', 'X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome', 1),
(1973, 'ORPHA:157', 'CPT2', 1),
(1974, 'ORPHA:157', 'CPTII', 1),
(1975, 'ORPHA:157', 'Carnitine palmitoyltransferase II deficiency', 1),
(1976, 'ORPHA:157', 'Carnitine palmitoyltransferase deficiency type 2', 1),
(1977, 'ORPHA:1570', 'De Smet-Fabry-Fryns syndrome', 1),
(1978, 'ORPHA:1570', 'Symbrachydactyly of hands and feet', 1),
(1979, 'ORPHA:1571', 'Knobloch syndrome', 1),
(1980, 'ORPHA:1571', 'Knobloch-Layer syndrome', 1),
(1981, 'ORPHA:1571', 'Retinal detachment-occipital encephalocele syndrome', 1),
(1982, 'ORPHA:1572', 'CVID', 1),
(1983, 'ORPHA:1572', 'Common variable immunodeficiency', 1),
(1984, 'ORPHA:1572', 'Idiopathic immunoglobulin deficiency', 1),
(1985, 'ORPHA:1572', 'Primary antibody deficiency', 1),
(1986, 'ORPHA:1572', 'Primary hypogammaglobulinemia', 1),
(1987, 'ORPHA:157215', 'HHRH', 1),
(1988, 'ORPHA:157215', 'Hereditary hypophosphatemic rickets with hypercalciuria', 1),
(1989, 'ORPHA:1573', 'HJMD', 1),
(1990, 'ORPHA:1573', 'Hypotrichosis with juvenile macular degeneration', 1),
(1991, 'ORPHA:1573', 'Hypotrichosis with juvenile macular dystrophy', 1),
(1992, 'ORPHA:1574', 'Mackay-Shek-Carr syndrome', 1),
(1993, 'ORPHA:1574', 'Retinal degeneration-nanophthalmos-glaucoma syndrome', 1),
(1994, 'ORPHA:1576', 'IBSN', 3),
(1995, 'ORPHA:1576', 'Infantile bilateral striatal necrosis', 3),
(1996, 'ORPHA:1576', 'Infantile striatonigral degeneration', 3),
(1997, 'ORPHA:1576', 'Infantile striatonigral necrosis', 3),
(1998, 'ORPHA:157713', 'Congenital or early infantile CACH syndrome', 2),
(1999, 'ORPHA:157716', 'Late infantile CACH syndrome', 2),
(2000, 'ORPHA:157719', 'Juvenile or adult CACH syndrome', 2);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(2001, 'ORPHA:157769', 'Incomplete situs inversus', 1),
(2002, 'ORPHA:157769', 'Partial situs inversus', 1),
(2003, 'ORPHA:157769', 'Situs ambiguous', 1),
(2004, 'ORPHA:157769', 'Situs ambiguus', 1),
(2005, 'ORPHA:157791', 'Epithelioid hemangioendothelioma', 1),
(2006, 'ORPHA:157794', 'HMPS', 1),
(2007, 'ORPHA:157794', 'Hereditary mixed polyposis syndrome', 1),
(2008, 'ORPHA:157798', 'Hyperplastic polyposis syndrome', 1),
(2009, 'ORPHA:157798', 'Serrated polyposis syndrome', 1),
(2010, 'ORPHA:1578', 'Hyperphenylalaninemia due to dehydratase deficiency', 2),
(2011, 'ORPHA:1578', 'Hyperphenylalaninemia due to pterin-4-alpha-carbinolamine dehydratase deficiency', 2),
(2012, 'ORPHA:1578', 'Hyperphenylalaninemia with primapterinuria', 2),
(2013, 'ORPHA:1578', 'Pterin-4 alpha-carbinolamine dehydratase deficiency', 2),
(2014, 'ORPHA:157801', 'MSSD', 1),
(2015, 'ORPHA:157801', 'Mesoaxial synostotic syndactyly with phalangeal reduction', 1),
(2016, 'ORPHA:157801', 'Syndactyly type 9', 1),
(2017, 'ORPHA:157801', 'Syndactyly, Malik-Percin type', 1),
(2018, 'ORPHA:157808', 'Congenital pseudarthrosis of the limbs', 1),
(2019, 'ORPHA:157808', 'Congenital pseudoarthrosis of the limbs', 1),
(2020, 'ORPHA:157820', 'CISS', 1),
(2021, 'ORPHA:157820', 'Cold-induced sweating syndrome', 1),
(2022, 'ORPHA:157823', 'Klüver-Bucy syndrome', 1),
(2023, 'ORPHA:157826', 'Congenital epulis', 1),
(2024, 'ORPHA:157826', 'Congenital gingival cell tumor', 1),
(2025, 'ORPHA:157826', 'Congenital granular cell tumor', 1),
(2026, 'ORPHA:157826', 'Neumann tumor', 1),
(2027, 'ORPHA:157832', 'Craniorhiny', 1),
(2028, 'ORPHA:157835', 'Paroxysmal hemicrania', 1),
(2029, 'ORPHA:157843', 'Trigeminal autonomic cephalalgia', 3),
(2030, 'ORPHA:157846', 'Adult basal ganglia disease', 1),
(2031, 'ORPHA:157846', 'Ferritin-related neurodegeneration', 1),
(2032, 'ORPHA:157846', 'Hereditary ferritinopathy', 1),
(2033, 'ORPHA:157846', 'Neuroferritinopathy', 1),
(2034, 'ORPHA:157850', 'Hallervorden-Spatz syndrome', 1),
(2035, 'ORPHA:157850', 'NBIA1', 1),
(2036, 'ORPHA:157850', 'Neurodegeneration with brain iron accumulation type 1', 1),
(2037, 'ORPHA:157850', 'PKAN', 1),
(2038, 'ORPHA:157850', 'Pantothenate kinase-associated neurodegeneration', 1),
(2039, 'ORPHA:157941', 'Early-onset prion disease with prominent psychiatric features', 1),
(2040, 'ORPHA:157941', 'HDL1', 1),
(2041, 'ORPHA:157941', 'Huntington disease-like 1', 1),
(2042, 'ORPHA:157946', 'HDL3', 1),
(2043, 'ORPHA:157946', 'Huntington disease-like 3', 1),
(2044, 'ORPHA:157949', 'CID due to RAG 1/2 deficiency', 1),
(2045, 'ORPHA:157949', 'Combined immunodeficiency due to RAG 1/2 deficiency', 1),
(2046, 'ORPHA:157949', 'Combined immunodeficiency with granulomatosis', 1),
(2047, 'ORPHA:157954', 'ANE syndrome', 1),
(2048, 'ORPHA:157954', 'Alopecia-progressive neurological defect-endocrinopathy syndrome', 1),
(2049, 'ORPHA:157962', 'Oculoauricular syndrome, Schorderet type', 1),
(2050, 'ORPHA:157965', 'SCD-EDS', 2),
(2051, 'ORPHA:157965', 'SLC39A13-related spEDS', 2),
(2052, 'ORPHA:157965', 'SLC39A13-related spondylodysplastic EDS', 2),
(2053, 'ORPHA:157965', 'SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome', 2),
(2054, 'ORPHA:157965', 'Spondylocheirodysplastic Ehlers-Danlos syndrome', 2),
(2055, 'ORPHA:157965', 'spEDS-SLC39A13', 2),
(2056, 'ORPHA:157973', 'Congenital muscular dystrophy due to LMNA mutation', 1),
(2057, 'ORPHA:157973', 'L-CMD', 1),
(2058, 'ORPHA:157973', 'LMNA-related congenital muscular dystrophy', 1),
(2059, 'ORPHA:157987', 'Non-Langerhans cell histiocytosis', 3),
(2060, 'ORPHA:157991', 'Generalized eruptive histiocytoma', 1),
(2061, 'ORPHA:157991', 'Generalized eruptive histiocytosis', 1),
(2062, 'ORPHA:157997', 'Benign cephalic histiocytosis', 1),
(2063, 'ORPHA:158', 'CDSP', 1),
(2064, 'ORPHA:158', 'CUD', 1),
(2065, 'ORPHA:158', 'Carnitine transporter defect', 1),
(2066, 'ORPHA:158', 'Carnitine uptake deficiency', 1),
(2067, 'ORPHA:158', 'Deficiency of plasma-membrane carnitine transporter', 1),
(2068, 'ORPHA:158', 'SPCD', 1),
(2069, 'ORPHA:158', 'Systemic primary carnitine deficiency', 1),
(2070, 'ORPHA:1580', 'Distal 10p deletion', 1),
(2071, 'ORPHA:1580', 'Distal monosomy 10p', 1),
(2072, 'ORPHA:1580', 'Monosomy 10pter', 1),
(2073, 'ORPHA:1580', 'Telomeric deletion 10p', 1),
(2074, 'ORPHA:158000', 'Juvenile xanthogranuloma', 1),
(2075, 'ORPHA:158003', 'Montgomery syndrome', 1),
(2076, 'ORPHA:158003', 'Xanthoma disseminatum', 1),
(2077, 'ORPHA:158008', 'Papular xanthoma', 1),
(2078, 'ORPHA:158011', 'Necrobiotic xanthogranuloma', 1),
(2079, 'ORPHA:158014', 'Destombes-Rosaï-Dorfman disease', 1),
(2080, 'ORPHA:158014', 'Rosaï-Dorfman disease', 1),
(2081, 'ORPHA:158014', 'Rosaï-Dorfman-Destombes disease', 1),
(2082, 'ORPHA:158014', 'SHML', 1),
(2083, 'ORPHA:158014', 'Sinus histiocytosis with massive lymphadenopathy', 1),
(2084, 'ORPHA:158019', 'Indeterminate cell histiocytosis', 1),
(2085, 'ORPHA:158019', 'Indeterminate dendritic cell neoplasm', 1),
(2086, 'ORPHA:158019', 'Indeterminate dendritic cell tumor', 1),
(2087, 'ORPHA:158022', 'Progressive nodular histiocytosis', 1),
(2088, 'ORPHA:158025', 'Hereditary progressive mucinous histiocytosis', 1),
(2089, 'ORPHA:158029', 'Sea-blue histiocytosis', 1),
(2090, 'ORPHA:158032', 'HLH', 3),
(2091, 'ORPHA:158032', 'Hemophagocytic lymphohistiocytosis', 3),
(2092, 'ORPHA:158032', 'Hemophagocytic syndrome', 3),
(2093, 'ORPHA:158038', 'Genetic hemophagocytic lymphohistiocytosis', 3),
(2094, 'ORPHA:158038', 'Primary hemophagocytic lymphohistiocytosis', 3),
(2095, 'ORPHA:158041', 'Acquired hemophagocytic lymphohistiocytosis', 3),
(2096, 'ORPHA:158041', 'Reactive hemophagocytic syndrome', 3),
(2097, 'ORPHA:158041', 'Secondary hemophagocytic lymphohistiocytosis', 3),
(2098, 'ORPHA:158048', 'Hemophagocytic syndrome associated with an infection', 1),
(2099, 'ORPHA:158048', 'IAHS', 1),
(2100, 'ORPHA:158048', 'VAHS', 1),
(2101, 'ORPHA:158048', 'Virus-associated hemophagocytic syndrome', 1),
(2102, 'ORPHA:158057', 'Acquired hemophagocytic lymphohistiocytosis associated with malignant disease', 1),
(2103, 'ORPHA:158061', 'Macrophage activation syndrome', 1),
(2104, 'ORPHA:1581', 'Non-distal deletion 10q', 1),
(2105, 'ORPHA:1581', 'Non-distal monosomy 10q', 1),
(2106, 'ORPHA:1581', 'Non-telomeric monosomy 10q', 1),
(2107, 'ORPHA:158124', 'Genetic dementia', 3),
(2108, 'ORPHA:158266', 'Huntington disease phenocopy syndrome', 3),
(2109, 'ORPHA:158266', 'Huntington disease-like syndrome', 3),
(2110, 'ORPHA:158300', 'Rare genetic hematologic disease', 3),
(2111, 'ORPHA:158661', 'Suprabasal epidermolysis bullosa simplex', 3),
(2112, 'ORPHA:158665', 'Basal epidermolysis bullosa simplex', 3),
(2113, 'ORPHA:158668', 'Ectodermal dysplasia-skin fragility syndrome', 1),
(2114, 'ORPHA:158668', 'Epidermolysis bullosa simplex due to plakophilin deficiency', 1),
(2115, 'ORPHA:158668', 'McGrath syndrome', 1),
(2116, 'ORPHA:158673', 'Acral dystrophic epidermolysis bullosa', 1),
(2117, 'ORPHA:158676', 'Dominant dystrophic epidermolysis bullosa, nails only', 1),
(2118, 'ORPHA:158676', 'Nails-only DDEB', 1),
(2119, 'ORPHA:158681', 'EBS-migr', 1),
(2120, 'ORPHA:158681', 'Epidermolysis bullosa simplex with circinate migratory erythema', 1),
(2121, 'ORPHA:158684', 'EBS-PA', 1),
(2122, 'ORPHA:158684', 'Epidermolysis bullosa simplex with pyloric atresia', 1),
(2123, 'ORPHA:158687', 'LAEB', 1),
(2124, 'ORPHA:158687', 'Lethal acantholytic epidermolysis bullosa', 1),
(2125, 'ORPHA:1587', 'Del(13)(q14)', 1),
(2126, 'ORPHA:1587', 'Deletion 13q14', 1),
(2127, 'ORPHA:1587', 'Monosomy 13q14', 1),
(2128, 'ORPHA:158766', 'Typical urticaria pigmentosa', 2),
(2129, 'ORPHA:158769', 'Plaque-form urticaria pigmentosa', 2),
(2130, 'ORPHA:158772', 'Nodular urticaria pigmentosa', 2),
(2131, 'ORPHA:158775', 'Smoldering systemic mastocytosis', 1),
(2132, 'ORPHA:158778', 'Isolated bone marrow mastocytosis', 1),
(2133, 'ORPHA:159', 'CACT deficiency', 1),
(2134, 'ORPHA:159', 'Carnitine-acylcarnitine translocase deficiency', 1),
(2135, 'ORPHA:1590', '13q32 deletion', 1),
(2136, 'ORPHA:1590', 'Deletion 13q32', 1),
(2137, 'ORPHA:1590', 'Distal 13q deletion', 1),
(2138, 'ORPHA:1590', 'Distal monosomy 13q', 1),
(2139, 'ORPHA:1590', 'Monosomy 13q32', 1),
(2140, 'ORPHA:1590', 'Telomeric deletion13q', 1),
(2141, 'ORPHA:1596', '15q26 deletion syndrome', 1),
(2142, 'ORPHA:1596', 'Distal 15q deletion syndrome', 1),
(2143, 'ORPHA:1596', 'Distal monosomy 15q', 1),
(2144, 'ORPHA:1596', 'Monosomy 15q26', 1),
(2145, 'ORPHA:1596', 'Telomeric 15q deletion syndrome', 1),
(2146, 'ORPHA:1597', 'Distal 17q deletion', 1),
(2147, 'ORPHA:1597', 'Distal monosomy 17q', 1),
(2148, 'ORPHA:1597', 'Monosomy 17qter', 1),
(2149, 'ORPHA:1597', 'Telomeric deletion 17q', 1),
(2150, 'ORPHA:1598', '18p- syndrome', 1),
(2151, 'ORPHA:1598', 'De Grouchy syndrome', 1),
(2152, 'ORPHA:1598', 'Monosomy 18p', 1),
(2153, 'ORPHA:16', 'Atypical X-linked achromatopsia', 1),
(2154, 'ORPHA:16', 'Blue cone monochromacy', 1),
(2155, 'ORPHA:16', 'Blue cone monochromatism', 1),
(2156, 'ORPHA:16', 'Color blindness, blue monocone monochromatic type', 1),
(2157, 'ORPHA:16', 'S cone monochromacy', 1),
(2158, 'ORPHA:16', 'S cone monochromatism', 1),
(2159, 'ORPHA:16', 'X-linked incomplete achromatopsia', 1),
(2160, 'ORPHA:160', 'Angiofollicular ganglionic hyperplasia', 1),
(2161, 'ORPHA:160', 'Angiofollicular lymph hyperplasia', 1),
(2162, 'ORPHA:160', 'Castleman disease', 1),
(2163, 'ORPHA:1600', '18q deletion syndrome', 1),
(2164, 'ORPHA:1600', '18q- syndrome', 1),
(2165, 'ORPHA:1600', 'Deletion 18q', 1),
(2166, 'ORPHA:1600', 'Monosomy 18q', 1),
(2167, 'ORPHA:160148', 'Cap inflammatory polyposis', 1),
(2168, 'ORPHA:160148', 'Cap polyposis', 1),
(2169, 'ORPHA:160148', 'Eroded polypoid hyperplasia', 1),
(2170, 'ORPHA:160148', 'Inflammatory myoglandular polyps', 1),
(2171, 'ORPHA:160148', 'Polypoid prolapsing folds', 1),
(2172, 'ORPHA:1606', '1p36 deletion syndrome', 1),
(2173, 'ORPHA:1606', 'Del(1)(p36)', 1),
(2174, 'ORPHA:1606', 'Deletion 1p36', 1),
(2175, 'ORPHA:1606', 'Deletion 1pter', 1),
(2176, 'ORPHA:1606', 'Monosomy 1p36', 1),
(2177, 'ORPHA:1606', 'Monosomy 1pter', 1),
(2178, 'ORPHA:1606', 'Subtelomeric 1p36 deletion', 1),
(2179, 'ORPHA:1617', '2q24 microdeletion syndrome', 1),
(2180, 'ORPHA:1617', 'Del(2)(q24)', 1),
(2181, 'ORPHA:1617', 'Monosomy 2q24', 1),
(2182, 'ORPHA:162', 'Cataract-glaucoma syndrome', 1),
(2183, 'ORPHA:1620', '3p- syndrome', 1),
(2184, 'ORPHA:1620', 'Distal 3p deletion', 1),
(2185, 'ORPHA:1620', 'Distal monosomy 3p', 1),
(2186, 'ORPHA:1620', 'Monosomy 3pter', 1),
(2187, 'ORPHA:1620', 'Telomeric monosomy 3p', 1),
(2188, 'ORPHA:1621', '3q13 microdeletion syndrome', 1),
(2189, 'ORPHA:1621', 'Del(3)(q13)', 1),
(2190, 'ORPHA:1621', 'Monosomy 3q13', 1),
(2191, 'ORPHA:162516', 'Isolated apertura pyriformis stenosis', 1),
(2192, 'ORPHA:162516', 'Isolated congenital nasal pyriform aperture stenosis', 1),
(2193, 'ORPHA:162516', 'Isolated nasal pyriform aperture hypoplasia', 1),
(2194, 'ORPHA:162526', 'Congenital auditory ossicle malformation without external ear abnormality', 1),
(2195, 'ORPHA:162526', 'Isolated congenital auditory ossicle malformation', 1),
(2196, 'ORPHA:1627', 'Del (5)(q35)', 1),
(2197, 'ORPHA:1627', 'Del (5)(qter)', 1),
(2198, 'ORPHA:1627', 'Deletion 5q35', 1),
(2199, 'ORPHA:1627', 'Distal 5q deletion', 1),
(2200, 'ORPHA:1627', 'Monosomy 5q35', 1),
(2201, 'ORPHA:1627', 'Telomeric deletion 5q', 1),
(2202, 'ORPHA:163', 'Bonneau-Beaumont syndrome', 1),
(2203, 'ORPHA:163', 'HHCS', 1),
(2204, 'ORPHA:163', 'Hereditary hyperferritinemia with congenital cataracts', 1),
(2205, 'ORPHA:163', 'Hereditary hyperferritinemia-cataract syndrome', 1),
(2206, 'ORPHA:163209', 'Brain malformation due to abnormal neuronal migration', 3),
(2207, 'ORPHA:163209', 'Non-syndromic cerebral malformation due to abnormal neuronal migration', 3),
(2208, 'ORPHA:163525', 'Subacute cutaneous lupus erythematosus', 1),
(2209, 'ORPHA:163531', 'Chronic cutaneous lupus erythematosus', 3),
(2210, 'ORPHA:163582', 'Rare bacterial infectious disease', 3),
(2211, 'ORPHA:163585', 'Rare viral disease', 3),
(2212, 'ORPHA:163588', 'Rare parasitic disease', 3),
(2213, 'ORPHA:163591', 'Rare mycosis', 3),
(2214, 'ORPHA:163596', 'Alpha-thalassemia hydrops fetalis', 2),
(2215, 'ORPHA:163596', 'Alpha-thalassemia major', 2),
(2216, 'ORPHA:163596', 'Hb Bart\'s hydrops fetalis', 2),
(2217, 'ORPHA:163596', 'Hemoglobin Bart\'s hydrops fetalis', 2),
(2218, 'ORPHA:163596', 'Homozygous alpha0-thalassemia', 2),
(2219, 'ORPHA:1636', 'Distal deletion 7q36', 1),
(2220, 'ORPHA:1636', 'Distal monosomy 7q36', 1),
(2221, 'ORPHA:1636', 'Monosomy 7qter', 1),
(2222, 'ORPHA:1636', 'Telomeric deletion 7q36', 1),
(2223, 'ORPHA:163631', 'Bile acid synthesis defect with cholestasis and malabsorption', 3),
(2224, 'ORPHA:163634', 'Maffucci syndrome', 1),
(2225, 'ORPHA:163637', 'Rare disorder related with pregnancy, childbirth and puerperium', 3),
(2226, 'ORPHA:163649', 'Spondyloepiphyseal dysplasia, Nishimura type', 1),
(2227, 'ORPHA:163649', 'Spondyloepiphyseal dysplasia-craniosynostosis-cleft palate-cataract-intellectual disability syndrome', 1),
(2228, 'ORPHA:163654', 'SED-BDS', 1),
(2229, 'ORPHA:163654', 'Spondyloepiphyseal dysplasia, Cantu type', 1),
(2230, 'ORPHA:163654', 'Spondyloepiphyseal dysplasia-brachydactyly-speech disorder syndrome', 1),
(2231, 'ORPHA:163654', 'Tattoo dysplasia', 1),
(2232, 'ORPHA:163662', 'Spondyloepiphyseal dysplasia, Reardon type', 1),
(2233, 'ORPHA:163665', 'Spondyloepiphyseal dysplasia tarda, Kohn type', 1),
(2234, 'ORPHA:163668', 'Spondyloepiphyseal dysplasia, MacDermot type', 1),
(2235, 'ORPHA:163668', 'Spondyloepiphyseal dysplasia-myopia-sensorineural deafness syndrome', 1),
(2236, 'ORPHA:163668', 'Spondyloepiphyseal dysplasia-myopia-sensorineural hearing loss syndrome', 1),
(2237, 'ORPHA:163681', 'CDFE syndrome', 1),
(2238, 'ORPHA:163681', 'CDFES', 1),
(2239, 'ORPHA:163681', 'Cortical dysplasia-focal epilepsy syndrome', 1),
(2240, 'ORPHA:163684', 'Leukoencephalopathy-dystonia-motor neuropathy syndrome', 1),
(2241, 'ORPHA:163690', 'HCS', 1),
(2242, 'ORPHA:163690', 'Hypotonia-cystinuria syndrome', 1),
(2243, 'ORPHA:163693', '2p21 deletion syndrome', 1),
(2244, 'ORPHA:163693', '2p21 microdeletion syndrome', 1),
(2245, 'ORPHA:163693', 'Del(2)(p21)', 1),
(2246, 'ORPHA:163693', 'Monosomy 2p21', 1),
(2247, 'ORPHA:163696', 'AMRF', 1),
(2248, 'ORPHA:163696', 'Action myoclonus-renal failure syndrome', 1),
(2249, 'ORPHA:163696', 'EPM4', 1),
(2250, 'ORPHA:163696', 'Myoclonus-nephropathy syndrome', 1),
(2251, 'ORPHA:163696', 'Progressive myoclonic epilepsy type 4', 1),
(2252, 'ORPHA:163696', 'Progressive myoclonus epilepsy type 4', 1),
(2253, 'ORPHA:163699', 'ASPS', 1),
(2254, 'ORPHA:163699', 'Alveolar soft part sarcoma', 1),
(2255, 'ORPHA:163699', 'Alveolar soft tissue sarcoma', 1),
(2256, 'ORPHA:163703', 'AERRPS', 1),
(2257, 'ORPHA:163703', 'Acute encephalitis with refractory repetitive partial seizures', 1),
(2258, 'ORPHA:163703', 'Acute non-herpetic encephalitis with severe refractory status epilepticus', 1),
(2259, 'ORPHA:163703', 'DESC syndrome', 1),
(2260, 'ORPHA:163703', 'Devastating epileptic encephalopathy in school-aged children', 1),
(2261, 'ORPHA:163703', 'FIRES', 1),
(2262, 'ORPHA:163703', 'Febrile infection-related epilepsy syndrome', 1),
(2263, 'ORPHA:163703', 'Fever-induced refractory epileptic encephalopathy in school-aged children', 1),
(2264, 'ORPHA:163703', 'Idiopathic catastrophic epileptic encephalopathy', 1),
(2265, 'ORPHA:163703', 'Severe refractory status epilepticus owing to presumed encephalitis', 1),
(2266, 'ORPHA:163708', 'Cryptogenic late-onset epileptic spasms', 1),
(2267, 'ORPHA:163708', 'Late-onset infantile spasms', 1),
(2268, 'ORPHA:163717', 'Benign FMTLE', 1),
(2269, 'ORPHA:163717', 'Benign familial mesial temporal lobe epilepsy', 1),
(2270, 'ORPHA:163721', 'Rolandic epilepsy-speech dyspraxia syndrome', 1),
(2271, 'ORPHA:163727', 'Rolandic epilepsy exercise-induced dystonia', 1),
(2272, 'ORPHA:163727', 'Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer\'s cramp syndrome', 1),
(2273, 'ORPHA:163746', 'Neurologic Waardenburg-Shah syndrome', 1),
(2274, 'ORPHA:163746', 'PCWH', 1),
(2275, 'ORPHA:163746', 'Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease', 1),
(2276, 'ORPHA:163746', 'WS4 plus', 1),
(2277, 'ORPHA:163892', 'Limbic encephalitis', 3),
(2278, 'ORPHA:163895', 'Paraneoplastic limbic encephalitis', 3),
(2279, 'ORPHA:163898', 'Classic paraneoplastic limbic encephalitis', 1),
(2280, 'ORPHA:163898', 'Classic paraneoplastic limbic encephalitis, with or without intracellular antigens', 1),
(2281, 'ORPHA:163903', 'Limbic encephalitis associated with antibodies to cell membrane antigens', 3),
(2282, 'ORPHA:163908', 'Limbic encephalitis with LGI1 antibodies', 1),
(2283, 'ORPHA:163908', 'Limbic encephalitis with leucine-rich glioma-inactivated 1 antibodies', 1),
(2284, 'ORPHA:163918', 'Non-paraneoplastic limbic encephalitis', 3),
(2285, 'ORPHA:163921', 'PALE', 1),
(2286, 'ORPHA:163921', 'Posttransplant acute limbic encephalitis', 1),
(2287, 'ORPHA:163924', 'Non-herpetic acute limbic encephalitis', 1),
(2288, 'ORPHA:163927', 'LPP', 1),
(2289, 'ORPHA:163927', 'Localized pustular psoriasis', 1),
(2290, 'ORPHA:163927', 'PPP', 1),
(2291, 'ORPHA:163927', 'Palmoplantar pustulosis', 1),
(2292, 'ORPHA:163927', 'Pustulosis palmaris et plantaris', 1),
(2293, 'ORPHA:163931', 'Acrodermatitis continua of Hallopeau', 1),
(2294, 'ORPHA:163934', 'Atopic keratoconjunctivitis', 1),
(2295, 'ORPHA:163937', 'MICPCH', 1),
(2296, 'ORPHA:163937', 'X-linked intellectual disability, Najm type', 1),
(2297, 'ORPHA:163937', 'X-linked intellectual disability-microcephaly-pontocerebellar hypoplasia syndrome', 1),
(2298, 'ORPHA:163956', 'X-linked intellectual disability, Nascimento type', 1),
(2299, 'ORPHA:163956', 'X-linked intellectual disability-nail dystrophy-seizures syndrome', 1),
(2300, 'ORPHA:163961', 'X-linked cerebral-cerebellar-coloboma syndrome', 1),
(2301, 'ORPHA:163961', 'X-linked intellectual disability, Kroes type', 1),
(2302, 'ORPHA:163966', 'X-linked dominant chondrodysplasia, Chassaing-Lacombe type', 1),
(2303, 'ORPHA:163966', 'X-linked dominant chondrodysplasia-hydrocephaly-microphthalmia syndrome', 1),
(2304, 'ORPHA:163971', 'X-linked intellectual disability, Cilliers type', 1),
(2305, 'ORPHA:163971', 'X-linked intellectual disability-microcephaly-testicular failure syndrome', 1),
(2306, 'ORPHA:163976', 'X-linked intellectual disability, Van Esch type', 1),
(2307, 'ORPHA:163979', 'X-linked intellectual disability-craniofacioskeletal syndrome', 1),
(2308, 'ORPHA:163985', 'Hyperekplexia-epilepsy syndrome', 1),
(2309, 'ORPHA:164001', 'Rare odontal or periodontal disorder', 3),
(2310, 'ORPHA:164004', 'Middle ear anomaly', 3),
(2311, 'ORPHA:1642', 'Distal deletion 9p', 1),
(2312, 'ORPHA:1642', 'Distal monosomy 9p', 1),
(2313, 'ORPHA:1642', 'Monosomy 9pter', 1),
(2314, 'ORPHA:1642', 'Telomeric deletion 9p', 1),
(2315, 'ORPHA:1643', 'Del(X)(p23)', 1),
(2316, 'ORPHA:1643', 'Xp22.3 microdeletion syndrome', 1),
(2317, 'ORPHA:1646', 'Male sterility due to chromosome Y deletion', 1),
(2318, 'ORPHA:1646', 'Partial chromosome Y deletion', 1),
(2319, 'ORPHA:1647', 'Delleman syndrome', 1),
(2320, 'ORPHA:1647', 'Delleman-Oorthuys syndrome', 1),
(2321, 'ORPHA:1647', 'Leichtman-Wood-Rohn syndrome', 1),
(2322, 'ORPHA:1647', 'OCCS', 1),
(2323, 'ORPHA:1647', 'Oculocerebrocutaneous syndrome', 1),
(2324, 'ORPHA:1647', 'Orbital cyst with cerebral and focal dermal malformations', 1),
(2325, 'ORPHA:164726', 'AML and myelodysplastic syndromes related to radiation', 1),
(2326, 'ORPHA:164726', 'Acute myeloid leukemia and myelodysplastic syndromes related to radiation', 1),
(2327, 'ORPHA:164736', 'FASPS', 1),
(2328, 'ORPHA:164736', 'Familial advanced sleep-phase syndrome', 1),
(2329, 'ORPHA:164823', 'Rare acquired aplastic anemia', 3),
(2330, 'ORPHA:165', 'Lipidosis with triglyceride storage disease', 3),
(2331, 'ORPHA:165', 'Neutral lipid storage disease', 3),
(2332, 'ORPHA:1652', 'Dent disease', 1),
(2333, 'ORPHA:1652', 'Dent syndrome', 1),
(2334, 'ORPHA:1652', 'Low-molecular-weight proteinuria with hypercalciuria and nephrocalcinosis', 1),
(2335, 'ORPHA:1652', 'Renal Fanconi syndrome with nephrocalcinosis and renal stones', 1),
(2336, 'ORPHA:1652', 'X-linked recessive hypercalciuric hypophosphatemic rickets', 1),
(2337, 'ORPHA:1652', 'X-linked recessive nephrolithiasis', 1),
(2338, 'ORPHA:1653', 'DD', 1),
(2339, 'ORPHA:1653', 'Dentin dysplasia', 1),
(2340, 'ORPHA:1655', 'Müllerian derivatives-lymphangiectasia-polydactyly syndrome', 1),
(2341, 'ORPHA:1655', 'Urioste syndrome', 1),
(2342, 'ORPHA:1656', 'Dermatitis herpetiformis', 1),
(2343, 'ORPHA:1656', 'Duhring-Brocq disease', 1),
(2344, 'ORPHA:165652', 'Rare genetic gastroenterological disease', 3),
(2345, 'ORPHA:165655', 'Genetic intestinal disease', 3),
(2346, 'ORPHA:165658', 'Genetic gastro-esophageal disease', 3),
(2347, 'ORPHA:165661', 'Genetic pancreatic disease', 3),
(2348, 'ORPHA:1657', 'Dermatoosteolysis, Kirghizian type', 1),
(2349, 'ORPHA:165704', 'Non-syndromic urogenital tract malformation', 3),
(2350, 'ORPHA:165707', 'Syndromic urogenital tract malformation', 3),
(2351, 'ORPHA:165711', 'Rare abdominal surgical disease', 3),
(2352, 'ORPHA:1658', 'Absence of dermatoglyphics-congenital milia syndrome', 1),
(2353, 'ORPHA:1658', 'Absence of fingerprints-congenital milia syndrome', 1),
(2354, 'ORPHA:1658', 'Baird syndrome', 1),
(2355, 'ORPHA:1658', 'Basan-Baird syndrome', 1),
(2356, 'ORPHA:165805', 'Familial mesial temporal lobe epilepsy with febrile seizures', 1),
(2357, 'ORPHA:1659', 'Cutis laxa-leukodystrophy', 1),
(2358, 'ORPHA:1659', 'Dermatoleukodystrophy', 1),
(2359, 'ORPHA:165955', 'Traumatic myiasis', 1),
(2360, 'ORPHA:165955', 'Wound myiasis', 1),
(2361, 'ORPHA:165958', 'Cavitary myiasis', 1),
(2362, 'ORPHA:165985', 'Diazoxide-sensitive diffuse hyperinsulinism', 3),
(2363, 'ORPHA:165985', 'Hyperinsulinemic hypoglycemia, diazoxide-sensitive diffuse form', 3),
(2364, 'ORPHA:165988', 'Diazoxide-resistant diffuse hyperinsulinism', 3),
(2365, 'ORPHA:165988', 'Hyperinsulinemic hypoglycemia, diazoxide-resistant diffuse form', 3),
(2366, 'ORPHA:165991', 'EIHI', 1),
(2367, 'ORPHA:165991', 'Exercise-induced hyperinsulinemic hypoglycemia', 1),
(2368, 'ORPHA:165991', 'Exercise-induced hyperinsulinism', 1),
(2369, 'ORPHA:165991', 'Hyperinsulinism due to SLC16A1 deficiency', 1),
(2370, 'ORPHA:165991', 'Hyperinsulinism due to monocarboxylate transporter 1 deficiency', 1),
(2371, 'ORPHA:166', 'CMT/HMSN', 3),
(2372, 'ORPHA:166', 'Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy', 3),
(2373, 'ORPHA:166', 'Charcot-Marie-Tooth hereditary neuropathy', 3),
(2374, 'ORPHA:1660', 'Dermoodontodysplasia', 1),
(2375, 'ORPHA:166002', 'Multiple epiphyseal dysplasia due to collagen 9 anomaly', 1),
(2376, 'ORPHA:166011', 'Multiple epiphyseal dysplasia, Beighton type', 1),
(2377, 'ORPHA:166011', 'Multiple epiphyseal dysplasia-myopia-deafness syndrome', 1),
(2378, 'ORPHA:166011', 'Multiple epiphyseal dysplasia-myopia-hearing loss syndrome', 1),
(2379, 'ORPHA:166016', 'Multiple epiphyseal dysplasia with Robin phenotype', 1),
(2380, 'ORPHA:166016', 'Multiple epiphyseal dysplasia, Lowry type', 1),
(2381, 'ORPHA:166024', 'Multiple epiphyseal dysplasia, Al-Gazali type', 1),
(2382, 'ORPHA:166024', 'Multiple epiphyseal dysplasia-macrocephaly-distinctive facies syndrome', 1),
(2383, 'ORPHA:166029', 'Multiple epiphyseal dysplasia, with severe proximal femoral dysplasia', 1),
(2384, 'ORPHA:166032', 'Multiple epiphyseal dysplasia, with miniepiphyses', 1),
(2385, 'ORPHA:166035', 'Brachydactyly-short stature-retinitis pigmentosa syndrome', 1),
(2386, 'ORPHA:166038', 'Metaphyseal chondrodysplasia, Kaitila type', 1),
(2387, 'ORPHA:166063', 'Fatal infantile encephalopathy with olivopontocerebellar hypoplasia', 1),
(2388, 'ORPHA:166063', 'Olivopontocerebellar hypoplasia', 1),
(2389, 'ORPHA:166063', 'PCH4', 1),
(2390, 'ORPHA:166063', 'Pontocerebellar hypoplasia type 4', 1),
(2391, 'ORPHA:166068', 'Fetal-onset olivopontocerebellar hypoplasia', 1),
(2392, 'ORPHA:166068', 'PCH5', 1),
(2393, 'ORPHA:166068', 'Pontocerebellar hypoplasia type 5', 1),
(2394, 'ORPHA:166073', 'Fatal infantile encephalopathy with mitochondrial respiratory chain defects', 1),
(2395, 'ORPHA:166073', 'PCH6', 1),
(2396, 'ORPHA:166073', 'Pontocerebellar hypoplasia type 6', 1),
(2397, 'ORPHA:166078', 'Von Willebrand disease type 1', 2),
(2398, 'ORPHA:166081', 'Von Willebrand disease type 2', 2),
(2399, 'ORPHA:166084', 'Von Willebrand disease type 2A', 2),
(2400, 'ORPHA:166087', 'Von Willebrand disease type 2B', 2),
(2401, 'ORPHA:166090', 'Von Willebrand disease type 2M', 2),
(2402, 'ORPHA:166093', 'Von Willebrand disease type 2N', 2),
(2403, 'ORPHA:166096', 'Von Willebrand disease type 3', 2),
(2404, 'ORPHA:1661', 'Corneal dystrophy epithelial-short stature syndrome', 1),
(2405, 'ORPHA:1661', 'Guízar Vázquez-Luengas-Muñoz syndrome', 1),
(2406, 'ORPHA:1661', 'X-linked corneal dermoid', 1),
(2407, 'ORPHA:166100', 'AD OSMED', 1),
(2408, 'ORPHA:166100', 'Autosomal dominant otospondylomegaepiphyseal dysplasia', 1),
(2409, 'ORPHA:166100', 'Stickler syndrome type 3', 1),
(2410, 'ORPHA:166100', 'Stickler syndrome, non-ocular type', 1),
(2411, 'ORPHA:166105', 'FASTKD2-related infantile mitochondrial encephalomyopathy', 1),
(2412, 'ORPHA:166108', 'Intellectual disability, Birk-Barel type', 1),
(2413, 'ORPHA:166108', 'Intellectual disability-hypotonia-facial dysmorphism syndrome', 1),
(2414, 'ORPHA:166113', 'Acrokeratosis of Bazex', 1),
(2415, 'ORPHA:166113', 'Acrokeratosis paraneoplastica', 1),
(2416, 'ORPHA:166113', 'Acrokeratosis paraneoplastica of Bazex', 1),
(2417, 'ORPHA:166113', 'Bazex syndrome', 1),
(2418, 'ORPHA:166119', 'Isolated osteopoikilosis', 1),
(2419, 'ORPHA:1662', 'Lethal hyperkeratosis-contracture syndrome', 1),
(2420, 'ORPHA:1662', 'Lethal restrictive dermopathy', 1),
(2421, 'ORPHA:1662', 'Lethal tight skin-contracture syndrome', 1),
(2422, 'ORPHA:1662', 'Restrictive dermopathy', 1),
(2423, 'ORPHA:166260', 'Capdepont teeth', 2),
(2424, 'ORPHA:166260', 'DGI-2', 2),
(2425, 'ORPHA:166260', 'DI-2', 2),
(2426, 'ORPHA:166260', 'Dentinogenesis imperfecta type 2', 2),
(2427, 'ORPHA:166260', 'Dentinogenesis imperfecta, Shields type 2', 2),
(2428, 'ORPHA:166265', 'Dentinogenesis imperfecta type 3', 2),
(2429, 'ORPHA:166265', 'Dentinogenesis imperfecta, Shields type 3', 2),
(2430, 'ORPHA:166272', 'Chondrodysplasia-dentinogenesis imperfecta-joint laxity syndrome', 1),
(2431, 'ORPHA:166272', 'Goldblatt chondrodysplasia', 1),
(2432, 'ORPHA:166272', 'Goldblatt syndrome', 1),
(2433, 'ORPHA:166272', 'ODCD', 1),
(2434, 'ORPHA:166272', 'Odontochondrodysplasia', 1),
(2435, 'ORPHA:166277', 'Suarez-Stickler syndrome', 1),
(2436, 'ORPHA:166277', 'Wormian bone-multiple fractures-dentinogenesis imperfecta-skeletal dysplasia', 1),
(2437, 'ORPHA:166282', 'Familial sick sinus syndrome', 1),
(2438, 'ORPHA:166286', 'Comedo nevus of the palm', 1),
(2439, 'ORPHA:166286', 'Porokeratotic eccrine nevus', 1),
(2440, 'ORPHA:166286', 'Porokeratotic eccrine ostial and dermal duct nevus', 1),
(2441, 'ORPHA:166291', 'Dirofilariasis', 1),
(2442, 'ORPHA:166295', 'Benign non-familial infantile seizures', 3),
(2443, 'ORPHA:166299', 'Benign partial epilepsy of infancy with complex partial seizures', 1),
(2444, 'ORPHA:166302', 'Benign partial epilepsy with secondarily generalized seizures in infancy', 1),
(2445, 'ORPHA:166305', 'Benign infantile seizures associated with mild gastroenteritis', 1),
(2446, 'ORPHA:166308', 'BIMSE', 1),
(2447, 'ORPHA:166308', 'Benign infantile focal epilepsy with midline spikes and waves during sleep', 1),
(2448, 'ORPHA:166311', 'Benign partial infantile seizures', 3),
(2449, 'ORPHA:166409', 'Photosensitive epilepsy', 1),
(2450, 'ORPHA:166412', 'Hot water reflex epilepsy', 1),
(2451, 'ORPHA:166415', 'Audiogenic seizures', 1),
(2452, 'ORPHA:166418', 'Eating epilepsy', 1),
(2453, 'ORPHA:166418', 'Eating reflex epilepsy', 1),
(2454, 'ORPHA:166418', 'Eating seizures', 1),
(2455, 'ORPHA:166421', 'Orgasm-induced seizures', 1),
(2456, 'ORPHA:166424', 'Thinking seizures', 1),
(2457, 'ORPHA:166427', 'Startle epilepsy', 1),
(2458, 'ORPHA:166430', 'Micturation-induced seizures', 1),
(2459, 'ORPHA:166433', 'Reading seizures', 1),
(2460, 'ORPHA:166463', 'Epilepsy syndrome', 3),
(2461, 'ORPHA:166466', 'Neurocutaneous syndrome with epilepsy', 3),
(2462, 'ORPHA:166469', 'Chromosomal anomaly with epilepsy as a major feature', 3),
(2463, 'ORPHA:166472', 'Monogenic disease with epilepsy', 3),
(2464, 'ORPHA:166475', 'Idiopathic or cryptogenic familial epilepsy syndrome with identified loci/genes', 3),
(2465, 'ORPHA:166478', 'Cerebral malformation with epilepsy', 3),
(2466, 'ORPHA:166481', 'Metabolic diseases with epilepsy', 3),
(2467, 'ORPHA:166484', 'Inflammatory and autoimmune disease with epilepsy', 3),
(2468, 'ORPHA:166487', 'Cerebral diseases of vascular origin with epilepsy', 3),
(2469, 'ORPHA:166490', 'Infectious disease with epilepsy', 3),
(2470, 'ORPHA:1665', 'Sporadic fetal brain disruption sequence', 1),
(2471, 'ORPHA:1666', 'Dextrocardia', 1),
(2472, 'ORPHA:1667', 'Early-onset diabetes mellitus with multiple epiphyseal dysplasia', 1),
(2473, 'ORPHA:1667', 'WRS', 1),
(2474, 'ORPHA:1667', 'Wolcott-Rallison syndrome', 1),
(2475, 'ORPHA:166775', 'Rare bleeding disorder due to an acquired coagulation factor defect', 3),
(2476, 'ORPHA:166775', 'Rare coagulopathy due to an acquired coagulation factor defect', 3),
(2477, 'ORPHA:166775', 'Rare hemorrhagic disorder due to an acquired coagulation factor defect', 3),
(2478, 'ORPHA:167', 'Chédiak-Higashi disease', 1),
(2479, 'ORPHA:167', 'Chédiak-Higashi syndrome', 1),
(2480, 'ORPHA:167', 'Chédiak-Higashi-Steinbrink syndrome', 1),
(2481, 'ORPHA:1670', 'Chronic diarrhea with villous atrophy', 1),
(2482, 'ORPHA:1671', 'SCM type 1', 2),
(2483, 'ORPHA:1671', 'SCM type I', 2),
(2484, 'ORPHA:1671', 'Split cord malformation type 1', 2),
(2485, 'ORPHA:1671', 'Split cord malformation type I', 2),
(2486, 'ORPHA:1672', 'Diencephalic cachexia', 1),
(2487, 'ORPHA:1672', 'Diencephalic syndrome', 1),
(2488, 'ORPHA:1672', 'Diencephalic syndrome of childhood', 1),
(2489, 'ORPHA:1672', 'Diencephalic syndrome of emaciation', 1),
(2490, 'ORPHA:1672', 'Russell diencephalic cachexia', 1),
(2491, 'ORPHA:1672', 'Russell syndrome', 1),
(2492, 'ORPHA:1675', 'Dihydropyrimidine dehydrogenase deficiency', 1),
(2493, 'ORPHA:1675', 'Familial pyrimidinemia', 1),
(2494, 'ORPHA:1676', 'Idiopathic pulmonary artery dilatation', 1),
(2495, 'ORPHA:167635', 'Arndt-Gottron disease', 1),
(2496, 'ORPHA:167635', 'Generalized lichenoid papular eruption', 1),
(2497, 'ORPHA:167635', 'Generalized papular and sclerodermoid lichen myxedematosus', 1),
(2498, 'ORPHA:167635', 'Scleromyxedema', 1),
(2499, 'ORPHA:1677', 'Familial idiopathic dilatation of the right atrium', 1),
(2500, 'ORPHA:167714', 'Unclassified AML', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(2501, 'ORPHA:167714', 'Unclassified acute myeloid leukemia', 3),
(2502, 'ORPHA:167759', 'Hereditary dentin defect', 3),
(2503, 'ORPHA:167762', 'Rare disease with dentinogenesis imperfecta', 3),
(2504, 'ORPHA:167848', 'Rare cardiomyopathy', 3),
(2505, 'ORPHA:1679', 'Diphtheria', 1),
(2506, 'ORPHA:168', 'Loose anagen syndrome', 1),
(2507, 'ORPHA:1681', 'Craniofacial duplication', 1),
(2508, 'ORPHA:1681', 'Diprosopia', 1),
(2509, 'ORPHA:1681', 'Diprosopus', 1),
(2510, 'ORPHA:168194', 'Rare cardiac tumor', 3),
(2511, 'ORPHA:1682', 'Arterial dissection-lentiginosis syndrome', 1),
(2512, 'ORPHA:168443', 'Spondyloepimetaphyseal dysplasia-hypotrichosis syndrome', 1),
(2513, 'ORPHA:168451', 'Spondyloepimetaphyseal dysplasia-abnormal dentition syndrome', 1),
(2514, 'ORPHA:168454', 'SEMD, Geneviève type', 1),
(2515, 'ORPHA:168454', 'SEMDG', 1),
(2516, 'ORPHA:168454', 'Spondyloepimetaphyseal dysplasia, Geneviève type', 1),
(2517, 'ORPHA:168486', 'Congenital NCL', 1),
(2518, 'ORPHA:168486', 'Congenital neuronal ceroid lipofuscinosis', 1),
(2519, 'ORPHA:168491', 'Jansky-Bielschowsky disease', 1),
(2520, 'ORPHA:168491', 'LINCL', 1),
(2521, 'ORPHA:168491', 'Late infantile NCL', 1),
(2522, 'ORPHA:168491', 'Late infantile neuronal ceroid lipofuscinosis', 1),
(2523, 'ORPHA:1685', 'Distomatosis', 1),
(2524, 'ORPHA:1685', 'Distomiasis', 1),
(2525, 'ORPHA:1685', 'Fluke infection', 1),
(2526, 'ORPHA:168544', 'Spondylometaphyseal dysplasia, Golden type', 1),
(2527, 'ORPHA:168544', 'X-linked spondylometaphyseal dysplasia', 1),
(2528, 'ORPHA:168549', 'Axial spondylometaphyseal dysplasia', 1),
(2529, 'ORPHA:168552', 'Spondylometaphyseal dysplasia-bowed forearms-facial dysmorphism syndrome', 1),
(2530, 'ORPHA:168555', 'Spondylometaphyseal dysplasia, A4 type', 1),
(2531, 'ORPHA:168558', '46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency', 1),
(2532, 'ORPHA:168558', 'XY sex reversal-adrenal failure', 1),
(2533, 'ORPHA:168563', '46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome', 1),
(2534, 'ORPHA:168566', 'Fatal mitochondrial disease due to COXPD3', 1),
(2535, 'ORPHA:168566', 'Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3', 1),
(2536, 'ORPHA:168569', 'H syndrome', 1),
(2537, 'ORPHA:168572', 'Congenital myopathy-cleft palate-malignant hyperthermia syndrome', 1),
(2538, 'ORPHA:168572', 'Native American myopathy', 1),
(2539, 'ORPHA:168577', 'CHC type 2', 1),
(2540, 'ORPHA:168577', 'Hereditary cryohydrocytosis type 2', 1),
(2541, 'ORPHA:168577', 'Hereditary cryohydrocytosis with reduced stomatin', 1),
(2542, 'ORPHA:168577', 'Stomatin-deficient cryohydrocytosis', 1),
(2543, 'ORPHA:168577', 'sdCHC', 1),
(2544, 'ORPHA:168583', 'Hereditary North American Indian childhood cirrhosis', 2),
(2545, 'ORPHA:168588', '11-beta-hydroxysteroid dehydrogenase deficiency type 1', 1),
(2546, 'ORPHA:168588', 'Hyperandrogenism due to cortisone reductase deficiency', 1),
(2547, 'ORPHA:168593', 'SIDDT', 1),
(2548, 'ORPHA:168593', 'Sudden infant death-dysgenesis of the testes syndrome', 1),
(2549, 'ORPHA:168598', 'Brain demyelination due to methionine adenosyltransferase deficiency', 1),
(2550, 'ORPHA:168598', 'MAT I/III deficiency', 1),
(2551, 'ORPHA:168598', 'MAT deficiency', 1),
(2552, 'ORPHA:168598', 'Methionine adenosyltransferase deficiency', 1),
(2553, 'ORPHA:1686', 'Cardiac diverticulum', 1),
(2554, 'ORPHA:168601', 'Congenital enterokinase deficiency', 1),
(2555, 'ORPHA:168601', 'Congenital enteropathy due to enteropeptidase deficiency', 1),
(2556, 'ORPHA:168606', 'Seborrhea-like dermatitis with psoriasiform elements', 1),
(2557, 'ORPHA:168612', 'Congenital deficiency in alpha-fetoprotein', 1),
(2558, 'ORPHA:168615', 'Hereditary persistence of alpha-fetoprotein', 1),
(2559, 'ORPHA:168621', 'Dysplasia epiphysealis capitis femoris', 1),
(2560, 'ORPHA:168621', 'Dysplasia of head of femur, Meyer type', 1),
(2561, 'ORPHA:168621', 'Meyer dysplasia', 1),
(2562, 'ORPHA:168624', 'Familial scaphocephaly syndrome, McGillivray type', 1),
(2563, 'ORPHA:168624', 'Scaphocephaly-macrocephaly-maxillary retrusion-intellectual disability syndrome', 1),
(2564, 'ORPHA:168629', 'Autosomal thrombocytopenia with normal platelets', 2),
(2565, 'ORPHA:168632', 'Generalized basaloid follicular hamartoma syndrome', 1),
(2566, 'ORPHA:168778', 'Rare ASD', 3),
(2567, 'ORPHA:168778', 'Rare PDD', 3),
(2568, 'ORPHA:168778', 'Rare autism spectrum disorder', 3),
(2569, 'ORPHA:168778', 'Rare pervasive developmental disorder', 3),
(2570, 'ORPHA:168782', 'Childhood disintegrative disorder', 1),
(2571, 'ORPHA:168782', 'Dementia infantilis', 1),
(2572, 'ORPHA:168782', 'Heller syndrome', 1),
(2573, 'ORPHA:168796', 'Atriodigital dysplasia, Slovenian type', 1),
(2574, 'ORPHA:168796', 'Cardiac conduction disease-dilated cardiomyopathy-brachydactyly syndrome', 1),
(2575, 'ORPHA:168796', 'Heart-hand syndrome, Slovenian type', 1),
(2576, 'ORPHA:168803', 'Primary peritoneal tumor', 3),
(2577, 'ORPHA:168807', 'Primary malignant peritoneal tumor', 3),
(2578, 'ORPHA:168811', 'Diffuse malignant peritoneal mesothelioma', 1),
(2579, 'ORPHA:168811', 'Malignant peritoneal mesothelioma', 1),
(2580, 'ORPHA:168811', 'Primary malignant peritoneal mesothelioma', 1),
(2581, 'ORPHA:168816', 'Benign multicystic peritoneal mesothelioma', 1),
(2582, 'ORPHA:168816', 'Multicystic mesothelioma', 1),
(2583, 'ORPHA:168816', 'Multilocular peritoneal inclusion cyst', 1),
(2584, 'ORPHA:168816', 'Peritoneal cystic mesothelioma', 1),
(2585, 'ORPHA:168829', 'EOPPC', 1),
(2586, 'ORPHA:168829', 'Extra-ovarian primary peritoneal carcinoma', 1),
(2587, 'ORPHA:168829', 'PPC', 1),
(2588, 'ORPHA:168829', 'Primary peritoneal carcinoma', 1),
(2589, 'ORPHA:168829', 'Primary peritoneal serous carcinoma', 1),
(2590, 'ORPHA:168829', 'Serous surface papillary carcinoma', 1),
(2591, 'ORPHA:168940', 'Chronic eosinophilic leukemia', 1),
(2592, 'ORPHA:168943', 'Myeloid/lymphoid neoplasms associated with eosinophilia and abnormality of PDGFRA, PDGFRB, FGFR1 or JAK2', 3),
(2593, 'ORPHA:168947', 'Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement', 1),
(2594, 'ORPHA:168950', 'Myeloid/lymphoid neoplasm associated with PDGFRB rearrangement', 1),
(2595, 'ORPHA:168953', '8p11 myeloproliferative syndrome', 1),
(2596, 'ORPHA:168953', 'Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement', 1),
(2597, 'ORPHA:168953', 'Stem cell leukemia/lymphoma', 1),
(2598, 'ORPHA:168956', 'HES', 3),
(2599, 'ORPHA:168956', 'Hypereosinophilic syndrome', 3),
(2600, 'ORPHA:168960', 'RAEB-t', 1),
(2601, 'ORPHA:168960', 'Refractory anemia with excess blasts in transformation', 1),
(2602, 'ORPHA:168966', 'Composite Hodgkin and non-Hodgkin lymphoma', 1),
(2603, 'ORPHA:168966', 'Composite lymphoma', 1),
(2604, 'ORPHA:168984', 'CLAPO syndrome', 1),
(2605, 'ORPHA:168999', 'Malignant melanoma of the mucosa', 1),
(2606, 'ORPHA:169', 'Pili annulati', 1),
(2607, 'ORPHA:169', 'Ringed hair disease', 1),
(2608, 'ORPHA:169079', 'Cernunnos XLFD', 1),
(2609, 'ORPHA:169079', 'Cernunnos deficiency', 1),
(2610, 'ORPHA:169079', 'Cernunnos-XLF deficiency', 1),
(2611, 'ORPHA:169079', 'Combined immunodeficiency-microcephaly-growth retardation-sensitivity to ionizing radiation syndrome', 1),
(2612, 'ORPHA:169079', 'NHEJ1 deficiency', 1),
(2613, 'ORPHA:169082', 'Combined immunodeficiency due to CD3gamma deficiency', 1),
(2614, 'ORPHA:169085', 'Familial CD8 deficiency', 1),
(2615, 'ORPHA:169085', 'Susceptibility to respiratory infections associated with CD8alpha chain mutation', 1),
(2616, 'ORPHA:169090', 'Combined immunodeficiency due to CRAC channel dysfunction', 1),
(2617, 'ORPHA:169090', 'Immune dysfunction due to T-cell inactivation due to calcium entry defect', 1),
(2618, 'ORPHA:169095', 'Alymphoid cystic thymic dysgenesis', 1),
(2619, 'ORPHA:169095', 'Nude/SCID', 1),
(2620, 'ORPHA:169095', 'Nude/severe combined immunodeficiency', 1),
(2621, 'ORPHA:169095', 'SCID due to FOXN1 deficiency', 1),
(2622, 'ORPHA:169095', 'Severe T-cell immunodeficiency-congenital alopecia-nail dystrophy syndrome', 1),
(2623, 'ORPHA:169095', 'Severe combined immunodeficiency due to FOXN1 deficiency', 1),
(2624, 'ORPHA:169095', 'Winged helix deficiency', 1),
(2625, 'ORPHA:169100', 'Immunodeficiency due to CD25 deficiency', 1),
(2626, 'ORPHA:169100', 'Interleukin-2 receptor alpha chain deficiency', 1),
(2627, 'ORPHA:169105', 'Good syndrome', 1),
(2628, 'ORPHA:169105', 'Thymoma-immunodeficiency syndrome', 1),
(2629, 'ORPHA:169110', 'Immunoglobulin heavy chain deficiency', 1),
(2630, 'ORPHA:169139', 'Transient hypogammaglobulinemia of infancy', 1),
(2631, 'ORPHA:169142', 'Neutrophil-specific granule deficiency', 1),
(2632, 'ORPHA:169142', 'Recurrent infection due to specific granule deficiency', 1),
(2633, 'ORPHA:169147', 'Immunodeficiency due to C1, C4, or C2 component complement deficiency', 1),
(2634, 'ORPHA:169147', 'Immunodeficiency due to a classical component pathway complement deficiency', 1),
(2635, 'ORPHA:169147', 'Immunodeficiency due to an early component of complement deficiency', 1),
(2636, 'ORPHA:169150', 'Immunodeficiency due to C5 to C9 component complement deficiency', 1),
(2637, 'ORPHA:169150', 'Immunodeficiency due to a late component of complement deficiency', 1),
(2638, 'ORPHA:169150', 'Terminal complement pathway deficiency', 1),
(2639, 'ORPHA:169154', 'T-B+ SCID due to IL-7Ralpha deficiency', 1),
(2640, 'ORPHA:169154', 'T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency', 1),
(2641, 'ORPHA:169157', 'T-B+ SCID due to CD45 deficiency', 1),
(2642, 'ORPHA:169157', 'T-B+ severe combined immunodeficiency due to CD45 deficiency', 1),
(2643, 'ORPHA:169160', 'T-B+ SCID due to CD3delta/CD3epsilon/CD3zeta', 1),
(2644, 'ORPHA:169160', 'T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta', 1),
(2645, 'ORPHA:169163', 'Familial scaphocephaly syndrome', 3),
(2646, 'ORPHA:169186', 'AR-CNM', 1),
(2647, 'ORPHA:169186', 'Autosomal recessive centronuclear myopathy', 1),
(2648, 'ORPHA:169189', 'AD-CNM', 1),
(2649, 'ORPHA:169189', 'Autosomal dominant centronuclear myopathy', 1),
(2650, 'ORPHA:1692', 'Mosaic trisomy 1', 1),
(2651, 'ORPHA:1692', 'Mosaic trisomy chromosome 1', 1),
(2652, 'ORPHA:1692', 'Trisomy 1 mosaicism', 1),
(2653, 'ORPHA:169346', 'DNA repair defect other than combined T-cell and B-cell immunodeficiencies', 3),
(2654, 'ORPHA:169349', 'Immuno-osseous dysplasia', 3),
(2655, 'ORPHA:169355', 'Immunodeficiency syndrome with autoimmunity', 3),
(2656, 'ORPHA:169361', 'Immune dysregulation disease with immunodeficiency', 3),
(2657, 'ORPHA:169443', 'Specific antibody deficiency with normal immunoglobulin concentrations and normal numbers of B cells', 3),
(2658, 'ORPHA:169464', 'Primary CD59 deficiency', 1),
(2659, 'ORPHA:169467', 'Recurrent Neisseria infections due to factor D deficiency', 1),
(2660, 'ORPHA:1695', 'Non-distal duplication 10q', 1),
(2661, 'ORPHA:1695', 'Non-distal trisomy 10q', 1),
(2662, 'ORPHA:1695', 'Non-telomeric trisomy 10q', 1),
(2663, 'ORPHA:169615', 'Idiopathic central precocious puberty', 2),
(2664, 'ORPHA:169618', 'Secondary central precocious puberty', 2),
(2665, 'ORPHA:169793', 'Severe factor IX deficiency', 2),
(2666, 'ORPHA:169793', 'Severe hemophilia B', 2),
(2667, 'ORPHA:169796', 'Moderately severe factor IX deficiency', 2),
(2668, 'ORPHA:169796', 'Moderately severe hemophilia B', 2),
(2669, 'ORPHA:169799', 'Mild factor IX deficiency', 2),
(2670, 'ORPHA:169799', 'Mild hemophilia B', 2),
(2671, 'ORPHA:1698', 'Mosaic trisomy 12', 1),
(2672, 'ORPHA:1698', 'Mosaic trisomy chromosome 12', 1),
(2673, 'ORPHA:1698', 'Trisomy 12 mosaicism', 1),
(2674, 'ORPHA:169802', 'Severe factor VIII deficiency', 2),
(2675, 'ORPHA:169802', 'Severe hemophilia A', 2),
(2676, 'ORPHA:169805', 'Moderately severe factor VIII deficiency', 2),
(2677, 'ORPHA:169805', 'Moderately severe hemophilia A', 2),
(2678, 'ORPHA:169808', 'Mild factor VIII deficiency', 2),
(2679, 'ORPHA:169808', 'Mild hemophilia A', 2),
(2680, 'ORPHA:169826', 'Congenital vitamin K-dependent coagulation factors deficiency', 3),
(2681, 'ORPHA:1699', 'Duplication 12p', 1),
(2682, 'ORPHA:1699', 'Trisomy 12p', 1),
(2683, 'ORPHA:17', 'Fatal infantile lactic acidosis with methylmalonic aciduria', 1),
(2684, 'ORPHA:170', 'Familial woolly hair syndrome', 1),
(2685, 'ORPHA:170', 'Familial wooly hair syndrome', 1),
(2686, 'ORPHA:170', 'Hereditary woolly hair syndrome', 1),
(2687, 'ORPHA:170', 'Hereditary wooly hair syndrome', 1),
(2688, 'ORPHA:170', 'Woolly hair', 1),
(2689, 'ORPHA:170', 'Wooly hair', 1),
(2690, 'ORPHA:1702', 'Non-distal duplication 13q', 1),
(2691, 'ORPHA:1702', 'Non-distal trisomy 13q', 1),
(2692, 'ORPHA:1702', 'Non-telomeric trisomy 13q', 1),
(2693, 'ORPHA:1703', 'Mosaic trisomy 14', 1),
(2694, 'ORPHA:1703', 'Mosaic trisomy chromosome 14', 1),
(2695, 'ORPHA:1703', 'Trisomy 14 mosaicism', 1),
(2696, 'ORPHA:1705', 'Distal duplication 14q', 1),
(2697, 'ORPHA:1705', 'Distal trisomy 14q', 1),
(2698, 'ORPHA:1705', 'Telomeric duplication 14q', 1),
(2699, 'ORPHA:1705', 'Trisomy 14qter', 1),
(2700, 'ORPHA:1706', 'Mosaic trisomy 15', 1),
(2701, 'ORPHA:1706', 'Mosaic trisomy chromosome 15', 1),
(2702, 'ORPHA:1706', 'Trisomy 15 mosaicism', 1),
(2703, 'ORPHA:1707', 'Distal duplication 15q', 2),
(2704, 'ORPHA:1707', 'Distal trisomy 15q', 2),
(2705, 'ORPHA:1707', 'Telomeric duplication 15q', 2),
(2706, 'ORPHA:1707', 'Trisomy 15qter', 2),
(2707, 'ORPHA:1708', 'Mosaic trisomy 16', 1),
(2708, 'ORPHA:1708', 'Mosaic trisomy chromosome 16', 1),
(2709, 'ORPHA:1708', 'Trisomy 16 mosaicism', 1),
(2710, 'ORPHA:171', 'PSC', 1),
(2711, 'ORPHA:171', 'Primary sclerosing cholangitis', 1),
(2712, 'ORPHA:1711', 'Mosaic trisomy 17', 1),
(2713, 'ORPHA:1711', 'Mosaic trisomy chromosome 17', 1),
(2714, 'ORPHA:1711', 'Trisomy 17 mosaicism', 1),
(2715, 'ORPHA:171201', 'High isolated anorectal malformation', 1),
(2716, 'ORPHA:171208', 'Intermediate isolated anorectal malformation', 1),
(2717, 'ORPHA:171215', 'Low isolated anorectal malformation', 1),
(2718, 'ORPHA:171220', 'Rectal duplication', 1),
(2719, 'ORPHA:1713', '17p11.2 microduplication syndrome', 1),
(2720, 'ORPHA:1713', 'Potocki-Lupski syndrome', 1),
(2721, 'ORPHA:1713', 'Trisomy 17p11.2', 1),
(2722, 'ORPHA:171430', 'Severe congenital nemaline myopathy', 1),
(2723, 'ORPHA:171433', 'Intermediate nemaline myopathy', 1),
(2724, 'ORPHA:171436', 'Typical nemaline myopathy', 1),
(2725, 'ORPHA:171439', 'Childhood-onset nemaline myopathy', 1),
(2726, 'ORPHA:171439', 'Mild nemaline myopathy', 1),
(2727, 'ORPHA:171442', 'Adult-onset nemaline myopathy', 1),
(2728, 'ORPHA:171445', 'Muscle filaminopathy', 1),
(2729, 'ORPHA:1715', 'Duplication 18p', 1),
(2730, 'ORPHA:1715', 'Duplication of the short arm of chromosome 18', 1),
(2731, 'ORPHA:1715', 'Trisomy 18p', 1),
(2732, 'ORPHA:1715', 'Trisomy of the short arm of chromosome 18', 1),
(2733, 'ORPHA:1716', 'Distal duplication 18q', 1),
(2734, 'ORPHA:1716', 'Distal trisomy 18q', 1),
(2735, 'ORPHA:1716', 'Telomeric duplication 18q', 1),
(2736, 'ORPHA:1716', 'Trisomy 18qter', 1),
(2737, 'ORPHA:171607', 'SPG34', 1),
(2738, 'ORPHA:171607', 'X-linked spastic paraplegia type 34', 1),
(2739, 'ORPHA:171612', 'Autosomal dominant spastic paraplegia type 37', 1),
(2740, 'ORPHA:171612', 'SPG37', 1),
(2741, 'ORPHA:171617', 'Autosomal dominant spastic paraplegia type 38', 1),
(2742, 'ORPHA:171617', 'SPG38', 1),
(2743, 'ORPHA:171622', 'Autosomal recessive spastic paraplegia type 32', 1),
(2744, 'ORPHA:171622', 'SPG32', 1),
(2745, 'ORPHA:171629', 'Autosomal recessive spastic paraplegia type 35', 1),
(2746, 'ORPHA:171629', 'SPG35', 1),
(2747, 'ORPHA:171673', 'Limbal stem cell deficiency', 1),
(2748, 'ORPHA:171676', 'Periventricular leukomalacia', 1),
(2749, 'ORPHA:171680', 'Lissencephaly due to TUBA1A mutation', 1),
(2750, 'ORPHA:171684', 'Idiopathic bilateral vestibulopathy', 1),
(2751, 'ORPHA:171690', 'Erythrocyte lactate transporter defect', 1),
(2752, 'ORPHA:171690', 'Metabolic myopathy due to lactate transporter defect', 1),
(2753, 'ORPHA:171695', 'Pallidopyramidal syndrome', 1),
(2754, 'ORPHA:171695', 'Parkinsonian-pyramidal syndrome', 1),
(2755, 'ORPHA:1717', 'Distal duplication 19q', 1),
(2756, 'ORPHA:1717', 'Distal trisomy 19q', 1),
(2757, 'ORPHA:1717', 'Telomeric duplication 19q', 1),
(2758, 'ORPHA:1717', 'Trisomy 19qter', 1),
(2759, 'ORPHA:171700', 'Diffuse panbronchiolitis', 1),
(2760, 'ORPHA:171703', 'Microcephaly-polymicrogyria-corpus callosum agenesis syndrome', 1),
(2761, 'ORPHA:171706', 'Short stature-delayed bone age due to thyroid hormone metabolism deficiency', 1),
(2762, 'ORPHA:171709', 'Male infertility due to globozoospermia', 2),
(2763, 'ORPHA:171709', 'Male infertility due to round-headed spermatozoa', 2),
(2764, 'ORPHA:171709', 'Round-headed sperm syndrome', 2),
(2765, 'ORPHA:171719', 'Cutis laxa-Marfanoid syndrome', 1),
(2766, 'ORPHA:171723', 'Hereditary mucosal leukokeratosis', 1),
(2767, 'ORPHA:171723', 'White sponge nevus', 1),
(2768, 'ORPHA:171723', 'White sponge nevus of Cannon', 1),
(2769, 'ORPHA:171829', '6q16 microdeletion syndrome', 1),
(2770, 'ORPHA:171829', 'Del(6)(q16)', 1),
(2771, 'ORPHA:171829', 'Monosomy 6q16', 1),
(2772, 'ORPHA:171829', 'Prader-Willi-like syndrome due to microdeletion 6q16', 1),
(2773, 'ORPHA:171839', 'Berant syndrome', 1),
(2774, 'ORPHA:171839', 'Capra-DeMarco syndrome', 1),
(2775, 'ORPHA:171839', 'Craniosynostosis-hydrocephalus-Arnold-Chiari malformation type I-radioulnar synostosis syndrome', 1),
(2776, 'ORPHA:171839', 'Familial scaphocephaly-radioulnar synostosis syndrome', 1),
(2777, 'ORPHA:171844', 'Blindness-scoliosis-arachnodactyly syndrome', 1),
(2778, 'ORPHA:171848', 'PHARC syndrome', 1),
(2779, 'ORPHA:171848', 'Peripheral neuropathy, Fiskerstrand type', 1),
(2780, 'ORPHA:171848', 'Polyneuropathy-deafness-ataxia-retinitis pigmentosa-cataract syndrome', 1),
(2781, 'ORPHA:171848', 'Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome', 1),
(2782, 'ORPHA:171851', 'Intellectual disability-enteropathy-deafness-peripheral neuropathy-ichthyosis-keratodermia syndrome', 1),
(2783, 'ORPHA:171851', 'Intellectual disability-enteropathy-hearing loss-peripheral neuropathy-ichthyosis-keratodermia syndrome', 1),
(2784, 'ORPHA:171851', 'MEDNIK syndrome', 1),
(2785, 'ORPHA:171860', 'Intellectual disability-cataracts-kyphosis syndrome', 1),
(2786, 'ORPHA:171863', 'Autosomal dominant spastic paraplegia type 42', 1),
(2787, 'ORPHA:171863', 'SPG42', 1),
(2788, 'ORPHA:171866', 'SEMD, aggrecan type', 1),
(2789, 'ORPHA:171866', 'Spondyloepimetaphyseal dysplasia, aggrecan type', 1),
(2790, 'ORPHA:171871', 'Autosomal dominant pseudohypoaldosteronism type 1', 2),
(2791, 'ORPHA:171871', 'Renal pseudohypoaldosteronism type 1', 2),
(2792, 'ORPHA:171876', 'Autosomal recessive pseudohypoaldosteronism type 1', 2),
(2793, 'ORPHA:171876', 'Generalized pseudohypoaldosteronism type 1', 2),
(2794, 'ORPHA:171881', 'Cap disease', 1),
(2795, 'ORPHA:171881', 'Cap myopathy', 1),
(2796, 'ORPHA:171886', 'Cylindrical spirals myopathy', 1),
(2797, 'ORPHA:171889', 'Myopathy with hexagonally cross-linked tubular arrays', 1),
(2798, 'ORPHA:171895', 'Myeloid hemopathy', 3),
(2799, 'ORPHA:171898', 'Lymphoid hemopathy', 3),
(2800, 'ORPHA:171901', 'Primary cutaneous T-cell lymphoma', 3),
(2801, 'ORPHA:171915', 'B-cell NHL', 3),
(2802, 'ORPHA:171915', 'B-cell non-Hodgkin lymphoma', 3),
(2803, 'ORPHA:171918', 'T-cell NHL', 3),
(2804, 'ORPHA:171918', 'T-cell non-Hodgkin lymphoma', 3),
(2805, 'ORPHA:171929', 'Trisomy 10p', 1),
(2806, 'ORPHA:172', 'PFIC', 1),
(2807, 'ORPHA:172', 'Progressive familial intrahepatic cholestasis', 1),
(2808, 'ORPHA:1723', 'Mosaic trisomy 2', 1),
(2809, 'ORPHA:1723', 'Mosaic trisomy chromosome 2', 1),
(2810, 'ORPHA:1723', 'Trisomy 2 mosaicism', 1),
(2811, 'ORPHA:1724', 'Mosaic trisomy 20', 1),
(2812, 'ORPHA:1724', 'Mosaic trisomy chromosome 20', 1),
(2813, 'ORPHA:1724', 'Trisomy 20 mosaicism', 1),
(2814, 'ORPHA:1727', '22q11.2 duplication syndrome', 1),
(2815, 'ORPHA:1727', '22q11.2 microduplication syndrome', 1),
(2816, 'ORPHA:1727', 'Dup(22)(q11)', 1),
(2817, 'ORPHA:1727', 'Duplication 22q11.2', 1),
(2818, 'ORPHA:1727', 'Trisomy 22q11.2', 1),
(2819, 'ORPHA:172976', 'Congenital myopathy with cores', 3),
(2820, 'ORPHA:173', 'Cholera', 1),
(2821, 'ORPHA:1738', 'Duplication 4p', 1),
(2822, 'ORPHA:1738', 'Duplication of the short arm of chromosome 4', 1),
(2823, 'ORPHA:1738', 'Trisomy 4p', 1),
(2824, 'ORPHA:1738', 'Trisomy of the short arm of chromosome 4', 1),
(2825, 'ORPHA:174', 'Metaphyseal chondrodysplasia, Schmid type', 1),
(2826, 'ORPHA:1742', 'Duplication 5p', 1),
(2827, 'ORPHA:1742', 'Duplication of the short arm of chromosome 5', 1),
(2828, 'ORPHA:1742', 'Trisomy 5p', 1),
(2829, 'ORPHA:1742', 'Trisomy of the short arm of chromosome 5', 1),
(2830, 'ORPHA:1745', 'Distal duplication 6p', 1),
(2831, 'ORPHA:1745', 'Distal trisomy 6p', 1),
(2832, 'ORPHA:1745', 'Telomeric duplication 6p', 1),
(2833, 'ORPHA:1745', 'Trisomy 6pter', 1),
(2834, 'ORPHA:174590', 'Congenital hypogonadotropic hypogonadism', 3),
(2835, 'ORPHA:1747', 'Mosaic trisomy 7', 1),
(2836, 'ORPHA:1747', 'Mosaic trisomy chromosome 7', 1),
(2837, 'ORPHA:1747', 'Trisomy 7 mosaicism', 1),
(2838, 'ORPHA:175', 'Autosomal recessive metaphyseal chondrodysplasia', 1),
(2839, 'ORPHA:175', 'Cartilage-hair hypoplasia', 1),
(2840, 'ORPHA:175', 'Metaphyseal chondrodysplasia, McKusick type', 1),
(2841, 'ORPHA:1752', 'Duplication 8q', 1),
(2842, 'ORPHA:1752', 'Trisomy 8q', 1),
(2843, 'ORPHA:1756', 'Caudal duplication', 1),
(2844, 'ORPHA:1756', 'Dipygus', 1),
(2845, 'ORPHA:1756', 'Split notochord syndrome', 1),
(2846, 'ORPHA:1757', 'Fibular dimelia-diplopodia syndrome', 1),
(2847, 'ORPHA:1757', 'Leg duplication-mirror foot syndrome', 1),
(2848, 'ORPHA:1759', 'Thoraco-abdominal enteric duplication', 1),
(2849, 'ORPHA:176', 'Non-rhizomelic chondrodysplasia punctata', 3),
(2850, 'ORPHA:1762', 'Distal duplication Xq', 1),
(2851, 'ORPHA:1762', 'Telomeric duplication Xq', 1),
(2852, 'ORPHA:1762', 'Trisomy Xq28', 1),
(2853, 'ORPHA:1764', 'Familial dysautonomia', 1),
(2854, 'ORPHA:1764', 'HSAN3', 1),
(2855, 'ORPHA:1764', 'Hereditary sensory and autonomic neuropathy type 3', 1),
(2856, 'ORPHA:1764', 'Hereditary sensory and autonomic neuropathy type III', 1),
(2857, 'ORPHA:1764', 'Riley-Day syndrome', 1),
(2858, 'ORPHA:1765', 'Dyschondrosteosis-nephritis syndrome', 1),
(2859, 'ORPHA:1766', 'CAMRQ syndrome', 1),
(2860, 'ORPHA:1766', 'Cerebellar ataxia-intellectual disability-dysequilibrium syndrome syndrome', 1),
(2861, 'ORPHA:1766', 'Dysequilibrium syndrome', 1),
(2862, 'ORPHA:1766', 'Non-progressive cerebellar ataxia-intellectual disability syndrome', 1),
(2863, 'ORPHA:1766', 'UTS', 1),
(2864, 'ORPHA:1766', 'Uner Tan syndrome', 1),
(2865, 'ORPHA:1768', 'Familial caudal dysgenesis', 1),
(2866, 'ORPHA:1768', 'Rudd-Klimek syndrome', 1),
(2867, 'ORPHA:177', 'RCDP', 1),
(2868, 'ORPHA:177', 'Rhizomelic chondrodysplasia punctata', 1),
(2869, 'ORPHA:1770', 'XY type gonadal dysgenesis-associated anomalies syndrome', 1),
(2870, 'ORPHA:177101', 'Rare adult hypothyroidism', 3),
(2871, 'ORPHA:177107', 'Syndromic hypothyroidism', 3),
(2872, 'ORPHA:1772', '45,X/46,XY MGD', 1),
(2873, 'ORPHA:1772', '45,X/46,XY mixed gonadal dysgenesis', 1),
(2874, 'ORPHA:1772', '45,X0/46,XY MGD', 1),
(2875, 'ORPHA:1772', '45,X0/46,XY mixed gonadal dysgenesis', 1),
(2876, 'ORPHA:1775', 'DC', 1),
(2877, 'ORPHA:1775', 'DKC', 1),
(2878, 'ORPHA:1775', 'Dyskeratosis congenita', 1),
(2879, 'ORPHA:1775', 'Zinsser-Engman-Cole syndrome', 1),
(2880, 'ORPHA:1777', 'Craniofacial dysmorphism-coloboma-corpus callosum agenesis syndrome', 1),
(2881, 'ORPHA:1777', 'Temtamy syndrome', 1),
(2882, 'ORPHA:1777', 'Temtamy-Shalash syndrome', 1),
(2883, 'ORPHA:1778', 'Facial dysmorphism-shawl scrotum-joint laxity syndrome', 1),
(2884, 'ORPHA:1778', 'Seaver-Cassidy syndrome', 1),
(2885, 'ORPHA:1779', 'Dysmorphism-cleft palate-loose skin syndrome', 1),
(2886, 'ORPHA:177901', 'Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1', 2),
(2887, 'ORPHA:177904', 'Prader-Willi syndrome due to paternal deletion of 15q11q13 type 2', 2),
(2888, 'ORPHA:177907', 'Prader-Willi syndrome due to translocation', 2),
(2889, 'ORPHA:177910', 'Prader-Willi syndrome due to imprinting mutation', 2),
(2890, 'ORPHA:177926', 'Symptomatic form of hemophilia A in female carriers', 2),
(2891, 'ORPHA:177929', 'Symptomatic form of hemophilia B in female carriers', 2),
(2892, 'ORPHA:178', 'Chordoma', 1),
(2893, 'ORPHA:178', 'Notochordal sarcoma', 1),
(2894, 'ORPHA:1780', 'Dysmorphism-multiple structural anomalies syndrome', 1),
(2895, 'ORPHA:1780', 'Thakker-Donnai syndrome', 1),
(2896, 'ORPHA:178025', 'Non-acquired combined pituitary hormone deficiencies without extrapituitary malformations', 3),
(2897, 'ORPHA:178029', 'CDI', 1),
(2898, 'ORPHA:178029', 'Central diabetes insipidus', 1),
(2899, 'ORPHA:178029', 'Neurogenic diabetes insipidus', 1),
(2900, 'ORPHA:178040', 'Rare peripheral precocious puberty', 3),
(2901, 'ORPHA:178045', 'Transient congenital hypothyroidism', 3),
(2902, 'ORPHA:178145', 'Moderate multiminicore disease with hand involvement', 2),
(2903, 'ORPHA:178148', 'Antenatal multiminicore disease with arthrogryposis multiplex congenita', 2),
(2904, 'ORPHA:1782', 'Dysosteosclerosis', 1),
(2905, 'ORPHA:178303', '8q22.1 microdeletion syndrome', 1),
(2906, 'ORPHA:178303', 'Monosomy 8q22.1', 1),
(2907, 'ORPHA:178303', 'Nablus mask-like facial syndrome', 1),
(2908, 'ORPHA:178307', 'RAK', 1),
(2909, 'ORPHA:178307', 'Reticulate acropigmentation of Kitamura', 1),
(2910, 'ORPHA:178311', 'Isolated SCCH', 1),
(2911, 'ORPHA:178311', 'Isolated sternocostoclavicular hyperostosis', 1),
(2912, 'ORPHA:178315', 'Embryonal sarcoma of the liver', 1),
(2913, 'ORPHA:178315', 'UES', 1),
(2914, 'ORPHA:178315', 'Undifferentiated embryonal sarcoma of the liver', 1),
(2915, 'ORPHA:178315', 'Undifferentiated sarcoma of the liver', 1),
(2916, 'ORPHA:178320', 'Acute lung injury', 1),
(2917, 'ORPHA:178333', 'AIED', 1),
(2918, 'ORPHA:178333', 'Forsius-Eriksson syndrome', 1),
(2919, 'ORPHA:178333', 'Forsius-Eriksson type ocular albinism', 1),
(2920, 'ORPHA:178333', 'Åland Islands eye disease', 1),
(2921, 'ORPHA:178338', 'UV-sensitive syndrome', 1),
(2922, 'ORPHA:178342', 'Inflammatory myofibroblastic tumor', 1),
(2923, 'ORPHA:178345', 'AEXS', 1),
(2924, 'ORPHA:178345', 'Aromatase excess syndrome', 1),
(2925, 'ORPHA:178345', 'Familial hyperestrogenism', 1),
(2926, 'ORPHA:178345', 'Hereditary prepubertal gynecomastia', 1),
(2927, 'ORPHA:178355', 'Smith-McCort dysplasia', 1),
(2928, 'ORPHA:178364', 'MCOPS5', 1),
(2929, 'ORPHA:178364', 'Syndromic microphthalmia type 5', 1),
(2930, 'ORPHA:178364', 'Syndromic microphthalmia/anophthalmia due to OTX2 mutation', 1),
(2931, 'ORPHA:178377', 'Osteosclerosis-developmental delay-craniosynostosis syndrome', 1),
(2932, 'ORPHA:178382', 'Congenital convex foot', 1),
(2933, 'ORPHA:178382', 'Congenital convex pes valgus', 1),
(2934, 'ORPHA:178382', 'Congenital rocker-bottom foot', 1),
(2935, 'ORPHA:178382', 'Congenital vertical talus', 1),
(2936, 'ORPHA:178389', 'Autosomal recessive osteoclast-poor osteopetrosis with hypogammaglobulinemia', 1),
(2937, 'ORPHA:178389', 'Autosomal recessive osteopetrosis type 7', 1),
(2938, 'ORPHA:178389', 'Osteopetrosis-hypogammaglobulinemia syndrome', 1),
(2939, 'ORPHA:178396', 'Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation', 1),
(2940, 'ORPHA:1784', 'Acrofrontofacionasal dysostosis', 1),
(2941, 'ORPHA:1784', 'Richieri-Costa-Colletto syndrome', 1),
(2942, 'ORPHA:178400', 'Distal anterior compartment myopathy', 1),
(2943, 'ORPHA:178400', 'Distal myopathy with anterior tibial onset', 1),
(2944, 'ORPHA:178461', 'X-linked myopathy with postural muscle atrophy', 1),
(2945, 'ORPHA:178461', 'XMPMA', 1),
(2946, 'ORPHA:178464', 'Edström Myopathy', 1),
(2947, 'ORPHA:178464', 'HIBM-ERF', 1),
(2948, 'ORPHA:178464', 'HMERF', 1),
(2949, 'ORPHA:178464', 'Hereditary inclusion body myopathy with early respiratory failure', 1),
(2950, 'ORPHA:178464', 'Hereditary myopathy with early respiratory failure', 1),
(2951, 'ORPHA:178464', 'MFM-titinopathy', 1),
(2952, 'ORPHA:178464', 'Myofibrillar myopathy with early respiratory failure', 1),
(2953, 'ORPHA:178464', 'Myofibrillar myopathy-titinopathy', 1),
(2954, 'ORPHA:178469', 'Autosomal dominant non-syndromic intellectual disability', 2),
(2955, 'ORPHA:178475', 'Cutaneous infectious botulism', 2),
(2956, 'ORPHA:178475', 'Cutaneous toxin-mediated botulism', 2),
(2957, 'ORPHA:178475', 'Inoculation botulism', 2),
(2958, 'ORPHA:178475', 'Skin infectious botulism', 2),
(2959, 'ORPHA:178475', 'Skin toxin-mediated botulism', 2),
(2960, 'ORPHA:178475', 'Wound botulism', 2),
(2961, 'ORPHA:178478', 'Infant botulism', 2),
(2962, 'ORPHA:178478', 'Infant intestinal botulism', 2),
(2963, 'ORPHA:178478', 'Infant intestinal toxemia botulism', 2),
(2964, 'ORPHA:178478', 'Infant intestinal toxin-mediated botulism', 2),
(2965, 'ORPHA:178478', 'Infantile botulism', 2),
(2966, 'ORPHA:178481', 'Intestinal botulism', 2),
(2967, 'ORPHA:178481', 'Intestinal colonization botulism', 2),
(2968, 'ORPHA:178481', 'Intestinal toxemia botulism', 2),
(2969, 'ORPHA:178481', 'Intestinal toxin-mediated botulism', 2),
(2970, 'ORPHA:178487', 'Adult intestinal botulism', 2),
(2971, 'ORPHA:178487', 'Adult intestinal colonization botulism', 2),
(2972, 'ORPHA:178487', 'Adult intestinal toxemia botulism', 2),
(2973, 'ORPHA:178487', 'Adult intestinal toxin-mediated botulism', 2),
(2974, 'ORPHA:178487', 'Infant-like botulism', 2),
(2975, 'ORPHA:178493', 'Myopic macular degeneration', 1),
(2976, 'ORPHA:178493', 'Myopic maculopathy', 1),
(2977, 'ORPHA:178506', 'Brain calcification, Rajab type', 1),
(2978, 'ORPHA:178509', 'Parkinsonism with alveolar hypoventilation and mental depression', 1),
(2979, 'ORPHA:178509', 'Perry syndrome', 1),
(2980, 'ORPHA:178512', 'Folliculotropic mycosis fungoides', 1),
(2981, 'ORPHA:178512', 'Mycosis fungoides-associated follicular mucinosis', 1),
(2982, 'ORPHA:178517', 'Localized pagetoid reticulosis', 1),
(2983, 'ORPHA:178517', 'Pagetoid reticulosis, Woringer-Kolopp type', 1),
(2984, 'ORPHA:178522', 'Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma', 1),
(2985, 'ORPHA:178528', 'Berti lymphoma', 1),
(2986, 'ORPHA:178528', 'Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma', 1),
(2987, 'ORPHA:178528', 'Primary cutaneous epidermotropic cytotoxic CD8+ T-cell lymphoma', 1),
(2988, 'ORPHA:178533', 'Primary cutaneous gamma/delta-positive T-cell lymphoma', 1),
(2989, 'ORPHA:178536', 'PCMZL', 1),
(2990, 'ORPHA:178536', 'Primary cutaneous marginal zone B-cell lymphoma', 1),
(2991, 'ORPHA:178540', 'PCFCL', 1),
(2992, 'ORPHA:178540', 'Primary cutaneous follicle center lymphoma', 1),
(2993, 'ORPHA:178544', 'PCDLBCL,LT', 1),
(2994, 'ORPHA:178544', 'Primary cutaneous diffuse large B-cell lymphoma, leg type', 1),
(2995, 'ORPHA:178548', 'Indolent primary cutaneous T-cell lymphoma', 3),
(2996, 'ORPHA:178551', 'Aggressive primary cutaneous T-cell lymphoma', 3),
(2997, 'ORPHA:178554', 'Aggressive primary cutaneous B-cell lymphoma', 3),
(2998, 'ORPHA:178557', 'Indolent primary cutaneous B-cell lymphoma', 3),
(2999, 'ORPHA:178563', 'Primary cutaneous B-cell lymphoma', 3),
(3000, 'ORPHA:178566', 'Mycosis fungoides and variants', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(3001, 'ORPHA:1786', 'Acrofacial dysostosis, Catania type', 1),
(3002, 'ORPHA:1786', 'Opitz-Caltabiano syndrome', 1),
(3003, 'ORPHA:1787', 'Acrofacial dysostosis, Palagonia type', 1),
(3004, 'ORPHA:1788', 'Acrofacial dysostosis, Rodríguez type', 1),
(3005, 'ORPHA:178996', 'Acquired neutropenia', 3),
(3006, 'ORPHA:178996', 'Immunologic neutropenia', 3),
(3007, 'ORPHA:179', 'Birdshot chorioretinitis', 1),
(3008, 'ORPHA:179', 'Birdshot chorioretinopathy', 1),
(3009, 'ORPHA:179', 'Birdshot retinochoroiditis', 1),
(3010, 'ORPHA:179', 'Birdshot retinochoroidopathy', 1),
(3011, 'ORPHA:179', 'Vitiliginous choroiditis', 1),
(3012, 'ORPHA:1790', 'Hypomandibular faciocranial dysostosis', 1),
(3013, 'ORPHA:179006', 'Primary immunodeficiency due to a defect in adaptive immunity', 3),
(3014, 'ORPHA:1791', 'Frontofacionasal dysplasia', 1),
(3015, 'ORPHA:1791', 'Gollop syndrome', 1),
(3016, 'ORPHA:1794', 'Oculomaxillofacial dysostosis', 1),
(3017, 'ORPHA:1794', 'Richieri-Costa-Gorlin syndrome', 1),
(3018, 'ORPHA:179490', 'Obesity due to congenital leptin resistance', 2),
(3019, 'ORPHA:179494', 'Obesity due to leptin receptor gene deficiency', 2),
(3020, 'ORPHA:1795', 'Peripheral dysostosis', 1),
(3021, 'ORPHA:1797', 'Autosomal dominant spondylocostal dysostosis', 1),
(3022, 'ORPHA:1797', 'Autosomal dominant spondylocostal dysplasia', 1),
(3023, 'ORPHA:1798', 'Autosomal dominant osteosclerosis, Stanescu type', 1),
(3024, 'ORPHA:1798', 'Craniofacial dysostosis-diaphyseal hyperplasia syndrome', 1),
(3025, 'ORPHA:1798', 'Dysostosis, Stanescu type', 1),
(3026, 'ORPHA:1798', 'Stanescu osteosclerosis', 1),
(3027, 'ORPHA:1799', 'Billard-Toutain-Maheut syndrome', 1),
(3028, 'ORPHA:1799', 'FOXP2-associated dysphasia', 1),
(3029, 'ORPHA:1799', 'Familial developmental dysphasia', 1),
(3030, 'ORPHA:18', 'Classic RTA', 1),
(3031, 'ORPHA:18', 'Distal renal tubular acidosis', 1),
(3032, 'ORPHA:18', 'Familial distal primary acidosis', 1),
(3033, 'ORPHA:18', 'Renal tubular acidosis type 1', 1),
(3034, 'ORPHA:18', 'dRTA', 1),
(3035, 'ORPHA:180', 'CHM', 1),
(3036, 'ORPHA:180', 'Choroideremia', 1),
(3037, 'ORPHA:180', 'Tapetochoroidal dystrophy', 1),
(3038, 'ORPHA:180062', 'Uterovaginal malformation', 3),
(3039, 'ORPHA:180065', 'Non-syndromic uterovaginal malformation', 3),
(3040, 'ORPHA:180068', 'Incomplete bilateral aplasia of the Müllerian ducts', 3),
(3041, 'ORPHA:180068', 'Partial bilateral aplasia of the Müllerian ducts', 3),
(3042, 'ORPHA:180071', 'Unicornuate uterus', 3),
(3043, 'ORPHA:180071', 'Unilateral aplasia of the Müllerian ducts', 3),
(3044, 'ORPHA:180074', 'Complete unilateral Müllerian aplasia', 1),
(3045, 'ORPHA:180074', 'Complete unilateral aplasia of the Müllerian ducts', 1),
(3046, 'ORPHA:180074', 'True unicornuate uterus', 1),
(3047, 'ORPHA:180074', 'Unicornuate uterus without rudimentary horn', 1),
(3048, 'ORPHA:180079', 'Incomplete unilateral Müllerian aplasia', 1),
(3049, 'ORPHA:180079', 'Incomplete unilateral aplasia of the Müllerian ducts', 1),
(3050, 'ORPHA:180079', 'Pseudounicornuate uterus', 1),
(3051, 'ORPHA:180079', 'Unicornuate uterus with rudimentary horn', 1),
(3052, 'ORPHA:180086', 'Bicervical bicornuate uterus', 1),
(3053, 'ORPHA:180086', 'Didelphys uterus', 1),
(3054, 'ORPHA:1801', 'Kyphomelic dysplasia', 1),
(3055, 'ORPHA:180106', 'Bicervical bicornuate uterus and blind hemivagina', 2),
(3056, 'ORPHA:180111', 'Bicervical bicornuate uterus with patent cervix and vagina', 2),
(3057, 'ORPHA:180114', 'Unicervical bicornuate uterus', 1),
(3058, 'ORPHA:180122', 'Septate uterus', 3),
(3059, 'ORPHA:180126', 'Complete septate uterus', 1),
(3060, 'ORPHA:180126', 'Total septate uterus', 1),
(3061, 'ORPHA:180129', 'Partial septate uterus', 1),
(3062, 'ORPHA:180129', 'Subtotal septate uterus', 1),
(3063, 'ORPHA:180129', 'Uterus subseptus', 1),
(3064, 'ORPHA:180134', 'Bicornuate uterus', 3),
(3065, 'ORPHA:180139', 'Uterine hypoplasia', 1),
(3066, 'ORPHA:180142', 'Absence of uterine body', 1),
(3067, 'ORPHA:180145', 'Uterine cervical aplasia and agenesis', 1),
(3068, 'ORPHA:180148', 'Syndromic uterovaginal malformation', 3),
(3069, 'ORPHA:180151', 'Rare vaginal malformation', 3),
(3070, 'ORPHA:180154', 'Septate vagina', 1),
(3071, 'ORPHA:180157', 'Longitudinal vaginal septum', 2),
(3072, 'ORPHA:180160', 'Transverse vaginal septum', 2),
(3073, 'ORPHA:180163', 'Rare breast malformation', 3),
(3074, 'ORPHA:180170', 'Excess breast volume or number', 3),
(3075, 'ORPHA:180173', 'Deficient breast volume or number', 3),
(3076, 'ORPHA:180176', 'Familial juvenile gigantomastia', 1),
(3077, 'ORPHA:180176', 'Familial juvenile hypertrophy of the breast', 1),
(3078, 'ORPHA:180176', 'Virginal breast hypertrophy', 1),
(3079, 'ORPHA:180182', 'Accessory breasts', 1),
(3080, 'ORPHA:180182', 'Polymastia', 1),
(3081, 'ORPHA:180182', 'Supernumerary breasts', 1),
(3082, 'ORPHA:180188', 'Isolated congenital amastia', 1),
(3083, 'ORPHA:180188', 'Isolated congenital breast hypoplasia/aplasia', 1),
(3084, 'ORPHA:180193', 'Syndromic breast hypoplasia/aplasia', 3),
(3085, 'ORPHA:180199', 'Rare non-malformative gynecologic or obstetric disease', 3),
(3086, 'ORPHA:1802', 'Diaphyseal dysplasia-anemia syndrome', 1),
(3087, 'ORPHA:1802', 'Ghosal hematodiaphyseal dysplasia', 1),
(3088, 'ORPHA:1802', 'Ghosal syndrome', 1),
(3089, 'ORPHA:180202', 'Rare non-malformative breast disease', 3),
(3090, 'ORPHA:180205', 'Rare non-malformative uterovaginal or vulvovaginal disease', 3),
(3091, 'ORPHA:180208', 'Anomaly of puberty or/and menstrual cycle', 3),
(3092, 'ORPHA:180220', 'Rare uterine adnexal tumor', 3),
(3093, 'ORPHA:180226', 'Embryonal carcinoma', 1),
(3094, 'ORPHA:180229', 'Polyembryoma', 1),
(3095, 'ORPHA:180234', 'Mixed germ cell tumor', 1),
(3096, 'ORPHA:180237', 'Benign tumor of fallopian tubes', 1),
(3097, 'ORPHA:180242', 'Cancer of fallopian tubes', 1),
(3098, 'ORPHA:180242', 'Malignant tubal tumor', 1),
(3099, 'ORPHA:180242', 'Malignant tumor of fallopian tubes', 1),
(3100, 'ORPHA:180242', 'Tubal cancer', 1),
(3101, 'ORPHA:180247', 'Vaginal carcinoma', 1),
(3102, 'ORPHA:180247', 'Vaginal malignant epithelial tumor', 1),
(3103, 'ORPHA:180250', 'Rare breast tumor', 3),
(3104, 'ORPHA:180253', 'Rare benign breast tumor', 3),
(3105, 'ORPHA:180257', 'Rare breast cancer', 3),
(3106, 'ORPHA:180257', 'Rare malignant breast tumor', 3),
(3107, 'ORPHA:180261', 'Cystosarcoma phyllodes of the breast', 1),
(3108, 'ORPHA:180261', 'Phyllodes tumor of the breast', 1),
(3109, 'ORPHA:180267', 'Giant adenofibroma of the breast', 1),
(3110, 'ORPHA:180275', 'Mammary Paget disease', 1),
(3111, 'ORPHA:180275', 'Paget disease of the breast', 1),
(3112, 'ORPHA:180275', 'Paget disease of the nipple', 1),
(3113, 'ORPHA:180275', 'Paget\'s disease of the nipple', 1),
(3114, 'ORPHA:1803', 'Rivera-Perez-Salas syndrome', 1),
(3115, 'ORPHA:1803', 'Thoracolimb dysplasia, Rivera type', 1),
(3116, 'ORPHA:1803', 'Thoracomelic dysplasia', 1),
(3117, 'ORPHA:180303', 'Rare non-malformative uterine adnexal disease', 3),
(3118, 'ORPHA:180312', 'Rare vulvovaginal tumor', 3),
(3119, 'ORPHA:1806', 'Ectodermal dysplasia-blindness syndrome', 1),
(3120, 'ORPHA:1807', 'FFDD type III', 2),
(3121, 'ORPHA:1807', 'FFDD3', 2),
(3122, 'ORPHA:1807', 'Focal facial dermal dysplasia 3, Setleis type', 2),
(3123, 'ORPHA:1807', 'Focal facial dermal dysplasia type III', 2),
(3124, 'ORPHA:1807', 'Setleis syndrome', 2),
(3125, 'ORPHA:180766', 'Malformative syndrome with dentinogenesis imperfecta', 3),
(3126, 'ORPHA:180772', 'Rare disease with autism', 3),
(3127, 'ORPHA:180776', 'Non-syndromic diaphragmatic or thoracic malformation', 3),
(3128, 'ORPHA:180779', 'Syndromic diaphragmatic or thoracic malformation', 3),
(3129, 'ORPHA:1808', 'Christianson-Fourie syndrome', 1),
(3130, 'ORPHA:1808', 'Hidrotic ectodermal dysplasia, Christianson-Fourie type', 1),
(3131, 'ORPHA:180821', 'Rare gastroesophageal tumor', 3),
(3132, 'ORPHA:180824', 'Rare pancreatic tumor', 3),
(3133, 'ORPHA:180824', 'Rare tumor of pancreas', 3),
(3134, 'ORPHA:1809', 'Halal-Setton-Wang syndrome', 1),
(3135, 'ORPHA:1809', 'Hidrotic ectodermal dysplasia, Halal type', 1),
(3136, 'ORPHA:1809', 'Trichodysplasia-abnormal dermatoglyphics-intellectual disability syndrome', 1),
(3137, 'ORPHA:181', 'Christ-Siemens-Touraine syndrome', 2),
(3138, 'ORPHA:181', 'X-linked anhidrotic ectodermal dysplasia', 2),
(3139, 'ORPHA:181', 'X-linked hypohidrotic ectodermal dysplasia', 2),
(3140, 'ORPHA:181', 'XHED', 2),
(3141, 'ORPHA:1810', 'AD-HED', 2),
(3142, 'ORPHA:1810', 'Autosomal dominant anhidrotic ectodermal dysplasia', 2),
(3143, 'ORPHA:1810', 'Autosomal dominant hypohidrotic ectodermal dysplasia', 2),
(3144, 'ORPHA:1811', 'Odontomicronychial dysplasia', 1),
(3145, 'ORPHA:1812', 'Ectodermal dysplasia-intellectual disability-central nervous system malformation syndrome', 1),
(3146, 'ORPHA:181368', 'Rare insulin-resistance syndrome', 3),
(3147, 'ORPHA:181371', 'Rare diabetes mellitus type 1', 3),
(3148, 'ORPHA:181371', 'Rare insulin-dependent diabetes mellitus', 3),
(3149, 'ORPHA:181376', 'Rare diabetes mellitus type 2', 3),
(3150, 'ORPHA:181376', 'Rare insulin-independent diabetes mellitus', 3),
(3151, 'ORPHA:181381', 'Other rare diabetes mellitus', 3),
(3152, 'ORPHA:181384', 'Rare hypothalamic or pituitary disease', 3),
(3153, 'ORPHA:181387', 'Rare disorder with multisystemic involvement and congenital hypogonadotropic hypogonadism', 3),
(3154, 'ORPHA:181390', 'Endocrinopathy with congenital hypogonadotropic hypogonadism as a major feature', 3),
(3155, 'ORPHA:181393', 'GHIS', 3),
(3156, 'ORPHA:181393', 'Growth hormone insensitivity syndrome', 3),
(3157, 'ORPHA:181393', 'Short stature due to a defect in growth hormone receptor or post-receptor pathway', 3),
(3158, 'ORPHA:181396', 'Rare hypothyroidism', 3),
(3159, 'ORPHA:181399', 'Rare hyperthyroidism', 3),
(3160, 'ORPHA:181402', 'Syndrome with hypoparathyroidism', 3),
(3161, 'ORPHA:181405', 'Rare hypoparathyroidism', 3),
(3162, 'ORPHA:181408', 'Rare hyperparathyroidism', 3),
(3163, 'ORPHA:181412', 'Adrenogenital syndrome', 3),
(3164, 'ORPHA:181415', 'Rare primary aldosteronism', 3),
(3165, 'ORPHA:181415', 'Rare primary hyperaldosteronism', 3),
(3166, 'ORPHA:181419', 'Rare hypoaldosteronism', 3),
(3167, 'ORPHA:181422', 'Rare hyperlipidemia', 3),
(3168, 'ORPHA:181428', 'Hyperalphalipoproteinemia', 3),
(3169, 'ORPHA:181431', 'Rare hypolipidemia', 3),
(3170, 'ORPHA:181437', 'Rare syndromic dyslipidemia', 3),
(3171, 'ORPHA:181441', 'Rare disorder with hypergonadotropic hypogonadism', 3),
(3172, 'ORPHA:181441', 'Rare disorder with primary hypogonadism', 3),
(3173, 'ORPHA:1816', 'Berlin syndrome', 1),
(3174, 'ORPHA:1816', 'Ectodermal dysplasia, Berlin type', 1),
(3175, 'ORPHA:1816', 'Leukomelanoderma-infantilism-intellectual disability-hypodontia-hypotrichosis syndrome', 1),
(3176, 'ORPHA:1818', 'Ectodermal dysplasia, trichoodontoonychial type', 1),
(3177, 'ORPHA:182', 'Chromoblastomycosis', 1),
(3178, 'ORPHA:182', 'Chromomycosis', 1),
(3179, 'ORPHA:182040', 'Aplastic anemia', 3),
(3180, 'ORPHA:182043', 'Rare constitutional hemolytic anemia', 3),
(3181, 'ORPHA:182047', 'Rare acquired hemolytic anemia', 3),
(3182, 'ORPHA:182050', 'MYH9-RD', 1),
(3183, 'ORPHA:182050', 'MYH9-related disease', 1),
(3184, 'ORPHA:182050', 'MYH9-related disorder', 1),
(3185, 'ORPHA:182050', 'MYH9-related syndrome', 1),
(3186, 'ORPHA:182050', 'MYH9-related syndromic thrombocytopenia', 1),
(3187, 'ORPHA:182054', 'Rare thrombotic disease of hematologic origin', 3),
(3188, 'ORPHA:182058', 'Primary orthostatic hypotension', 3),
(3189, 'ORPHA:182061', 'Cerebellar malformation', 3),
(3190, 'ORPHA:182064', 'Rare neuroinflammatory or neuroimmunological disease', 3),
(3191, 'ORPHA:182067', 'Glial tumor', 3),
(3192, 'ORPHA:182067', 'Glioma', 3),
(3193, 'ORPHA:182070', 'Rare neurodegenerative disease', 3),
(3194, 'ORPHA:182073', 'Syndromic neurometabolic disease with non-X-linked intellectual disability', 3),
(3195, 'ORPHA:182076', 'Syndromic neurometabolic disease with X-linked intellectual disability', 3),
(3196, 'ORPHA:182079', 'ARX-related epileptic encephalopathy', 3),
(3197, 'ORPHA:182083', 'Channelopathy with epilepsy', 3),
(3198, 'ORPHA:182086', 'Acquired peripheral neuropathy', 3),
(3199, 'ORPHA:182090', 'PAH', 3),
(3200, 'ORPHA:182090', 'Pulmonary arterial hypertension', 3),
(3201, 'ORPHA:182095', 'ILD', 3),
(3202, 'ORPHA:182095', 'Interstitial lung disease', 3),
(3203, 'ORPHA:182098', 'Pneumoconiosis', 3),
(3204, 'ORPHA:182101', 'Idiopathic eosinophilic pneumonia', 3),
(3205, 'ORPHA:182104', 'CTD-ILD', 3),
(3206, 'ORPHA:182104', 'Secondary ILD in childhood and adulthood associated with a connective tissue disease', 3),
(3207, 'ORPHA:182104', 'Secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease', 3),
(3208, 'ORPHA:182108', 'Thoracic malformation', 3),
(3209, 'ORPHA:182111', 'Respiratory malformation', 3),
(3210, 'ORPHA:182114', 'Rare urogenital tumor', 3),
(3211, 'ORPHA:182117', 'Non-syndromic urogenital tract malformation of female', 3),
(3212, 'ORPHA:182121', 'Non-syndromic urogenital tract malformation of male', 3),
(3213, 'ORPHA:182124', 'Non-syndromic urogenital tract malformation of male and female', 3),
(3214, 'ORPHA:182127', 'Extragonadal germinoma', 1),
(3215, 'ORPHA:182130', 'Tumor of endocrine glands', 3),
(3216, 'ORPHA:1822', 'Dysplasia epiphysealis hemimelica', 1),
(3217, 'ORPHA:1822', 'Trevor disease', 1),
(3218, 'ORPHA:182222', 'Rare systemic disease', 3),
(3219, 'ORPHA:182228', 'Systemic autoimmune disease', 3),
(3220, 'ORPHA:182231', 'Rare rheumatologic disease', 3),
(3221, 'ORPHA:1824', 'Epiphyseal dysplasia-microcephaly-nystagmus syndrome', 1),
(3222, 'ORPHA:1824', 'Lowry-Wood syndrome', 1),
(3223, 'ORPHA:1825', 'Epiphyseal dysplasia-deafness-dysmorphism syndrome', 1),
(3224, 'ORPHA:1825', 'Epiphyseal dysplasia-hearing loss-dysmorphism syndrome', 1),
(3225, 'ORPHA:1825', 'Finucane-Kurtz-Scott syndrome', 1),
(3226, 'ORPHA:1826', 'Frontometaphyseal dysplasia', 1),
(3227, 'ORPHA:1827', 'AFND', 1),
(3228, 'ORPHA:1827', 'Acromelic frontonasal dysostosis', 1),
(3229, 'ORPHA:1827', 'Acromelic frontonasal dysplasia', 1),
(3230, 'ORPHA:1827', 'Toriello syndrome', 1),
(3231, 'ORPHA:182734', 'Genetic urticaria', 3),
(3232, 'ORPHA:183', 'Churg-Strauss syndrome', 1),
(3233, 'ORPHA:183', 'EGPA', 1),
(3234, 'ORPHA:183', 'Eosinophilic granulomatosis with polyangiitis', 1),
(3235, 'ORPHA:183', 'Granulomatous allergic angiitis', 1),
(3236, 'ORPHA:1830', 'Schimke immuno-osseous dysplasia', 1),
(3237, 'ORPHA:1830', 'Schimke syndrome', 1),
(3238, 'ORPHA:1830', 'Spondyloepiphyseal dysplasia-nephrotic syndrome', 1),
(3239, 'ORPHA:1832', 'Lethal osteosclerotic bone dysplasia', 1),
(3240, 'ORPHA:1832', 'Raine syndrome', 1),
(3241, 'ORPHA:1834', 'Axial mesodermal dysplasia spectrum', 1),
(3242, 'ORPHA:1834', 'Blastogenesis defect', 1),
(3243, 'ORPHA:1834', 'Russell-Weaver-Bull syndrome', 1),
(3244, 'ORPHA:183422', 'Polymalformative genetic syndrome with increased risk of developing cancer', 3),
(3245, 'ORPHA:183426', 'Genetic epidermal disorder', 3),
(3246, 'ORPHA:183435', 'Genetic ichthyosis', 3),
(3247, 'ORPHA:183435', 'Inherited ichthyosis', 3),
(3248, 'ORPHA:183438', 'Genetic erythrokeratoderma', 3),
(3249, 'ORPHA:183441', 'Genetic acrokeratoderma', 3),
(3250, 'ORPHA:183444', 'Genetic porokeratosis', 3),
(3251, 'ORPHA:183447', 'Genetic epidermal appendage anomaly', 3),
(3252, 'ORPHA:183450', 'Genetic hair anomaly', 3),
(3253, 'ORPHA:183454', 'Genetic nail anomaly', 3),
(3254, 'ORPHA:183460', 'Genetic sebaceous gland anomaly', 3),
(3255, 'ORPHA:183463', 'Genetic pigmentation anomaly of the skin', 3),
(3256, 'ORPHA:183466', 'Genetic hyperpigmentation of the skin', 3),
(3257, 'ORPHA:183469', 'Genetic hypopigmentation of the skin', 3),
(3258, 'ORPHA:183472', 'Genetic dermis disorder', 3),
(3259, 'ORPHA:183478', 'Genetic skin vascular disorder', 3),
(3260, 'ORPHA:183481', 'Genetic mixed dermis disorder', 3),
(3261, 'ORPHA:183484', 'Genetic subcutaneous tissue disorder', 3),
(3262, 'ORPHA:183487', 'Genetic skin tumor', 3),
(3263, 'ORPHA:183490', 'Genetic photodermatosis', 3),
(3264, 'ORPHA:183490', 'Genetic skin photosensitivity', 3),
(3265, 'ORPHA:183490', 'Photogenodermatosis', 3),
(3266, 'ORPHA:183490', 'Photogénodermatose', 3),
(3267, 'ORPHA:183494', 'Genetic immune deficiency with skin involvement', 3),
(3268, 'ORPHA:183497', 'Genetic neuromuscular disease', 3),
(3269, 'ORPHA:183500', 'Genetic neurodegenerative disease', 3),
(3270, 'ORPHA:183503', 'Genetic central nervous system and retinal vascular disease', 3),
(3271, 'ORPHA:183506', 'Genetic central nervous system malformation', 3),
(3272, 'ORPHA:183509', 'Rare genetic headache', 3),
(3273, 'ORPHA:183512', 'Rare genetic epilepsy', 3),
(3274, 'ORPHA:183515', 'Rare genetic medullar disease', 3),
(3275, 'ORPHA:183518', 'Rare hereditary ataxia', 3),
(3276, 'ORPHA:183521', 'Rare genetic movement disorder', 3),
(3277, 'ORPHA:183524', 'Rare genetic bone disease', 3),
(3278, 'ORPHA:183527', 'Genetic bone tumor', 3),
(3279, 'ORPHA:183530', 'Rare genetic developmental defect during embryogenesis', 3),
(3280, 'ORPHA:183533', 'Genetic multiple congenital anomalies/dysmorphic syndrome', 3),
(3281, 'ORPHA:183536', 'Genetic congenital limb malformation', 3),
(3282, 'ORPHA:183539', 'Genetic renal or urinary tract malformation', 3),
(3283, 'ORPHA:183542', 'Genetic cranial malformation', 3),
(3284, 'ORPHA:183545', 'Genetic digestive tract malformation', 3),
(3285, 'ORPHA:183548', 'Genetic visceral malformation of the liver, biliary tract, pancreas or spleen', 3),
(3286, 'ORPHA:183554', 'Genetic respiratory or mediastinal malformation', 3),
(3287, 'ORPHA:183557', 'Genetic developmental defect of the eye', 3),
(3288, 'ORPHA:183570', 'Genetic malformation syndrome with short stature', 3),
(3289, 'ORPHA:183573', 'Genetic overgrowth/obesity syndrome', 3),
(3290, 'ORPHA:183576', 'Genetic branchial arch or oral-acral syndrome', 3),
(3291, 'ORPHA:183580', 'Genetic malformation syndrome with odontal and/or periodontal component', 3),
(3292, 'ORPHA:183583', 'Genetic head and neck malformation', 3),
(3293, 'ORPHA:183586', 'Genetic glomerular disease', 3),
(3294, 'ORPHA:183589', 'Genetic thrombotic microangiopathy', 3),
(3295, 'ORPHA:183592', 'Genetic renal tubular disease', 3),
(3296, 'ORPHA:183595', 'Genetic renal tumor', 3),
(3297, 'ORPHA:1836', 'Kantaputra mesomelic dysplasia', 1),
(3298, 'ORPHA:1836', 'MDK', 1),
(3299, 'ORPHA:1836', 'Mesomelic dysplasia, Kantaputra type', 1),
(3300, 'ORPHA:1836', 'Mesomelic dysplasia, Thai type', 1),
(3301, 'ORPHA:183607', 'Genetic lens and zonula anomaly', 3),
(3302, 'ORPHA:183616', 'Genetic neuro-ophthalmological disease', 3),
(3303, 'ORPHA:183619', 'Genetic eye tumor', 3),
(3304, 'ORPHA:183622', 'Genetic respiratory malformation', 3),
(3305, 'ORPHA:183625', 'Rare genetic diabetes mellitus', 3),
(3306, 'ORPHA:183628', 'Rare genetic hypothalamic or pituitary disease', 3),
(3307, 'ORPHA:183631', 'Rare genetic thyroid disease', 3),
(3308, 'ORPHA:183634', 'Rare genetic parathyroid disease and phosphocalcic metabolism disorder', 3),
(3309, 'ORPHA:183637', 'Rare genetic adrenal disease', 3),
(3310, 'ORPHA:183643', 'Genetic polyendocrinopathy', 3),
(3311, 'ORPHA:183651', 'Rare constitutional anemia', 3),
(3312, 'ORPHA:183654', 'Rare genetic coagulation disorder', 3),
(3313, 'ORPHA:183660', 'SCID', 3),
(3314, 'ORPHA:183660', 'Severe combined immunodeficiency', 3),
(3315, 'ORPHA:183663', 'HIGM with susceptibility to opportunistic infections', 1),
(3316, 'ORPHA:183663', 'Hyper-IgM syndrome with susceptibility to opportunistic infections', 1),
(3317, 'ORPHA:183666', 'HIGM without susceptibility to opportunistic infections', 1),
(3318, 'ORPHA:183666', 'Hyper-IgM syndrome without susceptibility to opportunistic infections', 1),
(3319, 'ORPHA:183669', 'Agammaglobulinemia', 3),
(3320, 'ORPHA:183675', 'IgG subclass deficiency with IgA subclass deficiency', 1),
(3321, 'ORPHA:183675', 'Isolated IgG subclass deficiency', 1),
(3322, 'ORPHA:183675', 'Kappa-chain deficiency', 1),
(3323, 'ORPHA:183675', 'Recurrent infections associated with rare immunoglobulin isotypes deficiency', 1),
(3324, 'ORPHA:183675', 'Selective IgG subclass deficiency', 1),
(3325, 'ORPHA:183678', 'HPS2', 2),
(3326, 'ORPHA:183678', 'Hermansky-Pudlak syndrome type 2', 2),
(3327, 'ORPHA:183678', 'Hermansky-Pudlak syndrome with neutropenia', 2),
(3328, 'ORPHA:183681', 'Functional neutrophil defect', 3),
(3329, 'ORPHA:1837', 'Rosenberg-Lohr syndrome', 1),
(3330, 'ORPHA:1837', 'Ulna metaphyseal dysplasia syndrome', 1),
(3331, 'ORPHA:183707', 'Neutrophil immunodeficiency syndrome', 1),
(3332, 'ORPHA:183710', 'Genetic susceptibility to infections due to particular pathogens', 3),
(3333, 'ORPHA:183713', 'Bacterial susceptibility due to TLR signaling pathway deficiency', 1),
(3334, 'ORPHA:183731', 'Rare genetic gynecological and obstetrical diseases', 3),
(3335, 'ORPHA:183734', 'Genetic gynecological tumor', 3),
(3336, 'ORPHA:183757', 'Rare genetic intellectual disability', 3),
(3337, 'ORPHA:183763', 'Rare genetic syndromic intellectual disability', 3),
(3338, 'ORPHA:183770', 'Rare genetic immune disease', 3),
(3339, 'ORPHA:1839', 'Hereditary mucoepithelial dysplasia', 1),
(3340, 'ORPHA:1839', 'Urban-Schosser-Spohn syndrome', 1),
(3341, 'ORPHA:184', 'CRBM', 1),
(3342, 'ORPHA:184', 'Cherubism', 1),
(3343, 'ORPHA:1842', 'Autosomal recessive lethal chondrodysplasia, round femoral inferior epiphysis type', 1),
(3344, 'ORPHA:1842', 'Bone dysplasia, lethal Holmgren type', 1),
(3345, 'ORPHA:1848', 'Renal agenesis, bilateral', 2),
(3346, 'ORPHA:185', 'Congenital pulmonary venolobar syndrome', 1),
(3347, 'ORPHA:185', 'Epibronchial right pulmonary vein syndrome', 1),
(3348, 'ORPHA:185', 'Halasz syndrome', 1),
(3349, 'ORPHA:185', 'Hypogenetic lung syndrome', 1),
(3350, 'ORPHA:185', 'Scimitar syndrome', 1),
(3351, 'ORPHA:1851', 'MCDK', 1),
(3352, 'ORPHA:1851', 'Multicystic dysplastic kidney', 1),
(3353, 'ORPHA:1851', 'Multicystic renal dysplasia', 1),
(3354, 'ORPHA:1852', 'X-linked retinal dysplasia', 1),
(3355, 'ORPHA:1855', 'SPENCD', 1),
(3356, 'ORPHA:1855', 'Spondyloenchondrodysplasia', 1),
(3357, 'ORPHA:1855', 'Spondyloenchondromatosis', 1),
(3358, 'ORPHA:1855', 'Spondylometaphyseal dysplasia with enchondromatous changes', 1),
(3359, 'ORPHA:1856', 'Spondyloperipheral dysplasia-short ulna syndrome', 1),
(3360, 'ORPHA:1858', 'Gurrieri-Sammito-Bellussi syndrome', 1),
(3361, 'ORPHA:1858', 'Skeletal dysplasia-epilepsy-short stature syndrome', 1),
(3362, 'ORPHA:186', 'Hanot syndrome', 1),
(3363, 'ORPHA:186', 'PBC', 1),
(3364, 'ORPHA:186', 'Primary biliary cholangitis', 1),
(3365, 'ORPHA:186', 'Primary biliary cirrhosis', 1),
(3366, 'ORPHA:1860', 'TD1', 2),
(3367, 'ORPHA:1860', 'Thanatophoric dwarfism type 1', 2),
(3368, 'ORPHA:1860', 'Thanatophoric dysplasia type 1', 2),
(3369, 'ORPHA:1861', 'Thoracic dysplasia-hydrocephalus syndrome', 1),
(3370, 'ORPHA:1865', 'Dyssegmental dysplasia, Silverman-Handmaker type', 1),
(3371, 'ORPHA:1866', 'Focal, segmental or multifocal dystonia', 3),
(3372, 'ORPHA:1867', 'Hereditary bullous dystrophy, macular type', 1),
(3373, 'ORPHA:187', 'Citrullinemia', 3),
(3374, 'ORPHA:1871', 'Cone dystrophy', 1),
(3375, 'ORPHA:1871', 'Progressive cone dystrophy', 1),
(3376, 'ORPHA:1872', 'Cone rod dystrophy', 1),
(3377, 'ORPHA:1873', 'Cone rod dystrophy-amelogenesis imperfecta syndrome', 1),
(3378, 'ORPHA:1873', 'Jalili syndrome', 1),
(3379, 'ORPHA:1875', 'Bassoe syndrome', 1),
(3380, 'ORPHA:1875', 'Congenital muscular dystrophy-infantile cataract-hypogonadism syndrome', 1),
(3381, 'ORPHA:1876', 'Oculogastrointestinal muscular dystrophy', 1),
(3382, 'ORPHA:1876', 'Visceral myopathy-familial external ophthalmoplegia syndrome', 1),
(3383, 'ORPHA:1878', 'Autosomal recessive limb-girdle muscular dystrophy type 2H', 1),
(3384, 'ORPHA:1878', 'LGMD due to TRIM32 deficiency', 1),
(3385, 'ORPHA:1878', 'LGMD type 2H', 1),
(3386, 'ORPHA:1878', 'LGMD2H', 1),
(3387, 'ORPHA:1878', 'Limb-girdle muscular dystrophy due to TRIM32 deficiency', 1),
(3388, 'ORPHA:1878', 'Limb-girdle muscular dystrophy type 2H', 1),
(3389, 'ORPHA:1878', 'Sarcotubular myopathy', 1),
(3390, 'ORPHA:1878', 'TRIM32-related  limb-girdle muscular dystrophy R8', 1),
(3391, 'ORPHA:1878', 'TRIM32-related LGMD R8', 1),
(3392, 'ORPHA:1879', 'MSBD syndrome', 1),
(3393, 'ORPHA:1879', 'Melorheostosis with osteopoikilosis', 1),
(3394, 'ORPHA:1879', 'Mixed sclerosing bone dystrophy', 1),
(3395, 'ORPHA:188', 'Capillary hyperpermeability syndrome', 1),
(3396, 'ORPHA:188', 'Capillary leak syndrome', 1),
(3397, 'ORPHA:188', 'Clarkson disease', 1),
(3398, 'ORPHA:188', 'Idiopathic capillary leak syndrome', 1),
(3399, 'ORPHA:188', 'SCLS', 1),
(3400, 'ORPHA:188', 'Systemic capillary leak syndrome', 1),
(3401, 'ORPHA:1880', 'Ebstein anomaly of the tricuspid valve', 1),
(3402, 'ORPHA:1880', 'Ebstein malformation', 1),
(3403, 'ORPHA:1882', 'ANOTHER syndrome', 1),
(3404, 'ORPHA:1882', 'HEDH syndrome', 1),
(3405, 'ORPHA:1882', 'Hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome', 1),
(3406, 'ORPHA:1883', 'Ectodermal dysplasia-sensorineural deafness syndrome', 1),
(3407, 'ORPHA:1883', 'Ectodermal dysplasia-sensorineural hearing loss syndrome', 1),
(3408, 'ORPHA:1884', 'Ectopia lentis-chorioretinal dystrophy-myopia syndrome', 1),
(3409, 'ORPHA:1884', 'Noble-Bass-Sherman syndrome', 1),
(3410, 'ORPHA:1885', 'Ectopia lentis syndrome', 1),
(3411, 'ORPHA:1885', 'Familial ectopia lentis', 1),
(3412, 'ORPHA:1885', 'Isolated ectopia lentis', 1),
(3413, 'ORPHA:189', 'Clouston syndrome', 1),
(3414, 'ORPHA:189', 'Hidrotic ectodermal dysplasia', 1),
(3415, 'ORPHA:1891', 'Intellectual disability-spasticity-ectrodactyly syndrome', 1),
(3416, 'ORPHA:1891', 'Jancar syndrome', 1),
(3417, 'ORPHA:1892', 'Ectrodactyly-polydactyly syndrome', 1),
(3418, 'ORPHA:189427', 'Cushing syndrome due to macronodular adrenal hyperplasia', 1),
(3419, 'ORPHA:189427', 'Primary bilateral macronodular adrenal hyperplasia', 1),
(3420, 'ORPHA:189439', 'PPNAD', 1),
(3421, 'ORPHA:189439', 'Primary pigmented nodular adrenal dysplasia', 1),
(3422, 'ORPHA:189439', 'Primary pigmented nodular adrenocortical disease', 1),
(3423, 'ORPHA:189466', 'Familial isolated hypoparathyroidism due to impaired PTH secretion', 2),
(3424, 'ORPHA:1895', 'Edinburgh malformation syndrome', 1),
(3425, 'ORPHA:1895', 'Typus Edinburgensis', 1),
(3426, 'ORPHA:1896', 'EEC syndrome', 1),
(3427, 'ORPHA:1896', 'Ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome', 1),
(3428, 'ORPHA:1897', 'EEM syndrome', 1),
(3429, 'ORPHA:1897', 'Ectodermal dysplasia-ectrodactyly-macular dystrophy syndrome', 1),
(3430, 'ORPHA:1899', 'Arthrochalasia Ehlers-Danlos syndrome', 1),
(3431, 'ORPHA:1899', 'Arthrochalasis multiplex congenita', 1),
(3432, 'ORPHA:1899', 'EDS VII', 1),
(3433, 'ORPHA:1899', 'Ehlers-Danlos syndrome type 7', 1),
(3434, 'ORPHA:1899', 'Ehlers-Danlos syndrome, arthrochalasia type', 1),
(3435, 'ORPHA:1899', 'aEDS', 1),
(3436, 'ORPHA:19', '2-hydroxyglutaric acidemia', 3),
(3437, 'ORPHA:19', '2-hydroxyglutaric aciduria', 3),
(3438, 'ORPHA:190', 'Coats disease', 1),
(3439, 'ORPHA:190', 'Congenital retinal telangiectasia', 1),
(3440, 'ORPHA:190', 'Leber miliary aneurysm', 1),
(3441, 'ORPHA:1900', 'Cutis hyperelastica', 2),
(3442, 'ORPHA:1900', 'EDS VIA', 2),
(3443, 'ORPHA:1900', 'Ehlers-Danlos syndrome type 6A', 2),
(3444, 'ORPHA:1900', 'Kyphoscoliotic EDS due to lysyl hydroxylase 1 deficiency', 2),
(3445, 'ORPHA:1900', 'Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency', 2),
(3446, 'ORPHA:1900', 'Lysyl hydroxylase-deficient EDS', 2),
(3447, 'ORPHA:1900', 'Ocular-scoliotic EDS', 2),
(3448, 'ORPHA:1900', 'kEDS-PLOD1', 2),
(3449, 'ORPHA:1901', 'Dermatosparaxis Ehlers-Danlos syndrome', 1),
(3450, 'ORPHA:1901', 'Ehlers-Danlos syndrome type 7C', 1),
(3451, 'ORPHA:1901', 'Human dermatosparaxis EDS VIIC', 1),
(3452, 'ORPHA:1901', 'dEDS', 1),
(3453, 'ORPHA:1902', 'Ehrlichiosis', 1),
(3454, 'ORPHA:1906', 'Fetal valproate spectrum disorder', 1),
(3455, 'ORPHA:1906', 'Fetal valproate syndrome', 1),
(3456, 'ORPHA:1906', 'Fetal valproic acid syndrome', 1),
(3457, 'ORPHA:1906', 'Valproic acid embryopathy', 1),
(3458, 'ORPHA:1908', 'Aminopterin embryopathy syndrome', 1),
(3459, 'ORPHA:1908', 'Aminopterin/methotrexate embryofetopathy', 1),
(3460, 'ORPHA:1908', 'Fetal aminopterin syndrome', 1),
(3461, 'ORPHA:1909', 'Fetal indomethacin syndrome', 1),
(3462, 'ORPHA:1909', 'Indomethacin embryofetopathy', 1),
(3463, 'ORPHA:191', 'Cockayne syndrome', 1),
(3464, 'ORPHA:1910', 'Fetal iodine syndrome', 1),
(3465, 'ORPHA:1911', 'Cocaine embryofetopathy', 1),
(3466, 'ORPHA:1911', 'Fetal cocaine syndrome', 1),
(3467, 'ORPHA:1912', 'Fetal dihydantoin syndrome', 1),
(3468, 'ORPHA:1912', 'Fetal hydantoin syndrome', 1),
(3469, 'ORPHA:1912', 'Phenytoin embryofetopathy', 1),
(3470, 'ORPHA:1913', 'Fetal trimethadione syndrome', 1),
(3471, 'ORPHA:1914', 'Vitamin K antagonist embryofetopathy', 1),
(3472, 'ORPHA:1914', 'Vitamin K antagonist embryopathy', 1),
(3473, 'ORPHA:1914', 'Warfarin embryofetopathy', 1),
(3474, 'ORPHA:1914', 'Warfarin embryopathy', 1),
(3475, 'ORPHA:1914', 'di Sala syndrome', 1),
(3476, 'ORPHA:1915', 'ARBD', 1),
(3477, 'ORPHA:1915', 'ARND', 1),
(3478, 'ORPHA:1915', 'Alcohol-related birth defects', 1),
(3479, 'ORPHA:1915', 'Alcohol-related neurodevelopmental disorder', 1),
(3480, 'ORPHA:1915', 'FAS', 1),
(3481, 'ORPHA:1915', 'FASD', 1),
(3482, 'ORPHA:1915', 'Fetal alcohol spectrum disorders', 1),
(3483, 'ORPHA:1915', 'Fetal alcohol syndrome', 1),
(3484, 'ORPHA:1916', 'DES embryofetopathy', 1),
(3485, 'ORPHA:1916', 'DES syndrome', 1),
(3486, 'ORPHA:1916', 'Diethylstilbestrol embryofetopathy', 1),
(3487, 'ORPHA:1916', 'Diethylstilbestrol syndrome', 1),
(3488, 'ORPHA:1916', 'Distilbene embryofetopathy', 1),
(3489, 'ORPHA:1917', 'Fetal methylmercury syndrome', 1),
(3490, 'ORPHA:1917', 'Methyl mercury antenatal infection', 1),
(3491, 'ORPHA:1917', 'Minamata disease', 1),
(3492, 'ORPHA:1918', 'Fetal minoxidil syndrome', 1),
(3493, 'ORPHA:1918', 'Minoxidil antenatal infection', 1),
(3494, 'ORPHA:1919', 'Phenobarbital embryopathy', 1),
(3495, 'ORPHA:192', 'CLS', 1),
(3496, 'ORPHA:192', 'Coffin-Lowry syndrome', 1),
(3497, 'ORPHA:1920', 'Toluene embryopathy', 1),
(3498, 'ORPHA:1923', 'MMI/CMZ embryofetopathy', 1),
(3499, 'ORPHA:1923', 'MMI/CMZ embryopathy', 1),
(3500, 'ORPHA:1923', 'Methimazole embryofetopathy', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(3501, 'ORPHA:1923', 'Methimazole/carbimazole embryofetopathy', 1),
(3502, 'ORPHA:1923', 'Methimazole/carbimazole embryopathy', 1),
(3503, 'ORPHA:1926', 'Diabetic embryopathy', 1),
(3504, 'ORPHA:1927', 'Emery-Nelson syndrome', 1),
(3505, 'ORPHA:1927', 'Hand and foot deformity-flat facies syndrome', 1),
(3506, 'ORPHA:1928', 'Congenital lobar emphysema', 1),
(3507, 'ORPHA:1928', 'Congenital lobar hyperinflation', 1),
(3508, 'ORPHA:1928', 'Infantile lobar hyperinflation', 1),
(3509, 'ORPHA:1929', 'Rasmussen subacute encephalitis', 1),
(3510, 'ORPHA:1929', 'Rasmussen syndrome', 1),
(3511, 'ORPHA:193', 'Cohen syndrome', 1),
(3512, 'ORPHA:1930', 'HSE', 1),
(3513, 'ORPHA:1930', 'HSV encephalitis', 1),
(3514, 'ORPHA:1930', 'HSVE', 1),
(3515, 'ORPHA:1930', 'Herpes simplex meningo-encephalitis', 1),
(3516, 'ORPHA:1930', 'Herpes simplex neuroinvasion', 1),
(3517, 'ORPHA:1930', 'Herpes simplex virus encephalitis', 1),
(3518, 'ORPHA:1930', 'Herpetic encephalitis', 1),
(3519, 'ORPHA:1931', 'Anterior encephalocele', 2),
(3520, 'ORPHA:1931', 'Frontal encephalocele', 2),
(3521, 'ORPHA:1933', 'Booth-Haworth-Dilling syndrome', 1),
(3522, 'ORPHA:1933', 'Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria', 1),
(3523, 'ORPHA:1933', 'Mitochondrial encephalomyopathy-aminoacidopathy syndrome', 1),
(3524, 'ORPHA:1933', 'mtDNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria', 1),
(3525, 'ORPHA:1934', 'EIEE', 1),
(3526, 'ORPHA:1934', 'Early infantile epileptic encephalopathy', 1),
(3527, 'ORPHA:1934', 'Early infantile epileptic encephalopathy with suppression-bursts', 1),
(3528, 'ORPHA:1934', 'Ohtahara syndrome', 1),
(3529, 'ORPHA:1935', 'Early myoclonic encephalopathy', 1),
(3530, 'ORPHA:1935', 'Early myoclonic encephalopathy with suppression-bursts', 1),
(3531, 'ORPHA:1937', 'Eng-Strom syndrome', 1),
(3532, 'ORPHA:1937', 'Short stature-locking fingers syndrome', 1),
(3533, 'ORPHA:1941', 'JAE', 1),
(3534, 'ORPHA:1941', 'Juvenile absence epilepsy', 1),
(3535, 'ORPHA:1942', 'Doose syndrome', 1),
(3536, 'ORPHA:1942', 'EMAS', 1),
(3537, 'ORPHA:1942', 'Epilepsy with myoclonic-astatic seizures', 1),
(3538, 'ORPHA:1942', 'Epilepsy with myoclonic-atonic seizures', 1),
(3539, 'ORPHA:1942', 'MAE', 1),
(3540, 'ORPHA:1942', 'Myoclonic atonic epilepsy', 1),
(3541, 'ORPHA:1942', 'Myoclonic-astastic epilepsy', 1),
(3542, 'ORPHA:1942', 'Myoclonic-astatic epilepsy in early childhood', 1),
(3543, 'ORPHA:1943', 'Early-onset progressive encephalopathy with migrant continuous myoclonus', 1),
(3544, 'ORPHA:1945', 'BECRS', 1),
(3545, 'ORPHA:1945', 'BECTS', 1),
(3546, 'ORPHA:1945', 'BRE', 1),
(3547, 'ORPHA:1945', 'Benign epilepsy of childhood with centrotemporal spikes', 1),
(3548, 'ORPHA:1945', 'Benign familial epilepsy of childhood with rolandic spikes', 1),
(3549, 'ORPHA:1945', 'Benign rolandic epilepsy', 1),
(3550, 'ORPHA:1945', 'Centrotemporal epilepsy', 1),
(3551, 'ORPHA:1945', 'Rolandic epilepsy', 1),
(3552, 'ORPHA:1946', 'Amelocerebrohypohidrotic syndrome', 1),
(3553, 'ORPHA:1946', 'Epilepsy-dementia-amelogenesis imperfecta syndrome', 1),
(3554, 'ORPHA:1946', 'Kohlschütter-Tönz syndrome', 1),
(3555, 'ORPHA:1947', 'CLN8 disease, Northern epilepsy variant', 1),
(3556, 'ORPHA:1947', 'NCL, Northern epilepsy variant', 1),
(3557, 'ORPHA:1947', 'Neuronal ceroid lipofuscinosis, Northern epilepsy variant', 1),
(3558, 'ORPHA:1947', 'Northern epilepsy', 1),
(3559, 'ORPHA:1947', 'Progressive epilepsy-intellectual disability syndrome, Finnish type', 1),
(3560, 'ORPHA:1948', 'Battaglia-Neri syndrome', 1),
(3561, 'ORPHA:1948', 'Epilepsy-microcephaly-skeletal dysplasia syndrome', 1),
(3562, 'ORPHA:1949', 'BFNS', 1),
(3563, 'ORPHA:1949', 'Benign familial neonatal convulsions', 1),
(3564, 'ORPHA:1949', 'Benign familial neonatal epilepsy', 1),
(3565, 'ORPHA:1949', 'Benign familial neonatal seizures', 1),
(3566, 'ORPHA:195', 'CES', 1),
(3567, 'ORPHA:195', 'Cat-eye syndrome', 1),
(3568, 'ORPHA:1951', 'Epilepsy-telangiectasia syndrome', 1),
(3569, 'ORPHA:1952', 'Epiphyseal stippling syndrome-osteoclastic hyperplasia syndrome', 1),
(3570, 'ORPHA:1952', 'Pacman dysplasia', 1),
(3571, 'ORPHA:1954', 'Congenital lethal erythroderma', 1),
(3572, 'ORPHA:1955', 'Erythrokeratodermia with ataxia', 1),
(3573, 'ORPHA:1955', 'SCA34', 1),
(3574, 'ORPHA:1955', 'Spinocerebellar ataxia and erythrokeratodermia', 1),
(3575, 'ORPHA:1955', 'Spinocerebellar ataxia type 34', 1),
(3576, 'ORPHA:1957', 'Esthesioneuroblastoma', 1),
(3577, 'ORPHA:1957', 'Olfactory neuroblastoma', 1),
(3578, 'ORPHA:1959', 'Autoimmune hemolytic anemia and autoimmune thrombocytopenia', 1),
(3579, 'ORPHA:1959', 'Evans syndrome', 1),
(3580, 'ORPHA:1959', 'Immune pancytopenia', 1),
(3581, 'ORPHA:1962', 'Exostoses-anetodermia-brachydactyly type E syndrome', 1),
(3582, 'ORPHA:1964', 'Char-Douglas-Dungan syndrome', 1),
(3583, 'ORPHA:1964', 'Extrasystoles-short stature-hyperpigmentation-microcephaly syndrome', 1),
(3584, 'ORPHA:1968', 'Blepharophimosis-telecanthus-microstomia syndrome', 1),
(3585, 'ORPHA:1968', 'Flat face-microstomia-ear anomaly syndrome', 1),
(3586, 'ORPHA:1968', 'Simosa craniofacial syndrome', 1),
(3587, 'ORPHA:1968', 'Simosa-Penchaszadeh-Bustos syndrome', 1),
(3588, 'ORPHA:1969', 'FACES syndrome', 1),
(3589, 'ORPHA:1969', 'Facial dysmorphism-anorexia-cachexia-eye and skin anomalies syndrome', 1),
(3590, 'ORPHA:1969', 'Friedman-Goodman syndrome', 1),
(3591, 'ORPHA:1970', 'Facial dysmorphism-macrocephaly-myopia-Dandy-Walker malformation syndrome', 1),
(3592, 'ORPHA:1972', 'Lethal faciocardiomelic dysplasia', 1),
(3593, 'ORPHA:1973', 'Eastman-Bixler syndrome', 1),
(3594, 'ORPHA:1973', 'Faciocardiorenal syndrome', 1),
(3595, 'ORPHA:1974', 'Aarskog-like syndrome', 1),
(3596, 'ORPHA:1974', 'Autosomal recessive faciodigitogenital syndrome', 1),
(3597, 'ORPHA:1974', 'Facio-digito-genital syndrome, Kuwait type', 1),
(3598, 'ORPHA:1974', 'Teebi-Naguib-Alawadi syndrome', 1),
(3599, 'ORPHA:1979', 'Combined insulin, insulin-like growth factor 1 (IGF1) and epidermal growth factor (EGF) deficiency', 1),
(3600, 'ORPHA:1979', 'Hoepffner-Dreyer-Reimers syndrome', 1),
(3601, 'ORPHA:1979', 'Lipodystrophy due to peptidic growth factors deficiency', 1),
(3602, 'ORPHA:1979', 'Werner-like syndrome due to combined growth factor deficiency', 1),
(3603, 'ORPHA:198', 'Occipital horn syndrome', 1),
(3604, 'ORPHA:1980', 'BSPDC', 1),
(3605, 'ORPHA:1980', 'Bilateral striopallidodentate calcinosis', 1),
(3606, 'ORPHA:1980', 'Cerebrovascular ferrocalcinosis', 1),
(3607, 'ORPHA:1980', 'Idiopathic basal ganglia calcification', 1),
(3608, 'ORPHA:1980', 'PFBC', 1),
(3609, 'ORPHA:1980', 'Primary familial brain calcification', 1),
(3610, 'ORPHA:1986', 'Bifid femur-monodactylous ectrodactyly syndrome', 1),
(3611, 'ORPHA:1986', 'Gollop-Wolfgang complex', 1),
(3612, 'ORPHA:1987', 'Congenital short femur', 1),
(3613, 'ORPHA:1987', 'Femoral agenesis/hypoplasia', 1),
(3614, 'ORPHA:1987', 'Femoral intercalary meromelia', 1),
(3615, 'ORPHA:1988', 'FFS', 1),
(3616, 'ORPHA:1988', 'FHUFS', 1),
(3617, 'ORPHA:1988', 'Femoral hypoplasia-unusual facies syndrome', 1),
(3618, 'ORPHA:1988', 'Femoral-facial syndrome', 1),
(3619, 'ORPHA:199', 'Brachmann-de Lange syndrome', 1),
(3620, 'ORPHA:199', 'Cornelia de Lange syndrome', 1),
(3621, 'ORPHA:1991', 'Cleft lip with or without cleft palate', 3),
(3622, 'ORPHA:1991', 'Tessier cleft number 1,2', 3),
(3623, 'ORPHA:199241', 'Pulmonary capillary hemangiomatosis', 1),
(3624, 'ORPHA:199244', 'Nelson syndrome', 1),
(3625, 'ORPHA:199247', 'Corticosteroid-binding globulin deficiency', 1),
(3626, 'ORPHA:199247', 'Transcortin deficiency', 1),
(3627, 'ORPHA:199251', 'Ledderhose disease', 1),
(3628, 'ORPHA:199251', 'Plantar fibromatosis', 1),
(3629, 'ORPHA:199257', 'Superficial fibromatosis', 3),
(3630, 'ORPHA:199260', 'Calcifying aponeurotic fibroma', 1),
(3631, 'ORPHA:199260', 'Juvenile aponeurotic fibromatosis', 1),
(3632, 'ORPHA:199260', 'Keasby tumor', 1),
(3633, 'ORPHA:199267', 'Inclusion body fibromatosis', 1),
(3634, 'ORPHA:199267', 'Infantile digital fibromatosis', 1),
(3635, 'ORPHA:199267', 'Recurring digital fibrous tumor of childhood', 1),
(3636, 'ORPHA:199267', 'Reye tumor', 1),
(3637, 'ORPHA:199276', 'Familial multiple lipomatosis', 1),
(3638, 'ORPHA:199279', 'Familial angiolipomatosis', 1),
(3639, 'ORPHA:199282', 'Harlequin syndrome', 1),
(3640, 'ORPHA:199282', 'Progressive isolated segmental anhidrosis', 1),
(3641, 'ORPHA:199285', 'Hereditary hypercarotenemia and vitamin A deficiency', 1),
(3642, 'ORPHA:199293', 'Congenital microgastria', 1),
(3643, 'ORPHA:199296', 'Congenital isolated ACTH deficiency', 1),
(3644, 'ORPHA:199299', 'Late-onset isolated ACTH deficiency', 1),
(3645, 'ORPHA:1993', 'Median cleft of the upper lip-corpus callosum lipoma-midline facial cutaneous polyps syndrome', 1),
(3646, 'ORPHA:1993', 'Pai syndrome', 1),
(3647, 'ORPHA:199302', 'Isolated cleft lip', 1),
(3648, 'ORPHA:199306', 'Alveolar cleft lip and palate', 1),
(3649, 'ORPHA:199306', 'Cleft lip and palate', 1),
(3650, 'ORPHA:199306', 'Cleft lip-alveolus-palate syndrome', 1),
(3651, 'ORPHA:199306', 'Cleft lip/palate', 1),
(3652, 'ORPHA:199306', 'FLP', 1),
(3653, 'ORPHA:199310', '46,XX/46,XY chimerism', 1),
(3654, 'ORPHA:199310', 'Tetragametic chimerism', 1),
(3655, 'ORPHA:199315', 'Familial clubfoot with or without associated lower limb anomalies', 1),
(3656, 'ORPHA:199318', '15q13.3 microdeletion syndrome', 1),
(3657, 'ORPHA:199318', 'Del(15)(q13.3)', 1),
(3658, 'ORPHA:199318', 'Monosomy 15q13.3', 1),
(3659, 'ORPHA:199323', 'Endophthalmitis', 1),
(3660, 'ORPHA:199326', 'Isolated autosomal dominant hypomagnesemia, Glaudemans type', 1),
(3661, 'ORPHA:199329', 'Congenital myopathy, Paradas type', 1),
(3662, 'ORPHA:199332', 'ECO syndrome', 1),
(3663, 'ORPHA:199332', 'Endocrine-cerebro-osteodysplasia syndrome', 1),
(3664, 'ORPHA:199337', 'Pancreatic insufficiency-anemia-hyperostosis syndrome', 1),
(3665, 'ORPHA:199340', 'Muscular dystrophy, Selcen type', 1),
(3666, 'ORPHA:199343', 'EAST syndrome', 1),
(3667, 'ORPHA:199343', 'Epilepsy-ataxia-sensorineural deafness-tubulopathy syndrome', 1),
(3668, 'ORPHA:199343', 'Epilepsy-ataxia-sensorineural hearing loss-tubulopathy syndrome', 1),
(3669, 'ORPHA:199343', 'SeSAME syndrome', 1),
(3670, 'ORPHA:199343', 'Seizures-sensorineural deafness-ataxia-intellectual disability-electrolyte imbalance syndrome', 1),
(3671, 'ORPHA:199343', 'Seizures-sensorineural hearing loss-ataxia-intellectual disability-electrolyte imbalance syndrome', 1),
(3672, 'ORPHA:199348', 'Thiamine-responsive encephalopathy', 1),
(3673, 'ORPHA:199351', 'Adult-onset dystonia-parkinsonism', 1),
(3674, 'ORPHA:199351', 'Dystonia-parkinsonism, Paisan-Ruiz type', 1),
(3675, 'ORPHA:199351', 'PARK14', 1),
(3676, 'ORPHA:199351', 'PLA2G6-related dystonia-parkinsonism', 1),
(3677, 'ORPHA:199354', 'CARASIL', 1),
(3678, 'ORPHA:199354', 'Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy', 1),
(3679, 'ORPHA:199354', 'Maeda syndrome', 1),
(3680, 'ORPHA:1995', 'Ausems-Wittebol Post-Hennekam syndrome', 1),
(3681, 'ORPHA:1995', 'Cleft lip-cone rod dystrophy syndrome', 1),
(3682, 'ORPHA:1995', 'Cleft lip-progressive retinopathy syndrome', 1),
(3683, 'ORPHA:1995', 'Cleft lip-retinopathy syndrome', 1),
(3684, 'ORPHA:199627', 'Atypical autism', 1),
(3685, 'ORPHA:199630', 'Isolated cerebellar vermis hypoplasia', 1),
(3686, 'ORPHA:199633', 'Non-syndromic brain malformation', 3),
(3687, 'ORPHA:199633', 'Non-syndromic cerebral malformation', 3),
(3688, 'ORPHA:199639', 'Syndrome with corpus callosum agenesis/dysgenesis as a major feature', 3),
(3689, 'ORPHA:199642', 'Isolated congenital microcephaly', 1),
(3690, 'ORPHA:199647', 'Isolated encephalocele', 1),
(3691, 'ORPHA:1997', 'BCD syndrome', 1),
(3692, 'ORPHA:1997', 'Blepharo-cheilo-odontic syndrome', 1),
(3693, 'ORPHA:1997', 'Blepharocheilodontic syndrome', 1),
(3694, 'ORPHA:1997', 'Clefting-ectropion-conical teeth syndrome', 1),
(3695, 'ORPHA:1997', 'Ectropion inferior-cleft lip and/or palate syndrome', 1),
(3696, 'ORPHA:1997', 'Elschnig syndrome', 1),
(3697, 'ORPHA:1997', 'Lagophthalmia-cleft lip and palate syndrome', 1),
(3698, 'ORPHA:20', '3-hydroxy-3-methylglutaric aciduria', 1),
(3699, 'ORPHA:20', '3-hydroxy-3-methylglutaryl-CoA lyase deficiency', 1),
(3700, 'ORPHA:20', 'HMG-CoA lyase deficiency', 1),
(3701, 'ORPHA:20', 'Hydroxymethylglutaric aciduria', 1),
(3702, 'ORPHA:200', 'Isolated corpus callosum agenesis', 1),
(3703, 'ORPHA:200037', 'Paroxysmal dystonia', 3),
(3704, 'ORPHA:2001', 'Cleft lip/palate-intestinal malrotation-cardiopathy syndrome', 1),
(3705, 'ORPHA:2001', 'McPherson-Clemens syndrome', 1),
(3706, 'ORPHA:2003', 'Cleft lip/palate-deafness-sacral lipoma syndrome', 1),
(3707, 'ORPHA:2003', 'Cleft lip/palate-hearing loss-sacral lipoma syndrome', 1),
(3708, 'ORPHA:2003', 'Lowry-Yong syndrome', 1),
(3709, 'ORPHA:2004', 'LC', 1),
(3710, 'ORPHA:2004', 'LTEC', 1),
(3711, 'ORPHA:2004', 'Laryngo-tracheo-esophageal cleft', 1),
(3712, 'ORPHA:2004', 'Laryngo-tracheo-esophageal diastema', 1),
(3713, 'ORPHA:2004', 'Laryngotracheoesophageal cleft', 1),
(3714, 'ORPHA:200418', 'Complete factor I deficiency', 1),
(3715, 'ORPHA:200418', 'Immunodeficiency with factor I anomaly', 1),
(3716, 'ORPHA:200421', 'Immunodeficiency with factor H anomaly', 1),
(3717, 'ORPHA:2006', 'Median cleft lip/mandibule', 1),
(3718, 'ORPHA:2006', 'Median cleft lower facial stage', 1),
(3719, 'ORPHA:2007', 'Alar cartilages hypoplasia-coloboma-telecanthus syndrome', 1),
(3720, 'ORPHA:2008', 'ACFS', 1),
(3721, 'ORPHA:2008', 'Acrocardiofacial syndrome', 1),
(3722, 'ORPHA:2008', 'CCGE syndrome', 1),
(3723, 'ORPHA:2008', 'Cleft palate-cardiac defect-genital anomalies-ectrodactyly syndrome', 1),
(3724, 'ORPHA:201', 'Cowden disease', 1),
(3725, 'ORPHA:201', 'Cowden syndrome', 1),
(3726, 'ORPHA:201', 'Multiple hamartoma syndrome', 1),
(3727, 'ORPHA:2010', 'Cleft palate-stapes fixation-oligodontia syndrome', 1),
(3728, 'ORPHA:2013', 'Cleft palate-large ears-small head syndrome', 1),
(3729, 'ORPHA:2013', 'Say-Barber-Hobbs syndrome', 1),
(3730, 'ORPHA:2014', 'Cleft palate', 3),
(3731, 'ORPHA:2015', 'Cleft palate-short stature-vertebral anomalies syndrome', 1),
(3732, 'ORPHA:2015', 'Mathieu-De Broca-Bony syndrome', 1),
(3733, 'ORPHA:2016', 'CPLS syndrome', 1),
(3734, 'ORPHA:2016', 'Cleft palate-lateral synechia syndrome', 1),
(3735, 'ORPHA:2017', 'Cleft sternum', 1),
(3736, 'ORPHA:2017', 'Sternal cleft', 1),
(3737, 'ORPHA:2017', 'Sternum bifidum', 1),
(3738, 'ORPHA:2019', 'FFU complex', 1),
(3739, 'ORPHA:2019', 'Femur-fibula-ulna complex', 1),
(3740, 'ORPHA:2019', 'Femur-fibula-ulna dysostosis', 1),
(3741, 'ORPHA:2019', 'Femur-fibula-ulna syndrome', 1),
(3742, 'ORPHA:2019', 'PFFD', 1),
(3743, 'ORPHA:202', 'Alopecia-deafness-hypogonadism syndrome', 1),
(3744, 'ORPHA:202', 'Alopecia-hearing loss-hypogonadism syndrome', 1),
(3745, 'ORPHA:202', 'Alopecia-sensorineural deafness-hypogonadism syndrome', 1),
(3746, 'ORPHA:202', 'Alopecia-sensorineural hearing loss-hypogonadism syndrome', 1),
(3747, 'ORPHA:202', 'Crandall syndrome', 1),
(3748, 'ORPHA:2020', 'CFTDM', 1),
(3749, 'ORPHA:2020', 'Congenital fiber-type disproportion myopathy', 1),
(3750, 'ORPHA:2021', 'Fibrochondrogenesis', 1),
(3751, 'ORPHA:2022', 'Endocardial fibroelastosis', 1),
(3752, 'ORPHA:2022', 'Endomyocardial fibroelastosis', 1),
(3753, 'ORPHA:2023', 'UPS', 1),
(3754, 'ORPHA:2023', 'Undifferentiated pleomorphic sarcoma', 1),
(3755, 'ORPHA:2024', 'Autosomal dominant gingival fibromatosis', 1),
(3756, 'ORPHA:2024', 'Autosomal dominant gingival hyperplasia', 1),
(3757, 'ORPHA:2024', 'Hereditary gingival fibromatosis', 1),
(3758, 'ORPHA:2024', 'Hereditary gingival hyperplasia', 1),
(3759, 'ORPHA:2025', 'Gingival fibromatosis-facial dysmorphism syndrome', 1),
(3760, 'ORPHA:2026', 'CGHT', 1),
(3761, 'ORPHA:2026', 'Congenital generalized hypertrichosis terminalis', 1),
(3762, 'ORPHA:2026', 'Gingival fibromatosis-hypertrichosis syndrome', 1),
(3763, 'ORPHA:2026', 'Hirsutism-congenital gingival hyperplasia syndrome', 1),
(3764, 'ORPHA:2026', 'Hypertrichosis with or without gingival hyperplasia', 1),
(3765, 'ORPHA:2027', 'Gingival fibromatosis-progressive deafness syndrome', 1),
(3766, 'ORPHA:2027', 'Gingival fibromatosis-progressive hearing loss syndrome', 1),
(3767, 'ORPHA:2027', 'Jones syndrome', 1),
(3768, 'ORPHA:2028', 'Juvenile hyaline fibromatosis', 2),
(3769, 'ORPHA:2028', 'Murray-Puretic-Drescher syndrome', 2),
(3770, 'ORPHA:2028', 'Puretic syndrome', 2),
(3771, 'ORPHA:202940', 'Anomaly of puberty or/and menstrual cycle of genetic origin', 3),
(3772, 'ORPHA:202948', 'Syndromic microphthalmia', 3),
(3773, 'ORPHA:202948', 'Syndromic microphthalmia-anophthalmia-coloboma', 3),
(3774, 'ORPHA:2030', 'Fibrosarcoma', 1),
(3775, 'ORPHA:2031', 'Hepatic fibrosis-renal cysts-intellectual disability syndrome', 1),
(3776, 'ORPHA:2031', 'Thompson-Baraitser syndrome', 1),
(3777, 'ORPHA:2032', 'IPF', 1),
(3778, 'ORPHA:2032', 'Idiopathic pulmonary fibrosis', 1),
(3779, 'ORPHA:2034', 'Filariasis', 3),
(3780, 'ORPHA:2035', 'Lymphatic filariasis', 1),
(3781, 'ORPHA:2036', 'Finlay-Marks syndrome', 1),
(3782, 'ORPHA:2036', 'Scalp-ear-nipple syndrome', 1),
(3783, 'ORPHA:2037', 'Congenital aortopulmonary artery fistula', 1),
(3784, 'ORPHA:2037', 'Congenital aortopulmonary septal defect', 1),
(3785, 'ORPHA:2037', 'Congenital aortopulmonary window', 1),
(3786, 'ORPHA:2038', 'PAVM', 1),
(3787, 'ORPHA:2038', 'Pulmonary arteriovenous malformation', 1),
(3788, 'ORPHA:2039', 'Congenital systemic arteriovenous fistula', 1),
(3789, 'ORPHA:204', 'Sporadic CJD', 1),
(3790, 'ORPHA:204', 'Sporadic Creutzfeldt-Jakob disease', 1),
(3791, 'ORPHA:2040', 'Congenital respiratory-biliary fistula', 1),
(3792, 'ORPHA:2041', 'Coronary arterial fistula', 1),
(3793, 'ORPHA:2044', 'Floating-Harbor syndrome', 1),
(3794, 'ORPHA:2045', 'FLOTCH syndrome', 1),
(3795, 'ORPHA:2045', 'Leukonychia totalis-trichilemmal cysts-ciliary dystrophy syndrome', 1),
(3796, 'ORPHA:2047', 'Flynn-Aird syndrome', 1),
(3797, 'ORPHA:2048', 'Bilateral anterior opercular syndrome', 1),
(3798, 'ORPHA:2048', 'Facio-pharyngo-glossal diplegia with automatic-voluntary movement dissociation', 1),
(3799, 'ORPHA:2048', 'Facio-pharyngo-glosso-masticatory diplegia', 1),
(3800, 'ORPHA:2048', 'Foix-Chavany-Marie syndrome', 1),
(3801, 'ORPHA:205', 'Bilirubin uridinediphosphate glucuronosyltransferase deficiency', 1),
(3802, 'ORPHA:205', 'Bilirubin-UGT deficiency', 1),
(3803, 'ORPHA:205', 'Crigler-Najjar syndrome', 1),
(3804, 'ORPHA:205', 'Hereditary unconjugated hyperbilirubinemia', 1),
(3805, 'ORPHA:205', 'UGT deficiency', 1),
(3806, 'ORPHA:2050', 'Bone fragility-craniosynostosis-proptosis-hydrocephalus syndrome', 1),
(3807, 'ORPHA:2050', 'Cole-Carpenter syndrome', 1),
(3808, 'ORPHA:2052', 'Cryptophthalmos-syndactyly syndrome', 1),
(3809, 'ORPHA:2052', 'Fraser syndrome', 1),
(3810, 'ORPHA:2053', 'Craniocarpotarsal dysplasia', 1),
(3811, 'ORPHA:2053', 'Craniocarpotarsal dystrophy', 1),
(3812, 'ORPHA:2053', 'Distal arthrogryposis type 2A', 1),
(3813, 'ORPHA:2053', 'Freeman-Burian syndrome', 1),
(3814, 'ORPHA:2053', 'Freeman-Sheldon syndrome', 1),
(3815, 'ORPHA:2053', 'Whistling face syndrome', 1),
(3816, 'ORPHA:2056', 'Essential fructosuria', 1),
(3817, 'ORPHA:2056', 'Fructokinase deficiency', 1),
(3818, 'ORPHA:2056', 'Ketohexokinase deficiency', 1),
(3819, 'ORPHA:2057', 'Blepharophimosis-ptosis-esotropia-syndactyly-short stature syndrome', 1),
(3820, 'ORPHA:2057', 'Frydman-Cohen-Karmon syndrome', 1),
(3821, 'ORPHA:2058', 'Fryns-Smeets-Thiry syndrome', 1),
(3822, 'ORPHA:2059', 'Diaphragmatic hernia-abnormal face-distal limb anomalies syndrome', 1),
(3823, 'ORPHA:2059', 'Fryns syndrome', 1),
(3824, 'ORPHA:2062', 'Copenhagen syndrome', 1),
(3825, 'ORPHA:2062', 'Progressive non-infectious anterior vertebral fusion', 1),
(3826, 'ORPHA:2063', 'SGFLD syndrome', 1),
(3827, 'ORPHA:2063', 'Splenogonadal fusion-limb defects-micrognathia syndrome', 1),
(3828, 'ORPHA:2064', 'Faulk-Epstein-Jones syndrome', 1),
(3829, 'ORPHA:2064', 'Posterior fusion of lumbosacral vertebrae-blepharoptosis syndrome', 1),
(3830, 'ORPHA:206428', 'HPRT deficiency', 3),
(3831, 'ORPHA:206428', 'HPRT1 deficiency', 3),
(3832, 'ORPHA:206428', 'Hypoxanthine-guanine phosphoribosyltransferase 1 deficiency', 3),
(3833, 'ORPHA:206428', 'Hypoxanthine-guanine phosphoribosyltransferase deficiency', 3),
(3834, 'ORPHA:206436', 'Infantile Krabbe disease', 2),
(3835, 'ORPHA:206436', 'Krabbe disease, classic form', 2),
(3836, 'ORPHA:206436', 'Krabbe disease, early-onset', 2),
(3837, 'ORPHA:206443', 'Krabbe disease, late-onset', 2),
(3838, 'ORPHA:206443', 'Late-infantile/juvenile Krabbe disease', 2),
(3839, 'ORPHA:206448', 'Adult Krabbe disease', 2),
(3840, 'ORPHA:206470', 'Cystadenoma of childhood', 1),
(3841, 'ORPHA:206470', 'Cystadenoma of ovary in childhood', 1),
(3842, 'ORPHA:206473', 'Borderline epithelial tumor of ovary', 1),
(3843, 'ORPHA:206473', 'Borderline ovarian epithelial tumor', 1),
(3844, 'ORPHA:206473', 'Ovarian tumor of low malignant potential', 1),
(3845, 'ORPHA:206484', 'Gonadoblastoma', 1),
(3846, 'ORPHA:206489', 'Malignant germ cell tumor of the vagina', 1),
(3847, 'ORPHA:206489', 'Vaginal germ cell cancer', 1),
(3848, 'ORPHA:206489', 'Vaginal germ cell malignant tumor', 1),
(3849, 'ORPHA:206492', 'Vulvovaginal rhabdomyosarcoma', 1),
(3850, 'ORPHA:2065', 'Galloway syndrome', 1),
(3851, 'ORPHA:2065', 'Galloway-Mowat syndrome', 1),
(3852, 'ORPHA:2065', 'Microcephaly-hiatus hernia-nephrotic syndrome', 1),
(3853, 'ORPHA:2065', 'Nephrosis-neuronal dysmigration syndrome', 1),
(3854, 'ORPHA:206538', 'Malignant non-dysgerminomatous germ cell tumor of ovary', 1),
(3855, 'ORPHA:206538', 'Non-dysgerminomatous germ cell cancer of ovary', 1),
(3856, 'ORPHA:206546', 'Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers', 1),
(3857, 'ORPHA:206549', 'Anoctamin-5-related  limb-girdle muscular dystrophy R12', 1),
(3858, 'ORPHA:206549', 'Anoctamin-5-related LGMD R12', 1),
(3859, 'ORPHA:206549', 'Autosomal recessive limb-girdle muscular dystrophy type 2L', 1),
(3860, 'ORPHA:206549', 'LGMD type 2L', 1),
(3861, 'ORPHA:206549', 'LGMD2L', 1),
(3862, 'ORPHA:206549', 'Limb-girdle muscular dystrophy type 2L', 1),
(3863, 'ORPHA:206554', 'Autosomal recessive LGMD type 2M', 1),
(3864, 'ORPHA:206554', 'Autosomal recessive limb-girdle muscular dystrophy type 2M', 1),
(3865, 'ORPHA:206554', 'Fukutin-related  limb-girdle muscular dystrophy R13', 1),
(3866, 'ORPHA:206554', 'Fukutin-related LGMD R13', 1),
(3867, 'ORPHA:206554', 'LGMD type 2M', 1),
(3868, 'ORPHA:206554', 'LGMD2M', 1),
(3869, 'ORPHA:206559', 'Autosomal recessive limb-girdle muscular dystrophy type 2N', 1),
(3870, 'ORPHA:206559', 'LGMD type 2N', 1),
(3871, 'ORPHA:206559', 'LGMD2N', 1),
(3872, 'ORPHA:206559', 'Limb-girdle muscular dystrophy type 2N', 1),
(3873, 'ORPHA:206559', 'POMT2-related  limb-girdle muscular dystrophy R14', 1),
(3874, 'ORPHA:206559', 'POMT2-related LGMD R14', 1),
(3875, 'ORPHA:206564', 'Autosomal recessive limb-girdle muscular dystrophy type 2O', 1),
(3876, 'ORPHA:206564', 'LGMD type 2O', 1),
(3877, 'ORPHA:206564', 'LGMD2O', 1),
(3878, 'ORPHA:206564', 'Limb-girdle muscular dystrophy type 2O', 1),
(3879, 'ORPHA:206564', 'POMGNT1-related  limb-girdle muscular dystrophy R15', 1),
(3880, 'ORPHA:206564', 'POMGNT1-related LGMD R15', 1),
(3881, 'ORPHA:206569', 'Anti-HMG-CoA myopathy', 1),
(3882, 'ORPHA:206569', 'Anti-SRP myopathy', 1),
(3883, 'ORPHA:206569', 'Autoimmune necrotizing myositis', 1),
(3884, 'ORPHA:206569', 'IMNM', 1),
(3885, 'ORPHA:206569', 'Immune myopathy with myocyte necrosis', 1),
(3886, 'ORPHA:206569', 'Immune-mediated necrotizing myopathy', 1),
(3887, 'ORPHA:206569', 'NAM', 1),
(3888, 'ORPHA:206572', 'Adult-onset overlap myositis', 1),
(3889, 'ORPHA:206572', 'Non-specific myositis', 1),
(3890, 'ORPHA:206572', 'Overlap myositis', 1),
(3891, 'ORPHA:206575', 'Acquired rippling muscle disease', 1),
(3892, 'ORPHA:206575', 'Immune-mediated rippling muscle disease', 1),
(3893, 'ORPHA:206575', 'Rippling muscle disease with myasthenia gravis', 1),
(3894, 'ORPHA:206580', 'Autosomal recessive distal spinal muscular atrophy type 4', 1),
(3895, 'ORPHA:206580', 'Autosomal recessive lower motor neuron disease with childhood onset', 1),
(3896, 'ORPHA:206580', 'Distal spinal muscular atrophy type 4', 1),
(3897, 'ORPHA:206580', 'dSMA4', 1),
(3898, 'ORPHA:206583', 'APBD', 2),
(3899, 'ORPHA:206583', 'Adult polyglucosan body disease', 2),
(3900, 'ORPHA:206586', 'Neurolymphomatosis', 1),
(3901, 'ORPHA:206594', 'Subacute inflammatory demyelinating polyneuropathy', 1),
(3902, 'ORPHA:206594', 'Subacute inflammatory demyelinating polyradiculoneuropathy', 1),
(3903, 'ORPHA:206599', 'Idiopathic asymptomatic hyperCKemia', 1),
(3904, 'ORPHA:206599', 'Isolated asymptomatic elevation of creatine phosphokinase', 1),
(3905, 'ORPHA:206599', 'Isolated asymptomatic hyperCKemia', 1),
(3906, 'ORPHA:2066', 'GABA transaminase deficiency', 1),
(3907, 'ORPHA:2066', 'Gamma-aminobutyric acid transaminase deficiency', 1),
(3908, 'ORPHA:206613', 'Infectious disease with peripheral neuropathy', 3),
(3909, 'ORPHA:206634', 'Genetic skeletal muscle disease', 3),
(3910, 'ORPHA:206638', 'Acquired skeletal muscle disease', 3),
(3911, 'ORPHA:206644', 'Progressive muscular dystrophy', 3),
(3912, 'ORPHA:206647', 'Myotonic dystrophy', 3),
(3913, 'ORPHA:206650', 'Autosomal dominant distal myopathy', 3),
(3914, 'ORPHA:206653', 'Autosomal recessive distal myopathy', 3),
(3915, 'ORPHA:206656', 'Non-dystrophic myopathy', 3),
(3916, 'ORPHA:206662', 'Inclusion myopathy', 3),
(3917, 'ORPHA:2067', 'GAPO syndrome', 1),
(3918, 'ORPHA:2067', 'Growth delay-alopecia-pseudoanodontia-optic atrophy syndrome', 1),
(3919, 'ORPHA:206701', 'Bulbospinal muscular atrophy', 3),
(3920, 'ORPHA:206704', 'Bulbospinal muscular atrophy of childhood', 3),
(3921, 'ORPHA:206707', 'Bulbospinal muscular atrophy of adult', 3),
(3922, 'ORPHA:206710', 'Generalized bulbospinal muscular atrophy', 3),
(3923, 'ORPHA:2069', 'Gastrocutaneous syndrome', 1),
(3924, 'ORPHA:206953', 'Lipid storage myopathy', 3),
(3925, 'ORPHA:206953', 'Muscular lipidosis', 3),
(3926, 'ORPHA:206959', 'Glycogen storage myopathy', 3),
(3927, 'ORPHA:206959', 'Muscular glycogenosis', 3),
(3928, 'ORPHA:206966', 'Mitochondrial myopathy', 3),
(3929, 'ORPHA:206970', 'Myotonic syndrome', 3),
(3930, 'ORPHA:206973', 'Congenital myotonia', 3),
(3931, 'ORPHA:206976', 'Periodic paralysis', 3),
(3932, 'ORPHA:206982', 'Muscular tumor', 3),
(3933, 'ORPHA:206988', 'Infectious, fungal or parasitic myopathy', 3),
(3934, 'ORPHA:206991', 'Viral myositis', 1),
(3935, 'ORPHA:206994', 'Bacterial myositis', 1),
(3936, 'ORPHA:206997', 'Parasitic myositis', 3),
(3937, 'ORPHA:207', 'Crouzon craniofacial dysostosis', 1),
(3938, 'ORPHA:207', 'Crouzon disease', 1),
(3939, 'ORPHA:2070', 'EGE', 1),
(3940, 'ORPHA:2070', 'Eosinophilic enteritis', 1),
(3941, 'ORPHA:2070', 'Eosinophilic gastroenteritis', 1),
(3942, 'ORPHA:2070', 'Eosinophilic gastroenterocolitis', 1),
(3943, 'ORPHA:207000', 'Fungal myositis', 1),
(3944, 'ORPHA:207012', 'Spinal muscular atrophy associated with central nervous system anomaly', 3),
(3945, 'ORPHA:207015', 'Rare hereditary disease with peripheral neuropathy', 3),
(3946, 'ORPHA:207018', 'Rare hereditary metabolic disease with peripheral neuropathy', 3),
(3947, 'ORPHA:207021', 'Rare hereditary systemic disease with peripheral neuropathy', 3),
(3948, 'ORPHA:207025', 'Rare hereditary neurologic disease with peripheral neuropathy', 3),
(3949, 'ORPHA:207028', 'Cerebellar ataxia with peripheral neuropathy', 3),
(3950, 'ORPHA:207038', 'Acute and subacute inflammatory demyelinating polyneuropathy', 3),
(3951, 'ORPHA:207038', 'Acute and subacute inflammatory demyelinating polyradiculoneuropathy', 3),
(3952, 'ORPHA:207046', 'Malignant lymphoma with peripheral neuropathy', 3),
(3953, 'ORPHA:207049', 'Qualitative or quantitative protein defects in neuromuscular diseases', 3),
(3954, 'ORPHA:207052', 'Qualitative or quantitative defects of sarcoglycan', 3),
(3955, 'ORPHA:207052', 'Sarcoglycanopathy', 3),
(3956, 'ORPHA:207060', 'Qualitative or quantitative defects of alpha-sarcoglycan', 3),
(3957, 'ORPHA:207063', 'Qualitative or quantitative defects of beta-sarcoglycan', 3),
(3958, 'ORPHA:207067', 'Qualitative or quantitative defects of gamma-sarcoglycan', 3),
(3959, 'ORPHA:207070', 'Qualitative or quantitative defects of delta-sarcoglycan', 3),
(3960, 'ORPHA:207073', 'Dysferlinopathy', 3),
(3961, 'ORPHA:207073', 'Qualitative or quantitative defects of dysferlin', 3),
(3962, 'ORPHA:207078', 'Caveolinopathy', 3),
(3963, 'ORPHA:207078', 'Qualitative or quantitative defects of caveolin-3', 3),
(3964, 'ORPHA:207085', 'Dystrophinopathy', 3),
(3965, 'ORPHA:207085', 'Qualitative or quantitative defects of dystrophin', 3),
(3966, 'ORPHA:207090', 'Qualitative or quantitative defects of collagen 6', 3),
(3967, 'ORPHA:207094', 'LAMA2-related muscular dystrophy', 3),
(3968, 'ORPHA:207094', 'Laminin subunit alpha 2-related muscular dystrophy', 3),
(3969, 'ORPHA:207094', 'Qualitative or quantitative defects of merosin', 3),
(3970, 'ORPHA:207098', 'Integrinopathy', 3),
(3971, 'ORPHA:207098', 'Qualitative or quantitative defects of integrin alpha-7', 3),
(3972, 'ORPHA:207101', 'Qualitative or quantitative defects of perlecan', 3),
(3973, 'ORPHA:207104', 'Qualitative or quantitative defects of calpain', 3),
(3974, 'ORPHA:207107', 'Qualitative or quantitative defects of TRIM32', 3),
(3975, 'ORPHA:207110', 'Qualitative or quantitative defects of myotubularin', 3),
(3976, 'ORPHA:207113', 'Qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan', 3),
(3977, 'ORPHA:207113', 'Secondary alpha-dystroglycanopathy', 3),
(3978, 'ORPHA:207113', 'Secondary dystroglycanopathy', 3),
(3979, 'ORPHA:207119', 'Qualitative or quantitative defects of FKRP', 3),
(3980, 'ORPHA:207122', 'Qualitative or quantitative defects of fukutin', 3),
(3981, 'ORPHA:2072', 'Cardiovascular Gaucher disease', 2),
(3982, 'ORPHA:2072', 'Gaucher disease type 3C', 2),
(3983, 'ORPHA:2072', 'Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome', 2),
(3984, 'ORPHA:2072', 'Gaucher-like disease', 2),
(3985, 'ORPHA:2073', 'Gélineau disease', 1),
(3986, 'ORPHA:2073', 'Narcolepsy type 1', 1),
(3987, 'ORPHA:2073', 'Narcolepsy-cataplexy', 1),
(3988, 'ORPHA:2074', 'Gemignani syndrome', 1),
(3989, 'ORPHA:2074', 'Spinocerebellar ataxia-amyotrophy-deafness syndrome', 1),
(3990, 'ORPHA:2074', 'Spinocerebellar ataxia-amyotrophy-hearing loss syndrome', 1),
(3991, 'ORPHA:2075', 'Gardner-Silengo-Wachtel syndrome', 1),
(3992, 'ORPHA:2075', 'Genitopalatocardiac syndrome', 1),
(3993, 'ORPHA:2076', 'X-linked intellectual disability-epilepsy syndrome', 3),
(3994, 'ORPHA:2077', 'German syndrome', 1),
(3995, 'ORPHA:2077', 'Hypotonia-arthrogryposis-facial dysmorphism-lymphedema syndrome', 1),
(3996, 'ORPHA:2078', 'Geroderma osteodysplastica', 1),
(3997, 'ORPHA:2083', 'MacDermot-Winter syndrome', 1),
(3998, 'ORPHA:2083', 'Prominent glabella-microcephaly-hypogenitalism syndrome', 1),
(3999, 'ORPHA:2084', 'GEMSS syndrome', 1),
(4000, 'ORPHA:2084', 'Glaucoma-ectopia lentis-microspherophakia-stiff joints-short stature syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(4001, 'ORPHA:208441', 'Bilateral parasagittal parieto-occipital polymicrogyria', 2),
(4002, 'ORPHA:208444', 'Bilateral frontal polymicrogyria', 2),
(4003, 'ORPHA:208447', 'Bilateral generalized polymicrogyria', 2),
(4004, 'ORPHA:2085', 'Glaucoma-sleep apnea syndrome', 1),
(4005, 'ORPHA:208508', 'ADCA2', 3),
(4006, 'ORPHA:208508', 'ADCAII', 3),
(4007, 'ORPHA:208508', 'Autosomal dominant cerebellar ataxia type 2', 3),
(4008, 'ORPHA:208508', 'Autosomal dominant cerebellar ataxia type II', 3),
(4009, 'ORPHA:208513', 'Congenital nonprogressive spinocerebellar ataxia', 1),
(4010, 'ORPHA:208513', 'SCA29', 1),
(4011, 'ORPHA:208513', 'Spinocerebellar ataxia type 29', 1),
(4012, 'ORPHA:208524', 'Herpetiform pemphigus', 1),
(4013, 'ORPHA:208593', 'Genetic hypoparathyroidism', 3),
(4014, 'ORPHA:208596', 'Genetic hyperparathyroidism', 3),
(4015, 'ORPHA:2086', 'Optic pathway glioma', 1),
(4016, 'ORPHA:208650', 'CAPS', 3),
(4017, 'ORPHA:208650', 'Cryopyrin-associated periodic syndrome', 3),
(4018, 'ORPHA:208650', 'Cryopyrinopathy', 3),
(4019, 'ORPHA:208650', 'NLRP3-associated systemic autoinflammatory disease', 3),
(4020, 'ORPHA:2088', 'Fanconi-Bickel syndrome', 1),
(4021, 'ORPHA:2088', 'GSD due to GLUT2 deficiency', 1),
(4022, 'ORPHA:2088', 'GSD type 11', 1),
(4023, 'ORPHA:2088', 'GSD type XI', 1),
(4024, 'ORPHA:2088', 'Glycogen storage disease due to GLUT2 deficiency', 1),
(4025, 'ORPHA:2088', 'Glycogen storage disease type 11', 1),
(4026, 'ORPHA:2088', 'Glycogen storage disease type XI', 1),
(4027, 'ORPHA:2088', 'Glycogenosis due to GLUT2 deficiency', 1),
(4028, 'ORPHA:2089', 'GSD due to hepatic glycogen synthase deficiency', 1),
(4029, 'ORPHA:2089', 'GSD type 0a', 1),
(4030, 'ORPHA:2089', 'Glycogen storage disease due to hepatic glycogen synthase deficiency', 1),
(4031, 'ORPHA:2089', 'Glycogen storage disease due to liver glycogen synthase deficiency', 1),
(4032, 'ORPHA:2089', 'Glycogen storage disease type 0a', 1),
(4033, 'ORPHA:2089', 'Glycogenosis type 0a', 1),
(4034, 'ORPHA:208974', 'CADP', 3),
(4035, 'ORPHA:208974', 'Chronic acquired demyelinating polyneuropathy', 3),
(4036, 'ORPHA:208978', 'Chronic polyradiculoneuropathy', 3),
(4037, 'ORPHA:208981', 'Polyradiculoneuropathy associated with IgG/IgA/IgM monoclonal gammopathy without known antibodies', 1),
(4038, 'ORPHA:208984', 'Acquired sensory ganglionopathy', 3),
(4039, 'ORPHA:208984', 'Acquired sensory neuronopathy', 3),
(4040, 'ORPHA:208989', 'Non-paraneoplastic sensory ganglionopathy', 3),
(4041, 'ORPHA:208989', 'Non-paraneoplastic sensory neuronopathy', 3),
(4042, 'ORPHA:208999', 'Paraneoplastic sensory ganglionopathy', 3),
(4043, 'ORPHA:208999', 'Paraneoplastic sensory neuronopathy', 3),
(4044, 'ORPHA:209', 'Cutis laxa', 3),
(4045, 'ORPHA:2090', 'GMS syndrome', 1),
(4046, 'ORPHA:2090', 'Goniodysgenesis-intellectual disability-short stature syndrome', 1),
(4047, 'ORPHA:209004', 'Axonal polyneuropathy associated with IgG/IgM/IgA monoclonal gammopathy', 1),
(4048, 'ORPHA:209007', 'Systemic inflammatory disease associated with an acquired peripheral neuropathy', 3),
(4049, 'ORPHA:209010', 'Peripheral neuropathy associated with monoclonal gammopathy', 3),
(4050, 'ORPHA:209013', 'Acquired amyloid peripheral neuropathy', 3),
(4051, 'ORPHA:209016', 'Hematological disease associated with an acquired peripheral neuropathy', 3),
(4052, 'ORPHA:209019', 'Solid tumor associated with an acquired peripheral neuropathy', 3),
(4053, 'ORPHA:209024', 'Qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase', 3),
(4054, 'ORPHA:209024', 'Qualitative or quantitative defects of protein POMGNT1', 3),
(4055, 'ORPHA:209027', 'Qualitative or quantitative defects of protein glycosyltransferase-like', 3),
(4056, 'ORPHA:209030', 'Qualitative or quantitative defects of protein O-mannosyltransferase 1', 3),
(4057, 'ORPHA:209033', 'Qualitative or quantitative defects of protein O-mannosyltransferase 2', 3),
(4058, 'ORPHA:209038', 'Qualitative or quantitative defects of myofibrillar proteins', 3),
(4059, 'ORPHA:209041', 'Qualitative or quantitative defects of desmin', 3),
(4060, 'ORPHA:209044', 'Qualitative or quantitative defects of alphaB-cristallin', 3),
(4061, 'ORPHA:209047', 'Qualitative or quantitative defects of filamin C', 3),
(4062, 'ORPHA:209050', 'Qualitative or quantitative defects of protein ZASP', 3),
(4063, 'ORPHA:209053', 'Qualitative or quantitative defects of titin', 3),
(4064, 'ORPHA:209056', 'Qualitative or quantitative defects of telethonin', 3),
(4065, 'ORPHA:209059', 'Qualitative or quantitative defects of alpha-actin', 3),
(4066, 'ORPHA:2091', 'Daneman-Davy-Mancer syndrome', 1),
(4067, 'ORPHA:2091', 'Multinodular goiter-cystic kidney-polydactyly syndrome', 1),
(4068, 'ORPHA:2091', 'Thyroid-renal-digital anomalies', 1),
(4069, 'ORPHA:209182', 'Qualitative or quantitative defects of nebulin', 3),
(4070, 'ORPHA:209185', 'Qualitative or quantitative defects of beta-myosin heavy chain (MYH7)', 3),
(4071, 'ORPHA:209188', 'Qualitative or quantitative defects of emerin', 3),
(4072, 'ORPHA:209193', 'Qualitative or quantitative defects of selenoprotein N1', 3),
(4073, 'ORPHA:209196', 'Qualitative or quantitative defects of plectin', 3),
(4074, 'ORPHA:209199', 'Qualitative or quantitative defects of protein SERCA1', 3),
(4075, 'ORPHA:2092', 'Focal dermal hypoplasia', 1),
(4076, 'ORPHA:2092', 'Goltz syndrome', 1),
(4077, 'ORPHA:2092', 'Goltz-Gorlin syndrome', 1),
(4078, 'ORPHA:209203', 'Qualitative or quantitative defects of glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase -', 3),
(4079, 'ORPHA:209224', 'Myotilinopathy', 3),
(4080, 'ORPHA:209224', 'Qualitative or quantitative defects of myotilin', 3),
(4081, 'ORPHA:209335', 'Autosomal dominant adult-onset proximal SMA', 1),
(4082, 'ORPHA:209335', 'Autosomal dominant adult-onset proximal spinal muscular atrophy', 1),
(4083, 'ORPHA:209335', 'Autosomal dominant late-onset spinal muscular atrophy, Finkel type', 1),
(4084, 'ORPHA:209335', 'Finkel disease', 1),
(4085, 'ORPHA:209335', 'SMAFK', 1),
(4086, 'ORPHA:209341', 'DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy', 2),
(4087, 'ORPHA:209341', 'DYNC1H1-related lower extremity-predominant autosomal dominant proximal spinal muscular atrophy', 2),
(4088, 'ORPHA:209341', 'SMALED1', 2),
(4089, 'ORPHA:209370', 'Severe congenital encephalopathy due to MECP2 mutation', 1),
(4090, 'ORPHA:209370', 'Severe neonatal-onset encephalopathy with microcephaly', 1),
(4091, 'ORPHA:2095', 'Craniofacial dysostosis-genital, dental, cardiac anomalies syndrome', 1),
(4092, 'ORPHA:2095', 'Cranofacial dysostosis-hypertrichosis-hypoplasia of labia majora syndrome', 1),
(4093, 'ORPHA:2095', 'Dental and eye anomalies-patent ductus arteriosus-normal intelligence syndrome', 1),
(4094, 'ORPHA:2095', 'GCM syndrome', 1),
(4095, 'ORPHA:2095', 'Gorlin-Chaudhry-Moss syndrome', 1),
(4096, 'ORPHA:2097', 'Grant syndrome', 1),
(4097, 'ORPHA:2098', 'Acromesomelic dysplasia, Grebe type', 1),
(4098, 'ORPHA:2098', 'Chondrodysplasia, Grebe type', 1),
(4099, 'ORPHA:209867', 'Autosomal dominant rhegmatogenous retinal detachment', 1),
(4100, 'ORPHA:209902', 'Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency', 1),
(4101, 'ORPHA:209905', 'Brain-lung-thyroid syndrome', 1),
(4102, 'ORPHA:209905', 'Choreoathetosis-hypothyroidism-neonatal respiratory distress syndrome', 1),
(4103, 'ORPHA:209908', 'CAS', 1),
(4104, 'ORPHA:209908', 'Childhood apraxia of speech', 1),
(4105, 'ORPHA:209908', 'Developmental verbal dyspraxia', 1),
(4106, 'ORPHA:209908', 'Speech and language disorder with orofacial dyspraxia', 1),
(4107, 'ORPHA:209908', 'Speech-language disorder type 1', 1),
(4108, 'ORPHA:209916', 'Extraskeletal myxoid chondrosarcoma', 1),
(4109, 'ORPHA:209919', 'Idiopathic copper-associated cirrhosis', 1),
(4110, 'ORPHA:209919', 'Non-Wilsonian hepatic copper toxicosis of infancy and childhood', 1),
(4111, 'ORPHA:209932', 'Cone dystrophy with supernormal rod ERG', 1),
(4112, 'ORPHA:209932', 'Cone dystrophy with supernormal rod electroretinogram', 1),
(4113, 'ORPHA:209932', 'Cone dystrophy with supernormal rod response', 1),
(4114, 'ORPHA:209932', 'Cone dystrophy with supernormal scotopic electroretinogram', 1),
(4115, 'ORPHA:209943', 'IRVAN syndrome', 1),
(4116, 'ORPHA:209943', 'Idiopathic retinal vasculitis-aneurysms-neuroretinitis syndrome', 1),
(4117, 'ORPHA:209951', 'Autosomal recessive spastic paraplegia type 18', 1),
(4118, 'ORPHA:209951', 'SPG18', 1),
(4119, 'ORPHA:209956', 'Idiopathic uveal effusion syndrome', 1),
(4120, 'ORPHA:209959', 'Endophthalmitis phacoanaphylactica', 1),
(4121, 'ORPHA:209959', 'Lens-induced endophthalmitis', 1),
(4122, 'ORPHA:209959', 'Lens-induced iridocyclitis', 1),
(4123, 'ORPHA:209959', 'Lens-induced uveitis', 1),
(4124, 'ORPHA:209959', 'Phacoallergic endophthalmitis', 1),
(4125, 'ORPHA:209959', 'Phacoanaphylactic uveitis', 1),
(4126, 'ORPHA:209959', 'Phacoantigenic endophthalmitis', 1),
(4127, 'ORPHA:209959', 'Phako-anaphylactic endophthalmitis', 1),
(4128, 'ORPHA:209964', 'Solitary rectal ulcer syndrome', 1),
(4129, 'ORPHA:209967', 'Episodic ataxia type 6', 1),
(4130, 'ORPHA:209970', 'Episodic ataxia type 7', 1),
(4131, 'ORPHA:209973', 'Benign nocturnal alternating hemiplegia of childhood', 1),
(4132, 'ORPHA:209978', 'Alternating hemiplegia', 3),
(4133, 'ORPHA:209981', 'IRIDA syndrome', 1),
(4134, 'ORPHA:209981', 'Iron-refractory iron deficiency anemia', 1),
(4135, 'ORPHA:209989', 'Non-papillary transitional cell carcinoma of the bladder', 1),
(4136, 'ORPHA:209989', 'Non-papillary urothelial carcinoma', 1),
(4137, 'ORPHA:210', 'Cyclosporosis', 1),
(4138, 'ORPHA:2101', 'Developmental delay-hypotonia-extremities hypertrophy syndrome', 1),
(4139, 'ORPHA:2101', 'Grubben-de Cock-Borghgraef syndrome', 1),
(4140, 'ORPHA:210110', 'Autosomal recessive intermediate osteopetrosis', 1),
(4141, 'ORPHA:210110', 'Intermediate osteopetrosis', 1),
(4142, 'ORPHA:210115', 'Autoinflammatory disease due to interleukin-1 receptor antagonist deficiency', 1),
(4143, 'ORPHA:210115', 'DIRA', 1),
(4144, 'ORPHA:210115', 'Interleukin-1 receptor antagonist deficiency', 1),
(4145, 'ORPHA:210115', 'OMPP', 1),
(4146, 'ORPHA:210115', 'Sterile multifocal osteomyelitis with periostitis and pustulosis', 1),
(4147, 'ORPHA:210122', 'ACDMPV', 1),
(4148, 'ORPHA:210122', 'Alveolar capillary dysplasia with misalignment of pulmonary veins', 1),
(4149, 'ORPHA:210122', 'Alveolar capillary dysplasia with misalignment of pulmonary vessels', 1),
(4150, 'ORPHA:210122', 'Congenital alveolar capillary dysplasia', 1),
(4151, 'ORPHA:210128', 'Encephalopathy due to urocanase deficiency', 1),
(4152, 'ORPHA:210128', 'Urocanic aciduria', 1),
(4153, 'ORPHA:210133', 'Leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome', 1),
(4154, 'ORPHA:210136', 'Pulmonary fibrosis-hepatic hyperplasia-bone marrow hypoplasia syndrome', 1),
(4155, 'ORPHA:210141', 'Inherited congenital spastic quadriplegia', 1),
(4156, 'ORPHA:210141', 'Inherited congenital spastic tetraplegia', 1),
(4157, 'ORPHA:210144', 'Lethal polymalformative syndrome, Boissel type', 1),
(4158, 'ORPHA:210159', 'Adult HCC', 1),
(4159, 'ORPHA:210159', 'Adult hepatocellular carcinoma', 1),
(4160, 'ORPHA:210163', 'Congenital lethal myopathy, Compton-North type', 1),
(4161, 'ORPHA:2102', 'GTP cyclohydrolase I deficiency', 2),
(4162, 'ORPHA:2102', 'GTPCH deficiency', 2),
(4163, 'ORPHA:2102', 'Hyperphenylalaninemia due to GTP cyclohydrolase deficiency', 2),
(4164, 'ORPHA:210272', 'Disembarkment syndrome', 1),
(4165, 'ORPHA:210272', 'Mal de débarquement', 1),
(4166, 'ORPHA:210272', 'MdD', 1),
(4167, 'ORPHA:210272', 'MdDS', 1),
(4168, 'ORPHA:210272', 'Sickness of disembarkment', 1),
(4169, 'ORPHA:2103', 'GBS', 3),
(4170, 'ORPHA:2103', 'Guillain-Barré syndrome', 3),
(4171, 'ORPHA:2103', 'Guillain-Barré-Strohl syndrome', 3),
(4172, 'ORPHA:2104', 'Dysmorphism-pectus carinatum-joint laxity syndrome', 1),
(4173, 'ORPHA:2104', 'Guízar Vázquez-Sánchez-Manzano syndrome', 1),
(4174, 'ORPHA:210548', 'Macrocephaly-intellectual disability-autism syndrome', 1),
(4175, 'ORPHA:210571', 'DYT16', 1),
(4176, 'ORPHA:210571', 'Dystonia 16', 1),
(4177, 'ORPHA:210571', 'Early-onset dystonia parkinsonism', 1),
(4178, 'ORPHA:210576', 'Congenital temporomandibular joint ankylosis', 1),
(4179, 'ORPHA:210576', 'Congenital trismus', 1),
(4180, 'ORPHA:210581', 'Temporomandibular joint anomaly', 3),
(4181, 'ORPHA:210584', 'Spindle cell hemangioendothelioma', 1),
(4182, 'ORPHA:210584', 'Spindle cell hemangioma', 1),
(4183, 'ORPHA:210589', 'Infantile hemangioma of rare localization', 3),
(4184, 'ORPHA:2107', 'Hall-Riggs syndrome', 1),
(4185, 'ORPHA:2108', 'François dyscephalic syndrome', 1),
(4186, 'ORPHA:2108', 'Hallermann-Streiff syndrome', 1),
(4187, 'ORPHA:2108', 'Oculomandibulofacial syndrome', 1),
(4188, 'ORPHA:2109', 'Dennis-Fairhurst-Moore syndrome', 1),
(4189, 'ORPHA:2109', 'Hallermann-Streiff-François syndrome, severe form', 1),
(4190, 'ORPHA:2109', 'Hallermann-Streiff-like syndrome', 1),
(4191, 'ORPHA:2109', 'Severe Hallermann-Streiff-François syndrome', 1),
(4192, 'ORPHA:211', 'Familial cylindromatosis', 2),
(4193, 'ORPHA:211', 'Turban tumor syndrome', 2),
(4194, 'ORPHA:2110', 'Hallux varus-preaxial polysyndactyly syndrome', 1),
(4195, 'ORPHA:2110', 'Kleiner-Holmes syndrome', 1),
(4196, 'ORPHA:211017', 'SCA30', 1),
(4197, 'ORPHA:211017', 'Spinocerebellar ataxia type 30', 1),
(4198, 'ORPHA:211037', 'Autosomal dominant proximal spinal muscular atrophy', 3),
(4199, 'ORPHA:211047', 'Specific learning difficulty', 3),
(4200, 'ORPHA:211047', 'Specific learning disability', 3),
(4201, 'ORPHA:211047', 'Specific learning disorder', 3),
(4202, 'ORPHA:211053', 'Dysphasia', 3),
(4203, 'ORPHA:211053', 'Specific language disorder', 3),
(4204, 'ORPHA:211062', 'Hereditary episodic ataxia', 3),
(4205, 'ORPHA:211067', 'Episodic ataxia type 5', 1),
(4206, 'ORPHA:2111', 'Cystic hamartoma of lung and kidney', 1),
(4207, 'ORPHA:2111', 'Graham-Boyle-Troxell syndrome', 1),
(4208, 'ORPHA:211237', 'Rare vascular tumor', 3),
(4209, 'ORPHA:211240', 'Genetic vascular anomaly', 3),
(4210, 'ORPHA:211243', 'Simple vascular malformation', 3),
(4211, 'ORPHA:211247', 'Rare capillary malformation', 3),
(4212, 'ORPHA:211252', 'Rare venous malformation', 3),
(4213, 'ORPHA:211255', 'Rare lymphatic system anomaly', 3),
(4214, 'ORPHA:211266', 'Rare arteriovenous malformation', 3),
(4215, 'ORPHA:211277', 'Complex vascular malformation with associated anomalies', 3),
(4216, 'ORPHA:211277', 'Hemangiolymphangioma', 3),
(4217, 'ORPHA:2114', 'BFHD', 1),
(4218, 'ORPHA:2114', 'Beukes familial hip dysplasia', 1),
(4219, 'ORPHA:2114', 'Cilliers-Beighton syndrome', 1),
(4220, 'ORPHA:2114', 'Hip dysplasia, Beukes type', 1),
(4221, 'ORPHA:2114', 'Premature degenerative osteoarthropathy of the hip', 1),
(4222, 'ORPHA:2115', 'Cranio-facio-digito-genital syndrome', 1),
(4223, 'ORPHA:2115', 'Harrod syndrome', 1),
(4224, 'ORPHA:2116', 'Aminoaciduria, Hartnup type', 1),
(4225, 'ORPHA:2116', 'Hartnup disease', 1),
(4226, 'ORPHA:2116', 'Hartnup disorder', 1),
(4227, 'ORPHA:2117', 'Hartsfield syndrome', 1),
(4228, 'ORPHA:2117', 'Holoprosencephaly-ectrodactyly-cleft lip/palate syndrome', 1),
(4229, 'ORPHA:2118', '4-HPPD deficiency', 1),
(4230, 'ORPHA:2118', '4-alpha-hydroxyphenylpyruvate hydroxylase deficiency', 1),
(4231, 'ORPHA:2118', '4-hydroxyphenylpyruvic acid dioxygenase deficiency', 1),
(4232, 'ORPHA:2118', 'Hawkinsinuria', 1),
(4233, 'ORPHA:2119', 'HEC syndrome', 1),
(4234, 'ORPHA:2119', 'Hydrocephalus-endocardial fibroelastosis-cataract syndrome', 1),
(4235, 'ORPHA:212', 'Cystathionase deficiency', 1),
(4236, 'ORPHA:212', 'Cystathionine gamma-lyase deficiency syndrome', 1),
(4237, 'ORPHA:212', 'Cystathioninuria', 1),
(4238, 'ORPHA:212', 'Gamma-cystathionase deficiency', 1),
(4239, 'ORPHA:2122', 'Kaposiform hemangioendothelioma', 1),
(4240, 'ORPHA:2123', 'Diffuse neonatal hemangiomatosis', 1),
(4241, 'ORPHA:2126', 'SFT/HPC', 1),
(4242, 'ORPHA:2126', 'Solitary fibrous tumor/hemangiopericytoma', 1),
(4243, 'ORPHA:2128', 'Hemi 3 syndrome', 1),
(4244, 'ORPHA:2128', 'Hemicorporal hypertrophy', 1),
(4245, 'ORPHA:2128', 'Isolated hemihyperplasia', 1),
(4246, 'ORPHA:2128', 'Isolated hemihypertrophy', 1),
(4247, 'ORPHA:213', 'Cystinosis', 1),
(4248, 'ORPHA:213', 'Protein defect of cystin transport', 1),
(4249, 'ORPHA:2130', 'Hemimelia', 3),
(4250, 'ORPHA:2130', 'Longitudinal meromelia', 3),
(4251, 'ORPHA:2131', 'AHC', 1),
(4252, 'ORPHA:2131', 'Alternating hemiplegia of childhood', 1),
(4253, 'ORPHA:2132', 'Hemoglobin C disease', 1),
(4254, 'ORPHA:2133', 'Hemoglobin E disease', 1),
(4255, 'ORPHA:2134', 'Atypical HUS', 1),
(4256, 'ORPHA:2134', 'Atypical hemolytic uremic syndrome', 1),
(4257, 'ORPHA:2134', 'aHUS', 1),
(4258, 'ORPHA:2135', 'Hennekam-Beemer syndrome', 1),
(4259, 'ORPHA:2135', 'Mastocytosis-short stature-deafness syndrome', 1),
(4260, 'ORPHA:2135', 'Mastocytosis-short stature-hearing loss syndrome', 1),
(4261, 'ORPHA:213500', 'Ovarian cancer', 3),
(4262, 'ORPHA:213500', 'Ovarian malignant tumor', 3),
(4263, 'ORPHA:213504', 'Adenocarcinoma of ovary', 1),
(4264, 'ORPHA:213504', 'Ovarian adenocarcinoma', 1),
(4265, 'ORPHA:213512', 'MMMT of the ovary', 1),
(4266, 'ORPHA:213512', 'Malignant mixed Müllerian tumor of the ovary', 1),
(4267, 'ORPHA:213512', 'Ovarian carcinosarcoma', 1),
(4268, 'ORPHA:213512', 'Ovarian malignant mixed Müllerian tumor', 1),
(4269, 'ORPHA:213512', 'Ovarian malignant mixed epithelial mesenchymal tumor', 1),
(4270, 'ORPHA:213517', 'Familial ovarian cancer', 3),
(4271, 'ORPHA:213517', 'Familial ovarian malignant tumor', 3),
(4272, 'ORPHA:213524', 'Hereditary site-specific ovarian cancer syndrome', 1),
(4273, 'ORPHA:213528', 'Rare adenocarcinoma of the breast', 1),
(4274, 'ORPHA:213531', 'Metaplastic carcinoma of the breast', 1),
(4275, 'ORPHA:213557', 'Salivary gland type cancer of the breast', 1),
(4276, 'ORPHA:213557', 'Salivary gland type carcinoma of the breast', 1),
(4277, 'ORPHA:213564', 'Rare cancer of uterus', 3),
(4278, 'ORPHA:213564', 'Rare malignant tumor of uterus', 3),
(4279, 'ORPHA:213564', 'Rare uterine cancer', 3),
(4280, 'ORPHA:213564', 'Rare uterine malignant tumor', 3),
(4281, 'ORPHA:213569', 'Rare cancer of corpus uteri', 3),
(4282, 'ORPHA:213569', 'Rare malignant tumor of corpus uteri', 3),
(4283, 'ORPHA:213574', 'Rare variants of adenocarcinoma of the corpus uteri', 1),
(4284, 'ORPHA:213589', 'Malignant mixed epithelial and mesenchymal tumor of corpus uteri', 3),
(4285, 'ORPHA:213589', 'Mixed epithelial and mesenchymal cancer of corpus uteri', 3),
(4286, 'ORPHA:2136', 'Hennekam syndrome', 1),
(4287, 'ORPHA:2136', 'Lymphedema-lymphangiectasia-intellectual disability syndrome', 1),
(4288, 'ORPHA:213600', 'Adenosarcoma of the corpus uteri', 1),
(4289, 'ORPHA:213605', 'Carcinofibroma of the corpus uteri', 1),
(4290, 'ORPHA:213610', 'Carcinosarcoma of the corpus uteri', 1),
(4291, 'ORPHA:213610', 'Malignant mixed Müllerian tumor of the corpus uteri', 1),
(4292, 'ORPHA:213610', 'Mixed Müllerian cancer of corpus uteri', 1),
(4293, 'ORPHA:213610', 'Uterine carcinosarcoma', 1),
(4294, 'ORPHA:213615', 'Rhabdomyosarcoma of the corpus uteri', 1),
(4295, 'ORPHA:213620', 'Sarcoma of the corpus uteri', 3),
(4296, 'ORPHA:213625', 'Leiomyosarcoma of the corpus uteri', 1),
(4297, 'ORPHA:213630', 'Malignant peripheral neuroectodermal tumor of the corpus uteri', 1),
(4298, 'ORPHA:213630', 'Peripheral neuroectodermal cancer of the corpus uteri', 1),
(4299, 'ORPHA:213630', 'Primitive neuroectodermal tumor of the corpus uteri', 1),
(4300, 'ORPHA:2137', 'AIH', 1),
(4301, 'ORPHA:2137', 'Autoimmune hepatitis', 1),
(4302, 'ORPHA:213711', 'Endometrial stromal sarcoma', 1),
(4303, 'ORPHA:213711', 'Stromal sarcoma of the corpus uteri', 1),
(4304, 'ORPHA:213716', 'Endometrial squamous cell carcinoma', 1),
(4305, 'ORPHA:213716', 'Squamous cell carcinoma of the corpus uteri', 1),
(4306, 'ORPHA:213721', 'Endometrial undifferentiated carcinoma', 1),
(4307, 'ORPHA:213721', 'Undifferentiated carcinoma of the corpus uteri', 1),
(4308, 'ORPHA:213726', 'Endometrial capillary carcinoma', 1),
(4309, 'ORPHA:213726', 'Papillary carcinoma of the corpus uteri', 1),
(4310, 'ORPHA:213731', 'High-grade neuroendocrine carcinoma of the corpus uteri', 1),
(4311, 'ORPHA:213731', 'High-grade neuroendocrine carcinoma of the uterine corpus', 1),
(4312, 'ORPHA:213731', 'Poorly differentiated neuroendocrine carcinoma of the corpus uteri', 1),
(4313, 'ORPHA:213731', 'Poorly differentiated neuroendocrine carcinoma of the endometrium', 1),
(4314, 'ORPHA:213736', 'Low-grade neuroendocrine tumor of the corpus uteri', 1),
(4315, 'ORPHA:213736', 'Low-grade neuroendocrine tumor of the uterine corpus', 1),
(4316, 'ORPHA:213736', 'Well-differentiated neuroendocrine neoplasm of the endometrium', 1),
(4317, 'ORPHA:213736', 'Well-differentiated neuroendocrine tumor of the corpus uteri', 1),
(4318, 'ORPHA:213736', 'Well-differentiated neuroendocrine tumor of the endometrium', 1),
(4319, 'ORPHA:213746', 'Endometrial transitional cell carcinoma', 1),
(4320, 'ORPHA:213746', 'Transitional cell carcinoma of the corpus uteri', 1),
(4321, 'ORPHA:213751', 'Germ cell cancer of the corpus uteri', 1),
(4322, 'ORPHA:213751', 'Malignant germ cell tumor of the corpus uteri', 1),
(4323, 'ORPHA:213761', 'Rare cancer of cervix uteri', 3),
(4324, 'ORPHA:213761', 'Rare cervical cancer', 3),
(4325, 'ORPHA:213761', 'Rare cervical malignant tumor', 3),
(4326, 'ORPHA:213761', 'Rare malignant tumor of cervix uteri', 3),
(4327, 'ORPHA:213767', 'Cervical squamous cell carcinoma', 1),
(4328, 'ORPHA:213767', 'Squamous cell carcinoma of the cervix uteri', 1),
(4329, 'ORPHA:213772', 'Adenocarcinoma of the cervix uteri', 1),
(4330, 'ORPHA:213772', 'Cervical adenocarcinoma', 1),
(4331, 'ORPHA:213777', 'High-grade neuroendocrine carcinoma of the cervix uteri', 1),
(4332, 'ORPHA:213777', 'High-grade neuroendocrine carcinoma of the uterine cervix', 1),
(4333, 'ORPHA:213777', 'Poorly differentiated neuroendocrine carcinoma of the cervix uteri', 1),
(4334, 'ORPHA:213777', 'Poorly differentiated neuroendocrine cervical carcinoma', 1),
(4335, 'ORPHA:213782', 'Cervical malignant mixed epithelial and mesenchymal tumor', 3),
(4336, 'ORPHA:213782', 'Malignant mixed epithelial and mesenchymal tumor of cervix uteri', 3),
(4337, 'ORPHA:213782', 'Mixed epithelial and mesenchymal cancer of cervix uteri', 3),
(4338, 'ORPHA:213787', 'Carcinosarcoma of the cervix uteri', 1),
(4339, 'ORPHA:213787', 'Cervical carcinosarcoma', 1),
(4340, 'ORPHA:213787', 'Cervical malignant Müllerian mixed tumor', 1),
(4341, 'ORPHA:213787', 'Malignant Müllerian mixed tumor of the cervix uteri', 1),
(4342, 'ORPHA:213792', 'Adenosarcoma of the cervix uteri', 1),
(4343, 'ORPHA:213792', 'Cervical adenosarcoma', 1),
(4344, 'ORPHA:213797', 'Cervical malignant mesenchymal tumor', 3),
(4345, 'ORPHA:213797', 'Cervical sarcoma', 3),
(4346, 'ORPHA:213797', 'Malignant mesenchymal tumor of cervix uteri', 3),
(4347, 'ORPHA:213797', 'Sarcoma of cervix uteri', 3),
(4348, 'ORPHA:2138', '46,XX ovotesticular DSD', 1),
(4349, 'ORPHA:2138', '46,XX ovotesticular disorder of sex development', 1),
(4350, 'ORPHA:213802', 'Cervical rhabdomyosarcoma', 1),
(4351, 'ORPHA:213802', 'Rhabdomyosarcoma of the cervix uteri', 1),
(4352, 'ORPHA:213807', 'Cervical leiomyosarcoma', 1),
(4353, 'ORPHA:213807', 'Leiomyosarcoma of the cervix uteri', 1),
(4354, 'ORPHA:213812', 'Cervical malignant peripheral neuroectodermal tumor', 1),
(4355, 'ORPHA:213812', 'Cervical peripheral neuroectodermal cancer', 1),
(4356, 'ORPHA:213812', 'Malignant peripheral neuroectodermal tumor of the cervix uteri', 1),
(4357, 'ORPHA:213812', 'Peripheral neuroectodermal cancer of cervix uteri', 1),
(4358, 'ORPHA:213812', 'Primitive neuroectodermal tumor of the cervix uteri', 1),
(4359, 'ORPHA:213817', 'Cervical papillary carcinoma', 1),
(4360, 'ORPHA:213817', 'Papillary carcinoma of the cervix uteri', 1),
(4361, 'ORPHA:213823', 'Adenoid cystic carcinoma of the cervix uteri', 1),
(4362, 'ORPHA:213823', 'Cervical adenoid cystic carcinoma', 1),
(4363, 'ORPHA:213828', 'Adenoid basal carcinoma of the cervix uteri', 1),
(4364, 'ORPHA:213828', 'Cervical adenoid basal carcinoma', 1),
(4365, 'ORPHA:213833', 'Glassy cell carcinoma of the cervix uteri', 1),
(4366, 'ORPHA:213837', 'Cervical germ cell cancer', 1),
(4367, 'ORPHA:213837', 'Cervical malignant germ cell tumor', 1),
(4368, 'ORPHA:213837', 'Germ cell cancer of the cervix uteri', 1),
(4369, 'ORPHA:213837', 'Malignant germ cell tumor of the cervix uteri', 1),
(4370, 'ORPHA:2139', 'Hernández-Aguirre Negrete syndrome', 1),
(4371, 'ORPHA:2139', 'Intellectual disability-epilepsy-bulbous nose syndrome', 1),
(4372, 'ORPHA:214', 'Cystinuria', 1),
(4373, 'ORPHA:214', 'Cystinuria-lysinuria syndrome', 1),
(4374, 'ORPHA:2140', 'CDH', 1),
(4375, 'ORPHA:2140', 'Congenital diaphragmatic hernia', 1),
(4376, 'ORPHA:2141', 'Diaphragmatic defect-limb deficiency-skull defect syndrome', 1),
(4377, 'ORPHA:2141', 'Froster-Huch syndrome', 1),
(4378, 'ORPHA:2143', 'DBS/FOAR syndrome', 1),
(4379, 'ORPHA:2143', 'Diaphragmatic hernia-exomphalos-hypertelorism syndrome', 1),
(4380, 'ORPHA:2143', 'Diaphragmatic hernia-hypertelorism-myopia-deafness syndrome', 1),
(4381, 'ORPHA:2143', 'Diaphragmatic hernia-hypertelorism-myopia-hearing loss syndrome', 1),
(4382, 'ORPHA:2143', 'Donnai-Barrow syndrome', 1),
(4383, 'ORPHA:2143', 'FOAR syndrome', 1),
(4384, 'ORPHA:2143', 'Facio-oculo-acoustico-renal syndrome', 1),
(4385, 'ORPHA:2143', 'Holmes-Schepens syndrome', 1),
(4386, 'ORPHA:2143', 'Syndrome of ocular and facial anomalies, telecanthus and deafness', 1),
(4387, 'ORPHA:2143', 'Syndrome of ocular and facial anomalies, telecanthus and hearing loss', 1),
(4388, 'ORPHA:2145', 'Craniosynostosis, Herrmann-Opitz type', 1),
(4389, 'ORPHA:2148', 'Lissencephaly type 1 due to doublecortin gene mutation', 1),
(4390, 'ORPHA:2148', 'X-linked lissencephaly type 1', 1),
(4391, 'ORPHA:2149', 'Nodular neuronal heterotopia', 1),
(4392, 'ORPHA:215', 'Congenital essential nyctalopia', 1),
(4393, 'ORPHA:215', 'Congenital stationary night blindness', 1),
(4394, 'ORPHA:2150', 'Hirschsprung disease-type D brachydactyly syndrome', 1),
(4395, 'ORPHA:2151', 'Hirschsprung disease-ganglioneuroblastoma syndrome', 1),
(4396, 'ORPHA:2152', 'Hirschsprung disease-intellectual disability syndrome', 1),
(4397, 'ORPHA:2152', 'Mowat-Wilson syndrome', 1),
(4398, 'ORPHA:2153', 'Al Gazali-Donnai-Muller syndrome', 1),
(4399, 'ORPHA:2153', 'Hirschsprung disease-nail hypoplasia-dysmorphism syndrome', 1),
(4400, 'ORPHA:2155', 'Hirschsprung disease-deafness-polydactyly syndrome', 1),
(4401, 'ORPHA:2155', 'Hirschsprung disease-hearing loss-polydactyly syndrome', 1),
(4402, 'ORPHA:2155', 'Santos-Mateus-Leal syndrome', 1),
(4403, 'ORPHA:2157', 'HAL deficiency', 1),
(4404, 'ORPHA:2157', 'HIS deficiency', 1),
(4405, 'ORPHA:2157', 'Histidase deficiency', 1),
(4406, 'ORPHA:2157', 'Histidine ammonia-lyase deficiency', 1),
(4407, 'ORPHA:2157', 'Histidinemia', 1),
(4408, 'ORPHA:2157', 'Histidinuria', 1),
(4409, 'ORPHA:2157', 'Hyperhistidinemia', 1),
(4410, 'ORPHA:2158', 'Histidinuria-renal tubular defect syndrome', 1),
(4411, 'ORPHA:216', 'NCL', 3),
(4412, 'ORPHA:216', 'Neuronal ceroid lipofuscinosis', 3),
(4413, 'ORPHA:2162', 'HPE', 1),
(4414, 'ORPHA:2162', 'Holoprosencephaly', 1),
(4415, 'ORPHA:2163', 'Camero-Lituania-Cohen syndrome', 1),
(4416, 'ORPHA:2163', 'Genoa syndrome', 1),
(4417, 'ORPHA:2163', 'Holoprosencephaly-craniosynostosis syndrome', 1),
(4418, 'ORPHA:2165', 'Holoprosencephaly-caudal dysgenesis syndrome', 1),
(4419, 'ORPHA:2166', 'Holoprosencephaly-postaxial polydactyly syndrome', 1),
(4420, 'ORPHA:2166', 'Pseudo-trisomy 13 syndrome', 1),
(4421, 'ORPHA:216675', 'Complete transposition', 3),
(4422, 'ORPHA:216675', 'TGA', 3),
(4423, 'ORPHA:216675', 'TGV', 3),
(4424, 'ORPHA:216675', 'Transposition of the great arteries', 3),
(4425, 'ORPHA:216675', 'Transposition of the great vessels', 3),
(4426, 'ORPHA:216694', 'Congenitally corrected transposition of the great arteries', 1),
(4427, 'ORPHA:216694', 'Congenitally corrected transposition of the great vessels', 1),
(4428, 'ORPHA:216694', 'Discordant ventriculoarterial and atrioventricular connections', 1),
(4429, 'ORPHA:216694', 'Double discordance', 1),
(4430, 'ORPHA:216694', 'L-transposition of the great arteries', 1),
(4431, 'ORPHA:216694', 'Levo-transposition of the great arteries', 1),
(4432, 'ORPHA:216694', 'Ventricular inversion', 1),
(4433, 'ORPHA:216694', 'Ventriculoarterial and atrioventricular discordance', 1),
(4434, 'ORPHA:2167', 'Cleft palate-Potter sequence-congenital heart anomalies-mesoaxial polydactyly-multiple malformations syndrome', 1),
(4435, 'ORPHA:2167', 'Holzgreve syndrome', 1),
(4436, 'ORPHA:2167', 'Holzgreve-Wagner-Rehder syndrome', 1),
(4437, 'ORPHA:216718', 'Isolated congenitally uncorrected transposition of the great arteries', 2),
(4438, 'ORPHA:216718', 'Isolated congenitally uncorrected transposition of the great vessels', 2),
(4439, 'ORPHA:216729', 'Congenitally uncorrected transposition of the great arteries with cardiac malformation', 2),
(4440, 'ORPHA:216729', 'Congenitally uncorrected transposition of the great vessels with cardiac malformation', 2),
(4441, 'ORPHA:216729', 'TGA with cardiac malformation', 2),
(4442, 'ORPHA:216796', 'Adair-Dighton syndrome', 2),
(4443, 'ORPHA:216796', 'Mild osteogenesis imperfecta', 2),
(4444, 'ORPHA:216796', 'Non-deforming osteogenesis imperfecta', 2),
(4445, 'ORPHA:216796', 'OI type 1', 2),
(4446, 'ORPHA:216796', 'Osteogenesis imperfecta type 1', 2),
(4447, 'ORPHA:216796', 'Van der Hoeve syndrome', 2),
(4448, 'ORPHA:216804', 'Lethal osteogenesis imperfecta', 2),
(4449, 'ORPHA:216804', 'OI type 2', 2),
(4450, 'ORPHA:216804', 'Osteogenesis imperfecta type 2', 2),
(4451, 'ORPHA:216812', 'OI type 3', 2),
(4452, 'ORPHA:216812', 'Osteogenesis imperfecta type 3', 2),
(4453, 'ORPHA:216812', 'Progressive deforming osteogenesis imperfecta', 2),
(4454, 'ORPHA:216812', 'Severe osteogenesis imperfecta', 2),
(4455, 'ORPHA:216820', 'OI type 4', 2),
(4456, 'ORPHA:216820', 'Osteogenesis imperfecta type 4', 2),
(4457, 'ORPHA:216828', 'OI type 5', 2),
(4458, 'ORPHA:216828', 'Osteogenesis imperfecta type 5', 2),
(4459, 'ORPHA:216866', 'Classic pantothenate kinase-associated neurodegeneration', 2),
(4460, 'ORPHA:216866', 'NBIA1, classic form', 2),
(4461, 'ORPHA:216866', 'Neurodegeneration with brain iron accumulation type 1, classic form', 2),
(4462, 'ORPHA:216866', 'PKAN, classic form', 2),
(4463, 'ORPHA:216873', 'Atypical pantothenate kinase-associated neurodegeneration', 2),
(4464, 'ORPHA:216873', 'NBIA1, atypical form', 2),
(4465, 'ORPHA:216873', 'Neurodegeneration with brain iron accumulation type 1, atypical form', 2),
(4466, 'ORPHA:216873', 'PKAN, atypical form', 2),
(4467, 'ORPHA:2169', 'Functional methionine synthase deficiency type cblE', 2),
(4468, 'ORPHA:2169', 'Methylcobalamin deficiency type cblE', 2),
(4469, 'ORPHA:216972', 'Niemann-Pick disease type C, severe perinatal form', 2),
(4470, 'ORPHA:216975', 'Niemann-Pick disease type C, severe early infantile neurologic onset', 2),
(4471, 'ORPHA:216978', 'Niemann-Pick disease type C, late infantile neurologic onset', 2),
(4472, 'ORPHA:216981', 'Niemann-Pick disease type C, classic form', 2),
(4473, 'ORPHA:216981', 'Niemann-Pick disease type C, juvenile neurologic onset', 2),
(4474, 'ORPHA:216986', 'Niemann-Pick disease type C, adult neurologic onset', 2),
(4475, 'ORPHA:217', 'Isolated Dandy-Walker malformation', 1),
(4476, 'ORPHA:2170', 'Functional methionine synthase deficiency type cblG', 2),
(4477, 'ORPHA:2170', 'Methylcobalamin deficiency type cblG', 2),
(4478, 'ORPHA:217008', 'Bockenheimer syndrome', 1),
(4479, 'ORPHA:217008', 'Genuine diffuse phlebectasia', 1),
(4480, 'ORPHA:217012', 'SCA31', 1),
(4481, 'ORPHA:217012', 'Spinocerebellar ataxia type 31', 1),
(4482, 'ORPHA:217017', 'Occipital atretic cephalocele-unusual facies-large feet syndrome', 1),
(4483, 'ORPHA:217017', 'Zechi-Ceide syndrome', 1),
(4484, 'ORPHA:217026', 'Hadziselimovic syndrome', 1),
(4485, 'ORPHA:217026', 'Microcephaly-facio-cardio-skeletal syndrome, Hadziselimovic type', 1),
(4486, 'ORPHA:217026', 'Microcephaly-faciocardioskeletal syndrome', 1),
(4487, 'ORPHA:217055', 'Autosomal recessive intermediate Charcot-Marie-Tooth disease type A', 1),
(4488, 'ORPHA:217055', 'RI-CMT type A', 1),
(4489, 'ORPHA:217059', 'Isolated congenital acropachy', 1),
(4490, 'ORPHA:217059', 'Isolated congenital digital clubbing', 1),
(4491, 'ORPHA:217059', 'Isolated congenital nail clubbing', 1),
(4492, 'ORPHA:217064', '5-fluorouracil intoxication', 1),
(4493, 'ORPHA:217064', '5-fluorouracil poisoning', 1),
(4494, 'ORPHA:217067', 'Pouchitis', 1),
(4495, 'ORPHA:217071', 'RCC', 3),
(4496, 'ORPHA:217071', 'Renal cell carcinoma', 3),
(4497, 'ORPHA:217074', 'Rare carcinoma of pancreas', 3),
(4498, 'ORPHA:217074', 'Rare pancreatic carcinoma', 3),
(4499, 'ORPHA:217080', 'Pulmonary fungal infections in patients deemed at risk', 1),
(4500, 'ORPHA:217085', 'Hunter syndrome type A', 2);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(4501, 'ORPHA:217085', 'Iduronate 2-sulfatase deficiency type A', 2),
(4502, 'ORPHA:217085', 'MPS2A', 2),
(4503, 'ORPHA:217085', 'MPSIIA', 2),
(4504, 'ORPHA:217085', 'Mucopolysaccharidosis type 2, severe form', 2),
(4505, 'ORPHA:217085', 'Mucopolysaccharidosis type 2A', 2),
(4506, 'ORPHA:217085', 'Mucopolysaccharidosis type II, severe form', 2),
(4507, 'ORPHA:217085', 'Mucopolysaccharidosis type IIA', 2),
(4508, 'ORPHA:217093', 'Hunter syndrome type B', 2),
(4509, 'ORPHA:217093', 'Iduronate 2-sulfatase deficiency type B', 2),
(4510, 'ORPHA:217093', 'MPS2B', 2),
(4511, 'ORPHA:217093', 'MPSIIB', 2),
(4512, 'ORPHA:217093', 'Mucopolysaccharidosis type 2, attenuated form', 2),
(4513, 'ORPHA:217093', 'Mucopolysaccharidosis type 2B', 2),
(4514, 'ORPHA:217093', 'Mucopolysaccharidosis type II, attenuated form', 2),
(4515, 'ORPHA:217093', 'Mucopolysaccharidosis type IIB', 2),
(4516, 'ORPHA:2172', 'Microcephaly-glomerulonephritis-marfanoid habitus syndrome', 1),
(4517, 'ORPHA:217253', 'Limbic encephalitis with N-methyl-D-aspartate receptor antibodies', 1),
(4518, 'ORPHA:217253', 'Limbic encephalitis with NMDA receptor antibodies', 1),
(4519, 'ORPHA:217260', 'PML', 1),
(4520, 'ORPHA:217260', 'Progressive multifocal leukoencephalitis', 1),
(4521, 'ORPHA:217260', 'Progressive multifocal leukoencephalopathy', 1),
(4522, 'ORPHA:217266', 'BNAR syndrome', 1),
(4523, 'ORPHA:217266', 'Bifid nose with or without anorectal and renal anomalies', 1),
(4524, 'ORPHA:217330', 'ADTKD-REN', 2),
(4525, 'ORPHA:217330', 'FJHN type 2', 2),
(4526, 'ORPHA:217330', 'Familial juvenile hyperuricemic nephropathy type 2', 2),
(4527, 'ORPHA:217330', 'REN-associated FJHN', 2),
(4528, 'ORPHA:217330', 'REN-associated familial juvenile hyperuricemic nephropathy', 2),
(4529, 'ORPHA:217330', 'REN-associated kidney disease', 2),
(4530, 'ORPHA:217330', 'REN-related autosomal dominant tubulointerstitial kidney disease', 2),
(4531, 'ORPHA:217335', 'MACS syndrome', 1),
(4532, 'ORPHA:217335', 'Macrocephaly-alopecia-cutis laxa-scoliosis syndrome', 1),
(4533, 'ORPHA:217335', 'RIN2 deficiency', 1),
(4534, 'ORPHA:217335', 'RIN2 syndrome', 1),
(4535, 'ORPHA:217335', 'Tall forehead-sparse hair-skin hyperextensibility-scoliosis syndrome', 1),
(4536, 'ORPHA:217340', '17q21.31 microduplication syndrome', 1),
(4537, 'ORPHA:217340', 'Dup(17)(q21.31)', 1),
(4538, 'ORPHA:217340', 'Trisomy 17q21.31', 1),
(4539, 'ORPHA:217346', '19q13.11 microdeletion syndrome', 1),
(4540, 'ORPHA:217346', 'Del(19)(q13.11)', 1),
(4541, 'ORPHA:217346', 'Monosomy 19q13.11', 1),
(4542, 'ORPHA:217371', 'Acute infantile liver failure due to synthesis defect of mitochondrial DNA-encoded proteins', 1),
(4543, 'ORPHA:217371', 'Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins', 1),
(4544, 'ORPHA:217377', 'Dup(X)(p11.22p11.23)', 1),
(4545, 'ORPHA:217377', 'Microduplication Xp11.22p11.23 syndrome', 1),
(4546, 'ORPHA:217377', 'Trisomy Xp11.22p11.23', 1),
(4547, 'ORPHA:217382', 'Neurodegenerative syndrome due to cerebral folate transport deficiency', 1),
(4548, 'ORPHA:217385', '17p13.3 duplication syndrome', 1),
(4549, 'ORPHA:217385', '17p13.3 microduplication syndrome', 1),
(4550, 'ORPHA:217385', 'Dup(17)(p13.3)', 1),
(4551, 'ORPHA:217385', 'Trisomy 17p13.3', 1),
(4552, 'ORPHA:217390', 'CID due to DOCK8 deficiency', 1),
(4553, 'ORPHA:217390', 'Combined immunodeficiency due to DOCK8 deficiency', 1),
(4554, 'ORPHA:217390', 'Combined immunodeficiency due to dedicator of cytokinesis 8 protein deficiency', 1),
(4555, 'ORPHA:217390', 'DOCK8 immunodeficiency syndrome', 1),
(4556, 'ORPHA:217396', 'Progressive polyneuropathy with bilateral striatal necrosis', 1),
(4557, 'ORPHA:217399', 'Congenital absence of pain with hyperhidrosis', 1),
(4558, 'ORPHA:217399', 'Congenital analgesia with hyperhidrosis', 1),
(4559, 'ORPHA:217399', 'Congenital indifference to pain with hyperhidrosis', 1),
(4560, 'ORPHA:217399', 'Congenital insensitivity to pain with hyperhidrosis', 1),
(4561, 'ORPHA:217407', 'Hereditary hypotrichosis with recurrent skin vesicles', 1),
(4562, 'ORPHA:217454', 'Rare hereditary thrombophilia', 3),
(4563, 'ORPHA:217467', 'Hereditary thrombophilia due to congenital HRG deficiency', 1),
(4564, 'ORPHA:217467', 'Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency', 1),
(4565, 'ORPHA:217557', 'Infantile cellular interstitial pneumonitis', 1),
(4566, 'ORPHA:217557', 'PIG', 1),
(4567, 'ORPHA:217557', 'Pulmonary interstitial glycogenosis', 1),
(4568, 'ORPHA:217560', 'NCHI', 1),
(4569, 'ORPHA:217560', 'NEHI', 1),
(4570, 'ORPHA:217560', 'Neuroendocrine cell hyperplasia of infancy', 1),
(4571, 'ORPHA:217563', 'Neonatal acute respiratory distress due to SP-B deficiency', 1),
(4572, 'ORPHA:217563', 'Neonatal acute respiratory distress due to surfactant protein B deficiency', 1),
(4573, 'ORPHA:217566', 'Chronic respiratory distress with surfactant metabolism deficiency', 1),
(4574, 'ORPHA:217569', 'Hypertrophic cardiomyopathy', 3),
(4575, 'ORPHA:217572', 'GSD with hypertrophic cardiomyopathy', 3),
(4576, 'ORPHA:217572', 'Glycogen storage disease with hypertrophic cardiomyopathy', 3),
(4577, 'ORPHA:217572', 'Glycogenosis with hypertrophic cardiomyopathy', 3),
(4578, 'ORPHA:217581', 'Lysosomal disease with hypertrophic cardiomyopathy', 3),
(4579, 'ORPHA:217587', 'Mitochondrial disease with hypertrophic cardiomyopathy', 3),
(4580, 'ORPHA:217591', 'Fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy', 3),
(4581, 'ORPHA:217595', 'Syndrome associated with hypertrophic cardiomyopathy', 3),
(4582, 'ORPHA:217598', 'Non-familial hypertrophic cardiomyopathy', 3),
(4583, 'ORPHA:2176', 'Infantile systemic hyalinosis', 2),
(4584, 'ORPHA:217601', 'Hypertrophic cardiomyopathy due to intensive athletic training', 1),
(4585, 'ORPHA:217604', 'Dilated cardiomyopathy', 3),
(4586, 'ORPHA:217607', 'Familial dilated cardiomyopathy', 3),
(4587, 'ORPHA:217610', 'Neuromuscular disease with dilated cardiomyopathy', 3),
(4588, 'ORPHA:217613', 'Mitochondrial disease with dilated cardiomyopathy', 3),
(4589, 'ORPHA:217616', 'Fatty acid oxidation and ketogenesis disorder with dilated cardiomyopathy', 3),
(4590, 'ORPHA:217619', 'Syndrome associated with dilated cardiomyopathy', 3),
(4591, 'ORPHA:217622', 'Neurosensory deafness with dilated cardiomyopathy', 1),
(4592, 'ORPHA:217622', 'Neurosensory hearing loss with dilated cardiomyopathy', 1),
(4593, 'ORPHA:217622', 'Sensorineural deafness with dilated cardiomyopathy', 1),
(4594, 'ORPHA:217622', 'Sensorineural hearing loss with dilated cardiomyopathy', 1),
(4595, 'ORPHA:217629', 'Non-familial dilated cardiomyopathy', 3),
(4596, 'ORPHA:217632', 'Restrictive cardiomyopathy', 3),
(4597, 'ORPHA:217635', 'Familial restrictive cardiomyopathy', 3),
(4598, 'ORPHA:217638', 'Lysosomal disease with restrictive cardiomyopathy', 3),
(4599, 'ORPHA:217656', 'Familial isolated ARVC', 1),
(4600, 'ORPHA:217656', 'Familial isolated ARVD', 1),
(4601, 'ORPHA:217656', 'Familial isolated arrhythmogenic right ventricular cardiomyopathy', 1),
(4602, 'ORPHA:217656', 'Familial isolated arrhythmogenic right ventricular dysplasia', 1),
(4603, 'ORPHA:217656', 'Familial isolated arrhythmogenic ventricular cardiomyopathy', 1),
(4604, 'ORPHA:217656', 'Familial isolated arrhythmogenic ventricular dysplasia', 1),
(4605, 'ORPHA:217678', 'Unclassified cardiomyopathy', 3),
(4606, 'ORPHA:2177', 'Hydranencephaly', 1),
(4607, 'ORPHA:217720', 'Non-familial restrictive cardiomyopathy', 3),
(4608, 'ORPHA:218', 'Darier disease', 1),
(4609, 'ORPHA:218', 'Darier-White disease', 1),
(4610, 'ORPHA:218', 'Keratosis follicularis', 1),
(4611, 'ORPHA:2180', 'Ferlini-Ragno-Calzolari syndrome', 1),
(4612, 'ORPHA:2180', 'Hydrocephalus-costovertebral dysplasia-Sprengel anomaly syndrome', 1),
(4613, 'ORPHA:2180', 'Waaler-Aarskog syndrome', 1),
(4614, 'ORPHA:2181', 'Daish-Hardman-Lamont syndrome', 1),
(4615, 'ORPHA:2181', 'Hydrocephaly-tall stature-joint laxity syndrome', 1),
(4616, 'ORPHA:2182', 'Bickers-Adams syndrome', 2),
(4617, 'ORPHA:2182', 'HSAS', 2),
(4618, 'ORPHA:2182', 'Hydrocephalus with stenosis of the aqueduct of Sylvius', 2),
(4619, 'ORPHA:2182', 'X-linked HSAS', 2),
(4620, 'ORPHA:2182', 'X-linked acqueductal stenosis', 2),
(4621, 'ORPHA:2182', 'X-linked hydrocephalus', 2),
(4622, 'ORPHA:2182', 'X-linked hydrocephalus with stenosis of aqueduct of Sylvius', 2),
(4623, 'ORPHA:2183', 'Hydrocephalus-obesity-hypogonadism syndrome', 1),
(4624, 'ORPHA:2183', 'Sengers-Hamel-Otten syndrome', 1),
(4625, 'ORPHA:2184', 'Hydrocephaly-low insertion umbilicus syndrome', 1),
(4626, 'ORPHA:2184', 'Palmer-Pagon syndrome', 1),
(4627, 'ORPHA:218436', 'Rare cardiac rhythm disease', 3),
(4628, 'ORPHA:218439', 'Non-genetic cardiac rhythm disease', 3),
(4629, 'ORPHA:2185', 'Congenital hydrocephalus', 1),
(4630, 'ORPHA:2186', 'Daentl-Townsend-Siegel syndrome', 1),
(4631, 'ORPHA:2186', 'Hydrocephalus-blue sclerae-nephropathy syndrome', 1),
(4632, 'ORPHA:2189', 'Hydrolethalus', 1),
(4633, 'ORPHA:219', 'Autosomal recessive limb-girdle muscular dystrophy type 2F', 1),
(4634, 'ORPHA:219', 'Delta-sarcoglycan-related  limb-girdle muscular dystrophy R6', 1),
(4635, 'ORPHA:219', 'Delta-sarcoglycan-related LGMD R6', 1),
(4636, 'ORPHA:219', 'Delta-sarcoglycanopathy', 1),
(4637, 'ORPHA:219', 'LGMD due to delta-sarcoglycan deficiency', 1),
(4638, 'ORPHA:219', 'LGMD type 2F', 1),
(4639, 'ORPHA:219', 'LGMD2F', 1),
(4640, 'ORPHA:219', 'Limb-girdle muscular dystrophy due to delta-sarcoglycan deficiency', 1),
(4641, 'ORPHA:219', 'Limb-girdle muscular dystrophy type 2F', 1),
(4642, 'ORPHA:2194', 'Anti-HLA hyperimmunization', 1),
(4643, 'ORPHA:2195', 'Dicarboxylic aminoaciduria', 1),
(4644, 'ORPHA:2195', 'Glutamate-aspartate transport defect', 1),
(4645, 'ORPHA:2196', 'FHHNC with severe ocular involvement', 1),
(4646, 'ORPHA:2196', 'Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement', 1),
(4647, 'ORPHA:2196', 'Hypercalciuria-bilateral macular coloboma syndrome', 1),
(4648, 'ORPHA:2196', 'Meier-Blumberg-Imahorn syndrome', 1),
(4649, 'ORPHA:2197', 'Idiopathic hypercalciuria', 1),
(4650, 'ORPHA:2198', 'Bennion-Patterson syndrome', 1),
(4651, 'ORPHA:2198', 'Howell-Evans syndrome', 1),
(4652, 'ORPHA:2198', 'Keratosis palmoplantaris-esophageal carcinoma syndrome', 1),
(4653, 'ORPHA:2198', 'Palmoplantar hyperkeratosis-esophageal carcinoma syndrome', 1),
(4654, 'ORPHA:2198', 'Palmoplantar keratoderma-esophageal carcinoma syndrome', 1),
(4655, 'ORPHA:2198', 'Tylosis-oesophageal carcinoma syndrome', 1),
(4656, 'ORPHA:2199', 'Diffuse erythrodermic palmoplantar keratoderma, Voerner type', 1),
(4657, 'ORPHA:2199', 'Diffuse erythrodermic palmoplantar keratoderma, Vörner type', 1),
(4658, 'ORPHA:2199', 'EPPK', 1),
(4659, 'ORPHA:2199', 'Epidermolytic palmoplantar keratoderma', 1),
(4660, 'ORPHA:2199', 'Epidermolytic palmoplantar keratoderma of Voerner', 1),
(4661, 'ORPHA:2199', 'Epidermolytic palmoplantar keratoderma of Vörner', 1),
(4662, 'ORPHA:22', '4-hydroxybutyric aciduria', 1),
(4663, 'ORPHA:22', 'Gamma-hydroxybutyric aciduria', 1),
(4664, 'ORPHA:22', 'SSADH deficiency', 1),
(4665, 'ORPHA:22', 'Succinic semialdehyde dehydrogenase deficiency', 1),
(4666, 'ORPHA:220', 'Denys-Drash syndrome', 1),
(4667, 'ORPHA:220', 'Drash syndrome', 1),
(4668, 'ORPHA:220', 'Wilms tumor-DSD syndrome', 1),
(4669, 'ORPHA:220', 'Wilms tumor-disorder of sex development syndrome', 1),
(4670, 'ORPHA:2200', 'Focal palmoplantar and gingival hyperkeratosis', 1),
(4671, 'ORPHA:2200', 'Focal palmoplantar and gingival keratoderma', 1),
(4672, 'ORPHA:2201', 'Palmoplantar hyperkeratosis-spastic paralysis syndrome', 1),
(4673, 'ORPHA:2201', 'Palmoplantar keratoderma-spastic paralysis syndrome', 1),
(4674, 'ORPHA:2201', 'Powell-Venencie-Gordon syndrome', 1),
(4675, 'ORPHA:2202', 'PPK-deafness syndrome', 1),
(4676, 'ORPHA:2202', 'Palmoplantar hyperkeratosis-deafness syndrome', 1),
(4677, 'ORPHA:2202', 'Palmoplantar hyperkeratosis-hearing loss syndrome', 1),
(4678, 'ORPHA:2202', 'Palmoplantar keratoderma-deafness syndrome', 1),
(4679, 'ORPHA:2202', 'Palmoplantar keratoderma-hearing loss syndrome', 1),
(4680, 'ORPHA:220295', 'XP/CS complex', 1),
(4681, 'ORPHA:220295', 'Xeroderma pigmentosum-Cockayne syndrome complex', 1),
(4682, 'ORPHA:2203', 'Hyperlysinemia', 1),
(4683, 'ORPHA:2203', 'Hyperlysinemia type I', 1),
(4684, 'ORPHA:2203', 'Lysine alpha-ketoglutarate reductase deficiency', 1),
(4685, 'ORPHA:220386', 'Semilobar holoprosencephaly', 2),
(4686, 'ORPHA:220393', 'Diffuse cutaneous systemic scleroderma', 2),
(4687, 'ORPHA:220393', 'Diffuse cutaneous systemic sclerosis', 2),
(4688, 'ORPHA:220393', 'Progressive cutaneous systemic scleroderma', 2),
(4689, 'ORPHA:220393', 'Progressive cutaneous systemic sclerosis', 2),
(4690, 'ORPHA:2204', 'Dysplastic cortical hyperostosis', 1),
(4691, 'ORPHA:2204', 'Kozlowski-Tsuruta syndrome', 1),
(4692, 'ORPHA:220402', 'Limited cutaneous systemic scleroderma', 2),
(4693, 'ORPHA:220402', 'Limited cutaneous systemic sclerosis', 2),
(4694, 'ORPHA:220407', 'Limited systemic sclerosis', 2),
(4695, 'ORPHA:220407', 'Systemic sclerosis sine scleroderma', 2),
(4696, 'ORPHA:220436', 'Factor V Quebec', 1),
(4697, 'ORPHA:220436', 'Quebec platelet disorder', 1),
(4698, 'ORPHA:220443', 'Bleeding diathesis due to thromboxane synthesis deficiency', 1),
(4699, 'ORPHA:220448', 'Macrothrombocytopenia with mitral valve insufficiency', 1),
(4700, 'ORPHA:220452', 'Isolated hereditary giant platelet disorder', 3),
(4701, 'ORPHA:220452', 'Isolated hereditary macrothrombocytopenia', 3),
(4702, 'ORPHA:220452', 'Isolated inherited giant platelet disorder', 3),
(4703, 'ORPHA:220452', 'Isolated inherited macrothrombocytopenia', 3),
(4704, 'ORPHA:220460', 'AFAP', 1),
(4705, 'ORPHA:220460', 'Attenuated FAP', 1),
(4706, 'ORPHA:220460', 'Attenuated familial adenomatous polyposis', 1),
(4707, 'ORPHA:220460', 'Attenuated familial polyposis coli', 1),
(4708, 'ORPHA:220465', 'Laron syndrome with immunodeficiency', 1),
(4709, 'ORPHA:220465', 'Laron-like syndrome', 1),
(4710, 'ORPHA:220465', 'Short stature due to STAT5b deficiency', 1),
(4711, 'ORPHA:220489', 'Iron overload disease', 3),
(4712, 'ORPHA:220489', 'Rare hereditary hemochromatosis', 3),
(4713, 'ORPHA:220493', 'JS-O', 1),
(4714, 'ORPHA:220493', 'Joubert syndrome with ocular defect', 1),
(4715, 'ORPHA:220493', 'Joubert syndrome with retinopathy', 1),
(4716, 'ORPHA:220497', 'JS-R', 1),
(4717, 'ORPHA:220497', 'Joubert syndrome with renal defect', 1),
(4718, 'ORPHA:2206', 'Ankylosing vertebral hyperostosis with tylosis', 1),
(4719, 'ORPHA:2207', 'Familial primary hyperparathyroidism', 3),
(4720, 'ORPHA:2209', 'Hyperphenylalaninemic embryopathy', 1),
(4721, 'ORPHA:2209', 'Maternal PKU', 1),
(4722, 'ORPHA:2209', 'Maternal hyperphenylalaninemia', 1),
(4723, 'ORPHA:2209', 'Maternal phenylketonuria', 1),
(4724, 'ORPHA:2209', 'Phenylketonuric embryopathy', 1),
(4725, 'ORPHA:221', 'Adult dermatomyositis', 1),
(4726, 'ORPHA:221', 'Dermatomyositis', 1),
(4727, 'ORPHA:221008', 'Poikiloderma of Rothmund-Thomson type 1', 2),
(4728, 'ORPHA:221008', 'RTS1', 2),
(4729, 'ORPHA:221008', 'Rothmund-Thomson syndrome type 1', 2),
(4730, 'ORPHA:221016', 'Poikiloderma of Rothmund-Thomson type 2', 2),
(4731, 'ORPHA:221016', 'RTS2', 2),
(4732, 'ORPHA:221016', 'Rothmund-Thomson syndrome type 2', 2),
(4733, 'ORPHA:221039', 'Hereditary sclerosing poikiloderma, Weary type', 1),
(4734, 'ORPHA:221043', 'Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome', 1),
(4735, 'ORPHA:221043', 'POIKTMP syndrome', 1),
(4736, 'ORPHA:221046', 'Poikiloderma with neutropenia', 1),
(4737, 'ORPHA:221046', 'Poikiloderma with neutropenia, Clericuzio type', 1),
(4738, 'ORPHA:221054', 'Acrocephalopolydactylous dysplasia', 1),
(4739, 'ORPHA:221054', 'Acrocephalopolydactyly', 1),
(4740, 'ORPHA:221054', 'Elejalde syndrome', 1),
(4741, 'ORPHA:221061', 'Familial brain cavernous angioma', 1),
(4742, 'ORPHA:221061', 'Familial cerebral cavernoma', 1),
(4743, 'ORPHA:221061', 'Familial cerebral cavernous malformation', 1),
(4744, 'ORPHA:221061', 'Hereditary brain cavernous angioma', 1),
(4745, 'ORPHA:221061', 'Hereditary cerebral cavernoma', 1),
(4746, 'ORPHA:221061', 'Hereditary cerebral cavernous malformation', 1),
(4747, 'ORPHA:221074', 'MBD', 1),
(4748, 'ORPHA:221074', 'Marchiafava-Bignami disease', 1),
(4749, 'ORPHA:221078', 'Combined hyperactive dysfunction syndrome of the cranial nerves', 1),
(4750, 'ORPHA:221083', 'Facial hemispasm', 1),
(4751, 'ORPHA:221083', 'Focal myoclonus of face', 1),
(4752, 'ORPHA:221083', 'Hemifacial spasm', 1),
(4753, 'ORPHA:221091', 'Trigeminal neuralgia', 1),
(4754, 'ORPHA:221098', 'Glossopharyngeal neuralgia', 1),
(4755, 'ORPHA:2211', 'Acrofrontofacionasal dysostosis type 2', 1),
(4756, 'ORPHA:2211', 'Acrofrontofacionasal syndrome type 2', 1),
(4757, 'ORPHA:2211', 'Hypertelorism-hypospadias-polysyndactyly syndrome', 1),
(4758, 'ORPHA:2211', 'Naguib-Richieri-Costa syndrome', 1),
(4759, 'ORPHA:221106', 'Isolated facial myokymia', 1),
(4760, 'ORPHA:221109', 'Cranial neuralgia', 3),
(4761, 'ORPHA:221109', 'Facial neuralgia', 3),
(4762, 'ORPHA:221114', 'Acquired peripheral movement disorder', 3),
(4763, 'ORPHA:221117', 'Gerstmann syndrome', 1),
(4764, 'ORPHA:221120', 'ASSA', 1),
(4765, 'ORPHA:221120', 'Aminopterin syndrome-like sine aminopterin', 1),
(4766, 'ORPHA:221120', 'Pseudoaminopterin syndrome', 1),
(4767, 'ORPHA:221126', 'Cerebral proliferative glomeruloid vasculopathy', 1),
(4768, 'ORPHA:221126', 'Encephaloclastic proliferative vasculopathy', 1),
(4769, 'ORPHA:221126', 'Fowler vasculopaty', 1),
(4770, 'ORPHA:221126', 'Hydrocephaly/hydranencephaly due to cerebral vasculopathy', 1),
(4771, 'ORPHA:221126', 'Proliferative vasculopathy and hydranencephaly/hydrocephaly', 1),
(4772, 'ORPHA:221139', 'Combined immunodeficiency with faciooculoskeletal anomalies', 1),
(4773, 'ORPHA:221139', 'Roifman-Chitayat syndrome', 1),
(4774, 'ORPHA:221142', 'Confetti-like macular atrophy', 1),
(4775, 'ORPHA:221145', 'ARCL1C', 1),
(4776, 'ORPHA:221145', 'Autosomal recessive cutis laxa type 1C', 1),
(4777, 'ORPHA:221145', 'Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies', 1),
(4778, 'ORPHA:221145', 'Urban-Rifkin-Davis syndrome', 1),
(4779, 'ORPHA:221150', 'Pitt-Hopkins-like syndrome', 1),
(4780, 'ORPHA:2213', 'Bixler-Christian-Gorlin syndrome', 1),
(4781, 'ORPHA:2213', 'HMC syndrome', 1),
(4782, 'ORPHA:2213', 'Hypertelorism-microtia-facial clefting syndrome', 1),
(4783, 'ORPHA:2215', 'Froster-Iskenius-Waterson-Hall syndrome', 1),
(4784, 'ORPHA:2215', 'Malignant hyperthermia-arthrogryposis-torticollis syndrome', 1),
(4785, 'ORPHA:2215', 'Multiple pterygium-malignant hyperthermia syndrome', 1),
(4786, 'ORPHA:2216', 'Maternal hyperthermia-induced birth defects', 1),
(4787, 'ORPHA:2218', 'Cervical hypertrichosis-peripheral neuropathy syndrome', 1),
(4788, 'ORPHA:222', 'Erosive pustular dermatosis of the scalp', 1),
(4789, 'ORPHA:2220', 'Hairy elbows syndrome', 1),
(4790, 'ORPHA:2220', 'Hypertrichosis cubiti', 1),
(4791, 'ORPHA:2220', 'MacDermot-Patton-Williams syndrome', 1),
(4792, 'ORPHA:2221', 'Acquired hypertrichosis lanuginosa', 1),
(4793, 'ORPHA:2222', 'Hypertrichosis lanuginosa congenita', 1),
(4794, 'ORPHA:2222', 'Hypertrichosis universalis', 1),
(4795, 'ORPHA:2224', 'Hypertryptophanemia', 1),
(4796, 'ORPHA:222628', 'Hereditary poikiloderma', 3),
(4797, 'ORPHA:2228', 'Hypodontia-dysplasia of nails syndrome', 1),
(4798, 'ORPHA:2228', 'Hypodontia-nail dysgenesis syndrome', 1),
(4799, 'ORPHA:2228', 'Tooth and nail syndrome', 1),
(4800, 'ORPHA:2228', 'Witkop syndrome', 1),
(4801, 'ORPHA:2229', 'Cardiogenital syndrome', 1),
(4802, 'ORPHA:2229', 'Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome', 1),
(4803, 'ORPHA:2229', 'Malouf syndrome', 1),
(4804, 'ORPHA:2229', 'Najjar syndrome', 1),
(4805, 'ORPHA:223', 'Nephrogenic diabetes insipidus', 1),
(4806, 'ORPHA:2230', 'Hypogonadotropic hypogonadism-frontoparietal alopecia syndrome', 1),
(4807, 'ORPHA:2230', 'Salti-Salem syndrome', 1),
(4808, 'ORPHA:2232', 'Al Awadi-Farag-Teebi syndrome', 1),
(4809, 'ORPHA:2232', 'Primary hypergonadotropic hypogonadism-partial alopecia syndrome', 1),
(4810, 'ORPHA:2233', 'Cantalamessa-Baldini-Ambrosi syndrome', 1),
(4811, 'ORPHA:2233', 'Hypogonadism-mitral valve prolapse-intellectual disability syndrome', 1),
(4812, 'ORPHA:2234', 'Male hypergonadotropic hypogonadism-intellectual disability-skeletal anomalies syndrome', 1),
(4813, 'ORPHA:2234', 'Sohval-Soffer syndrome', 1),
(4814, 'ORPHA:2235', 'Chang-Davidson-Carlson syndrome', 1),
(4815, 'ORPHA:2235', 'Hypogonadotropic hypogonadism-retinitis pigmentosa syndrome', 1),
(4816, 'ORPHA:2237', 'Barakat syndrome', 1),
(4817, 'ORPHA:2237', 'HDR syndrome', 1),
(4818, 'ORPHA:2237', 'Hypoparathyroidism-sensorineural deafness-renal disease syndrome', 1),
(4819, 'ORPHA:2237', 'Hypoparathyroidism-sensorineural hearing loss-renal disease syndrome', 1),
(4820, 'ORPHA:223713', 'Mitochondrial oxidative phosphorylation disorder', 3),
(4821, 'ORPHA:223713', 'OXPHOS disease', 3),
(4822, 'ORPHA:223727', 'Bone sarcoma', 3),
(4823, 'ORPHA:223735', 'Lymphoma', 3),
(4824, 'ORPHA:2238', 'Familial isolated hypoparathyroidism', 1),
(4825, 'ORPHA:2239', 'Familial isolated hypoparathyroidism due to agenesis of parathyroid gland', 2),
(4826, 'ORPHA:224', 'NDM', 3),
(4827, 'ORPHA:224', 'Neonatal diabetes mellitus', 3),
(4828, 'ORPHA:2241', 'Berdon syndrome', 1),
(4829, 'ORPHA:2241', 'MMIHS', 1),
(4830, 'ORPHA:2241', 'Megacystis-microcolon-intestinal hypoperistalsis syndrome', 1),
(4831, 'ORPHA:2241', 'Megacystis-microcolon-intestinal hypoperistalsis-hydronephrosis syndrome', 1),
(4832, 'ORPHA:2246', 'Cerebellar hypoplasia-tapetoretinal degeneration syndrome', 1),
(4833, 'ORPHA:2248', 'HLHS', 1),
(4834, 'ORPHA:2248', 'Hypoplastic left heart syndrome', 1),
(4835, 'ORPHA:2249', 'Ulna hypoplasia-intellectual disability syndrome', 1),
(4836, 'ORPHA:225', 'MIDD', 1),
(4837, 'ORPHA:225', 'Maternally-inherited diabetes and deafness', 1),
(4838, 'ORPHA:225', 'Maternally-inherited diabetes and hearing loss', 1),
(4839, 'ORPHA:225', 'Mitochondrial diabetes', 1),
(4840, 'ORPHA:2250', 'Bosma arhinia-microphthalmia syndrome', 1),
(4841, 'ORPHA:2250', 'Bosma-Henkin-Christiansen syndrome', 1),
(4842, 'ORPHA:2250', 'Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome', 1),
(4843, 'ORPHA:2251', 'Sparse hair-short stature-skin anomalies syndrome', 1),
(4844, 'ORPHA:2251', 'Thumb deformity-alopecia-pigmentation anomaly syndrome', 1),
(4845, 'ORPHA:225123', 'Hemochromatosis type 3', 1),
(4846, 'ORPHA:225123', 'TFR2-related hemochromatosis', 1),
(4847, 'ORPHA:225147', 'ABSN', 1),
(4848, 'ORPHA:225147', 'Acute bilateral striatal necrosis', 1),
(4849, 'ORPHA:225147', 'Sporadic IBSN', 1),
(4850, 'ORPHA:225147', 'Sporadic infantile bilateral striatal necrosis', 1),
(4851, 'ORPHA:225147', 'Sporadic infantile striatonigral degeneration', 1),
(4852, 'ORPHA:225147', 'Sporadic infantile striatonigral necrosis', 1),
(4853, 'ORPHA:225154', 'Familial IBSN', 1),
(4854, 'ORPHA:225154', 'Familial infantile bilateral striatal necrosis', 1),
(4855, 'ORPHA:225154', 'Familial infantile striatonigral degeneration', 1),
(4856, 'ORPHA:225154', 'Familial infantile striatonigral necrosis', 1),
(4857, 'ORPHA:2252', 'Radial hypoplasia-triphalangeal thumbs-hypospadias-maxillary diastema syndrome', 1),
(4858, 'ORPHA:2252', 'Schmitt-Gillenwater-Kelly syndrome', 1),
(4859, 'ORPHA:2253', 'Foveal hypoplasia-presenile cataract syndrome', 1),
(4860, 'ORPHA:2253', 'O\'Donnell-Pappas syndrome', 1),
(4861, 'ORPHA:2254', 'Norman disease', 1),
(4862, 'ORPHA:2254', 'PCH1', 1),
(4863, 'ORPHA:2254', 'Pontocerebellar hypoplasia type 1', 1),
(4864, 'ORPHA:2255', 'Pancreatic hypoplasia-diabetes-congenital heart disease syndrome', 1),
(4865, 'ORPHA:2255', 'Yorifuji-Okuno syndrome', 1),
(4866, 'ORPHA:2256', 'Fibulo-ulnar hypoplasia-renal anomalies syndrome', 1),
(4867, 'ORPHA:2256', 'Saito-Kuba-Tsuruta syndrome', 1),
(4868, 'ORPHA:225681', 'Lysosomal disease with epilepsy', 3),
(4869, 'ORPHA:225686', 'Peroxisomal disease with epilepsy', 3),
(4870, 'ORPHA:225689', 'Amino acid or protein metabolism disease with epilepsy', 3),
(4871, 'ORPHA:225692', 'Metal transport or utilization disorder with epilepsy', 3),
(4872, 'ORPHA:225696', 'Energy metabolism disorder with epilepsy', 3),
(4873, 'ORPHA:2257', 'Primary pulmonary hypoplasia', 1),
(4874, 'ORPHA:225700', 'Mitochondrial disease with epilepsy', 3),
(4875, 'ORPHA:225703', 'Mitochondrial disease with peripheral neuropathy', 3),
(4876, 'ORPHA:225707', 'Metabolic neurotransmission anomaly with epilepsy', 3),
(4877, 'ORPHA:225710', 'Sterol metabolism disorder with epilepsy', 3),
(4878, 'ORPHA:225713', 'Other metabolic disease with epilepsy', 3),
(4879, 'ORPHA:226', 'Dihydropteridine reductase deficiency', 2),
(4880, 'ORPHA:226', 'Hyperphenylalaninemia due to dihydropteridine reductase deficiency', 2),
(4881, 'ORPHA:226', 'PKU type 2', 2),
(4882, 'ORPHA:226', 'Phenylketonuria type 2', 2),
(4883, 'ORPHA:2260', 'Oligomeganephronia', 1),
(4884, 'ORPHA:2260', 'Oligomeganephronic renal hypoplasia', 1),
(4885, 'ORPHA:2261', 'Goldblatt-Wallis syndrome', 1),
(4886, 'ORPHA:2261', 'Hypospadias-intellectual disability, Goldblatt type syndrome', 1),
(4887, 'ORPHA:226292', 'Permanent congenital hypothyroidism', 3),
(4888, 'ORPHA:226295', 'Primary congenital hypothyroidism', 3),
(4889, 'ORPHA:226298', 'Central congenital hypothyroidism', 3),
(4890, 'ORPHA:226298', 'Secondary hypothyroidism', 3),
(4891, 'ORPHA:226307', 'Hypothyroidism due to deficient transcription factors involved in pituitary development or function', 1),
(4892, 'ORPHA:226310', 'Peripheral hypothyroidism', 3),
(4893, 'ORPHA:226313', 'Congenital hypothyroidism due to maternal intake of antithyroid drugs', 1),
(4894, 'ORPHA:226316', 'Genetic transient congenital hypothyroidism', 1),
(4895, 'ORPHA:2266', 'Hypotrichosis-intellectual disability, Lopes type', 1),
(4896, 'ORPHA:2266', 'Lopes-Marques de Faria syndrome', 1),
(4897, 'ORPHA:2268', 'ICF syndrome', 1),
(4898, 'ORPHA:2268', 'Immunodeficiency-centromeric instability-facial anomalies syndrome', 1),
(4899, 'ORPHA:2269', 'Ichthyosis-alopecia-eclabion-ectropion-intellectual disability syndrome', 1),
(4900, 'ORPHA:2269', 'Jagell-Holmgren-Hofer syndrome', 1),
(4901, 'ORPHA:227', 'Diphallia', 1),
(4902, 'ORPHA:2271', 'Congenital ichthyosis-microcephalus-quadriplegia syndrome', 1),
(4903, 'ORPHA:2271', 'Congenital ichthyosis-microcephalus-tetraplegia syndrome', 1),
(4904, 'ORPHA:2272', 'Clayton Smith-Donnai syndrome', 1),
(4905, 'ORPHA:2272', 'Ichthyosis-oral and digital anomalies syndrome', 1),
(4906, 'ORPHA:2273', 'IFAP syndrome', 1),
(4907, 'ORPHA:2273', 'Ichthyosis follicularis-alopecia-photophobia syndrome', 1),
(4908, 'ORPHA:2273', 'Ichthyosis follicularis-atrichia-photophobia syndrome', 1),
(4909, 'ORPHA:2274', 'Dykes-Marks-Harper syndrome', 1),
(4910, 'ORPHA:2274', 'Ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome', 1),
(4911, 'ORPHA:227510', 'MSA, cerebellar type', 2),
(4912, 'ORPHA:227510', 'MSA-c', 2),
(4913, 'ORPHA:227510', 'Multiple system atrophy, cerebellar type', 2),
(4914, 'ORPHA:227510', 'Sporadic OPCA type 1', 2),
(4915, 'ORPHA:227510', 'Sporadic olivopontocerebellar atrophy type 1', 2),
(4916, 'ORPHA:227535', 'Familial breast cancer', 1),
(4917, 'ORPHA:227535', 'Familial breast carcinoma', 1),
(4918, 'ORPHA:227535', 'Hereditary breast cancer', 1),
(4919, 'ORPHA:227535', 'Hereditary breast carcinoma', 1),
(4920, 'ORPHA:227796', 'Fundus albipunctatus', 1),
(4921, 'ORPHA:2278', 'Ichthyosis-intellectual disability-dwarfism-renal impairment syndrome', 1),
(4922, 'ORPHA:2278', 'Passwell-Goodman-Siprkowski syndrome', 1),
(4923, 'ORPHA:227972', 'Toxic oil syndrome', 1),
(4924, 'ORPHA:227976', 'Autosomal recessive optic atrophy, OPA7 type', 1),
(4925, 'ORPHA:227982', 'APS type 3', 1),
(4926, 'ORPHA:227982', 'APS3', 1),
(4927, 'ORPHA:227982', 'Autoimmune polyendocrine syndrome type 3', 1),
(4928, 'ORPHA:227982', 'Autoimmune polyendocrinopathy type 3', 1),
(4929, 'ORPHA:227982', 'Autoimmune polyglandular syndrome type 3', 1),
(4930, 'ORPHA:227990', 'APS type 4', 1),
(4931, 'ORPHA:227990', 'APS4', 1),
(4932, 'ORPHA:227990', 'Autoimmune polyendocrine syndrome type 4', 1),
(4933, 'ORPHA:227990', 'Autoimmune polyendocrinopathy type 4', 1),
(4934, 'ORPHA:227990', 'Autoimmune polyglandular syndrome type 4', 1),
(4935, 'ORPHA:228000', 'Idiopathic CD4 lymphocytopenia', 1),
(4936, 'ORPHA:228003', 'SCID due to CORO1A deficiency', 1),
(4937, 'ORPHA:228003', 'SCID due to coronin-1A deficiency', 1),
(4938, 'ORPHA:228003', 'Severe combined immunodeficiency due to CORO1A deficiency', 1),
(4939, 'ORPHA:228003', 'Severe combined immunodeficiency due to coronin-1A deficiency', 1),
(4940, 'ORPHA:228012', 'Progressive neurosensory deafness-hypertrophic cardiomyopathy syndrome', 1),
(4941, 'ORPHA:228012', 'Progressive neurosensory hearing loss-hypertrophic cardiomyopathy syndrome', 1),
(4942, 'ORPHA:228012', 'Progressive sensorineural deafness-hypertrophic cardiomyopathy syndrome', 1),
(4943, 'ORPHA:228012', 'Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome', 1),
(4944, 'ORPHA:228113', 'Anal fistula', 1),
(4945, 'ORPHA:228116', 'Hughes-Stovin syndrome', 1),
(4946, 'ORPHA:228119', 'Fusariosis', 1),
(4947, 'ORPHA:228119', 'Fusarium infection', 1),
(4948, 'ORPHA:228123', 'California disease', 1),
(4949, 'ORPHA:228123', 'Coccidioides infection', 1),
(4950, 'ORPHA:228123', 'Coccidioidomycosis', 1),
(4951, 'ORPHA:228123', 'Desert fever', 1),
(4952, 'ORPHA:228123', 'Desert rheumatism', 1),
(4953, 'ORPHA:228123', 'San Joaquin valley fever', 1),
(4954, 'ORPHA:228123', 'Valley fever', 1),
(4955, 'ORPHA:228140', 'Familial paroxysmal ventricular fibrillation, non Brugada type', 1),
(4956, 'ORPHA:228140', 'Idiopathic ventricular fibrillation, non Brugada type', 1),
(4957, 'ORPHA:228145', 'Multiple sclerosis variant', 3),
(4958, 'ORPHA:228157', 'Acute multiple sclerosis, Marburg type', 1),
(4959, 'ORPHA:228157', 'Acute multiple sclerosis, Marburg variant', 1),
(4960, 'ORPHA:228157', 'Marburg acute multiple sclerosis', 1),
(4961, 'ORPHA:228165', 'Baló concentric sclerosis', 1),
(4962, 'ORPHA:228165', 'Concentric demyelination', 1),
(4963, 'ORPHA:228169', 'ADSD', 1),
(4964, 'ORPHA:228169', 'Autosomal dominant striatal neurodegeneration', 1),
(4965, 'ORPHA:228174', 'Autosomal dominant Charcot-Marie-Tooth disease type 2N', 1),
(4966, 'ORPHA:228174', 'CMT2N', 1),
(4967, 'ORPHA:228179', 'Autosomal dominant Charcot-Marie-Tooth disease type 2M', 1),
(4968, 'ORPHA:228179', 'CMT2M', 1),
(4969, 'ORPHA:228184', 'Atriodigital dysplasia', 3),
(4970, 'ORPHA:228184', 'Heart-hand syndrome', 3),
(4971, 'ORPHA:228190', 'Patent arterial duct-bicuspid aortic valve-hand anomalies syndrome', 1),
(4972, 'ORPHA:228190', 'Patent ductus arteriosus-bicuspid aortic valve-hand anomalies syndrome', 1),
(4973, 'ORPHA:2282', 'Dysmorphism-short stature-deafness-disorder of sex development syndrome', 1),
(4974, 'ORPHA:2282', 'Dysmorphism-short stature-hearing loss-disorder of sex development syndrome', 1),
(4975, 'ORPHA:2282', 'Ieshima-Koeda-Inagaki syndrome', 1),
(4976, 'ORPHA:228215', 'Genetic dermis elastic tissue disorder', 3),
(4977, 'ORPHA:228218', 'Acquired dermis elastic tissue disorder', 3),
(4978, 'ORPHA:228221', 'Acquired dermis elastic tissue disorder with decreased elastic tissue', 3),
(4979, 'ORPHA:228224', 'Acquired dermis elastic tissue disorder with increased elastic tissue', 3),
(4980, 'ORPHA:228227', 'Late-onset focal dermal elastosis', 1),
(4981, 'ORPHA:228227', 'PXE-like late-onset focal dermal elastosis', 1),
(4982, 'ORPHA:228227', 'Pseudoxanthoma-like late-onset focal dermal elastosis', 1),
(4983, 'ORPHA:228236', 'Elastotic striae', 1),
(4984, 'ORPHA:228236', 'Linear focal dermal elastosis', 1),
(4985, 'ORPHA:228236', 'Linear focal elastosis', 1),
(4986, 'ORPHA:228240', 'Elastoderma', 1),
(4987, 'ORPHA:228243', 'Elastofibroma dorsi', 1),
(4988, 'ORPHA:228247', 'Acquired Gronblad-Strandberg-Touraine syndrome', 1),
(4989, 'ORPHA:228247', 'Acquired PXE', 1),
(4990, 'ORPHA:228247', 'Acquired pseudoxanthoma elasticum', 1),
(4991, 'ORPHA:228254', 'Elastoma', 1),
(4992, 'ORPHA:228254', 'Juvenile elastoma without osteopoikilosis', 1),
(4993, 'ORPHA:228254', 'Nevus elasticus', 1),
(4994, 'ORPHA:228254', 'Weidman juvenile elastoma', 1),
(4995, 'ORPHA:228264', 'Papular elastorrhexis', 1),
(4996, 'ORPHA:228272', 'Primary anetoderma', 1),
(4997, 'ORPHA:228272', 'Primary macular atrophy', 1),
(4998, 'ORPHA:228277', 'Familial anetoderma', 1),
(4999, 'ORPHA:228277', 'Hereditary anetoderma', 1),
(5000, 'ORPHA:228277', 'Hereditary macular atrophy', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(5001, 'ORPHA:228285', 'Acquired cutis laxa', 1),
(5002, 'ORPHA:228285', 'Cutis laxa acquisita', 1),
(5003, 'ORPHA:228290', 'White fibrous papulosis of the neck', 1),
(5004, 'ORPHA:228293', 'PXE-like papillary dermal elastolysis', 1),
(5005, 'ORPHA:228293', 'Pseudoxanthoma elasticum-like papillary dermal elastolysis', 1),
(5006, 'ORPHA:228299', 'Mid-dermal elastolysis', 1),
(5007, 'ORPHA:228302', 'CPT2, adult-onset form', 2),
(5008, 'ORPHA:228302', 'CPT2, myopathic form', 2),
(5009, 'ORPHA:228302', 'CPTII, adult-onset form', 2),
(5010, 'ORPHA:228302', 'CPTII, myopathic form', 2),
(5011, 'ORPHA:228302', 'Carnitine palmitoyl transferase II deficiency, adult-onset form', 2),
(5012, 'ORPHA:228302', 'Carnitine palmitoyl transferase II deficiency, myopathic form', 2),
(5013, 'ORPHA:228302', 'Carnitine palmitoyl transferase deficiency type 2, adult-onset form', 2),
(5014, 'ORPHA:228302', 'Carnitine palmitoyl transferase deficiency type 2, myopathic form', 2),
(5015, 'ORPHA:228305', 'CPT2, hepatocardiomuscular form', 2),
(5016, 'ORPHA:228305', 'CPT2, severe infantile form', 2),
(5017, 'ORPHA:228305', 'CPTII, hepatocardiomuscular form', 2),
(5018, 'ORPHA:228305', 'CPTII, severe infantile form', 2),
(5019, 'ORPHA:228305', 'Carnitine palmitoyl transferase II deficiency, hepatocardiomuscular form', 2),
(5020, 'ORPHA:228305', 'Carnitine palmitoyl transferase II deficiency, severe infantile form', 2),
(5021, 'ORPHA:228305', 'Carnitine palmitoyl transferase deficiency type 2, hepatocardiomuscular form', 2),
(5022, 'ORPHA:228305', 'Carnitine palmitoyl transferase deficiency type 2, severe infantile form', 2),
(5023, 'ORPHA:228308', 'CPT2, lethal systemic form', 2),
(5024, 'ORPHA:228308', 'CPT2, neonatal form', 2),
(5025, 'ORPHA:228308', 'CPTII, lethal systemic form', 2),
(5026, 'ORPHA:228308', 'CPTII, neonatal form', 2),
(5027, 'ORPHA:228308', 'Carnitine palmitoyl transferase II deficiency, lethal systemic form', 2),
(5028, 'ORPHA:228308', 'Carnitine palmitoyl transferase II deficiency, neonatal form', 2),
(5029, 'ORPHA:228308', 'Carnitine palmitoyl transferase deficiency type 2, lethal systemic form', 2),
(5030, 'ORPHA:228308', 'Carnitine palmitoyl transferase deficiency type 2, neonatal form', 2),
(5031, 'ORPHA:228312', 'Autoimmune hemolytic anemia, cold type', 3),
(5032, 'ORPHA:228312', 'Cold AIHA', 3),
(5033, 'ORPHA:228312', 'cAHA', 3),
(5034, 'ORPHA:228312', 'cAIHA', 3),
(5035, 'ORPHA:228329', 'CLN1 disease', 2),
(5036, 'ORPHA:228337', 'CLN10 disease', 2),
(5037, 'ORPHA:228337', 'Cathepsin D deficiency', 2),
(5038, 'ORPHA:228340', 'CLN4A disease', 2),
(5039, 'ORPHA:228343', 'CLN4B disease', 2),
(5040, 'ORPHA:228346', 'CLN3 disease', 2),
(5041, 'ORPHA:228346', 'Classic juvenile NCL', 2),
(5042, 'ORPHA:228346', 'Classic juvenile neuronal ceroid lipofuscinosis', 2),
(5043, 'ORPHA:228349', 'CLN2 disease', 2),
(5044, 'ORPHA:228349', 'Classic late infantile NCL', 2),
(5045, 'ORPHA:228349', 'Classic late infantile neuronal ceroid lipofuscinosis', 2),
(5046, 'ORPHA:228354', 'CLN8 disease', 2),
(5047, 'ORPHA:228357', 'CLN9 disease', 2),
(5048, 'ORPHA:228360', 'CLN5 disease', 2),
(5049, 'ORPHA:228363', 'CLN6 disease', 2),
(5050, 'ORPHA:228366', 'CLN7 disease', 2),
(5051, 'ORPHA:228371', 'Foodborne botulism', 2),
(5052, 'ORPHA:228371', 'Intoxication botulism', 2),
(5053, 'ORPHA:228374', 'AR-CMT2B5', 1),
(5054, 'ORPHA:228374', 'Autosomal recessive Charcot-Marie-Tooth disease type 2B5', 1),
(5055, 'ORPHA:228374', 'Charcot-Marie-Tooth disease type 2B5', 1),
(5056, 'ORPHA:228374', 'SEOAN due to NEFL deficiency', 1),
(5057, 'ORPHA:228374', 'Severe early-onset axonal neuropathy due to NEFL deficiency', 1),
(5058, 'ORPHA:228374', 'Severe early-onset axonal neuropathy due to light neurofilament subunit deficiency', 1),
(5059, 'ORPHA:228379', 'Cyclosporine-induced folliculodystrophy', 1),
(5060, 'ORPHA:228379', 'Pilomatrix dysplasia', 1),
(5061, 'ORPHA:228379', 'TS', 1),
(5062, 'ORPHA:228379', 'Trichodysplasia spinulosa', 1),
(5063, 'ORPHA:228379', 'VATS', 1),
(5064, 'ORPHA:228379', 'Virus-associated trichodysplasia spinulosa', 1),
(5065, 'ORPHA:228384', '5q14.3 microdeletion syndrome', 1),
(5066, 'ORPHA:228384', 'Del(5)(q14.3)', 1),
(5067, 'ORPHA:228384', 'Monosomy 5q14.3', 1),
(5068, 'ORPHA:228387', 'Spondylo-megaepiphyseal-metaphyseal dysplasia', 1),
(5069, 'ORPHA:228390', 'ALX4-related FNDAG', 1),
(5070, 'ORPHA:228390', 'Craniofrontonasal dysplasia with alopecia and hypogonadism', 1),
(5071, 'ORPHA:228390', 'Frontonasal dysplasia type 2', 1),
(5072, 'ORPHA:228390', 'Frontonasal dysplasia with alopecia and genital abnomality', 1),
(5073, 'ORPHA:228390', 'Frontonasal dysplasia-alopecia-genital anomalies syndrome', 1),
(5074, 'ORPHA:228396', 'Ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome', 1),
(5075, 'ORPHA:228399', '8q12 microduplication syndrome', 1),
(5076, 'ORPHA:228399', 'Dup(8)(q12)', 1),
(5077, 'ORPHA:228399', 'Trisomy 8q12', 1),
(5078, 'ORPHA:228402', '2q23.1 microdeletion syndrome', 1),
(5079, 'ORPHA:228402', 'Del(2)(q23.1)', 1),
(5080, 'ORPHA:228402', 'Monosomy 2q23.1', 1),
(5081, 'ORPHA:228402', 'Pseudo-Angelman syndrome', 1),
(5082, 'ORPHA:228410', 'PHD syndrome', 1),
(5083, 'ORPHA:228410', 'Polyvalvular heart disease syndrome', 1),
(5084, 'ORPHA:228415', '5q35 microduplication syndrome', 1),
(5085, 'ORPHA:228415', 'Dup(5)(q35)', 1),
(5086, 'ORPHA:228415', 'Trisomy 5q35', 1),
(5087, 'ORPHA:228423', 'Combined immunodeficiency with susceptibility to mycobacterial, viral and fungal infections', 1),
(5088, 'ORPHA:228423', 'Dendritic cell, monocyte, B and NK lymphoid deficiency', 1),
(5089, 'ORPHA:228423', 'MonoMAC', 1),
(5090, 'ORPHA:228423', 'Monocyte-B-natural killer-dendritic cell deficiency syndrome', 1),
(5091, 'ORPHA:228423', 'Monocytopenia and mycobacterial infection syndrome', 1),
(5092, 'ORPHA:228423', 'Monocytopenia with susceptibility to infections', 1),
(5093, 'ORPHA:228426', 'Syndromic multisystem autoimmune disease due to Itch deficiency', 1),
(5094, 'ORPHA:2285', 'Bull-Nixon syndrome', 1),
(5095, 'ORPHA:2285', 'Primary basilar invagination', 1),
(5096, 'ORPHA:2287', 'Fused mandibular incisors', 1),
(5097, 'ORPHA:2289', 'Neuronal intranuclear inclusion disease', 1),
(5098, 'ORPHA:229', 'Annuloaortic ectasia', 1),
(5099, 'ORPHA:229', 'Cystic medial necrosis of aorta', 1),
(5100, 'ORPHA:229', 'Familial aortic dissection', 1),
(5101, 'ORPHA:2290', 'Congenital microvillous atrophy', 1),
(5102, 'ORPHA:2290', 'Congenital microvillus atrophy', 1),
(5103, 'ORPHA:2290', 'MVID', 1),
(5104, 'ORPHA:2290', 'Microvillous inclusion disease', 1),
(5105, 'ORPHA:2290', 'Microvillus inclusion disease', 1),
(5106, 'ORPHA:2291', 'Congenital velopharyngeal incompetence', 1),
(5107, 'ORPHA:2292', 'Congenital bowing of long bones', 1),
(5108, 'ORPHA:2295', 'Familial articular hypermobility syndrome', 1),
(5109, 'ORPHA:2295', 'Familial joint instability syndrome', 1),
(5110, 'ORPHA:2295', 'Familial joint laxity', 1),
(5111, 'ORPHA:2295', 'Joint instability syndrome', 1),
(5112, 'ORPHA:2297', 'Insulin-resistance syndrome type A', 1),
(5113, 'ORPHA:229717', 'Isolated agammaglobulinemia', 1),
(5114, 'ORPHA:229717', 'Isolated hypogammaglobulinemia', 1),
(5115, 'ORPHA:229720', 'Syndromic agammaglobulinemia', 3),
(5116, 'ORPHA:2298', 'Insulin-resistance syndrome type B', 1),
(5117, 'ORPHA:2299', 'Aortic arch interruption', 1),
(5118, 'ORPHA:23', 'ASA deficiency', 1),
(5119, 'ORPHA:23', 'ASL deficiency', 1),
(5120, 'ORPHA:23', 'Argininosuccinase deficiency', 1),
(5121, 'ORPHA:23', 'Argininosuccinatelyase deficiency', 1),
(5122, 'ORPHA:23', 'Argininosuccinic acid lyase deficiency', 1),
(5123, 'ORPHA:23', 'Argininosuccinic aciduria', 1),
(5124, 'ORPHA:230', 'Dopamine beta-hydroxylase deficiency', 1),
(5125, 'ORPHA:230', 'Noradrenaline deficiency', 1),
(5126, 'ORPHA:230', 'Norepinephrine deficiency', 1),
(5127, 'ORPHA:2300', 'Familial intestinal polyatresia syndrome', 1),
(5128, 'ORPHA:2300', 'Multiple intestinal atresia', 1),
(5129, 'ORPHA:2301', 'Congenital short bowel syndrome', 1),
(5130, 'ORPHA:2302', 'Asbestos intoxication', 1),
(5131, 'ORPHA:2302', 'Asbestosis', 1),
(5132, 'ORPHA:2305', 'Isotretinoin embryopathy', 1),
(5133, 'ORPHA:2305', 'Isotretinoin syndrome', 1),
(5134, 'ORPHA:2305', 'Retinoic acid embryopathy', 1),
(5135, 'ORPHA:2305', 'Retinoids embryopathy', 1),
(5136, 'ORPHA:2306', 'Isotretinoin-like syndrome', 1),
(5137, 'ORPHA:2306', 'Kawashima syndrome', 1),
(5138, 'ORPHA:2306', 'Microtia-aortic arch syndrome', 1),
(5139, 'ORPHA:2307', 'IVIC syndrome', 1),
(5140, 'ORPHA:2307', 'Oculo-oto-radial syndrome', 1),
(5141, 'ORPHA:2307', 'Radial ray defects, hearing impairment, external ophthalmoplegia, and thrombocytopenia', 1),
(5142, 'ORPHA:2308', 'Del(11)(q23.3)', 1),
(5143, 'ORPHA:2308', 'Del(11)(qter)', 1),
(5144, 'ORPHA:2308', 'Distal deletion 11q', 1),
(5145, 'ORPHA:2308', 'Distal monosomy 11q', 1),
(5146, 'ORPHA:2308', 'Jacobsen syndrome', 1),
(5147, 'ORPHA:2308', 'Monosomy 11qter', 1),
(5148, 'ORPHA:2308', 'Telomeric deletion 11q', 1),
(5149, 'ORPHA:230800', 'Toxin-mediated infectious botulism', 2),
(5150, 'ORPHA:230800', 'Toxin-mediated infective botulism', 2),
(5151, 'ORPHA:230839', 'Classical-like EDS type 1', 1),
(5152, 'ORPHA:230839', 'Classical-like Ehlers-Danlos syndrome type 1', 1),
(5153, 'ORPHA:230839', 'Ehlers-Danlos syndrome due to tenascin-X deficiency', 1),
(5154, 'ORPHA:230839', 'clEDS type 1', 1),
(5155, 'ORPHA:230851', 'Cardiac-valvular EDS', 1),
(5156, 'ORPHA:230851', 'Cardiac-valvular Ehlers-Danlos syndrome', 1),
(5157, 'ORPHA:230851', 'cvEDS', 1),
(5158, 'ORPHA:230857', 'EDS/OI syndrome', 1),
(5159, 'ORPHA:230857', 'Ehlers-Danlos/osteogenesis imperfecta syndrome', 1),
(5160, 'ORPHA:2309', 'PC', 1),
(5161, 'ORPHA:2309', 'Pachyonychia congenita', 1),
(5162, 'ORPHA:231', 'Dracunculiasis', 1),
(5163, 'ORPHA:231', 'Dracunculosis', 1),
(5164, 'ORPHA:231', 'Guinea worm disease', 1),
(5165, 'ORPHA:231', 'Medina worm disease', 1),
(5166, 'ORPHA:231', 'Medinensis', 1),
(5167, 'ORPHA:2310', 'Absence deformity of leg-cataract syndrome', 1),
(5168, 'ORPHA:231013', 'Congenital trigeminal anesthesia', 1),
(5169, 'ORPHA:231031', 'Erythema palmare hereditarium', 1),
(5170, 'ORPHA:231031', 'Lane disease', 1),
(5171, 'ORPHA:231031', 'Red palms disease', 1),
(5172, 'ORPHA:231040', 'Familial generalized lentiginosis', 1),
(5173, 'ORPHA:231040', 'Familial lentigines profusa', 1),
(5174, 'ORPHA:231040', 'Familial multiple lentigines syndrome without systemic involvement', 1),
(5175, 'ORPHA:231080', 'High-grade dysplasia in patients with Barrett esophagus', 1),
(5176, 'ORPHA:2311', 'Autosomal recessive spondylocostal dysostosis', 1),
(5177, 'ORPHA:2311', 'Jarcho-Levin syndrome', 1),
(5178, 'ORPHA:231108', 'Familial rhabdoid tumor', 2),
(5179, 'ORPHA:231108', 'RTPS', 2),
(5180, 'ORPHA:231108', 'Rhabdoid tumor predisposition syndrome', 2),
(5181, 'ORPHA:231111', 'DILE', 1),
(5182, 'ORPHA:231111', 'Drug-induced lupus erythematosus', 1),
(5183, 'ORPHA:231117', 'Beckwith-Wiedemann syndrome due to imprinting defect of 11p15', 2),
(5184, 'ORPHA:231120', 'Beckwith-Wiedemann syndrome due to CDKN1C mutation', 2),
(5185, 'ORPHA:231127', 'Beckwith-Wiedemann syndrome due to 11p15 microdeletion', 2),
(5186, 'ORPHA:231130', 'Beckwith-Wiedemann syndrome due to 11p15 translocation/inversion', 2),
(5187, 'ORPHA:231137', 'Silver-Russell syndrome due to 7p11.2-p13 microduplication', 2),
(5188, 'ORPHA:231137', 'Silver-Russell syndrome due to 7p11.2p13 microduplication', 2),
(5189, 'ORPHA:231137', 'Silver-Russell syndrome due to dup(7)(p11.2p13)', 2),
(5190, 'ORPHA:231137', 'Silver-Russell syndrome due to trisomy 7p11.2-p13', 2),
(5191, 'ORPHA:231137', 'Silver-Russell syndrome due to trisomy 7p11.2p13', 2),
(5192, 'ORPHA:231140', 'Silver-Russell syndrome due to an imprinting defect of 11p15', 2),
(5193, 'ORPHA:231144', 'Silver-Russell syndrome due to 11p15 microduplication', 2),
(5194, 'ORPHA:231147', 'Silver-Russell syndrome due to maternal uniparental disomy of chromosome 11', 2),
(5195, 'ORPHA:231147', 'UPD(11)mat', 2),
(5196, 'ORPHA:231154', 'CID due to partial RAG1 deficiency', 1),
(5197, 'ORPHA:231154', 'CID with expansion of gamma delta T cells', 1),
(5198, 'ORPHA:231154', 'Combined immunodeficiency due to partial RAG1 deficiency', 1),
(5199, 'ORPHA:231154', 'Combined immunodeficiency with expansion of gamma delta T cells', 1),
(5200, 'ORPHA:231160', 'Familial berry aneurysm', 1),
(5201, 'ORPHA:231160', 'Familial cerebral saccular aneurysm', 1),
(5202, 'ORPHA:231160', 'Familial intracranial saccular aneurysm', 1),
(5203, 'ORPHA:231169', 'USH1', 2),
(5204, 'ORPHA:231169', 'Usher syndrome type 1', 2),
(5205, 'ORPHA:231178', 'USH2', 2),
(5206, 'ORPHA:231178', 'Usher syndrome type 2', 2),
(5207, 'ORPHA:231183', 'USH3', 2),
(5208, 'ORPHA:231183', 'Usher syndrome type 3', 2),
(5209, 'ORPHA:2312', 'Lucey-Driscoll syndrome', 1),
(5210, 'ORPHA:2312', 'Transient familial neonatal hyperbilirubinemia', 1),
(5211, 'ORPHA:231214', 'Beta-thalassemia major', 2),
(5212, 'ORPHA:231214', 'Cooley anemia', 2),
(5213, 'ORPHA:231214', 'Mediterranean anemia', 2),
(5214, 'ORPHA:231222', 'Beta-thalassemia intermedia', 2),
(5215, 'ORPHA:231226', 'Dominant beta-thalassemia', 2),
(5216, 'ORPHA:231226', 'Inclusion body beta-thalassemia', 2),
(5217, 'ORPHA:231230', 'Beta-thalassemia associated with another Hb anomaly', 3),
(5218, 'ORPHA:231230', 'Beta-thalassemia associated with another hemoglobin anomaly', 3),
(5219, 'ORPHA:231237', 'Delta-beta-thalassemia', 1),
(5220, 'ORPHA:231242', 'C-beta-thalassemia', 1),
(5221, 'ORPHA:231242', 'HbC-beta-thalassemia syndrome', 1),
(5222, 'ORPHA:231242', 'Hemoglobin C-beta-thalassemia syndrome', 1),
(5223, 'ORPHA:231249', 'E-beta-thalassemia', 1),
(5224, 'ORPHA:231249', 'HbE-beta-thalassemia syndrome', 1),
(5225, 'ORPHA:231249', 'Hemoglobin E-beta-thalassemia syndrome', 1),
(5226, 'ORPHA:231386', 'Beta-thalassemia with other manifestations', 3),
(5227, 'ORPHA:231393', 'Beta-thalassemia-X-linked thrombocytopenia syndrome', 1),
(5228, 'ORPHA:231393', 'XLTT', 1),
(5229, 'ORPHA:2314', 'AD-HIES', 1),
(5230, 'ORPHA:2314', 'Autosomal dominant HIES', 1),
(5231, 'ORPHA:2314', 'Autosomal dominant hyper-IgE syndrome', 1),
(5232, 'ORPHA:2314', 'Autosomal dominant hyperimmunoglobulin E syndrome', 1),
(5233, 'ORPHA:2314', 'Buckley syndrome', 1),
(5234, 'ORPHA:2314', 'Hyperimmunoglobulin E syndrome type 1', 1),
(5235, 'ORPHA:2314', 'Hyperimmunoglobulin E-recurrent infection syndrome', 1),
(5236, 'ORPHA:2314', 'Job syndrome', 1),
(5237, 'ORPHA:2314', 'STAT3 deficiency', 1),
(5238, 'ORPHA:231401', 'ATMDS', 1),
(5239, 'ORPHA:231401', 'Acquired HbH disease', 1),
(5240, 'ORPHA:231401', 'Acquired hemoglobin H disease', 1),
(5241, 'ORPHA:231401', 'Alpha-thalassemia-myelodysplastic syndrome', 1),
(5242, 'ORPHA:231413', 'Variant of GBS', 3),
(5243, 'ORPHA:231413', 'Variant of Guillain-Barré syndrome', 3),
(5244, 'ORPHA:231416', 'Regional variant of GBS', 3),
(5245, 'ORPHA:231416', 'Regional variant of Guillain-Barré syndrome', 3),
(5246, 'ORPHA:231419', 'Functional variant of GBS', 3),
(5247, 'ORPHA:231419', 'Functional variant of Guillain-Barré syndrome', 3),
(5248, 'ORPHA:231426', 'PCB variant of GBS', 1),
(5249, 'ORPHA:231426', 'PCB variant of Guillain-Barré syndrome', 1),
(5250, 'ORPHA:231426', 'Pharyngeal-cervical-brachial variant of Guillain-Barré syndrome', 1),
(5251, 'ORPHA:231426', 'Pharyngeal-cervical-brachial weakness', 1),
(5252, 'ORPHA:231426', 'Pharyngo-cervico-brachial variant of GBS', 1),
(5253, 'ORPHA:231426', 'Pharyngo-cervico-brachial variant of Guillain-Barré syndrome', 1),
(5254, 'ORPHA:231445', 'Paraparetic variant of GBS', 1),
(5255, 'ORPHA:231445', 'Paraparetic variant of Guillain-Barré syndrome', 1),
(5256, 'ORPHA:231450', 'Acute pure sensory GBS', 1),
(5257, 'ORPHA:231450', 'Acute pure sensory Guillain-Barré syndrome', 1),
(5258, 'ORPHA:231450', 'Acute pure sensory neuropathy', 1),
(5259, 'ORPHA:231457', 'Acute panautonomic GBS', 1),
(5260, 'ORPHA:231457', 'Acute panautonomic Guillain-Barré syndrome', 1),
(5261, 'ORPHA:231457', 'Acute panautonomic neuropathy', 1),
(5262, 'ORPHA:231457', 'Acute pandysautonomia', 1),
(5263, 'ORPHA:231466', 'ASAN', 1),
(5264, 'ORPHA:231466', 'Acute sensory ataxic GBS', 1),
(5265, 'ORPHA:231466', 'Acute sensory ataxic Guillain-Barré syndrome', 1),
(5266, 'ORPHA:231466', 'Acute sensory ataxic neuropathy', 1),
(5267, 'ORPHA:2315', 'JBS', 1),
(5268, 'ORPHA:2315', 'Johanson-Blizzard syndrome', 1),
(5269, 'ORPHA:231500', 'HPS with pulmonary fibrosis', 2),
(5270, 'ORPHA:231500', 'Hermansky-Pudlak syndrome with pulmonary fibrosis', 2),
(5271, 'ORPHA:231512', 'HPS without pulmonary fibrosis', 2),
(5272, 'ORPHA:231512', 'Hermansky-Pudlak syndrome without pulmonary fibrosis', 2),
(5273, 'ORPHA:231531', 'HPS7', 2),
(5274, 'ORPHA:231531', 'Hermansky-Pudlak syndrome type 7', 2),
(5275, 'ORPHA:231537', 'HPS8', 2),
(5276, 'ORPHA:231537', 'Hermansky-Pudlak syndrome type 8', 2),
(5277, 'ORPHA:231556', 'Late-onset localized junctional epidermolysis bullosa-intellectual disability syndrome', 1),
(5278, 'ORPHA:231568', 'Autosomal dominant dystrophic epidermolysis bullosa, Pasini and Cockayne-Touraine types', 1),
(5279, 'ORPHA:231568', 'DDEB, Pasini and Cockayne-Touraine types', 1),
(5280, 'ORPHA:231568', 'DDEB, generalized', 1),
(5281, 'ORPHA:231568', 'DDEB-gen', 1),
(5282, 'ORPHA:231568', 'Generalized dominant dystrophic epidermolysis bullosa', 1),
(5283, 'ORPHA:231573', 'CEVD', 1),
(5284, 'ORPHA:231573', 'Congenital erosive and vesicular dermatosis', 1),
(5285, 'ORPHA:231573', 'Congenital erosive and vesicular dermatosis with reticulated supple scarring', 1),
(5286, 'ORPHA:231580', 'PUAH', 1),
(5287, 'ORPHA:231580', 'Primary unilateral adrenal hyperplasia', 1),
(5288, 'ORPHA:2316', 'Alopecia-anosmia-conductive hearing loss-hypogonadism syndrome', 1),
(5289, 'ORPHA:2316', 'Alopecia-anosmia-deafness-hypogonadism syndrome', 1),
(5290, 'ORPHA:2316', 'Johnson neuroectodermal syndrome', 1),
(5291, 'ORPHA:2316', 'Johnson-McMillin syndrome', 1),
(5292, 'ORPHA:231625', 'Adrenocortical carcinoma with pure aldosterone hypersecretion', 1),
(5293, 'ORPHA:231625', 'Pure APAC', 1),
(5294, 'ORPHA:231625', 'Pure aldosterone-producing adrenocortical carcinoma', 1),
(5295, 'ORPHA:231625', 'Pure aldosterone-secreting adrenocortical carcinoma', 1),
(5296, 'ORPHA:231632', 'Ectopic aldosterone-producing tumor', 1),
(5297, 'ORPHA:231632', 'Extra-adrenal aldosterone-producing tumor', 1),
(5298, 'ORPHA:231637', 'Rare surgically correctable form of primary aldosteronism', 3),
(5299, 'ORPHA:231641', 'Rare non surgically correctable form of primary aldosteronism', 3),
(5300, 'ORPHA:231662', 'Congenital IGHD type IA', 2),
(5301, 'ORPHA:231662', 'Congenital isolated GH deficiency type IA', 2),
(5302, 'ORPHA:231662', 'Congenital isolated growth hormone deficiency type IA', 2),
(5303, 'ORPHA:231662', 'Isolated growth hormone deficiency type IA', 2),
(5304, 'ORPHA:231671', 'Congenital IGHD type IB', 2),
(5305, 'ORPHA:231671', 'Congenital isolated GH deficiency type IB', 2),
(5306, 'ORPHA:231671', 'Congenital isolated growth hormone deficiency type IB', 2),
(5307, 'ORPHA:231671', 'Isolated growth hormone deficiency type IB', 2),
(5308, 'ORPHA:231679', 'Congenital IGHD type II', 2),
(5309, 'ORPHA:231679', 'Congenital isolated GH deficiency type II', 2),
(5310, 'ORPHA:231679', 'Congenital isolated growth hormone deficiency type II', 2),
(5311, 'ORPHA:231679', 'Isolated growth hormone deficiency type II', 2),
(5312, 'ORPHA:231692', 'Congenital IGHD type III', 2),
(5313, 'ORPHA:231692', 'Congenital isolated GH deficiency type III', 2),
(5314, 'ORPHA:231692', 'Congenital isolated growth hormone deficiency type III', 2),
(5315, 'ORPHA:231692', 'Isolated growth hormone deficiency type III', 2),
(5316, 'ORPHA:231692', 'X-linked IGHD', 2),
(5317, 'ORPHA:231692', 'X-linked isolated growth hormone deficiency', 2),
(5318, 'ORPHA:231720', 'Non-acquired combined pituitary hormone deficiency-deafness-rigid cervical spine syndrome', 1),
(5319, 'ORPHA:231720', 'Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome', 1),
(5320, 'ORPHA:231736', 'MPPC syndrome', 1),
(5321, 'ORPHA:231736', 'Microcornea-posterior megalolenticonus-persistent fetal vasculature-coloboma syndrome', 1),
(5322, 'ORPHA:231742', 'Epibulbar lipodermoid-preauricular appendage-polythelia syndrome', 1),
(5323, 'ORPHA:2318', 'Arima syndrome', 1),
(5324, 'ORPHA:2318', 'CORS', 1),
(5325, 'ORPHA:2318', 'Cerebellooculorenal syndrome', 1),
(5326, 'ORPHA:2318', 'Dekaban-Arima syndrome', 1),
(5327, 'ORPHA:2318', 'JS type B', 1),
(5328, 'ORPHA:2318', 'JS-OR', 1),
(5329, 'ORPHA:2318', 'Joubert syndrome with Senior-Loken syndrome', 1),
(5330, 'ORPHA:2318', 'Joubert syndrome with oculorenal defect', 1),
(5331, 'ORPHA:2319', 'Cleft lip/palate-abnormal thumbs-microcephaly syndrome', 1),
(5332, 'ORPHA:2319', 'Juberg-Hayward syndrome', 1),
(5333, 'ORPHA:2319', 'Orocraniodigital syndrome', 1),
(5334, 'ORPHA:232', 'Sickle cell anemia', 1),
(5335, 'ORPHA:232', 'Sickle cell disease', 1),
(5336, 'ORPHA:232035', 'Infectious embryofetopathy', 3),
(5337, 'ORPHA:2321', 'Jung syndrome', 1),
(5338, 'ORPHA:2322', 'Kabuki make-up syndrome', 1),
(5339, 'ORPHA:2322', 'Kabuki syndrome', 1),
(5340, 'ORPHA:2322', 'Niikawa-Kuroki syndrome', 1),
(5341, 'ORPHA:232288', 'Alpha-thalassemia-related diseases', 3),
(5342, 'ORPHA:2323', 'HRD syndrome', 1),
(5343, 'ORPHA:2323', 'Hypoparathyroidism-intellectual disability-dysmorphism syndrome', 1),
(5344, 'ORPHA:2323', 'Hypoparathyroidism-short stature-intellectual disability-seizures syndrome', 1),
(5345, 'ORPHA:2323', 'Richardson-Kirk syndrome', 1),
(5346, 'ORPHA:2323', 'SSS', 1),
(5347, 'ORPHA:2323', 'Sanjad-Sakati syndrome', 1),
(5348, 'ORPHA:2324', 'Kaler-Garrity-Stern syndrome', 1),
(5349, 'ORPHA:2324', 'Osteopenia-intellectual disability-sparse hair syndrome', 1),
(5350, 'ORPHA:2325', 'Epidermolysis bullosa simplex with deafness, alopecia, anodontia/hypodontia and nail dystrophy', 1),
(5351, 'ORPHA:2325', 'Kallin syndrome', 1),
(5352, 'ORPHA:2326', 'Kallmann syndrome-heart disease syndrome', 1),
(5353, 'ORPHA:2328', 'Cleft lip/palate-facial, eye, heart and intestinal anomalies syndrome', 1),
(5354, 'ORPHA:2328', 'Kapur-Toriello syndrome', 1),
(5355, 'ORPHA:2329', 'Karsch-Neugebauer syndrome', 1),
(5356, 'ORPHA:2329', 'Split hand/split foot-nystagmus syndrome', 1),
(5357, 'ORPHA:233', 'DRS', 1),
(5358, 'ORPHA:233', 'DURS', 1),
(5359, 'ORPHA:233', 'Duane retraction syndrome', 1),
(5360, 'ORPHA:233', 'Duane syndrome', 1),
(5361, 'ORPHA:233', 'Stilling-Turk-Duane syndrome', 1),
(5362, 'ORPHA:2330', 'Hemangioma-thrombocytopenia syndrome', 1),
(5363, 'ORPHA:2330', 'Kasabach-Merritt syndrome', 1),
(5364, 'ORPHA:2331', 'Kawasaki disease', 1),
(5365, 'ORPHA:2331', 'Mucocutaneous lymph node syndrome', 1),
(5366, 'ORPHA:2332', 'KBG syndrome', 1),
(5367, 'ORPHA:2332', 'Short stature-facial and skeletal anomalies-intellectual disability-macrodontia syndrome', 1),
(5368, 'ORPHA:2333', 'Kenny syndrome', 1),
(5369, 'ORPHA:2333', 'Kenny-Caffey syndrome', 1),
(5370, 'ORPHA:2334', 'Autosomal dominant keratitis', 1),
(5371, 'ORPHA:2334', 'Hereditary keratitis', 1),
(5372, 'ORPHA:233655', 'Rare genetic vascular disease', 3),
(5373, 'ORPHA:2337', 'Autosomal dominant diffuse palmoplantar keratoderma, Norrbotten type', 1),
(5374, 'ORPHA:2337', 'Diffuse palmoplantar keratoderma, Bothnian type', 1),
(5375, 'ORPHA:2337', 'NEPPK', 1),
(5376, 'ORPHA:2337', 'Non-epidermolytic palmoplantar keratoderma', 1),
(5377, 'ORPHA:2338', 'Isolated punctate PPK', 3),
(5378, 'ORPHA:2338', 'Isolated punctate palmoplantar hyperkeratosis', 3),
(5379, 'ORPHA:2338', 'Isolated punctate palmoplantar keratoderma', 3),
(5380, 'ORPHA:2339', 'Keratosis follicularis-dwarfism-cerebral atrophy syndrome', 1),
(5381, 'ORPHA:234', 'Dubin-Johnson syndrome', 1),
(5382, 'ORPHA:234', 'Dubin-Sprinz disease', 1),
(5383, 'ORPHA:234', 'Hyperbilirubinemia type 2', 1),
(5384, 'ORPHA:234', 'Sprinz-Nelson syndrome', 1),
(5385, 'ORPHA:2340', 'Keratosis follicularis spinulosa decalvans', 1),
(5386, 'ORPHA:2342', 'Haim-Munk syndrome', 1),
(5387, 'ORPHA:2342', 'Keratosis palmoplantaris-periodontopathia-onychogryposis syndrome', 1),
(5388, 'ORPHA:2342', 'Palmoplantar hyperkeratosis-periodontopathia-onychogryposis syndrome', 1),
(5389, 'ORPHA:2342', 'Palmoplantar keratoderma-periodontopathia-onychogryposis syndrome', 1),
(5390, 'ORPHA:2343', 'Isolated cloverleaf skull syndrome', 1),
(5391, 'ORPHA:2345', 'Congenital cervical vertebral fusion', 1),
(5392, 'ORPHA:2345', 'Congenital fused cervical segments', 1),
(5393, 'ORPHA:2345', 'Isolated Klippel-Feil syndrome', 1),
(5394, 'ORPHA:2345', 'Klippel-Feil malformation', 1),
(5395, 'ORPHA:2345', 'Klippel-Feil sequence', 1),
(5396, 'ORPHA:2346', 'Angioosteohypertrophic syndrome', 1),
(5397, 'ORPHA:2346', 'Klippel-Trénaunay-Weber syndrome', 1),
(5398, 'ORPHA:2347', 'Lethal Kniest-like dysplasia', 1),
(5399, 'ORPHA:2348', 'Dunnigan syndrome', 1),
(5400, 'ORPHA:2348', 'FPLD2', 1),
(5401, 'ORPHA:2348', 'Familial partial lipodystrophy type 2', 1),
(5402, 'ORPHA:2348', 'Familial partial lipodystrophy, Dunnigan type', 1),
(5403, 'ORPHA:2349', 'Hoffmann syndrome', 1),
(5404, 'ORPHA:2349', 'Kocher-Debré-Semelaigne syndrome', 1),
(5405, 'ORPHA:2349', 'Muscular pseudohypertrophy-hypothyroidism syndrome', 1),
(5406, 'ORPHA:235', 'Dubowitz syndrome', 1),
(5407, 'ORPHA:2351', 'Kousseff syndrome', 1),
(5408, 'ORPHA:2351', 'Sacral meningocele-conotruncal heart defects syndrome', 1),
(5409, 'ORPHA:2353', 'BRSS', 1),
(5410, 'ORPHA:2353', 'Hypotelorism-cleft palate-hypospadias syndrome', 1),
(5411, 'ORPHA:2353', 'Schilbach-Rott syndrome', 1),
(5412, 'ORPHA:2356', 'Arachnoid cyst', 1),
(5413, 'ORPHA:2357', 'Bronchogenic cyst', 1),
(5414, 'ORPHA:235832', 'Congenital vascular bone syndrome', 3),
(5415, 'ORPHA:235936', 'FH', 3),
(5416, 'ORPHA:235936', 'Familial hyperaldosteronism', 3),
(5417, 'ORPHA:236', 'Duplication 9p', 1),
(5418, 'ORPHA:236', 'Duplication of the short arm of chromosome 9', 1),
(5419, 'ORPHA:236', 'Trisomy 9p', 1),
(5420, 'ORPHA:236', 'Trisomy of the short arm of chromosome 9', 1),
(5421, 'ORPHA:2363', 'LADD syndrome', 1),
(5422, 'ORPHA:2363', 'LARD syndrome', 1),
(5423, 'ORPHA:2363', 'Lacrimoauriculodentodigital syndrome', 1),
(5424, 'ORPHA:2363', 'Lacrimoauriculoradiodental syndrome', 1),
(5425, 'ORPHA:2363', 'Levy-Hollister syndrome', 1),
(5426, 'ORPHA:2364', 'GSD due to lactate dehydrogenase deficiency', 1),
(5427, 'ORPHA:2364', 'Glycogen storage disease due to lactate dehydrogenase deficiency', 1),
(5428, 'ORPHA:2364', 'Glycogenosis due to lactate dehydrogenase deficiency', 1),
(5429, 'ORPHA:2364', 'LDH deficiency', 1),
(5430, 'ORPHA:2368', 'Gastroschisis', 1),
(5431, 'ORPHA:2368', 'Laparoschisis', 1),
(5432, 'ORPHA:2369', 'Body stalk anomaly', 1),
(5433, 'ORPHA:2369', 'LBWC syndrome', 1),
(5434, 'ORPHA:2369', 'Limb body wall complex', 1),
(5435, 'ORPHA:237', 'Duplication of urethra', 1),
(5436, 'ORPHA:2370', 'Larsen-like osseous dysplasia-short stature syndrome', 1),
(5437, 'ORPHA:2371', 'Lethal Larsen-like syndrome', 1),
(5438, 'ORPHA:2372', 'Laryngocele', 1),
(5439, 'ORPHA:2373', 'Congenital laryngomalacia', 1),
(5440, 'ORPHA:2374', 'Congenital laryngeal web', 1),
(5441, 'ORPHA:2375', 'Laryngeal abductor paralysis-intellectual disability syndrome', 1),
(5442, 'ORPHA:2375', 'Plott syndrome', 1),
(5443, 'ORPHA:2377', 'Laurence-Moon syndrome', 1),
(5444, 'ORPHA:2378', 'Laurin-Sandrow syndrome', 1),
(5445, 'ORPHA:2378', 'Mirror hands and feets-nasal defects syndrome', 1),
(5446, 'ORPHA:2378', 'Sandrow syndrome', 1),
(5447, 'ORPHA:2379', 'Early-onset parkinsonism-intellectual disability syndrome', 1),
(5448, 'ORPHA:2379', 'Laxova-Opitz syndrome', 1),
(5449, 'ORPHA:2379', 'Waisman syndrome', 1),
(5450, 'ORPHA:238', 'Digestive duplication', 1),
(5451, 'ORPHA:2380', 'Aseptic necrosis of the capital femoral epiphysis', 1),
(5452, 'ORPHA:2380', 'Legg-Calvé-Perthes disease', 1),
(5453, 'ORPHA:2380', 'Osteochondrosis of the capital femoral epiphysis', 1),
(5454, 'ORPHA:2380', 'Perthes disease', 1),
(5455, 'ORPHA:2382', 'Lennox-Gastaut syndrome', 1),
(5456, 'ORPHA:238269', 'AApoAII amyloidosis', 2),
(5457, 'ORPHA:238269', 'Apolipoprotein A-II amyloidosis', 2),
(5458, 'ORPHA:238269', 'Familial amyloid nephropathy due to apolipoprotein A-II variant', 2),
(5459, 'ORPHA:238269', 'Familial renal amyloidosis due to apolipoprotein A-II variant', 2),
(5460, 'ORPHA:238269', 'Hereditary amyloid nephropathy due to apolipoprotein A-II variant', 2),
(5461, 'ORPHA:238269', 'Hereditary renal amyloidosis due to apolipoprotein A-II variant', 2),
(5462, 'ORPHA:238305', 'Infundibulo-neurohypophysitis', 1),
(5463, 'ORPHA:238329', 'Mitochondrial encephalomyopathy due to COXPD6', 1),
(5464, 'ORPHA:238329', 'Mitochondrial encephalomyopathy due to combined oxidative phosphorylation defect 6', 1),
(5465, 'ORPHA:238329', 'Severe X-linked mitochondrial encephalomyopathy', 1),
(5466, 'ORPHA:238446', '15q11q13 duplication syndrome', 1),
(5467, 'ORPHA:238446', '15q11q13 microduplication syndrome', 1),
(5468, 'ORPHA:238446', 'Dup(15)(q11q13)', 1),
(5469, 'ORPHA:238446', 'Trisomy 15q11q13', 1),
(5470, 'ORPHA:238455', 'IPD', 1),
(5471, 'ORPHA:238455', 'Infantile dystonia-parkinsonism', 1),
(5472, 'ORPHA:238455', 'PKDYS', 1),
(5473, 'ORPHA:238459', 'CDG syndrome type IIf', 1),
(5474, 'ORPHA:238459', 'CDG-IIf', 1),
(5475, 'ORPHA:238459', 'CDG2F', 1),
(5476, 'ORPHA:238459', 'CMP-sialic acid transporter deficiency', 1),
(5477, 'ORPHA:238459', 'Carbohydrate deficient glycoprotein syndrome type IIf', 1),
(5478, 'ORPHA:238459', 'Congenital disorder of glycosylation type 2f', 1),
(5479, 'ORPHA:238459', 'Congenital disorder of glycosylation type IIf', 1),
(5480, 'ORPHA:238459', 'SLC35A1-CDG', 1),
(5481, 'ORPHA:238468', 'Anhidrotic ectodermal dysplasia', 1),
(5482, 'ORPHA:238468', 'HED', 1),
(5483, 'ORPHA:238468', 'Hypohidrotic ectodermal dysplasia', 1),
(5484, 'ORPHA:238475', 'Familial hypercholanemia', 1),
(5485, 'ORPHA:238475', 'Hereditary hypercholanemia', 1),
(5486, 'ORPHA:238505', 'Autosomal recessive lymphoproliferative disease due to CD27 deficiency', 1),
(5487, 'ORPHA:238505', 'CD27 deficiency', 1),
(5488, 'ORPHA:238505', 'Combined immunodeficiency due to CD27 deficiency', 1),
(5489, 'ORPHA:238510', 'Lymphoproliferative syndrome', 3),
(5490, 'ORPHA:238517', 'Hypotonia-cystinuria type 1 syndrome', 3),
(5491, 'ORPHA:238523', 'Atypical HCS', 1),
(5492, 'ORPHA:238523', 'Atypical hypotonia-cystinuria syndrome', 1),
(5493, 'ORPHA:238536', 'Congenital secondary erythrocytosis', 3),
(5494, 'ORPHA:238536', 'Congenital secondary polycythemia', 3),
(5495, 'ORPHA:238547', 'Acquired secondary erythrocytosis', 3),
(5496, 'ORPHA:238547', 'Acquired secondary polycythemia', 3),
(5497, 'ORPHA:238557', 'Chuvash erythrocytosis', 1),
(5498, 'ORPHA:238557', 'Chuvash polycythemia', 1),
(5499, 'ORPHA:238557', 'Von Hippel-Lindau-dependent polycythemia', 1),
(5500, 'ORPHA:238569', 'IL10-related early-onset IBD', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(5501, 'ORPHA:238569', 'IL10-related early-onset inflammatory bowel disease', 1),
(5502, 'ORPHA:238569', 'Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome', 1),
(5503, 'ORPHA:238578', 'Familial clubfoot due to 17q23.1q23.2 microduplication', 2),
(5504, 'ORPHA:238578', 'Hereditary clubfoot due to 17q23.1-q23.2 microduplication', 2),
(5505, 'ORPHA:238583', 'Hyperphenylalaninemia due to BH4 deficiency', 1),
(5506, 'ORPHA:238583', 'Hyperphenylalaninemia due to tetrahydrobiopterin deficiency', 1),
(5507, 'ORPHA:238583', 'Non-phenylketonuric hyperphenylalaninemia', 1),
(5508, 'ORPHA:238593', 'IgG4-related mesenteritis', 1),
(5509, 'ORPHA:238593', 'Isolated mesenteric lipodystrophy', 1),
(5510, 'ORPHA:238593', 'Lipomatous mesenteritis', 1),
(5511, 'ORPHA:238593', 'Liposclerotic mesenteritis', 1),
(5512, 'ORPHA:238593', 'Mesenteric lipogranuloma', 1),
(5513, 'ORPHA:238593', 'Mesenteric panniculitis', 1),
(5514, 'ORPHA:238593', 'Sclerosing mesenteritis', 1),
(5515, 'ORPHA:2386', 'Leukoencephalopathy-palmoplantar keratoderma syndrome', 1),
(5516, 'ORPHA:238606', 'POT', 1),
(5517, 'ORPHA:238606', 'Primary orthostatic tremor', 1),
(5518, 'ORPHA:238613', 'Beckwith-Wiedemann syndrome due to NSD1 mutation', 2),
(5519, 'ORPHA:238621', 'Ileal pouch anal anastomosis related faecal incontinence', 1),
(5520, 'ORPHA:238624', 'Benign intracranial hypertension', 1),
(5521, 'ORPHA:238624', 'IIH', 1),
(5522, 'ORPHA:238624', 'Idiopathic intracranial hypertension', 1),
(5523, 'ORPHA:238624', 'Pseudotumor cerebri', 1),
(5524, 'ORPHA:238637', 'Megacystis-megaureter syndrome', 1),
(5525, 'ORPHA:238637', 'Megaureter-megacystis syndrome', 1),
(5526, 'ORPHA:238642', 'Primary megaureter, adult-onset form', 2),
(5527, 'ORPHA:238646', 'Congenital primary megaureter, obstructed form', 2),
(5528, 'ORPHA:238650', 'Congenital primary megaureter, refluxing form', 2),
(5529, 'ORPHA:238654', 'Congenital primary megaureter, nonrefluxing and unobstructed form', 2),
(5530, 'ORPHA:238666', 'Gonadotropic deficiency', 1),
(5531, 'ORPHA:238666', 'Isolated congenital gonadotropin deficiency', 1),
(5532, 'ORPHA:238666', 'Isolated congenital hypogonadotropic hypogonadism', 1),
(5533, 'ORPHA:238666', 'Isolated gonadotropin-releasing hormone deficiency', 1),
(5534, 'ORPHA:238670', 'Isolated TRF deficiency', 1),
(5535, 'ORPHA:238670', 'Isolated TRH deficiency', 1),
(5536, 'ORPHA:238670', 'Isolated TSH-releasing factor deficiency', 1),
(5537, 'ORPHA:238670', 'Isolated prothyroliberin deficiency', 1),
(5538, 'ORPHA:238670', 'Isolated protirelin deficiency', 1),
(5539, 'ORPHA:238670', 'Isolated thyroliberin deficiency', 1),
(5540, 'ORPHA:238670', 'Isolated thyrotropin-releasing factor deficiency', 1),
(5541, 'ORPHA:238670', 'Isolated thyrotropin-releasing hormone deficiency', 1),
(5542, 'ORPHA:238688', 'Neonatal iodine exposure', 1),
(5543, 'ORPHA:238696', 'Transient congenital hypothyroidism due to maternal factor', 3),
(5544, 'ORPHA:238699', 'Transient congenital hypothyroidism due to neonatal factor', 3),
(5545, 'ORPHA:2387', 'Leukonychia totalis', 1),
(5546, 'ORPHA:238722', 'Familial congenital controlateral synkinesia', 1),
(5547, 'ORPHA:238722', 'Familial congenital mirror movements', 1),
(5548, 'ORPHA:238722', 'Hereditary congenital controlateral synkinesia', 1),
(5549, 'ORPHA:238722', 'Hereditary congenital mirror movements', 1),
(5550, 'ORPHA:238722', 'Isolated congenital controlateral synkinesia', 1),
(5551, 'ORPHA:238722', 'Isolated congenital mirror movements', 1),
(5552, 'ORPHA:238744', 'MDN syndrome', 1),
(5553, 'ORPHA:238744', 'Mammary-digital-nail syndrome', 1),
(5554, 'ORPHA:238744', 'Onycho-digito-mammary syndrome', 1),
(5555, 'ORPHA:238750', '4q21 microdeletion syndrome', 1),
(5556, 'ORPHA:238750', 'Del(4)(q21)', 1),
(5557, 'ORPHA:238750', 'Monosomy 4q21', 1),
(5558, 'ORPHA:238755', 'Autosomal dominant limb-girdle muscular dystrophy type 1H', 1),
(5559, 'ORPHA:238755', 'LGMD1H', 1),
(5560, 'ORPHA:238763', 'Glaucoma secondary to spherophakia/ectopia lentis and megalocornea', 1),
(5561, 'ORPHA:238763', 'Megalocornea-spherophakia-secondary glaucoma syndrome', 1),
(5562, 'ORPHA:238769', '1q44 microdeletion syndrome', 1),
(5563, 'ORPHA:238769', 'Del(1)(q44)', 1),
(5564, 'ORPHA:238769', 'Monosomy 1q44', 1),
(5565, 'ORPHA:2388', 'ChAc', 1),
(5566, 'ORPHA:2388', 'Chorea-acanthocytosis', 1),
(5567, 'ORPHA:2388', 'Choreoacanthocytosis', 1),
(5568, 'ORPHA:2388', 'Levine-Critchley syndrome', 1),
(5569, 'ORPHA:239', 'Dyggve-Melchior-Clausen disease', 1),
(5570, 'ORPHA:2390', 'Lichtenstein syndrome', 1),
(5571, 'ORPHA:2391', 'Congenitally short costocoracoid ligament', 1),
(5572, 'ORPHA:2394', 'DLD deficiency', 2),
(5573, 'ORPHA:2394', 'Dihydrolipoamide dehydrogenase deficiency', 2),
(5574, 'ORPHA:2394', 'E3-deficient maple syrup urine disease', 2),
(5575, 'ORPHA:2394', 'Pyruvate dehydrogenase E3 deficiency', 2),
(5576, 'ORPHA:2396', 'Encephalocraniocutaneous lipomatosis', 1),
(5577, 'ORPHA:2396', 'Haberland syndrome', 1),
(5578, 'ORPHA:2398', 'Cephalothoracic lipodystrophy', 1),
(5579, 'ORPHA:2398', 'Familial benign cervical lipomatosis', 1),
(5580, 'ORPHA:2398', 'Launois-Bensaude lipomatosis', 1),
(5581, 'ORPHA:2398', 'Madelung disease', 1),
(5582, 'ORPHA:2398', 'Multiple symmetric lipomatosis', 1),
(5583, 'ORPHA:2399', 'Nasopalpebral lipoma-coloboma syndrome', 1),
(5584, 'ORPHA:24', 'Fumarase deficiency', 1),
(5585, 'ORPHA:24', 'Fumaric aciduria', 1),
(5586, 'ORPHA:240', 'Léri-Weill dyschondrosteosis', 1),
(5587, 'ORPHA:240', 'Léri-Weill syndrome', 1),
(5588, 'ORPHA:2400', 'Lisker-Garcia-Ramos syndrome', 1),
(5589, 'ORPHA:2400', 'Peripheral motor neuropathy-dysautonomia syndrome', 1),
(5590, 'ORPHA:240071', 'Classic PSP syndrome', 2),
(5591, 'ORPHA:240071', 'Classic progressive supranuclear palsy syndrome', 2),
(5592, 'ORPHA:240071', 'Richardson syndrome', 2),
(5593, 'ORPHA:240071', 'Steele-Richardson-Olszewski disease', 2),
(5594, 'ORPHA:240085', 'PSP-p', 2),
(5595, 'ORPHA:240085', 'PSP-parkinsonism', 2),
(5596, 'ORPHA:240085', 'Progressive supranuclear palsy-parkinsonism syndrome', 2),
(5597, 'ORPHA:240094', 'PSP-PAGF', 2),
(5598, 'ORPHA:240094', 'PSP-pure akinesia with gait freezing', 2),
(5599, 'ORPHA:240094', 'Progressive supranuclear palsy-pure akinesia with gait freezing syndrome', 2),
(5600, 'ORPHA:240103', 'PSP-CBS', 2),
(5601, 'ORPHA:240103', 'PSP-corticobasal syndrome', 2),
(5602, 'ORPHA:240103', 'Progressive supranuclear palsy-corticobasal syndrome', 2),
(5603, 'ORPHA:240112', 'PSP-AOS', 2),
(5604, 'ORPHA:240112', 'PSP-PNFA', 2),
(5605, 'ORPHA:240112', 'Progressive supranuclear palsy-apraxia of speech syndrome', 2),
(5606, 'ORPHA:240112', 'Progressive supranuclear palsy-progressive non-fluent aphasia syndrome', 2),
(5607, 'ORPHA:240371', 'Syndromic obesity', 3),
(5608, 'ORPHA:2404', 'Loiasis', 1),
(5609, 'ORPHA:2405', 'Escher-Hirt syndrome', 1),
(5610, 'ORPHA:2405', 'Thickened earlobes-conductive deafness syndrome', 1),
(5611, 'ORPHA:2405', 'Thickened earlobes-conductive hearing loss syndrome', 1),
(5612, 'ORPHA:2406', 'Cerebromedullospinal disconnection', 1),
(5613, 'ORPHA:2406', 'Locked-in syndrome', 1),
(5614, 'ORPHA:2407', 'LOC syndrome', 1),
(5615, 'ORPHA:2407', 'LOGIC syndrome', 1),
(5616, 'ORPHA:2407', 'Laryngeal and ocular granulation tissue in children from the Indian subcontinent syndrome', 1),
(5617, 'ORPHA:2407', 'Laryngo-onycho-cutaneous syndrome', 1),
(5618, 'ORPHA:2407', 'Shabbir syndrome', 1),
(5619, 'ORPHA:240760', 'Microcephaly and chromosomal instability without immunodeficiency', 1),
(5620, 'ORPHA:240760', 'NBS-like disorder', 1),
(5621, 'ORPHA:240760', 'NBSLD', 1),
(5622, 'ORPHA:240760', 'Nijmegen breakage syndrome-like disorder', 1),
(5623, 'ORPHA:240760', 'RAD50 deficiency', 1),
(5624, 'ORPHA:2408', 'Deafness-nephritis-ano-rectal malformation syndrome', 1),
(5625, 'ORPHA:2408', 'Hearing loss-nephritis-ano-rectal malformation syndrome', 1),
(5626, 'ORPHA:2408', 'Lowe-Kohn-Cohen syndrome', 1),
(5627, 'ORPHA:2409', 'Lowry-MacLean syndrome', 1),
(5628, 'ORPHA:241', 'Dyschromatosis universalis hereditaria', 1),
(5629, 'ORPHA:2410', 'Hypergonadotropic hypogonadism-cataract syndrome', 1),
(5630, 'ORPHA:2410', 'Lubinsky syndrome', 1),
(5631, 'ORPHA:2412', 'Collins-Pope syndrome', 1),
(5632, 'ORPHA:2412', 'Dislocation of the hip-dysmorphism syndrome', 1),
(5633, 'ORPHA:2414', 'Congenital pulmonary lymphangiectasia', 1),
(5634, 'ORPHA:2414', 'Pulmonary lymphangiomatosis', 1),
(5635, 'ORPHA:2415', 'LM', 3),
(5636, 'ORPHA:2415', 'Lymphangioma', 3),
(5637, 'ORPHA:2415', 'Rare lymphatic malformation', 3),
(5638, 'ORPHA:2416', 'Congenital primary lymphedema without systemic or visceral involvement', 3),
(5639, 'ORPHA:242', '46,XY CGD', 1),
(5640, 'ORPHA:242', '46,XY complete gonadal dysgenesis', 1),
(5641, 'ORPHA:242', '46,XY pure gonadal dysgenesis', 1),
(5642, 'ORPHA:242', 'Swyer syndrome', 1),
(5643, 'ORPHA:2420', 'Primary pulmonary lymphoma', 1),
(5644, 'ORPHA:2427', 'Macrocephaly-short stature-paraplegia syndrome', 1),
(5645, 'ORPHA:2427', 'Volcke-Soekarman syndrome', 1),
(5646, 'ORPHA:2429', 'Fryns macrocephaly', 1),
(5647, 'ORPHA:2429', 'Macrocephaly-spastic paraplegia-dysmorphism syndrome', 1),
(5648, 'ORPHA:243', '46,XX complete gonadal dysgenesis', 1),
(5649, 'ORPHA:243', '46,XX gonadal dysgenesis', 1),
(5650, 'ORPHA:243', '46,XX ovarian dysgenesis', 1),
(5651, 'ORPHA:243', '46,XX pure gonadal dysgenesis', 1),
(5652, 'ORPHA:243', 'FSH-RO', 1),
(5653, 'ORPHA:243', 'Follicular stimulating hormone-resistant ovaries', 1),
(5654, 'ORPHA:243', 'Hypergonadotropic ovarian dysgenesis', 1),
(5655, 'ORPHA:243', 'XX female gonadal dysgenesis', 1),
(5656, 'ORPHA:243', 'XX-GD', 1),
(5657, 'ORPHA:2430', 'Congenital macroglossia', 1),
(5658, 'ORPHA:2432', 'Macrosomia-microphthalmia-cleft palate syndrome', 1),
(5659, 'ORPHA:2432', 'Teebi-Al Saleh-Hassoon syndrome', 1),
(5660, 'ORPHA:243343', 'DMG dehydrogenase deficiency', 1),
(5661, 'ORPHA:243343', 'DMGDH deficiency', 1),
(5662, 'ORPHA:243343', 'Dimethylglycine dehydrogenase deficiency', 1),
(5663, 'ORPHA:243367', 'AFLP', 1),
(5664, 'ORPHA:243367', 'Acute fatty liver of pregnancy', 1),
(5665, 'ORPHA:2435', 'Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndrome', 1),
(5666, 'ORPHA:2435', 'Westerhof-Beemer-Cormane syndrome', 1),
(5667, 'ORPHA:2437', 'Czeizel-Losonci syndrome', 1),
(5668, 'ORPHA:2437', 'Split hand with obstructive uropathy, spina bifida and diaphragmatic defects', 1),
(5669, 'ORPHA:2437', 'Split hand-urinary anomalies-spina bifida syndrome', 1),
(5670, 'ORPHA:2438', 'HFGS', 1),
(5671, 'ORPHA:2438', 'Hand-foot-genital syndrome', 1),
(5672, 'ORPHA:2438', 'Hand-foot-uterus syndrome', 1),
(5673, 'ORPHA:2439', 'Patterson-Stevenson syndrome', 1),
(5674, 'ORPHA:2439', 'Patterson-Stevenson-Fontaine syndrome', 1),
(5675, 'ORPHA:2439', 'Split foot deformity-mandibulofacial dysostosis syndrome', 1),
(5676, 'ORPHA:244', 'PCD', 1),
(5677, 'ORPHA:244', 'Primary ciliary dyskinesia', 1),
(5678, 'ORPHA:2440', 'Ectrodactyly', 1),
(5679, 'ORPHA:2440', 'Isolated split hand-split foot malformation', 1),
(5680, 'ORPHA:2440', 'SHFM', 1),
(5681, 'ORPHA:2440', 'Split hand foot malformation', 1),
(5682, 'ORPHA:2442', 'Duncan disease', 3),
(5683, 'ORPHA:2442', 'Purtilo syndrome', 3),
(5684, 'ORPHA:2442', 'X-linked lymphoproliferative disease', 3),
(5685, 'ORPHA:2442', 'XLP', 3),
(5686, 'ORPHA:244242', 'HELLP syndrome', 1),
(5687, 'ORPHA:244242', 'Hemolysis, elevated liver enzymes, low platelets in pregnancy', 1),
(5688, 'ORPHA:244242', 'Hemolysis-elevated liver enzymes-low platelets syndrome', 1),
(5689, 'ORPHA:244275', 'De novo thrombotic microangiopathy after kidney transplantation', 1),
(5690, 'ORPHA:244283', 'BASM syndrome', 1),
(5691, 'ORPHA:244283', 'Biliary atresia with splenic malformation syndrome', 1),
(5692, 'ORPHA:2443', 'Mitochondrial oxidative phosphorylation disorder due to nDNA anomalies', 3),
(5693, 'ORPHA:2443', 'Mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies', 3),
(5694, 'ORPHA:2443', 'OXPHOS disease due to nDNA anomalies', 3),
(5695, 'ORPHA:2443', 'OXPHOS disease due to nuclear DNA anomalies', 3),
(5696, 'ORPHA:244305', 'Dominant hypophosphatemia with nephrolithiasis or osteoporosis', 1),
(5697, 'ORPHA:244310', 'CDG syndrome type In', 1),
(5698, 'ORPHA:244310', 'CDG-In', 1),
(5699, 'ORPHA:244310', 'CDG1N', 1),
(5700, 'ORPHA:244310', 'Carbohydrate deficient glycoprotein syndrome type In', 1),
(5701, 'ORPHA:244310', 'Congenital disorder of glycosylation type 1n', 1),
(5702, 'ORPHA:244310', 'Congenital disorder of glycosylation type In', 1),
(5703, 'ORPHA:244310', 'Man5GlcNAc2-PP-Dol flippase deficiency', 1),
(5704, 'ORPHA:244310', 'RFT1-CDG', 1),
(5705, 'ORPHA:2444', 'CCAM', 1),
(5706, 'ORPHA:2444', 'CPAM', 1),
(5707, 'ORPHA:2444', 'Congenital cystic adenomatoid malformation of the lung', 1),
(5708, 'ORPHA:2444', 'Congenital cystic adenomatous malformation of the lung', 1),
(5709, 'ORPHA:2444', 'Congenital cystic disease of the lung', 1),
(5710, 'ORPHA:2444', 'Congenital pulmonary airway malformation', 1),
(5711, 'ORPHA:2445', 'Conotruncal heart malformations', 3),
(5712, 'ORPHA:2447', 'Congenital mitral malformation', 3),
(5713, 'ORPHA:245', 'Mandibulofacial dysostosis with preaxial limb anomalies', 1),
(5714, 'ORPHA:245', 'NAFD', 1),
(5715, 'ORPHA:245', 'Nager acrofacial dysostosis', 1),
(5716, 'ORPHA:245', 'Nager syndrome', 1),
(5717, 'ORPHA:245', 'Preaxial acrodysostosis', 1),
(5718, 'ORPHA:2451', 'Cutaneous and mucosal venous malformation', 1),
(5719, 'ORPHA:2451', 'Mucocutaneous venous malformations', 1),
(5720, 'ORPHA:2451', 'VMCM', 1),
(5721, 'ORPHA:2456', 'Familial supernumerary nipples', 1),
(5722, 'ORPHA:2456', 'Isolated polythelia', 1),
(5723, 'ORPHA:2457', 'MAD', 1),
(5724, 'ORPHA:2457', 'Mandibuloacral dysplasia', 1),
(5725, 'ORPHA:2459', 'Mansonelliasis', 1),
(5726, 'ORPHA:2459', 'Mansonellosis', 1),
(5727, 'ORPHA:246', 'Acrofacial dysostosis, Genee-Wiedemann type', 1),
(5728, 'ORPHA:246', 'Mandibulofacial dysostosis with postaxial limb anomalies', 1),
(5729, 'ORPHA:246', 'Miller syndrome', 1),
(5730, 'ORPHA:246', 'POADS', 1),
(5731, 'ORPHA:246', 'Postaxial acrodysostosis', 1),
(5732, 'ORPHA:246', 'Postaxial acrofacial dysostosis', 1),
(5733, 'ORPHA:2460', 'Marden-Walker-like syndrome', 1),
(5734, 'ORPHA:2460', 'VDEGS', 1),
(5735, 'ORPHA:2460', 'Van den Ende-Gupta syndrome', 1),
(5736, 'ORPHA:2461', 'Marden-Walker syndrome', 1),
(5737, 'ORPHA:2462', 'Marfanoid craniosynostosis syndrome', 1),
(5738, 'ORPHA:2462', 'SGS', 1),
(5739, 'ORPHA:2462', 'Shprintzen-Goldberg syndrome', 1),
(5740, 'ORPHA:2463', 'Marfanoid habitus-autosomal recessive intellectual disability syndrome', 1),
(5741, 'ORPHA:2464', 'Marfanoid syndrome, De Silva type', 1),
(5742, 'ORPHA:2466', 'Intellectual disability-aphasia-shuffling gait-adducted thumbs syndrome', 2),
(5743, 'ORPHA:2466', 'MASA syndrome', 2),
(5744, 'ORPHA:2467', 'Systemic mastocytosis', 3),
(5745, 'ORPHA:247', 'ARVC', 3),
(5746, 'ORPHA:247', 'ARVD', 3),
(5747, 'ORPHA:247', 'Arrhythmogenic right ventricular cardiomyopathy', 3),
(5748, 'ORPHA:247', 'Arrhythmogenic right ventricular dysplasia', 3),
(5749, 'ORPHA:2470', 'Anophthalmia-pulmonary hypoplasia syndrome', 1),
(5750, 'ORPHA:2470', 'MCOPS9', 1),
(5751, 'ORPHA:2470', 'Matthew-Wood syndrome', 1),
(5752, 'ORPHA:2470', 'Syndromic microphthalmia type 9', 1),
(5753, 'ORPHA:2471', 'McDonough syndrome', 1),
(5754, 'ORPHA:247165', 'Erythroedema polyneuritis', 1),
(5755, 'ORPHA:247165', 'Feer disease', 1),
(5756, 'ORPHA:247165', 'Infantile acrodynia', 1),
(5757, 'ORPHA:247165', 'Infantile mercury intoxication', 1),
(5758, 'ORPHA:247165', 'Infantile mercury poisoning', 1),
(5759, 'ORPHA:247165', 'Pink disease', 1),
(5760, 'ORPHA:247165', 'Swift disease', 1),
(5761, 'ORPHA:247165', 'Swift-Feer disease', 1),
(5762, 'ORPHA:247198', 'PCCA', 1),
(5763, 'ORPHA:247198', 'Progressive cerebello-cerebral atrophy', 1),
(5764, 'ORPHA:247203', 'BDC', 1),
(5765, 'ORPHA:247203', 'Bellini carcinoma', 1),
(5766, 'ORPHA:247203', 'Bellini duct carcinoma', 1),
(5767, 'ORPHA:247203', 'CDC', 1),
(5768, 'ORPHA:247203', 'Collecting duct carcinoma', 1),
(5769, 'ORPHA:247234', 'Idiopathic late-onset cerebellar ataxia', 1),
(5770, 'ORPHA:247234', 'SAOA', 1),
(5771, 'ORPHA:247234', 'Sporadic adult-onset ataxia of unknown etiology', 1),
(5772, 'ORPHA:247239', 'Non-hereditary degenerative ataxia', 3),
(5773, 'ORPHA:247242', 'Acquired ataxia', 3),
(5774, 'ORPHA:247245', 'Hemosiderosis of the central nervous system', 1),
(5775, 'ORPHA:247245', 'Superficial hemosiderosis of the CNS', 1),
(5776, 'ORPHA:247245', 'Superficial hemosiderosis of the central nervous system', 1),
(5777, 'ORPHA:247245', 'Superficial siderosis', 1),
(5778, 'ORPHA:247245', 'Superficial siderosis of the CNS', 1),
(5779, 'ORPHA:247245', 'Superficial siderosis of the central nervous system', 1),
(5780, 'ORPHA:247257', 'Inhalation anthrax disease', 1),
(5781, 'ORPHA:247257', 'Inhalational anthrax', 1),
(5782, 'ORPHA:247257', 'Pulmonary anthrax', 1),
(5783, 'ORPHA:247257', 'Respiratory anthrax', 1),
(5784, 'ORPHA:247257', 'Respiratory anthrax disease', 1),
(5785, 'ORPHA:247262', 'Hyperphosphatasia-intellectual disability syndrome', 1),
(5786, 'ORPHA:247262', 'Mabry syndrome', 1),
(5787, 'ORPHA:2473', 'Hydrometrocolpos-postaxial polydactyly syndrome', 1),
(5788, 'ORPHA:2473', 'Kaufman-Mckusick syndrome', 1),
(5789, 'ORPHA:2473', 'McKusick-Kaufman syndrome', 1),
(5790, 'ORPHA:247353', 'GPP', 1),
(5791, 'ORPHA:247353', 'Generalized pustular psoriasis', 1),
(5792, 'ORPHA:247378', 'Autosomal recessive secondary erythrocytosis not associated with VHL gene', 1),
(5793, 'ORPHA:247378', 'Autosomal recessive secondary erythrocytosis, non-Chuvash type', 1),
(5794, 'ORPHA:247378', 'Autosomal recessive secondary polycythemia not associated with VHL gene', 1),
(5795, 'ORPHA:247378', 'Autosomal recessive secondary polycythemia, non-Chuvash type', 1),
(5796, 'ORPHA:2475', 'White forelock with malformations', 1),
(5797, 'ORPHA:247511', 'Autosomal dominant secondary erythrocytosis', 1),
(5798, 'ORPHA:247511', 'Autosomal dominant secondary polycythemia', 1),
(5799, 'ORPHA:247522', 'Primary ciliary dyskinesia-retinitis pigmentosa syndrome', 1),
(5800, 'ORPHA:247525', 'ASS deficiency', 1),
(5801, 'ORPHA:247525', 'Argininosuccinate synthase deficiency', 1),
(5802, 'ORPHA:247525', 'Argininosuccinate synthetase deficiency', 1),
(5803, 'ORPHA:247525', 'Argininosuccinic acid synthase deficiency', 1),
(5804, 'ORPHA:247525', 'Argininosuccinic acid synthetase deficiency', 1),
(5805, 'ORPHA:247525', 'CTLN1', 1),
(5806, 'ORPHA:247525', 'Citrullinemia type 1', 1),
(5807, 'ORPHA:247525', 'Citrullinemia type I', 1),
(5808, 'ORPHA:247525', 'Classic citrullinemia', 1),
(5809, 'ORPHA:247546', 'Acute neonatal citrullinemia type 1', 2),
(5810, 'ORPHA:247546', 'Acute neonatal citrullinemia type I', 2),
(5811, 'ORPHA:247546', 'Classic citrullinemia type 1', 2),
(5812, 'ORPHA:247546', 'Classic citrullinemia type I', 2),
(5813, 'ORPHA:247573', 'Adult-onset citrullinemia type 1', 2),
(5814, 'ORPHA:247573', 'Adult-onset citrullinemia type I', 2),
(5815, 'ORPHA:247573', 'Late-onset citrullinemia type 1', 2),
(5816, 'ORPHA:247573', 'Late-onset citrullinemia type I', 2),
(5817, 'ORPHA:247582', 'Citrin deficiency', 3),
(5818, 'ORPHA:247585', 'Adult-onset citrin deficiency', 1),
(5819, 'ORPHA:247585', 'Adult-onset citrullinemia type 2', 1),
(5820, 'ORPHA:247585', 'Adult-onset citrullinemia type II', 1),
(5821, 'ORPHA:247585', 'CTLN2', 1),
(5822, 'ORPHA:247585', 'Citrullinemia type 2', 1),
(5823, 'ORPHA:247585', 'Citrullinemia type II', 1),
(5824, 'ORPHA:247598', 'NICCD', 1),
(5825, 'ORPHA:247598', 'Neonatal intrahepatic cholestasis caused by citrin deficiency', 1),
(5826, 'ORPHA:247598', 'Neonatal intrahepatic cholestasis due to citrin deficiency', 1),
(5827, 'ORPHA:2476', 'Dysraphism-cleft lip/palate-limb reduction defects syndrome', 1),
(5828, 'ORPHA:2476', 'Medeira-Dennis-Donnai syndrome', 1),
(5829, 'ORPHA:247604', 'JPLS', 1),
(5830, 'ORPHA:247604', 'Juvenile PLS', 1),
(5831, 'ORPHA:247604', 'Juvenile primary lateral sclerosis', 1),
(5832, 'ORPHA:247623', 'Perinatal lethal Rathbun disease', 2),
(5833, 'ORPHA:247623', 'Perinatal lethal hypophosphatasia', 2),
(5834, 'ORPHA:247623', 'Perinatal lethal phosphoethanolaminuria', 2),
(5835, 'ORPHA:247638', 'Prenatal benign Rathbun disease', 2),
(5836, 'ORPHA:247638', 'Prenatal benign hypophosphatasia', 2),
(5837, 'ORPHA:247638', 'Prenatal benign phosphoethanolaminuria', 2),
(5838, 'ORPHA:247651', 'Infantile Rathbun disease', 2),
(5839, 'ORPHA:247651', 'Infantile hypophosphatasia', 2),
(5840, 'ORPHA:247651', 'Infantile phosphoethanolaminuria', 2),
(5841, 'ORPHA:247667', 'Childhood-onset Rathbun disease', 2),
(5842, 'ORPHA:247667', 'Childhood-onset hypophosphatasia', 2),
(5843, 'ORPHA:247667', 'Childhood-onset phosphoethanolaminuria', 2),
(5844, 'ORPHA:247676', 'Adult Rathbun disease', 2),
(5845, 'ORPHA:247676', 'Adult hypophosphatasia', 2),
(5846, 'ORPHA:247676', 'Adult phosphoethanolaminuria', 2),
(5847, 'ORPHA:247685', 'Odontohypophosphatasia', 2),
(5848, 'ORPHA:247691', 'RVCL', 1),
(5849, 'ORPHA:247691', 'RVCL-S', 1),
(5850, 'ORPHA:247691', 'Retinal vasculopathy and cerebral leukoencephalopathy', 1),
(5851, 'ORPHA:247691', 'Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations', 1),
(5852, 'ORPHA:247698', 'MEN2A', 2),
(5853, 'ORPHA:247698', 'Multiple endocrine neoplasia type 2A', 2),
(5854, 'ORPHA:247698', 'PTC syndrome', 2),
(5855, 'ORPHA:247698', 'Sipple syndrome', 2),
(5856, 'ORPHA:2477', 'Macroencephaly', 1),
(5857, 'ORPHA:2477', 'Megalencephaly', 1),
(5858, 'ORPHA:247709', 'MEN2B', 2),
(5859, 'ORPHA:247709', 'Multiple endocrine neoplasia type 2B', 2),
(5860, 'ORPHA:247709', 'Multiple endocrine neoplasia type 3', 2),
(5861, 'ORPHA:247709', 'Wagenmann-Froboese syndrome', 2),
(5862, 'ORPHA:247718', 'IMAM', 1),
(5863, 'ORPHA:247718', 'Inflammatory myopathy with abundant macrophages', 1),
(5864, 'ORPHA:247724', 'Idiopathic eosinophilia-associated myopathy', 1),
(5865, 'ORPHA:247724', 'Idiopathic eosinophilic myositis', 1),
(5866, 'ORPHA:247762', 'Lipoblastoma', 1),
(5867, 'ORPHA:247765', 'X-linked cerebellar ataxia', 3),
(5868, 'ORPHA:247768', 'Müllerian aplasia and hyperandrogenism', 1),
(5869, 'ORPHA:247768', 'Müllerian duct failure and hyperandrogenism', 1),
(5870, 'ORPHA:247768', 'WNT4 deficiency', 1),
(5871, 'ORPHA:247775', 'Congenital absence of uterus and vagina', 2),
(5872, 'ORPHA:247775', 'MRKH syndrome type 1', 2),
(5873, 'ORPHA:247775', 'Mayer-Rokitansky-Küster-Hauser syndrome type 1', 2),
(5874, 'ORPHA:247775', 'Rokitansky sequence', 2),
(5875, 'ORPHA:247790', 'FTH1-associated iron overload', 1),
(5876, 'ORPHA:247790', 'FTH1-related iron overload', 1),
(5877, 'ORPHA:247794', 'Juvenile cataract-microcornea-renal glucosuria syndrome', 1),
(5878, 'ORPHA:247794', 'Juvenile cataract-microcornea-renal glycosuria syndrome', 1),
(5879, 'ORPHA:247798', 'MUTYH-related AFAP', 2),
(5880, 'ORPHA:247798', 'MUTYH-related attenuated FAP', 2),
(5881, 'ORPHA:247798', 'MUTYH-related attenuated familial adenomatous polyposis', 2),
(5882, 'ORPHA:247798', 'MUTYH-related attenuated familial polyposis coli', 2),
(5883, 'ORPHA:2478', 'MLC', 1),
(5884, 'ORPHA:2478', 'Megalencephalic leukodystrophy', 1),
(5885, 'ORPHA:2478', 'Megalencephalic leukoencephalopathy with subcortical cysts', 1),
(5886, 'ORPHA:2478', 'Megalencephaly-cystic leukodystrophy syndrome', 1),
(5887, 'ORPHA:2478', 'Vacuolating megalencephalic leukoencephalopathy with subcortical cysts', 1),
(5888, 'ORPHA:2478', 'Van der Knaap syndrome', 1),
(5889, 'ORPHA:247806', 'APC-related AFAP', 2),
(5890, 'ORPHA:247806', 'APC-related attenuated FAP', 2),
(5891, 'ORPHA:247806', 'APC-related attenuated familial adenomatous polyposis', 2),
(5892, 'ORPHA:247806', 'APC-related attenuated familial polyposis coli', 2),
(5893, 'ORPHA:247815', 'Autosomal recessive ataxia due to PEX10 deficiency', 1),
(5894, 'ORPHA:247815', 'Mild peroxisomal disorder due to PEX10 deficiency', 1),
(5895, 'ORPHA:247820', 'EDSS', 1),
(5896, 'ORPHA:247820', 'EDSS1', 1),
(5897, 'ORPHA:247820', 'Ectodermal dysplasia-syndactyly syndrome', 1),
(5898, 'ORPHA:247827', 'EDCS', 1),
(5899, 'ORPHA:247827', 'EDSS2', 1),
(5900, 'ORPHA:247827', 'Ectodermal dysplasia-cutaneous syndactyly syndrome', 1),
(5901, 'ORPHA:247834', 'OCMD', 1),
(5902, 'ORPHA:247834', 'OMD', 1),
(5903, 'ORPHA:247834', 'Occult macular dystrophy', 1),
(5904, 'ORPHA:247868', 'FCAS2', 1),
(5905, 'ORPHA:247868', 'Familial cold autoinflammatory syndrome type 2', 1),
(5906, 'ORPHA:247868', 'NAPS12', 1),
(5907, 'ORPHA:247868', 'NLRP12-associated hereditary periodic fever syndrome', 1),
(5908, 'ORPHA:2479', 'MMR syndrome', 1),
(5909, 'ORPHA:2479', 'Megalocornea-intellectual disability syndrome', 1),
(5910, 'ORPHA:2479', 'Neuhäuser syndrome', 1),
(5911, 'ORPHA:248', 'AR-HED', 2),
(5912, 'ORPHA:248', 'Autosomal recessive anhidrotic ectodermal dysplasia', 2),
(5913, 'ORPHA:248', 'Autosomal recessive hypohidrotic ectodermal dysplasia', 2),
(5914, 'ORPHA:248095', 'Idiopathic hypertrophic osteoarthropathy', 3),
(5915, 'ORPHA:248095', 'PHO', 3),
(5916, 'ORPHA:248095', 'Primary hypertrophic osteoarthropathy', 3),
(5917, 'ORPHA:2481', 'NCM', 1),
(5918, 'ORPHA:2481', 'Neurocutaneous melanocytosis', 1),
(5919, 'ORPHA:2481', 'Neurocutaneous melanosis', 1),
(5920, 'ORPHA:248111', 'JHD', 1),
(5921, 'ORPHA:248111', 'Juvenile Huntington chorea', 1),
(5922, 'ORPHA:248111', 'Juvenile Huntington disease', 1),
(5923, 'ORPHA:2482', 'Melhem-Fahl syndrome', 1),
(5924, 'ORPHA:248293', 'Rare deficiency anemia', 3),
(5925, 'ORPHA:248296', 'Constitutional deficiency anemia', 3),
(5926, 'ORPHA:2483', 'Melkersson-Rosenthal syndrome', 1),
(5927, 'ORPHA:248302', 'Rare acquired deficiency anemia', 3),
(5928, 'ORPHA:248308', 'Rare bleeding disorder', 3),
(5929, 'ORPHA:248308', 'Rare hemorrhagic disorder', 3),
(5930, 'ORPHA:248315', 'Rare bleeding disorder due to a coagulation factors defect', 3),
(5931, 'ORPHA:248315', 'Rare coagulopathy due to a coagulation factor defect', 3),
(5932, 'ORPHA:248315', 'Rare hemorrhagic disorder due to a coagulation factors defect', 3),
(5933, 'ORPHA:248326', 'Rare bleeding disorder due to a platelet anomaly', 3),
(5934, 'ORPHA:248326', 'Rare bleeding disorder due to a thrombopathy and/or thrombocytopenia', 3),
(5935, 'ORPHA:248326', 'Rare coagulopathy due to a platelet anomaly', 3),
(5936, 'ORPHA:248326', 'Rare coagulopathy due to a thrombopathy and/or thrombocytopenia', 3),
(5937, 'ORPHA:248326', 'Rare hemorrhagic disorder due to a platelet anomaly', 3),
(5938, 'ORPHA:248326', 'Rare hemorrhagic disorder due to a thrombopathy and/or thrombocytopenia', 3),
(5939, 'ORPHA:248340', 'Isolated delta-SPD', 1),
(5940, 'ORPHA:248340', 'Isolated delta-storage pool disease', 1),
(5941, 'ORPHA:248340', 'Isolated dense-SPD', 1),
(5942, 'ORPHA:248340', 'Isolated dense-storage pool disease', 1),
(5943, 'ORPHA:248347', 'Rare bleeding disorder due to an acquired platelet anomaly', 3),
(5944, 'ORPHA:248347', 'Rare bleeding disorder due to an acquired thrombopathy and/or thrombocytopenia', 3),
(5945, 'ORPHA:248347', 'Rare coagulopathy due to an acquired platelet anomaly', 3),
(5946, 'ORPHA:248347', 'Rare coagulopathy due to an acquired thrombopathy and/or thrombocytopenia', 3),
(5947, 'ORPHA:248347', 'Rare hemorrhagic disorder due to an acquired platelet anomaly', 3),
(5948, 'ORPHA:248347', 'Rare hemorrhagic disorder due to an acquired thrombopathy and/or thrombocytopenia', 3),
(5949, 'ORPHA:248358', 'Rare thrombotic disorder due to a coagulation factors defect', 3),
(5950, 'ORPHA:248361', 'Rare thrombotic disorder due to a constitutional coagulation factors defect', 3),
(5951, 'ORPHA:248365', 'Rare thrombotic disorder due to an acquired coagulation factors defect', 3),
(5952, 'ORPHA:248368', 'Rare thrombotic disorder due to a platelet anomaly', 3),
(5953, 'ORPHA:2484', 'Melnick-Needles osteodysplasty', 1),
(5954, 'ORPHA:2484', 'Melnick-Needles syndrome', 1),
(5955, 'ORPHA:248401', 'Rare thrombotic disorder due to a constitutional platelet anomaly', 3),
(5956, 'ORPHA:248404', 'Rare thrombotic disorder due to an acquired platelet anomaly', 3),
(5957, 'ORPHA:248408', 'Familial hypodysfibrinogenemia', 2),
(5958, 'ORPHA:2485', 'Melorheostosis', 1),
(5959, 'ORPHA:2487', 'Fried-Goldberg-Mundel syndrome', 1),
(5960, 'ORPHA:2487', 'Lower limb malformation-hypospadias syndrome', 1),
(5961, 'ORPHA:2489', 'Upper limb defect-eye and ear abnormalities syndrome', 1),
(5962, 'ORPHA:249', 'Fibrous dysplasia of bone', 1),
(5963, 'ORPHA:2491', 'Müllerian duct anomalies-limb anomalies syndrome', 1),
(5964, 'ORPHA:2492', 'FATCO syndrome', 1),
(5965, 'ORPHA:2492', 'Fibular aplasia-tibial campomelia-oligosyndactyly syndrome', 1),
(5966, 'ORPHA:2492', 'Hecht-Scott syndrome', 1),
(5967, 'ORPHA:2494', 'Giant hypertrophic gastritis', 1),
(5968, 'ORPHA:2494', 'Hypoproteinemic hypertrophic gastropathy', 1),
(5969, 'ORPHA:2494', 'Ménétrier disease', 1),
(5970, 'ORPHA:2495', 'Meningioma', 1),
(5971, 'ORPHA:2496', '8q13 microdeletion syndrome', 1),
(5972, 'ORPHA:2496', 'Del(8)q(13)', 1),
(5973, 'ORPHA:2496', 'Mesomelia-synostoses syndrome', 1),
(5974, 'ORPHA:2496', 'Mesomelia-synostoses syndrome, Verloes-David-Pfeiffer type', 1),
(5975, 'ORPHA:2496', 'Mesomelic dysplasia with acral synostoses, Verloes-David-Pfeiffer type', 1),
(5976, 'ORPHA:2496', 'Monosomy 8q13', 1),
(5977, 'ORPHA:2496', 'Verloes-David syndrome', 1),
(5978, 'ORPHA:2497', 'Fryns-Hofkens-Fabry syndrome', 1),
(5979, 'ORPHA:2497', 'Ulna hypoplasia', 1),
(5980, 'ORPHA:2497', 'Upper limb mesomelic dysplasia', 1),
(5981, 'ORPHA:2498', 'Fusion of metacarpals 4 and 5', 1),
(5982, 'ORPHA:2498', 'Syndactyly type 8', 1),
(5983, 'ORPHA:2499', 'Metachondromatosis', 1),
(5984, 'ORPHA:25', 'GA1', 1),
(5985, 'ORPHA:25', 'GCDHD', 1),
(5986, 'ORPHA:25', 'Glutaric acidemia type 1', 1),
(5987, 'ORPHA:25', 'Glutaric aciduria type 1', 1),
(5988, 'ORPHA:25', 'Glutaryl-CoA dehydrogenase deficiency', 1),
(5989, 'ORPHA:25', 'Glutaryl-coenzyme A dehydrogenase deficiency', 1),
(5990, 'ORPHA:250', 'Frontonasal dysplasia', 3),
(5991, 'ORPHA:250', 'Median cleft face syndrome', 3),
(5992, 'ORPHA:2500', 'Acrogeria', 1),
(5993, 'ORPHA:2500', 'Acrogeria, Gottron type', 1),
(5994, 'ORPHA:2500', 'Acrometageria', 1),
(5995, 'ORPHA:2500', 'Gottron syndrome', 1),
(5996, 'ORPHA:2501', 'Metaphyseal chondrodysplasia, Spahr type', 1),
(5997, 'ORPHA:250165', 'Genetic polycythemia', 3),
(5998, 'ORPHA:2502', 'Metaphyseal dysostosis-intellectual disability-conductive deafness syndrome', 1),
(5999, 'ORPHA:2502', 'Metaphyseal dysostosis-intellectual disability-conductive hearing loss syndrome', 1),
(6000, 'ORPHA:2504', 'Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(6001, 'ORPHA:2505', 'CCSF', 1),
(6002, 'ORPHA:2505', 'Circumferential skin creases, Kunze type', 1),
(6003, 'ORPHA:2505', 'Congenital circumferential skin folds', 1),
(6004, 'ORPHA:2505', 'Kunze-Riehm syndrome', 1),
(6005, 'ORPHA:2505', 'Multiple benign circumferential skin creases on limbs', 1),
(6006, 'ORPHA:2508', 'ACC-abnormal genitalia syndrome', 1),
(6007, 'ORPHA:2508', 'Corpus callosum agenesis-abnormal genitalia syndrome', 1),
(6008, 'ORPHA:2508', 'Microcephaly-corpus callosum agenesis-abnormal genitalia syndrome', 1),
(6009, 'ORPHA:2508', 'Proud syndrome', 1),
(6010, 'ORPHA:2508', 'Proud-Levine-Carpenter syndrome', 1),
(6011, 'ORPHA:250805', 'Serpinopathy', 3),
(6012, 'ORPHA:250808', 'Serpinopathy with toxic serpin polymerization', 3),
(6013, 'ORPHA:250811', 'Serpinopathy with loss of serpin function', 3),
(6014, 'ORPHA:250831', 'LPA', 1),
(6015, 'ORPHA:250831', 'Logopenic primary progressive aphasia', 1),
(6016, 'ORPHA:250831', 'Logopenic progressive aphasia', 1),
(6017, 'ORPHA:250831', 'Logopenic variant PPA', 1),
(6018, 'ORPHA:250908', 'Rare neoplastic disease', 3),
(6019, 'ORPHA:250908', 'Rare tumoral disease', 3),
(6020, 'ORPHA:250923', 'Isolated aniridia', 1),
(6021, 'ORPHA:250932', 'Autosomal dominant optic atrophy and peripheral neuropathy', 1),
(6022, 'ORPHA:250972', 'Polymicrogyria with optic nerve hypoplasia', 1),
(6023, 'ORPHA:250977', '5-amino-4-imidazole carboxamide ribosiduria', 1),
(6024, 'ORPHA:250977', 'AICA-ribosiduria', 1),
(6025, 'ORPHA:250977', 'AICA-ribosiduria due to ATIC deficiency', 1),
(6026, 'ORPHA:250977', 'AICAR transformylase/IMP cyclohydrolase deficiency', 1),
(6027, 'ORPHA:250977', 'ATIC deficiency', 1),
(6028, 'ORPHA:250984', 'Autosomal recessive Stickler syndrome', 2),
(6029, 'ORPHA:250989', '1q21.1 microdeletion syndrome', 1),
(6030, 'ORPHA:250989', 'Del(1)(q21)', 1),
(6031, 'ORPHA:250989', 'Monosomy 1q21.1', 1),
(6032, 'ORPHA:250994', '1q21.1 microduplication syndrome', 1),
(6033, 'ORPHA:250994', 'Dup(1)(q21.1)', 1),
(6034, 'ORPHA:250994', 'Trisomy 1q21.1', 1),
(6035, 'ORPHA:250999', '1q41q42 microdeletion syndrome', 1),
(6036, 'ORPHA:250999', 'Del(1)(q41q42)', 1),
(6037, 'ORPHA:250999', 'Monosomy 1q41q42', 1),
(6038, 'ORPHA:251', 'EDM', 3),
(6039, 'ORPHA:251', 'MED', 3),
(6040, 'ORPHA:251', 'Multiple epiphyseal dysplasia', 3),
(6041, 'ORPHA:251', 'Polyepiphyseal dysplasia', 3),
(6042, 'ORPHA:2510', 'Micro syndrome', 1),
(6043, 'ORPHA:2510', 'WARBM', 1),
(6044, 'ORPHA:2510', 'Warburg micro syndrome', 1),
(6045, 'ORPHA:251004', 'Paternal uniparental disomy of chromosome 1', 1),
(6046, 'ORPHA:251004', 'UPD(1)pat', 1),
(6047, 'ORPHA:251009', 'Maternal uniparental disomy of chromosome 1', 1),
(6048, 'ORPHA:251009', 'UPD(1)mat', 1),
(6049, 'ORPHA:251014', '2q31.1 microdeletion syndrome', 1),
(6050, 'ORPHA:251014', 'Del(2)(q31.1)', 1),
(6051, 'ORPHA:251014', 'Monosomy 2q31.1', 1),
(6052, 'ORPHA:251019', '2q32q33 microdeletion syndrome', 1),
(6053, 'ORPHA:251019', 'Del(2)(q32)', 1),
(6054, 'ORPHA:251019', 'Del(2)(q32q33)', 1),
(6055, 'ORPHA:251019', 'Monosomy 2q32', 1),
(6056, 'ORPHA:251019', 'Monosomy 2q32q33', 1),
(6057, 'ORPHA:251028', '2q33.1 microdeletion syndrome', 2),
(6058, 'ORPHA:251028', 'Del(2)(q33.1)', 2),
(6059, 'ORPHA:251028', 'Monosomy 2q33.1', 2),
(6060, 'ORPHA:251028', 'SATB2-associated syndrome due to a chromosomal rearrangement', 2),
(6061, 'ORPHA:251038', '3q29 microduplication syndrome', 1),
(6062, 'ORPHA:251038', 'Trisomy 3q29', 1),
(6063, 'ORPHA:251043', 'Ring 5', 1),
(6064, 'ORPHA:251043', 'Ring chromosome 5', 1),
(6065, 'ORPHA:251043', 'Ring chromosome 5 syndrome', 1),
(6066, 'ORPHA:251046', '6p22 microdeletion syndrome', 1),
(6067, 'ORPHA:251046', 'Del(6)(p22)', 1),
(6068, 'ORPHA:251046', 'Monosomy 6p22', 1),
(6069, 'ORPHA:251056', '6q25 microdeletion syndrome', 1),
(6070, 'ORPHA:251056', 'Del(6)(q25)', 1),
(6071, 'ORPHA:251056', 'Monosomy 6q25', 1),
(6072, 'ORPHA:251061', '7q31 microdeletion syndrome', 1),
(6073, 'ORPHA:251061', 'Del(7)(q31)', 1),
(6074, 'ORPHA:251061', 'Monosomy 7q31', 1),
(6075, 'ORPHA:251066', '8p11.2 deletion syndrome', 1),
(6076, 'ORPHA:251066', 'Del(8)(p11.2)', 1),
(6077, 'ORPHA:251066', 'Monosomy 8p11.2', 1),
(6078, 'ORPHA:251071', '8p23.1 microdeletion syndrome', 1),
(6079, 'ORPHA:251071', 'Del(8)(p23.1)', 1),
(6080, 'ORPHA:251071', 'Monosomy 8p23.1', 1),
(6081, 'ORPHA:251076', '8p23.1 duplication syndrome', 1),
(6082, 'ORPHA:251076', 'Dup(8)(p23.1p23.1)', 1),
(6083, 'ORPHA:251076', 'Trisomy 8p23.1', 1),
(6084, 'ORPHA:2511', 'Microbrachycephaly-ptosis-cleft lip syndrome', 1),
(6085, 'ORPHA:2511', 'Richieri Costa-Guion Almeida-Ramos syndrome', 1),
(6086, 'ORPHA:2512', 'Autosomal recessive primary microcephaly', 2),
(6087, 'ORPHA:2512', 'MCPH', 2),
(6088, 'ORPHA:2512', 'Microcephalia vera', 2),
(6089, 'ORPHA:2512', 'Microcephaly vera', 2),
(6090, 'ORPHA:2512', 'True microcephaly', 2),
(6091, 'ORPHA:251262', 'Familial osteochondritis dissecans', 1),
(6092, 'ORPHA:251262', 'Osteochondritis dissecans and short stature', 1),
(6093, 'ORPHA:251274', 'FH-III', 1),
(6094, 'ORPHA:251274', 'FH3', 1),
(6095, 'ORPHA:251274', 'Familial hyperaldosteronism type 3', 1),
(6096, 'ORPHA:251274', 'Familial hyperaldosteronism type III', 1),
(6097, 'ORPHA:251279', 'Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome', 1),
(6098, 'ORPHA:251279', 'Nanophthalmos-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome', 1),
(6099, 'ORPHA:251282', 'Autosomal dominant spastic ataxia type 1', 1),
(6100, 'ORPHA:251282', 'SPAX1', 1),
(6101, 'ORPHA:251287', 'Benign concentric annular macular dystrophy', 1),
(6102, 'ORPHA:251290', 'Parietal foramina with clavicular hypoplasia', 1),
(6103, 'ORPHA:251290', 'Parietal foramina with cleidocranial dysplasia', 1),
(6104, 'ORPHA:251295', 'PPRCA', 1),
(6105, 'ORPHA:251295', 'Pigmented paravenous retinochoroidal atrophy', 1),
(6106, 'ORPHA:2513', 'Castro Gago-Pombo-Novo syndrome', 1),
(6107, 'ORPHA:2513', 'Microcephaly-albinism-digital anomalies syndrome', 1),
(6108, 'ORPHA:251304', 'Infantile onset panniculitis with uveitis and systemic granulomatosis', 1),
(6109, 'ORPHA:251307', 'Idiopathic recurrent pericarditis', 1),
(6110, 'ORPHA:251307', 'Idiopathic relapsing pericarditis', 1),
(6111, 'ORPHA:251312', 'Overlapping connective tissue disease', 3),
(6112, 'ORPHA:251325', 'Drug-induced vasculitis', 1),
(6113, 'ORPHA:251328', 'Unclassified vasculitis', 1),
(6114, 'ORPHA:251332', 'Persistent fever/inflammation of unknown origin', 1),
(6115, 'ORPHA:251332', 'Unexplained long-lasting fever/inflammatory syndrome', 1),
(6116, 'ORPHA:251347', 'ATLD', 1),
(6117, 'ORPHA:251347', 'Ataxia-telangiectasia-like disorder', 1),
(6118, 'ORPHA:251355', 'Double heterozygotes sickling disorder', 3),
(6119, 'ORPHA:251355', 'Sickle cell disease associated with an other hemoglobin anomaly', 3),
(6120, 'ORPHA:251359', 'HbS-beta-thalassemia syndrome', 1),
(6121, 'ORPHA:251359', 'Sickle cell-beta-thalassemia disease syndrome', 1),
(6122, 'ORPHA:251365', 'HbSC disease', 1),
(6123, 'ORPHA:251365', 'Sickle cell-hemoglobin C disease syndrome', 1),
(6124, 'ORPHA:251370', 'HbSD disease', 1),
(6125, 'ORPHA:251370', 'Sickle cell-hemoglobin D disease syndrome', 1),
(6126, 'ORPHA:251375', 'HbSE disease', 1),
(6127, 'ORPHA:251375', 'Sickle cell-hemoglobin E disease syndrome', 1),
(6128, 'ORPHA:251380', 'HPFH-sickle cell disease syndrome', 1),
(6129, 'ORPHA:251380', 'Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome', 1),
(6130, 'ORPHA:251383', 'CK syndrome', 1),
(6131, 'ORPHA:251383', 'X-linked intellectual disability-microcephaly-cortical malformation-thin habitus syndrome', 1),
(6132, 'ORPHA:251393', 'JEB-nH loc', 2),
(6133, 'ORPHA:251393', 'Localized junctional epidermolysis bullosa, non-Herlitz type', 2),
(6134, 'ORPHA:2514', 'Autosomal dominant primary microcephaly', 2),
(6135, 'ORPHA:2515', 'Microcephaly-cardiomyopathy syndrome', 1),
(6136, 'ORPHA:2515', 'Winship-Viljoen-Leary syndrome', 1),
(6137, 'ORPHA:251510', '46,XY PGD', 1),
(6138, 'ORPHA:251510', '46,XY partial gonadal dysgenesis', 1),
(6139, 'ORPHA:251510', '46,XY partial testicular dysgenesis', 1),
(6140, 'ORPHA:251515', 'DA10', 1),
(6141, 'ORPHA:251515', 'Distal arthrogryposis type 10', 1),
(6142, 'ORPHA:251515', 'Plantar flexion contracture', 1),
(6143, 'ORPHA:251515', 'Short Achilles tendon', 1),
(6144, 'ORPHA:251515', 'Short tendo calcaneus', 1),
(6145, 'ORPHA:251523', 'Hyperzincemia and hypercalprotectinemia', 1),
(6146, 'ORPHA:251523', 'Hz/Hc', 1),
(6147, 'ORPHA:251523', 'PAMI syndrome', 1),
(6148, 'ORPHA:251523', 'PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome', 1),
(6149, 'ORPHA:251529', 'Toxic or drug-related embryofetopathy', 3),
(6150, 'ORPHA:251535', 'Maternal disease-related embryofetopathy', 3),
(6151, 'ORPHA:251558', 'Rare tumor of neuroepithelial tissue', 3),
(6152, 'ORPHA:251561', 'High-grade astrocytoma', 3),
(6153, 'ORPHA:251576', 'Gliosarcoma', 2),
(6154, 'ORPHA:251579', 'Giant cell glioblastoma', 2),
(6155, 'ORPHA:251582', 'Gliomatosis cerebri', 1),
(6156, 'ORPHA:251589', 'Anaplastic astrocytoma', 1),
(6157, 'ORPHA:251592', 'Low-grade astrocytoma', 3),
(6158, 'ORPHA:251595', 'Diffuse astrocytoma', 1),
(6159, 'ORPHA:251598', 'Protoplasmic astrocytoma', 2),
(6160, 'ORPHA:2516', 'Ellis-Yale-Winter syndrome', 1),
(6161, 'ORPHA:2516', 'Microcephaly-cardiac defect-lung malsegmentation syndrome', 1),
(6162, 'ORPHA:251601', 'Fibrillary astrocytoma', 2),
(6163, 'ORPHA:251604', 'Gemistocytic astrocytoma', 2),
(6164, 'ORPHA:251607', 'PXA', 1),
(6165, 'ORPHA:251607', 'Pleomorphic xanthoastrocytoma', 1),
(6166, 'ORPHA:251612', 'Pilocytic astrocytoma', 1),
(6167, 'ORPHA:251615', 'Pilomyxoid astrocytoma', 2),
(6168, 'ORPHA:251618', 'SEGA', 1),
(6169, 'ORPHA:251618', 'Subependymal giant cell astrocytoma', 1),
(6170, 'ORPHA:251623', 'Pituicytoma', 1),
(6171, 'ORPHA:251627', 'Oligodendroglioma', 1),
(6172, 'ORPHA:251630', 'Anaplastic oligodendroglioma', 1),
(6173, 'ORPHA:251636', 'Classic ependymoma', 1),
(6174, 'ORPHA:251636', 'Ependymoma', 1),
(6175, 'ORPHA:251639', 'Subependymoma', 1),
(6176, 'ORPHA:251643', 'Myxopapillary ependymoma', 1),
(6177, 'ORPHA:251646', 'Anaplastic ependymoma', 1),
(6178, 'ORPHA:251651', 'Mixed oligodendroglial and astrocytic tumor', 3),
(6179, 'ORPHA:251651', 'Oligoastrocytic tumor', 3),
(6180, 'ORPHA:251656', 'MOA', 1),
(6181, 'ORPHA:251656', 'Mixed oligoastrocytoma', 1),
(6182, 'ORPHA:251656', 'Oligoastrocytoma', 1),
(6183, 'ORPHA:251663', 'Anaplastic oligoastrocytoma', 1),
(6184, 'ORPHA:251663', 'aMOA', 1),
(6185, 'ORPHA:251668', 'Glial tumor of neuroepithelial tissue with unknown origin', 3),
(6186, 'ORPHA:251671', 'Angiocentric glioma', 1),
(6187, 'ORPHA:251674', 'Chordoid glioma', 1),
(6188, 'ORPHA:251679', 'Astroblastoma', 1),
(6189, 'ORPHA:2518', 'Autosomal recessive chorioretinopathy-microcephaly syndrome', 1),
(6190, 'ORPHA:2518', 'Autosomal recessive chorioretinopathy-microcephaly-intellectual disability syndrome', 1),
(6191, 'ORPHA:251852', 'Embryonal tumor of neuroepithelial tissue', 3),
(6192, 'ORPHA:251855', 'Anaplastic/large cell medulloblastoma', 2),
(6193, 'ORPHA:251858', 'MBEN', 2),
(6194, 'ORPHA:251858', 'Medulloblastoma with extensive nodularity', 2),
(6195, 'ORPHA:251863', 'Desmoplastic/nodular medulloblastoma', 2),
(6196, 'ORPHA:251867', 'Classic medulloblastoma', 2),
(6197, 'ORPHA:251870', 'CNS PNET', 3),
(6198, 'ORPHA:251870', 'Central nervous system embryonal tumor', 3),
(6199, 'ORPHA:251870', 'Central nervous system primitive neuroectodermal tumor', 3),
(6200, 'ORPHA:251877', 'Ganglioneuroblastoma', 1),
(6201, 'ORPHA:251880', 'Ependymoblastoma', 1),
(6202, 'ORPHA:251883', 'Medulloepithelioma of the central nervous system', 1),
(6203, 'ORPHA:251896', 'Choroid plexus tumor', 3),
(6204, 'ORPHA:251899', 'Choroid plexus carcinoma', 1),
(6205, 'ORPHA:2519', 'Microcephaly-seizures-intellectual disability-heart disease syndrome', 1),
(6206, 'ORPHA:251902', 'Atypical CPP', 1),
(6207, 'ORPHA:251902', 'Atypical choroid plexus papilloma', 1),
(6208, 'ORPHA:251902', 'Atypical papilloma of choroid plexus', 1),
(6209, 'ORPHA:251905', 'Pineal tumor of neuroepithelial tissue', 3),
(6210, 'ORPHA:251909', 'Pineoblastoma', 1),
(6211, 'ORPHA:251912', 'Pineocytoma', 1),
(6212, 'ORPHA:251915', 'PTPR', 1),
(6213, 'ORPHA:251915', 'Papillary tumor of the pineal region', 1),
(6214, 'ORPHA:251919', 'Pineal parenchymal tumor of intermediate differenciation', 1),
(6215, 'ORPHA:251924', 'Neuronal tumor', 3),
(6216, 'ORPHA:251927', 'EVN', 1),
(6217, 'ORPHA:251927', 'Extraventricular neurocytoma', 1),
(6218, 'ORPHA:251931', 'Cerebellar liponeurocytoma', 1),
(6219, 'ORPHA:251934', 'Mixed neuronal-glial tumor', 3),
(6220, 'ORPHA:251937', 'Gangliocytoma', 1),
(6221, 'ORPHA:251940', 'DIA/DIG', 1),
(6222, 'ORPHA:251940', 'Desmoplastic infantile astrocytoma/ganglioglioma', 1),
(6223, 'ORPHA:251946', 'DNET', 1),
(6224, 'ORPHA:251946', 'Dysembryoplastic neuroepithelial tumor', 1),
(6225, 'ORPHA:251949', 'Ganglioglioma', 1),
(6226, 'ORPHA:251957', 'Anaplastic ganglioglioma', 1),
(6227, 'ORPHA:251962', 'PGNT', 1),
(6228, 'ORPHA:251962', 'Papillary glioneuronal tumor', 1),
(6229, 'ORPHA:251962', 'Pseudopapillary ganglioglioneurocytoma', 1),
(6230, 'ORPHA:251962', 'Pseudopapillary neurocytoma with glial differentiation', 1),
(6231, 'ORPHA:251975', 'RGNT', 1),
(6232, 'ORPHA:251975', 'Rosette-forming glioneuronal tumor', 1),
(6233, 'ORPHA:251992', 'Ganglioneuroma', 1),
(6234, 'ORPHA:251995', 'Primary germ cell tumor of CNS', 3),
(6235, 'ORPHA:251995', 'Primary germ cell tumor of central nervous system', 3),
(6236, 'ORPHA:252006', 'Endodermal sinus tumor of CNS', 2),
(6237, 'ORPHA:252006', 'Endodermal sinus tumor of central nervous system', 2),
(6238, 'ORPHA:252006', 'Intracranial endodermal sinus tumor', 2),
(6239, 'ORPHA:252006', 'Intracranial yolk sac tumor', 2),
(6240, 'ORPHA:252006', 'Yolk sac tumor of CNS', 2),
(6241, 'ORPHA:252006', 'Yolk sac tumor of central nervous system', 2),
(6242, 'ORPHA:252015', 'Choriocarcinoma of the central nervous system', 1),
(6243, 'ORPHA:252018', 'Teratoma of the central nervous system', 2),
(6244, 'ORPHA:252021', 'Mixed germ cell tumor of CNS', 2),
(6245, 'ORPHA:252021', 'Mixed germ cell tumor of central nervous system', 2),
(6246, 'ORPHA:252025', 'Tumor of meninges', 3),
(6247, 'ORPHA:252028', 'Primary melanocytic lesion of CNS', 3),
(6248, 'ORPHA:252028', 'Primary melanocytic lesion of central nervous system', 3),
(6249, 'ORPHA:252028', 'Primary melanocytic tumor of CNS', 3),
(6250, 'ORPHA:252028', 'Primary melanocytic tumor of central nervous system', 3),
(6251, 'ORPHA:252031', 'DLM', 1),
(6252, 'ORPHA:252031', 'Diffuse leptomeningeal melanocytosis', 1),
(6253, 'ORPHA:252031', 'Leptomeningeal melanomatosis', 1),
(6254, 'ORPHA:252046', 'Meningeal melanocytoma', 1),
(6255, 'ORPHA:252050', 'Malignant melanoma of meninges', 1),
(6256, 'ORPHA:252050', 'Primary melanoma of the CNS', 1),
(6257, 'ORPHA:252050', 'Primary melanoma of the central nervous system', 1),
(6258, 'ORPHA:252054', 'Hemangioblastoma', 1),
(6259, 'ORPHA:252057', 'Rare tumor of cranial and spinal nerves', 3),
(6260, 'ORPHA:252057', 'Tumor of cranial and spinal nerves', 3),
(6261, 'ORPHA:2521', 'Microcephaly-cleft palate-abnormal retinal pigmentation syndrome', 1),
(6262, 'ORPHA:252128', 'Malignant perineurioma', 2),
(6263, 'ORPHA:252128', 'Malignant peripheral nerve sheath tumor with perineurial differentiation', 2),
(6264, 'ORPHA:252131', 'BPNST', 3),
(6265, 'ORPHA:252131', 'Benign peripheral nerve sheath tumor', 3),
(6266, 'ORPHA:252164', 'Benign schwannoma', 1),
(6267, 'ORPHA:252164', 'Neurilemmoma', 1),
(6268, 'ORPHA:252164', 'Neurilemoma', 1),
(6269, 'ORPHA:252164', 'Peripheral fibroblastoma', 1),
(6270, 'ORPHA:252175', 'Acoustic neurilemoma', 2),
(6271, 'ORPHA:252175', 'Acoustic neurinoma', 2),
(6272, 'ORPHA:252175', 'Acoustic neuroma', 2),
(6273, 'ORPHA:252175', 'Vestibular schwannoma', 2),
(6274, 'ORPHA:252183', 'Neurofibroma', 1),
(6275, 'ORPHA:252190', 'Inherited nervous system cancer-predisposing syndrome', 3),
(6276, 'ORPHA:2522', 'Microcephaly-cervical spine fusion anomalies syndrome', 1),
(6277, 'ORPHA:252202', 'CMMR-D syndrome', 1),
(6278, 'ORPHA:252202', 'Constitutional mismatch repair deficiency syndrome', 1),
(6279, 'ORPHA:252206', 'Melanoma and neural system tumor syndrome', 1),
(6280, 'ORPHA:252206', 'Melanoma-astrocytoma syndrome', 1),
(6281, 'ORPHA:252212', 'MPNST with rhabdomyosarcomatous differentiation', 2),
(6282, 'ORPHA:252212', 'MTT', 2),
(6283, 'ORPHA:252212', 'Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differenciation', 2),
(6284, 'ORPHA:252212', 'Malignant triton tumor', 2),
(6285, 'ORPHA:2523', 'Franek-Bocker-Kahlen syndrome', 1),
(6286, 'ORPHA:2523', 'Microcephaly-brain defect-spasticity-hypernatremia syndrome', 1),
(6287, 'ORPHA:2524', 'PCH2', 1),
(6288, 'ORPHA:2524', 'Pontocerebellar hypoplasia type 2', 1),
(6289, 'ORPHA:2526', 'MLCRD', 1),
(6290, 'ORPHA:2526', 'Microcephaly-lymphedema-chorioretinopathy syndrome', 1),
(6291, 'ORPHA:2528', 'Microcephaly-microcornea syndrome, Seemanova type', 1),
(6292, 'ORPHA:2528', 'Seemanova-Lesny syndrome', 1),
(6293, 'ORPHA:253', 'SED and SEMD', 3),
(6294, 'ORPHA:253', 'Spondyloepiphyseal dysplasia and spondyloepimetaphyseal dysplasia', 3),
(6295, 'ORPHA:2533', 'Kawashima-Tsuji syndrome', 1),
(6296, 'ORPHA:2533', 'Microcephaly-deafness-intellectual disability syndrome', 1),
(6297, 'ORPHA:2533', 'Microcephaly-hearing loss-intellectual disability syndrome', 1),
(6298, 'ORPHA:2536', 'Microcornea-glaucoma-absent frontal sinuses syndrome', 1),
(6299, 'ORPHA:2538', 'Microgastria-limb reduction defect syndrome', 1),
(6300, 'ORPHA:254', 'Spondylometaphyseal dysplasia', 3),
(6301, 'ORPHA:2542', 'Isolated anophthalmia-microphthalmia syndrome', 3),
(6302, 'ORPHA:2542', 'Isolated microphthalmia-anophthalmia-coloboma', 3),
(6303, 'ORPHA:254334', 'Autosomal recessive intermediate Charcot-Marie-Tooth disease type B', 1),
(6304, 'ORPHA:254334', 'RI-CMT type B', 1),
(6305, 'ORPHA:254343', 'Autosomal recessive spastic ataxia type 4', 1),
(6306, 'ORPHA:254343', 'Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome', 1),
(6307, 'ORPHA:254343', 'SPAX4', 1),
(6308, 'ORPHA:254346', '19p13.12 microdeletion syndrome', 1),
(6309, 'ORPHA:254346', 'Del(19)(p13.12)', 1),
(6310, 'ORPHA:254346', 'Monosomy 19p13.12', 1),
(6311, 'ORPHA:254351', 'Distal 7q11.23 microdeletion syndrome', 1),
(6312, 'ORPHA:254351', 'Distal del(7)(q11.23)', 1),
(6313, 'ORPHA:254351', 'Distal monosomy 7q11.23', 1),
(6314, 'ORPHA:254361', 'Autosomal recessive limb-girdle muscular dystrophy type 2Q', 1),
(6315, 'ORPHA:254361', 'LGMD type 2Q', 1),
(6316, 'ORPHA:254361', 'LGMD2Q', 1),
(6317, 'ORPHA:254361', 'Limb-girdle muscular dystrophy type 2Q', 1),
(6318, 'ORPHA:254361', 'Plectin-related  limb-girdle muscular dystrophy R17', 1),
(6319, 'ORPHA:254361', 'Plectin-related LGMD R17', 1),
(6320, 'ORPHA:254367', 'Rare LP', 3),
(6321, 'ORPHA:254367', 'Rare lichen planus', 3),
(6322, 'ORPHA:254370', 'Rare cutaneous LP', 3),
(6323, 'ORPHA:254370', 'Rare cutaneous lichen planus', 3),
(6324, 'ORPHA:254373', 'Rare mucosal LP', 3),
(6325, 'ORPHA:254373', 'Rare mucosal lichen planus', 3),
(6326, 'ORPHA:254379', 'Blaschkoid LP', 1),
(6327, 'ORPHA:254379', 'Blaschkoid lichen planus', 1),
(6328, 'ORPHA:254379', 'Linear LP', 1),
(6329, 'ORPHA:254379', 'Linear lichen planus', 1),
(6330, 'ORPHA:254395', 'Actinic LP', 1),
(6331, 'ORPHA:254395', 'Actinic lichen planus', 1),
(6332, 'ORPHA:254395', 'Lichen planus actinus', 1),
(6333, 'ORPHA:254395', 'Lichen planus subtropicus', 1),
(6334, 'ORPHA:254395', 'Lichen planus tropicus', 1),
(6335, 'ORPHA:254395', 'Lichenoid melanodermatitis', 1),
(6336, 'ORPHA:254395', 'Summertime actinic lichenoid eruption', 1),
(6337, 'ORPHA:254411', 'Annular atrophic LP', 1),
(6338, 'ORPHA:254411', 'Annular atrophic lichen planus', 1),
(6339, 'ORPHA:254424', 'Annular LP', 1),
(6340, 'ORPHA:254424', 'Annular lichen planus', 1),
(6341, 'ORPHA:254449', 'Atrophic LP', 1),
(6342, 'ORPHA:254449', 'Atrophic lichen planus', 1),
(6343, 'ORPHA:254463', 'LP pigmentosa', 1),
(6344, 'ORPHA:254463', 'LP pigmentosus', 1),
(6345, 'ORPHA:254463', 'Lichen planus pigmentosa', 1),
(6346, 'ORPHA:254463', 'Lichen planus pigmentosus', 1),
(6347, 'ORPHA:254463', 'Lichen planus pigmentosus inversus', 1),
(6348, 'ORPHA:254478', 'LP pemphigoides', 1),
(6349, 'ORPHA:254478', 'Lichen planus pemphigoides', 1),
(6350, 'ORPHA:254492', 'FFA', 1),
(6351, 'ORPHA:254492', 'Frontal fibrosing alopecia', 1),
(6352, 'ORPHA:254504', 'Inhalation botulism', 2),
(6353, 'ORPHA:254504', 'Inhalational botulism', 2),
(6354, 'ORPHA:254509', 'Iatrogenic botulism', 2),
(6355, 'ORPHA:254509', 'Inadvertent botulism', 2),
(6356, 'ORPHA:254516', 'Temple syndrome', 1),
(6357, 'ORPHA:254519', 'KOS', 1),
(6358, 'ORPHA:254519', 'Kagami-Ogata syndrome', 1),
(6359, 'ORPHA:254525', 'Paternal del(14)(q32.2)', 2),
(6360, 'ORPHA:254525', 'Temple syndrome due to paternal 14q32.2 microdeletion', 2),
(6361, 'ORPHA:254528', 'Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion', 2),
(6362, 'ORPHA:254528', 'Maternal del(14)(q32.2)', 2),
(6363, 'ORPHA:254528', 'Maternal monosomy 14q32.2', 2),
(6364, 'ORPHA:254531', 'Temple syndrome due to paternal 14q32.2 hypomethylation', 2),
(6365, 'ORPHA:254534', 'Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation', 2),
(6366, 'ORPHA:254685', 'Gestational trophoblastic disease', 3),
(6367, 'ORPHA:254688', 'Complete hydatidiform mole', 2),
(6368, 'ORPHA:254688', 'Complete molar pregnancy', 2),
(6369, 'ORPHA:254693', 'Incomplete hydatidiform mole', 2),
(6370, 'ORPHA:254693', 'Incomplete molar pregnancy', 2),
(6371, 'ORPHA:254693', 'Partial hydatidiform mole', 2),
(6372, 'ORPHA:254693', 'Partial molar pregnancy', 2),
(6373, 'ORPHA:254698', 'Epithelioid trophoblastic tumor', 1),
(6374, 'ORPHA:2547', 'Microphthalmia-microtia-fetal akinesia syndrome', 1),
(6375, 'ORPHA:2547', 'Thomas-Jewett-Raines syndrome', 1),
(6376, 'ORPHA:254704', 'Benign hyperferritinemia', 1),
(6377, 'ORPHA:254704', 'Genetic hyperferritinemia without iron overload', 1),
(6378, 'ORPHA:254746', 'Pyruvate metabolism disorder', 3),
(6379, 'ORPHA:254749', 'Citric acid cycle disorder', 3),
(6380, 'ORPHA:254749', 'Krebs cycle disorder', 3),
(6381, 'ORPHA:254749', 'TCA cycle disorder', 3),
(6382, 'ORPHA:254749', 'Tricarboxylic acid cycle disorder', 3),
(6383, 'ORPHA:254758', 'Mitochondrial oxidative phosphorylation disorder due to mitochondrial DNA anomalies', 3),
(6384, 'ORPHA:254758', 'Mitochondrial oxidative phosphorylation disorder due to mtDNA anomalies', 3),
(6385, 'ORPHA:254758', 'OXPHOS disease due to mitochondrial DNA anomalies', 3),
(6386, 'ORPHA:254758', 'OXPHOS disease due to mtDNA anomalies', 3),
(6387, 'ORPHA:254767', 'Mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mitochondrial DNA', 3),
(6388, 'ORPHA:254767', 'Mitochondrial oxidative phosphorylation disorder due to a large-scale single deletion of mtDNA', 3),
(6389, 'ORPHA:254767', 'OXPHOS disease due to a large-scale single deletion of mitochondrial DNA', 3),
(6390, 'ORPHA:254767', 'OXPHOS disease due to a large-scale single deletion of mtDNA', 3),
(6391, 'ORPHA:254776', 'Mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA', 3),
(6392, 'ORPHA:254776', 'Mitochondrial oxidative phosphorylation disorder due to a point mutation of mtDNA', 3),
(6393, 'ORPHA:254776', 'OXPHOS disease due to a point mutation of mitochondrial DNA', 3),
(6394, 'ORPHA:254776', 'OXPHOS disease due to a point mutation of mtDNA', 3),
(6395, 'ORPHA:254788', 'Maternally-inherited mitochondrial myopathy', 3),
(6396, 'ORPHA:254788', 'Mitochondrial DNA-related mitochondrial myopathy', 3),
(6397, 'ORPHA:254788', 'mtDNA-related mitochondrial myopathy', 3),
(6398, 'ORPHA:254803', 'Mitochondrial DNA depletion syndrome, encephalomyopathic form', 3),
(6399, 'ORPHA:254803', 'mtDNA depletion syndrome, encephalomyopathic form', 3),
(6400, 'ORPHA:254807', 'Multiple mitochondrial DNA deletion syndrome', 3),
(6401, 'ORPHA:254807', 'Multiple mtDNA deletion syndrome', 3),
(6402, 'ORPHA:254818', 'Ataxia neuropathy spectrum', 3),
(6403, 'ORPHA:254822', 'Mitochondrial oxidative phosphorylation disorder with no known mechanism', 3),
(6404, 'ORPHA:254822', 'OXPHOS disease with no known mechanism', 3),
(6405, 'ORPHA:254827', 'Mitochondrial membrane transport disorder', 3),
(6406, 'ORPHA:254830', 'Mitochondrial substrate carrier disorder', 3),
(6407, 'ORPHA:254834', 'Mitochondrial protein import disorder', 3),
(6408, 'ORPHA:254837', 'Unspecified mitochondrial disorder', 3),
(6409, 'ORPHA:254843', 'Exercise intolerance with lactic acidosis', 3),
(6410, 'ORPHA:254846', 'Isolated oxidative phosphorylation complex disorder', 3),
(6411, 'ORPHA:254846', 'Isolated respiratory chain complex disorder', 3),
(6412, 'ORPHA:254851', 'Maternally-inherited mitochondrial dystonia', 1),
(6413, 'ORPHA:254851', 'Mitochondrial DNA-related dystonia', 1),
(6414, 'ORPHA:254851', 'mtDNA-related dystonia', 1),
(6415, 'ORPHA:254854', 'Pure mitochondrial myopathy', 1),
(6416, 'ORPHA:254857', 'LIMD', 1),
(6417, 'ORPHA:254857', 'LIMM', 1),
(6418, 'ORPHA:254857', 'Lethal infantile mitochondrial disease', 1),
(6419, 'ORPHA:254857', 'Lethal infantile mitochondrial myopathy', 1),
(6420, 'ORPHA:254864', 'Benign COX deficiency', 1),
(6421, 'ORPHA:254864', 'Infantile reversible cytochrome C oxidase deficiency myopathy', 1),
(6422, 'ORPHA:254864', 'Mitochondrial myopathy with reversible COX deficiency', 1),
(6423, 'ORPHA:254864', 'Mitochondrial myopathy with reversible complex IV deficiency', 1),
(6424, 'ORPHA:254864', 'Mitochondrial myopathy with reversible cytochrome C oxidase deficiency', 1),
(6425, 'ORPHA:254864', 'Reversible infantile cytochrome C oxidase deficiency', 1),
(6426, 'ORPHA:254864', 'Reversible infantile respiratory chain deficiency', 1),
(6427, 'ORPHA:254871', 'Deoxyguanosine kinase deficiency', 3),
(6428, 'ORPHA:254871', 'Mitochondrial DNA depletion syndrome, hepatocerebral form', 3),
(6429, 'ORPHA:254871', 'mtDNA depletion syndrome, hepatocerebral form', 3),
(6430, 'ORPHA:254875', 'Mitochondrial DNA depletion syndrome, myopathic form', 1),
(6431, 'ORPHA:254875', 'mtDNA depletion syndrome, myopathic form', 1),
(6432, 'ORPHA:254881', 'MSCAE', 1),
(6433, 'ORPHA:254881', 'Mitochondrial spinocerebellar ataxia with epilepsy', 1),
(6434, 'ORPHA:254881', 'SCAE', 1),
(6435, 'ORPHA:254881', 'Spinocerebellar ataxia with epilepsy', 1),
(6436, 'ORPHA:254886', 'Autosomal recessive progressive external ophthalmoplegia', 1),
(6437, 'ORPHA:254886', 'arPEO', 1),
(6438, 'ORPHA:254892', 'Autosomal dominant progressive external ophthalmoplegia', 1),
(6439, 'ORPHA:254892', 'adPEO', 1),
(6440, 'ORPHA:254898', 'Deafness-encephaloneuropathy-obesity-valvulopathy syndrome', 1),
(6441, 'ORPHA:254898', 'Hearing loss-encephaloneuropathy-obesity-valvulopathy syndrome', 1),
(6442, 'ORPHA:2549', 'Hemifacial microsomia-radial defects syndrome', 1),
(6443, 'ORPHA:2549', 'Moeschler-Clarren syndrome', 1),
(6444, 'ORPHA:2549', 'Oculoauriculovertebral spectrum with radial defects', 1),
(6445, 'ORPHA:254902', 'Renal tubulopathy-encephalopathy-liver failure syndrome', 1),
(6446, 'ORPHA:254905', 'Isolated COX deficiency', 1),
(6447, 'ORPHA:254905', 'Isolated cytochrome C oxidase deficiency', 1),
(6448, 'ORPHA:254905', 'Isolated mitochondrial respiratory chain complex IV deficiency', 1),
(6449, 'ORPHA:254913', 'Isolated ATP synthase deficiency', 1),
(6450, 'ORPHA:254913', 'Isolated mitochondrial respiratory chain complex V deficiency', 1),
(6451, 'ORPHA:254920', 'COXPD2', 1),
(6452, 'ORPHA:254920', 'Combined oxidative phosphorylation defect type 2', 1),
(6453, 'ORPHA:254925', 'COXPD4', 1),
(6454, 'ORPHA:254925', 'Combined oxidative phosphorylation defect type 4', 1),
(6455, 'ORPHA:254930', 'COXPD7', 1),
(6456, 'ORPHA:254930', 'Combined oxidative phosphorylation defect type 7', 1),
(6457, 'ORPHA:254930', 'Severe C12ORF65-related COXPD', 1),
(6458, 'ORPHA:254930', 'Severe C12ORF65-related combined oxidative phosphorylation defect', 1),
(6459, 'ORPHA:255', 'Dopa-responsive dystonia', 3),
(6460, 'ORPHA:255', 'HPD with diurnal fluctuation', 3),
(6461, 'ORPHA:255', 'Hereditary progressive dystonia with diurnal fluctuation', 3),
(6462, 'ORPHA:2551', 'Microspherophakia-metaphyseal dysplasia syndrome', 1),
(6463, 'ORPHA:2551', 'Verloes-Van Maldergem-de Marneffe syndrome', 1),
(6464, 'ORPHA:255132', 'Adult-onset autosomal recessive sideroblastic anemia', 1),
(6465, 'ORPHA:255132', 'GLRX5-related sideroblastic anemia', 1),
(6466, 'ORPHA:255138', 'PDHBD', 2),
(6467, 'ORPHA:255138', 'Pyruvate dehydrogenase E1-beta deficiency', 2),
(6468, 'ORPHA:255138', 'Pyruvate dehydrogenase complex E1 component subunit beta deficiency', 2),
(6469, 'ORPHA:255182', '2-oxoglutarate complex deficiency', 2),
(6470, 'ORPHA:255182', 'Branched chain alpha-ketoacid dehydrogenase complex deficiency', 2),
(6471, 'ORPHA:255182', 'Diaphorase deficiency', 2),
(6472, 'ORPHA:255182', 'Dihydrolipoyl dehydrogenase deficiency', 2),
(6473, 'ORPHA:255182', 'Glycine cleavage system L protein deficiency', 2),
(6474, 'ORPHA:255182', 'Lipoamide dehydrogenase deficiency', 2),
(6475, 'ORPHA:255182', 'Pyruvate dehydrogenase E3-binding protein deficiency', 2),
(6476, 'ORPHA:255182', 'Pyruvate dehydrogenase complex component E3 deficiency', 2),
(6477, 'ORPHA:255182', 'Pyruvate dehydrogenase protein X component deficiency', 2),
(6478, 'ORPHA:2552', 'Microsporidiosis', 1),
(6479, 'ORPHA:255210', 'MILS', 1),
(6480, 'ORPHA:255210', 'Maternally-inherited Leigh disease', 1),
(6481, 'ORPHA:255210', 'Maternally-inherited infantile subacute necrotizing encephalopathy', 1),
(6482, 'ORPHA:255210', 'Mitochondrial DNA-associated Leigh syndrome', 1),
(6483, 'ORPHA:255210', 'mtDNA-associated Leigh syndrome', 1),
(6484, 'ORPHA:255229', 'Navajo neurohepatopathy', 1),
(6485, 'ORPHA:255229', 'Navajo neuropathy', 1),
(6486, 'ORPHA:255235', 'Mitochondrial DNA depletion syndrome, encephalomyopathic form with renal tubulopathy', 1),
(6487, 'ORPHA:255235', 'mtDNA depletion syndrome, encephalomyopathic form with renal tubulopathy', 1),
(6488, 'ORPHA:255241', 'Infantile subacute necrotizing encephalopathy with leukodystrophy', 1),
(6489, 'ORPHA:255241', 'Leigh disease with leukodystrophy', 1),
(6490, 'ORPHA:255241', 'Leigh syndrome with leukodystrophy', 1),
(6491, 'ORPHA:255249', 'Infantile subacute necrotizing encephalopathy with nephrotic syndrome', 1),
(6492, 'ORPHA:255249', 'Leigh disease with nephrotic syndrome', 1),
(6493, 'ORPHA:255249', 'Leigh syndrome with nephrotic syndrome', 1),
(6494, 'ORPHA:2554', 'Ear-patella-short stature syndrome', 1),
(6495, 'ORPHA:2554', 'Meier-Gorlin syndrome', 1),
(6496, 'ORPHA:2556', 'MCOPS7', 1),
(6497, 'ORPHA:2556', 'MIDAS syndrome', 1),
(6498, 'ORPHA:2556', 'MLS syndrome', 1),
(6499, 'ORPHA:2556', 'Microphthalmia with linear skin defects syndrome', 1),
(6500, 'ORPHA:2556', 'Microphthalmia-dermal aplasia-sclerocornea syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(6501, 'ORPHA:2556', 'Syndromic microphthalmia type 7', 1),
(6502, 'ORPHA:2557', 'Intellectual disability, Mietens-Weber type', 1),
(6503, 'ORPHA:2557', 'Mietens syndrome', 1),
(6504, 'ORPHA:2558', 'Microcephaly-hypergonadotropic hypogonadism-short stature syndrome', 1),
(6505, 'ORPHA:2558', 'Mikati-Najjar-Sahli syndrome', 1),
(6506, 'ORPHA:256', 'Dystonia musculorum deformans', 1),
(6507, 'ORPHA:256', 'EOTD', 1),
(6508, 'ORPHA:256', 'Early-onset generalized limb-onset dystonia', 1),
(6509, 'ORPHA:256', 'Early-onset generalized torsion dystonia', 1),
(6510, 'ORPHA:256', 'Early-onset isolated dystonia', 1),
(6511, 'ORPHA:256', 'Early-onset primary dystonia', 1),
(6512, 'ORPHA:256', 'Early-onset torsion dystonia', 1),
(6513, 'ORPHA:256', 'Idiopathic torsion dystonia', 1),
(6514, 'ORPHA:256', 'Oppenheim dystonia', 1),
(6515, 'ORPHA:2560', 'Moebius syndrome-axonal neuropathy-hypogonadotropic hypogonadism syndrome', 1),
(6516, 'ORPHA:2561', 'Ackerman fused molar roots syndrome', 1),
(6517, 'ORPHA:2561', 'Pyramidal molars-abnormal upper lip syndrome', 1),
(6518, 'ORPHA:2563', 'MOMO syndrome', 1),
(6519, 'ORPHA:2563', 'Macrocephaly-obesity-mental disability-ocular abnormalities syndrome', 1),
(6520, 'ORPHA:2563', 'Macrosomia-obesity-macrocephaly-ocular abnormalities syndrome', 1),
(6521, 'ORPHA:2564', 'Sommer-Hines syndrome', 1),
(6522, 'ORPHA:2564', 'Tetramelic monodactyly', 1),
(6523, 'ORPHA:2565', 'Mononen-Karnes-Senac syndrome', 1),
(6524, 'ORPHA:2565', 'Skeletal dysplasia-brachydactyly syndrome', 1),
(6525, 'ORPHA:2566', 'CAEBV syndrome', 1),
(6526, 'ORPHA:2566', 'Chronic EBV infection syndrome', 1),
(6527, 'ORPHA:2566', 'Chronic Epstein-Barr virus infection syndrome', 1),
(6528, 'ORPHA:257', 'EBS-MD', 1),
(6529, 'ORPHA:257', 'Epidermolysis bullosa simplex with muscular dystrophy', 1),
(6530, 'ORPHA:257', 'Limb-girdle muscular dystrophy with epidermolysis bullosa simplex', 1),
(6531, 'ORPHA:2570', 'Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome', 1),
(6532, 'ORPHA:2570', 'Morse-Rawnsley-Sargent syndrome', 1),
(6533, 'ORPHA:2571', 'Woods-Black-Norbury syndrome', 1),
(6534, 'ORPHA:2571', 'X-linked immunoneurologic disorder', 1),
(6535, 'ORPHA:2572', 'Bedouin spastic ataxia syndrome', 1),
(6536, 'ORPHA:2572', 'Mousa-Al Din-Al Nassar syndrome', 1),
(6537, 'ORPHA:2572', 'Spastic ataxia-corneal dystrophy syndrome', 1),
(6538, 'ORPHA:2572', 'Spastic ataxia-ocular anomalies syndrome', 1),
(6539, 'ORPHA:2573', 'Idiopathic Moyamoya disease', 1),
(6540, 'ORPHA:2573', 'Moyamoya disease', 1),
(6541, 'ORPHA:2574', 'Alopecia-epilepsy-intellectual disability syndrome, Moynahan type', 1),
(6542, 'ORPHA:2574', 'Moynahan syndrome', 1),
(6543, 'ORPHA:2575', 'Cystic fibrosis-gastritis-megaloblastic anemia syndrome', 1),
(6544, 'ORPHA:2575', 'Lubani-Al Saleh-Teebi syndrome', 1),
(6545, 'ORPHA:2576', 'MUL', 1),
(6546, 'ORPHA:2576', 'Mulibrey growth disorder', 1),
(6547, 'ORPHA:2576', 'Mulibrey nanism', 1),
(6548, 'ORPHA:2576', 'Muscle-liver-brain-eye nanism', 1),
(6549, 'ORPHA:2578', 'Atypical MRKH syndrome', 2),
(6550, 'ORPHA:2578', 'MRKH syndrome type 2', 2),
(6551, 'ORPHA:2578', 'MURCS association', 2),
(6552, 'ORPHA:2578', 'Mayer-Rokitansky-Küster-Hauser syndrome type 2', 2),
(6553, 'ORPHA:2578', 'Müllerian duct aplasia-renal dysplasia-cervical somite anomalies syndrome', 2),
(6554, 'ORPHA:2579', 'Furukawa-Takagi-Nakao syndrome', 1),
(6555, 'ORPHA:2579', 'Muscular atrophy-ataxia-retinitis pigmentosa-diabetes mellitus syndrome', 1),
(6556, 'ORPHA:258', 'CMD1A', 1),
(6557, 'ORPHA:258', 'Congenital muscular dystrophy due to laminin alpha2 deficiency', 1),
(6558, 'ORPHA:258', 'Congenital muscular dystrophy type 1A', 1),
(6559, 'ORPHA:258', 'Laminin subunit alpha 2-related congenital muscular dystrophy', 1),
(6560, 'ORPHA:258', 'MDC1A', 1),
(6561, 'ORPHA:258', 'Merosin-negative congenital muscular dystrophy', 1),
(6562, 'ORPHA:2582', 'Myalgia-eosinophilia syndrome associated with tryptophan', 1),
(6563, 'ORPHA:2583', 'Madura foot', 1),
(6564, 'ORPHA:2583', 'Mycetoma', 1),
(6565, 'ORPHA:2584', 'Classic mycosis fungoides', 1),
(6566, 'ORPHA:2584', 'Mycosis fungoides, Alibert-Bazin type', 1),
(6567, 'ORPHA:2585', 'Ataxia-pancytopenia syndrome', 1),
(6568, 'ORPHA:2585', 'Myelocerebellar disorder', 1),
(6569, 'ORPHA:2587', 'MPO deficiency', 1),
(6570, 'ORPHA:2587', 'Myeloperoxidase deficiency', 1),
(6571, 'ORPHA:2588', 'Facial dysmorphism-intellectual disability-short stature-deafness syndrome', 1),
(6572, 'ORPHA:2588', 'Facial dysmorphism-intellectual disability-short stature-hearing loss syndrome', 1),
(6573, 'ORPHA:2588', 'Myhre syndrome', 1),
(6574, 'ORPHA:2589', 'Myoclonus-cerebellar ataxia-deafness syndrome', 1),
(6575, 'ORPHA:2589', 'Myoclonus-cerebellar ataxia-hearing loss syndrome', 1),
(6576, 'ORPHA:2590', 'Hereditary myoclonus-progressive distal muscular atrophy syndrome', 1),
(6577, 'ORPHA:2590', 'Jankovic-Rivera syndrome', 1),
(6578, 'ORPHA:2590', 'SMA-PME', 1),
(6579, 'ORPHA:2590', 'Spinal muscular atrophy-progressive myoclonic epilepsy syndrome', 1),
(6580, 'ORPHA:2591', 'Infantile myofibromatosis', 1),
(6581, 'ORPHA:2593', 'Tubular aggregate myopathy', 1),
(6582, 'ORPHA:2596', 'Myopathy and diabetes mellitus', 1),
(6583, 'ORPHA:25968', 'Benign occipital epilepsy', 1),
(6584, 'ORPHA:2597', 'Mitochondrial myopathy-lactic acidosis-deafness syndrome', 1),
(6585, 'ORPHA:2597', 'Mitochondrial myopathy-lactic acidosis-hearing loss syndrome', 1),
(6586, 'ORPHA:2598', 'MLASA', 1),
(6587, 'ORPHA:2598', 'Mitochondrial myopathy and sideroblastic anemia', 1),
(6588, 'ORPHA:2598', 'Myopathy, lactic acidosis and sideroblastic anemia', 1),
(6589, 'ORPHA:25980', 'X-linked myopathy with excessive autophagy', 1),
(6590, 'ORPHA:25980', 'XMEA', 1),
(6591, 'ORPHA:26', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis', 1),
(6592, 'ORPHA:26', 'Methylmalonic acidemia with homocystinuria', 1),
(6593, 'ORPHA:26', 'Methylmalonic aciduria with homocystinuria', 1),
(6594, 'ORPHA:260305', 'ARSA', 1),
(6595, 'ORPHA:260305', 'Autosomal recessive sideroblastic anemia', 1),
(6596, 'ORPHA:260305', 'Congenital sideroblastic anemia', 1),
(6597, 'ORPHA:2604', 'Familial hollow visceral myopathy', 1),
(6598, 'ORPHA:2604', 'Familial visceral myopathy', 1),
(6599, 'ORPHA:2604', 'Hereditary hollow visceral myopathy', 1),
(6600, 'ORPHA:2604', 'Megaduodenum and/or megacystis', 1),
(6601, 'ORPHA:2608', 'N syndrome', 1),
(6602, 'ORPHA:2609', 'Isolated NADH-CoQ reductase deficiency', 1),
(6603, 'ORPHA:2609', 'Isolated NADH-coenzyme Q reductase deficiency', 1),
(6604, 'ORPHA:2609', 'Isolated NADH-ubiquinone reductase deficiency', 1),
(6605, 'ORPHA:2609', 'Isolated complex I deficiency', 1),
(6606, 'ORPHA:2609', 'Isolated mitochondrial respiratory chain complex I deficiency', 1),
(6607, 'ORPHA:261', 'EDMD', 1),
(6608, 'ORPHA:261', 'Emery-Dreifuss muscular dystrophy', 1),
(6609, 'ORPHA:26106', 'FDGC', 1),
(6610, 'ORPHA:26106', 'Familial diffuse cancer of stomach', 1),
(6611, 'ORPHA:26106', 'Familial diffuse gastric cancer', 1),
(6612, 'ORPHA:26106', 'HDGC', 1),
(6613, 'ORPHA:26106', 'Hereditary diffuse cancer of stomach', 1),
(6614, 'ORPHA:26106', 'Hereditary diffuse gastric adenocarcinoma', 1),
(6615, 'ORPHA:26106', 'Hereditary diffuse gastric cancer', 1),
(6616, 'ORPHA:2611', 'Linear hamartoma syndrome', 1),
(6617, 'ORPHA:2611', 'Linear verrucous nevus syndrome', 1),
(6618, 'ORPHA:261102', 'Distal 7q11.23 microduplication syndrome', 1),
(6619, 'ORPHA:261102', 'Distal dup(7)(q11.23)', 1),
(6620, 'ORPHA:261102', 'Distal trisomy 7q11.23', 1),
(6621, 'ORPHA:261102', 'Dup7q11.23D', 1),
(6622, 'ORPHA:261112', '9p deletion syndrome', 1),
(6623, 'ORPHA:261112', '9p- syndrome', 1),
(6624, 'ORPHA:261112', 'Alfi syndrome', 1),
(6625, 'ORPHA:261112', 'Monosomy 9p', 1),
(6626, 'ORPHA:261120', '14q11.2 microdeletion syndrome', 1),
(6627, 'ORPHA:261120', 'Del(14)(q11.2)', 1),
(6628, 'ORPHA:261120', 'Monosomy 14q11.2', 1),
(6629, 'ORPHA:261144', '14q12 microdeletion syndrome', 1),
(6630, 'ORPHA:261144', 'Del(14)(q12)', 1),
(6631, 'ORPHA:261144', 'Monosomy 14q12', 1),
(6632, 'ORPHA:261183', '15q11.2 BP1-BP2 microdeletion syndrome', 1),
(6633, 'ORPHA:261183', '15q11.2 microdeletion syndrome', 1),
(6634, 'ORPHA:261183', 'Del(15)(q11.2)', 1),
(6635, 'ORPHA:261183', 'Monosomy 15q11.2', 1),
(6636, 'ORPHA:261190', '15q14 microdeletion syndrome', 1),
(6637, 'ORPHA:261190', 'Del(15)(q14)', 1),
(6638, 'ORPHA:261190', 'Monosomy 15q14', 1),
(6639, 'ORPHA:261197', 'Proximal 16p11.2 microdeletion syndrome', 1),
(6640, 'ORPHA:261197', 'Proximal del(16)(p11.2)', 1),
(6641, 'ORPHA:261197', 'Proximal monosomy 16p11.2', 1),
(6642, 'ORPHA:2612', 'Linear nevus sebaceus syndrome', 1),
(6643, 'ORPHA:2612', 'Nevus sebaceus of Jadassohn', 1),
(6644, 'ORPHA:2612', 'Nevus sebaceus syndrome', 1),
(6645, 'ORPHA:2612', 'Organoid nevus syndrome', 1),
(6646, 'ORPHA:2612', 'Schimmelpenning syndrome', 1),
(6647, 'ORPHA:2612', 'Solomon syndrome', 1),
(6648, 'ORPHA:261204', '16p11.2p12.2 microduplication syndrome', 1),
(6649, 'ORPHA:261204', 'Dup(16)(p11.2p12.2)', 1),
(6650, 'ORPHA:261204', 'Trisomy 16p11.2p12.2', 1),
(6651, 'ORPHA:261211', '16p11.2p12.2 microdeletion syndrome', 1),
(6652, 'ORPHA:261211', 'Del(16)(p11.2p12.2)', 1),
(6653, 'ORPHA:261211', 'Monosomy 16p11.2p12.2', 1),
(6654, 'ORPHA:261222', 'Distal 16p11.2 microdeletion syndrome', 1),
(6655, 'ORPHA:261222', 'Distal del(16)(p11.2)', 1),
(6656, 'ORPHA:261222', 'Distal monosomy 16p11.2', 1),
(6657, 'ORPHA:261229', '14q11.2 microduplication syndrome', 1),
(6658, 'ORPHA:261229', 'Dup(14)(q11.2)', 1),
(6659, 'ORPHA:261229', 'Trisomy 14q11.2', 1),
(6660, 'ORPHA:261236', '16p13.11 microdeletion syndrome', 1),
(6661, 'ORPHA:261236', 'Del(16)(p13.11)', 1),
(6662, 'ORPHA:261236', 'Monosomy 16p13.11', 1),
(6663, 'ORPHA:261243', '16p13.11 microduplication syndrome', 1),
(6664, 'ORPHA:261243', 'Dup(16)(p13.11)', 1),
(6665, 'ORPHA:261243', 'Trisomy 16p13.11', 1),
(6666, 'ORPHA:261250', '16q24.3 microdeletion syndrome', 1),
(6667, 'ORPHA:261250', 'Del(16)(q24.3)', 1),
(6668, 'ORPHA:261250', 'Monosomy 16q24.3', 1),
(6669, 'ORPHA:261257', 'Distal 17p13.3 microdeletion syndrome', 1),
(6670, 'ORPHA:261257', 'Distal del(17)(p13.3 )', 1),
(6671, 'ORPHA:261257', 'Distal monosomy 17p13.3', 1),
(6672, 'ORPHA:261265', '17q12 microdeletion syndrome', 1),
(6673, 'ORPHA:261265', 'Del(17)(q12)', 1),
(6674, 'ORPHA:261265', 'Monosomy 17q12', 1),
(6675, 'ORPHA:261272', '17q12 microduplication syndrome', 1),
(6676, 'ORPHA:261272', 'Dup(17)(q12)', 1),
(6677, 'ORPHA:261272', 'Trisomy 17q12', 1),
(6678, 'ORPHA:261279', '17q23.1q23.2 microdeletion syndrome', 1),
(6679, 'ORPHA:261279', 'Del(17)(q23.1q23.2)', 1),
(6680, 'ORPHA:261279', 'Monosomy 17q23.1q23.2', 1),
(6681, 'ORPHA:261290', 'Dup(17p)', 1),
(6682, 'ORPHA:261290', 'Trisomy 17p', 1),
(6683, 'ORPHA:261295', '20p12.3 microdeletion syndrome', 1),
(6684, 'ORPHA:261295', 'Del(20)(p12.3)', 1),
(6685, 'ORPHA:261295', 'Monosomy 20p12.3', 1),
(6686, 'ORPHA:2613', 'Nail-patella-like renal disease', 1),
(6687, 'ORPHA:2613', 'Salcedo syndrome', 1),
(6688, 'ORPHA:261304', 'Paternal 20q13.2q13.3 microdeletion syndrome', 1),
(6689, 'ORPHA:261304', 'Paternal del(20)(q13.2q13.3)', 1),
(6690, 'ORPHA:261304', 'Paternal monosomy 20q13.2q13.3', 1),
(6691, 'ORPHA:261311', '20q13.33 microdeletion syndrome', 1),
(6692, 'ORPHA:261311', 'Del(20)(q13.33)', 1),
(6693, 'ORPHA:261311', 'Monosomy 20q13.33', 1),
(6694, 'ORPHA:261318', 'Dup(20p)', 1),
(6695, 'ORPHA:261318', 'Duplication of 20p', 1),
(6696, 'ORPHA:261318', 'Partial duplication of chromosome 20p', 1),
(6697, 'ORPHA:261318', 'Partial duplication of the short arm of chromosome 20', 1),
(6698, 'ORPHA:261318', 'Partial trisomy of chromosome 20p', 1),
(6699, 'ORPHA:261318', 'Partial trisomy of the short arm of chromosome 20', 1),
(6700, 'ORPHA:261318', 'Trisomy 20p', 1),
(6701, 'ORPHA:261323', '21q22.11q22.12 microdeletion syndrome', 1),
(6702, 'ORPHA:261323', 'Del(21)(q22.11q22.12)', 1),
(6703, 'ORPHA:261323', 'Monosomy 21q22.11q22.12', 1),
(6704, 'ORPHA:261330', 'Distal 22q11.2 microdeletion syndrome', 1),
(6705, 'ORPHA:261330', 'Distal del(22)(q11.2)', 1),
(6706, 'ORPHA:261330', 'Distal monosomy 22q11.2', 1),
(6707, 'ORPHA:261337', 'Distal 22q11.2 microduplication syndrome', 1),
(6708, 'ORPHA:261337', 'Distal dup(22)(q11.2)', 1),
(6709, 'ORPHA:261337', 'Distal trisomy 22q11.2', 1),
(6710, 'ORPHA:261344', 'Duplication 1q', 1),
(6711, 'ORPHA:261344', 'Trisomy 1q', 1),
(6712, 'ORPHA:261349', '2p15p16.1 microdeletion syndrome', 1),
(6713, 'ORPHA:261349', 'Del(2)(p15p16.1)', 1),
(6714, 'ORPHA:261349', 'Monosomy 2p15p16.1', 1),
(6715, 'ORPHA:26137', 'JTA', 1),
(6716, 'ORPHA:26137', 'Juvenile temporal arteritis', 1),
(6717, 'ORPHA:26137', 'Non-giant cell granulomatous temporal arteritis with eosinophilia', 1),
(6718, 'ORPHA:2614', 'Nail-patella syndrome', 1),
(6719, 'ORPHA:2614', 'Onychoosteodysplasia', 1),
(6720, 'ORPHA:2614', 'Turner-Kieser syndrome', 1),
(6721, 'ORPHA:261476', 'Complex GKD', 1),
(6722, 'ORPHA:261476', 'Complex glycerol kinase deficiency', 1),
(6723, 'ORPHA:261476', 'Del(X)(p21)', 1),
(6724, 'ORPHA:261476', 'Xp21 contiguous gene deletion syndrome', 1),
(6725, 'ORPHA:261476', 'Xp21 deletion syndrome', 1),
(6726, 'ORPHA:261476', 'Xp21 microdeletion syndrome', 1),
(6727, 'ORPHA:261483', 'Dup(X)(q27.3q28)', 1),
(6728, 'ORPHA:261483', 'Trisomy Xq27.3-q28', 1),
(6729, 'ORPHA:261483', 'Trisomy Xq27.3q28', 1),
(6730, 'ORPHA:261483', 'Xq27.3-q28 microduplication syndrome', 1),
(6731, 'ORPHA:261483', 'Xq27.3q28 duplication syndrome', 1),
(6732, 'ORPHA:261494', 'Kleefstra syndrome', 1),
(6733, 'ORPHA:261501', 'Atypical Norrie disease due to Xp11.3 microdeletion', 1),
(6734, 'ORPHA:261501', 'Atypical Norrie disease due to del(X)(p11.3)', 1),
(6735, 'ORPHA:261501', 'Atypical Norrie disease due to nullisomy Xp11.3', 1),
(6736, 'ORPHA:261519', 'Maternal uniparental disomy of chromosome X', 1),
(6737, 'ORPHA:261519', 'UPD(X)mat', 1),
(6738, 'ORPHA:261524', 'Paternal uniparental disomy of chromosome X', 1),
(6739, 'ORPHA:261524', 'UPD(X)pat', 1),
(6740, 'ORPHA:261529', 'Ring chromosome Y', 1),
(6741, 'ORPHA:261529', 'Ring chromosome Y syndrome', 1),
(6742, 'ORPHA:261529', 'r(Y)', 1),
(6743, 'ORPHA:261534', '49,XXXYY syndrome', 1),
(6744, 'ORPHA:261537', 'Hirschsprung disease and intellectual disability due to 2q22 microdeletion', 2),
(6745, 'ORPHA:261537', 'Hirschsprung disease and intellectual disability due to del(2)(q22)', 2),
(6746, 'ORPHA:261537', 'Hirschsprung disease and intellectual disability due to monosomy 2q22', 2),
(6747, 'ORPHA:261537', 'Mowat-Wilson syndrome due to 2q22 microdeletion', 2),
(6748, 'ORPHA:261537', 'Mowat-Wilson syndrome due to del(2)q(22)', 2),
(6749, 'ORPHA:261537', 'Mowat-Wilson syndrome due to monosomy 2q22', 2),
(6750, 'ORPHA:261552', 'Hirschsprung disease and intellectual disability due to a ZEB2 point mutation', 2),
(6751, 'ORPHA:261552', 'Mowat-Wilson syndrome due to a ZEB2 point mutation', 2),
(6752, 'ORPHA:261584', 'Colorectal adenomatous polyposis due to monosomy 5q22.2', 2),
(6753, 'ORPHA:261584', 'FAP due to monosomy 5q22.2', 2),
(6754, 'ORPHA:261584', 'Familial adenomatous polyposis due to 5q22.2 microdeletion', 2),
(6755, 'ORPHA:261584', 'Familial adenomatous polyposis due to del(5)(q22.2)', 2),
(6756, 'ORPHA:261584', 'Familial adenomatous polyposis due to monosomy 5q22.2', 2),
(6757, 'ORPHA:261584', 'Familial polyposis coli due to monosomy 5q22.2', 2),
(6758, 'ORPHA:2616', '3-M syndrome', 1),
(6759, 'ORPHA:2616', '3M syndrome', 1),
(6760, 'ORPHA:2616', 'Yakut short stature syndrome', 1),
(6761, 'ORPHA:261600', 'Alagille syndrome due to 20p12 microdeletion', 2),
(6762, 'ORPHA:261600', 'Alagille syndrome due to del(20)(p12)', 2),
(6763, 'ORPHA:261600', 'Alagille syndrome due to monosomy 20p12', 2),
(6764, 'ORPHA:261600', 'Alagille-Watson syndrome due to monosomy 20p12', 2),
(6765, 'ORPHA:261600', 'Arteriohepatic dysplasia due to monosomy 20p12', 2),
(6766, 'ORPHA:261600', 'Syndromic bile duct paucity due to monosomy 20p12', 2),
(6767, 'ORPHA:261619', 'Alagille syndrome due to a JAG1 point mutation', 2),
(6768, 'ORPHA:261619', 'Alagille-Watson syndrome due to a JAG1 point mutation', 2),
(6769, 'ORPHA:261619', 'Arteriohepatic dysplasia due to a JAG1 point mutation', 2),
(6770, 'ORPHA:261619', 'Syndromic bile duct paucity due to a JAG1 point mutation', 2),
(6771, 'ORPHA:261629', 'Alagille syndrome due to a NOTCH2 point mutation', 2),
(6772, 'ORPHA:261629', 'Alagille-Watson syndrome due to a NOTCH2 point mutation', 2),
(6773, 'ORPHA:261629', 'Arteriohepatic dysplasia due to a NOTCH2 point mutation', 2),
(6774, 'ORPHA:261629', 'Syndromic bile duct paucity due to a NOTCH2 point mutation', 2),
(6775, 'ORPHA:261638', 'Duane-radial ray syndrome due to monosomy 20q13', 2),
(6776, 'ORPHA:261638', 'Okihiro syndrome due to 20q13 microdeletion', 2),
(6777, 'ORPHA:261638', 'Okihiro syndrome due to del(20)(q13)', 2),
(6778, 'ORPHA:261638', 'Okihiro syndrome due to monosomy 20q13', 2),
(6779, 'ORPHA:261647', 'Duane-radial ray syndrome due to a point mutation', 2),
(6780, 'ORPHA:261647', 'Okihiro syndrome due to a point mutation', 2),
(6781, 'ORPHA:261652', 'Kleefstra syndrome due to a point mutation', 2),
(6782, 'ORPHA:261697', 'Anomaly of chromosome 1', 3),
(6783, 'ORPHA:2617', 'Bird-headed dwarfism, Montreal type', 1),
(6784, 'ORPHA:2617', 'Microcephalic primordial dwarfism, Montreal type', 1),
(6785, 'ORPHA:261700', 'Anomaly of chromosome 2', 3),
(6786, 'ORPHA:261703', 'Anomaly of chromosome 3', 3),
(6787, 'ORPHA:261706', 'Anomaly of chromosome 4', 3),
(6788, 'ORPHA:261709', 'Anomaly of chromosome 5', 3),
(6789, 'ORPHA:261712', 'Anomaly of chromosome 6', 3),
(6790, 'ORPHA:261715', 'Anomaly of chromosome 7', 3),
(6791, 'ORPHA:261718', 'Anomaly of chromosome 8', 3),
(6792, 'ORPHA:261721', 'Anomaly of chromosome 9', 3),
(6793, 'ORPHA:261724', 'Anomaly of chromosome 10', 3),
(6794, 'ORPHA:261730', 'Anomaly of chromosome 11', 3),
(6795, 'ORPHA:261733', 'Anomaly of chromosome 12', 3),
(6796, 'ORPHA:261736', 'Anomaly of chromosome 13', 3),
(6797, 'ORPHA:261739', 'Anomaly of chromosome 14', 3),
(6798, 'ORPHA:261742', 'Anomaly of chromosome 15', 3),
(6799, 'ORPHA:261745', 'Anomaly of chromosome 16', 3),
(6800, 'ORPHA:261748', 'Anomaly of chromosome 17', 3),
(6801, 'ORPHA:261751', 'Anomaly of chromosome 18', 3),
(6802, 'ORPHA:261754', 'Anomaly of chromosome 19', 3),
(6803, 'ORPHA:261757', 'Anomaly of chromosome 20', 3),
(6804, 'ORPHA:261760', 'Anomaly of chromosome 21', 3),
(6805, 'ORPHA:261763', 'Anomaly of chromosome 22', 3),
(6806, 'ORPHA:261766', 'Partial deletion of chromosome 1', 3),
(6807, 'ORPHA:261766', 'Partial monosomy of chromosome 1', 3),
(6808, 'ORPHA:261771', 'Partial deletion of chromosome 2', 3),
(6809, 'ORPHA:261771', 'Partial monosomy of chromosome 2', 3),
(6810, 'ORPHA:261776', 'Partial deletion of chromosome 3', 3),
(6811, 'ORPHA:261776', 'Partial monosomy of chromosome 3', 3),
(6812, 'ORPHA:261781', 'Partial deletion of chromosome 4', 3),
(6813, 'ORPHA:261781', 'Partial monosomy of chromosome 4', 3),
(6814, 'ORPHA:261786', 'Partial deletion of chromosome 5', 3),
(6815, 'ORPHA:261786', 'Partial monosomy of chromosome 5', 3),
(6816, 'ORPHA:261791', 'Partial deletion of chromosome 6', 3),
(6817, 'ORPHA:261791', 'Partial monosomy of chromosome 6', 3),
(6818, 'ORPHA:261796', 'Partial deletion of chromosome 7', 3),
(6819, 'ORPHA:261796', 'Partial monosomy of chromosome 7', 3),
(6820, 'ORPHA:261801', 'Partial deletion of chromosome 8', 3),
(6821, 'ORPHA:261801', 'Partial monosomy of chromosome 8', 3),
(6822, 'ORPHA:261806', 'Partial deletion of chromosome 9', 3),
(6823, 'ORPHA:261806', 'Partial monosomy of chromosome 9', 3),
(6824, 'ORPHA:261811', 'Partial deletion of chromosome 10', 3),
(6825, 'ORPHA:261811', 'Partial monosomy of chromosome 10', 3),
(6826, 'ORPHA:261816', 'Partial deletion of chromosome 11', 3),
(6827, 'ORPHA:261816', 'Partial monosomy of chromosome 11', 3),
(6828, 'ORPHA:261821', 'Partial deletion of chromosome 12q', 3),
(6829, 'ORPHA:261821', 'Partial deletion of the long arm of chromosome 12', 3),
(6830, 'ORPHA:261821', 'Partial monosomy of chromosome 12q', 3),
(6831, 'ORPHA:261821', 'Partial monosomy of the long arm of chromosome 12', 3),
(6832, 'ORPHA:261826', 'Partial deletion of chromosome 16', 3),
(6833, 'ORPHA:261826', 'Partial monosomy of chromosome 16', 3),
(6834, 'ORPHA:261831', 'Partial deletion of chromosome 17', 3),
(6835, 'ORPHA:261831', 'Partial monosomy of chromosome 17', 3),
(6836, 'ORPHA:261836', 'Partial deletion of chromosome 18', 3),
(6837, 'ORPHA:261836', 'Partial monosomy of chromosome 18', 3),
(6838, 'ORPHA:261841', 'Partial deletion of chromosome 19', 3),
(6839, 'ORPHA:261841', 'Partial monosomy of chromosome 19', 3),
(6840, 'ORPHA:261846', 'Partial deletion of chromosome 20', 3),
(6841, 'ORPHA:261846', 'Partial monosomy of chromosome 20', 3),
(6842, 'ORPHA:261857', 'Partial deletion of chromosome 1p', 3),
(6843, 'ORPHA:261857', 'Partial deletion of the short arm of chromosome 1', 3),
(6844, 'ORPHA:261857', 'Partial monosomy of chromosome 1p', 3),
(6845, 'ORPHA:261857', 'Partial monosomy of the short arm of chromosome 1', 3),
(6846, 'ORPHA:261866', 'Partial deletion of chromosome 2p', 3),
(6847, 'ORPHA:261866', 'Partial deletion of the short arm of chromosome 2', 3),
(6848, 'ORPHA:261866', 'Partial monosomy of chromosome 2p', 3),
(6849, 'ORPHA:261866', 'Partial monosomy of the short arm of chromosome 2', 3),
(6850, 'ORPHA:261875', 'Partial deletion of chromosome 3p', 3),
(6851, 'ORPHA:261875', 'Partial deletion of the short arm of chromosome 3', 3),
(6852, 'ORPHA:261875', 'Partial monosomy of chromosome 3p', 3),
(6853, 'ORPHA:261875', 'Partial monosomy of the short arm of chromosome 3', 3),
(6854, 'ORPHA:261884', 'Partial deletion of chromosome 4p', 3),
(6855, 'ORPHA:261884', 'Partial deletion of the short arm of chromosome 4', 3),
(6856, 'ORPHA:261884', 'Partial monosomy of chromosome 4p', 3),
(6857, 'ORPHA:261884', 'Partial monosomy of the short arm of chromosome 4', 3),
(6858, 'ORPHA:261893', 'Partial deletion of chromosome 5p', 3),
(6859, 'ORPHA:261893', 'Partial deletion of the short arm of chromosome 5', 3),
(6860, 'ORPHA:261893', 'Partial monosomy of chromosome 5p', 3),
(6861, 'ORPHA:261893', 'Partial monosomy of the short arm of chromosome 5', 3),
(6862, 'ORPHA:2619', 'Brachydactylous dwarfism, Mseleni type', 1),
(6863, 'ORPHA:2619', 'Mseleni joint disease', 1),
(6864, 'ORPHA:261902', 'Partial deletion of chromosome 6p', 3),
(6865, 'ORPHA:261902', 'Partial deletion of the short arm of chromosome 6', 3),
(6866, 'ORPHA:261902', 'Partial monosomy of chromosome 6p', 3),
(6867, 'ORPHA:261902', 'Partial monosomy of the short arm of chromosome 6', 3),
(6868, 'ORPHA:261911', 'Partial deletion of chromosome 7p', 3),
(6869, 'ORPHA:261911', 'Partial deletion of the short arm of chromosome 7', 3),
(6870, 'ORPHA:261911', 'Partial monosomy of chromosome 7p', 3),
(6871, 'ORPHA:261911', 'Partial monosomy of the short arm of chromosome 7', 3),
(6872, 'ORPHA:261920', 'Partial deletion of chromosome 8p', 3),
(6873, 'ORPHA:261920', 'Partial deletion of the short arm of chromosome 8', 3),
(6874, 'ORPHA:261920', 'Partial monosomy of chromosome 8p', 3),
(6875, 'ORPHA:261920', 'Partial monosomy of the short arm of chromosome 8', 3),
(6876, 'ORPHA:261929', 'Partial deletion of chromosome 9p', 3),
(6877, 'ORPHA:261929', 'Partial deletion of the short arm of chromosome 9', 3),
(6878, 'ORPHA:261929', 'Partial monosomy of chromosome 9p', 3),
(6879, 'ORPHA:261929', 'Partial monosomy of the short arm of chromosome 9', 3),
(6880, 'ORPHA:261938', 'Partial deletion of chromosome 10p', 3),
(6881, 'ORPHA:261938', 'Partial deletion of the short arm of chromosome 10', 3),
(6882, 'ORPHA:261938', 'Partial monosomy of chromosome 10p', 3),
(6883, 'ORPHA:261938', 'Partial monosomy of the short arm of chromosome 10', 3),
(6884, 'ORPHA:261947', 'Partial deletion of chromosome 11p', 3),
(6885, 'ORPHA:261947', 'Partial deletion of the short arm of chromosome 11', 3),
(6886, 'ORPHA:261947', 'Partial monosomy of chromosome 11p', 3),
(6887, 'ORPHA:261947', 'Partial monosomy of the short arm of chromosome 11', 3),
(6888, 'ORPHA:261956', 'Partial deletion of chromosome 16p', 3),
(6889, 'ORPHA:261956', 'Partial deletion of the short arm of chromosome 16', 3),
(6890, 'ORPHA:261956', 'Partial monosomy of chromosome 16p', 3),
(6891, 'ORPHA:261956', 'Partial monosomy of the short arm of chromosome 16', 3),
(6892, 'ORPHA:261965', 'Partial deletion of chromosome 17p', 3),
(6893, 'ORPHA:261965', 'Partial deletion of the short arm of chromosome 17', 3),
(6894, 'ORPHA:261965', 'Partial monosomy of chromosome 17p', 3),
(6895, 'ORPHA:261965', 'Partial monosomy of the short arm of chromosome 17', 3),
(6896, 'ORPHA:261974', 'Partial deletion of chromosome 18p', 3),
(6897, 'ORPHA:261974', 'Partial deletion of the short arm of chromosome 18', 3),
(6898, 'ORPHA:261974', 'Partial monosomy of chromosome 18p', 3),
(6899, 'ORPHA:261974', 'Partial monosomy of the short arm of chromosome 18', 3),
(6900, 'ORPHA:261983', 'Partial deletion of chromosome 19p', 3),
(6901, 'ORPHA:261983', 'Partial deletion of the short arm of chromosome 19', 3),
(6902, 'ORPHA:261983', 'Partial monosomy of chromosome 19p', 3),
(6903, 'ORPHA:261983', 'Partial monosomy of the short arm of chromosome 19', 3),
(6904, 'ORPHA:261992', 'Partial deletion of chromosome 20p', 3),
(6905, 'ORPHA:261992', 'Partial deletion of the short arm of chromosome 20', 3),
(6906, 'ORPHA:261992', 'Partial monosomy of chromosome 20p', 3),
(6907, 'ORPHA:261992', 'Partial monosomy of the short arm of chromosome 20', 3),
(6908, 'ORPHA:261992', 'Pure partial 20p deletion', 3),
(6909, 'ORPHA:262', 'Duchenne and Becker muscular dystrophy', 3),
(6910, 'ORPHA:262', 'Severe dystrophinopathy, Duchenne and Becker type', 3),
(6911, 'ORPHA:262001', 'Partial deletion of chromosome 1q', 3),
(6912, 'ORPHA:262001', 'Partial deletion of the long arm of chromosome 1', 3),
(6913, 'ORPHA:262001', 'Partial monosomy of chromosome 1q', 3),
(6914, 'ORPHA:262001', 'Partial monosomy of the long arm of chromosome 1', 3),
(6915, 'ORPHA:262010', 'Partial deletion of chromosome 2q', 3),
(6916, 'ORPHA:262010', 'Partial deletion of the long arm of chromosome 2', 3),
(6917, 'ORPHA:262010', 'Partial monosomy of chromosome 2q', 3),
(6918, 'ORPHA:262010', 'Partial monosomy of the long arm of chromosome 2', 3),
(6919, 'ORPHA:262019', 'Partial deletion of chromosome 3q', 3),
(6920, 'ORPHA:262019', 'Partial deletion of the long arm of chromosome 3', 3),
(6921, 'ORPHA:262019', 'Partial monosomy of chromosome 3q', 3),
(6922, 'ORPHA:262019', 'Partial monosomy of the long arm of chromosome 3', 3),
(6923, 'ORPHA:262029', 'Partial deletion of chromosome 4q', 3),
(6924, 'ORPHA:262029', 'Partial deletion of the long arm of chromosome 4', 3),
(6925, 'ORPHA:262029', 'Partial monosomy of chromosome 4q', 3),
(6926, 'ORPHA:262029', 'Partial monosomy of the long arm of chromosome 4', 3),
(6927, 'ORPHA:262038', 'Partial deletion of chromosome 5q', 3),
(6928, 'ORPHA:262038', 'Partial deletion of the long arm of chromosome 5', 3),
(6929, 'ORPHA:262038', 'Partial monosomy of chromosome 5q', 3),
(6930, 'ORPHA:262038', 'Partial monosomy of the long arm of chromosome 5', 3),
(6931, 'ORPHA:262047', 'Partial deletion of chromosome 6q', 3),
(6932, 'ORPHA:262047', 'Partial deletion of the long arm of chromosome 6', 3),
(6933, 'ORPHA:262047', 'Partial monosomy of chromosome 6q', 3),
(6934, 'ORPHA:262047', 'Partial monosomy of the long arm of chromosome 6', 3),
(6935, 'ORPHA:262056', 'Partial deletion of chromosome 7q', 3),
(6936, 'ORPHA:262056', 'Partial deletion of the long arm of chromosome 7', 3),
(6937, 'ORPHA:262056', 'Partial monosomy of chromosome 7q', 3),
(6938, 'ORPHA:262056', 'Partial monosomy of the long arm of chromosome 7', 3),
(6939, 'ORPHA:262065', 'Partial deletion of chromosome 8q', 3),
(6940, 'ORPHA:262065', 'Partial deletion of the long arm of chromosome 8', 3),
(6941, 'ORPHA:262065', 'Partial monosomy of chromosome 8q', 3),
(6942, 'ORPHA:262065', 'Partial monosomy of the long arm of chromosome 8', 3),
(6943, 'ORPHA:262074', 'Partial deletion of chromosome 9q', 3),
(6944, 'ORPHA:262074', 'Partial deletion of the long arm of chromosome 9', 3),
(6945, 'ORPHA:262074', 'Partial monosomy of chromosome 9q', 3),
(6946, 'ORPHA:262074', 'Partial monosomy of the long arm of chromosome 9', 3),
(6947, 'ORPHA:262083', 'Partial deletion of chromosome 10q', 3),
(6948, 'ORPHA:262083', 'Partial deletion of the long arm of chromosome 10', 3),
(6949, 'ORPHA:262083', 'Partial monosomy of chromosome 10q', 3),
(6950, 'ORPHA:262083', 'Partial monosomy of the long arm of chromosome 10', 3),
(6951, 'ORPHA:262092', 'Partial deletion of chromosome 11q', 3),
(6952, 'ORPHA:262092', 'Partial deletion of the long arm of chromosome 11', 3),
(6953, 'ORPHA:262092', 'Partial monosomy of chromosome 11q', 3),
(6954, 'ORPHA:262092', 'Partial monosomy of the long arm of chromosome 11', 3),
(6955, 'ORPHA:262101', 'Partial deletion of chromosome 13q', 3),
(6956, 'ORPHA:262101', 'Partial deletion of the long arm of chromosome 13', 3),
(6957, 'ORPHA:262101', 'Partial monosomy of chromosome 13q', 3),
(6958, 'ORPHA:262101', 'Partial monosomy of the long arm of chromosome 13', 3),
(6959, 'ORPHA:262110', 'Partial deletion of chromosome 14q', 3),
(6960, 'ORPHA:262110', 'Partial deletion of the long arm of chromosome 14', 3),
(6961, 'ORPHA:262110', 'Partial monosomy of chromosome 14q', 3),
(6962, 'ORPHA:262110', 'Partial monosomy of the long arm of chromosome 14', 3),
(6963, 'ORPHA:262119', 'Partial deletion of chromosome 15q', 3),
(6964, 'ORPHA:262119', 'Partial deletion of the long arm of chromosome 15', 3),
(6965, 'ORPHA:262119', 'Partial monosomy of chromosome 15q', 3),
(6966, 'ORPHA:262119', 'Partial monosomy of the long arm of chromosome 15', 3),
(6967, 'ORPHA:262128', 'Partial deletion of chromosome 16q', 3),
(6968, 'ORPHA:262128', 'Partial deletion of the long arm of chromosome 16', 3),
(6969, 'ORPHA:262128', 'Partial monosomy of chromosome 16q', 3),
(6970, 'ORPHA:262128', 'Partial monosomy of the long arm of chromosome 16', 3),
(6971, 'ORPHA:262137', 'Partial deletion of chromosome 17q', 3),
(6972, 'ORPHA:262137', 'Partial deletion of the long arm of chromosome 17', 3),
(6973, 'ORPHA:262137', 'Partial monosomy of chromosome 17q', 3),
(6974, 'ORPHA:262137', 'Partial monosomy of the long arm of chromosome 17', 3),
(6975, 'ORPHA:262146', 'Partial deletion of chromosome 18q', 3),
(6976, 'ORPHA:262146', 'Partial deletion of the long arm of chromosome 18', 3),
(6977, 'ORPHA:262146', 'Partial monosomy of chromosome 18q', 3),
(6978, 'ORPHA:262146', 'Partial monosomy of the long arm of chromosome 18', 3),
(6979, 'ORPHA:262155', 'Partial deletion of chromosome 19q', 3),
(6980, 'ORPHA:262155', 'Partial deletion of the long arm of chromosome 19', 3),
(6981, 'ORPHA:262155', 'Partial monosomy of chromosome 19q', 3),
(6982, 'ORPHA:262155', 'Partial monosomy of the long arm of chromosome 19', 3),
(6983, 'ORPHA:262164', 'Partial deletion of chromosome 20q', 3),
(6984, 'ORPHA:262164', 'Partial deletion of the long arm of chromosome 20', 3),
(6985, 'ORPHA:262164', 'Partial monosomy of chromosome 20q', 3),
(6986, 'ORPHA:262164', 'Partial monosomy of the long arm of chromosome 20', 3),
(6987, 'ORPHA:262173', 'Partial deletion of chromosome 21q', 3),
(6988, 'ORPHA:262173', 'Partial deletion of the long arm of chromosome 21', 3),
(6989, 'ORPHA:262173', 'Partial monosomy of chromosome 21q', 3),
(6990, 'ORPHA:262173', 'Partial monosomy of the long arm of chromosome 21', 3),
(6991, 'ORPHA:262182', 'Partial deletion of chromosome 22q', 3),
(6992, 'ORPHA:262182', 'Partial deletion of the long arm of chromosome 22', 3),
(6993, 'ORPHA:262182', 'Partial monosomy of chromosome 22q', 3),
(6994, 'ORPHA:262182', 'Partial monosomy of the long arm of chromosome 22', 3),
(6995, 'ORPHA:262191', 'Partial duplication of chromosome 1', 3),
(6996, 'ORPHA:262191', 'Partial trisomy of chromosome 1', 3),
(6997, 'ORPHA:262196', 'Partial duplication of chromosome 2', 3),
(6998, 'ORPHA:262196', 'Partial trisomy of chromosome 2', 3),
(6999, 'ORPHA:262201', 'Partial duplication of chromosome 3', 3),
(7000, 'ORPHA:262201', 'Partial trisomy of chromosome 3', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(7001, 'ORPHA:262206', 'Partial duplication of chromosome 4', 3),
(7002, 'ORPHA:262206', 'Partial trisomy of chromosome 4', 3),
(7003, 'ORPHA:262211', 'Partial duplication/triplication of chromosome 5', 3),
(7004, 'ORPHA:262211', 'Partial trisomy/tetrasomy of chromosome 5', 3),
(7005, 'ORPHA:2623', 'Geleophysic dwarfism', 1),
(7006, 'ORPHA:2623', 'Geleophysic dysplasia', 1),
(7007, 'ORPHA:262628', 'Partial duplication of chromosome 6', 3),
(7008, 'ORPHA:262628', 'Partial trisomy of chromosome 6', 3),
(7009, 'ORPHA:262633', 'Partial duplication of chromosome 7', 3),
(7010, 'ORPHA:262633', 'Partial trisomy of chromosome 7', 3),
(7011, 'ORPHA:262638', 'Partial duplication of chromosome 8', 3),
(7012, 'ORPHA:262638', 'Partial trisomy of chromosome 8', 3),
(7013, 'ORPHA:262643', 'Partial duplication/triplication of chromosome 9', 3),
(7014, 'ORPHA:262643', 'Partial trisomy/tetrasomy of chromosome 9', 3),
(7015, 'ORPHA:262648', 'Partial duplication of chromosome 10', 3),
(7016, 'ORPHA:262648', 'Partial trisomy of chromosome 10', 3),
(7017, 'ORPHA:262653', 'Partial duplication of chromosome 11', 3),
(7018, 'ORPHA:262653', 'Partial trisomy of chromosome 11', 3),
(7019, 'ORPHA:262658', 'Partial duplication/triplication of chromosome 12p', 3),
(7020, 'ORPHA:262658', 'Partial duplication/triplication of the short arm of chromosome 12', 3),
(7021, 'ORPHA:262658', 'Partial trisomy/tetrasomy of chromosome 12p', 3),
(7022, 'ORPHA:262658', 'Partial trisomy/tetrasomy of the short arm of chromosome 12', 3),
(7023, 'ORPHA:262672', 'Partial duplication of chromosome 16', 3),
(7024, 'ORPHA:262672', 'Partial trisomy of chromosome 16', 3),
(7025, 'ORPHA:262677', 'Partial duplication of chromosome 17', 3),
(7026, 'ORPHA:262677', 'Partial trisomy of chromosome 17', 3),
(7027, 'ORPHA:262682', 'Partial duplication/triplication of chromosome 18', 3),
(7028, 'ORPHA:262682', 'Partial trisomy/tetrasomy of chromosome 18', 3),
(7029, 'ORPHA:262687', 'Partial duplication of chromosome 19', 3),
(7030, 'ORPHA:262687', 'Partial trisomy of chromosome 19', 3),
(7031, 'ORPHA:262692', 'Partial duplication of chromosome 20', 3),
(7032, 'ORPHA:262692', 'Partial trisomy of chromosome 20', 3),
(7033, 'ORPHA:262698', 'Partial duplication of chromosome 2p', 3),
(7034, 'ORPHA:262698', 'Partial duplication of the short arm of chromosome 2', 3),
(7035, 'ORPHA:262698', 'Partial trisomy of chromosome 2p', 3),
(7036, 'ORPHA:262707', 'Partial duplication of chromosome 3p', 3),
(7037, 'ORPHA:262707', 'Partial duplication of the short arm of chromosome 3', 3),
(7038, 'ORPHA:262707', 'Partial trisomy of chromosome 3p', 3),
(7039, 'ORPHA:262707', 'Partial trisomy of the short arm of chromosome 3', 3),
(7040, 'ORPHA:262716', 'Partial duplication of chromosome 4p', 3),
(7041, 'ORPHA:262716', 'Partial duplication of the short arm of chromosome 4', 3),
(7042, 'ORPHA:262716', 'Partial trisomy of chromosome 4p', 3),
(7043, 'ORPHA:262716', 'Partial trisomy of the short arm of chromosome 4', 3),
(7044, 'ORPHA:262725', 'Partial duplication/triplication of chromosome 5p', 3),
(7045, 'ORPHA:262725', 'Partial duplication/triplication of the short arm of chromosome 5', 3),
(7046, 'ORPHA:262725', 'Partial trisomy/tetrasomy of chromosome 5p', 3),
(7047, 'ORPHA:262725', 'Partial trisomy/tetrasomy of the short arm of chromosome 5', 3),
(7048, 'ORPHA:262740', 'Partial duplication of chromosome 6p', 3),
(7049, 'ORPHA:262740', 'Partial duplication of the short arm of chromosome 6', 3),
(7050, 'ORPHA:262740', 'Partial trisomy of chromosome 6p', 3),
(7051, 'ORPHA:262740', 'Partial trisomy of the short arm of chromosome 6', 3),
(7052, 'ORPHA:262749', 'Partial duplication of chromosome 7p', 3),
(7053, 'ORPHA:262749', 'Partial duplication of the short arm of chromosome 7', 3),
(7054, 'ORPHA:262749', 'Partial trisomy of chromosome 7p', 3),
(7055, 'ORPHA:262749', 'Partial trisomy of the short arm of chromosome 7', 3),
(7056, 'ORPHA:262758', 'Partial duplication of chromosome 8p', 3),
(7057, 'ORPHA:262758', 'Partial duplication of the short arm of chromosome 8', 3),
(7058, 'ORPHA:262758', 'Partial trisomy of chromosome 8p', 3),
(7059, 'ORPHA:262758', 'Partial trisomy of the short arm of chromosome 8', 3),
(7060, 'ORPHA:262767', 'Partial duplication of chromosome 9p', 3),
(7061, 'ORPHA:262767', 'Partial duplication of the short arm of chromosome 9', 3),
(7062, 'ORPHA:262767', 'Partial trisomy of chromosome 9p', 3),
(7063, 'ORPHA:262767', 'Partial trisomy/tetrasomy of the short arm of chromosome 9', 3),
(7064, 'ORPHA:262776', 'Partial duplication of chromosome 10p', 3),
(7065, 'ORPHA:262776', 'Partial duplication of the short arm of chromosome 10', 3),
(7066, 'ORPHA:262776', 'Partial trisomy of chromosome 10p', 3),
(7067, 'ORPHA:262776', 'Partial trisomy of the short arm of chromosome 10', 3),
(7068, 'ORPHA:262785', 'Partial duplication of chromosome 11p', 3),
(7069, 'ORPHA:262785', 'Partial duplication of the short arm of chromosome 11', 3),
(7070, 'ORPHA:262785', 'Partial trisomy of chromosome 11p', 3),
(7071, 'ORPHA:262785', 'Partial trisomy of the short arm of chromosome 11', 3),
(7072, 'ORPHA:262794', 'Partial duplication of chromosome 16p', 3),
(7073, 'ORPHA:262794', 'Partial duplication of the short arm of chromosome 16', 3),
(7074, 'ORPHA:262794', 'Partial trisomy of chromosome 16p', 3),
(7075, 'ORPHA:262794', 'Partial trisomy of the short arm of chromosome 16', 3),
(7076, 'ORPHA:262803', 'Partial duplication of chromosome 17p', 3),
(7077, 'ORPHA:262803', 'Partial duplication of the short arm of chromosome 17', 3),
(7078, 'ORPHA:262803', 'Partial trisomy of chromosome 17p', 3),
(7079, 'ORPHA:262803', 'Partial trisomy of the short arm of chromosome 17', 3),
(7080, 'ORPHA:262812', 'Partial duplication/triplication of chromosome 18p', 3),
(7081, 'ORPHA:262812', 'Partial duplication/triplication of the short arm of chromosome 18', 3),
(7082, 'ORPHA:262812', 'Partial trisomy/tetrasomy of chromosome 18p', 3),
(7083, 'ORPHA:262812', 'Partial trisomy/tetrasomy of the short arm of chromosome 18', 3),
(7084, 'ORPHA:262833', 'Partial duplication of chromosome 1q', 3),
(7085, 'ORPHA:262833', 'Partial duplication of the long arm of chromosome 1', 3),
(7086, 'ORPHA:262833', 'Partial trisomy of chromosome 1q', 3),
(7087, 'ORPHA:262833', 'Partial trisomy of the long arm of chromosome 1', 3),
(7088, 'ORPHA:262842', 'Partial duplication of chromosome 2q', 3),
(7089, 'ORPHA:262842', 'Partial duplication of the long arm of chromosome 2', 3),
(7090, 'ORPHA:262842', 'Partial trisomy of chromosome 2q', 3),
(7091, 'ORPHA:262842', 'Partial trisomy of the long arm of chromosome 2', 3),
(7092, 'ORPHA:262851', 'Partial duplication of chromosome 3q', 3),
(7093, 'ORPHA:262851', 'Partial duplication of the long arm of chromosome 3', 3),
(7094, 'ORPHA:262851', 'Partial trisomy of chromosome 3q', 3),
(7095, 'ORPHA:262860', 'Partial duplication of chromosome 4q', 3),
(7096, 'ORPHA:262860', 'Partial duplication of the long arm of chromosome 4', 3),
(7097, 'ORPHA:262860', 'Partial trisomy of chromosome 4q', 3),
(7098, 'ORPHA:262860', 'Partial trisomy of the long arm of chromosome 4', 3),
(7099, 'ORPHA:262869', 'Partial duplication of chromosome 5q', 3),
(7100, 'ORPHA:262869', 'Partial duplication of the long arm of chromosome 5', 3),
(7101, 'ORPHA:262869', 'Partial trisomy of chromosome 5q', 3),
(7102, 'ORPHA:262869', 'Partial trisomy of the long arm of chromosome 5', 3),
(7103, 'ORPHA:262878', 'Partial duplication of chromosome 6q', 3),
(7104, 'ORPHA:262878', 'Partial duplication of the long arm of chromosome 6', 3),
(7105, 'ORPHA:262878', 'Partial trisomy of chromosome 6q', 3),
(7106, 'ORPHA:262878', 'Partial trisomy of the long arm of chromosome 6', 3),
(7107, 'ORPHA:262887', 'Partial duplication of chromosome 7q', 3),
(7108, 'ORPHA:262887', 'Partial duplication of the long arm of chromosome 7', 3),
(7109, 'ORPHA:262887', 'Partial trisomy of chromosome 7q', 3),
(7110, 'ORPHA:262887', 'Partial trisomy of the long arm of chromosome 7', 3),
(7111, 'ORPHA:262896', 'Partial duplication of chromosome 8q', 3),
(7112, 'ORPHA:262896', 'Partial duplication of the long arm of chromosome 8', 3),
(7113, 'ORPHA:262896', 'Partial trisomy of chromosome 8q', 3),
(7114, 'ORPHA:262896', 'Partial trisomy of the long arm of chromosome 8', 3),
(7115, 'ORPHA:262905', 'Partial duplication of chromosome 9q', 3),
(7116, 'ORPHA:262905', 'Partial duplication of the long arm of chromosome 9', 3),
(7117, 'ORPHA:262905', 'Partial trisomy of chromosome 9q', 3),
(7118, 'ORPHA:262905', 'Partial trisomy of the long arm of chromosome 9', 3),
(7119, 'ORPHA:262914', 'Partial duplication of chromosome 10q', 3),
(7120, 'ORPHA:262914', 'Partial duplication of the long arm of chromosome 10', 3),
(7121, 'ORPHA:262914', 'Partial trisomy of chromosome 10q', 3),
(7122, 'ORPHA:262914', 'Partial trisomy of the long arm of chromosome 10', 3),
(7123, 'ORPHA:262923', 'Partial duplication of chromosome 11q', 3),
(7124, 'ORPHA:262923', 'Partial duplication of the long arm of chromosome 11', 3),
(7125, 'ORPHA:262923', 'Partial trisomy of chromosome 11q', 3),
(7126, 'ORPHA:262923', 'Partial trisomy of the long arm of chromosome 11', 3),
(7127, 'ORPHA:262932', 'Partial duplication of chromosome 13q', 3),
(7128, 'ORPHA:262932', 'Partial duplication of the long arm of chromosome 13', 3),
(7129, 'ORPHA:262932', 'Partial trisomy of chromosome 13q', 3),
(7130, 'ORPHA:262932', 'Partial trisomy of the long arm of chromosome 13', 3),
(7131, 'ORPHA:262941', 'Partial duplication of chromosome 14q', 3),
(7132, 'ORPHA:262941', 'Partial duplication of the long arm of chromosome 14', 3),
(7133, 'ORPHA:262941', 'Partial trisomy of chromosome 14q', 3),
(7134, 'ORPHA:262941', 'Partial trisomy of the long arm of chromosome 14', 3),
(7135, 'ORPHA:262950', 'Partial duplication of chromosome 15q', 3),
(7136, 'ORPHA:262950', 'Partial duplication of the long arm of chromosome 15', 3),
(7137, 'ORPHA:262950', 'Partial trisomy of chromosome 15q', 3),
(7138, 'ORPHA:262950', 'Partial trisomy of the long arm of chromosome 15', 3),
(7139, 'ORPHA:262959', 'Partial duplication of chromosome 16q', 3),
(7140, 'ORPHA:262959', 'Partial duplication of the long arm of chromosome 16', 3),
(7141, 'ORPHA:262959', 'Partial trisomy of chromosome 16q', 3),
(7142, 'ORPHA:262959', 'Partial trisomy of the long arm of chromosome 16', 3),
(7143, 'ORPHA:262968', 'Partial duplication of chromosome 17q', 3),
(7144, 'ORPHA:262968', 'Partial duplication of the long arm of chromosome 17', 3),
(7145, 'ORPHA:262968', 'Partial trisomy of chromosome 17q', 3),
(7146, 'ORPHA:262968', 'Partial trisomy of the long arm of chromosome 17', 3),
(7147, 'ORPHA:262977', 'Partial duplication of chromosome 18q', 3),
(7148, 'ORPHA:262977', 'Partial duplication of the long arm of chromosome 18', 3),
(7149, 'ORPHA:262977', 'Partial trisomy of chromosome 18q', 3),
(7150, 'ORPHA:262977', 'Partial trisomy of the long arm of chromosome 18', 3),
(7151, 'ORPHA:262986', 'Partial duplication of chromosome 19q', 3),
(7152, 'ORPHA:262986', 'Partial duplication of the long arm of chromosome 19', 3),
(7153, 'ORPHA:262986', 'Partial trisomy of chromosome 19q', 3),
(7154, 'ORPHA:262986', 'Partial trisomy of the long arm of chromosome 19', 3),
(7155, 'ORPHA:262995', 'Partial duplication of chromosome 20q', 3),
(7156, 'ORPHA:262995', 'Partial duplication of the long arm of chromosome 20', 3),
(7157, 'ORPHA:262995', 'Partial trisomy of chromosome 20q', 3),
(7158, 'ORPHA:262995', 'Partial trisomy of the long arm of chromosome 20', 3),
(7159, 'ORPHA:263', 'LGMD', 3),
(7160, 'ORPHA:263', 'Limb-girdle muscular dystrophy', 3),
(7161, 'ORPHA:263004', 'Partial duplication of chromosome 22q', 3),
(7162, 'ORPHA:263004', 'Partial duplication of the long arm of chromosome 22', 3),
(7163, 'ORPHA:263004', 'Partial trisomy of chromosome 22q', 3),
(7164, 'ORPHA:263004', 'Partial trisomy of the long arm of chromosome 22', 3),
(7165, 'ORPHA:263019', 'UPD(1)', 3),
(7166, 'ORPHA:263019', 'Uniparental disomy of chromosome 1', 3),
(7167, 'ORPHA:263024', 'UPD(6)', 3),
(7168, 'ORPHA:263024', 'Uniparental disomy of chromosome 6', 3),
(7169, 'ORPHA:263029', 'UPD(7)', 3),
(7170, 'ORPHA:263029', 'Uniparental disomy of chromosome 7', 3),
(7171, 'ORPHA:263034', 'UPD(11)', 3),
(7172, 'ORPHA:263034', 'Uniparental disomy of chromosome 11', 3),
(7173, 'ORPHA:263044', 'UPD(13)', 3),
(7174, 'ORPHA:263044', 'Uniparental disomy of chromosome 13', 3),
(7175, 'ORPHA:263049', 'UPD(14)', 3),
(7176, 'ORPHA:263049', 'Uniparental disomy of chromosome 14', 3),
(7177, 'ORPHA:263054', 'UPD(15)', 3),
(7178, 'ORPHA:263054', 'Uniparental disomy of chromosome 15', 3),
(7179, 'ORPHA:263059', 'UPD(20)', 3),
(7180, 'ORPHA:263059', 'Uniparental disomy of chromosome 20', 3),
(7181, 'ORPHA:263064', 'UPD(21)', 3),
(7182, 'ORPHA:263064', 'Uniparental disomy of chromosome 21', 3),
(7183, 'ORPHA:2631', 'Mesomelic dwarfism-cleft palate-camptodactyly syndrome', 1),
(7184, 'ORPHA:2631', 'Mesomelic dysplasia, Kozlowski-Reardon type', 1),
(7185, 'ORPHA:2631', 'Mesomelic dysplasia, Reardon type', 1),
(7186, 'ORPHA:2631', 'Reardon-Hall-Slaney syndrome', 1),
(7187, 'ORPHA:2632', 'Langer mesomelic dysplasia', 1),
(7188, 'ORPHA:2632', 'Mesomelic dwarfism, Langer type', 1),
(7189, 'ORPHA:263297', 'GSD type 15', 1),
(7190, 'ORPHA:263297', 'GSD type XV', 1),
(7191, 'ORPHA:263297', 'GSD with severe cardiomyopathy due to glycogenin deficiency', 1),
(7192, 'ORPHA:263297', 'Glycogen storage disease type 15', 1),
(7193, 'ORPHA:263297', 'Glycogen storage disease type XV', 1),
(7194, 'ORPHA:263297', 'Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency', 1),
(7195, 'ORPHA:263297', 'Glycogenosis type 15', 1),
(7196, 'ORPHA:263297', 'Glycogenosis type XV', 1),
(7197, 'ORPHA:263297', 'Glycogenosis with severe cardiomyopathy due to glycogenin deficiency', 1),
(7198, 'ORPHA:2633', 'Mesomelic dwarfism, Nievergelt type', 1),
(7199, 'ORPHA:2633', 'Mesomelic dysplasia, Nievergelt type', 1),
(7200, 'ORPHA:2633', 'Nievergelt syndrome', 1),
(7201, 'ORPHA:263310', 'Primary thymic epithelial neoplasm type A', 2),
(7202, 'ORPHA:263310', 'Primary thymic epithelial tumor type A', 2),
(7203, 'ORPHA:263310', 'Thymoma type A', 2),
(7204, 'ORPHA:263317', 'Primary thymic epithelial neoplasm type B', 2),
(7205, 'ORPHA:263317', 'Primary thymic epithelial tumor type B', 2),
(7206, 'ORPHA:263317', 'Thymoma type B', 2),
(7207, 'ORPHA:263324', 'Primary thymic epithelial neoplasm type AB', 2),
(7208, 'ORPHA:263324', 'Primary thymic epithelial tumor type AB', 2),
(7209, 'ORPHA:263324', 'Thymoma type AB', 2),
(7210, 'ORPHA:263331', 'Well-differentiated thymic neuroendocrine carcinoma', 2),
(7211, 'ORPHA:263335', 'Moderately-differentiated thymic neuroendocrine carcinoma', 2),
(7212, 'ORPHA:263339', 'Poorly differentiated thymic neuroendocrine carcinoma', 2),
(7213, 'ORPHA:263347', 'MRCS syndrome', 1),
(7214, 'ORPHA:263347', 'Microcornea-rod-cone dystrophy-cataract-posterior staphyloma syndrome', 1),
(7215, 'ORPHA:263352', 'Postcardiotomy right ventricular failure', 1),
(7216, 'ORPHA:263355', 'ATR-X-related syndrome', 3),
(7217, 'ORPHA:2634', 'Mesomelic dwarfism, Reinhardt-Pfeiffer type', 1),
(7218, 'ORPHA:2634', 'Reinhardt-Pfeiffer mesomelic dysplasia', 1),
(7219, 'ORPHA:2634', 'Reinhardt-Pfeiffer syndrome', 1),
(7220, 'ORPHA:263410', 'Infantile spasms-psychomotor retardation-progressive brain atrophy-basal ganglia disease syndrome', 1),
(7221, 'ORPHA:263413', 'Angiosarcoma', 1),
(7222, 'ORPHA:263425', 'Nevus fusculoceruleus ophthalmomaxillaris', 1),
(7223, 'ORPHA:263425', 'Nevus of Ota', 1),
(7224, 'ORPHA:263432', 'Nevus fuscocaeruleus acromiodeltoideus', 1),
(7225, 'ORPHA:263432', 'Nevus of Ito', 1),
(7226, 'ORPHA:263435', 'Congenital smooth muscle hamartoma', 1),
(7227, 'ORPHA:263440', 'Neuroacanthocytosis', 3),
(7228, 'ORPHA:263455', 'Hyperinsulinemic hypoglycemia due to HNF4A deficiency', 1),
(7229, 'ORPHA:263455', 'Hyperinsulinism due to HNF4A deficiency', 1),
(7230, 'ORPHA:263458', 'Hyperinsulinemic hypoglycemia due to INSR deficiency', 1),
(7231, 'ORPHA:263458', 'Hyperinsulinemic hypoglycemia due to insulin receptor deficiency', 1),
(7232, 'ORPHA:263458', 'Hyperinsulinism due to INSR deficiency', 1),
(7233, 'ORPHA:263463', 'CHST3-related skeletal dysplasia', 1),
(7234, 'ORPHA:263463', 'Chondrodysplasia with congenital joint dislocations, CHST3 type', 1),
(7235, 'ORPHA:263463', 'SDCD, CHST3 type', 1),
(7236, 'ORPHA:263463', 'Spondyloepiphyseal dysplasia with congenital joint dyslocations, CHST3 type', 1),
(7237, 'ORPHA:263479', 'FHI', 1),
(7238, 'ORPHA:263479', 'Fuchs heterochromic iridocyclitis', 1),
(7239, 'ORPHA:26348', 'Acquired hypoprothrombinemia', 1),
(7240, 'ORPHA:26348', 'Acquired prothrombin deficiency', 1),
(7241, 'ORPHA:263482', 'Pseudo-Morquio syndrome type 2', 1),
(7242, 'ORPHA:263482', 'Spondyloepiphyseal dysplasia, Maroteaux type', 1),
(7243, 'ORPHA:263487', 'CDG syndrome type IIi', 1),
(7244, 'ORPHA:263487', 'CDG-IIi', 1),
(7245, 'ORPHA:263487', 'CDG2I', 1),
(7246, 'ORPHA:263487', 'COG5-CDG', 1),
(7247, 'ORPHA:263487', 'Carbohydrate deficient glycoprotein syndrome type IIi', 1),
(7248, 'ORPHA:263487', 'Congenital disorder of glycosylation type 2i', 1),
(7249, 'ORPHA:263487', 'Congenital disorder of glycosylation type IIi', 1),
(7250, 'ORPHA:26349', 'Protein S acquired deficiency', 1),
(7251, 'ORPHA:263494', 'CDG syndrome type Io', 1),
(7252, 'ORPHA:263494', 'CDG-Io', 1),
(7253, 'ORPHA:263494', 'CDG1O', 1),
(7254, 'ORPHA:263494', 'Carbohydrate deficient glycoprotein syndrome type Io', 1),
(7255, 'ORPHA:263494', 'Congenital disorder of glycosylation type 1o', 1),
(7256, 'ORPHA:263494', 'Congenital disorder of glycosylation type Io', 1),
(7257, 'ORPHA:263494', 'DPM3-CDG', 1),
(7258, 'ORPHA:2635', 'Metatropic dwarfism', 1),
(7259, 'ORPHA:2635', 'Metatropic dysplasia', 1),
(7260, 'ORPHA:263501', 'CDG syndrome type IIj', 1),
(7261, 'ORPHA:263501', 'CDG-IIj', 1),
(7262, 'ORPHA:263501', 'CDG2J', 1),
(7263, 'ORPHA:263501', 'COG4-CDG', 1),
(7264, 'ORPHA:263501', 'Carbohydrate deficient glycoprotein syndrome type IIj', 1),
(7265, 'ORPHA:263501', 'Congenital disorder of glycosylation type 2j', 1),
(7266, 'ORPHA:263501', 'Congenital disorder of glycosylation type IIj', 1),
(7267, 'ORPHA:263508', 'CDG syndrome type IIg', 1),
(7268, 'ORPHA:263508', 'CDG-IIg', 1),
(7269, 'ORPHA:263508', 'CDG2G', 1),
(7270, 'ORPHA:263508', 'COG1-CDG', 1),
(7271, 'ORPHA:263508', 'Carbohydrate deficient glycoprotein syndrome type IIg', 1),
(7272, 'ORPHA:263508', 'Congenital disorder of glycosylation type 2g', 1),
(7273, 'ORPHA:263508', 'Congenital disorder of glycosylation type IIg', 1),
(7274, 'ORPHA:263516', 'CLN14 disease', 2),
(7275, 'ORPHA:263516', 'EPM3', 2),
(7276, 'ORPHA:263516', 'PME type 3', 2),
(7277, 'ORPHA:263516', 'Progressive myoclonic epilepsy due to KCTD7 deficiency', 2),
(7278, 'ORPHA:263516', 'Progressive myoclonic epilepsy type 3', 2),
(7279, 'ORPHA:263516', 'Progressive myoclonus epilepsy type 3', 2),
(7280, 'ORPHA:263524', 'ANEC', 1),
(7281, 'ORPHA:263524', 'Acute necrotizing encephalopathy of childhood', 1),
(7282, 'ORPHA:263524', 'Isolated ANE', 1),
(7283, 'ORPHA:263524', 'Isolated acute necrotizing encephalopathy', 1),
(7284, 'ORPHA:263534', 'Acral PSS', 1),
(7285, 'ORPHA:263534', 'Acral deciduous skin', 1),
(7286, 'ORPHA:263534', 'Acral peeling skin syndrome', 1),
(7287, 'ORPHA:263534', 'Localized PSS', 1),
(7288, 'ORPHA:263534', 'Localized deciduous skin', 1),
(7289, 'ORPHA:263543', 'Generalized PSS', 1),
(7290, 'ORPHA:263543', 'Generalized deciduous skin', 1),
(7291, 'ORPHA:263543', 'Generalized peeling skin syndrome', 1),
(7292, 'ORPHA:263548', 'Generalized deciduous skin type A', 2),
(7293, 'ORPHA:263548', 'Generalized peeling skin syndrome type A', 2),
(7294, 'ORPHA:263548', 'Non-inflammatory generalized peeling skin syndrome type A.', 2),
(7295, 'ORPHA:263548', 'Non-inflammatory peeling skin syndrome type A', 2),
(7296, 'ORPHA:263548', 'PSS type A', 2),
(7297, 'ORPHA:263548', 'Peeling skin syndrome type A', 2),
(7298, 'ORPHA:263553', 'Generalized deciduous skin type B', 2),
(7299, 'ORPHA:263553', 'Generalized peeling skin syndrome type B', 2),
(7300, 'ORPHA:263553', 'Inflammatory peeling skin syndrome', 2),
(7301, 'ORPHA:263553', 'PSS type B', 2),
(7302, 'ORPHA:263553', 'Peeling skin syndrome type B', 2),
(7303, 'ORPHA:263558', 'Generalized deciduous skin type C', 2),
(7304, 'ORPHA:263558', 'Generalized peeling skin syndrome type C', 2),
(7305, 'ORPHA:263558', 'Peeling skin syndrome type C', 2),
(7306, 'ORPHA:2636', 'MOPD types I and III', 1),
(7307, 'ORPHA:2636', 'Microcephalic osteodysplastic primordial dwarfism types I and III', 1),
(7308, 'ORPHA:2636', 'Microcephalic osteodysplastic primordial dwarfism, Taybi-Linder type', 1),
(7309, 'ORPHA:2636', 'Primordial microcephalic dwarfism, Crachami type', 1),
(7310, 'ORPHA:2636', 'Taybi-Linder syndrome', 1),
(7311, 'ORPHA:263662', 'Familial multiple meningioma', 1),
(7312, 'ORPHA:263665', 'NK-cell enteropathy', 1),
(7313, 'ORPHA:2637', 'MOPD type II', 1),
(7314, 'ORPHA:2637', 'Majewski osteodysplastic primordial dwarfism type II', 1),
(7315, 'ORPHA:2637', 'Microcephalic osteodysplastic primordial dwarfism type II', 1),
(7316, 'ORPHA:263708', 'Complex chromosomal rearrangement', 3),
(7317, 'ORPHA:263711', 'X chromosome anomaly', 3),
(7318, 'ORPHA:263714', 'X chromosome number anomaly', 3),
(7319, 'ORPHA:263717', 'X chromosome number anomaly with female phenotype', 3),
(7320, 'ORPHA:263720', 'X chromosome number anomaly with male phenotype', 3),
(7321, 'ORPHA:263723', 'Polysomy of X chromosome', 3),
(7322, 'ORPHA:263726', 'Partial deletion of chromosome X', 3),
(7323, 'ORPHA:263726', 'Partial monosomy of chromosome X', 3),
(7324, 'ORPHA:263731', 'Partial deletion of chromosome Xp', 3),
(7325, 'ORPHA:263731', 'Partial deletion of the short arm of chromosome X', 3),
(7326, 'ORPHA:263731', 'Partial monosomy of chromosome Xp', 3),
(7327, 'ORPHA:263731', 'Partial monosomy of the short arm of chromosome X', 3),
(7328, 'ORPHA:263746', 'Y chromosome number anomaly', 3),
(7329, 'ORPHA:263749', 'X and Y chromosomal anomaly', 3),
(7330, 'ORPHA:263756', 'Partial deletion of chromosome Xq', 3),
(7331, 'ORPHA:263756', 'Partial deletion of the long arm of chromosome X', 3),
(7332, 'ORPHA:263756', 'Partial monosomy of chromosome Xq', 3),
(7333, 'ORPHA:263756', 'Partial monosomy of the long arm of chromosome X', 3),
(7334, 'ORPHA:263768', 'Partial duplication of chromosome X', 3),
(7335, 'ORPHA:263768', 'Partial trisomy of chromosome X', 3),
(7336, 'ORPHA:263775', 'Partial duplication of chromosome Xp', 3),
(7337, 'ORPHA:263775', 'Partial duplication of the short arm of chromosome X', 3),
(7338, 'ORPHA:263775', 'Partial trisomy of  chromosome Xp', 3),
(7339, 'ORPHA:263775', 'Partial trisomy of the short arm of chromosome X', 3),
(7340, 'ORPHA:263783', 'Partial duplication of chromosome Xq', 3),
(7341, 'ORPHA:263783', 'Partial duplication of the long arm of chromosome X', 3),
(7342, 'ORPHA:263783', 'Partial trisomy of  chromosome Xq', 3),
(7343, 'ORPHA:263783', 'Partial trisomy of the long arm of chromosome X', 3),
(7344, 'ORPHA:263793', 'UPD(X)', 3),
(7345, 'ORPHA:263793', 'Uniparental disomy of chromosome X', 3),
(7346, 'ORPHA:263798', 'Y chromosomal anomaly', 3),
(7347, 'ORPHA:2639', 'Du Pan syndrome', 1),
(7348, 'ORPHA:2639', 'Fibular aplasia-complex brachydactyly syndrome', 1),
(7349, 'ORPHA:264200', '14q22-q23 microdeletion syndrome', 1),
(7350, 'ORPHA:264200', '14q22q23 microdeletion syndrome', 1),
(7351, 'ORPHA:264200', 'Del(14)(q22q23)', 1),
(7352, 'ORPHA:264200', 'Monosomy 14q22-q23', 1),
(7353, 'ORPHA:264200', 'Monosomy 14q22q23', 1),
(7354, 'ORPHA:2643', 'Microcephalic primordial dwarfism, Toriello type', 1),
(7355, 'ORPHA:264431', 'Partial duplication of chromosome 1p', 3),
(7356, 'ORPHA:264431', 'Partial duplication of the short arm of chromosome 1', 3),
(7357, 'ORPHA:264431', 'Partial trisomy of chromosome 1p', 3),
(7358, 'ORPHA:264450', 'Duplication 8p', 1),
(7359, 'ORPHA:264450', 'Trisomy 8p', 1),
(7360, 'ORPHA:2645', 'Osteoglophonic dwarfism', 1),
(7361, 'ORPHA:2645', 'Osteoglosphonic dysplasia', 1),
(7362, 'ORPHA:264580', 'GSD due to liver phosphorylase kinase deficiency', 1),
(7363, 'ORPHA:264580', 'GSD type 9A', 1),
(7364, 'ORPHA:264580', 'GSD type 9C', 1),
(7365, 'ORPHA:264580', 'GSD type IXa', 1),
(7366, 'ORPHA:264580', 'GSD type IXc', 1),
(7367, 'ORPHA:264580', 'Glycogen storage disease due to liver phosphorylase kinase deficiency', 1),
(7368, 'ORPHA:264580', 'Glycogen storage disease type 9A', 1),
(7369, 'ORPHA:264580', 'Glycogen storage disease type 9C', 1),
(7370, 'ORPHA:264580', 'Glycogen storage disease type IXa', 1),
(7371, 'ORPHA:264580', 'Glycogen storage disease type IXc', 1),
(7372, 'ORPHA:264580', 'Glycogenosis due to liver phosphorylase kinase deficiency', 1),
(7373, 'ORPHA:264580', 'Glycogenosis type 9A', 1),
(7374, 'ORPHA:264580', 'Glycogenosis type 9C', 1),
(7375, 'ORPHA:264580', 'Glycogenosis type IXa', 1),
(7376, 'ORPHA:264580', 'Glycogenosis type IXc', 1),
(7377, 'ORPHA:264580', 'XLG', 1),
(7378, 'ORPHA:2646', 'Parastremmatic dwarfism', 1),
(7379, 'ORPHA:264656', 'ILD specific to childhood', 3),
(7380, 'ORPHA:264656', 'Interstitial lung disease specific to childhood', 3),
(7381, 'ORPHA:264665', 'Primary ILD specific to childhood', 3),
(7382, 'ORPHA:264665', 'Primary interstitial lung disease specific to childhood', 3),
(7383, 'ORPHA:264670', 'Primary ILD specific to childhood due to alveolar structure disorder', 3),
(7384, 'ORPHA:264670', 'Primary interstitial lung disease specific to childhood due to alveolar structure disorder', 3),
(7385, 'ORPHA:264675', 'Congenital PAP', 1),
(7386, 'ORPHA:264675', 'Congenital pulmonary alveolar proteinosis', 1),
(7387, 'ORPHA:264675', 'Hereditary pulmonary alveolar proteinosis', 1),
(7388, 'ORPHA:264683', 'Primary ILD specific to childhood due to alveolar vascular disorder', 3),
(7389, 'ORPHA:264683', 'Primary interstitial lung disease specific to childhood due to alveolar vascular disorder', 3),
(7390, 'ORPHA:264688', 'Congenital chylothorax', 1),
(7391, 'ORPHA:264691', 'Isolated pulmonary capillaritis', 1),
(7392, 'ORPHA:264694', 'ILD specific to infancy', 3),
(7393, 'ORPHA:264694', 'Interstitial lung disease specific to infancy', 3),
(7394, 'ORPHA:264699', 'Secondary  ILD specific to childhood associated with a systemic disease', 3),
(7395, 'ORPHA:264699', 'Secondary interstitial lung disease specific to childhood associated with a systemic disease', 3),
(7396, 'ORPHA:264704', 'Secondary  ILD specific to childhood associated with a connective tissue disease', 3),
(7397, 'ORPHA:264704', 'Secondary interstitial lung disease specific to childhood associated with a connective tissue disease', 3),
(7398, 'ORPHA:264709', 'Secondary ILD specific to childhood associated with a systemic vasculitis', 3),
(7399, 'ORPHA:264709', 'Secondary interstitial lung disease specific to childhood associated with a systemic vasculitis', 3),
(7400, 'ORPHA:264714', 'Secondary ILD specific to childhood associated with a granulomatous disease', 3),
(7401, 'ORPHA:264714', 'Secondary interstitial lung disease specific to childhood associated with a granulomatous disease', 3),
(7402, 'ORPHA:264719', 'Secondary ILD specific to childhood associated with a metabolic disease', 3),
(7403, 'ORPHA:264719', 'Secondary interstitial lung disease specific to childhood associated with a metabolic disease', 3),
(7404, 'ORPHA:264735', 'ILD specific to adulthood', 3),
(7405, 'ORPHA:264735', 'Interstitial lung disease specific to adulthood', 3),
(7406, 'ORPHA:264740', 'Primary ILD specific to adulthood', 3),
(7407, 'ORPHA:264740', 'Primary interstitial lung disease specific to adulthood', 3),
(7408, 'ORPHA:264745', 'Secondary ILD specific to adulthood associated with a systemic disease', 3),
(7409, 'ORPHA:264745', 'Secondary interstitial lung disease specific to adulthood associated with a systemic disease', 3),
(7410, 'ORPHA:264757', 'ILD in childhood and adulthood', 3),
(7411, 'ORPHA:264757', 'Interstitial lung disease in childhood and adulthood', 3),
(7412, 'ORPHA:264762', 'Primary ILD in childhood and adulthood', 3),
(7413, 'ORPHA:264762', 'Primary interstitial lung disease in childhood and adulthood', 3),
(7414, 'ORPHA:264930', 'Primary ILD in childhood and adulthood due to alveolar structure disorder', 3),
(7415, 'ORPHA:264930', 'Primary interstitial lung disease in childhood and adulthood due to alveolar structure disorder', 3),
(7416, 'ORPHA:264935', 'Primary ILD in childhood and adulthood due to alveolar vascular disorder', 3),
(7417, 'ORPHA:264935', 'Primary interstitial lung disease in childhood and adulthood due to alveolar vascular disorder', 3),
(7418, 'ORPHA:264944', 'Secondary ILD in childhood and adulthood', 3),
(7419, 'ORPHA:264944', 'Secondary interstitial lung disease in childhood and adulthood', 3),
(7420, 'ORPHA:264949', 'Secondary ILD in childhood and adulthood associated with a systemic disease', 3),
(7421, 'ORPHA:264949', 'Secondary interstitial lung disease in childhood and adulthood associated with a systemic disease', 3),
(7422, 'ORPHA:264968', 'Secondary ILD in childhood and adulthood associated with a metabolic disease', 3),
(7423, 'ORPHA:264968', 'Secondary interstitial lung disease in childhood and adulthood associated with a metabolic disease', 3),
(7424, 'ORPHA:264973', 'Secondary ILD in childhood and adulthood associated with a systemic vasculitis', 3),
(7425, 'ORPHA:264973', 'Secondary interstitial lung disease in childhood and adulthood associated with a systemic vasculitis', 3),
(7426, 'ORPHA:264978', 'Drug or radiation exposure-related interstitial lung disease', 1),
(7427, 'ORPHA:264984', 'Exposure-related interstitial lung disease', 3),
(7428, 'ORPHA:264992', 'Genetic ILD', 3),
(7429, 'ORPHA:264992', 'Genetic interstitial lung disease', 3),
(7430, 'ORPHA:2653', 'Osteochondrodysplatic dwarfism-deafness-retinitis pigmentosa syndrome', 1),
(7431, 'ORPHA:2653', 'Osteochondrodysplatic dwarfism-hearing loss-retinitis pigmentosa syndrome', 1),
(7432, 'ORPHA:2653', 'Osteochondrodysplatic nanism-deafness-retinitis pigmentosa syndrome', 1),
(7433, 'ORPHA:2653', 'Osteochondrodysplatic nanism-hearing loss-retinitis pigmentosa syndrome', 1),
(7434, 'ORPHA:2655', 'TD', 1),
(7435, 'ORPHA:2655', 'Thanatophoric dysplasia', 1),
(7436, 'ORPHA:2658', 'Lenz-Majewski hyperostotic dwarfism', 1),
(7437, 'ORPHA:266', 'Autosomal dominant limb-girdle muscular dystrophy type 1A', 1),
(7438, 'ORPHA:266', 'LGMD1A', 1),
(7439, 'ORPHA:266', 'Limb-girdle muscular dystrophy due to myotilin deficiency', 1),
(7440, 'ORPHA:2662', 'Keipert syndrome', 1),
(7441, 'ORPHA:2662', 'Nasodigitoacoustic syndrome', 1),
(7442, 'ORPHA:2663', 'Deafness-cataract-skeletal anomalies syndrome', 1),
(7443, 'ORPHA:2663', 'Nathalie syndrome', 1),
(7444, 'ORPHA:2663', 'Sensorineural hearing loss-cataract-skeletal anomalies-cardiomyopathy syndrome', 1),
(7445, 'ORPHA:2665', 'Congenital mesoblastic nephroma', 1),
(7446, 'ORPHA:2666', 'Adult familial nephronophthisis-spastic quadriparesia syndrome', 1),
(7447, 'ORPHA:2668', 'Edwards-Patton-Dilly syndrome', 1),
(7448, 'ORPHA:2668', 'Nephropathy-deafness-hyperparathyroidism syndrome', 1),
(7449, 'ORPHA:2668', 'Nephropathy-hearing loss-hyperparathyroidism syndrome', 1),
(7450, 'ORPHA:2669', 'Braun-Bayer syndrome', 1),
(7451, 'ORPHA:2669', 'Nephrosis-deafness-urinary tract-digital malformations syndrome', 1),
(7452, 'ORPHA:2669', 'Nephrosis-hearing loss-urinary tract-digital malformations syndrome', 1),
(7453, 'ORPHA:267', 'Autosomal recessive limb-girdle muscular dystrophy type 2A', 1),
(7454, 'ORPHA:267', 'Calpain-3-related  limb-girdle muscular dystrophy R1', 1),
(7455, 'ORPHA:267', 'Calpain-3-related LGMD R1', 1),
(7456, 'ORPHA:267', 'LGMD type 2A', 1),
(7457, 'ORPHA:267', 'LGMD2A', 1),
(7458, 'ORPHA:267', 'Limb-girdle muscular dystrophy due to calpain deficiency', 1),
(7459, 'ORPHA:267', 'Limb-girdle muscular dystrophy type 2A', 1),
(7460, 'ORPHA:267', 'Primary calpainopathy', 1),
(7461, 'ORPHA:2670', 'Microcoria-congenital nephrosis syndrome', 1),
(7462, 'ORPHA:2670', 'Pierson syndrome', 1),
(7463, 'ORPHA:2671', 'Neu-Laxova syndrome', 1),
(7464, 'ORPHA:2672', 'Neuhauser-Eichner-Opitz syndrome', 1),
(7465, 'ORPHA:2672', 'Recurrent encephalophathy of childhood', 1),
(7466, 'ORPHA:2673', 'Freire Maia-Pinheiro-Opitz syndrome', 1),
(7467, 'ORPHA:2673', 'Neurofaciodigitorenal syndrome', 1),
(7468, 'ORPHA:2674', 'Cyprus facial-neuromusculoskeletal syndrome', 1),
(7469, 'ORPHA:2678', 'Familial café-au-lait spots', 1),
(7470, 'ORPHA:2678', 'Multiple café-au-lait spots', 1),
(7471, 'ORPHA:2678', 'Multiple café-au-lait syndrome', 1),
(7472, 'ORPHA:2678', 'NF6', 1),
(7473, 'ORPHA:2678', 'Neurofibromatosis type 6', 1),
(7474, 'ORPHA:26790', 'Adenomucinosis', 1),
(7475, 'ORPHA:26790', 'Gelatinous ascites', 1),
(7476, 'ORPHA:26790', 'PMP', 1),
(7477, 'ORPHA:26790', 'Pseudomyxoma peritonei', 1),
(7478, 'ORPHA:26791', 'Glutaric acidemia type 2', 1),
(7479, 'ORPHA:26791', 'Glutaric aciduria type 2', 1),
(7480, 'ORPHA:26791', 'MAD deficiency', 1),
(7481, 'ORPHA:26791', 'MADD', 1),
(7482, 'ORPHA:26791', 'Multiple acyl-CoA dehydrogenase deficiency', 1),
(7483, 'ORPHA:26792', 'ACADS deficiency', 1),
(7484, 'ORPHA:26792', 'SCAD deficiency', 1),
(7485, 'ORPHA:26792', 'SCADD', 1),
(7486, 'ORPHA:26792', 'Short chain acyl-CoA dehydrogenase deficiency', 1),
(7487, 'ORPHA:26793', 'VLCAD deficiency', 1),
(7488, 'ORPHA:26793', 'VLCADD', 1),
(7489, 'ORPHA:26793', 'Very long chain acyl-CoA dehydrogenase deficiency', 1),
(7490, 'ORPHA:268', 'Autosomal recessive limb-girdle muscular dystrophy type 2B', 1),
(7491, 'ORPHA:268', 'Dysferlin-related  limb-girdle muscular dystrophy R2', 1),
(7492, 'ORPHA:268', 'Dysferlin-related LGMD R2', 1),
(7493, 'ORPHA:268', 'LGMD due to dysferlin deficiency', 1),
(7494, 'ORPHA:268', 'LGMD type 2B', 1),
(7495, 'ORPHA:268', 'LGMD2B', 1),
(7496, 'ORPHA:268', 'Limb-girdle muscular dystrophy due to dysferlin deficiency', 1),
(7497, 'ORPHA:268', 'Limb-girdle muscular dystrophy type 2B', 1),
(7498, 'ORPHA:2680', 'Hypomyelination neuropathy-arthrogryposis syndrome', 1),
(7499, 'ORPHA:268114', 'RALD', 1),
(7500, 'ORPHA:268114', 'RAS-associated autoimmune leukoproliferative disease', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(7501, 'ORPHA:268129', 'Spheroid body myopathy', 1),
(7502, 'ORPHA:268139', 'Intraocular medulloepithelioma', 1),
(7503, 'ORPHA:268139', 'Orbital medulloepithelioma', 1),
(7504, 'ORPHA:268145', 'Classic BCKD deficiency', 2),
(7505, 'ORPHA:268145', 'Classic MSUD', 2),
(7506, 'ORPHA:268145', 'Classic branched-chain alpha-ketoacid dehydrogenase deficiency', 2),
(7507, 'ORPHA:268145', 'Classic branched-chain ketoaciduria', 2),
(7508, 'ORPHA:268145', 'Classic maple syrup urine disease', 2),
(7509, 'ORPHA:268162', 'Intermediate BCKD deficiency', 2),
(7510, 'ORPHA:268162', 'Intermediate MSUD', 2),
(7511, 'ORPHA:268162', 'Intermediate branched-chain alpha-ketoacid dehydrogenase deficiency', 2),
(7512, 'ORPHA:268162', 'Intermediate maple syrup urine disease', 2),
(7513, 'ORPHA:268173', 'Intermittent BCKD deficiency', 2),
(7514, 'ORPHA:268173', 'Intermittent MSUD', 2),
(7515, 'ORPHA:268173', 'Intermittent branched-chain alpha-ketoacid dehydrogenase deficiency', 2),
(7516, 'ORPHA:268173', 'Intermittent maple syrup urine disease', 2),
(7517, 'ORPHA:268184', 'Thiamine-responsive BCKD deficiency', 2),
(7518, 'ORPHA:268184', 'Thiamine-responsive MSUD', 2),
(7519, 'ORPHA:268184', 'Thiamine-responsive branched-chain alpha-ketoacid dehydrogenase deficiency', 2),
(7520, 'ORPHA:268184', 'Thiamine-responsive maple syrup urine disease', 2),
(7521, 'ORPHA:268249', 'MMF embryopathy', 1),
(7522, 'ORPHA:268249', 'Mycophenolate mofetil embryopathy', 1),
(7523, 'ORPHA:268261', '21q22.13q22.2 microdeletion syndrome', 2),
(7524, 'ORPHA:268261', 'DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion', 2),
(7525, 'ORPHA:268261', 'Del(21)(q22.13q22.2)', 2),
(7526, 'ORPHA:268261', 'Monosomy 21q22.13q22.2', 2),
(7527, 'ORPHA:268316', 'Complication in hemodialysis', 1),
(7528, 'ORPHA:268322', 'Hereditary thrombocytopenia with normal platelets', 1),
(7529, 'ORPHA:268337', 'Autosomal recessive intermediate Charcot-Marie-Tooth disease', 3),
(7530, 'ORPHA:268337', 'RI-CMT', 3),
(7531, 'ORPHA:268357', 'Neural tube closure defect', 3),
(7532, 'ORPHA:268363', 'Open iniencephaly', 2),
(7533, 'ORPHA:268366', 'Closed iniencephaly', 2),
(7534, 'ORPHA:268369', 'Spina bifida aperta', 1),
(7535, 'ORPHA:268377', 'Total spina bifida aperta', 2),
(7536, 'ORPHA:268384', 'Thoracolumbosacral spina bifida aperta', 2),
(7537, 'ORPHA:268388', 'Lumbosacral spina bifida aperta', 2),
(7538, 'ORPHA:268392', 'Cervical spina bifida aperta', 2),
(7539, 'ORPHA:268397', 'Cervicothoracic spina bifida aperta', 2),
(7540, 'ORPHA:2686', 'Cyclic neutropenia', 1),
(7541, 'ORPHA:268740', 'Upper thoracic spina bifida aperta', 2),
(7542, 'ORPHA:268744', 'Spina bifida cystica', 3),
(7543, 'ORPHA:268748', 'Total spina bifida cystica', 2),
(7544, 'ORPHA:268752', 'Thoracolumbosacral spina bifida cystica', 2),
(7545, 'ORPHA:268758', 'Lumbosacral spina bifida cystica', 2),
(7546, 'ORPHA:268762', 'Cervical spina bifida cystica', 2),
(7547, 'ORPHA:268766', 'Cervicothoracic spina bifida cystica', 2),
(7548, 'ORPHA:268770', 'Upper thoracic spina bifida cystica', 2),
(7549, 'ORPHA:2688', 'Adult chronic idiopathic neutropenia', 1),
(7550, 'ORPHA:2688', 'Adult idiopathic neutropenia', 1),
(7551, 'ORPHA:268810', 'Posterior meningocele', 1),
(7552, 'ORPHA:268813', 'Myelocystocele', 1),
(7553, 'ORPHA:268817', 'Cephalocele', 3),
(7554, 'ORPHA:268820', 'Cranial meningocele', 1),
(7555, 'ORPHA:268823', 'Occipital encephalocele', 2),
(7556, 'ORPHA:268826', 'Parietal encephalocele', 2),
(7557, 'ORPHA:268829', 'Basal encephalocele', 2),
(7558, 'ORPHA:268832', 'Lipoma associated with neurospinal dysraphism', 3),
(7559, 'ORPHA:268835', 'Lipomyelomeningocele', 1),
(7560, 'ORPHA:268838', 'Leptomyelolipoma', 1),
(7561, 'ORPHA:268843', 'Malformation of the neurenteric canal, spinal cord and column', 3),
(7562, 'ORPHA:268861', 'Primary tethered cord syndrome', 1),
(7563, 'ORPHA:268861', 'Primary tethered spinal cord syndrome', 1),
(7564, 'ORPHA:268865', 'Neurenteric cyst', 1),
(7565, 'ORPHA:268868', 'Isolated amyelia', 1),
(7566, 'ORPHA:268882', 'Arnold-Chiari malformation type 1', 1),
(7567, 'ORPHA:268882', 'Arnold-Chiari malformation type I', 1),
(7568, 'ORPHA:268882', 'Chiari malformation type 1', 1),
(7569, 'ORPHA:268882', 'Chiari malformation type I', 1),
(7570, 'ORPHA:268920', 'Isolated macrencephaly', 2),
(7571, 'ORPHA:268920', 'Isolated megalencephaly', 2),
(7572, 'ORPHA:268926', 'Midline brain malformation', 3),
(7573, 'ORPHA:268926', 'Midline cerebral malformation', 3),
(7574, 'ORPHA:268936', 'Isolated arhinencephaly', 1),
(7575, 'ORPHA:268940', 'Bilateral polymicrogyria', 1),
(7576, 'ORPHA:268943', 'Unilateral polymicrogyria', 1),
(7577, 'ORPHA:268947', 'Unilateral focal polymicrogyria', 2),
(7578, 'ORPHA:268950', 'Brain cortical dysplasia', 3),
(7579, 'ORPHA:268950', 'Cerebral cortical dysplasia', 3),
(7580, 'ORPHA:268961', 'FCD type I', 2),
(7581, 'ORPHA:268961', 'Isolated focal cortical dysplasia type I', 2),
(7582, 'ORPHA:268973', 'FCD type Ia', 2),
(7583, 'ORPHA:268973', 'Isolated focal cortical dysplasia type Ia', 2),
(7584, 'ORPHA:268980', 'FCD type Ib', 2),
(7585, 'ORPHA:268980', 'Isolated focal cortical dysplasia type Ib', 2),
(7586, 'ORPHA:268987', 'FCD type Ic', 2),
(7587, 'ORPHA:268987', 'Isolated focal cortical dysplasia type Ic', 2),
(7588, 'ORPHA:268994', 'Cortical dysplasia, Taylor type', 2),
(7589, 'ORPHA:268994', 'FCD type II', 2),
(7590, 'ORPHA:268994', 'Isolated focal cortical dysplasia type 2', 2),
(7591, 'ORPHA:268994', 'Isolated focal cortical dysplasia type II', 2),
(7592, 'ORPHA:269', 'FSH dystrophy', 1),
(7593, 'ORPHA:269', 'FSHD', 1),
(7594, 'ORPHA:269', 'Facioscapulohumeral dystrophy', 1),
(7595, 'ORPHA:269', 'Facioscapulohumeral muscular dystrophy', 1),
(7596, 'ORPHA:269', 'Facioscapulohumeral myopathy', 1),
(7597, 'ORPHA:269', 'Landouzy-Dejerine dystrophy', 1),
(7598, 'ORPHA:269', 'Landouzy-Dejerine myopathy', 1),
(7599, 'ORPHA:2690', 'Neutropenia-monocytopenia-deafness syndrome', 1),
(7600, 'ORPHA:2690', 'Neutropenia-monocytopenia-hearing loss syndrome', 1),
(7601, 'ORPHA:269001', 'FCD type IIa', 2),
(7602, 'ORPHA:269001', 'Isolated focal cortical dysplasia type IIa', 2),
(7603, 'ORPHA:269008', 'FCD type IIb', 2),
(7604, 'ORPHA:269008', 'Isolated focal cortical dysplasia type IIb', 2),
(7605, 'ORPHA:269190', 'Encephaloclastic disorder', 3),
(7606, 'ORPHA:269194', 'Central nervous system cystic malformation', 3),
(7607, 'ORPHA:269197', 'Glioependymal/ependymal cyst', 1),
(7608, 'ORPHA:269203', 'Isolated cerebellar vermis agenesis', 1),
(7609, 'ORPHA:269206', 'Isolated total cerebellar vermis agenesis', 2),
(7610, 'ORPHA:269209', 'Isolated partial cerebellar vermis agenesis', 2),
(7611, 'ORPHA:269212', 'Isolated Dandy-Walker malformation with hydrocephalus', 2),
(7612, 'ORPHA:269215', 'Isolated Dandy-Walker malformation without hydrocephalus', 2),
(7613, 'ORPHA:269218', 'Isolated unilateral hemispheric cerebellar hypoplasia', 1),
(7614, 'ORPHA:269221', 'Isolated bilateral hemispheric cerebellar hypoplasia', 1),
(7615, 'ORPHA:269224', 'Diffuse cerebellar malformation', 3),
(7616, 'ORPHA:269224', 'Global cerebellar malformation', 3),
(7617, 'ORPHA:269229', 'PTCD', 1),
(7618, 'ORPHA:269229', 'Pontine tegmental cap dysplasia', 1),
(7619, 'ORPHA:2695', 'Bifid nose', 1),
(7620, 'ORPHA:269505', 'Congenital communicating hydrocephalus', 2),
(7621, 'ORPHA:269505', 'Congenital non-obstructive hydrocephalus', 2),
(7622, 'ORPHA:269510', 'Congenital non-communicating hydrocephalus', 2),
(7623, 'ORPHA:269510', 'Congenital obstructive hydrocephalus', 2),
(7624, 'ORPHA:269523', 'Syndrome with a cerebellar malformation as a major feature', 3),
(7625, 'ORPHA:269528', 'Syndrome with microcephaly as a major feature', 3),
(7626, 'ORPHA:269531', 'Other syndrome with a central nervous system malformation as a major feature', 3),
(7627, 'ORPHA:269546', 'Syndrome with a Dandy-Walker malformation as a major feature', 3),
(7628, 'ORPHA:269550', 'Genetic non-syndromic central nervous system malformation', 3),
(7629, 'ORPHA:269553', 'Genetic brain malformation', 3),
(7630, 'ORPHA:269553', 'Genetic cerebral malformation', 3),
(7631, 'ORPHA:269557', 'Genetic posterior fossa malformation', 3),
(7632, 'ORPHA:269560', 'Genetic cerebellar malformation', 3),
(7633, 'ORPHA:269564', 'Genetic syndrome with a CNS malformation as major feature', 3),
(7634, 'ORPHA:269564', 'Genetic syndrome with a central nervous system malformation as a major feature', 3),
(7635, 'ORPHA:269567', 'Genetic syndrome with a cerebellar malformation as a major feature', 3),
(7636, 'ORPHA:269570', 'Genetic syndrome with a Dandy-Walker malformation as a major feature', 3),
(7637, 'ORPHA:269573', 'Genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature', 3),
(7638, 'ORPHA:2697', 'ARC syndrome', 1),
(7639, 'ORPHA:2697', 'Arthrogryposis-renal dysfunction-cholestasis syndrome', 1),
(7640, 'ORPHA:2698', 'Bart-Pumphrey syndrome', 1),
(7641, 'ORPHA:2698', 'Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome', 1),
(7642, 'ORPHA:2698', 'Knuckle pads-leukonychia-sensorineural deafness-palmoplantar keratoderma syndrome', 1),
(7643, 'ORPHA:2698', 'Knuckle pads-leukonychia-sensorineural hearing loss-palmoplantar hyperkeratosis syndrome', 1),
(7644, 'ORPHA:2698', 'Knuckle pads-leukonychia-sensorineural hearing loss-palmoplantar keratoderma syndrome', 1),
(7645, 'ORPHA:2699', 'Median nodule of the upper lip', 1),
(7646, 'ORPHA:27', 'Methylmalonyl-CoA mutase deficiency', 1),
(7647, 'ORPHA:27', 'Methylmalonyl-Coenzyme A mutase deficiency', 1),
(7648, 'ORPHA:27', 'Vitamin B12-unresponsive methylmalonic acidemia', 1),
(7649, 'ORPHA:27', 'Vitamin B12-unresponsive methylmalonic aciduria', 1),
(7650, 'ORPHA:270', 'OPMD', 1),
(7651, 'ORPHA:270', 'Oculopharyngeal muscular dystrophy', 1),
(7652, 'ORPHA:2700', 'Cancrum oris', 1),
(7653, 'ORPHA:2700', 'Noma', 1),
(7654, 'ORPHA:2701', 'Mazzanti syndrome', 1),
(7655, 'ORPHA:2701', 'NS/LAH', 1),
(7656, 'ORPHA:2701', 'Noonan syndrome-like disorder with loose anagen hair', 1),
(7657, 'ORPHA:2703', 'Nova syndrome', 1),
(7658, 'ORPHA:2703', 'Port-wine nevi-mega cisterna magna-hydrocephalus syndrome', 1),
(7659, 'ORPHA:2704', 'Hydronephrosis-inverted smile syndrome', 1),
(7660, 'ORPHA:2704', 'Inverted smile-neurogenic bladder syndrome', 1),
(7661, 'ORPHA:2704', 'Ochoa syndrome', 1),
(7662, 'ORPHA:2704', 'Partial facial palsy with urinary abnormalities', 1),
(7663, 'ORPHA:2704', 'Urofacial syndrome', 1),
(7664, 'ORPHA:2707', 'Oculocerebrofacial syndrome, Kaufman type', 1),
(7665, 'ORPHA:2709', 'Gingival hypertrophy-corneal dystrophy', 1),
(7666, 'ORPHA:2709', 'Oculodental syndrome, Rutherfurd type', 1),
(7667, 'ORPHA:2709', 'Rutherfurd syndrome', 1),
(7668, 'ORPHA:2710', 'Meyer-Schwickerath syndrome', 1),
(7669, 'ORPHA:2710', 'ODDD syndrome', 1),
(7670, 'ORPHA:2710', 'Oculodentodigital dysplasia', 1),
(7671, 'ORPHA:2710', 'Oculodentoosseous dysplasia', 1),
(7672, 'ORPHA:2712', 'Cataract-microphthalmia-radiculomegaly-cardiac septal defect syndrome', 1),
(7673, 'ORPHA:2712', 'OFCD syndrome', 1),
(7674, 'ORPHA:2712', 'Oculofaciocardiodental syndrome', 1),
(7675, 'ORPHA:2713', 'Oculoosteocutaneous syndrome', 1),
(7676, 'ORPHA:2714', 'Oculo-palato-cerebral dwarfism', 1),
(7677, 'ORPHA:2714', 'Oculo-palato-cerebral syndrome', 1),
(7678, 'ORPHA:2715', 'Hunter-Jurenka-Thompson syndrome', 1),
(7679, 'ORPHA:2715', 'ORC syndrome', 1),
(7680, 'ORPHA:2715', 'Oculorenocerebellar syndrome', 1),
(7681, 'ORPHA:2715', 'Severe oculo-renal-cerebellar syndrome', 1),
(7682, 'ORPHA:2717', 'MOTA syndrome', 1),
(7683, 'ORPHA:2717', 'Manitoba oculotrichoanal syndrome', 1),
(7684, 'ORPHA:2717', 'Marles syndrome', 1),
(7685, 'ORPHA:2717', 'Marles-Greenberg-Persaud syndrome', 1),
(7686, 'ORPHA:2717', 'Oculotrichoanal syndrome', 1),
(7687, 'ORPHA:2718', 'Cecato de Lima-Pinheiro syndrome', 1),
(7688, 'ORPHA:2718', 'Oculotrichodysplasia', 1),
(7689, 'ORPHA:271832', 'Genetic mesenchymal tumor', 3),
(7690, 'ORPHA:271832', 'Genetic soft tissue tumor', 3),
(7691, 'ORPHA:271835', 'Genetic digestive tract tumor', 3),
(7692, 'ORPHA:271841', 'Genetic cardiac tumor', 3),
(7693, 'ORPHA:271844', 'Genetic urogenital tumor', 3),
(7694, 'ORPHA:271847', 'Genetic neuroendocrine tumor', 3),
(7695, 'ORPHA:271853', 'Genetic cardiac anomaly', 3),
(7696, 'ORPHA:271861', 'Familial TTR-related amyloidosis', 3),
(7697, 'ORPHA:271861', 'Familial transthyretin-related amyloidosis', 3),
(7698, 'ORPHA:271861', 'Hereditary ATTR amyloidosis', 3),
(7699, 'ORPHA:271870', 'Rare genetic systemic or rheumatologic disease', 3),
(7700, 'ORPHA:2719', 'Cross syndrome', 1),
(7701, 'ORPHA:2719', 'Oculocerebral hypopigmentation syndrome, Cross type', 1),
(7702, 'ORPHA:272', 'Congenital muscular dystrophy, Fukuyama type', 1),
(7703, 'ORPHA:272', 'FCMD', 1),
(7704, 'ORPHA:272', 'Fukuyama congenital muscular dystrophy', 1),
(7705, 'ORPHA:2720', 'Oculocerebral hypopigmentation syndrome, Preus type', 1),
(7706, 'ORPHA:2721', 'OODD', 1),
(7707, 'ORPHA:2721', 'Odonto-onycho-dermal dysplasia', 1),
(7708, 'ORPHA:2722', 'Odonto-onycho dysplasia-alopecia syndrome', 1),
(7709, 'ORPHA:2723', 'Freire-Maia syndrome', 1),
(7710, 'ORPHA:2723', 'Odontotrichomelic syndrome', 1),
(7711, 'ORPHA:2724', 'Boder syndrome', 1),
(7712, 'ORPHA:2724', 'Odontomatosis-aortae esophagus stenosis syndrome', 1),
(7713, 'ORPHA:2725', 'Al Gazali-Al Talabani syndrome', 1),
(7714, 'ORPHA:2725', 'Al Gazali-Lytle syndrome', 1),
(7715, 'ORPHA:2725', 'Eye defects-arachnodactyly-cardiopathy syndrome', 1),
(7716, 'ORPHA:2728', 'BMRS, Ohdo type', 1),
(7717, 'ORPHA:2728', 'Blepharophimosis syndrome, Ohdo type', 1),
(7718, 'ORPHA:2728', 'Blepharophimosis-intellectual disability syndrome, Ohdo type', 1),
(7719, 'ORPHA:2728', 'Ohdo syndrome', 1),
(7720, 'ORPHA:2728', 'Ohdo-Madokoro-Sonoda syndrome', 1),
(7721, 'ORPHA:2729', 'Okamoto syndrome', 1),
(7722, 'ORPHA:273', 'DM1', 1),
(7723, 'ORPHA:273', 'MD1', 1),
(7724, 'ORPHA:273', 'Myotonic dystrophy type 1', 1),
(7725, 'ORPHA:273', 'Steinert disease', 1),
(7726, 'ORPHA:273', 'Steinert myotonic dystrophy', 1),
(7727, 'ORPHA:2730', 'Postaxial tetramelic oligodactyly', 1),
(7728, 'ORPHA:2732', 'Olivopontocerebellar atrophy-deafness syndrome', 1),
(7729, 'ORPHA:2732', 'Olivopontocerebellar atrophy-hearing loss syndrome', 1),
(7730, 'ORPHA:2733', 'Omodysplasia', 1),
(7731, 'ORPHA:2736', 'Czeizel syndrome', 1),
(7732, 'ORPHA:2736', 'Lethal omphalocele-cleft palate syndrome', 1),
(7733, 'ORPHA:2737', 'Onchocerciasis', 1),
(7734, 'ORPHA:274', 'Bernard-Soulier syndrome', 1),
(7735, 'ORPHA:274', 'Giant platelet syndrome', 1),
(7736, 'ORPHA:274', 'Hemorrhagiparous thrombocytic dystrophy', 1),
(7737, 'ORPHA:2741', 'OMM syndrome', 1),
(7738, 'ORPHA:2741', 'Ophthalmomandibulomelic dysplasia', 1),
(7739, 'ORPHA:2741', 'Pillay syndrome', 1),
(7740, 'ORPHA:2743', 'Levic-Stefanovic-Nikolic syndrome', 1),
(7741, 'ORPHA:2743', 'Ophthalmoplegia-intellectual disability-lingua scrotalis syndrome', 1),
(7742, 'ORPHA:2744', 'HGPPS', 1),
(7743, 'ORPHA:2744', 'Horizontal gaze palsy with progressive scoliosis', 1),
(7744, 'ORPHA:2744', 'Progressive external ophthalmoplegia and scoliosis', 1),
(7745, 'ORPHA:2745', 'Hypertelorism-oesophageal abnormality-hypospadias syndrome', 1),
(7746, 'ORPHA:2745', 'Hypospadias-dysphagia syndrome', 1),
(7747, 'ORPHA:2745', 'Hypospadias-hypertelorism syndrome', 1),
(7748, 'ORPHA:2745', 'Opitz G/BBB syndrome', 1),
(7749, 'ORPHA:2745', 'Opitz syndrome', 1),
(7750, 'ORPHA:2745', 'Opitz-Frias syndrome', 1),
(7751, 'ORPHA:2746', 'Opsismodysplasia', 1),
(7752, 'ORPHA:2749', 'Oroacral syndrome', 3),
(7753, 'ORPHA:2749', 'Oromandibular-limb hypogenesis syndrome', 3),
(7754, 'ORPHA:275', 'SCID due to ARTEMIS deficiency', 1),
(7755, 'ORPHA:275', 'SCID due to DCLRE1C deficiency', 1),
(7756, 'ORPHA:275', 'SCID, Athabascan type', 1),
(7757, 'ORPHA:275', 'SCID, Athabaskan type', 1),
(7758, 'ORPHA:275', 'Severe combined immunodeficiency due to ARTEMIS deficiency', 1),
(7759, 'ORPHA:275', 'Severe combined immunodeficiency due to DCLRE1C deficiency', 1),
(7760, 'ORPHA:275', 'Severe combined immunodeficiency, Athabascan type', 1),
(7761, 'ORPHA:275', 'Severe combined immunodeficiency, Athabaskan type', 1),
(7762, 'ORPHA:2750', 'OFD1', 1),
(7763, 'ORPHA:2750', 'OFDI', 1),
(7764, 'ORPHA:2750', 'OFDSI', 1),
(7765, 'ORPHA:2750', 'Oral-facial-digital syndrome type 1', 1),
(7766, 'ORPHA:2750', 'Orofaciodigital syndrome type 1', 1),
(7767, 'ORPHA:2750', 'Papillon-Léage-Psaume syndrome', 1),
(7768, 'ORPHA:2751', 'Mohr syndrome', 1),
(7769, 'ORPHA:2751', 'OFD2', 1),
(7770, 'ORPHA:2751', 'Oral-facial-digital syndrome type 2', 1),
(7771, 'ORPHA:2751', 'Orofaciodigital syndrome type 2', 1),
(7772, 'ORPHA:2752', 'OFD3', 1),
(7773, 'ORPHA:2752', 'Oral-facial-digital syndrome type 3', 1),
(7774, 'ORPHA:2752', 'Orofaciodigital syndrome type 3', 1),
(7775, 'ORPHA:2752', 'Sugarman syndrome', 1),
(7776, 'ORPHA:2753', 'Baraitser-Burn syndrome', 1),
(7777, 'ORPHA:2753', 'Mohr-Majewski syndrome', 1),
(7778, 'ORPHA:2753', 'OFD4', 1),
(7779, 'ORPHA:2753', 'Oral-facial-digital syndrome type 4', 1),
(7780, 'ORPHA:2753', 'Orofaciodigital syndrome type 4', 1),
(7781, 'ORPHA:2754', 'Joubert syndrome with oral-facial-digital syndrome', 1),
(7782, 'ORPHA:2754', 'Joubert syndrome with orofaciodigital defect', 1),
(7783, 'ORPHA:2754', 'OFD6', 1),
(7784, 'ORPHA:2754', 'Oral-facial-digital syndrome type 6', 1),
(7785, 'ORPHA:2754', 'Orofaciodigital syndrome type 6', 1),
(7786, 'ORPHA:2754', 'Polydactyly-cleft lip/palate-psychomotor retardation syndrome', 1),
(7787, 'ORPHA:2754', 'Váradi syndrome', 1),
(7788, 'ORPHA:2754', 'Váradi-Papp syndrome', 1),
(7789, 'ORPHA:2755', 'OFD8', 1),
(7790, 'ORPHA:2755', 'Oral-facial-digital syndrome type 8', 1),
(7791, 'ORPHA:2755', 'Oral-facial-digital syndrome, Edwards type', 1),
(7792, 'ORPHA:2755', 'Orofaciodigital syndrome type 8', 1),
(7793, 'ORPHA:2755', 'Orofaciodigital syndrome, Edwards type', 1),
(7794, 'ORPHA:275517', 'ALPS with recurrent viral infections', 1),
(7795, 'ORPHA:275517', 'Autoimmune lymphoproliferative syndrome with recurrent viral infections', 1),
(7796, 'ORPHA:275517', 'CEDS', 1),
(7797, 'ORPHA:275517', 'Caspase 8 deficiency syndrome', 1),
(7798, 'ORPHA:275523', 'DALD', 1),
(7799, 'ORPHA:275523', 'Dianzani autoimmune lymphoproliferative disease', 1),
(7800, 'ORPHA:275534', 'Myostatin-related muscle hypertrophy', 1),
(7801, 'ORPHA:275543', 'CRASH syndrome', 1),
(7802, 'ORPHA:275543', 'Corpus callosum hypoplasia-retardation-adducted thumbs-spasticity-hydrocephalus syndrome', 1),
(7803, 'ORPHA:275543', 'L1 syndrome', 1),
(7804, 'ORPHA:275543', 'L1CAM syndrome', 1),
(7805, 'ORPHA:275555', 'Preeclampsia', 1),
(7806, 'ORPHA:2756', 'Figuera syndrome', 1),
(7807, 'ORPHA:2756', 'OFD10', 1),
(7808, 'ORPHA:2756', 'Oral-facial-digital syndrome type 10', 1),
(7809, 'ORPHA:2756', 'Orofaciodigital syndrome type 10', 1),
(7810, 'ORPHA:2756', 'Orofaciodigital syndrome with fibular aplasia', 1),
(7811, 'ORPHA:275729', 'Rare bleeding disorder due to a constitutional thrombocytopenia', 3),
(7812, 'ORPHA:275729', 'Rare bleeding disorder due to a quantitative platelet defect', 3),
(7813, 'ORPHA:275729', 'Rare coagulopathy due to a constitutional thrombocytopenia', 3),
(7814, 'ORPHA:275729', 'Rare coagulopathy due to a quantitative platelet defect', 3),
(7815, 'ORPHA:275729', 'Rare hemorrhagic disorder due to a constitutional thrombocytopenia', 3),
(7816, 'ORPHA:275729', 'Rare hemorrhagic disorder due to a quantitative platelet defect', 3),
(7817, 'ORPHA:275736', 'Rare bleeding disorder due to a constitutional thrombopathy', 3),
(7818, 'ORPHA:275736', 'Rare bleeding disorder due to a qualitative platelet defect', 3),
(7819, 'ORPHA:275736', 'Rare coagulopathy due to a constitutional thrombopathy', 3),
(7820, 'ORPHA:275736', 'Rare coagulopathy due to a qualitative platelet defect', 3),
(7821, 'ORPHA:275736', 'Rare hemorrhagic disorder due to a constitutional thrombopathy', 3),
(7822, 'ORPHA:275736', 'Rare hemorrhagic disorder due to a qualitative platelet defect', 3),
(7823, 'ORPHA:275742', 'Genetic infertility', 3),
(7824, 'ORPHA:275745', 'Alpha-thalassemia and related diseases', 3),
(7825, 'ORPHA:275749', 'Beta-thalassemia and related diseases', 3),
(7826, 'ORPHA:275752', 'Sickle cell disease and related diseases', 3),
(7827, 'ORPHA:275761', 'LAL deficiency', 1),
(7828, 'ORPHA:275761', 'Lysosomal acid lipase deficiency', 1),
(7829, 'ORPHA:275766', 'IPAH', 2),
(7830, 'ORPHA:275766', 'Idiopathic pulmonary arterial hypertension', 2),
(7831, 'ORPHA:275766', 'Primary pulmonary arterial hypertension', 2),
(7832, 'ORPHA:275777', 'FPAH', 2),
(7833, 'ORPHA:275777', 'Familial pulmonary arterial hypertension', 2),
(7834, 'ORPHA:275777', 'HPAH', 2),
(7835, 'ORPHA:275777', 'Hereditary pulmonary arterial hypertension', 2),
(7836, 'ORPHA:275777', 'Heritable pulmonary arterial hypertension', 2),
(7837, 'ORPHA:275786', 'Drug- or toxin-induced PAH', 3),
(7838, 'ORPHA:275786', 'Drug- or toxin-induced pulmonary arterial hypertension', 3),
(7839, 'ORPHA:275791', 'PAH associated with another disease', 3),
(7840, 'ORPHA:275791', 'Pulmonary arterial hypertension associated with another disease', 3),
(7841, 'ORPHA:275791', 'Secondary PAH', 3),
(7842, 'ORPHA:275798', 'PAH associated with connective tissue disease', 3),
(7843, 'ORPHA:275798', 'Pulmonary arterial hypertension associated with connective tissue disease', 3),
(7844, 'ORPHA:275803', 'PAH associated with congenital heart disease', 3),
(7845, 'ORPHA:275803', 'Pulmonary arterial hypertension associated with congenital heart disease', 3),
(7846, 'ORPHA:275808', 'PAH associated with HIV infaction', 3),
(7847, 'ORPHA:275808', 'Pulmonary arterial hypertension associated with HIV infection', 3),
(7848, 'ORPHA:275813', 'PAH associated with portal hypertension', 3),
(7849, 'ORPHA:275813', 'POPH', 3),
(7850, 'ORPHA:275813', 'Portopulmonary hypertension', 3),
(7851, 'ORPHA:275813', 'Pulmonary arterial hypertension associated with portal hypertension', 3),
(7852, 'ORPHA:275823', 'PAH associated with schistosomiasis', 3),
(7853, 'ORPHA:275823', 'Pulmonary arterial hypertension associated with schistosomiasis', 3),
(7854, 'ORPHA:275828', 'PAH associated with chronic hemolytic anemia', 3),
(7855, 'ORPHA:275828', 'Pulmonary arterial hypertension associated with chronic hemolytic anemia', 3),
(7856, 'ORPHA:275837', 'PH due to lung disease and/or hypoxia', 3),
(7857, 'ORPHA:275837', 'PH owing to lung disease and/or hypoxia', 3),
(7858, 'ORPHA:275837', 'Pulmonary hypertension due to lung disease and/or hypoxia', 3),
(7859, 'ORPHA:275837', 'Pulmonary hypertension owing to lung disease and/or hypoxia', 3),
(7860, 'ORPHA:275844', 'PH with unclear multifactorial mechanism', 3),
(7861, 'ORPHA:275844', 'Pulmonary hypertension with unclear multifactorial mechanism', 3),
(7862, 'ORPHA:275853', 'Syndrome with pulmonary hypertension as a major feature', 3),
(7863, 'ORPHA:275864', 'Behavioral variant of frontotemporal dementia', 1),
(7864, 'ORPHA:275864', 'bv-FTD', 1),
(7865, 'ORPHA:275872', 'FTD-ALS', 1),
(7866, 'ORPHA:275872', 'FTD-MND', 1),
(7867, 'ORPHA:275872', 'Frontotemporal dementia with amyotrophic lateral sclerosis', 1),
(7868, 'ORPHA:275872', 'Frontotemporal dementia with motor neuron disease', 1),
(7869, 'ORPHA:2759', 'Imperforate oropharynx-costovertebral anomalies syndrome', 1),
(7870, 'ORPHA:2759', 'Seghers syndrome', 1),
(7871, 'ORPHA:275938', 'HDFN', 3),
(7872, 'ORPHA:275938', 'Hemolytic disease due to fetomaternal alloimmunization', 3),
(7873, 'ORPHA:275938', 'Hemolytic disease of the fetus and newborn', 3),
(7874, 'ORPHA:275944', 'Anti-K HDN', 1),
(7875, 'ORPHA:275944', 'Hemolytic disease of the newborn with Kell alloimmunization', 1),
(7876, 'ORPHA:275944', 'Maternal anti-Kell alloimmunization', 1),
(7877, 'ORPHA:276', 'SCIDX1', 1),
(7878, 'ORPHA:276', 'T-B+ SCID due to gamma chain deficiency', 1),
(7879, 'ORPHA:276', 'T-B+ severe combined immunodeficiency due to gamma chain deficiency', 1),
(7880, 'ORPHA:276', 'T-B+ severe combined immunodeficiency, X-linked', 1),
(7881, 'ORPHA:2760', 'OSLAM syndrome', 1),
(7882, 'ORPHA:2760', 'Osteosarcoma-limb anomalies-erythroid macrocytosis syndrome', 1),
(7883, 'ORPHA:276058', 'Genetic neurodegenerative disease with dementia', 3),
(7884, 'ORPHA:276061', 'Genetic frontotemporal degeneration with dementia', 3),
(7885, 'ORPHA:276066', 'Bile acid CoA ligase deficiency and defective amidation', 1),
(7886, 'ORPHA:276142', 'Rare tumor of salivary glands', 3),
(7887, 'ORPHA:276145', 'Malignant epithelial tumor of salivary glands', 1),
(7888, 'ORPHA:276148', 'Benign epithelial tumor of salivary glands', 1),
(7889, 'ORPHA:276152', 'MEN4', 1),
(7890, 'ORPHA:276152', 'Multiple endocrine neoplasia type 4', 1),
(7891, 'ORPHA:276161', 'MEN', 3),
(7892, 'ORPHA:276161', 'Multiple endocrine neoplasia', 3),
(7893, 'ORPHA:276174', 'Idiopathic recurrent stupor', 1),
(7894, 'ORPHA:276183', 'Cerebellar ataxia with azoospermia and intellectual disability', 1),
(7895, 'ORPHA:276183', 'SCA32', 1),
(7896, 'ORPHA:276183', 'Spinocerebellar ataxia type 32', 1),
(7897, 'ORPHA:276193', 'SCA35', 1),
(7898, 'ORPHA:276193', 'Spinocerebellar ataxia type 35', 1),
(7899, 'ORPHA:276198', 'Asidan', 1),
(7900, 'ORPHA:276198', 'SCA36', 1),
(7901, 'ORPHA:276198', 'Spinocerebellar ataxia type 36', 1),
(7902, 'ORPHA:2762', 'Familial ectopic ossification', 1),
(7903, 'ORPHA:2762', 'POH', 1),
(7904, 'ORPHA:2762', 'Progressive osseous heteroplasia', 1),
(7905, 'ORPHA:276212', 'Arylsulfatase B deficiency, rapidly progressing', 2),
(7906, 'ORPHA:276212', 'MPS6, rapidly progressing', 2),
(7907, 'ORPHA:276212', 'MPSVI, rapidly progressing', 2),
(7908, 'ORPHA:276212', 'Mucopolysaccharidosis type 6, rapidly progressing', 2),
(7909, 'ORPHA:276212', 'Mucopolysaccharidosis type VI, rapidly progressing', 2),
(7910, 'ORPHA:276223', 'Arylsulfatase B deficiency, slowly progressing', 2),
(7911, 'ORPHA:276223', 'MPS6, slowly progressing', 2),
(7912, 'ORPHA:276223', 'MPSVI, slowly progressing', 2),
(7913, 'ORPHA:276223', 'Mucopolysaccharidosis type 6, slowly progressing', 2),
(7914, 'ORPHA:276223', 'Mucopolysaccharidosis type VI, slowly progressing', 2),
(7915, 'ORPHA:276234', 'Non-syndromic male infertility due asthenozoospermia', 1),
(7916, 'ORPHA:276234', 'Non-syndromic male infertility due to sperm motility disorder', 1),
(7917, 'ORPHA:276238', 'Machado-Joseph disease type 1', 2),
(7918, 'ORPHA:276238', 'SCA3, Joseph type', 2),
(7919, 'ORPHA:276238', 'Spinocerebellar ataxia type 3, Joseph type', 2),
(7920, 'ORPHA:276241', 'Machado-Joseph disease type 2', 2),
(7921, 'ORPHA:276241', 'SCA3, Thomas type', 2),
(7922, 'ORPHA:276241', 'Spinocerebellar ataxia, Thomas type', 2),
(7923, 'ORPHA:276244', 'Machado-Joseph disease type 3', 2),
(7924, 'ORPHA:276244', 'SCA3, Machado type', 2),
(7925, 'ORPHA:276244', 'Spinocerebellar ataxia type 3, Machado type', 2),
(7926, 'ORPHA:276280', 'HHML', 1),
(7927, 'ORPHA:276280', 'Hemihyperplasia-multiple lipomatosis syndrome', 1),
(7928, 'ORPHA:2763', 'Gracile bone dysplasia', 1),
(7929, 'ORPHA:2763', 'Osteocraniosplenic syndrome', 1),
(7930, 'ORPHA:2763', 'Osteocraniostenosis', 1),
(7931, 'ORPHA:276399', 'FMNG', 1),
(7932, 'ORPHA:276399', 'Familial MNG', 1),
(7933, 'ORPHA:276399', 'Familial multinodular goiter', 1),
(7934, 'ORPHA:2764', 'König disease', 1),
(7935, 'ORPHA:2764', 'Osteochondritis dissecans', 1),
(7936, 'ORPHA:276402', 'Limbic encephalitis with caspr2 antibodies', 1),
(7937, 'ORPHA:276405', 'Green jaundice', 1),
(7938, 'ORPHA:276405', 'Hyperbiliverdinemia', 1),
(7939, 'ORPHA:276413', '10q22.3q23.3 microdeletion syndrome', 1),
(7940, 'ORPHA:276413', 'Del(10)(q22.3q23.3)', 1),
(7941, 'ORPHA:276413', 'Deletion 10q22.3q23.3', 1),
(7942, 'ORPHA:276413', 'Monosomy 10q22.3q23.3', 1),
(7943, 'ORPHA:276422', '10q22.3q23.3 microduplication syndrome', 1),
(7944, 'ORPHA:276422', 'Dup(10)(q22.3q23.3)', 1),
(7945, 'ORPHA:276422', 'Trisomy 10q22.3q23.3', 1),
(7946, 'ORPHA:276429', 'Hypnic headache', 1),
(7947, 'ORPHA:276432', 'Ogden syndrome', 1),
(7948, 'ORPHA:276432', 'Premature aging appearance-developmental delay-cardiac arrhythmia syndrome', 1),
(7949, 'ORPHA:276435', 'LOSMoN', 1),
(7950, 'ORPHA:276435', 'Late-onset spinal motor neuronopathy', 1),
(7951, 'ORPHA:276435', 'Lower motor neuron syndrome with late-adult onset', 1),
(7952, 'ORPHA:276435', 'SMAJ', 1),
(7953, 'ORPHA:276435', 'Spinal muscular atrophy, Jokela type', 1),
(7954, 'ORPHA:276525', 'FHI', 3),
(7955, 'ORPHA:276525', 'Familial hyperinsulinemic hypoglycemia', 3),
(7956, 'ORPHA:276525', 'Familial hyperinsulinism', 3),
(7957, 'ORPHA:276556', 'Hyperinsulinemic hypoglycemia due to UCP2 deficiency', 1),
(7958, 'ORPHA:276556', 'Hyperinsulinism due to UCP2 deficiency', 1),
(7959, 'ORPHA:276575', 'Autosomal dominant hyperinsulinemic hypoglycemia due to SUR1 deficiency', 1),
(7960, 'ORPHA:276575', 'Autosomal dominant hyperinsulinism due to SUR1 deficiency', 1),
(7961, 'ORPHA:276580', 'Autosomal dominant hyperinsulinemic hypoglycemia due to Kir6.2 deficiency', 1),
(7962, 'ORPHA:276580', 'Autosomal dominant hyperinsulinism due to Kir6.2 deficiency', 1),
(7963, 'ORPHA:276580', 'Dominant KATP hyperinsulinism due to Kir6.2 deficiency', 1),
(7964, 'ORPHA:276585', 'Diazoxide-resistant hyperinsulinemic hypoglycemia', 3),
(7965, 'ORPHA:276585', 'Diazoxide-resistant hyperinsulinism', 3),
(7966, 'ORPHA:276598', 'Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency', 1),
(7967, 'ORPHA:276598', 'Hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form', 1),
(7968, 'ORPHA:276603', 'Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency', 1),
(7969, 'ORPHA:276603', 'Hyperinsulinemic hypoglycemia due to Kir6.2 deficiency, diazoxide-resistant focal form', 1),
(7970, 'ORPHA:276608', 'NIPHS', 1),
(7971, 'ORPHA:276608', 'Non-insulinoma pancreatogenous hypoglycemia syndrome', 1),
(7972, 'ORPHA:276621', 'Sporadic pheochromocytoma/secreting paraganglioma', 1),
(7973, 'ORPHA:276630', 'Symptomatic form of Coffin-Lowry syndrome in female carriers', 1),
(7974, 'ORPHA:2767', 'Carpotarsal osteochondromatosis', 1),
(7975, 'ORPHA:2767', 'Maroteaux-Le Merrer-Bensahel syndrome', 1),
(7976, 'ORPHA:2768', 'Blount disease', 1),
(7977, 'ORPHA:2768', 'Infantile tibia vara', 1),
(7978, 'ORPHA:2768', 'Osteochondrosis deformans tibiae', 1),
(7979, 'ORPHA:2768', 'Tibia vara Blount', 1),
(7980, 'ORPHA:2769', 'Familial osteodysplasia, Anderson type', 1),
(7981, 'ORPHA:277', 'ADA deficiency', 1),
(7982, 'ORPHA:277', 'SCID due to adenosine deaminase deficiency', 1),
(7983, 'ORPHA:277', 'Severe combined immunodeficiency due to adenosine deaminase deficiency', 1),
(7984, 'ORPHA:2770', 'NHD', 1),
(7985, 'ORPHA:2770', 'Nasu-Hakola disease', 1),
(7986, 'ORPHA:2770', 'PLO-SL', 1),
(7987, 'ORPHA:2770', 'PLOSL', 1),
(7988, 'ORPHA:2770', 'Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy', 1),
(7989, 'ORPHA:2771', 'Bruck syndrome', 1),
(7990, 'ORPHA:2771', 'Osteogenesis imperfecta-congenital joint contractures syndrome', 1),
(7991, 'ORPHA:2772', 'Congenital osteogenesis imperfecta-microcephaly-cataracts syndrome', 1),
(7992, 'ORPHA:2773', 'Al Gazali-Nair syndrome', 1),
(7993, 'ORPHA:2773', 'Osteogenesis imperfecta-retinopathy-seizures-intellectual disability syndrome', 1),
(7994, 'ORPHA:2774', 'Idiopathic multicentric osteolysis with or without nephropathy', 1),
(7995, 'ORPHA:2774', 'Multicentric carpo-tarsal osteolysis with or without nephropathy', 1),
(7996, 'ORPHA:2776', 'Autosomal recessive distal osteolysis syndrome', 1),
(7997, 'ORPHA:2776', 'Distal osteolysis-short stature-intellectual disability syndrome', 1),
(7998, 'ORPHA:2776', 'Petit-Fryns syndrome', 1),
(7999, 'ORPHA:2777', 'Axial osteosclerosis', 1),
(8000, 'ORPHA:2777', 'Osteomesopyknosis', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(8001, 'ORPHA:2779', 'Osteopathia striata-pigmentary dermopathy-white forelock syndrome', 1),
(8002, 'ORPHA:2779', 'Whyte-Murphy syndrome', 1),
(8003, 'ORPHA:2780', 'Hyperostosis generalisata with striations', 1),
(8004, 'ORPHA:2780', 'Osteopathia striata-cranial sclerosis syndrome', 1),
(8005, 'ORPHA:2780', 'Robinow-Unger syndrome', 1),
(8006, 'ORPHA:2781', 'Osteopetrosis and related disorders', 3),
(8007, 'ORPHA:2783', 'Autosomal dominant osteopetrosis type 1', 1),
(8008, 'ORPHA:2785', 'Carbonic anhydrase 2 deficiency', 1),
(8009, 'ORPHA:2785', 'Guibaud-Vainsel syndrome', 1),
(8010, 'ORPHA:2785', 'Marble brain disease', 1),
(8011, 'ORPHA:2785', 'Mixed RTA', 1),
(8012, 'ORPHA:2785', 'Mixed renal tubular acidosis', 1),
(8013, 'ORPHA:2785', 'Osteopetrosis with renal tubular acidosis', 1),
(8014, 'ORPHA:2785', 'Renal tubular acidosis type 3', 1),
(8015, 'ORPHA:2786', 'Hernández-Fragoso syndrome', 1),
(8016, 'ORPHA:2786', 'OOCHS', 1),
(8017, 'ORPHA:2786', 'Osteoporosis-oculocutaneous hypopigmentation syndrome', 1),
(8018, 'ORPHA:2787', 'Heide syndrome', 1),
(8019, 'ORPHA:2787', 'Osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome', 1),
(8020, 'ORPHA:2788', 'OPPG', 1),
(8021, 'ORPHA:2788', 'Ocular form of osteogenesis imperfecta', 1),
(8022, 'ORPHA:2788', 'Osteoporosis-pseudoglioma syndrome', 1),
(8023, 'ORPHA:2789', 'Lateral meningocele syndrome', 1),
(8024, 'ORPHA:2789', 'Lehman syndrome', 1),
(8025, 'ORPHA:2790', 'Autosomal dominant osteosclerosis, Worth type', 1),
(8026, 'ORPHA:2790', 'Endosteal hyperostosis, Worth type', 1),
(8027, 'ORPHA:2790', 'Worth syndrome', 1),
(8028, 'ORPHA:2791', 'Globodontia', 1),
(8029, 'ORPHA:2791', 'Otodental dysplasia', 1),
(8030, 'ORPHA:2791', 'Otodental syndrome', 1),
(8031, 'ORPHA:2792', 'Fara-Chlupackova syndrome', 1),
(8032, 'ORPHA:2792', 'OFC syndrome', 1),
(8033, 'ORPHA:2792', 'Otofaciocervical syndrome', 1),
(8034, 'ORPHA:2793', 'Otoonychoperoneal syndrome', 1),
(8035, 'ORPHA:2795', 'Fowler syndrome', 1),
(8036, 'ORPHA:2795', 'Fowler urethral sphincter dysfunction syndrome', 1),
(8037, 'ORPHA:2795', 'Fowler-Christmas-Chapple syndrome', 1),
(8038, 'ORPHA:2796', 'PDP', 1),
(8039, 'ORPHA:2796', 'Pachydermoperiostosis', 1),
(8040, 'ORPHA:2796', 'Touraine-Solente-Gole syndrome', 1),
(8041, 'ORPHA:2798', 'Kuzniecky syndrome', 1),
(8042, 'ORPHA:2798', 'Pachygyria-intellectual disability-epilepsy syndrome', 1),
(8043, 'ORPHA:279882', 'Spasmus nutans', 1),
(8044, 'ORPHA:279888', 'Acute endophthalmitis', 2),
(8045, 'ORPHA:279891', 'Chronic endophthalmitis', 2),
(8046, 'ORPHA:279894', 'Toxic maculopathy due to antimalarial drugs', 1),
(8047, 'ORPHA:279897', 'Primary oculocerebral lymphoma', 1),
(8048, 'ORPHA:279897', 'Primary oculocerebral non-Hodgkin lymphoma', 1),
(8049, 'ORPHA:279904', 'PIOL', 1),
(8050, 'ORPHA:279904', 'Primary intraocular lymphoma', 1),
(8051, 'ORPHA:279904', 'Primary intraocular non-Hodgkin lymphoma', 1),
(8052, 'ORPHA:279911', 'Primary organ-specific lymphoma', 3),
(8053, 'ORPHA:279914', 'IU', 1),
(8054, 'ORPHA:279914', 'Intermediate uveitis', 1),
(8055, 'ORPHA:279919', 'Infectious posterior uveitis', 1),
(8056, 'ORPHA:279922', 'Infectious anterior uveitis', 1),
(8057, 'ORPHA:279925', 'Infectious panuveitis', 1),
(8058, 'ORPHA:279928', 'Paraneoplastic uveitis', 1),
(8059, 'ORPHA:279934', 'Mitochondrial DNA depletion syndrome, hepatocerebral form due to DGUOK deficiency', 1),
(8060, 'ORPHA:279943', 'Hereditary neutrophilia', 1),
(8061, 'ORPHA:279947', 'POIS', 1),
(8062, 'ORPHA:279947', 'Postorgasmic illness syndrome', 1),
(8063, 'ORPHA:28', 'Adenosylcobalamin deficiency', 1),
(8064, 'ORPHA:28', 'Vitamin B12-responsive methylmalonic acidemia', 1),
(8065, 'ORPHA:28', 'Vitamin B12-responsive methylmalonic aciduria', 1),
(8066, 'ORPHA:280', '4p- syndrome', 1),
(8067, 'ORPHA:280', 'Distal deletion 4p', 1),
(8068, 'ORPHA:280', 'Distal monosomy 4p', 1),
(8069, 'ORPHA:280', 'Telomeric deletion 4p', 1),
(8070, 'ORPHA:280', 'Wolf-Hirschhorn syndrome', 1),
(8071, 'ORPHA:2800', 'Extramammary Paget disease', 1),
(8072, 'ORPHA:280062', 'Calciphylaxis', 1),
(8073, 'ORPHA:280065', 'Calciphylaxis cutis', 2),
(8074, 'ORPHA:280068', 'Visceral calciphylaxis', 2),
(8075, 'ORPHA:280071', 'ALG11-CDG', 1),
(8076, 'ORPHA:280071', 'CDG syndrome type Ip', 1),
(8077, 'ORPHA:280071', 'CDG-Ip', 1),
(8078, 'ORPHA:280071', 'CDG1P', 1),
(8079, 'ORPHA:280071', 'Carbohydrate deficient glycoprotein syndrome type Ip', 1),
(8080, 'ORPHA:280071', 'Congenital disorder of glycosylation type 1p', 1),
(8081, 'ORPHA:280071', 'Congenital disorder of glycosylation type Ip', 1),
(8082, 'ORPHA:2801', 'Familial osteoectasia', 1),
(8083, 'ORPHA:2801', 'Hereditary hyperphosphatasia', 1),
(8084, 'ORPHA:2801', 'Hyperostosis corticalis deformans juvenilis', 1),
(8085, 'ORPHA:2801', 'JPG', 1),
(8086, 'ORPHA:2801', 'Juvenile Paget disease', 1),
(8087, 'ORPHA:280133', 'C3 deficiency', 1),
(8088, 'ORPHA:280133', 'Complement component 3 deficiency', 1),
(8089, 'ORPHA:280142', 'SCID due to LCK deficiency', 1),
(8090, 'ORPHA:280142', 'SCID due to lymphocyte-specific protein tyrosine kinase deficiency', 1),
(8091, 'ORPHA:280142', 'Severe combined immunodeficiency due to LCK deficiency', 1),
(8092, 'ORPHA:280142', 'Severe combined immunodeficiency due to lymphocyte-specific protein tyrosine kinase deficiency', 1),
(8093, 'ORPHA:280183', 'Methylmalonic acidemia, TCb1R type', 1),
(8094, 'ORPHA:280183', 'Methylmalonic acidemia, TCbIR type', 1),
(8095, 'ORPHA:280183', 'Methylmalonic aciduria due to transcobalamin receptor defect', 1),
(8096, 'ORPHA:280195', 'Septopreoptic HPE', 2),
(8097, 'ORPHA:280195', 'Septopreoptic holoprosencephaly', 2),
(8098, 'ORPHA:2802', 'Pagon-Bird-Detter syndrome', 1),
(8099, 'ORPHA:2802', 'X-linked sideroblastic anemia and spinocerebellar ataxia', 1),
(8100, 'ORPHA:2802', 'X-linked sideroblastic anemia with ataxia', 1),
(8101, 'ORPHA:2802', 'XLSA-A', 1),
(8102, 'ORPHA:280200', 'HPE, minor form', 1),
(8103, 'ORPHA:280200', 'HPE-L', 1),
(8104, 'ORPHA:280200', 'Holoprosencephaly, minor form', 1),
(8105, 'ORPHA:280200', 'Holoprosencephaly-like', 1),
(8106, 'ORPHA:280200', 'Microform HPE', 1),
(8107, 'ORPHA:280200', 'Microform holoprosencephaly', 1),
(8108, 'ORPHA:280205', 'LTEC0', 2),
(8109, 'ORPHA:280205', 'Laryngo-tracheo-esophageal cleft type 0', 2),
(8110, 'ORPHA:280205', 'Laryngotracheoesophageal cleft type 0', 2),
(8111, 'ORPHA:280210', 'Connatal PMD', 2),
(8112, 'ORPHA:280210', 'Pelizaeus-Merzbacher disease type II', 2),
(8113, 'ORPHA:280210', 'Pelizaeus-Merzbacher disease, connatal form', 2),
(8114, 'ORPHA:280210', 'Severe PMD', 2),
(8115, 'ORPHA:280219', 'Classic PMD', 2),
(8116, 'ORPHA:280219', 'Pelizaeus-Merzbacher disease, classic form', 2),
(8117, 'ORPHA:280224', 'Pelizaeus-Merzbacher disease, transitional form', 2),
(8118, 'ORPHA:280224', 'Transitional PMD', 2),
(8119, 'ORPHA:280229', 'Pelizaeus-Merzbacher disease in female carriers', 2),
(8120, 'ORPHA:280234', 'Null syndrome', 2),
(8121, 'ORPHA:280234', 'PLP1 null syndrome', 2),
(8122, 'ORPHA:280234', 'Pelizaeus-Merzbacher disease, null syndrome', 2),
(8123, 'ORPHA:280270', 'PMLD', 1),
(8124, 'ORPHA:280270', 'Pelizaeus-Merzbacher-like disease', 1),
(8125, 'ORPHA:280282', 'PMLD1', 2),
(8126, 'ORPHA:280282', 'Pelizaeus-Merzbacher-like disease due to GJC2 mutation', 2),
(8127, 'ORPHA:280288', 'Mitochondrial HSP60 chaperonopathy', 2),
(8128, 'ORPHA:280288', 'Pelizaeus-Merzbacher-like disease due to HSPD1 mutation', 2),
(8129, 'ORPHA:280293', 'Pelizaeus-Merzbacher-like disease due to AIMP1 mutation', 2),
(8130, 'ORPHA:280302', 'AIP type 1', 2),
(8131, 'ORPHA:280302', 'Autoimmune pancreatitis type 1', 2),
(8132, 'ORPHA:280302', 'IgG4-related pancreatitis', 2),
(8133, 'ORPHA:280302', 'Lymphoplasmacytic sclerosing pancreatitis', 2),
(8134, 'ORPHA:280315', 'AIP type 2', 2),
(8135, 'ORPHA:280315', 'Autoimmune pancreatitis type 2', 2),
(8136, 'ORPHA:280315', 'Duct-centric pancreatitis', 2),
(8137, 'ORPHA:280325', '12p13.33 microdeletion syndrome', 1),
(8138, 'ORPHA:280325', 'Del(12)(p13.33)', 1),
(8139, 'ORPHA:280325', 'Distal deletion 12p', 1),
(8140, 'ORPHA:280325', 'Distal monosomy 12p', 1),
(8141, 'ORPHA:280333', 'Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16', 1),
(8142, 'ORPHA:280333', 'Alpha-dystroglycan-related LGMD R16', 1),
(8143, 'ORPHA:280333', 'Autosomal recessive limb-girdle muscular dystrophy type 2P', 1),
(8144, 'ORPHA:280333', 'LGMD type 2P', 1),
(8145, 'ORPHA:280333', 'LGMD2P', 1),
(8146, 'ORPHA:280333', 'Limb-girdle muscular dystrophy type 2P', 1),
(8147, 'ORPHA:280342', 'Rare systemic or rheumatological disease of childhood', 3),
(8148, 'ORPHA:280356', 'FPLD4', 1),
(8149, 'ORPHA:280356', 'PLIN1-related FPLD', 1),
(8150, 'ORPHA:280356', 'PLIN1-related familial partial lipodystrophy', 1),
(8151, 'ORPHA:280365', 'Autosomal semi-dominant severe lipodystrophic laminopathy', 1),
(8152, 'ORPHA:280369', 'Rare pediatric vasculitis', 3),
(8153, 'ORPHA:280373', 'Rare pediatric systemic disease', 3),
(8154, 'ORPHA:280379', 'Erythropoietic uroporphyria associated with myeloid malignancy', 1),
(8155, 'ORPHA:280384', 'IDMDC', 1),
(8156, 'ORPHA:280384', 'Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome', 1),
(8157, 'ORPHA:280397', 'Familial Alzheimer-like prion disease', 1),
(8158, 'ORPHA:2804', 'Pallister-W syndrome', 1),
(8159, 'ORPHA:2804', 'W syndrome', 1),
(8160, 'ORPHA:280400', 'Familial prion disease', 3),
(8161, 'ORPHA:280400', 'Genetic human prion disease', 3),
(8162, 'ORPHA:280400', 'Inherited human prion disease', 3),
(8163, 'ORPHA:280403', 'Familial omphalocele syndrome with facial dysmorphism', 1),
(8164, 'ORPHA:280406', 'Familial steroid-resistant nephrotic syndrome with sensorineural deafness', 1),
(8165, 'ORPHA:280406', 'Familial steroid-resistant nephrotic syndrome with sensorineural hearing loss', 1),
(8166, 'ORPHA:2805', 'Congenital pancreatic agenesis', 1),
(8167, 'ORPHA:2805', 'Partial agenesis of the pancreas', 1),
(8168, 'ORPHA:2805', 'Partial pancreatic agenesis', 1),
(8169, 'ORPHA:280553', 'Fatal infantile hypertonic myofibrillar myopathy', 1),
(8170, 'ORPHA:280558', 'WABS', 1),
(8171, 'ORPHA:280558', 'Warsaw breakage syndrome', 1),
(8172, 'ORPHA:280576', 'NGPS', 1),
(8173, 'ORPHA:280576', 'Nestor-Guillermo progeria syndrome', 1),
(8174, 'ORPHA:280586', 'Chondrodysplasia with joint dislocations, gPAPP type', 1),
(8175, 'ORPHA:280586', 'gPAPP deficiency', 1),
(8176, 'ORPHA:280598', 'Hereditary sensorimotor neuropathy with hyperelastic skin', 1),
(8177, 'ORPHA:2806', 'Dawson encephalitis', 1),
(8178, 'ORPHA:2806', 'SSPE', 1),
(8179, 'ORPHA:2806', 'Subacute inclusion body encephalitis', 1),
(8180, 'ORPHA:2806', 'Subacute sclerosing leukoencephalitis', 1),
(8181, 'ORPHA:2806', 'Subacute sclerosing panencephalitis', 1),
(8182, 'ORPHA:2806', 'Van Bogaert disease', 1),
(8183, 'ORPHA:2806', 'Van Bogaert encephalitis', 1),
(8184, 'ORPHA:280615', 'Hemoglobinopathy Toms River', 1),
(8185, 'ORPHA:280615', 'Transient neonatal cyanosis and anemia due to Toms River Hemoglobin', 1),
(8186, 'ORPHA:280620', 'EPM6', 1),
(8187, 'ORPHA:280620', 'GOSR2-related progressive myoclonus ataxia', 1),
(8188, 'ORPHA:280620', 'North Sea progressive myoclonus epilepsy', 1),
(8189, 'ORPHA:280620', 'PME type 6', 1),
(8190, 'ORPHA:280620', 'Progressive myoclonic epilepsy type 6', 1),
(8191, 'ORPHA:280620', 'Progressive myoclonus epilepsy type 6', 1),
(8192, 'ORPHA:280628', 'FPHH', 1),
(8193, 'ORPHA:280628', 'Familial progressive hyper- and hypopigmentation', 1),
(8194, 'ORPHA:280633', 'Congenital disorder of glycosylation due to PIGN deficiency', 1),
(8195, 'ORPHA:280633', 'Multiple congenital anomalies-hypotonia-seizures syndrome', 1),
(8196, 'ORPHA:280633', 'PIGN-CDG', 1),
(8197, 'ORPHA:280640', 'Occipital MCD', 1),
(8198, 'ORPHA:280640', 'Occipital malformations of cortical development', 1),
(8199, 'ORPHA:280640', 'Occipital pachygyria and polymicrogyria', 1),
(8200, 'ORPHA:280651', 'Acrodysostosis with multiple hormone resistance', 1),
(8201, 'ORPHA:280654', 'Autosomal recessive nail dysplasia', 1),
(8202, 'ORPHA:280663', 'HPS9', 2),
(8203, 'ORPHA:280663', 'Hermansky-Pudlak syndrome type 9', 2),
(8204, 'ORPHA:280671', 'Congenital megaconial myopathy', 1),
(8205, 'ORPHA:280671', 'Congenital muscular dystrophy due to phosphatidylcholine biosynthesis defect', 1),
(8206, 'ORPHA:280671', 'Congenital muscular dystrophy with mitochondrial structural abnormalities', 1),
(8207, 'ORPHA:280671', 'Megaconial congenital muscular dystrophy', 1),
(8208, 'ORPHA:280679', 'Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome', 1),
(8209, 'ORPHA:280679', 'Moyamoya disease-short stature-facial dysmorphism-hypergonadotropic hypogonadism', 1),
(8210, 'ORPHA:2807', 'CPP', 1),
(8211, 'ORPHA:2807', 'Choroid plexus papilloma', 1),
(8212, 'ORPHA:2807', 'Papilloma of choroid plexus', 1),
(8213, 'ORPHA:280763', 'AP4 deficiency syndrome', 1),
(8214, 'ORPHA:280763', 'Severe intellectual disability and progressive spastic paraplegia', 1),
(8215, 'ORPHA:280774', 'GET', 1),
(8216, 'ORPHA:280774', 'Generalized essential telangiectasia', 1),
(8217, 'ORPHA:280779', 'CCV', 1),
(8218, 'ORPHA:280779', 'Cutaneous collagenous vasculopathy', 1),
(8219, 'ORPHA:280785', 'Bullous DCM', 2),
(8220, 'ORPHA:280785', 'Bullous diffuse cutaneous mastocytosis', 2),
(8221, 'ORPHA:280794', 'Infiltrative small vesicular DCM', 2),
(8222, 'ORPHA:280794', 'Infiltrative small vesicular diffuse cutaneous mastocytosis', 2),
(8223, 'ORPHA:280794', 'Pseudoxanthomatous DCM', 2),
(8224, 'ORPHA:280794', 'Pseudoxanthomatous diffuse cutaneous mastocytosis', 2),
(8225, 'ORPHA:2808', 'Familial vocal cord dysfunction', 1),
(8226, 'ORPHA:2808', 'Gerhardt syndrome', 1),
(8227, 'ORPHA:2808', 'Laryngeal abductor paralysis', 1),
(8228, 'ORPHA:280802', 'Congenital intrapulmonary sequestration', 2),
(8229, 'ORPHA:280802', 'Intralobar congenital bronchopulmonary sequestration', 2),
(8230, 'ORPHA:280802', 'Intralobar congenital pulmonary sequestration', 2),
(8231, 'ORPHA:280811', 'Congenital extrapulmonary sequestration', 2),
(8232, 'ORPHA:280811', 'Extralobar congenital bronchopulmonary sequestration', 2),
(8233, 'ORPHA:280811', 'Extralobar congenital pulmonary sequestration', 2),
(8234, 'ORPHA:280821', 'Communicating congenital bronchopulmonary-foregut malformation', 2),
(8235, 'ORPHA:280827', 'CPAM type 0', 2),
(8236, 'ORPHA:280827', 'Congenital cystic adenomatoid malformation of the lung type 0', 2),
(8237, 'ORPHA:280827', 'Congenital cystic adenomatous malformation of the lung type 0', 2),
(8238, 'ORPHA:280827', 'Congenital pulmonary airway malformation type 0', 2),
(8239, 'ORPHA:280832', 'CCAM type 1', 2),
(8240, 'ORPHA:280832', 'CPAM type 1', 2),
(8241, 'ORPHA:280832', 'Congenital cystic adenomatoid malformation of the lung type 1', 2),
(8242, 'ORPHA:280832', 'Congenital cystic adenomatous malformation of the lung type 1', 2),
(8243, 'ORPHA:280832', 'Congenital cystic disease of the lung type 1', 2),
(8244, 'ORPHA:280832', 'Congenital pulmonary airway malformation type 1', 2),
(8245, 'ORPHA:280840', 'CCAM type 2', 2),
(8246, 'ORPHA:280840', 'CPAM type 2', 2),
(8247, 'ORPHA:280840', 'Congenital cystic adenomatoid malformation of the lung type 2', 2),
(8248, 'ORPHA:280840', 'Congenital cystic adenomatous malformation of the lung type 2', 2),
(8249, 'ORPHA:280840', 'Congenital cystic disease of the lung type 2', 2),
(8250, 'ORPHA:280840', 'Congenital pulmonary airway malformation type 2', 2),
(8251, 'ORPHA:280847', 'CCAM type 3', 2),
(8252, 'ORPHA:280847', 'CPAM type 3', 2),
(8253, 'ORPHA:280847', 'Congenital cystic adenomatoid malformation of the lung type 3', 2),
(8254, 'ORPHA:280847', 'Congenital cystic adenomatous malformation of the lung type 3', 2),
(8255, 'ORPHA:280847', 'Congenital cystic disease of the lung type 3', 2),
(8256, 'ORPHA:280847', 'Congenital pulmonary airway malformation type 3', 2),
(8257, 'ORPHA:280854', 'CPAM type 4', 2),
(8258, 'ORPHA:280854', 'Congenital cystic adenomatoid malformation of the lung type 4', 2),
(8259, 'ORPHA:280854', 'Congenital cystic adenomatous malformation of the lung type 4', 2),
(8260, 'ORPHA:280854', 'Congenital pulmonary airway malformation type 4', 2),
(8261, 'ORPHA:280886', 'Anterior uveitis', 3),
(8262, 'ORPHA:280886', 'Iridocyclitis', 3),
(8263, 'ORPHA:280892', 'Choroiditis', 3),
(8264, 'ORPHA:280892', 'Posterior uveitis', 3),
(8265, 'ORPHA:280898', 'Panuveitis', 3),
(8266, 'ORPHA:280898', 'Total uveitis', 3),
(8267, 'ORPHA:2809', 'Familial recurrent Bell palsy', 1),
(8268, 'ORPHA:2809', 'Familial recurrent peripheral facial palsy', 1),
(8269, 'ORPHA:280914', 'Idiopathic anterior uveitis', 1),
(8270, 'ORPHA:280917', 'Idiopathic posterior uveitis', 1),
(8271, 'ORPHA:280921', 'Idiopathic panuveitis', 1),
(8272, 'ORPHA:280926', 'Systemic diseases with anterior uveitis', 3),
(8273, 'ORPHA:280930', 'Systemic diseases with posterior uveitis', 3),
(8274, 'ORPHA:280933', 'Systemic diseases with panuveitis', 3),
(8275, 'ORPHA:281', 'Cri du chat syndrome', 1),
(8276, 'ORPHA:281', 'Deletion 5p', 1),
(8277, 'ORPHA:281', 'Monosomy 5p', 1),
(8278, 'ORPHA:281082', 'Inherited non-syndromic ichthyosis', 3),
(8279, 'ORPHA:281085', 'Inherited ichthyosis syndromic form', 3),
(8280, 'ORPHA:281090', 'Recessive X-linked ichthyosis with extracutaneous manifestations', 1),
(8281, 'ORPHA:281090', 'Syndromic RXLI', 1),
(8282, 'ORPHA:281090', 'Syndromic recessive X-linked ichthyosis', 1),
(8283, 'ORPHA:281097', 'ARCI', 3),
(8284, 'ORPHA:281097', 'Autosomal recessive congenital ichthyosis', 3),
(8285, 'ORPHA:281103', 'KPI', 3),
(8286, 'ORPHA:281103', 'Keratinopathic ichthyosis', 3),
(8287, 'ORPHA:281122', 'SHCB', 1),
(8288, 'ORPHA:281122', 'SICI', 1),
(8289, 'ORPHA:281122', 'Self-healing collodion baby', 1),
(8290, 'ORPHA:281122', 'Self-improving collodion baby', 1),
(8291, 'ORPHA:281122', 'Self-improving congenital ichthyosis', 1),
(8292, 'ORPHA:281127', 'Acral SHCB', 1),
(8293, 'ORPHA:281127', 'Acral self-healing collodion baby', 1),
(8294, 'ORPHA:281139', 'AEI', 1),
(8295, 'ORPHA:281139', 'Annular epidermolytic ichthyosis', 1),
(8296, 'ORPHA:281190', 'CRIE', 1),
(8297, 'ORPHA:281190', 'Congenital reticular ichthyosiform erythroderma', 1),
(8298, 'ORPHA:281190', 'IWC', 1),
(8299, 'ORPHA:281190', 'Ichthyosis variegata', 1),
(8300, 'ORPHA:281190', 'Ichthyosis with confetti', 1),
(8301, 'ORPHA:2812', 'Hard skin syndrome, Parana type', 1),
(8302, 'ORPHA:2812', 'Parana hard skin syndrome', 1),
(8303, 'ORPHA:281201', 'KLICK syndrome', 1),
(8304, 'ORPHA:281201', 'Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome', 1),
(8305, 'ORPHA:281210', 'X-linked ichthyosis syndrome', 3),
(8306, 'ORPHA:281217', 'Autosomal ichthyosis syndrome', 3),
(8307, 'ORPHA:281222', 'Autosomal ichthyosis syndrome with prominent hair abnormalities', 3),
(8308, 'ORPHA:281238', 'Autosomal ichthyosis syndrome with prominent neurologic signs', 3),
(8309, 'ORPHA:281241', 'Autosomal ichthyosis syndrome with fatal disease course', 3),
(8310, 'ORPHA:281244', 'Autosomal ichthyosis syndrome with other associated signs', 3),
(8311, 'ORPHA:2815', 'Spastic paraparesis-deafness syndrome', 1),
(8312, 'ORPHA:2815', 'Spastic paraparesis-hearing loss syndrome', 1),
(8313, 'ORPHA:2815', 'Wells-Jankovic syndrome', 1),
(8314, 'ORPHA:2818', 'Spastic paraplegia-glaucoma-intellectual disability syndrome', 1),
(8315, 'ORPHA:2819', 'Bahemuka-Brown syndrome', 1),
(8316, 'ORPHA:2819', 'Spastic paraplegia-facial-cutaneous lesions syndrome', 1),
(8317, 'ORPHA:282', 'FTD', 3),
(8318, 'ORPHA:282', 'Frontotemporal dementia', 3),
(8319, 'ORPHA:2820', 'Fitzsimmons-Walson-Mellor syndrome', 1),
(8320, 'ORPHA:2820', 'Spastic paraplegia-nephritis-deafness syndrome', 1),
(8321, 'ORPHA:2820', 'Spastic paraplegia-nephritis-hearing loss syndrome', 1),
(8322, 'ORPHA:2821', 'Antinolo-Nieto-Borrego syndrome', 1),
(8323, 'ORPHA:2821', 'Spastic paraplegia-neuropathy-poikiloderma syndrome', 1),
(8324, 'ORPHA:282124', 'Partial deletion of chromosome 12', 3),
(8325, 'ORPHA:282124', 'Partial monosomy of chromosome 12', 3),
(8326, 'ORPHA:282166', 'Inherited CJD', 1),
(8327, 'ORPHA:282166', 'Inherited Creutzfeldt-Jakob disease', 1),
(8328, 'ORPHA:282196', 'APS', 3),
(8329, 'ORPHA:282196', 'Autoimmune polyendocrinopathy', 3),
(8330, 'ORPHA:282196', 'Autoimmune polyglandular syndrome', 3),
(8331, 'ORPHA:2822', 'Autosomal recessive spastic paraplegia type 11', 1),
(8332, 'ORPHA:2822', 'Nakamura-Osame syndrome', 1),
(8333, 'ORPHA:2822', 'SPG11', 1),
(8334, 'ORPHA:2822', 'Spastic paraplegia-intellectual disability-thin corpus callosum syndrome', 1),
(8335, 'ORPHA:2824', 'Fitzsimmons-McLachlan-Gilbert syndrome', 1),
(8336, 'ORPHA:2824', 'Paraplegia-intellectual disability-hyperkeratosis syndrome', 1),
(8337, 'ORPHA:2825', 'PARC syndrome', 1),
(8338, 'ORPHA:2825', 'Poikiloderma-alopecia-retrognathism-cleft palate syndrome', 1),
(8339, 'ORPHA:2826', 'Spastic paraplegia-precocious puberty syndrome', 1),
(8340, 'ORPHA:2828', 'Early-onset Parkinson disease', 1),
(8341, 'ORPHA:2828', 'YOPD', 1),
(8342, 'ORPHA:2828', 'Young-onset Parkinson disease', 1),
(8343, 'ORPHA:283', 'Demodicidosis', 1),
(8344, 'ORPHA:283', 'Demodicosis', 1),
(8345, 'ORPHA:2831', 'Rhizomelic dysplasia, Patterson-Lowry type', 1),
(8346, 'ORPHA:2832', 'Lopes-Gorlin syndrome', 1),
(8347, 'ORPHA:2832', 'Short tarsus-absence of lower eyelashes syndrome', 1),
(8348, 'ORPHA:2833', 'Stiff skin syndrome', 1),
(8349, 'ORPHA:2834', 'WSS', 2),
(8350, 'ORPHA:2834', 'Wrinkled skin syndrome', 2),
(8351, 'ORPHA:2834', 'Wrinkly skin syndrome', 2),
(8352, 'ORPHA:2835', 'Pectus excavatum-macrocephaly-dysplastic nails syndrome', 1),
(8353, 'ORPHA:2835', 'Zori-Stalker-Williams syndrome', 1),
(8354, 'ORPHA:2836', 'PEHO syndrome', 1),
(8355, 'ORPHA:2836', 'Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy', 1),
(8356, 'ORPHA:2836', 'Progressive encephalopathy-optic atrophy syndrome', 1),
(8357, 'ORPHA:28378', 'Keratosis palmoplantaris-corneal dystrophy syndrome', 1),
(8358, 'ORPHA:28378', 'Oculocutaneous tyrosinemia', 1),
(8359, 'ORPHA:28378', 'Richner-Hanhart syndrome', 1),
(8360, 'ORPHA:28378', 'Tyrosinemia due to TAT deficiency', 1),
(8361, 'ORPHA:28378', 'Tyrosinemia due to tyrosine aminotransferase deficiency', 1),
(8362, 'ORPHA:28378', 'Tyrosinemia type 2', 1),
(8363, 'ORPHA:28378', 'Tyrosinemia type II', 1),
(8364, 'ORPHA:2838', 'Renal caliceal diverticuli-deafness syndrome', 1),
(8365, 'ORPHA:2838', 'Renal caliceal diverticuli-hearing loss syndrome', 1),
(8366, 'ORPHA:2839', 'Kosenow syndrome', 1),
(8367, 'ORPHA:2839', 'Pelvis-shoulder dysplasia', 1),
(8368, 'ORPHA:2839', 'Scapuloiliac dysostosis', 1),
(8369, 'ORPHA:284', 'Alveolar echinococcosis', 1),
(8370, 'ORPHA:284', 'Echinococcus multilocularis infection', 1),
(8371, 'ORPHA:2840', 'Pelvic dysplasia-arthrogryposis of lower limbs syndrome', 1),
(8372, 'ORPHA:2840', 'Ray-Peterson-Scott syndrome', 1),
(8373, 'ORPHA:2841', 'Benign chronic familial pemphigus of Hailey-Hailey', 1),
(8374, 'ORPHA:2841', 'Familial benign chronic pemphigus', 1),
(8375, 'ORPHA:2841', 'Hailey-Hailey disease', 1),
(8376, 'ORPHA:284139', 'Larsen-like syndrome, B3GAT3 type', 1),
(8377, 'ORPHA:284139', 'Multiple joint dislocations-short stature-craniofacial dysmorphism-congenital heart defects syndrome', 1),
(8378, 'ORPHA:284149', 'Craniosynostosis-dental anomalies', 1),
(8379, 'ORPHA:284149', 'Kreiborg-Pakistani syndrome', 1),
(8380, 'ORPHA:284160', '8q21.11 microdeletion syndrome', 1),
(8381, 'ORPHA:284160', 'Del(8)(q21.11)', 1),
(8382, 'ORPHA:284160', 'Deletion 8q21.11', 1),
(8383, 'ORPHA:284160', 'Monosomy 8q21.11', 1),
(8384, 'ORPHA:284169', '10p12p11 microdeletion syndrome', 2),
(8385, 'ORPHA:284169', 'Del(10)(p11.21p12.31)', 2),
(8386, 'ORPHA:284169', 'Deletion 10p11.21p12.31', 2),
(8387, 'ORPHA:284169', 'Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion', 2),
(8388, 'ORPHA:284169', 'Monosomy 10p11.21p12.31', 2),
(8389, 'ORPHA:284180', 'Dup(X)(p22)', 1),
(8390, 'ORPHA:284180', 'Dup(X)(p22.13p22.2)', 1),
(8391, 'ORPHA:284180', 'Duplication Xp22', 1),
(8392, 'ORPHA:284180', 'Xp22.13p22.2 duplication syndrome', 1),
(8393, 'ORPHA:2842', 'Penoscrotal transposition', 1),
(8394, 'ORPHA:284227', 'TEMPI syndrome', 1),
(8395, 'ORPHA:284227', 'Telangiectasia-erythrocytosis-monoclonal gammopathy-perinephric-fluid collections-intrapulmonary shunting syndrome', 1),
(8396, 'ORPHA:284232', 'Autosomal dominant Charcot-Marie-Tooth disease type 2O', 1),
(8397, 'ORPHA:284232', 'CMT2O', 1),
(8398, 'ORPHA:284247', 'FRAM', 1),
(8399, 'ORPHA:284247', 'Familial retinal arterial macroaneurysm', 1),
(8400, 'ORPHA:284247', 'Retinal arterial macroaneurysm and supravalvular pulmonic stenosis', 1),
(8401, 'ORPHA:284264', 'IgG4-related disease', 3),
(8402, 'ORPHA:284264', 'IgG4-related sclerosing disease', 3),
(8403, 'ORPHA:284264', 'IgG4-related systemic disease', 3),
(8404, 'ORPHA:284264', 'Immunoglobulin G4-related sclerosing disease', 3),
(8405, 'ORPHA:284271', 'Autosomal recessive cerebellar ataxia-psychomotor delay syndrome', 1),
(8406, 'ORPHA:284271', 'Autosomal recessive spinocerebellar ataxia type 11', 1),
(8407, 'ORPHA:284271', 'SCAR11', 1),
(8408, 'ORPHA:284282', 'Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to WWOX deficiency', 1),
(8409, 'ORPHA:284282', 'Autosomal recessive spinocerebellar ataxia type 12', 1),
(8410, 'ORPHA:284282', 'SCAR12', 1),
(8411, 'ORPHA:284289', 'Adult-onset autosomal recessive cerebellar ataxia', 1),
(8412, 'ORPHA:284289', 'Autosomal recessive spinocerebellar ataxia type 10', 1),
(8413, 'ORPHA:284289', 'SCAR10', 1),
(8414, 'ORPHA:2843', 'Essential pentosuria', 1),
(8415, 'ORPHA:2843', 'Pentosuria', 1),
(8416, 'ORPHA:2843', 'Xylitol dehydrogenase deficiency', 1),
(8417, 'ORPHA:284324', 'Autosomal recessive spinocerebellar ataxia type 7', 1),
(8418, 'ORPHA:284324', 'Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia', 1),
(8419, 'ORPHA:284324', 'SCAR7', 1),
(8420, 'ORPHA:284332', 'Autosomal recessive spinocerebellar ataxia type 6', 1),
(8421, 'ORPHA:284332', 'Infantile-onset autosomal recessive nonprogressive cerebellar ataxia', 1),
(8422, 'ORPHA:284332', 'SCAR6', 1),
(8423, 'ORPHA:284339', 'PCH7', 1),
(8424, 'ORPHA:284339', 'Pontocerebellar hypoplasia type 7', 1),
(8425, 'ORPHA:284339', 'Pontocerebellar hypoplasia-46,XY disorder of sex development syndrome', 1),
(8426, 'ORPHA:284343', 'DICER1 syndrome', 2),
(8427, 'ORPHA:284343', 'PPB familial tumor susceptibility syndrome', 2),
(8428, 'ORPHA:284343', 'PPBFTDS', 2),
(8429, 'ORPHA:284343', 'Pleuro-pulmonary blastoma familial tumor susceptibility syndrome', 2),
(8430, 'ORPHA:284343', 'Pleuropulmonary blastoma familial tumor susceptibility syndrome', 2),
(8431, 'ORPHA:284362', 'FLIT', 2),
(8432, 'ORPHA:284362', 'Fetal lung interstitial tumor', 2),
(8433, 'ORPHA:284362', 'Immature interstitial mesenchymal tumor', 2),
(8434, 'ORPHA:284385', 'Familial intrahepatic cholestasis', 3),
(8435, 'ORPHA:284388', 'RCVS', 1),
(8436, 'ORPHA:284388', 'Reversible cerebral vasoconstriction syndrome', 1),
(8437, 'ORPHA:284395', 'WDFA', 1),
(8438, 'ORPHA:284395', 'Well-differentiated fetal adenocarcinoma of the lung', 1),
(8439, 'ORPHA:284400', 'Poorly differentiated neuroendocrine carcinoma of the bladder', 1),
(8440, 'ORPHA:284400', 'SCCB', 1),
(8441, 'ORPHA:284400', 'Small cell bladder cancer', 1),
(8442, 'ORPHA:284400', 'Small cell bladder carcinoma', 1),
(8443, 'ORPHA:284400', 'Small cell carcinoma of the bladder', 1),
(8444, 'ORPHA:284400', 'Small cell carcinoma of the urinary bladder', 1),
(8445, 'ORPHA:284411', 'Glycerol kinase deficiency, juvenile form', 2),
(8446, 'ORPHA:284414', 'Glycerol kinase deficiency, adult form', 2),
(8447, 'ORPHA:284417', 'PSAT deficiency, infantile/juvenile form', 2),
(8448, 'ORPHA:284417', 'Phosphoserine aminotransferase deficiency, infantile/juvenile form', 2),
(8449, 'ORPHA:284426', 'GSD due to lactate dehydrogenase M-subunit deficiency', 2),
(8450, 'ORPHA:284426', 'GSD type 11', 2),
(8451, 'ORPHA:284426', 'Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency', 2),
(8452, 'ORPHA:284426', 'Glycogen storage disease type 11', 2),
(8453, 'ORPHA:284426', 'Glycogenosis due to lactate dehydrogenase M-subunit deficiency', 2),
(8454, 'ORPHA:284426', 'Glycogenosis type 11', 2),
(8455, 'ORPHA:284426', 'LDH-M subunit deficiency', 2),
(8456, 'ORPHA:284426', 'Lactate dehydrogenase A deficiency', 2),
(8457, 'ORPHA:284435', 'GSD due to lactate dehydrogenase H-subunit deficiency', 2),
(8458, 'ORPHA:284435', 'Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency', 2),
(8459, 'ORPHA:284435', 'Glycogenosis due to lactate dehydrogenase H-subunit deficiency', 2),
(8460, 'ORPHA:284435', 'LDH-H subunit deficiency', 2),
(8461, 'ORPHA:284435', 'Lactate dehydrogenase B deficiency', 2),
(8462, 'ORPHA:284448', 'CLIPPERS', 1),
(8463, 'ORPHA:284448', 'Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids', 1),
(8464, 'ORPHA:284454', 'AZOOR', 1),
(8465, 'ORPHA:284454', 'Acute zonal occult outer retinopathy', 1),
(8466, 'ORPHA:284460', 'AAOR', 1),
(8467, 'ORPHA:284460', 'Acute annular outer retinopathy', 1),
(8468, 'ORPHA:2846', 'Congenital pericardium anomaly', 3),
(8469, 'ORPHA:2847', 'Pericardial and diaphragmatic defect', 1),
(8470, 'ORPHA:284786', 'Qualitative or quantitative defects of troponin', 3),
(8471, 'ORPHA:284790', 'Qualitative or quantitative defects of tropomyosin', 3),
(8472, 'ORPHA:2848', 'Arthropathy-camptodactyly syndrome', 1),
(8473, 'ORPHA:2848', 'CACP syndrome', 1),
(8474, 'ORPHA:2848', 'Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome', 1),
(8475, 'ORPHA:2848', 'Jacobs syndrome', 1),
(8476, 'ORPHA:2848', 'Pericarditis-arthropathy-camptodactyly syndrome', 1),
(8477, 'ORPHA:284804', 'Ocular albinism', 3),
(8478, 'ORPHA:284811', 'Syndromic oculocutaneous albinism', 3),
(8479, 'ORPHA:284814', 'Disorder of phenylalanine metabolism', 3),
(8480, 'ORPHA:284818', 'Disorder of tyrosine metabolism', 3),
(8481, 'ORPHA:2849', 'Nephroblastomatosis-fetal ascites-macrosomia-Wilms tumor syndrome', 1),
(8482, 'ORPHA:2849', 'Perlman syndrome', 1),
(8483, 'ORPHA:284963', 'MFS1', 2),
(8484, 'ORPHA:284963', 'Marfan syndrome type 1', 2),
(8485, 'ORPHA:284973', 'MFS2', 2),
(8486, 'ORPHA:284973', 'Marfan syndrome type 2', 2),
(8487, 'ORPHA:284979', 'Neonatal MFS', 1),
(8488, 'ORPHA:284979', 'Neonatal Marfan syndrome', 1),
(8489, 'ORPHA:284984', 'Aneurysm-osteoarthritis syndrome', 1),
(8490, 'ORPHA:284993', 'Marfan and Marfan-related disorders', 3),
(8491, 'ORPHA:285', 'EDS III', 1),
(8492, 'ORPHA:285', 'EDS-HT', 1),
(8493, 'ORPHA:285', 'Ehlers-Danlos syndrome hypermobility type', 1),
(8494, 'ORPHA:285', 'Ehlers-Danlos syndrome type 3', 1),
(8495, 'ORPHA:285', 'Hypermobile Ehlers-Danlos syndrome', 1),
(8496, 'ORPHA:285', 'hEDS', 1),
(8497, 'ORPHA:2850', 'Alopecia-intellectual disability syndrome', 1),
(8498, 'ORPHA:2850', 'Perniola-Krajewska-Carnevale syndrome', 1),
(8499, 'ORPHA:285014', 'Rare disease with thoracic aortic aneurysm and aortic dissection', 3),
(8500, 'ORPHA:2854', 'Fibular hypoplasia or aplasia-femoral bowing-oligodactyly syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(8501, 'ORPHA:2854', 'Fuhrmann syndrome', 1),
(8502, 'ORPHA:2854', 'Fuhrmann-Rieger-de Sousa syndrome', 1),
(8503, 'ORPHA:2855', 'Perrault syndrome', 1),
(8504, 'ORPHA:2855', 'XX gonodal dysgenesis-deafness syndrome', 1),
(8505, 'ORPHA:2855', 'XX gonodal dysgenesis-hearing loss syndrome', 1),
(8506, 'ORPHA:2856', 'PMDS', 1),
(8507, 'ORPHA:2856', 'Persistent Müllerian derivatives', 1),
(8508, 'ORPHA:2856', 'Persistent Müllerian duct syndrome', 1),
(8509, 'ORPHA:285657', 'Disorder of folate metabolism and transport', 3),
(8510, 'ORPHA:286', 'Arterial-ecchymotic EDS', 1),
(8511, 'ORPHA:286', 'EDS IV', 1),
(8512, 'ORPHA:286', 'Ehlers-Danlos syndrome type 4', 1),
(8513, 'ORPHA:286', 'Sack-Barabas syndrome', 1),
(8514, 'ORPHA:286', 'Vascular Ehlers-Danlos syndrome', 1),
(8515, 'ORPHA:286', 'vEDS', 1),
(8516, 'ORPHA:2863', 'Short stature-wormian bones-dextrocardia syndrome', 1),
(8517, 'ORPHA:2863', 'Stratton-Parker syndrome', 1),
(8518, 'ORPHA:2865', 'Al Gazali-Aziz-Salem syndrome', 1),
(8519, 'ORPHA:2865', 'Short stature-webbed neck-heart disease syndrome', 1),
(8520, 'ORPHA:2866', 'Short stature-deafness-neutrophil dysfunction-dysmorphism syndrome', 1),
(8521, 'ORPHA:2866', 'Short stature-hearing loss-neutrophil dysfunction-dysmorphism syndrome', 1),
(8522, 'ORPHA:2866', 'Thong-Douglas-Ferrante syndrome', 1),
(8523, 'ORPHA:2867', 'Mievis-Verellen-Dumoulin syndrome', 1),
(8524, 'ORPHA:2867', 'Short stature, Brussels type', 1),
(8525, 'ORPHA:2868', 'Short stature-valvular heart disease-characteristic facies syndrome', 1),
(8526, 'ORPHA:2869', 'Hamartomatous intestinal polyposis', 1),
(8527, 'ORPHA:2869', 'PJS', 1),
(8528, 'ORPHA:2869', 'Peutz-Jeghers syndrome', 1),
(8529, 'ORPHA:2869', 'Polyps and spots syndrome', 1),
(8530, 'ORPHA:287', 'Classical EDS', 1),
(8531, 'ORPHA:287', 'Classical Ehlers-Danlos syndrome', 1),
(8532, 'ORPHA:287', 'cEDS', 1),
(8533, 'ORPHA:2871', 'Pfeiffer-Palm-Teller syndrome', 1),
(8534, 'ORPHA:2872', 'Cardiocranial syndrome, Pfeiffer type', 1),
(8535, 'ORPHA:2872', 'Craniosynostosis-congenital heart disease-intellectual disability syndrome', 1),
(8536, 'ORPHA:2872', 'Pfeiffer-Singer-Zschiesche syndrome', 1),
(8537, 'ORPHA:2874', 'Phakomatosis pigmentokeratotica', 1),
(8538, 'ORPHA:2875', 'Phakomatosis pigmentovascularis', 1),
(8539, 'ORPHA:2876', 'PHAVER syndrome', 1),
(8540, 'ORPHA:2876', 'Powell-Chandra-Saal syndrome', 1),
(8541, 'ORPHA:2878', 'Phocomelia-ectrodactyly-deafness-sinus arrhythmia syndrome', 1),
(8542, 'ORPHA:2878', 'Phocomelia-ectrodactyly-hearing loss-sinus arrhythmia syndrome', 1),
(8543, 'ORPHA:2878', 'Stoll-Lévy-Francfort syndrome', 1),
(8544, 'ORPHA:2879', 'Al Awadi-Raas-Rothschild syndrome', 1),
(8545, 'ORPHA:2879', 'Aplasia/hypoplasia of limbs and pelvis', 1),
(8546, 'ORPHA:2879', 'Congenital absence of ulna and fibula', 1),
(8547, 'ORPHA:2879', 'Phocomelia, Schinzel type', 1),
(8548, 'ORPHA:2879', 'Severe limb deficit', 1),
(8549, 'ORPHA:288', 'HE', 1),
(8550, 'ORPHA:288', 'Hereditary elliptocytosis', 1),
(8551, 'ORPHA:2880', 'PEPCK deficiency', 1),
(8552, 'ORPHA:2880', 'Phosphoenolpyruvate carboxykinase deficiency', 1),
(8553, 'ORPHA:2881', 'Cutaneous photosensitivity-lethal colitis syndrome', 1),
(8554, 'ORPHA:2882', 'Phytosterolemia', 1),
(8555, 'ORPHA:2882', 'Sitosterolemia', 1),
(8556, 'ORPHA:2884', 'Piebaldism', 1),
(8557, 'ORPHA:2885', 'Piebald trait-neurologic defects syndrome', 1),
(8558, 'ORPHA:2885', 'Telfer-Sugar-Jaeger syndrome', 1),
(8559, 'ORPHA:2886', 'Pierre Robin sequence-congenital heart defect-talipes syndrome', 1),
(8560, 'ORPHA:2886', 'Pierre Robin syndrome-congenital heart defect-talipes syndrome', 1),
(8561, 'ORPHA:2886', 'TARP syndrome', 1),
(8562, 'ORPHA:2886', 'Talipes equinovarus-atrial septal defect-Robin sequence-persistence of the left superior vena cava syndrome', 1),
(8563, 'ORPHA:2888', 'Chitayat-Meunier-Hodgkinson syndrome', 1),
(8564, 'ORPHA:2888', 'Pierre Robin sequence-faciodigital anomaly syndrome', 1),
(8565, 'ORPHA:2888', 'Pierre Robin syndrome-faciodigital anomaly syndrome', 1),
(8566, 'ORPHA:2889', 'Pili torti', 1),
(8567, 'ORPHA:2889', 'Twisted hair', 1),
(8568, 'ORPHA:289', 'Chondroectodermal dysplasia', 1),
(8569, 'ORPHA:289', 'Ellis Van Creveld syndrome', 1),
(8570, 'ORPHA:289', 'Mesodermic dysplasia', 1),
(8571, 'ORPHA:2890', 'Pili torti-onychodysplasia syndrome', 1),
(8572, 'ORPHA:289098', 'Disorders of vitamin D metabolism', 3),
(8573, 'ORPHA:2891', 'Pili torti-developmental delay-neurological abnormalities syndrome', 1),
(8574, 'ORPHA:289103', 'Hypocalcemic rickets', 3),
(8575, 'ORPHA:289157', '1-alpha-hydroxylase deficiency', 1),
(8576, 'ORPHA:289157', 'Hypocalcemic vitamin D-dependent rickets', 1),
(8577, 'ORPHA:289157', 'PDDRI', 1),
(8578, 'ORPHA:289157', 'Pseudovitamin D-deficient rickets', 1),
(8579, 'ORPHA:289157', 'VDDI', 1),
(8580, 'ORPHA:289157', 'VDDR-I', 1),
(8581, 'ORPHA:289157', 'Vitamin D dependent rickets type I', 1),
(8582, 'ORPHA:289157', 'Vitamin D-dependency type I', 1),
(8583, 'ORPHA:289176', 'ARHR', 1),
(8584, 'ORPHA:289176', 'Autosomal recessive hypophosphatemic rickets', 1),
(8585, 'ORPHA:2892', 'Euhidrotic ectodermal dysplasia', 1),
(8586, 'ORPHA:2892', 'Kopysc-Barczyk-Krol syndrome', 1),
(8587, 'ORPHA:2892', 'Pilodental dysplasia-refractive errors syndrome', 1),
(8588, 'ORPHA:289266', 'Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation', 1),
(8589, 'ORPHA:289290', 'ADK hypermethioninemia', 1),
(8590, 'ORPHA:289290', 'Hypermethioninemia encephalopathy due to ADK deficiency', 1),
(8591, 'ORPHA:289290', 'Hypermethioninemia encephalopathy due to adenosine kinase deficiency', 1),
(8592, 'ORPHA:289307', 'Developmental delay due to ALDH6A1 deficiency', 1),
(8593, 'ORPHA:289307', 'Developmental delay due to MMSDH deficiency', 1),
(8594, 'ORPHA:289307', 'Developmental delay due to methylmalonate semialdehyde dehydrogenase deficiency', 1),
(8595, 'ORPHA:289326', 'HAM/TSP', 1),
(8596, 'ORPHA:289326', 'HTLV-1-associated myelopathy/tropical spastic paraparesis', 1),
(8597, 'ORPHA:289326', 'Human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis', 1),
(8598, 'ORPHA:289326', 'Human T-lymphotropic virus type-1-associated myelopathy/tropical spastic paraparesis', 1),
(8599, 'ORPHA:289326', 'TSP', 1),
(8600, 'ORPHA:289326', 'Tropical spastic paraparesis', 1),
(8601, 'ORPHA:289347', 'IDH', 1),
(8602, 'ORPHA:289347', 'Infective dermatitis associated with HTLV-1', 1),
(8603, 'ORPHA:289347', 'Infective dermatitis associated with human T-lymphotropic virus type 1', 1),
(8604, 'ORPHA:289347', 'Infective dermatitis associated with human T-lymphotropic virus type I', 1),
(8605, 'ORPHA:289356', 'NGCO', 1),
(8606, 'ORPHA:289356', 'Primary non-gestational choriocarcinoma of ovary', 1),
(8607, 'ORPHA:289356', 'Primary non-gestational ovarian choriocarcinoma', 1),
(8608, 'ORPHA:289362', 'Non-CNS-localized embryonal carcinoma', 2),
(8609, 'ORPHA:289362', 'Non-central nervous system-localized embryonal carcinoma', 2),
(8610, 'ORPHA:289365', 'Familial VUR', 1),
(8611, 'ORPHA:289365', 'Familial vesicoureteral reflux', 1),
(8612, 'ORPHA:289377', 'EOMFC', 1),
(8613, 'ORPHA:289377', 'Early-onset myopathy with fatal cardiomyopathy', 1),
(8614, 'ORPHA:289377', 'Salih myopathy', 1),
(8615, 'ORPHA:289380', 'Congenital myosclerosis, Löwenthal type', 1),
(8616, 'ORPHA:289380', 'Myosclerosis', 1),
(8617, 'ORPHA:289385', 'Cancer diagnosed during pregnancy', 1),
(8618, 'ORPHA:289385', 'Malignancy diagnosed during pregnancy', 1),
(8619, 'ORPHA:289390', 'Primary Sjögren syndrome', 1),
(8620, 'ORPHA:289390', 'Primary Sjögren-Gougerot syndrome', 1),
(8621, 'ORPHA:289465', 'Congenital absence of fingerprints', 1),
(8622, 'ORPHA:289465', 'Immigration delay disease', 1),
(8623, 'ORPHA:289465', 'Isolated congenital adermatoglyphia', 1),
(8624, 'ORPHA:289478', 'PASH syndrome', 1),
(8625, 'ORPHA:289478', 'Pyoderma gangrenosum-acne-suppurative hidradenitis syndrome', 1),
(8626, 'ORPHA:289483', 'Intellectual disability-alacrima-achalasia syndrome', 1),
(8627, 'ORPHA:289494', '4H leukodystrophy', 1),
(8628, 'ORPHA:289494', 'POLR-related leukodystrophy', 1),
(8629, 'ORPHA:289499', 'CCMCO', 1),
(8630, 'ORPHA:289499', 'Congenital cataract microcornea with corneal opacity', 1),
(8631, 'ORPHA:289504', 'CMAMMA', 1),
(8632, 'ORPHA:289504', 'Combined malonic and methylmalonic acidemia', 1),
(8633, 'ORPHA:289504', 'Combined malonic and methylmalonic aciduria', 1),
(8634, 'ORPHA:289513', '12q15q21.1 microdeletion syndrome', 1),
(8635, 'ORPHA:289513', 'Del(12)(q15)(q21.1)', 1),
(8636, 'ORPHA:289513', 'Deletion 12q15q21.1', 1),
(8637, 'ORPHA:289513', 'Monosomy 12q15q21.1', 1),
(8638, 'ORPHA:289522', 'Microtriplication 11q24.1', 1),
(8639, 'ORPHA:289522', 'Tetrasomy 11q24.1', 1),
(8640, 'ORPHA:289539', 'BAP1-related tumor predisposition syndrome', 1),
(8641, 'ORPHA:289539', 'Tumor susceptibility linked to germline BAP1 mutations', 1),
(8642, 'ORPHA:289548', 'Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency', 1),
(8643, 'ORPHA:289553', 'Dysmorphism-conductive hearing loss-heart defect syndrome', 1),
(8644, 'ORPHA:289560', 'MPAN', 1),
(8645, 'ORPHA:289560', 'Mitochondrial membrane protein-associated neurodegeneration', 1),
(8646, 'ORPHA:289560', 'NBIA due to C19orf12 mutation', 1),
(8647, 'ORPHA:289560', 'NBIA4', 1),
(8648, 'ORPHA:289560', 'Neurodegeneration with brain iron accumulation due to C19orf12 mutation', 1),
(8649, 'ORPHA:289560', 'Neurodegeneration with brain iron accumulation type 4', 1),
(8650, 'ORPHA:289573', 'Multiple mitochondrial dysfunctions syndrome', 3),
(8651, 'ORPHA:289586', 'Autosomal recessive exfoliative ichthyosis', 1),
(8652, 'ORPHA:289586', 'Exfoliative ichthyosis', 1),
(8653, 'ORPHA:289586', 'Ichthyosis exfoliativa', 1),
(8654, 'ORPHA:289596', 'JNA', 1),
(8655, 'ORPHA:289596', 'Juvenile nasopharyngeal angiofibroma', 1),
(8656, 'ORPHA:2896', 'Pitt-Hopkins syndrome', 1),
(8657, 'ORPHA:289601', 'CALJA', 1),
(8658, 'ORPHA:289601', 'Calcification of joints and arteries', 1),
(8659, 'ORPHA:289601', 'Hereditary arterial and articular multiple calcification syndrome', 1),
(8660, 'ORPHA:289635', 'Rare virus associated tumor', 3),
(8661, 'ORPHA:289638', 'EBV-related tumor', 3),
(8662, 'ORPHA:289638', 'Epstein-Barr Virus-related tumor', 3),
(8663, 'ORPHA:289644', 'EBV-associated lymphoproliferative disorder', 3),
(8664, 'ORPHA:289644', 'Epstein-Barr virus-associated malignant lymphoproliferative disorder', 3),
(8665, 'ORPHA:289651', 'EBV-associated carcinoma', 3),
(8666, 'ORPHA:289651', 'Epstein-Barr Virus-associated carcinoma', 3),
(8667, 'ORPHA:289656', 'EBV-associated mesenchymal tumor', 3),
(8668, 'ORPHA:289656', 'Epstein-Barr Virus-associated mesenchymal tumor', 3),
(8669, 'ORPHA:289661', 'EBV-positive DLBCL of the elderly', 1),
(8670, 'ORPHA:289661', 'Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly', 1),
(8671, 'ORPHA:289666', 'PBL', 1),
(8672, 'ORPHA:289666', 'Plasmablastic lymphoma', 1),
(8673, 'ORPHA:289682', 'Lymphoepithelial-like carcinoma', 1),
(8674, 'ORPHA:289685', 'Myopericytoma', 1),
(8675, 'ORPHA:2897', 'Pityriasis rubra pilaris', 1),
(8676, 'ORPHA:2898', 'Hyde Forster-McCarthy-Berry syndrome', 1),
(8677, 'ORPHA:2898', 'X-linked intellectual disability-plagiocephaly syndrome', 1),
(8678, 'ORPHA:289825', 'Late-onset primary lymphedema without systemic or visceral involvement', 3),
(8679, 'ORPHA:289829', 'Disorder of tryptophan metabolism', 3),
(8680, 'ORPHA:289832', 'Disorder of lysine and hydroxylysine metabolism', 3),
(8681, 'ORPHA:289841', 'Disorder of glutamine metabolism', 3),
(8682, 'ORPHA:289846', 'Glutathione synthetase deficiency with 5-oxoprolinuria', 2),
(8683, 'ORPHA:289849', 'Glutathione synthetase deficiency without 5-oxoprolinuria', 2),
(8684, 'ORPHA:289857', 'Classic glycine encephalopathy', 2),
(8685, 'ORPHA:289857', 'Neonatal NKH', 2),
(8686, 'ORPHA:289857', 'Neonatal glycine encephalopathy', 2),
(8687, 'ORPHA:289857', 'Neonatal non-ketotic hyperglycinemia', 2),
(8688, 'ORPHA:289860', 'Infantile NKH', 2),
(8689, 'ORPHA:289860', 'Infantile glycine encephalopathy', 2),
(8690, 'ORPHA:289860', 'Infantile non-ketotic hyperglycinemia', 2),
(8691, 'ORPHA:289863', 'Atypical NKA', 2),
(8692, 'ORPHA:289863', 'Atypical glycine encephalopathy', 2),
(8693, 'ORPHA:289863', 'Atypical non-ketotic hyperglycinemia', 2),
(8694, 'ORPHA:289866', 'Disorder of proline metabolism', 3),
(8695, 'ORPHA:289869', 'Disorder of ornithine metabolism', 3),
(8696, 'ORPHA:289877', 'Transient hyperammonemia of the newborn', 1),
(8697, 'ORPHA:289891', 'Glycine N-methyltransferase deficiency', 1),
(8698, 'ORPHA:289891', 'Hypermethioninemia due to GNMT deficiency', 1),
(8699, 'ORPHA:289891', 'Hypermethioninemia due to glycine N-methyltransferase deficiency', 1),
(8700, 'ORPHA:289899', 'Organic aciduria', 3),
(8701, 'ORPHA:2899', 'Brachyolmia-amelogenesis imperfecta syndrome', 1),
(8702, 'ORPHA:2899', 'Platyspondyly-amelogenesis imperfecta syndrome', 1),
(8703, 'ORPHA:2899', 'Verloes-Bourguignon syndrome', 1),
(8704, 'ORPHA:289902', '3-methylglutaconic aciduria', 3),
(8705, 'ORPHA:289916', 'Complete deficiency of methylmalonyl-CoA mutase', 2),
(8706, 'ORPHA:289916', 'Vitamin B12-unresponsive methylmalonic acidemia type mut0', 2),
(8707, 'ORPHA:289916', 'Vitamin B12-unresponsive methylmalonic aciduria type mut0', 2),
(8708, 'ORPHA:29', 'Complete mevalonate kinase deficiency', 1),
(8709, 'ORPHA:29', 'MVA', 1),
(8710, 'ORPHA:29', 'Mevalonic aciduria', 1),
(8711, 'ORPHA:290', 'CRS', 1),
(8712, 'ORPHA:290', 'Congenital rubella syndrome', 1),
(8713, 'ORPHA:290', 'Fetal rubella syndrome', 1),
(8714, 'ORPHA:290', 'Mother-to-child transmission of rubella syndrome', 1),
(8715, 'ORPHA:2900', 'Leri pleonosteosis', 1),
(8716, 'ORPHA:2901', 'Acute brachial plexus neuritis', 1),
(8717, 'ORPHA:2901', 'Brachial plexus neuritis', 1),
(8718, 'ORPHA:2901', 'Immune brachial plexus neuropathy', 1),
(8719, 'ORPHA:2901', 'Mononeuritis multiplex with brachial predilection', 1),
(8720, 'ORPHA:2901', 'Neuralgic amyotrophy', 1),
(8721, 'ORPHA:2901', 'Neuralgic shoulder amyotrophy', 1),
(8722, 'ORPHA:2902', 'Chronic eosinophilic pneumonia', 1),
(8723, 'ORPHA:2902', 'Idiopathic chronic eosinophilic pneumonia', 1),
(8724, 'ORPHA:2903', 'Familial spontaneous pneumothorax', 1),
(8725, 'ORPHA:2905', 'Crow-Fukase syndrome', 1),
(8726, 'ORPHA:2905', 'Osteosclerotic myeloma', 1),
(8727, 'ORPHA:2905', 'PEP syndrome', 1),
(8728, 'ORPHA:2905', 'POEMS syndrome', 1),
(8729, 'ORPHA:2905', 'Polyneuropathy-endocrinopathy-plasma cell dyscrasia syndrome', 1),
(8730, 'ORPHA:2905', 'Takatsuki syndrome', 1),
(8731, 'ORPHA:2907', 'Hereditary acrokeratotic poikiloderma', 1),
(8732, 'ORPHA:2907', 'Weary syndrome', 1),
(8733, 'ORPHA:29072', 'Familial pheochromocytoma-paraganglioma', 1),
(8734, 'ORPHA:29072', 'Hereditary pheochromocytoma-paraganglioma', 1),
(8735, 'ORPHA:29073', 'Kahler disease', 1),
(8736, 'ORPHA:29073', 'Medullary plasmacytoma', 1),
(8737, 'ORPHA:29073', 'Multiple myeloma', 1),
(8738, 'ORPHA:29073', 'Myelomatosis', 1),
(8739, 'ORPHA:29073', 'Plasma cell myeloma', 1),
(8740, 'ORPHA:2908', 'Congenital bullous poikiloderma', 1),
(8741, 'ORPHA:2908', 'Kindler syndrome', 1),
(8742, 'ORPHA:2908', 'Poikiloderma of Kindler', 1),
(8743, 'ORPHA:290836', 'Systemic disease with skin involvement', 3),
(8744, 'ORPHA:290839', 'Autoinflammatory syndrome with immune deficiency', 3),
(8745, 'ORPHA:290842', 'Autoinflammatory syndrome with skin involvement', 3),
(8746, 'ORPHA:290849', 'Rare head and neck tumor', 3),
(8747, 'ORPHA:2909', 'Poikiloderma of Rothmund-Thomson', 1),
(8748, 'ORPHA:2909', 'RTS', 1),
(8749, 'ORPHA:2909', 'Rothmund-Thomson syndrome', 1),
(8750, 'ORPHA:291', 'Antenatal varicella virus infection', 1),
(8751, 'ORPHA:291', 'Congenital varicella syndrome', 1),
(8752, 'ORPHA:291', 'Mother-to-child transmission of varicella syndrome', 1),
(8753, 'ORPHA:2911', 'Poland anomaly', 1),
(8754, 'ORPHA:2911', 'Poland sequence', 1),
(8755, 'ORPHA:2911', 'Poland syndrome', 1),
(8756, 'ORPHA:2912', 'Poliomyelitis', 1),
(8757, 'ORPHA:2913', 'Non-syndromic polydactyly', 3),
(8758, 'ORPHA:2916', 'Postaxial polydactyly-dental and vertebral anomalies syndrome', 1),
(8759, 'ORPHA:2917', 'Czeizel-Brooser syndrome', 1),
(8760, 'ORPHA:2917', 'Polydactyly-myopia syndrome', 1),
(8761, 'ORPHA:2919', 'OFD5', 1),
(8762, 'ORPHA:2919', 'Oral-facial-digital syndrome type 5', 1),
(8763, 'ORPHA:2919', 'Orofaciodigital syndrome type 5', 1),
(8764, 'ORPHA:2919', 'Orofaciodigital syndrome, Thurston type', 1),
(8765, 'ORPHA:2919', 'Polydactyly postaxial with median cleft of upper lip', 1),
(8766, 'ORPHA:2919', 'Thurston syndrome', 1),
(8767, 'ORPHA:292', 'Antenatal enterovirus infection', 1),
(8768, 'ORPHA:292', 'Congenital enterovirus infection', 1),
(8769, 'ORPHA:292', 'Mother-to-child transmission of enterovirus infection', 1),
(8770, 'ORPHA:2920', 'Oliver syndrome', 1),
(8771, 'ORPHA:2920', 'Postaxial polydactyly-intellectual disability syndrome', 1),
(8772, 'ORPHA:29207', 'Arthritis urethritica', 1),
(8773, 'ORPHA:29207', 'Fiessinger-Leroy disease', 1),
(8774, 'ORPHA:29207', 'Fiessinger-Leroy-Reiter syndrome', 1),
(8775, 'ORPHA:29207', 'Polyarthritis enterica', 1),
(8776, 'ORPHA:29207', 'Reactive arthritis', 1),
(8777, 'ORPHA:29207', 'Reiter disease', 1),
(8778, 'ORPHA:29207', 'Reiter syndrome', 1),
(8779, 'ORPHA:29207', 'Venereal arthritis', 1),
(8780, 'ORPHA:2921', 'Pfeiffer-Mayer syndrome', 1),
(8781, 'ORPHA:2921', 'Preaxial polydactyly-colobomata-intellectual disability syndrome', 1),
(8782, 'ORPHA:2924', 'ADPCLD', 1),
(8783, 'ORPHA:2924', 'Autosomal dominant polycystic liver disease', 1),
(8784, 'ORPHA:2924', 'Isolated polycystic liver disease', 1),
(8785, 'ORPHA:2924', 'PCLD', 1),
(8786, 'ORPHA:2926', 'Congenital aplasia of the extensor muscles of the fingers and thumb associated with generalized polyneuropathy', 1),
(8787, 'ORPHA:2926', 'Digital extensor muscle aplasia-polyneuropathy', 1),
(8788, 'ORPHA:2926', 'Hamanishi-Ueba-Tsuji syndrome', 1),
(8789, 'ORPHA:2926', 'Polyneuropathy-hand defect syndrome', 1),
(8790, 'ORPHA:2928', 'Lundberg syndrome', 1),
(8791, 'ORPHA:2928', 'Polyneuropathy-intellectual disability-acromicria-premature menopause syndrome', 1),
(8792, 'ORPHA:2929', 'JIP', 1),
(8793, 'ORPHA:2929', 'JPS', 1),
(8794, 'ORPHA:2929', 'Juvenile gastrointestinal polyposis', 1),
(8795, 'ORPHA:2929', 'Juvenile intestinal polyposis', 1),
(8796, 'ORPHA:2929', 'Juvenile polyposis syndrome', 1),
(8797, 'ORPHA:293', 'Antenatal herpes simplex virus infection', 1),
(8798, 'ORPHA:293', 'Congenital herpes simplex virus infection', 1),
(8799, 'ORPHA:293', 'Mother-to-child transmission of herpes simplex virus infection', 1),
(8800, 'ORPHA:2930', 'Cronkhite-Canada syndrome', 1),
(8801, 'ORPHA:2930', 'Gastrointestinal polyposis-ectodermal changes syndrome', 1),
(8802, 'ORPHA:2930', 'Gastrointestinal polyposis-skin pigmentation-alopecia-fingernail changes syndrome', 1),
(8803, 'ORPHA:293144', 'Familial clubfoot due to 5q31 microdeletion', 2),
(8804, 'ORPHA:293144', 'Hereditary clubfoot due to 5q31 microdeletion', 2),
(8805, 'ORPHA:293150', 'Familial clubfoot due to PITX1 point mutation', 2),
(8806, 'ORPHA:293150', 'Hereditary clubfoot due to PITX1 point mutation', 2),
(8807, 'ORPHA:293165', 'Skin fragility-woolly hair-palmoplantar hyperkeratosis syndrome', 1),
(8808, 'ORPHA:293165', 'Skin fragility-woolly hair-palmoplantar keratoderma syndrome', 1),
(8809, 'ORPHA:293168', 'IAHSP', 1),
(8810, 'ORPHA:293168', 'Infantile-onset ascending hereditary spastic paralysis', 1),
(8811, 'ORPHA:293173', 'AGEP', 1),
(8812, 'ORPHA:293173', 'Acute generalized exanthematous pustulosis', 1),
(8813, 'ORPHA:293173', 'Pustular drug eruption', 1),
(8814, 'ORPHA:293173', 'Toxic pustuloderma', 1),
(8815, 'ORPHA:293181', 'Epilepsy of infancy with migrating focal seizures', 1),
(8816, 'ORPHA:293181', 'MMPEI', 1),
(8817, 'ORPHA:293181', 'MMPSI', 1),
(8818, 'ORPHA:293181', 'MPEI', 1),
(8819, 'ORPHA:293181', 'MPSI', 1),
(8820, 'ORPHA:293181', 'Malignant migrating focal seizures of infancy', 1),
(8821, 'ORPHA:293181', 'Malignant migrating partial epilepsy of infancy', 1),
(8822, 'ORPHA:293181', 'Malignant migrating partial seizures of infancy', 1),
(8823, 'ORPHA:293181', 'Migrating partial epilepsy of infancy', 1),
(8824, 'ORPHA:293181', 'Migrating partial seizures of infancy', 1),
(8825, 'ORPHA:293199', 'Pleomorphic rhabdomyosarcoma', 2),
(8826, 'ORPHA:2932', 'CIDP', 1),
(8827, 'ORPHA:2932', 'Chronic inflammatory demyelinating polyneuropathy', 1),
(8828, 'ORPHA:2932', 'Chronic inflammatory demyelinating polyradiculoneuropathy', 1),
(8829, 'ORPHA:293202', 'Epithelioid sarcoma', 1),
(8830, 'ORPHA:293208', 'Celiac artery compression syndrome', 1),
(8831, 'ORPHA:293208', 'Dunbar syndrome', 1),
(8832, 'ORPHA:293208', 'MALS', 1),
(8833, 'ORPHA:293208', 'Median arcuate ligament syndrome', 1),
(8834, 'ORPHA:293284', 'BH4-responsive HPA/PKU', 2),
(8835, 'ORPHA:293284', 'BH4-responsive hyperphenylalaninemia/phenylketonuria', 2),
(8836, 'ORPHA:293284', 'Tetrahydrobiopterin-responsive HPA/PKU', 2),
(8837, 'ORPHA:293284', 'Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria', 2),
(8838, 'ORPHA:293355', 'Methylmalonic acidemia without homocystinuria', 3),
(8839, 'ORPHA:293355', 'Methylmalonic aciduria without homocystinuria', 3),
(8840, 'ORPHA:293375', 'GWCD', 1),
(8841, 'ORPHA:293375', 'Grayson-Wilbrandt corneal dystrophy', 1),
(8842, 'ORPHA:293381', 'Dystrophia Helsinglandica', 1),
(8843, 'ORPHA:293381', 'Dystrophia Smolandiensis', 1),
(8844, 'ORPHA:293381', 'ERED', 1),
(8845, 'ORPHA:293381', 'Epithelial recurrent erosion dystrophy', 1),
(8846, 'ORPHA:293381', 'Recurrent hereditary corneal erosions', 1),
(8847, 'ORPHA:2934', 'Bonneau syndrome', 1),
(8848, 'ORPHA:2934', 'Polysyndactyly-cardiac malformation syndrome', 1),
(8849, 'ORPHA:293462', 'PDCD', 1),
(8850, 'ORPHA:293462', 'Pre-Descemet corneal dystrophy', 1),
(8851, 'ORPHA:2935', 'Crossed polysyndactyly', 1),
(8852, 'ORPHA:293603', 'Autosomal recessive CHED', 1),
(8853, 'ORPHA:293603', 'Autosomal recessive congenital hereditary endothelial dystrophy', 1),
(8854, 'ORPHA:293603', 'CHED2', 1),
(8855, 'ORPHA:293603', 'CHEDII', 1),
(8856, 'ORPHA:293603', 'Congenital hereditary endothelial dystrophy type 2', 1),
(8857, 'ORPHA:293603', 'Congenital hereditary endothelial dystrophy type II', 1),
(8858, 'ORPHA:293603', 'Infantile hereditary endothelial dystrophy', 1),
(8859, 'ORPHA:293603', 'Maumenee corneal dystrophy', 1),
(8860, 'ORPHA:293621', 'X-linked endothelial corneal dystrophy', 1),
(8861, 'ORPHA:293621', 'XECD', 1),
(8862, 'ORPHA:293633', 'PYCR1 deficiency', 2),
(8863, 'ORPHA:293633', 'PYCR1-related De Barsy syndrome', 2),
(8864, 'ORPHA:293633', 'Pyrroline-5-carboxylate reductase 1 deficiency', 2),
(8865, 'ORPHA:293642', 'BMRS', 3),
(8866, 'ORPHA:293642', 'Blepharophimosis-intellectual disability syndrome', 3),
(8867, 'ORPHA:293707', 'BMRS, MKB type', 1),
(8868, 'ORPHA:293707', 'BMRS, Maat-Kievit-Brunner type', 1),
(8869, 'ORPHA:293707', 'Blepharophimosis-intellectual disability syndrome, MKB type', 1),
(8870, 'ORPHA:293707', 'Blepharophimosis-intellectual disability syndrome, Maat-Kievit-Brunner type', 1),
(8871, 'ORPHA:293707', 'X-linked Ohdo syndrome', 1),
(8872, 'ORPHA:293725', 'BMRS type V', 1),
(8873, 'ORPHA:293725', 'BMRS, Verloes type', 1),
(8874, 'ORPHA:293725', 'Blepharophimosis-intellectual disability syndrome type V', 1),
(8875, 'ORPHA:293725', 'Blepharophimosis-intellectual disability syndrome, Verloes type', 1),
(8876, 'ORPHA:293807', 'Ketamine-induced biliary dilatation', 1),
(8877, 'ORPHA:293812', 'Fixed drug eruption', 1),
(8878, 'ORPHA:293815', 'Toxic dermatosis', 3),
(8879, 'ORPHA:293822', 'MITF-related melanoma and renal cell carcinoma predisposition syndrome', 1),
(8880, 'ORPHA:293825', 'CDA IV', 1),
(8881, 'ORPHA:293825', 'CDA due to KLF1 mutation', 1),
(8882, 'ORPHA:293825', 'CDA type 4', 1),
(8883, 'ORPHA:293825', 'CDA type IV', 1),
(8884, 'ORPHA:293825', 'CDAN4', 1),
(8885, 'ORPHA:293825', 'Congenital dyserythropoietic anemia due to KLF1 mutation', 1),
(8886, 'ORPHA:293825', 'Congenital dyserythropoietic anemia type 4', 1),
(8887, 'ORPHA:293825', 'Congenital dyserythropoietic anemia type IV', 1),
(8888, 'ORPHA:293830', 'Constitutional dyserythropoietic anemia', 3),
(8889, 'ORPHA:293843', '3MC syndrome', 1),
(8890, 'ORPHA:293843', 'Craniofacial-ulnar-renal syndrome', 1),
(8891, 'ORPHA:293843', 'Malpuech-Michels-Mingarelli-Carnevale syndrome', 1),
(8892, 'ORPHA:293864', 'Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome', 1),
(8893, 'ORPHA:293888', 'Familial isolated arrhythmogenic ventricular cardiomyopathy, left dominant form', 2),
(8894, 'ORPHA:293888', 'Familial isolated arrhythmogenic ventricular dysplasia, left dominant form', 2),
(8895, 'ORPHA:293899', 'Familial isolated arrhythmogenic ventricular cardiomyopathy, biventricular form', 2),
(8896, 'ORPHA:293899', 'Familial isolated arrhythmogenic ventricular dysplasia, biventricular form', 2),
(8897, 'ORPHA:293910', 'Familial isolated arrhythmogenic ventricular cardiomyopathy, classic form', 2),
(8898, 'ORPHA:293910', 'Familial isolated arrhythmogenic ventricular cardiomyopathy, right dominant form', 2),
(8899, 'ORPHA:293910', 'Familial isolated arrhythmogenic ventricular dysplasia, classic form', 2),
(8900, 'ORPHA:293910', 'Familial isolated arrhythmogenic ventricular dysplasia, right dominant form', 2),
(8901, 'ORPHA:293925', 'Lethal occipital encephalocele-skeletal dysplasia syndrome', 1),
(8902, 'ORPHA:293936', 'Autosomal dominant keratoconus with early-onset anterior polar cataracts', 1),
(8903, 'ORPHA:293936', 'EDICT syndrome', 1),
(8904, 'ORPHA:293936', 'Endothelial dystrophy-iris hypoplasia-congenital cataract-stromal thinning syndrome', 1),
(8905, 'ORPHA:293936', 'Familial keratoconus with cataract', 1),
(8906, 'ORPHA:293936', 'KTCNCT', 1),
(8907, 'ORPHA:293939', 'Distal Xq28 microduplication syndrome', 1),
(8908, 'ORPHA:293939', 'Distal dup(X)q(28)', 1),
(8909, 'ORPHA:293939', 'Distal trisomy Xq28', 1),
(8910, 'ORPHA:293948', '1p21.3 microdeletion syndrome', 1),
(8911, 'ORPHA:293948', 'Del(1)(p21.3)', 1),
(8912, 'ORPHA:293948', 'Monosomy 1p21.3', 1),
(8913, 'ORPHA:293955', 'Childhood encephalopathy due to thiamine pyrophosphokinase deficiency', 1),
(8914, 'ORPHA:293958', 'HPPD', 1),
(8915, 'ORPHA:293958', 'Hypertelorism-preauricular sinus-punctual pits-deafness syndrome', 1),
(8916, 'ORPHA:293958', 'Hypertelorism-preauricular sinus-punctual pits-hearing loss syndrome', 1),
(8917, 'ORPHA:293964', 'Hypoinsulinemic hypoglycemia and body hemihypertrophy', 1),
(8918, 'ORPHA:293967', 'Hypogonadotropic hypogonadism-severe microcephaly-sensorineural deafness-dysmorphism syndrome', 1),
(8919, 'ORPHA:293967', 'Hypogonadotropic hypogonadism-severe microcephaly-sensorineural hearing loss-dysmorphism syndrome', 1),
(8920, 'ORPHA:293978', 'DAVID syndrome', 1),
(8921, 'ORPHA:293978', 'Deficiency in anterior pituitary function-variable immunodeficiency syndrome', 1),
(8922, 'ORPHA:293987', 'ROHHAD', 1),
(8923, 'ORPHA:293987', 'ROHHADNET', 1),
(8924, 'ORPHA:293987', 'Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome', 1),
(8925, 'ORPHA:293987', 'Rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation-neural tumors syndrome', 1),
(8926, 'ORPHA:294', 'Antenatal CMV infection', 1),
(8927, 'ORPHA:294', 'Antenatal cytomegalovirus infection', 1),
(8928, 'ORPHA:294', 'Fetal cytomegalovirus syndrome', 1),
(8929, 'ORPHA:294', 'Mother-to-child transmission of cytomegalovirus syndrome', 1),
(8930, 'ORPHA:2940', 'Porencephaly', 1),
(8931, 'ORPHA:294016', 'MIC-CAP syndrome', 1),
(8932, 'ORPHA:294016', 'MIC-CM syndrome', 1),
(8933, 'ORPHA:294016', 'Microcephaly-capillary malformation syndrome', 1),
(8934, 'ORPHA:294016', 'Microcephaly-cutaneous capillary malformation syndrome', 1),
(8935, 'ORPHA:294023', 'Neonatal inflammatory skin and bowel disease', 1),
(8936, 'ORPHA:294026', 'Syndactyly-nystagmus syndrome due to 2q31.1 microduplication', 1),
(8937, 'ORPHA:294026', 'Syndactyly-nystagmus syndrome due to dup(2)(q31.1)', 1),
(8938, 'ORPHA:294026', 'Syndactyly-nystagmus syndrome due to trisomy 2q31.1', 1),
(8939, 'ORPHA:294049', 'Multiple joint dislocations-short stature-hyperlaxity-craniofacial dysmorphism syndrome', 1),
(8940, 'ORPHA:294049', 'Reunion Island Larsen-like syndrome', 1),
(8941, 'ORPHA:294057', 'Rare nevus', 3),
(8942, 'ORPHA:294060', 'Multiple pterygium syndrome', 3),
(8943, 'ORPHA:2941', 'Bonnemann-Meinecke syndrome', 1),
(8944, 'ORPHA:2941', 'Porencephaly-cerebellar hypoplasia-internal malformations syndrome', 1),
(8945, 'ORPHA:2942', 'Postpolio sequelae', 1),
(8946, 'ORPHA:2942', 'Postpolio syndrome', 1),
(8947, 'ORPHA:2942', 'Postpoliomyelitic syndrome', 1),
(8948, 'ORPHA:2942', 'Postpoliomyelitis sequelae', 1),
(8949, 'ORPHA:2942', 'Postpoliomyelitis syndrome', 1),
(8950, 'ORPHA:294415', 'Ivemark II syndrome', 1),
(8951, 'ORPHA:294415', 'Renal-hepatic-pancreatic dysplasia', 1),
(8952, 'ORPHA:294415', 'Renohepaticopancreatic dysplasia', 1),
(8953, 'ORPHA:294422', 'CIF', 1),
(8954, 'ORPHA:294422', 'Chronic intestinal failure', 1),
(8955, 'ORPHA:2946', 'Brachydactyly, long thumb type', 1),
(8956, 'ORPHA:2946', 'Brachydactyly-long thumb syndrome', 1),
(8957, 'ORPHA:2947', 'Carnevale-Hernández-del Castillo syndrome', 1),
(8958, 'ORPHA:2947', 'Triphalangeal thumbs-brachyectrodactyly syndrome', 1),
(8959, 'ORPHA:294925', 'Amelia', 3),
(8960, 'ORPHA:294927', 'Intercalary limb defects', 3),
(8961, 'ORPHA:294927', 'Intercalary meromelia', 3),
(8962, 'ORPHA:294944', 'Congenital deformities of limbs', 3),
(8963, 'ORPHA:294947', 'Congenital deformities of fingers', 3),
(8964, 'ORPHA:294949', 'Joint formation defects', 3),
(8965, 'ORPHA:294951', 'Congenital joint dislocations', 3),
(8966, 'ORPHA:294953', 'Non syndromic limb overgrowth', 3),
(8967, 'ORPHA:294955', 'Syndrome with limb reduction defects', 3),
(8968, 'ORPHA:294957', 'Dysostosis with combined reduction defects of upper and lower limbs', 3),
(8969, 'ORPHA:294959', 'Syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy', 3),
(8970, 'ORPHA:294963', 'Popliteal pterygium syndrome', 3),
(8971, 'ORPHA:294965', 'LCCS', 3),
(8972, 'ORPHA:294965', 'Lethal congenital contracture syndrome', 3),
(8973, 'ORPHA:294967', 'Amelia of upper limb', 1),
(8974, 'ORPHA:294969', 'Amelia of lower limb', 1),
(8975, 'ORPHA:294971', 'Tetra-amelia', 1),
(8976, 'ORPHA:294971', 'Total amelia', 1),
(8977, 'ORPHA:294973', 'Congenital absence of humerus', 1),
(8978, 'ORPHA:294973', 'Congenital hypoplasia of humerus', 1),
(8979, 'ORPHA:294973', 'Humeral agenesis/hypoplasia', 1),
(8980, 'ORPHA:294973', 'Humeral intercalary meromelia', 1),
(8981, 'ORPHA:294975', 'Congenital absence of upper arm and forearm with hand present', 1),
(8982, 'ORPHA:294975', 'Humero-radio-ulnar intercalary transverse meromelia', 1),
(8983, 'ORPHA:294977', 'Congenital absence of thigh and lower leg with foot present', 1),
(8984, 'ORPHA:294977', 'Femorotibiofibular intercalary transverse meromelia', 1),
(8985, 'ORPHA:294979', 'Congenital absence of both forearm and hand', 1),
(8986, 'ORPHA:294979', 'Radio-ulnar terminal transverse meromelia', 1),
(8987, 'ORPHA:294981', 'Congenital absence of both lower leg and foot', 1),
(8988, 'ORPHA:294981', 'Tibiofibular terminal transverse meromelia', 1),
(8989, 'ORPHA:294983', 'Acheiria', 1),
(8990, 'ORPHA:294983', 'Congenital absence of hand', 1),
(8991, 'ORPHA:294986', 'Apodia', 1),
(8992, 'ORPHA:294986', 'Congenital absence of foot', 1),
(8993, 'ORPHA:294988', 'Congenital absence/hypoplasia of thumb', 1),
(8994, 'ORPHA:294988', 'Congenital hypoplasia of thumb', 1),
(8995, 'ORPHA:294988', 'Thumb hypodactyly', 1),
(8996, 'ORPHA:294988', 'Thumb oligodactyly', 1),
(8997, 'ORPHA:295', 'Fetal parvovirus syndrome', 1),
(8998, 'ORPHA:295', 'Mother-to-child transmission of parvovirus syndrome', 1),
(8999, 'ORPHA:295', 'Parvovirus antenatal infection', 1),
(9000, 'ORPHA:2950', 'TPT-PS syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(9001, 'ORPHA:2950', 'Triphalangeal thumb-polysyndactyly syndrome', 1),
(9002, 'ORPHA:295000', 'Amniotic band sequence', 1),
(9003, 'ORPHA:295000', 'Amniotic band syndrome', 1),
(9004, 'ORPHA:295000', 'Congenital ring constrictions', 1),
(9005, 'ORPHA:295000', 'Constriction band syndrome', 1),
(9006, 'ORPHA:295000', 'Constriction rings syndrome', 1),
(9007, 'ORPHA:295000', 'Streeter dysplasia', 1),
(9008, 'ORPHA:295002', 'Hyperphalangy', 1),
(9009, 'ORPHA:295002', 'Supernumerary phalanges', 1),
(9010, 'ORPHA:295002', 'Supernumerary phalanx', 1),
(9011, 'ORPHA:295004', 'Central polydactyly', 1),
(9012, 'ORPHA:295004', 'Mesoaxial polydactyly', 1),
(9013, 'ORPHA:295012', 'Mitten hand', 1),
(9014, 'ORPHA:295012', 'Syndactyly type 6', 1),
(9015, 'ORPHA:295012', 'Syndactyly, mitten type', 1),
(9016, 'ORPHA:295012', 'Unilateral syndactyly of digits 2-5', 1),
(9017, 'ORPHA:295014', 'Familial isolated clinodactyly of fingers', 1),
(9018, 'ORPHA:295016', 'Camptodactyly of fingers', 1),
(9019, 'ORPHA:295018', 'Congenital pseudarthrosis of the tibia', 2),
(9020, 'ORPHA:295018', 'Congenital pseudoarthrosis of the tibia', 2),
(9021, 'ORPHA:295020', 'Congenital pseudarthrosis of the femur', 2),
(9022, 'ORPHA:295020', 'Congenital pseudoarthrosis of the femur', 2),
(9023, 'ORPHA:295022', 'Congenital pseudarthrosis of the fibula', 2),
(9024, 'ORPHA:295022', 'Congenital pseudoarthrosis of the fibula', 2),
(9025, 'ORPHA:295024', 'Congenital pseudarthrosis of the radius', 2),
(9026, 'ORPHA:295024', 'Congenital pseudoarthrosis of the radius', 2),
(9027, 'ORPHA:295026', 'Congenital pseudarthrosis of the ulna', 2),
(9028, 'ORPHA:295026', 'Congenital pseudoarthrosis of the ulna', 2),
(9029, 'ORPHA:295028', 'Tibio-fibular fusion', 1),
(9030, 'ORPHA:295028', 'Tibio-fibular synostosis', 1),
(9031, 'ORPHA:295030', 'True congenital shoulder dislocation', 1),
(9032, 'ORPHA:295032', 'Isolated congenital elbow dislocation', 1),
(9033, 'ORPHA:295032', 'Isolated congenital radial head dislocation', 1),
(9034, 'ORPHA:295034', 'Congenital knee dislocation', 1),
(9035, 'ORPHA:295036', 'Congenital patella dislocation', 1),
(9036, 'ORPHA:295044', 'Macrodactyly of fingers', 1),
(9037, 'ORPHA:295044', 'Macrodactyly of hand', 1),
(9038, 'ORPHA:295047', 'Macrodactyly of foot', 1),
(9039, 'ORPHA:295047', 'Macrodactyly of toes', 1),
(9040, 'ORPHA:295049', 'Upper limb hypertrophy', 1),
(9041, 'ORPHA:295051', 'Lower limb hypertrophy', 1),
(9042, 'ORPHA:2951', 'Absent thumb-short stature-immunodeficiency syndrome', 1),
(9043, 'ORPHA:295187', 'SD1, Weidenreich type', 2),
(9044, 'ORPHA:295187', 'SD1a', 2),
(9045, 'ORPHA:295187', 'Syndactyly type 1, Weidenreich type', 2),
(9046, 'ORPHA:295187', 'Syndactyly type 1a', 2),
(9047, 'ORPHA:295187', 'Zygodactyly type 1', 2),
(9048, 'ORPHA:295187', 'Zygodactyly, Weidenreich type', 2),
(9049, 'ORPHA:295189', 'SD1, Lueken type', 2),
(9050, 'ORPHA:295189', 'SD1b', 2),
(9051, 'ORPHA:295189', 'Syndactyly type 1, Lueken type', 2),
(9052, 'ORPHA:295189', 'Syndactyly type 1b', 2),
(9053, 'ORPHA:295189', 'Zygodactyly type 2', 2),
(9054, 'ORPHA:295189', 'Zygodactyly, Lueken type', 2),
(9055, 'ORPHA:295191', 'SD1, Montagu type', 2),
(9056, 'ORPHA:295191', 'SD1c', 2),
(9057, 'ORPHA:295191', 'Syndactyly type 1, Montagu type', 2),
(9058, 'ORPHA:295191', 'Syndactyly type 1c', 2),
(9059, 'ORPHA:295191', 'Zygodactyly type 3', 2),
(9060, 'ORPHA:295191', 'Zygodactyly, Montagu type', 2),
(9061, 'ORPHA:295193', 'SD1, Castilla type', 2),
(9062, 'ORPHA:295193', 'SD1d', 2),
(9063, 'ORPHA:295193', 'Syndactyly type 1, Castilla type', 2),
(9064, 'ORPHA:295193', 'Syndactyly type 1d', 2),
(9065, 'ORPHA:295193', 'Zygodactyly type 4', 2),
(9066, 'ORPHA:295193', 'Zygodactyly, Castilla type', 2),
(9067, 'ORPHA:295195', 'SD2, Vordingborg type', 2),
(9068, 'ORPHA:295195', 'SD2a', 2),
(9069, 'ORPHA:295195', 'SPD, Vordingborg type', 2),
(9070, 'ORPHA:295195', 'SPD1', 2),
(9071, 'ORPHA:295195', 'Synpolydactyly type 1', 2),
(9072, 'ORPHA:295195', 'Synpolydactyly, Vordingborg type', 2),
(9073, 'ORPHA:295197', 'SD2, Debeer type', 2),
(9074, 'ORPHA:295197', 'SD2b', 2),
(9075, 'ORPHA:295197', 'SPD, Debeer type', 2),
(9076, 'ORPHA:295197', 'SPD2', 2),
(9077, 'ORPHA:295197', 'Synpolydactyly type 2', 2),
(9078, 'ORPHA:295197', 'Synpolydactyly, Debeer type', 2),
(9079, 'ORPHA:295199', 'SD2, Malik type', 2),
(9080, 'ORPHA:295199', 'SD2c', 2),
(9081, 'ORPHA:295199', 'SPD, Malik type', 2),
(9082, 'ORPHA:295199', 'SPD3', 2),
(9083, 'ORPHA:295199', 'Synpolydactyly type 3', 2),
(9084, 'ORPHA:295199', 'Synpolydactyly, Malik type', 2),
(9085, 'ORPHA:2952', 'Adducted thumbs-arthrogryposis syndrome, Christian type', 1),
(9086, 'ORPHA:295201', 'Congenital vertical talus, unilateral', 2),
(9087, 'ORPHA:295203', 'Congenital vertical talus, bilateral', 2),
(9088, 'ORPHA:295213', 'Humero-ulnar fusion, unilateral', 2),
(9089, 'ORPHA:295213', 'Humero-ulnar synostosis, unilateral', 2),
(9090, 'ORPHA:295215', 'Humero-ulnar fusion, bilateral', 2),
(9091, 'ORPHA:295215', 'Humero-ulnar synostosis, bilateral', 2),
(9092, 'ORPHA:295217', 'Radio-ulnar fusion, unilateral', 2),
(9093, 'ORPHA:295217', 'Radio-ulnar synostosis, unilateral', 2),
(9094, 'ORPHA:295219', 'Radio-ulnar fusion, bilateral', 2),
(9095, 'ORPHA:295219', 'Radio-ulnar synostosis, bilateral', 2),
(9096, 'ORPHA:295225', 'Congenital elbow dislocation, unilateral', 2),
(9097, 'ORPHA:295227', 'Congenital elbow dislocation, bilateral', 2),
(9098, 'ORPHA:295229', 'Congenital genu recurvatum', 2),
(9099, 'ORPHA:295232', 'Congenital genu flexum', 2),
(9100, 'ORPHA:295239', 'Macrodactyly of fingers, unilateral', 2),
(9101, 'ORPHA:295239', 'Macrodactyly of hand, unilateral', 2),
(9102, 'ORPHA:295241', 'Macrodactyly of fingers, bilateral', 2),
(9103, 'ORPHA:295241', 'Macrodactyly of hand, bilateral', 2),
(9104, 'ORPHA:295243', 'Macrodactyly of foot, unilateral', 2),
(9105, 'ORPHA:295243', 'Macrodactyly of toes, unilateral', 2),
(9106, 'ORPHA:295245', 'Macrodactyly of foot, bilateral', 2),
(9107, 'ORPHA:295245', 'Macrodactyly of toes, bilateral', 2),
(9108, 'ORPHA:2953', 'Adducted thumb-clubfoot syndrome', 1),
(9109, 'ORPHA:2953', 'Distal arthrogryposis with peculiar facies and hydronephrosis', 1),
(9110, 'ORPHA:2953', 'Dündar syndrome', 1),
(9111, 'ORPHA:2953', 'Ehlers-Danlos syndrome, Kosho type', 1),
(9112, 'ORPHA:2953', 'Musculocontractural Ehlers-Danlos syndrome', 1),
(9113, 'ORPHA:2953', 'mcEDS', 1),
(9114, 'ORPHA:2956', 'Acrodysplasia scoliosis', 1),
(9115, 'ORPHA:2956', 'Brachydactyly-scoliosis-carpal fusion syndrome', 1),
(9116, 'ORPHA:2956', 'Prata-Liberal-Goncalves syndrome', 1),
(9117, 'ORPHA:2957', 'Guttmacher syndrome', 1),
(9118, 'ORPHA:2957', 'Preaxial deficiency-postaxial polydactyly-hypospadias syndrome', 1),
(9119, 'ORPHA:2958', 'Prieto-Badia-Mulas syndrome', 1),
(9120, 'ORPHA:2958', 'X-linked intellectual disability-dysmorphism-cerebral atrophy syndrome', 1),
(9121, 'ORPHA:2959', 'Mulvihill-Smith syndrome', 1),
(9122, 'ORPHA:2959', 'Progeria-short stature-pigmented nevi syndrome', 1),
(9123, 'ORPHA:296', 'Dyschondroplasia', 1),
(9124, 'ORPHA:296', 'Ollier disease', 1),
(9125, 'ORPHA:2962', 'Cutis laxa-corneal clouding-intellectual disability syndrome', 1),
(9126, 'ORPHA:2962', 'De Barsy syndrome', 1),
(9127, 'ORPHA:2962', 'Progeroid syndrome, De Barsy type', 1),
(9128, 'ORPHA:2963', 'Fontaine progeroid syndrome', 1),
(9129, 'ORPHA:2963', 'Petty syndrome', 1),
(9130, 'ORPHA:2963', 'Petty-Laxova-Wiedemann syndrome', 1),
(9131, 'ORPHA:2963', 'Progeroid syndrome, Petty type', 1),
(9132, 'ORPHA:2964', 'Autosomal dominant prognathism', 1),
(9133, 'ORPHA:2965', 'Lactotroph adenoma', 1),
(9134, 'ORPHA:2965', 'PRL-secreting pituitary adenoma', 1),
(9135, 'ORPHA:2965', 'PRLoma', 1),
(9136, 'ORPHA:2965', 'Pituitary lactotrophic adenoma', 1),
(9137, 'ORPHA:2965', 'Prolactin-secreting pituitary adenoma', 1),
(9138, 'ORPHA:2965', 'Prolactinoma', 1),
(9139, 'ORPHA:2966', 'Properdin deficiency', 1),
(9140, 'ORPHA:2967', 'Haptocorrin deficiency', 1),
(9141, 'ORPHA:2967', 'TCI deficiency', 1),
(9142, 'ORPHA:2967', 'Transcobalamin I deficiency', 1),
(9143, 'ORPHA:2967', 'Transcobalamin-1 deficiency', 1),
(9144, 'ORPHA:2968', 'LAD', 1),
(9145, 'ORPHA:2968', 'Leukocyte adhesion deficiency', 1),
(9146, 'ORPHA:2969', 'Cohen-Hayden syndrome', 1),
(9147, 'ORPHA:2969', 'Proteus-like syndrome', 1),
(9148, 'ORPHA:297', 'TBE', 1),
(9149, 'ORPHA:297', 'Tick-borne encephalitis', 1),
(9150, 'ORPHA:2970', 'Abdominal muscle deficiency syndrome', 1),
(9151, 'ORPHA:2970', 'Eagle-Barret syndrome', 1),
(9152, 'ORPHA:2970', 'Obrinsky syndrome', 1),
(9153, 'ORPHA:2970', 'Prune belly syndrome', 1),
(9154, 'ORPHA:2970', 'Triad syndrome', 1),
(9155, 'ORPHA:2971', 'Peroxisomal acyl-CoA oxidase deficiency', 1),
(9156, 'ORPHA:2971', 'Pseudo-NALD', 1),
(9157, 'ORPHA:2971', 'Pseudo-neonatal adrenoleukodystrophy', 1),
(9158, 'ORPHA:2971', 'Pseudoadrenoleukodystrophy', 1),
(9159, 'ORPHA:2972', 'Non-eruption of teeth-maxillary hypoplasia-genu valgum syndrome', 1),
(9160, 'ORPHA:2972', 'Stoelinga-de Koomen-Davis syndrome', 1),
(9161, 'ORPHA:2973', '46,XX disorder of sex development-anorectal anomalies syndrome', 1),
(9162, 'ORPHA:2975', '46,XX disorder of sex development-skeletal anomalies syndrome', 1),
(9163, 'ORPHA:2976', 'Patterson pseudoleprechaunism syndrome', 1),
(9164, 'ORPHA:2976', 'Patterson syndrome', 1),
(9165, 'ORPHA:2976', 'Pseudoleprechaunism syndrome, Patterson type', 1),
(9166, 'ORPHA:2978', 'CIPO', 1),
(9167, 'ORPHA:2978', 'Chronic intestinal pseudoobstruction', 1),
(9168, 'ORPHA:298', 'MNGIE', 1),
(9169, 'ORPHA:298', 'Mitochondrial neurogastrointestinal encephalomyopathy', 1),
(9170, 'ORPHA:2980', 'Acrootoocular syndrome', 1),
(9171, 'ORPHA:2980', 'Pseudopapilledema-blepharophimosis-hand anomalies syndrome', 1),
(9172, 'ORPHA:2982', '46,XX DSD', 3),
(9173, 'ORPHA:2982', '46,XX disorder of sex development', 3),
(9174, 'ORPHA:29822', 'Episodic spontaneous hypothermia', 1),
(9175, 'ORPHA:29822', 'Shapiro syndrome', 1),
(9176, 'ORPHA:29822', 'Spontaneous periodic hypothermia', 1),
(9177, 'ORPHA:2983', 'Disorder of sex development-intellectual disability syndrome', 1),
(9178, 'ORPHA:2983', 'Verloes-Gillerot-Fryns syndrome', 1),
(9179, 'ORPHA:2985', 'Absent eyebrows and eyelashes-intellectual disability syndrome', 1),
(9180, 'ORPHA:2985', 'Hal-Berg-Rudolph syndrome', 1),
(9181, 'ORPHA:2985', 'Pseudoprogeria syndrome', 1),
(9182, 'ORPHA:298644', 'Disorder of thiamine metabolism and transport', 3),
(9183, 'ORPHA:2987', 'Antecubital pterygium syndrome', 1),
(9184, 'ORPHA:2988', 'Khalifa-Graham syndrome', 1),
(9185, 'ORPHA:2988', 'Pterygium colli-intellectual disability-digital anomalies syndrome', 1),
(9186, 'ORPHA:2990', 'Autosomal recessive multiple pterygium syndrome', 1),
(9187, 'ORPHA:2990', 'Autosomal recessive non-lethal multiple pterygium syndrome', 1),
(9188, 'ORPHA:2990', 'EVMPS', 1),
(9189, 'ORPHA:2990', 'Escobar syndrome', 1),
(9190, 'ORPHA:2990', 'Escobar variant multiple pterygium syndrome', 1),
(9191, 'ORPHA:2994', 'Haspeslagh-Fryns-Muelenaere syndrome', 1),
(9192, 'ORPHA:2994', 'Short stature-craniofacial anomalies-genital hypoplasia syndrome', 1),
(9193, 'ORPHA:2995', 'Baraitser-Winter cerebrofrontofacial syndrome', 1),
(9194, 'ORPHA:2997', 'Ptosis-vocal cord paralysis syndrome', 1),
(9195, 'ORPHA:2997', 'Tucker syndrome', 1),
(9196, 'ORPHA:2999', 'McPherson-Hall syndrome', 1),
(9197, 'ORPHA:2999', 'Ptosis-strabismus-ectopic pupils syndrome', 1),
(9198, 'ORPHA:30', 'Hereditary orotic aciduria', 1),
(9199, 'ORPHA:30', 'Orotidylic decarboxylase deficiency', 1),
(9200, 'ORPHA:30', 'Uridine monophosphate synthetase deficiency', 1),
(9201, 'ORPHA:300', 'Bifunctional enzyme deficiency', 1),
(9202, 'ORPHA:3000', 'FMPP', 1),
(9203, 'ORPHA:3000', 'Familial gonadotropin-independent male-limited sexual precocity', 1),
(9204, 'ORPHA:3000', 'Familial male-limited precocious puberty', 1),
(9205, 'ORPHA:3000', 'Male-limited precocious puberty', 1),
(9206, 'ORPHA:3000', 'Testotoxicosis', 1),
(9207, 'ORPHA:300179', 'Ehlers-Danlos syndrome with kyphoscoliosis, myopathy, and deafness', 2),
(9208, 'ORPHA:300179', 'Ehlers-Danlos syndrome with kyphoscoliosis, myopathy, and hearing loss', 2),
(9209, 'ORPHA:300179', 'FKBP14-related EDS', 2),
(9210, 'ORPHA:300179', 'FKBP22-deficient EDS', 2),
(9211, 'ORPHA:300179', 'Kyphoscoliotic EDS due to FKBP22 deficiency', 2),
(9212, 'ORPHA:300179', 'Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency', 2),
(9213, 'ORPHA:300179', 'kEDS-FKBP14', 2),
(9214, 'ORPHA:3002', 'ITP', 1),
(9215, 'ORPHA:3002', 'Immune thrombocytopenia', 1),
(9216, 'ORPHA:3002', 'Immune thrombocytopenic purpura', 1),
(9217, 'ORPHA:300284', 'Bone fragility-contractures-arterial rupture-deafness syndrome', 1),
(9218, 'ORPHA:300284', 'Bone fragility-contractures-arterial rupture-hearing loss syndrome', 1),
(9219, 'ORPHA:300284', 'Connective tissue disorder due to LH3 deficiency', 1),
(9220, 'ORPHA:300284', 'Connective tissue disorder due to lysyl hydroxylase-3 deficiency', 1),
(9221, 'ORPHA:300293', 'Transient infantile hypertriglyceridemia and fatty liver', 1),
(9222, 'ORPHA:300293', 'Transient infantile hypertriglyceridemia and hepatosteatosis', 1),
(9223, 'ORPHA:300298', 'Severe congenital hypochromic anemia with ringed sideroblasts', 1),
(9224, 'ORPHA:300298', 'Severe congenital hypochromic sideroblastic anemia', 1),
(9225, 'ORPHA:3003', 'Camera syndrome', 1),
(9226, 'ORPHA:3003', 'Pyknoachondrogenesis', 1),
(9227, 'ORPHA:300305', '11p15.4 microduplication syndrome', 1),
(9228, 'ORPHA:300305', 'Dup(11)p(15.4)', 1),
(9229, 'ORPHA:300305', 'Trisomy 11p15.4', 1),
(9230, 'ORPHA:300313', 'Congenital cataract-deafness-severe developmental delay syndrome', 1),
(9231, 'ORPHA:300313', 'Congenital cataract-hearing loss-severe developmental delay syndrome', 1),
(9232, 'ORPHA:300313', 'Huppke-Brendel syndrome', 1),
(9233, 'ORPHA:300313', 'Lethal neurodegenerative disorder due to copper transport defect', 1),
(9234, 'ORPHA:300319', 'CMT2P', 1),
(9235, 'ORPHA:300319', 'Charcot-Marie-Tooth disease type 2P', 1),
(9236, 'ORPHA:300324', 'PPBL', 1),
(9237, 'ORPHA:300324', 'Persistent polyclonal B-cell lymphocytosis', 1),
(9238, 'ORPHA:300324', 'Persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes', 1),
(9239, 'ORPHA:300333', 'Nephrotic syndrome-deafness-pretibial epidermolysis bullosa syndrome', 1),
(9240, 'ORPHA:300333', 'Nephrotic syndrome-hearing loss-pretibial epidermolysis bullosa syndrome', 1),
(9241, 'ORPHA:300345', 'Autosomal SLE', 1),
(9242, 'ORPHA:300345', 'Autosomal systemic lupus erythematosus', 1),
(9243, 'ORPHA:300345', 'Familial SLE', 1),
(9244, 'ORPHA:300345', 'Familial systemic lupus erythematosus', 1),
(9245, 'ORPHA:300359', 'FACU', 1),
(9246, 'ORPHA:300359', 'Familial atypical cold urticaria', 1),
(9247, 'ORPHA:300359', 'Familial cold urticaria with common variable immunodeficiency', 1),
(9248, 'ORPHA:300359', 'PLAID', 1),
(9249, 'ORPHA:300359', 'PLCG2-associated antibody deficiency and immune dysregulation', 1),
(9250, 'ORPHA:300373', 'Familial infantile gigantism', 1),
(9251, 'ORPHA:300373', 'Hereditary infantile gigantism', 1),
(9252, 'ORPHA:300373', 'Hereditary pituitary hyperplasia', 1),
(9253, 'ORPHA:300373', 'Infantile gigantism due to pituitary hyperplasia', 1),
(9254, 'ORPHA:300373', 'X-LAG', 1),
(9255, 'ORPHA:300373', 'X-linked acrogigantism', 1),
(9256, 'ORPHA:300382', 'Progeroid and marfanoid aspect-lipodystrophy syndrome', 1),
(9257, 'ORPHA:300385', 'Pituitary carcinoma', 1),
(9258, 'ORPHA:3004', 'Mirror polydactyly-vertebral segmentation-limbs defects syndrome', 1),
(9259, 'ORPHA:300493', 'Sagliker syndrome', 1),
(9260, 'ORPHA:300496', 'MCAHS type 2', 1),
(9261, 'ORPHA:300496', 'Multiple congenital anomalies-hypotonia-seizures syndrome type 2', 1),
(9262, 'ORPHA:3005', 'Metaphyseal dysplasia, Pyle type', 1),
(9263, 'ORPHA:3005', 'Pyle disease', 1),
(9264, 'ORPHA:300501', 'Painful orbital and systemic neurofibromas-marfanoid habitus syndrome', 1),
(9265, 'ORPHA:300504', 'Acanthoma of the nail matrix', 1),
(9266, 'ORPHA:300504', 'Onychocytic matricoma', 1),
(9267, 'ORPHA:300512', 'Onychomatricoma', 1),
(9268, 'ORPHA:300515', 'Rare nail tumor', 3),
(9269, 'ORPHA:300525', 'PHA2D', 2),
(9270, 'ORPHA:300525', 'Pseudohypoaldosteronism type 2D', 2),
(9271, 'ORPHA:300530', 'PHA2E', 2),
(9272, 'ORPHA:300530', 'Pseudohypoaldosteronism type 2E', 2),
(9273, 'ORPHA:300536', 'CDG syndrome type Ir', 1),
(9274, 'ORPHA:300536', 'CDG-Ir', 1),
(9275, 'ORPHA:300536', 'CDG1R', 1),
(9276, 'ORPHA:300536', 'Carbohydrate deficient glycoprotein syndrome type Ir', 1),
(9277, 'ORPHA:300536', 'Congenital disorder of glycosylation type 1r', 1),
(9278, 'ORPHA:300536', 'Congenital disorder of glycosylation type Ir', 1),
(9279, 'ORPHA:300536', 'DDOST-CDG', 1),
(9280, 'ORPHA:300547', 'Autosomal recessive infantile hypercalcemia', 1),
(9281, 'ORPHA:300547', 'Familial infantile hypercalcemia with suppressed intact parathyroid hormone', 1),
(9282, 'ORPHA:300552', 'Follicular cholangitis and pancreatitis', 1),
(9283, 'ORPHA:300552', 'Follicular pancreatocholangitis', 1),
(9284, 'ORPHA:300557', 'Ampullary carcinoma', 1),
(9285, 'ORPHA:300557', 'Ampulloma', 1),
(9286, 'ORPHA:300557', 'Carcinoma of the ampulla of Vater', 1),
(9287, 'ORPHA:300564', 'CPFE', 1),
(9288, 'ORPHA:300564', 'Combined pulmonary fibrosis-emphysema syndrome', 1),
(9289, 'ORPHA:300570', 'Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation', 1),
(9290, 'ORPHA:300573', 'Polymicrogyria due to TUBB2B mutation', 1),
(9291, 'ORPHA:300576', 'Autosomal dominant ectodermal dysplasia-cancer predisposition syndrome', 1),
(9292, 'ORPHA:300576', 'Oligodontia-cancer predisposition syndrome', 1),
(9293, 'ORPHA:300579', 'Staphylococcal toxemia', 3),
(9294, 'ORPHA:3006', 'Antiquitin deficiency', 1),
(9295, 'ORPHA:3006', 'Pyridoxine-dependent epilepsy', 1),
(9296, 'ORPHA:3006', 'Vitamin B6-dependent seizures', 1),
(9297, 'ORPHA:300605', 'JALS', 1),
(9298, 'ORPHA:300605', 'Juvenile Charcot disease', 1),
(9299, 'ORPHA:300605', 'Juvenile Lou Gehrig disease', 1),
(9300, 'ORPHA:300605', 'Juvenile amyotrophic lateral sclerosis', 1),
(9301, 'ORPHA:300751', 'Familial dilated cardiomyopathy with conduction defect due to LMNA mutation', 1),
(9302, 'ORPHA:300755', 'Laminopathy with striated muscle involvement', 3),
(9303, 'ORPHA:300758', 'Laminopathy with peripheral neuropathy', 3),
(9304, 'ORPHA:300763', 'Laminopathy with lipodystrophy', 3),
(9305, 'ORPHA:300766', 'Laminopathy with premature aging', 3),
(9306, 'ORPHA:3008', 'Ataxia with lactic acidosis type 2', 1),
(9307, 'ORPHA:3008', 'Ataxia with lactic acidosis type II', 1),
(9308, 'ORPHA:3008', 'Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency', 1),
(9309, 'ORPHA:3008', 'Leigh syndrome due to PC deficiency', 1),
(9310, 'ORPHA:3008', 'Leigh syndrome due to pyruvate carboxylase deficiency', 1),
(9311, 'ORPHA:3008', 'Pyruvate carboxylase deficiency', 1),
(9312, 'ORPHA:300842', 'Indolent B-cell NHL', 3),
(9313, 'ORPHA:300842', 'Indolent B-cell non-Hodgkin lymphoma', 3),
(9314, 'ORPHA:300846', 'Aggressive B-cell NHL', 3),
(9315, 'ORPHA:300846', 'Aggressive B-cell non-Hodgkin lymphoma', 3),
(9316, 'ORPHA:300849', 'DLBCL of the CNS', 1),
(9317, 'ORPHA:300849', 'Diffuse large B-cell lymphoma of the central nervous system', 1),
(9318, 'ORPHA:300857', 'T-cell/histiocyte rich large B cell lymphoma', 1),
(9319, 'ORPHA:300857', 'THRLBCL', 1),
(9320, 'ORPHA:300865', 'Primary C-ALCL', 1),
(9321, 'ORPHA:300865', 'Primary cutaneous anaplastic large cell lymphoma', 1),
(9322, 'ORPHA:300865', 'Regressive atypical histiocytosis', 1),
(9323, 'ORPHA:300869', 'SDRPL', 1),
(9324, 'ORPHA:300869', 'Splenic diffuse red pulp lymphoma', 1),
(9325, 'ORPHA:300869', 'Splenic diffuse red pulp small B-cell lymphoma', 1),
(9326, 'ORPHA:300878', 'HCL-v', 1),
(9327, 'ORPHA:300878', 'Hairy cell leukemia variant', 1),
(9328, 'ORPHA:300878', 'Leukemic reticuloendotheliosis variant', 1),
(9329, 'ORPHA:300878', 'Prolymphocytic variant of HCL', 1),
(9330, 'ORPHA:300878', 'Prolymphocytic variant of hairy cell leukemia', 1),
(9331, 'ORPHA:300888', 'DLBCL with chronic inflammation', 1),
(9332, 'ORPHA:300888', 'Diffuse large B-cell lymphoma with chronic inflammation', 1),
(9333, 'ORPHA:300895', 'ALK+ ALCL', 2),
(9334, 'ORPHA:300895', 'ALK+ anaplastic large cell lymphoma', 2),
(9335, 'ORPHA:300895', 'ALK-positive anaplastic large cell lymphoma', 2),
(9336, 'ORPHA:300903', 'ALK- ALCL', 2),
(9337, 'ORPHA:300903', 'ALK- anaplastic large cell lymphoma', 2),
(9338, 'ORPHA:300903', 'ALK-negative anaplastic large cell lymphoma', 2),
(9339, 'ORPHA:300912', 'Marginal zone lymphoma', 3),
(9340, 'ORPHA:301', 'Ependymal tumor', 3),
(9341, 'ORPHA:3010', 'Dysharmonic skeletal maturation-muscular fiber disproportion syndrome', 1),
(9342, 'ORPHA:3010', 'Qazi-Markouizos syndrome', 1),
(9343, 'ORPHA:3011', 'Spastic quadriplegia-retinitis pigmentosa-intellectual disability syndrome', 1),
(9344, 'ORPHA:3011', 'Spastic tetraplegia-retinitis pigmentosa-intellectual disability syndrome', 1),
(9345, 'ORPHA:3015', 'Radio-renal syndrome', 1),
(9346, 'ORPHA:3016', 'Absent radius-anogenital anomalies syndrome', 1),
(9347, 'ORPHA:3018', 'Rambaud-Gallian syndrome', 1),
(9348, 'ORPHA:3018', 'Rambaud-Gallian-Touchard syndrome', 1),
(9349, 'ORPHA:3018', 'Retinal ischemic syndrome-digestive tract small vessel hyalinosis-diffuse cerebral calcifications syndrome', 1),
(9350, 'ORPHA:3019', 'Cherubism-gingival fibromatosis-intellectual disability syndrome', 1),
(9351, 'ORPHA:3019', 'Ramon syndrome', 1),
(9352, 'ORPHA:302', 'Epidermodysplasia verruciformis', 1),
(9353, 'ORPHA:302', 'Lewandowsky-Lutz syndrome', 1),
(9354, 'ORPHA:302', 'Lutz-Lewandowsky epidermodysplasia verruciformis', 1),
(9355, 'ORPHA:3020', 'Facial nerve palsy due to VZV', 1),
(9356, 'ORPHA:3020', 'Facial nerve palsy due to herpes zoster infection', 1),
(9357, 'ORPHA:3020', 'Facial nerve paralysis due to VZV', 1),
(9358, 'ORPHA:3020', 'Ramsay Hunt syndrome', 1),
(9359, 'ORPHA:3021', 'RAPADILINO syndrome', 1),
(9360, 'ORPHA:3023', 'External auditory canal atresia-vertical talus-hypertelorism syndrome', 1),
(9361, 'ORPHA:3023', 'Rasmussen-Johnsen-Thomsen syndrome', 1),
(9362, 'ORPHA:3026', 'Goldblatt-Viljoen syndrome', 1),
(9363, 'ORPHA:3026', 'Radial ray hypoplasia-choanal atresia syndrome', 1),
(9364, 'ORPHA:3027', 'Caudal dysplasia', 1),
(9365, 'ORPHA:3027', 'Caudal regression sequence', 1),
(9366, 'ORPHA:3027', 'Sacral agenesis syndrome', 1),
(9367, 'ORPHA:3027', 'Sacral regression syndrome', 1),
(9368, 'ORPHA:303', 'DEB', 3),
(9369, 'ORPHA:303', 'Dermolytic epidermolysis bullosa', 3),
(9370, 'ORPHA:303', 'Dystrophic epidermolysis bullosa', 3),
(9371, 'ORPHA:303', 'Epidermolysis bullosa dystrophica', 3),
(9372, 'ORPHA:3032', 'Goldston syndrome', 1),
(9373, 'ORPHA:3032', 'Meckel syndrome type 7', 1),
(9374, 'ORPHA:3032', 'Meckel-like syndrome type 1', 1),
(9375, 'ORPHA:3032', 'NPHP3-related Meckel-like syndrome', 1),
(9376, 'ORPHA:3032', 'Renal-hepatic-pancreatic dysplasia-Dandy-Walker cysts syndrome', 1),
(9377, 'ORPHA:3033', 'Primitive renal tubule syndrome', 1),
(9378, 'ORPHA:3033', 'Renal tubular dysgenesis', 1),
(9379, 'ORPHA:3033', 'Renotubular dysgenesis', 1),
(9380, 'ORPHA:3034', 'Delayed membranous cranial ossification', 1),
(9381, 'ORPHA:3034', 'Gonzales-del Angel syndrome', 1),
(9382, 'ORPHA:3035', 'Game-Friedman-Paradice syndrome', 1),
(9383, 'ORPHA:3035', 'Growth delay-hydrocephaly-lung hypoplasia syndrome', 1),
(9384, 'ORPHA:3038', 'Delayed speech-facial asymmetry-strabismus-ear lobe creases syndrome', 1),
(9385, 'ORPHA:3038', 'Mehes syndrome', 1),
(9386, 'ORPHA:30391', 'Isolated atresia of bile ducts', 1),
(9387, 'ORPHA:30391', 'Isolated biliary atresia', 1),
(9388, 'ORPHA:30391', 'Non-syndromic biliary atresia', 1),
(9389, 'ORPHA:304', 'EBS', 3),
(9390, 'ORPHA:304', 'EEB', 3),
(9391, 'ORPHA:304', 'Epidermolysis bullosa simplex', 3),
(9392, 'ORPHA:304055', 'Pituitary tumor', 3),
(9393, 'ORPHA:3041', 'Intellectual disability-balding-patella luxation-acromicria syndrome', 1),
(9394, 'ORPHA:3041', 'Scholte-Begeer-van Essen syndrome', 1),
(9395, 'ORPHA:3042', 'Intellectual disability-cataracts-calcified pinnae-myopathy syndrome', 1),
(9396, 'ORPHA:3042', 'Primrose syndrome', 1),
(9397, 'ORPHA:3044', 'Intellectual disability-dysmorphism-hypogonadism-diabetes mellitus syndrome', 1),
(9398, 'ORPHA:3047', 'Blepharophimosis-intellectual disability syndrome, SBBYS type', 1),
(9399, 'ORPHA:3047', 'Hypothyroidism-dysmorphism-postaxial polydactyly-intellectual disability syndrome', 1),
(9400, 'ORPHA:3047', 'SBBYS variant of Ohdo syndrome', 1),
(9401, 'ORPHA:3047', 'SBBYSS', 1),
(9402, 'ORPHA:3047', 'Say-Barber-Biesecker-Young-Simpson syndrome', 1),
(9403, 'ORPHA:305', 'EBJ', 3),
(9404, 'ORPHA:305', 'Epidermolysis bullosa atrophicans', 3),
(9405, 'ORPHA:305', 'JEB', 3),
(9406, 'ORPHA:305', 'Junctional epidermolysis bullosa', 3),
(9407, 'ORPHA:3051', 'Intellectual disability-sparse hair-brachydactyly syndrome', 1),
(9408, 'ORPHA:3051', 'Nicolaides-Baraitser syndrome', 1),
(9409, 'ORPHA:3052', 'Tranebjaerg-Svejgaard syndrome', 1),
(9410, 'ORPHA:3052', 'X-linked intellectual disability-seizures-psoriasis syndrome', 1),
(9411, 'ORPHA:3055', 'X-linked intellectual disability-hypogonadism-ichthyosis-obesity-short stature syndrome', 1),
(9412, 'ORPHA:3055', 'Young-Hughes syndrome', 1),
(9413, 'ORPHA:3056', 'X-linked intellectual disability, Brooks type', 1),
(9414, 'ORPHA:3057', 'Brunner syndrome', 1),
(9415, 'ORPHA:3057', 'Monoamine oxidase A deficiency', 1),
(9416, 'ORPHA:306', 'BFIE', 1),
(9417, 'ORPHA:306', 'BFIS', 1),
(9418, 'ORPHA:306', 'Benign familial infantile convulsions', 1),
(9419, 'ORPHA:306', 'Benign familial infantile epilepsy', 1),
(9420, 'ORPHA:306', 'Benign familial infantile seizures', 1),
(9421, 'ORPHA:3063', 'Snyder-Robinson syndrome', 1),
(9422, 'ORPHA:3063', 'X-linked intellectual disability, Snyder type', 1),
(9423, 'ORPHA:306431', 'Acquired adult-onset immunodeficiency', 1),
(9424, 'ORPHA:306431', 'Adult-onset immunodeficiency with acquired anti-interferon-gamma autoantibodies', 1),
(9425, 'ORPHA:306431', 'Adult-onset immunodeficiency with anti-interferon-gamma autoantibodies', 1),
(9426, 'ORPHA:306498', 'PHTS', 3),
(9427, 'ORPHA:306498', 'PTEN hamartoma tumor syndrome', 3),
(9428, 'ORPHA:306504', 'Congenital ILNEB syndrome', 1),
(9429, 'ORPHA:306504', 'Congenital NEP syndrome', 1),
(9430, 'ORPHA:306504', 'Congenital interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome', 1),
(9431, 'ORPHA:306504', 'Congenital nephrotic syndrome-epidermolysis bullosa-pulmonary disease syndrome', 1),
(9432, 'ORPHA:306504', 'Congenital nephrotic syndrome-interstitial lung disease-epidermolysis bullosa syndrome', 1),
(9433, 'ORPHA:306504', 'JEB with respiratory and renal involvement', 1),
(9434, 'ORPHA:306504', 'JEB-RR', 1),
(9435, 'ORPHA:306504', 'Junctional epidermolysis bullosa with respiratory and renal involvement', 1),
(9436, 'ORPHA:306511', 'Autosomal recessive spastic paraplegia type 48', 1),
(9437, 'ORPHA:306511', 'SPG48', 1),
(9438, 'ORPHA:306516', 'FHHNC', 3),
(9439, 'ORPHA:306516', 'Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis', 3),
(9440, 'ORPHA:306516', 'Michellis-Castrillo syndrome', 3),
(9441, 'ORPHA:306519', 'Genetic primary hypomagnesemia with hypocalciuria', 3),
(9442, 'ORPHA:306522', 'Genetic primary hypomagnesemia with normocalciuria', 3),
(9443, 'ORPHA:306527', 'Isolated hereditary congenital facial paralysis', 1),
(9444, 'ORPHA:306530', 'Congenital hereditary facial palsy with variable deafness', 1),
(9445, 'ORPHA:306530', 'Congenital hereditary facial palsy with variable hearing loss', 1),
(9446, 'ORPHA:306530', 'Congenital hereditary facial paralysis with variable deafness', 1),
(9447, 'ORPHA:306530', 'Congenital hereditary facial paralysis-variable deafness syndrome', 1),
(9448, 'ORPHA:306530', 'Congenital hereditary facial paralysis-variable hearing loss syndrome', 1),
(9449, 'ORPHA:306542', 'ALX1-related frontonasal dysplasia', 1),
(9450, 'ORPHA:306542', 'Frontonasal dysplasia type 3', 1),
(9451, 'ORPHA:306542', 'Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome', 1),
(9452, 'ORPHA:306547', 'Porencephaly-microcephaly-bilateral congenital cataract syndrome', 1),
(9453, 'ORPHA:306550', 'FADD-related immunodeficiency', 1),
(9454, 'ORPHA:306553', 'Myospherulosis', 1),
(9455, 'ORPHA:306553', 'Spherulocytosis', 1),
(9456, 'ORPHA:306553', 'Subcutaneous spherulocystic disease', 1),
(9457, 'ORPHA:306558', 'Primary microcephaly-epilepsy-permanent neonatal diabetes syndrome', 1),
(9458, 'ORPHA:306577', 'Sodium channelopathy-related small fiber neuropathy', 1),
(9459, 'ORPHA:306588', 'ADOS', 2),
(9460, 'ORPHA:306588', 'Autosomal dominant Opitz BBB/G syndrome', 2),
(9461, 'ORPHA:306588', 'Autosomal dominant Opitz G/BBB syndrome', 2),
(9462, 'ORPHA:306588', 'Autosomal dominant Opitz syndrome', 2),
(9463, 'ORPHA:306597', 'X-linked Opitz BBB/G syndrome', 2),
(9464, 'ORPHA:306597', 'X-linked Opitz G/BBB syndrome', 2),
(9465, 'ORPHA:306597', 'X-linked Opitz syndrome', 2),
(9466, 'ORPHA:306597', 'XLOS', 2),
(9467, 'ORPHA:306617', 'SPG1', 2),
(9468, 'ORPHA:306617', 'X-linked complicated spastic paraplegia type 1', 2),
(9469, 'ORPHA:306633', 'Rare tumor of gallbladder and EBT', 3),
(9470, 'ORPHA:306633', 'Rare tumor of gallbladder and extrahepatic biliary tract', 3),
(9471, 'ORPHA:306636', 'Rare tumor of liver and IBT', 3),
(9472, 'ORPHA:306636', 'Rare tumor of liver and intrahepatic biliary tract', 3),
(9473, 'ORPHA:306640', 'Rare intoxication due to medical products', 3),
(9474, 'ORPHA:306644', 'Complication after organ transplantation', 1),
(9475, 'ORPHA:306648', 'Non-infectious anterior uveitis', 3),
(9476, 'ORPHA:306648', 'Non-infectious iridocyclitis', 3),
(9477, 'ORPHA:306658', 'Familial normophosphatemic tumoral calcinosis', 2),
(9478, 'ORPHA:306661', 'Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome', 2),
(9479, 'ORPHA:306661', 'Hypercalcemic tumoral calcinosis', 2),
(9480, 'ORPHA:306666', 'Rare parkinsonian syndrome due to neurodegenerative disease', 3),
(9481, 'ORPHA:306669', 'HP-HA syndrome', 1),
(9482, 'ORPHA:306669', 'Hemiparkinsonism-hemiatrophy syndrome', 1),
(9483, 'ORPHA:306674', 'Kufor-Rakeb syndrome', 1),
(9484, 'ORPHA:306674', 'PARK9', 1),
(9485, 'ORPHA:306679', 'Rare parkinsonian syndrome due to intoxication', 3),
(9486, 'ORPHA:306682', 'Manganese intoxication', 1),
(9487, 'ORPHA:306682', 'Manganese poisoning', 1),
(9488, 'ORPHA:306682', 'Manganism', 1),
(9489, 'ORPHA:306686', 'Delayed encephalopathy due to CO poisoning', 1),
(9490, 'ORPHA:306686', 'Delayed encephalopathy due to carbon monoxide poisoning', 1),
(9491, 'ORPHA:306692', 'Cyanide-induced parkinsonism-dystonia', 1),
(9492, 'ORPHA:306695', 'Miscellaneous movement disorder due to neurodegenerative disease', 3),
(9493, 'ORPHA:306708', 'Frontotemporal neurodegeneration with movement disorder', 3),
(9494, 'ORPHA:306712', 'Rare tremor disorder', 3),
(9495, 'ORPHA:306715', 'Rare choreic movement disorder', 3),
(9496, 'ORPHA:306719', 'Neurodegenerative disease with chorea', 3),
(9497, 'ORPHA:306727', 'Postinfectious autoimmune disease with chorea', 3),
(9498, 'ORPHA:306731', 'Sydenham chorea', 1),
(9499, 'ORPHA:306734', 'DYT21', 1),
(9500, 'ORPHA:306734', 'Primary dystonia, DYT21 type', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(9501, 'ORPHA:306741', 'HD-HA syndrome', 1),
(9502, 'ORPHA:306741', 'Hemidystonia-hemiatrophy syndrome', 1),
(9503, 'ORPHA:306747', 'Rare myoclonus', 3),
(9504, 'ORPHA:306750', 'Primary myoclonus', 3),
(9505, 'ORPHA:306753', 'Rare disease with myoclonus as a major feature', 3),
(9506, 'ORPHA:306756', 'Epilepsy and/or ataxia with myoclonus as a major feature', 3),
(9507, 'ORPHA:306759', 'Non progressive epilepsy and/or ataxia with myoclonus as a major feature', 3),
(9508, 'ORPHA:306765', 'Motor stereotypies', 3),
(9509, 'ORPHA:306768', 'Rare paroxysmal movement disorder', 3),
(9510, 'ORPHA:306773', 'Hyperekplexia', 3),
(9511, 'ORPHA:306776', 'Sporadic hyperekplexia', 1),
(9512, 'ORPHA:3068', 'Chudley-Rozdilsky syndrome', 1),
(9513, 'ORPHA:3068', 'Intellectual disability-myopathy-short stature-endocrine defect syndrome', 1),
(9514, 'ORPHA:307', 'JME', 1),
(9515, 'ORPHA:307', 'Juvenile myoclonic epilepsy', 1),
(9516, 'ORPHA:307', 'Juvenile myoclonus epilepsy', 1),
(9517, 'ORPHA:307052', 'Rare genetic hypokinetic movement disorder', 3),
(9518, 'ORPHA:307052', 'Rare genetic parkinsonian disorder', 3),
(9519, 'ORPHA:307055', 'Rare parkinsonian syndrome due to genetic neurodegenerative disease', 3),
(9520, 'ORPHA:307058', 'Miscellaneous movement disorder due to genetic neurodegenerative disease', 3),
(9521, 'ORPHA:307061', 'Rare genetic tremor disorder', 3),
(9522, 'ORPHA:307064', 'Rare genetic myoclonus', 3),
(9523, 'ORPHA:307067', 'Rare genetic disease with myoclonus as a major feature', 3),
(9524, 'ORPHA:3071', 'Costello syndrome', 1),
(9525, 'ORPHA:3071', 'FCS syndrome', 1),
(9526, 'ORPHA:3071', 'Faciocutaneoskeletal syndrome', 1),
(9527, 'ORPHA:307141', 'Diffuse PPK', 3),
(9528, 'ORPHA:307141', 'Diffuse keratosis palmoplantaris', 3),
(9529, 'ORPHA:307141', 'Diffuse palmoplantar hyperkeratosis', 3),
(9530, 'ORPHA:307141', 'Diffuse palmoplantar keratoderma', 3),
(9531, 'ORPHA:307148', 'Isolated diffuse PPK', 3),
(9532, 'ORPHA:307148', 'Isolated diffuse keratosis palmoplantaris', 3),
(9533, 'ORPHA:307148', 'Isolated diffuse palmoplantar hyperkeratosis', 3),
(9534, 'ORPHA:307148', 'Isolated diffuse palmoplantar keratoderma', 3),
(9535, 'ORPHA:3074', 'Intellectual disability-short stature-hypertelorism syndrome', 1),
(9536, 'ORPHA:3074', 'Stoll-Géraudel-Chauvin syndrome', 1),
(9537, 'ORPHA:3077', 'Lindsay-Burn syndrome', 1),
(9538, 'ORPHA:3077', 'PPM-X', 1),
(9539, 'ORPHA:3077', 'X-linked intellectual disability-psychosis-macroorchidism syndrome', 1),
(9540, 'ORPHA:307711', 'Disease with diffuse palmoplantar hyperkeratosis as a major feature', 3),
(9541, 'ORPHA:307711', 'Disease with diffuse palmoplantar keratoderma as a major feature', 3),
(9542, 'ORPHA:307766', 'CHAC syndrome', 1),
(9543, 'ORPHA:307766', 'CHACS', 1),
(9544, 'ORPHA:307766', 'Curly hair-acral keratoderma-caries syndrome', 1),
(9545, 'ORPHA:307773', 'Autosomal dominant diffuse mutilating palmoplantar hyperkeratosis', 3),
(9546, 'ORPHA:307773', 'Autosomal dominant diffuse mutilating palmoplantar keratoderma', 3),
(9547, 'ORPHA:3078', 'Severe X-linked intellectual disability, Gustavson type', 1),
(9548, 'ORPHA:307804', 'Autosomal recessive disease with diffuse palmoplantar hyperkeratosis as a major feature', 3),
(9549, 'ORPHA:307804', 'Autosomal recessive disease with diffuse palmoplantar keratoderma as a major feature', 3),
(9550, 'ORPHA:307837', 'Focal PPK', 3),
(9551, 'ORPHA:307837', 'Focal keratosis palmoplantaris', 3),
(9552, 'ORPHA:307837', 'Focal palmoplantar hyperkeratosis', 3),
(9553, 'ORPHA:307837', 'Focal palmoplantar keratoderma', 3),
(9554, 'ORPHA:307846', 'Isolated focal PPK', 3),
(9555, 'ORPHA:307846', 'Isolated focal keratosis palmoplantaris', 3),
(9556, 'ORPHA:307846', 'Isolated focal palmoplantar hyperkeratosis', 3),
(9557, 'ORPHA:307846', 'Isolated focal palmoplantar keratoderma', 3),
(9558, 'ORPHA:307871', 'Disease with focal palmoplantar hyperkeratosis as a major feature', 3),
(9559, 'ORPHA:307871', 'Disease with focal palmoplantar keratoderma as a major feature', 3),
(9560, 'ORPHA:3079', 'Intellectual disability, Buenos-Aires type', 1),
(9561, 'ORPHA:3079', 'Mutchinick syndrome', 1),
(9562, 'ORPHA:307936', 'HOPP syndrome', 1),
(9563, 'ORPHA:307936', 'Hypotrichosis-osteolysis-periodontitis-palmoplantar hyperkeratosis syndrome', 1),
(9564, 'ORPHA:307936', 'Hypotrichosis-osteolysis-periodontitis-palmoplantar keratoderma syndrome', 1),
(9565, 'ORPHA:307936', 'Hypotrichosis-striate palmoplantar hyperkeratosis-acroosteolysis-periodontitis syndrome', 1),
(9566, 'ORPHA:307936', 'Hypotrichosis-striate palmoplantar keratoderma-acroosteolysis-periodontitis syndrome', 1),
(9567, 'ORPHA:307967', 'Punctate PPK', 3),
(9568, 'ORPHA:307967', 'Punctate keratosis palmoplantaris', 3),
(9569, 'ORPHA:307967', 'Punctate palmoplantar hyperkeratosis', 3),
(9570, 'ORPHA:307967', 'Punctate palmoplantar keratoderma', 3),
(9571, 'ORPHA:307995', 'Marginal papular palmoplantar hyperkeratosis', 3),
(9572, 'ORPHA:307995', 'Marginal papular palmoplantar keratoderma', 3),
(9573, 'ORPHA:308', 'PME type 1', 1),
(9574, 'ORPHA:308', 'Progressive myoclonic epilepsy type 1', 1),
(9575, 'ORPHA:308', 'Progressive myoclonus epilepsy type 1', 1),
(9576, 'ORPHA:308', 'ULD', 1),
(9577, 'ORPHA:308', 'Unverricht-Lundborg disease', 1),
(9578, 'ORPHA:3080', 'Intellectual disability, Wolff type', 1),
(9579, 'ORPHA:3080', 'Wolff-Zimmermann syndrome', 1),
(9580, 'ORPHA:308013', 'Focal acral hyperkeratosis', 1),
(9581, 'ORPHA:308013', 'PPKP3 without elastoidosis', 1),
(9582, 'ORPHA:308013', 'PPPK3 without elastoidosis', 1),
(9583, 'ORPHA:308013', 'Punctate palmoplantar hyperkeratosis type 3 without elastoidosis', 1),
(9584, 'ORPHA:308013', 'Punctate palmoplantar keratoderma type 3 without elastoidosis', 1),
(9585, 'ORPHA:308023', 'Disease with punctate palmoplantar hyperkeratosis as a major feature', 3),
(9586, 'ORPHA:308023', 'Disease with punctate palmoplantar keratoderma as a major feature', 3),
(9587, 'ORPHA:308031', 'Autosomal dominant disease associated with punctate palmoplantar hyperkeratosis as a major feature', 3),
(9588, 'ORPHA:308031', 'Autosomal dominant disease associated with punctate palmoplantar keratoderma as a major feature', 3),
(9589, 'ORPHA:308041', 'Autosomal recessive disease associated with punctate palmoplantar hyperkeratosis as a major feature', 3),
(9590, 'ORPHA:308041', 'Autosomal recessive disease associated with punctate palmoplantar keratoderma as a major feature', 3),
(9591, 'ORPHA:308166', 'Erythrokeratoderma variabilis progressiva', 3),
(9592, 'ORPHA:3082', 'Intellectual disability-polydactyly-uncombable hair syndrome', 1),
(9593, 'ORPHA:3082', 'Kozlowski-Krajewska syndrome', 1),
(9594, 'ORPHA:308380', 'Functional methionine synthase deficiency type cblDv1', 2),
(9595, 'ORPHA:308380', 'Methylcobalamin deficiency type cblDv1', 2),
(9596, 'ORPHA:308386', 'Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type A', 2),
(9597, 'ORPHA:308386', 'MOCOD type A', 2),
(9598, 'ORPHA:308386', 'Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A', 2),
(9599, 'ORPHA:308393', 'Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type B', 2),
(9600, 'ORPHA:308393', 'MOCOD type B', 2),
(9601, 'ORPHA:308393', 'Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B', 2),
(9602, 'ORPHA:308400', 'Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase type C', 2),
(9603, 'ORPHA:308400', 'MOCOD type C', 2),
(9604, 'ORPHA:308400', 'Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C', 2),
(9605, 'ORPHA:308407', 'Disorder of beta and omega amino acid metabolism', 3),
(9606, 'ORPHA:308410', 'Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency', 1),
(9607, 'ORPHA:308425', 'MCEE deficiency', 1),
(9608, 'ORPHA:308425', 'Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency', 1),
(9609, 'ORPHA:308425', 'Methylmalonic acidemia due to methylmalonyl-CoA racemase deficiency', 1),
(9610, 'ORPHA:308425', 'Methylmalonic aciduria due to methylmalonyl-CoA epimerase deficiency', 1),
(9611, 'ORPHA:308425', 'Methylmalonic aciduria due to methylmalonyl-CoA racemase deficiency', 1),
(9612, 'ORPHA:308442', 'Vitamin B12-responsive methylmalonic acidemia, type cblDv2', 2),
(9613, 'ORPHA:308442', 'Vitamin B12-responsive methylmalonic aciduria, type cblDv2', 2),
(9614, 'ORPHA:308448', 'Aminoacylase deficiency', 3),
(9615, 'ORPHA:308451', 'Disorder of neutral amino acid transport', 3),
(9616, 'ORPHA:308459', 'Disorder of glycolysis', 3),
(9617, 'ORPHA:308463', 'Disorder of fructose metabolism', 3),
(9618, 'ORPHA:308467', 'Disorder of galactose metabolism', 3),
(9619, 'ORPHA:308473', 'Erythrocyte GALE deficiency', 2),
(9620, 'ORPHA:308473', 'Erythrocyte GALE-D', 2),
(9621, 'ORPHA:308473', 'Erythrocyte UDP-galactose-4-epimerase deficiency', 2),
(9622, 'ORPHA:308473', 'Erythrocyte epimerase deficiency galactosemia', 2),
(9623, 'ORPHA:308473', 'Erythrocyte galactose epimerase deficiency', 2),
(9624, 'ORPHA:308473', 'Erythrocyte uridine diphosphate galactose-4-epimerase deficiency', 2),
(9625, 'ORPHA:308487', 'Generalized GALE deficiency', 2),
(9626, 'ORPHA:308487', 'Generalized GALE-D', 2),
(9627, 'ORPHA:308487', 'Generalized UDP-galactose-4-epimerase deficiency', 2),
(9628, 'ORPHA:308487', 'Generalized epimerase deficiency galactosemia', 2),
(9629, 'ORPHA:308487', 'Generalized galactose epimerase deficiency', 2),
(9630, 'ORPHA:308487', 'Generalized uridine diphosphate galactose-4-epimerase deficiency', 2),
(9631, 'ORPHA:3085', 'Retinitis pigmentosa-intellectual disability- labyrinthine deafness-hypogenitalism syndrome', 1),
(9632, 'ORPHA:3085', 'Retinitis pigmentosa-intellectual disability-deafness-hypogonadism syndrome', 1),
(9633, 'ORPHA:3085', 'Retinitis pigmentosa-intellectual disability-sensorineural hearing loss-hypogenitalism syndrome', 1),
(9634, 'ORPHA:308520', 'GSD due to glycogen synthase deficiency', 3),
(9635, 'ORPHA:308520', 'Glycogen storage disease due to glycogen synthase deficiency', 3),
(9636, 'ORPHA:308520', 'Glycogenosis due to glycogen synthase deficiency', 3),
(9637, 'ORPHA:308552', 'Alpha-1,4-glucosidase acid deficiency, infantile onset', 2),
(9638, 'ORPHA:308552', 'GSD due to acid maltase deficiency, infantile onset', 2),
(9639, 'ORPHA:308552', 'GSD type 2, infantile onset', 2),
(9640, 'ORPHA:308552', 'GSD type II, infantile onset', 2),
(9641, 'ORPHA:308552', 'Glycogen storage disease due to acid maltase deficiency, infantile onset', 2),
(9642, 'ORPHA:308552', 'Glycogen storage disease type 2, infantile onset', 2),
(9643, 'ORPHA:308552', 'Glycogen storage disease type II, infantile onset', 2),
(9644, 'ORPHA:308552', 'Glycogenosis due to acid maltase deficiency, infantile onset', 2),
(9645, 'ORPHA:308552', 'Glycogenosis type 2, infantile onset', 2),
(9646, 'ORPHA:308552', 'Glycogenosis type II, infantile onset', 2),
(9647, 'ORPHA:308552', 'Pompe disease, infantile onset', 2),
(9648, 'ORPHA:3086', 'ADVIRC', 1),
(9649, 'ORPHA:3086', 'Autosomal dominant vitreoretinochoroidopathy', 1),
(9650, 'ORPHA:308621', 'GBE deficiency, progressive hepatic form', 2),
(9651, 'ORPHA:308621', 'GSD due to glycogen branching enzyme deficiency, progressive hepatic form', 2),
(9652, 'ORPHA:308621', 'GSD type 4, progressive hepatic form', 2),
(9653, 'ORPHA:308621', 'GSDIV, progressive hepatic form', 2),
(9654, 'ORPHA:308621', 'Glycogen storage disease due to glycogen branching enzyme deficiency, progressive hepatic form', 2),
(9655, 'ORPHA:308621', 'Glycogen storage disease type 4, progressive hepatic form', 2),
(9656, 'ORPHA:308621', 'Glycogen storage disease type IV, progressive hepatic form', 2),
(9657, 'ORPHA:308621', 'Glycogenosis due to glycogen branching enzyme deficiency, progressive hepatic form', 2),
(9658, 'ORPHA:308621', 'Glycogenosis type 4, progressive hepatic form', 2),
(9659, 'ORPHA:308621', 'Glycogenosis type IV, progressive hepatic form', 2),
(9660, 'ORPHA:308638', 'GBE deficiency, non progressive hepatic form', 2),
(9661, 'ORPHA:308638', 'GSD due to glycogen branching enzyme deficiency, non progressive hepatic form', 2),
(9662, 'ORPHA:308638', 'GSD type 4, non progressive hepatic form', 2),
(9663, 'ORPHA:308638', 'GSDIV, non progressive hepatic form', 2),
(9664, 'ORPHA:308638', 'Glycogen storage disease due to glycogen branching enzyme deficiency, non progressive hepatic form', 2),
(9665, 'ORPHA:308638', 'Glycogen storage disease type 4, non progressive hepatic form', 2),
(9666, 'ORPHA:308638', 'Glycogen storage disease type IV, non progressive hepatic form', 2),
(9667, 'ORPHA:308638', 'Glycogenosis due to glycogen branching enzyme deficiency, non progressive hepatic form', 2),
(9668, 'ORPHA:308638', 'Glycogenosis type 4, non progressive hepatic form', 2),
(9669, 'ORPHA:308638', 'Glycogenosis type IV, non progressive hepatic form', 2),
(9670, 'ORPHA:308655', 'GBE deficiency, fatal perinatal neuromuscular form', 2),
(9671, 'ORPHA:308655', 'GSD due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form', 2),
(9672, 'ORPHA:308655', 'GSD type 4, fatal perinatal neuromuscular form', 2),
(9673, 'ORPHA:308655', 'GSDIV, fatal perinatal neuromuscular form', 2),
(9674, 'ORPHA:308655', 'Glycogen storage disease due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form', 2),
(9675, 'ORPHA:308655', 'Glycogen storage disease type 4, fatal perinatal neuromuscular form', 2),
(9676, 'ORPHA:308655', 'Glycogen storage disease type IV, fatal perinatal neuromuscular form', 2),
(9677, 'ORPHA:308655', 'Glycogenosis due to glycogen branching enzyme deficiency, fatal perinatal neuromuscular form', 2),
(9678, 'ORPHA:308655', 'Glycogenosis type 4, fatal perinatal neuromuscular form', 2),
(9679, 'ORPHA:308655', 'Glycogenosis type IV, fatal perinatal neuromuscular form', 2),
(9680, 'ORPHA:308670', 'GBE deficiency, congenital neuromuscular form', 2),
(9681, 'ORPHA:308670', 'GSD due to glycogen branching enzyme deficiency, congenital neuromuscular form', 2),
(9682, 'ORPHA:308670', 'GSD type 4, congenital neuromuscular form', 2),
(9683, 'ORPHA:308670', 'GSDIV, congenital neuromuscular form', 2),
(9684, 'ORPHA:308670', 'Glycogen storage disease due to glycogen branching enzyme deficiency, congenital neuromuscular form', 2),
(9685, 'ORPHA:308670', 'Glycogen storage disease type 4, congenital neuromuscular form', 2),
(9686, 'ORPHA:308670', 'Glycogen storage disease type IV, congenital neuromuscular form', 2),
(9687, 'ORPHA:308670', 'Glycogenosis due to glycogen branching enzyme deficiency, congenital neuromuscular form', 2),
(9688, 'ORPHA:308670', 'Glycogenosis type 4, congenital neuromuscular form', 2),
(9689, 'ORPHA:308670', 'Glycogenosis type IV, congenital neuromuscular form', 2),
(9690, 'ORPHA:308684', 'GBE deficiency, childhood combined hepatic and myopathic form', 2),
(9691, 'ORPHA:308684', 'GSD due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form', 2),
(9692, 'ORPHA:308684', 'GSD type 4, childhood combined hepatic and myopathic form', 2),
(9693, 'ORPHA:308684', 'GSDIV, childhood combined hepatic and myopathic form', 2),
(9694, 'ORPHA:308684', 'Glycogen storage disease due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form', 2),
(9695, 'ORPHA:308684', 'Glycogen storage disease type 4, childhood combined hepatic and myopathic form', 2),
(9696, 'ORPHA:308684', 'Glycogen storage disease type IV, childhood combined hepatic and myopathic form', 2),
(9697, 'ORPHA:308684', 'Glycogenosis due to glycogen branching enzyme deficiency, childhood combined hepatic and myopathic form', 2),
(9698, 'ORPHA:308684', 'Glycogenosis type 4, childhood combined hepatic and myopathic form', 2),
(9699, 'ORPHA:308684', 'Glycogenosis type IV, childhood combined hepatic and myopathic form', 2),
(9700, 'ORPHA:308698', 'GBE deficiency, childhood neuromuscular form', 2),
(9701, 'ORPHA:308698', 'GSD due to glycogen branching enzyme deficiency, childhood neuromuscular form', 2),
(9702, 'ORPHA:308698', 'GSD type 4, childhood neuromuscular form', 2),
(9703, 'ORPHA:308698', 'GSDIV, childhood neuromuscular form', 2),
(9704, 'ORPHA:308698', 'Glycogen storage disease due to glycogen branching enzyme deficiency, childhood neuromuscular form', 2),
(9705, 'ORPHA:308698', 'Glycogen storage disease type 4, childhood neuromuscular form', 2),
(9706, 'ORPHA:308698', 'Glycogen storage disease type IV, childhood neuromuscular form', 2),
(9707, 'ORPHA:308698', 'Glycogenosis due to glycogen branching enzyme deficiency, childhood neuromuscular form', 2),
(9708, 'ORPHA:308698', 'Glycogenosis type 4, childhood neuromuscular form', 2),
(9709, 'ORPHA:308698', 'Glycogenosis type IV, childhood neuromuscular form', 2),
(9710, 'ORPHA:308712', 'GBE deficiency, adult neuromuscular form', 2),
(9711, 'ORPHA:308712', 'GSD due to glycogen branching enzyme deficiency, adult neuromuscular form', 2),
(9712, 'ORPHA:308712', 'GSD type 4, adult neuromuscular form', 2),
(9713, 'ORPHA:308712', 'GSDIV, adult neuromuscular form', 2),
(9714, 'ORPHA:308712', 'Glycogen storage disease due to glycogen branching enzyme deficiency, adult neuromuscular form', 2),
(9715, 'ORPHA:308712', 'Glycogen storage disease type 4, adult neuromuscular form', 2),
(9716, 'ORPHA:308712', 'Glycogen storage disease type IV, adult neuromuscular form', 2),
(9717, 'ORPHA:308712', 'Glycogenosis due to glycogen branching enzyme deficiency, adult neuromuscular form', 2),
(9718, 'ORPHA:308712', 'Glycogenosis type 4, adult neuromuscular form', 2),
(9719, 'ORPHA:308712', 'Glycogenosis type IV, adult neuromuscular form', 2),
(9720, 'ORPHA:3088', 'Dyskeratosis congenita with bilateral exudative retinopathy', 1),
(9721, 'ORPHA:3088', 'Retinopathy-anemia-central nervous system anomalies syndrome', 1),
(9722, 'ORPHA:3088', 'Revesz syndrome', 1),
(9723, 'ORPHA:3088', 'Revesz-DeBuse syndrome', 1),
(9724, 'ORPHA:308993', 'Glycerol kinase deficiency', 3),
(9725, 'ORPHA:308998', 'Disorder of glyoxylate metabolism', 3),
(9726, 'ORPHA:309', 'Familial partial epilepsy', 3),
(9727, 'ORPHA:3090', 'Congenital pulmonary venous connection anomaly', 3),
(9728, 'ORPHA:3090', 'Congenital pulmonary venous return anomaly', 3),
(9729, 'ORPHA:309001', 'Disorder of carbohydrate absorption and transport', 3),
(9730, 'ORPHA:309005', 'Disorder of lipid metabolism', 3),
(9731, 'ORPHA:309015', 'Familial lipoprotein lipase deficiency', 2),
(9732, 'ORPHA:309015', 'LPL deficiency', 2),
(9733, 'ORPHA:309020', 'Familial APOC2 deficiency', 2),
(9734, 'ORPHA:309020', 'Familial apoC-II deficiency', 2),
(9735, 'ORPHA:309020', 'Familial apolipoprotein C-II deficiency', 2),
(9736, 'ORPHA:309025', 'Mevalonate kinase deficiency', 3),
(9737, 'ORPHA:309028', 'Disorder of lipid absorption and transport', 3),
(9738, 'ORPHA:309031', 'Pancreatic triacylglycerol lipase deficiency', 1),
(9739, 'ORPHA:309031', 'Pancreatic triglyceride lipase deficiency', 1),
(9740, 'ORPHA:3091', 'Congenital systemic veins anomaly', 3),
(9741, 'ORPHA:309108', 'Pancreatic colipase deficiency', 1),
(9742, 'ORPHA:309111', 'Combined pancreatic lipase-colipase deficiency', 1),
(9743, 'ORPHA:309115', 'Disorder of fatty acid oxidation and ketogenesis', 3),
(9744, 'ORPHA:309120', 'Acyl-CoA dehydrogenase deficiency', 3),
(9745, 'ORPHA:309127', '3-hydroxyacyl-CoA dehydrogenase deficiency', 3),
(9746, 'ORPHA:309130', 'Disorder of carnitine cycle and carnitine transport', 3),
(9747, 'ORPHA:309133', 'Metabolic disease due to other fatty acid oxidation disorder', 3),
(9748, 'ORPHA:309136', 'Mitochondrial disorder due to a defect in assembly or maturation of the respiratory chain complexes', 3),
(9749, 'ORPHA:309144', 'Gangliosidosis', 3),
(9750, 'ORPHA:309147', 'Hyper-beta-alaninemia', 1),
(9751, 'ORPHA:309147', 'Hyperalaninemia', 1),
(9752, 'ORPHA:309152', 'GM2 gangliosidosis', 3),
(9753, 'ORPHA:309155', 'Hexosaminidases A and B deficiency, infantile form', 2),
(9754, 'ORPHA:309155', 'Infantile GM2 gangliosidosis 0 variant', 2),
(9755, 'ORPHA:309155', 'Sandhoff disease, infantile form', 2),
(9756, 'ORPHA:309162', 'Hexosaminidases A and B deficiency, juvenile form', 2),
(9757, 'ORPHA:309162', 'Juvenile GM2 gangliosidosis 0 variant', 2),
(9758, 'ORPHA:309162', 'Sandhoff disease, juvenile form', 2),
(9759, 'ORPHA:309169', 'Adult GM2 gangliosidosis 0 variant', 2),
(9760, 'ORPHA:309169', 'Hexosaminidases A and B deficiency, adult form', 2),
(9761, 'ORPHA:309169', 'Sandhoff disease, adult form', 2),
(9762, 'ORPHA:309178', 'GM2 gangliosidosis, B variant, infantile form', 2),
(9763, 'ORPHA:309178', 'Hexosaminidase A deficiency, infantile form', 2),
(9764, 'ORPHA:309178', 'Tay-Sachs disease, B variant, infantile form', 2),
(9765, 'ORPHA:309185', 'GM2 gangliosidosis, B variant, juvenile form', 2),
(9766, 'ORPHA:309185', 'Hexosaminidase A deficiency, juvenile form', 2),
(9767, 'ORPHA:309185', 'Tay-Sachs disease, B variant, juvenile form', 2),
(9768, 'ORPHA:309192', 'GM2 gangliosidosis, B variant, adult form', 2),
(9769, 'ORPHA:309192', 'Hexosaminidase A deficiency, adult form', 2),
(9770, 'ORPHA:309192', 'Tay-Sachs disease, B variant, adult form', 2),
(9771, 'ORPHA:3092', 'Fixed subaortic stenosis', 1),
(9772, 'ORPHA:309239', 'GM2 gangliosidosis, B1 variant', 2),
(9773, 'ORPHA:309239', 'Hexosaminidase A deficiency, B1 variant', 2),
(9774, 'ORPHA:309239', 'Tay-Sachs disease, B1 variant', 2),
(9775, 'ORPHA:30924', 'HOMG1', 1),
(9776, 'ORPHA:30924', 'HSH', 1),
(9777, 'ORPHA:30924', 'Hypomagnesemia caused by selective magnesium malabsorption', 1),
(9778, 'ORPHA:30924', 'Hypomagnesemia intestinal type 1', 1),
(9779, 'ORPHA:30924', 'Intestinal hypomagnesemia with secondary hypocalcemia', 1),
(9780, 'ORPHA:30924', 'PHSH', 1),
(9781, 'ORPHA:30924', 'Primary hypomagnesemia with secondary hypocalcemia', 1),
(9782, 'ORPHA:309246', 'GM2 gangliosidosis, AB variant', 1),
(9783, 'ORPHA:309246', 'Hexosaminidase activator deficiency', 1),
(9784, 'ORPHA:30925', 'Hereditary CDI', 2),
(9785, 'ORPHA:30925', 'Hereditary central diabetes insipidus', 2),
(9786, 'ORPHA:30925', 'Hereditary neurogenic diabetes insipidus', 2),
(9787, 'ORPHA:309252', 'Atypical Gaucher disease due to saposin C deficiency', 2),
(9788, 'ORPHA:309256', 'Arylsulfatase A deficiency, late infantile form', 2),
(9789, 'ORPHA:309256', 'MLD, late infantile form', 2),
(9790, 'ORPHA:309256', 'Metachromatic leukodystrophy, late infantile form', 2),
(9791, 'ORPHA:309263', 'Arylsulfatase A deficiency, juvenile form', 2),
(9792, 'ORPHA:309263', 'MLD, juvenile form', 2),
(9793, 'ORPHA:309263', 'Metachromatic leukodystrophy, juvenile form', 2),
(9794, 'ORPHA:309271', 'Arylsulfatase A deficiency, adult form', 2),
(9795, 'ORPHA:309271', 'MLD, adult form', 2),
(9796, 'ORPHA:309271', 'Metachromatic leukodystrophy, adult form', 2),
(9797, 'ORPHA:309279', 'Glycoproteinosis', 3),
(9798, 'ORPHA:309282', 'Alpha-mannosidosis, infantile form', 2),
(9799, 'ORPHA:309282', 'Lysosomal alpha-D-mannosidase deficiency, infantile form', 2),
(9800, 'ORPHA:309288', 'Alpha-mannosidosis, adult form', 2),
(9801, 'ORPHA:309288', 'Lysosomal alpha-D-mannosidase deficiency, adult form', 2),
(9802, 'ORPHA:309294', 'Sialidosis', 3),
(9803, 'ORPHA:309297', 'GALNS deficiency', 2),
(9804, 'ORPHA:309297', 'Galactosamine-6-sulfatase deficiency', 2),
(9805, 'ORPHA:309297', 'MPS4A', 2),
(9806, 'ORPHA:309297', 'MPSIVA', 2),
(9807, 'ORPHA:309297', 'Morquio disease type A', 2),
(9808, 'ORPHA:309297', 'Mucopolysaccharidosis type 4A', 2),
(9809, 'ORPHA:309297', 'Mucopolysaccharidosis type IVA', 2),
(9810, 'ORPHA:309297', 'N-acetylgalactosamine-6-sulfate sulfatase deficiency', 2),
(9811, 'ORPHA:3093', 'Congenital aortic valve stenosis', 1),
(9812, 'ORPHA:309310', 'Beta-D-galactosidase deficiency', 2),
(9813, 'ORPHA:309310', 'MPS4B', 2),
(9814, 'ORPHA:309310', 'MPSIVB', 2),
(9815, 'ORPHA:309310', 'Morquio disease type B', 2),
(9816, 'ORPHA:309310', 'Mucopolysaccharidosis type 4B', 2),
(9817, 'ORPHA:309310', 'Mucopolysaccharidosis type IVB', 2),
(9818, 'ORPHA:309319', 'Disorder of sialic acid metabolism', 3),
(9819, 'ORPHA:309324', 'Free sialic acid storage disease, infantile form', 2),
(9820, 'ORPHA:309324', 'ISSD', 2),
(9821, 'ORPHA:309331', 'Intermediate severe Salla disease', 2),
(9822, 'ORPHA:309334', 'Salla disease', 2),
(9823, 'ORPHA:309337', 'Lysosomal glycogen storage disease', 3),
(9824, 'ORPHA:309340', 'Disorder of lysosomal-related organelles', 3),
(9825, 'ORPHA:309347', 'Disorder of protein N-glycosylation', 3),
(9826, 'ORPHA:309447', 'Disorder of protein O-glycosylation', 3),
(9827, 'ORPHA:309450', 'Disorder of O-xylosylglycan synthesis', 3),
(9828, 'ORPHA:309458', 'Disorder of O-N-acetylgalactosaminylglycan synthesis', 3),
(9829, 'ORPHA:309463', 'Disorder of O-xylosyl/N-acetylgalactosaminylglycan synthesis', 3),
(9830, 'ORPHA:309469', 'Disorder of O-mannosylglycan synthesis', 3),
(9831, 'ORPHA:3095', 'Atypical RTT', 1),
(9832, 'ORPHA:3095', 'Atypical Rett syndrome', 1),
(9833, 'ORPHA:3095', 'Rett syndrome variant', 1),
(9834, 'ORPHA:309505', 'Disorder of fucoglycosan synthesis', 3),
(9835, 'ORPHA:309515', 'Disorder of glycosphingolipid and GPI-anchored proteins glycosylation', 3),
(9836, 'ORPHA:309515', 'Disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation', 3),
(9837, 'ORPHA:309526', 'Disorder of multiple glycosylation', 3),
(9838, 'ORPHA:309568', 'Defect in COG complex', 3),
(9839, 'ORPHA:309568', 'Defect in conserved oligomeric Golgi complex', 3),
(9840, 'ORPHA:3096', 'Reye syndrome', 1),
(9841, 'ORPHA:3097', 'Meacham syndrome', 1),
(9842, 'ORPHA:3097', 'Meacham-Winn-Culler syndrome', 1),
(9843, 'ORPHA:3097', 'Rhabdomyomatous dysplasia-cardiopathy-genital anomalies syndrome', 1),
(9844, 'ORPHA:309778', 'Defect in V-ATPase', 3),
(9845, 'ORPHA:309789', 'Rhizomelic chondrodysplasia punctata type 1', 2),
(9846, 'ORPHA:309796', 'Rhizomelic chondrodysplasia punctata type 2', 2),
(9847, 'ORPHA:3098', 'Rhizomelic syndrome, Urbach type', 1),
(9848, 'ORPHA:309803', 'Rhizomelic chondrodysplasia punctata type 3', 2),
(9849, 'ORPHA:309810', 'Disorder of peroxisomal alpha-, beta- and omega-oxidation', 3),
(9850, 'ORPHA:309813', 'Disorder of porphyrin and heme metabolism', 3),
(9851, 'ORPHA:309816', 'Disorder of bilirubin metabolism and excretion', 3),
(9852, 'ORPHA:309819', 'Disorder of pterin metabolism', 3),
(9853, 'ORPHA:309824', 'Disorder of metabolite absorption and transport', 3),
(9854, 'ORPHA:309827', 'Disorder of vitamin and non-protein cofactor absorption and transport', 3),
(9855, 'ORPHA:309830', 'Disorder of catecholamine synthesis', 3),
(9856, 'ORPHA:309833', 'Disorder of other vitamins and cofactors metabolism and transport', 3),
(9857, 'ORPHA:309836', 'Disorder of mineral absorption and transport', 3),
(9858, 'ORPHA:309839', 'Disorder of copper metabolism', 3),
(9859, 'ORPHA:309842', 'Disorder of iron metabolism and transport', 3),
(9860, 'ORPHA:309845', 'Disorder of zinc metabolism and transport', 3),
(9861, 'ORPHA:309848', 'Disorder of magnesium transport', 3),
(9862, 'ORPHA:309851', 'Disorder of manganese transport', 3),
(9863, 'ORPHA:309854', 'Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome', 1),
(9864, 'ORPHA:3099', 'Acute rheumatic fever', 1),
(9865, 'ORPHA:3099', 'Rheumatic fever', 1),
(9866, 'ORPHA:31', 'Alpha-ketoglutarate dehydrogenase deficiency', 1),
(9867, 'ORPHA:31', 'Oxoglutaric aciduria', 1),
(9868, 'ORPHA:310', 'Reflex epilepsy', 3),
(9869, 'ORPHA:310050', 'Acquired immunodeficiency', 3),
(9870, 'ORPHA:3101', 'Myotonia-intellectual disability-skeletal anomalies syndrome', 1),
(9871, 'ORPHA:3101', 'Richieri Costa-da Silva syndrome', 1),
(9872, 'ORPHA:3102', 'Richieri Costa-Pereira syndrome', 1),
(9873, 'ORPHA:3102', 'Short stature-Pierre Robin sequence-cleft mandible-hand anomalies clubfoot syndrome', 1),
(9874, 'ORPHA:3102', 'Short stature-Pierre Robin syndrome-cleft mandible-hand anomalies clubfoot syndrome', 1),
(9875, 'ORPHA:3103', 'Pseudothalidomide syndrome', 1),
(9876, 'ORPHA:3103', 'Roberts syndrome', 1),
(9877, 'ORPHA:3103', 'Roberts-SC phocomelia syndrome', 1),
(9878, 'ORPHA:3103', 'SC phocomelia', 1),
(9879, 'ORPHA:3103', 'SC pseudothalidomide syndrome', 1),
(9880, 'ORPHA:3104', 'Pierre Robin sequence-oligodactyly syndrome', 1),
(9881, 'ORPHA:3104', 'Robin sequence-oligodactyly syndrome', 1),
(9882, 'ORPHA:31043', 'FHHNC without severe ocular involvement', 1),
(9883, 'ORPHA:31043', 'Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement', 1),
(9884, 'ORPHA:31043', 'HOMG3', 1),
(9885, 'ORPHA:31043', 'Renal hypomagnesemia type 3', 1),
(9886, 'ORPHA:3107', 'Autosomal dominant Robinow syndrome', 2),
(9887, 'ORPHA:3109', 'MRKH syndrome', 1),
(9888, 'ORPHA:3109', 'Mayer-Rokitansky-Küster-Hauser syndrome', 1),
(9889, 'ORPHA:3109', 'Rokitansky syndrome', 1),
(9890, 'ORPHA:3110', 'Rombo syndrome', 1),
(9891, 'ORPHA:3111', 'Hyperbilirubinemia, Rotor type', 1),
(9892, 'ORPHA:3111', 'Rotor syndrome', 1),
(9893, 'ORPHA:31112', 'DFSP', 1),
(9894, 'ORPHA:31112', 'Dermatofibrosarcoma protuberans', 1),
(9895, 'ORPHA:31142', 'Oral erosive lichen', 1),
(9896, 'ORPHA:3115', 'Hereditary areflexic dystasia, Roussy-Lévy type', 1),
(9897, 'ORPHA:3115', 'Roussy-Lévy syndrome', 1),
(9898, 'ORPHA:31150', 'ATP-binding cassette transporter A1 deficiency', 1),
(9899, 'ORPHA:31150', 'Analphalipoproteinemia', 1),
(9900, 'ORPHA:31150', 'Tangier disease', 1),
(9901, 'ORPHA:31153', 'Hypoalphalipoproteinemia', 3),
(9902, 'ORPHA:31154', 'Hypobetalipoproteinemia', 3),
(9903, 'ORPHA:312', 'Autosomal dominant epidermolytic ichthyosis', 1),
(9904, 'ORPHA:312', 'BCIE', 1),
(9905, 'ORPHA:312', 'Bullous congenital ichthyosiform erythroderma', 1),
(9906, 'ORPHA:312', 'Bullous congenital ichthyosiform erythroderma of Brock', 1),
(9907, 'ORPHA:312', 'Bullous ichthyosis', 1),
(9908, 'ORPHA:312', 'EHK', 1),
(9909, 'ORPHA:312', 'EI', 1),
(9910, 'ORPHA:312', 'Epidermolytic hyperkeratosis', 1),
(9911, 'ORPHA:312', 'Ichthyosis hystrix Brocq type', 1),
(9912, 'ORPHA:31202', 'Melioidosis', 1),
(9913, 'ORPHA:31204', 'Nocardiosis', 1),
(9914, 'ORPHA:31205', 'Rat-bite fever', 1),
(9915, 'ORPHA:3121', 'Ruvalcaba syndrome', 1),
(9916, 'ORPHA:3124', 'Hyperlysinemia type II', 1),
(9917, 'ORPHA:3124', 'Saccharopine dehydrogenase deficiency', 1),
(9918, 'ORPHA:3124', 'Saccharopinuria', 1),
(9919, 'ORPHA:3129', 'Sarcosine dehydrogenase complex deficiency', 1),
(9920, 'ORPHA:3129', 'Sarcosinemia', 1),
(9921, 'ORPHA:313', 'Classic lamellar ichthyosis', 1),
(9922, 'ORPHA:313', 'Congenital lamellar ichthyosis', 1),
(9923, 'ORPHA:313', 'LI', 1),
(9924, 'ORPHA:313', 'Lamellar ichthyosis', 1),
(9925, 'ORPHA:3130', 'Komuragaeri disease', 1),
(9926, 'ORPHA:3130', 'Satoyoshi syndrome', 1),
(9927, 'ORPHA:3132', 'Microcephaly-hypogammaglobulinemia-abnormal immunity syndrome', 1),
(9928, 'ORPHA:3132', 'Say-Barber-Miller syndrome', 1),
(9929, 'ORPHA:3133', 'Say-Field-Coldwell syndrome', 1),
(9930, 'ORPHA:3133', 'Triphalangeal thumbs-dislocation of patella syndrome', 1),
(9931, 'ORPHA:3134', 'SCARF syndrome', 1),
(9932, 'ORPHA:3135', 'Familial Scheuermann disease', 1),
(9933, 'ORPHA:3135', 'Familial Scheuermann juvenile kyphosis', 1),
(9934, 'ORPHA:3135', 'Familial spinal osteochondrosis', 1),
(9935, 'ORPHA:3137', 'Alpha-N-acetylgalactosaminidase deficiency', 1),
(9936, 'ORPHA:3137', 'NAGA deficiency', 1),
(9937, 'ORPHA:3137', 'Schindler disease', 1),
(9938, 'ORPHA:313772', 'AFG3L2-related spastic ataxia-myoclonic epilepsy-neuropathy syndrome', 1),
(9939, 'ORPHA:313772', 'Autosomal recessive spastic ataxia type 5', 1),
(9940, 'ORPHA:313772', 'Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome', 1),
(9941, 'ORPHA:313772', 'SPAX5', 1),
(9942, 'ORPHA:313781', '20p subtelomeric deletion syndrome', 1),
(9943, 'ORPHA:313781', '20p13 microdeletion syndrome', 1),
(9944, 'ORPHA:313781', 'Del(20)(p13)', 1),
(9945, 'ORPHA:313781', 'Monosomy 20p13', 1),
(9946, 'ORPHA:313795', 'Jawad syndrome', 1),
(9947, 'ORPHA:3138', 'Pallister ulnar-mammary syndrome', 1),
(9948, 'ORPHA:3138', 'Schinzel syndrome', 1),
(9949, 'ORPHA:3138', 'UMS', 1),
(9950, 'ORPHA:3138', 'Ulnar-mammary syndrome', 1),
(9951, 'ORPHA:313800', 'Optic nerve edema-splenomegaly syndrome', 1),
(9952, 'ORPHA:313808', 'ALSP', 1),
(9953, 'ORPHA:313808', 'Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia', 1),
(9954, 'ORPHA:313808', 'Autosomal dominant leukoencephalopathy with neuroaxonal spheroids', 1),
(9955, 'ORPHA:313808', 'FPSG', 1),
(9956, 'ORPHA:313808', 'Familial dementia, Neumann type', 1),
(9957, 'ORPHA:313808', 'Familial progressive subcortical gliosis', 1),
(9958, 'ORPHA:313808', 'GPSC', 1),
(9959, 'ORPHA:313808', 'HDLS', 1),
(9960, 'ORPHA:313808', 'Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia', 1),
(9961, 'ORPHA:313808', 'Hereditary diffuse leukoencephalopathy with spheroids', 1),
(9962, 'ORPHA:313808', 'POLD', 1),
(9963, 'ORPHA:313808', 'Pigmentary orthochromatic leukodystrophy', 1),
(9964, 'ORPHA:313808', 'Subcortical gliosis of Neumann', 1),
(9965, 'ORPHA:313838', 'CRMCC', 1),
(9966, 'ORPHA:313838', 'Cerebroretinal microangiopathy with calcifications and cysts', 1),
(9967, 'ORPHA:313838', 'Coats plus syndrome', 1),
(9968, 'ORPHA:313846', 'Familial cutaneous telangiectasia and oropharyngeal cancer predisposition syndrome', 1),
(9969, 'ORPHA:313850', 'Infantile cerebellar-retinal degeneration', 1),
(9970, 'ORPHA:313855', 'FGFR2-related bent bone dysplasia', 1),
(9971, 'ORPHA:313855', 'Perinatal lethal bent bone dysplasia', 1),
(9972, 'ORPHA:313884', '12p12.1 microdeletion syndrome', 1),
(9973, 'ORPHA:313884', 'Del(12)(p12.1)', 1),
(9974, 'ORPHA:313884', 'Monosomy 12p12.1', 1),
(9975, 'ORPHA:313892', 'Developmental and speech delay due to SOX5 deficiency', 1),
(9976, 'ORPHA:313906', 'Congenital pancreatic cyst', 1),
(9977, 'ORPHA:313906', 'Neonatal congenital pancreatic cyst', 1),
(9978, 'ORPHA:313906', 'True congenital pancreatic cyst', 1),
(9979, 'ORPHA:313920', 'EBV-associated gastric carcinoma', 1),
(9980, 'ORPHA:313920', 'EBVaGC', 1),
(9981, 'ORPHA:313920', 'Epstein-Barr virus-associated gastric carcinoma', 1),
(9982, 'ORPHA:313936', 'PENS syndrome', 1),
(9983, 'ORPHA:313936', 'Papular epidermal nevi with skyline basal cell layers syndrome', 1),
(9984, 'ORPHA:313947', '2q23.1 microduplication syndrome', 1),
(9985, 'ORPHA:313947', 'Dup(2)(q23.1)', 1),
(9986, 'ORPHA:313947', 'Trisomy 2q23.1', 1),
(9987, 'ORPHA:314', 'Erythroderma desquamativum', 1),
(9988, 'ORPHA:314', 'Leiner disease', 1),
(9989, 'ORPHA:314002', 'Contractures-webbed neck-micrognathia-hypoplastic nipples syndrome', 1),
(9990, 'ORPHA:314002', 'Dinno syndrome', 1),
(9991, 'ORPHA:314017', 'Idiopathic linear interstitial keratitis', 1),
(9992, 'ORPHA:314022', 'Familial fundic gland polyposis with gastric cancer', 1),
(9993, 'ORPHA:314022', 'GAPPS', 1),
(9994, 'ORPHA:314022', 'Gastric adenocarcinoma and proximal polyposis of the stomach', 1),
(9995, 'ORPHA:314029', 'High bone mass OI', 1),
(9996, 'ORPHA:314029', 'High bone mass osteogenesis imperfecta', 1),
(9997, 'ORPHA:314034', '7p22.1 microduplication syndrome', 1),
(9998, 'ORPHA:314034', 'Dup(7)(p22.1)', 1),
(9999, 'ORPHA:314034', 'Trisomy 7p22.1', 1),
(10000, 'ORPHA:314041', 'Marfanoid habitus-inguinal hernia-advanced bone age syndrome', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(10001, 'ORPHA:314051', 'COXPD12', 1),
(10002, 'ORPHA:314051', 'Combined oxidative phosphorylation defect type 12', 1),
(10003, 'ORPHA:314051', 'LTBL', 1),
(10004, 'ORPHA:314051', 'Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome', 1),
(10005, 'ORPHA:3143', 'APS type 2', 1),
(10006, 'ORPHA:3143', 'APS2', 1),
(10007, 'ORPHA:3143', 'Autoimmune polyendocrine syndrome type 2', 1),
(10008, 'ORPHA:3143', 'Autoimmune polyendocrinopathy type 2', 1),
(10009, 'ORPHA:3143', 'Autoimmune polyglandular syndrome type 2', 1),
(10010, 'ORPHA:3143', 'Autoimmune thyroid disease and/or type 1 diabetes-Addison disease syndrome', 1),
(10011, 'ORPHA:3143', 'Schmidt syndrome', 1),
(10012, 'ORPHA:314373', 'Chronic infantile diarrhea due to guanylate cyclase 2C overactivity', 1),
(10013, 'ORPHA:314376', 'Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency', 1),
(10014, 'ORPHA:314376', 'Meconium ileus due to guanylate cyclase 2C deficiency', 1),
(10015, 'ORPHA:314381', 'Familial dysautonomia with contractures', 1),
(10016, 'ORPHA:314381', 'HSAN6', 1),
(10017, 'ORPHA:314381', 'Hereditary sensory and autonomic neuropathy type 6', 1),
(10018, 'ORPHA:314381', 'Hereditary sensory and autonomic neuropathy type VI', 1),
(10019, 'ORPHA:314389', 'Dup(X)(q12-q13.3)', 1),
(10020, 'ORPHA:314389', 'Xq12-q13.3 duplication syndrome', 1),
(10021, 'ORPHA:314394', 'SOFT syndrome', 1),
(10022, 'ORPHA:314394', 'Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome', 1),
(10023, 'ORPHA:314399', 'Autosomal dominant aplasia and myelodysplasia', 1),
(10024, 'ORPHA:314399', 'Autosomal dominant aplastic anemia and myelodysplasia', 1),
(10025, 'ORPHA:3144', 'Chondrodysplasia with snail-like pelvis', 1),
(10026, 'ORPHA:3144', 'SLC35D1-CDG', 1),
(10027, 'ORPHA:3144', 'Schneckenbecken dysplasia', 1),
(10028, 'ORPHA:314404', 'ADCA-DN syndrome', 1),
(10029, 'ORPHA:314404', 'Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome', 1),
(10030, 'ORPHA:314404', 'Autosomal dominant cerebellar ataxia-hearing loss-narcolepsy syndrome', 1),
(10031, 'ORPHA:314419', 'Ameloblastoma', 1),
(10032, 'ORPHA:314422', 'Ameloblastic carcinoma', 1),
(10033, 'ORPHA:314425', 'Rare odontogenic tumor', 3),
(10034, 'ORPHA:314432', 'Spigelian hernia-cryptorchidism syndrome', 1),
(10035, 'ORPHA:314451', 'Demons-Meigs syndrome', 1),
(10036, 'ORPHA:314451', 'Meigs syndrome', 1),
(10037, 'ORPHA:314459', 'Pseudo-Demons-Meigs syndrome', 1),
(10038, 'ORPHA:314459', 'Pseudo-Meigs syndrome', 1),
(10039, 'ORPHA:314466', 'Atypical Demons-Meigs syndrome', 1),
(10040, 'ORPHA:314466', 'Atypical Meigs syndrome', 1),
(10041, 'ORPHA:314466', 'Incomplete Meigs syndrome', 1),
(10042, 'ORPHA:314473', 'Ovarian fibroma', 1),
(10043, 'ORPHA:314478', 'Ovarian fibrothecoma', 1),
(10044, 'ORPHA:314485', 'Autosomal recessive distal spinal muscular atrophy type 5', 1),
(10045, 'ORPHA:314485', 'Young adult-onset dHMN', 1),
(10046, 'ORPHA:314485', 'Young adult-onset distal hereditary motor neuropathy', 1),
(10047, 'ORPHA:314485', 'dSMA5', 1),
(10048, 'ORPHA:3145', 'Nephrogenic diabetes insipidus-intracranial calcification-facial dysmorphism syndrome', 1),
(10049, 'ORPHA:314555', 'Craniofacial dysplasia-osteopenia syndrome', 1),
(10050, 'ORPHA:314555', 'Hamamy syndrome', 1),
(10051, 'ORPHA:314566', 'PPAOS', 1),
(10052, 'ORPHA:314566', 'Primary progressive apraxia of speech', 1),
(10053, 'ORPHA:314572', 'Autosomal recessive leukoencephalopathy-ischemic stroke-retinitis pigmentosa syndrome', 1),
(10054, 'ORPHA:314575', 'Intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome', 1),
(10055, 'ORPHA:314585', '15q overgrowth syndrome', 1),
(10056, 'ORPHA:314588', 'Distal tetrasomy 15q', 2),
(10057, 'ORPHA:314588', 'Tetrasomy 15(q25-qter)', 2),
(10058, 'ORPHA:314588', 'Tetrasomy 15q26', 2),
(10059, 'ORPHA:314597', 'Chudley-McCullough syndrome', 1),
(10060, 'ORPHA:314603', 'ARSAL', 1),
(10061, 'ORPHA:314603', 'Autosomal recessive spastic ataxia type 3', 1),
(10062, 'ORPHA:314603', 'Autosomal recessive spastic ataxia with leukoencephalopathy', 1),
(10063, 'ORPHA:314603', 'SPAX3', 1),
(10064, 'ORPHA:314613', 'Growing teratoma syndrome', 1),
(10065, 'ORPHA:314621', 'DPG-plus syndrome', 1),
(10066, 'ORPHA:314621', 'Duplication of the pituitary gland', 1),
(10067, 'ORPHA:314621', 'Duplication of the pituitary gland-plus syndrome', 1),
(10068, 'ORPHA:314621', 'Hypophyseal duplication', 1),
(10069, 'ORPHA:314629', 'CLN11 disease', 2),
(10070, 'ORPHA:314632', 'ATP13A2-related juvenile neuronal ceroid lipofuscinosis', 1),
(10071, 'ORPHA:314632', 'CLN12 disease', 1),
(10072, 'ORPHA:314632', 'Juvenile parkinsonism-neuronal ceroid lipofuscinosis', 1),
(10073, 'ORPHA:314637', 'COXPD10', 1),
(10074, 'ORPHA:314637', 'Combined oxidative phosphorylation defect type 10', 1),
(10075, 'ORPHA:314637', 'Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency', 1),
(10076, 'ORPHA:314647', 'Non-progressive cerebellar ataxia with intellectual disability', 1),
(10077, 'ORPHA:314652', 'Autosomal dominant beta2-microglobulinic amyloidosis', 1),
(10078, 'ORPHA:314652', 'Variant ABeta2M amyloidosis', 1),
(10079, 'ORPHA:314655', '5q31.3 microdeletion syndrome', 2),
(10080, 'ORPHA:314655', 'Del(5)(q31.3)', 2),
(10081, 'ORPHA:314655', 'Monosomy 5q31.3', 2),
(10082, 'ORPHA:314655', 'Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion', 2),
(10083, 'ORPHA:314662', 'Segmental progressive overgrowth syndrome with fibroadipose hyperplasia', 1),
(10084, 'ORPHA:314667', 'CDG syndrome type IIk', 1),
(10085, 'ORPHA:314667', 'CDG-IIk', 1),
(10086, 'ORPHA:314667', 'CDG2K', 1),
(10087, 'ORPHA:314667', 'Carbohydrate deficient glycoprotein syndrome type IIk', 1),
(10088, 'ORPHA:314667', 'Congenital disorder of glycosylation type 2k', 1),
(10089, 'ORPHA:314667', 'Congenital disorder of glycosylation type IIk', 1),
(10090, 'ORPHA:314667', 'TMEM165-CDG', 1),
(10091, 'ORPHA:314679', 'Cerebrofacioarticular syndrome', 1),
(10092, 'ORPHA:314679', 'Van Maldergem syndrome', 1),
(10093, 'ORPHA:314684', 'Primary bone lymphoma', 1),
(10094, 'ORPHA:314689', 'CID due to STK4 deficiency', 1),
(10095, 'ORPHA:314689', 'Combined immunodeficiency due to STK4 deficiency', 1),
(10096, 'ORPHA:314697', 'Acquired porencephaly', 2),
(10097, 'ORPHA:314701', 'Primary systemic amyloidosis', 2),
(10098, 'ORPHA:314701', 'Systemic AL amyloidosis', 2),
(10099, 'ORPHA:314709', 'Localized AL amyloidosis', 2),
(10100, 'ORPHA:314709', 'Primary localized amyloidosis', 2),
(10101, 'ORPHA:314718', 'Lethal arteriopathy syndrome due to fibulin-4 deficiency', 1),
(10102, 'ORPHA:314721', 'Atypical dentin dysplasia due to SMOC2 deficiency', 2),
(10103, 'ORPHA:314721', 'Dentin dysplasia type 1 with microdontia and shape anomalies', 2),
(10104, 'ORPHA:314749', 'Rare disease with Cushing syndrome as a major feature', 3),
(10105, 'ORPHA:314753', 'Endocrine active pituitary adenoma', 3),
(10106, 'ORPHA:314753', 'Functioning pituitary adenoma', 3),
(10107, 'ORPHA:314753', 'Secreting pituitary adenoma', 3),
(10108, 'ORPHA:314759', 'Mixed functioning pituitary adenoma', 3),
(10109, 'ORPHA:314759', 'Mixed secreting pituitary adenoma', 3),
(10110, 'ORPHA:314769', 'GH and PRL cosecreting pituitary adenoma', 1),
(10111, 'ORPHA:314769', 'Growth hormone and prolactin cosecreting pituitary adenoma', 1),
(10112, 'ORPHA:314769', 'Somatolactotropinoma', 1),
(10113, 'ORPHA:314769', 'Somatomammotropinoma', 1),
(10114, 'ORPHA:314769', 'Somatoprolactinoma', 1),
(10115, 'ORPHA:314777', 'FIPA', 1),
(10116, 'ORPHA:314777', 'Familial isolated pituitary adenoma', 1),
(10117, 'ORPHA:314786', 'Silent pituitary adenoma', 2),
(10118, 'ORPHA:314790', 'Null pituitary adenoma', 2),
(10119, 'ORPHA:314795', 'SHOX-related short stature', 1),
(10120, 'ORPHA:3148', 'MPNST', 1),
(10121, 'ORPHA:3148', 'Malignant neurilemmoma', 1),
(10122, 'ORPHA:3148', 'Malignant neurofibroma', 1),
(10123, 'ORPHA:3148', 'Malignant peripheral nerve sheath tumor', 1),
(10124, 'ORPHA:3148', 'Malignant schwannoma', 1),
(10125, 'ORPHA:3148', 'Neurofibrosarcoma', 1),
(10126, 'ORPHA:3148', 'Neurogenic sarcoma', 1),
(10127, 'ORPHA:314802', 'Short stature due to partial GHR deficiency', 1),
(10128, 'ORPHA:314802', 'Short stature due to partial growth hormone receptor deficiency', 1),
(10129, 'ORPHA:314811', 'Ghrelin receptor deficiency', 1),
(10130, 'ORPHA:314811', 'Short stature due to GHSR deficiency', 1),
(10131, 'ORPHA:314811', 'Short stature due to growth hormone secretagogue receptor deficiency', 1),
(10132, 'ORPHA:314822', 'Primary renal tubular acidosis', 3),
(10133, 'ORPHA:314889', 'AD pRTA', 2),
(10134, 'ORPHA:314889', 'Autosomal dominant proximal renal tubular acidosis', 2),
(10135, 'ORPHA:314911', 'Infantile Canavan disease', 2),
(10136, 'ORPHA:314911', 'Neonatal Canavan disease', 2),
(10137, 'ORPHA:314911', 'Severe Canavan disease', 2),
(10138, 'ORPHA:314918', 'Juvenile Canavan disease', 2),
(10139, 'ORPHA:314918', 'Mild Canavan disease', 2),
(10140, 'ORPHA:314950', 'Clonal hypereosinophilic syndrome', 1),
(10141, 'ORPHA:314950', 'HES-M', 1),
(10142, 'ORPHA:314950', 'HES-N', 1),
(10143, 'ORPHA:314950', 'Neoplastic hypereosinophilic syndrome', 1),
(10144, 'ORPHA:314950', 'Primary HES', 1),
(10145, 'ORPHA:314950', 'Primary hypereosinophilic syndrome', 1),
(10146, 'ORPHA:314962', 'HES-R', 1),
(10147, 'ORPHA:314962', 'Reactive hypereosinophilic syndrome', 1),
(10148, 'ORPHA:314962', 'Secondary HES', 1),
(10149, 'ORPHA:314962', 'Secondary hypereosinophilic syndrome', 1),
(10150, 'ORPHA:314970', 'HES-L', 2),
(10151, 'ORPHA:314970', 'Lymphocytic hypereosinophilic syndrome', 2),
(10152, 'ORPHA:314970', 'Lymphocytic variant HES', 2),
(10153, 'ORPHA:314970', 'Lymphoid HES', 2),
(10154, 'ORPHA:314978', 'X-linked non progressive cerebellar ataxia', 1),
(10155, 'ORPHA:314993', 'Cataract-congenital heart disease-neural tube defect syndrome', 1),
(10156, 'ORPHA:315', 'Degos genodermatosis \"en cocardes\"', 1),
(10157, 'ORPHA:315', 'Erythrokeratoderma \'\'en cocardes\'\'', 1),
(10158, 'ORPHA:3151', 'Multiple sclerosis-ichthyosis-factor VIII deficiency syndrome', 1),
(10159, 'ORPHA:3152', 'Cortical hyperostosis-syndactyly syndrome', 1),
(10160, 'ORPHA:3152', 'Sclerosteosis', 1),
(10161, 'ORPHA:315306', 'Classic 21-OHD CAH, salt wasting form', 2),
(10162, 'ORPHA:315306', 'Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form', 2),
(10163, 'ORPHA:315311', 'Classic 21-OHD CAH, simple virilizing form', 2),
(10164, 'ORPHA:315311', 'Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form', 2),
(10165, 'ORPHA:315350', 'Autoimmune disease with skin involvement', 3),
(10166, 'ORPHA:3156', 'Nephronophthisis with retinal dystrophy', 1),
(10167, 'ORPHA:3156', 'Renal dysplasia-retinal aplasia syndrome', 1),
(10168, 'ORPHA:3156', 'SLSN', 1),
(10169, 'ORPHA:3156', 'Senior-Loken syndrome', 1),
(10170, 'ORPHA:3157', 'De Morsier syndrome', 1),
(10171, 'ORPHA:3157', 'SOD', 1),
(10172, 'ORPHA:3157', 'Septo-optic dysplasia', 1),
(10173, 'ORPHA:3157', 'Septo-optic dysplasia spectrum', 1),
(10174, 'ORPHA:316', 'Darier-Gottron disease', 1),
(10175, 'ORPHA:316', 'Erythrokeratodermia progressiva symmetrica', 1),
(10176, 'ORPHA:316', 'Progressive symmetric erythrokeratodermia', 1),
(10177, 'ORPHA:316', 'Progressive symmetric erythrokeratodermia, Gottron type', 1),
(10178, 'ORPHA:3161', 'Congenital bronchopulmonary sequestration', 1),
(10179, 'ORPHA:3161', 'Congenital pulmonary sequestration', 1),
(10180, 'ORPHA:3162', 'Sézary lymphoma', 1),
(10181, 'ORPHA:3162', 'Sézary syndrome', 1),
(10182, 'ORPHA:316226', 'SPAX', 3),
(10183, 'ORPHA:316226', 'Spastic ataxia', 3),
(10184, 'ORPHA:316235', 'AD-SPAX', 3),
(10185, 'ORPHA:316235', 'Autosomal dominant spastic ataxia', 3),
(10186, 'ORPHA:316240', 'AR-SPAX', 3),
(10187, 'ORPHA:316240', 'Autosomal recessive spastic ataxia', 3),
(10188, 'ORPHA:316244', 'Partial deletion of chromosome 12p', 3),
(10189, 'ORPHA:316244', 'Partial deletion of the short arm of chromosome 12', 3),
(10190, 'ORPHA:316244', 'Partial monosomy of chromosome 12p', 3),
(10191, 'ORPHA:316244', 'Partial monosomy of the short arm of chromosome 12', 3),
(10192, 'ORPHA:3163', 'Lipodystrophy-Rieger anomaly-diabetes syndrome', 1),
(10193, 'ORPHA:3163', 'Rieger anomaly-partial lipodystrophy syndrome', 1),
(10194, 'ORPHA:3163', 'SHORT syndrome', 1),
(10195, 'ORPHA:3164', 'Omphalocele syndrome, Shprintzen-Goldberg type', 1),
(10196, 'ORPHA:3165', 'Diffuse fasciitis with eosinophilia', 1),
(10197, 'ORPHA:3165', 'Eosinophilic fasciitis', 1),
(10198, 'ORPHA:3165', 'Shulman syndrome', 1),
(10199, 'ORPHA:3166', 'Sialuria', 1),
(10200, 'ORPHA:3166', 'Sialuria, French type', 1),
(10201, 'ORPHA:3167', 'Siegler-Brewer-Carey syndrome', 1),
(10202, 'ORPHA:3168', 'Brachydactyly-symphalangism syndrome', 1),
(10203, 'ORPHA:3168', 'Sillence syndrome', 1),
(10204, 'ORPHA:3169', 'Sirenomelia', 1),
(10205, 'ORPHA:317', 'EKV', 1),
(10206, 'ORPHA:317', 'Erythrokeratodermia variabilis', 1),
(10207, 'ORPHA:317', 'Erythrokeratodermia variabilis, Mendes da Costa type', 1),
(10208, 'ORPHA:31709', 'ICCA syndrome', 1),
(10209, 'ORPHA:31709', 'Infantile convulsions and choreoathetosis', 1),
(10210, 'ORPHA:31709', 'Paroxysmal kinesigenic dyskinesia and infantile convulsions', 1),
(10211, 'ORPHA:3172', 'Eyebrow duplication-syndactyly syndrome', 1),
(10212, 'ORPHA:3173', 'Infantile spasms-broad thumbs syndrome', 1),
(10213, 'ORPHA:3173', 'Tsao-Ellingson syndrome', 1),
(10214, 'ORPHA:31740', 'Extrinsic allergic alveolitis', 3),
(10215, 'ORPHA:31740', 'Hypersensitivity pneumonitis', 3),
(10216, 'ORPHA:317416', 'T-B+ SCID', 3),
(10217, 'ORPHA:317416', 'T-B+ severe combined immunodeficiency', 3),
(10218, 'ORPHA:317419', 'T-B- SCID', 3),
(10219, 'ORPHA:317419', 'T-B- severe combined immunodeficiency', 3),
(10220, 'ORPHA:317425', 'SCID due to DNA-PKcs deficiency', 1),
(10221, 'ORPHA:317425', 'Severe combined immunodeficiency due to DNA-PKcs deficiency', 1),
(10222, 'ORPHA:317428', 'CID due to ORAI1 deficiency', 2),
(10223, 'ORPHA:317428', 'Combined immunodeficiency due to ORAI1 deficiency', 2),
(10224, 'ORPHA:317430', 'CID due to STIM1 deficiency', 2),
(10225, 'ORPHA:317430', 'Combined immunodeficiency due to STIM1 deficiency', 2),
(10226, 'ORPHA:317473', 'CID due to IKAROS deficiency', 1),
(10227, 'ORPHA:317473', 'Combined immunodeficiency due to IKAROS deficiency', 1),
(10228, 'ORPHA:317473', 'Pancytopenia due to IKZF1 mutations', 1),
(10229, 'ORPHA:317476', 'CID due to MAGT1 deficiency', 1),
(10230, 'ORPHA:317476', 'Combined immunodeficiency due to MAGT1 deficiency', 1),
(10231, 'ORPHA:317476', 'X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia', 1),
(10232, 'ORPHA:317476', 'XMEN', 1),
(10233, 'ORPHA:3175', 'X-linked spasticity-intellectual disability-epilepsy syndrome', 1),
(10234, 'ORPHA:3176', 'Spina bifida-hypospadias syndrome', 1),
(10235, 'ORPHA:3177', 'Der Kaloustian-Jarudi-Khoury syndrome', 1),
(10236, 'ORPHA:3177', 'Spinocerebellar degeneration-corneal dystrophy syndrome', 1),
(10237, 'ORPHA:318', 'AML M6', 1),
(10238, 'ORPHA:318', 'Acute erythroid leukemia', 1),
(10239, 'ORPHA:318', 'Acute myeloid leukemia M6', 1),
(10240, 'ORPHA:318', 'Erythroleukemia', 1),
(10241, 'ORPHA:3180', 'Spondylocamptodactyly syndrome', 1),
(10242, 'ORPHA:3181', 'High scapula', 1),
(10243, 'ORPHA:3181', 'Sprengel deformity', 1),
(10244, 'ORPHA:31824', 'Colchicine poisoning', 1),
(10245, 'ORPHA:31825', 'Methanol poisoning', 1),
(10246, 'ORPHA:31826', 'Ethylene glycol poisoning', 1),
(10247, 'ORPHA:31827', 'Paraquat poisoning', 1),
(10248, 'ORPHA:31828', 'Digitalis poisoning', 1),
(10249, 'ORPHA:31837', 'Pulmonary venoocclusive disease', 1),
(10250, 'ORPHA:3184', 'Steatocystoma multiplex-natal teeth syndrome', 1),
(10251, 'ORPHA:3186', 'Holoprosencephaly-radial heart renal anomalies syndrome', 1),
(10252, 'ORPHA:3186', 'Steinfeld syndrome', 1),
(10253, 'ORPHA:3188', 'Congenital pulmonary veins atresia or stenosis', 1),
(10254, 'ORPHA:3189', 'Congenital pulmonary valve stenosis', 1),
(10255, 'ORPHA:319', 'Osseous Ewing sarcoma', 1),
(10256, 'ORPHA:319', 'Skeletal Ewing sarcoma', 1),
(10257, 'ORPHA:3190', 'Subpulmonary stenosis', 2),
(10258, 'ORPHA:3191', 'Onat syndrome', 1),
(10259, 'ORPHA:3191', 'Subaortic stenosis-short stature syndrome', 1),
(10260, 'ORPHA:319160', 'CNM4', 1),
(10261, 'ORPHA:319160', 'Centronuclear myopathy type 4', 1),
(10262, 'ORPHA:319160', 'Congenital myopathy with internal nuclei and atypical cores', 1),
(10263, 'ORPHA:319171', 'Distal 17p13.1 microdeletion syndrome', 1),
(10264, 'ORPHA:319171', 'Distal del(17)(p13.1)', 1),
(10265, 'ORPHA:319182', 'Hypertrichosis-short stature-facial dysmorphism-developmental delay syndrome', 1),
(10266, 'ORPHA:319182', 'Wiedemann-Steiner syndrome', 1),
(10267, 'ORPHA:319189', 'Familial cortical myoclonus', 1),
(10268, 'ORPHA:319192', 'Diencephalic-mesencephalic junction dysplasia', 1),
(10269, 'ORPHA:319195', 'Chondroectodermal dysplasia with night blindness', 1),
(10270, 'ORPHA:319199', 'Autosomal recessive spastic paraplegia type 53', 1),
(10271, 'ORPHA:319199', 'SPG53', 1),
(10272, 'ORPHA:3192', 'Supravalvular pulmonary stenosis', 2),
(10273, 'ORPHA:319205', 'BMAH', 2),
(10274, 'ORPHA:319205', 'Bilateral adrenal hemorrhage', 2),
(10275, 'ORPHA:319205', 'Bilateral massive adrenal hemorrhage', 2),
(10276, 'ORPHA:319213', 'Lujo hemorrhagic fever', 1),
(10277, 'ORPHA:319213', 'Zambian hemorrhagic fever', 1),
(10278, 'ORPHA:319218', 'EHF', 1),
(10279, 'ORPHA:319218', 'Ebola fever', 1),
(10280, 'ORPHA:319218', 'Ebola hemorrhagic fever', 1),
(10281, 'ORPHA:319218', 'Ebola virus disease', 1),
(10282, 'ORPHA:319223', 'Argentine hemorrhagic fever', 1),
(10283, 'ORPHA:319223', 'Argentinian hemorrhagic fever', 1),
(10284, 'ORPHA:319223', 'Junin hemorrhagic fever', 1),
(10285, 'ORPHA:319229', 'Bolivian hemorrhagic fever', 1),
(10286, 'ORPHA:319229', 'Machupo hemorrhagic fever', 1),
(10287, 'ORPHA:319234', 'Guanarito hemorrhagic fever', 1),
(10288, 'ORPHA:319234', 'Venezuelan hemorrhagic fever', 1),
(10289, 'ORPHA:319239', 'Brazilian hemorrhagic fever', 1),
(10290, 'ORPHA:319239', 'Sabia hemorrhagic fever', 1),
(10291, 'ORPHA:319244', 'Chapare hemorrhagic fever', 1),
(10292, 'ORPHA:319247', 'Hantavirus pulmonary syndrome', 1),
(10293, 'ORPHA:319251', 'Rift valley fever', 1),
(10294, 'ORPHA:319254', 'Kyasanur forest disease', 1),
(10295, 'ORPHA:319254', 'Kyasanur hemorrhagic fever', 1),
(10296, 'ORPHA:319254', 'Monkey disease', 1),
(10297, 'ORPHA:319254', 'Monkey fever', 1),
(10298, 'ORPHA:319266', 'Omsk hemorrhagic fever', 1),
(10299, 'ORPHA:319276', 'CCRCC', 1),
(10300, 'ORPHA:319276', 'Clear cell renal carcinoma', 1),
(10301, 'ORPHA:319276', 'Clear cell renal cell adenocarcinoma', 1),
(10302, 'ORPHA:319276', 'Clear cell renal cell carcinoma', 1),
(10303, 'ORPHA:319287', 'MCRCC', 2),
(10304, 'ORPHA:319287', 'Multilocular clear cell adenocarcinoma', 2),
(10305, 'ORPHA:319287', 'Multilocular clear cell carcinoma', 2),
(10306, 'ORPHA:319287', 'Multilocular clear cell renal cell adenocarcinoma', 2),
(10307, 'ORPHA:319287', 'Multilocular clear cell renal cell carcinoma', 2),
(10308, 'ORPHA:319287', 'Multilocular cystic renal cell adenocarcinoma', 2),
(10309, 'ORPHA:319287', 'Multilocular cystic renal cell carcinoma', 2),
(10310, 'ORPHA:319287', 'Multilocular cystic renal neoplasm of low malignant potential', 2),
(10311, 'ORPHA:319298', 'Papillary renal cell adenocarcinoma', 1),
(10312, 'ORPHA:319298', 'Papillary renal cell carcinoma', 1),
(10313, 'ORPHA:3193', 'SVAS', 1),
(10314, 'ORPHA:3193', 'Supravalvular aortic stenosis', 1),
(10315, 'ORPHA:319303', 'Chromophobe renal cell adenocarcinoma', 1),
(10316, 'ORPHA:319303', 'Chromophobe renal cell carcinoma', 1),
(10317, 'ORPHA:319308', 'Carcinoma associated with MITF/TFE translocation', 1),
(10318, 'ORPHA:319308', 'MiT family translocation renal cell carcinoma', 1),
(10319, 'ORPHA:319308', 'Translocation renal cell carcinoma', 1),
(10320, 'ORPHA:319319', 'Renal medullary carcinoma', 1),
(10321, 'ORPHA:319322', 'Mucinous tubular and spindle cell renal carcinoma', 1),
(10322, 'ORPHA:319325', 'Tubulocystic renal cell carcinoma', 1),
(10323, 'ORPHA:319328', 'Inherited renal cancer-predisposing syndrome', 3),
(10324, 'ORPHA:319332', 'Autosomal recessive myogenic AMC', 1),
(10325, 'ORPHA:319332', 'Autosomal recessive myogenic arthrogryposis multiplex congenita', 1),
(10326, 'ORPHA:319332', 'SYNE1-related AMC', 1),
(10327, 'ORPHA:319332', 'SYNE1-related arthrogryposis multiplex congenita', 1),
(10328, 'ORPHA:319340', 'Carney complex variant', 1),
(10329, 'ORPHA:319340', 'Carney complex-trismus-pseudocamptodactyly syndrome', 1),
(10330, 'ORPHA:3194', 'CDO syndrome', 1),
(10331, 'ORPHA:3194', 'Corneodermatoosseous syndrome', 1),
(10332, 'ORPHA:3194', 'Stern-Lubinsky-Durrie syndrome', 1),
(10333, 'ORPHA:319462', 'Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations', 1),
(10334, 'ORPHA:319465', 'Familial AML', 1),
(10335, 'ORPHA:319465', 'Inherited AML', 1),
(10336, 'ORPHA:319465', 'Inherited acute myeloid leukemia', 1),
(10337, 'ORPHA:319465', 'Pure familial AML', 1),
(10338, 'ORPHA:319465', 'Pure familial acute myeloid leukemia', 1),
(10339, 'ORPHA:319480', 'AML with CEBPA somatic mutations', 1),
(10340, 'ORPHA:319480', 'Acute myeloid leukemia with CEBPA somatic mutations', 1),
(10341, 'ORPHA:319487', 'FNMTC', 1),
(10342, 'ORPHA:319487', 'Familial papillary or follicular thyroid carcinoma', 1),
(10343, 'ORPHA:319487', 'Familial pure nonmedullary thyroid carcinoma', 1),
(10344, 'ORPHA:319494', 'Familial nonmedullary thyroid carcinoma', 3),
(10345, 'ORPHA:319504', 'COXPD8', 1),
(10346, 'ORPHA:319504', 'Combined oxidative phosphorylation defect type 8', 1),
(10347, 'ORPHA:319509', 'COXPD9', 1),
(10348, 'ORPHA:319509', 'Combined oxidative phosphorylation defect type 9', 1),
(10349, 'ORPHA:319514', 'COXPD13', 1),
(10350, 'ORPHA:319514', 'Combined oxidative phosphorylation defect type 13', 1),
(10351, 'ORPHA:319519', 'COXPD14', 1),
(10352, 'ORPHA:319519', 'Combined oxidative phosphorylation defect type 14', 1),
(10353, 'ORPHA:319524', 'COXPD15', 1),
(10354, 'ORPHA:319524', 'Combined oxidative phosphorylation defect type 15', 1),
(10355, 'ORPHA:319535', 'Autosomal recessive MSMD due to a complete deficiency', 3),
(10356, 'ORPHA:319535', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a complete deficiency', 3),
(10357, 'ORPHA:319539', 'Autosomal recessive MSMD due to a partial deficiency', 3),
(10358, 'ORPHA:319539', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to a partial deficiency', 3),
(10359, 'ORPHA:319543', 'Autosomal dominant MSMD due to a partial deficiency', 3),
(10360, 'ORPHA:319543', 'Autosomal dominant mendelian susceptibility to mycobacterial diseases due to a partial deficiency', 3),
(10361, 'ORPHA:319547', 'MSMD due to complete IFNgammaR2 deficiency', 1),
(10362, 'ORPHA:319547', 'MSMD due to complete interferon gamma receptor 2 deficiency', 1),
(10363, 'ORPHA:319547', 'Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency', 1),
(10364, 'ORPHA:319547', 'Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 2 deficiency', 1),
(10365, 'ORPHA:319552', 'MSMD due to complete IL12RB1 deficiency', 1),
(10366, 'ORPHA:319552', 'MSMD due to complete interleukin 12 receptor beta 1 deficiency', 1),
(10367, 'ORPHA:319552', 'Mendelian susceptibility to interleukin 12 receptor beta 1 deficiency', 1),
(10368, 'ORPHA:319552', 'Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency', 1),
(10369, 'ORPHA:319558', 'MSMD due to complete IL12B deficiency', 1),
(10370, 'ORPHA:319558', 'MSMD due to complete interleukin 12B deficiency', 1),
(10371, 'ORPHA:319558', 'Mendelian susceptibility to mycobacterial diseases due to complete IL12B deficiency', 1),
(10372, 'ORPHA:319558', 'Mendelian susceptibility to mycobacterial diseases due to complete interleukin 12B deficiency', 1),
(10373, 'ORPHA:319563', 'MSMD due to complete ISG15 deficiency', 1),
(10374, 'ORPHA:319563', 'Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency', 1),
(10375, 'ORPHA:319569', 'Autosomal recessive MSMD due to partial IFNgammaR1 deficiency', 1),
(10376, 'ORPHA:319569', 'Autosomal recessive MSMD due to partial interferon gamma receptor 1 deficiency', 1),
(10377, 'ORPHA:319569', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency', 1),
(10378, 'ORPHA:319569', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency', 1),
(10379, 'ORPHA:319574', 'Autosomal recessive MSMD due to partial IFNgammaR2 deficiency', 1),
(10380, 'ORPHA:319574', 'Autosomal recessive MSMD due to partial interferon gamma receptor 2 deficiency', 1),
(10381, 'ORPHA:319574', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency', 1),
(10382, 'ORPHA:319574', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 2 deficiency', 1),
(10383, 'ORPHA:319581', 'Autosomal dominant MSMD due to partial IFNgammaR1 deficiency', 1),
(10384, 'ORPHA:319581', 'Autosomal dominant MSMD due to partial interferon gamma receptor 1 deficiency', 1),
(10385, 'ORPHA:319581', 'Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency', 1),
(10386, 'ORPHA:319581', 'Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 1 deficiency', 1),
(10387, 'ORPHA:319589', 'Autosomal dominant MSMD due to partial IFNgammaR2 deficiency', 1),
(10388, 'ORPHA:319589', 'Autosomal dominant MSMD due to partial interferon gamma receptor 2 deficiency', 1),
(10389, 'ORPHA:319589', 'Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency', 1),
(10390, 'ORPHA:319589', 'Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial interferon gamma receptor 2 deficiency', 1),
(10391, 'ORPHA:319595', 'MSMD due to partial STAT1 deficiency', 1),
(10392, 'ORPHA:319595', 'MSMD due to partial signal transducer and activator of transcription 1 deficiency', 1),
(10393, 'ORPHA:319595', 'Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency', 1),
(10394, 'ORPHA:319595', 'Mendelian susceptibility to mycobacterial diseases due to partial signal transducer and activator of transcription 1 deficiency', 1),
(10395, 'ORPHA:3196', 'Lyngstadaas syndrome', 1),
(10396, 'ORPHA:3196', 'Steroid dehydrogenase deficiency-dental anomalies syndrome', 1),
(10397, 'ORPHA:319600', 'MSMD due to partial IRF8 deficiency', 1),
(10398, 'ORPHA:319600', 'MSMD due to partial interferon regulatory factor 8 deficiency', 1),
(10399, 'ORPHA:319600', 'Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency', 1),
(10400, 'ORPHA:319600', 'Mendelian susceptibility to mycobacterial diseases due to partial interferon regulatory factor 8 deficiency', 1),
(10401, 'ORPHA:319605', 'X-linked MSMD', 1),
(10402, 'ORPHA:319605', 'X-linked mendelian susceptibility to mycobacterial diseases', 1),
(10403, 'ORPHA:319612', 'X-linked MSMD due to IKBKG deficiency', 2),
(10404, 'ORPHA:319612', 'X-linked MSMD due to NEMO deficiency', 2),
(10405, 'ORPHA:319612', 'X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency', 2),
(10406, 'ORPHA:319612', 'X-linked mendelian susceptibility to mycobacterial diseases due to NEMO deficiency', 2),
(10407, 'ORPHA:319623', 'X-linked MSMD due to CYBB deficiency', 2),
(10408, 'ORPHA:319623', 'X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency', 2),
(10409, 'ORPHA:319635', 'Amyloidosis cutis dyschromia', 1),
(10410, 'ORPHA:319635', 'Amyloidosis cutis dyschromica', 1),
(10411, 'ORPHA:319640', 'MCDR2', 1),
(10412, 'ORPHA:319640', 'Retinal macular dystrophy type 2', 1),
(10413, 'ORPHA:319646', 'CDG syndrome type It', 1),
(10414, 'ORPHA:319646', 'CDG-It', 1),
(10415, 'ORPHA:319646', 'CDG1T', 1),
(10416, 'ORPHA:319646', 'Congenital disorder of glycosylation type 1t', 1),
(10417, 'ORPHA:319646', 'Congenital disorder of glycosylation type It', 1),
(10418, 'ORPHA:319646', 'PGM1-CDG', 1),
(10419, 'ORPHA:319646', 'PGM1-related congenital disorder of glycosylation', 1),
(10420, 'ORPHA:319646', 'Phosphoglucomutase-1 deficiency', 1),
(10421, 'ORPHA:319651', 'Constitutional megaloblastic anemia with severe neurologic disease', 1),
(10422, 'ORPHA:319651', 'DHFR deficiency', 1),
(10423, 'ORPHA:319651', 'Dihydrofolate reductase deficiency', 1),
(10424, 'ORPHA:319667', 'Primary lymphoid conjunctival tumor', 1),
(10425, 'ORPHA:319667', 'Primary lymphoma of the conjunctiva', 1),
(10426, 'ORPHA:319671', 'Alazami syndrome', 1),
(10427, 'ORPHA:319671', 'Microcephalic primordial dwarfism, Alazami type', 1),
(10428, 'ORPHA:319675', 'Microcephalic primordial dwarfism, Dauber type', 1),
(10429, 'ORPHA:319678', 'Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome', 1),
(10430, 'ORPHA:3197', 'Congenital stiff man syndrome', 1),
(10431, 'ORPHA:3197', 'Familial startle disease', 1),
(10432, 'ORPHA:3197', 'Hereditary hyperekplexia', 1),
(10433, 'ORPHA:3197', 'Hereditary hyperexplexia', 1),
(10434, 'ORPHA:3197', 'Kok disease', 1),
(10435, 'ORPHA:3197', 'Stiff baby syndrome', 1),
(10436, 'ORPHA:319719', 'Autoinflammatory syndrome of childhood', 3),
(10437, 'ORPHA:3198', 'Moersch-Woltman syndrome', 1),
(10438, 'ORPHA:3198', 'SMS', 1),
(10439, 'ORPHA:3198', 'SPS', 1),
(10440, 'ORPHA:3198', 'Stiff man syndrome', 1),
(10441, 'ORPHA:3198', 'Stiff person spectrum disorder', 1),
(10442, 'ORPHA:3199', 'Stimmler syndrome', 1),
(10443, 'ORPHA:32', 'Glutathione synthetase deficiency', 1),
(10444, 'ORPHA:32', 'Pyroglutamicaciduria', 1),
(10445, 'ORPHA:320', '11-beta-hydroxysteroid dehydrogenase deficiency type 2', 1),
(10446, 'ORPHA:320', 'Apparent mineralocorticoid excess', 1),
(10447, 'ORPHA:320', 'Ulick syndrome', 1),
(10448, 'ORPHA:3200', 'Arthrogryposis-ectodermal dysplasia syndrome', 1),
(10449, 'ORPHA:3200', 'Stoll-Alembik-Finck syndrome', 1),
(10450, 'ORPHA:3201', 'Stoll-Kieny-Dott syndrome', 1),
(10451, 'ORPHA:3201', 'Ventricular extrasystoles with syncopal episodes-perodactyly-Robin sequence syndrome', 1),
(10452, 'ORPHA:3202', 'Dehydrated hereditary stomatocytosis', 1),
(10453, 'ORPHA:3202', 'Hereditary xerocytosis', 1),
(10454, 'ORPHA:3203', 'Overhydrated hereditary stomatocytosis', 1),
(10455, 'ORPHA:320332', 'X-linked pure spastic paraplegia', 3),
(10456, 'ORPHA:320335', 'Pure or complex familial spastic paraplegia', 3),
(10457, 'ORPHA:320335', 'Pure or complex hereditary spastic paraplegia', 3),
(10458, 'ORPHA:320335', 'Pure or complicated familial spastic paraplegia', 3),
(10459, 'ORPHA:320335', 'Pure or complicated hereditary spastic paraplegia', 3),
(10460, 'ORPHA:320342', 'Pure or complex autosomal dominant spastic paraplegia', 3),
(10461, 'ORPHA:320342', 'Pure or complicated autosomal dominant spastic paraplegia', 3),
(10462, 'ORPHA:320346', 'Pure or complex autosomal recessive spastic paraplegia', 3),
(10463, 'ORPHA:320346', 'Pure or complicated autosomal recessive spastic paraplegia', 3),
(10464, 'ORPHA:320350', 'Pure or complex X-linked spastic paraplegia', 3),
(10465, 'ORPHA:320350', 'Pure or complicated X-linked spastic paraplegia', 3),
(10466, 'ORPHA:320355', 'Autosomal dominant spastic paraplegia type 41', 1),
(10467, 'ORPHA:320355', 'SPG41', 1),
(10468, 'ORPHA:320360', 'MT-ATP6-related mitochondrial spastic paraplegia', 1),
(10469, 'ORPHA:320360', 'Maternally-inherited SPG', 1),
(10470, 'ORPHA:320360', 'Maternally-inherited spastic paraplegia', 1),
(10471, 'ORPHA:320365', 'Autosomal dominant spastic paraplegia type 36', 1),
(10472, 'ORPHA:320365', 'SPG36', 1),
(10473, 'ORPHA:320370', 'Autosomal recessive spastic paraplegia type 43', 1),
(10474, 'ORPHA:320370', 'SPG43', 1),
(10475, 'ORPHA:320375', 'Autosomal recessive spastic paraplegia type 55', 1),
(10476, 'ORPHA:320375', 'SPG55', 1),
(10477, 'ORPHA:320380', 'Autosomal recessive spastic paraplegia type 54', 1),
(10478, 'ORPHA:320380', 'SPG54', 1),
(10479, 'ORPHA:320385', 'Autosomal recessive spastic paraplegia type 49', 1),
(10480, 'ORPHA:320385', 'HSAN due to TECPR2 mutation', 1),
(10481, 'ORPHA:320385', 'Hereditary sensory and autonomic neuropathy due to TECPR2 mutation', 1),
(10482, 'ORPHA:320385', 'SPG49', 1),
(10483, 'ORPHA:320391', 'Autosomal recessive spastic paraplegia type 46', 1),
(10484, 'ORPHA:320391', 'SPG46', 1),
(10485, 'ORPHA:320396', 'Autosomal recessive spastic paraplegia type 45', 1),
(10486, 'ORPHA:320396', 'Autosomal recessive spastic paraplegia type 65', 1),
(10487, 'ORPHA:320396', 'SPG45', 1),
(10488, 'ORPHA:320396', 'SPG65', 1),
(10489, 'ORPHA:3204', 'Stormorken syndrome', 1),
(10490, 'ORPHA:3204', 'Stormorken-Sjaastad-Langslet syndrome', 1),
(10491, 'ORPHA:3204', 'Thrombocytopathy-asplenia-miosis syndrome', 1),
(10492, 'ORPHA:320401', 'Autosomal recessive spastic paraplegia type 44', 1),
(10493, 'ORPHA:320401', 'SPG44', 1),
(10494, 'ORPHA:320406', 'SPOAN', 1),
(10495, 'ORPHA:320406', 'Spastic paraplegia-optic atrophy-neuropathy syndrome', 1),
(10496, 'ORPHA:320411', 'Autosomal recessive spastic paraplegia type 56', 1),
(10497, 'ORPHA:320411', 'SPG56', 1),
(10498, 'ORPHA:3205', 'Encephalofacial angiomatosis', 1),
(10499, 'ORPHA:3205', 'Encephalotrigeminal angiomatosis', 1),
(10500, 'ORPHA:3205', 'SWS', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(10501, 'ORPHA:3205', 'Sturge-Weber syndrome', 1),
(10502, 'ORPHA:3205', 'Sturge-Weber-Dimitri syndrome', 1),
(10503, 'ORPHA:3205', 'Sturge-Weber-Krabbe angiomatosis', 1),
(10504, 'ORPHA:3205', 'Sturge-Weber-Krabbe syndrome', 1),
(10505, 'ORPHA:3206', 'Neonatal Schwartz-Jampel syndrome', 1),
(10506, 'ORPHA:3206', 'SJS2', 1),
(10507, 'ORPHA:3206', 'Schwartz-Jampel syndrome type 2', 1),
(10508, 'ORPHA:3206', 'Stüve-Wiedemann dysplasia', 1),
(10509, 'ORPHA:3206', 'Stüve-Wiedemann syndrome', 1),
(10510, 'ORPHA:3207', 'Curatolo-Cilio-Pessagno syndrome', 1),
(10511, 'ORPHA:3207', 'White matter hypoplasia-corpus callosum agenesis-intellectual disability syndrome', 1),
(10512, 'ORPHA:3208', 'Isolated mitochondrial respiratory chain complex II deficiency', 1),
(10513, 'ORPHA:3208', 'Isolated succinate  dehydrogenase deficiency', 1),
(10514, 'ORPHA:3208', 'Isolated succinate-CoQ reductase deficiency', 1),
(10515, 'ORPHA:3208', 'Isolated succinate-coenzyme Q reductase deficiency', 1),
(10516, 'ORPHA:3208', 'Isolated succinate-ubiquinone reductase deficiency', 1),
(10517, 'ORPHA:321', 'Bessel-Hagen disease', 1),
(10518, 'ORPHA:321', 'Multiple cartilaginous exostoses', 1),
(10519, 'ORPHA:321', 'Multiple osteochondromas', 1),
(10520, 'ORPHA:3210', 'Summitt syndrome', 1),
(10521, 'ORPHA:3214', 'Deaf blind hypopigmentation syndrome, Yemenite type', 1),
(10522, 'ORPHA:3214', 'Warburg-Thomsen syndrome', 1),
(10523, 'ORPHA:3214', 'Yemenite deaf-blind hypopigmentation syndrome', 1),
(10524, 'ORPHA:3216', 'Conductive deafness-malformed external ear syndrome', 1),
(10525, 'ORPHA:3216', 'Conductive hearing loss-malformed external ear syndrome', 1),
(10526, 'ORPHA:3216', 'Mengel-Konigsmark syndrome', 1),
(10527, 'ORPHA:3217', 'Deafness-small bowel diverticulosis-neuropathy syndrome', 1),
(10528, 'ORPHA:3217', 'Groll-Hirschowitz syndrome', 1),
(10529, 'ORPHA:3217', 'Hearing loss-small bowel diverticulosis-neuropathy syndrome', 1),
(10530, 'ORPHA:3218', 'Chitty-Hall-Baraitser syndrome', 1),
(10531, 'ORPHA:3218', 'Deafness-epiphyseal dysplasia-short stature syndrome', 1),
(10532, 'ORPHA:3218', 'Hearing loss-epiphyseal dysplasia-short stature syndrome', 1),
(10533, 'ORPHA:3219', 'Deafness-skeletal dysplasia-coarse face with full lips syndrome', 1),
(10534, 'ORPHA:3219', 'Deafness-skeletal dysplasia-lip granuloma syndrome', 1),
(10535, 'ORPHA:3219', 'Fountain syndrome', 1),
(10536, 'ORPHA:3219', 'Hearing loss-skeletal dysplasia-coarse face with full lips syndrome', 1),
(10537, 'ORPHA:3219', 'Hearing loss-skeletal dysplasia-lip granuloma syndrome', 1),
(10538, 'ORPHA:322', 'BEEC', 1),
(10539, 'ORPHA:322', 'Bladder exstrophy-epispadias-cloacal extrophy complex', 1),
(10540, 'ORPHA:322', 'EEC', 1),
(10541, 'ORPHA:322', 'Exstrophy-epispadias complex', 1),
(10542, 'ORPHA:3220', 'Deafness-enamel hypoplasia-nail defects syndrome', 1),
(10543, 'ORPHA:3220', 'Hearing loss-enamel hypoplasia-nail defects syndrome', 1),
(10544, 'ORPHA:3220', 'Heimler syndrome', 1),
(10545, 'ORPHA:322126', 'Genetic tumor of hematopoietic and lymphoid tissues', 3),
(10546, 'ORPHA:3222', 'PRPP synthetase superactivity', 1),
(10547, 'ORPHA:3222', 'PRPS1 superactivity', 1),
(10548, 'ORPHA:3222', 'Phosphoribosylpyrophosphate synthetase superactivity', 1),
(10549, 'ORPHA:3224', 'Deafness-genital anomalies-metacarpal and metatarsal synostosis syndrome', 1),
(10550, 'ORPHA:3224', 'Hearing loss-genital anomalies-metacarpal and metatarsal synostosis syndrome', 1),
(10551, 'ORPHA:3224', 'Pfeiffer-Kapferer syndrome', 1),
(10552, 'ORPHA:3225', 'Hearing loss-familial salivary gland insensitivity to aldosterone syndrome', 1),
(10553, 'ORPHA:3225', 'Tungland-Bellman syndrome', 1),
(10554, 'ORPHA:3226', 'Deafness-lymphedema-leukemia syndrome', 1),
(10555, 'ORPHA:3226', 'Emberger syndrome', 1),
(10556, 'ORPHA:3226', 'Hearing loss-lymphedema-leukemia syndrome', 1),
(10557, 'ORPHA:3230', 'Deafness-oligodontia syndrome', 1),
(10558, 'ORPHA:3230', 'Hearing loss-oligodontia syndrome', 1),
(10559, 'ORPHA:3231', 'Deafness-onychodystrophy syndrome', 3),
(10560, 'ORPHA:3231', 'Hearing loss-onychodystrophy syndrome', 3),
(10561, 'ORPHA:3232', 'Deafness-ear malformation-facial palsy syndrome', 1),
(10562, 'ORPHA:3232', 'Hearing loss-ear malformation-facial palsy syndrome', 1),
(10563, 'ORPHA:3232', 'Sellars-Beighton syndrome', 1),
(10564, 'ORPHA:3233', 'Cochleosaccular degeneration-cataract syndrome', 1),
(10565, 'ORPHA:3235', 'Progressive deafness with stapes fixation', 1),
(10566, 'ORPHA:3235', 'Progressive hearing loss with stapes fixation', 1),
(10567, 'ORPHA:3235', 'Stapedo-vestibular ankylosis', 1),
(10568, 'ORPHA:3235', 'Thies-Reis syndrome', 1),
(10569, 'ORPHA:3236', 'Conductive deafness-ptosis-skeletal anomalies syndrome', 1),
(10570, 'ORPHA:3236', 'Conductive hearing loss-ptosis-skeletal anomalies syndrome', 1),
(10571, 'ORPHA:3236', 'Jackson-Barr syndrome', 1),
(10572, 'ORPHA:3237', 'Deafness-Hermann type symphalangism syndrome', 1),
(10573, 'ORPHA:3237', 'Facio-audio-symphalangism', 1),
(10574, 'ORPHA:3237', 'Hearing loss-Hermann type symphalangism syndrome', 1),
(10575, 'ORPHA:3237', 'Multiple synostoses syndrome', 1),
(10576, 'ORPHA:3237', 'Symphalangism-brachydactyly syndrome', 1),
(10577, 'ORPHA:3237', 'WL syndrome', 1),
(10578, 'ORPHA:3238', 'Cardiospondylocarpofacial syndrome', 1),
(10579, 'ORPHA:3238', 'Forney syndrome', 1),
(10580, 'ORPHA:3238', 'Forney-Robinson-Pascoe syndrome', 1),
(10581, 'ORPHA:3238', 'Mitral regurgitation-deafness-skeletal anomalies syndrome', 1),
(10582, 'ORPHA:3238', 'Mitral regurgitation-hearing loss-skeletal anomalies syndrome', 1),
(10583, 'ORPHA:3239', 'Deafness-vitiligo-achalasia syndrome', 1),
(10584, 'ORPHA:3239', 'Hearing loss-vitiligo-achalasia syndrome', 1),
(10585, 'ORPHA:324', 'Alpha-galactosidase A deficiency', 1),
(10586, 'ORPHA:324', 'Anderson-Fabry disease', 1),
(10587, 'ORPHA:324', 'Angiokeratoma corporis diffusum', 1),
(10588, 'ORPHA:324', 'Diffuse angiokeratoma', 1),
(10589, 'ORPHA:324', 'FD', 1),
(10590, 'ORPHA:324', 'Fabry disease', 1),
(10591, 'ORPHA:3240', 'Central nervous system calcification-deafness-tubular acidosis-anemia syndrome', 1),
(10592, 'ORPHA:3240', 'Central nervous system calcification-hearing loss-tubular acidosis-anemia syndrome', 1),
(10593, 'ORPHA:3240', 'Yoshimura-Takeshita syndrome', 1),
(10594, 'ORPHA:3241', 'Deafness-craniofacial syndrome', 1),
(10595, 'ORPHA:3241', 'Hearing loss-craniofacial syndrome', 1),
(10596, 'ORPHA:3242', 'Renpenning syndrome', 1),
(10597, 'ORPHA:3242', 'X-linked intellectual disability due to PQBP1 mutations', 1),
(10598, 'ORPHA:3242', 'X-linked intellectual disability, Renpenning type', 1),
(10599, 'ORPHA:324262', 'Autosomal recessive congenital cerebellar ataxia due to MGLUR1 deficiency', 2),
(10600, 'ORPHA:324262', 'Autosomal recessive congenital cerebellar ataxia due to metabotropic glutamate receptor 1 deficiency', 2),
(10601, 'ORPHA:324262', 'Autosomal recessive spinocerebellar ataxia type 13', 2),
(10602, 'ORPHA:324262', 'SCAR13', 2),
(10603, 'ORPHA:324290', 'Early-onset Lafora body disease', 1),
(10604, 'ORPHA:324294', 'T-cell immunodeficiency due to RHOH deficiency', 1),
(10605, 'ORPHA:324294', 'T-cell immunodeficiency with epidermodysplasia verruciformis', 1),
(10606, 'ORPHA:324299', 'Multiple paragangliomas associated with erythrocytosis', 1),
(10607, 'ORPHA:324299', 'Multiple paragangliomas associated with polycythemia', 1),
(10608, 'ORPHA:324299', 'Paraganglioma-somatostatinoma-polycythemia syndrome', 1),
(10609, 'ORPHA:3243', 'Acute febrile neutrophilic dermatosis', 1),
(10610, 'ORPHA:3243', 'Sweet syndrome', 1),
(10611, 'ORPHA:324307', 'Severe lateral tibial bowing with short stature', 1),
(10612, 'ORPHA:324313', '9p13 microdeletion syndrome', 1),
(10613, 'ORPHA:324313', 'Del(9)(p13)', 1),
(10614, 'ORPHA:324313', 'Monosomy 9p13', 1),
(10615, 'ORPHA:324321', 'Sinoatrial node dysfunction and deafness', 1),
(10616, 'ORPHA:324321', 'Sinoatrial node dysfunction and hearing loss', 1),
(10617, 'ORPHA:324353', 'Congenital achiasma', 1),
(10618, 'ORPHA:324364', 'Mixed sclerosing bone dystrophy with extra-skeletal manifestations', 1),
(10619, 'ORPHA:324381', 'HIBM4', 1),
(10620, 'ORPHA:324381', 'Hereditary inclusion body myopathy type 4', 1),
(10621, 'ORPHA:324410', 'X-linked intellectual disability-cardiomegaly-congestive heart failure syndrome', 1),
(10622, 'ORPHA:324416', 'Muscular hypertrophy-hepatomegaly-polyhydramnios syndrome', 1),
(10623, 'ORPHA:324422', 'ALG13-CDG', 1),
(10624, 'ORPHA:324422', 'CDG syndrome type Is', 1),
(10625, 'ORPHA:324422', 'CDG-Is', 1),
(10626, 'ORPHA:324422', 'CDG1S', 1),
(10627, 'ORPHA:324422', 'Congenital disorder of glycosylation type 1s', 1),
(10628, 'ORPHA:324422', 'Congenital disorder of glycosylation type Is', 1),
(10629, 'ORPHA:324442', 'ARAN-NM', 1),
(10630, 'ORPHA:324442', 'ARCMT2-NM', 1),
(10631, 'ORPHA:324442', 'Autosomal recessive Charcot-Marie-Tooth disease type 2 with neuromyotonia', 1),
(10632, 'ORPHA:324442', 'Autosomal recessive axonal neuropathy with neuromyotonia', 1),
(10633, 'ORPHA:324525', 'Hypertrophic cardiomyopathy and renal tubular disease due to mitochondrial DNA mutation', 1),
(10634, 'ORPHA:324525', 'Hypertrophic cardiomyopathy and renal tubular disease due to mtDNA mutation', 1),
(10635, 'ORPHA:324530', 'APLAID', 1),
(10636, 'ORPHA:324530', 'Autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation', 1),
(10637, 'ORPHA:324535', 'COXPD11', 1),
(10638, 'ORPHA:324535', 'Combined oxidative phosphorylation defect type 11', 1),
(10639, 'ORPHA:324540', 'Aphonia-deafness-retinal dystrophy-bifid halluces-intellectual disability syndrome', 1),
(10640, 'ORPHA:324540', 'Aphonia-deafness-retinal dystrophy-duplicated halluces-intellectual disability syndrome', 1),
(10641, 'ORPHA:324540', 'Aphonia-hearing loss-retinal dystrophy-duplicated halluces-intellectual disability syndrome', 1),
(10642, 'ORPHA:324561', 'Cole disease', 1),
(10643, 'ORPHA:324561', 'Guttate hypopigmentation and punctate palmoplantar keratoderma', 1),
(10644, 'ORPHA:324561', 'Hypopigmentation and punctate keratosis of the palms and soles', 1),
(10645, 'ORPHA:324561', 'Hypopigmentation-punctate palmoplantar keratoderma syndrome', 1),
(10646, 'ORPHA:324569', 'PCH8', 1),
(10647, 'ORPHA:324569', 'Pontocerebellar hypoplasia due to CHMP1A mutation', 1),
(10648, 'ORPHA:324569', 'Pontocerebellar hypoplasia type 8', 1),
(10649, 'ORPHA:324575', 'Hyperinsulinemic hypoglycemia due to HNF1A deficiency', 1),
(10650, 'ORPHA:324575', 'Hyperinsulinism due to HNF1A deficiency', 1),
(10651, 'ORPHA:324581', 'Benign Samaritan congenital myopathy', 1),
(10652, 'ORPHA:324585', 'Autosomal dominant intermediate CMT disease with neuropathic pain', 1),
(10653, 'ORPHA:324585', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain', 1),
(10654, 'ORPHA:324588', 'FDFM', 1),
(10655, 'ORPHA:324588', 'Familial dyskinesia and facial myokymia', 1),
(10656, 'ORPHA:3246', 'Learman syndrome', 1),
(10657, 'ORPHA:3246', 'Symphalangism with multiple anomalies of hands and feet', 1),
(10658, 'ORPHA:324601', 'X-linked cleft palate and ankyloglossia', 1),
(10659, 'ORPHA:324604', 'Classic MmD', 2),
(10660, 'ORPHA:324604', 'Classic multiminicore disease', 2),
(10661, 'ORPHA:324604', 'Classic multiminicore myopathy', 2),
(10662, 'ORPHA:324611', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to KIF5A mutation', 1),
(10663, 'ORPHA:324611', 'CMT2 due to KIF5A mutation', 1),
(10664, 'ORPHA:324625', 'Chikungunya', 1),
(10665, 'ORPHA:324632', 'Hendra virus infection', 1),
(10666, 'ORPHA:324636', 'Autoerythrocyte sensitization syndrome', 1),
(10667, 'ORPHA:324636', 'GDS', 1),
(10668, 'ORPHA:324636', 'Gardner-Diamond syndrome', 1),
(10669, 'ORPHA:324636', 'Painful bruising syndrome', 1),
(10670, 'ORPHA:324636', 'Psychogenic purpura', 1),
(10671, 'ORPHA:324648', 'Invasive non-typhoidal salmonella disease', 1),
(10672, 'ORPHA:324648', 'Invasive non-typhoidal salmonellosis', 1),
(10673, 'ORPHA:324648', 'iNTS disease', 1),
(10674, 'ORPHA:324703', 'ABeta amyloidosis, Piedmont type', 2),
(10675, 'ORPHA:324703', 'ABetaL34V amyloidosis', 2),
(10676, 'ORPHA:324703', 'ABetaL34V-related amyloidosis', 2),
(10677, 'ORPHA:324703', 'HCHWA, Piedmont type', 2),
(10678, 'ORPHA:324703', 'Hereditary cerebral hemorrhage with amyloidosis, Piedmont type', 2),
(10679, 'ORPHA:324708', 'ABeta amyloidosis, Iowa type', 2),
(10680, 'ORPHA:324708', 'ABetaD23N amyloidosis', 2),
(10681, 'ORPHA:324708', 'HCHWA, Iowa type', 2),
(10682, 'ORPHA:324708', 'Hereditary cerebral hemorrhage with amyloidosis, Iowa type', 2),
(10683, 'ORPHA:324713', 'ABeta amyloidosis, Italian type', 2),
(10684, 'ORPHA:324713', 'ABetaE22K amyloidosis', 2),
(10685, 'ORPHA:324713', 'HCHWA, Italian type', 2),
(10686, 'ORPHA:324713', 'Hereditary cerebral hemorrhage with amyloidosis, Italian type', 2),
(10687, 'ORPHA:324718', 'ABeta amyloidosis, Flemish type', 2),
(10688, 'ORPHA:324718', 'ABetaA21G amyloidosis', 2),
(10689, 'ORPHA:324718', 'ABetaA21G-related amyloidosis', 2),
(10690, 'ORPHA:324718', 'HCHWA, Flemish type', 2),
(10691, 'ORPHA:324718', 'Hereditary cerebral hemorrhage with amyloidosis, Flemish type', 2),
(10692, 'ORPHA:324723', 'ABeta amyloidosis, Arctic type', 2),
(10693, 'ORPHA:324723', 'ABetaE22G amyloidosis', 2),
(10694, 'ORPHA:324723', 'HCHWA, Arctic type', 2),
(10695, 'ORPHA:324723', 'Hereditary cerebral hemorrhage with amyloidosis, Arctic type', 2),
(10696, 'ORPHA:324737', 'CDG syndrome type Iq', 1),
(10697, 'ORPHA:324737', 'CDG-Iq', 1),
(10698, 'ORPHA:324737', 'CDG1Q', 1),
(10699, 'ORPHA:324737', 'Congenital disorder of glycosylation type 1q', 1),
(10700, 'ORPHA:324737', 'Congenital disorder of glycosylation type Iq', 1),
(10701, 'ORPHA:324737', 'SRD5A3-CDG', 1),
(10702, 'ORPHA:324761', 'Microcephalic primordial dwarfism', 3),
(10703, 'ORPHA:324764', 'Trichorhinophalangeal syndrome', 3),
(10704, 'ORPHA:324767', 'Non-familial rare disease with dilated cardiomyopathy', 3),
(10705, 'ORPHA:3248', 'Distal symphalangism', 1),
(10706, 'ORPHA:324924', 'Hereditary periodic fever syndrome', 3),
(10707, 'ORPHA:324927', 'Pyogenic autoinflammatory syndrome', 3),
(10708, 'ORPHA:324930', 'Granulomatous autoinflammatory syndrome', 3),
(10709, 'ORPHA:324933', 'Mixed autoinflammatory and autoimmune syndrome', 3),
(10710, 'ORPHA:324936', 'Unclassified autoinflammatory syndrome', 3),
(10711, 'ORPHA:324939', 'Periodic fever syndrome of childhood', 3),
(10712, 'ORPHA:324942', 'Pyogenic autoinflammatory syndrome of childhood', 3),
(10713, 'ORPHA:324950', 'Granulomatous autoinflammatory syndrome of childhood', 3),
(10714, 'ORPHA:324953', 'Unclassified autoinflammatory syndrome of childhood', 3),
(10715, 'ORPHA:324960', 'Unexplained periodic fever syndrome of childhood', 3),
(10716, 'ORPHA:324964', 'CNO/CRMO', 1),
(10717, 'ORPHA:324964', 'Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis', 1),
(10718, 'ORPHA:324972', 'MAGIC syndrome', 1),
(10719, 'ORPHA:324972', 'Mouth and genital ulcers-inflamed cartilage syndrome', 1),
(10720, 'ORPHA:324977', 'ALDD syndrome', 1),
(10721, 'ORPHA:324977', 'Autoinflammation-lipodystrophy-dermatosis syndrome', 1),
(10722, 'ORPHA:324977', 'PRAAS', 1),
(10723, 'ORPHA:324977', 'Proteasome disability syndrome', 1),
(10724, 'ORPHA:324977', 'Proteasome-associated autoinflammatory syndrome', 1),
(10725, 'ORPHA:325', 'Congenital factor II deficiency', 1),
(10726, 'ORPHA:325', 'Dysprothrombinemia', 1),
(10727, 'ORPHA:325', 'Hypoprothrombinemia', 1),
(10728, 'ORPHA:325', 'Prothrombin deficiency', 1),
(10729, 'ORPHA:3250', 'Proximal symphalangism', 1),
(10730, 'ORPHA:3250', 'Symphalangism, Cushing type', 1),
(10731, 'ORPHA:325055', '46,XX disorder of gonadal development', 3),
(10732, 'ORPHA:325061', '46,XX DSD induced by fetoplacental androgens excess', 3),
(10733, 'ORPHA:325061', '46,XX disorder of sex development induced by fetoplacental androgens excess', 3),
(10734, 'ORPHA:325093', '46,XX DSD induced by endogenous maternal-derived androgen', 3),
(10735, 'ORPHA:325093', '46,XX disorder of sex development induced by endogenous maternal-derived androgen', 3),
(10736, 'ORPHA:325099', '46,XX DSD induced by exogenous maternal-derived androgen', 3),
(10737, 'ORPHA:325099', '46,XX disorder of sex development induced by exogenous maternal-derived androgen', 3),
(10738, 'ORPHA:325109', 'Syndrome with 46,XX DSD', 3),
(10739, 'ORPHA:325109', 'Syndrome with 46,XX disorder of sex development', 3),
(10740, 'ORPHA:325118', '46,XY disorder of gonadal development', 3),
(10741, 'ORPHA:325124', 'Bilateral anorchia', 1),
(10742, 'ORPHA:325124', 'Testicular agenesis', 1),
(10743, 'ORPHA:3253', 'CLPED1', 1),
(10744, 'ORPHA:3253', 'Cleft lip/palate-ectodermal dysplasia syndrome', 1),
(10745, 'ORPHA:3253', 'Cleft lip/palate-syndactyly-pili torti syndrome', 1),
(10746, 'ORPHA:3253', 'Syndactyly-ectodermal dysplasia-cleft/lip palate', 1),
(10747, 'ORPHA:3253', 'Zlotogora-Zilberman-Tenenbaum syndrome', 1),
(10748, 'ORPHA:325345', '46,XY ovotesticular DSD', 1),
(10749, 'ORPHA:325345', '46,XY ovotesticular disorder of sex development', 1),
(10750, 'ORPHA:325351', '46,XY DSD of endocrine origin', 3),
(10751, 'ORPHA:325351', '46,XY disorder of sex development of endocrine origin', 3),
(10752, 'ORPHA:325357', '46,XY DSD due to impaired androgen production', 3),
(10753, 'ORPHA:325357', '46,XY disorder of sex development due to impaired androgen production', 3),
(10754, 'ORPHA:325448', '46,XY DSD due to LHB deficiency', 2),
(10755, 'ORPHA:325448', '46,XY DSD due to luteinizing hormone subunit beta deficiency', 2),
(10756, 'ORPHA:325448', '46,XY disorder of sex development due to LHB deficiency', 2),
(10757, 'ORPHA:325448', '46,XY disorder of sex development due to luteinizing hormone subunit beta deficiency', 2),
(10758, 'ORPHA:325448', 'Leydig cell hypoplasia due to LHB deficiency', 2),
(10759, 'ORPHA:325448', 'Leydig cell hypoplasia due to luteinizing hormone subunit beta deficiency', 2),
(10760, 'ORPHA:3255', 'Filippi syndrome', 1),
(10761, 'ORPHA:3255', 'Type 1 syndactyly-microcephaly-intellectual disability syndrome', 1),
(10762, 'ORPHA:325511', '46,XY DSD due to a cholesterol synthesis defect', 3),
(10763, 'ORPHA:325511', '46,XY disorder of sex development due to a cholesterol synthesis defect', 3),
(10764, 'ORPHA:325524', 'Classic CLAH', 2),
(10765, 'ORPHA:325524', 'Classic congenital lipoid adrenal hyperplasia due to STAR deficency', 2),
(10766, 'ORPHA:325529', 'Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency', 2),
(10767, 'ORPHA:325537', '46,XY DSD induced by maternal-exposure to endocrine disruptors', 3),
(10768, 'ORPHA:325537', '46,XY disorder of sex development induced by maternal exposure to endocrine disruptors', 3),
(10769, 'ORPHA:325546', 'Sex chromosome DSD', 3),
(10770, 'ORPHA:325546', 'Sex chromosome disorder of sex development', 3),
(10771, 'ORPHA:325620', 'DSD of gynecological interest', 3),
(10772, 'ORPHA:325620', 'Disorder of sex development of gynecological interest', 3),
(10773, 'ORPHA:325632', '46,XY DSD of gynecological interest', 3),
(10774, 'ORPHA:325632', '46,XY disorder of sex development of gynecological interest', 3),
(10775, 'ORPHA:325638', 'Syndrome with DSD of gynecological interest', 3),
(10776, 'ORPHA:325638', 'Syndrome with disorder of sex development of gynecological interest', 3),
(10777, 'ORPHA:325665', 'Genetic DSD of gynecological interest', 3),
(10778, 'ORPHA:325665', 'Genetic disorder of sex development of gynecological interest', 3),
(10779, 'ORPHA:325690', 'Genetic DSD', 3),
(10780, 'ORPHA:325690', 'Genetic disorder of sex development', 3),
(10781, 'ORPHA:325697', 'Genetic 46,XX DSD', 3),
(10782, 'ORPHA:325697', 'Genetic 46,XX disorder of sex development', 3),
(10783, 'ORPHA:325706', 'Genetic 46,XY DSD', 3),
(10784, 'ORPHA:325706', 'Genetic 46,XY disorder of sex development', 3),
(10785, 'ORPHA:325713', 'Genetic 46,XY DSD of endocrine origin', 3),
(10786, 'ORPHA:325713', 'Genetic 46,XY disorder of sex development of endocrine origin', 3),
(10787, 'ORPHA:3258', 'Cenani syndactyly', 1),
(10788, 'ORPHA:3258', 'Cenani-Lenz syndactyly', 1),
(10789, 'ORPHA:3258', 'Cenani-Lenz syndrome', 1),
(10790, 'ORPHA:3258', 'Syndactyly type 7', 1),
(10791, 'ORPHA:3259', 'Syndactyly-polydactyly-ear lobe syndrome', 1),
(10792, 'ORPHA:326', 'Congenital factor V deficiency', 1),
(10793, 'ORPHA:326', 'Owren disease', 1),
(10794, 'ORPHA:326', 'Parahemophilia', 1),
(10795, 'ORPHA:326', 'Proaccelerin deficiency', 1),
(10796, 'ORPHA:3260', 'Idiopathic hypereosinophilic syndrome', 1),
(10797, 'ORPHA:3261', 'ALPS', 1),
(10798, 'ORPHA:3261', 'Autoimmune lymphoproliferative syndrome', 1),
(10799, 'ORPHA:3261', 'Canale-Smith syndrome', 1),
(10800, 'ORPHA:3262', 'Dobrow syndrome', 1),
(10801, 'ORPHA:3262', 'Syngnathia-multiple anomalies syndrome', 1),
(10802, 'ORPHA:3263', 'Syngnathia-cleft palate syndrome', 1),
(10803, 'ORPHA:3265', 'Humero-radial fusion', 1),
(10804, 'ORPHA:3265', 'Humero-radial synostosis', 1),
(10805, 'ORPHA:3266', 'Humero-radio-ulnar fusion', 1),
(10806, 'ORPHA:3266', 'Humero-radio-ulnar synostosis', 1),
(10807, 'ORPHA:3267', 'Familial lambdoid synostosis', 1),
(10808, 'ORPHA:3268', 'Giuffré-Tsukahara syndrome', 1),
(10809, 'ORPHA:3268', 'Radioulnar synostosis-microcephaly-scoliosis syndrome', 1),
(10810, 'ORPHA:3268', 'Tsukahara syndrome', 1),
(10811, 'ORPHA:3269', 'Congenital radioulnar synostosis', 1),
(10812, 'ORPHA:3269', 'Radioulnar fusion', 1),
(10813, 'ORPHA:327', 'Congenital factor VII deficiency', 1),
(10814, 'ORPHA:327', 'Congenital proconvertin deficiency', 1),
(10815, 'ORPHA:327', 'Hypoproconvertinemia', 1),
(10816, 'ORPHA:3270', 'Der Kaloustian-McIntosh-Silver syndrome', 1),
(10817, 'ORPHA:3270', 'Radioulnar synostosis-developmental delay-hypotonia syndrome', 1),
(10818, 'ORPHA:3273', 'Synovial sarcoma', 1),
(10819, 'ORPHA:3273', 'Synovialosarcoma', 1),
(10820, 'ORPHA:3275', 'Spondylocarpotarsal synostosis', 1),
(10821, 'ORPHA:3275', 'Synspondylism', 1),
(10822, 'ORPHA:3276', 'Disorder of plasmalogens biosynthesis', 3),
(10823, 'ORPHA:328', 'Congenital Stuart factor deficiency', 1),
(10824, 'ORPHA:328', 'Congenital factor X deficiency', 1),
(10825, 'ORPHA:328', 'Stuart-Prower factor deficiency', 1),
(10826, 'ORPHA:3280', 'Hydromyelia', 3),
(10827, 'ORPHA:3280', 'Syringomyelia', 3),
(10828, 'ORPHA:3282', 'Chaotic atrial tachycardia', 1),
(10829, 'ORPHA:3282', 'MAT', 1),
(10830, 'ORPHA:3282', 'Multifocal atrial tachycardia', 1),
(10831, 'ORPHA:3283', 'His bundle tachycardia', 1),
(10832, 'ORPHA:3283', 'JET', 1),
(10833, 'ORPHA:3283', 'Junctional ectopic tachycardia', 1),
(10834, 'ORPHA:3286', 'Bidirectional ventricular tachycardia induced by catecholamine', 1),
(10835, 'ORPHA:3286', 'CPVT', 1),
(10836, 'ORPHA:3286', 'Catecholaminergic polymorphic ventricular tachycardia', 1),
(10837, 'ORPHA:3286', 'Malignant paroxysmal ventricular tachycardia', 1),
(10838, 'ORPHA:3286', 'Polymorphic ventricular tachycardia induced by catecholamines', 1),
(10839, 'ORPHA:3287', 'Takayasu arteritis', 1),
(10840, 'ORPHA:329', 'Congenital factor XI deficiency', 1),
(10841, 'ORPHA:329', 'Hemophilia C', 1),
(10842, 'ORPHA:329', 'PTA deficiency', 1),
(10843, 'ORPHA:329', 'Plasma thromboplastin antecedent deficiency', 1),
(10844, 'ORPHA:329', 'Rosenthal factor deficiency', 1),
(10845, 'ORPHA:329', 'Rosenthal syndrome', 1),
(10846, 'ORPHA:3291', 'Teebi-Shaltout syndrome', 1),
(10847, 'ORPHA:329173', 'Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis', 1),
(10848, 'ORPHA:329178', 'CDG syndrome type Iu', 1),
(10849, 'ORPHA:329178', 'CDG-Iu', 1),
(10850, 'ORPHA:329178', 'CDG1U', 1),
(10851, 'ORPHA:329178', 'CMD with intellectual disability and severe epilepsy', 1),
(10852, 'ORPHA:329178', 'Carbohydrate deficient glycoprotein syndrome type Iu', 1),
(10853, 'ORPHA:329178', 'Congenital disorder of glycosylation type 1u', 1),
(10854, 'ORPHA:329178', 'Congenital disorder of glycosylation type Iu', 1),
(10855, 'ORPHA:329178', 'Congenital muscular dystrophy with intellectual disability and severe epilepsy', 1),
(10856, 'ORPHA:329178', 'DPM2-CDG', 1),
(10857, 'ORPHA:329191', 'Tall stature-scoliosis-macrodactyly of the great toes syndrome', 1),
(10858, 'ORPHA:329191', 'Tall stature-scoliosis-macrodactyly of the halluces syndrome', 1),
(10859, 'ORPHA:329195', 'Developmental delay with ASD and gait instability', 1),
(10860, 'ORPHA:329195', 'Developmental delay with autism spectrum disorder and gait instability', 1),
(10861, 'ORPHA:3292', 'Tel Hashomer camptodactyly syndrome', 1),
(10862, 'ORPHA:329211', 'ADNIV', 1),
(10863, 'ORPHA:329211', 'Autosomal dominant neovascular inflammatory vitreoretinopathy', 1),
(10864, 'ORPHA:329217', 'CSVT', 1),
(10865, 'ORPHA:329217', 'Cerebral sinovenous thrombosis', 1),
(10866, 'ORPHA:329224', 'Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome', 1),
(10867, 'ORPHA:329228', 'Microcephalic primordial dwarfism due to ZNF335 deficiency', 1),
(10868, 'ORPHA:329228', 'Microcephalic primordial dwarfism, Walsh type', 1),
(10869, 'ORPHA:329235', 'IGSF1 deficiency syndrome', 1),
(10870, 'ORPHA:329235', 'X-linked central congenital hypothyroidism with late-onset macroorchidism', 1),
(10871, 'ORPHA:329235', 'X-linked central congenital hypothyroidism with late-onset testicular enlargement', 1),
(10872, 'ORPHA:329242', 'Congenital chronic diarrhea with exudative enteropathy', 1),
(10873, 'ORPHA:329242', 'Congenital chronic diarrhea with protein-losing enteropathy', 1),
(10874, 'ORPHA:329249', 'Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency', 2),
(10875, 'ORPHA:329252', 'Spondylocostal dysostosis-hypospadias-intellectual disability syndrome', 1),
(10876, 'ORPHA:329258', 'Autosomal dominant Charcot-Marie-Tooth disease type 2Q', 1),
(10877, 'ORPHA:329258', 'CMT2Q', 1),
(10878, 'ORPHA:329284', 'BPAN', 1),
(10879, 'ORPHA:329284', 'Beta-propeller protein-associated neurodegeneration', 1),
(10880, 'ORPHA:329284', 'NBIA5', 1),
(10881, 'ORPHA:329284', 'Neurodegeneration with brain iron accumulation type 5', 1),
(10882, 'ORPHA:329284', 'SENDA', 1),
(10883, 'ORPHA:329284', 'Static encephalopathy of childhood with neurodegeneration in adulthood', 1),
(10884, 'ORPHA:3293', 'Telecanthus-hypertelorism-strabismus-pes cavus syndrome', 1),
(10885, 'ORPHA:329303', 'PLA2G6-associated neurodegeneration', 3),
(10886, 'ORPHA:329303', 'PLAN', 3),
(10887, 'ORPHA:329308', 'FAHN', 1),
(10888, 'ORPHA:329308', 'Fatty acid hydroxylase-associated neurodegeneration', 1),
(10889, 'ORPHA:329314', 'Adult-onset multiple mitochondrial DNA deletion syndrome due to DGUOK deficiency', 1),
(10890, 'ORPHA:329314', 'Adult-onset multiple mtDNA deletion syndrome due to DGUOK deficiency', 1),
(10891, 'ORPHA:329319', 'Familial thrombocytosis with transverse limb defect', 1),
(10892, 'ORPHA:329319', 'Hereditary thrombocytosis with transverse limb defect', 1),
(10893, 'ORPHA:329319', 'Thrombocythemia with distal limb defects', 1),
(10894, 'ORPHA:329324', 'Cutaneous hemangioma with muscle or bone atrophy', 1),
(10895, 'ORPHA:329324', 'Inverse Klippel-Trénaunay syndrome', 1),
(10896, 'ORPHA:329329', 'Autosomal recessive frontotemporal pachygyria', 1),
(10897, 'ORPHA:329332', 'Microcephaly-cerebellar hypoplasia-cardiac conduction defect syndrome', 1),
(10898, 'ORPHA:329332', 'Microcephaly-cerebellar hypoplasia-congenital heart conduction defect syndrome', 1),
(10899, 'ORPHA:329336', 'Adult-onset CPEO with mitochondrial myopathy', 1),
(10900, 'ORPHA:329336', 'Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy', 1),
(10901, 'ORPHA:329341', 'Limbic encephalitis with DPP6 antibodies', 1),
(10902, 'ORPHA:329341', 'Limbic encephalitis with DPPX antibodies', 1),
(10903, 'ORPHA:329341', 'Limbic encephalitis with dipeptidyl-peptidase 6 antibodies', 1),
(10904, 'ORPHA:3294', 'Extensor tendons of finger anomalies', 1),
(10905, 'ORPHA:3294', 'Hapnes-Boman-Skeie syndrome', 1),
(10906, 'ORPHA:329457', 'DA5D', 1),
(10907, 'ORPHA:329457', 'Distal arthrogryposis type 5 without ophthalmoparesis', 1),
(10908, 'ORPHA:329457', 'Distal arthrogryposis type 5 without ophthalmoplegia', 1),
(10909, 'ORPHA:329457', 'Distal arthrogryposis type 5D', 1),
(10910, 'ORPHA:329466', 'Autosomal dominant focal dystonia, DYT25 type', 1),
(10911, 'ORPHA:329466', 'DYT25', 1),
(10912, 'ORPHA:329466', 'Dystonia 25', 1),
(10913, 'ORPHA:329469', 'Acute megakaryoblastic leukemia without Down syndrome', 2),
(10914, 'ORPHA:329469', 'Non-DS-AMKL', 2),
(10915, 'ORPHA:329475', 'Spastic paraplegia-Paget disease of bone syndrome', 1),
(10916, 'ORPHA:329478', 'Adult-onset distal myopathy due to VCP mutation', 1),
(10917, 'ORPHA:329481', 'LPG', 1),
(10918, 'ORPHA:329481', 'Lipoprotein glomerulopathy', 1),
(10919, 'ORPHA:32960', 'Familial Hibernian fever', 1),
(10920, 'ORPHA:32960', 'TNF receptor 1-associated periodic syndrome', 1),
(10921, 'ORPHA:32960', 'TRAPS syndrome', 1),
(10922, 'ORPHA:32960', 'Tumor necrosis factor receptor 1 associated periodic syndrome', 1),
(10923, 'ORPHA:329802', '5p13 microduplication syndrome', 1),
(10924, 'ORPHA:329802', 'Dup(5)(p13)', 1),
(10925, 'ORPHA:329802', 'Trisomy 5p13', 1),
(10926, 'ORPHA:329813', 'Androgenetic/biparental mosaicism', 1),
(10927, 'ORPHA:329813', 'Genome-wide paternal uniparental disomy mosaicism', 1),
(10928, 'ORPHA:329813', 'Mosaic genome-wide paternal UPD', 1),
(10929, 'ORPHA:329813', 'Mosaic genome-wide paternal uniparental disomy', 1),
(10930, 'ORPHA:329874', 'IGCM', 1),
(10931, 'ORPHA:329874', 'Idiopathic giant cell myocarditis', 1),
(10932, 'ORPHA:329883', 'Hypertrophic gastropathy without hypoproteinemia', 1),
(10933, 'ORPHA:329883', 'Non-hypoproteinemic hypertrophic gastropathy', 1),
(10934, 'ORPHA:329888', 'JIIM', 3),
(10935, 'ORPHA:329888', 'Juvenile idiopathic inflammatory myopathy', 3),
(10936, 'ORPHA:329894', 'Juvenile overlap myositis', 1),
(10937, 'ORPHA:3299', 'Tetanus', 1),
(10938, 'ORPHA:329903', 'Ig-mediated MPGN', 2),
(10939, 'ORPHA:329903', 'Ig-mediated membranoproliferative glomerulonephritis', 2),
(10940, 'ORPHA:329903', 'Immunoglobulin-mediated MPGN', 2),
(10941, 'ORPHA:329903', 'Immunoglobulin-mediated membranoproliferative glomerulonephritis', 2),
(10942, 'ORPHA:329918', 'C3 glomerulopathy', 2),
(10943, 'ORPHA:329918', 'Non-Ig-mediated MPGN', 2),
(10944, 'ORPHA:329918', 'Non-Ig-mediated membranoproliferative glomerulonephritis', 2),
(10945, 'ORPHA:329918', 'Non-immunoglobulin-mediated MPGN', 2),
(10946, 'ORPHA:329918', 'Non-immunoglobulin-mediated membranoproliferative glomerulonephritis', 2),
(10947, 'ORPHA:329931', 'C3 glomerulonephritis', 2),
(10948, 'ORPHA:329942', 'Transient neonatal MAD deficiency', 1),
(10949, 'ORPHA:329942', 'Transient neonatal MADD', 1),
(10950, 'ORPHA:329942', 'Transient neonatal glutaric acidemia type 2', 1),
(10951, 'ORPHA:329942', 'Transient neonatal glutaric aciduria type 2', 1),
(10952, 'ORPHA:329942', 'Transient neonatal multiple acyl-CoA dehydrogenase deficiency', 1),
(10953, 'ORPHA:329967', 'Intermittent hydrarthrosis', 1),
(10954, 'ORPHA:329971', 'Generalized juvenile polyposis/juvenile polyposis coli', 2),
(10955, 'ORPHA:329977', 'Classic appendiceal neuroendocrine tumor', 2),
(10956, 'ORPHA:329977', 'Classic appendix neuroendocrine tumor', 2),
(10957, 'ORPHA:329977', 'Classic neuroendocrine tumor of appendix', 2),
(10958, 'ORPHA:329984', 'GCC', 2),
(10959, 'ORPHA:329984', 'Goblet cell adenocarcinoid', 2),
(10960, 'ORPHA:329984', 'Goblet cell carcinoid', 2),
(10961, 'ORPHA:329984', 'Goblet cell carcinoma', 2),
(10962, 'ORPHA:329984', 'Goblet cell tumor', 2),
(10963, 'ORPHA:33', 'Isovaleric acid CoA dehydrogenase deficiency', 1),
(10964, 'ORPHA:33', 'Isovaleric acidemia', 1),
(10965, 'ORPHA:330', 'Congenital Hageman factor deficiency', 1),
(10966, 'ORPHA:330', 'Congenital factor XII deficiency', 1),
(10967, 'ORPHA:330001', 'ATTRwt amyloidosis', 1),
(10968, 'ORPHA:330001', 'ATTRwt-related amyloidosis', 1),
(10969, 'ORPHA:330001', 'SSA', 1),
(10970, 'ORPHA:330001', 'Senile systemic amyloidosis', 1),
(10971, 'ORPHA:330001', 'Wild type ATTR amyloidosis', 1),
(10972, 'ORPHA:330001', 'Wild type ATTR-related amyloidosis', 1),
(10973, 'ORPHA:33001', 'Lymphedema-distichiasis syndrome', 1),
(10974, 'ORPHA:330012', 'High altitude pulmonary edema', 1),
(10975, 'ORPHA:330015', 'Lead intoxication', 1),
(10976, 'ORPHA:330015', 'Lead poisoning', 1),
(10977, 'ORPHA:330015', 'Plumbism', 1),
(10978, 'ORPHA:330015', 'Saturnism', 1),
(10979, 'ORPHA:330021', 'Hydrargyria', 1),
(10980, 'ORPHA:330021', 'Mercurialism', 1),
(10981, 'ORPHA:330021', 'Mercury intoxication', 1),
(10982, 'ORPHA:330021', 'Mercury poisoning', 1),
(10983, 'ORPHA:330029', 'Hypotrichosis-deafness syndrome', 1),
(10984, 'ORPHA:330029', 'Hypotrichosis-hearing loss syndrome', 1),
(10985, 'ORPHA:330032', 'HbLepore-beta-thalassemia syndrome', 1),
(10986, 'ORPHA:330032', 'Hemoglobin Lepore-beta-thalassemia syndrome', 1),
(10987, 'ORPHA:330032', 'Lepore-beta-thalassemia syndrome', 1),
(10988, 'ORPHA:330041', 'Hemoglobin M disease', 1),
(10989, 'ORPHA:330041', 'M hemoglobinopathy', 1),
(10990, 'ORPHA:330050', 'DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect', 2),
(10991, 'ORPHA:330054', 'Congenital cataract-progressive muscular hypotonia-deafness-developmental delay syndrome', 1),
(10992, 'ORPHA:330054', 'Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome', 1),
(10993, 'ORPHA:330058', 'Hydroa vacciniforme', 1),
(10994, 'ORPHA:330061', 'Actinic prurigo', 1),
(10995, 'ORPHA:330061', 'Familial polymorphous light eruption of American Indians', 1),
(10996, 'ORPHA:330061', 'Hereditary polymorphous light eruption of American Indians', 1),
(10997, 'ORPHA:330061', 'Hutchinson summer prurigo', 1),
(10998, 'ORPHA:330061', 'Hydroa aestivale', 1),
(10999, 'ORPHA:330064', 'Actinic reticuloid', 1),
(11000, 'ORPHA:330064', 'Chronic actinic dermatitis', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(11001, 'ORPHA:330064', 'Chronic photosensitivity dermatitis', 1),
(11002, 'ORPHA:3301', 'Tetraamelia-multiple malformations syndrome', 1),
(11003, 'ORPHA:3301', 'Zimmer phocomelia', 1),
(11004, 'ORPHA:330197', 'Genetic MCA/variable MR', 3),
(11005, 'ORPHA:330197', 'Genetic multiple congenital anomalies-variable intellectual disability with or without dysmorphism syndrome', 3),
(11006, 'ORPHA:330197', 'Genetic multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome', 3),
(11007, 'ORPHA:330206', 'Genetic MCA', 3),
(11008, 'ORPHA:330206', 'Genetic multiple congenital anomalies without intellectual disability (with or without dysmorphism)', 3),
(11009, 'ORPHA:330206', 'Genetic multiple congenital anomalies/dysmorphic syndrome without intellectual disability', 3),
(11010, 'ORPHA:3303', 'Tetralogy of Fallot', 1),
(11011, 'ORPHA:3304', 'Bindewald-Ulmer-Müller syndrome', 1),
(11012, 'ORPHA:3304', 'Fallot complex-intellectual disability-growth delay syndrome', 1),
(11013, 'ORPHA:3305', 'Tetraploidy', 1),
(11014, 'ORPHA:3306', 'Duplication/inversion 15q11', 1),
(11015, 'ORPHA:3306', 'Inv dup (15) syndrome', 1),
(11016, 'ORPHA:3306', 'Inverted duplicated chromosome 15 syndrome', 1),
(11017, 'ORPHA:3306', 'Isodicentric chromosome 15 syndrome', 1),
(11018, 'ORPHA:3306', 'Non-distal tetrasomy 15q', 1),
(11019, 'ORPHA:3306', 'Non-telomeric tetrasomy 15q', 1),
(11020, 'ORPHA:3306', 'idic (15) syndrome', 1),
(11021, 'ORPHA:33067', 'Metaphyseal chondrodysplasia, Jansen type', 1),
(11022, 'ORPHA:33069', 'Dravet syndrome', 1),
(11023, 'ORPHA:33069', 'SMEI', 1),
(11024, 'ORPHA:33069', 'Severe myoclonic epilepsy of infancy', 1),
(11025, 'ORPHA:33069', 'Severe myoclonus epilepsy of infancy', 1),
(11026, 'ORPHA:3307', 'Isochromosome 18p', 1),
(11027, 'ORPHA:3307', 'Tetrasomy 18p', 1),
(11028, 'ORPHA:3309', 'Isochromosome 5p', 1),
(11029, 'ORPHA:3309', 'Tetrasomy 5p', 1),
(11030, 'ORPHA:331', 'Congenital factor XIII deficiency', 1),
(11031, 'ORPHA:331', 'Fibrin-stabilizing factor deficiency', 1),
(11032, 'ORPHA:3310', 'Isochromosome 9p', 1),
(11033, 'ORPHA:3310', 'Tetrasomy 9p', 1),
(11034, 'ORPHA:33108', 'Autosomal recessive lethal multiple pterygium syndrome', 1),
(11035, 'ORPHA:33108', 'LMPS', 1),
(11036, 'ORPHA:33108', 'Lethal multiple pterygium syndrome', 1),
(11037, 'ORPHA:33110', 'Agammaglobulinemia, non-Bruton type', 2),
(11038, 'ORPHA:33110', 'Autosomal agammaglobulinemia', 2),
(11039, 'ORPHA:33111', 'Granulomatous slack skin', 1),
(11040, 'ORPHA:331176', 'Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency', 1),
(11041, 'ORPHA:331176', 'SCN4', 1),
(11042, 'ORPHA:331176', 'Severe congenital neutropenia type 4', 1),
(11043, 'ORPHA:331176', 'Severe congenital neutropenia-pulmonary hypertension-superficial venous angiectasis syndrome', 1),
(11044, 'ORPHA:331184', 'Constitutional neutropenia with extra-hematopoietic manifestations', 3),
(11045, 'ORPHA:331187', 'Immunodeficiency due to MASP-2 deficiency', 1),
(11046, 'ORPHA:331190', 'Immunodeficiency due to ficolin3 deficiency', 1),
(11047, 'ORPHA:331193', 'Other immunodeficiency syndromes due to defects in innate immunity', 3),
(11048, 'ORPHA:3312', 'Fetal thalidomide syndrome', 1),
(11049, 'ORPHA:3312', 'Thalidomide embryopathy', 1),
(11050, 'ORPHA:331206', 'SCID due to complete RAG1/2 deficiency', 1),
(11051, 'ORPHA:331206', 'Severe combined immunodeficiency due to complete RAG1/2 deficiency', 1),
(11052, 'ORPHA:331217', 'Syndrome with combined immunodeficiency', 3),
(11053, 'ORPHA:331220', 'Immunodeficiency due to absence of thymus', 3),
(11054, 'ORPHA:331223', 'Hyper-IgE syndrome', 3),
(11055, 'ORPHA:331226', 'Autosomal recessive hyper-IgE syndrome due to TYK2 deficiency', 1),
(11056, 'ORPHA:331226', 'Susceptibility to infection due to TYK2 deficiency', 1),
(11057, 'ORPHA:331232', 'Immunodeficiency with isotype or light chain deficiencies with normal number of B-cells', 3),
(11058, 'ORPHA:331235', 'Selective IgM deficiency', 1),
(11059, 'ORPHA:331235', 'Selective immunoglobulin M deficiency', 1),
(11060, 'ORPHA:331240', 'Immunodeficiency with severe reduction in serum IgG and IgA with normal/elevated IgM and normal number of B-cells', 3),
(11061, 'ORPHA:331244', 'Other immunodeficiency syndrome with predominantly antibody defects', 3),
(11062, 'ORPHA:331249', 'Immunodeficiency syndrome with hypopigmentation', 3),
(11063, 'ORPHA:3314', 'Aseptic necrosis of phalangeal epiphyses', 1),
(11064, 'ORPHA:3314', 'Osteochondrosis of phalangeal epiphyses', 1),
(11065, 'ORPHA:3314', 'Thiemann disease, familial form', 1),
(11066, 'ORPHA:3316', 'Potter sequence-cleft lip/palate-cardiopathy syndrome', 1),
(11067, 'ORPHA:3316', 'Thomas syndrome', 1),
(11068, 'ORPHA:3317', 'Barnes syndrome', 1),
(11069, 'ORPHA:3317', 'Thoracolaryngopelvic dysplasia', 1),
(11070, 'ORPHA:3318', 'ET', 1),
(11071, 'ORPHA:3318', 'Essential thrombocythemia', 1),
(11072, 'ORPHA:3318', 'Essential thrombocytosis', 1),
(11073, 'ORPHA:3319', 'CAMT', 1),
(11074, 'ORPHA:3319', 'Congenital amegakaryocytic thrombocytopenia', 1),
(11075, 'ORPHA:332', 'Congenital intrinsic factor deficiency', 1),
(11076, 'ORPHA:332', 'Congenital pernicious anemia', 1),
(11077, 'ORPHA:332', 'Gastric intrinsic factor deficiency', 1),
(11078, 'ORPHA:332', 'Hereditary juvenile megaloblastic anemia due to intrinsic factor deficiency', 1),
(11079, 'ORPHA:332', 'IFD', 1),
(11080, 'ORPHA:332', 'Intrinsic factor deficiency', 1),
(11081, 'ORPHA:3320', 'TAR syndrome', 1),
(11082, 'ORPHA:3320', 'Thrombocytopenia-absent radius syndrome', 1),
(11083, 'ORPHA:33208', 'Idiopathic excessive sleepiness', 1),
(11084, 'ORPHA:33208', 'Idiopathic hypersomnia', 1),
(11085, 'ORPHA:3322', 'Hoyeraal-Hreidarsson syndrome', 1),
(11086, 'ORPHA:3322', 'Progressive pancytopenia-immunodeficiency-cerebellar hypoplasia syndrome', 1),
(11087, 'ORPHA:33226', 'Waldenström macroglobulinemia', 1),
(11088, 'ORPHA:3324', 'Familial thrombomodulin anomalies', 1),
(11089, 'ORPHA:3325', 'HAT', 1),
(11090, 'ORPHA:3325', 'HIT', 1),
(11091, 'ORPHA:3325', 'Heparin-associated thrombocytopenia', 1),
(11092, 'ORPHA:3325', 'Heparin-induced thrombocytopenia', 1),
(11093, 'ORPHA:3325', 'Heparin-induced thrombocytopenia type 2', 1),
(11094, 'ORPHA:3326', 'Thymic-renal-anal-lung dysplasia', 1),
(11095, 'ORPHA:3327', 'Cutler-Bass-Romshe syndrome', 1),
(11096, 'ORPHA:3327', 'Thyrocerebrorenal syndrome', 1),
(11097, 'ORPHA:33276', 'Kaposi sarcoma', 1),
(11098, 'ORPHA:3328', 'Absent tibia-polydactyly-arachnoid cyst syndrome', 1),
(11099, 'ORPHA:3328', 'Holmes-Collins syndrome', 1),
(11100, 'ORPHA:3329', 'Aplasia of tibia with split-hand/split-foot deformity', 1),
(11101, 'ORPHA:3329', 'SHFLD syndrome', 1),
(11102, 'ORPHA:3329', 'SHFM associated with aplasia of long bones', 1),
(11103, 'ORPHA:3329', 'Split hand/foot malformation with long bone deficiency', 1),
(11104, 'ORPHA:3329', 'Split-hand/foot malformation associated with aplasia of long bones', 1),
(11105, 'ORPHA:3329', 'TH-SHFM', 1),
(11106, 'ORPHA:3329', 'Tibial aplasia-ectrodactyly syndrome', 1),
(11107, 'ORPHA:3329', 'Tibial hemimelia with split hand/foot malformation', 1),
(11108, 'ORPHA:3329', 'Tibial hemimelia-ectrodactyly syndrome', 1),
(11109, 'ORPHA:333', 'Acid ceramidase deficiency', 1),
(11110, 'ORPHA:333', 'Farber disease', 1),
(11111, 'ORPHA:333', 'Farber lipogranulomatosis', 1),
(11112, 'ORPHA:33314', 'Jessner lymphocytic infiltration of the skin', 1),
(11113, 'ORPHA:33314', 'Jessner-Kanof lymphocytic infiltration of the skin', 1),
(11114, 'ORPHA:3332', 'Hypoplastic tibia-polydactyly syndrome', 1),
(11115, 'ORPHA:3332', 'Hypoplastic tibiae-postaxial polydactyly syndrome', 1),
(11116, 'ORPHA:3332', 'Werner mesomelic syndrome', 1),
(11117, 'ORPHA:33355', 'AK2 deficiency', 1),
(11118, 'ORPHA:33355', 'Congenital aleukocytosis', 1),
(11119, 'ORPHA:33355', 'De Vaal disease', 1),
(11120, 'ORPHA:33355', 'Generalized hematopoietic hypoplasia', 1),
(11121, 'ORPHA:33355', 'Reticular dysgenesis', 1),
(11122, 'ORPHA:33355', 'SCID with leukopenia', 1),
(11123, 'ORPHA:33355', 'Severe combined immunodeficiency with leukopenia', 1),
(11124, 'ORPHA:33364', 'Trichothiodystrophy', 1),
(11125, 'ORPHA:3337', 'DeToni-Debré-Fanconi syndrome', 1),
(11126, 'ORPHA:3337', 'Primary Fanconi renal syndrome', 1),
(11127, 'ORPHA:3337', 'Primary Fanconi renotubular syndrome', 1),
(11128, 'ORPHA:3338', 'Corpus callosum agenesis-blepharophimosis-Robin sequence syndrome', 1),
(11129, 'ORPHA:3338', 'Toriello-Carey syndrome', 1),
(11130, 'ORPHA:3339', 'Aplasia cutis congenita-epibulbar dermoids syndrome', 1),
(11131, 'ORPHA:3339', 'Oculoectodermal syndrome', 1),
(11132, 'ORPHA:3339', 'Toriello-Lacassie-Droste syndrome', 1),
(11133, 'ORPHA:334', 'Familial atrial fibrillation', 1),
(11134, 'ORPHA:33402', 'Childhood-onset HCC', 1),
(11135, 'ORPHA:33402', 'Childhood-onset hepatocellular carcinoma', 1),
(11136, 'ORPHA:33402', 'Pediatric HCC', 1),
(11137, 'ORPHA:33402', 'Pediatric hepatocellular carcinoma', 1),
(11138, 'ORPHA:33408', 'Bullous lichen planus', 1),
(11139, 'ORPHA:3341', 'Torticollis-keloids-cryptorchidism-renal dysplasia syndrome', 1),
(11140, 'ORPHA:3342', 'ATS', 1),
(11141, 'ORPHA:3342', 'Arterial tortuosity syndrome', 1),
(11142, 'ORPHA:3343', 'Toxocariasis', 1),
(11143, 'ORPHA:3344', 'Anterior bowing of legs with dwarfism', 1),
(11144, 'ORPHA:3344', 'WNS', 1),
(11145, 'ORPHA:3344', 'Weismann-Netter syndrome', 1),
(11146, 'ORPHA:3344', 'Weismann-Netter-Stuhl syndrome', 1),
(11147, 'ORPHA:33445', 'Elejalde disease', 1),
(11148, 'ORPHA:33445', 'Neuroectodermal melanolysosomal disease', 1),
(11149, 'ORPHA:3346', 'Tracheal agenesis', 1),
(11150, 'ORPHA:3347', 'Congenital tracheobronchomegaly', 1),
(11151, 'ORPHA:3347', 'Idiopathic tracheobronchomegaly', 1),
(11152, 'ORPHA:3347', 'Mounier-Kühn syndrome', 1),
(11153, 'ORPHA:3347', 'Tracheobronchomegaly', 1),
(11154, 'ORPHA:33475', 'Meningococcal meningitis', 1),
(11155, 'ORPHA:3348', 'Tracheobronchopathia osteochondroplastica', 1),
(11156, 'ORPHA:3348', 'Tracheopathia osteoplastica', 1),
(11157, 'ORPHA:335', 'Congenital fibrinogen deficiency', 1),
(11158, 'ORPHA:3350', 'Neuhauser-Daly-Magnelli syndrome', 1),
(11159, 'ORPHA:3350', 'Tremor-nystagmus-duodenal ulcer syndrome', 1),
(11160, 'ORPHA:3351', 'Kersey syndrome', 1),
(11161, 'ORPHA:3351', 'Trichodental syndrome', 1),
(11162, 'ORPHA:3352', 'TDO syndrome', 1),
(11163, 'ORPHA:3352', 'Tricho-dento-osseous syndrome', 1),
(11164, 'ORPHA:3353', 'Pinheiro-Freire Maia-Miranda syndrome', 1),
(11165, 'ORPHA:3353', 'Trichodermodysplasia-dental alterations syndrome', 1),
(11166, 'ORPHA:33543', 'Kleine-Levin syndrome', 1),
(11167, 'ORPHA:3355', 'Trichoodontoonychial dysplasia', 1),
(11168, 'ORPHA:3355', 'Trichoodontoonychial dysplasia with bone deficiency in frontoparietal region', 1),
(11169, 'ORPHA:33572', '5-oxoprolinase deficiency', 1),
(11170, 'ORPHA:33572', 'Oxoprolinuria due to oxoprolinase deficiency', 1),
(11171, 'ORPHA:33573', 'Gamma-glutamyl transferase deficiency', 1),
(11172, 'ORPHA:33573', 'Gamma-glutamyl transpeptidase deficiency', 1),
(11173, 'ORPHA:33573', 'Glutathionuria', 1),
(11174, 'ORPHA:33574', 'Gamma-glutamylcysteine synthetase deficiency', 1),
(11175, 'ORPHA:33574', 'Glutamate-cysteine ligase deficiency', 1),
(11176, 'ORPHA:33577', 'Idiopathic lobular panniculitis', 1),
(11177, 'ORPHA:33577', 'Idiopathic nodular panniculitis', 1),
(11178, 'ORPHA:33577', 'Nodular non-suppurative panniculitis', 1),
(11179, 'ORPHA:33577', 'Pfeiffer-Weber-Christian syndrome', 1),
(11180, 'ORPHA:33577', 'Relapsing febrile nodular nonsuppurative panniculitis', 1),
(11181, 'ORPHA:33577', 'Relapsing febrile nodular panniculitis', 1),
(11182, 'ORPHA:33577', 'WCD', 1),
(11183, 'ORPHA:33577', 'Weber-Christian disease', 1),
(11184, 'ORPHA:33577', 'Weber-Christian panniculitis', 1),
(11185, 'ORPHA:3361', 'Trichodysplasia-xeroderma syndrome', 1),
(11186, 'ORPHA:3363', 'Long eyelashes-intellectual disability syndrome', 1),
(11187, 'ORPHA:3363', 'Oliver-McFarlane syndrome', 1),
(11188, 'ORPHA:3363', 'Trichomegaly-retina pigmentary degeneration-dwarfism syndrome', 1),
(11189, 'ORPHA:3365', 'Hunter-Rudd-Hoffmann syndrome', 1),
(11190, 'ORPHA:3365', 'Trigonocephaly-broad thumbs syndrome', 1),
(11191, 'ORPHA:3366', 'Isolated trigonocephaly', 1),
(11192, 'ORPHA:3366', 'Non-syndromic metopic craniosynostosis', 1),
(11193, 'ORPHA:3368', 'Trigonocephaly-bifid nose-acral anomalies syndrome', 1),
(11194, 'ORPHA:3369', 'Say-Meyer syndrome', 1),
(11195, 'ORPHA:3369', 'Trigonocephaly-short stature-developmental delay syndrome', 1),
(11196, 'ORPHA:337', 'FOP', 1),
(11197, 'ORPHA:337', 'Fibrodysplasia ossificans progressiva', 1),
(11198, 'ORPHA:337', 'Myositis ossificans progressiva', 1),
(11199, 'ORPHA:337', 'Stone man syndrome', 1),
(11200, 'ORPHA:3374', 'Triopia', 1),
(11201, 'ORPHA:3375', '47,XXX syndrome', 1),
(11202, 'ORPHA:3375', 'Triple X syndrome', 1),
(11203, 'ORPHA:3375', 'Triplo-X syndrome', 1),
(11204, 'ORPHA:3375', 'Trisomy X', 1),
(11205, 'ORPHA:3375', 'XXX syndrome', 1),
(11206, 'ORPHA:3376', 'Triploidy', 1),
(11207, 'ORPHA:3377', 'Distal arthrogryposis type 7', 1),
(11208, 'ORPHA:3377', 'Dutch-Kentucky syndrome', 1),
(11209, 'ORPHA:3377', 'Hecht syndrome', 1),
(11210, 'ORPHA:3377', 'Hecht-Beals syndrome', 1),
(11211, 'ORPHA:3377', 'Trismus-pseudocamptodactyly syndrome', 1),
(11212, 'ORPHA:3378', 'Patau syndrome', 1),
(11213, 'ORPHA:3378', 'Trisomy 13', 1),
(11214, 'ORPHA:3379', 'Distal duplication 17q', 1),
(11215, 'ORPHA:3379', 'Distal trisomy 17q', 1),
(11216, 'ORPHA:3379', 'Telomeric duplication 17q', 1),
(11217, 'ORPHA:3379', 'Trisomy 17qter', 1),
(11218, 'ORPHA:3380', 'Chromosome 18 duplication', 1),
(11219, 'ORPHA:3380', 'Edwards syndrome', 1),
(11220, 'ORPHA:3380', 'Trisomy 18', 1),
(11221, 'ORPHA:3383', 'Humerus trochlea aplasia', 1),
(11222, 'ORPHA:3384', 'Common aorticopulmonary trunk', 1),
(11223, 'ORPHA:3384', 'Common arterial trunk', 1),
(11224, 'ORPHA:3384', 'TAC', 1),
(11225, 'ORPHA:3384', 'Truncus arteriosus', 1),
(11226, 'ORPHA:3385', 'African trypanosomiasis', 1),
(11227, 'ORPHA:3385', 'Sleeping sickness', 1),
(11228, 'ORPHA:3386', 'American trypanosomiasis', 1),
(11229, 'ORPHA:3386', 'Chagas disease', 1),
(11230, 'ORPHA:3387', 'Hairy throat syndrome', 1),
(11231, 'ORPHA:3387', 'Isolated anterior cervical hypertrichosis', 1),
(11232, 'ORPHA:3387', 'Tsukahara-Kajii syndrome', 1),
(11233, 'ORPHA:3388', 'Neural tube defect', 3),
(11234, 'ORPHA:3389', 'Tuberculosis', 1),
(11235, 'ORPHA:3392', 'Tularemia', 1),
(11236, 'ORPHA:3394', 'Malignant mesenchymal tumor', 3),
(11237, 'ORPHA:3394', 'Malignant soft tissue tumor', 3),
(11238, 'ORPHA:3394', 'Soft part sarcoma', 3),
(11239, 'ORPHA:3394', 'Soft tissue sarcoma', 3),
(11240, 'ORPHA:3398', 'TEN', 3),
(11241, 'ORPHA:3398', 'Thymic epithelial neoplasm', 3),
(11242, 'ORPHA:3398', 'Thymic epithelial tumor', 3),
(11243, 'ORPHA:3399', 'Germ cell tumor', 3),
(11244, 'ORPHA:340', 'Hantavirosis', 1),
(11245, 'ORPHA:340', 'Hantavirus fever', 1),
(11246, 'ORPHA:340', 'Hemorrhagic fever-renal syndrome', 1),
(11247, 'ORPHA:3400', 'Aorto-ventricular tunnel', 1),
(11248, 'ORPHA:3402', 'Transient tyrosinemia of the neonate', 1),
(11249, 'ORPHA:3402', 'Transient tyrosinemia of the newborn', 1),
(11250, 'ORPHA:3403', 'Uhl anomaly', 1),
(11251, 'ORPHA:3404', 'Renal dysplasia-limb defects syndrome', 1),
(11252, 'ORPHA:3404', 'Renal dysplasia-mesomelia-radiohumeral fusion syndrome', 1),
(11253, 'ORPHA:3404', 'Ulbright-Hodes syndrome', 1),
(11254, 'ORPHA:3405', 'Umbilical cord ulceration-intestinal atresia syndrome', 1),
(11255, 'ORPHA:3406', 'Ulerythema ophryogenesis', 1),
(11256, 'ORPHA:3408', 'Hip dysplasia-enchondromata-ecchondroma syndrome', 1),
(11257, 'ORPHA:3408', 'Upington disease', 1),
(11258, 'ORPHA:3409', 'Intellectual disability-short stature-hand contractures-genital anomalies syndrome', 1),
(11259, 'ORPHA:3409', 'Prader-Willi habitus-osteopenia-camptodactyly syndrome', 1),
(11260, 'ORPHA:3409', 'Urban-Rogers-Meyer syndrome', 1),
(11261, 'ORPHA:341', 'Viral hemorrhagic fever', 3),
(11262, 'ORPHA:3411', 'Double uterus and obstructed hemivagina syndrome', 1),
(11263, 'ORPHA:3411', 'Double uterus-hemivagina-renal agenesis syndrome', 1),
(11264, 'ORPHA:3411', 'Herlyn-Werner syndrome', 1),
(11265, 'ORPHA:3411', 'OHVIRA syndrome', 1),
(11266, 'ORPHA:3411', 'Obstructed hemivagina and ipsilateral renal anomaly', 1),
(11267, 'ORPHA:3411', 'Wunderlich syndrome', 1),
(11268, 'ORPHA:3412', 'Sujansky-Leonard syndrome', 1),
(11269, 'ORPHA:3412', 'VACTERL with hydrocephalus', 1),
(11270, 'ORPHA:34149', 'ADTKD', 1),
(11271, 'ORPHA:34149', 'Autosomal dominant medullary cystic kidney disease', 1),
(11272, 'ORPHA:34149', 'Autosomal dominant tubulointerstitial kidney disease', 1),
(11273, 'ORPHA:34149', 'MCKD', 1),
(11274, 'ORPHA:3416', 'Hyperostosis corticalis generalisata', 1),
(11275, 'ORPHA:3416', 'Hyperphosphatasemia tarda', 1),
(11276, 'ORPHA:3416', 'Van Buchem disease', 1),
(11277, 'ORPHA:3417', 'Van den Bosch syndrome', 1),
(11278, 'ORPHA:342', 'Benign paroxysmal peritonitis', 1),
(11279, 'ORPHA:342', 'Benign recurrent polyserositis', 1),
(11280, 'ORPHA:342', 'FMF', 1),
(11281, 'ORPHA:342', 'Familial Mediterranean fever', 1),
(11282, 'ORPHA:342', 'Familial paroxysmal polyserositis', 1),
(11283, 'ORPHA:342', 'Periodic disease', 1),
(11284, 'ORPHA:34217', 'KWWH type I', 1),
(11285, 'ORPHA:34217', 'Keratoderma with woolly hair type I', 1),
(11286, 'ORPHA:34217', 'Keratosis palmoplantaris with arrythmogenic cardiomyopathy', 1),
(11287, 'ORPHA:34217', 'Naxos disease', 1),
(11288, 'ORPHA:34217', 'Palmoplantar hyperkeratosis with arrythmogenic cardiomyopathy', 1),
(11289, 'ORPHA:34217', 'Palmoplantar keratoderma with arrythmogenic cardiomyopathy', 1),
(11290, 'ORPHA:3424', 'Velo-facial-skeletal syndrome', 1),
(11291, 'ORPHA:3426', 'DORV', 1),
(11292, 'ORPHA:3426', 'Double outlet right ventricle', 1),
(11293, 'ORPHA:3427', 'DOLV', 1),
(11294, 'ORPHA:3427', 'Double outlet left ventricle', 1),
(11295, 'ORPHA:3429', 'Cleft lip-limb and heart malformations syndrome', 1),
(11296, 'ORPHA:3429', 'Verloove Vanhorick-Brubakk syndrome', 1),
(11297, 'ORPHA:343', 'HIDS', 1),
(11298, 'ORPHA:343', 'Hyper-IgD syndrome', 1),
(11299, 'ORPHA:343', 'Hyperimmunoglobinemia D with recurrent fever', 1),
(11300, 'ORPHA:343', 'Hyperimmunoglobulinemia D syndrome', 1),
(11301, 'ORPHA:343', 'Hyperimmunoglobulinemia D with periodic fever', 1),
(11302, 'ORPHA:343', 'Partial mevalonate kinase deficiency', 1),
(11303, 'ORPHA:3433', 'Microcephaly-brachydactyly-kyphoscoliosis syndrome', 1),
(11304, 'ORPHA:3433', 'Viljoen-Kallis-Voges syndrome', 1),
(11305, 'ORPHA:3434', 'MCOPS8', 1),
(11306, 'ORPHA:3434', 'MMEP syndrome', 1),
(11307, 'ORPHA:3434', 'Microcephaly-microphthalmia-ectrodactyly of lower limbs-prognathism syndrome', 1),
(11308, 'ORPHA:3434', 'Syndromic microphthalmia type 8', 1),
(11309, 'ORPHA:3434', 'Viljoen-Smart syndrome', 1),
(11310, 'ORPHA:3437', 'Uveomenigitic syndrome', 1),
(11311, 'ORPHA:3437', 'Vogt-Koyanagi-Harada disease', 1),
(11312, 'ORPHA:3439', 'DK phocomelia syndrome', 1),
(11313, 'ORPHA:3439', 'Phocomelia-thrombocytopenia-encephalocele-urogenital malformations syndrome', 1),
(11314, 'ORPHA:3439', 'Von Voss-Cherstvoy syndrome', 1),
(11315, 'ORPHA:344', 'Arbovirus fever', 3),
(11316, 'ORPHA:3440', 'Waardenburg syndrome', 1),
(11317, 'ORPHA:3447', 'Camptodactyly-overgrowth-unusual facies syndrome', 1),
(11318, 'ORPHA:3447', 'Weaver syndrome', 1),
(11319, 'ORPHA:3448', 'Weaver-Williams syndrome', 1),
(11320, 'ORPHA:3449', 'Spherophakia-brachymorphia syndrome', 1),
(11321, 'ORPHA:3449', 'Weill-Marchesani syndrome', 1),
(11322, 'ORPHA:345', 'Dissecting cellulitis of the scalp', 1),
(11323, 'ORPHA:3451', 'Infantile spasms', 1),
(11324, 'ORPHA:3451', 'Intellectual disability-hypsarrhythmia syndrome', 1),
(11325, 'ORPHA:3451', 'West syndrome', 1),
(11326, 'ORPHA:34514', 'Autosomal recessive limb-girdle muscular dystrophy type 2G', 1),
(11327, 'ORPHA:34514', 'LGMD due to telethonin deficiency', 1),
(11328, 'ORPHA:34514', 'LGMD type 2G', 1),
(11329, 'ORPHA:34514', 'LGMD2G', 1),
(11330, 'ORPHA:34514', 'Limb-girdle muscular dystrophy due to telethonin deficiency', 1),
(11331, 'ORPHA:34514', 'Limb-girdle muscular dystrophy type 2G', 1),
(11332, 'ORPHA:34514', 'Telethonin-related  limb-girdle muscular dystrophy R7', 1),
(11333, 'ORPHA:34514', 'Telethonin-related LGMD R7', 1),
(11334, 'ORPHA:34515', 'Autosomal recessive limb-girdle muscular dystrophy type 2I', 1),
(11335, 'ORPHA:34515', 'FKRP-related  limb-girdle muscular dystrophy R9', 1),
(11336, 'ORPHA:34515', 'FKRP-related LGMD R9', 1),
(11337, 'ORPHA:34515', 'LGMD due to FKRP deficiency', 1),
(11338, 'ORPHA:34515', 'LGMD type 2I', 1),
(11339, 'ORPHA:34515', 'LGMD2I', 1),
(11340, 'ORPHA:34515', 'Limb-girdle muscular dystrophy due to FKRP deficiency', 1),
(11341, 'ORPHA:34515', 'Limb-girdle muscular dystrophy type 2I', 1),
(11342, 'ORPHA:34516', 'Autosomal dominant limb-girdle muscular dystrophy type 1D', 1),
(11343, 'ORPHA:34516', 'DNAJB6-related  LGMD D1', 1),
(11344, 'ORPHA:34516', 'DNAJB6-related  limb-girdle muscular dystrophy D1', 1),
(11345, 'ORPHA:34516', 'LGMD type 1D', 1),
(11346, 'ORPHA:34516', 'LGMD1D', 1),
(11347, 'ORPHA:34516', 'Limb-girdle muscular dystrophy type 1D', 1),
(11348, 'ORPHA:3452', 'Intestinal lipodystrophy', 1),
(11349, 'ORPHA:3452', 'Whipple disease', 1),
(11350, 'ORPHA:34520', 'Congenital muscular dystrophy with ITGA7 deficiency', 1),
(11351, 'ORPHA:34520', 'Congenital muscular dystrophy with integrin alpha-7 deficiency', 1),
(11352, 'ORPHA:34526', 'Genetic primary hypomagnesemia', 3),
(11353, 'ORPHA:34527', 'Familial primary hypomagnesemia with normocalciuria and normocalcemia', 1),
(11354, 'ORPHA:34528', 'Autosomal dominant primary hypomagnesemia with hypocalciuria', 1),
(11355, 'ORPHA:34528', 'HOMG2', 1),
(11356, 'ORPHA:34528', 'Isolated autosomal dominant hypomagnesemia', 1),
(11357, 'ORPHA:34528', 'Isolated renal magnesium wasting', 1),
(11358, 'ORPHA:34528', 'Renal hypomagnesemia type 2', 1),
(11359, 'ORPHA:3453', 'APECED syndrome', 1),
(11360, 'ORPHA:3453', 'APS type 1', 1),
(11361, 'ORPHA:3453', 'APS1', 1),
(11362, 'ORPHA:3453', 'Autoimmune hypoparathyroidism-chronic candidiasis-Addison disease syndrome', 1),
(11363, 'ORPHA:3453', 'Autoimmune polyendocrine syndrome type 1', 1),
(11364, 'ORPHA:3453', 'Autoimmune polyendocrinopathy type 1', 1),
(11365, 'ORPHA:3453', 'Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome', 1),
(11366, 'ORPHA:3453', 'Autoimmune polyglandular syndrome type 1', 1),
(11367, 'ORPHA:3453', 'HAM syndrome', 1),
(11368, 'ORPHA:3453', 'Hypoparathyroidism-Addison disease-mucocutaneous candidiasis syndrome', 1),
(11369, 'ORPHA:3453', 'MEDAC syndrome', 1),
(11370, 'ORPHA:3453', 'Multiple endocrine deficiency-Addison disease-candidiasis syndrome', 1),
(11371, 'ORPHA:34533', 'Corneal dystrophy', 3),
(11372, 'ORPHA:3454', 'Foot contractures-muscle atrophy-oculomotor apraxia syndrome', 1),
(11373, 'ORPHA:3454', 'Intellectual disability-developmental delay-contractures syndrome', 1),
(11374, 'ORPHA:3454', 'Wieacker-Wolff syndrome', 1),
(11375, 'ORPHA:3455', 'Neonatal progeroid syndrome', 1),
(11376, 'ORPHA:3455', 'Wiedemann-Rautenstrauch syndrome', 1),
(11377, 'ORPHA:3456', 'Cervicooculoacoustic syndrome', 1),
(11378, 'ORPHA:3456', 'Wildervanck syndrome', 1),
(11379, 'ORPHA:34587', 'Danon disease', 1),
(11380, 'ORPHA:34587', 'GSD due to LAMP-2 deficiency', 1),
(11381, 'ORPHA:34587', 'Glycogen storage disease due to LAMP-2 deficiency', 1),
(11382, 'ORPHA:34587', 'Glycogenosis due to LAMP-2 deficiency', 1),
(11383, 'ORPHA:34587', 'Lysosomal glycogen storage disease with normal acid maltase activity', 1),
(11384, 'ORPHA:3459', 'WTS', 1),
(11385, 'ORPHA:3459', 'Wilson-Turner syndrome', 1),
(11386, 'ORPHA:3459', 'X-linked intellectual disability-gynecomastia-obesity syndrome', 1),
(11387, 'ORPHA:34592', 'Bare lymphocyte syndrome type 1', 1),
(11388, 'ORPHA:34592', 'Immunodeficiency by defective expression of MHC class I', 1),
(11389, 'ORPHA:34592', 'MHC class I deficiency', 1),
(11390, 'ORPHA:346', 'Quinquaud folliculitis decalvans', 1),
(11391, 'ORPHA:3463', 'DIDMOAD syndrome', 1),
(11392, 'ORPHA:3463', 'Diabetes insipidus-diabetes mellitus-optic atrophy-deafness syndrome', 1),
(11393, 'ORPHA:3463', 'Diabetes insipidus-diabetes mellitus-optic atrophy-hearing loss syndrome', 1),
(11394, 'ORPHA:3463', 'Wolfram syndrome', 1),
(11395, 'ORPHA:3464', 'Diabetes-hypogonadism-deafness-intellectual disability syndrome', 1),
(11396, 'ORPHA:3464', 'Diabetes-hypogonadism-hearing loss-intellectual disability syndrome', 1),
(11397, 'ORPHA:3464', 'Woodhouse-Sakati syndrome', 1),
(11398, 'ORPHA:3465', 'Congenital suprabulbar paresis', 1),
(11399, 'ORPHA:3465', 'Worster-Drought syndrome', 1),
(11400, 'ORPHA:3466', 'WT limb-blood syndrome', 1),
(11401, 'ORPHA:3467', 'Classic xanthinuria', 1),
(11402, 'ORPHA:3467', 'Hereditary xanthinuria', 1),
(11403, 'ORPHA:3467', 'Xanthic urolithiasis', 1),
(11404, 'ORPHA:3467', 'Xanthine stone disease', 1),
(11405, 'ORPHA:3469', 'Garcia-Lurie syndrome', 1),
(11406, 'ORPHA:3469', 'XK aprosencephaly syndrome', 1),
(11407, 'ORPHA:3469', 'XK syndrome', 1),
(11408, 'ORPHA:3469', 'XK-aprosencephaly', 1),
(11409, 'ORPHA:347', 'Frasier syndrome', 1),
(11410, 'ORPHA:3471', 'Azoospermia-sinopulmonary infections syndrome', 1),
(11411, 'ORPHA:3471', 'Young syndrome', 1),
(11412, 'ORPHA:3472', 'Cleidocranial dysplasia-micrognathia-absent thumbs syndrome', 1),
(11413, 'ORPHA:3472', 'Yunis-Varon syndrome', 1),
(11414, 'ORPHA:3473', 'Gingival fibromatosis-hepatosplenomegaly-other anomalies syndrome', 1),
(11415, 'ORPHA:3473', 'Laband syndrome', 1),
(11416, 'ORPHA:3473', 'Zimmermann-Laband syndrome', 1),
(11417, 'ORPHA:3474', 'CHIME syndrome', 1),
(11418, 'ORPHA:3474', 'Coloboma-congenital heart disease-ichthyosiform dermatosis-intellectual disability-ear anomalies syndrome', 1),
(11419, 'ORPHA:3474', 'Congenital disorder of glycosylation due to PIGL deficiency', 1),
(11420, 'ORPHA:3474', 'Neuroectodermal dysplasia, CHIME type', 1),
(11421, 'ORPHA:3474', 'Neuroectodermal syndrome, Zunich type', 1),
(11422, 'ORPHA:3474', 'PIGL-CDG', 1),
(11423, 'ORPHA:3474', 'Zunich-Kaye syndrome', 1),
(11424, 'ORPHA:348', 'FBPase deficiency', 1),
(11425, 'ORPHA:348', 'Fructose-1,6-bisphosphatase deficiency', 1),
(11426, 'ORPHA:348', 'Fructose-1,6-diphosphatase deficiency', 1),
(11427, 'ORPHA:349', 'Alpha-L-fucosidase deficiency', 1),
(11428, 'ORPHA:349', 'Fucosidosis', 1),
(11429, 'ORPHA:35', 'Ketotic hyperglycinemia', 1),
(11430, 'ORPHA:35', 'Propionic acidemia', 1),
(11431, 'ORPHA:35', 'Propionic aciduria', 1),
(11432, 'ORPHA:35', 'Propionyl-CoA carboxylase deficiency', 1),
(11433, 'ORPHA:35062', 'Idiopathic disseminated CMV infection', 1),
(11434, 'ORPHA:35062', 'Idiopathic disseminated cytomegalovirus infection', 1),
(11435, 'ORPHA:35063', 'Fulminant viral hepatitis', 1),
(11436, 'ORPHA:35069', 'INAD', 1),
(11437, 'ORPHA:35069', 'INAD1', 1),
(11438, 'ORPHA:35069', 'Infantile neuroaxonal dystrophy', 1),
(11439, 'ORPHA:35069', 'PLAN', 1),
(11440, 'ORPHA:35069', 'Phospholipase A2-associated neurodegeneration', 1),
(11441, 'ORPHA:35069', 'Seitelberger disease', 1),
(11442, 'ORPHA:35078', 'T-B+ SCID due to JAK3 deficiency', 1),
(11443, 'ORPHA:35078', 'T-B+ severe combined immunodeficiency due to JAK3 deficiency', 1),
(11444, 'ORPHA:35093', 'Isolated dolichocephaly', 1),
(11445, 'ORPHA:35093', 'Isolated scaphocephaly', 1),
(11446, 'ORPHA:35093', 'Non-syndromic sagittal synostosis', 1),
(11447, 'ORPHA:35098', 'Isolated plagiocephaly', 1),
(11448, 'ORPHA:35098', 'Non-syndromic unicoronal synostosis', 1),
(11449, 'ORPHA:35098', 'Synostotic plagiocephaly', 1),
(11450, 'ORPHA:35099', 'Isolated brachycephaly', 1),
(11451, 'ORPHA:35099', 'Non-syndromic bicoronal synostosis', 1),
(11452, 'ORPHA:351', 'Galactosialidosis', 1),
(11453, 'ORPHA:351', 'Goldberg syndrome', 1),
(11454, 'ORPHA:351', 'Neuraminidase deficiency with beta-galactosidase deficiency', 1),
(11455, 'ORPHA:35107', 'Desmosterolosis', 1),
(11456, 'ORPHA:35120', 'Hemolytic anemia due to pyrimidine 5\' nucleotidase deficiency', 1),
(11457, 'ORPHA:35120', 'P5N deficiency', 1),
(11458, 'ORPHA:35120', 'UMPH1 deficiency', 1),
(11459, 'ORPHA:35120', 'Uridine 5\'-monophosphate hydrolase deficiency', 1),
(11460, 'ORPHA:35121', 'Lysosomal acid phosphatase deficiency', 1),
(11461, 'ORPHA:35122', 'CSID', 1),
(11462, 'ORPHA:35122', 'Congenital sucrase-isomaltase deficiency', 1),
(11463, 'ORPHA:35122', 'Congenital sucrose intolerance', 1),
(11464, 'ORPHA:35122', 'Disaccharide intolerance', 1),
(11465, 'ORPHA:35125', 'Epidermal hamartoma syndrome', 1),
(11466, 'ORPHA:35125', 'Epidermal nevus syndrome', 1),
(11467, 'ORPHA:35173', 'CDPX2', 1),
(11468, 'ORPHA:35173', 'CDPXD', 1),
(11469, 'ORPHA:35173', 'CPXD', 1),
(11470, 'ORPHA:35173', 'Chondrodystrophia calcificans congenita', 1),
(11471, 'ORPHA:35173', 'Conradi-Hünermann-Happle syndrome', 1),
(11472, 'ORPHA:35173', 'X-linked chondrodysplasia punctata type 2', 1),
(11473, 'ORPHA:35173', 'X-linked dominant chondrodysplasia punctata', 1),
(11474, 'ORPHA:352', 'Galactosemia', 3),
(11475, 'ORPHA:352301', 'Disorder of phospholipids, sphingolipids and fatty acids biosynthesis', 3),
(11476, 'ORPHA:352306', 'Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement', 3),
(11477, 'ORPHA:352309', 'Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with peripheral nerves predominant involvement', 3),
(11478, 'ORPHA:352312', 'Disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement', 3),
(11479, 'ORPHA:352328', '3-methylglutaconic aciduria with deafness-encephalopathy-Leigh-like syndrome', 1),
(11480, 'ORPHA:352328', '3-methylglutaconic aciduria with hearing loss-encephalopathy-Leigh-like syndrome', 1),
(11481, 'ORPHA:352328', 'MEGDEL syndrome', 1),
(11482, 'ORPHA:352333', 'Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome', 1),
(11483, 'ORPHA:352333', 'Congenital ichthyosis-intellectual disability-spastic tetraplegia syndrome', 1),
(11484, 'ORPHA:352403', 'Ataxie spinocérébelleuse à début infantile avec retard psychomoteur', 1),
(11485, 'ORPHA:352403', 'Autosomal recessive spinocerebellar ataxia type 14', 1),
(11486, 'ORPHA:352403', 'Infantile-onset spinocerebellar ataxia-psychomotor delay syndrome', 1),
(11487, 'ORPHA:352403', 'SCAR14', 1),
(11488, 'ORPHA:352403', 'SPARCA', 1),
(11489, 'ORPHA:352403', 'SPARCA1', 1),
(11490, 'ORPHA:352403', 'Spectrin-associated autosomal recessive cerebellar ataxia', 1),
(11491, 'ORPHA:352403', 'Spectrin-associated autosomal recessive cerebellar ataxia type 1', 1),
(11492, 'ORPHA:352447', 'Mitochondrial DNA maintenance syndrome due to MGME1 deficiency', 1),
(11493, 'ORPHA:352447', 'PEO-myopathy-emaciation syndrome', 1),
(11494, 'ORPHA:352447', 'Progressive external ophthalmoplegia-myopathy-emaciation syndrome', 1),
(11495, 'ORPHA:352447', 'mtDNA maintenance syndrome due to MGME1 deficiency', 1),
(11496, 'ORPHA:352456', 'Mitochondrial DNA maintenance syndrome', 3),
(11497, 'ORPHA:352456', 'mtDNA maintenance syndrome', 3),
(11498, 'ORPHA:352470', 'DNA2-related mitochondrial DNA deletion syndrome', 1),
(11499, 'ORPHA:352470', 'Mitochondrial DNA deletion syndrome with limb-girdle weakness', 1),
(11500, 'ORPHA:352470', 'Mitochondrial DNA deletion syndrome with progressive myopathy', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(11501, 'ORPHA:352470', 'mtDNA deletion syndrome with limb-girdle weakness', 1),
(11502, 'ORPHA:352470', 'mtDNA deletion syndrome with progressive myopathy', 1),
(11503, 'ORPHA:352479', 'Autosomal recessive limb-girdle muscular dystrophy type 2U', 1),
(11504, 'ORPHA:352479', 'ISPD-related  limb-girdle muscular dystrophy R20', 1),
(11505, 'ORPHA:352479', 'ISPD-related LGMD R20', 1),
(11506, 'ORPHA:352479', 'LGMD  type 2U', 1),
(11507, 'ORPHA:352479', 'LGMD2U', 1),
(11508, 'ORPHA:352479', 'Limb-girdle muscular dystrophy type 2U', 1),
(11509, 'ORPHA:352490', 'ASD due to AUTS2 deficiency', 1),
(11510, 'ORPHA:352490', 'AUTS2 syndrome', 1),
(11511, 'ORPHA:352490', 'Autism spectrum disorder due to AUTS2 deficiency', 1),
(11512, 'ORPHA:352530', 'Autosomal recessive intellectual disability due to TRAPPC9 deficiency', 1),
(11513, 'ORPHA:352530', 'Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome', 1),
(11514, 'ORPHA:352540', 'Oncogenic hypophosphatemic osteomalacia', 1),
(11515, 'ORPHA:352540', 'Oncogenic osteomalacia', 1),
(11516, 'ORPHA:352540', 'TIO', 1),
(11517, 'ORPHA:352540', 'Tumor-induced osteomalacia', 1),
(11518, 'ORPHA:352563', 'COXPD16', 1),
(11519, 'ORPHA:352563', 'Combined oxidative phosphorylation defect type 16', 1),
(11520, 'ORPHA:352563', 'Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency', 1),
(11521, 'ORPHA:352577', 'Bainbridge-Ropers syndrome', 1),
(11522, 'ORPHA:352577', 'Severe feeding difficulties-failure to thrive-microcephaly due to ASXL3 deficiency syndrome', 1),
(11523, 'ORPHA:352582', 'FIME', 1),
(11524, 'ORPHA:352582', 'Familial infantile myoclonic epilepsy', 1),
(11525, 'ORPHA:352582', 'Familial infantile myoclonus epilepsy', 1),
(11526, 'ORPHA:352587', 'Focal epilepsy-intellectual disability-cerebro-cerebellar malformation', 1),
(11527, 'ORPHA:352587', 'Focal epilepsy-intellectual disability-dysarthria-ataxia syndrome', 1),
(11528, 'ORPHA:352596', 'PMED', 1),
(11529, 'ORPHA:352596', 'Progressive myoclonic epilepsy with dystonia', 1),
(11530, 'ORPHA:352596', 'Progressive myoclonus epilepsy with dystonia', 1),
(11531, 'ORPHA:352629', '16q24.1 microdeletion syndrome', 1),
(11532, 'ORPHA:352629', 'Del(16)(q24.1)', 1),
(11533, 'ORPHA:352629', 'Monosomy 16q24.1', 1),
(11534, 'ORPHA:352636', 'Phalangeal microgeodic syndrome', 1),
(11535, 'ORPHA:352636', 'Phalangeal osteolysis', 1),
(11536, 'ORPHA:352641', 'Autosomal recessive cerebellar ataxia due to GBA2 deficiency', 1),
(11537, 'ORPHA:352641', 'Autosomal recessive cerebellar ataxia with late-onset spasticity', 1),
(11538, 'ORPHA:352649', 'Brain dopamine-serotonin vesicular transport disease', 1),
(11539, 'ORPHA:352654', 'Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome', 1),
(11540, 'ORPHA:352657', 'HBID', 1),
(11541, 'ORPHA:352657', 'Hereditary benign corneal intraepithelial dyskeratosis', 1),
(11542, 'ORPHA:352657', 'Hereditary benign intraepithelial dyskeratosis', 1),
(11543, 'ORPHA:352662', 'Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome', 1),
(11544, 'ORPHA:352665', '9q21.3 microdeletion syndrome', 2),
(11545, 'ORPHA:352665', 'Del(9)(q21.3)', 2),
(11546, 'ORPHA:352665', 'Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion', 2),
(11547, 'ORPHA:352670', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type F', 1),
(11548, 'ORPHA:352670', 'CMTDIF', 1),
(11549, 'ORPHA:352675', 'CMT6X', 1),
(11550, 'ORPHA:352675', 'CMTX6', 1),
(11551, 'ORPHA:352675', 'X-linked Charcot-Marie-Tooth disease type 6', 1),
(11552, 'ORPHA:352682', 'Cobblestone lissencephaly without muscular or eye involvement', 1),
(11553, 'ORPHA:352682', 'Cobblestone lissencephaly without muscular or ocular involvement', 1),
(11554, 'ORPHA:352682', 'Lissencephaly type 2 without muscular or eye involvement', 1),
(11555, 'ORPHA:352682', 'Lissencephaly type 2 without muscular or ocular involvement', 1),
(11556, 'ORPHA:352687', 'Congenital muscular alpha-dystroglycanopathy with brain and eye anomalies', 3),
(11557, 'ORPHA:352687', 'Lissencephaly type 2 with muscular and ocular involvement', 3),
(11558, 'ORPHA:352687', 'MDDGA', 3),
(11559, 'ORPHA:352709', 'CLN13 disease', 2),
(11560, 'ORPHA:352712', 'FILS syndrome', 1),
(11561, 'ORPHA:352712', 'Facial dysmorphism-immunodeficiency-livedo-short stature syndrome', 1),
(11562, 'ORPHA:352718', 'Progressive retinal dystrophy due to retinol transport defect', 1),
(11563, 'ORPHA:352718', 'Retinol dystrophy-iris coloboma-comedogenic acne syndrome', 1),
(11564, 'ORPHA:352723', 'Attenuated Chédiak-Higashi syndrome', 1),
(11565, 'ORPHA:352723', 'Atypical Chédiak-Higashi syndrome', 1),
(11566, 'ORPHA:352728', 'Disorder of melanin metabolism', 3),
(11567, 'ORPHA:352731', 'OCA1', 1),
(11568, 'ORPHA:352731', 'Oculocutaneous albinism type 1', 1),
(11569, 'ORPHA:352734', 'MP OCA type 1', 2),
(11570, 'ORPHA:352734', 'Minimal pigment oculocutaneous albinism type 1', 2),
(11571, 'ORPHA:352734', 'OCA1-MP', 2),
(11572, 'ORPHA:352737', 'OCA1-TS', 2),
(11573, 'ORPHA:352737', 'TS OCA type 1', 2),
(11574, 'ORPHA:352737', 'Temperature-sensitive oculocutaneous albinism type 1', 2),
(11575, 'ORPHA:352740', 'Ocular albinism with congenital sensorineural deafness', 1),
(11576, 'ORPHA:352740', 'Ocular albinism with congenital sensorineural hearing loss', 1),
(11577, 'ORPHA:352740', 'Waardenburg syndrome type 2 with ocular albinism', 1),
(11578, 'ORPHA:352745', 'OCA7', 1),
(11579, 'ORPHA:352745', 'Oculocutaneous albinism type 7', 1),
(11580, 'ORPHA:352763', 'Buschke scleredema', 1),
(11581, 'ORPHA:352763', 'Scleredema', 1),
(11582, 'ORPHA:353', 'Autosomal recessive limb-girdle muscular dystrophy type 2C', 1),
(11583, 'ORPHA:353', 'Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5', 1),
(11584, 'ORPHA:353', 'Gamma-sarcoglycan-related LGMD R5', 1),
(11585, 'ORPHA:353', 'Gamma-sarcoglycanopathy', 1),
(11586, 'ORPHA:353', 'LGMD due to gamma-sarcoglycan deficiency', 1),
(11587, 'ORPHA:353', 'LGMD type 2C', 1),
(11588, 'ORPHA:353', 'LGMD2C', 1),
(11589, 'ORPHA:353', 'Limb-girdle muscular dystrophy due to gamma-sarcoglycan deficiency', 1),
(11590, 'ORPHA:353', 'Limb-girdle muscular dystrophy type 2C', 1),
(11591, 'ORPHA:353217', 'AGC1 deficiency', 1),
(11592, 'ORPHA:353217', 'Epileptic encephalopathy with global cerebral demyelination', 1),
(11593, 'ORPHA:353217', 'Mitochondrial aspartate-glutamate carrier 1 deficiency', 1),
(11594, 'ORPHA:353220', 'FPLCA', 1),
(11595, 'ORPHA:353220', 'Familial primary localized cutaneous amyloidosis', 1),
(11596, 'ORPHA:353253', 'BMS', 1),
(11597, 'ORPHA:353253', 'Burning mouth syndrome', 1),
(11598, 'ORPHA:353253', 'Oral dysesthesia', 1),
(11599, 'ORPHA:353253', 'Orodynia', 1),
(11600, 'ORPHA:353253', 'Stomatodynia', 1),
(11601, 'ORPHA:353253', 'Stomatopyrosis', 1),
(11602, 'ORPHA:353277', 'Rubinstein-Taybi syndrome due to CREBBP mutations', 2),
(11603, 'ORPHA:353281', 'Rubinstein-Taybi syndrome due to 16p13.3 microdeletion', 2),
(11604, 'ORPHA:353284', 'Rubinstein-Taybi syndrome due to EP300 haploinsufficiency', 2),
(11605, 'ORPHA:353298', 'Roifman syndrome', 1),
(11606, 'ORPHA:353298', 'Spondyloepiphyseal dysplasia-retinal dystrophy-immunodeficiency syndrome', 1),
(11607, 'ORPHA:353308', 'Pyruvate carboxylase deficiency type A', 2),
(11608, 'ORPHA:353308', 'Pyruvate carboxylase deficiency, infantile type', 2),
(11609, 'ORPHA:353314', 'Pyruvate carboxylase deficiency type B', 2),
(11610, 'ORPHA:353314', 'Pyruvate carboxylase deficiency, severe neonatal type', 2),
(11611, 'ORPHA:353320', 'Pyruvate carboxylase deficiency type C', 2),
(11612, 'ORPHA:353320', 'Pyruvate carboxylase deficiency, benign type', 2),
(11613, 'ORPHA:353327', 'Congenital myasthenic syndromes with glycosylation defect', 2),
(11614, 'ORPHA:353334', 'Congenital arteriovenous anastomoses of the retina', 1),
(11615, 'ORPHA:353334', 'Congenital arteriovenous communication of the retina', 1),
(11616, 'ORPHA:353334', 'Congenital retinal arteriovenous anastomoses', 1),
(11617, 'ORPHA:353334', 'Congenital retinal arteriovenous communication', 1),
(11618, 'ORPHA:353344', 'Aneurysmal telangiectasia', 1),
(11619, 'ORPHA:353344', 'Idiopathic macular telangiectasia type 1', 1),
(11620, 'ORPHA:353344', 'Visible and exudative idiopathic juxtafoveolar retinal telangiectasis', 1),
(11621, 'ORPHA:353351', 'Idiopathic macular telangiectasia type 3', 1),
(11622, 'ORPHA:353351', 'Occlusive idiopathic juxtafoveolar retinal telangiectasis', 1),
(11623, 'ORPHA:353356', 'Retinal vasoproliferative tumor', 1),
(11624, 'ORPHA:353356', 'VPTR', 1),
(11625, 'ORPHA:353356', 'Vasoproliferative tumor of the ocular fundus', 1),
(11626, 'ORPHA:353356', 'Vasoproliferative tumor of the retina', 1),
(11627, 'ORPHA:354', 'Beta-galactosidase-1 deficiency', 1),
(11628, 'ORPHA:354', 'GLB1 deficiency', 1),
(11629, 'ORPHA:354', 'GM1 gangliosidosis', 1),
(11630, 'ORPHA:354', 'Landing disease', 1),
(11631, 'ORPHA:355', 'Acid beta-glucosidase deficiency', 1),
(11632, 'ORPHA:355', 'Gaucher disease', 1),
(11633, 'ORPHA:355', 'Glucocerebrosidase deficiency', 1),
(11634, 'ORPHA:356', 'Gerstmann-Straussler-Scheinker syndrome', 1),
(11635, 'ORPHA:356', 'Subacute spongiform encephalopathy, Gerstmann-Straussler type', 1),
(11636, 'ORPHA:35612', 'Nanophthalmia', 1),
(11637, 'ORPHA:35612', 'Nanophthalmos', 1),
(11638, 'ORPHA:35656', 'CoQ10 deficiency', 3),
(11639, 'ORPHA:35656', 'Coenzyme Q10 deficiency', 3),
(11640, 'ORPHA:35664', 'ALDH18A1-related De Barsy syndrome', 2),
(11641, 'ORPHA:35664', 'Delta-1-pyrroline 5-carboxylate synthetase deficiency', 2),
(11642, 'ORPHA:35664', 'Neurocutaneous syndrome, Bicknell type', 2),
(11643, 'ORPHA:35664', 'P5CS deficiency', 2),
(11644, 'ORPHA:35686', 'Geographic helicoid peripapillary choroidopathy', 1),
(11645, 'ORPHA:35686', 'Serpiginous choroiditis', 1),
(11646, 'ORPHA:35687', 'Erdheim-Chester disease', 1),
(11647, 'ORPHA:35689', 'Adult-onset PLS', 1),
(11648, 'ORPHA:35689', 'Adult-onset primary lateral sclerosis', 1),
(11649, 'ORPHA:35689', 'PLS', 1),
(11650, 'ORPHA:35689', 'Primary lateral sclerosis', 1),
(11651, 'ORPHA:356947', '3q26q27 microdeletion syndrome', 1),
(11652, 'ORPHA:356947', 'Del(3)(q26q27)', 1),
(11653, 'ORPHA:356947', 'Monosomy 3q26q27', 1),
(11654, 'ORPHA:35696', 'COXPD', 3),
(11655, 'ORPHA:35696', 'Combined OXPHOS defect', 3),
(11656, 'ORPHA:35696', 'Combined OXPHOS deficiency', 3),
(11657, 'ORPHA:35696', 'Combined oxidative phosphorylation defect', 3),
(11658, 'ORPHA:35696', 'Mitochondrial disorder due to a defect in mitochondrial protein synthesis', 3),
(11659, 'ORPHA:356961', 'CDG syndrome type IIm', 1),
(11660, 'ORPHA:356961', 'CDG-IIm', 1),
(11661, 'ORPHA:356961', 'CDG2M', 1),
(11662, 'ORPHA:356961', 'Congenital disorder of glycosylation type 2m', 1),
(11663, 'ORPHA:356961', 'Congenital disorder of glycosylation type IIm', 1),
(11664, 'ORPHA:356961', 'SLC35A2-CDG', 1),
(11665, 'ORPHA:356978', 'Combined D-2-hydroxyglutaric acidemia and L-2-hydroxyglutaric acidemia', 1),
(11666, 'ORPHA:356978', 'Combined D-2-hydroxyglutaric aciduria and L-2-hydroxyglutaric aciduria', 1),
(11667, 'ORPHA:356978', 'D,L-2-HGA', 1),
(11668, 'ORPHA:356978', 'D,L-2-hydroxyglutaric acidemia', 1),
(11669, 'ORPHA:356978', 'D,L-2-hydroxyglutaric aciduria', 1),
(11670, 'ORPHA:35698', 'Mitochondrial DNA depletion syndrome', 3),
(11671, 'ORPHA:35698', 'mtDNA depletion syndrome', 3),
(11672, 'ORPHA:356996', 'ANK3-related intellectual disability-sleep disturbance syndrome', 1),
(11673, 'ORPHA:357001', '19p13.13 microdeletion syndrome', 1),
(11674, 'ORPHA:357001', 'Del(19)(p13.13)', 1),
(11675, 'ORPHA:357001', 'Monosomy 19p13.13', 1),
(11676, 'ORPHA:357008', 'HUS with DGKE deficiency', 1),
(11677, 'ORPHA:357008', 'Hemolytic uremic syndrome with DGKE deficiency', 1),
(11678, 'ORPHA:35701', '3-hydroxy-3-methylglutaryl-CoA synthase deficiency', 1),
(11679, 'ORPHA:35701', 'HMG-CoA synthase deficiency', 1),
(11680, 'ORPHA:357027', 'Hereditary retinoblastoma', 2),
(11681, 'ORPHA:357034', 'Non-hereditary retinoblastoma', 2),
(11682, 'ORPHA:35704', 'AGAT deficiency', 1),
(11683, 'ORPHA:35704', 'L-Arginine:glycine amidinotransferase deficiency', 1),
(11684, 'ORPHA:357043', 'ALS4', 1),
(11685, 'ORPHA:357043', 'Amyotrophic lateral sclerosis type 4', 1),
(11686, 'ORPHA:357043', 'Distal hereditary motor neuropathy with upper motor neuron signs', 1),
(11687, 'ORPHA:357043', 'dHMN with upper motor neuron signs', 1),
(11688, 'ORPHA:35705', 'Neurometabolic disorder due to serine deficiency', 3),
(11689, 'ORPHA:35705', 'Serine deficiency', 3),
(11690, 'ORPHA:357058', 'ARCL2A', 1),
(11691, 'ORPHA:357058', 'Autosomal recessive cutis laxa type 2A', 1),
(11692, 'ORPHA:35706', 'Glutaric acidemia type 3', 1),
(11693, 'ORPHA:35706', 'Glutaric aciduria type 3', 1),
(11694, 'ORPHA:35706', 'Glutaryl-CoA oxidase deficiency', 1),
(11695, 'ORPHA:357064', 'ARCL2, progeroid type', 1),
(11696, 'ORPHA:357064', 'ARCL2B', 1),
(11697, 'ORPHA:357064', 'Autosomal recessive cutis laxa type 2, progeroid type', 1),
(11698, 'ORPHA:357064', 'Autosomal recessive cutis laxa type 2B', 1),
(11699, 'ORPHA:357074', 'ARCL2, Debré type', 2),
(11700, 'ORPHA:357074', 'ARCL2, classic type', 2),
(11701, 'ORPHA:357074', 'Autosomal recessive cutis laxa type 2, Debré type', 2),
(11702, 'ORPHA:357074', 'Autosomal recessive cutis laxa type 2, classic type', 2),
(11703, 'ORPHA:35708', 'AADC deficiency', 1),
(11704, 'ORPHA:35708', 'Aromatic L-amino acid decarboxylase deficiency', 1),
(11705, 'ORPHA:35710', 'Glucose-galactose malabsorption', 1),
(11706, 'ORPHA:35710', 'SGLT1 deficiency', 1),
(11707, 'ORPHA:357107', 'ATOS', 2),
(11708, 'ORPHA:357107', 'Arterial TOS', 2),
(11709, 'ORPHA:357107', 'Arterial cervical rib syndrome', 2),
(11710, 'ORPHA:357107', 'Arterial costoclavicular syndrome', 2),
(11711, 'ORPHA:357107', 'Arterial hyperabduction syndrome', 2),
(11712, 'ORPHA:357107', 'Arterial scalenus anticus syndrome', 2),
(11713, 'ORPHA:357107', 'Arterial thoracic outlet compression syndrome', 2),
(11714, 'ORPHA:357107', 'Arterial thoracic outlet syndrome', 2),
(11715, 'ORPHA:357131', 'Effort subclavian vein thrombosis', 2),
(11716, 'ORPHA:357131', 'Paget-Schrotter disease', 2),
(11717, 'ORPHA:357131', 'VTOS', 2),
(11718, 'ORPHA:357131', 'Venous TOS', 2),
(11719, 'ORPHA:357131', 'Venous cervical rib syndrome', 2),
(11720, 'ORPHA:357131', 'Venous costoclavicular syndrome', 2),
(11721, 'ORPHA:357131', 'Venous hyperabduction syndrome', 2),
(11722, 'ORPHA:357131', 'Venous scalenus anticus syndrome', 2),
(11723, 'ORPHA:357131', 'Venous thoracic outlet compression syndrome', 2),
(11724, 'ORPHA:357131', 'Venous thoracic outlet syndrome', 2),
(11725, 'ORPHA:357154', 'OSMF', 1),
(11726, 'ORPHA:357154', 'Oral submucous fibrosis', 1),
(11727, 'ORPHA:357158', 'Macroblepharon-ectropion-hypertelorism-macrostomia syndrome', 1),
(11728, 'ORPHA:357158', 'Mandibulofacial dysostosis-macroblepharon-macrostomia syndrome', 1),
(11729, 'ORPHA:357175', 'Short ulna-dysmorphism-hypotonia-intellectual disability syndrome', 1),
(11730, 'ORPHA:357220', 'Primary essential cutis verticis gyrata', 1),
(11731, 'ORPHA:357225', 'Primary non-essential cutis verticis gyrata', 1),
(11732, 'ORPHA:357237', 'SCID due to CARD11 deficiency', 1),
(11733, 'ORPHA:357237', 'Severe combined immunodeficiency due to CARD11 deficiency', 1),
(11734, 'ORPHA:357329', 'Combined immunodeficiency due to IL21R deficiency', 1),
(11735, 'ORPHA:357332', 'Synactyly-camptodactyly and clinodactyly of fifth fingers-bifid halluces syndrome', 1),
(11736, 'ORPHA:357332', 'Syndactyly-camptodactyly and clinodactyly of fifth fingers-bifid toes syndrome', 1),
(11737, 'ORPHA:357332', 'Wahab syndrome', 1),
(11738, 'ORPHA:35737', 'Ectasic coloboma', 1),
(11739, 'ORPHA:35737', 'Morning glory disc anomaly', 1),
(11740, 'ORPHA:35737', 'Morning glory syndrome', 1),
(11741, 'ORPHA:357502', 'Idiopathic nephrotic syndrome', 3),
(11742, 'ORPHA:357506', 'Genetic non-syndromic renal or urinary tract malformation', 3),
(11743, 'ORPHA:358', 'Gitelman syndrome', 1),
(11744, 'ORPHA:358', 'Primary renal tubular hypokalemic hypomagnesemia with hypocalciuria', 1),
(11745, 'ORPHA:35807', 'MOGCT', 3),
(11746, 'ORPHA:35807', 'Malignant germ cell tumor of ovary', 3),
(11747, 'ORPHA:35807', 'Malignant ovarian germ cell tumor', 3),
(11748, 'ORPHA:35807', 'Ovarian germ cell cancer', 3),
(11749, 'ORPHA:35808', 'Malignant ovarian SCST', 3),
(11750, 'ORPHA:35808', 'Malignant ovarian sex cord-stromal tumor', 3),
(11751, 'ORPHA:35808', 'Malignant sex cord stromal tumor of ovary', 3),
(11752, 'ORPHA:35858', 'Familial megaloblastic anemia', 1),
(11753, 'ORPHA:35858', 'Imerslund-Gräsbeck syndrome', 1),
(11754, 'ORPHA:35858', 'Selective cobalamin malabsorption with proteinuria', 1),
(11755, 'ORPHA:35878', 'HI/HA syndrome', 1),
(11756, 'ORPHA:35878', 'Hyperinsulinism-hyperammonemia syndrome', 1),
(11757, 'ORPHA:35889', 'Acute opioid poisoning', 1),
(11758, 'ORPHA:359', 'Hereditary glaucoma', 3),
(11759, 'ORPHA:359', 'Pediatric-onset glaucoma of genetic origin', 3),
(11760, 'ORPHA:35909', 'Combined deficiency of factor V and factor VIII', 1),
(11761, 'ORPHA:35909', 'F5F8D', 1),
(11762, 'ORPHA:35909', 'FV and FVIII combined deficiency', 1),
(11763, 'ORPHA:35981', 'Polymicrogyria', 3),
(11764, 'ORPHA:36', 'ACS', 1),
(11765, 'ORPHA:36', 'Acrocallosal syndrome', 1),
(11766, 'ORPHA:360', 'GBM', 1),
(11767, 'ORPHA:360', 'Glioblastoma', 1),
(11768, 'ORPHA:360', 'Glioblastoma multiforme', 1),
(11769, 'ORPHA:361', 'Familial glucocorticoid deficiency', 1),
(11770, 'ORPHA:36204', 'Intestinal lymphangiectasia', 3),
(11771, 'ORPHA:36234', 'Bacterial TSS', 1),
(11772, 'ORPHA:36234', 'Bacterial toxic-shock syndrome', 1),
(11773, 'ORPHA:36235', 'Staphylococcal scarlet fever', 1),
(11774, 'ORPHA:36236', 'Generalized exfoliative disease', 1),
(11775, 'ORPHA:36236', 'SSSS', 1),
(11776, 'ORPHA:36236', 'Staphylococcal scalded skin syndrome', 1),
(11777, 'ORPHA:36237', 'Bullous impetigo', 1),
(11778, 'ORPHA:36238', 'Staphylococcal necrotizing pneumonia', 1),
(11779, 'ORPHA:36258', 'Buerger disease', 1),
(11780, 'ORPHA:36258', 'Thromboangiitis obliterans', 1),
(11781, 'ORPHA:36273', 'Borrmann gastric cancer type 4', 1),
(11782, 'ORPHA:36273', 'Gastric linitis plastica', 1),
(11783, 'ORPHA:36273', 'Linitis plastica of the stomach', 1),
(11784, 'ORPHA:363189', 'Congenital anomaly of the great veins', 3),
(11785, 'ORPHA:363203', 'Ring chromosome', 3),
(11786, 'ORPHA:363245', 'Genetic progeroid syndrome', 3),
(11787, 'ORPHA:363250', 'Ciliopathy', 3),
(11788, 'ORPHA:363294', 'Genetic syndromic Pierre Robin syndrome', 3),
(11789, 'ORPHA:363300', 'Genetic intractable diarrhea of infancy', 3),
(11790, 'ORPHA:363306', 'Genetic intestinal disease due to fat malabsorption', 3),
(11791, 'ORPHA:363314', 'Familial intestinal polyposis', 3),
(11792, 'ORPHA:363314', 'Genetic intestinal polyposis', 3),
(11793, 'ORPHA:363396', 'High myopia-sensorineural deafness syndrome', 1),
(11794, 'ORPHA:363396', 'High myopia-sensorineural hearing loss syndrome', 1),
(11795, 'ORPHA:363400', 'Severe neurodegenerative syndrome due to BSCL2 deficiency', 1),
(11796, 'ORPHA:363400', 'Severe neurodegenerative syndrome with lipodystrophy', 1),
(11797, 'ORPHA:363409', 'Fetal akinesia-cerebral and retinal hemorrhage syndrome', 1),
(11798, 'ORPHA:363409', 'LCCS5', 1),
(11799, 'ORPHA:363409', 'Lethal congenital contracture syndrome type 5', 1),
(11800, 'ORPHA:363412', 'HBSL', 1),
(11801, 'ORPHA:363412', 'Hypomyelination with brain stem and spinal cord involvement and leg spasticity', 1),
(11802, 'ORPHA:363417', 'Temtamy preaxial brachydactyly syndrome', 1),
(11803, 'ORPHA:363424', 'IBA57 deficiency', 1),
(11804, 'ORPHA:363424', 'MMDS3', 1),
(11805, 'ORPHA:363424', 'Multiple mitochondrial dysfunctions syndrome type 3', 1),
(11806, 'ORPHA:363429', 'Autosomal recessive cerebellar ataxia-pyramidal signs-nystagmus-oculomotor apraxia syndrome', 1),
(11807, 'ORPHA:363432', 'Autosomal recessive congenital cerebellar ataxia due to GRID2 deficiency', 2),
(11808, 'ORPHA:363432', 'Autosomal recessive congenital cerebellar ataxia due to ionotropic glutamate receptor delta-2 subunit deficiency', 2),
(11809, 'ORPHA:363432', 'SCAR18', 2),
(11810, 'ORPHA:363444', 'BBIS', 1),
(11811, 'ORPHA:363444', 'Beaulieu-Boycott-Innes syndrome', 1),
(11812, 'ORPHA:363444', 'THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome', 1),
(11813, 'ORPHA:363447', 'Autosomal dominant childhood-onset proximal spinal muscular atrophy', 1),
(11814, 'ORPHA:363447', 'Lower extremity-predominant autosomal dominant proximal spinal muscular atrophy', 1),
(11815, 'ORPHA:363447', 'SMALED', 1),
(11816, 'ORPHA:363454', 'BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy', 2),
(11817, 'ORPHA:363454', 'BICD2-related lower extremity-predominant autosomal dominant proximal spinal muscular atrophy with contractures', 2),
(11818, 'ORPHA:363454', 'SMALED2', 2),
(11819, 'ORPHA:363472', 'Testicular and paratesticular tumor', 3),
(11820, 'ORPHA:363472', 'Tumor of testis and paratestis', 3),
(11821, 'ORPHA:363478', 'Adenocarcinoma of the paratestis', 1),
(11822, 'ORPHA:363478', 'Paratesticular adenocarcinoma', 1),
(11823, 'ORPHA:363483', 'Teratoma of the testis', 1),
(11824, 'ORPHA:363483', 'Testicular teratoma', 1),
(11825, 'ORPHA:363489', 'Sex cord-stromal tumor of testis', 1),
(11826, 'ORPHA:363489', 'Testicular sex cord-stromal tumor', 1),
(11827, 'ORPHA:363494', 'Non-dysgerminomatous germ cell tumor of testis', 1),
(11828, 'ORPHA:363494', 'Non-seminomatous germ cell tumor of testis', 1),
(11829, 'ORPHA:363494', 'Testicular non seminomatous germ cell tumor', 1),
(11830, 'ORPHA:363494', 'Testicular non-dysgerminomatous germ cell tumor', 1),
(11831, 'ORPHA:363504', 'Germ cell tumor of testis', 3),
(11832, 'ORPHA:363504', 'Testicular germ cell tumor', 3),
(11833, 'ORPHA:363523', 'Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome', 1),
(11834, 'ORPHA:363523', 'Shaheen syndrome', 1),
(11835, 'ORPHA:363528', 'Intellectual disability-strabismus syndrome', 1),
(11836, 'ORPHA:363534', 'Mitochondrial DNA depletion syndrome, hepatocerebrorenal form', 1),
(11837, 'ORPHA:363534', 'mtDNA depletion syndrome, hepatocerebrorenal form', 1),
(11838, 'ORPHA:363540', 'Leukoencephalopathy with mild cerebellar ataxia and white matter edema', 1),
(11839, 'ORPHA:363549', 'AESD', 1),
(11840, 'ORPHA:363549', 'AIEF', 1),
(11841, 'ORPHA:363549', 'Acute encephalopathy with biphasic seizures and late reduced diffusion', 1),
(11842, 'ORPHA:363549', 'Acute infantile encephalopathy predominantly affecting the frontal lobes', 1),
(11843, 'ORPHA:36355', 'Bleeding disorder due to ADP platelet receptor P2Y12 defect', 1),
(11844, 'ORPHA:36355', 'Bleeding disorder due to P2Y12 defect', 1),
(11845, 'ORPHA:363558', 'NORSE', 1),
(11846, 'ORPHA:363558', 'New-onset refractory status epilepticus', 1),
(11847, 'ORPHA:363567', 'Acute encephalopathy with inflammation-mediated status epilepticus', 3),
(11848, 'ORPHA:363579', 'Extragonadal germ cell tumor', 3),
(11849, 'ORPHA:363582', 'Gonadal germ cell tumor', 3),
(11850, 'ORPHA:363611', 'CTCF-related neurodevelopmental disorder', 1),
(11851, 'ORPHA:363618', 'LCPS', 1),
(11852, 'ORPHA:363618', 'LMNA-related cardiocutaneous progeria syndrome', 1),
(11853, 'ORPHA:363623', 'Autosomal recessive limb-girdle muscular dystrophy type 2T', 1),
(11854, 'ORPHA:363623', 'GMPPB-related  limb-girdle muscular dystrophy R19', 1),
(11855, 'ORPHA:363623', 'GMPPB-related LGMD R19', 1),
(11856, 'ORPHA:363623', 'LGMD type 2T', 1),
(11857, 'ORPHA:363623', 'LGMD2T', 1),
(11858, 'ORPHA:363623', 'Limb-girdle muscular dystrophy type 2T', 1),
(11859, 'ORPHA:363649', 'MDP syndrome', 1),
(11860, 'ORPHA:363649', 'MDPL syndrome', 1),
(11861, 'ORPHA:363649', 'Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome', 1),
(11862, 'ORPHA:363649', 'Mandibular hypoplasia-hearing loss-progeroid syndrome', 1),
(11863, 'ORPHA:363654', 'X-linked parkinsonism-spasticity syndrome', 1),
(11864, 'ORPHA:363654', 'XPDS', 1),
(11865, 'ORPHA:363659', '20q11.2 microduplication syndrome', 1),
(11866, 'ORPHA:363659', 'Dup(20)(q11.2)', 1),
(11867, 'ORPHA:363665', 'Acroosteolysis-keloid-like lesions-premature aging syndrome', 1),
(11868, 'ORPHA:363665', 'Premature aging syndrome, Penttinen type', 1),
(11869, 'ORPHA:36367', 'Distal deletion 1q', 1),
(11870, 'ORPHA:36367', 'Distal monosomy 1q', 1),
(11871, 'ORPHA:36367', 'Monosomy 1qter', 1),
(11872, 'ORPHA:36367', 'Telomeric deletion 1q', 1),
(11873, 'ORPHA:363677', 'Childhood-onset autosomal recessive myopathy with external ophthalmoplegia', 1),
(11874, 'ORPHA:363680', '2p13.2 microdeletion syndrome', 1),
(11875, 'ORPHA:363680', 'Del(2)(p13.2)', 1),
(11876, 'ORPHA:363686', 'Severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome', 1),
(11877, 'ORPHA:363694', 'HUPRA syndrome', 1),
(11878, 'ORPHA:363694', 'Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome', 1),
(11879, 'ORPHA:363700', 'Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion', 2),
(11880, 'ORPHA:363700', 'Von Recklinghausen disease due to NF1 mutation or intragenic deletion', 2),
(11881, 'ORPHA:363705', 'Cantu craniofaciofrontodigital syndrome', 1),
(11882, 'ORPHA:363705', 'Craniofaciofrontodigital syndrome', 1),
(11883, 'ORPHA:363710', 'SCA37', 1),
(11884, 'ORPHA:363710', 'Spinocerebellar ataxia type 37', 1),
(11885, 'ORPHA:363710', 'Spinocerebellar ataxia with altered vertical eye movements', 1),
(11886, 'ORPHA:363717', 'Alexander disease type I', 2),
(11887, 'ORPHA:363717', 'AxD type I', 2),
(11888, 'ORPHA:363722', 'Alexander disease type II', 2),
(11889, 'ORPHA:363722', 'AxD type II', 2),
(11890, 'ORPHA:363727', 'X-linked dyserythropoietic anemia with abnormal platelets and neutropenia', 1),
(11891, 'ORPHA:363741', 'Colobomatous microphthalmia-obesity-hypogenitalism-intellectual disability syndrome', 1),
(11892, 'ORPHA:363746', 'Balint syndrome', 1),
(11893, 'ORPHA:363746', 'Balint-Holmes syndrome', 1),
(11894, 'ORPHA:363746', 'Optic ataxia-gaze apraxia-simultanagnosia syndrome', 1),
(11895, 'ORPHA:36382', 'Familial CAD', 1),
(11896, 'ORPHA:36382', 'Familial cervical artery dissection', 1),
(11897, 'ORPHA:36382', 'Hereditary CAD', 1),
(11898, 'ORPHA:36382', 'Hereditary cervical artery dissection', 1),
(11899, 'ORPHA:36383', 'COL4A1-related brain small vessel disease with hemorrhage', 1),
(11900, 'ORPHA:36383', 'COL4A1-related familial vascular leukoencephalopathy', 1),
(11901, 'ORPHA:36383', 'COL4A1-related retinal arteriolar tortuosity-infantile hemiparesis-autosomal dominant leukoencephalopathy syndrome', 1),
(11902, 'ORPHA:36386', 'HSAN1', 1),
(11903, 'ORPHA:36386', 'Hereditary sensory and autonomic neuropathy type 1', 1),
(11904, 'ORPHA:36386', 'Hereditary sensory and autonomic neuropathy type I', 1),
(11905, 'ORPHA:36387', 'GEFS+', 1),
(11906, 'ORPHA:36387', 'Generalized epilepsy with febrile seizures-plus', 1),
(11907, 'ORPHA:36387', 'Genetic epilepsy with febrile seizures-plus', 1),
(11908, 'ORPHA:36388', 'PCD', 3),
(11909, 'ORPHA:36388', 'PNS', 3),
(11910, 'ORPHA:36388', 'Paraneoplastic cerebellar degeneration', 3),
(11911, 'ORPHA:36388', 'Paraneoplastic neurologic syndrome', 3),
(11912, 'ORPHA:363958', '17q21.31 microdeletion syndrome', 2),
(11913, 'ORPHA:363958', 'Del(17)(q21.31)', 2),
(11914, 'ORPHA:363958', 'Monosomy 17q21.31', 2),
(11915, 'ORPHA:363965', 'Koolen-De Vries syndrome due to a point mutation', 2),
(11916, 'ORPHA:363969', 'Autosomal recessive cerebral atrophy', 1),
(11917, 'ORPHA:36397', 'Adiposalgia', 1),
(11918, 'ORPHA:36397', 'Adipose tissue rheumatism', 1),
(11919, 'ORPHA:36397', 'Adiposis dolorosa', 1),
(11920, 'ORPHA:36397', 'Dercum disease', 1),
(11921, 'ORPHA:36397', 'Lipomatosis dolorosa', 1),
(11922, 'ORPHA:363972', 'CBL syndrome', 1),
(11923, 'ORPHA:363972', 'Noonan syndrome-like disorder with JMML', 1),
(11924, 'ORPHA:363972', 'Noonan syndrome-like disorder with juvenile myelomonocytic leukemia', 1),
(11925, 'ORPHA:363976', 'GCT of bone', 1),
(11926, 'ORPHA:363976', 'Giant cell tumor of bone', 1),
(11927, 'ORPHA:363976', 'Osteoclastoma', 1),
(11928, 'ORPHA:363981', 'CMT4B3', 1),
(11929, 'ORPHA:363981', 'Charcot-Marie-Tooth disease type 4B3', 1),
(11930, 'ORPHA:363981', 'Charcot-Marie-Tooth disease with focally folded myelin', 1),
(11931, 'ORPHA:363989', 'Familial benign flecked retina', 1),
(11932, 'ORPHA:363992', '15q26.3 microdeletion syndrome', 1),
(11933, 'ORPHA:363992', 'Ichthyosis-short stature-brachydactyly-microspherophakia syndrome', 1),
(11934, 'ORPHA:363999', 'NIHF', 2),
(11935, 'ORPHA:363999', 'Non-immune HF', 2),
(11936, 'ORPHA:363999', 'Non-immune fetal edema', 2),
(11937, 'ORPHA:363999', 'Non-immune fetal hydrops', 2),
(11938, 'ORPHA:363999', 'Non-immune hydrops fetalis', 2),
(11939, 'ORPHA:364', 'G6P deficiency', 1),
(11940, 'ORPHA:364', 'GSD due to G6P deficiency', 1),
(11941, 'ORPHA:364', 'GSD type 1', 1),
(11942, 'ORPHA:364', 'GSD type I', 1),
(11943, 'ORPHA:364', 'Glycogen storage disease due to G6P deficiency', 1),
(11944, 'ORPHA:364', 'Glycogen storage disease due to glucose-6-phosphatase deficiency', 1),
(11945, 'ORPHA:364', 'Glycogen storage disease type 1', 1),
(11946, 'ORPHA:364', 'Glycogen storage disease type I', 1),
(11947, 'ORPHA:364', 'Glycogenosis type 1', 1),
(11948, 'ORPHA:364', 'Glycogenosis type I', 1),
(11949, 'ORPHA:364', 'Hepatorenal glycogenosis', 1),
(11950, 'ORPHA:364', 'Von Gierke disease', 1),
(11951, 'ORPHA:364013', 'IHF', 2),
(11952, 'ORPHA:364013', 'Immune HF', 2),
(11953, 'ORPHA:364013', 'Immune fetal edema', 2),
(11954, 'ORPHA:364013', 'Immune fetal hydrops', 2),
(11955, 'ORPHA:364013', 'Immune hydrops fetalis', 2),
(11956, 'ORPHA:364028', 'X-linked intellectual disability due to GRIA3 mutations', 1),
(11957, 'ORPHA:364033', 'Systemic EBV+ T-cell LPD of childhood', 1),
(11958, 'ORPHA:364033', 'Systemic EBV-positive T-cell lymphoproliferative disease of childhood', 1),
(11959, 'ORPHA:364033', 'Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood', 1),
(11960, 'ORPHA:364039', 'Angiocentric cutaneous T-cell lymphoma of childhood', 1),
(11961, 'ORPHA:364039', 'HVLL', 1),
(11962, 'ORPHA:364039', 'Hydroa vacciniforme-like lymphoma', 1),
(11963, 'ORPHA:364039', 'Hydroa-like cutaneous T-cell lymphoma', 1),
(11964, 'ORPHA:364043', 'ALK+ LBCL', 1),
(11965, 'ORPHA:364043', 'ALK+ large B-cell lymphoma', 1),
(11966, 'ORPHA:364043', 'ALK-positive large B-cell lymphoma', 1),
(11967, 'ORPHA:364055', 'EOSRD', 1),
(11968, 'ORPHA:364055', 'Early-onset severe retinal dystrophy', 1),
(11969, 'ORPHA:364055', 'SECORD', 1),
(11970, 'ORPHA:364055', 'Severe early-childhood-onset retinal dystrophy', 1),
(11971, 'ORPHA:364063', 'Infantile epileptic-dyskinetic encephalopathy', 1),
(11972, 'ORPHA:36412', 'Anti-C1q vasculitis', 1),
(11973, 'ORPHA:36412', 'Hypocomplementemic urticarial vasculitis', 1),
(11974, 'ORPHA:36412', 'Mac Duffie hypocomplementemic urticarial vasculitis', 1),
(11975, 'ORPHA:36412', 'Mac Duffie syndrome', 1),
(11976, 'ORPHA:36412', 'McDuffie hypocomplementemic urticarial vasculitis', 1),
(11977, 'ORPHA:36412', 'McDuffie syndrome', 1),
(11978, 'ORPHA:364198', 'Bipartite talus', 1),
(11979, 'ORPHA:36426', 'Dermatostomatitis, Stevens Johnson type', 2),
(11980, 'ORPHA:36426', 'Stevens-Johnson syndrome', 2),
(11981, 'ORPHA:364526', 'Primary bone dysplasia', 3),
(11982, 'ORPHA:364526', 'Primary osteodysplasia', 3),
(11983, 'ORPHA:364526', 'Primary skeletal dysplasia', 3),
(11984, 'ORPHA:364531', 'Primary bone dysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments', 3),
(11985, 'ORPHA:364531', 'Primary osteodysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments', 3),
(11986, 'ORPHA:364531', 'Primary skeletal dysplasia with progressive ossification of skin, skeletal muscle, fascia, tendons and ligaments', 3),
(11987, 'ORPHA:364536', 'Primary bone dysplasia with micromelia', 3),
(11988, 'ORPHA:364536', 'Primary osteodysplasia with micromelia', 3),
(11989, 'ORPHA:364536', 'Primary skeletal dysplasia with micromelia', 3),
(11990, 'ORPHA:364541', 'OPD spectrum disorder', 3),
(11991, 'ORPHA:364541', 'OPSD', 3),
(11992, 'ORPHA:364541', 'Otopalatodigital syndrome spectrum disorder', 3),
(11993, 'ORPHA:364559', 'Dysostosis', 3),
(11994, 'ORPHA:364568', 'Dysostosis with limb anomaly as a major feature', 3),
(11995, 'ORPHA:364571', 'Dysostosis with limb and face anomalies as a major feature', 3),
(11996, 'ORPHA:364574', 'Acrofacial dysostosis', 3),
(11997, 'ORPHA:364577', 'Intellectual disability-brachydactyly-Pierre Robin syndrome', 1),
(11998, 'ORPHA:364803', 'Rare bone disease related to a common gene or pathway defect', 3),
(11999, 'ORPHA:364817', 'Aggrecan-related bone disorder', 3),
(12000, 'ORPHA:364820', 'TRPV4-related bone disorder', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(12001, 'ORPHA:365', 'Alpha-1,4-glucosidase acid deficiency', 1),
(12002, 'ORPHA:365', 'GSD due to acid maltase deficiency', 1),
(12003, 'ORPHA:365', 'GSD type 2', 1),
(12004, 'ORPHA:365', 'GSD type II', 1),
(12005, 'ORPHA:365', 'Glycogen storage disease due to acid maltase deficiency', 1),
(12006, 'ORPHA:365', 'Glycogen storage disease type 2', 1),
(12007, 'ORPHA:365', 'Glycogen storage disease type II', 1),
(12008, 'ORPHA:365', 'Glycogenosis due to acid maltase deficiency', 1),
(12009, 'ORPHA:365', 'Glycogenosis type 2', 1),
(12010, 'ORPHA:365', 'Glycogenosis type II', 1),
(12011, 'ORPHA:365', 'Pompe disease', 1),
(12012, 'ORPHA:365563', 'Primary short bowel syndrome', 3),
(12013, 'ORPHA:366', 'Amylo-1,6-glucosidase deficiency', 1),
(12014, 'ORPHA:366', 'Cori disease', 1),
(12015, 'ORPHA:366', 'Cori-Forbes disease', 1),
(12016, 'ORPHA:366', 'Forbes disease', 1),
(12017, 'ORPHA:366', 'GDE deficiency', 1),
(12018, 'ORPHA:366', 'GSD due to glycogen debranching enzyme deficiency', 1),
(12019, 'ORPHA:366', 'GSD type 3', 1),
(12020, 'ORPHA:366', 'GSDIII', 1),
(12021, 'ORPHA:366', 'Glycogen storage disease due to glycogen debranching enzyme deficiency', 1),
(12022, 'ORPHA:366', 'Glycogen storage disease type 3', 1),
(12023, 'ORPHA:366', 'Glycogen storage disease type III', 1),
(12024, 'ORPHA:366', 'Glycogenosis due to glycogen debranching enzyme deficiency', 1),
(12025, 'ORPHA:366', 'Glycogenosis type 3', 1),
(12026, 'ORPHA:366', 'Glycogenosis type III', 1),
(12027, 'ORPHA:366', 'Limit dextrinosis', 1),
(12028, 'ORPHA:367', 'Amylopectinosis', 1),
(12029, 'ORPHA:367', 'Andersen disease', 1),
(12030, 'ORPHA:367', 'GSD due to glycogen branching enzyme deficiency', 1),
(12031, 'ORPHA:367', 'GSD type 4', 1),
(12032, 'ORPHA:367', 'GSD type IV', 1),
(12033, 'ORPHA:367', 'Glycogen storage disease due to glycogen branching enzyme deficiency', 1),
(12034, 'ORPHA:367', 'Glycogen storage disease type 4', 1),
(12035, 'ORPHA:367', 'Glycogen storage disease type IV', 1),
(12036, 'ORPHA:367', 'Glycogenosis due to glycogen branching enzyme deficiency', 1),
(12037, 'ORPHA:367', 'Glycogenosis type 4', 1),
(12038, 'ORPHA:367', 'Glycogenosis type IV', 1),
(12039, 'ORPHA:368', 'GSD due to muscle glycogen phosphorylase deficiency', 1),
(12040, 'ORPHA:368', 'GSD type 5', 1),
(12041, 'ORPHA:368', 'GSD type V', 1),
(12042, 'ORPHA:368', 'Glycogen storage disease due to muscle glycogen phosphorylase deficiency', 1),
(12043, 'ORPHA:368', 'Glycogen storage disease type 5', 1),
(12044, 'ORPHA:368', 'Glycogen storage disease type V', 1),
(12045, 'ORPHA:368', 'Glycogenosis due to muscle glycogen phosphorylase deficiency', 1),
(12046, 'ORPHA:368', 'Glycogenosis type 5', 1),
(12047, 'ORPHA:368', 'Glycogenosis type V', 1),
(12048, 'ORPHA:368', 'McArdle disease', 1),
(12049, 'ORPHA:368', 'Myophosphorylase deficiency', 1),
(12050, 'ORPHA:36899', 'Alcohol-responsive dystonia', 1),
(12051, 'ORPHA:36899', 'Hereditary essential myoclonus', 1),
(12052, 'ORPHA:36899', 'Myoclonic dystonia', 1),
(12053, 'ORPHA:36899', 'Myoclonus-dystonia syndrome', 1),
(12054, 'ORPHA:369', 'GSD due to liver glycogen phosphorylase deficiency', 1),
(12055, 'ORPHA:369', 'GSD type 6', 1),
(12056, 'ORPHA:369', 'GSD type VI', 1),
(12057, 'ORPHA:369', 'Glycogen storage disease due to liver glycogen phosphorylase deficiency', 1),
(12058, 'ORPHA:369', 'Glycogen storage disease type 6', 1),
(12059, 'ORPHA:369', 'Glycogen storage disease type VI', 1),
(12060, 'ORPHA:369', 'Glycogenosis due to liver glycogen phosphorylase deficiency', 1),
(12061, 'ORPHA:369', 'Glycogenosis type 6', 1),
(12062, 'ORPHA:369', 'Glycogenosis type VI', 1),
(12063, 'ORPHA:369', 'Hepatic glycogen phosphorylase deficiency', 1),
(12064, 'ORPHA:369', 'Hepatic phosphorylase deficiency', 1),
(12065, 'ORPHA:369', 'Hers disease', 1),
(12066, 'ORPHA:369', 'Liver glycogen phosphorylase deficiency', 1),
(12067, 'ORPHA:36913', 'Autoimmune hypoparathyroidism', 1),
(12068, 'ORPHA:369837', 'Congenital disorder of glycosylation due to PIGT deficiency', 1),
(12069, 'ORPHA:369837', 'Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome', 1),
(12070, 'ORPHA:369837', 'MCAHS type 3', 1),
(12071, 'ORPHA:369837', 'Multiple congenital anomalies-hypotonia-seizures syndrome type 3', 1),
(12072, 'ORPHA:369837', 'PIGT-CDG', 1),
(12073, 'ORPHA:369840', 'Autosomal recessive limb-girdle muscular dystrophy type 2S', 1),
(12074, 'ORPHA:369840', 'LGMD type 2S', 1),
(12075, 'ORPHA:369840', 'LGMD2S', 1),
(12076, 'ORPHA:369840', 'Limb-girdle muscular dystrophy type 2S', 1),
(12077, 'ORPHA:369840', 'TRAPPC11-related  limb-girdle muscular dystrophy R18', 1),
(12078, 'ORPHA:369840', 'TRAPPC11-related LGMD R18', 1),
(12079, 'ORPHA:369847', 'Intellectual disability-hyperkinetic movement-truncal ataxia syndrome', 1),
(12080, 'ORPHA:369852', 'Congenital neutropenia-bone marrow fibrosis-nephromegaly syndrome', 1),
(12081, 'ORPHA:369852', 'Congenital neutropenia-myelofibrosis-nephromegaly syndrome', 1),
(12082, 'ORPHA:369852', 'VPS45 deficiency', 1),
(12083, 'ORPHA:369861', 'Congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome', 1),
(12084, 'ORPHA:369861', 'SIFD syndrome', 1),
(12085, 'ORPHA:369867', 'Autosomal recessive intermediate Charcot-Marie-Tooth disease type C', 1),
(12086, 'ORPHA:369867', 'RI-CMT type C', 1),
(12087, 'ORPHA:369873', 'Obesity due to SIM1 deficiency', 2),
(12088, 'ORPHA:369881', '2p21 microdeletion syndrome without cystinuria', 1),
(12089, 'ORPHA:369881', 'Del(2)(p21) without cystinuria', 1),
(12090, 'ORPHA:369886', '2p21 contiguous gene deletion syndrome', 3),
(12091, 'ORPHA:369886', 'Homozygous 2p21 microdeletion syndrome', 3),
(12092, 'ORPHA:369891', 'Developmental delay-facial dysmorphism syndrome due to MED13L deficiency', 1),
(12093, 'ORPHA:369891', 'MED13L-related intellectual disability syndrome', 1),
(12094, 'ORPHA:369897', 'Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies', 1),
(12095, 'ORPHA:369897', 'mtDNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies', 1),
(12096, 'ORPHA:369913', 'COXPD17', 1),
(12097, 'ORPHA:369913', 'Combined oxidative phosphorylation defect type 17', 1),
(12098, 'ORPHA:369920', 'PCH9', 1),
(12099, 'ORPHA:369920', 'Pontocerebellar hypoplasia type 9', 1),
(12100, 'ORPHA:369929', 'Primary hyperaldosteronism-seizures-neurological abnormalities syndrome', 1),
(12101, 'ORPHA:369939', 'Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome', 1),
(12102, 'ORPHA:369939', 'Severe motor and intellectual disabilities-sensorineural hearing loss-dystonia syndrome', 1),
(12103, 'ORPHA:369942', 'CADDS', 1),
(12104, 'ORPHA:369942', 'Contiguous ABCD1 DXS1357E deletion syndrome', 1),
(12105, 'ORPHA:369942', 'Zellweger-like contiguous gene deletion syndrome', 1),
(12106, 'ORPHA:369950', 'Der(8)t(8;12)', 1),
(12107, 'ORPHA:369950', 'Intellectual disability-seizures-macrocephaly-obesity syndrome', 1),
(12108, 'ORPHA:369955', 'CblJ defects', 2),
(12109, 'ORPHA:369955', 'Cobalamin J defect', 2),
(12110, 'ORPHA:369955', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblJ', 2),
(12111, 'ORPHA:369955', 'Methylmalonic acidemia with homocystinuria, type cblJ', 2),
(12112, 'ORPHA:369955', 'Methylmalonic aciduria with homocystinuria, type cblJ', 2),
(12113, 'ORPHA:369962', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblX', 2),
(12114, 'ORPHA:369962', 'Methylmalonic acidemia with homocystinuria, type cblX', 2),
(12115, 'ORPHA:369962', 'Methylmalonic aciduria with homocystinuria, type cblX', 2),
(12116, 'ORPHA:369970', 'MMCAT syndrome', 1),
(12117, 'ORPHA:369970', 'Microcornea-myopic chorioretinal atrophy-telecanthus syndrome', 1),
(12118, 'ORPHA:369979', 'Finger hyperphalangy-toe anomalies-severe pectus excavatum syndrome', 1),
(12119, 'ORPHA:369992', 'Congenital erythroderma-hypotrichosis-recurrent infections-multiple food allergies syndrome', 1),
(12120, 'ORPHA:369992', 'SAM syndrome', 1),
(12121, 'ORPHA:369992', 'Severe dermatitis-multiple allergies-metabolic wasting syndrome', 1),
(12122, 'ORPHA:369999', 'Diffuse palmoplantar keratoderma with painful fissures', 1),
(12123, 'ORPHA:37', 'AEZ', 1),
(12124, 'ORPHA:37', 'Acrodermatitis enteropathica', 1),
(12125, 'ORPHA:37', 'Acrodermatitis enteropathica, zinc deficiency type', 1),
(12126, 'ORPHA:37', 'Inherited zinc deficiency', 1),
(12127, 'ORPHA:370', 'GSD due to phosphorylase kinase deficiency', 3),
(12128, 'ORPHA:370', 'GSD type 9', 3),
(12129, 'ORPHA:370', 'GSD type IX', 3),
(12130, 'ORPHA:370', 'Glycogen storage disease due to PhK deficiency', 3),
(12131, 'ORPHA:370', 'Glycogen storage disease due to phosphorylase kinase deficiency', 3),
(12132, 'ORPHA:370', 'Glycogen storage disease type 9', 3),
(12133, 'ORPHA:370', 'Glycogen storage disease type IX', 3),
(12134, 'ORPHA:370', 'Glycogenosis due to phosphorylase kinase deficiency', 3),
(12135, 'ORPHA:370', 'Glycogenosis type 9', 3),
(12136, 'ORPHA:370', 'Glycogenosis type IX', 3),
(12137, 'ORPHA:370', 'Gycogenosis due to PhK deficiency', 3),
(12138, 'ORPHA:370002', 'Focal palmoplantar keratoderma with joint keratoses', 1),
(12139, 'ORPHA:370010', 'Intellectual disability-facial dysmorphism-hand anomalies syndrome', 1),
(12140, 'ORPHA:370015', 'Spondyloepimetaphyseal dysplasia, Isidor type', 1),
(12141, 'ORPHA:370019', 'Spondylometaphyseal dysplasia, Czarny-Ratajczak type', 1),
(12142, 'ORPHA:370022', 'Ataxia-intellectual disability-oculomotor apraxia-cerebellar cysts syndrome', 1),
(12143, 'ORPHA:370022', 'Poretti-Boltshauser syndrome', 1),
(12144, 'ORPHA:370026', 'AML with t(8;16)(p11;p13) translocation', 1),
(12145, 'ORPHA:370026', 'Acute myeloid leukemia with t(8;16)(p11;p13) translocation', 1),
(12146, 'ORPHA:370034', 'Familial syringomyelia', 2),
(12147, 'ORPHA:370039', 'Angora hair nevus', 1),
(12148, 'ORPHA:370039', 'Schauder syndrome', 1),
(12149, 'ORPHA:370046', 'Aplasia cutis congenita-nevus sebaceus syndrome', 1),
(12150, 'ORPHA:370046', 'Didymosis aplasticosebacea', 1),
(12151, 'ORPHA:370052', 'SCALP syndrome', 1),
(12152, 'ORPHA:370052', 'Sebaceous nevus-CNS malformations-aplasia cutis congenital-limbal dermoid-pigmented nevus syndrome', 1),
(12153, 'ORPHA:370052', 'Sebaceous nevus-central nervous system malformations-aplasia cutis congenital-limbal dermoid-pigmented nevus syndrome', 1),
(12154, 'ORPHA:370059', 'NEVADA syndrome', 1),
(12155, 'ORPHA:370059', 'Nevus epidermicus verrucosus with angiodysplasia and aneurysms', 1),
(12156, 'ORPHA:370068', 'FACS', 3),
(12157, 'ORPHA:370068', 'Fetal AEDS', 3),
(12158, 'ORPHA:370068', 'Fetal anticonvulsant syndrome', 3),
(12159, 'ORPHA:370068', 'Fetal antiepileptic drug syndrome', 3),
(12160, 'ORPHA:370076', 'Fetal carbamazepine syndrome', 1),
(12161, 'ORPHA:370079', 'Proximal 16p11.2 microduplication syndrome', 1),
(12162, 'ORPHA:370079', 'Proximal dup(16)(p11.2)', 1),
(12163, 'ORPHA:370079', 'Proximal trisomy 16p11.2', 1),
(12164, 'ORPHA:370088', 'Acute infantile liver failure-multisystemic involvement syndrome', 1),
(12165, 'ORPHA:370091', 'OCA5', 1),
(12166, 'ORPHA:370091', 'Oculocutaneous albinism type 5', 1),
(12167, 'ORPHA:370097', 'OCA6', 1),
(12168, 'ORPHA:370097', 'Oculocutaneous albinism type 6', 1),
(12169, 'ORPHA:370103', 'Primary dystonia, DYT17 type', 1),
(12170, 'ORPHA:370106', 'Rare disorder with dystonia and other neurologic or systemic manifestation', 3),
(12171, 'ORPHA:370109', 'Ataxia-telangiectasia variant', 1),
(12172, 'ORPHA:370109', 'v-AT', 1),
(12173, 'ORPHA:370127', 'Medich giant platelet syndrome', 1),
(12174, 'ORPHA:370127', 'Medich macrothrombocytopenia', 1),
(12175, 'ORPHA:370131', 'White platelet syndrome', 1),
(12176, 'ORPHA:370334', 'EOE', 1),
(12177, 'ORPHA:370334', 'Extraosseous Ewing sarcoma', 1),
(12178, 'ORPHA:370334', 'Extraosseous Ewing tumor', 1),
(12179, 'ORPHA:370334', 'Extraskeletal Ewing sarcoma', 1),
(12180, 'ORPHA:370334', 'Extraskeletal Ewing tumor', 1),
(12181, 'ORPHA:370348', 'PPNET', 1),
(12182, 'ORPHA:370348', 'Peripheral PNET', 1),
(12183, 'ORPHA:370348', 'Peripheral neuroepithelioma', 1),
(12184, 'ORPHA:370348', 'Peripheral primitive neuroectodermal tumor', 1),
(12185, 'ORPHA:370396', 'SCCO', 1),
(12186, 'ORPHA:370396', 'Small cell carcinoma of the ovary', 1),
(12187, 'ORPHA:370396', 'Small cell ovarian carcinoma', 1),
(12188, 'ORPHA:37042', 'Autoimmune enteropathy type 1', 1),
(12189, 'ORPHA:37042', 'IPEX', 1),
(12190, 'ORPHA:37042', 'Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome', 1),
(12191, 'ORPHA:370921', 'CDG syndrome type Iw', 1),
(12192, 'ORPHA:370921', 'CDG-Iw', 1),
(12193, 'ORPHA:370921', 'CDG1W', 1),
(12194, 'ORPHA:370921', 'Congenital disorder of glycosylation type 1w', 1),
(12195, 'ORPHA:370921', 'Congenital disorder of glycosylation type Iw', 1),
(12196, 'ORPHA:370921', 'STT3A-CDG', 1),
(12197, 'ORPHA:370924', 'CDG syndrome type Ix', 1),
(12198, 'ORPHA:370924', 'CDG-Ix', 1),
(12199, 'ORPHA:370924', 'CDG1X', 1),
(12200, 'ORPHA:370924', 'Carbohydrate deficient glycoprotein syndrome type Ix', 1),
(12201, 'ORPHA:370924', 'Congenital disorder of glycosylation type 1x', 1),
(12202, 'ORPHA:370924', 'Congenital disorder of glycosylation type Ix', 1),
(12203, 'ORPHA:370924', 'STT3B-CDG', 1),
(12204, 'ORPHA:370927', 'CDG syndrome type Iy', 1),
(12205, 'ORPHA:370927', 'CDG-Iy', 1),
(12206, 'ORPHA:370927', 'CDG1Y', 1),
(12207, 'ORPHA:370927', 'Carbohydrate deficient glycoprotein syndrome type Iy', 1),
(12208, 'ORPHA:370927', 'Congenital disorder of glycosylation type 1y', 1),
(12209, 'ORPHA:370927', 'Congenital disorder of glycosylation type Iy', 1),
(12210, 'ORPHA:370927', 'SSR4-CDG', 1),
(12211, 'ORPHA:370930', 'XYLT1-CDG', 1),
(12212, 'ORPHA:370933', 'GM3 synthase deficiency', 1),
(12213, 'ORPHA:370933', 'ST3GAL5-CDG', 1),
(12214, 'ORPHA:370943', 'Autism spectrum disorder-epilepsy-arthrogryposis syndrome', 1),
(12215, 'ORPHA:370943', 'SLC35A3-CDG', 1),
(12216, 'ORPHA:370953', 'CMD due to dystroglycanopathy', 3),
(12217, 'ORPHA:370953', 'Congenital muscular dystrophy due to dystroglycanopathy', 3),
(12218, 'ORPHA:370959', 'CMD with cerebellar involvement', 1),
(12219, 'ORPHA:370959', 'CMD-CRB', 1),
(12220, 'ORPHA:370959', 'Congenital muscular dystrophy with cerebellar involvement', 1),
(12221, 'ORPHA:370968', 'CMD with intellectual disability', 1),
(12222, 'ORPHA:370968', 'CMD-MR', 1),
(12223, 'ORPHA:370968', 'Congenital muscular dystrophy with intellectual disability', 1),
(12224, 'ORPHA:370980', 'CMD without intellectual disability', 1),
(12225, 'ORPHA:370980', 'CMD-no MR', 1),
(12226, 'ORPHA:370980', 'Congenital muscular dystrophy without intellectual disability', 1),
(12227, 'ORPHA:370980', 'Congenital muscular dystrophy-dystroglycanopathy without intellectual disability', 1),
(12228, 'ORPHA:370997', 'MEB disease with bilateral multicystic leucodystrophy', 1),
(12229, 'ORPHA:370997', 'Muscle-eye-brain disease with bilateral multicystic leucodystrophy', 1),
(12230, 'ORPHA:371', 'GSD due to muscle phosphofructokinase deficiency', 1),
(12231, 'ORPHA:371', 'GSD type 7', 1),
(12232, 'ORPHA:371', 'GSD type VII', 1),
(12233, 'ORPHA:371', 'Glycogen storage disease due to muscle phosphofructokinase deficiency', 1),
(12234, 'ORPHA:371', 'Glycogen storage disease type 7', 1),
(12235, 'ORPHA:371', 'Glycogen storage disease type VII', 1),
(12236, 'ORPHA:371', 'Glycogenosis due to muscle phosphofructokinase deficiency', 1),
(12237, 'ORPHA:371', 'Glycogenosis type 7', 1),
(12238, 'ORPHA:371', 'Glycogenosis type VII', 1),
(12239, 'ORPHA:371', 'Tarui disease', 1),
(12240, 'ORPHA:371007', 'CMDH', 1),
(12241, 'ORPHA:371007', 'Congenital muscular dystrophy with hyperlaxity', 1),
(12242, 'ORPHA:371024', 'Alpha-dystroglycanopathy', 3),
(12243, 'ORPHA:371024', 'Dystroglycanopathy', 3),
(12244, 'ORPHA:371024', 'Qualitative or quantitative defects of alpha-dystroglycan', 3),
(12245, 'ORPHA:371040', 'Primary alpha-dystroglycanopathy', 3),
(12246, 'ORPHA:371040', 'Primary dystroglycanopathy', 3),
(12247, 'ORPHA:371040', 'Primary qualitative or quantitative defects of alpha-dystroglycan', 3),
(12248, 'ORPHA:371047', 'CDG with neurological involvement', 3),
(12249, 'ORPHA:371047', 'Congenital disorder of glycosylation with neurological involvement', 3),
(12250, 'ORPHA:371054', 'X-linked CDG with intellectual disability as a major feature', 3),
(12251, 'ORPHA:371054', 'X-linked congenital disorder of glycosylation with intellectual disability as a major feature', 3),
(12252, 'ORPHA:371064', 'Non-X-linked CDG with intellectual disability as a major feature', 3),
(12253, 'ORPHA:371064', 'Non-X-linked congenital disorder of glycosylation with intellectual disability as a major feature', 3),
(12254, 'ORPHA:371071', 'CDG with epilepsy as a major feature', 3),
(12255, 'ORPHA:371071', 'Congenital disorder of glycosylation with epilepsy as a major feature', 3),
(12256, 'ORPHA:371157', 'CDG with hepatic involvement', 3),
(12257, 'ORPHA:371157', 'Congenital disorder of glycosylation with hepatic involvement', 3),
(12258, 'ORPHA:371176', 'CDG with dilated cardiomyopathy', 3),
(12259, 'ORPHA:371176', 'Congenital disorder of glycosylation with dilated cardiomyopathy', 3),
(12260, 'ORPHA:371183', 'CDG with cardiac malformation as a major feature', 3),
(12261, 'ORPHA:371183', 'Congenital disorder of glycosylation with cardiac malformation as a major feature', 3),
(12262, 'ORPHA:371188', 'CDG with intestinal involvement', 3),
(12263, 'ORPHA:371188', 'Congenital disorder of glycosylation with intestinal involvement', 3),
(12264, 'ORPHA:371195', 'CDG-related bone disorder', 3),
(12265, 'ORPHA:371195', 'Congenital disorder of glycosylation-related bone disorder', 3),
(12266, 'ORPHA:371200', 'CDG with skin involvement', 3),
(12267, 'ORPHA:371200', 'Congenital disorder of glycosylation with skin involvement', 3),
(12268, 'ORPHA:371207', 'CDG with nephropathy as a major feature', 3),
(12269, 'ORPHA:371207', 'Congenital disorder of glycosylation with nephropathy as a major feature', 3),
(12270, 'ORPHA:371212', 'CDG with deafness as a major feature', 3),
(12271, 'ORPHA:371212', 'CDG with hearing loss as a major feature', 3),
(12272, 'ORPHA:371212', 'Congenital disorder of glycosylation with deafness as a major feature', 3),
(12273, 'ORPHA:371212', 'Congenital disorder of glycosylation with hearing loss as a major feature', 3),
(12274, 'ORPHA:371235', 'CDG with developmental anomaly', 3),
(12275, 'ORPHA:371235', 'Congenital disorder of glycosylation with developmental anomaly', 3),
(12276, 'ORPHA:371364', 'Hypotonia-speech impairment-severe cognitive delay syndrome', 1),
(12277, 'ORPHA:371364', 'IHPRF syndrome', 1),
(12278, 'ORPHA:371364', 'Infantile hypotonia-psychomotor retardation-characteristic facies syndrome', 1),
(12279, 'ORPHA:371428', 'MONA spectrum', 1),
(12280, 'ORPHA:371428', 'Multicentric osteolysis-nodulosis-arthropathy spectrum', 1),
(12281, 'ORPHA:371428', 'NAO syndrome', 1),
(12282, 'ORPHA:371428', 'Nodulosis-arthropathy-osteolysis syndrome', 1),
(12283, 'ORPHA:371428', 'Torg-Winchester syndrome', 1),
(12284, 'ORPHA:371433', 'Genetic periodic paralysis', 3),
(12285, 'ORPHA:371436', 'Genetic neurovascular malformation', 3),
(12286, 'ORPHA:371442', 'Sphingolipidosis with epilepsy', 3),
(12287, 'ORPHA:371445', 'Genetic syndromic esophageal malformation', 3),
(12288, 'ORPHA:371861', 'Genetic hyperaldosteronism', 3),
(12289, 'ORPHA:37202', 'Bladder pain syndrome', 1),
(12290, 'ORPHA:37202', 'IC/BPS', 1),
(12291, 'ORPHA:37202', 'IC/PBS', 1),
(12292, 'ORPHA:37202', 'Interstitial cystitis', 1),
(12293, 'ORPHA:37202', 'Interstitial cystitis/bladder pain syndrome', 1),
(12294, 'ORPHA:37202', 'Interstitial cystitis/painful bladder syndrome', 1),
(12295, 'ORPHA:37202', 'Painful bladder syndrome', 1),
(12296, 'ORPHA:373', 'DGSX', 1),
(12297, 'ORPHA:373', 'Golabi-Rosen syndrome', 1),
(12298, 'ORPHA:373', 'SDYS', 1),
(12299, 'ORPHA:373', 'SGBS', 1),
(12300, 'ORPHA:373', 'SGBS1', 1),
(12301, 'ORPHA:373', 'Simpson dysmorphia syndrome', 1),
(12302, 'ORPHA:373', 'Simpson-Golabi-Behmel syndrome', 1),
(12303, 'ORPHA:373', 'Simpson-Golabi-Behmel syndrome type 1', 1),
(12304, 'ORPHA:373', 'X-linked dysplasia gigantism syndrome', 1),
(12305, 'ORPHA:375', 'Anti-GBM syndrome', 1),
(12306, 'ORPHA:375', 'Anti-glomerular basement membrane disease', 1),
(12307, 'ORPHA:375', 'Goodpasture syndrome', 1),
(12308, 'ORPHA:37553', 'Andersen syndrome', 1),
(12309, 'ORPHA:37553', 'Andersen-Tawil syndrome', 1),
(12310, 'ORPHA:37553', 'LQT7', 1),
(12311, 'ORPHA:37553', 'Long QT syndrome type 7', 1),
(12312, 'ORPHA:37559', 'Acquired kinky hair syndrome', 1),
(12313, 'ORPHA:376', 'Camptodactyly-cleft palate-clubfoot syndrome', 1),
(12314, 'ORPHA:376', 'Distal arthrogryposis type 3', 1),
(12315, 'ORPHA:376', 'Distal arthrogryposis type IIA', 1),
(12316, 'ORPHA:376', 'Gordon syndrome', 1),
(12317, 'ORPHA:37612', 'Episodic ataxia type 1', 1),
(12318, 'ORPHA:37612', 'Episodic ataxia with myokymia', 1),
(12319, 'ORPHA:376724', 'Generalized isolated dystonia', 3),
(12320, 'ORPHA:377', 'Basal cell nevus syndrome', 1),
(12321, 'ORPHA:377', 'Gorlin syndrome', 1),
(12322, 'ORPHA:377', 'Gorlin-Goltz syndrome', 1),
(12323, 'ORPHA:377', 'NBCCS', 1),
(12324, 'ORPHA:377', 'Nevoid basal cell carcinoma syndrome', 1),
(12325, 'ORPHA:37748', 'Chronic urticaria with gammopathy', 1),
(12326, 'ORPHA:37748', 'Chronic urticaria with macroglobulinemia', 1),
(12327, 'ORPHA:37748', 'Schnitzler syndrome', 1),
(12328, 'ORPHA:379', 'CGD', 1),
(12329, 'ORPHA:379', 'Chronic granulomatous disease', 1),
(12330, 'ORPHA:379', 'Chronic septic granulomatosis', 1),
(12331, 'ORPHA:38', 'AKE', 1),
(12332, 'ORPHA:38', 'Acrokeratoelastoidosis of Costa', 1),
(12333, 'ORPHA:38', 'PPKP3', 1),
(12334, 'ORPHA:38', 'Punctate palmoplantar hyperkeratosis type 3', 1),
(12335, 'ORPHA:38', 'Punctate palmoplantar keratoderma type 3', 1),
(12336, 'ORPHA:380', 'GCPS', 1),
(12337, 'ORPHA:380', 'Greig cephalopolysyndactyly syndrome', 1),
(12338, 'ORPHA:381', 'Chédiak-Higashi-like syndrome', 1),
(12339, 'ORPHA:381', 'Griscelli syndrome', 1),
(12340, 'ORPHA:381', 'Griscelli-Pruniéras syndrome', 1),
(12341, 'ORPHA:381', 'Partial albinism-immunodeficiency syndrome', 1),
(12342, 'ORPHA:382', 'GAMT deficiency', 1),
(12343, 'ORPHA:382', 'Guanidinoacetate methyltransferase deficiency', 1),
(12344, 'ORPHA:384', 'Huriez syndrome', 1),
(12345, 'ORPHA:384', 'Palmoplantar hyperkeratosis-sclerodactyly syndrome', 1),
(12346, 'ORPHA:384', 'Palmoplantar keratoderma-sclerodactyly syndrome', 1),
(12347, 'ORPHA:384', 'Scleroatrophic syndrome', 1),
(12348, 'ORPHA:384', 'Sclerotylosis', 1),
(12349, 'ORPHA:385', 'NBIA', 3),
(12350, 'ORPHA:385', 'Neurodegeneration with brain iron accumulation', 3),
(12351, 'ORPHA:386', 'Biliary hamartoma', 1),
(12352, 'ORPHA:386', 'Hepatic cystic hamartoma', 1),
(12353, 'ORPHA:386', 'MHL', 1),
(12354, 'ORPHA:386', 'Mesenchymal hamartoma of liver', 1),
(12355, 'ORPHA:386', 'VMC', 1),
(12356, 'ORPHA:386', 'Von Meyenburg complexes disease', 1),
(12357, 'ORPHA:388', 'Aganglionic megacolon', 1),
(12358, 'ORPHA:388', 'Congenital intestinal aganglionosis', 1),
(12359, 'ORPHA:388', 'HSCR', 1),
(12360, 'ORPHA:388', 'Hirschsprung disease', 1),
(12361, 'ORPHA:38874', 'Dihydropyrimidinase deficiency', 1),
(12362, 'ORPHA:38874', 'Dihydropyrimidinuria', 1),
(12363, 'ORPHA:389', 'Histiocytosis X', 1),
(12364, 'ORPHA:389', 'Langerhans cell granulomatosis', 1),
(12365, 'ORPHA:389', 'Langerhans cell histiocytosis', 1),
(12366, 'ORPHA:39', 'Acromelanosis', 1),
(12367, 'ORPHA:390', 'Darling disease', 1),
(12368, 'ORPHA:390', 'Histoplasmosis', 1),
(12369, 'ORPHA:39041', 'Combined immunodeficiency with hypereosinophilia', 1),
(12370, 'ORPHA:39041', 'Omenn syndrome', 1),
(12371, 'ORPHA:39044', 'Choroidal melanoma', 1),
(12372, 'ORPHA:39044', 'Iris melanoma', 1),
(12373, 'ORPHA:39044', 'Uveal melanoma', 1),
(12374, 'ORPHA:391', 'Classic Hodgkin disease', 1),
(12375, 'ORPHA:391', 'Classic Hodgkin lymphoma', 1),
(12376, 'ORPHA:391307', 'Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome', 1),
(12377, 'ORPHA:391311', 'Predisposition to severe viral infection due to STAT1 deficiency', 1),
(12378, 'ORPHA:391311', 'STAT1 deficiency', 1),
(12379, 'ORPHA:391311', 'Susceptibility to viral and mycobacterial infections due to STAT1 deficiency', 1),
(12380, 'ORPHA:391316', 'Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression', 1),
(12381, 'ORPHA:391320', 'East Texas bleeding disorder', 1),
(12382, 'ORPHA:391327', 'X-linked calvarial hyperostosis', 1),
(12383, 'ORPHA:391330', 'X-linked osteoporosis with fractures', 1),
(12384, 'ORPHA:391343', 'Fatal post-viral neurodegenerative disorder', 1),
(12385, 'ORPHA:391348', 'Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome', 1),
(12386, 'ORPHA:391351', 'CMT4K', 1),
(12387, 'ORPHA:391351', 'Charcot-Marie-Tooth disease type 4K', 1),
(12388, 'ORPHA:391351', 'SURF1-related CMT4', 1),
(12389, 'ORPHA:391351', 'SURF1-related Charcot-Marie-Tooth disease type 4', 1),
(12390, 'ORPHA:391351', 'SURF1-related severe demyelinating Charcot-Marie-Tooth disease', 1),
(12391, 'ORPHA:391366', 'Growth retardation-mild developmental delay-chronic hepatitis syndrome', 1),
(12392, 'ORPHA:391372', 'FOXP1 syndrome', 1),
(12393, 'ORPHA:391372', 'Intellectual disability-severe speech delay-mild dysmorphism syndrome', 1),
(12394, 'ORPHA:391376', 'Asparagine synthetase deficiency', 1),
(12395, 'ORPHA:391376', 'Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome', 1),
(12396, 'ORPHA:391381', 'Disorder of asparagine metabolism', 3),
(12397, 'ORPHA:391384', 'FEPS', 1),
(12398, 'ORPHA:391384', 'Familial episodic pain syndrome', 1),
(12399, 'ORPHA:391389', 'Familial episodic pain syndrome with predominantly upper body involvement', 2),
(12400, 'ORPHA:391392', 'Familial episodic pain syndrome with predominantly lower limb involvement', 2),
(12401, 'ORPHA:391397', 'CIP with hyperhidrosis and gastrointestinal dysfunction', 1),
(12402, 'ORPHA:391397', 'Congenital insensitivity to pain with hyperhidrosis and gastrointestinal dysfunction', 1),
(12403, 'ORPHA:391397', 'HSAN with hyperhidrosis and gastrointestinal dysfunction', 1),
(12404, 'ORPHA:391397', 'HSAN7', 1),
(12405, 'ORPHA:391397', 'Hereditary sensory and autonomic neuropathy type 7', 1),
(12406, 'ORPHA:391397', 'Hereditary sensory and autonomic neuropathy type VII', 1),
(12407, 'ORPHA:391397', 'Hereditary sensory and autonomic neuropathy with hyperhidrosis and gastrointestinal dysfunction', 1),
(12408, 'ORPHA:391408', 'Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome', 1),
(12409, 'ORPHA:391411', 'Atypical juvenile parkinsonism', 1),
(12410, 'ORPHA:391417', '2-methyl-3-hydroxybutyric aciduria', 1),
(12411, 'ORPHA:391417', '2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency', 1),
(12412, 'ORPHA:391417', 'HSD10 deficiency', 1),
(12413, 'ORPHA:391417', 'HSD10 disease', 1),
(12414, 'ORPHA:391417', 'MHBD deficiency', 1),
(12415, 'ORPHA:391428', '2-methyl-3-hydroxybutyric aciduria, classic type', 2),
(12416, 'ORPHA:391428', '2-methyl-3-hydroxybutyric aciduria, infantile type', 2),
(12417, 'ORPHA:391428', '2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, classic type', 2),
(12418, 'ORPHA:391428', '2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, infantile type', 2),
(12419, 'ORPHA:391428', 'HSD10 deficiency, classic type', 2),
(12420, 'ORPHA:391428', 'HSD10 deficiency, infantile type', 2),
(12421, 'ORPHA:391428', 'HSD10 disease, classic type', 2),
(12422, 'ORPHA:391428', 'HSD10 disease, infantile type', 2),
(12423, 'ORPHA:391428', 'MHBD deficiency, classic type', 2),
(12424, 'ORPHA:391428', 'MHBD deficiency, infantile type', 2),
(12425, 'ORPHA:391457', '2-methyl-3-hydroxybutyric aciduria, neonatal type', 2),
(12426, 'ORPHA:391457', '2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, neonatal type', 2),
(12427, 'ORPHA:391457', 'HSD10 deficiency, neonatal type', 2),
(12428, 'ORPHA:391457', 'HSD10 disease, neonatal type', 2),
(12429, 'ORPHA:391457', 'MHBD deficiency, neonatal type', 2),
(12430, 'ORPHA:391474', 'ALX3-related frontonasal dysplasia', 1),
(12431, 'ORPHA:391474', 'Frontonasal dysplasia type 1', 1),
(12432, 'ORPHA:391474', 'Frontorhiny', 1),
(12433, 'ORPHA:391474', 'Isolated median cleft face syndrome', 1),
(12434, 'ORPHA:391487', 'Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome', 1),
(12435, 'ORPHA:391490', 'Adult-onset acquired myasthenia', 2),
(12436, 'ORPHA:391490', 'Adult-onset autoimmune myasthenia gravis', 2),
(12437, 'ORPHA:391490', 'Adult-onset myasthenia gravis', 2),
(12438, 'ORPHA:391497', 'Childhood myasthenia gravis', 2),
(12439, 'ORPHA:391497', 'Juvenile acquired myasthenia', 2),
(12440, 'ORPHA:391497', 'Juvenile autoimmune myasthenia gravis', 2),
(12441, 'ORPHA:391497', 'Juvenile myasthenia gravis', 2),
(12442, 'ORPHA:391504', 'NMG', 2),
(12443, 'ORPHA:391504', 'Neonatal myasthenia gravis', 2),
(12444, 'ORPHA:391504', 'Transient neonatal acquired myasthenia', 2),
(12445, 'ORPHA:391504', 'Transient neonatal autoimmune myasthenia gravis', 2),
(12446, 'ORPHA:391504', 'Transient neonatal myasthenia gravis', 2),
(12447, 'ORPHA:391641', 'Brunner-Winter syndrome type 1', 2),
(12448, 'ORPHA:391641', 'Digital anomalies with short palpebral fissures and atresia of esophagus or duodenum type 1', 2),
(12449, 'ORPHA:391641', 'FGLDS1', 2),
(12450, 'ORPHA:391641', 'FS1', 2),
(12451, 'ORPHA:391641', 'Feingold syndrome type 1', 2),
(12452, 'ORPHA:391641', 'MMT type 1', 2),
(12453, 'ORPHA:391641', 'MODED syndrome type 1', 2),
(12454, 'ORPHA:391641', 'Microcephaly-digital anomalies-normal intelligence syndrome type 1', 2),
(12455, 'ORPHA:391641', 'Microcephaly-intellectual disability-tracheoesophageal fistula syndrome type 1', 2),
(12456, 'ORPHA:391641', 'Microcephaly-oculo-digito-esophageal-duodenal syndrome syndrome type 1', 2),
(12457, 'ORPHA:391641', 'ODED syndrome type 1', 2),
(12458, 'ORPHA:391641', 'Oculo-digito-esophageal-duodenal syndrome type 1', 2),
(12459, 'ORPHA:391646', 'Brachydactyly-short stature-microcephaly syndrome', 2),
(12460, 'ORPHA:391646', 'Brunner-Winter syndrome type 2', 2),
(12461, 'ORPHA:391646', 'FGLDS2', 2),
(12462, 'ORPHA:391646', 'FS2', 2),
(12463, 'ORPHA:391646', 'Feingold syndrome type 2', 2),
(12464, 'ORPHA:391646', 'MMT type 2', 2),
(12465, 'ORPHA:391646', 'Microcephaly-digital anomalies-normal intelligence syndrome type 2', 2),
(12466, 'ORPHA:391646', 'Microcephaly-intellectual disability-tracheoesophageal fistula syndrome type 2', 2),
(12467, 'ORPHA:391651', 'Glomus tumor', 1),
(12468, 'ORPHA:391655', 'Off-periods in Parkinson disease not responding to oral treatment', 1),
(12469, 'ORPHA:391665', 'HoFH', 1),
(12470, 'ORPHA:391665', 'Homozygous familial hypercholesterolemia', 1),
(12471, 'ORPHA:391673', 'Necrotizing enterocolitis', 1),
(12472, 'ORPHA:391677', 'SOPH syndrome', 1),
(12473, 'ORPHA:391677', 'Short stature-optic atrophy-Pelger-Huët anomaly syndrome', 1),
(12474, 'ORPHA:391711', 'Persistent combined dystonia', 3),
(12475, 'ORPHA:391723', 'Appendiceal mucinous adenocarcinoma', 1),
(12476, 'ORPHA:391723', 'Mucinous adenocarcinoma of the appendix', 1),
(12477, 'ORPHA:391799', 'Rare genetic dystonia', 3),
(12478, 'ORPHA:391799', 'Rare genetic dystonic disorder', 3),
(12479, 'ORPHA:392', 'Atriodigital dysplasia type 1', 1),
(12480, 'ORPHA:392', 'HOS', 1),
(12481, 'ORPHA:392', 'Heart-hand syndrome type 1', 1),
(12482, 'ORPHA:392', 'Holt-Oram syndrome', 1),
(12483, 'ORPHA:393', '46,XX testicular DSD', 1),
(12484, 'ORPHA:393', '46,XX testicular disorder of sex development', 1),
(12485, 'ORPHA:393', 'De la Chapelle syndrome', 1),
(12486, 'ORPHA:393', 'XX, male syndrome', 1),
(12487, 'ORPHA:394', 'Classic homocystinuria', 1),
(12488, 'ORPHA:394', 'Cystathionine beta-synthase deficiency', 1),
(12489, 'ORPHA:394', 'Homocystinuria due to cystathionine beta-synthase deficiency', 1),
(12490, 'ORPHA:394529', 'Glutaric aciduria type 2, severe neonatal type', 2),
(12491, 'ORPHA:394529', 'MAD deficiency, severe neonatal type', 2),
(12492, 'ORPHA:394529', 'MADD, severe neonatal type', 2),
(12493, 'ORPHA:394529', 'Multiple acyl-CoA dehydrogenase deficiency, severe neonatal type', 2),
(12494, 'ORPHA:394532', 'Glutaric aciduria type 2, mild type', 2),
(12495, 'ORPHA:394532', 'MAD deficiency, mild type', 2),
(12496, 'ORPHA:394532', 'MADD, mild type', 2),
(12497, 'ORPHA:394532', 'Multiple acyl-CoA dehydrogenase deficiency, mild type', 2),
(12498, 'ORPHA:395', 'Homocystinuria due to methylene tetrahydrofolate reductase deficiency', 1),
(12499, 'ORPHA:395', 'MTHFR deficiency', 1),
(12500, 'ORPHA:395', 'Methylene tetrahydrofolate reductase deficiency', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(12501, 'ORPHA:396', 'Chronic hiccup', 1),
(12502, 'ORPHA:397', 'Giant cell arteritis', 1),
(12503, 'ORPHA:397', 'Horton disease', 1),
(12504, 'ORPHA:397', 'Temporal arteritis', 1),
(12505, 'ORPHA:397587', 'Deep dermatophytosis', 1),
(12506, 'ORPHA:397587', 'Disseminated granulomatous dermatophytosis', 1),
(12507, 'ORPHA:397590', 'Silver-Russell syndrome due to a point mutation', 2),
(12508, 'ORPHA:397593', 'Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency', 1),
(12509, 'ORPHA:397596', 'APDS', 1),
(12510, 'ORPHA:397596', 'Activated PI3K-delta syndrome', 1),
(12511, 'ORPHA:397596', 'Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation', 1),
(12512, 'ORPHA:397606', 'Chronic diarrhea with HSAN', 1),
(12513, 'ORPHA:397606', 'Chronic diarrhea with hereditary sensory and autonomic neuropathy', 1),
(12514, 'ORPHA:397606', 'PrP systemic amyloidosis', 1),
(12515, 'ORPHA:397606', 'Prion protein systemic amyloidosis', 1),
(12516, 'ORPHA:397612', 'Macrocephaly-developmental delay syndrome', 1),
(12517, 'ORPHA:397615', 'Obesity due to CEP19 deficiency', 2),
(12518, 'ORPHA:397618', 'FHONDA syndrome', 1),
(12519, 'ORPHA:397618', 'Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome', 1),
(12520, 'ORPHA:397623', 'SAMS syndrome', 1),
(12521, 'ORPHA:397623', 'Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome', 1),
(12522, 'ORPHA:397685', 'Familial hyperprolactinemia', 1),
(12523, 'ORPHA:397685', 'Familial isolated prolactin receptor deficiency', 1),
(12524, 'ORPHA:397692', 'Hereditary isolated aplastic anemia', 1),
(12525, 'ORPHA:397695', '3q27.3 microdeletion syndrome', 1),
(12526, 'ORPHA:397695', 'Del(3)(q27.3)', 1),
(12527, 'ORPHA:397709', 'Autosomal recessive spinocerebellar ataxia type 20', 1),
(12528, 'ORPHA:397709', 'Intellectual disability-coarse face-macrocephaly-cerebellar hypoplasia syndrome', 1),
(12529, 'ORPHA:397709', 'Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome', 1),
(12530, 'ORPHA:397709', 'SCAR20', 1),
(12531, 'ORPHA:397715', 'JBTS with JATD', 1),
(12532, 'ORPHA:397715', 'Joubert syndrome with JATD', 1),
(12533, 'ORPHA:397715', 'Joubert syndrome with Jeune asphyxiating thoracic dystrophy', 1),
(12534, 'ORPHA:397725', 'COASY protein-associated neurodegeneration', 1),
(12535, 'ORPHA:397725', 'CoPAN', 1),
(12536, 'ORPHA:397725', 'NBIA6', 1),
(12537, 'ORPHA:397725', 'Neurodegeneration with brain iron accumulation due to COASY mutation', 1),
(12538, 'ORPHA:397735', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MARS mutation', 1),
(12539, 'ORPHA:397735', 'Autosomal dominant Charcot-Marie-Tooth disease type 2U', 1),
(12540, 'ORPHA:397735', 'CMT2U', 1),
(12541, 'ORPHA:397744', 'Peripheral neuropathy-myopathy-hoarseness-deafness syndrome', 1),
(12542, 'ORPHA:397744', 'Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome', 1),
(12543, 'ORPHA:397750', 'Periodic paralysis with later-onset distal motor neuropathy', 1),
(12544, 'ORPHA:397755', 'Periodic paralysis with transient compartment-like syndrome', 1),
(12545, 'ORPHA:397758', 'Retinal dystrophy with inner nuclear layer and ganglion cell anomalies', 1),
(12546, 'ORPHA:397758', 'Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies', 1),
(12547, 'ORPHA:397787', 'SCID due to IKK2 deficiency', 1),
(12548, 'ORPHA:397787', 'Severe combined immunodeficiency due to IKK2 deficiency', 1),
(12549, 'ORPHA:397802', 'T+ B+ severe combined immunodeficiency', 3),
(12550, 'ORPHA:397922', 'Cerebro-cutaneous syndrome with iron overload', 1),
(12551, 'ORPHA:397922', 'Ferro-cerebro-cutaneous syndrome', 1),
(12552, 'ORPHA:397927', 'Sacral agenesis-abnormal ossification of the vertebral bodies-persistent notochordal canal syndrome', 1),
(12553, 'ORPHA:397933', 'IQSEC2-related syndromic intellectual disability', 1),
(12554, 'ORPHA:397933', 'Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome', 1),
(12555, 'ORPHA:397937', 'PGBM1', 1),
(12556, 'ORPHA:397937', 'Polyglucosan body myopathy type 1', 1),
(12557, 'ORPHA:397941', 'Carbohydrate deficient glycoprotein syndrome type II due to MAN1B1 deficiency', 1),
(12558, 'ORPHA:397941', 'Congenital disorder of glycosylation type 2 due to MAN1B1 deficiency', 1),
(12559, 'ORPHA:397941', 'Congenital disorder of glycosylation type II due to MAN1B1 deficiency', 1),
(12560, 'ORPHA:397941', 'Intellectual disability-truncal obesity syndrome', 1),
(12561, 'ORPHA:397941', 'MAN1B1-CDG', 1),
(12562, 'ORPHA:397946', 'Autosomal spastic ataxia type 2', 1),
(12563, 'ORPHA:397946', 'Autosomal spastic paraplegia type 58', 1),
(12564, 'ORPHA:397946', 'SPAX2', 1),
(12565, 'ORPHA:397946', 'SPG58', 1),
(12566, 'ORPHA:397951', 'Microcephaly-thin corpus callosum-intellectual disability syndrome', 1),
(12567, 'ORPHA:397959', 'TCR-alpha-beta+ T-cell deficiency', 1),
(12568, 'ORPHA:397959', 'TCR-alpha-beta-positive T-cell deficiency', 1),
(12569, 'ORPHA:397964', 'Combined immunodeficiency due to MALT1 deficiency', 1),
(12570, 'ORPHA:397968', 'CMT2R', 1),
(12571, 'ORPHA:397968', 'Charcot-Marie-Tooth disease type 2R', 1),
(12572, 'ORPHA:397973', 'Intellectual disability-obesity-prognathism-eye and skin anomalies syndrome', 1),
(12573, 'ORPHA:397973', 'MOMES syndrome', 1),
(12574, 'ORPHA:398043', 'Cancer of penis', 3),
(12575, 'ORPHA:398043', 'Malignant penile tumor', 3),
(12576, 'ORPHA:398043', 'Malignant tumor of penis', 3),
(12577, 'ORPHA:398043', 'Penile cancer', 3),
(12578, 'ORPHA:398053', 'Adenocarcinoma of the penis', 1),
(12579, 'ORPHA:398053', 'Penile adenocarcinoma', 1),
(12580, 'ORPHA:398058', 'Penile squamous cell carcinoma', 1),
(12581, 'ORPHA:398058', 'Squamous cell carcinoma of the penis', 1),
(12582, 'ORPHA:398063', 'Refractory CD', 1),
(12583, 'ORPHA:398063', 'Refractory celiac disease', 1),
(12584, 'ORPHA:398063', 'Refractory sprue', 1),
(12585, 'ORPHA:398069', 'MAGEL2-related PWLS', 1),
(12586, 'ORPHA:398069', 'MAGEL2-related Prader-Willi-like syndrome', 1),
(12587, 'ORPHA:398069', 'Schaaf-Yang syndrome', 1),
(12588, 'ORPHA:398073', 'PWS-like', 3),
(12589, 'ORPHA:398073', 'Prader-Willi-like syndrome', 3),
(12590, 'ORPHA:398079', 'SIM1-related PWLS', 1),
(12591, 'ORPHA:398079', 'SIM1-related Prader-Willi-like syndrome', 1),
(12592, 'ORPHA:398088', 'Hereditary cryohydrocytosis with normal stomatin', 1),
(12593, 'ORPHA:398091', 'Secondary neonatal autoimmune disease', 3),
(12594, 'ORPHA:398091', 'Transplacentally acquired neonatal autoimmune disease', 3),
(12595, 'ORPHA:398097', 'Neonatal Hughes syndrome', 1),
(12596, 'ORPHA:398097', 'Neonatal antiphospholipid antibody syndrome', 1),
(12597, 'ORPHA:398097', 'Neonatal antiphospholipid syndrome', 1),
(12598, 'ORPHA:398109', 'Neonatal AHA', 1),
(12599, 'ORPHA:398109', 'Neonatal AIHA', 1),
(12600, 'ORPHA:398109', 'Neonatal autoimmune hemolytic anemia', 1),
(12601, 'ORPHA:398117', 'Neonatal DM', 1),
(12602, 'ORPHA:398117', 'Neonatal dermatomyositis', 1),
(12603, 'ORPHA:39812', 'GVH', 1),
(12604, 'ORPHA:39812', 'Graft versus host disease', 1),
(12605, 'ORPHA:398124', 'Neonatal lupus erythematosus', 1),
(12606, 'ORPHA:398127', 'Neonatal scleroderma', 1),
(12607, 'ORPHA:398147', 'AFP', 1),
(12608, 'ORPHA:398147', 'Atypical facial pain', 1),
(12609, 'ORPHA:398147', 'PIFP', 1),
(12610, 'ORPHA:398147', 'Persistent idiopathic facial pain', 1),
(12611, 'ORPHA:398156', 'OAFNS', 1),
(12612, 'ORPHA:398156', 'Oculoauriculofrontonasal syndrome', 1),
(12613, 'ORPHA:398166', 'FFDD', 1),
(12614, 'ORPHA:398166', 'Focal facial dermal dysplasia', 1),
(12615, 'ORPHA:398173', 'FFDD type II', 2),
(12616, 'ORPHA:398173', 'FFDD2', 2),
(12617, 'ORPHA:398173', 'Focal facial dermal dysplasia 2, Brauer-Setleis type', 2),
(12618, 'ORPHA:398173', 'Focal facial dermal dysplasia type II', 2),
(12619, 'ORPHA:398189', 'FFDD type IV', 2),
(12620, 'ORPHA:398189', 'FFDD4', 2),
(12621, 'ORPHA:398189', 'Focal facial dermal dysplasia 4', 2),
(12622, 'ORPHA:398189', 'Focal facial dermal dysplasia type IV', 2),
(12623, 'ORPHA:398189', 'Focal facial preauricular dysplasia', 2),
(12624, 'ORPHA:398934', 'Epithelial cancer of ovary', 3),
(12625, 'ORPHA:398934', 'Malignant epithelial tumor of ovary', 3),
(12626, 'ORPHA:398934', 'Ovarian epithelial cancer', 3),
(12627, 'ORPHA:398934', 'Ovarian malignant epithelial tumor', 3),
(12628, 'ORPHA:398940', 'Malignant non-epithelial tumor of ovary', 3),
(12629, 'ORPHA:398940', 'Non-epithelial cancer of ovary', 3),
(12630, 'ORPHA:398940', 'Ovarian malignant non-epithelial tumor', 3),
(12631, 'ORPHA:398940', 'Ovarian non-epithelial cancer', 3),
(12632, 'ORPHA:398961', 'Mucinous adenocarcinoma of ovary', 1),
(12633, 'ORPHA:398961', 'Ovarian mucinous adenocarcinoma', 1),
(12634, 'ORPHA:398971', 'Clear cell adenocarcinoma of the ovary', 1),
(12635, 'ORPHA:398971', 'Ovarian clear cell adenocarcinoma', 1),
(12636, 'ORPHA:398980', 'PPSPC', 1),
(12637, 'ORPHA:398980', 'Primary peritoneal serous/papillary carcinoma', 1),
(12638, 'ORPHA:398987', 'Immature teratoma of ovary', 1),
(12639, 'ORPHA:398987', 'Malignant teratoma of ovary', 1),
(12640, 'ORPHA:398987', 'Ovarian immature teratoma', 1),
(12641, 'ORPHA:398987', 'Ovarian malignant teratoma', 1),
(12642, 'ORPHA:399', 'Huntington chorea', 1),
(12643, 'ORPHA:399', 'Huntington disease', 1),
(12644, 'ORPHA:399058', 'Alpha-B crystallin-related late-onset distal myopathy', 1),
(12645, 'ORPHA:399058', 'Alpha-B crystallin-related late-onset myopathy', 1),
(12646, 'ORPHA:399058', 'Late-onset distal crystallinopathy', 1),
(12647, 'ORPHA:399081', 'KLHL9-related early-onset distal myopathy', 1),
(12648, 'ORPHA:399086', 'Distal myopathy type 3', 1),
(12649, 'ORPHA:399086', 'Finnish upper limb-onset distal myopathy', 1),
(12650, 'ORPHA:399086', 'MPD3', 1),
(12651, 'ORPHA:399096', 'Distal anoctaminopathy', 1),
(12652, 'ORPHA:399096', 'MMD3', 1),
(12653, 'ORPHA:399096', 'Miyoshi muscular dystrophy type 3', 1),
(12654, 'ORPHA:399103', 'Distal nebulin myopathy', 1),
(12655, 'ORPHA:399103', 'Nebulin-related early-onset distal myopathy', 1),
(12656, 'ORPHA:399158', 'Bone necrosis', 3),
(12657, 'ORPHA:399158', 'Osteonecrosis', 3),
(12658, 'ORPHA:399164', 'AVN', 3),
(12659, 'ORPHA:399164', 'Avascular necrosis', 3),
(12660, 'ORPHA:399169', 'Secondary AVN', 3),
(12661, 'ORPHA:399169', 'Secondary avascular necrosis', 3),
(12662, 'ORPHA:399175', 'Traumatic AVN', 1),
(12663, 'ORPHA:399175', 'Traumatic avascular necrosis', 1),
(12664, 'ORPHA:399180', 'Secondary non-traumatic AVN', 1),
(12665, 'ORPHA:399180', 'Secondary non-traumatic avascular necrosis', 1),
(12666, 'ORPHA:399180', 'Secondary non-traumatic osteonecrosis', 1),
(12667, 'ORPHA:399185', 'Rare hereditary disease with avascular necrosis', 3),
(12668, 'ORPHA:399293', 'Osteonecrosis of the jaw', 1),
(12669, 'ORPHA:399302', 'Primary AVN', 3),
(12670, 'ORPHA:399302', 'Primary avascular necrosis', 3),
(12671, 'ORPHA:399307', 'Idiopathic AVN', 1),
(12672, 'ORPHA:399307', 'Idiopathic avascular necrosis', 1),
(12673, 'ORPHA:399319', 'Osteochondrosis', 3),
(12674, 'ORPHA:399329', 'Epiphysiolysis of the hip', 1),
(12675, 'ORPHA:399329', 'Epiphysiolysis of the upper femur', 1),
(12676, 'ORPHA:399329', 'Femoral head epiphysiolysis', 1),
(12677, 'ORPHA:399329', 'SCFE', 1),
(12678, 'ORPHA:399329', 'SUFE', 1),
(12679, 'ORPHA:399329', 'Slipped capital femoral epiphysis', 1),
(12680, 'ORPHA:399329', 'Slipped upper femoral epiphysis', 1),
(12681, 'ORPHA:399380', 'Bone necrosis of genetic origin', 3),
(12682, 'ORPHA:399380', 'Osteonecrosis of genetic origin', 3),
(12683, 'ORPHA:399388', 'Avascular necrosis of genetic origin', 3),
(12684, 'ORPHA:399391', 'Osteochondrosis of genetic origin', 3),
(12685, 'ORPHA:399572', 'Rare male infertility due to gonadotropic axis disorder', 3),
(12686, 'ORPHA:399572', 'Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder', 3),
(12687, 'ORPHA:399572', 'Rare male infertility due to hypothalamic-pituitary-testicular axis disorder', 3),
(12688, 'ORPHA:399584', 'Rare male infertility due to adrenal disorder', 3),
(12689, 'ORPHA:399685', 'Rare male infertility due to testicular endocrine disorder', 3),
(12690, 'ORPHA:399764', 'Male infertility due to gonadal dysgenesis or sperm disorder', 3),
(12691, 'ORPHA:399764', 'Male infertility due to testicular dysgenesis or sperm disorder', 3),
(12692, 'ORPHA:399771', 'Male infertility due to sperm disorder', 3),
(12693, 'ORPHA:399775', 'Male infertility with spermatogenesis disorder', 3),
(12694, 'ORPHA:399786', 'Male infertility with spermatogenesis disorder due to single gene mutation', 3),
(12695, 'ORPHA:399805', 'Male infertility with azoospermia or oligozoospermia due to single gene mutation', 1),
(12696, 'ORPHA:399808', 'Male infertility with teratozoospermia due to single gene mutation', 1),
(12697, 'ORPHA:399813', 'Male infertility due to asthenozoospermia', 3),
(12698, 'ORPHA:399813', 'Male infertility due to sperm motility disorder', 3),
(12699, 'ORPHA:399824', 'Rare disorder due to impaired sperm transport', 3),
(12700, 'ORPHA:399824', 'Rare disorder with obstructive azoospermia', 3),
(12701, 'ORPHA:399831', 'Rare female infertility due to gonadotropic axis disorder', 3),
(12702, 'ORPHA:399831', 'Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder', 3),
(12703, 'ORPHA:399831', 'Rare female infertility due to hypothalamic-pituitary-ovarian axis disorder', 3),
(12704, 'ORPHA:399839', 'Rare female infertility due to a congenital hypogonadotropic hypogonadism', 3),
(12705, 'ORPHA:399846', 'Rare disorder with female infertility due to a congenital hypogonadotropic hypogonadism', 3),
(12706, 'ORPHA:399849', 'Rare female infertility due to an adrenal disorder', 3),
(12707, 'ORPHA:399853', 'Rare female infertility due to an anomaly of ovarian function', 3),
(12708, 'ORPHA:399877', 'Rare female infertility due to gonadal dysgenesis', 3),
(12709, 'ORPHA:399877', 'Rare female infertility due to ovarian dysgenesis', 3),
(12710, 'ORPHA:399882', 'Rare female infertility due to an implantation defect', 3),
(12711, 'ORPHA:399980', 'Rare genetic male infertility', 3),
(12712, 'ORPHA:399983', 'Rare male infertility due to gonadotropic axis disorder of genetic origin', 3),
(12713, 'ORPHA:399983', 'Rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin', 3),
(12714, 'ORPHA:399983', 'Rare male infertility due to hypothalamic-pituitary-testicular axis disorder of genetic origin', 3),
(12715, 'ORPHA:399994', 'Rare male infertility due to adrenal disorder of genetic origin', 3),
(12716, 'ORPHA:399998', 'Male infertility due to impaired sperm transport of genetic origin', 3),
(12717, 'ORPHA:399998', 'Male infertility due to obstructive azoospermia of genetic origin', 3),
(12718, 'ORPHA:40', 'Acromesomelic dysplasia, Maroteaux type', 1),
(12719, 'ORPHA:400', 'Cystic echinococcosis', 1),
(12720, 'ORPHA:400', 'Hydatid disease', 1),
(12721, 'ORPHA:400', 'Hydatidosis', 1),
(12722, 'ORPHA:400003', 'Rare genetic disorder due to impaired sperm transport', 3),
(12723, 'ORPHA:400003', 'Rare genetic disorder with obstructive azoospermia', 3),
(12724, 'ORPHA:400008', 'Rare genetic female infertility', 3),
(12725, 'ORPHA:400011', 'Rare female infertility due to gonadotropic axis disorder of genetic origin', 3),
(12726, 'ORPHA:400011', 'Rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin', 3),
(12727, 'ORPHA:400011', 'Rare female infertility due to hypothalamic-pituitary-testicular axis disorder of genetic origin', 3),
(12728, 'ORPHA:400018', 'Rare female infertility due to adrenal disorder of genetic origin', 3),
(12729, 'ORPHA:400022', 'Rare female infertility due to an anomaly of ovarian function of genetic origin', 3),
(12730, 'ORPHA:400025', 'Female infertility due to an implantation defect of genetic origin', 3),
(12731, 'ORPHA:401', 'Hymenolepiasis', 1),
(12732, 'ORPHA:401764', 'Pancytopenia-developmental delay syndrome', 1),
(12733, 'ORPHA:401764', 'Trilineage bone marrow failure-developmental delay syndrome', 1),
(12734, 'ORPHA:401768', 'Proximal myopathy with extrapyramidal signs', 1),
(12735, 'ORPHA:401777', 'BBSOAS', 1),
(12736, 'ORPHA:401777', 'Bosch-Boonstra-Schaaf optic atrophy syndrome', 1),
(12737, 'ORPHA:401777', 'Optic atrophy-intellectual disability syndrome', 1),
(12738, 'ORPHA:401780', 'Autosomal recessive spastic paraplegia type 61', 1),
(12739, 'ORPHA:401780', 'SPG61', 1),
(12740, 'ORPHA:401785', 'Autosomal recessive spastic paraplegia type 62', 1),
(12741, 'ORPHA:401785', 'SPG62', 1),
(12742, 'ORPHA:401795', 'Autosomal recessive spastic paraplegia type 59', 1),
(12743, 'ORPHA:401795', 'SPG59', 1),
(12744, 'ORPHA:401800', 'Autosomal recessive spastic paraplegia type 60', 1),
(12745, 'ORPHA:401800', 'SPG60', 1),
(12746, 'ORPHA:401805', 'Autosomal recessive spastic paraplegia type 63', 1),
(12747, 'ORPHA:401805', 'SPG63', 1),
(12748, 'ORPHA:401810', 'Autosomal recessive spastic paraplegia type 64', 1),
(12749, 'ORPHA:401810', 'SPG64', 1),
(12750, 'ORPHA:401815', 'Autosomal recessive spastic paraplegia type 66', 1),
(12751, 'ORPHA:401815', 'SPG66', 1),
(12752, 'ORPHA:401820', 'Autosomal recessive spastic paraplegia type 67', 1),
(12753, 'ORPHA:401820', 'SPG67', 1),
(12754, 'ORPHA:401830', 'Autosomal recessive spastic paraplegia type 69', 1),
(12755, 'ORPHA:401830', 'SPG69', 1),
(12756, 'ORPHA:401835', 'Autosomal recessive spastic paraplegia type 70', 1),
(12757, 'ORPHA:401835', 'SPG70', 1),
(12758, 'ORPHA:401840', 'Autosomal recessive spastic paraplegia type 71', 1),
(12759, 'ORPHA:401840', 'SPG71', 1),
(12760, 'ORPHA:401849', 'Autosomal spastic paraplegia type 72', 1),
(12761, 'ORPHA:401849', 'SPG72', 1),
(12762, 'ORPHA:401854', 'Lipoate biosynthesis defect', 3),
(12763, 'ORPHA:401854', 'Lipoic acid biosynthesis defect', 3),
(12764, 'ORPHA:401859', 'Lipoic acid synthetase deficiency', 1),
(12765, 'ORPHA:401862', 'Lipoyl transferase 1 deficiency', 1),
(12766, 'ORPHA:401866', 'Childhood-onset spasticity with hyperglycinemia', 1),
(12767, 'ORPHA:401866', 'Childhood-onset spasticity with variant non-ketotic hyperglycinemia', 1),
(12768, 'ORPHA:401866', 'Spasticity-ataxia-gait anomalies syndrome', 1),
(12769, 'ORPHA:401869', 'MMDS1', 1),
(12770, 'ORPHA:401869', 'Multiple mitochondrial dysfunctions syndrome type 1', 1),
(12771, 'ORPHA:401869', 'NFU1 deficiency', 1),
(12772, 'ORPHA:401874', 'BOLA3 deficiency', 1),
(12773, 'ORPHA:401874', 'MMDS2', 1),
(12774, 'ORPHA:401874', 'Multiple mitochondrial dysfunctions syndrome type 2', 1),
(12775, 'ORPHA:401901', 'C9ORF72-related Huntington disease phenocopy', 1),
(12776, 'ORPHA:401901', 'C9ORF72-related Huntington disease-like syndrome', 1),
(12777, 'ORPHA:401901', 'Huntington disease phenocopy due to C9ORF72 expansions', 1),
(12778, 'ORPHA:401901', 'Huntington disease-like syndrome due to C9ORF72 expansions', 1),
(12779, 'ORPHA:401911', 'AXIN2-related AFAP', 2),
(12780, 'ORPHA:401911', 'AXIN2-related attenuated FAP', 2),
(12781, 'ORPHA:401911', 'AXIN2-related attenuated familial adenomatous polyposis', 2),
(12782, 'ORPHA:401911', 'AXIN2-related attenuated familial polyposis coli', 2),
(12783, 'ORPHA:401920', 'FHCC', 1),
(12784, 'ORPHA:401920', 'Fibrolamellar hepatocarcinoma', 1),
(12785, 'ORPHA:401920', 'Fibrolamellar hepatocellular carcinoma', 1),
(12786, 'ORPHA:401923', '9q31.1q31.3 microdeletion syndrome', 1),
(12787, 'ORPHA:401923', 'Del(9)(q31.1q31.3)', 1),
(12788, 'ORPHA:401923', 'Monosomy 9q31.1q31.3', 1),
(12789, 'ORPHA:401935', '14q24.1q24.3 microdeletion syndrome', 1),
(12790, 'ORPHA:401935', 'Del(14)(q24.1q24.3)', 1),
(12791, 'ORPHA:401935', 'Monosomy 14q24.1q24.3', 1),
(12792, 'ORPHA:401942', 'Familial median cleft of the upper and lower lips', 1),
(12793, 'ORPHA:401945', 'Moyamoya disease with early-onset achalasia', 1),
(12794, 'ORPHA:401948', 'CA-VA deficiency', 1),
(12795, 'ORPHA:401948', 'Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency', 1),
(12796, 'ORPHA:401953', 'Episodic ataxia type 8', 1),
(12797, 'ORPHA:401953', 'Episodic ataxia with slurred speech', 1),
(12798, 'ORPHA:401959', 'Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome', 1),
(12799, 'ORPHA:401964', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons', 1),
(12800, 'ORPHA:401964', 'Autosomal dominant hereditary motor and sensory neuropathy type 2 with giant axons', 1),
(12801, 'ORPHA:401964', 'CMT2 with giant axons', 1),
(12802, 'ORPHA:401964', 'HMSN2 with giant axons', 1),
(12803, 'ORPHA:401973', 'MEND syndrome', 1),
(12804, 'ORPHA:401973', 'Male EBP disorder with neurological defects', 1),
(12805, 'ORPHA:401979', 'Autosomal recessive spondylometaphyseal dysplasia, Mégarbané type', 1),
(12806, 'ORPHA:401986', '1p31p32 microdeletion syndrome', 1),
(12807, 'ORPHA:401986', 'Del(1)(p31p32)', 1),
(12808, 'ORPHA:401986', 'Monosomy 1p31p32', 1),
(12809, 'ORPHA:401993', 'Cold-induced sweating syndrome-hyperthermia spectrum', 3),
(12810, 'ORPHA:401996', 'KIN', 1),
(12811, 'ORPHA:401996', 'Karyomegalic interstitial nephritis', 1),
(12812, 'ORPHA:401996', 'Systemic karyomegaly', 1),
(12813, 'ORPHA:402003', 'Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering', 1),
(12814, 'ORPHA:402007', 'Lichen myxedematosus', 3),
(12815, 'ORPHA:402014', 'AML with t(6;9)(p23;q34)', 1),
(12816, 'ORPHA:402014', 'Acute myeloid leukemia with t(6;9)(p23;q34)', 1),
(12817, 'ORPHA:402017', 'AML with t(9;11)(p22;q23)', 1),
(12818, 'ORPHA:402017', 'Acute myeloid leukemia with t(9;11)(p22;q23)', 1),
(12819, 'ORPHA:402020', 'AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)', 1),
(12820, 'ORPHA:402020', 'Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2)', 1),
(12821, 'ORPHA:402023', 'Megakaryoblastic AML with t(1;22)(p13;q13)', 1),
(12822, 'ORPHA:402023', 'Megakaryoblastic acute myeloid leukemia with t(1;22)(p13;q13)', 1),
(12823, 'ORPHA:402026', 'AML with NPM1 somatic mutations', 1),
(12824, 'ORPHA:402026', 'Acute myeloid leukemia with NPM1 somatic mutations', 1),
(12825, 'ORPHA:402029', 'EGID', 3),
(12826, 'ORPHA:402029', 'Primary eosinophilic gastrointestinal disease', 3),
(12827, 'ORPHA:402035', 'Eosinophilic colitis', 1),
(12828, 'ORPHA:402041', 'AR dRTA', 2),
(12829, 'ORPHA:402041', 'Autosomal recessive distal RTA', 2),
(12830, 'ORPHA:402041', 'Autosomal recessive distal renal tubular acidosis', 2),
(12831, 'ORPHA:402075', 'Familial BAV', 1),
(12832, 'ORPHA:402075', 'Familial bicuspid aortic valve', 1),
(12833, 'ORPHA:402082', 'EPM5', 1),
(12834, 'ORPHA:402082', 'PME type 5', 1),
(12835, 'ORPHA:402082', 'Progressive myoclonic epilepsy type 5', 1),
(12836, 'ORPHA:402082', 'Progressive myoclonus epilepsy type 5', 1),
(12837, 'ORPHA:402364', 'Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly', 1),
(12838, 'ORPHA:402823', 'HDV', 1),
(12839, 'ORPHA:402823', 'Hepatitis D virus', 1),
(12840, 'ORPHA:402823', 'Hepatitis delta', 1),
(12841, 'ORPHA:403', 'Dexamethasone-sensitive hypertension', 1),
(12842, 'ORPHA:403', 'FH-I', 1),
(12843, 'ORPHA:403', 'FH1', 1),
(12844, 'ORPHA:403', 'Familial hyperaldosteronism type 1', 1),
(12845, 'ORPHA:403', 'Familial hyperaldosteronism type I', 1),
(12846, 'ORPHA:403', 'GRA', 1),
(12847, 'ORPHA:403', 'Glucocorticoid-remediable aldosteronism', 1),
(12848, 'ORPHA:403', 'Glucocorticoid-sensitive hypertension', 1),
(12849, 'ORPHA:40366', 'Acitretin/etretinate embryopathy', 1),
(12850, 'ORPHA:40366', 'Fetal acitretin/etretinate syndrome', 1),
(12851, 'ORPHA:40366', 'Retinoid embryopathy', 1),
(12852, 'ORPHA:404', 'FH-II', 1),
(12853, 'ORPHA:404', 'FH2', 1),
(12854, 'ORPHA:404', 'Familial adrenal adenoma', 1),
(12855, 'ORPHA:404', 'Familial hyperaldosteronism type 2', 1),
(12856, 'ORPHA:404', 'Familial hyperaldosteronism type II', 1),
(12857, 'ORPHA:404437', 'Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome', 1),
(12858, 'ORPHA:404440', 'Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency', 1),
(12859, 'ORPHA:404443', 'DNMT3A-related overgrowth syndrome', 1),
(12860, 'ORPHA:404443', 'Tall stature-intellectual disability-facial dysmorphism syndrome', 1),
(12861, 'ORPHA:404443', 'Tatton-Brown-Rahman overgrowth syndrome', 1),
(12862, 'ORPHA:404448', 'ADNP syndrome', 1),
(12863, 'ORPHA:404448', 'ADNP-related syndromic intellectual disability-autism spectrum disorder', 1),
(12864, 'ORPHA:404448', 'HVDAS', 1),
(12865, 'ORPHA:404448', 'Helsmoortel-Van Der Aa Syndrome', 1),
(12866, 'ORPHA:404451', 'FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome', 1),
(12867, 'ORPHA:404454', 'Alacrimia-choreoathetosis-liver dysfunction syndrome', 1),
(12868, 'ORPHA:404454', 'NGLY1 deficiency', 1),
(12869, 'ORPHA:404454', 'NGLY1-CDDG', 1),
(12870, 'ORPHA:404463', 'Multisystemic smooth muscle dysfunction syndrome', 1),
(12871, 'ORPHA:404466', 'Female infertility due to zona pellucida defect', 1),
(12872, 'ORPHA:404469', 'Rare female infertility due to oocyte maturation defect', 3),
(12873, 'ORPHA:404473', 'CTNNB1 syndrome', 1),
(12874, 'ORPHA:404473', 'Severe intellectual disability-progressive spastic diplegia syndrome', 1),
(12875, 'ORPHA:404476', 'GLOW syndrome', 1),
(12876, 'ORPHA:404476', 'Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome', 1),
(12877, 'ORPHA:404481', 'Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome', 3),
(12878, 'ORPHA:404493', 'Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency', 1),
(12879, 'ORPHA:404493', 'SCAR23', 1),
(12880, 'ORPHA:404493', 'Spinocerebellar ataxia autosomal recessive type 23', 1),
(12881, 'ORPHA:404499', 'Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency', 1),
(12882, 'ORPHA:404499', 'Autosomal recessive spinocerebellar ataxia type 15', 1),
(12883, 'ORPHA:404499', 'SCAR15', 1),
(12884, 'ORPHA:404499', 'Salih ataxia', 1),
(12885, 'ORPHA:404507', 'Chondromyxoid fibroma', 1),
(12886, 'ORPHA:404511', 'Clear cell papillary renal cell carcinoma', 2),
(12887, 'ORPHA:404514', 'Acquired cystic disease-associated renal cell carcinoma', 1),
(12888, 'ORPHA:404521', 'Diaphragmatic spinal muscular atrophy type 2', 1),
(12889, 'ORPHA:404521', 'SMARD2', 1),
(12890, 'ORPHA:404521', 'Severe infantile axonal neuropathy with respiratory failure type 2', 1),
(12891, 'ORPHA:404521', 'Spinal muscular atrophy with respiratory distress type 2', 1),
(12892, 'ORPHA:404521', 'X-linked spinal muscular atrophy with respiratory distress', 1),
(12893, 'ORPHA:404538', 'X-linked dHMN', 3),
(12894, 'ORPHA:404538', 'X-linked distal hereditary motor neuropathy', 3),
(12895, 'ORPHA:404538', 'X-linked distal spinal muscular atrophy', 3),
(12896, 'ORPHA:404546', 'DITRA', 1),
(12897, 'ORPHA:404546', 'Deficiency of IL-36R antagonist', 1),
(12898, 'ORPHA:404546', 'Deficiency of IL-36Ra', 1),
(12899, 'ORPHA:404553', 'Vasculitis due to ADA2 deficiency', 1),
(12900, 'ORPHA:404553', 'Vasculitis due to DADA2', 1),
(12901, 'ORPHA:404560', 'B-K mole syndrome', 1),
(12902, 'ORPHA:404560', 'FAMM-PC syndrome', 1),
(12903, 'ORPHA:404560', 'FAMMM syndrome', 1),
(12904, 'ORPHA:404560', 'Familial atypical mole syndrome', 1),
(12905, 'ORPHA:404560', 'Familial atypical multiple mole melanoma syndrome', 1),
(12906, 'ORPHA:404560', 'Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome', 1),
(12907, 'ORPHA:404560', 'Familial dysplastic nevus syndrome', 1),
(12908, 'ORPHA:404560', 'Melanoma-pancreatic cancer syndrome', 1),
(12909, 'ORPHA:404568', 'Dysostosis of genetic origin', 3),
(12910, 'ORPHA:404571', 'Dysostosis of genetic origin with limb anomaly as a major feature', 3),
(12911, 'ORPHA:404574', 'Genetic syndrome with limb reduction defects', 3),
(12912, 'ORPHA:404577', 'Genetic syndrome with limb malformations as a major feature', 3),
(12913, 'ORPHA:404580', 'Juvenile polyarthritis', 3),
(12914, 'ORPHA:404580', 'Juvenile polyarticular arthritis', 3),
(12915, 'ORPHA:404580', 'Polyarticular JIA', 3),
(12916, 'ORPHA:404580', 'Polyarticular juvenile idiopathic arthritis', 3),
(12917, 'ORPHA:404584', 'Rare genetic bone development disorder', 3),
(12918, 'ORPHA:404584', 'Rare genetic skeletal development disorder', 3),
(12919, 'ORPHA:405', 'FBH', 1),
(12920, 'ORPHA:405', 'FBHH', 1),
(12921, 'ORPHA:405', 'FHH', 1),
(12922, 'ORPHA:405', 'Familial benign hypercalcemia', 1),
(12923, 'ORPHA:405', 'Familial benign hypocalciuric hypercalcemia', 1),
(12924, 'ORPHA:405', 'Familial hypocalciuric hypercalcemia', 1),
(12925, 'ORPHA:407', 'Glycine encephalopathy', 1),
(12926, 'ORPHA:407', 'NKA', 1),
(12927, 'ORPHA:407', 'Non-ketotic hyperglycinemia', 1),
(12928, 'ORPHA:408', 'Hyperglycerolemia', 1),
(12929, 'ORPHA:408', 'Isolated glycerol kinase deficiency', 1),
(12930, 'ORPHA:409', 'Flegel disease', 1),
(12931, 'ORPHA:409', 'Hyperkeratosis lenticularis perstans', 1),
(12932, 'ORPHA:40923', 'Eales disease', 1),
(12933, 'ORPHA:40923', 'Idiopathic retinal perivasculitis', 1),
(12934, 'ORPHA:40923', 'Idiopathic retinal vasculitis', 1),
(12935, 'ORPHA:41', 'Acropigmentation of Dohi', 1),
(12936, 'ORPHA:41', 'Dyschromatosis symmetrica hereditaria', 1),
(12937, 'ORPHA:411493', 'CLP1-related pontocerebellar hypoplasia', 1),
(12938, 'ORPHA:411493', 'PCH10', 1),
(12939, 'ORPHA:411493', 'Pontocerebellar hypoplasia type 10', 1),
(12940, 'ORPHA:411501', 'Williams-Campbell syndrome', 1),
(12941, 'ORPHA:411511', 'Angelman syndrome due to a point mutation', 2),
(12942, 'ORPHA:411515', 'Angelman syndrome due to imprinting defect in 15q11-q13', 2),
(12943, 'ORPHA:411527', 'CRVO', 1),
(12944, 'ORPHA:411527', 'Central retinal vein occlusion', 1),
(12945, 'ORPHA:411536', 'Mild PRPP synthetase superactivity', 2),
(12946, 'ORPHA:411536', 'Mild PRPS1 superactivity', 2),
(12947, 'ORPHA:411536', 'Mild phosphoribosylpyrophosphate synthetase superactivity', 2),
(12948, 'ORPHA:411543', 'Severe PRPP synthetase superactivity', 2),
(12949, 'ORPHA:411543', 'Severe PRPS1 superactivity', 2),
(12950, 'ORPHA:411543', 'Severe phosphoribosylpyrophosphate synthetase superactivity', 2),
(12951, 'ORPHA:411590', 'Wolfram-like syndrome', 1),
(12952, 'ORPHA:411593', 'Hirata disease', 1),
(12953, 'ORPHA:411593', 'Insulin autoimmune syndrome', 1),
(12954, 'ORPHA:411602', 'Autosomal dominant late-onset Parkinson disease', 1),
(12955, 'ORPHA:411602', 'Hereditary late-onset Parkinson disease', 1),
(12956, 'ORPHA:411602', 'LOPD', 1),
(12957, 'ORPHA:411629', 'Infantile nephropathic cystinosis', 2),
(12958, 'ORPHA:411634', 'Intermediate cystinosis', 2),
(12959, 'ORPHA:411634', 'Juvenile cystinosis', 2),
(12960, 'ORPHA:411634', 'Juvenile nephropathic cystinosis', 2),
(12961, 'ORPHA:411641', 'Adult-onset cystinosis', 2),
(12962, 'ORPHA:411641', 'Non-nephropathic cystinosis', 2),
(12963, 'ORPHA:411641', 'Ocular cystinosis', 2),
(12964, 'ORPHA:411696', 'PPI-REE', 1),
(12965, 'ORPHA:411696', 'PPI-responsive esophageal eosinophilia', 1),
(12966, 'ORPHA:411696', 'PPIRee', 1),
(12967, 'ORPHA:411696', 'Proton-pump inhibitor-responsive esophageal eosinophilia', 1),
(12968, 'ORPHA:411703', 'Non-tuberculous mycobacterial lung disease', 1),
(12969, 'ORPHA:411703', 'Pulmonary non-tuberculous mycobacterial infection', 1),
(12970, 'ORPHA:411709', 'Renal agenesis', 1),
(12971, 'ORPHA:411712', 'Maternal riboflavin deficiency', 1),
(12972, 'ORPHA:411777', 'GEKA', 1),
(12973, 'ORPHA:411777', 'Generalized eruptive keratoacanthoma', 1),
(12974, 'ORPHA:411777', 'Generalized eruptive keratoacanthomas of Grzybowski', 1),
(12975, 'ORPHA:411777', 'Grzybowski syndrome', 1),
(12976, 'ORPHA:411788', 'Familial isolated trichomegaly', 1),
(12977, 'ORPHA:411986', 'Early-onset epileptic encephalopathy-cortical blindness-intellectual disability-facial dysmorphism syndrome', 1),
(12978, 'ORPHA:411986', 'Epilepsy-cortical blindness-intellectual disability-facial dysmorphism syndrome', 1),
(12979, 'ORPHA:412', 'Broad-beta disease', 1),
(12980, 'ORPHA:412', 'Dysbetalipoproteinemia', 1),
(12981, 'ORPHA:412', 'Familial dyslipidemia type 3', 1),
(12982, 'ORPHA:412', 'HLP type 3', 1),
(12983, 'ORPHA:412', 'Hyperlipidemia type 3', 1),
(12984, 'ORPHA:412', 'Hyperlipoproteinemia type 3', 1),
(12985, 'ORPHA:412', 'Remnant hyperlipoproteinemia', 1),
(12986, 'ORPHA:412022', 'FDLAB syndrome', 1),
(12987, 'ORPHA:412022', 'Facial dysmorphism-lens dislocation-anterior segment abnormalities-nontraumatic conjunctive cysts syndrome', 1),
(12988, 'ORPHA:412022', 'Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome', 1),
(12989, 'ORPHA:412022', 'Traboulsi syndrome', 1),
(12990, 'ORPHA:412035', '13q12.3 microdeletion syndrome', 1),
(12991, 'ORPHA:412035', 'Del(13)(q12.3)', 1),
(12992, 'ORPHA:412035', 'Monosomy 13q12.3', 1),
(12993, 'ORPHA:412057', 'Autosomal recessive cerebellar ataxia due to STUB1 deficiency', 1),
(12994, 'ORPHA:412057', 'SCAR16', 1),
(12995, 'ORPHA:412057', 'Spinocerebellar ataxia autosomal recessive type 16', 1),
(12996, 'ORPHA:412066', 'PRKAR1B-related neurodegenerative dementia with intermediate filaments', 1),
(12997, 'ORPHA:412069', 'AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome', 1),
(12998, 'ORPHA:412069', 'Xia-Gibbs syndrome', 1),
(12999, 'ORPHA:412181', 'DST-related epidermolysis bullosa simplex', 1),
(13000, 'ORPHA:412181', 'EBS-AR BP230', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(13001, 'ORPHA:412181', 'Epidermolysis bullosa simplex due to BP230 deficiency', 1),
(13002, 'ORPHA:412189', 'EBS-AR exophilin 5', 1),
(13003, 'ORPHA:412189', 'Epidermolysis bullosa simplex due to exophilin 5 deficiency', 1),
(13004, 'ORPHA:412206', 'PFE', 1),
(13005, 'ORPHA:412206', 'Primary failure of tooth eruption', 1),
(13006, 'ORPHA:412206', 'Primary retention of teeth', 1),
(13007, 'ORPHA:412217', 'Dystonia-aphonia syndrome', 1),
(13008, 'ORPHA:414', 'Gyrate atrophy of choroid and retina', 1),
(13009, 'ORPHA:414', 'HOGA', 1),
(13010, 'ORPHA:414', 'Hyperornithinemia', 1),
(13011, 'ORPHA:414', 'Hyperornithinemia-gyrate atrophy of choroid and retina syndrome', 1),
(13012, 'ORPHA:414', 'Ornithine aminotransferase deficiency', 1),
(13013, 'ORPHA:414726', 'Genetic craniofacial cleft', 3),
(13014, 'ORPHA:414726', 'Genetic facial cleft', 3),
(13015, 'ORPHA:415', 'HHH syndrome', 1),
(13016, 'ORPHA:415', 'Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome', 1),
(13017, 'ORPHA:415', 'ORNT1 deficiency', 1),
(13018, 'ORPHA:415', 'Ornithine carrier deficiency', 1),
(13019, 'ORPHA:415', 'Ornithine translocase deficiency', 1),
(13020, 'ORPHA:415', 'Triple H syndrome', 1),
(13021, 'ORPHA:415286', 'Bilirubin encephalopathy', 3),
(13022, 'ORPHA:415286', 'Kernicterus', 3),
(13023, 'ORPHA:416', 'Primary hyperoxaluria', 1),
(13024, 'ORPHA:417', 'NSHPT', 1),
(13025, 'ORPHA:417', 'Neonatal severe primary hyperparathyroidism', 1),
(13026, 'ORPHA:41751', 'BCD', 1),
(13027, 'ORPHA:41751', 'Bietti crystalline corneoretinal dystrophy', 1),
(13028, 'ORPHA:41751', 'Bietti crystalline dystrophy', 1),
(13029, 'ORPHA:41751', 'Bietti crystalline retinopathy', 1),
(13030, 'ORPHA:418', 'CAH', 3),
(13031, 'ORPHA:418', 'Congenital adrenal hyperplasia', 3),
(13032, 'ORPHA:418945', 'Carcinoma of esophagus, salivary gland type', 1),
(13033, 'ORPHA:418945', 'Esophageal carcinoma, salivary gland type', 1),
(13034, 'ORPHA:418951', 'Undifferentiated carcinoma of esophagus', 1),
(13035, 'ORPHA:418951', 'Undifferentiated esophageal carcinoma', 1),
(13036, 'ORPHA:418959', 'Gastric squamous cell carcinoma', 1),
(13037, 'ORPHA:418959', 'Squamous cell carcinoma of the stomach', 1),
(13038, 'ORPHA:419', 'Hyperprolinemia type 1', 1),
(13039, 'ORPHA:419', 'Proline oxidase deficiency', 1),
(13040, 'ORPHA:42', 'ACADM deficiency', 1),
(13041, 'ORPHA:42', 'Carnitine deficiency secondary to medium-chain acyl-CoA dehydrogenase deficiency', 1),
(13042, 'ORPHA:42', 'MCAD deficiency', 1),
(13043, 'ORPHA:42', 'MCADD', 1),
(13044, 'ORPHA:42', 'Medium chain acyl-CoA dehydrogenase deficiency', 1),
(13045, 'ORPHA:42', 'Medium chain acyl-coenzyme A dehydrogenase deficiency', 1),
(13046, 'ORPHA:420179', 'Malan overgrowth syndrome', 1),
(13047, 'ORPHA:420179', 'Sotos syndrome 2', 1),
(13048, 'ORPHA:420259', 'Secondary PAP', 1),
(13049, 'ORPHA:420259', 'Secondary pulmonary alveolar proteinosis', 1),
(13050, 'ORPHA:420402', 'SCD syndrome', 1),
(13051, 'ORPHA:420402', 'Semicircular canal dehiscence syndrome', 1),
(13052, 'ORPHA:420429', 'Alpha-1,4-glucosidase acid deficiency, late-onset', 2),
(13053, 'ORPHA:420429', 'GSD due to acid maltase deficiency, late-onset', 2),
(13054, 'ORPHA:420429', 'GSD type 2, late-onset', 2),
(13055, 'ORPHA:420429', 'GSD type II, late-onset', 2),
(13056, 'ORPHA:420429', 'Glycogen storage disease due to acid maltase deficiency, late-onset', 2),
(13057, 'ORPHA:420429', 'Glycogen storage disease type 2, late-onset', 2),
(13058, 'ORPHA:420429', 'Glycogen storage disease type II, late-onset', 2),
(13059, 'ORPHA:420429', 'Glycogenosis type 2, late-onset', 2),
(13060, 'ORPHA:420429', 'Glycogenosis type II, late-onset', 2),
(13061, 'ORPHA:420429', 'Pompe disease, late-onset', 2),
(13062, 'ORPHA:420485', 'Cranio-cervical dystonia with laryngeal and upper-limb involvement', 1),
(13063, 'ORPHA:420485', 'DYT24', 1),
(13064, 'ORPHA:420485', 'Dystonia 24', 1),
(13065, 'ORPHA:420492', 'Adult-onset cervical dystonia, DYT23 type', 1),
(13066, 'ORPHA:420492', 'DYT23', 1),
(13067, 'ORPHA:420492', 'Dystonia 23', 1),
(13068, 'ORPHA:420556', 'Visual snow syndrome', 1),
(13069, 'ORPHA:420561', 'Severe intellectual disability-aplasia/hypoplasia of thumb and hallux syndrome', 1),
(13070, 'ORPHA:420561', 'TMBTS', 1),
(13071, 'ORPHA:420561', 'Temple-Baraitser syndrome', 1),
(13072, 'ORPHA:420566', 'Bleeding disorder due to CalDAG-GEFI deficiency', 1),
(13073, 'ORPHA:420566', 'Bleeding disorder due to calcium- and DAG-regulated guanine exchange factor-1 deficiency', 1),
(13074, 'ORPHA:420573', 'SCID due to CTPS1 deficiency', 1),
(13075, 'ORPHA:420573', 'Severe combined immunodeficiency due to CTPS1 deficiency', 1),
(13076, 'ORPHA:420584', 'Culler-Jones syndrome', 1),
(13077, 'ORPHA:420584', 'Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome', 1),
(13078, 'ORPHA:420611', 'TMD', 1),
(13079, 'ORPHA:420611', 'Transient abnormal myelopoiesis', 1),
(13080, 'ORPHA:420611', 'Transient myeloproliferative disease', 1),
(13081, 'ORPHA:420611', 'Transient myeloproliferative syndrome', 1),
(13082, 'ORPHA:42062', 'Iminoglycinuria', 1),
(13083, 'ORPHA:420686', 'KWWH type IV', 1),
(13084, 'ORPHA:420686', 'Keratoderma with woolly hair type IV', 1),
(13085, 'ORPHA:420686', 'Woolly hair-palmoplantar hyperkeratosis syndrome', 1),
(13086, 'ORPHA:420686', 'Woolly hair-palmoplantar keratoderma syndrome', 1),
(13087, 'ORPHA:420699', 'Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency', 1),
(13088, 'ORPHA:420702', 'Autosomal recessive severe congenital neutropenia due to CSF3R deficiency', 1),
(13089, 'ORPHA:420728', 'COXPD20', 1),
(13090, 'ORPHA:420728', 'Combined oxidative phosphorylation defect type 20', 1),
(13091, 'ORPHA:420733', 'COXPD21', 1),
(13092, 'ORPHA:420733', 'Combined oxidative phosphorylation defect type 21', 1),
(13093, 'ORPHA:420741', 'RIDDLE syndrome', 1),
(13094, 'ORPHA:420741', 'RNF168 deficiency', 1),
(13095, 'ORPHA:420741', 'Radiosensitivity-immunodeficiency-dysmorphic features-learning difficulties syndrome', 1),
(13096, 'ORPHA:420755', 'Rare genetic odontal or periodontal disorder', 3),
(13097, 'ORPHA:420789', 'Anti-IgLON5 disease', 1),
(13098, 'ORPHA:420789', 'Anti-IgLON5 syndrome', 1),
(13099, 'ORPHA:420789', 'Autoimmune encephalopathy with parasomnia and obstructive sleep apnea', 1),
(13100, 'ORPHA:420794', 'Cono-spondylar dysplasia', 1),
(13101, 'ORPHA:420794', 'Short stature-kyphosis-hypoplasia of basal ilia-cone epiphyses-facial dysmorphism syndrome', 1),
(13102, 'ORPHA:422', 'Idiopathic and/or familial pulmonary arterial hypertension', 1),
(13103, 'ORPHA:422', 'Idiopathic/heritable pulmonary arterial hypertension', 1),
(13104, 'ORPHA:422526', 'Hereditary clear cell renal cell adenocarcinoma', 1),
(13105, 'ORPHA:422526', 'Hereditary clear cell renal cell carcinoma', 1),
(13106, 'ORPHA:423', 'Hyperthermia of anesthesia', 1),
(13107, 'ORPHA:423', 'Malignant hyperthermia of anesthesia', 1),
(13108, 'ORPHA:423275', 'SCA40', 1),
(13109, 'ORPHA:423275', 'Spinocerebellar ataxia type 40', 1),
(13110, 'ORPHA:423296', 'SCA38', 1),
(13111, 'ORPHA:423296', 'Spinocerebellar ataxia type 38', 1),
(13112, 'ORPHA:423306', 'Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome', 1),
(13113, 'ORPHA:423384', 'Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency', 1),
(13114, 'ORPHA:423454', 'Ectodermal dysplasia-short stature syndrome', 1),
(13115, 'ORPHA:423454', 'Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome', 1),
(13116, 'ORPHA:423454', 'Short stature-nail dysplasia-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome', 1),
(13117, 'ORPHA:423461', 'ML 3 alpha/beta', 2),
(13118, 'ORPHA:423461', 'ML III alpha/beta', 2),
(13119, 'ORPHA:423461', 'Mucolipidosis type 3 alpha/beta', 2),
(13120, 'ORPHA:423461', 'Mucolipidosis type III alpha/beta', 2),
(13121, 'ORPHA:423470', 'ML 3 gamma', 2),
(13122, 'ORPHA:423470', 'ML III gamma', 2),
(13123, 'ORPHA:423470', 'Mucolipidosis type 3 gamma', 2),
(13124, 'ORPHA:423470', 'Mucolipidosis type III gamma', 2),
(13125, 'ORPHA:423479', 'X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome', 1),
(13126, 'ORPHA:423655', 'ARX-related encephalopathy-brain malformation spectrum', 3),
(13127, 'ORPHA:423662', 'Rare autonomic nervous system disorder', 3),
(13128, 'ORPHA:423693', 'DORV with subaortic or doubly committed VSD', 2),
(13129, 'ORPHA:423693', 'Double outlet right ventricle with subaortic or doubly committed ventricular septal defect', 2),
(13130, 'ORPHA:423712', 'DORV with atrioventricular septal defect, pulmonary stenosis, heterotaxy', 2),
(13131, 'ORPHA:423712', 'Double outlet right ventricle with atrioventricular septal defect, pulmonary stenosis, heterotaxy', 2),
(13132, 'ORPHA:423717', 'Cutaneous larva migrans', 1),
(13133, 'ORPHA:423771', 'Rare carcinoma of stomach', 3),
(13134, 'ORPHA:423771', 'Rare gastric carcinoma', 3),
(13135, 'ORPHA:423776', 'Hereditary cancer of stomach', 3),
(13136, 'ORPHA:423776', 'Hereditary gastric cancer', 3),
(13137, 'ORPHA:423786', 'Undifferentiated carcinoma of stomach', 1),
(13138, 'ORPHA:423786', 'Undifferentiated gastric carcinoma', 1),
(13139, 'ORPHA:423793', 'Rare tumor of small bowel', 3),
(13140, 'ORPHA:423793', 'Rare tumor of small intestine', 3),
(13141, 'ORPHA:423798', 'Mesenchymal tumor of small bowel', 3),
(13142, 'ORPHA:423798', 'Mesenchymal tumor of small intestine', 3),
(13143, 'ORPHA:423894', 'Microcephaly-complex motor and sensory axonal neuropathy syndrome', 1),
(13144, 'ORPHA:423957', 'Rare carcinoma of small bowel', 3),
(13145, 'ORPHA:423957', 'Rare carcinoma of small intestine', 3),
(13146, 'ORPHA:423968', 'Squamous cell carcinoma of the small bowel', 1),
(13147, 'ORPHA:423968', 'Squamous cell carcinoma of the small intestine', 1),
(13148, 'ORPHA:423975', 'NET of the small intestine', 3),
(13149, 'ORPHA:423975', 'Neuroendocrine neoplasm of the small intestine', 3),
(13150, 'ORPHA:423975', 'Neuroendocrine tumor of small bowel', 3),
(13151, 'ORPHA:423975', 'Neuroendocrine tumor of the small intestine', 3),
(13152, 'ORPHA:423982', 'Appendiceal epithelial tumor', 3),
(13153, 'ORPHA:423982', 'Epithelial tumor of the appendix', 3),
(13154, 'ORPHA:423991', 'Rare epithelial tumor of colon', 3),
(13155, 'ORPHA:423994', 'Squamous cell carcinoma of the colon', 1),
(13156, 'ORPHA:423998', 'Rare epithelial tumor of rectum', 3),
(13157, 'ORPHA:423998', 'Rare rectal epithelial tumor', 3),
(13158, 'ORPHA:424', 'Familial hyperthyroidism due to mutations in TSH receptor', 1),
(13159, 'ORPHA:424', 'Familial non-immune hyperthyroidism', 1),
(13160, 'ORPHA:424', 'Resistance to thyroid stimulating hormone', 1),
(13161, 'ORPHA:424002', 'Rectal squamous cell carcinoma', 1),
(13162, 'ORPHA:424002', 'Squamous cell carcinoma of the rectum', 1),
(13163, 'ORPHA:424010', 'Epithelial tumor of anal canal', 3),
(13164, 'ORPHA:424013', 'Carcinoma of the anal canal', 3),
(13165, 'ORPHA:424016', 'Adenocarcinoma of the anal canal', 1),
(13166, 'ORPHA:424019', 'Squamous cell carcinoma of the anal canal', 1),
(13167, 'ORPHA:424027', 'EPM8', 1),
(13168, 'ORPHA:424027', 'PME type 8', 1),
(13169, 'ORPHA:424027', 'Progressive myoclonic epilepsy due to CERS1 deficiency', 1),
(13170, 'ORPHA:424027', 'Progressive myoclonic epilepsy type 8', 1),
(13171, 'ORPHA:424027', 'Progressive myoclonus epilepsy type 8', 1),
(13172, 'ORPHA:424033', 'Rare epithelial tumor of pancreas', 3),
(13173, 'ORPHA:424033', 'Rare pancreatic epithelial tumor', 3),
(13174, 'ORPHA:424039', 'Pancreatic squamous cell carcinoma', 1),
(13175, 'ORPHA:424039', 'Squamous cell carcinoma of pancreas', 1),
(13176, 'ORPHA:424046', 'Acinar cell carcinoma of pancreas', 1),
(13177, 'ORPHA:424046', 'Pancreatic acinar cell carcinoma', 1),
(13178, 'ORPHA:424053', 'Mucinous cystadenocarcinoma of the pancreas', 1),
(13179, 'ORPHA:424053', 'Pancreatic mucinous cystadenocarcinoma', 1),
(13180, 'ORPHA:424058', 'IPMN', 1),
(13181, 'ORPHA:424058', 'Intraductal papillary mucinous carcinoma of pancreas', 1),
(13182, 'ORPHA:424058', 'Pancreatic intraductal papillary mucinous carcinoma', 1),
(13183, 'ORPHA:424065', 'Pancreatic solid pseudopapillary carcinoma', 1),
(13184, 'ORPHA:424065', 'Solid pseudopapillary carcinoma of pancreas', 1),
(13185, 'ORPHA:424065', 'Solid pseudopapillary neoplasm of the pancreas', 1),
(13186, 'ORPHA:424073', 'Pancreatic serous cystadenocarcinoma', 1),
(13187, 'ORPHA:424073', 'Serous cystadenocarcinoma of pancreas', 1),
(13188, 'ORPHA:424080', 'OGCT of pancreas', 1),
(13189, 'ORPHA:424080', 'Osteoclastic giant cell tumor of pancreas', 1),
(13190, 'ORPHA:424080', 'Pancreatic osteoclastic giant cell tumor', 1),
(13191, 'ORPHA:424080', 'Pancreatic undifferentiated carcinoma with osteoclast-like giant cells', 1),
(13192, 'ORPHA:424080', 'Undifferentiated carcinoma of pancreas with osteoclast-like giant cells', 1),
(13193, 'ORPHA:424099', 'Colobomatous microphthalmia-rhizomelic dysplasia syndrome', 1),
(13194, 'ORPHA:424099', 'Microphthalmia-coloboma-rhizomelic skeletal dysplasia', 1),
(13195, 'ORPHA:424107', 'Congenital myopathy with myasthenic-like onset', 1),
(13196, 'ORPHA:424261', 'Autosomal recessive limb-girdle muscular dystrophy type 2Y', 1),
(13197, 'ORPHA:424261', 'Autosomal recessive muscular dystrophy due to LAP1B deficiency', 1),
(13198, 'ORPHA:424261', 'Autosomal recessive muscular dystrophy due to Torsin-1A-interacting protein 1 deficiency', 1),
(13199, 'ORPHA:424261', 'LGMD type 2Y', 1),
(13200, 'ORPHA:424261', 'LGMD2Y', 1),
(13201, 'ORPHA:424261', 'Muscular dystrophy with progressive weakness, distal contractures and rigid spine', 1),
(13202, 'ORPHA:424261', 'TOR1AIP1-related LGMD', 1),
(13203, 'ORPHA:424261', 'TOR1AIP1-related limb-girdle muscular dystrophy', 1),
(13204, 'ORPHA:424925', 'Qualitative or quantitative defects of Torsin-1A-interacting protein 1', 3),
(13205, 'ORPHA:424933', 'Rare malignant epithelial tumor of liver and IBT', 3),
(13206, 'ORPHA:424933', 'Rare malignant epithelial tumor of liver and intrahepatic biliary tract', 3),
(13207, 'ORPHA:424936', 'Carcinoma of liver and IBT', 3),
(13208, 'ORPHA:424936', 'Carcinoma of liver and intrahepatic biliary tract', 3),
(13209, 'ORPHA:424943', 'Adenocarcinoma of the liver and IBT', 1),
(13210, 'ORPHA:424943', 'Adenocarcinoma of the liver and intrahepatic biliary tract', 1),
(13211, 'ORPHA:424970', 'Undifferentiated carcinoma of liver and IBT', 1),
(13212, 'ORPHA:424970', 'Undifferentiated carcinoma of liver and intrahepatic biliary tract', 1),
(13213, 'ORPHA:424975', 'Squamous cell carcinoma of liver and IBT', 1),
(13214, 'ORPHA:424975', 'Squamous cell carcinoma of liver and intrahepatic biliary tract', 1),
(13215, 'ORPHA:424982', 'Biliary cystadenocarcinoma', 1),
(13216, 'ORPHA:424982', 'Intrahepatic bile duct cystadenocarcinoma', 1),
(13217, 'ORPHA:424991', 'Adenocarcinoma of the gallbladder and EBT', 1),
(13218, 'ORPHA:424991', 'Adenocarcinoma of the gallbladder and extrahepatic biliary tract', 1),
(13219, 'ORPHA:424996', 'Squamous cell carcinoma of gallbladder and extrahepatic biliary tract', 1),
(13220, 'ORPHA:424996', 'Squamous cell carcinoma of gallblader and EBT', 1),
(13221, 'ORPHA:425', 'ApoA-I deficiency', 1),
(13222, 'ORPHA:425', 'Apolipoprotein A-I deficiency', 1),
(13223, 'ORPHA:425', 'Familial apoA-I deficiency', 1),
(13224, 'ORPHA:425', 'Familial hypoalphalipoproteinemia', 1),
(13225, 'ORPHA:425003', 'Inherited digestive cancer-predisposing syndrome', 3),
(13226, 'ORPHA:425120', 'SAVI', 1),
(13227, 'ORPHA:425120', 'STING-associated vasculopathy with onset in infancy', 1),
(13228, 'ORPHA:425368', 'Rare epithelial tumor of small bowel', 3),
(13229, 'ORPHA:425368', 'Rare epithelial tumor of small intestine', 3),
(13230, 'ORPHA:42642', 'Marshall syndrome with periodic fever', 1),
(13231, 'ORPHA:42642', 'PFAPA syndrome', 1),
(13232, 'ORPHA:42642', 'Periodic fever-aphtous stomatitis-pharyngitis-adenopathy syndrome', 1),
(13233, 'ORPHA:42665', 'Hypopigmentation-deafness syndrome', 1),
(13234, 'ORPHA:42665', 'Hypopigmentation-hearing loss syndrome', 1),
(13235, 'ORPHA:42665', 'Tietz syndrome', 1),
(13236, 'ORPHA:427', 'Familial hypoaldosteronism', 1),
(13237, 'ORPHA:42738', 'Severe congenital neutropenia', 3),
(13238, 'ORPHA:42775', 'PHACE syndrome', 1),
(13239, 'ORPHA:42775', 'PHACES syndrome', 1),
(13240, 'ORPHA:42775', 'Pascual-Castroviejo syndrome type 2', 1),
(13241, 'ORPHA:428', 'AD hypocalcemia', 2),
(13242, 'ORPHA:428', 'Autosomal dominant hypocalcemia', 2),
(13243, 'ORPHA:429', 'Hypochondroplasia', 1),
(13244, 'ORPHA:43', 'ALD', 1),
(13245, 'ORPHA:43', 'X-ALD', 1),
(13246, 'ORPHA:43', 'X-linked ALD', 1),
(13247, 'ORPHA:43', 'X-linked adrenoleukodystrophy', 1),
(13248, 'ORPHA:431140', 'X-linked colobomatous microphthalmia-microcephaly-intellectual disability-short stature syndrome', 1),
(13249, 'ORPHA:431140', 'X-linked colobomatous microphthalmia-microcephaly-short stature-psychomotor retardation syndrome', 1),
(13250, 'ORPHA:431149', 'Combined immunodeficiency due to OX40 deficiency', 1),
(13251, 'ORPHA:431149', 'Combined immunodeficiency with childhood-onset Kaposi sarcoma', 1),
(13252, 'ORPHA:431149', 'Combined immunodeficiency with impaired immunity to HHV-8', 1),
(13253, 'ORPHA:431149', 'Combined immunodeficiency with impaired immunity to human herpes virus 8', 1),
(13254, 'ORPHA:43115', 'Aconitase deficiency', 1),
(13255, 'ORPHA:43115', 'Hereditary myopathy with lactic acidosis due to ISCU deficiency', 1),
(13256, 'ORPHA:43115', 'ISCU myopathy', 1),
(13257, 'ORPHA:43115', 'Iron-sulfur cluster deficiency myopathy', 1),
(13258, 'ORPHA:43115', 'Myopathy with exercise intolerance, Swedish type', 1),
(13259, 'ORPHA:431156', 'Primary immunodeficiency with predisposition to severe viral infection', 3),
(13260, 'ORPHA:43116', 'Serotonergic syndrome', 1),
(13261, 'ORPHA:43116', 'Serotonin storm', 1),
(13262, 'ORPHA:43116', 'Serotonin syndrome', 1),
(13263, 'ORPHA:43116', 'Serotonin toxicity', 1),
(13264, 'ORPHA:43116', 'Serotonin toxidrome', 1),
(13265, 'ORPHA:431166', 'Primary immunodeficiency with post-MMR vaccine viral infection', 1),
(13266, 'ORPHA:431166', 'Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection', 1),
(13267, 'ORPHA:43117', 'Acute tricyclic antidepressant poisoning', 1),
(13268, 'ORPHA:43119', 'Acute poisoning by drugs with membrane-stabilizing effect', 1),
(13269, 'ORPHA:431255', 'Neurogenic scapuloperoneal amyotrophy, New England type', 1),
(13270, 'ORPHA:431255', 'SPSMA', 1),
(13271, 'ORPHA:431255', 'Scapuloperoneal neuronopathy', 1),
(13272, 'ORPHA:431255', 'Scapuloperoneal spinal muscular atrophy', 1),
(13273, 'ORPHA:431263', 'Late-onset SPMD with hyaline bodies', 3),
(13274, 'ORPHA:431263', 'Late-onset scapuloperoneal muscular dystrophy with hyaline bodies', 3),
(13275, 'ORPHA:431263', 'Late-onset scapuloperoneal syndrome, myopathic type', 3),
(13276, 'ORPHA:431272', 'X-linked SPMD', 1),
(13277, 'ORPHA:431272', 'X-linked scapuloperoneal muscular dystrophy', 1),
(13278, 'ORPHA:431272', 'X-linked scapuloperoneal syndrome', 1),
(13279, 'ORPHA:431320', 'SPOAN and SPOAN-related disorder', 3),
(13280, 'ORPHA:431320', 'Spastic paraplegia-optic atrophy-neuropathy and spastic paraplegia-optic atrophy-neuropathy-related disorder', 3),
(13281, 'ORPHA:431329', 'Autosomal recessive spastic paraplegia type 57', 1),
(13282, 'ORPHA:431329', 'SPG57', 1),
(13283, 'ORPHA:431329', 'Spastic paraplegia due to partial TFG deficiency', 1),
(13284, 'ORPHA:431341', 'Patent urachus', 1),
(13285, 'ORPHA:431344', 'Urachal sinus', 1),
(13286, 'ORPHA:431347', 'Urachal diverticulum', 1),
(13287, 'ORPHA:431347', 'Vesicourachal diverticulum', 1),
(13288, 'ORPHA:431353', 'Pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis', 3),
(13289, 'ORPHA:431361', '2,4-dienoyl-CoA reductase deficiency', 1),
(13290, 'ORPHA:431361', 'DECR deficiency with hyperlysinemia', 1),
(13291, 'ORPHA:431361', 'Progressive encephalopathy with leukodystrophy due to DECR deficiency', 1),
(13292, 'ORPHA:432', 'Normosmic congenital hypogonadotropic hypogonadism', 2),
(13293, 'ORPHA:432', 'Normosmic idiopathic hypogonadotropic hypogonadism', 2),
(13294, 'ORPHA:432', 'nIHH', 2),
(13295, 'ORPHA:43393', 'Lambert-Eaton myasthenic syndrome', 1),
(13296, 'ORPHA:434179', 'Microcephaly-cerebral malformation-orofaciodigital syndrome', 1),
(13297, 'ORPHA:434179', 'OFD14', 1),
(13298, 'ORPHA:434179', 'Oral-facial-digital syndrome type 14', 1),
(13299, 'ORPHA:434179', 'Orofaciodigital syndrome type 14', 1),
(13300, 'ORPHA:434786', 'Rare genetic autonomic nervous system disorder', 3),
(13301, 'ORPHA:434809', 'Syndrome with woolly hair', 3),
(13302, 'ORPHA:435329', 'Familial ossifying fibroma', 1),
(13303, 'ORPHA:435329', 'Multiple ossifying fibroma', 1),
(13304, 'ORPHA:435365', 'Fetal lower urinary tract obstruction', 3),
(13305, 'ORPHA:435365', 'LUTO', 3),
(13306, 'ORPHA:435372', 'Anterior urethral valve', 1),
(13307, 'ORPHA:435387', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to VCP mutation', 1),
(13308, 'ORPHA:435387', 'Autosomal dominant Charcot-Marie-Tooth disease type 2Y', 1),
(13309, 'ORPHA:435387', 'CMT2 due to VCP mutation', 1),
(13310, 'ORPHA:435387', 'CMT2Y', 1),
(13311, 'ORPHA:435438', 'EPM7', 1),
(13312, 'ORPHA:435438', 'MEAK', 1),
(13313, 'ORPHA:435438', 'Myoclonus epilepsy and ataxia due to potassium channel mutation', 1),
(13314, 'ORPHA:435438', 'PME type 7', 1),
(13315, 'ORPHA:435438', 'Progressive myoclonic epilepsy due to KV3.1 deficiency', 1),
(13316, 'ORPHA:435438', 'Progressive myoclonic epilepsy type 7', 1),
(13317, 'ORPHA:435438', 'Progressive myoclonus epilepsy type 7', 1),
(13318, 'ORPHA:435554', 'Genetic precocious puberty', 3),
(13319, 'ORPHA:435561', 'Precocious puberty in female', 3),
(13320, 'ORPHA:435564', 'Genetic precocious puberty in female', 3),
(13321, 'ORPHA:435603', 'Genetic otorhinolaryngological malformation', 3),
(13322, 'ORPHA:435606', 'Genetic nose and cavum anomaly', 3),
(13323, 'ORPHA:435609', 'Genetic larynx anomaly', 3),
(13324, 'ORPHA:435612', 'Genetic tracheal anomaly', 3),
(13325, 'ORPHA:435628', 'Generalized lipodystrophy-progeroid features-severe intellectual disability syndrome', 1),
(13326, 'ORPHA:435628', 'Keppen-Lubinsky syndrome', 1),
(13327, 'ORPHA:435638', '3p25.3 microdeletion syndrome', 1),
(13328, 'ORPHA:435638', 'Del(3)p(25.3)', 1),
(13329, 'ORPHA:435638', 'Intellectual disability-epilepsy-stereotypic hand movement syndrome', 1),
(13330, 'ORPHA:435638', 'Monosomy 3p25.3', 1),
(13331, 'ORPHA:435651', 'CIDEC-related FPLD', 1),
(13332, 'ORPHA:435651', 'CIDEC-related familial partial lipodystrophy', 1),
(13333, 'ORPHA:435651', 'FPLD5', 1),
(13334, 'ORPHA:435660', 'FPLD6', 1),
(13335, 'ORPHA:435660', 'LIPE-related FPLD', 1),
(13336, 'ORPHA:435660', 'LIPE-related familial partial lipodystrophy', 1),
(13337, 'ORPHA:435743', 'Congenital urachal anomaly', 3),
(13338, 'ORPHA:435804', 'Short stature-advanced bone age-early-onset osteoarthritis syndrome', 1),
(13339, 'ORPHA:435819', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation', 1),
(13340, 'ORPHA:435819', 'CMT2 due to TFG mutation', 1),
(13341, 'ORPHA:435845', 'Lethal neonatal rigidity-multifocal seizure syndrome', 1),
(13342, 'ORPHA:435845', 'Lethal neonatal spasticity-epileptic encephalopathy syndrome', 1),
(13343, 'ORPHA:435930', 'Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome', 1),
(13344, 'ORPHA:435934', 'COG2-CDG', 1),
(13345, 'ORPHA:435934', 'COG2-related congenital disorder of glycosylation', 1),
(13346, 'ORPHA:435938', 'X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome', 1),
(13347, 'ORPHA:435953', 'Progeroid features-hepatocellular carcinoma predisposition syndrome', 1),
(13348, 'ORPHA:435953', 'Ruijs-Aalfs syndrome', 1),
(13349, 'ORPHA:435988', 'CAID syndrome', 1),
(13350, 'ORPHA:435988', 'Chronic atrial and intestinal dysrhythmia syndrome', 1),
(13351, 'ORPHA:435988', 'Chronic atrial dysrhythmia-intestinal motility disorder', 1),
(13352, 'ORPHA:435998', 'Autosomal recessive intermediate Charcot-Marie-Tooth disease type D', 1),
(13353, 'ORPHA:435998', 'RI-CMT type D', 1),
(13354, 'ORPHA:436', 'HPP', 1),
(13355, 'ORPHA:436', 'Hypophosphatasia', 1),
(13356, 'ORPHA:436', 'Phosphoethanolaminuria', 1),
(13357, 'ORPHA:436', 'Rathbun disease', 1),
(13358, 'ORPHA:436003', '5q23 microdeletion syndrome', 1),
(13359, 'ORPHA:436003', 'Contractures-developmental delay-Pierre Robin syndrome', 1),
(13360, 'ORPHA:436141', 'Severe intellectual disability-hypotonia-strabismus-coarse face-planovalgus syndrome', 1),
(13361, 'ORPHA:436144', 'Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome', 1),
(13362, 'ORPHA:436151', 'Intellectual disability-expressive aphasia-facial dysmorphism syndrome', 1),
(13363, 'ORPHA:436151', 'Intellectual disability-loss of expressive language-facial dysmorphism syndrome', 1),
(13364, 'ORPHA:436159', 'ALPS due to CTLA4 haploinsuffiency', 1),
(13365, 'ORPHA:436159', 'Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency', 1),
(13366, 'ORPHA:436159', 'CHAI', 1),
(13367, 'ORPHA:436159', 'CTLA-4 haploinsufficiency with autoimmune infiltration disease', 1),
(13368, 'ORPHA:436166', 'NLRC4-related MAS', 1),
(13369, 'ORPHA:436166', 'NLRC4-related autoinflammatory syndrome with MAS', 1),
(13370, 'ORPHA:436166', 'NLRC4-related autoinflammatory syndrome with macrophage activation syndrome', 1),
(13371, 'ORPHA:436166', 'NLRC4-related infantile enterocolitis-autoinflammatory syndrome', 1),
(13372, 'ORPHA:436166', 'NLRC4-related macrophage activation syndrome', 1),
(13373, 'ORPHA:436166', 'Periodic fever-infantile enterocolitis-autoinflammatory syndrome', 1),
(13374, 'ORPHA:436169', 'THBD-related bleeding disorder', 1),
(13375, 'ORPHA:436169', 'THBD-related coagulopathy', 1),
(13376, 'ORPHA:436169', 'Thrombomodulin-related bleeding disorder', 1),
(13377, 'ORPHA:436169', 'Thrombomodulin-related coagulopathy', 1),
(13378, 'ORPHA:436174', 'CAGSSS', 1),
(13379, 'ORPHA:436174', 'Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome', 1),
(13380, 'ORPHA:436182', 'Microcephalic primordial dwarfism-insulin resistance syndrome', 1),
(13381, 'ORPHA:436242', 'Familial atrial tachyarrhythmia-infra-Hisian cardiac conduction disease', 1),
(13382, 'ORPHA:436245', 'Retinal dystrophy-juvenile cataract-short stature syndrome', 1),
(13383, 'ORPHA:436245', 'Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome', 1),
(13384, 'ORPHA:436252', 'CID-MIA/early-onset IBD', 1),
(13385, 'ORPHA:436252', 'Combined immunodeficiency-enteropathy spectrum', 1),
(13386, 'ORPHA:436271', 'Non-progressive predominantly posterior cavitating leukoencephalopathy with peripheral neuropathy', 1),
(13387, 'ORPHA:436274', 'PXE-like syndrome with retinitis pigmentosa', 1),
(13388, 'ORPHA:436274', 'Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa', 1),
(13389, 'ORPHA:437', 'Hypophosphatemic rickets', 3),
(13390, 'ORPHA:437552', 'Autosomal recessive primary immunodeficiency with defective spontaneous NK cell cytotoxicity', 1),
(13391, 'ORPHA:437552', 'Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity', 1),
(13392, 'ORPHA:437552', 'CD16 deficiency', 1),
(13393, 'ORPHA:437572', 'MYH7-related late-onset SPMD', 1),
(13394, 'ORPHA:437572', 'MYH7-related late-onset scapuloperoneal muscular dystrophy', 1),
(13395, 'ORPHA:437572', 'MYH7-related late-onset scapuloperoneal syndrome', 1),
(13396, 'ORPHA:438072', 'Disorder of keton body transport', 3),
(13397, 'ORPHA:438075', 'Ketoacidosis due to monocarboxylate transporter-1 deficiency', 1),
(13398, 'ORPHA:438114', 'RARS-related autosomal recessive hypomyelinating leukodystrophy', 1),
(13399, 'ORPHA:438117', 'Bilateral hip and radial head dislocations-short stature-scoliosis-carpal coalitions-pes cavus-facial dysmorphism syndrome', 1),
(13400, 'ORPHA:438117', 'Steel syndrome', 1),
(13401, 'ORPHA:438134', 'PCNA-related progressive neurodegenerative photosensitivity syndrome', 1),
(13402, 'ORPHA:438159', 'STAT3-related early-onset multisystem autoimmune disease', 1),
(13403, 'ORPHA:438178', 'FAR1 deficiency', 1),
(13404, 'ORPHA:438178', 'Fatty acyl-CoA reductase 1 deficiency', 1),
(13405, 'ORPHA:438178', 'PFCRD', 1),
(13406, 'ORPHA:438178', 'Peroxisomal fatty acyl-CoA reductase 1 disorder', 1),
(13407, 'ORPHA:438207', 'Severe autosomal recessive macrothrombocytopenia', 1),
(13408, 'ORPHA:438213', 'PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome', 1),
(13409, 'ORPHA:438216', 'PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation', 2),
(13410, 'ORPHA:438266', 'PERM', 2),
(13411, 'ORPHA:438266', 'Progressive encephalomyelitis with rigidity and myoclonus', 2),
(13412, 'ORPHA:438274', 'GCGR-related hyperglucagonemia', 1),
(13413, 'ORPHA:438274', 'Mahvash disease', 1),
(13414, 'ORPHA:438279', 'Human infection by orthopoxvirus', 1),
(13415, 'ORPHA:439', 'Isolated right ventricular hypoplasia', 1),
(13416, 'ORPHA:439167', 'Placental insufficiency', 1),
(13417, 'ORPHA:439167', 'Uteroplacental vascular insufficiency', 1),
(13418, 'ORPHA:439175', 'Childhood AIS', 1),
(13419, 'ORPHA:439175', 'Childhood arterial ischemic stroke', 1),
(13420, 'ORPHA:439175', 'Pediatric AIS', 1),
(13421, 'ORPHA:439175', 'Pediatric arterial ischemic stroke', 1),
(13422, 'ORPHA:439196', 'NAE', 1),
(13423, 'ORPHA:439196', 'Necrolytic acral erythema', 1),
(13424, 'ORPHA:439196', 'Zinc-responsive necrolytic acral erythema', 1),
(13425, 'ORPHA:439202', 'Chronic obstetric brachial plexus injury', 1),
(13426, 'ORPHA:439202', 'Chronic obstetric brachial plexus palsy', 1),
(13427, 'ORPHA:439202', 'Non-recovering OBPI', 1),
(13428, 'ORPHA:439202', 'Non-recovering OBPL', 1),
(13429, 'ORPHA:439202', 'Non-recovering obstetric brachial plexus lesion', 1),
(13430, 'ORPHA:439212', 'EMARDD', 1),
(13431, 'ORPHA:439212', 'Early-onset myopathy-areflexia-respiratory distress-dysphagia syndrome', 1),
(13432, 'ORPHA:439218', 'KCNQ2-NEE', 1),
(13433, 'ORPHA:439218', 'KCNQ2-related epileptic encephalopathy', 1),
(13434, 'ORPHA:439218', 'KCNQ2-related neonatal epileptic encephalopathy', 1),
(13435, 'ORPHA:439224', 'ALECT2 amyloidosis', 1),
(13436, 'ORPHA:439224', 'Leukocyte chemotactic factor-2 amyloidosis', 1),
(13437, 'ORPHA:439232', 'AApoAIV amyloidosis', 1),
(13438, 'ORPHA:439232', 'Apolipoprotein A-IV amyloidosis', 1),
(13439, 'ORPHA:439246', 'ABeta2M amyloidosis', 3),
(13440, 'ORPHA:439246', 'Beta2-microglobulinic amyloidosis', 3),
(13441, 'ORPHA:439254', 'Familial cerebral amyloid angiopathy', 1),
(13442, 'ORPHA:439254', 'ITM2B amyloidosis', 1),
(13443, 'ORPHA:439254', 'ITM2B-related amyloidosis', 1),
(13444, 'ORPHA:439254', 'ITM2B-related cerebral amyloid angiopathy', 1),
(13445, 'ORPHA:439729', 'Cutaneous PAN', 2),
(13446, 'ORPHA:439729', 'Cutaneous periarteritis nodosa', 2),
(13447, 'ORPHA:439729', 'Cutaneous polyarteritis nodosa', 2),
(13448, 'ORPHA:439737', 'Primary PAN', 2),
(13449, 'ORPHA:439737', 'Primary periarteritis nodosa', 2),
(13450, 'ORPHA:439737', 'Primary polyarteritis nodosa', 2),
(13451, 'ORPHA:439746', 'Secondary PAN', 2),
(13452, 'ORPHA:439746', 'Secondary periarteritis nodosa', 2),
(13453, 'ORPHA:439746', 'Secondary polyarteritis nodosa', 2),
(13454, 'ORPHA:439755', 'Single-organ PAN', 2),
(13455, 'ORPHA:439755', 'Single-organ periarteritis nodosa', 2),
(13456, 'ORPHA:439755', 'Single-organ polyarteritis nodosa', 2),
(13457, 'ORPHA:439762', 'Systemic PAN', 2),
(13458, 'ORPHA:439762', 'Systemic periarteritis nodosa', 2),
(13459, 'ORPHA:439762', 'Systemic polyarteritis nodosa', 2),
(13460, 'ORPHA:439822', 'PDE4D haploinsufficiency syndrome', 1),
(13461, 'ORPHA:439849', 'Autosomal recessive severe congenital neutropenia', 3),
(13462, 'ORPHA:439854', 'Fatal congenital hypertrophic cardiomyopathy due to GSD', 1),
(13463, 'ORPHA:439854', 'Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease', 1),
(13464, 'ORPHA:439854', 'Fatal congenital hypertrophic cardiomyopathy due to glycogenosis', 1),
(13465, 'ORPHA:439881', 'Croupous bronchitis', 1),
(13466, 'ORPHA:439881', 'Fibrinous bronchitis', 1),
(13467, 'ORPHA:439881', 'Plastic bronchitis', 1),
(13468, 'ORPHA:439881', 'Pseudo-membranous bronchitis', 1),
(13469, 'ORPHA:439897', 'Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome', 1),
(13470, 'ORPHA:44', 'NALD', 1),
(13471, 'ORPHA:44', 'Neonatal adrenoleukodystrophy', 1),
(13472, 'ORPHA:440221', 'Congenital CNIII lesion', 1),
(13473, 'ORPHA:440221', 'Congenital oculomotor nerve palsy', 1),
(13474, 'ORPHA:440221', 'Congenital third cranial nerve palsy', 1),
(13475, 'ORPHA:440233', 'Benign congenital sixth cranial nerve palsy', 1),
(13476, 'ORPHA:440233', 'Congenital CNVI palsy', 1),
(13477, 'ORPHA:440233', 'Congenital abducens nerve palsy', 1),
(13478, 'ORPHA:440354', 'Autosomal dominant myopia-midfacial retrusion-sensorineural deafness-rhizomelic dysplasia syndrome', 1),
(13479, 'ORPHA:440354', 'Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome', 1),
(13480, 'ORPHA:440368', 'NSTI', 1),
(13481, 'ORPHA:440368', 'Necrotizing soft tissue infection', 1),
(13482, 'ORPHA:440392', 'Interstitial lung disease due to SP-C deficiency', 1),
(13483, 'ORPHA:440392', 'Interstitial lung disease due to surfactant protein C deficiency', 1),
(13484, 'ORPHA:440402', 'Interstitial lung disease due to ABCA3 deficiency', 1),
(13485, 'ORPHA:440402', 'Interstitial lung disease due to ATP-binding cassette subfamily A member 3 deficiency', 1),
(13486, 'ORPHA:440427', 'Hereditary pulmonary alveolar proteinosis with hepatic involvement', 1),
(13487, 'ORPHA:440427', 'Interstitial lung and liver disease', 1),
(13488, 'ORPHA:440427', 'PAP, Reunion island type', 1),
(13489, 'ORPHA:440427', 'Pulmonary alveolar proteinosis, Reunion island type', 1),
(13490, 'ORPHA:440427', 'Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency', 1),
(13491, 'ORPHA:440437', 'FCCTX', 1),
(13492, 'ORPHA:440437', 'Familial colorectal cancer Type X', 1),
(13493, 'ORPHA:440701', 'Disorders of pentose/polyol metabolism', 3),
(13494, 'ORPHA:440706', 'Ribose-5-P isomerase deficiency', 1),
(13495, 'ORPHA:440713', 'Isolated SHPK deficiency', 1),
(13496, 'ORPHA:440713', 'Isolated sedoheptulokinase deficiency', 1),
(13497, 'ORPHA:440724', 'Extensive peripapillary myelinated nerve fibers', 1),
(13498, 'ORPHA:440727', 'CHR-RPE', 1),
(13499, 'ORPHA:440727', 'Combined hamartoma of the retina and RPE', 1),
(13500, 'ORPHA:440727', 'Combined hamartoma of the retina and retinal pigment epithelium', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(13501, 'ORPHA:440731', 'L-ferritin deficiency', 1),
(13502, 'ORPHA:440987', 'Isolated agenesis of gallbladder', 1),
(13503, 'ORPHA:441', 'Bradbury-Eggleston syndrome', 1),
(13504, 'ORPHA:441', 'Idiopathic orthostatic hypotension', 1),
(13505, 'ORPHA:441', 'PAF', 1),
(13506, 'ORPHA:441', 'Pure autonomic failure', 1),
(13507, 'ORPHA:441', 'Pure dysautonomia', 1),
(13508, 'ORPHA:441', 'Pure idiopatic dysautonomia', 1),
(13509, 'ORPHA:441434', 'Syndromic hereditary optic neuropathy', 3),
(13510, 'ORPHA:441447', 'Early-onset posterior subcapsular cataract', 2),
(13511, 'ORPHA:441452', 'Early-onset lamellar cataract', 2),
(13512, 'ORPHA:442', 'Congenital hypothyroidism', 3),
(13513, 'ORPHA:442582', 'AH amyloidosis', 1),
(13514, 'ORPHA:442582', 'Heavy chain amyloidosis', 1),
(13515, 'ORPHA:442835', 'Undetermined EOEE', 1),
(13516, 'ORPHA:442835', 'Undetermined early-onset epileptic encephalopathy', 1),
(13517, 'ORPHA:443057', 'Porphyria cutanea tarda type I', 2),
(13518, 'ORPHA:443057', 'Sporadic porphyria cutanea tarda', 2),
(13519, 'ORPHA:443062', 'Familial porphyria cutanea tarda', 2),
(13520, 'ORPHA:443062', 'Porphyria cutanea tarda type II', 2),
(13521, 'ORPHA:443070', 'Hemicrania continua', 1),
(13522, 'ORPHA:443073', 'CMT2S', 1),
(13523, 'ORPHA:443073', 'Charcot-Marie-Tooth disease type 2S', 1),
(13524, 'ORPHA:443079', 'CSCR', 1),
(13525, 'ORPHA:443079', 'Central serous chorioretinopathy', 1),
(13526, 'ORPHA:443084', 'Baroreflex failure', 1),
(13527, 'ORPHA:443087', '46,XY disorder of sex development due to testicular 17,20-desmolase deficiency', 1),
(13528, 'ORPHA:443090', '46,XY disorder of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect', 3),
(13529, 'ORPHA:443095', 'Hyperinsulinemic hypoglycaemia', 3),
(13530, 'ORPHA:443098', 'Hyperostosis cranialis interna', 1),
(13531, 'ORPHA:443101', 'Hypothalamic adipsic hypernatraemia syndrome', 1),
(13532, 'ORPHA:443159', 'Lymphoplasmacytic lymphoma without IgM production', 1),
(13533, 'ORPHA:443159', 'Lymphoplasmacytic lymphoma without Immunoglobulin M production', 1),
(13534, 'ORPHA:443162', 'MHAC', 1),
(13535, 'ORPHA:443162', 'NDE1-related microhydranencephaly', 1),
(13536, 'ORPHA:443167', 'NMC', 1),
(13537, 'ORPHA:443167', 'NUT midline carcinoma', 1),
(13538, 'ORPHA:443173', 'Postpartum psychosis', 1),
(13539, 'ORPHA:443173', 'Puerperal psychosis', 1),
(13540, 'ORPHA:443180', 'Spontaneous cerebrospinal fluid leak', 1),
(13541, 'ORPHA:443180', 'Spontaneous intracranial hypotension', 1),
(13542, 'ORPHA:443192', 'Classic SPS', 2),
(13543, 'ORPHA:443192', 'Classic stiff person syndrome', 2),
(13544, 'ORPHA:443197', 'X-linked dominant erythropoietic protoporphyria', 1),
(13545, 'ORPHA:443197', 'X-linked dominant protoporphyria', 1),
(13546, 'ORPHA:443197', 'X-linked erythropoietic protoporphyria', 1),
(13547, 'ORPHA:443197', 'XLDPP', 1),
(13548, 'ORPHA:443197', 'XLP', 1),
(13549, 'ORPHA:443197', 'XLPP', 1),
(13550, 'ORPHA:443227', 'Paratyphoid fever', 1),
(13551, 'ORPHA:443236', 'Familial orthostatic tachycardia due to norepinephrine transporter deficiency', 1),
(13552, 'ORPHA:443236', 'Orthostatic intolerance due to NET deficiency', 1),
(13553, 'ORPHA:443236', 'POTS due to NET deficiency', 1),
(13554, 'ORPHA:443236', 'Postural orthostatic tachycardia syndrome due to NET deficiency', 1),
(13555, 'ORPHA:443287', 'ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor', 3),
(13556, 'ORPHA:443291', 'HIV-associated cancer', 1),
(13557, 'ORPHA:443291', 'HIV-related cancer', 1),
(13558, 'ORPHA:443804', 'Focal stiff limb syndrome', 2),
(13559, 'ORPHA:443804', 'Focal stiff-person syndrome', 2),
(13560, 'ORPHA:443804', 'Stiff leg syndrome', 2),
(13561, 'ORPHA:443811', 'CID due to PGM3 deficiency', 1),
(13562, 'ORPHA:443811', 'Combined immunodeficiency due to PGM3 deficiency', 1),
(13563, 'ORPHA:443811', 'PGM3-CDG', 1),
(13564, 'ORPHA:443811', 'PGM3-related congenital disorder of glycosylation', 1),
(13565, 'ORPHA:443909', 'Familial nonpolyposis colon cancer', 3),
(13566, 'ORPHA:443909', 'Familial nonpolyposis colorectal cancer', 3),
(13567, 'ORPHA:443909', 'HNPCC', 3),
(13568, 'ORPHA:443909', 'Hereditary nonpolyposis colon cancer', 3),
(13569, 'ORPHA:443909', 'Hereditary nonpolyposis colorectal cancer', 3),
(13570, 'ORPHA:443950', 'DNAJB2-related CMT2', 1),
(13571, 'ORPHA:443950', 'DNAJB2-related Charcot-Marie-Tooth disease type 2', 1),
(13572, 'ORPHA:443988', 'Congenital nephrosis-cerebral ventriculomegaly syndrome', 1),
(13573, 'ORPHA:443988', 'VMCKD', 1),
(13574, 'ORPHA:443988', 'Ventriculomegaly-cystic kidney disease', 1),
(13575, 'ORPHA:443995', 'MFDA', 1),
(13576, 'ORPHA:443995', 'Mandibulofacial dysostosis with alopecia', 1),
(13577, 'ORPHA:444', 'Hypotrichosis, Marie Unna type', 1),
(13578, 'ORPHA:444', 'MUHH', 1),
(13579, 'ORPHA:444', 'Marie Unna congenital hypotrichosis', 1),
(13580, 'ORPHA:444', 'Marie Unna hereditary hypotrichosis', 1),
(13581, 'ORPHA:444002', '11q22.2q22.3 microdeletion syndrome', 1),
(13582, 'ORPHA:444002', 'Del(11)(q22.2q22.3)', 1),
(13583, 'ORPHA:444002', 'Monosomy 11q22.2q22.3', 1),
(13584, 'ORPHA:444013', 'COXPD23', 1),
(13585, 'ORPHA:444013', 'Combined oxidative phosphorylation defect type 23', 1),
(13586, 'ORPHA:444048', '46,XX ovarian dysgenesis-short stature syndrome', 1),
(13587, 'ORPHA:444051', '20q11.2 microdeletion syndrome', 1),
(13588, 'ORPHA:444051', 'Del(20)(q11.2)', 1),
(13589, 'ORPHA:444051', 'Monosomy 20q11', 1),
(13590, 'ORPHA:444069', 'Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome', 1),
(13591, 'ORPHA:444072', 'Cerebellar-facial-dental syndrome', 1),
(13592, 'ORPHA:444072', 'Cerebellofaciodental syndrome', 1),
(13593, 'ORPHA:444077', 'CHOPS syndrome', 1),
(13594, 'ORPHA:444077', 'Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome', 1),
(13595, 'ORPHA:444092', 'Autoimmune interstitial lung disease-arthritis syndrome', 1),
(13596, 'ORPHA:444092', 'COPA syndrome', 1),
(13597, 'ORPHA:444099', 'Autosomal dominant spastic paraplegia type 73', 1),
(13598, 'ORPHA:444099', 'SPG73', 1),
(13599, 'ORPHA:444116', 'Hereditary amyloidosis', 3),
(13600, 'ORPHA:444138', 'PLACK syndrome', 1),
(13601, 'ORPHA:444138', 'Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome', 1),
(13602, 'ORPHA:444316', 'Idiopathic phalangeal acro-osteolysis', 1),
(13603, 'ORPHA:444316', 'Idiopathic phalangeal acroosteolysis', 1),
(13604, 'ORPHA:444458', 'COXPD24', 1),
(13605, 'ORPHA:444458', 'Combined oxidative phosphorylation defect type 24', 1),
(13606, 'ORPHA:444463', 'Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome', 1),
(13607, 'ORPHA:444463', 'Evans syndrome associated with primary immunodeficiency', 1),
(13608, 'ORPHA:444463', 'TPPII deficiency', 1),
(13609, 'ORPHA:444463', 'TPPII-related immunodeficiency, autoimmunity, and neurodevelopmental delay with impaired glycolysis and lysosomal expansion disease', 1),
(13610, 'ORPHA:444463', 'TRIANGLE disease', 1),
(13611, 'ORPHA:444463', 'Tripeptidyl-peptidase II deficiency', 1),
(13612, 'ORPHA:444490', 'Familial chylomicronemia syndrome', 1),
(13613, 'ORPHA:444916', 'Pseudohypoaldosteronism', 3),
(13614, 'ORPHA:444941', 'Caudal regression-sirenomelia spectrum', 3),
(13615, 'ORPHA:445018', 'CID due to LRBA deficiency', 1),
(13616, 'ORPHA:445018', 'Combined immunodeficiency due to LRBA deficiency', 1),
(13617, 'ORPHA:445038', '3-methylglutaconic aciduria type 7', 1),
(13618, 'ORPHA:445038', '3-methylglutaconic aciduria-cataract-neurologic involvement-neutropenia syndrome', 1),
(13619, 'ORPHA:445038', 'MGA7', 1),
(13620, 'ORPHA:445062', 'Combined cerebellar and peripheral ataxia-deafness-diabetes mellitus syndrome', 1),
(13621, 'ORPHA:445062', 'Combined cerebellar and peripheral ataxia-hearing loss-diabetes mellitus syndrome', 1),
(13622, 'ORPHA:445062', 'Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome', 1),
(13623, 'ORPHA:445110', 'LGMD due to POMK deficiency', 1),
(13624, 'ORPHA:445110', 'Limb-girdle muscular dystrophy due to POMK deficiency', 1),
(13625, 'ORPHA:445197', 'Secondary vasculitis', 3),
(13626, 'ORPHA:446', 'Neonatal hemochromatosis', 1),
(13627, 'ORPHA:447', 'Marchiafava-Micheli disease', 1),
(13628, 'ORPHA:447', 'PNH', 1),
(13629, 'ORPHA:447', 'Paroxysmal nocturnal hemoglobinuria', 1),
(13630, 'ORPHA:447731', 'NIK deficiency', 1),
(13631, 'ORPHA:447731', 'Primary immunodeficiency with multifaceted aberrant lymphoid immunity', 1),
(13632, 'ORPHA:447737', 'DOCK2 deficiency', 1),
(13633, 'ORPHA:447740', 'Susceptibility to localized juvenile periodontitis', 1),
(13634, 'ORPHA:447753', 'AD-SPG9A', 1),
(13635, 'ORPHA:447753', 'Autosomal dominant spastic paraplegia type 9A', 1),
(13636, 'ORPHA:447753', 'Cataracts-motor neuropathy-short stature-skeletal anomalies syndrome', 1),
(13637, 'ORPHA:447753', 'Spastic paraparesis-amyopathy-cataracts-gastroesophageal reflux syndrome', 1),
(13638, 'ORPHA:447757', 'AD-SPG9B', 1),
(13639, 'ORPHA:447757', 'Autosomal dominant spastic paraplegia type 9B', 1),
(13640, 'ORPHA:447760', 'AR-SPG9B', 1),
(13641, 'ORPHA:447760', 'Autosomal recessive spastic paraplegia type 9B', 1),
(13642, 'ORPHA:447764', 'IgG4-related sclerosing cholangitis', 1),
(13643, 'ORPHA:447771', 'Sclerosing cholangitis', 3),
(13644, 'ORPHA:447774', 'Secondary sclerosing cholangitis', 1),
(13645, 'ORPHA:447777', 'KTOC', 1),
(13646, 'ORPHA:447777', 'Keratocystic odontogenic tumor', 1),
(13647, 'ORPHA:447777', 'Odontogenic keratocystoma', 1),
(13648, 'ORPHA:447784', 'Mitochondrial pyruvate carrier deficiency', 1),
(13649, 'ORPHA:447788', 'Cerebral visual impairment', 1),
(13650, 'ORPHA:447788', 'Cortical visual impairment', 1),
(13651, 'ORPHA:447792', 'Hemochromatosis type 5', 1),
(13652, 'ORPHA:447795', 'Lipoyl transferase 2 deficiency', 1),
(13653, 'ORPHA:447874', 'Biological anomaly without phenotypic characterization', 3),
(13654, 'ORPHA:447877', 'PPAP', 2),
(13655, 'ORPHA:447877', 'Polymerase proofreading-related adenomatous polyposis', 2),
(13656, 'ORPHA:447881', 'Idiopathic dropped head syndrome', 1),
(13657, 'ORPHA:447881', 'Isolated neck extensor myopathy', 1),
(13658, 'ORPHA:447893', 'Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome', 2),
(13659, 'ORPHA:447896', 'TACH syndrome', 2),
(13660, 'ORPHA:447896', 'Tremor-ataxia-central hypomyelination syndrome', 2),
(13661, 'ORPHA:447954', 'COXPD25', 1),
(13662, 'ORPHA:447954', 'Combined oxidative phosphorylation defect type 25', 1),
(13663, 'ORPHA:447961', 'Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome', 1),
(13664, 'ORPHA:447964', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to NAGLU mutation', 1),
(13665, 'ORPHA:447964', 'Autosomal dominant Charcot-Marie-Tooth disease type 2V', 1),
(13666, 'ORPHA:447964', 'CMT2V', 1),
(13667, 'ORPHA:447964', 'Hereditary adult-onset painful axonal polyneuropathy', 1),
(13668, 'ORPHA:447974', 'Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome', 1),
(13669, 'ORPHA:447977', 'Progressive scapulohumeroperoneal distal myopathy', 1),
(13670, 'ORPHA:447980', '19p13.3 microduplication syndrome', 1),
(13671, 'ORPHA:447980', 'Dup(19)(p13.13)', 1),
(13672, 'ORPHA:447985', 'Partial duplication of chromosome 19p', 3),
(13673, 'ORPHA:447985', 'Partial duplication of the short arm of chromosome 19', 3),
(13674, 'ORPHA:447985', 'Partial trisomy of chromosome 19p', 3),
(13675, 'ORPHA:447985', 'Partial trisomy of the short arm of chromosome 19', 3),
(13676, 'ORPHA:447997', 'ASCT1 deficiency', 1),
(13677, 'ORPHA:447997', 'Spastic quadriplegia-thin corpus callosum-progressive postnatal microcephaly syndrome', 1),
(13678, 'ORPHA:447997', 'Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome', 1),
(13679, 'ORPHA:448', 'Hemophilia', 3),
(13680, 'ORPHA:448010', 'CAD-CDG', 1),
(13681, 'ORPHA:448010', 'CDG syndrome type Iz', 1),
(13682, 'ORPHA:448010', 'CDG-Iz', 1),
(13683, 'ORPHA:448010', 'CDG1Z', 1),
(13684, 'ORPHA:448010', 'Carbohydrate deficient glycoprotein syndrome type Iz', 1),
(13685, 'ORPHA:448010', 'Congenital disorder of glycosylation type 1z', 1),
(13686, 'ORPHA:448237', 'Zika virus disease', 1),
(13687, 'ORPHA:448237', 'Zika virus infection', 1),
(13688, 'ORPHA:448242', 'Autosomal recessive brachyolmia', 1),
(13689, 'ORPHA:448242', 'Brachyolmia, Hobaek/Toledo type', 1),
(13690, 'ORPHA:448251', 'Lichtenstein-Knorr syndrome', 1),
(13691, 'ORPHA:448251', 'Progressive autosomal recessive ataxia-deafness syndrome', 1),
(13692, 'ORPHA:448251', 'Progressive autosomal recessive ataxia-sensorineural hearing loss syndrome', 1),
(13693, 'ORPHA:448251', 'SCAR19', 1),
(13694, 'ORPHA:448264', 'Isolated focal non-epidermolytic palmoplantar keratoderma', 1),
(13695, 'ORPHA:448267', 'Regressive spondylometaphyseal dysplasia', 1),
(13696, 'ORPHA:448270', 'Ectopia cordis', 1),
(13697, 'ORPHA:448426', 'Genetic primary orthostatic hypotension', 3),
(13698, 'ORPHA:44890', 'GIST', 1),
(13699, 'ORPHA:44890', 'Gastrointestinal stromal sarcoma', 1),
(13700, 'ORPHA:44890', 'Gastrointestinal stromal tumor', 1),
(13701, 'ORPHA:449', 'Hepatoblastoma', 1),
(13702, 'ORPHA:449266', 'Pleural empyema', 1),
(13703, 'ORPHA:449280', 'Scedosporiosis', 1),
(13704, 'ORPHA:449285', 'Snakebite envenomation', 1),
(13705, 'ORPHA:449291', 'Symptomatic form of fragile X syndrome in female carrier', 1),
(13706, 'ORPHA:449395', 'IgG4-related kidney disease', 1),
(13707, 'ORPHA:449400', 'IgG4-related aortitis', 1),
(13708, 'ORPHA:449427', 'Idiopathic hypertrophic pachymeningitis', 1),
(13709, 'ORPHA:449427', 'IgG4-related pachymeningitis', 1),
(13710, 'ORPHA:449432', 'IgG4-related sialadenitis', 1),
(13711, 'ORPHA:449432', 'IgG4-related submandibular gland disease', 1),
(13712, 'ORPHA:449432', 'Küttner tumor', 1),
(13713, 'ORPHA:449563', 'IgG4-related ophthalmic disease', 1),
(13714, 'ORPHA:449566', 'Eosinophilic angiocentric fibrosis', 1),
(13715, 'ORPHA:449566', 'IgG4-related eosinophilic angiocentric fibrosis', 1),
(13716, 'ORPHA:45', 'AMP deaminase deficiency', 1),
(13717, 'ORPHA:45', 'Adenosine monophosphate deaminase deficiency', 1),
(13718, 'ORPHA:45', 'Myoadenylate deaminase deficiency', 1),
(13719, 'ORPHA:450', 'Heterotaxia', 3),
(13720, 'ORPHA:450', 'Heterotaxy syndrome', 3),
(13721, 'ORPHA:450', 'Lateralization defect', 3),
(13722, 'ORPHA:450', 'Visceral heterotaxy', 3),
(13723, 'ORPHA:450322', 'Polyclonal hyperviscosity syndrome', 1),
(13724, 'ORPHA:451602', 'Primary cutaneous plasmacytosis', 1),
(13725, 'ORPHA:451607', 'Cutaneous pseudolymphoma', 1),
(13726, 'ORPHA:451612', 'Familial congenital nasolacrimal duct obstruction', 1),
(13727, 'ORPHA:452', 'X-linked lissencephaly with abnormal genitalia', 1),
(13728, 'ORPHA:452', 'X-linked lissencephaly with ambiguous genitalia', 1),
(13729, 'ORPHA:452', 'X-linked lissencephaly-corpus callosum agenesis-genital anomalies syndrome', 1),
(13730, 'ORPHA:452', 'XLAG (X-linked lissencephaly with abnormal genitalia) syndrome', 1),
(13731, 'ORPHA:453499', 'Au-Kline syndrome', 1),
(13732, 'ORPHA:453499', 'Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome', 1),
(13733, 'ORPHA:453504', 'Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation', 2),
(13734, 'ORPHA:453510', 'Congenital absence of pain with severe intellectual disability', 1),
(13735, 'ORPHA:453510', 'Congenital analgesia with severe intellectual disability', 1),
(13736, 'ORPHA:453510', 'Congenital insensitivity to pain with preserved temperature sensation', 1),
(13737, 'ORPHA:453510', 'Congenital insensitivity to pain with severe intellectual disability', 1),
(13738, 'ORPHA:453510', 'Congenital insensitivity to pain with severe non-progressive cognitive delay', 1),
(13739, 'ORPHA:453521', 'Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency', 1),
(13740, 'ORPHA:453521', 'SCAR17', 1),
(13741, 'ORPHA:453521', 'Spinocerebellar ataxia autosomal recessive type 17', 1),
(13742, 'ORPHA:453533', 'Polyendocrine-polyneuropathy syndrome', 1),
(13743, 'ORPHA:45358', 'Congenital fibrosis of extraocular muscles', 1),
(13744, 'ORPHA:45358', 'FEOM', 1),
(13745, 'ORPHA:454', 'Acquired ichthyosis', 1),
(13746, 'ORPHA:45448', 'Miyoshi myopathy', 1),
(13747, 'ORPHA:45452', 'Idiopathic neonatal atrial flutter', 1),
(13748, 'ORPHA:45453', 'Incessant infant ventricular tachycardia', 1),
(13749, 'ORPHA:454700', 'Acquired Creutzfeldt-Jakob disease', 3),
(13750, 'ORPHA:454706', 'PMA', 1),
(13751, 'ORPHA:454706', 'Progressive muscular atrophy', 1),
(13752, 'ORPHA:454710', 'Anti-p200 pemphigoid', 1),
(13753, 'ORPHA:454714', 'PCL', 1),
(13754, 'ORPHA:454714', 'Plasma cell leukemia', 1),
(13755, 'ORPHA:454718', 'Adie syndrome', 1),
(13756, 'ORPHA:454718', 'Holmes-Adie syndrome', 1),
(13757, 'ORPHA:454718', 'Tonic pupil-tendon areflexia syndrome', 1),
(13758, 'ORPHA:454723', 'Endometrioid carcinoma of ovary', 1),
(13759, 'ORPHA:454742', 'Variably protease-sensitive prionopathy', 1),
(13760, 'ORPHA:454745', 'Kuru', 1),
(13761, 'ORPHA:454750', 'H-type tracheoesophageal fistula', 1),
(13762, 'ORPHA:454750', 'Isolated tracheoesophageal fistula', 1),
(13763, 'ORPHA:454821', 'Pleomorphic salivary gland adenoma', 2),
(13764, 'ORPHA:454831', 'Acute radiation sickness', 1),
(13765, 'ORPHA:454831', 'Acute radiation syndrome', 1),
(13766, 'ORPHA:454836', 'Avian influenza', 1),
(13767, 'ORPHA:454840', 'NTHL1-related AFAP', 2),
(13768, 'ORPHA:454840', 'NTHL1-related attenuated FAP', 2),
(13769, 'ORPHA:454840', 'NTHL1-related attenuated familial adenomatous polyposis', 2),
(13770, 'ORPHA:454887', 'Corticobasal syndrome', 1),
(13771, 'ORPHA:455', 'Ichthyosis bullosa of Siemens', 1),
(13772, 'ORPHA:455', 'SEI', 1),
(13773, 'ORPHA:455', 'Superficial epidermolytic ichthyosis', 1),
(13774, 'ORPHA:456298', '1p35.2 microdeletion syndrome', 1),
(13775, 'ORPHA:456298', 'Del(1)(p35.2)', 1),
(13776, 'ORPHA:456298', 'Deletion 1p35.2', 1),
(13777, 'ORPHA:456298', 'Monosomy 1p35.2', 1),
(13778, 'ORPHA:456312', 'IMNEPD', 1),
(13779, 'ORPHA:456312', 'Infantile multisystem neurologic-endocrine-pancreatic disease', 1),
(13780, 'ORPHA:456318', 'HSAN1E', 1),
(13781, 'ORPHA:456318', 'HSN1E', 1),
(13782, 'ORPHA:456318', 'Hereditary sensory neuropathy-deafness-dementia syndrome', 1),
(13783, 'ORPHA:456318', 'Hereditary sensory neuropathy-sensorineural hearing loss-dementia syndrome', 1),
(13784, 'ORPHA:456328', 'X-linked myotubular myopathy-abnormal genitalia syndrome', 1),
(13785, 'ORPHA:456328', 'Xq28 contiguous gene deletion syndrome', 1),
(13786, 'ORPHA:456333', 'Hereditary neuroendocrine tumor of small bowel', 1),
(13787, 'ORPHA:456333', 'Hereditary neuroendocrine tumor of small intestine', 1),
(13788, 'ORPHA:456369', 'Polyglucosan body myopathy type 2', 1),
(13789, 'ORPHA:457', 'HI', 1),
(13790, 'ORPHA:457', 'Harlequin ichthyosis', 1),
(13791, 'ORPHA:457', 'Ichthyosis congenita, Harlequin type', 1),
(13792, 'ORPHA:457', 'Ichthyosis fetalis, Harlequin type', 1),
(13793, 'ORPHA:457050', 'Autosomal dominant mitochondrial myopathy with exercise intolerance', 1),
(13794, 'ORPHA:457059', 'Pseudohypoparathyroidism with Albright hereditary osteodystrophy', 3),
(13795, 'ORPHA:457062', 'Pseudohypoparathyroidism without Albright hereditary osteodystrophy', 3),
(13796, 'ORPHA:457074', 'Congenital nemaline myopathy', 3),
(13797, 'ORPHA:457077', 'TAFRO syndrome', 1),
(13798, 'ORPHA:457077', 'Thrombocytopenia-anasarca-fever-renal insufficiency-organomegaly syndrome', 1),
(13799, 'ORPHA:457083', 'Isolated splenogonadal fusion', 1),
(13800, 'ORPHA:457083', 'SGF', 1),
(13801, 'ORPHA:457088', 'Invasive candidiasis-deep dermatophytosis syndrome', 1),
(13802, 'ORPHA:457088', 'Predisposition to invasive fungal disease due to CARD9 deficiency', 1),
(13803, 'ORPHA:457095', 'Actinomycosis', 1),
(13804, 'ORPHA:457185', 'COQ4-related neonatal encephalomyopathy', 1),
(13805, 'ORPHA:457185', 'Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome', 1),
(13806, 'ORPHA:457193', 'Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome', 1),
(13807, 'ORPHA:457205', 'ANOAC', 1),
(13808, 'ORPHA:457205', 'Axonal neuropathy-optic atrophy-cognitive deficit syndrome', 1),
(13809, 'ORPHA:457205', 'Infantile-onset axonal motor and sensory neuropathy-optic atrophy-neurodegenerative syndrome', 1),
(13810, 'ORPHA:457212', 'Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome', 1),
(13811, 'ORPHA:457223', 'Syndromic sensorineural deafness due to COXPD', 1),
(13812, 'ORPHA:457223', 'Syndromic sensorineural deafness due to combined oxidative phosphorylation defect', 1),
(13813, 'ORPHA:457223', 'Syndromic sensorineural hearing loss due to COXPD', 1),
(13814, 'ORPHA:457240', 'X-linked intellectual disability-short stature-overweight syndrome', 1),
(13815, 'ORPHA:457246', 'CCSK', 1),
(13816, 'ORPHA:457246', 'Clear cell sarcoma of kidney', 1),
(13817, 'ORPHA:457260', 'X-linked intellectual disability-hypotonia-movement disorder syndrome', 1),
(13818, 'ORPHA:457265', 'EPM9', 1),
(13819, 'ORPHA:457265', 'PME type 9', 1),
(13820, 'ORPHA:457265', 'Progressive myoclonic epilepsy due to LMNB2 deficiency', 1),
(13821, 'ORPHA:457265', 'Progressive myoclonic epilepsy type 9', 1),
(13822, 'ORPHA:457265', 'Progressive myoclonus epilepsy type 9', 1),
(13823, 'ORPHA:457279', 'Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome', 1),
(13824, 'ORPHA:457284', 'Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome', 1),
(13825, 'ORPHA:457351', 'Microcephaly-intellectual disability-sensorineural deafness-epilepsy-abnormal muscle tone syndrome', 1),
(13826, 'ORPHA:457351', 'Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome', 1),
(13827, 'ORPHA:457359', 'Megalencephaly-severe kyphoscoliosis-overgrowth syndrome', 1),
(13828, 'ORPHA:457365', 'Intellectual disability-muscle weakness-short stature-facial dysmorphism syndrome', 1),
(13829, 'ORPHA:457375', 'ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement', 1),
(13830, 'ORPHA:457375', 'Martsolf-like syndrome', 1),
(13831, 'ORPHA:457378', 'Complex lethal osteochondrodysplasia', 1),
(13832, 'ORPHA:457378', 'Complex lethal osteochondrodysplasia, Symoens-Barnes-Gistelinck type', 1),
(13833, 'ORPHA:457395', 'Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome', 1),
(13834, 'ORPHA:457406', 'MMDS4', 1),
(13835, 'ORPHA:457406', 'Multiple mitochondrial dysfunctions syndrome type 4', 1),
(13836, 'ORPHA:457485', 'MINDS syndrome', 1),
(13837, 'ORPHA:457485', 'Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome', 1),
(13838, 'ORPHA:457485', 'Smith-Kingsmore syndrome', 1),
(13839, 'ORPHA:458718', 'Idiopathic SCAD', 1),
(13840, 'ORPHA:458718', 'Idiopathic spontaneous coronary artery dissection', 1),
(13841, 'ORPHA:458758', 'Composite hemangioendothelioma', 1),
(13842, 'ORPHA:458763', 'Retiform hemangioendothelioma', 1),
(13843, 'ORPHA:458768', 'Dabska tumor', 1),
(13844, 'ORPHA:458768', 'Primary intralymphatic angioendothelioma', 1),
(13845, 'ORPHA:458775', 'Congenital hemangioma', 3),
(13846, 'ORPHA:458785', 'Partially involuting congenital hemangioma', 1),
(13847, 'ORPHA:458792', 'Mixed cystic lymphangioma', 1),
(13848, 'ORPHA:458792', 'Mixed cystic lymphatic malformation', 1),
(13849, 'ORPHA:458798', 'SCA41', 1),
(13850, 'ORPHA:458798', 'Spinocerebellar ataxia type 41', 1),
(13851, 'ORPHA:458803', 'SCA42', 1),
(13852, 'ORPHA:458803', 'Spinocerebellar ataxia type 42', 1),
(13853, 'ORPHA:458827', 'Vascular tumor with associated anomalies', 3),
(13854, 'ORPHA:458830', 'Rare capillary malformation with associated anomalies', 3),
(13855, 'ORPHA:458833', 'Common cystic lymphatic malformation', 3),
(13856, 'ORPHA:458837', 'Rare combined vascular malformation', 3),
(13857, 'ORPHA:458844', 'Rare vascular malformation of major vessels', 3),
(13858, 'ORPHA:459033', 'AOA4', 1),
(13859, 'ORPHA:459033', 'Ataxia-oculomotor apraxia type 4', 1),
(13860, 'ORPHA:459051', 'SED, Stanescu type', 1),
(13861, 'ORPHA:459051', 'Spondyloepiphyseal dysplasia, Stanescu type', 1),
(13862, 'ORPHA:459056', 'Autosomal recessive spastic paraplegia type 75', 1),
(13863, 'ORPHA:459056', 'SPG75', 1),
(13864, 'ORPHA:459061', 'Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome', 1),
(13865, 'ORPHA:459061', 'Developmental delay-short stature-dysmorphic features-sparse hair syndrome', 1),
(13866, 'ORPHA:459061', 'Loucks-Innes syndrome', 1),
(13867, 'ORPHA:459070', 'X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome', 1),
(13868, 'ORPHA:459074', '7q36.3 microduplication syndrome', 1),
(13869, 'ORPHA:459074', 'Corpus callosum agenesis-macrocephaly-hypertelorism syndrome', 1),
(13870, 'ORPHA:459074', 'Dup(7)(q36.3)', 1),
(13871, 'ORPHA:459345', 'Immunodeficiency due to a complement cascade component deficiency', 3),
(13872, 'ORPHA:459348', 'Immunodeficiency due to a complement regulatory deficiency', 3),
(13873, 'ORPHA:459353', 'C1 inhibitor deficiency', 1),
(13874, 'ORPHA:459526', 'Rare genetic capillary malformation', 3),
(13875, 'ORPHA:459537', 'Genetic complex vascular malformation with associated anomalies', 3),
(13876, 'ORPHA:459537', 'Genetic hemangiolymphangioma', 3),
(13877, 'ORPHA:459543', 'Rare genetic vascular tumor', 3),
(13878, 'ORPHA:459548', 'Rare genetic venous malformation', 3),
(13879, 'ORPHA:459787', 'Lethal multiple congenital anomalies/dysmorphic syndrome', 3),
(13880, 'ORPHA:46', 'ADSL deficiency', 1),
(13881, 'ORPHA:46', 'Adenylosuccinase deficiency', 1),
(13882, 'ORPHA:46', 'Adenylosuccinate lyase deficiency', 1),
(13883, 'ORPHA:46059', 'Lathosterolosis', 1),
(13884, 'ORPHA:46059', 'Sterol C5-desaturase deficiency', 1),
(13885, 'ORPHA:461', 'RXLI', 1),
(13886, 'ORPHA:461', 'Recessive X-linked ichthyosis', 1),
(13887, 'ORPHA:461', 'Steroid sulfatase deficiency', 1),
(13888, 'ORPHA:461', 'X-linked ichthyosis', 1),
(13889, 'ORPHA:461', 'XLI', 1),
(13890, 'ORPHA:46135', 'PCNSL', 1),
(13891, 'ORPHA:46135', 'Primary CNS lymphoma', 1),
(13892, 'ORPHA:46135', 'Primary brain lymphoma', 1),
(13893, 'ORPHA:46135', 'Primary central nervous system lymphoma', 1),
(13894, 'ORPHA:46348', 'Familial rectal pain', 1),
(13895, 'ORPHA:46348', 'Paroxysmal extreme pain disorder', 1),
(13896, 'ORPHA:464', 'Bloch-Siemens syndrome', 1),
(13897, 'ORPHA:464', 'Bloch-Sulzberger syndrome', 1),
(13898, 'ORPHA:464', 'Incontinentia pigmenti', 1),
(13899, 'ORPHA:464282', 'SPPRS syndrome', 1),
(13900, 'ORPHA:464282', 'Spastic paraplegia-psychomotor retardation-seizures syndrome', 1),
(13901, 'ORPHA:464282', 'Spastic paraplegia-severe developmental delay-epilepsy syndrome', 1),
(13902, 'ORPHA:464288', 'SBIDDS', 1),
(13903, 'ORPHA:464288', 'Short stature-brachydactyly-obesity-global developmental delay syndrome', 1),
(13904, 'ORPHA:464306', 'DYRK1A-related intellectual disability syndrome', 1),
(13905, 'ORPHA:464311', 'DYRK1A-related intellectual disability syndrome due to a point mutation', 2),
(13906, 'ORPHA:464311', 'Intellectual disability syndrome due to a DYRK1A point mutation', 2),
(13907, 'ORPHA:464318', 'Verrucous hemangioma', 1),
(13908, 'ORPHA:464321', 'Cutaneovisceral angiomatosis-thrombocytopenia syndrome', 1),
(13909, 'ORPHA:464321', 'MLT', 1),
(13910, 'ORPHA:464321', 'Multifocal lymphangioendotheliomatosis with thrombocytopenia', 1),
(13911, 'ORPHA:464321', 'Multifocal lymphangioendotheliomatosis-thrombocytopenia syndrome', 1),
(13912, 'ORPHA:464329', 'Kaposiform lymphangiomatosis', 1),
(13913, 'ORPHA:464336', 'B-cell expansion with NF-kB and T-cell anergy disease', 1),
(13914, 'ORPHA:464336', 'BENTA disease', 1),
(13915, 'ORPHA:464343', 'CAPS', 1),
(13916, 'ORPHA:464343', 'Catastrophic APS', 1),
(13917, 'ORPHA:464343', 'Catastrophic antiphospholipid syndrome', 1),
(13918, 'ORPHA:464359', 'Benign metanephric tumor', 1),
(13919, 'ORPHA:464366', 'Lethal skeletal dysplasia-fetal akinesia-contractures-thoracic dysplasia-pulmonary hypoplasia syndrome', 1),
(13920, 'ORPHA:464366', 'NEK9-related lethal skeletal dysplasia', 1),
(13921, 'ORPHA:464370', 'Neonatal alloimmune neutropenia', 1),
(13922, 'ORPHA:464440', 'Primary dystonia, DYT27 type', 1),
(13923, 'ORPHA:464443', 'CDG syndrome type IIL', 1),
(13924, 'ORPHA:464443', 'CDG-IIL', 1),
(13925, 'ORPHA:464443', 'CDG2L', 1),
(13926, 'ORPHA:464443', 'COG6-CGD', 1),
(13927, 'ORPHA:464443', 'Congenital disorder of glycosylation type 2l', 1),
(13928, 'ORPHA:464443', 'Congenital disorder of glycosylation type IIL', 1),
(13929, 'ORPHA:464453', 'Acquired methemoglobinemia', 1),
(13930, 'ORPHA:464453', 'Drug-induced methemoglobinemia', 1),
(13931, 'ORPHA:464458', 'Acetaminophen poisoning', 1),
(13932, 'ORPHA:464458', 'Paracetamol poisoning', 1),
(13933, 'ORPHA:464724', 'Fever-associated acute infantile liver failure syndrome', 1),
(13934, 'ORPHA:464738', 'Basel-Vanagaite-Smirin-Yosef syndrome', 1),
(13935, 'ORPHA:464756', 'Familial gastric type 1 neuroendocrine tumor', 1),
(13936, 'ORPHA:464760', 'Familial CODA', 1),
(13937, 'ORPHA:464760', 'Familial cavitary optic disc anomaly', 1),
(13938, 'ORPHA:464764', 'Immune-mediated acquired neuromuscular junction disease', 3),
(13939, 'ORPHA:46484', 'Oligodendroglial tumor', 3),
(13940, 'ORPHA:46485', 'Superficial pemphigus', 3),
(13941, 'ORPHA:46486', 'Cicatricial pemphigoid', 1),
(13942, 'ORPHA:46486', 'Mucosal pemphigoid', 1),
(13943, 'ORPHA:46486', 'Mucosynechial pemphigoid', 1),
(13944, 'ORPHA:46486', 'Mucous membrane pemphigoid', 1),
(13945, 'ORPHA:46487', 'Acquired epidermolysis bullosa', 1),
(13946, 'ORPHA:46487', 'Epidermolysis bullosa acquisita', 1),
(13947, 'ORPHA:46488', 'Linear IgA dermatosis', 1),
(13948, 'ORPHA:465', 'Congenital PAI-1 deficiency', 1),
(13949, 'ORPHA:465', 'Congenital plasminogen activator inhibitor type 1 deficiency', 1),
(13950, 'ORPHA:46532', 'HPFH-beta-thalassemia syndrome', 1),
(13951, 'ORPHA:46532', 'Hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome', 1),
(13952, 'ORPHA:465508', 'Symptomatic form of HFE-related hereditary hemochromatosis', 1),
(13953, 'ORPHA:465508', 'Symptomatic form of classic hemochromatosis', 1),
(13954, 'ORPHA:465508', 'Symptomatic form of hemochromatosis type 1', 1),
(13955, 'ORPHA:465824', 'Fetal encasement syndrome', 1),
(13956, 'ORPHA:466', 'Fatal familial insomnia', 1),
(13957, 'ORPHA:466026', 'Class I G6PD deficiency', 1),
(13958, 'ORPHA:466026', 'Class I glucose-6-phosphate dehydrogenase deficiency', 1),
(13959, 'ORPHA:466026', 'Severe hemolytic anemia due to G6PD deficiency', 1),
(13960, 'ORPHA:466066', 'Genetic hemoglobinopathy', 3),
(13961, 'ORPHA:466084', 'Genetic otorhinolaryngologic disease', 3),
(13962, 'ORPHA:46627', 'Char syndrome', 1),
(13963, 'ORPHA:46627', 'Patent ductus arteriosus with facial dysmorphism and abnormal fifth digits', 1),
(13964, 'ORPHA:466650', 'Exercise-induced malignant hyperthermia', 1),
(13965, 'ORPHA:466650', 'Exertional heat stroke', 1),
(13966, 'ORPHA:466658', 'Rare disease with malignant hyperthermia', 3),
(13967, 'ORPHA:466670', 'Cyanide poisoning', 1),
(13968, 'ORPHA:466677', 'Scorpion envenomation', 1),
(13969, 'ORPHA:466682', 'Euthyroid Graves ophthalmopathy', 1),
(13970, 'ORPHA:466682', 'Euthyroid Graves orbitopathy', 1),
(13971, 'ORPHA:466688', 'Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome', 1),
(13972, 'ORPHA:466695', 'Supratip dysplasia', 1),
(13973, 'ORPHA:466703', 'CDG syndrome type IIp', 1),
(13974, 'ORPHA:466703', 'CDG-IIp', 1),
(13975, 'ORPHA:466703', 'CDG2P', 1),
(13976, 'ORPHA:466703', 'Carbohydrate deficient glycoprotein syndrome type IIp', 1),
(13977, 'ORPHA:466703', 'Congenital disorder of glycosylation type 2p', 1),
(13978, 'ORPHA:466703', 'Congenital disorder of glycosylation type IIp', 1),
(13979, 'ORPHA:466703', 'TMEM199-CDG', 1),
(13980, 'ORPHA:466718', 'MCRPE', 1),
(13981, 'ORPHA:466718', 'Martinique crinkled retinal pigment epitheliopathy', 1),
(13982, 'ORPHA:466722', 'Autosomal recessive spastic paraplegia type 77', 1),
(13983, 'ORPHA:466722', 'SPG77', 1),
(13984, 'ORPHA:466729', 'Familial patent arterial duct', 1),
(13985, 'ORPHA:466768', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to MORC2 mutation', 1),
(13986, 'ORPHA:466768', 'Autosomal dominant Charcot-Marie-Tooth disease type 2Z', 1),
(13987, 'ORPHA:466768', 'CMT2Z', 1),
(13988, 'ORPHA:466775', 'ARCMT2X', 1),
(13989, 'ORPHA:466775', 'Autosomal recessive Charcot-Marie-Tooth disease type 2 due to SPG11 mutation', 1),
(13990, 'ORPHA:466775', 'Autosomal recessive Charcot-Marie-Tooth disease type 2X', 1),
(13991, 'ORPHA:466775', 'CMT2X', 1),
(13992, 'ORPHA:466784', 'COXPD28', 1),
(13993, 'ORPHA:466784', 'Combined oxidative phosphorylation defect type 28', 1),
(13994, 'ORPHA:466784', 'Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect', 1),
(13995, 'ORPHA:466791', 'Macrocephaly-intellectual disability-left ventricular non compaction syndrome', 1),
(13996, 'ORPHA:466794', 'Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome', 1),
(13997, 'ORPHA:466794', 'Autosomal recessive spinocerebellar ataxia type 21', 1),
(13998, 'ORPHA:466794', 'SCAR21', 1),
(13999, 'ORPHA:466801', 'Autosomal recessive limb-girdle muscular dystrophy type 2W', 1),
(14000, 'ORPHA:466801', 'LGMD type 2W', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(14001, 'ORPHA:466801', 'LGMD2W', 1),
(14002, 'ORPHA:466801', 'LIMS2-related LGM', 1),
(14003, 'ORPHA:466801', 'LIMS2-related limb-girdle muscular dystrophy', 1),
(14004, 'ORPHA:466801', 'Limb-girdle muscular dystrophy type 2W', 1),
(14005, 'ORPHA:466806', 'Autosomal dominant thrombocytopenia with platelet secretion defect', 1),
(14006, 'ORPHA:466921', 'Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome', 1),
(14007, 'ORPHA:466926', 'SSM syndrome', 1),
(14008, 'ORPHA:466926', 'Seizures-scoliosis-macrocephaly syndrome', 1),
(14009, 'ORPHA:466934', 'VPS11-related autosomal recessive hypomyelinating leukodystrophy', 1),
(14010, 'ORPHA:466934', 'VPS11-related autosomal recessive hypomyelinating leukoencephalopathy', 1),
(14011, 'ORPHA:466943', 'WAC-related facial dysmorphism-developmental delay-behavioral abnormalities syndrome', 1),
(14012, 'ORPHA:466950', 'Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation', 2),
(14013, 'ORPHA:466962', 'SMARCA4-deficient sarcoma of thorax', 1),
(14014, 'ORPHA:466962', 'SMARCA4-deficient thoracic sarcoma', 1),
(14015, 'ORPHA:467', 'Congenital combined pituitary hormone deficiency', 3),
(14016, 'ORPHA:467', 'Congenital hypopituitarism', 3),
(14017, 'ORPHA:467', 'Non-acquired combined pituitary hormone deficiency', 3),
(14018, 'ORPHA:467166', 'Brain stem asymmetry-superior cerebellar and basal ganglia dysplasia syndrome', 1),
(14019, 'ORPHA:467166', 'Tubulinopathy-associated dysgyria', 1),
(14020, 'ORPHA:467176', 'Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome', 1),
(14021, 'ORPHA:46724', 'Cerebral arteriovenous malformation', 1),
(14022, 'ORPHA:46724', 'Intracranial arteriovenous malformation', 1),
(14023, 'ORPHA:468620', 'Intellectual disability-epilepsy-extrapyramidal syndrome', 1),
(14024, 'ORPHA:468631', 'Microcephalic primordial dwarfism due to RTTN deficiency', 1),
(14025, 'ORPHA:468635', 'CMUSE', 1),
(14026, 'ORPHA:468635', 'Cryptogenic multifocal ulcerous stenosing enteritis', 1),
(14027, 'ORPHA:468641', 'CEAS', 1),
(14028, 'ORPHA:468641', 'Chronic enteropathy associated with SLCO2A1 gene', 1),
(14029, 'ORPHA:468661', 'Autosomal recessive spastic paraplegia type 74', 1),
(14030, 'ORPHA:468661', 'SPG74', 1),
(14031, 'ORPHA:468666', 'Isolated generalized anhidrosis with normal sweat glands', 1),
(14032, 'ORPHA:468672', 'Colobomatous macrophthalmia-microcornea syndrome', 1),
(14033, 'ORPHA:468672', 'MACOM syndrome', 1),
(14034, 'ORPHA:468678', 'Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome', 1),
(14035, 'ORPHA:468678', 'White-Sutton syndrome', 1),
(14036, 'ORPHA:468684', 'CCDC115-CDG', 1),
(14037, 'ORPHA:468684', 'CDG syndrome type IIo', 1),
(14038, 'ORPHA:468684', 'CDG-IIo', 1),
(14039, 'ORPHA:468684', 'CDG2O', 1),
(14040, 'ORPHA:468684', 'Carbohydrate deficient glycoprotein syndrome type IIo', 1),
(14041, 'ORPHA:468684', 'Congenital disorder of glycosylation type 2o', 1),
(14042, 'ORPHA:468684', 'Congenital disorder of glycosylation type IIo', 1),
(14043, 'ORPHA:468699', 'CDG syndrome type IIn', 1),
(14044, 'ORPHA:468699', 'CDG-IIn', 1),
(14045, 'ORPHA:468699', 'CDG2N', 1),
(14046, 'ORPHA:468699', 'Carbohydrate deficient glycoprotein syndrome type IIn', 1),
(14047, 'ORPHA:468699', 'Congenital disorder of glycosylation type 2n', 1),
(14048, 'ORPHA:468699', 'Congenital disorder of glycosylation type IIn', 1),
(14049, 'ORPHA:468699', 'SLC39A8 deficiency', 1),
(14050, 'ORPHA:468699', 'SLC39A8-CDG', 1),
(14051, 'ORPHA:468717', 'Rhizomelic chondrodysplasia punctata type 5', 2),
(14052, 'ORPHA:468726', 'Severe primary trimethylaminuria', 1),
(14053, 'ORPHA:468726', 'TMAU', 1),
(14054, 'ORPHA:469', 'Hereditary fructose intolerance', 1),
(14055, 'ORPHA:469', 'Hereditary fructose-1-phosphate aldolase deficiency', 1),
(14056, 'ORPHA:469', 'Hereditary fructosemia', 1),
(14057, 'ORPHA:47', 'BTK-deficiency', 2),
(14058, 'ORPHA:47', 'Bruton type agammaglobulinemia', 2),
(14059, 'ORPHA:47', 'X-linked agammaglobulinemia', 2),
(14060, 'ORPHA:470', 'Hyperdibasic aminoaciduria', 1),
(14061, 'ORPHA:470', 'LPI', 1),
(14062, 'ORPHA:470', 'Lysinuric protein intolerance', 1),
(14063, 'ORPHA:47044', 'HPRCC', 1),
(14064, 'ORPHA:47044', 'Hereditary papillary renal cell carcinoma', 1),
(14065, 'ORPHA:47045', 'FCAS', 1),
(14066, 'ORPHA:47045', 'FCU', 1),
(14067, 'ORPHA:47045', 'Familial cold autoinflammatory syndrome', 1),
(14068, 'ORPHA:47045', 'Familial cold urticaria', 1),
(14069, 'ORPHA:471383', 'Genetic lethal multiple congenital anomalies/dysmorphic syndrome', 3),
(14070, 'ORPHA:47159', 'Proximal renal tubular acidosis', 1),
(14071, 'ORPHA:47159', 'Renal tubular acidosis type 2', 1),
(14072, 'ORPHA:47159', 'pRTA', 1),
(14073, 'ORPHA:472', 'Cystoisosporiasis', 1),
(14074, 'ORPHA:472', 'Isosporiasis', 1),
(14075, 'ORPHA:474', 'Asphyxiating thoracic dystrophy of the newborn', 1),
(14076, 'ORPHA:474', 'JATD', 1),
(14077, 'ORPHA:474', 'Jeune asphyxiating thoracic dystrophy', 1),
(14078, 'ORPHA:474', 'Jeune syndrome', 1),
(14079, 'ORPHA:474347', 'Congenital anomaly of interventricular communication', 3),
(14080, 'ORPHA:474347', 'Congenital ventricular septal anomaly', 3),
(14081, 'ORPHA:474347', 'Rare congenital anomaly of ventricular septum', 3),
(14082, 'ORPHA:475', 'CPD IV', 1),
(14083, 'ORPHA:475', 'Cerebelloparenchymal disorder IV', 1),
(14084, 'ORPHA:475', 'Classic Joubert syndrome', 1),
(14085, 'ORPHA:475', 'Joubert syndrome', 1),
(14086, 'ORPHA:475', 'Joubert syndrome type A', 1),
(14087, 'ORPHA:475', 'Joubert-Boltshauser syndrome', 1),
(14088, 'ORPHA:475', 'Pure Joubert syndrome', 1),
(14089, 'ORPHA:476084', 'Autosomal recessive limb-girdle muscular dystrophy-cardiac arrhythmia syndrome', 1),
(14090, 'ORPHA:476084', 'BVES-related LGMD', 1),
(14091, 'ORPHA:476084', 'BVES-related limb-girdle muscular dystrophy', 1),
(14092, 'ORPHA:476084', 'LGMD type 2X', 1),
(14093, 'ORPHA:476084', 'LGMD2X', 1),
(14094, 'ORPHA:476084', 'Limb-girdle muscular dystrophy 2X', 1),
(14095, 'ORPHA:476093', 'Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome', 1),
(14096, 'ORPHA:476096', 'EKC syndrome', 1),
(14097, 'ORPHA:476096', 'Erythrokeratodermia-cardiomyopathy syndrome', 1),
(14098, 'ORPHA:476102', 'Behçet-like disease due to HA20', 1),
(14099, 'ORPHA:476102', 'Behçet-like disease due to haploinsufficiency of A20', 1),
(14100, 'ORPHA:476102', 'Hereditary pediatric Behçet-like disease', 1),
(14101, 'ORPHA:476109', 'Axonal HMSN', 3),
(14102, 'ORPHA:476109', 'Axonal hereditary motor and sensory neuropathy', 3),
(14103, 'ORPHA:476113', 'CID due to TFRC deficiency', 1),
(14104, 'ORPHA:476113', 'Combined immunodeficiency due to TFRC deficiency', 1),
(14105, 'ORPHA:476113', 'TFRC-related combined immunodeficiency', 1),
(14106, 'ORPHA:476116', 'Demyelinating HMSN', 3),
(14107, 'ORPHA:476116', 'Demyelinating hereditary motor and sensory neuropathy', 3),
(14108, 'ORPHA:476119', 'Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome', 1),
(14109, 'ORPHA:47612', 'Felty syndrome', 1),
(14110, 'ORPHA:47612', 'Splenomegaly-neutropenia-rheumatoid arthritis syndrome', 1),
(14111, 'ORPHA:476123', 'Intermediate CMT', 3),
(14112, 'ORPHA:476123', 'Intermediate Charcot-Marie-Tooth disease', 3),
(14113, 'ORPHA:476123', 'Intermediate hereditary motor and sensory neuropathy', 3),
(14114, 'ORPHA:476126', 'Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome', 1),
(14115, 'ORPHA:476394', 'PMP2-related CMT1', 1),
(14116, 'ORPHA:476394', 'PMP2-related Charcot-Marie-Tooth disease type 1', 1),
(14117, 'ORPHA:476394', 'PMP2-related Charcot-Marie-Tooth neuropathy type 1', 1),
(14118, 'ORPHA:476394', 'PMP2-related hereditary motor and sensory neuropathy type 1', 1),
(14119, 'ORPHA:476403', 'Hypercontractile muscle stiffness syndrome', 3),
(14120, 'ORPHA:476406', 'Congenital generalized hypercontractile muscle stiffness syndrome', 1),
(14121, 'ORPHA:477', 'Ichthyosis hystrix Rheydt type', 1),
(14122, 'ORPHA:477', 'KID syndrome', 1),
(14123, 'ORPHA:477', 'KID/HID syndrome', 1),
(14124, 'ORPHA:477', 'Keratitis-ichthyosis-deafness/Hystrix-like ichthyosis-deafness syndrome', 1),
(14125, 'ORPHA:477', 'Keratitis-ichthyosis-hearing loss/Hystrix-like ichthyosis-hearing loss syndrome', 1),
(14126, 'ORPHA:477', 'Senter syndrome', 1),
(14127, 'ORPHA:477647', 'Type 1 interferonopathy', 3),
(14128, 'ORPHA:477650', 'Fibroblastic rheumatism', 1),
(14129, 'ORPHA:477661', 'IL21-related infantile IBD', 1),
(14130, 'ORPHA:477661', 'IL21-related infantile inflammatory bowel disease', 1),
(14131, 'ORPHA:477673', 'Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome', 1),
(14132, 'ORPHA:477684', 'COXPD26', 1),
(14133, 'ORPHA:477684', 'Combined oxidative phosphorylation defect type 26', 1),
(14134, 'ORPHA:477738', 'Pediatric multiple sclerosis', 1),
(14135, 'ORPHA:477742', 'Nodular fasciitis', 1),
(14136, 'ORPHA:477742', 'Pseudosarcomatous fasciitis', 1),
(14137, 'ORPHA:477742', 'Pseudosarcomatous fibromatosis', 1),
(14138, 'ORPHA:477749', 'PADMAL', 1),
(14139, 'ORPHA:477749', 'Pontine autosomal dominant microangiopathy with leukoencephalopathy', 1),
(14140, 'ORPHA:477754', 'Genetic cerebral small vessel disease', 3),
(14141, 'ORPHA:477759', 'COL4A1 or COL4A2-related cerebral angiopathy', 3),
(14142, 'ORPHA:477759', 'COL4A1 or COL4A2-related cerebral small vessel disease', 3),
(14143, 'ORPHA:477762', 'COL4A1 or COL4A2-related cerebral angiopathy with ischemic tendancy', 3),
(14144, 'ORPHA:477762', 'COL4A1 or COL4A2-related cerebral small vessel disease with ischemic tendancy', 3),
(14145, 'ORPHA:477765', 'COL4A1 or COL4A2-related cerebral angiopathy with hemorrhagic tendancy', 3),
(14146, 'ORPHA:477765', 'COL4A1 or COL4A2-related cerebral small vessel disease with hemorrhagic tendancy', 3),
(14147, 'ORPHA:477768', 'Moyamoya angiopathy', 3),
(14148, 'ORPHA:477771', 'Rare disorder with a moyamoya angiopathy', 3),
(14149, 'ORPHA:477774', 'COXPD27', 1),
(14150, 'ORPHA:477774', 'Combined oxidative phosphorylation defect type 27', 1),
(14151, 'ORPHA:477781', 'Primary condylar hyperplasia', 1),
(14152, 'ORPHA:477781', 'Type 1 condylar hyperplasia', 1),
(14153, 'ORPHA:477787', 'Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder', 1),
(14154, 'ORPHA:477787', 'PLA2G4A-related platelet dysfunction', 1),
(14155, 'ORPHA:477787', 'Platelet dysfunction due to cytosolic phospholipase-A2 alpha deficiency', 1),
(14156, 'ORPHA:477794', 'Syndromic constitutional thrombocytopenia', 3),
(14157, 'ORPHA:477797', 'Constitutional thrombocytopenia without extra-hematopoietic manifestations', 3),
(14158, 'ORPHA:477797', 'Isolated constitutional thrombocytopenia', 3),
(14159, 'ORPHA:477797', 'Non-syndromic constitutional thrombocytopenia', 3),
(14160, 'ORPHA:477805', 'Genetic cardiac malformation', 3),
(14161, 'ORPHA:477808', 'Other genetic dermis disorder', 3),
(14162, 'ORPHA:477811', 'Rare hypercholesterolemia', 3),
(14163, 'ORPHA:477814', 'Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome', 1),
(14164, 'ORPHA:477817', '17p11.2p12 microduplication syndrome', 1),
(14165, 'ORPHA:477817', 'Dup(17)(p11.2p12)', 1),
(14166, 'ORPHA:477817', 'PMP22-RAI1 contiguous gene duplication syndrome', 1),
(14167, 'ORPHA:477817', 'Trisomy 17p11.2-p12', 1),
(14168, 'ORPHA:477817', 'Trisomy 17p11.2p12', 1),
(14169, 'ORPHA:477817', 'Yuan-Harel-Lupski syndrome', 1),
(14170, 'ORPHA:477831', 'Kosaki overgrowth syndrome', 1),
(14171, 'ORPHA:477831', 'Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome', 1),
(14172, 'ORPHA:477857', 'Autosomal recessive MSMD due to complete RORgamma receptor defiency', 1),
(14173, 'ORPHA:477857', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency', 1),
(14174, 'ORPHA:477857', 'Autosomal recessive primary immunodeficiency due to RORC mutation', 1),
(14175, 'ORPHA:477993', 'Palatal anomalies-multiple diastemata-facial dysmorphism-developmental delay syndrome', 1),
(14176, 'ORPHA:477993', 'Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome', 1),
(14177, 'ORPHA:478', 'Congenital hypogonadotropic hypogonadism with anosmia', 2),
(14178, 'ORPHA:478', 'Kallmann syndrome', 2),
(14179, 'ORPHA:478', 'Olfacto-genital pathological sequence', 2),
(14180, 'ORPHA:478029', 'COXPD29', 1),
(14181, 'ORPHA:478029', 'Combined oxidative phosphorylation defect type 29', 1),
(14182, 'ORPHA:478042', 'COXPD30', 1),
(14183, 'ORPHA:478042', 'Combined oxidative phosphorylation defect type 30', 1),
(14184, 'ORPHA:478049', 'Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome', 1),
(14185, 'ORPHA:478664', 'HSAN8', 1),
(14186, 'ORPHA:478664', 'Hereditary sensory and autonomic neuropathy type 8', 1),
(14187, 'ORPHA:478664', 'Hereditary sensory and autonomic neuropathy type VIII', 1),
(14188, 'ORPHA:48', 'Congenital bilateral absence of vas deferens', 1),
(14189, 'ORPHA:48', 'Congenital bilateral agenesis of vas deferens', 1),
(14190, 'ORPHA:48', 'Congenital bilateral aplasia of vas deferens', 1),
(14191, 'ORPHA:480', 'Kearns-Sayre syndrome', 1),
(14192, 'ORPHA:480476', 'NR1H4 deficiency', 2),
(14193, 'ORPHA:480476', 'PFIC5', 2),
(14194, 'ORPHA:480476', 'Progressive familial intrahepatic cholestasis type 5', 2),
(14195, 'ORPHA:480483', 'PFIC4', 2),
(14196, 'ORPHA:480483', 'Progressive familial intrahepatic cholestasis type 4', 2),
(14197, 'ORPHA:480483', 'TJP2 deficit', 2),
(14198, 'ORPHA:480491', 'MYO5B deficiency', 2),
(14199, 'ORPHA:480491', 'MYO5B-related progressive familial intrahepatic cholestasis', 2),
(14200, 'ORPHA:480501', 'Choledochal cyst', 1),
(14201, 'ORPHA:480501', 'Congenital cystic dilatation of the biliary tract', 1),
(14202, 'ORPHA:480506', 'PIHL', 1),
(14203, 'ORPHA:480506', 'Primary hepatolithiasis', 1),
(14204, 'ORPHA:480506', 'Primary intrahepatic lithiasis', 1),
(14205, 'ORPHA:480512', 'IAD', 1),
(14206, 'ORPHA:480512', 'Idiopathic adult ductopenia', 1),
(14207, 'ORPHA:480512', 'Idiopathic ductopenia', 1),
(14208, 'ORPHA:480520', 'Caroli syndrome', 1),
(14209, 'ORPHA:480524', 'Idiopathic peliosis hepatis', 1),
(14210, 'ORPHA:480524', 'Idiopathic peliosis hepatitis', 1),
(14211, 'ORPHA:480528', 'Lethal hydranencephaly-diaphragmatic hernia syndrome', 1),
(14212, 'ORPHA:480531', 'Congenital portosystemic shunt', 1),
(14213, 'ORPHA:480531', 'Congenital portosystemic venous fistula', 1),
(14214, 'ORPHA:480536', 'MSH3-related AFAP', 2),
(14215, 'ORPHA:480536', 'MSH3-related attenuated FAP', 2),
(14216, 'ORPHA:480536', 'MSH3-related attenuated familial adenomatous polyposis', 2),
(14217, 'ORPHA:480536', 'MSH3-related attenuated familial polyposis coli', 2),
(14218, 'ORPHA:480541', 'High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement', 1),
(14219, 'ORPHA:480549', 'Non-SCID', 3),
(14220, 'ORPHA:480549', 'Non-severe combined immunodeficiency', 3),
(14221, 'ORPHA:480553', 'Aneurysmal bone cyst', 1),
(14222, 'ORPHA:480556', 'Isolated neonatal sclerosing cholangitis', 1),
(14223, 'ORPHA:480682', 'Autosomal recessive limb-girdle muscular dystrophy type 2Z', 1),
(14224, 'ORPHA:480682', 'LGMD type 2Z', 1),
(14225, 'ORPHA:480682', 'LGMD2Z', 1),
(14226, 'ORPHA:480682', 'Limb-girdle muscular dystrophy type 2Z', 1),
(14227, 'ORPHA:480682', 'POGLUT1-related  limb-girdle muscular dystrophy R21', 1),
(14228, 'ORPHA:480682', 'POGLUT1-related LGMD R21', 1),
(14229, 'ORPHA:480701', 'Facial diplegia with paresthesias', 1),
(14230, 'ORPHA:480701', 'Facial diplegia with paresthesias variant of GBS', 1),
(14231, 'ORPHA:480701', 'Facial diplegia with paresthesias variant of Guillain-Barré syndrome', 1),
(14232, 'ORPHA:480851', 'Hereditary thrombocytopenia with early-onset myelofibrosis', 1),
(14233, 'ORPHA:480864', 'Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome', 1),
(14234, 'ORPHA:480864', 'TANGO2-related metabolic encephalopathy-arrhythmia syndrome', 1),
(14235, 'ORPHA:480880', 'X-linked facial dysmorphism-short stature-choanal atresia-intellectual disability syndrome limited to females', 1),
(14236, 'ORPHA:480880', 'X-linked female restricted facial dysmorphism-short stature-choanal atresia-intellectual disability', 1),
(14237, 'ORPHA:480898', 'Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndrome', 1),
(14238, 'ORPHA:480907', 'X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome', 1),
(14239, 'ORPHA:481', 'Kennedy disease', 1),
(14240, 'ORPHA:481', 'SBMA', 1),
(14241, 'ORPHA:481', 'SMAX1', 1),
(14242, 'ORPHA:481', 'X-linked BSMA', 1),
(14243, 'ORPHA:481', 'X-linked bulbospinal amyotrophy', 1),
(14244, 'ORPHA:481', 'X-linked bulbospinal muscular atrophy', 1),
(14245, 'ORPHA:481', 'X-linked spinal and bulbar muscular atrophy', 1),
(14246, 'ORPHA:48104', 'Pyoderma gangrenosum', 1),
(14247, 'ORPHA:481152', 'PYCR2-related microcephaly-progressive leukoencephalopathy', 1),
(14248, 'ORPHA:481508', 'Gastroenteric neuroendocrine neoplasm', 3),
(14249, 'ORPHA:48162', 'Lewis-Sumner syndrome', 2),
(14250, 'ORPHA:48162', 'MADSAM', 2),
(14251, 'ORPHA:48162', 'Multifocal acquired demyelinating sensory and motor neuropathy', 2),
(14252, 'ORPHA:481662', 'Familial Chilblain lupus', 1),
(14253, 'ORPHA:481665', 'USP18 deficiency', 1),
(14254, 'ORPHA:481671', 'Type 1 interferonopathy of childhood', 3),
(14255, 'ORPHA:481771', 'Genetic alopecia', 3),
(14256, 'ORPHA:481986', 'Familial schizencephaly', 2),
(14257, 'ORPHA:482', 'Eosinophilic lymphogranuloma', 1),
(14258, 'ORPHA:482', 'Kimura disease', 1),
(14259, 'ORPHA:482072', 'HTRA1-related cerebral angiopathy', 3),
(14260, 'ORPHA:482072', 'HTRA1-related cerebral small vessel disease', 3),
(14261, 'ORPHA:482077', 'HTRA1-related autosomal dominant cerebral angiopathy', 1),
(14262, 'ORPHA:482077', 'HTRA1-related autosomal dominant cerebral small vessel disease', 1),
(14263, 'ORPHA:482092', 'Rare idiopathic macular telangiectasia', 3),
(14264, 'ORPHA:482601', 'ADSSL1-related distal myopathy', 1),
(14265, 'ORPHA:482601', 'Adenylosuccinate synthetase-like 1-related distal myopathy', 1),
(14266, 'ORPHA:482606', 'X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome', 1),
(14267, 'ORPHA:483', 'Congenital high-molecular-weight kininogen deficiency', 1),
(14268, 'ORPHA:48372', 'Nodular regenerative hyperplasia of the liver', 1),
(14269, 'ORPHA:48372', 'Non-cirrhotic nodulation', 1),
(14270, 'ORPHA:48377', 'Pustulosis subcornealis', 1),
(14271, 'ORPHA:48377', 'Sneddon-Wilkinson disease', 1),
(14272, 'ORPHA:48377', 'Subcorneal pustular dermatitis', 1),
(14273, 'ORPHA:48377', 'Subcorneal pustular dermatosis', 1),
(14274, 'ORPHA:48431', 'CCFDN', 1),
(14275, 'ORPHA:48431', 'Congenital cataracts-facial dysmorphism-neuropathy syndrome', 1),
(14276, 'ORPHA:48435', 'Postinfectious vasculitis', 1),
(14277, 'ORPHA:48471', 'Lissencephaly', 3),
(14278, 'ORPHA:485', 'Kniest dysplasia', 1),
(14279, 'ORPHA:485275', 'Acquired schizencephaly', 2),
(14280, 'ORPHA:485350', 'CLCN4-related X-linked intellectual disability syndrome', 1),
(14281, 'ORPHA:485358', 'PTU embryofetopathy', 1),
(14282, 'ORPHA:485358', 'PTU embryopathy', 1),
(14283, 'ORPHA:485358', 'Propylthiouracil embryofetopathy', 1),
(14284, 'ORPHA:485358', 'Propylthiouracil embryopathy', 1),
(14285, 'ORPHA:485382', 'Genetic non-acquired premature ovarian failure', 3),
(14286, 'ORPHA:485405', '16p12.1p12.3 triplication syndrome', 1),
(14287, 'ORPHA:485405', 'Tetrasomy 16p12.1p12.3', 1),
(14288, 'ORPHA:485405', 'Trip(16)(p12.1p12.3)', 1),
(14289, 'ORPHA:485418', 'EMILIN-1-related connective tissue disease', 1),
(14290, 'ORPHA:485421', 'Leigh-like basal ganglia disease-optic atrophy-peripheral neuropathy syndrome', 2),
(14291, 'ORPHA:485421', 'Leigh-like encephalopathy-optic atrophy-peripheral neuropathy syndrome', 2),
(14292, 'ORPHA:485421', 'MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect', 2),
(14293, 'ORPHA:485426', 'Isolated CHF', 1),
(14294, 'ORPHA:485426', 'Isolated congenital hepatic fibrosis', 1),
(14295, 'ORPHA:485631', 'BASD', 3),
(14296, 'ORPHA:485631', 'Congenital bile acid synthesis defect', 3),
(14297, 'ORPHA:486', 'Autosomal dominant severe congenital neutropenia', 1),
(14298, 'ORPHA:48652', '22q13.3 deletion', 1),
(14299, 'ORPHA:48652', 'Monosomy 22q13.3', 1),
(14300, 'ORPHA:48652', 'Phelan-McDermid syndrome', 1),
(14301, 'ORPHA:486811', 'Prenatal-onset spinal muscular atrophy with congenital bone fractures', 1),
(14302, 'ORPHA:486811', 'SMABF', 1),
(14303, 'ORPHA:486815', 'Congenital muscular dystrophy, Davignon-Chauveau type', 1),
(14304, 'ORPHA:486815', 'Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome', 1),
(14305, 'ORPHA:48686', 'Body cavity-based lymphoma', 1),
(14306, 'ORPHA:48686', 'PEL', 1),
(14307, 'ORPHA:48686', 'Primary effusion lymphoma', 1),
(14308, 'ORPHA:486955', 'Rare pediatric rheumatologic disease', 3),
(14309, 'ORPHA:487', 'GALC deficiency', 1),
(14310, 'ORPHA:487', 'Galactocerebrosidase deficiency', 1),
(14311, 'ORPHA:487', 'Galactosylceramidase deficiency', 1),
(14312, 'ORPHA:487', 'Globoid cell leukodystrophy', 1),
(14313, 'ORPHA:487', 'Krabbe disease', 1),
(14314, 'ORPHA:48736', 'Embryonal carcinoma of the CNS', 2),
(14315, 'ORPHA:48736', 'Embryonal carcinoma of the central nervous system', 2),
(14316, 'ORPHA:487796', 'Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome', 1),
(14317, 'ORPHA:487796', 'Takenouchi-Kosaki syndrome', 1),
(14318, 'ORPHA:487809', 'Childhood-onset collagenous gastritis', 1),
(14319, 'ORPHA:487809', 'Pediatric collagenous gastritis', 1),
(14320, 'ORPHA:487814', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation', 1),
(14321, 'ORPHA:487814', 'CMT2 due to DGAT2 mutation', 1),
(14322, 'ORPHA:487825', 'Pierpont syndrome', 1),
(14323, 'ORPHA:487825', 'Plantar lipomatosis-facial dysmorphism-developmental delay syndrome', 1),
(14324, 'ORPHA:487825', 'Plantar lipomatosis-unusual facies-developmental delay syndrome', 1),
(14325, 'ORPHA:488', 'Urachal cyst', 1),
(14326, 'ORPHA:488168', 'Microcephaly-congenital cataract-psoriasiform dermatitis syndrome', 1),
(14327, 'ORPHA:488168', 'SMO deficiency', 1),
(14328, 'ORPHA:488168', 'Sterol-C4-methyl oxidase deficiency', 1),
(14329, 'ORPHA:48818', 'Aceruloplasminemia', 1),
(14330, 'ORPHA:48818', 'Hereditary ceruloplasmin deficiency', 1),
(14331, 'ORPHA:488191', 'Female infertility due to oocyte meiotic arrest', 1),
(14332, 'ORPHA:488197', 'Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome', 1),
(14333, 'ORPHA:488232', 'SFMMP', 1),
(14334, 'ORPHA:488232', 'Split-foot malformation-mesoaxial polydactyly syndrome', 1),
(14335, 'ORPHA:488232', 'Split-foot malformation-mesoaxial polydactyly-nail abnormalities-sensorineural hearing loss syndrome', 1),
(14336, 'ORPHA:488239', 'AMNR', 1),
(14337, 'ORPHA:488239', 'Acute macular neuroretinopathy', 1),
(14338, 'ORPHA:488265', 'OFD', 1),
(14339, 'ORPHA:488265', 'Osteofibrous dysplasia', 1),
(14340, 'ORPHA:488280', '14q32 duplication syndrome', 1),
(14341, 'ORPHA:488280', 'Dup(14)q(32)', 1),
(14342, 'ORPHA:488280', 'Predisposition to adult-onset myeloproliferative neoplasm due to 14q32 duplication', 1),
(14343, 'ORPHA:488280', 'Trisomy 14q32', 1),
(14344, 'ORPHA:488333', 'Autosomal dominant Charcot-Marie-Tooth disease type 2 due to HARS mutation', 1),
(14345, 'ORPHA:488333', 'Autosomal dominant Charcot-Marie-Tooth disease type 2W', 1),
(14346, 'ORPHA:488333', 'CMT2W', 1),
(14347, 'ORPHA:488434', 'Camptodactyly syndrome, Guadalajara type 3', 1),
(14348, 'ORPHA:488437', 'SIX2-related FND', 1),
(14349, 'ORPHA:488437', 'SIX2-related frontonasal dysplasia', 1),
(14350, 'ORPHA:488586', 'Amyoplasia congenita', 1),
(14351, 'ORPHA:488586', 'Congenital amyoplasia', 1),
(14352, 'ORPHA:488594', 'Autosomal recessive spastic paraplegia type 76', 1),
(14353, 'ORPHA:488594', 'SPG76', 1),
(14354, 'ORPHA:488613', 'Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome', 1),
(14355, 'ORPHA:488618', 'Short stature-developmental delay-congenital heart defect syndrome', 1),
(14356, 'ORPHA:488618', 'TKT deficiency', 1),
(14357, 'ORPHA:488618', 'Transketolase deficiency', 1),
(14358, 'ORPHA:488627', 'Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome', 1),
(14359, 'ORPHA:488632', 'TBCK-related intellectual disability syndrome', 1),
(14360, 'ORPHA:488635', 'Congenital disorder of glycosylation due to PIGG deficiency', 1),
(14361, 'ORPHA:488635', 'Early-onset epilepsy-intellectual disability-brain anomalies syndrome', 1),
(14362, 'ORPHA:488635', 'PIGG-CDG', 1),
(14363, 'ORPHA:488642', 'TELO2-related intellectual disability-neurodevelopmental disorder', 1),
(14364, 'ORPHA:488642', 'You-Hoover-Fong syndrome', 1),
(14365, 'ORPHA:488647', 'DDX41-related hematologic malignancy predisposition syndrome', 1),
(14366, 'ORPHA:488650', 'Distal myopathy, Tateyama type', 1),
(14367, 'ORPHA:48918', 'Focal myositis', 1),
(14368, 'ORPHA:48918', 'Focal nodular myositis', 1),
(14369, 'ORPHA:48918', 'Inflammatory pseudotumor of skeletal muscle', 1),
(14370, 'ORPHA:49', 'Aphallia', 1),
(14371, 'ORPHA:49', 'Penile agenesis', 1),
(14372, 'ORPHA:49', 'Penis agenesis', 1),
(14373, 'ORPHA:490', 'Omphalomesenteric cyst', 1),
(14374, 'ORPHA:49041', 'Idiopathic retroperitoneal fibrosis', 1),
(14375, 'ORPHA:49041', 'IgG4-related retroperitoneal fibrosis', 1),
(14376, 'ORPHA:49041', 'Ormond disease', 1),
(14377, 'ORPHA:49042', 'DGI', 1),
(14378, 'ORPHA:49042', 'DGI without OI', 1),
(14379, 'ORPHA:49042', 'DI', 1),
(14380, 'ORPHA:49042', 'Dentinogenesis imperfecta', 1),
(14381, 'ORPHA:49042', 'Dentinogenesis imperfecta without osteogenesis imperfecta', 1),
(14382, 'ORPHA:49042', 'Non-syndromic DGI', 1),
(14383, 'ORPHA:49042', 'Non-syndromic dentinogenesis imperfecta', 1),
(14384, 'ORPHA:49042', 'Opalescent teeth without OI', 1),
(14385, 'ORPHA:49042', 'Opalescent teeth without osteogenesis imperfecta', 1),
(14386, 'ORPHA:492', 'Proliferating trichilemmal cyst', 1),
(14387, 'ORPHA:493', 'Familial keratoacanthoma', 1),
(14388, 'ORPHA:493', 'Hereditary keratoacanthoma', 1),
(14389, 'ORPHA:493', 'Multiple keratoacanthoma', 1),
(14390, 'ORPHA:493342', 'Vibratory urticaria', 1),
(14391, 'ORPHA:493348', 'Vibratory angioedema', 1),
(14392, 'ORPHA:49382', 'ACHM', 1),
(14393, 'ORPHA:49382', 'Achromatopsia', 1),
(14394, 'ORPHA:49382', 'Complete or incomplete color blindness', 1),
(14395, 'ORPHA:49382', 'Pingelapese blindness', 1),
(14396, 'ORPHA:49382', 'Rod monochromacy', 1),
(14397, 'ORPHA:49382', 'Rod monochromatism', 1),
(14398, 'ORPHA:49382', 'Total color blindness', 1),
(14399, 'ORPHA:494', 'Keratoderma hereditarium mutilans', 1),
(14400, 'ORPHA:494', 'Mutilating keratoderma of Vohwinkel', 1),
(14401, 'ORPHA:494', 'Mutilating keratoderma plus deafness', 1),
(14402, 'ORPHA:494', 'Mutilating keratoderma plus hearing loss', 1),
(14403, 'ORPHA:494', 'PPK mutilans and deafness', 1),
(14404, 'ORPHA:494', 'PPK mutilans and hearing loss', 1),
(14405, 'ORPHA:494', 'Vohwinkel syndrome', 1),
(14406, 'ORPHA:494344', 'RERE-related neurodevelopmental syndrome', 1),
(14407, 'ORPHA:494348', 'Early-onset familial noncirrhotic portal hypertension', 1),
(14408, 'ORPHA:494418', 'Carcinoma of vulva', 1),
(14409, 'ORPHA:494418', 'Vulvar carcinoma', 1),
(14410, 'ORPHA:494421', 'Sacrococcygeal teratoma', 2),
(14411, 'ORPHA:494424', 'ECAA', 1),
(14412, 'ORPHA:494424', 'ECCA', 1),
(14413, 'ORPHA:494424', 'Extracranial carotid artery aneurysm', 1),
(14414, 'ORPHA:494428', 'IPPFE', 1),
(14415, 'ORPHA:494428', 'Idiopathic pleuroparenchymal fibroelastosis', 1),
(14416, 'ORPHA:494428', 'Idiopathic pleuropulmonary fibroelastosis', 1),
(14417, 'ORPHA:494433', 'MIRAGE syndrome', 1),
(14418, 'ORPHA:494433', 'Myelodysplasia-infection-restriction of growth-adrenal hypoplasia-genital anomalies-enteropathy syndrome', 1),
(14419, 'ORPHA:494433', 'Myelodysplasia-infection-restriction of growth-adrenal hypoplasia-genital phenotypes-enteropathy syndrome', 1),
(14420, 'ORPHA:494439', 'Retinitis pigmentosa-deafness-premature aging-short stature-facial dysmorphism syndrome', 1),
(14421, 'ORPHA:494439', 'Retinitis pigmentosa-hearing loss-premature aging-short stature-facial dysmorphism syndrome', 1),
(14422, 'ORPHA:494444', 'DIAPH1-related sensorineural deafness-thrombocytopenia syndrome', 1),
(14423, 'ORPHA:494444', 'DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome', 1),
(14424, 'ORPHA:494448', 'Squamous cell carcinoma of the vulva', 2),
(14425, 'ORPHA:494448', 'Vulvar squamous cell carcinoma', 2),
(14426, 'ORPHA:494451', 'Basal cell carcinoma of vulva', 2),
(14427, 'ORPHA:494451', 'Vulvar basal cell carcinoma', 2),
(14428, 'ORPHA:494454', 'Adenocarcinoma of the vulva', 2),
(14429, 'ORPHA:494454', 'Vulvar adenocarcinoma', 2),
(14430, 'ORPHA:494457', 'Rare hyperkinetic movement disorder', 3),
(14431, 'ORPHA:494526', 'Infantile-onset generalized dyskinesia with orofacial involvement', 1),
(14432, 'ORPHA:494526', 'Infantile-onset orofacial-trunk-limbs dyskinesia', 1),
(14433, 'ORPHA:494541', 'Childhood-onset benign chorea with striatal involvement', 1),
(14434, 'ORPHA:494547', 'Squamous cell carcinoma of the hypopharynx', 1),
(14435, 'ORPHA:494550', 'Squamous cell carcinoma of the larynx', 1),
(14436, 'ORPHA:495', 'Greither disease', 1),
(14437, 'ORPHA:495', 'Keratosis extremitatum hereditaria progrediens', 1),
(14438, 'ORPHA:495', 'Keratosis palmoplantaris transgrediens et progrediens', 1),
(14439, 'ORPHA:495', 'Progressive diffuse PPK', 1),
(14440, 'ORPHA:495', 'Progressive diffuse palmoplantar keratoderma', 1),
(14441, 'ORPHA:495', 'Transgrediens et progrediens PPK', 1),
(14442, 'ORPHA:495', 'Transgrediens et progrediens palmoplantar keratoderma', 1),
(14443, 'ORPHA:495274', 'AR-CMT2T', 1),
(14444, 'ORPHA:495274', 'Autosomal recessive axonal Charcot-Marie-Tooth disease type 2T', 1),
(14445, 'ORPHA:495274', 'CMT2T', 1),
(14446, 'ORPHA:495274', 'Charcot-Marie-Tooth disease type 2T', 1),
(14447, 'ORPHA:49566', 'Acquired purpura fulminans', 1),
(14448, 'ORPHA:495818', '9q33.3q34.11 microdeletion syndrome', 1),
(14449, 'ORPHA:495818', 'Del(9)(q33.3q34.11)', 1),
(14450, 'ORPHA:495818', 'Deletion 9q33.3q34.11', 1),
(14451, 'ORPHA:495818', 'Monosomy 9q33.3q34.11', 1),
(14452, 'ORPHA:495844', 'C11ORF73-related autosomal recessive hypomyelinating leukodystrophy', 1),
(14453, 'ORPHA:495844', 'C11ORF73-related autosomal recessive hypomyelinating leukoencephalopathy', 1),
(14454, 'ORPHA:495844', 'Hypomyelinating leukodystrophy due to hikeshi deficiency', 1),
(14455, 'ORPHA:495875', 'Congenital agenesis of labia majora or scrotum-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome', 1),
(14456, 'ORPHA:495875', 'Congenital labioscrotal agenesis-cerebellar malformation-corneal dystrophy-facial dysmorphism syndrome', 1),
(14457, 'ORPHA:495879', 'Congenital absence of the scrotum', 1),
(14458, 'ORPHA:495879', 'Congenital agenesis of the scrotum', 1),
(14459, 'ORPHA:495879', 'Congenital scrotal absence', 1),
(14460, 'ORPHA:495879', 'Congenital scrotal agenesis', 1),
(14461, 'ORPHA:495930', 'Familial monosomy 7 syndrome', 1),
(14462, 'ORPHA:496641', 'Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome', 1),
(14463, 'ORPHA:496686', 'Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome', 1),
(14464, 'ORPHA:496689', 'Kyphoscoliosis-lateral tongue atrophy-HSP syndrome', 1),
(14465, 'ORPHA:496689', 'Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome', 1),
(14466, 'ORPHA:496693', 'Gershoni-Baruch syndrome', 1),
(14467, 'ORPHA:496693', 'Omphalocele-diaphragmatic hernia-cardiovascular anomalies-radial ray defect syndrome', 1),
(14468, 'ORPHA:496751', 'EVEN-plus syndrome', 1),
(14469, 'ORPHA:496751', 'Epiphysial-vertebral-ear dysplasia-nose-plus associated findings syndrome', 1),
(14470, 'ORPHA:496756', 'Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome', 1),
(14471, 'ORPHA:496790', 'Harel-Yoon syndrome', 1),
(14472, 'ORPHA:496790', 'Ocular anomalies-axonal neuropathy-developmental delay syndrome', 1),
(14473, 'ORPHA:496916', 'Rare genetic hyperkinetic movement disorder', 3),
(14474, 'ORPHA:496924', 'Non-inflammatory vasculopathy', 3),
(14475, 'ORPHA:497188', 'DIPG', 1),
(14476, 'ORPHA:497188', 'Diffuse intrinsic pontine glioma', 1),
(14477, 'ORPHA:497623', 'C12ORF65-related COXPD', 3),
(14478, 'ORPHA:497623', 'C12ORF65-related combined oxidative phosphorylation defect', 3),
(14479, 'ORPHA:497737', 'Epidermal nevus with epidermolytic hyperkeratosis', 1),
(14480, 'ORPHA:497737', 'Epidermolytic epidermal nevus', 1),
(14481, 'ORPHA:497737', 'Epidermolytic nevus', 1),
(14482, 'ORPHA:497737', 'Epidermolytic verrucous epidermal nevus', 1),
(14483, 'ORPHA:497757', 'MME-related autosomal dominant CMT2', 1),
(14484, 'ORPHA:497757', 'MME-related autosomal dominant Charcot Marie Tooth disease type 2', 1),
(14485, 'ORPHA:497757', 'MME-related autosomal dominant hereditary motor and sensory neuropathy type 2', 1),
(14486, 'ORPHA:497764', 'SCA43', 1),
(14487, 'ORPHA:497764', 'Spinocerebellar ataxia type 43', 1),
(14488, 'ORPHA:497906', 'Childhood-onset basal ganglia degeneration syndrome', 1),
(14489, 'ORPHA:497906', 'Lenk-Ploski syndrome', 1),
(14490, 'ORPHA:498', 'Keratosis pilaris atrophicans', 3),
(14491, 'ORPHA:49804', 'Amyloid lichen', 1),
(14492, 'ORPHA:49804', 'Lichen amyloidosis', 1),
(14493, 'ORPHA:49804', 'Lichen amyloidosus', 1),
(14494, 'ORPHA:498228', 'Cystic epithelial-stromal tumors of the prostate', 1),
(14495, 'ORPHA:498228', 'Cystosarcoma phyllodes of the prostate', 1),
(14496, 'ORPHA:498228', 'Phyllodes tumor of the prostate', 1),
(14497, 'ORPHA:498228', 'Phyllodes type of atypical prostatic hyperplasia', 1),
(14498, 'ORPHA:498251', 'Luteal-phase-dependent febrile episode', 1),
(14499, 'ORPHA:498251', 'Luteal-phase-dependent periodic fever', 1),
(14500, 'ORPHA:498251', 'Menstrual cycle-dependent febrile episode', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(14501, 'ORPHA:498251', 'Menstrual cycle-dependent periodic fever', 1),
(14502, 'ORPHA:49827', 'Rogers syndrome', 1),
(14503, 'ORPHA:49827', 'TRMA', 1),
(14504, 'ORPHA:49827', 'Thiamine-responsive megaloblastic anemia syndrome', 1),
(14505, 'ORPHA:49827', 'Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness', 1),
(14506, 'ORPHA:49827', 'Thiamine-responsive megaloblastic anemia with diabetes mellitus and sensorineural hearing loss', 1),
(14507, 'ORPHA:498345', 'Biliary atresia and associated disorders', 3),
(14508, 'ORPHA:498350', 'Syndromic biliary atresia', 3),
(14509, 'ORPHA:498359', 'Aquagenic keratoderma', 1),
(14510, 'ORPHA:498359', 'Aquagenic palmoplantar keratoderma', 1),
(14511, 'ORPHA:498359', 'Aquagenic syringeal acrokeratoderma', 1),
(14512, 'ORPHA:498359', 'Aquagenic wrinkling of the palms', 1),
(14513, 'ORPHA:498359', 'Transient reactive papulotranslucent acrokeratoderma', 1),
(14514, 'ORPHA:498445', 'Genetic inflammatory or rheumatoid-like osteoarthropathy', 3),
(14515, 'ORPHA:498448', 'Overgrowth or tall stature syndrome with skeletal involvement', 3),
(14516, 'ORPHA:498451', 'Dysostosis with brachydactyly without extraskeletal manifestations', 3),
(14517, 'ORPHA:498454', 'Dysostosis with brachydactyly with extraskeletal manifestations', 3),
(14518, 'ORPHA:498457', 'Longitudinal limb defect', 3),
(14519, 'ORPHA:498461', 'Terminal transverse limb defect', 3),
(14520, 'ORPHA:498464', 'Non-syndromic preaxial polydactyly', 3),
(14521, 'ORPHA:498467', 'Non-syndromic postaxial polydactyly', 3),
(14522, 'ORPHA:498470', 'Non-syndromic complex polydactyly', 3),
(14523, 'ORPHA:498474', 'Hyaline fibromatosis syndrome', 1),
(14524, 'ORPHA:498477', 'Ectrodactyly with and without other manifestations', 3),
(14525, 'ORPHA:498481', 'LRP5-related primary osteoporosis', 1),
(14526, 'ORPHA:498485', 'Overgrowth-metaphyseal undermodeling-spondylar dysplasia syndrome', 1),
(14527, 'ORPHA:498488', 'Overgrowth syndrome with 2q37 translocation', 1),
(14528, 'ORPHA:498491', 'Complete hemimelia', 3),
(14529, 'ORPHA:498494', 'Mirror-image polydactyly', 1),
(14530, 'ORPHA:498497', 'Short rib-polydactyly syndrome type 5', 1),
(14531, 'ORPHA:498602', 'Sugarman brachydactyly', 1),
(14532, 'ORPHA:498602', 'Sugarman-Hager-Kulik syndrome', 1),
(14533, 'ORPHA:498693', 'MYBPC1-related autosomal recessive non-lethal AMC syndrome', 1),
(14534, 'ORPHA:498693', 'MYBPC1-related autosomal recessive non-lethal arthrogryposis multiplex congenita syndrome', 1),
(14535, 'ORPHA:498700', 'Limbic encephalitis with neurexin-3 antibodies', 1),
(14536, 'ORPHA:499', 'Kerion celsi', 1),
(14537, 'ORPHA:499004', 'TBM', 1),
(14538, 'ORPHA:499004', 'Tubercular meningitis', 1),
(14539, 'ORPHA:499004', 'Tuberculous meningitis', 1),
(14540, 'ORPHA:499009', 'Congenital syphilis', 1),
(14541, 'ORPHA:499009', 'MTCT of syphilis', 1),
(14542, 'ORPHA:499009', 'Mother-to-child transmission of syphilis', 1),
(14543, 'ORPHA:499047', 'Autoimmune/inflammatory optic neuropathy', 3),
(14544, 'ORPHA:499085', 'CRION', 1),
(14545, 'ORPHA:499085', 'Chronic recurrent isolated optic neuritis', 1),
(14546, 'ORPHA:499085', 'Chronic relapsing inflammatory optic neuropathy', 1),
(14547, 'ORPHA:499096', 'ION', 1),
(14548, 'ORPHA:499096', 'Isolated optic neuritis', 1),
(14549, 'ORPHA:499103', 'RINR', 1),
(14550, 'ORPHA:499103', 'Recurrent idiopathic neuroretinitis', 1),
(14551, 'ORPHA:499107', 'Idiopathic OPN', 1),
(14552, 'ORPHA:499107', 'Idiopathic optic perineuritis', 1),
(14553, 'ORPHA:499182', 'Calcified epithelial carcinoma of Malherbe', 1),
(14554, 'ORPHA:499182', 'Calcifying epitheliocarcinoma', 1),
(14555, 'ORPHA:499182', 'Malignant pilomatricoma', 1),
(14556, 'ORPHA:499182', 'Pilomatrix carcinoma', 1),
(14557, 'ORPHA:499182', 'Trichomatrical carcinoma', 1),
(14558, 'ORPHA:5', 'LCHAD deficiency', 1),
(14559, 'ORPHA:5', 'LCHADD', 1),
(14560, 'ORPHA:5', 'Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency', 1),
(14561, 'ORPHA:5', 'Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency', 1),
(14562, 'ORPHA:50', 'Agenesis of corpus callosum with chorioretinal abnormality', 1),
(14563, 'ORPHA:50', 'Aicardi syndrome', 1),
(14564, 'ORPHA:500', 'Cardiomyopathic lentiginosis', 1),
(14565, 'ORPHA:500', 'Familial multiple lentigines syndrome', 1),
(14566, 'ORPHA:500', 'LEOPARD syndrome', 1),
(14567, 'ORPHA:500', 'Noonan syndrome with multiple lentigines', 1),
(14568, 'ORPHA:500055', '16p13.2 microdeletion syndrome', 1),
(14569, 'ORPHA:500055', 'Del(16)(p13.2)', 1),
(14570, 'ORPHA:500055', 'Monosomy 16p13.2', 1),
(14571, 'ORPHA:500062', 'Infantile-onset periodic fever-panniculitis-dermatosis syndrome', 1),
(14572, 'ORPHA:500062', 'ORAS', 1),
(14573, 'ORPHA:500062', 'OTULIN deficiency', 1),
(14574, 'ORPHA:500062', 'OTULIN-related autoinflammatory syndrome', 1),
(14575, 'ORPHA:500062', 'Otulipenia', 1),
(14576, 'ORPHA:500095', 'Tall stature-intellectual disability-renal anomalies syndrome', 1),
(14577, 'ORPHA:500095', 'Thauvin-Robinet-Faivre syndrome', 1),
(14578, 'ORPHA:500135', 'MARCH syndrome', 1),
(14579, 'ORPHA:500135', 'Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome', 1),
(14580, 'ORPHA:500144', 'Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome', 1),
(14581, 'ORPHA:500150', 'Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome', 1),
(14582, 'ORPHA:500150', 'ZTTK syndrome', 1),
(14583, 'ORPHA:500150', 'Zhu-Tokita-Takenouchi-Kim syndrome', 1),
(14584, 'ORPHA:500159', 'Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom', 1),
(14585, 'ORPHA:500163', 'SIN3A-related intellectual disability syndrome', 1),
(14586, 'ORPHA:500163', 'WITKOS', 1),
(14587, 'ORPHA:500163', 'Witteveen-Kolk syndrome', 1),
(14588, 'ORPHA:500166', 'SIN3A-related intellectual disability syndrome due to a point mutation', 2),
(14589, 'ORPHA:500180', 'Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder', 1),
(14590, 'ORPHA:500188', 'X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome', 1),
(14591, 'ORPHA:500464', 'Squamous cell carcinoma of the nasal cavity and paranasal sinuses', 1),
(14592, 'ORPHA:500464', 'Squamous cell carcinoma of the nasal cavity and sinuses', 1),
(14593, 'ORPHA:500478', 'Squamous cell carcinoma of the oropharynx', 1),
(14594, 'ORPHA:500481', 'Squamous cell carcinoma of salivary glands', 2),
(14595, 'ORPHA:500533', 'PMSE syndrome', 1),
(14596, 'ORPHA:500533', 'Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome', 1),
(14597, 'ORPHA:500545', 'Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract', 1),
(14598, 'ORPHA:500548', 'Osteosclerotic metaphyseal dysplasia', 1),
(14599, 'ORPHA:501', 'EPM2', 1),
(14600, 'ORPHA:501', 'Lafora disease', 1),
(14601, 'ORPHA:501', 'PME type 2', 1),
(14602, 'ORPHA:501', 'Progressive myoclonic epilepsy type 2', 1),
(14603, 'ORPHA:501', 'Progressive myoclonus epilepsy type 2', 1),
(14604, 'ORPHA:502', 'Deletion 8q24.1', 1),
(14605, 'ORPHA:502', 'Langer-Giedion syndrome', 1),
(14606, 'ORPHA:502', 'Monosomy 8q24.1', 1),
(14607, 'ORPHA:502', 'Trichorhinophalangeal syndrome type 2', 1),
(14608, 'ORPHA:502305', 'Cochleovestibular dysplasia', 1),
(14609, 'ORPHA:502318', 'Cochlear nerve deficiency', 1),
(14610, 'ORPHA:502363', 'Squamous cell carcinoma of the oral cavity', 1),
(14611, 'ORPHA:502366', 'Squamous cell carcinoma of the lip', 1),
(14612, 'ORPHA:502369', 'Squamous cell carcinoma of oral cavity and lip', 3),
(14613, 'ORPHA:502423', 'Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome', 1),
(14614, 'ORPHA:502423', 'Mitochondrial myopathy-cerebellar atrophy-pigmentary retinopathy syndrome', 1),
(14615, 'ORPHA:502430', 'Metopic ridging-ptosis-facial dysmorphism syndrome', 1),
(14616, 'ORPHA:502434', 'STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome', 1),
(14617, 'ORPHA:502437', '4q25 proximal deletion syndrome', 1),
(14618, 'ORPHA:502437', 'Proximal del(4)(q25)', 1),
(14619, 'ORPHA:502437', 'Proximal monosomy 4q25', 1),
(14620, 'ORPHA:502444', 'ACER3-related early childhood-onset progressive leukodystrophy', 1),
(14621, 'ORPHA:502444', 'Alkaline ceramidase 3 deficiency', 1),
(14622, 'ORPHA:502444', 'Leukodystrophy due to alkaline ceramidase 3 deficiency', 1),
(14623, 'ORPHA:502499', 'Erythema exsudativum multiforme majus', 1),
(14624, 'ORPHA:502499', 'Erythema multiforme major', 1),
(14625, 'ORPHA:502499', 'Erythema multiforme majus', 1),
(14626, 'ORPHA:50251', 'Pleural mesothelioma', 1),
(14627, 'ORPHA:503', 'Larsen syndrome', 1),
(14628, 'ORPHA:504', 'Creeping myiasis', 1),
(14629, 'ORPHA:504', 'Migratory myiasis', 1),
(14630, 'ORPHA:504476', 'CABV syndrome', 1),
(14631, 'ORPHA:504476', 'CANVAS', 1),
(14632, 'ORPHA:504476', 'Cerebellar ataxia with bilateral vestibulopathy syndrome', 1),
(14633, 'ORPHA:504476', 'Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome', 1),
(14634, 'ORPHA:504523', 'SCID due to LAT deficiency', 1),
(14635, 'ORPHA:504523', 'Severe combined immunodeficiency due to LAT deficiency', 1),
(14636, 'ORPHA:504530', 'CID due to Moesin deficiency', 1),
(14637, 'ORPHA:504530', 'Combined immunodeficiency due to Moesin deficiency', 1),
(14638, 'ORPHA:504530', 'MSN-related combined immunodeficiency', 1),
(14639, 'ORPHA:504530', 'X-linked Moesin-associated immunodeficiency', 1),
(14640, 'ORPHA:505', 'Graham Little syndrome', 1),
(14641, 'ORPHA:505', 'Graham Little-Piccardi-Lassueur syndrome', 1),
(14642, 'ORPHA:505', 'Piccardi-Lassueur-Little syndrome', 1),
(14643, 'ORPHA:505208', '3-methylglutaconic aciduria type 8', 1),
(14644, 'ORPHA:505208', 'MGA8', 1),
(14645, 'ORPHA:505216', '3-methylglutaconic aciduria type 9', 1),
(14646, 'ORPHA:505216', '3-methylglutaconic aciduria-epilepsy-spasticity-severe intellectual disability syndrome', 1),
(14647, 'ORPHA:505216', 'MGA9', 1),
(14648, 'ORPHA:505227', 'CID due to GINS1 deficiency', 1),
(14649, 'ORPHA:505227', 'Combined immunodeficiency due to GINS1 deficiency', 1),
(14650, 'ORPHA:505227', 'Combined immunodeficiency with intrauterine growth retardation-NK cell deficiency-neutropenia', 1),
(14651, 'ORPHA:505227', 'Combined immunodeficiency with intrauterine growth retardation-natural killer cell deficiency-neutropenia', 1),
(14652, 'ORPHA:505237', 'Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome', 1),
(14653, 'ORPHA:505242', 'Cerebrorenal syndrome, Perez type', 1),
(14654, 'ORPHA:505242', 'Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome', 1),
(14655, 'ORPHA:505248', 'Mucopolysaccharidosis-like plus disease', 1),
(14656, 'ORPHA:505248', 'Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders', 1),
(14657, 'ORPHA:505395', 'VIDD', 1),
(14658, 'ORPHA:505395', 'Ventilator-induced diaphragmatic dysfunction', 1),
(14659, 'ORPHA:505652', 'CDKL5 deficiency disorder', 1),
(14660, 'ORPHA:505652', 'CDKL5-related epileptic encephalopathy', 1),
(14661, 'ORPHA:506', 'Infantile subacute necrotizing encephalopathy', 3),
(14662, 'ORPHA:506', 'Leigh disease', 3),
(14663, 'ORPHA:506', 'Leigh syndrome', 3),
(14664, 'ORPHA:506052', 'Neuroendocrine neoplasm of pancreas', 3),
(14665, 'ORPHA:506052', 'PNEN', 3),
(14666, 'ORPHA:506052', 'Pancreatic NEN', 3),
(14667, 'ORPHA:506052', 'Pancreatic neuroendocrine neoplasm', 3),
(14668, 'ORPHA:506060', 'Functioning PNET', 3),
(14669, 'ORPHA:506060', 'Functioning neuroendocrine tumor of pancreas', 3),
(14670, 'ORPHA:506060', 'Functioning pancreatic NET', 3),
(14671, 'ORPHA:506060', 'Functioning pancreatic neuroendocrine tumor', 3),
(14672, 'ORPHA:506060', 'Functioning well-differentiated NEN of pancreas', 3),
(14673, 'ORPHA:506060', 'Functioning well-differentiated neuroendocrine neoplasm of pancreas', 3),
(14674, 'ORPHA:506060', 'Functioning well-differentiated pancreatic NEN', 3),
(14675, 'ORPHA:506060', 'Functioning well-differentiated pancreatic neuroendocrine neoplasm', 3),
(14676, 'ORPHA:506075', 'Non-functioning PNET', 1),
(14677, 'ORPHA:506075', 'Non-functioning neuroendocrine tumor of pancreas', 1),
(14678, 'ORPHA:506075', 'Non-functioning pancreatic NET', 1),
(14679, 'ORPHA:506075', 'Non-functioning pancreatic neuroendocrine tumor', 1),
(14680, 'ORPHA:506075', 'Non-functioning well-differentiated NEN of pancreas', 1),
(14681, 'ORPHA:506075', 'Non-functioning well-differentiated neuroendocrine neoplasm of pancreas', 1),
(14682, 'ORPHA:506075', 'Non-functioning well-differentiated pancreatic NEN', 1),
(14683, 'ORPHA:506075', 'Non-functioning well-differentiated pancreatic neuroendocrine neoplasm', 1),
(14684, 'ORPHA:506090', 'Serotonin-producing PNET', 1),
(14685, 'ORPHA:506090', 'Serotonin-producing neuroendocrine tumor of pancreas', 1),
(14686, 'ORPHA:506090', 'Serotonin-producing pancreatic NET', 1),
(14687, 'ORPHA:506090', 'Serotonin-producing pancreatic neuroendocrine tumor', 1),
(14688, 'ORPHA:506098', 'Neuroendocrine carcinoma of pancreas', 1),
(14689, 'ORPHA:506098', 'Pancreatic NEC', 1),
(14690, 'ORPHA:506098', 'Pancreatic neuroendocrine carcinoma', 1),
(14691, 'ORPHA:506098', 'Poorly-differentiated NEN of pancreas', 1),
(14692, 'ORPHA:506098', 'Poorly-differentiated neuroendocrine neoplasm of pancreas', 1),
(14693, 'ORPHA:506098', 'Poorly-differentiated pancreatic NEN', 1),
(14694, 'ORPHA:506098', 'Poorly-differentiated pancreatic neuroendocrine neoplasm', 1),
(14695, 'ORPHA:506112', 'MiNEN of pancreas', 1),
(14696, 'ORPHA:506112', 'Mixed neuroendocrine-nonneuroendocrine neoplasm of pancreas', 1),
(14697, 'ORPHA:506112', 'Pancreatic MiNEN', 1),
(14698, 'ORPHA:506112', 'Pancreatic mixed neuroendocrine-nonneuroendocrine neoplasm', 1),
(14699, 'ORPHA:506136', 'Esophageal NEN', 1),
(14700, 'ORPHA:506136', 'Esophageal neuroendocrine neoplasm', 1),
(14701, 'ORPHA:506136', 'NEN of esophagus', 1),
(14702, 'ORPHA:506136', 'Neuroendocrine neoplasm of esophagus', 1),
(14703, 'ORPHA:506207', 'Rare disorder potentially indicated for transplant', 3),
(14704, 'ORPHA:506210', 'Rare disorder potentially indicated for liver transplant', 3),
(14705, 'ORPHA:506213', 'Rare disorder potentially indicated for kidney transplant', 3),
(14706, 'ORPHA:506216', 'Rare disorder potentially indicated for bowel transplant', 3),
(14707, 'ORPHA:506219', 'Rare disorder potentially indicated for hematopoietic stem cell transplant', 3),
(14708, 'ORPHA:506222', 'Rare disorder potentially indicated for lung transplant', 3),
(14709, 'ORPHA:506225', 'Rare disorder potentially indicated for heart transplant', 3),
(14710, 'ORPHA:506307', 'Apple-peel intestinal atresia-ocular anomalies-microcephaly syndrome', 1),
(14711, 'ORPHA:506307', 'Jejunal atresia-microcephaly-ocular anomalies syndrome', 1),
(14712, 'ORPHA:506307', 'Stromme syndrome', 1),
(14713, 'ORPHA:506334', 'Familial steroid-resistant nephrotic syndrome with adrenal insufficiency', 1),
(14714, 'ORPHA:506334', 'Primary adrenal insufficiency-steroid-resistant nephrotic syndrome due to SGPL1 deficiency', 1),
(14715, 'ORPHA:506353', 'Autosomal recessive complex SPG due to Kennedy pathway dysfunction', 1),
(14716, 'ORPHA:506353', 'Autosomal recessive complex spastic paraplegia due to Kennedy pathway dysfunction', 1),
(14717, 'ORPHA:506358', 'Gabriele-de Vries syndrome', 1),
(14718, 'ORPHA:506358', 'YY1 haploinsufficiency syndrome', 1),
(14719, 'ORPHA:506784', 'SJS/TEN overlap syndrome', 2),
(14720, 'ORPHA:506784', 'Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome', 2),
(14721, 'ORPHA:506784', 'Stevens-Johnson/TEN overlap syndrome', 2),
(14722, 'ORPHA:506784', 'Stevens-Johnson/toxic epidermal necrolysis overlap syndrome', 2),
(14723, 'ORPHA:507', 'Leishmaniasis', 1),
(14724, 'ORPHA:508', 'Donohue syndrome', 1),
(14725, 'ORPHA:508', 'Leprechaunism', 1),
(14726, 'ORPHA:50809', 'Singh-Williams-McAlister syndrome', 1),
(14727, 'ORPHA:50809', 'Talo-patello-scaphoid osteolysis', 1),
(14728, 'ORPHA:508093', 'Autosomal recessive childhood-onset dystonia, DYT29 type', 1),
(14729, 'ORPHA:508093', 'Childhood-onset generalized dystonia-optic atrophy syndrome', 1),
(14730, 'ORPHA:508093', 'DYT29', 1),
(14731, 'ORPHA:508093', 'Dystonia 29', 1),
(14732, 'ORPHA:508093', 'MEPAN syndrome', 1),
(14733, 'ORPHA:508093', 'Mitochondrial enoyl CoA reductase protein-associated neurodegeneration syndrome', 1),
(14734, 'ORPHA:50810', 'Basel-Vanagaite-Sirota syndrome', 1),
(14735, 'ORPHA:50810', 'Microlissencephaly-micromelia syndrome', 1),
(14736, 'ORPHA:50811', 'Lipodystrophy-intellectual disability-deafness syndrome', 1),
(14737, 'ORPHA:50811', 'Lipodystrophy-intellectual disability-hearing loss syndrome', 1),
(14738, 'ORPHA:50811', 'Rajab-Spranger syndrome', 1),
(14739, 'ORPHA:50812', 'Ahn-Lerman-Sagie syndrome', 1),
(14740, 'ORPHA:50812', 'Zellweger-like syndrome without peroxisomal anomalies', 1),
(14741, 'ORPHA:50814', 'Boyadjiev-Jabs syndrome', 1),
(14742, 'ORPHA:50814', 'Craniolenticulosutural dysplasia', 1),
(14743, 'ORPHA:50815', 'Branchiogenic deafness syndrome', 1),
(14744, 'ORPHA:50815', 'Branchiogenic hearing loss syndrome', 1),
(14745, 'ORPHA:50815', 'Mégarbané-Loiselet syndrome', 1),
(14746, 'ORPHA:50817', 'Duane anomaly-myopathy-scoliosis syndrome', 1),
(14747, 'ORPHA:50817', 'Verloes-Deprez syndrome', 1),
(14748, 'ORPHA:50839', 'Bartonellosis due to Bartonella henselae infection', 1),
(14749, 'ORPHA:50839', 'Cat-scratch disease', 1),
(14750, 'ORPHA:508410', 'Familial intestinal malrotation', 1),
(14751, 'ORPHA:508476', 'Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-deafness syndrome', 1),
(14752, 'ORPHA:508476', 'Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome', 1),
(14753, 'ORPHA:508476', 'Hyaluronidase 2 deficiency', 1),
(14754, 'ORPHA:508488', '8q24.3 microdeletion syndrome', 1),
(14755, 'ORPHA:508488', 'Del(8)(q24.3)', 1),
(14756, 'ORPHA:508488', 'Deletion 8q24.3', 1),
(14757, 'ORPHA:508488', 'Monosomy 8q24.3', 1),
(14758, 'ORPHA:508488', 'Verheij syndrome', 1),
(14759, 'ORPHA:508498', 'Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome', 1),
(14760, 'ORPHA:508501', 'OFD18', 1),
(14761, 'ORPHA:508501', 'Oral-facial-digital syndrome type 18', 1),
(14762, 'ORPHA:508501', 'Oral-facial-digital syndrome with short stature and brachymesophalangy', 1),
(14763, 'ORPHA:508501', 'Orofaciodigital syndrome type 18', 1),
(14764, 'ORPHA:508512', 'Congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome', 1),
(14765, 'ORPHA:508523', 'Hyperphenylalaninemia due to DNAJC12 deficiency', 1),
(14766, 'ORPHA:508523', 'Non-phenylketonuric non-BH4-deficiency hyperphenylalaninemia', 1),
(14767, 'ORPHA:508529', 'Generalized basal epidermolysis bullosa simplex with skin atrophy, scarring and hair loss', 1),
(14768, 'ORPHA:508533', 'EXTL3-related neuro-immuno-skeletal dysplasia syndrome', 1),
(14769, 'ORPHA:508533', 'Neuro-immuno-skeletal dysplasia syndrome due to EXTL3 deficiency', 1),
(14770, 'ORPHA:508533', 'Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome', 1),
(14771, 'ORPHA:508542', 'Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome', 1),
(14772, 'ORPHA:508542', 'MYSM1 deficiency', 1),
(14773, 'ORPHA:509', 'Leptospirosis', 1),
(14774, 'ORPHA:50918', 'Histiocytic necrotizing lymphadenitis', 1),
(14775, 'ORPHA:50918', 'Kikuchi disease', 1),
(14776, 'ORPHA:50918', 'Kikuchi-Fujimoto disease', 1),
(14777, 'ORPHA:50942', 'Keratosis palmoplantaris striata', 1),
(14778, 'ORPHA:50942', 'Keratosis palmoplantaris striata et areata', 1),
(14779, 'ORPHA:50942', 'Keratosis palmoplantaris varians of Wachters', 1),
(14780, 'ORPHA:50942', 'Striate palmoplantar keratoderma', 1),
(14781, 'ORPHA:50943', 'Erythrokeratolysis hiemalis', 1),
(14782, 'ORPHA:50943', 'Keratolytic winter erythema', 1),
(14783, 'ORPHA:50943', 'Oudtshoorn disease', 1),
(14784, 'ORPHA:50944', 'Eccrine tumors-ectodermal dysplasia', 1),
(14785, 'ORPHA:50944', 'Keratosis palmoplantaris-cystic eyelids-hypodontia-hypotrichosis syndrome', 1),
(14786, 'ORPHA:50944', 'Palmoplantar hyperkeratosis-cystic eyelids-hypodontia-hypotrichosis syndrome', 1),
(14787, 'ORPHA:50944', 'Palmoplantar keratoderma-cystic eyelids-hypodontia-hypotrichosis syndrome', 1),
(14788, 'ORPHA:50944', 'SSPS', 1),
(14789, 'ORPHA:50944', 'Schöpf-Schulz-Passarge syndrome', 1),
(14790, 'ORPHA:50945', 'BLC', 1),
(14791, 'ORPHA:50945', 'BOCD', 1),
(14792, 'ORPHA:50945', 'Blomstrand chondrodysplasia', 1),
(14793, 'ORPHA:50945', 'Blomstrand lethal chondrodysplasia', 1),
(14794, 'ORPHA:50945', 'Blomstrand osteochondrodysplasia', 1),
(14795, 'ORPHA:50945', 'Chondrodysplasia, Blomstrand type', 1),
(14796, 'ORPHA:51', 'Aicardi-Goutières syndrome', 1),
(14797, 'ORPHA:51', 'Encephalopathy with basal ganglia calcification', 1),
(14798, 'ORPHA:51', 'Encephalopathy with intracranial calcification and chronic lymphocytosis of cerebrospinal fluid', 1),
(14799, 'ORPHA:510', 'HPRT complete deficiency', 1),
(14800, 'ORPHA:510', 'HPRT deficiency grade IV', 1),
(14801, 'ORPHA:510', 'Hypoxanthine guanine phosphoribosyltransferase complete deficiency', 1),
(14802, 'ORPHA:510', 'Hypoxanthine guanine phosphoribosyltransferase deficiency, grade IV', 1),
(14803, 'ORPHA:510', 'Lesch-Nyhan syndrome', 1),
(14804, 'ORPHA:51083', 'Familial short QT syndrome', 1),
(14805, 'ORPHA:51083', 'SQTS', 1),
(14806, 'ORPHA:51084', 'Torsade-de-pointes syndrome with short coupling interval', 1),
(14807, 'ORPHA:511', 'BCKD deficiency', 1),
(14808, 'ORPHA:511', 'BCKDH deficiency', 1),
(14809, 'ORPHA:511', 'Branched-chain 2-ketoacid dehydrogenase deficiency', 1),
(14810, 'ORPHA:511', 'Branched-chain ketoaciduria', 1),
(14811, 'ORPHA:511', 'MSUD', 1),
(14812, 'ORPHA:511', 'Maple syrup urine disease', 1),
(14813, 'ORPHA:51188', 'Ethylmalonic encephalopathy', 1),
(14814, 'ORPHA:512', 'Arylsulfatase A deficiency', 1),
(14815, 'ORPHA:512', 'MLD', 1),
(14816, 'ORPHA:512', 'Metachromatic leukodystrophy', 1),
(14817, 'ORPHA:512017', 'CLPD-NK', 1),
(14818, 'ORPHA:512017', 'CNKL', 1),
(14819, 'ORPHA:512017', 'Chronic NK lymphocytosis', 1),
(14820, 'ORPHA:512017', 'Chronic NK-cell lymphocytosis', 1),
(14821, 'ORPHA:512017', 'Chronic lymphoproliferative disorder of NK-cells', 1),
(14822, 'ORPHA:512017', 'Chronic lymphoproliferative disorder of natural killer cells', 1),
(14823, 'ORPHA:512017', 'NK-cell lineage granular lymphocyte proliferative disorder', 1),
(14824, 'ORPHA:512034', 'Large granular lymphocyte leukemia', 3),
(14825, 'ORPHA:51208', 'FTCD deficiency', 1),
(14826, 'ORPHA:51208', 'Formiminoglutamic aciduria', 1),
(14827, 'ORPHA:51208', 'Formiminotransferase cyclodeaminase deficiency', 1),
(14828, 'ORPHA:51208', 'Glutamate formiminotransferase deficiency', 1),
(14829, 'ORPHA:512103', 'AREI', 1),
(14830, 'ORPHA:512103', 'Autosomal recessive epidermolytic ichthyosis', 1),
(14831, 'ORPHA:512260', 'Congenital cerebellar ataxia due to RNU12 mutation', 1),
(14832, 'ORPHA:513', 'ALL', 3),
(14833, 'ORPHA:513', 'Acute lymphoblastic leukemia', 3),
(14834, 'ORPHA:513', 'Acute lymphoblastic leukemia/lymphoma', 3),
(14835, 'ORPHA:513', 'Acute lymphocytic leukemia', 3),
(14836, 'ORPHA:513', 'Precursor lymphoid neoplasm', 3),
(14837, 'ORPHA:513436', 'Autosomal recessive spastic paraplegia type 78', 1),
(14838, 'ORPHA:513436', 'SPG78', 1),
(14839, 'ORPHA:513456', 'Intellectual disability-seizures-abnormal gait-facial dysmorphism syndrome', 1),
(14840, 'ORPHA:513456', 'Skraban-Deardorff syndrome', 1),
(14841, 'ORPHA:514', 'AML M5', 1),
(14842, 'ORPHA:514', 'Acute monoblastic or monocytic leukemia', 1),
(14843, 'ORPHA:514', 'Acute monoblastic/monocytic leukemia', 1),
(14844, 'ORPHA:514352', 'Congenital brachyesophagus-intrathoracic stomach-vertebral anomalies syndrome', 1),
(14845, 'ORPHA:514352', 'Serpentine-like syndrome', 1),
(14846, 'ORPHA:514980', 'ATP13A2-related parkinsonism', 3),
(14847, 'ORPHA:51577', 'Cobblestone lissencephaly', 3),
(14848, 'ORPHA:51577', 'Lissencephaly type 2', 3),
(14849, 'ORPHA:51608', 'Generalized arterial calcification of infancy', 1),
(14850, 'ORPHA:51608', 'Idiopathic infantile arterial calcification', 1),
(14851, 'ORPHA:51608', 'Idiopathic obliterative arteriopathy', 1),
(14852, 'ORPHA:51608', 'Infantile arteriosclerosis', 1),
(14853, 'ORPHA:51608', 'Occlusive infantile arteriopathy', 1),
(14854, 'ORPHA:51636', 'WHIM syndrome', 1),
(14855, 'ORPHA:51636', 'WILM', 1),
(14856, 'ORPHA:51636', 'Warts-hypogammaglobulinemia-infections-myelokathexis syndrome', 1),
(14857, 'ORPHA:51636', 'Warts-infections-leukopenia-myelokatexis syndrome', 1),
(14858, 'ORPHA:517', 'AML M4', 1),
(14859, 'ORPHA:517', 'AMMoL', 1),
(14860, 'ORPHA:517', 'Acute myelomonocytic leukemia', 1),
(14861, 'ORPHA:518', 'AMKL', 1),
(14862, 'ORPHA:518', 'AML M7', 1),
(14863, 'ORPHA:518', 'Acute megakaryoblastic leukemia', 1),
(14864, 'ORPHA:518', 'Acute megakaryocytic leukemia', 1),
(14865, 'ORPHA:518', 'Acute myeloid leukemia M7', 1),
(14866, 'ORPHA:51890', 'ACNES', 1),
(14867, 'ORPHA:51890', 'Anterior cutaneous nerve entrapment syndrome', 1),
(14868, 'ORPHA:51890', 'Intercostal nerve syndrome', 1),
(14869, 'ORPHA:51890', 'Rectus abdominis syndrome', 1),
(14870, 'ORPHA:519', 'AML', 3),
(14871, 'ORPHA:519', 'Acute myelogenous leukemia', 3),
(14872, 'ORPHA:519', 'Acute myeloid leukemia', 3),
(14873, 'ORPHA:519264', 'Inflammatory/autoimmune disorder involving the lacrimal system', 3),
(14874, 'ORPHA:519266', 'Rare disorder of the ocular adnexa', 3),
(14875, 'ORPHA:519268', 'Rare disorder with ectropion', 3),
(14876, 'ORPHA:519270', 'Rare disorder with entropion', 3),
(14877, 'ORPHA:519272', 'Structural developmental eye defect', 3),
(14878, 'ORPHA:519274', 'Syndromic lacrimal system disorder', 3),
(14879, 'ORPHA:519276', 'Anterior segment developmental abnormality with extraocular manifestations', 3),
(14880, 'ORPHA:519278', 'Infective keratitis', 3),
(14881, 'ORPHA:519280', 'Rare conjunctivitis', 3),
(14882, 'ORPHA:519282', 'Rare corneal disorder', 3),
(14883, 'ORPHA:519284', 'Rare disorder of the anterior segment of the eye', 3),
(14884, 'ORPHA:519286', 'Rare disorder of the pupil', 3),
(14885, 'ORPHA:519288', 'Rare disorder with corneal involvement as a major feature', 3),
(14886, 'ORPHA:519290', 'Rare inflammatory/autoimmune corneal disorder', 3),
(14887, 'ORPHA:519292', 'Syndromic ectopia lentis', 3),
(14888, 'ORPHA:519294', 'Syndromic microspherophakia', 3),
(14889, 'ORPHA:519296', 'Rare disorder with pigmented sclera', 3),
(14890, 'ORPHA:519298', 'Rare scleral disorder', 3),
(14891, 'ORPHA:519300', 'Isolated chorioretinal dystrophy', 3),
(14892, 'ORPHA:519302', 'Isolated macular dystrophy', 3),
(14893, 'ORPHA:519304', 'Isolated vitreoretinopathy', 3),
(14894, 'ORPHA:519306', 'Isolated progressive inherited retinal disorder', 3),
(14895, 'ORPHA:519309', 'Rare choroidal disorder', 3),
(14896, 'ORPHA:519311', 'Rare disorder of the posterior segment of the eye', 3),
(14897, 'ORPHA:519313', 'Rare macular disorder', 3),
(14898, 'ORPHA:519315', 'Rare retinal disorder', 3),
(14899, 'ORPHA:519317', 'Rare retinal vasculopathy', 3),
(14900, 'ORPHA:519319', 'Isolated stationary inherited retinal disorder', 3),
(14901, 'ORPHA:519321', 'Syndromic chorioretinal dystrophy', 3),
(14902, 'ORPHA:519323', 'Syndromic macular dystrophy', 3),
(14903, 'ORPHA:519325', 'Syndromic inherited retinal disorder', 3),
(14904, 'ORPHA:519325', 'Syndromic retinal dystrophy', 3),
(14905, 'ORPHA:519327', 'Syndromic vitreoretinopathy', 3),
(14906, 'ORPHA:519329', 'Rare disorder involving multiple structures of the eye', 3),
(14907, 'ORPHA:519331', 'Secondary early-onset glaucoma', 3),
(14908, 'ORPHA:519333', 'Congenital optic disc excavation', 3),
(14909, 'ORPHA:519337', 'Disorder with optic nerve compression', 3),
(14910, 'ORPHA:519339', 'Pseudopapilledema', 3),
(14911, 'ORPHA:519341', 'Rare brainstem or cerebellar disorder with ophthalmic involvement as a major feature', 3),
(14912, 'ORPHA:519343', 'Rare ophthalmic disorder with cortical involvement', 3),
(14913, 'ORPHA:519345', 'Rare disorder with optic disc malformation', 3),
(14914, 'ORPHA:519347', 'Rare neuromuscular disorder with ocular motility/alignment anomaly', 3),
(14915, 'ORPHA:519349', 'Rare ophthalmic disorder with cranial nerve involvement', 3),
(14916, 'ORPHA:519351', 'Rare optic nerve disorder', 3),
(14917, 'ORPHA:519353', 'Rare trochlear nerve disorder', 3),
(14918, 'ORPHA:519355', 'Rare ocular motility/alignment disorder', 3),
(14919, 'ORPHA:519384', 'Congenital anophthalmos with cyst', 1),
(14920, 'ORPHA:519384', 'Congenital cystic eye', 1),
(14921, 'ORPHA:519386', 'Isolated congenital entropion', 1),
(14922, 'ORPHA:519388', 'Autosomal recessive anterior segment dysgenesis', 1),
(14923, 'ORPHA:519390', 'Isolated blepharochalasis', 1),
(14924, 'ORPHA:519392', 'Isolated iridoschisis', 1),
(14925, 'ORPHA:519396', 'Isolated microspherophakia', 1),
(14926, 'ORPHA:519398', 'Isolated foveal hypoplasia', 1),
(14927, 'ORPHA:519400', 'Peripapillary staphyloma', 1),
(14928, 'ORPHA:519402', 'Isolated megalopapilla', 1),
(14929, 'ORPHA:519404', 'Optic disc pit', 1),
(14930, 'ORPHA:519406', 'Thygeson superficial punctate keratitis', 1),
(14931, 'ORPHA:519406', 'Thygeson superficial punctate keratopathy', 1),
(14932, 'ORPHA:519408', 'Mooren ulcer', 1),
(14933, 'ORPHA:519410', 'Terrien marginal degeneration', 1),
(14934, 'ORPHA:519930', 'Fungal keratitis', 1),
(14935, 'ORPHA:519930', 'Keratomycosis', 1),
(14936, 'ORPHA:519930', 'Mycotic keratitis', 1),
(14937, 'ORPHA:52', 'Alagille syndrome', 1),
(14938, 'ORPHA:52', 'Alagille-Watson syndrome', 1),
(14939, 'ORPHA:52', 'Arteriohepatic dysplasia', 1),
(14940, 'ORPHA:52', 'Syndromic bile duct paucity', 1),
(14941, 'ORPHA:520', 'AML M3', 1),
(14942, 'ORPHA:520', 'AML with t(15;17)(q22;q12);(PML/RARalpha) and variants', 1),
(14943, 'ORPHA:520', 'APML', 1),
(14944, 'ORPHA:520', 'Acute myeloblastic leukemia 3', 1),
(14945, 'ORPHA:520', 'Acute myeloid leukemia with t(15;17)(q22;q12);(PML/RARalpha) and variants', 1),
(14946, 'ORPHA:520', 'Acute promyelocytic leukemia', 1),
(14947, 'ORPHA:52022', '11p11.2 deletion', 1),
(14948, 'ORPHA:52022', 'Potocki-Shaffer syndrome', 1),
(14949, 'ORPHA:52022', 'Proximal 11p deletion syndrome', 1),
(14950, 'ORPHA:52047', 'Braddock syndrome', 1),
(14951, 'ORPHA:52047', 'Vater-like syndrome with pulmonary hypertension, abnormal ears and growth deficiency', 1),
(14952, 'ORPHA:52054', 'Craniosynostosis-intracranial calcifications syndrome', 1),
(14953, 'ORPHA:52054', 'Longman-Tolmie syndrome', 1),
(14954, 'ORPHA:52055', 'Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome', 1),
(14955, 'ORPHA:52055', 'Graham-Cox syndrome', 1),
(14956, 'ORPHA:52056', 'Morava-Mehes syndrome', 1),
(14957, 'ORPHA:52056', 'Ulnar/fibula ray defect-brachydactyly syndrome', 1),
(14958, 'ORPHA:520814', 'Rare disorder of the visual organs', 3),
(14959, 'ORPHA:520817', 'Isolated inherited retinal disorder', 3),
(14960, 'ORPHA:520820', 'Progressive external ophthalmoplegia', 3),
(14961, 'ORPHA:521', 'CML', 1),
(14962, 'ORPHA:521', 'Chronic granulocytic leukemia', 1),
(14963, 'ORPHA:521', 'Chronic myelogenous leukemia', 1),
(14964, 'ORPHA:521', 'Chronic myeloid leukemia', 1),
(14965, 'ORPHA:521123', 'Radiation-induced plexopathy', 1),
(14966, 'ORPHA:521127', 'Osteoradionecrosis of the mandible', 1),
(14967, 'ORPHA:521132', 'Radiation-induced disorder', 3),
(14968, 'ORPHA:521219', 'Extrinsic biliary compression syndrome', 1),
(14969, 'ORPHA:521219', 'Mirizzi syndrome', 1),
(14970, 'ORPHA:521232', 'Genetic primary orthostatic disorder', 3),
(14971, 'ORPHA:521236', 'Primary orthostatic disorder', 3),
(14972, 'ORPHA:521258', 'Dup(X)(q25)', 1),
(14973, 'ORPHA:521258', 'Xq25 microduplication syndrome', 1),
(14974, 'ORPHA:521258', 'Xq25 microtriplication', 1),
(14975, 'ORPHA:521305', 'Proximal myopathy with focal depletion of mitochondria', 1),
(14976, 'ORPHA:521308', 'Frontonasal dysplasia-bifid nose-upper limb anomalies syndrome', 1),
(14977, 'ORPHA:521390', 'SINO syndrome', 1),
(14978, 'ORPHA:521390', 'Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome', 1),
(14979, 'ORPHA:521406', 'Dystonia-parkinsonism-hypermanganesemia syndrome', 1),
(14980, 'ORPHA:521411', 'Autosomal recessive axonal CMT due to copper metabolism defect', 1),
(14981, 'ORPHA:521411', 'Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect', 1),
(14982, 'ORPHA:521414', 'ATP1A1-related CMT2', 1),
(14983, 'ORPHA:521414', 'ATP1A1-related autosomal dominant Charcot-Marie-Tooth disease type 2', 1),
(14984, 'ORPHA:521414', 'Autosomal dominant Charcot-Marie-Tooth disease type 2DD', 1),
(14985, 'ORPHA:521414', 'CMT2DD', 1),
(14986, 'ORPHA:521426', 'PLAA-associated neurodevelopmental disorder', 1),
(14987, 'ORPHA:521426', 'PLAAND', 1),
(14988, 'ORPHA:521432', 'Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome', 1),
(14989, 'ORPHA:521438', 'Congenital NAD deficiency disorder', 1),
(14990, 'ORPHA:521438', 'Congenital vertebral-cardiac-renal anomalies syndrome', 1),
(14991, 'ORPHA:521445', 'Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome', 1),
(14992, 'ORPHA:521450', 'LAMA5-related multisystemic syndrome', 1),
(14993, 'ORPHA:522037', 'Primary autoimmune enteropathy', 1),
(14994, 'ORPHA:522043', 'Syndromic autoimmune enteropathy', 3),
(14995, 'ORPHA:522077', 'Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome', 1),
(14996, 'ORPHA:522077', 'SYT1-related neurodevelopmental disorder', 1),
(14997, 'ORPHA:522504', 'Rare genetic disorder of the visual organs', 3),
(14998, 'ORPHA:522506', 'Rare genetic brainstem or cerebellar disorder with ophthalmic involvement as a major feature', 3),
(14999, 'ORPHA:522508', 'Rare genetic ophthalmic disorder with cortical involvement', 3),
(15000, 'ORPHA:522510', 'Rare genetic ophthalmic disorder with cranial nerve involvement', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(15001, 'ORPHA:522512', 'Rare genetic optic nerve disorder', 3),
(15002, 'ORPHA:522514', 'Congenital optic disc excavation of genetic origin', 3),
(15003, 'ORPHA:522516', 'Rare genetic ocular motility/alignment disorder', 3),
(15004, 'ORPHA:522518', 'Rare genetic disorder with strabismus', 3),
(15005, 'ORPHA:522520', 'Syndromic genetic disorder with strabismus', 3),
(15006, 'ORPHA:522522', 'Rare genetic neuromuscular disorder with ocular motility/alignment anomaly', 3),
(15007, 'ORPHA:522524', 'Rare genetic disorder of the ocular adnexa', 3),
(15008, 'ORPHA:522526', 'Rare genetic palpebral disorder', 3),
(15009, 'ORPHA:522528', 'Rare genetic eyelid malposition disorder', 3),
(15010, 'ORPHA:522530', 'Rare genetic disorder with entropion', 3),
(15011, 'ORPHA:522532', 'Rare genetic disorder of the lacrimal apparatus', 3),
(15012, 'ORPHA:522534', 'Lacrimal drainage system anomaly of genetic origin', 3),
(15013, 'ORPHA:522536', 'Structural developmental eye defect of genetic origin', 3),
(15014, 'ORPHA:522538', 'Rare genetic disorder of the anterior segment of the eye', 3),
(15015, 'ORPHA:522540', 'Anterior segment developmental anomaly of genetic origin', 3),
(15016, 'ORPHA:522542', 'Rare genetic disorder with conjunctival involvement as a major feature', 3),
(15017, 'ORPHA:522544', 'Rare genetic conjunctivitis', 3),
(15018, 'ORPHA:522546', 'Rare genetic disorder with lens opacification', 3),
(15019, 'ORPHA:522548', 'Syndromic genetic cataract', 3),
(15020, 'ORPHA:522550', 'Lens size anomaly of genetic origin', 3),
(15021, 'ORPHA:522552', 'Lens position anomaly of genetic origin', 3),
(15022, 'ORPHA:522554', 'Syndromic genetic ectopia lentis', 3),
(15023, 'ORPHA:522556', 'Rare genetic corneal disorder', 3),
(15024, 'ORPHA:522558', 'Rare genetic disorder with corneal involvement as a major feature', 3),
(15025, 'ORPHA:522560', 'Genetic corneal dystrophy', 3),
(15026, 'ORPHA:522562', 'Genetic superficial corneal dystrophy', 3),
(15027, 'ORPHA:522564', 'Syndromic genetic keratoconus', 3),
(15028, 'ORPHA:522566', 'Rare genetic inflammatory/autoimmune corneal disorder', 3),
(15029, 'ORPHA:522568', 'Rare genetic disorder of the pupil', 3),
(15030, 'ORPHA:522570', 'Rare genetic disorder of the posterior segment of the eye', 3),
(15031, 'ORPHA:522572', 'Rare genetic retinal disorder', 3),
(15032, 'ORPHA:522574', 'Rare genetic macular disorder', 3),
(15033, 'ORPHA:522576', 'Rare genetic retinal vasculopathy', 3),
(15034, 'ORPHA:522578', 'Rare genetic disorder involving multiple structures of the eye', 3),
(15035, 'ORPHA:522580', 'Secondary early-onset glaucoma of genetic origin', 3),
(15036, 'ORPHA:522584', 'Rare genetic choroidal disorder', 3),
(15037, 'ORPHA:523', 'Familial leiomyomatosis and renal cell cancer', 1),
(15038, 'ORPHA:523', 'Familial leiomyomatosis cutis et uteri', 1),
(15039, 'ORPHA:523', 'Familial leiomyomatosis with renal carcinoma', 1),
(15040, 'ORPHA:523', 'Familial multiple cutaneous leiomyomas', 1),
(15041, 'ORPHA:523', 'HLRCC', 1),
(15042, 'ORPHA:523', 'Hereditary leiomyomatosis', 1),
(15043, 'ORPHA:523', 'Hereditary leiomyomatosis and renal cell cancer', 1),
(15044, 'ORPHA:523', 'Hereditary leiomyomatosis with renal carcinoma', 1),
(15045, 'ORPHA:523', 'Hereditary multiple cutaneous leiomyomas', 1),
(15046, 'ORPHA:523', 'MCUL', 1),
(15047, 'ORPHA:523', 'Multiple cutaneous and uterine leiomyomas', 1),
(15048, 'ORPHA:523', 'Reed syndrome', 1),
(15049, 'ORPHA:523000', 'Pediatric-onset glaucoma', 3),
(15050, 'ORPHA:52368', 'DDON syndrome', 1),
(15051, 'ORPHA:52368', 'Deafness-dystonia-optic neuronopathy syndrome', 1),
(15052, 'ORPHA:52368', 'Hearing loss-dystonia-optic neuronopathy syndrome', 1),
(15053, 'ORPHA:52368', 'Mohr-Tranebjaerg syndrome', 1),
(15054, 'ORPHA:524', 'Li-Fraumeni syndrome', 1),
(15055, 'ORPHA:52416', 'LCM', 1),
(15056, 'ORPHA:52416', 'MCL', 1),
(15057, 'ORPHA:52416', 'Mantle cell lymphoma', 1),
(15058, 'ORPHA:52416', 'Mantle zone lymphoma', 1),
(15059, 'ORPHA:52417', 'Extranodal marginal zone B-cell lymphoma', 1),
(15060, 'ORPHA:52417', 'MALT lymphoma', 1),
(15061, 'ORPHA:52417', 'MALToma', 1),
(15062, 'ORPHA:52417', 'Mucosa-associated lymphatic tissue lymphoma', 1),
(15063, 'ORPHA:52417', 'Mucosa-associated lymphoid tissue lymphoma', 1),
(15064, 'ORPHA:52427', 'RPA', 1),
(15065, 'ORPHA:52427', 'Retinitis punctata albescens', 1),
(15066, 'ORPHA:52429', 'Branchiootic syndrome', 1),
(15067, 'ORPHA:52430', 'IBMPFD', 1),
(15068, 'ORPHA:52430', 'Inclusion body myopathy with Paget disease of bone and frontotemporal dementia', 1),
(15069, 'ORPHA:52430', 'Limb-girdle muscular dystrophy with Paget disease of bone', 1),
(15070, 'ORPHA:52430', 'Pagetoid amyotrophic lateral sclerosis', 1),
(15071, 'ORPHA:52430', 'Pagetoid neuroskeletal syndrome', 1),
(15072, 'ORPHA:525', 'Follicular lichen planus', 1),
(15073, 'ORPHA:525', 'LPP', 1),
(15074, 'ORPHA:525', 'Lichen follicularis', 1),
(15075, 'ORPHA:525', 'Lichen planopilaris', 1),
(15076, 'ORPHA:525', 'Lichen planus follicularis', 1),
(15077, 'ORPHA:52503', 'Creatine transporter deficiency', 1),
(15078, 'ORPHA:52503', 'SLC6A8 deficiency', 1),
(15079, 'ORPHA:52503', 'X-linked creatine transporter deficiency', 1),
(15080, 'ORPHA:52530', 'PT-VWD', 1),
(15081, 'ORPHA:52530', 'Platelet type-von Willebrand disease', 1),
(15082, 'ORPHA:52530', 'Pseudo-von Willebrand disease', 1),
(15083, 'ORPHA:52530', 'Pseudo-von Willebrand disease type 2B', 1),
(15084, 'ORPHA:525677', 'Genetic congenital malformation of the eye with glaucoma as a major feature', 3),
(15085, 'ORPHA:525731', 'Pediatric-onset Basedow disease', 1),
(15086, 'ORPHA:525731', 'Pediatric-onset Graves disease', 1),
(15087, 'ORPHA:525738', 'Prepubertal anorexia nervosa', 1),
(15088, 'ORPHA:526', 'Liddle syndrome', 1),
(15089, 'ORPHA:526', 'Pseudoaldosteronism', 1),
(15090, 'ORPHA:526', 'Pseudohyperaldosteronism type 1', 1),
(15091, 'ORPHA:52662', 'Acquired embryofetopathy', 3),
(15092, 'ORPHA:52662', 'Rare teratologic disease', 3),
(15093, 'ORPHA:52688', 'Myelodysplastic syndrome', 3),
(15094, 'ORPHA:527276', 'Encephalopathy due to mitochondrial and peroxisomal fission defect', 1),
(15095, 'ORPHA:527450', 'Severe myopia-generalized joint laxity-short stature syndrome', 1),
(15096, 'ORPHA:527468', 'Diaphragmatic hernia-short bowel-asplenia syndrome', 1),
(15097, 'ORPHA:527497', 'Autosomal recessive hypomyelinating leukodystrophy-progressive spastic ataxia', 1),
(15098, 'ORPHA:527497', 'NKX6-2-related autosomal recessive hypomyelinating leukodystrophy', 1),
(15099, 'ORPHA:527497', 'SPAX8', 1),
(15100, 'ORPHA:52759', 'Systemic vasculitis', 3),
(15101, 'ORPHA:52759', 'Vasculitis', 3),
(15102, 'ORPHA:528', 'BSCL', 1),
(15103, 'ORPHA:528', 'Berardinelli-Seip congenital lipodystrophy', 1),
(15104, 'ORPHA:528', 'Berardinelli-Seip syndrome', 1),
(15105, 'ORPHA:528', 'CGL', 1),
(15106, 'ORPHA:528', 'Congenital generalized lipodystrophy', 1),
(15107, 'ORPHA:528', 'Lipoatrophic diabetes', 1),
(15108, 'ORPHA:528084', 'Complex neurodevelopmental disorder', 1),
(15109, 'ORPHA:528084', 'Non-specific syndromic intellectual disability', 1),
(15110, 'ORPHA:528091', 'Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome', 1),
(15111, 'ORPHA:528105', 'HELIX syndrome', 1),
(15112, 'ORPHA:528105', 'Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome', 1),
(15113, 'ORPHA:528623', 'HAE with C1 inhibitor deficiency', 1),
(15114, 'ORPHA:528623', 'HAE with C1Inh deficiency', 1),
(15115, 'ORPHA:528623', 'Hereditary angioedema with C1Inh deficiency', 1),
(15116, 'ORPHA:528623', 'Hereditary angioneurotic edema with C1 inhibitor deficiency', 1),
(15117, 'ORPHA:528623', 'Hereditary angioneurotic edema with C1Inh deficiency', 1),
(15118, 'ORPHA:528647', 'HAE with normal C1 inhibitor', 1),
(15119, 'ORPHA:528647', 'HAE with normal C1Inh', 1),
(15120, 'ORPHA:528647', 'Hereditary angioedema with normal C1 inhibitor', 1),
(15121, 'ORPHA:528647', 'Hereditary angioedema with normal C1Inh', 1),
(15122, 'ORPHA:528647', 'Hereditary angioneurotic edema with normal C1 inhibitor', 1),
(15123, 'ORPHA:528647', 'Hereditary angioneurotic edema with normal C1Inh', 1),
(15124, 'ORPHA:528663', 'Acquired angioedema with C1Inh deficiency', 1),
(15125, 'ORPHA:528663', 'Acquired angioneurotic edema with C1 inhibitor deficiency', 1),
(15126, 'ORPHA:528663', 'Acquired angioneurotic edema with C1Inh deficiency', 1),
(15127, 'ORPHA:529', 'Roch-Leri mesosomatous lipomatosis', 1),
(15128, 'ORPHA:52901', 'Isolated FSH deficiency', 1),
(15129, 'ORPHA:52901', 'Isolated follicle stimulating hormone deficiency', 1),
(15130, 'ORPHA:529468', 'Monoclonal MCAD', 1),
(15131, 'ORPHA:529468', 'Monoclonal mast cell activation syndrome', 1),
(15132, 'ORPHA:529574', 'DRS with deafness', 1),
(15133, 'ORPHA:529574', 'DRS with hearing loss', 1),
(15134, 'ORPHA:529574', 'DURS with deafness', 1),
(15135, 'ORPHA:529574', 'DURS with hearing loss', 1),
(15136, 'ORPHA:529574', 'Duane retraction syndrome with congenital deafness', 1),
(15137, 'ORPHA:529574', 'Duane retraction syndrome with congenital hearing loss', 1),
(15138, 'ORPHA:529665', 'GPAA1-related biosynthesis defect', 1),
(15139, 'ORPHA:529665', 'Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome', 1),
(15140, 'ORPHA:529799', 'ABE', 1),
(15141, 'ORPHA:529799', 'Acute bilirubin encephalopathy', 1),
(15142, 'ORPHA:529799', 'Acute kernicterus', 1),
(15143, 'ORPHA:529808', 'BIND', 1),
(15144, 'ORPHA:529808', 'Bilirubin-induced neurological dysfunction', 1),
(15145, 'ORPHA:529808', 'CBE', 1),
(15146, 'ORPHA:529808', 'Chronic bilirubin encephalopathy', 1),
(15147, 'ORPHA:529808', 'KSD', 1),
(15148, 'ORPHA:529808', 'Kernicterus spectrum disorder', 1),
(15149, 'ORPHA:529828', 'Enzalutamide toxicity', 1),
(15150, 'ORPHA:529831', 'Letrozole toxicity', 1),
(15151, 'ORPHA:529852', 'Combined HCC-CC', 1),
(15152, 'ORPHA:529852', 'Combined hepatocellular carcinoma and cholangiocarcinoma', 1),
(15153, 'ORPHA:529852', 'Combined hepatocellular-cholangiocarcinoma', 1),
(15154, 'ORPHA:529852', 'Hepatocholangiocarcinoma', 1),
(15155, 'ORPHA:529852', 'cHCC-CC', 1),
(15156, 'ORPHA:529864', 'Secondary erythermalgia', 1),
(15157, 'ORPHA:529864', 'Secondary erythromelalgia', 1),
(15158, 'ORPHA:52994', 'Orbital leiomyoma', 1),
(15159, 'ORPHA:529962', '17q24.2 microdeletion syndrome', 1),
(15160, 'ORPHA:529962', 'Del(17)(q24)', 1),
(15161, 'ORPHA:529965', 'Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome', 1),
(15162, 'ORPHA:529965', 'Pilarowski-Bjornsson syndrome', 1),
(15163, 'ORPHA:529970', 'Acephalic spermatozoa syndrome', 2),
(15164, 'ORPHA:529970', 'Male infertility due to acephalic spermatozoa', 2),
(15165, 'ORPHA:529974', 'Immune dysregulation with inflammatory bowel disease', 3),
(15166, 'ORPHA:529977', 'Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome', 1),
(15167, 'ORPHA:529980', 'Inflammatory bowel disease-recurrent sinopulmonary infections syndrome', 1),
(15168, 'ORPHA:529980', 'NFAT5 haploinsufficiency', 1),
(15169, 'ORPHA:53', 'Albers-Schönberg osteopetrosis', 1),
(15170, 'ORPHA:53', 'Osteopetrosis autosomal dominant type 2', 1),
(15171, 'ORPHA:530', 'Hyalinosis cutis et mucosae', 1),
(15172, 'ORPHA:530', 'Lipoid proteinosis', 1),
(15173, 'ORPHA:530', 'Urbach-Wiethe disease', 1),
(15174, 'ORPHA:530033', 'Dermoid or epidermoid cyst of the CNS', 1),
(15175, 'ORPHA:530033', 'Dermoid or epidermoid cyst of the central nervous system', 1),
(15176, 'ORPHA:530298', 'Early onset familial encephalopathy with neuroserpin inclusion bodies', 2),
(15177, 'ORPHA:530298', 'Progressive myoclonic epilepsy with neuroserpin inclusion bodies', 2),
(15178, 'ORPHA:530303', 'Late-onset familial encephalopathy with neuroserpin inclusion bodies', 2),
(15179, 'ORPHA:530303', 'Progressive dementia with neuroserpin inclusion bodies', 2),
(15180, 'ORPHA:530313', 'PIK3CA-related overgrowth syndrome', 3),
(15181, 'ORPHA:530313', 'PROS', 3),
(15182, 'ORPHA:53035', 'Caroli disease', 1),
(15183, 'ORPHA:530792', 'RELA fusion-positive ependymoma', 1),
(15184, 'ORPHA:530792', 'Supratentorial C11ORF95-RELA fused ependymoma', 1),
(15185, 'ORPHA:530838', 'KRT1-related diffuse NEPPK', 1),
(15186, 'ORPHA:530838', 'KRT1-related diffuse nonepidermolytic keratoderma', 1),
(15187, 'ORPHA:530849', 'Familial APOA5 deficiency', 2),
(15188, 'ORPHA:530849', 'Familial apolipoprotein A-V deficiency', 2),
(15189, 'ORPHA:530849', 'Familial apolipoprotein A5 deficiency', 2),
(15190, 'ORPHA:530983', 'Lamb-Shaffer syndrome', 1),
(15191, 'ORPHA:530983', 'SOX5 haploinsufficiency syndrome', 1),
(15192, 'ORPHA:530995', 'MPAL', 1),
(15193, 'ORPHA:530995', 'Mixed phenotype acute leukemia', 1),
(15194, 'ORPHA:531', 'Lissencephaly due to 17p13.3 deletion', 1),
(15195, 'ORPHA:531', 'Miller-Dieker syndrome', 1),
(15196, 'ORPHA:531', 'Monosomy 17p13.3', 1),
(15197, 'ORPHA:531', 'Telomeric deletion 17p', 1),
(15198, 'ORPHA:531151', '9q21.13 microdeletion syndrome', 1),
(15199, 'ORPHA:53271', 'Muenke syndrome', 1),
(15200, 'ORPHA:53296', 'Familial cutaneous collagenoma', 1),
(15201, 'ORPHA:533', 'Listeria infection', 1),
(15202, 'ORPHA:533', 'Listeriosis', 1),
(15203, 'ORPHA:53347', 'Brody myopathy', 1),
(15204, 'ORPHA:53351', 'DYT3', 1),
(15205, 'ORPHA:53351', 'Lubag', 1),
(15206, 'ORPHA:53351', 'Lubag syndrome', 1),
(15207, 'ORPHA:53351', 'X-linked dystonia-parkinsonism', 1),
(15208, 'ORPHA:53351', 'XDP', 1),
(15209, 'ORPHA:53372', 'Familial trembling of the chin', 1),
(15210, 'ORPHA:53372', 'Hereditary chin myoclonus', 1),
(15211, 'ORPHA:53372', 'Hereditary chin-trembling', 1),
(15212, 'ORPHA:53372', 'Hereditary geniospasm', 1),
(15213, 'ORPHA:534', 'Lowe disease', 1),
(15214, 'ORPHA:534', 'Lowe oculo-cerebro-renal dystrophy', 1),
(15215, 'ORPHA:534', 'Lowe oculo-cerebro-renal syndrome', 1),
(15216, 'ORPHA:534', 'Lowe oculocerebrorenal dystrophy', 1),
(15217, 'ORPHA:534', 'Lowe syndrome', 1),
(15218, 'ORPHA:534', 'OCRL', 1),
(15219, 'ORPHA:534', 'Oculocerebrorenal syndrome of Lowe', 1),
(15220, 'ORPHA:534', 'Phosphatidylinositol 4,5-biphosphate 5-phosphatase deficiency', 1),
(15221, 'ORPHA:535', 'Rare cutaneous lupus erythematosus', 3),
(15222, 'ORPHA:53540', 'Enhanced S-cone syndrome', 1),
(15223, 'ORPHA:53540', 'Goldmann-Favre syndrome', 1),
(15224, 'ORPHA:53540', 'Retinoschisis with early nyctalopia', 1),
(15225, 'ORPHA:535453', 'Familial LMF1 deficiency', 2),
(15226, 'ORPHA:535453', 'Familial lipase maturation factor 1 deficiency', 2),
(15227, 'ORPHA:535458', 'Familial GPIHBP1 deficiency', 2),
(15228, 'ORPHA:535458', 'Familial glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 deficiency', 2),
(15229, 'ORPHA:53583', 'DYT9', 1),
(15230, 'ORPHA:53583', 'Episodic choreoathetosis/spasticity', 1),
(15231, 'ORPHA:53583', 'Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity', 1),
(15232, 'ORPHA:536', 'Disseminated lupus erythematosus', 1),
(15233, 'ORPHA:536', 'SLE', 1),
(15234, 'ORPHA:536', 'Systemic lupus erythematosus', 1),
(15235, 'ORPHA:536391', 'RASopathy', 3),
(15236, 'ORPHA:536467', 'B3GALT6-related spEDS', 2),
(15237, 'ORPHA:536467', 'B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome', 2),
(15238, 'ORPHA:536467', 'Beta3GalT6-deficient EDS', 2),
(15239, 'ORPHA:536467', 'Ehlers-Danlos syndrome progeroid type 2', 2),
(15240, 'ORPHA:536467', 'spEDS-B3GALT6', 2),
(15241, 'ORPHA:536471', 'Spondylodysplastic EDS', 1),
(15242, 'ORPHA:536471', 'Spondylodysplastic Ehlers-Danlos syndrome', 1),
(15243, 'ORPHA:536471', 'spEDS', 1),
(15244, 'ORPHA:536516', 'EDS/myopathy overlap syndrome', 1),
(15245, 'ORPHA:536516', 'Myopathic EDS', 1),
(15246, 'ORPHA:536516', 'Myopathic Ehlers-Danlos syndrome', 1),
(15247, 'ORPHA:536532', 'AEBP1-related EDS', 1),
(15248, 'ORPHA:536532', 'AEBP1-related Ehlers-Danlos syndrome', 1),
(15249, 'ORPHA:536532', 'Classical-like EDS type 2', 1),
(15250, 'ORPHA:536532', 'Classical-like Ehlers-Danlos syndrome type 2', 1),
(15251, 'ORPHA:536532', 'clEDS type 2', 1),
(15252, 'ORPHA:536545', 'EDS VI', 1),
(15253, 'ORPHA:536545', 'Ehlers-Danlos syndrome type 6', 1),
(15254, 'ORPHA:536545', 'Kyphoscoliotic EDS', 1),
(15255, 'ORPHA:536545', 'Kyphoscoliotic Ehlers-Danlos syndrome', 1),
(15256, 'ORPHA:536545', 'kEDS', 1),
(15257, 'ORPHA:53689', 'Congenital chloride diarrhea', 1),
(15258, 'ORPHA:53690', 'Congenital lactase deficiency', 1),
(15259, 'ORPHA:53691', 'Congenital cornea plana', 1),
(15260, 'ORPHA:53693', 'Fellman disease', 1),
(15261, 'ORPHA:53693', 'GRACILE syndrome', 1),
(15262, 'ORPHA:53693', 'Growth restriction-aminoaciduria-cholestasis-iron overload-lactic acidosis-early death syndrome', 1),
(15263, 'ORPHA:53696', 'AAHD', 1),
(15264, 'ORPHA:53696', 'Arthrogryposis-anterior horn cell disease syndrome', 1),
(15265, 'ORPHA:53696', 'Vuopala disease', 1),
(15266, 'ORPHA:53697', 'GDD', 1),
(15267, 'ORPHA:53697', 'Gnathodiaphyseal dysplasia', 1),
(15268, 'ORPHA:53698', 'Hyaline body myopathy', 1),
(15269, 'ORPHA:537', 'Lyell syndrome', 2),
(15270, 'ORPHA:537', 'Toxic epidermal necrolysis', 2),
(15271, 'ORPHA:537072', 'PLG-related HAE with normal C1 inhibitor', 2),
(15272, 'ORPHA:537072', 'PLG-related hereditary angioedema with normal C1Inh', 2),
(15273, 'ORPHA:53715', 'Familial tumoral calcinosis', 1),
(15274, 'ORPHA:53719', 'Bonnet-Dechaume-Blanc syndrome', 1),
(15275, 'ORPHA:53719', 'CAMS2', 1),
(15276, 'ORPHA:53719', 'Cerebrofacial arteriovenous metameric syndrome type 2', 1),
(15277, 'ORPHA:53719', 'Wyburn-Mason syndrome', 1),
(15278, 'ORPHA:53721', 'Cobb syndrome', 1),
(15279, 'ORPHA:53721', 'Cutaneomeningospinal angiomatosis', 1),
(15280, 'ORPHA:53721', 'SAMS 1-31', 1),
(15281, 'ORPHA:53721', 'Spinal arteriovenous metameric syndrome', 1),
(15282, 'ORPHA:53739', 'Distal hereditary motor neuropathy', 3),
(15283, 'ORPHA:53739', 'Distal spinal muscular atrophy', 3),
(15284, 'ORPHA:53739', 'dHMN', 3),
(15285, 'ORPHA:53739', 'dSMA', 3),
(15286, 'ORPHA:537891', 'ANGPT1-related HAE with normal C1 inhibitor', 2),
(15287, 'ORPHA:537891', 'ANGPT1-related hereditary angioedema with normal C1Inh', 2),
(15288, 'ORPHA:538', 'LAM', 1),
(15289, 'ORPHA:538', 'Lymphangioleiomyomatosis', 1),
(15290, 'ORPHA:538096', 'Autosomal recessive lethal neonatal axonal sensorimotor polyneuropathy', 1),
(15291, 'ORPHA:538101', 'Congenital axonal neuropathy with encephalopathy', 1),
(15292, 'ORPHA:538238', 'Neurological channelopathy of the central nervous system due to a genetic chloride channel defect', 3),
(15293, 'ORPHA:538574', 'Palmoplantar keratoderma-Charcot-Marie-Tooth syndrome', 1),
(15294, 'ORPHA:538574', 'Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome', 1),
(15295, 'ORPHA:538756', 'Familial multiple discoid fibromas', 1),
(15296, 'ORPHA:538756', 'Familial multiple trichodiscomas', 1),
(15297, 'ORPHA:538863', 'Classic pyoderma gangrenosum', 2),
(15298, 'ORPHA:538863', 'Ulcerative pyoderma gangrenosum', 2),
(15299, 'ORPHA:538866', 'Pustular pyoderma gangrenosum', 2),
(15300, 'ORPHA:538869', 'Bullous pyoderma gangrenosum', 2),
(15301, 'ORPHA:538869', 'Phemphigoid pyoderma gangrenosum', 2),
(15302, 'ORPHA:538872', 'Granulomatous pyoderma gangrenosum', 2),
(15303, 'ORPHA:538872', 'Vegetative pyoderma gangrenosum', 2),
(15304, 'ORPHA:538931', 'SAP deficiency', 1),
(15305, 'ORPHA:538931', 'SH2D1A/SLAM-associated protein deficiency', 1),
(15306, 'ORPHA:538931', 'X-linked lymphoproliferative disease due to SH2D1A deficiency', 1),
(15307, 'ORPHA:538931', 'X-linked lymphoproliferative syndrome type 1', 1),
(15308, 'ORPHA:538931', 'XLP1', 1),
(15309, 'ORPHA:538934', 'X-linked lymphoproliferative disease due to XIAP deficiency', 1),
(15310, 'ORPHA:538934', 'X-linked lymphoproliferative syndrome type 2', 1),
(15311, 'ORPHA:538934', 'XIAP deficiency syndrome', 1),
(15312, 'ORPHA:538934', 'XLP2', 1),
(15313, 'ORPHA:538958', 'CID due to CD70 deficiency', 1),
(15314, 'ORPHA:538958', 'Combined immunodeficiency due to CD70 deficiency', 1),
(15315, 'ORPHA:538963', 'Autosomal recessive lymphoproliferative disease due to ITK deficiency', 1),
(15316, 'ORPHA:538963', 'Combined immunodeficiency due to ITK deficiency', 1),
(15317, 'ORPHA:538963', 'ITK deficiency', 1),
(15318, 'ORPHA:54', 'OA1', 1),
(15319, 'ORPHA:54', 'Ocular albinism type 1', 1),
(15320, 'ORPHA:54', 'Ocular albinism, Nettleship-Falls type', 1),
(15321, 'ORPHA:54', 'X-linked recessive ocular albinism', 1),
(15322, 'ORPHA:54', 'XLOA', 1),
(15323, 'ORPHA:540', 'Familial HLH', 1),
(15324, 'ORPHA:540', 'Familial hemophagocytic lymphohistiocytosis', 1),
(15325, 'ORPHA:54028', 'Kelly-Paterson syndrome', 1),
(15326, 'ORPHA:54028', 'Plummer-Vinson syndrome', 1),
(15327, 'ORPHA:54028', 'Sideropenic dysphagia', 1),
(15328, 'ORPHA:54057', 'Moschcowitz disease', 1),
(15329, 'ORPHA:54057', 'TTP', 1),
(15330, 'ORPHA:54057', 'Thrombotic thrombocytopenic purpura', 1),
(15331, 'ORPHA:541', 'Primary cutaneous CD30+ T-cell lymphoproliferative disease', 3),
(15332, 'ORPHA:541', 'Primary cutaneous Ki-1+ T-cell lymphoproliferative disease', 3),
(15333, 'ORPHA:541423', 'Growth delay-intellectual disability-hepatopathy syndrome', 1),
(15334, 'ORPHA:541443', 'AOLCA', 1),
(15335, 'ORPHA:541443', 'Anomalous aortic origin of the left coronary artery', 1),
(15336, 'ORPHA:541443', 'L-ACAOS', 1),
(15337, 'ORPHA:541443', 'Left coronary artery from right aortic sinus', 1),
(15338, 'ORPHA:541454', 'AORCA', 1),
(15339, 'ORPHA:541454', 'Anomalous aortic origin of the right coronary artery', 1),
(15340, 'ORPHA:541454', 'R-ACAOS', 1),
(15341, 'ORPHA:541454', 'Right coronary artery from left aortic sinus', 1),
(15342, 'ORPHA:541478', 'AAOCA', 3),
(15343, 'ORPHA:541478', 'Anomalous aortic origin of coronary artery', 3),
(15344, 'ORPHA:541507', 'ACAPA', 1),
(15345, 'ORPHA:541507', 'Anomalous origin of coronary artery from the pulmonary artery', 1),
(15346, 'ORPHA:542', 'Primary cutaneous lymphoma', 3),
(15347, 'ORPHA:542301', 'Severe combined immunodeficiency due to CARMIL2 deficiency', 1),
(15348, 'ORPHA:542301', 'Severe combined immunodeficiency due to RLTPR deficiency', 1),
(15349, 'ORPHA:542306', 'GNB5-related intellectual disability-cardiac arrhythmia syndrome', 1),
(15350, 'ORPHA:542310', 'LCC', 1),
(15351, 'ORPHA:542310', 'Labrune syndrome', 1),
(15352, 'ORPHA:542310', 'Leukoencephalopathy with calcifications and cysts', 1),
(15353, 'ORPHA:542323', 'CAR T cell therapy-associated CRS', 1),
(15354, 'ORPHA:542323', 'CAR T cell therapy-associated cytokine release syndrome', 1),
(15355, 'ORPHA:542323', 'Chimeric antigen receptor-T cell therapy-associated cytokine release syndrome', 1),
(15356, 'ORPHA:54247', 'Benson syndrome', 1),
(15357, 'ORPHA:54247', 'Biparietal Alzheimer disease', 1),
(15358, 'ORPHA:54247', 'PCA', 1),
(15359, 'ORPHA:54247', 'Posterior cortical atrophy', 1),
(15360, 'ORPHA:54251', 'Aseptic abscesses syndrome', 1),
(15361, 'ORPHA:54251', 'Aseptic systemic abscesses', 1),
(15362, 'ORPHA:54251', 'Corticosteroid-sensitive aseptic abscess syndrome', 1),
(15363, 'ORPHA:54251', 'Disseminated aseptic abscesses', 1),
(15364, 'ORPHA:542568', 'Quadricuspid aortic valve', 1),
(15365, 'ORPHA:542585', 'Auditory neuropathy-optic atrophy syndrome', 1),
(15366, 'ORPHA:542592', 'Necrobiosis lipoidica', 1),
(15367, 'ORPHA:542592', 'Oppenheim-Urbach disease', 1),
(15368, 'ORPHA:54260', 'LVNC', 1),
(15369, 'ORPHA:54260', 'Left ventricular hypertrabeculation', 1),
(15370, 'ORPHA:54260', 'Left ventricular noncompaction', 1),
(15371, 'ORPHA:54260', 'Spongy myocardium', 1),
(15372, 'ORPHA:542643', 'Livedo reticularis with summer ulcerations', 1),
(15373, 'ORPHA:542643', 'Livedoid vasculopathy', 1),
(15374, 'ORPHA:542643', 'Milian atrophie blanche', 1),
(15375, 'ORPHA:542643', 'Segmental hyalinizing vasculitis', 1),
(15376, 'ORPHA:542657', 'Carbonic anhydrase XII deficiency', 1),
(15377, 'ORPHA:542657', 'Isolated hyperchlorhidrosis', 1),
(15378, 'ORPHA:54272', 'Hepatocellular adenoma', 1),
(15379, 'ORPHA:542822', 'Anomaly of the coronary ostia', 3),
(15380, 'ORPHA:543', 'Burkitt lymphoma', 1),
(15381, 'ORPHA:543', 'Small non-cleaved cell lymphoma', 1),
(15382, 'ORPHA:543470', 'Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome', 1),
(15383, 'ORPHA:54368', 'Sarcocystosis', 1),
(15384, 'ORPHA:54368', 'Sarcosporidiosis', 1),
(15385, 'ORPHA:54370', 'Mesangiocapillary glomerulonephritis', 1),
(15386, 'ORPHA:54370', 'Primary MPGN', 1),
(15387, 'ORPHA:54370', 'Primary membranoproliferative glomerulonephritis', 1),
(15388, 'ORPHA:544', 'DLBCL', 3),
(15389, 'ORPHA:544', 'Diffuse large B-cell lymphoma', 3),
(15390, 'ORPHA:544254', 'SYNGAP1-related DEE', 1),
(15391, 'ORPHA:544254', 'SYNGAP1-related developmental and epileptic encephalopathy', 1),
(15392, 'ORPHA:544458', 'HUS', 3),
(15393, 'ORPHA:544458', 'Hemolytic uremic syndrome', 3),
(15394, 'ORPHA:544469', 'PRUNE1-related neurological syndrome', 1),
(15395, 'ORPHA:544472', 'Atypical hemolytic uremic syndrome with complement gene abnormality', 2),
(15396, 'ORPHA:544472', 'aHUS with complement gene abnormality', 2),
(15397, 'ORPHA:544482', 'Infection-related HUS', 1),
(15398, 'ORPHA:544482', 'Infection-related hemolytic uremic syndrome', 1),
(15399, 'ORPHA:544488', 'Bachmann-Bupp syndrome', 1),
(15400, 'ORPHA:544488', 'Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome', 1),
(15401, 'ORPHA:544488', 'Ornithine decarboxylase deficiency', 1),
(15402, 'ORPHA:544493', 'S. pneumoniae-associated HUS', 2),
(15403, 'ORPHA:544493', 'SP-HUS', 2),
(15404, 'ORPHA:544493', 'Streptococcus pneumoniae-associated hemolytic uremic syndrome', 2),
(15405, 'ORPHA:544503', 'RNF13-related severe EOEE', 1),
(15406, 'ORPHA:544503', 'RNF13-related severe early-onset epileptic encephalopathy', 1),
(15407, 'ORPHA:544578', 'Congenital primary megaureter, refluxing and obstructed form', 2),
(15408, 'ORPHA:544590', 'Collagen-related glomerular basement membrane disease', 3),
(15409, 'ORPHA:544602', 'Congenital myopathy with fast-twitch fiber atrophy', 1),
(15410, 'ORPHA:544602', 'Congenital myopathy with reduced type 2 muscle fibers', 1),
(15411, 'ORPHA:544602', 'Congenital myopathy with reduced type II muscle fibers', 1),
(15412, 'ORPHA:544602', 'Congenital myopathy with type 2 muscle fiber atrophy', 1),
(15413, 'ORPHA:544602', 'Congenital myopathy with type II fiber atrophy', 1),
(15414, 'ORPHA:544628', 'Atypical Fanconi syndrome-neonatal hyperinsulinism syndrome', 1),
(15415, 'ORPHA:545', 'Follicular lymphoma', 1),
(15416, 'ORPHA:54595', 'Craniopharyngioma', 1),
(15417, 'ORPHA:547', 'NHL', 3),
(15418, 'ORPHA:547', 'Non-Hodgkin lymphoma', 3),
(15419, 'ORPHA:548', 'Leprosy', 1),
(15420, 'ORPHA:549', 'Legionellosis', 1),
(15421, 'ORPHA:549', 'Legionnaires disease', 1),
(15422, 'ORPHA:55', 'OCA', 3),
(15423, 'ORPHA:55', 'Oculocutaneous albinism', 3),
(15424, 'ORPHA:550', 'MELAS', 1),
(15425, 'ORPHA:550', 'Mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes', 1),
(15426, 'ORPHA:550', 'Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes', 1),
(15427, 'ORPHA:550', 'Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes', 1),
(15428, 'ORPHA:551', 'Fukuhara syndrome', 1),
(15429, 'ORPHA:551', 'MERRF', 1),
(15430, 'ORPHA:551', 'Myoclonus epilepsy associated with ragged-red fibres', 1),
(15431, 'ORPHA:552', 'MODY', 1),
(15432, 'ORPHA:552', 'Maturity-onset diabetes of the young', 1),
(15433, 'ORPHA:553', 'Cushing syndrome', 3),
(15434, 'ORPHA:553', 'Hyperadrenocorticism', 3),
(15435, 'ORPHA:553', 'Hypercortisolism', 3),
(15436, 'ORPHA:555402', 'CARKD deficiency', 1),
(15437, 'ORPHA:555402', 'NAD(P)HX dehydratase deficiency', 1),
(15438, 'ORPHA:555407', 'Apolipoprotein A-I binding protein deficiency', 1),
(15439, 'ORPHA:555407', 'NAD(P)HX epimerase deficiency', 1),
(15440, 'ORPHA:555434', 'Fibrohistiocytic inflammatory pseudotumor of the liver', 2),
(15441, 'ORPHA:555437', 'IgG4-related inflammatory pseudotumor of the liver', 2),
(15442, 'ORPHA:555437', 'Lymphoplasmacytic inflammatory pseudotumor of the liver', 2),
(15443, 'ORPHA:555874', 'Congenital tricuspid valve dysplasia', 1),
(15444, 'ORPHA:555877', 'Dystrophie valvulaire associée à FLNA', 1),
(15445, 'ORPHA:555877', 'FLNA-related X-linked myxomatous valvular dysplasia', 1),
(15446, 'ORPHA:555877', 'FLNA-related valvular dystrophy', 1),
(15447, 'ORPHA:555877', 'Filamin A-related X-linked myxomatous valvular dysplasia', 1),
(15448, 'ORPHA:555905', 'IgA pemphigus', 1),
(15449, 'ORPHA:55595', 'Autosomal dominant limb-girdle muscular dystrophy type 1F', 1),
(15450, 'ORPHA:55595', 'LGMD type 1F', 1),
(15451, 'ORPHA:55595', 'LGMD1F', 1),
(15452, 'ORPHA:55595', 'Limb-girdle muscular dystrophy type 1F', 1),
(15453, 'ORPHA:55595', 'TNP03-related  LGMD D2', 1),
(15454, 'ORPHA:55595', 'TNP03-related  limb-girdle muscular dystrophy D2', 1),
(15455, 'ORPHA:55596', 'Autosomal dominant limb-girdle muscular dystrophy type 1G', 1),
(15456, 'ORPHA:55596', 'HNRNPDL-related  LGMD D3', 1),
(15457, 'ORPHA:55596', 'HNRNPDL-related  limb-girdle muscular dystrophy D3', 1),
(15458, 'ORPHA:55596', 'LGMD type 1G', 1),
(15459, 'ORPHA:55596', 'LGMD1G', 1),
(15460, 'ORPHA:55596', 'Limb-girdle muscular dystrophy type 1G', 1),
(15461, 'ORPHA:556', 'Malakoplakia', 1),
(15462, 'ORPHA:556030', 'Early-onset familial hyperreninemic hypoaldosteronism', 2),
(15463, 'ORPHA:556030', 'Early-onset familial hypoaldosteronism', 2),
(15464, 'ORPHA:556030', 'Severe aldosterone synthase deficiency', 2),
(15465, 'ORPHA:556037', 'Late-onset familial hyperreninemic hypoaldosteronism', 2),
(15466, 'ORPHA:556037', 'Late-onset familial hypoaldosteronism', 2),
(15467, 'ORPHA:556037', 'Mild aldosterone synthase deficiency', 2),
(15468, 'ORPHA:556508', 'Rare disorder due to poisoning', 3),
(15469, 'ORPHA:55654', 'Hereditary hypotrichosis simplex', 1),
(15470, 'ORPHA:55654', 'Hypotrichosis simplex', 1),
(15471, 'ORPHA:55655', 'Pneumococcal meningitis', 1),
(15472, 'ORPHA:556955', 'Pancreatic agenesis-holoprosencephaly syndrome', 1),
(15473, 'ORPHA:556985', 'Early-onset calcifying leukoencephalopathy-skeletal dysplasia', 1),
(15474, 'ORPHA:557', 'Isolated anorectal malformation', 3),
(15475, 'ORPHA:557003', 'Oculo-cerebro-dental syndrome', 1),
(15476, 'ORPHA:557003', 'Oculocerebrodental syndrome', 1),
(15477, 'ORPHA:557056', 'Spastic ataxia-dysarthria due to glutaminase deficiency', 1),
(15478, 'ORPHA:557064', 'Neonatal epileptic encephalopathy due to glutaminase deficiency', 1),
(15479, 'ORPHA:557866', 'Rare disorder with Hirschsprung disease as a major feature', 3),
(15480, 'ORPHA:558', 'MFS', 1),
(15481, 'ORPHA:558', 'Marfan syndrome', 1),
(15482, 'ORPHA:558411', 'Idiopathic gastroparesis', 1),
(15483, 'ORPHA:55880', 'Chondrosarcoma', 1),
(15484, 'ORPHA:55881', 'Adamantinoma', 1),
(15485, 'ORPHA:55881', 'Adamantinoma of long bones', 1),
(15486, 'ORPHA:559', 'Marinesco-Sjögren syndrome', 1),
(15487, 'ORPHA:56', 'Alkaptonuria', 1),
(15488, 'ORPHA:56', 'Hereditary ochronosis', 1),
(15489, 'ORPHA:56', 'Homogentisic acid oxidase deficiency', 1),
(15490, 'ORPHA:560', 'Marshall syndrome', 1),
(15491, 'ORPHA:56044', 'Carcinoma of gallbladder and EBT', 3),
(15492, 'ORPHA:56044', 'Carcinoma of gallbladder and extrahepatic biliary tract', 3),
(15493, 'ORPHA:561', 'Accelerated skeletal maturation-facial dysmorphism-failure to thrive syndrome', 1),
(15494, 'ORPHA:561', 'Marshall-Smith syndrome', 1),
(15495, 'ORPHA:561854', 'FOXG1 syndrome', 1),
(15496, 'ORPHA:561854', 'FOXG1-related epileptic encephalopathy', 1),
(15497, 'ORPHA:562', 'Gonadotropin-independent female-limited sexual precocity', 1),
(15498, 'ORPHA:562', 'McCune-Albright syndrome', 1),
(15499, 'ORPHA:562509', 'HO-1 deficiency', 1),
(15500, 'ORPHA:562509', 'Heme oxygenase-1 deficiency', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(15501, 'ORPHA:562528', 'CLIFAHDD syndrome', 1),
(15502, 'ORPHA:562528', 'Congenital limbs-face contractures-hypotonia-developmental delay syndrome', 1),
(15503, 'ORPHA:562538', 'Autosomal recessive extra-oral halitosis', 1),
(15504, 'ORPHA:562538', 'MTO-deficiency', 1),
(15505, 'ORPHA:562538', 'Methanethiol oxidase deficiency', 1),
(15506, 'ORPHA:562559', 'Anterior maxillary protrusion-strabismus-intellectual disability syndrome', 1),
(15507, 'ORPHA:562559', 'MRAMS syndrome', 1),
(15508, 'ORPHA:562569', 'TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome', 1),
(15509, 'ORPHA:562639', 'Overlap syndromes of autoimmune liver diseases', 1),
(15510, 'ORPHA:562639', 'PBC/PSC and AIH overlap syndrome', 1),
(15511, 'ORPHA:562639', 'Primary biliary cholangitis/primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome', 1),
(15512, 'ORPHA:563', 'Peripartum cardiomyopathy', 1),
(15513, 'ORPHA:563', 'Postpartum cardiomyopathy', 1),
(15514, 'ORPHA:56304', 'AO2', 1),
(15515, 'ORPHA:56304', 'AOII', 1),
(15516, 'ORPHA:56304', 'Atelosteogenesis type 2', 1),
(15517, 'ORPHA:56304', 'Atelosteogenesis type II', 1),
(15518, 'ORPHA:56304', 'De la Chapelle dysplasia', 1),
(15519, 'ORPHA:56304', 'Neonatal osseous dysplasia type 1', 1),
(15520, 'ORPHA:56305', 'AO3', 1),
(15521, 'ORPHA:56305', 'AOIII', 1),
(15522, 'ORPHA:56305', 'Atelosteogenesis type 3', 1),
(15523, 'ORPHA:56305', 'Atelosteogenesis type III', 1),
(15524, 'ORPHA:563576', 'AIH type 1', 2),
(15525, 'ORPHA:563576', 'Autoimmune hepatitis type 1', 2),
(15526, 'ORPHA:563581', 'AIH type 2', 2),
(15527, 'ORPHA:563581', 'Autoimmune hepatitis type 2', 2),
(15528, 'ORPHA:563589', 'Autoantibody-negative autoimmune hepatitis', 2),
(15529, 'ORPHA:563589', 'Seronegative AIH', 2),
(15530, 'ORPHA:563589', 'Seronegative autoimmune hepatitis', 2),
(15531, 'ORPHA:563609', 'Isolated anencephaly', 2),
(15532, 'ORPHA:563612', 'Isolated exencephaly', 2),
(15533, 'ORPHA:563666', 'Serous cystadenoma of childhood', 2),
(15534, 'ORPHA:563666', 'Serous cystadenoma of ovary in childhood', 2),
(15535, 'ORPHA:563671', 'Mucinous cystadenoma of childhood', 2),
(15536, 'ORPHA:563671', 'Mucinous cystadenoma of ovary in childhood', 2),
(15537, 'ORPHA:563676', 'Seromucinous cystadenoma of childhood', 2),
(15538, 'ORPHA:563676', 'Seromucinous cystadenoma of ovary in childhood', 2),
(15539, 'ORPHA:563684', 'Furuncular myiasis due to Dermatobia hominis', 2),
(15540, 'ORPHA:563684', 'Furunculoid myiasis due to Dermatobia hominis', 2),
(15541, 'ORPHA:563684', 'Furunculous myiasis due to Dermatobia hominis', 2),
(15542, 'ORPHA:563687', 'Furuncular myiasis due to Cordylobia anthropophaga', 2),
(15543, 'ORPHA:563687', 'Furunculoid myiasis due to Cordylobia anthropophaga', 2),
(15544, 'ORPHA:563687', 'Furunculous myiasis due to Cordylobia anthropophaga', 2),
(15545, 'ORPHA:563690', 'Furuncular myiasis due to Cordylobia rodhaini', 2),
(15546, 'ORPHA:563690', 'Furunculoid myiasis due to Cordylobia rodhaini', 2),
(15547, 'ORPHA:563690', 'Furunculous myiasis due to Cordylobia rodhaini', 2),
(15548, 'ORPHA:563708', 'Syndromic congenital sodium diarrhea', 1),
(15549, 'ORPHA:563708', 'Syndromic congenital tufting enteropathy', 1),
(15550, 'ORPHA:563951', 'Isolated congenital aglossia', 2),
(15551, 'ORPHA:563954', 'Isolated congenital hypoglossia', 2),
(15552, 'ORPHA:563991', 'Aseptic necrosis of the tarsal bone', 1),
(15553, 'ORPHA:563991', 'Avascular necrosis of the tarsal bone', 1),
(15554, 'ORPHA:563991', 'Kohler disease', 1),
(15555, 'ORPHA:563991', 'Osteochondrosis of the tarsal bone', 1),
(15556, 'ORPHA:564', 'Meckel syndrome', 1),
(15557, 'ORPHA:564', 'Meckel-Gruber syndrome', 1),
(15558, 'ORPHA:564003', 'Avascular necrosis of the metatarsal bone', 1),
(15559, 'ORPHA:564003', 'Freiberg disease', 1),
(15560, 'ORPHA:564003', 'Freiberg infraction', 1),
(15561, 'ORPHA:564003', 'Osteochondrosis of the metatarsal bone', 1),
(15562, 'ORPHA:564127', 'Genetic nephrotic syndrome', 3),
(15563, 'ORPHA:564127', 'Hereditary nephrotic syndrome', 3),
(15564, 'ORPHA:564178', 'Primary hypomagnesemia with refractory seizures and intellectual disability', 1),
(15565, 'ORPHA:56425', 'CAD', 1),
(15566, 'ORPHA:56425', 'CAS', 1),
(15567, 'ORPHA:56425', 'Chronic cold agglutinin disease', 1),
(15568, 'ORPHA:56425', 'Cold agglutinin disease', 1),
(15569, 'ORPHA:56425', 'Cold agglutinin syndrome', 1),
(15570, 'ORPHA:565', 'MD', 1),
(15571, 'ORPHA:565', 'Menkes disease', 1),
(15572, 'ORPHA:565', 'Menkes kinky hair disease', 1),
(15573, 'ORPHA:565', 'Menkes syndrome', 1),
(15574, 'ORPHA:565612', 'Neutral lipid storage disease with severe cardiovascular involvement', 1),
(15575, 'ORPHA:565612', 'TGCV', 1),
(15576, 'ORPHA:565612', 'Triglyceride deposit cardiomyovasculopathy', 1),
(15577, 'ORPHA:565624', 'COXPD39', 1),
(15578, 'ORPHA:565624', 'Combined oxidative phosphorylation defect type 39', 1),
(15579, 'ORPHA:565624', 'GFM2-related combined oxidative phosphorylation defect', 1),
(15580, 'ORPHA:565641', 'Aplastic desmosis coli', 1),
(15581, 'ORPHA:565641', 'Primary desmosis coli', 1),
(15582, 'ORPHA:565779', 'Rare disorder potentially indicated for transplant or complication after transplantation', 3),
(15583, 'ORPHA:565782', 'Methotrexate toxicity', 1),
(15584, 'ORPHA:565788', 'Infantile inflammatory bowel disease with neurological involvement', 1),
(15585, 'ORPHA:565837', 'LGMD type R23', 1),
(15586, 'ORPHA:565837', 'Laminin subunit alpha 2-related LGMD R23', 1),
(15587, 'ORPHA:565837', 'Laminin subunit alpha 2-related late-onset muscular dystrophy', 1),
(15588, 'ORPHA:565837', 'Laminin subunit alpha 2-related limb-girdle muscular dystrophy R23', 1),
(15589, 'ORPHA:565858', 'Craniosynostosis-microretrognathia-severe intellectual disability syndrome', 1),
(15590, 'ORPHA:565899', 'LGMD type R24', 1),
(15591, 'ORPHA:565899', 'Limb-girdle muscular dystrophy type R24', 1),
(15592, 'ORPHA:565899', 'POMGNT2-related LGMD R24', 1),
(15593, 'ORPHA:565899', 'POMGNT2-related limb-girdle muscular dystrophy R24', 1),
(15594, 'ORPHA:565899', 'POMGNT2-related muscular dystrophy', 1),
(15595, 'ORPHA:565909', 'Calpain-3-related LGMD  D4', 1),
(15596, 'ORPHA:565909', 'Calpain-3-related limb-girdle muscular dystrophy D4', 1),
(15597, 'ORPHA:565909', 'LGMD type D4', 1),
(15598, 'ORPHA:565909', 'LGMD1I', 1),
(15599, 'ORPHA:565909', 'Limb-girdle muscular dystrophy type D4', 1),
(15600, 'ORPHA:566', 'Congenital microcoria', 1),
(15601, 'ORPHA:566', 'Congenital miosis', 1),
(15602, 'ORPHA:566067', 'CAIN', 1),
(15603, 'ORPHA:566067', 'CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome', 1),
(15604, 'ORPHA:566175', 'CD55 deficiency', 1),
(15605, 'ORPHA:566175', 'CHAPLE syndrome', 1),
(15606, 'ORPHA:566175', 'Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome', 1),
(15607, 'ORPHA:566192', 'CARST', 1),
(15608, 'ORPHA:566192', 'Congenital autosomal recessive small-platelet thrombocytopenia', 1),
(15609, 'ORPHA:566231', 'RTHa', 1),
(15610, 'ORPHA:566231', 'Resistance to thyroid hormone alpha', 1),
(15611, 'ORPHA:566231', 'Resistance to thyroid hormone due to a mutation in TRa', 1),
(15612, 'ORPHA:566231', 'Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha', 1),
(15613, 'ORPHA:566243', 'RTHb', 1),
(15614, 'ORPHA:566243', 'Resistance to thyroid hormone beta', 1),
(15615, 'ORPHA:566243', 'Resistance to thyroid hormone due to a mutation in TRb', 1),
(15616, 'ORPHA:566243', 'Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta', 1),
(15617, 'ORPHA:566393', 'Acute MCL', 2),
(15618, 'ORPHA:566393', 'Acute mast cell leukemia', 2),
(15619, 'ORPHA:566396', 'Chronic MCL', 2),
(15620, 'ORPHA:566396', 'Chronic mast cell leukemia', 2),
(15621, 'ORPHA:566841', 'Hepatic adenomatosis', 1),
(15622, 'ORPHA:566841', 'Liver adenomatosis', 1),
(15623, 'ORPHA:566847', 'AP/AT spectum', 1),
(15624, 'ORPHA:566847', 'Aprosencephaly/atelencephaly spectrum', 1),
(15625, 'ORPHA:566852', 'Atelencephalic microcephaly', 2),
(15626, 'ORPHA:566852', 'Atelencephaly', 2),
(15627, 'ORPHA:566857', 'Aprosencephaly', 2),
(15628, 'ORPHA:566862', 'Isomerism of left atrial appendage', 1),
(15629, 'ORPHA:566862', 'LAI', 1),
(15630, 'ORPHA:566862', 'Left sided atrial isomerism', 1),
(15631, 'ORPHA:566943', 'Brailsford disease', 1),
(15632, 'ORPHA:566943', 'Mueller-Weiss osteonecrosis of the tarsal bone', 1),
(15633, 'ORPHA:566943', 'Mueller-Weiss syndrome', 1),
(15634, 'ORPHA:567', '22q11.2 deletion syndrome', 1),
(15635, 'ORPHA:567', '22q11DS', 1),
(15636, 'ORPHA:567', 'CATCH 22', 1),
(15637, 'ORPHA:567', 'Cayler cardiofacial syndrome', 1),
(15638, 'ORPHA:567', 'Conotruncal anomaly face syndrome', 1),
(15639, 'ORPHA:567', 'DiGeorge sequence', 1),
(15640, 'ORPHA:567', 'DiGeorge syndrome', 1),
(15641, 'ORPHA:567', 'Microdeletion 22q11.2', 1),
(15642, 'ORPHA:567', 'Monosomy 22q11', 1),
(15643, 'ORPHA:567', 'Sedlackova syndrome', 1),
(15644, 'ORPHA:567', 'Shprintzen syndrome', 1),
(15645, 'ORPHA:567', 'Takao syndrome', 1),
(15646, 'ORPHA:567', 'Velocardiofacial syndrome', 1),
(15647, 'ORPHA:567502', 'B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome', 1),
(15648, 'ORPHA:567502', 'BILU syndrome', 1),
(15649, 'ORPHA:567502', 'Hoffman syndrome', 1),
(15650, 'ORPHA:567544', 'Idiopathic non-lupus FHN', 1),
(15651, 'ORPHA:567544', 'Idiopathic non-lupus full-house nephropathy', 1),
(15652, 'ORPHA:567546', 'Idiopathic SSNS with secondary steroid resistance', 1),
(15653, 'ORPHA:567546', 'Idiopathic steroid-sensitive nephrotic syndrome with secondary steroid resistance', 1),
(15654, 'ORPHA:567546', 'Secondary SRNS', 1),
(15655, 'ORPHA:567546', 'Secondary steroid-resistant nephrotic syndrome', 1),
(15656, 'ORPHA:567548', 'Idiopathic SRNS', 1),
(15657, 'ORPHA:567548', 'Idiopathic steroid-resistant nephrotic syndrome', 1),
(15658, 'ORPHA:567550', 'Idiopathic multidrug-resistant nephrotic syndrome', 2),
(15659, 'ORPHA:567552', 'Idiopathic steroid-resistant nephrotic syndrome with sensitivity to intensified immunosuppression', 2),
(15660, 'ORPHA:567552', 'Idiopathic steroid-resistant nephrotic syndrome with sensitivity to second-line immunosuppressive therapy', 2),
(15661, 'ORPHA:567554', 'Systemic disease with glomerulopathy as a major feature', 3),
(15662, 'ORPHA:567556', 'Genetic systemic disease with glomerulopathy as a major feature', 3),
(15663, 'ORPHA:567558', 'Non-genetic systemic disease with glomerulopathy as a major feature', 3),
(15664, 'ORPHA:567560', 'Systemic vasculitis associated with glomerulopathy', 3),
(15665, 'ORPHA:567562', 'Disorder with multisystemic involvement and glomerulopathy', 3),
(15666, 'ORPHA:567564', 'Nephrotic syndrome without extrarenal manifestations', 3),
(15667, 'ORPHA:567983', 'PNAC', 1),
(15668, 'ORPHA:567983', 'Parenteral nutrition-associated cholestasis', 1),
(15669, 'ORPHA:568', 'Lenz microphthalmia', 1),
(15670, 'ORPHA:568', 'Microphthalmia, Lenz type', 1),
(15671, 'ORPHA:568041', 'Primary lymphedema without systemic or visceral involvement', 3),
(15672, 'ORPHA:568044', 'Primary lymphedema with systemic or visceral involvement', 3),
(15673, 'ORPHA:568047', 'Disorder with multisystemic involvement and primary lymphedema', 3),
(15674, 'ORPHA:568051', 'GJC2-related late-onset primary lymphedema', 1),
(15675, 'ORPHA:568056', 'Disseminated warts-impaired cell-mediated immunity-primary lymphedema-anogenital dysplasia syndrome', 1),
(15676, 'ORPHA:568056', 'WILD syndrome', 1),
(15677, 'ORPHA:568056', 'Warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome', 1),
(15678, 'ORPHA:568062', 'Generalized lymphatic dysplasia of Fotiou', 1),
(15679, 'ORPHA:568062', 'PIEZO1-related LRHF/GLD', 1),
(15680, 'ORPHA:568062', 'PIEZO1-related generalized lymphatic dysplasia with non-immune hydrops fetalis', 1),
(15681, 'ORPHA:568062', 'PIEZO1-related generalized lymphatic dysplasia with systemic involvement', 1),
(15682, 'ORPHA:568062', 'PIEZO1-related lymphatic-related hydrops fetalis', 1),
(15683, 'ORPHA:568065', 'EPHB4-related LRHF/GLD', 1),
(15684, 'ORPHA:568065', 'EPHB4-related generalized lymphatic dysplasia with atrial septal defect', 1),
(15685, 'ORPHA:568065', 'EPHB4-related generalized lymphatic dysplasia with non-immune hydrops fetalis', 1),
(15686, 'ORPHA:568065', 'EPHB4-related lymphatic-related hydrops fetalis', 1),
(15687, 'ORPHA:569', 'Familial or sporadic hemiplegic migraine', 1),
(15688, 'ORPHA:569164', 'AFH', 1),
(15689, 'ORPHA:569164', 'Angiomatoid fibrous histiocytoma', 1),
(15690, 'ORPHA:569248', 'MCST', 1),
(15691, 'ORPHA:569248', 'Microcystic stromal tumor', 1),
(15692, 'ORPHA:569274', 'ISCA1 deficiency', 1),
(15693, 'ORPHA:569274', 'MMDS5', 1),
(15694, 'ORPHA:569274', 'Multiple mitochondrial dysfunctions syndrome type 5', 1),
(15695, 'ORPHA:569290', 'Multiple mitochondrial dysfunctions syndrome type 6', 1),
(15696, 'ORPHA:569290', 'PMPCB deficiency', 1),
(15697, 'ORPHA:56970', 'Human prion disease', 3),
(15698, 'ORPHA:56970', 'TSE', 3),
(15699, 'ORPHA:56970', 'Transmissible spongiform encephalopathy', 3),
(15700, 'ORPHA:569816', 'CELSR1-related late-onset primary lymphedema', 1),
(15701, 'ORPHA:569821', 'Congenital primary lymphedema of Gordon', 1),
(15702, 'ORPHA:569821', 'VEGFC-related congenital primary lymphedema', 1),
(15703, 'ORPHA:57', 'GSD due to aldolase A deficiency', 1),
(15704, 'ORPHA:57', 'GSD type 12', 1),
(15705, 'ORPHA:57', 'GSD type XII', 1),
(15706, 'ORPHA:57', 'Glycogen storage disease due to aldolase A deficiency', 1),
(15707, 'ORPHA:57', 'Glycogen storage disease type 12', 1),
(15708, 'ORPHA:57', 'Glycogen storage disease type XII', 1),
(15709, 'ORPHA:57', 'Glycogenosis due to aldolase A deficiency', 1),
(15710, 'ORPHA:57', 'Glycogenosis type 12', 1),
(15711, 'ORPHA:57', 'Glycogenosis type XII', 1),
(15712, 'ORPHA:570', 'Congenital facial diplegia', 1),
(15713, 'ORPHA:570', 'Moebius syndrome', 1),
(15714, 'ORPHA:570', 'Möbius syndrome', 1),
(15715, 'ORPHA:570371', 'Bartter syndrome type 5', 2),
(15716, 'ORPHA:570371', 'Transient antenatal Bartter syndrome', 2),
(15717, 'ORPHA:570422', 'GALM deficiency', 1),
(15718, 'ORPHA:570422', 'Galactose mutarotase deficiency', 1),
(15719, 'ORPHA:570422', 'Galactosemia type 4', 1),
(15720, 'ORPHA:570431', 'HHV-8-negative multicentric Castleman disease', 2),
(15721, 'ORPHA:570431', 'Human herpesvirus-8-negative multicentric Castleman disease', 2),
(15722, 'ORPHA:570431', 'Idiopathic multicentric Castleman disease', 2),
(15723, 'ORPHA:570438', 'HHV-8-associated multicentric Castleman disease', 2),
(15724, 'ORPHA:570438', 'Human herpesvirus-8-associated multicentric Castleman disease', 2),
(15725, 'ORPHA:570470', 'Ricin poisoning', 1),
(15726, 'ORPHA:570491', 'QRSL1-related COXPD', 1),
(15727, 'ORPHA:570491', 'QRSL1-related combined oxidative phosphorylation defect', 1),
(15728, 'ORPHA:570762', 'Bacterial endocarditis', 1),
(15729, 'ORPHA:570762', 'Infectious endocarditis', 1),
(15730, 'ORPHA:570762', 'Infective endocarditis', 1),
(15731, 'ORPHA:57145', 'SUNCT syndrome', 1),
(15732, 'ORPHA:57145', 'Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing', 1),
(15733, 'ORPHA:57146', 'Rare hepatic disease', 3),
(15734, 'ORPHA:57196', 'Medial condensing osteitis of the clavicle', 1),
(15735, 'ORPHA:57196', 'Osteitis condensans of the clavicle', 1),
(15736, 'ORPHA:572', 'Bare lymphocyte syndrome type 2', 1),
(15737, 'ORPHA:572', 'Immunodeficiency by defective expression of MHC class II', 1),
(15738, 'ORPHA:572', 'MHC class II deficiency', 1),
(15739, 'ORPHA:572013', 'Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome', 1),
(15740, 'ORPHA:572333', '3q23 microdeletion syndrome', 1),
(15741, 'ORPHA:572333', 'BPES plus', 1),
(15742, 'ORPHA:572333', 'Blepharophimosis-ptosis-epicanthus inversus syndrome plus', 1),
(15743, 'ORPHA:572354', 'BPES type 1', 2),
(15744, 'ORPHA:572354', 'Blepharophimosis-ptosis-epicanthus inversus syndrome type 1', 2),
(15745, 'ORPHA:572361', 'BPES type 2', 2),
(15746, 'ORPHA:572361', 'Blepharophimosis-ptosis-epicanthus inversus syndrome type 2', 2),
(15747, 'ORPHA:572385', 'Brachydactyly type B1', 2),
(15748, 'ORPHA:572428', 'Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia', 1),
(15749, 'ORPHA:572428', 'OAS1 deficiency', 1),
(15750, 'ORPHA:572428', 'OAS1-related infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia', 1),
(15751, 'ORPHA:572543', 'RFVT2-related riboflavin transporter deficiency', 2),
(15752, 'ORPHA:572543', 'RTD2', 2),
(15753, 'ORPHA:572543', 'Riboflavin transporter deficiency 2', 2),
(15754, 'ORPHA:572550', 'RFVT3-related riboflavin transporter deficiency', 2),
(15755, 'ORPHA:572550', 'RTD3', 2),
(15756, 'ORPHA:572550', 'Riboflavin transporter deficiency 3', 2),
(15757, 'ORPHA:572761', 'DONSON-related microcephaly-short stature-limb abnormalities spectrum', 1),
(15758, 'ORPHA:572768', 'MIMIS', 2),
(15759, 'ORPHA:572768', 'Microcephaly-micromelia syndrome', 2),
(15760, 'ORPHA:572773', 'MISSLA', 2),
(15761, 'ORPHA:572773', 'Microcephaly-short stature-limb abnormalities syndrome', 2),
(15762, 'ORPHA:572798', 'Mitochondrial tryptophanyl-tRNA synthetase deficiency', 1),
(15763, 'ORPHA:572798', 'WARS2-related combined oxidative phosphorylation defect', 1),
(15764, 'ORPHA:573', 'Monilethrix', 1),
(15765, 'ORPHA:573', 'Moniliform hair syndrome', 1),
(15766, 'ORPHA:573163', 'Pheochromocytoma-paraganglioma', 3),
(15767, 'ORPHA:573253', 'SCM type 2', 2),
(15768, 'ORPHA:573253', 'SCM type II', 2),
(15769, 'ORPHA:573253', 'Split cord malformation type 2', 2),
(15770, 'ORPHA:573253', 'Split cord malformation type II', 2),
(15771, 'ORPHA:573278', 'SCM', 1),
(15772, 'ORPHA:573278', 'Split cord malformation', 1),
(15773, 'ORPHA:574', '21q deletion syndrome', 1),
(15774, 'ORPHA:574', '21q- syndrome', 1),
(15775, 'ORPHA:574', 'Monosomy 21', 1),
(15776, 'ORPHA:574', 'Partial 21q monosomy', 1),
(15777, 'ORPHA:574918', 'Predisposition to severe viral infection due to IRF7 deficiency', 1),
(15778, 'ORPHA:574957', 'Autosomal recessive MSMD due to partial JAK1 deficiency', 1),
(15779, 'ORPHA:574957', 'Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency', 1),
(15780, 'ORPHA:575', 'Muckle-Wells syndrome', 1),
(15781, 'ORPHA:575', 'Neutrophilic urticaria', 1),
(15782, 'ORPHA:575553', 'CARASAL', 1),
(15783, 'ORPHA:575553', 'Cathepsin A-related arteriopathy-strokes-leukoencephalopathy', 1),
(15784, 'ORPHA:576', 'I-cell disease', 1),
(15785, 'ORPHA:576', 'Mucolipidosis type II', 1),
(15786, 'ORPHA:576', 'Mucolipidosis type II alpha/beta', 1),
(15787, 'ORPHA:576', 'N-acetylglucosamine 1-phosphotransferase deficiency', 1),
(15788, 'ORPHA:576074', 'MERS', 1),
(15789, 'ORPHA:576074', 'Middle East respiratory syndrome', 1),
(15790, 'ORPHA:576227', 'Balanced complete atrioventricular canal', 2),
(15791, 'ORPHA:576227', 'CAVC without ventricular hypoplasia', 2),
(15792, 'ORPHA:576227', 'Complete AVSD without ventricular hypoplasia', 2),
(15793, 'ORPHA:576227', 'Complete atrioventricular canal defect without ventricular hypoplasia', 2),
(15794, 'ORPHA:576227', 'Complete atrioventricular septal defect with balanced ventricles', 2),
(15795, 'ORPHA:576227', 'Complete atrioventricular septal defect without ventricular hypoplasia', 2),
(15796, 'ORPHA:576232', 'PAVC with ventricular hypoplasia', 2),
(15797, 'ORPHA:576232', 'Partial AVSD with ventricular hypoplasia', 2),
(15798, 'ORPHA:576232', 'Partial atrioventricular canal defect with ventricular hypoplasia', 2),
(15799, 'ORPHA:576232', 'Partial atrioventricular septal defect with ventricular hypoplasia', 2),
(15800, 'ORPHA:576232', 'Partial atrioventricular septal defect with ventricular imbalance', 2),
(15801, 'ORPHA:576232', 'Unbalanced partial atrioventricular canal', 2),
(15802, 'ORPHA:576235', 'Balanced partial atrioventricular canal', 2),
(15803, 'ORPHA:576235', 'PAVC without ventricular hypoplasia', 2),
(15804, 'ORPHA:576235', 'Partial AVSD without ventricular hypoplasia', 2),
(15805, 'ORPHA:576235', 'Partial atrioventricular canal defect without ventricular hypoplasia', 2),
(15806, 'ORPHA:576235', 'Partial atrioventricular septal defect with balanced ventricles', 2),
(15807, 'ORPHA:576235', 'Partial atrioventricular septal defect without ventricular hypoplasia', 2),
(15808, 'ORPHA:576242', 'Intermediate AVSD', 1),
(15809, 'ORPHA:576242', 'Intermediate atrioventricular canal defect', 1),
(15810, 'ORPHA:576242', 'Intermediate atrioventricular septal defect', 1),
(15811, 'ORPHA:576242', 'Transitional atrioventricular canal defect', 1),
(15812, 'ORPHA:576278', 'SAS', 1),
(15813, 'ORPHA:576278', 'SATB2-associated syndrome', 1),
(15814, 'ORPHA:576283', 'SATB2-associated syndrome due to a pathogenic variant', 2),
(15815, 'ORPHA:576283', 'SATB2-associated syndrome due to a point mutation', 2),
(15816, 'ORPHA:576349', 'FCAS4', 1),
(15817, 'ORPHA:576349', 'Familial cold autoinflammatory syndrome 4', 1),
(15818, 'ORPHA:576349', 'NLRC4-related familial cold autoinflammatory syndrome', 1),
(15819, 'ORPHA:576349', 'NLRC4-related familial cold urticaria', 1),
(15820, 'ORPHA:576356', 'Idiopathic human prion disease', 3),
(15821, 'ORPHA:576356', 'Sporadic human prion disease', 3),
(15822, 'ORPHA:576360', 'Acquired human prion disease', 3),
(15823, 'ORPHA:576360', 'Infectious human prion disease', 3),
(15824, 'ORPHA:576370', 'Variant Creutzfeldt-Jakob disease', 1),
(15825, 'ORPHA:576370', 'Variant MCJ', 1),
(15826, 'ORPHA:576370', 'vCJD', 1),
(15827, 'ORPHA:576379', 'Iatrogenic Creutzfeldt-Jakob disease', 1),
(15828, 'ORPHA:576379', 'Iatrogenic MCJ', 1),
(15829, 'ORPHA:576379', 'iCJD', 1),
(15830, 'ORPHA:576742', 'Genetic HUS', 3),
(15831, 'ORPHA:576742', 'Genetic hemolytic uremic syndrome', 3),
(15832, 'ORPHA:577', 'Mucolipidosis type III', 1),
(15833, 'ORPHA:577', 'Pseudo-Hurler polydystrophy', 1),
(15834, 'ORPHA:57777', 'Cirrhotic cardiomyopathy', 1),
(15835, 'ORPHA:57782', 'Mazabraud syndrome', 1),
(15836, 'ORPHA:57782', 'Myxoma with fibrous dysplasia', 1),
(15837, 'ORPHA:578', 'Mucolipidosis type IV', 1),
(15838, 'ORPHA:579', 'Alpha-L-iduronidase deficiency', 1),
(15839, 'ORPHA:579', 'MPS1', 1),
(15840, 'ORPHA:579', 'MPSI', 1),
(15841, 'ORPHA:579', 'Mucopolysaccharidosis type 1', 1),
(15842, 'ORPHA:579', 'Mucopolysaccharidosis type I', 1),
(15843, 'ORPHA:58', 'Alexander disease', 1),
(15844, 'ORPHA:58', 'AxD', 1),
(15845, 'ORPHA:580', 'Hunter syndrome', 1),
(15846, 'ORPHA:580', 'Iduronate 2-sulfatase deficiency', 1),
(15847, 'ORPHA:580', 'MPS2', 1),
(15848, 'ORPHA:580', 'MPSII', 1),
(15849, 'ORPHA:580', 'Mucopolysaccharidosis type 2', 1),
(15850, 'ORPHA:580', 'Mucopolysaccharidosis type II', 1),
(15851, 'ORPHA:58017', 'Classic hairy cell leukemia', 1),
(15852, 'ORPHA:58017', 'HCL-C', 1),
(15853, 'ORPHA:58017', 'Leukemic reticuloendotheliosis', 1),
(15854, 'ORPHA:58040', 'Osteoblastoma', 1),
(15855, 'ORPHA:580572', 'ITPN', 1),
(15856, 'ORPHA:580572', 'Intraductal tubulopapillary neoplasm of pancreas', 1),
(15857, 'ORPHA:580933', 'Lethal brain and heart developmental defects', 1),
(15858, 'ORPHA:580940', 'QRICH1-related intellectual disability-chondrodysplasia syndrome', 1),
(15859, 'ORPHA:580951', 'Punctate inner choroidopathy', 1),
(15860, 'ORPHA:581', 'MPS3', 1),
(15861, 'ORPHA:581', 'MPSIII', 1),
(15862, 'ORPHA:581', 'Mucopolysaccharidosis type 3', 1),
(15863, 'ORPHA:581', 'Mucopolysaccharidosis type III', 1),
(15864, 'ORPHA:581', 'Sanfilippo disease', 1),
(15865, 'ORPHA:581271', 'Cramp-fasciculation syndrome', 1),
(15866, 'ORPHA:582', 'MPS4', 1),
(15867, 'ORPHA:582', 'MPSIV', 1),
(15868, 'ORPHA:582', 'Morquio disease', 1),
(15869, 'ORPHA:582', 'Mucopolysaccharidosis type 4', 1),
(15870, 'ORPHA:582', 'Mucopolysaccharidosis type IV', 1),
(15871, 'ORPHA:583', 'ARSB deficiency', 1),
(15872, 'ORPHA:583', 'ASB deficiency', 1),
(15873, 'ORPHA:583', 'Arylsulfatase B deficiency', 1),
(15874, 'ORPHA:583', 'MPS6', 1),
(15875, 'ORPHA:583', 'MPSVI', 1),
(15876, 'ORPHA:583', 'Maroteaux-Lamy disease', 1),
(15877, 'ORPHA:583', 'Mucopolysaccharidosis type 6', 1),
(15878, 'ORPHA:583', 'Mucopolysaccharidosis type VI', 1),
(15879, 'ORPHA:583', 'N-acetylgalactosamine 4-sulfatase deficiency', 1),
(15880, 'ORPHA:583097', 'CIL-F', 1),
(15881, 'ORPHA:583097', 'Congenital infiltrating lipomatosis of the face', 1),
(15882, 'ORPHA:583097', 'Facial infused lipomatosis', 1),
(15883, 'ORPHA:583097', 'Fibroadipose infiltrating lipomatosis', 1),
(15884, 'ORPHA:583595', 'Serine biosynthesis pathway deficiency, infantile/juvenile form', 1),
(15885, 'ORPHA:583602', 'Neu-laxova syndrome due to phosphoserine aminotransferase deficiency', 2),
(15886, 'ORPHA:583602', 'Phosphoserine aminotransferase deficiency, prenatal form', 2),
(15887, 'ORPHA:583607', '3-phosphoglycerate dehydrogenase deficiency, prenatal form', 2),
(15888, 'ORPHA:583607', 'Neu-laxova syndrome due to 3-phosphoglycerate dehydrogenase deficiency', 2),
(15889, 'ORPHA:583612', '3-phosphoserine phosphatase deficiency, prenatal form', 2),
(15890, 'ORPHA:583612', 'Neu-laxova syndrome due to 3-phosphoserine phosphatase deficiency', 2),
(15891, 'ORPHA:583856', 'Isolated splenic vein thrombosis', 1),
(15892, 'ORPHA:583861', 'Isolated mesenteric vein thrombosis', 1),
(15893, 'ORPHA:584', 'Beta-glucuronidase deficiency', 1),
(15894, 'ORPHA:584', 'MPS7', 1),
(15895, 'ORPHA:584', 'MPSVII', 1),
(15896, 'ORPHA:584', 'Mucopolysaccharidosis type 7', 1),
(15897, 'ORPHA:584', 'Mucopolysaccharidosis type VII', 1),
(15898, 'ORPHA:584', 'Sly disease', 1),
(15899, 'ORPHA:585', 'Juvenile sulfatidosis, Austin type', 1),
(15900, 'ORPHA:585', 'MSD', 1),
(15901, 'ORPHA:585', 'Mucosulfatidosis', 1),
(15902, 'ORPHA:585', 'Multiple sulfatase deficiency', 1),
(15903, 'ORPHA:585867', 'AML with BCR-ABL1', 1),
(15904, 'ORPHA:585867', 'AML with t(9;22)(q34.1;q11.2)', 1),
(15905, 'ORPHA:585867', 'Acute myeloid leukemia with t(9;22)(q34.1;q11.2)', 1),
(15906, 'ORPHA:585877', 'B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormality', 2),
(15907, 'ORPHA:585909', 'B-ALL with t(9;22)(q34.1;q11.2)', 2),
(15908, 'ORPHA:585909', 'B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)', 2),
(15909, 'ORPHA:585909', 'BCR-ABL1-like B-ALL', 2),
(15910, 'ORPHA:585909', 'Philadelphia chromosome-like B-ALL', 2),
(15911, 'ORPHA:585918', 'B Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A Rearranged', 2),
(15912, 'ORPHA:585918', 'B lymphoblastic leukemia lymphoma with t(v;11q23); MLL rearranged', 2),
(15913, 'ORPHA:585918', 'B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)', 2),
(15914, 'ORPHA:585929', 'B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1', 2),
(15915, 'ORPHA:585929', 'B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)', 2),
(15916, 'ORPHA:585929', 'B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1', 2),
(15917, 'ORPHA:585936', 'B-lymphoblastic leukemia/lymphoma with hyperdiploidy', 2),
(15918, 'ORPHA:585942', 'B-lymphoblastic leukemia/lymphoma with hypodiploidy', 2),
(15919, 'ORPHA:585942', 'Hypodiploid ALL', 2),
(15920, 'ORPHA:585948', 'B lymphoblastic leukemia lymphoma with t(5;14)(q31;q32); IL3-IGH', 2),
(15921, 'ORPHA:585948', 'B-lymphoblastic leukemia/lymphoma with t(5;14)(q31.1;q32.3)', 2),
(15922, 'ORPHA:585956', 'B lymphoblastic leukemia lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1', 2),
(15923, 'ORPHA:585956', 'B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)', 2),
(15924, 'ORPHA:586', 'CF', 1),
(15925, 'ORPHA:586', 'Cystic fibrosis', 1),
(15926, 'ORPHA:586', 'Mucoviscidosis', 1),
(15927, 'ORPHA:586130', 'Sporadic fatal insomnia', 1),
(15928, 'ORPHA:587', 'Muir-Torre syndrome', 1),
(15929, 'ORPHA:587', 'Multiple keratoacanthoma, Muir-Torre type', 1),
(15930, 'ORPHA:588', 'MEB syndrome', 1),
(15931, 'ORPHA:588', 'Muscle-eye-brain disease', 1),
(15932, 'ORPHA:588', 'Muscle-eye-brain syndrome', 1),
(15933, 'ORPHA:588', 'Santavuori congenital muscular dystrophy', 1),
(15934, 'ORPHA:589', 'Acquired myasthenia', 1),
(15935, 'ORPHA:589', 'Autoimmune myasthenia gravis', 1),
(15936, 'ORPHA:589', 'Myasthenia gravis', 1),
(15937, 'ORPHA:589435', 'SMD-corneal dystrophy syndrome', 1),
(15938, 'ORPHA:589435', 'Spondylometaphyseal dysplasia-corneal dystrophy syndrome', 1),
(15939, 'ORPHA:589442', 'Liberfarb syndrome', 1),
(15940, 'ORPHA:589442', 'Short stature-skeletal dysplasia-retinal degeneration-intellectual disability-sensorineural hearing loss syndrome', 1),
(15941, 'ORPHA:589515', 'PADDAS syndrome', 1),
(15942, 'ORPHA:589515', 'PUM1-associated developmental disability-ataxia-seizure syndrome', 1),
(15943, 'ORPHA:589515', 'SCA47', 1),
(15944, 'ORPHA:589522', 'SCA46', 1),
(15945, 'ORPHA:589522', 'Spinocerebellar ataxia type 46', 1),
(15946, 'ORPHA:589527', 'SCA45', 1),
(15947, 'ORPHA:589527', 'Spinocerebellar ataxia type 45', 1),
(15948, 'ORPHA:589534', 'MPAL with t(9;22)(q34.1;q11.2); BCR-ABL1', 2),
(15949, 'ORPHA:589534', 'Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)', 2),
(15950, 'ORPHA:589542', 'Myeloid/lymphoid neoplasm associated with JAK2 rearrangement', 1),
(15951, 'ORPHA:589542', 'Myeloid/lymphoid neoplasms with PCM1-JAK2', 1),
(15952, 'ORPHA:589547', 'GRIN2B-related developmental delay, intellectual disability and autism spectrum disorder', 1),
(15953, 'ORPHA:589595', 'MPAL with t(v;11q23.3); KMT2A rearranged', 2),
(15954, 'ORPHA:589595', 'MPAL with t(v;11q23.3); MLL rearranged', 2),
(15955, 'ORPHA:589595', 'Mixed phenotype acute leukemia with t(v;11q23.3)', 2),
(15956, 'ORPHA:589608', 'Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies', 1),
(15957, 'ORPHA:589608', 'RHOA-related mosaic ectodermal dysplasia', 1),
(15958, 'ORPHA:589618', 'DYT28', 1),
(15959, 'ORPHA:589618', 'Dystonia 28', 1),
(15960, 'ORPHA:589618', 'KMT2B-related dystonia', 1),
(15961, 'ORPHA:589746', 'Inherited gynecological cancer-predisposing syndrome', 3),
(15962, 'ORPHA:589821', 'Congenital-onset Steinert disease', 2),
(15963, 'ORPHA:589821', 'Congenital-onset Steinert myotonic dystrophy', 2),
(15964, 'ORPHA:589821', 'Congenital-onset myotonic dystrophy type 1', 2),
(15965, 'ORPHA:589824', 'Childhood-onset Steinert disease', 2),
(15966, 'ORPHA:589824', 'Childhood-onset Steinert myotonic dystrophy', 2),
(15967, 'ORPHA:589824', 'Childhood-onset myotonic dystrophy type 1', 2),
(15968, 'ORPHA:589827', 'Juvenile-onset Steinert disease', 2),
(15969, 'ORPHA:589827', 'Juvenile-onset Steinert myotonic dystrophy', 2),
(15970, 'ORPHA:589827', 'Juvenile-onset myotonic dystrophy type 1', 2),
(15971, 'ORPHA:589830', 'Adult-onset Steinert disease', 2),
(15972, 'ORPHA:589830', 'Adult-onset Steinert myotonic dystrophy', 2),
(15973, 'ORPHA:589830', 'Adult-onset myotonic dystrophy type 1', 2),
(15974, 'ORPHA:589833', 'Late-onset Steinert disease', 2),
(15975, 'ORPHA:589833', 'Late-onset Steinert myotonic dystrophy', 2),
(15976, 'ORPHA:589833', 'Late-onset myotonic dystrophy type 1', 2),
(15977, 'ORPHA:589856', 'Choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome', 1),
(15978, 'ORPHA:589856', 'KMT2D-related choanal atresia-athelia-hypothyroidism-delayed puberty-short stature syndrome', 1),
(15979, 'ORPHA:589905', 'Chung-Jansen syndrome', 1),
(15980, 'ORPHA:589905', 'PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome', 1),
(15981, 'ORPHA:59', 'AHDS', 1),
(15982, 'ORPHA:59', 'Allan-Herndon-Dudley syndrome', 1),
(15983, 'ORPHA:59', 'MCT8 deficiency', 1),
(15984, 'ORPHA:59', 'Monocarboxylate transporter 8 deficiency', 1),
(15985, 'ORPHA:59', 'X-linked intellectual disability-hypotonia syndrome', 1),
(15986, 'ORPHA:590', 'CMS', 1),
(15987, 'ORPHA:590', 'Congenital myasthenic syndrome', 1),
(15988, 'ORPHA:590539', 'Isolated melanocytic schwannoma', 1),
(15989, 'ORPHA:590539', 'Isolated melanotic schwannoma', 1),
(15990, 'ORPHA:591', 'Furuncular myiasis', 1),
(15991, 'ORPHA:591', 'Furunculoid myiasis', 1),
(15992, 'ORPHA:591', 'Furunculous myiasis', 1),
(15993, 'ORPHA:59135', 'Distal myopathy type 1', 1),
(15994, 'ORPHA:59135', 'Gowers disease', 1),
(15995, 'ORPHA:59135', 'Laing early-onset distal myopathy', 1),
(15996, 'ORPHA:59135', 'MPD1', 1),
(15997, 'ORPHA:59181', 'Sorsby pseudoinflammatory fundus dystrophy', 1),
(15998, 'ORPHA:592', 'MMF', 1),
(15999, 'ORPHA:592', 'Macrophagic myofasciitis', 1),
(16000, 'ORPHA:592564', 'GNAO1-related developmental delay-seizures-movement disorder spectrum', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(16001, 'ORPHA:592564', 'GNAO1-related spectrum', 1),
(16002, 'ORPHA:592570', 'TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome', 1),
(16003, 'ORPHA:592574', 'Menke-Hennekam syndrome', 1),
(16004, 'ORPHA:592850', 'NMOSD with anti-AQP4 antibodies', 2),
(16005, 'ORPHA:592850', 'Neuromyelitis optica spectrum disorder with anti-AQP4 antibodies', 2),
(16006, 'ORPHA:592850', 'Neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibodies', 2),
(16007, 'ORPHA:592856', 'NMOSD with anti-MOG antibodies', 2),
(16008, 'ORPHA:592856', 'Neuromyelitis optica spectrum disorder with anti-MOG antibodies', 2),
(16009, 'ORPHA:592856', 'Neuromyelitis optica spectrum disorder with anti-myelin oligodendrocyte glycoprotein antibodies', 2),
(16010, 'ORPHA:592869', 'NMOSD without anti-MOG antibodies and without anti-AQP4 antibodies', 2),
(16011, 'ORPHA:592869', 'Neuromyelitis optica spectrum disorder without anti-MOG and without anti-AQP4 antibodies', 2),
(16012, 'ORPHA:592873', 'Acute transverse myelitis with anti-MOG antibodies', 2),
(16013, 'ORPHA:592873', 'Acute transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies', 2),
(16014, 'ORPHA:592885', 'Isolated optic neuritis without anti-MOG antibodies', 2),
(16015, 'ORPHA:592888', 'Optic neuritis with anti-MOG antibodies', 2),
(16016, 'ORPHA:592888', 'Optic neuritis with anti-myelin oligodendrocyte glycoprotein antibodies', 2),
(16017, 'ORPHA:592894', 'ADEM with anti-MOG antibodies', 2),
(16018, 'ORPHA:592894', 'Acute disseminated encephalomyelitis with anti-MOG antibodies', 2),
(16019, 'ORPHA:592894', 'Acute disseminated encephalomyelitis with anti-myelin oligodendrocyte glycoprotein antibodies', 2),
(16020, 'ORPHA:592900', 'Acute disseminated encephalomyelitis without anti-MOG antibodies', 2),
(16021, 'ORPHA:59298', 'Myelinoclastic diffuse sclerosis', 1),
(16022, 'ORPHA:59298', 'Schilder disease', 1),
(16023, 'ORPHA:593', 'Myofibrillar myopathy', 3),
(16024, 'ORPHA:59303', 'IHSC', 1),
(16025, 'ORPHA:59303', 'Ichthyosis-hypotrichosis-sclerosing cholangitis syndrome', 1),
(16026, 'ORPHA:59303', 'NISCH syndrome', 1),
(16027, 'ORPHA:59303', 'Neonatal ichthyosis-sclerosing cholangitis syndrome', 1),
(16028, 'ORPHA:59305', 'GTN', 3),
(16029, 'ORPHA:59305', 'Gestational trophoblastic neoplasm', 3),
(16030, 'ORPHA:59306', 'MLS', 1),
(16031, 'ORPHA:59306', 'McLeod neuroacanthocytosis syndrome', 1),
(16032, 'ORPHA:59306', 'X-linked McLeod syndrome', 1),
(16033, 'ORPHA:59315', 'Rhombencephalosynapsis', 1),
(16034, 'ORPHA:595', 'CNM', 3),
(16035, 'ORPHA:595', 'Centronuclear myopathy', 3),
(16036, 'ORPHA:595098', 'LQT8 type 1', 2),
(16037, 'ORPHA:595098', 'TS1', 2),
(16038, 'ORPHA:595098', 'Timothy syndrome type 1', 2),
(16039, 'ORPHA:595105', 'LQT8 type 2', 2),
(16040, 'ORPHA:595105', 'TS2', 2),
(16041, 'ORPHA:595105', 'Timothy syndrome type 2', 2),
(16042, 'ORPHA:595109', 'ATS', 2),
(16043, 'ORPHA:595109', 'Atypical LQT8', 2),
(16044, 'ORPHA:595109', 'Atypical Timothy syndrome', 2),
(16045, 'ORPHA:595133', 'PEComa', 1),
(16046, 'ORPHA:595133', 'Perivascular Epithelioid Cell Neoplasm', 1),
(16047, 'ORPHA:595133', 'Perivascular epithelioid tumour', 1),
(16048, 'ORPHA:595216', 'FD/MAS spectrum', 3),
(16049, 'ORPHA:595216', 'FD/MAS syndrome', 3),
(16050, 'ORPHA:595216', 'Fibrous dysplasia/McCune-Albright spectrum', 3),
(16051, 'ORPHA:595216', 'Fibrous dysplasia/McCune-Albright syndrome', 3),
(16052, 'ORPHA:596', 'X-linked centronuclear myopathy', 1),
(16053, 'ORPHA:596', 'X-linked myotubular myopathy', 1),
(16054, 'ORPHA:596', 'XLCNM', 1),
(16055, 'ORPHA:596', 'XLMTM', 1),
(16056, 'ORPHA:597', 'Central core disease', 1),
(16057, 'ORPHA:598', 'MmD', 1),
(16058, 'ORPHA:598', 'Multiminicore disease', 1),
(16059, 'ORPHA:598', 'Multiminicore myopathy', 1),
(16060, 'ORPHA:599', 'Distal muscular dystrophy', 3),
(16061, 'ORPHA:599', 'Distal myopathy', 3),
(16062, 'ORPHA:6', '3-methylcrotonyl-CoA carboxylase deficiency', 1),
(16063, 'ORPHA:6', '3-methylcrotonylglycinuria', 1),
(16064, 'ORPHA:6', 'MCC deficiency', 1),
(16065, 'ORPHA:6', 'MCCD', 1),
(16066, 'ORPHA:60', 'Alpha-1-antitrypsin deficiency', 1),
(16067, 'ORPHA:600', 'Distal myopathy with vocal cord weakness', 1),
(16068, 'ORPHA:600', 'MATR3-related distal myopathy', 1),
(16069, 'ORPHA:600', 'VCPDM', 1),
(16070, 'ORPHA:600', 'Vocal cord and pharyngeal distal myopathy', 1),
(16071, 'ORPHA:60014', 'Argyria', 1),
(16072, 'ORPHA:60014', 'Silver staining', 1),
(16073, 'ORPHA:60015', 'Catlin marks', 1),
(16074, 'ORPHA:60015', 'Enlarged parietal foramina', 1),
(16075, 'ORPHA:60015', 'Fenestrae parietales symmetricae', 1),
(16076, 'ORPHA:60015', 'Foramina parietalia permagna', 1),
(16077, 'ORPHA:60015', 'Hereditary cranium bifidum', 1),
(16078, 'ORPHA:60015', 'Symmetric parietal foramina', 1),
(16079, 'ORPHA:60025', 'Pulmonary alveolar microlithiasis', 1),
(16080, 'ORPHA:60026', 'Pulmonary nodular lymphoid hyperplasia', 1),
(16081, 'ORPHA:60026', 'Pulmonary pseudolymphoma', 1),
(16082, 'ORPHA:60030', 'Aortic aneurysm syndrome due to TGF-beta receptors anomalies', 1),
(16083, 'ORPHA:60030', 'Loeys-Dietz syndrome', 1),
(16084, 'ORPHA:60032', 'Recurrent respiratory papillomatosis', 1),
(16085, 'ORPHA:60033', 'Idiopathic bronchiectasis', 1),
(16086, 'ORPHA:60039', 'Alcock syndrome', 1),
(16087, 'ORPHA:60039', 'Pudendal algia', 1),
(16088, 'ORPHA:60039', 'Pudendal nerve entrapment syndrome', 1),
(16089, 'ORPHA:60039', 'Pudendal neuralgia', 1),
(16090, 'ORPHA:60039', 'Pudendal neuralgia by pudendal nerve entrapment', 1),
(16091, 'ORPHA:60039', 'Pudendalgia', 1),
(16092, 'ORPHA:60040', 'MCAP', 1),
(16093, 'ORPHA:60040', 'MCM', 1),
(16094, 'ORPHA:60040', 'MCMTC', 1),
(16095, 'ORPHA:60040', 'Macrocephaly-capillary malformation syndrome', 1),
(16096, 'ORPHA:60040', 'Macrocephaly-cutis marmorata telangiectatica congenita syndrome', 1),
(16097, 'ORPHA:60040', 'Megalencephaly-capillary malformation syndrome', 1),
(16098, 'ORPHA:60040', 'Megalencephaly-capillary malformation-polymicrogyria syndrome', 1),
(16099, 'ORPHA:60040', 'Megalencephaly-cutis marmorata telangiectatica congenita syndrome', 1),
(16100, 'ORPHA:60041', 'Congenital atrioventricular block', 1),
(16101, 'ORPHA:60041', 'Congenital heart block', 1),
(16102, 'ORPHA:602', 'DMRV', 1),
(16103, 'ORPHA:602', 'Distal myopathy with rimmed vacuoles', 1),
(16104, 'ORPHA:602', 'Distal myopathy, Nonaka type', 1),
(16105, 'ORPHA:602', 'GNE myopathy', 1),
(16106, 'ORPHA:602', 'HIBM2', 1),
(16107, 'ORPHA:602', 'Hereditary inclusion body myopathy type 2', 1),
(16108, 'ORPHA:602', 'IBM2', 1),
(16109, 'ORPHA:602', 'Inclusion body myopathy type 2', 1),
(16110, 'ORPHA:602', 'Nonaka myopathy', 1),
(16111, 'ORPHA:602', 'Quadriceps-sparing myopathy', 1),
(16112, 'ORPHA:603', 'Distal myopathy, Welander type', 1),
(16113, 'ORPHA:603', 'WDM', 1),
(16114, 'ORPHA:606', 'Myotonic dystrophy type 2', 1),
(16115, 'ORPHA:606', 'Proximal myotonic dystrophy', 1),
(16116, 'ORPHA:606', 'Proximal myotonic myopathy', 1),
(16117, 'ORPHA:606', 'Ricker disease', 1),
(16118, 'ORPHA:606', 'Ricker syndrome', 1),
(16119, 'ORPHA:607', 'NEM', 3),
(16120, 'ORPHA:607', 'NM', 3),
(16121, 'ORPHA:607', 'Nemaline myopathy', 3),
(16122, 'ORPHA:607', 'Nemaline rod myopathy', 3),
(16123, 'ORPHA:609', 'Distal myopathy, Udd type', 1),
(16124, 'ORPHA:609', 'Distal titinopathy', 1),
(16125, 'ORPHA:609', 'Finnish tibial muscular dystrophy', 1),
(16126, 'ORPHA:609', 'TMD', 1),
(16127, 'ORPHA:609', 'Tibial muscular dystrophy', 1),
(16128, 'ORPHA:609', 'Udd myopathy', 1),
(16129, 'ORPHA:61', 'Alpha-mannosidosis', 1),
(16130, 'ORPHA:61', 'Lysosomal alpha-D-mannosidase deficiency', 1),
(16131, 'ORPHA:610', 'Benign autosomal dominant myopathy', 1),
(16132, 'ORPHA:610', 'Bethlem myopathy', 1),
(16133, 'ORPHA:611', 'IBM', 1),
(16134, 'ORPHA:611', 'Inclusion body myositis', 1),
(16135, 'ORPHA:611', 'Sporadic inclusion body myositis', 1),
(16136, 'ORPHA:611', 'sIBM', 1),
(16137, 'ORPHA:612', 'K+-aggravated myotonia', 3),
(16138, 'ORPHA:612', 'K-aggravated myotonia', 3),
(16139, 'ORPHA:612', 'PAM', 3),
(16140, 'ORPHA:612', 'Potassium-aggravated myotonia', 3),
(16141, 'ORPHA:614', 'Myotonia congenita', 1),
(16142, 'ORPHA:614', 'Thomsen and Becker disease', 1),
(16143, 'ORPHA:615', 'Familial atrial myxoma', 1),
(16144, 'ORPHA:616', 'Medulloblastoma', 1),
(16145, 'ORPHA:617', 'Congenital primary megalo-ureter', 1),
(16146, 'ORPHA:617', 'Congenital primary megaureter', 1),
(16147, 'ORPHA:618', 'Familial melanoma', 1),
(16148, 'ORPHA:62', 'Alpha-sarcoglycan-related  limb-girdle muscular dystrophy R3', 1),
(16149, 'ORPHA:62', 'Alpha-sarcoglycan-related LGMD R3', 1),
(16150, 'ORPHA:62', 'Alpha-sarcoglycanopathy', 1),
(16151, 'ORPHA:62', 'Autosomal recessive limb-girdle muscular dystrophy type 2D', 1),
(16152, 'ORPHA:62', 'LGMD due to alpha-sarcoglycan deficiency', 1),
(16153, 'ORPHA:62', 'LGMD type 2D', 1),
(16154, 'ORPHA:62', 'LGMD2D', 1),
(16155, 'ORPHA:62', 'Limb-girdle muscular dystrophy due to alpha-sarcoglycan deficiency', 1),
(16156, 'ORPHA:62', 'Limb-girdle muscular dystrophy type 2D', 1),
(16157, 'ORPHA:620', 'Common mesentery', 1),
(16158, 'ORPHA:620', 'Universal mesentery', 1),
(16159, 'ORPHA:621', 'Autosomal recessive methemoglobinemia', 1),
(16160, 'ORPHA:621', 'Congenital methemoglobinemia', 1),
(16161, 'ORPHA:621', 'Hereditary methemoglobinemia', 1),
(16162, 'ORPHA:622', 'Functional methionine synthase deficiency', 1),
(16163, 'ORPHA:622', 'Homocystinuria without methylmalonic aciduria', 1),
(16164, 'ORPHA:622', 'Methylcobalamin deficiency', 1),
(16165, 'ORPHA:624', 'Familial multiple nevi flammei', 1),
(16166, 'ORPHA:624', 'Familial multiple port-wine stains', 1),
(16167, 'ORPHA:626', 'Congenital pigmented nevus', 1),
(16168, 'ORPHA:626', 'GMN', 1),
(16169, 'ORPHA:626', 'Giant congenital melanocytic nevus', 1),
(16170, 'ORPHA:626', 'Giant pigmented hairy nevus', 1),
(16171, 'ORPHA:626', 'LCMN', 1),
(16172, 'ORPHA:626', 'Large congenital melanocytic nevus', 1),
(16173, 'ORPHA:627', 'Nance-Horan syndrome', 1),
(16174, 'ORPHA:628', 'Diastrophic dwarfism', 1),
(16175, 'ORPHA:628', 'Diastrophic dysplasia', 1),
(16176, 'ORPHA:629', 'Kowarski syndrome', 2),
(16177, 'ORPHA:629', 'Short stature due to growth hormone qualitative anomaly', 2),
(16178, 'ORPHA:63', 'Alport deafness-nephropathy', 1),
(16179, 'ORPHA:63', 'Alport hearing loss-nephropathy', 1),
(16180, 'ORPHA:63', 'Alport syndrome', 1),
(16181, 'ORPHA:631', 'Congenital IGHD', 1),
(16182, 'ORPHA:631', 'Congenital isolated GH deficiency', 1),
(16183, 'ORPHA:631', 'Congenital isolated growth hormone deficiency', 1),
(16184, 'ORPHA:631', 'Non-acquired isolated growth hormone deficiency', 1),
(16185, 'ORPHA:632', 'Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia', 2),
(16186, 'ORPHA:63259', 'Iniencephaly', 1),
(16187, 'ORPHA:63260', 'Craniorachischisis', 1),
(16188, 'ORPHA:63273', 'Distal ABD-filaminopathy', 1),
(16189, 'ORPHA:63273', 'Distal myopathy with posterior leg and anterior hand involvement', 1),
(16190, 'ORPHA:63275', 'Gestational pemphigoid', 1),
(16191, 'ORPHA:63275', 'Pemphigoid gestationis', 1),
(16192, 'ORPHA:633', 'Complete growth hormone insensitivity', 1),
(16193, 'ORPHA:633', 'GH receptor deficiency', 1),
(16194, 'ORPHA:633', 'Growth hormone receptor deficiency', 1),
(16195, 'ORPHA:633', 'Laron syndrome', 1),
(16196, 'ORPHA:633', 'Laron-type dwarfism', 1),
(16197, 'ORPHA:633', 'Primary GH insensitivity', 1),
(16198, 'ORPHA:633', 'Primary GH resistance', 1),
(16199, 'ORPHA:633', 'Primary growth hormone insensitivity', 1),
(16200, 'ORPHA:633', 'Primary growth hormone resistance', 1),
(16201, 'ORPHA:633', 'Short stature due to growth hormone resistance', 1),
(16202, 'ORPHA:634', 'Bamboo hair syndrome', 1),
(16203, 'ORPHA:634', 'Comèl-Netherton syndrome', 1),
(16204, 'ORPHA:634', 'NS', 1),
(16205, 'ORPHA:634', 'Netherton syndrome', 1),
(16206, 'ORPHA:63440', 'Acrocephaly', 1),
(16207, 'ORPHA:63440', 'Hypsicephaly', 1),
(16208, 'ORPHA:63440', 'Hypsocephaly', 1),
(16209, 'ORPHA:63440', 'Isolated oxycephaly', 1),
(16210, 'ORPHA:63440', 'Pyrgocephaly', 1),
(16211, 'ORPHA:63440', 'Turricephaly', 1),
(16212, 'ORPHA:63442', 'ASPED', 1),
(16213, 'ORPHA:63442', 'Angel-shaped phalango-epiphyseal dysplasia', 1),
(16214, 'ORPHA:63443', 'Rare epithelial tumor of stomach', 3),
(16215, 'ORPHA:63443', 'Rare gastric epithelial tumor', 3),
(16216, 'ORPHA:63446', 'Acrocapitofemoral dysplasia', 1),
(16217, 'ORPHA:63454', 'Pattern dystrophy', 3),
(16218, 'ORPHA:63454', 'Patterned dystrophy of the retinal pigment epithelium', 3),
(16219, 'ORPHA:63455', 'Paraneoplastic pemphigus', 1),
(16220, 'ORPHA:635', 'Neuroblastoma', 1),
(16221, 'ORPHA:636', 'NF1', 1),
(16222, 'ORPHA:636', 'Neurofibromatosis type 1', 1),
(16223, 'ORPHA:636', 'Von Recklinghausen disease', 1),
(16224, 'ORPHA:637', 'NF2', 1),
(16225, 'ORPHA:637', 'Neurofibromatosis type 2', 1),
(16226, 'ORPHA:638', 'NFNS', 1),
(16227, 'ORPHA:638', 'Neurofibromatosis type 1-Noonan syndrome', 1),
(16228, 'ORPHA:638', 'Neurofibromatosis-Noonan syndrome', 1),
(16229, 'ORPHA:63862', 'Schisis association', 1),
(16230, 'ORPHA:639', 'Anti-MAG neuropathy', 1),
(16231, 'ORPHA:639', 'Neuropathy associated with monoclonal IgM antibodies to myelin-associated glycoprotein', 1),
(16232, 'ORPHA:639', 'Polyneuropathy associated with IgM monoclonal gammapathy with anti-MAG', 1),
(16233, 'ORPHA:63999', 'Fibrosing mediastinitis', 1),
(16234, 'ORPHA:63999', 'IgG4-related mediastinitis', 1),
(16235, 'ORPHA:63999', 'Mediastinal fibrosis', 1),
(16236, 'ORPHA:63999', 'Sclerosing mediastinitis', 1),
(16237, 'ORPHA:64', 'Alström syndrome', 1),
(16238, 'ORPHA:640', 'Current pressure-sensitive neuropathy', 1),
(16239, 'ORPHA:640', 'HNPP', 1),
(16240, 'ORPHA:640', 'Hereditary neuropathy with liability to pressure palsies', 1),
(16241, 'ORPHA:640', 'Heterozygous microdeletion 17p11.2p12', 1),
(16242, 'ORPHA:640', 'Potato-grubbing palsy', 1),
(16243, 'ORPHA:640', 'Tomaculous neuropathy', 1),
(16244, 'ORPHA:640', 'Tulip-bulb digger\'s palsy', 1),
(16245, 'ORPHA:641', 'MMN', 1),
(16246, 'ORPHA:641', 'MMNCB', 1),
(16247, 'ORPHA:641', 'Multifocal motor neuropathy', 1),
(16248, 'ORPHA:641', 'Multifocal motor neuropathy with conduction block', 1),
(16249, 'ORPHA:642', 'CIPA', 1),
(16250, 'ORPHA:642', 'Congenital insensitivity to pain with anhidrosis', 1),
(16251, 'ORPHA:642', 'HSAN4', 1),
(16252, 'ORPHA:642', 'Hereditary sensory and autonomic neuropathy type 4', 1),
(16253, 'ORPHA:642', 'Hereditary sensory and autonomic neuropathy type IV', 1),
(16254, 'ORPHA:64280', 'Childhood absence epilepsy', 1),
(16255, 'ORPHA:64280', 'Pyknolepsy', 1),
(16256, 'ORPHA:643', 'GAN', 1),
(16257, 'ORPHA:643', 'Giant axonal neuropathy', 1),
(16258, 'ORPHA:644', 'NARP syndrome', 1),
(16259, 'ORPHA:644', 'Neurogenic muscle weakness-ataxia-retinitis pigmentosa syndrome', 1),
(16260, 'ORPHA:644', 'Neuropathy-ataxia-retinitis pigmentosa syndrome', 1),
(16261, 'ORPHA:64542', 'Acrofacial dysostosis, Kennedy-Teebi type', 1),
(16262, 'ORPHA:64542', 'Kennedy-Teebi syndrome', 1),
(16263, 'ORPHA:64545', 'BINS', 1),
(16264, 'ORPHA:64545', 'Benign idiopathic neonatal seizures', 1),
(16265, 'ORPHA:64545', 'Benign nonfamilial neonatal seizures', 1),
(16266, 'ORPHA:646', 'Niemann-Pick disease type C', 1),
(16267, 'ORPHA:64686', 'Painful ophthalmoplegia', 1),
(16268, 'ORPHA:64686', 'Tolosa-Hunt syndrome', 1),
(16269, 'ORPHA:64692', 'Bartonellosis due to Bartonella bacilliformis infection', 1),
(16270, 'ORPHA:64692', 'Carrion disease', 1),
(16271, 'ORPHA:64692', 'Oroya fever', 1),
(16272, 'ORPHA:64694', 'Bartonellosis due to Bartonella quintana infection', 1),
(16273, 'ORPHA:64694', 'Trench fever', 1),
(16274, 'ORPHA:647', 'AT V1', 1),
(16275, 'ORPHA:647', 'Ataxia-telangiectasia, variant 1', 1),
(16276, 'ORPHA:647', 'Berlin breakage syndrome', 1),
(16277, 'ORPHA:647', 'Immunodeficiency-microcephaly-chromosomal instability syndrome', 1),
(16278, 'ORPHA:647', 'Microcephaly-immunodeficiency-lymphoreticuloma syndrome', 1),
(16279, 'ORPHA:647', 'NBS', 1),
(16280, 'ORPHA:647', 'Nijmegen breakage syndrome', 1),
(16281, 'ORPHA:647', 'Seemanova syndrome type 2', 1),
(16282, 'ORPHA:64720', 'Leiomyosarcoma', 1),
(16283, 'ORPHA:64722', 'Granulomatous mastitis', 1),
(16284, 'ORPHA:64722', 'Idiopathic granulomatous mastitis', 1),
(16285, 'ORPHA:64734', 'ICE syndrome', 1),
(16286, 'ORPHA:64734', 'Iridocorneal endothelial syndrome', 1),
(16287, 'ORPHA:64739', 'OHSS', 1),
(16288, 'ORPHA:64739', 'Ovarian hyperstimulation syndrome', 1),
(16289, 'ORPHA:64741', 'Pneumoblastoma', 1),
(16290, 'ORPHA:64741', 'Pulmonary blastoma', 1),
(16291, 'ORPHA:64742', 'Pleuropulmonary blastoma', 1),
(16292, 'ORPHA:64743', 'Hepatoportal sclerosis', 1),
(16293, 'ORPHA:64743', 'Obliterative portal venopathy', 1),
(16294, 'ORPHA:64744', 'IgG4-related thyroid disease', 1),
(16295, 'ORPHA:64744', 'Riedel disease', 1),
(16296, 'ORPHA:64744', 'Riedel thyroiditis', 1),
(16297, 'ORPHA:64745', 'PUPPP', 1),
(16298, 'ORPHA:64745', 'Polymorphic eruption of pregnancy', 1),
(16299, 'ORPHA:64745', 'Pruritic urticarial papules and plaques of pregnancy', 1),
(16300, 'ORPHA:64746', 'Autosomal dominant Charcot-Marie-Tooth disease type 2', 3),
(16301, 'ORPHA:64746', 'Autosomal dominant axonal Charcot-Marie-Tooth disease', 3),
(16302, 'ORPHA:64746', 'CMT2', 3),
(16303, 'ORPHA:64746', 'Hereditary motor and sensory neuropathy type 2', 3),
(16304, 'ORPHA:64747', 'CMTX', 3),
(16305, 'ORPHA:64747', 'X-linked Charcot-Marie-Tooth disease', 3),
(16306, 'ORPHA:64747', 'X-linked hereditary motor and sensory neuropathy', 3),
(16307, 'ORPHA:64748', 'Charcot-Marie-Tooth disease type 3', 1),
(16308, 'ORPHA:64748', 'Dejerine-Sottas syndrome', 1),
(16309, 'ORPHA:64748', 'HMSN 3', 1),
(16310, 'ORPHA:64748', 'HMSN III', 1),
(16311, 'ORPHA:64748', 'Hereditary motor and sensory neuropathy type 3', 1),
(16312, 'ORPHA:64748', 'Hereditary motor and sensory neuropathy type III', 1),
(16313, 'ORPHA:64749', 'AR-CMT1', 3),
(16314, 'ORPHA:64749', 'Autosomal recessive demyelinating Charcot-Marie-Tooth', 3),
(16315, 'ORPHA:64749', 'CMT4', 3),
(16316, 'ORPHA:64749', 'Charcot-Marie-Tooth disease type 4', 3),
(16317, 'ORPHA:64751', 'Charcot-Marie-Tooth disease-pyramidal features syndrome', 1),
(16318, 'ORPHA:64751', 'HMSN 5', 1),
(16319, 'ORPHA:64751', 'HMSN V', 1),
(16320, 'ORPHA:64751', 'Hereditary motor and sensory neuropathy type 5', 1),
(16321, 'ORPHA:64751', 'Hereditary motor and sensory neuropathy type V', 1),
(16322, 'ORPHA:64752', 'Congenital insensitivity to pain and thermal analgesia', 1),
(16323, 'ORPHA:64752', 'HSAN5', 1),
(16324, 'ORPHA:64752', 'Hereditary sensory and autonomic neuropathy type 5', 1),
(16325, 'ORPHA:64752', 'Hereditary sensory and autonomic neuropathy type V', 1),
(16326, 'ORPHA:64753', 'AOA2', 1),
(16327, 'ORPHA:64753', 'Ataxia-oculomotor apraxia type 2', 1),
(16328, 'ORPHA:64753', 'SCAN 2', 1),
(16329, 'ORPHA:64753', 'SCAR1', 1),
(16330, 'ORPHA:64753', 'Spinocerebellar ataxia with axonal neuropathy type 2', 1),
(16331, 'ORPHA:64754', 'Nevus comedonicus syndrome', 1),
(16332, 'ORPHA:64755', 'Becker nevus syndrome', 1),
(16333, 'ORPHA:64755', 'Pigmentary hairy epidermal nevus', 1),
(16334, 'ORPHA:648', 'Noonan syndrome', 1),
(16335, 'ORPHA:649', 'Atrophia bulborum hereditaria', 1),
(16336, 'ORPHA:649', 'Episkopi blindness', 1),
(16337, 'ORPHA:649', 'Norrie disease', 1),
(16338, 'ORPHA:649', 'Norrie-Warburg disease', 1),
(16339, 'ORPHA:65', 'Amaurosis congenita of Leber', 1),
(16340, 'ORPHA:65', 'Leber congenital amaurosis', 1),
(16341, 'ORPHA:650', 'LCAT deficiency', 1),
(16342, 'ORPHA:650', 'Lecithin-cholesterol acyltransferase deficiency', 1),
(16343, 'ORPHA:652', 'MEN1', 1),
(16344, 'ORPHA:652', 'Multiple endocrine neoplasia type 1', 1),
(16345, 'ORPHA:652', 'Wermer syndrome', 1),
(16346, 'ORPHA:65250', 'Perineural cyst', 1),
(16347, 'ORPHA:65250', 'Tarlov cyst', 1),
(16348, 'ORPHA:65282', 'Carvajal syndrome', 1),
(16349, 'ORPHA:65282', 'KWWH type II', 1),
(16350, 'ORPHA:65282', 'Keratoderma with woolly hair type II', 1),
(16351, 'ORPHA:65282', 'Woolly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome', 1),
(16352, 'ORPHA:65282', 'Woolly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome', 1),
(16353, 'ORPHA:65282', 'Wooly hair-palmoplantar hyperkeratosis-dilated cardiomyopathy syndrome', 1),
(16354, 'ORPHA:65282', 'Wooly hair-palmoplantar keratoderma-dilated cardiomyopathy syndrome', 1),
(16355, 'ORPHA:65283', 'LQT8', 1),
(16356, 'ORPHA:65283', 'Long QT syndrome type 8', 1),
(16357, 'ORPHA:65283', 'Long QT syndrome-syndactyly syndrome', 1),
(16358, 'ORPHA:65283', 'Timothy syndrome', 1),
(16359, 'ORPHA:65284', 'BBGD', 1),
(16360, 'ORPHA:65284', 'BTBGD', 1),
(16361, 'ORPHA:65284', 'Biotin-responsive basal ganglia disease', 1),
(16362, 'ORPHA:65284', 'Biotin-thiamine-responsive basal ganglia disease', 1),
(16363, 'ORPHA:65285', 'Dysplastic gangliocytoma of the cerebellum', 1),
(16364, 'ORPHA:65285', 'LDD', 1),
(16365, 'ORPHA:65285', 'Lhermitte-Duclos disease', 1),
(16366, 'ORPHA:65286', '3q subtelomere deletion syndrome', 1),
(16367, 'ORPHA:65286', '3q29 microdeletion syndrome', 1),
(16368, 'ORPHA:65286', '3qter deletion', 1),
(16369, 'ORPHA:65286', 'Del(3)(q29)', 1),
(16370, 'ORPHA:65286', 'Monosomy 3q29', 1),
(16371, 'ORPHA:65286', 'Monosomy 3qter', 1),
(16372, 'ORPHA:65287', 'Beta-alanine synthase deficiency', 1),
(16373, 'ORPHA:65287', 'Beta-ureidopropionase deficiency', 1),
(16374, 'ORPHA:65288', 'Pancreatic and cerebellar agenesis', 1),
(16375, 'ORPHA:65288', 'Permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome', 1),
(16376, 'ORPHA:653', 'MEN2', 1),
(16377, 'ORPHA:653', 'Multiple endocrine neoplasia type 2', 1),
(16378, 'ORPHA:654', 'Nephroblastoma', 1),
(16379, 'ORPHA:654', 'Renal embryonic tumor', 1),
(16380, 'ORPHA:654', 'Wilms tumor', 1),
(16381, 'ORPHA:655', 'Nephronophthisis', 1),
(16382, 'ORPHA:656', 'Familial idiopathic steroid-resistant nephrotic syndrome', 1),
(16383, 'ORPHA:656', 'Genetic SRNS', 1),
(16384, 'ORPHA:656', 'Genetic steroid-resistant nephrotic syndrome', 1),
(16385, 'ORPHA:656', 'Hereditary steroid-resistant nephrotic syndrome', 1),
(16386, 'ORPHA:65681', 'Vaginal atresia', 1),
(16387, 'ORPHA:65682', 'BRIC', 1),
(16388, 'ORPHA:65682', 'Benign recurrent intrahepatic cholestasis', 1),
(16389, 'ORPHA:65682', 'Summerskill-Walshe-Tygstrup syndrome', 1),
(16390, 'ORPHA:65683', 'Epilepsy due to FCD', 1),
(16391, 'ORPHA:65683', 'Isolated focal cortical dysplasia', 1),
(16392, 'ORPHA:65684', 'Benign focal amyotrophy', 1),
(16393, 'ORPHA:65684', 'Hirayama disease', 1),
(16394, 'ORPHA:65684', 'JMADUE', 1),
(16395, 'ORPHA:65684', 'Juvenile muscular atrophy of distal upper extremity', 1),
(16396, 'ORPHA:65684', 'Juvenile muscular atrophy of the distal upper limb', 1),
(16397, 'ORPHA:65684', 'Monomelic amyotrophy', 1),
(16398, 'ORPHA:657', 'CHI', 3),
(16399, 'ORPHA:657', 'Congenital isolated hyperinsulinism', 3),
(16400, 'ORPHA:657', 'PHHI', 3),
(16401, 'ORPHA:657', 'Persistent hyperinsulinemic hypoglycemia of infancy', 3),
(16402, 'ORPHA:65720', 'Arthrogryposis-severe scoliosis syndrome', 1),
(16403, 'ORPHA:65720', 'Distal arthrogryposis type 4', 1),
(16404, 'ORPHA:65720', 'Distal arthrogryposis type IID', 1),
(16405, 'ORPHA:65743', 'Autosomal dominant multiple pterygium syndrome', 1),
(16406, 'ORPHA:65743', 'Distal arthrogryposis type 8', 1),
(16407, 'ORPHA:65748', 'Familial primary self-healing squamous epithelioma of the skin, Ferguson-Smith type', 1),
(16408, 'ORPHA:65748', 'Ferguson-Smith disease', 1),
(16409, 'ORPHA:65748', 'MSSE', 1),
(16410, 'ORPHA:65748', 'Multiple keratoacanthoma, Ferguson-Smith type', 1),
(16411, 'ORPHA:65748', 'Multiple self-healing squamous epithelioma', 1),
(16412, 'ORPHA:65748', 'Self-healing squamous epithelioma type 1', 1),
(16413, 'ORPHA:65753', 'Autosomal dominant demyelinating Charcot-Marie-Tooth disease', 3),
(16414, 'ORPHA:65753', 'CMT1', 3),
(16415, 'ORPHA:65753', 'Charcot-Marie-Tooth disease type 1', 3),
(16416, 'ORPHA:65753', 'Charcot-Marie-Tooth neuropathy type 1', 3),
(16417, 'ORPHA:65753', 'Hereditary motor and sensory neuropathy type 1', 3),
(16418, 'ORPHA:65759', 'ACPS2', 1),
(16419, 'ORPHA:65759', 'Acrocephalopolysyndactyly type 2', 1),
(16420, 'ORPHA:65759', 'Carpenter syndrome', 1),
(16421, 'ORPHA:65798', 'ACPS4', 1),
(16422, 'ORPHA:65798', 'Acrocephalopolysyndactyly type 4', 1),
(16423, 'ORPHA:65798', 'Goodman syndrome', 1),
(16424, 'ORPHA:658', 'Angioneurotic edema', 3),
(16425, 'ORPHA:658', 'Bradykinine-induced angioedema', 3),
(16426, 'ORPHA:658', 'Non histamine-induced angioedema', 3),
(16427, 'ORPHA:658', 'Non-histaminic angioedema', 3),
(16428, 'ORPHA:659', 'Mutilating palmoplantar hyperkeratosis with periorificial keratotic plaques', 1),
(16429, 'ORPHA:659', 'Mutilating palmoplantar keratoderma with periorificial keratotic plaques', 1),
(16430, 'ORPHA:659', 'Olmsted syndrome', 1),
(16431, 'ORPHA:659', 'Palmoplantar and periorificial keratoderma', 1),
(16432, 'ORPHA:660', 'Omphalocele', 1),
(16433, 'ORPHA:661', 'CCHS', 1),
(16434, 'ORPHA:661', 'Central congenital hypoventilation syndrome', 1),
(16435, 'ORPHA:661', 'Congenital central alveolar hypoventilation syndrome', 1),
(16436, 'ORPHA:661', 'Ondine curse', 1),
(16437, 'ORPHA:661', 'Ondine syndrome', 1),
(16438, 'ORPHA:662', 'Lymphedema with yellow nails', 1),
(16439, 'ORPHA:662', 'YNS', 1),
(16440, 'ORPHA:662', 'Yellow nail syndrome', 1),
(16441, 'ORPHA:663', 'Maternally-inherited CPEO', 1),
(16442, 'ORPHA:663', 'Maternally-inherited chronic progressive external ophthalmoplegia', 1),
(16443, 'ORPHA:663', 'Mitochondrial DNA-related progressive external ophthalmoplegia', 1),
(16444, 'ORPHA:663', 'mtDNA-related progressive external ophthalmoplegia', 1),
(16445, 'ORPHA:664', 'OCT deficiency', 1),
(16446, 'ORPHA:664', 'OTC deficiency', 1),
(16447, 'ORPHA:664', 'Ornithine carbamoyltransferase deficiency', 1),
(16448, 'ORPHA:664', 'Ornithine transcarbamylase deficiency', 1),
(16449, 'ORPHA:66518', 'Short fifth metacarpals-insulin resistance syndrome', 1),
(16450, 'ORPHA:66529', 'Ampulla cardiomyopathy', 1),
(16451, 'ORPHA:66529', 'Apical ballooning syndrome', 1),
(16452, 'ORPHA:66529', 'Ballooning cardiomyopathy', 1),
(16453, 'ORPHA:66529', 'Broken heart syndrome', 1),
(16454, 'ORPHA:66529', 'Stress cardiomyopathy', 1),
(16455, 'ORPHA:66529', 'Tako-Tsubo cardiomyopathy', 1),
(16456, 'ORPHA:66529', 'Tako-Tsubo syndrome', 1),
(16457, 'ORPHA:66529', 'Takotsubo cardiomyopathy', 1),
(16458, 'ORPHA:66529', 'Takotsubo syndrome', 1),
(16459, 'ORPHA:66529', 'Transient left ventricular apical ballooning syndrome', 1),
(16460, 'ORPHA:666', 'Brittle bone disease', 1),
(16461, 'ORPHA:666', 'Glass bone disease', 1),
(16462, 'ORPHA:666', 'Lobstein disease', 1),
(16463, 'ORPHA:666', 'OI', 1),
(16464, 'ORPHA:666', 'Osteogenesis imperfecta', 1),
(16465, 'ORPHA:666', 'Osteopsathyrosis', 1),
(16466, 'ORPHA:666', 'Porak and Durante disease', 1),
(16467, 'ORPHA:66624', 'PANDAS', 1),
(16468, 'ORPHA:66624', 'Pediatric autoimmune disorders associated with Streptococcus infections', 1),
(16469, 'ORPHA:66624', 'Pediatric autoimmune neuropsychiatric disorders associated with Streptococcus infections', 1),
(16470, 'ORPHA:66625', 'Cerebrooculonasal syndrome', 1),
(16471, 'ORPHA:66627', 'Diffuse-type GCT', 1),
(16472, 'ORPHA:66627', 'Diffuse-type giant cell tumor', 1),
(16473, 'ORPHA:66627', 'Pigmented villonodular synovitis', 1),
(16474, 'ORPHA:66627', 'TGCT', 1),
(16475, 'ORPHA:66627', 'TSGCT', 1),
(16476, 'ORPHA:66627', 'Tenosynovial giant cell tumor', 1),
(16477, 'ORPHA:66628', 'Obesity due to congenital leptin deficiency', 2),
(16478, 'ORPHA:66629', 'GOSHS', 1),
(16479, 'ORPHA:66629', 'Goldberg-Shprintzen megacolon syndrome', 1),
(16480, 'ORPHA:66629', 'Megacolon-microcephaly syndrome', 1),
(16481, 'ORPHA:66630', 'Congenital pseudarthrosis of the clavicle', 1),
(16482, 'ORPHA:66630', 'Congenital pseudoarthrosis of the clavicle', 1),
(16483, 'ORPHA:66631', 'CEDNIK syndrome', 1),
(16484, 'ORPHA:66631', 'Cerebral dysgenesis-neuropathy-ichthyosis-palmoplantar keratoderma syndrome', 1),
(16485, 'ORPHA:66633', 'Sensorineural deafness-early graying-essential tremor syndrome', 1),
(16486, 'ORPHA:66633', 'Sensorineural hearing loss-early graying-essential tremor syndrome', 1),
(16487, 'ORPHA:66634', '3-methylglutaconic aciduria type 5', 1),
(16488, 'ORPHA:66634', 'DCMA syndrome', 1),
(16489, 'ORPHA:66634', 'Dilated cardiomyopathy with ataxia', 1),
(16490, 'ORPHA:66634', 'MGA5', 1),
(16491, 'ORPHA:66637', 'Diaphanospondylodysostosis', 1),
(16492, 'ORPHA:66646', 'Cutaneous mastocytosis', 3),
(16493, 'ORPHA:66661', 'Mast cell sarcoma', 1),
(16494, 'ORPHA:66662', 'Extracutaneous mastocytoma', 1),
(16495, 'ORPHA:667', 'Autosomal recessive malignant osteopetrosis', 1),
(16496, 'ORPHA:667', 'Infantile malignant osteopetrosis', 1),
(16497, 'ORPHA:668', 'Osteogenic sarcoma', 1),
(16498, 'ORPHA:668', 'Osteosarcoma', 1),
(16499, 'ORPHA:67', 'Amoebiasis due to Entamoeba histolytica', 1),
(16500, 'ORPHA:67036', 'Autosomal dominant optic atrophy and cataract', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(16501, 'ORPHA:67036', 'Autosomal dominant optic atrophy type 3', 1),
(16502, 'ORPHA:67036', 'OPA3, autosomal dominant', 1),
(16503, 'ORPHA:67038', 'B-CLL', 1),
(16504, 'ORPHA:67038', 'B-cell chronic lymphocytic leukemia', 1),
(16505, 'ORPHA:67038', 'B-cell chronic lymphoid leukemia', 1),
(16506, 'ORPHA:67038', 'Small lymphocytic lymphoma', 1),
(16507, 'ORPHA:67039', 'Segmental odontomaxillary dysplasia', 1),
(16508, 'ORPHA:67041', 'Hyaluronidase deficiency', 1),
(16509, 'ORPHA:67041', 'MPS9', 1),
(16510, 'ORPHA:67041', 'MPSIX', 1),
(16511, 'ORPHA:67041', 'Mucopolysaccharidosis type 9', 1),
(16512, 'ORPHA:67041', 'Mucopolysaccharidosis type IX', 1),
(16513, 'ORPHA:67042', 'Autosomal dominant late-onset retinal degeneration', 1),
(16514, 'ORPHA:67042', 'LORD', 1),
(16515, 'ORPHA:67042', 'Late-onset retinal degeneration', 1),
(16516, 'ORPHA:67043', 'Amoebic keratitis', 1),
(16517, 'ORPHA:67044', 'Congenital dyserythropoietic anemia with thombocytopenia', 1),
(16518, 'ORPHA:67044', 'Thrombocytopenia with congenital dyserythropoietic anemia', 1),
(16519, 'ORPHA:67044', 'X-linked congenital dyserythropoietic anemia with thrombocytopenia', 1),
(16520, 'ORPHA:67044', 'XDAT', 1),
(16521, 'ORPHA:67045', 'MRGH', 2),
(16522, 'ORPHA:67045', 'X-linked intellectual disability with isolated growth hormone deficiency', 2),
(16523, 'ORPHA:67046', '3-methylglutaconic aciduria type 1', 1),
(16524, 'ORPHA:67046', '3-methylglutaconyl-CoA hydratase deficiency', 1),
(16525, 'ORPHA:67046', '3MG-CoA hydratase deficiency', 1),
(16526, 'ORPHA:67046', 'MGA1', 1),
(16527, 'ORPHA:67047', '3-methylglutaconic aciduria type 3', 1),
(16528, 'ORPHA:67047', 'Autosomal recessive optic atrophy plus syndrome', 1),
(16529, 'ORPHA:67047', 'Autosomal recessive optic atrophy type 3', 1),
(16530, 'ORPHA:67047', 'Costeff optic atrophy syndrome', 1),
(16531, 'ORPHA:67047', 'Costeff syndrome', 1),
(16532, 'ORPHA:67047', 'Infantile optic atrophy with chorea and spastic paraplegia', 1),
(16533, 'ORPHA:67047', 'MGA3', 1),
(16534, 'ORPHA:67048', '3-methylglutaconic aciduria type 4', 1),
(16535, 'ORPHA:67048', 'MGA4', 1),
(16536, 'ORPHA:671', 'Primary cutis verticis gyrata', 3),
(16537, 'ORPHA:672', 'Hypothalamic hamartoblastoma syndrome', 1),
(16538, 'ORPHA:672', 'Pallister-Hall syndrome', 1),
(16539, 'ORPHA:673', 'Malaria', 1),
(16540, 'ORPHA:674', 'Accessory pancreas', 1),
(16541, 'ORPHA:675', 'Annular pancreas', 1),
(16542, 'ORPHA:676', 'Hereditary chronic pancreatitis', 1),
(16543, 'ORPHA:677', 'Pancreatoblastoma', 1),
(16544, 'ORPHA:678', 'Keratosis palmoplantar-periodontopathy syndrome', 1),
(16545, 'ORPHA:678', 'PLS', 1),
(16546, 'ORPHA:678', 'Papillon-Lefèvre syndrome', 1),
(16547, 'ORPHA:679', 'Degos disease', 1),
(16548, 'ORPHA:679', 'Köhlmeier-Degos disease', 1),
(16549, 'ORPHA:679', 'Köhlmeier-Degos-Delort-Tricort syndrome', 1),
(16550, 'ORPHA:679', 'Malignant atrophic papulosis', 1),
(16551, 'ORPHA:679', 'Papulosis atrophican maligna', 1),
(16552, 'ORPHA:68', 'Amoebiasis due to free-living amoebae', 1),
(16553, 'ORPHA:681', 'Hypokalemic periodic paralysis', 1),
(16554, 'ORPHA:681', 'Westphall disease', 1),
(16555, 'ORPHA:682', 'Adynamia episodica hereditaria', 1),
(16556, 'ORPHA:682', 'Familial hyperPP', 1),
(16557, 'ORPHA:682', 'Familial hyperkalemic periodic paralysis', 1),
(16558, 'ORPHA:682', 'Gamstorp disease', 1),
(16559, 'ORPHA:682', 'Gamstorp episodic adynamy', 1),
(16560, 'ORPHA:682', 'HYPP', 1),
(16561, 'ORPHA:682', 'HyperKPP', 1),
(16562, 'ORPHA:682', 'HyperPP', 1),
(16563, 'ORPHA:682', 'Hyperkalemic PP', 1),
(16564, 'ORPHA:682', 'Hyperkalemic periodic paralysis', 1),
(16565, 'ORPHA:682', 'Primary hyperPP', 1),
(16566, 'ORPHA:682', 'Primary hyperkalemic periodic paralysis', 1),
(16567, 'ORPHA:683', 'PSP syndrome', 1),
(16568, 'ORPHA:683', 'Progressive supranuclear palsy', 1),
(16569, 'ORPHA:68329', 'Rare maxillo-facial surgical disease', 3),
(16570, 'ORPHA:68329', 'Rare maxillofacial anomaly', 3),
(16571, 'ORPHA:68334', 'Rare bleeding disorder due to a constitutional coagulation factors defect', 3),
(16572, 'ORPHA:68334', 'Rare coagulopathy due to a constitutional coagulation factors defect', 3),
(16573, 'ORPHA:68334', 'Rare hemorrhagic disorder due to a constitutional coagulation factors defect', 3),
(16574, 'ORPHA:68335', 'Rare chromosomal anomaly', 3),
(16575, 'ORPHA:68336', 'Rare genetic tumor', 3),
(16576, 'ORPHA:68341', 'Multiple congenital anomalies/dysmorphic syndrome', 3),
(16577, 'ORPHA:68346', 'Rare genetic skin disease', 3),
(16578, 'ORPHA:68346', 'Rare genodermatosis', 3),
(16579, 'ORPHA:68347', 'Tumor of hematopoietic and lymphoid tissues', 3),
(16580, 'ORPHA:68354', 'Rare sleep disorder', 3),
(16581, 'ORPHA:68356', 'Leukodystrophy', 3),
(16582, 'ORPHA:68361', 'Rare deafness', 3),
(16583, 'ORPHA:68361', 'Rare hearing loss', 3),
(16584, 'ORPHA:68362', 'Rare vascular disease', 3),
(16585, 'ORPHA:68363', 'Rare dystonia', 3),
(16586, 'ORPHA:68363', 'Rare dystonic disorder', 3),
(16587, 'ORPHA:68364', 'Hemoglobinopathy', 3),
(16588, 'ORPHA:68366', 'Lysosomal disease', 3),
(16589, 'ORPHA:68367', 'Rare inborn errors of metabolism', 3),
(16590, 'ORPHA:68367', 'Rare metabolic disease', 3),
(16591, 'ORPHA:68373', 'Peroxisomal disease', 3),
(16592, 'ORPHA:68378', 'Congenital limb malformation', 3),
(16593, 'ORPHA:68380', 'Mitochondrial disease', 3),
(16594, 'ORPHA:68381', 'Neuromuscular disease', 3),
(16595, 'ORPHA:68383', 'Rare constitutional aplastic anemia', 3),
(16596, 'ORPHA:68385', 'Neurometabolic disease', 3),
(16597, 'ORPHA:684', 'Paramyotonia congenita', 1),
(16598, 'ORPHA:684', 'Paramyotonia congenita of Von Eulenburg', 1),
(16599, 'ORPHA:68402', 'Rare hypokinetic movement disorder', 3),
(16600, 'ORPHA:68402', 'Rare parkinsonian disorder', 3),
(16601, 'ORPHA:68411', 'Rare bone tumor', 3),
(16602, 'ORPHA:68415', 'Rare parathyroid disease and phosphocalcic metabolism anomaly', 3),
(16603, 'ORPHA:68416', 'Rare infectious disease', 3),
(16604, 'ORPHA:68419', 'Vascular anomaly or angioma', 3),
(16605, 'ORPHA:685', 'Familial spastic paraplegia', 3),
(16606, 'ORPHA:685', 'HSP', 3),
(16607, 'ORPHA:685', 'Hereditary spastic paraparesis', 3),
(16608, 'ORPHA:685', 'Hereditary spastic paraplegia', 3),
(16609, 'ORPHA:685', 'SPG', 3),
(16610, 'ORPHA:685', 'Strümpell-Lorrain disease', 3),
(16611, 'ORPHA:69', 'Amyloidosis', 3),
(16612, 'ORPHA:69028', 'Dysostosis with brachydactyly', 3),
(16613, 'ORPHA:69061', 'Idiopathic steroid-sensitive nephrotic syndrome', 1),
(16614, 'ORPHA:69063', 'Alloimmune neonatal renal disease', 1),
(16615, 'ORPHA:69063', 'Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization', 1),
(16616, 'ORPHA:69063', 'FMAIG', 1),
(16617, 'ORPHA:69063', 'Fetomaternal alloimmunization with antenatal glomerulopathies', 1),
(16618, 'ORPHA:69063', 'Neonatal glomerulopathy due to neprilysin alloimmunization', 1),
(16619, 'ORPHA:69063', 'Neonatal membranous glomerulopathy with maternal NEP deficiency', 1),
(16620, 'ORPHA:69063', 'Neonatal membranous glomerulopathy with maternal neutral endopeptidase deficiency', 1),
(16621, 'ORPHA:69076', 'Familial renal glucosuria', 1),
(16622, 'ORPHA:69076', 'Familial renal glycosuria', 1),
(16623, 'ORPHA:69076', 'SGLT2 deficiency', 1),
(16624, 'ORPHA:69077', 'Malignant rhabdoid tumor', 1),
(16625, 'ORPHA:69077', 'Rhabdoid tumor', 1),
(16626, 'ORPHA:69078', 'Liposarcoma', 1),
(16627, 'ORPHA:69082', 'OTUDP syndrome', 1),
(16628, 'ORPHA:69082', 'Odonto-tricho-ungual-digito-palmar syndrome', 1),
(16629, 'ORPHA:69082', 'Odonto-tricho-ungual-digito-palmar syndrome, Mendoza-Valiente type', 1),
(16630, 'ORPHA:69083', 'Ectodermal dysplasia with natal teeth, Turnpenny type', 1),
(16631, 'ORPHA:69084', 'HNED', 1),
(16632, 'ORPHA:69084', 'Hair-nail ectodermal dysplasia', 1),
(16633, 'ORPHA:69084', 'PHNED', 1),
(16634, 'ORPHA:69084', 'Pure hair and nail ectodermal dysplasia', 1),
(16635, 'ORPHA:69085', 'LMS', 1),
(16636, 'ORPHA:69085', 'Limb-mammary syndrome', 1),
(16637, 'ORPHA:69087', 'NFJ syndrome', 1),
(16638, 'ORPHA:69087', 'Naegeli syndrome', 1),
(16639, 'ORPHA:69087', 'Naegeli-Franceschetti-Jadassohn syndrome', 1),
(16640, 'ORPHA:69088', 'Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome', 1),
(16641, 'ORPHA:69088', 'OL-EDA-ID', 1),
(16642, 'ORPHA:69125', 'Anonychia with flexural pigmentation', 1),
(16643, 'ORPHA:69126', 'FRA', 1),
(16644, 'ORPHA:69126', 'Familial recurrent arthritis', 1),
(16645, 'ORPHA:69126', 'PAPA syndrome', 1),
(16646, 'ORPHA:69126', 'Pyogenic arthritis-pyoderma gangrenosum-acne syndrome', 1),
(16647, 'ORPHA:69663', 'ABCB4-related cholelithiasis', 1),
(16648, 'ORPHA:69663', 'LPAC', 1),
(16649, 'ORPHA:69663', 'Low phospholipid-associated cholelithiasis', 1),
(16650, 'ORPHA:69665', 'Gravidic intrahepatic cholestasis', 1),
(16651, 'ORPHA:69665', 'Intrahepatic cholestasis of pregnancy', 1),
(16652, 'ORPHA:69665', 'Pregnancy-related cholestasis', 1),
(16653, 'ORPHA:69665', 'Recurrent intrahepatic cholestasis of pregnancy', 1),
(16654, 'ORPHA:69723', 'Tyrosinemia due to 4-hydroxyphenylpyruvate dioxygenase deficiency', 1),
(16655, 'ORPHA:69723', 'Tyrosinemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency', 1),
(16656, 'ORPHA:69723', 'Tyrosinemia due to HPD deficiency', 1),
(16657, 'ORPHA:69723', 'Tyrosinemia type 3', 1),
(16658, 'ORPHA:69723', 'Tyrosinemia type III', 1),
(16659, 'ORPHA:69735', 'Hypotrichosis-lymphedema-telangiectasia-membranoproliferative glomerulonephritis syndrome', 1),
(16660, 'ORPHA:69735', 'Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome', 1),
(16661, 'ORPHA:69736', 'BADI', 1),
(16662, 'ORPHA:69736', 'Bilateral acute depigmentation of the iris', 1),
(16663, 'ORPHA:69737', 'Bosley-Salih-Alorainy syndrome', 1),
(16664, 'ORPHA:69739', 'ABSD', 1),
(16665, 'ORPHA:69739', 'Athabascan brainstem dysgenesis syndrome', 1),
(16666, 'ORPHA:69739', 'Athabaskan brainstem dysgenesis syndrome', 1),
(16667, 'ORPHA:69739', 'Navajo brainstem syndrome', 1),
(16668, 'ORPHA:69744', 'Circumscribed palmoplantar hypokeratosis', 1),
(16669, 'ORPHA:69745', 'Follicular dyskeratoma', 1),
(16670, 'ORPHA:69745', 'Warty dyskeratoma', 1),
(16671, 'ORPHA:699', 'Pearson syndrome', 1),
(16672, 'ORPHA:7', '3C syndrome', 1),
(16673, 'ORPHA:7', 'Craniocerebellocardiac dysplasia', 1),
(16674, 'ORPHA:7', 'Ritscher-Schinzel syndrome', 1),
(16675, 'ORPHA:70', 'Proximal spinal muscular atrophy', 1),
(16676, 'ORPHA:70', 'SMA', 1),
(16677, 'ORPHA:700', 'Alopecia totalis', 1),
(16678, 'ORPHA:701', 'Alopecia universalis', 1),
(16679, 'ORPHA:702', 'Diffuse familial brain sclerosis', 1),
(16680, 'ORPHA:702', 'PMD', 1),
(16681, 'ORPHA:702', 'Pelizaeus-Merzbacher brain sclerosis', 1),
(16682, 'ORPHA:702', 'Pelizaeus-Merzbacher disease', 1),
(16683, 'ORPHA:702', 'Sudanophilic leukodystrophy, Paelizeus-Merzbacher type', 1),
(16684, 'ORPHA:703', 'Bullous pemphigoid', 1),
(16685, 'ORPHA:704', 'Pemphigus vulgaris', 1),
(16686, 'ORPHA:70472', 'COX deficiency, French-Canadian type', 1),
(16687, 'ORPHA:70472', 'Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type', 1),
(16688, 'ORPHA:70472', 'Cytochrome C oxidase deficiency, French-Canadian type', 1),
(16689, 'ORPHA:70472', 'Cytochrome oxidase deficiency, Saguenay-Lac-Saint-Jean type', 1),
(16690, 'ORPHA:70472', 'Leigh syndrome, French-Canadian type', 1),
(16691, 'ORPHA:70472', 'Leigh syndrome, Saguenay-Lac-Saint-Jean type', 1),
(16692, 'ORPHA:70472', 'SLSJ-COX deficiency', 1),
(16693, 'ORPHA:70474', 'Cardiomyopathy with hypotonia due to cytochrome C oxidase deficiency', 1),
(16694, 'ORPHA:70474', 'Cardiomyopathy with myopathy due to COX deficiency', 1),
(16695, 'ORPHA:70474', 'Leigh disease with myopathy', 1),
(16696, 'ORPHA:70474', 'Leigh syndrome with cardiomyopathy', 1),
(16697, 'ORPHA:70475', 'Radiation proctitis', 1),
(16698, 'ORPHA:70476', 'Spring catarrh', 1),
(16699, 'ORPHA:70476', 'Vernal keratoconjunctivitis', 1),
(16700, 'ORPHA:70482', 'Carcinoma of esophagus', 3),
(16701, 'ORPHA:70482', 'Esophageal carcinoma', 3),
(16702, 'ORPHA:705', 'Goiter-deafness syndrome', 1),
(16703, 'ORPHA:705', 'Goiter-hearing loss syndrome', 1),
(16704, 'ORPHA:705', 'Pendred syndrome', 1),
(16705, 'ORPHA:70567', 'Bile duct cancer', 1),
(16706, 'ORPHA:70567', 'CCA', 1),
(16707, 'ORPHA:70567', 'Cholangiocarcinoma', 1),
(16708, 'ORPHA:70568', 'PTLD', 1),
(16709, 'ORPHA:70568', 'Post-transplant lymphoproliferative disease', 1),
(16710, 'ORPHA:70573', 'SCLC', 1),
(16711, 'ORPHA:70573', 'Small cell lung cancer', 1),
(16712, 'ORPHA:70578', 'Adult ARDS', 1),
(16713, 'ORPHA:70578', 'Adult acute respiratory distress syndrome', 1),
(16714, 'ORPHA:70587', 'Hyaline membrane disease', 1),
(16715, 'ORPHA:70587', 'Infant ARDS', 1),
(16716, 'ORPHA:70587', 'Infant acute respiratory distress syndrome', 1),
(16717, 'ORPHA:70587', 'Infant respiratory distress syndrome', 1),
(16718, 'ORPHA:70587', 'Neonatal respiratory distress syndrome', 1),
(16719, 'ORPHA:70588', 'Meconium aspiration syndrome', 1),
(16720, 'ORPHA:70589', 'BPD', 1),
(16721, 'ORPHA:70589', 'Bronchopulmonary dysplasia', 1),
(16722, 'ORPHA:70590', 'Apnea of infancy', 1),
(16723, 'ORPHA:70590', 'Infantile apnea', 1),
(16724, 'ORPHA:70591', 'CTEPH', 1),
(16725, 'ORPHA:70591', 'Chronic thromboembolic pulmonary hypertension', 1),
(16726, 'ORPHA:70592', 'IRAK4 deficiency', 1),
(16727, 'ORPHA:70592', 'Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency', 1),
(16728, 'ORPHA:70593', 'Immunodeficiency due to selective anti-polysaccharide antibody deficiency', 1),
(16729, 'ORPHA:70593', 'Specific anti-polysaccharide antibody deficiency', 1),
(16730, 'ORPHA:70594', 'Autosomal recessive sepiapterin reductase-deficient DRD', 1),
(16731, 'ORPHA:70594', 'DRD due to SRD', 1),
(16732, 'ORPHA:70594', 'Dopa-responsive dystonia due to sepiapterin reductase deficiency', 1),
(16733, 'ORPHA:70594', 'SPR deficiency', 1),
(16734, 'ORPHA:70594', 'Sepiapterin reductase deficiency', 1),
(16735, 'ORPHA:70595', 'SANDO', 1),
(16736, 'ORPHA:70595', 'Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome', 1),
(16737, 'ORPHA:70596', 'Antenatal EBV infection', 1),
(16738, 'ORPHA:70596', 'Antenatal Epstein-Barr virus infection', 1),
(16739, 'ORPHA:70596', 'Congenital EBV infection', 1),
(16740, 'ORPHA:70596', 'Congenital Epstein-Barr virus infection', 1),
(16741, 'ORPHA:70596', 'Mother-to-child transmission of Epstein-Barr virus infection', 1),
(16742, 'ORPHA:707', 'Plague', 1),
(16743, 'ORPHA:707', 'Yersiniosis', 1),
(16744, 'ORPHA:708', 'Peters anomaly', 1),
(16745, 'ORPHA:708', 'Peters congenital glaucoma', 1),
(16746, 'ORPHA:709', 'Krause-Kivlin syndrome', 1),
(16747, 'ORPHA:709', 'Krause-van Schooneveld-Kivlin syndrome', 1),
(16748, 'ORPHA:709', 'Peters anomaly with short limb dwarfism', 1),
(16749, 'ORPHA:709', 'Peters plus syndrome', 1),
(16750, 'ORPHA:71', 'Anderson disease', 1),
(16751, 'ORPHA:71', 'CMRD', 1),
(16752, 'ORPHA:71', 'CRD', 1),
(16753, 'ORPHA:71', 'Chylomicron retention disease', 1),
(16754, 'ORPHA:710', 'ACS5', 1),
(16755, 'ORPHA:710', 'Acrocephalosyndactyly type 5', 1),
(16756, 'ORPHA:710', 'Pfeiffer syndrome', 1),
(16757, 'ORPHA:71198', 'Rare pulmonary hypertension', 3),
(16758, 'ORPHA:712', 'Hemolytic anemia due to glucophosphate isomerase deficiency', 1),
(16759, 'ORPHA:71202', 'Rare bleeding disorder due to a constitutional platelet anomaly', 3),
(16760, 'ORPHA:71202', 'Rare bleeding disorder due to a constitutional thrombopathy and/or thrombocytopenia', 3),
(16761, 'ORPHA:71202', 'Rare coagulopathy due to a constitutional platelet anomaly', 3),
(16762, 'ORPHA:71202', 'Rare coagulopathy due to a constitutional thrombopathy and/or thrombocytopenia', 3),
(16763, 'ORPHA:71202', 'Rare hemorrhagic disorder due to a constitutional platelet anomaly', 3),
(16764, 'ORPHA:71202', 'Rare hemorrhagic disorder due to a constitutional thrombopathy and/or thrombocytopenia', 3),
(16765, 'ORPHA:71203', 'Autoimmune thrombocytopenia', 3),
(16766, 'ORPHA:71209', 'Rare mesenchymal tumor', 3),
(16767, 'ORPHA:71209', 'Rare soft tissue tumor', 3),
(16768, 'ORPHA:71211', 'Devic disease', 1),
(16769, 'ORPHA:71211', 'NMOSD', 1),
(16770, 'ORPHA:71211', 'Neuromyelitis optica spectrum disorder', 1),
(16771, 'ORPHA:71212', 'Hyperinsulinemic hypoglycemia due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency', 1),
(16772, 'ORPHA:71212', 'Hyperinsulinism due to SCHAD deficiency', 1),
(16773, 'ORPHA:71212', 'Hyperinsulinism due to glutamodehydrogenase deficiency', 1),
(16774, 'ORPHA:71212', 'Hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency', 1),
(16775, 'ORPHA:71212', 'SCHAD deficiency', 1),
(16776, 'ORPHA:71213', 'Retinal capillary malformation', 1),
(16777, 'ORPHA:71267', 'Dentinogenesis imperfecta-short stature-deafness-intellectual disability syndrome', 1),
(16778, 'ORPHA:71267', 'Dentinogenesis imperfecta-short stature-hearing loss-intellectual disability syndrome', 1),
(16779, 'ORPHA:71271', 'Split hand-split foot-deafness syndrome', 1),
(16780, 'ORPHA:71271', 'Split hand-split foot-hearing loss syndrome', 1),
(16781, 'ORPHA:71272', 'Sandifer syndrome', 1),
(16782, 'ORPHA:71273', 'Left renal vein entrapment syndrome', 1),
(16783, 'ORPHA:71273', 'RNS', 1),
(16784, 'ORPHA:71273', 'Renal nutcracker syndrome', 1),
(16785, 'ORPHA:71274', 'DPL', 1),
(16786, 'ORPHA:71274', 'Diffuse peritoneal leiomyomatosis', 1),
(16787, 'ORPHA:71274', 'Disseminated peritoneal leiomyomatosis', 1),
(16788, 'ORPHA:71274', 'LPD', 1),
(16789, 'ORPHA:71274', 'Leiomyomatosis peritonealis disseminate', 1),
(16790, 'ORPHA:71275', 'Rh deficiency syndrome', 1),
(16791, 'ORPHA:71275', 'Rh-null syndrome', 1),
(16792, 'ORPHA:71276', 'Imploding antrum syndrome', 1),
(16793, 'ORPHA:71276', 'Silent sinus syndrome', 1),
(16794, 'ORPHA:71277', 'Classic GLUT1 deficiency syndrome', 1),
(16795, 'ORPHA:71277', 'Classic GLUT1-DS', 1),
(16796, 'ORPHA:71277', 'Classic glucose transporter type 1 deficiency syndrome', 1),
(16797, 'ORPHA:71277', 'De Vivo disease', 1),
(16798, 'ORPHA:71277', 'Encephalopathy due to GLUT1 deficiency', 1),
(16799, 'ORPHA:71278', 'Congenital brain dysgenesis due to glutamine synthetase deficiency', 1),
(16800, 'ORPHA:71278', 'Inherited GS deficiency', 1),
(16801, 'ORPHA:71278', 'Inherited glutamine synthetase deficiency', 1),
(16802, 'ORPHA:71279', 'CANDA syndrome', 1),
(16803, 'ORPHA:71279', 'CANOMAD syndrome', 1),
(16804, 'ORPHA:71279', 'Chronic ataxic neuropathy-ophthalmoplegia-IgM paraprotein-cold agglutinins-disialosyl antibodies syndrome', 1),
(16805, 'ORPHA:71279', 'Chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies', 1),
(16806, 'ORPHA:71281', 'Rare central nervous system and retinal vascular disease', 3),
(16807, 'ORPHA:71289', 'ATRUS syndrome', 1),
(16808, 'ORPHA:71289', 'Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome', 1),
(16809, 'ORPHA:71290', 'FPD/AML', 1),
(16810, 'ORPHA:71290', 'FPDMM', 1),
(16811, 'ORPHA:71290', 'FPS/AML', 1),
(16812, 'ORPHA:71290', 'Familial platelet disorder with associated myeloid malignancy', 1),
(16813, 'ORPHA:71290', 'Familial platelet disorder with predisposition to acute myelogenous leukemia', 1),
(16814, 'ORPHA:71290', 'Familial platelet disorder with predisposition to myeloid malignancy', 1),
(16815, 'ORPHA:71290', 'Familial platelet disorder with propensity to acute myeloid leukemia', 1),
(16816, 'ORPHA:71290', 'Familial thrombocytopenia with propensity to acute myelogenous leukemia', 1),
(16817, 'ORPHA:713', 'GSD due to phosphoglycerate kinase 1 deficiency', 1),
(16818, 'ORPHA:713', 'Glycogen storage disease due to phosphoglycerate kinase 1 deficiency', 1),
(16819, 'ORPHA:713', 'Glycogenosis due to phosphoglycerate kinase 1 deficiency', 1),
(16820, 'ORPHA:714', 'Hemolytic anemia due to diphosphoglycerate mutase deficiency', 1),
(16821, 'ORPHA:71493', 'Familial thrombocythemia', 1),
(16822, 'ORPHA:71493', 'Familial thrombocytosis', 1),
(16823, 'ORPHA:71493', 'Hereditary thrombocythemia', 1),
(16824, 'ORPHA:715', 'GSD due to muscle phosphorylase kinase deficiency', 1),
(16825, 'ORPHA:715', 'GSD type 9D', 1),
(16826, 'ORPHA:715', 'GSD type 9E', 1),
(16827, 'ORPHA:715', 'GSD type IXd', 1),
(16828, 'ORPHA:715', 'GSD type IXe', 1),
(16829, 'ORPHA:715', 'Glycogen storage disease due to muscle phosphorylase kinase deficiency', 1),
(16830, 'ORPHA:715', 'Glycogen storage disease type 9D', 1),
(16831, 'ORPHA:715', 'Glycogen storage disease type 9E', 1),
(16832, 'ORPHA:715', 'Glycogen storage disease type IXd', 1),
(16833, 'ORPHA:715', 'Glycogen storage disease type IXe', 1),
(16834, 'ORPHA:715', 'Glycogenosis due to muscle phosphorylase kinase deficiency', 1),
(16835, 'ORPHA:715', 'Glycogenosis type 9D', 1),
(16836, 'ORPHA:715', 'Glycogenosis type 9E', 1),
(16837, 'ORPHA:715', 'Glycogenosis type IXd', 1),
(16838, 'ORPHA:715', 'Glycogenosis type IXe', 1),
(16839, 'ORPHA:71505', 'CAR syndrome', 1),
(16840, 'ORPHA:71505', 'Cancer-associated retinopathy', 1),
(16841, 'ORPHA:71505', 'Paraneoplastic retinopathy', 1),
(16842, 'ORPHA:71517', 'DYT12', 1),
(16843, 'ORPHA:71517', 'Dystonia 12', 1),
(16844, 'ORPHA:71517', 'Rapid-onset dystonia-parkinsonism', 1),
(16845, 'ORPHA:71518', 'Benign paroxysmal torticollis of infancy', 1),
(16846, 'ORPHA:71519', 'Psychogenic dystonia', 1),
(16847, 'ORPHA:71519', 'Psychogenic movement disorders', 1),
(16848, 'ORPHA:71526', 'Obesity due to pro-opiomelanocortin deficiency', 2),
(16849, 'ORPHA:71526', 'POMC deficiency', 2),
(16850, 'ORPHA:71528', 'Obesity due to prohormone convertase I deficiency', 2),
(16851, 'ORPHA:71528', 'PCI deficiency', 2),
(16852, 'ORPHA:71529', 'MC4R deficiency', 2),
(16853, 'ORPHA:71529', 'Obesity due to melanocortin 4 receptor deficiency', 2),
(16854, 'ORPHA:716', 'PAH deficiency', 1),
(16855, 'ORPHA:716', 'PKU', 1),
(16856, 'ORPHA:716', 'Phenylalanine hydroxylase deficiency', 1),
(16857, 'ORPHA:716', 'Phenylketonuria', 1),
(16858, 'ORPHA:718', 'Isolated Pierre Robin sequence', 1),
(16859, 'ORPHA:718', 'Isolated Pierre Robin syndrome', 1),
(16860, 'ORPHA:71859', 'Rare genetic neurological disorder', 3),
(16861, 'ORPHA:71862', 'Inherited retinal disorder', 3),
(16862, 'ORPHA:71862', 'Retinal dystrophy', 3),
(16863, 'ORPHA:71864', 'Muscular channelopathy', 3),
(16864, 'ORPHA:72', 'Angelman syndrome', 1),
(16865, 'ORPHA:720', 'Pili bifurcati', 1),
(16866, 'ORPHA:721', 'Alpha storage pool deficiency', 1),
(16867, 'ORPHA:721', 'GPS', 1),
(16868, 'ORPHA:721', 'Gray platelet syndrome', 1),
(16869, 'ORPHA:721', 'Platelet alpha-granule deficiency', 1),
(16870, 'ORPHA:722', 'Hypoplasminogenemia', 1),
(16871, 'ORPHA:722', 'Plasminogen deficiency type 1', 1),
(16872, 'ORPHA:723', 'Pneumocystosis', 1),
(16873, 'ORPHA:724', 'IAEP', 1),
(16874, 'ORPHA:724', 'Idiopathic acute eosinophilic pneumonia', 1),
(16875, 'ORPHA:725', 'CSWS', 1),
(16876, 'ORPHA:725', 'CSWSS syndrome', 1),
(16877, 'ORPHA:725', 'Continuous spikes and waves during sleep', 1),
(16878, 'ORPHA:725', 'Continuous spikes and waves during slow-wave sleep', 1),
(16879, 'ORPHA:725', 'Epileptic encephalopathy with continuous spike-and-wave during slow sleep', 1),
(16880, 'ORPHA:726', 'Alpers progressive sclerosing poliodystrophy', 1),
(16881, 'ORPHA:726', 'Alpers syndrome', 1),
(16882, 'ORPHA:726', 'Alpers-Huttenlocher syndrome', 1),
(16883, 'ORPHA:726', 'Progressive neuronal degeneration of childhood with liver disease', 1),
(16884, 'ORPHA:727', 'MPA', 1),
(16885, 'ORPHA:727', 'Micropolyangiitis', 1),
(16886, 'ORPHA:727', 'Microscopic polyangiitis', 1),
(16887, 'ORPHA:727', 'Microscopic polyarteritis', 1),
(16888, 'ORPHA:728', 'Polychondropathia', 1),
(16889, 'ORPHA:728', 'Relapsing polychondritis', 1),
(16890, 'ORPHA:729', 'Acquired primary erythrocytosis', 1),
(16891, 'ORPHA:729', 'Osler-Vaquez disease', 1),
(16892, 'ORPHA:729', 'PV', 1),
(16893, 'ORPHA:729', 'Polycythemia rubra vera', 1),
(16894, 'ORPHA:729', 'Polycythemia vera', 1),
(16895, 'ORPHA:729', 'Vaquez disease', 1),
(16896, 'ORPHA:73', 'Gorham disease', 1),
(16897, 'ORPHA:73', 'Gorham syndrome', 1),
(16898, 'ORPHA:73', 'Gorham-Stout disease', 1),
(16899, 'ORPHA:73', 'Idiopathic massive osteolysis', 1),
(16900, 'ORPHA:73', 'Progressive massive osteolysis', 1),
(16901, 'ORPHA:73', 'Vanishing bone disease', 1),
(16902, 'ORPHA:730', 'ADPKD', 1),
(16903, 'ORPHA:730', 'Autosomal dominant polycystic kidney disease', 1),
(16904, 'ORPHA:73014', 'IDI', 3),
(16905, 'ORPHA:73014', 'Intractable diarrhea of infancy', 3),
(16906, 'ORPHA:731', 'AR-PKD', 1),
(16907, 'ORPHA:731', 'Autosomal recessive polycystic kidney disease', 1),
(16908, 'ORPHA:732', 'Polymyositis', 1),
(16909, 'ORPHA:73217', 'Aplasia of the Müllerian ducts', 3),
(16910, 'ORPHA:73217', 'Müllerian aplasia', 3),
(16911, 'ORPHA:73217', 'Müllerian duct failure', 3),
(16912, 'ORPHA:73220', 'X-linked intellectual disability-hypotonic face syndrome', 3),
(16913, 'ORPHA:73223', 'Global developmental delay-osteopenia-ectodermal defect syndrome', 1),
(16914, 'ORPHA:73224', 'Tubular renal disease-cardiomyopathy syndrome', 1),
(16915, 'ORPHA:73229', 'Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome', 1),
(16916, 'ORPHA:73229', 'HANAC syndrome', 1),
(16917, 'ORPHA:73229', 'Hereditary angiopathy-nephropathy-aneurysms-muscle cramps syndrome', 1),
(16918, 'ORPHA:73230', 'Ossification anomalies-psychomotor developmental delay syndrome', 1),
(16919, 'ORPHA:73245', 'Spinal muscular atrophy-Dandy-Walker malformation-cataracts syndrome', 1),
(16920, 'ORPHA:73246', 'Visceral neuropathy-brain anomalies-facial dysmorphism-developmental delay syndrome', 1),
(16921, 'ORPHA:73247', 'EoE', 1),
(16922, 'ORPHA:73247', 'Eosinophilic esophagitis', 1),
(16923, 'ORPHA:73256', 'Central neurocytoma', 1),
(16924, 'ORPHA:73260', 'Paracoccidioidomycosis', 1),
(16925, 'ORPHA:73263', 'Mucormycosis', 1),
(16926, 'ORPHA:73263', 'Zygomycosis', 1),
(16927, 'ORPHA:73267', 'Hypernychthemeral syndrome', 1),
(16928, 'ORPHA:73267', 'Non-24-hour sleep-wake syndrome', 1),
(16929, 'ORPHA:73271', 'Bleeding diathesis due to a collagen receptor defect', 1),
(16930, 'ORPHA:73272', 'Growth delay due to insulin-like growth factor type 1 deficiency', 1),
(16931, 'ORPHA:73272', 'Growth delay-deafness-intellectual disability syndrome', 1),
(16932, 'ORPHA:73272', 'Growth delay-hearing loss-intellectual disability syndrome', 1),
(16933, 'ORPHA:73272', 'IGF-1 deficiency', 1),
(16934, 'ORPHA:73272', 'Primary insulin-like growth factor deficiency', 1),
(16935, 'ORPHA:73273', 'Growth delay due to insulin-like growth factor I resistance', 1),
(16936, 'ORPHA:73273', 'Resistance to IGF-1', 1),
(16937, 'ORPHA:73274', 'Acquired hemophilia', 1),
(16938, 'ORPHA:733', 'Colorectal adenomatous polyposis', 1),
(16939, 'ORPHA:733', 'FAP', 1),
(16940, 'ORPHA:733', 'Familial adenomatous polyposis', 1),
(16941, 'ORPHA:733', 'Familial polyposis coli', 1),
(16942, 'ORPHA:734', 'Alpha delta granule deficiency', 1),
(16943, 'ORPHA:734', 'Alpha dense granule deficiency', 1),
(16944, 'ORPHA:734', 'Combined alpha-delta platelet storage pool deficiency', 1),
(16945, 'ORPHA:73423', 'Acute ackee fruit intoxication', 1),
(16946, 'ORPHA:73423', 'Acute intoxication by Blighia sapida', 1),
(16947, 'ORPHA:73423', 'Jamaican vomiting sickness', 1),
(16948, 'ORPHA:73423', 'Jamaican vomiting syndrome', 1),
(16949, 'ORPHA:735', 'Porokeratosis of Mibelli', 1),
(16950, 'ORPHA:737', 'Palmar, plantar and disseminated porokeratosis', 1),
(16951, 'ORPHA:737', 'Porokeratosis plantaris palmaris et disseminata', 1),
(16952, 'ORPHA:738', 'Porphyria', 3),
(16953, 'ORPHA:739', 'Prader-Labhart-Willi syndrome', 1),
(16954, 'ORPHA:739', 'Prader-Willi syndrome', 1),
(16955, 'ORPHA:74', 'Angiostrongyliasis', 1),
(16956, 'ORPHA:740', 'HGPS', 1),
(16957, 'ORPHA:740', 'Hutchinson-Gilford progeria syndrome', 1),
(16958, 'ORPHA:740', 'Progeria', 1),
(16959, 'ORPHA:741', 'Familial mitral valve prolapse', 1),
(16960, 'ORPHA:742', 'Hyperimidodipeptiduria', 1),
(16961, 'ORPHA:742', 'Prolidase deficiency', 1),
(16962, 'ORPHA:743', 'Autosomal recessive thrombophilia due to congenital protein S deficiency', 1),
(16963, 'ORPHA:743', 'Severe hereditary thrombophilia due to congenital protein S deficiency', 1),
(16964, 'ORPHA:744', 'Partial gigantism-nevi-hemihypertrophy-macrocephaly syndrome', 1),
(16965, 'ORPHA:744', 'Proteus syndrome', 1),
(16966, 'ORPHA:745', 'Autosomal recessive thrombophilia due to PC deficiency', 1),
(16967, 'ORPHA:745', 'Autosomal recessive thrombophilia due to congenital protein C deficiency', 1),
(16968, 'ORPHA:745', 'Severe hereditary thrombophilia due to congenital protein C deficiency', 1),
(16969, 'ORPHA:746', 'Mitochondrial trifunctional protein deficiency', 1),
(16970, 'ORPHA:746', 'TFP deficiency', 1),
(16971, 'ORPHA:746', 'TFPD', 1),
(16972, 'ORPHA:747', 'Autoimmune PAP', 1),
(16973, 'ORPHA:747', 'Autoimmune pulmonary alveolar proteinosis', 1),
(16974, 'ORPHA:747', 'Idiopathic PAP', 1),
(16975, 'ORPHA:747', 'Idiopathic pulmonary alveolar proteinosis', 1),
(16976, 'ORPHA:747', 'aPAP', 1),
(16977, 'ORPHA:747', 'iPAP', 1),
(16978, 'ORPHA:748', 'Idiopathic infection caused by BCG or atypical mycobacteria', 3),
(16979, 'ORPHA:748', 'MSMD', 3),
(16980, 'ORPHA:748', 'Mendelian susceptibility to atypical mycobacteria', 3),
(16981, 'ORPHA:748', 'Mendelian susceptibility to mycobacterial diseases', 3),
(16982, 'ORPHA:748', 'Mendelian susceptibility to mycobacterial infections', 3),
(16983, 'ORPHA:749', 'Congenital prekallikrein deficiency', 1),
(16984, 'ORPHA:750', 'Pseudoachondroplasia', 1),
(16985, 'ORPHA:750', 'Pseudoachondroplastic dysplasia', 1),
(16986, 'ORPHA:750', 'Pseudoachondroplastic spondyloepiphyseal dysplasia', 1),
(16987, 'ORPHA:75110', 'Myiasis', 3),
(16988, 'ORPHA:752', '17-beta-hydroxysteroid dehydrogenase 3 deficiency', 1),
(16989, 'ORPHA:752', '17-ketoreductase deficiency', 1),
(16990, 'ORPHA:752', '17-ketosteroidreductase deficiency', 1),
(16991, 'ORPHA:752', '46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency', 1),
(16992, 'ORPHA:75233', 'Wolman disease', 2),
(16993, 'ORPHA:75234', 'Cholesterol ester storage disease', 2),
(16994, 'ORPHA:75234', 'Cholesteryl ester storage disease', 2),
(16995, 'ORPHA:75249', 'Familial isolated restrictive cardiomyopathy', 1),
(16996, 'ORPHA:75249', 'Familial or idiopathic restrictive cardiomyopathy', 1),
(16997, 'ORPHA:753', '46,XY DSD due to 5-alpha-reductase 2 deficiency', 1),
(16998, 'ORPHA:753', '46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency', 1),
(16999, 'ORPHA:753', 'Pseudovaginal perineoscrotal hypospadias', 1),
(17000, 'ORPHA:753', 'Steroid 5-alpha-reductase deficiency', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(17001, 'ORPHA:75325', 'Osteosclerosis-ichthyosis-premature ovarian failure syndrome', 1),
(17002, 'ORPHA:75325', 'Sclerosing dysplasia of bone-ichthyosis-premature ovarian failure syndrome', 1),
(17003, 'ORPHA:75326', 'Retinal arterial tortuosity', 1),
(17004, 'ORPHA:75326', 'Retinal arteriolar tortuosity', 1),
(17005, 'ORPHA:75326', 'Retinal hemorrhage with vascular tortuosity', 1),
(17006, 'ORPHA:75326', 'Tortuosity of retinal arteries', 1),
(17007, 'ORPHA:75327', 'CAPE dystrophy', 1),
(17008, 'ORPHA:75327', 'CAPED', 1),
(17009, 'ORPHA:75327', 'Central areolar pigment epithelial dystrophy', 1),
(17010, 'ORPHA:75327', 'Central retinal pigment epithelial dystrophy', 1),
(17011, 'ORPHA:75327', 'MCDR1', 1),
(17012, 'ORPHA:75327', 'NCMD', 1),
(17013, 'ORPHA:75327', 'North Carolina macular dystrophy', 1),
(17014, 'ORPHA:75327', 'North Carolina macular dystrophy, retinal 1', 1),
(17015, 'ORPHA:75327', 'Progressive foveal dystrophy', 1),
(17016, 'ORPHA:75373', 'CRAPB', 1),
(17017, 'ORPHA:75373', 'PBCRA', 1),
(17018, 'ORPHA:75373', 'Progressive bifocal chorioretinal atrophy', 1),
(17019, 'ORPHA:75374', 'Bradyopsia', 1),
(17020, 'ORPHA:75374', 'PERRS', 1),
(17021, 'ORPHA:75374', 'Prolonged electroretinal response suppression', 1),
(17022, 'ORPHA:75376', 'DHRD', 1),
(17023, 'ORPHA:75376', 'Dominant drusen', 1),
(17024, 'ORPHA:75376', 'Dominant radial drusen', 1),
(17025, 'ORPHA:75376', 'Doyne honeycomb retinal dystrophy', 1),
(17026, 'ORPHA:75376', 'Familial drusen', 1),
(17027, 'ORPHA:75376', 'Malattia leventinese', 1),
(17028, 'ORPHA:75377', 'Areolar atrophy of the macula', 1),
(17029, 'ORPHA:75377', 'CACD', 1),
(17030, 'ORPHA:75377', 'Central areolar choroidal dystrophy', 1),
(17031, 'ORPHA:75377', 'Central areolar choroidal sclerosis', 1),
(17032, 'ORPHA:75378', 'Oligocone syndrome', 1),
(17033, 'ORPHA:75378', 'Oligocone trichromacy', 1),
(17034, 'ORPHA:75381', 'Autosomal dominant cystoid macular edema', 1),
(17035, 'ORPHA:75381', 'Cystoid macular dystrophy', 1),
(17036, 'ORPHA:75381', 'DCMD', 1),
(17037, 'ORPHA:75381', 'Familial macular edema', 1),
(17038, 'ORPHA:75382', 'Congenital stationary night blindness, Oguchi type', 1),
(17039, 'ORPHA:75382', 'Oguchi disease', 1),
(17040, 'ORPHA:75382', 'Oguchi syndrome', 1),
(17041, 'ORPHA:75389', 'Brain malformation-congenital heart disease-postaxial polydactyly syndrome', 1),
(17042, 'ORPHA:75389', 'Goossens-Devriendt syndrome', 1),
(17043, 'ORPHA:75391', 'Primary immunodeficiency due to MCM4 deficiency', 1),
(17044, 'ORPHA:75391', 'Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency', 1),
(17045, 'ORPHA:75392', 'EDS VIII', 1),
(17046, 'ORPHA:75392', 'Ehlers-Danlos syndrome type 8', 1),
(17047, 'ORPHA:75392', 'Ehlers-Danlos syndrome, periodontitis type', 1),
(17048, 'ORPHA:75392', 'Periodontal Ehlers-Danlos syndrome', 1),
(17049, 'ORPHA:75392', 'pEDS', 1),
(17050, 'ORPHA:754', 'AIS', 3),
(17051, 'ORPHA:754', 'Androgen insensitivity syndrome', 3),
(17052, 'ORPHA:754', 'Androgen resistance syndrome', 3),
(17053, 'ORPHA:754', 'Goldberg-Maxwell syndrome', 3),
(17054, 'ORPHA:754', 'Morris syndrome', 3),
(17055, 'ORPHA:754', 'Testicular feminization syndrome', 3),
(17056, 'ORPHA:75496', 'B4GALT7-related spondylodysplastic EDS', 2),
(17057, 'ORPHA:75496', 'B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome', 2),
(17058, 'ORPHA:75496', 'EDS progeroid type 1', 2),
(17059, 'ORPHA:75496', 'EDS with short stature and limb anomalies', 2),
(17060, 'ORPHA:75496', 'spEDS-B4GALT7', 2),
(17061, 'ORPHA:75497', 'EDS V', 1),
(17062, 'ORPHA:75497', 'Ehlers-Danlos syndrome type 5', 1),
(17063, 'ORPHA:75497', 'X-linked Ehlers-Danlos syndrome', 1),
(17064, 'ORPHA:755', '46,XY DSD due to LH resistance or LHB deficiency', 1),
(17065, 'ORPHA:755', '46,XY DSD due to luteinizing hormone resistance or luteinizing hormone beta subunit deficiency', 1),
(17066, 'ORPHA:755', '46,XY disorder of sex development due to LH resistance or LHB deficiency', 1),
(17067, 'ORPHA:755', '46,XY disorder of sex development due to luteinizing hormone resistance or luteinizing hormone beta subunit deficiency', 1),
(17068, 'ORPHA:755', 'Leydig cell hypoplasia', 1),
(17069, 'ORPHA:75508', 'Angioosteohypotrophic syndrome', 1),
(17070, 'ORPHA:75508', 'Phlebectatic osteohypoplastic angiodysplasia', 1),
(17071, 'ORPHA:75508', 'Servelle-Martorell syndrome', 1),
(17072, 'ORPHA:75563', 'X-linked sideroblastic anemia', 1),
(17073, 'ORPHA:75563', 'XLSA', 1),
(17074, 'ORPHA:75564', 'AISA', 1),
(17075, 'ORPHA:75564', 'Acquired idiopathic sideroblastic anemia', 1),
(17076, 'ORPHA:75564', 'Primary acquired sideroblastic anemia', 1),
(17077, 'ORPHA:75564', 'RARS', 1),
(17078, 'ORPHA:75564', 'Refractory anemia with ringed sideroblasts', 1),
(17079, 'ORPHA:75565', 'Davies disease', 1),
(17080, 'ORPHA:75565', 'TEMF', 1),
(17081, 'ORPHA:75565', 'Tropical endomyocardial fibrosis', 1),
(17082, 'ORPHA:75566', 'Eosinophilic endocarditis', 1),
(17083, 'ORPHA:75566', 'Loeffler endocarditis', 1),
(17084, 'ORPHA:75567', 'PPFG', 1),
(17085, 'ORPHA:75567', 'Primary progressive freezing gait', 1),
(17086, 'ORPHA:756', 'PHA type 1', 1),
(17087, 'ORPHA:756', 'Pseudohypoaldosteronism type 1', 1),
(17088, 'ORPHA:757', 'Chloride shunt syndrome', 1),
(17089, 'ORPHA:757', 'Familial hyperkalemic hypertension', 1),
(17090, 'ORPHA:757', 'Gordon hyperkalemia-hypertension syndrome', 1),
(17091, 'ORPHA:757', 'Hyperkalemia-hypertension syndrome, Gordon type', 1),
(17092, 'ORPHA:757', 'Hypertensive hyperkalemia', 1),
(17093, 'ORPHA:757', 'Mineralocorticoid resistant hyperkalemia', 1),
(17094, 'ORPHA:757', 'PHA2', 1),
(17095, 'ORPHA:757', 'PHAII', 1),
(17096, 'ORPHA:757', 'Pseudohypoaldosteronism type 2', 1),
(17097, 'ORPHA:757', 'Spitzer-Weinstein syndrome', 1),
(17098, 'ORPHA:758', 'Gronblad-Strandberg-Touraine syndrome', 1),
(17099, 'ORPHA:758', 'PXE', 1),
(17100, 'ORPHA:758', 'Pseudoxanthoma elasticum', 1),
(17101, 'ORPHA:75840', 'Congenital muscular dystrophy, Ullrich type', 1),
(17102, 'ORPHA:75840', 'Scleroatonic muscular dystrophy', 1),
(17103, 'ORPHA:75840', 'UCMD', 1),
(17104, 'ORPHA:75840', 'Ullrich disease', 1),
(17105, 'ORPHA:75857', '6q terminal deletion syndrome', 1),
(17106, 'ORPHA:75858', 'Intellectual disability-truncal obesity-retinal dystrophy-micropenis syndrome', 1),
(17107, 'ORPHA:75858', 'MORM syndrome', 1),
(17108, 'ORPHA:759', 'CPP', 1),
(17109, 'ORPHA:759', 'Central precocious puberty', 1),
(17110, 'ORPHA:759', 'Gonadotropin-dependant precocious puberty', 1),
(17111, 'ORPHA:76', 'Anguilluliasis', 1),
(17112, 'ORPHA:76', 'Anguillulosis', 1),
(17113, 'ORPHA:76', 'Strongyloidiasis', 1),
(17114, 'ORPHA:760', 'PNP deficiency', 1),
(17115, 'ORPHA:760', 'PNPase deficiency', 1),
(17116, 'ORPHA:760', 'Purine nucleoside phosphorylase deficiency', 1),
(17117, 'ORPHA:761', 'Anaphylactoid purpura', 1),
(17118, 'ORPHA:761', 'Henoch-Schönlein purpura', 1),
(17119, 'ORPHA:761', 'IgA vasculitis', 1),
(17120, 'ORPHA:761', 'Immunoglobulin A vasculitis', 1),
(17121, 'ORPHA:761', 'Purpura rheumatica', 1),
(17122, 'ORPHA:761', 'Rheumatoid purpura', 1),
(17123, 'ORPHA:763', 'Pycnodysostosis', 1),
(17124, 'ORPHA:763', 'Pyknodysostosis', 1),
(17125, 'ORPHA:764', 'Myositis purulenta tropica', 1),
(17126, 'ORPHA:764', 'Myositis tropicans', 1),
(17127, 'ORPHA:764', 'PM', 1),
(17128, 'ORPHA:764', 'Pyomyositis', 1),
(17129, 'ORPHA:764', 'Suppurative myositis', 1),
(17130, 'ORPHA:764', 'Tropical pyomyositis', 1),
(17131, 'ORPHA:765', 'PDH', 1),
(17132, 'ORPHA:765', 'PDHC', 1),
(17133, 'ORPHA:765', 'Pyruvate dehydrogenase complex deficiency', 1),
(17134, 'ORPHA:765', 'Pyruvate dehydrogenase deficiency', 1),
(17135, 'ORPHA:766', 'Hemolytic anemia due to red cell pyruvate kinase deficiency', 1),
(17136, 'ORPHA:766', 'Pyruvate kinase deficiency of erythrocytes', 1),
(17137, 'ORPHA:767', 'Küssmaul-Maier disease', 1),
(17138, 'ORPHA:767', 'PAN', 1),
(17139, 'ORPHA:767', 'Periarteritis nodosa', 1),
(17140, 'ORPHA:767', 'Polyarteritis nodosa', 1),
(17141, 'ORPHA:768', 'Congenital long QT syndrome', 3),
(17142, 'ORPHA:768', 'Familial long QT syndrome', 3),
(17143, 'ORPHA:768', 'LQTS', 3),
(17144, 'ORPHA:769', 'Rabson-Mendenhall syndrome', 1),
(17145, 'ORPHA:770', 'Rabies', 1),
(17146, 'ORPHA:772', 'IRD', 1),
(17147, 'ORPHA:772', 'Infantile Refsum disease', 1),
(17148, 'ORPHA:77240', 'Primary lymphedema', 3),
(17149, 'ORPHA:77258', 'Trichorhinophalangeal syndrome type 1 and 3', 1),
(17150, 'ORPHA:77259', 'Gaucher disease type 1', 2),
(17151, 'ORPHA:77259', 'Non-cerebral juvenile Gaucher disease', 2),
(17152, 'ORPHA:77260', 'Acute neuronopathic Gaucher disease', 2),
(17153, 'ORPHA:77260', 'Gaucher disease type 2', 2),
(17154, 'ORPHA:77260', 'Infantile cerebral Gaucher disease', 2),
(17155, 'ORPHA:77261', 'Cerebral juvenile and adult form of Gaucher disease', 2),
(17156, 'ORPHA:77261', 'Chronic neuronopathic Gaucher disease', 2),
(17157, 'ORPHA:77261', 'Gaucher disease type 3', 2),
(17158, 'ORPHA:77261', 'Gaucher disease, subacute neuronopathic type', 2),
(17159, 'ORPHA:77292', 'Niemann-Pick disease type A', 1),
(17160, 'ORPHA:77293', 'Niemann-Pick disease type B', 1),
(17161, 'ORPHA:77295', 'Dentoleukoencephalopathy', 2),
(17162, 'ORPHA:77295', 'Leukodystrophy with oligodontia', 2),
(17163, 'ORPHA:77295', 'Odontoleukodystrophy', 2),
(17164, 'ORPHA:77296', 'Hyperostosis frontalis interna', 1),
(17165, 'ORPHA:77296', 'Morgagni-Stewart-Morel syndrome', 1),
(17166, 'ORPHA:77297', 'Chronic recurrent multifocal osteomyelitis-congenital dyserythropoietic anemia-neutrophilic dermatosis syndrome', 1),
(17167, 'ORPHA:77297', 'Majeed syndrome', 1),
(17168, 'ORPHA:77298', 'Anophthalmia/microphthalmia-esophageal atresia syndrome', 1),
(17169, 'ORPHA:77298', 'MCOPS3', 1),
(17170, 'ORPHA:77298', 'Syndromic microphthalmia type 3', 1),
(17171, 'ORPHA:77299', 'MCOPS10', 1),
(17172, 'ORPHA:77299', 'MOBA syndrome', 1),
(17173, 'ORPHA:77299', 'Microphthalmia-brain atrophy syndrome', 1),
(17174, 'ORPHA:77299', 'Syndromic microphthalmia type 10', 1),
(17175, 'ORPHA:773', 'Adult Refsum disease', 1),
(17176, 'ORPHA:773', 'Classic Refsum disease', 1),
(17177, 'ORPHA:773', 'HMSN 4', 1),
(17178, 'ORPHA:773', 'HMSN IV', 1),
(17179, 'ORPHA:773', 'Hereditary motor and sensory neuropathy type 4', 1),
(17180, 'ORPHA:773', 'Hereditary motor and sensory neuropathy type IV', 1),
(17181, 'ORPHA:773', 'Heredopathia atactica polyneuritiformis', 1),
(17182, 'ORPHA:773', 'Phytanic-CoA hydroxylase deficiency', 1),
(17183, 'ORPHA:773', 'Refsum disease', 1),
(17184, 'ORPHA:77300', 'Auricular abnormalities-cleft lip with or without cleft palate-ocular abnormalities syndrome', 1),
(17185, 'ORPHA:77301', 'Microdeletion 9q22.3', 1),
(17186, 'ORPHA:77301', 'Monosomy 9q22.3', 1),
(17187, 'ORPHA:774', 'HHT', 1),
(17188, 'ORPHA:774', 'Hereditary hemorrhagic telangiectasia', 1),
(17189, 'ORPHA:774', 'Rendu-Osler disease', 1),
(17190, 'ORPHA:774', 'Rendu-Osler-Weber disease', 1),
(17191, 'ORPHA:776', 'Lujan syndrome', 1),
(17192, 'ORPHA:776', 'Lujan-Fryns syndrome', 1),
(17193, 'ORPHA:776', 'X-linked intellectual disability with marfanoid habitus', 1),
(17194, 'ORPHA:777', 'X-linked non-syndromic intellectual disability', 2),
(17195, 'ORPHA:778', 'Rett syndrome', 1),
(17196, 'ORPHA:77828', 'Genetic obesity', 3),
(17197, 'ORPHA:77830', 'Rare genetic odontologic disease', 3),
(17198, 'ORPHA:779', 'Primary biliary cirrhosis and systemic scleroderma', 1),
(17199, 'ORPHA:779', 'Reynolds syndrome', 1),
(17200, 'ORPHA:78', 'Ancylostomiasis', 1),
(17201, 'ORPHA:78', 'Ankylostomiasis', 1),
(17202, 'ORPHA:78', 'Hookworm infection', 1),
(17203, 'ORPHA:780', 'Rhabdomyosarcoma', 1),
(17204, 'ORPHA:781', 'Coxiellosis', 1),
(17205, 'ORPHA:781', 'Infection due to Coxiella burnetii', 1),
(17206, 'ORPHA:781', 'Nine Mile fever', 1),
(17207, 'ORPHA:781', 'Q fever', 1),
(17208, 'ORPHA:781', 'Quadrilateral fever', 1),
(17209, 'ORPHA:781', 'Query fever', 1),
(17210, 'ORPHA:782', 'Axenfeld syndrome', 1),
(17211, 'ORPHA:782', 'Axenfeld-Rieger syndrome', 1),
(17212, 'ORPHA:782', 'Rieger syndrome', 1),
(17213, 'ORPHA:783', 'Broad thumb-hallux syndrome', 1),
(17214, 'ORPHA:783', 'Broad thumbs-halluces syndrome', 1),
(17215, 'ORPHA:783', 'Rubinstein-Taybi syndrome', 1),
(17216, 'ORPHA:785', 'Estrogen resistance syndrome', 1),
(17217, 'ORPHA:786', 'Generalized glucocorticoid resistance syndrome', 1),
(17218, 'ORPHA:79', 'Congenital alpha2-antiplasmin deficiency', 1),
(17219, 'ORPHA:790', 'Retinoblastoma', 1),
(17220, 'ORPHA:79062', 'Disorder of amino acid and other organic acid metabolism', 3),
(17221, 'ORPHA:79076', 'Infantile juvenile polyposis syndrome', 2),
(17222, 'ORPHA:79076', 'Juvenile polyposis of infancy', 2),
(17223, 'ORPHA:79078', 'Chronic dacryoadenitis and sialadenitis', 1),
(17224, 'ORPHA:79078', 'IgG4-related dacryoadenitis and sialadenitis', 1),
(17225, 'ORPHA:79078', 'Mikulicz disease', 1),
(17226, 'ORPHA:79083', 'FPLD3', 1),
(17227, 'ORPHA:79083', 'Familial partial lipodystrophy type 3', 1),
(17228, 'ORPHA:79083', 'PPARG-related FPLD', 1),
(17229, 'ORPHA:79083', 'PPARG-related familial partial lipodystrophy', 1),
(17230, 'ORPHA:79084', 'FPLD1', 1),
(17231, 'ORPHA:79084', 'Familial partial lipodystrophy type 1', 1),
(17232, 'ORPHA:79084', 'Familial partial lipodystrophy, Köbberling type', 1),
(17233, 'ORPHA:79085', 'AKT2-related FPLD', 1),
(17234, 'ORPHA:79085', 'AKT2-related familial partial lipodystrophy', 1),
(17235, 'ORPHA:79086', 'Acquired generalized lipodystrophy', 1),
(17236, 'ORPHA:79086', 'Acquired lipoatrophic diabetes', 1),
(17237, 'ORPHA:79086', 'Lawrence syndrome', 1),
(17238, 'ORPHA:79086', 'Lawrence-Seip syndrome', 1),
(17239, 'ORPHA:79087', 'Acquired partial lipodystrophy', 1),
(17240, 'ORPHA:79087', 'Barraquer-Simons syndrome', 1),
(17241, 'ORPHA:79087', 'Progressive cephalothoracic lipodystrophy', 1),
(17242, 'ORPHA:79088', 'Localized lipodystrophy', 3),
(17243, 'ORPHA:79091', 'HIBM3', 1),
(17244, 'ORPHA:79091', 'Hereditary inclusion body myopathy type 3', 1),
(17245, 'ORPHA:79091', 'Hereditary inclusion body myopathy-joint contractures-ophthalmoplegia syndrome', 1),
(17246, 'ORPHA:79091', 'IBM3', 1),
(17247, 'ORPHA:79091', 'Inclusion body myopathy type 3', 1),
(17248, 'ORPHA:79093', 'Angiodysgenetic necrotizing myelopathy', 1),
(17249, 'ORPHA:79093', 'Familial osteosclerosis with abnormalities of the nervous system and meninges', 1),
(17250, 'ORPHA:79093', 'Foix-Alajouanine syndrome', 1),
(17251, 'ORPHA:79093', 'Subacute angiohypertrophic myelomalacia', 1),
(17252, 'ORPHA:79093', 'Subacute ascending necrotizing myelitis', 1),
(17253, 'ORPHA:79093', 'Subacute necrotizing myelitis', 1),
(17254, 'ORPHA:79094', 'Grange occlusive arterial syndrome', 1),
(17255, 'ORPHA:79094', 'Grange syndrome', 1),
(17256, 'ORPHA:79094', 'Progressive arterial occlusive disease-hypertension-heart defects-bone fragility-brachysyndactyly syndrome', 1),
(17257, 'ORPHA:79095', '2-methylacyl-CoA racemase deficiency', 1),
(17258, 'ORPHA:79095', 'AMACR deficiency', 1),
(17259, 'ORPHA:79095', 'Alpha-methyl-acyl-CoA racemase deficiency', 1),
(17260, 'ORPHA:79095', 'BASD4', 1),
(17261, 'ORPHA:79095', 'Congenital bile acid synthesis defect type 4', 1),
(17262, 'ORPHA:79095', 'Liver disease-retinitis pigmentosa-polyneuropathy-epilepsy syndrome', 1),
(17263, 'ORPHA:79096', 'PNPO deficiency', 1),
(17264, 'ORPHA:79096', 'PNPO-related neonatal epileptic encephalopathy', 1),
(17265, 'ORPHA:79096', 'Pyridoxal phosphate-dependent seizures', 1),
(17266, 'ORPHA:79096', 'Pyridoxal phosphate-responsive seizures', 1),
(17267, 'ORPHA:79096', 'Pyridoxamine 5\'-oxidase deficiency', 1),
(17268, 'ORPHA:79096', 'Pyridoxamine 5\'-phosphate oxidase deficiency', 1),
(17269, 'ORPHA:79097', 'Folinic acid-responsive seizures', 1),
(17270, 'ORPHA:79098', 'Sympathetic ophthalmia', 1),
(17271, 'ORPHA:79098', 'Sympathetic uveitis', 1),
(17272, 'ORPHA:79099', 'Ackerman dermatitis syndrome', 1),
(17273, 'ORPHA:79099', 'Ackerman syndrome', 1),
(17274, 'ORPHA:79099', 'IGDA', 1),
(17275, 'ORPHA:79099', 'Interstitial granulomatous dermatitis with arthritis', 1),
(17276, 'ORPHA:791', 'Retinitis pigmentosa', 1),
(17277, 'ORPHA:79100', 'Atrophoderma vermiculata', 1),
(17278, 'ORPHA:79100', 'Folliculitis ulerythematosa reticulate', 1),
(17279, 'ORPHA:79101', 'Delta-1-pyrroline-5-carboxylate dehydrogenase deficiency', 1),
(17280, 'ORPHA:79101', 'Hyperprolinemia type 2', 1),
(17281, 'ORPHA:79102', 'Thyrotoxic hypokalemic periodic paralysis', 1),
(17282, 'ORPHA:79102', 'Thyrotoxic periodic paralysis', 1),
(17283, 'ORPHA:79105', 'Fibromyxosarcoma', 1),
(17284, 'ORPHA:79105', 'Myxofibrosarcoma', 1),
(17285, 'ORPHA:79105', 'Myxoid malignant fibrous histiocytoma', 1),
(17286, 'ORPHA:79106', 'Eiken syndrome', 1),
(17287, 'ORPHA:79107', 'Developmental malformations-deafness-dystonia syndrome', 1),
(17288, 'ORPHA:79107', 'Developmental malformations-hearing loss-dystonia syndrome', 1),
(17289, 'ORPHA:79113', 'MFDM syndrome', 1),
(17290, 'ORPHA:79113', 'Mandibulofacial dysostosis, Guion-Almeida type', 1),
(17291, 'ORPHA:79113', 'Mandibulofacial dysostosis-microcephaly syndrome', 1),
(17292, 'ORPHA:79118', 'Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome', 1),
(17293, 'ORPHA:79124', 'Hepatic veno-occlusive disease-immunodeficiency syndrome', 1),
(17294, 'ORPHA:79124', 'VODI syndrome', 1),
(17295, 'ORPHA:79126', 'Acute interstitial pneumonia', 1),
(17296, 'ORPHA:79126', 'Acute interstitial pneumonitis', 1),
(17297, 'ORPHA:79126', 'Hamman-Rich syndrome', 1),
(17298, 'ORPHA:79127', 'RB-ILD', 1),
(17299, 'ORPHA:79127', 'Respiratory bronchiolitis-interstitial lung disease syndrome', 1),
(17300, 'ORPHA:79128', 'Lymphocytic interstitial pneumonia', 1),
(17301, 'ORPHA:79128', 'Lymphoid interstitial pneumonia', 1),
(17302, 'ORPHA:79129', 'Trichodysplasia-amelogenesis imperfecta syndrome', 1),
(17303, 'ORPHA:79133', 'Bitemporal aplasia cutis congenita', 2),
(17304, 'ORPHA:79133', 'Brauer syndrome', 2),
(17305, 'ORPHA:79133', 'FFDD type I', 2),
(17306, 'ORPHA:79133', 'FFDD1', 2),
(17307, 'ORPHA:79133', 'Focal facial dermal dysplasia 1, Brauer type', 2),
(17308, 'ORPHA:79133', 'Focal facial dermal dysplasia type 1', 2),
(17309, 'ORPHA:79133', 'Focal facial dermal dysplasia type I', 2),
(17310, 'ORPHA:79134', 'DEND syndrome', 1),
(17311, 'ORPHA:79134', 'Developmental delay-epilepsy-neonatal diabetes syndrome', 1),
(17312, 'ORPHA:79135', 'Episodic ataxia type 3', 1),
(17313, 'ORPHA:79135', 'Episodic ataxia-vertigo-tinnitus-myokymia syndrome', 1),
(17314, 'ORPHA:79136', 'Episodic ataxia type 4', 1),
(17315, 'ORPHA:79136', 'PATX', 1),
(17316, 'ORPHA:79136', 'Periodic vestibulocerebellar ataxia', 1),
(17317, 'ORPHA:79137', 'GEPD', 1),
(17318, 'ORPHA:79137', 'Generalized epilepsy-paroxysmal dyskinesia syndrome', 1),
(17319, 'ORPHA:79138', 'Bickerstaff brainstem encephalitis', 1),
(17320, 'ORPHA:79139', 'Japanese encephalitis', 1),
(17321, 'ORPHA:79140', 'Cutaneous neuroendocrine carcinoma', 1),
(17322, 'ORPHA:79140', 'MCC', 1),
(17323, 'ORPHA:79140', 'Merkel cell carcinoma', 1),
(17324, 'ORPHA:79141', 'Hereditary painful callosities', 1),
(17325, 'ORPHA:79141', 'Keratosis palmoplantaris nummularis', 1),
(17326, 'ORPHA:79141', 'PPK nummularis', 1),
(17327, 'ORPHA:79141', 'Plamoplantar hyperkeratosis nummularis', 1),
(17328, 'ORPHA:79141', 'Plamoplantar keratoderma nummularis', 1),
(17329, 'ORPHA:79143', 'Isolated anonychia', 1),
(17330, 'ORPHA:79143', 'Isolated congenital anonychia', 1),
(17331, 'ORPHA:79144', 'COIF', 1),
(17332, 'ORPHA:79144', 'COIF syndrome', 1),
(17333, 'ORPHA:79144', 'Congenital onychodysplasia of the index fingers', 1),
(17334, 'ORPHA:79144', 'Iso-Kikuchi syndrome', 1),
(17335, 'ORPHA:79144', 'Isolated congenital onychodysplasia', 1),
(17336, 'ORPHA:79145', 'Dowling-Degos disease', 1),
(17337, 'ORPHA:79145', 'Reticular pigment anomaly of flexures', 1),
(17338, 'ORPHA:79146', 'Familial progressive hyperpigmentation', 1),
(17339, 'ORPHA:79146', 'Melanosis diffusa congenita', 1),
(17340, 'ORPHA:79146', 'Melanosis universalis hereditaria', 1),
(17341, 'ORPHA:79146', 'Universal melanosis', 1),
(17342, 'ORPHA:79147', 'Familial reactive perforating collagenosis', 1),
(17343, 'ORPHA:79148', 'Elastosis perforans serpiginosa', 1),
(17344, 'ORPHA:79149', 'Dermochondrocorneal dystrophy', 1),
(17345, 'ORPHA:79149', 'François syndrome', 1),
(17346, 'ORPHA:79150', 'LWNH', 1),
(17347, 'ORPHA:79150', 'Linear and whorled nevoid hypermelanosis', 1),
(17348, 'ORPHA:79151', 'AKV of Hopf', 1),
(17349, 'ORPHA:79151', 'Acrokeratosis verruciformis of Hopf', 1),
(17350, 'ORPHA:79152', 'Disseminated superficial actinic porokeratosis', 1),
(17351, 'ORPHA:79153', 'Idiopathic trachyonychia', 1),
(17352, 'ORPHA:79154', '2-aminoadipic 2-oxoadipic aciduria', 1),
(17353, 'ORPHA:79154', 'Alpha-aminoadipic aciduria', 1),
(17354, 'ORPHA:79155', 'Hydroxykynureninuria', 1),
(17355, 'ORPHA:79155', 'Kynureninase deficiency', 1),
(17356, 'ORPHA:79155', 'Xanthurenic aciduria', 1),
(17357, 'ORPHA:79156', 'Seizures-intellectual disability due to hydroxylysinuria syndrome', 1),
(17358, 'ORPHA:79157', '2-methylbutyric aciduria', 1),
(17359, 'ORPHA:79157', '2-methylbutyryl-CoA dehydrogenase deficiency', 1),
(17360, 'ORPHA:79157', 'Developmental delay due to 2-methylbutyryl-CoA dehydrogenase deficiency', 1),
(17361, 'ORPHA:79157', 'SBCAD deficiency', 1),
(17362, 'ORPHA:79157', 'Short/branched-chain acyl-coA dehydrogenase deficiency', 1),
(17363, 'ORPHA:79158', 'Cerebral organic aciduria', 3),
(17364, 'ORPHA:79159', 'Isobutyric aciduria', 1),
(17365, 'ORPHA:79159', 'Isobutyryl-CoA dehydrogenase deficiency', 1),
(17366, 'ORPHA:79161', 'Disorder of carbohydrate metabolism', 3),
(17367, 'ORPHA:79163', 'Classic organic aciduria', 3),
(17368, 'ORPHA:79166', 'Disorder of amino acid absorption and transport', 3),
(17369, 'ORPHA:79167', 'Disorder of urea cycle metabolism and ammonia detoxification', 3),
(17370, 'ORPHA:79168', 'Disorder of bile acid synthesis', 3),
(17371, 'ORPHA:79169', 'Disorder of neurotransmitter metabolism and transport', 3),
(17372, 'ORPHA:79171', 'Disorder of cobalamin metabolism and transport', 3),
(17373, 'ORPHA:79172', 'CCDS', 3),
(17374, 'ORPHA:79172', 'CDS', 3),
(17375, 'ORPHA:79172', 'Cerebral creatine deficiency syndrome', 3),
(17376, 'ORPHA:79172', 'Creatine deficiency syndrome', 3),
(17377, 'ORPHA:79173', 'Cytosolic methyl group transfer or sulfur amino acid metabolism disorder', 3),
(17378, 'ORPHA:79173', 'Disorder of methionine cycle and sulfur amino acid metabolism', 3),
(17379, 'ORPHA:79174', 'Disorder of fatty acid oxidation and ketone body metabolism', 3),
(17380, 'ORPHA:79175', 'Disorder of GABA metabolism', 3),
(17381, 'ORPHA:79175', 'Disorder of gamma-aminobutyric acid metabolism', 3),
(17382, 'ORPHA:79177', 'Gluconeogenesis disorder', 3),
(17383, 'ORPHA:79178', 'Glucose transport disorder', 3),
(17384, 'ORPHA:79179', 'Disorder of glycerol metabolism', 3),
(17385, 'ORPHA:79181', 'Disorder of histidine metabolism', 3),
(17386, 'ORPHA:79183', 'Disorder of ketolysis', 3),
(17387, 'ORPHA:79185', 'Disorder of ornithine or proline metabolism', 3),
(17388, 'ORPHA:79186', 'Disorder of pentose phosphate metabolism', 3),
(17389, 'ORPHA:79187', 'Disorder of peptide metabolism', 3),
(17390, 'ORPHA:79188', 'Peroxisomal beta-oxidation disorder', 3),
(17391, 'ORPHA:79189', 'Peroxisome biogenesis disorder', 3),
(17392, 'ORPHA:79189', 'Peroxisome biogenesis disorder spectrum', 3),
(17393, 'ORPHA:79190', 'Disorder of phenylalanin or tyrosine metabolism', 3),
(17394, 'ORPHA:79191', 'Disorder of purine metabolism', 3),
(17395, 'ORPHA:79192', 'Disorder of pyridoxine metabolism', 3),
(17396, 'ORPHA:79193', 'Disorder of pyrimidine metabolism', 3),
(17397, 'ORPHA:79194', 'Disorder of serine or glycine metabolism', 3),
(17398, 'ORPHA:79195', 'Sterol biosynthesis disorder', 3),
(17399, 'ORPHA:79196', 'Disorder of the gamma-glutamyl cycle', 3),
(17400, 'ORPHA:79197', 'Disorder of branched-chain amino acid metabolism', 3),
(17401, 'ORPHA:792', 'X-linked juvenile retinoschisis', 1),
(17402, 'ORPHA:792', 'X-linked retinoschisis', 1),
(17403, 'ORPHA:792', 'XLRS', 1),
(17404, 'ORPHA:79200', 'Disorder of energy metabolism', 3),
(17405, 'ORPHA:79201', 'GSD', 3),
(17406, 'ORPHA:79201', 'Glycogen storage disease', 3),
(17407, 'ORPHA:79201', 'Glycogenosis', 3),
(17408, 'ORPHA:79204', 'Lipid storage disease', 3),
(17409, 'ORPHA:79207', 'Disorder of lysosomal amino acid transport', 3),
(17410, 'ORPHA:79212', 'Mucolipidosis', 3),
(17411, 'ORPHA:79213', 'Mucopolysaccharidosis', 3),
(17412, 'ORPHA:79214', 'Disorder of biogenic amine metabolism and transport', 3),
(17413, 'ORPHA:79215', 'Oligosaccharidosis', 3),
(17414, 'ORPHA:79217', 'Other metabolic disease with skin involvement', 3),
(17415, 'ORPHA:79219', 'Metabolic disease involving other neurotransmitter deficiency', 3),
(17416, 'ORPHA:79224', 'Disorder of purine or pyrimidine metabolism', 3),
(17417, 'ORPHA:79225', 'Sphingolipidosis', 3),
(17418, 'ORPHA:79226', 'Sterol metabolism disorder', 3),
(17419, 'ORPHA:79230', 'Hemochromatosis type 2', 1),
(17420, 'ORPHA:79230', 'Juvenile hemochromatosis', 1),
(17421, 'ORPHA:79233', 'HPRT deficiency, grade I', 1),
(17422, 'ORPHA:79233', 'HPRT partial deficiency', 1),
(17423, 'ORPHA:79233', 'HPRT-related gout', 1),
(17424, 'ORPHA:79233', 'HPRT-related hyperuricemia', 1),
(17425, 'ORPHA:79233', 'HPRT1 partial deficiency', 1),
(17426, 'ORPHA:79233', 'Hypoxanthine guanine phosphoribosyltransferase 1 partial deficiency', 1),
(17427, 'ORPHA:79233', 'Hypoxanthine guanine phosphoribosyltransferase deficiency, grade I', 1),
(17428, 'ORPHA:79233', 'Hypoxanthine guanine phosphoribosyltransferase partial deficiency', 1),
(17429, 'ORPHA:79233', 'Kelley-Seegmiller syndrome', 1),
(17430, 'ORPHA:79234', 'Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 1', 2),
(17431, 'ORPHA:79234', 'Bilirubin-UGT deficiency type 1', 2),
(17432, 'ORPHA:79234', 'Crigler-Najjar syndrome type 1', 2),
(17433, 'ORPHA:79234', 'Hereditary unconjugated hyperbilirubinemia type 1', 2),
(17434, 'ORPHA:79234', 'UGT deficiency type 1', 2),
(17435, 'ORPHA:79235', 'Arias syndrome', 2),
(17436, 'ORPHA:79235', 'Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 2', 2),
(17437, 'ORPHA:79235', 'Bilirubin-UGT deficiency type 2', 2),
(17438, 'ORPHA:79235', 'Crigler-Najjar syndrome type 2', 2),
(17439, 'ORPHA:79235', 'Hereditary unconjugated hyperbilirubinemia type 2', 2),
(17440, 'ORPHA:79235', 'UGT deficiency type 2', 2),
(17441, 'ORPHA:79237', 'GALK deficiency', 1),
(17442, 'ORPHA:79237', 'GALK-D', 1),
(17443, 'ORPHA:79237', 'Galactokinase deficiency', 1),
(17444, 'ORPHA:79237', 'Galactokinase deficiency galactosemia', 1),
(17445, 'ORPHA:79237', 'Galactosemia type 2', 1),
(17446, 'ORPHA:79238', 'Epimerase deficiency galactosemia', 1),
(17447, 'ORPHA:79238', 'GALE deficiency', 1),
(17448, 'ORPHA:79238', 'GALE-D', 1),
(17449, 'ORPHA:79238', 'Galactose epimerase deficiency', 1),
(17450, 'ORPHA:79238', 'Galactosemia type 3', 1),
(17451, 'ORPHA:79238', 'UDP-galactose-4-epimerase deficiency', 1),
(17452, 'ORPHA:79238', 'Uridine diphosphate galactose-4-epimerase deficiency', 1),
(17453, 'ORPHA:79239', 'Classic galactosemia', 1),
(17454, 'ORPHA:79239', 'GALT deficiency', 1),
(17455, 'ORPHA:79239', 'Galactose-1-phosphate uridyltransferase deficiency', 1),
(17456, 'ORPHA:79239', 'Galactosemia type 1', 1),
(17457, 'ORPHA:79240', 'GSD due to liver and muscle phosphorylase kinase deficiency', 1),
(17458, 'ORPHA:79240', 'GSD type 9B', 1),
(17459, 'ORPHA:79240', 'GSD type IXb', 1),
(17460, 'ORPHA:79240', 'Glycogen storage disease due to liver and muscle phosphorylase kinase deficiency', 1),
(17461, 'ORPHA:79240', 'Glycogen storage disease type 9B', 1),
(17462, 'ORPHA:79240', 'Glycogen storage disease type IXb', 1),
(17463, 'ORPHA:79240', 'Glycogenosis due to liver and muscle phosphorylase kinase deficiency', 1),
(17464, 'ORPHA:79240', 'Glycogenosis type 9B', 1),
(17465, 'ORPHA:79240', 'Glycogenosis type IXb', 1),
(17466, 'ORPHA:79241', 'Biotinidase deficiency', 1),
(17467, 'ORPHA:79241', 'Juvenile-onset multiple carboxylase deficiency', 1),
(17468, 'ORPHA:79241', 'Late-onset multiple carboxylase deficiency', 1),
(17469, 'ORPHA:79242', 'Early-onset multiple carboxylase deficiency', 1),
(17470, 'ORPHA:79242', 'Holocarboxylase synthetase deficiency', 1),
(17471, 'ORPHA:79242', 'Neonatal multiple carboxylase deficiency', 1),
(17472, 'ORPHA:79243', 'PDHAD', 2),
(17473, 'ORPHA:79243', 'Pyruvate decarboxylase deficiency', 2),
(17474, 'ORPHA:79243', 'Pyruvate dehydrogenase E1-alpha deficiency', 2),
(17475, 'ORPHA:79243', 'Pyruvate dehydrogenase complex E1 component subunit alpha deficiency', 2),
(17476, 'ORPHA:79244', 'Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex deficiency', 2),
(17477, 'ORPHA:79244', 'Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex deficiency', 2),
(17478, 'ORPHA:79244', 'Pyruvate dehydrogenase E2 deficiency', 2),
(17479, 'ORPHA:79244', 'Pyruvate dehydrogenase complex component E2 deficiency', 2),
(17480, 'ORPHA:79246', 'PDH phosphatase deficiency', 2),
(17481, 'ORPHA:79246', 'Pyruvate dehydrogenase phosphatase deficiency', 2),
(17482, 'ORPHA:79253', 'Mild PKU', 2),
(17483, 'ORPHA:79253', 'Mild phenylketonuria', 2),
(17484, 'ORPHA:79253', 'Variant PKU', 2),
(17485, 'ORPHA:79253', 'Variant phenylketonuria', 2),
(17486, 'ORPHA:79253', 'mPKU', 2),
(17487, 'ORPHA:79254', 'Classic PKU', 2),
(17488, 'ORPHA:79254', 'Classic phenylketonuria', 2),
(17489, 'ORPHA:79255', 'GM1 gangliosidosis type 1', 2),
(17490, 'ORPHA:79255', 'Infantile GM1 gangliosidosis', 2),
(17491, 'ORPHA:79255', 'Norman-Landing disease', 2),
(17492, 'ORPHA:79256', 'GM1 gangliosidosis type 2', 2),
(17493, 'ORPHA:79256', 'Juvenile GM1 gangliosidosis', 2),
(17494, 'ORPHA:79256', 'Late-infantile GM1 gangliosidosis', 2),
(17495, 'ORPHA:79257', 'Adult-onset GM1 gangliosidosis', 2),
(17496, 'ORPHA:79257', 'GM1 gangliosidosis type 3', 2),
(17497, 'ORPHA:79258', 'G6P deficiency type 1a', 2),
(17498, 'ORPHA:79258', 'GSD due to G6P deficiency type 1a', 2),
(17499, 'ORPHA:79258', 'GSD due to G6P deficiency type Ia', 2),
(17500, 'ORPHA:79258', 'GSD type 1a', 2);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(17501, 'ORPHA:79258', 'GSDIa', 2),
(17502, 'ORPHA:79258', 'Glycogen storage disease due to G6P deficiency type Ia', 2),
(17503, 'ORPHA:79258', 'Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia', 2),
(17504, 'ORPHA:79258', 'Glycogen storage disease type 1a', 2),
(17505, 'ORPHA:79258', 'Glycogenosis due to glucose-6-phosphatase deficiency type 1a', 2),
(17506, 'ORPHA:79258', 'Glycogenosis due to glucose-6-phosphatase deficiency type Ia', 2),
(17507, 'ORPHA:79258', 'Glycogenosis type Ia', 2),
(17508, 'ORPHA:79259', 'G6P deficiency type Ib', 2),
(17509, 'ORPHA:79259', 'G6P translocase deficiency', 2),
(17510, 'ORPHA:79259', 'G6PT deficiency', 2),
(17511, 'ORPHA:79259', 'GSD due to G6P deficiency type 1b', 2),
(17512, 'ORPHA:79259', 'GSD due to G6P deficiency type Ib', 2),
(17513, 'ORPHA:79259', 'GSD due to G6PT deficiency', 2),
(17514, 'ORPHA:79259', 'GSD type 1 non a', 2),
(17515, 'ORPHA:79259', 'GSD type 1b', 2),
(17516, 'ORPHA:79259', 'GSD type Ib', 2),
(17517, 'ORPHA:79259', 'GSDIb', 2),
(17518, 'ORPHA:79259', 'Glycogen storage disease due to G6P deficiency type Ib', 2),
(17519, 'ORPHA:79259', 'Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib', 2),
(17520, 'ORPHA:79259', 'Glycogen storage disease type 1b', 2),
(17521, 'ORPHA:79259', 'Glycogen storage disease type Ib', 2),
(17522, 'ORPHA:79259', 'Glycogenosis due to glucose-6-phosphatase deficiency type 1b', 2),
(17523, 'ORPHA:79259', 'Glycogenosis due to glucose-6-phosphatase transport defect type Ib', 2),
(17524, 'ORPHA:79259', 'Glycogenosis type 1b', 2),
(17525, 'ORPHA:79259', 'Glycogenosis type Ib', 2),
(17526, 'ORPHA:79262', 'ANCL', 1),
(17527, 'ORPHA:79262', 'Adult NCL', 1),
(17528, 'ORPHA:79262', 'Adult neuronal ceroid lipofuscinosis', 1),
(17529, 'ORPHA:79262', 'Kufs disease', 1),
(17530, 'ORPHA:79263', 'Hagberg-Santavuori disease', 1),
(17531, 'ORPHA:79263', 'INCL', 1),
(17532, 'ORPHA:79263', 'Infantile NCL', 1),
(17533, 'ORPHA:79263', 'Infantile neuronal ceroid lipofuscinosis', 1),
(17534, 'ORPHA:79263', 'Santavuori disease', 1),
(17535, 'ORPHA:79263', 'Santavuori-Haltia disease', 1),
(17536, 'ORPHA:79264', 'Batten disease', 1),
(17537, 'ORPHA:79264', 'JNCL', 1),
(17538, 'ORPHA:79264', 'Juvenile NCL', 1),
(17539, 'ORPHA:79264', 'Juvenile neuronal ceroid lipofuscinosis', 1),
(17540, 'ORPHA:79264', 'Spielmeyer-Vogt disease', 1),
(17541, 'ORPHA:79269', 'Heparan sulfamidase deficiency', 2),
(17542, 'ORPHA:79269', 'MPS3A', 2),
(17543, 'ORPHA:79269', 'MPSIIIA', 2),
(17544, 'ORPHA:79269', 'Mucopolysaccharidosis type 3A', 2),
(17545, 'ORPHA:79269', 'Mucopolysaccharidosis type IIIA', 2),
(17546, 'ORPHA:79269', 'Sanfilippo syndrome type A', 2),
(17547, 'ORPHA:79270', 'MPS3B', 2),
(17548, 'ORPHA:79270', 'MPSIIIB', 2),
(17549, 'ORPHA:79270', 'Mucopolysaccharidosis type 3B', 2),
(17550, 'ORPHA:79270', 'Mucopolysaccharidosis type IIIB', 2),
(17551, 'ORPHA:79270', 'N-acetyl-alpha-glucosaminidase deficiency', 2),
(17552, 'ORPHA:79270', 'Sanfilippo syndrome type B', 2),
(17553, 'ORPHA:79271', 'HGSNAT deficiency', 2),
(17554, 'ORPHA:79271', 'Heparan-alpha-glucosaminide N-acetyltransferase deficiency', 2),
(17555, 'ORPHA:79271', 'MPS3C', 2),
(17556, 'ORPHA:79271', 'MPSIIIC', 2),
(17557, 'ORPHA:79271', 'Mucopolysaccharidosis type 3C', 2),
(17558, 'ORPHA:79271', 'Mucopolysaccharidosis type IIIC', 2),
(17559, 'ORPHA:79271', 'Sanfilippo syndrome type C', 2),
(17560, 'ORPHA:79272', 'GNS deficiency', 2),
(17561, 'ORPHA:79272', 'Glucosamine N-acetyl-6-sulfatase deficiency', 2),
(17562, 'ORPHA:79272', 'MPS3D', 2),
(17563, 'ORPHA:79272', 'MPSIIID', 2),
(17564, 'ORPHA:79272', 'Mucopolysaccharidosis type 3D', 2),
(17565, 'ORPHA:79272', 'Mucopolysaccharidosis type IIID', 2),
(17566, 'ORPHA:79272', 'Sanfilippo syndrome type D', 2),
(17567, 'ORPHA:79273', 'Hereditary coproporphyria', 1),
(17568, 'ORPHA:79276', 'Acute intermittent porphyria', 1),
(17569, 'ORPHA:79277', 'CEP', 1),
(17570, 'ORPHA:79277', 'Congenital erythropoietic porphyria', 1),
(17571, 'ORPHA:79277', 'Günther disease', 1),
(17572, 'ORPHA:79278', 'Autosomal erythropoietic protoporphyria', 1),
(17573, 'ORPHA:79278', 'EPP', 1),
(17574, 'ORPHA:79279', 'Alpha-N-acetylgalactosaminidase deficiency type 1', 2),
(17575, 'ORPHA:79279', 'NAGA deficiency type 1', 2),
(17576, 'ORPHA:79279', 'Schindler disease type 1', 2),
(17577, 'ORPHA:79280', 'Adult-onset Alpha-N-acetylgalactosaminidase deficiency', 2),
(17578, 'ORPHA:79280', 'Alpha-N-acetylgalactosaminidase deficiency type 2', 2),
(17579, 'ORPHA:79280', 'Kanzaki disease', 2),
(17580, 'ORPHA:79280', 'NAGA deficiency type 2', 2),
(17581, 'ORPHA:79280', 'Schindler disease type 2', 2),
(17582, 'ORPHA:79281', 'Alpha-N-acetylgalactosaminidase deficiency type 3', 2),
(17583, 'ORPHA:79281', 'NAGA deficiency type 3', 2),
(17584, 'ORPHA:79281', 'Schindler disease type 3', 2),
(17585, 'ORPHA:79282', 'CblC defect', 2),
(17586, 'ORPHA:79282', 'Cobalamin C defect', 2),
(17587, 'ORPHA:79282', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblC', 2),
(17588, 'ORPHA:79282', 'Methylmalonic acidemia with homocystinuria, type cblC', 2),
(17589, 'ORPHA:79282', 'Methylmalonic aciduria with homocystinuria, type cblC', 2),
(17590, 'ORPHA:79283', 'CblD defect', 2),
(17591, 'ORPHA:79283', 'Cobalamin D defect', 2),
(17592, 'ORPHA:79283', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblD', 2),
(17593, 'ORPHA:79283', 'Methylmalonic acidemia with homocystinuria, type cblD', 2),
(17594, 'ORPHA:79283', 'Methylmalonic aciduria with homocystinuria, type cblD', 2),
(17595, 'ORPHA:79284', 'CblF defect', 2),
(17596, 'ORPHA:79284', 'Cobalamin F defect', 2),
(17597, 'ORPHA:79284', 'Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblF', 2),
(17598, 'ORPHA:79284', 'Lysosomal membrane cobalamin transporter deficiency', 2),
(17599, 'ORPHA:79284', 'Methylmalonic acidemia with homocystinuria type cblF', 2),
(17600, 'ORPHA:79284', 'Methylmalonic aciduria with homocystinuria, type cblF', 2),
(17601, 'ORPHA:79292', 'FED', 2),
(17602, 'ORPHA:79292', 'Fish-eye disease', 2),
(17603, 'ORPHA:79292', 'Partial LCAT deficiency', 2),
(17604, 'ORPHA:79293', 'Complete LCAT deficiency', 2),
(17605, 'ORPHA:79293', 'FLD', 2),
(17606, 'ORPHA:79293', 'Familial LCAT deficiency', 2),
(17607, 'ORPHA:79293', 'Norum disease', 2),
(17608, 'ORPHA:79298', 'Diazoxide-resistant focal hyperinsulinism', 3),
(17609, 'ORPHA:79298', 'Hyperinsulinemic hypoglycemia, diazoxide-resistant focal form', 3),
(17610, 'ORPHA:79299', 'Hyperinsulinemic hypoglycemia due to glucokinase deficiency', 1),
(17611, 'ORPHA:79299', 'Hyperinsulinism due to glucokinase deficiency', 1),
(17612, 'ORPHA:793', 'SAPHO syndrome', 1),
(17613, 'ORPHA:793', 'Synovitis-acne-pustulosis-hyperostosis-osteitis syndrome', 1),
(17614, 'ORPHA:79301', '3-beta-hydroxy-delta-5-C27-steroid oxidoreductase deficiency', 1),
(17615, 'ORPHA:79301', 'BASD1', 1),
(17616, 'ORPHA:79301', 'Congenital bile acid synthesis defect type 1', 1),
(17617, 'ORPHA:79302', 'BASD3', 1),
(17618, 'ORPHA:79302', 'Congenital bile acid synthesis defect type 3', 1),
(17619, 'ORPHA:79302', 'Oxysterol 7-alpha-hydroxylase deficiency', 1),
(17620, 'ORPHA:79303', 'BASD2', 1),
(17621, 'ORPHA:79303', 'Cholestasis with delta(4)-3-oxosteroid 5-beta-reductase deficiency', 1),
(17622, 'ORPHA:79303', 'Congenital bile acid synthesis defect type 2', 1),
(17623, 'ORPHA:79304', 'BSEP deficiency', 2),
(17624, 'ORPHA:79304', 'PFIC2', 2),
(17625, 'ORPHA:79304', 'Progressive familial intrahepatic cholestasis type 2', 2),
(17626, 'ORPHA:79305', 'PFIC3', 2),
(17627, 'ORPHA:79305', 'Progressive familial intrahepatic cholestasis type 3', 2),
(17628, 'ORPHA:79306', 'Byler disease', 2),
(17629, 'ORPHA:79306', 'FIC1 deficiency', 2),
(17630, 'ORPHA:79306', 'PFIC1', 2),
(17631, 'ORPHA:79306', 'Progressive familial intrahepatic cholestasis type 1', 2),
(17632, 'ORPHA:79310', 'Vitamin B12-responsive methylmalonic acidemia type cblA', 2),
(17633, 'ORPHA:79310', 'Vitamin B12-responsive methylmalonic aciduria type cblA', 2),
(17634, 'ORPHA:79311', 'Vitamin B12-responsive methylmalonic acidemia type cblB', 2),
(17635, 'ORPHA:79311', 'Vitamin B12-responsive methylmalonic aciduria, type cblB', 2),
(17636, 'ORPHA:79312', 'Partial deficiency of methylmalonyl-CoA mutase', 2),
(17637, 'ORPHA:79312', 'Vitamin B12-unresponsive methylmalonic acidemia type mut-', 2),
(17638, 'ORPHA:79312', 'Vitamin B12-unresponsive methylmalonic aciduria type mut-', 2),
(17639, 'ORPHA:79314', 'L-2-HGA', 1),
(17640, 'ORPHA:79314', 'L-2-hydroxyglutaric acidemia', 1),
(17641, 'ORPHA:79314', 'L-2-hydroxyglutaric aciduria', 1),
(17642, 'ORPHA:79315', 'D-2-HGA', 1),
(17643, 'ORPHA:79315', 'D-2-hydroxyglutaric acidemia', 1),
(17644, 'ORPHA:79315', 'D-2-hydroxyglutaric aciduria', 1),
(17645, 'ORPHA:79318', 'CDG syndrome type Ia', 1),
(17646, 'ORPHA:79318', 'CDG-Ia', 1),
(17647, 'ORPHA:79318', 'CDG1A', 1),
(17648, 'ORPHA:79318', 'Carbohydrate deficient glycoprotein syndrome type Ia', 1),
(17649, 'ORPHA:79318', 'Congenital disorder of glycosylation type 1a', 1),
(17650, 'ORPHA:79318', 'Congenital disorder of glycosylation type Ia', 1),
(17651, 'ORPHA:79318', 'PMM2-CDG', 1),
(17652, 'ORPHA:79318', 'Phosphomannomutase 2 deficiency', 1),
(17653, 'ORPHA:79319', 'CDG syndrome type Ib', 1),
(17654, 'ORPHA:79319', 'CDG-Ib', 1),
(17655, 'ORPHA:79319', 'CDG1B', 1),
(17656, 'ORPHA:79319', 'Carbohydrate deficient glycoprotein syndrome type Ib', 1),
(17657, 'ORPHA:79319', 'Congenital disorder of glycosylation type 1b', 1),
(17658, 'ORPHA:79319', 'Congenital disorder of glycosylation type Ib', 1),
(17659, 'ORPHA:79319', 'MPI-CDG', 1),
(17660, 'ORPHA:79319', 'Phosphomannose isomerase deficiency', 1),
(17661, 'ORPHA:79320', 'ALG6-CDG', 1),
(17662, 'ORPHA:79320', 'CDG syndrome type Ic', 1),
(17663, 'ORPHA:79320', 'CDG-Ic', 1),
(17664, 'ORPHA:79320', 'CDG1C', 1),
(17665, 'ORPHA:79320', 'Carbohydrate deficient glycoprotein syndrome type Ic', 1),
(17666, 'ORPHA:79320', 'Congenital disorder of glycosylation type 1c', 1),
(17667, 'ORPHA:79320', 'Congenital disorder of glycosylation type Ic', 1),
(17668, 'ORPHA:79320', 'Glucosyltransferase 1 deficiency', 1),
(17669, 'ORPHA:79321', 'ALG3-CDG', 1),
(17670, 'ORPHA:79321', 'CDG syndrome type Id', 1),
(17671, 'ORPHA:79321', 'CDG-Id', 1),
(17672, 'ORPHA:79321', 'CDG1D', 1),
(17673, 'ORPHA:79321', 'Carbohydrate deficient glycoprotein syndrome type Id', 1),
(17674, 'ORPHA:79321', 'Congenital disorder of glycosylation type 1d', 1),
(17675, 'ORPHA:79321', 'Congenital disorder of glycosylation type Id', 1),
(17676, 'ORPHA:79321', 'Mannosyltransferase 6 deficiency', 1),
(17677, 'ORPHA:79322', 'CDG syndrome type Ie', 1),
(17678, 'ORPHA:79322', 'CDG-Ie', 1),
(17679, 'ORPHA:79322', 'CDG1E', 1),
(17680, 'ORPHA:79322', 'Carbohydrate deficient glycoprotein syndrome type Ie', 1),
(17681, 'ORPHA:79322', 'Congenital disorder of glycosylation type 1e', 1),
(17682, 'ORPHA:79322', 'Congenital disorder of glycosylation type Ie', 1),
(17683, 'ORPHA:79322', 'DPM1-CDG', 1),
(17684, 'ORPHA:79322', 'Dol-P-mannosyltransferase deficiency', 1),
(17685, 'ORPHA:79323', 'CDG syndrome type If', 1),
(17686, 'ORPHA:79323', 'CDG-If', 1),
(17687, 'ORPHA:79323', 'CDG1F', 1),
(17688, 'ORPHA:79323', 'Carbohydrate deficient glycoprotein syndrome type If', 1),
(17689, 'ORPHA:79323', 'Congenital disorder of glycosylation type 1f', 1),
(17690, 'ORPHA:79323', 'Congenital disorder of glycosylation type If', 1),
(17691, 'ORPHA:79323', 'MPDU1-CDG', 1),
(17692, 'ORPHA:79324', 'ALG12-CDG', 1),
(17693, 'ORPHA:79324', 'CDG syndrome type Ig', 1),
(17694, 'ORPHA:79324', 'CDG-Ig', 1),
(17695, 'ORPHA:79324', 'CDG1G', 1),
(17696, 'ORPHA:79324', 'Carbohydrate deficient glycoprotein syndrome type Ig', 1),
(17697, 'ORPHA:79324', 'Congenital disorder of glycosylation type 1g', 1),
(17698, 'ORPHA:79324', 'Congenital disorder of glycosylation type Ig', 1),
(17699, 'ORPHA:79324', 'Mannosyltransferase 8 deficiency', 1),
(17700, 'ORPHA:79325', 'ALG8-CDG', 1),
(17701, 'ORPHA:79325', 'CDG syndrome type Ih', 1),
(17702, 'ORPHA:79325', 'CDG-Ih', 1),
(17703, 'ORPHA:79325', 'CDG1H', 1),
(17704, 'ORPHA:79325', 'Carbohydrate deficient glycoprotein syndrome type Ih', 1),
(17705, 'ORPHA:79325', 'Congenital disorder of glycosylation type 1h', 1),
(17706, 'ORPHA:79325', 'Congenital disorder of glycosylation type Ih', 1),
(17707, 'ORPHA:79325', 'Glucosyltransferase 2 deficiency', 1),
(17708, 'ORPHA:79326', 'ALG2-CDG', 1),
(17709, 'ORPHA:79326', 'CDG syndrome type Ii', 1),
(17710, 'ORPHA:79326', 'CDG-Ii', 1),
(17711, 'ORPHA:79326', 'CDG1I', 1),
(17712, 'ORPHA:79326', 'Carbohydrate deficient glycoprotein syndrome type Ii', 1),
(17713, 'ORPHA:79326', 'Congenital disorder of glycosylation type 1i', 1),
(17714, 'ORPHA:79326', 'Congenital disorder of glycosylation type Ii', 1),
(17715, 'ORPHA:79326', 'Mannosyltransferase 2 deficiency', 1),
(17716, 'ORPHA:79327', 'ALG1-CDG', 1),
(17717, 'ORPHA:79327', 'CDG syndrome type Ik', 1),
(17718, 'ORPHA:79327', 'CDG-Ik', 1),
(17719, 'ORPHA:79327', 'CDG1K', 1),
(17720, 'ORPHA:79327', 'Carbohydrate deficient glycoprotein syndrome type Ik', 1),
(17721, 'ORPHA:79327', 'Congenital disorder of glycosylation type 1k', 1),
(17722, 'ORPHA:79327', 'Congenital disorder of glycosylation type Ik', 1),
(17723, 'ORPHA:79327', 'Mannosyltransferase 1 deficiency', 1),
(17724, 'ORPHA:79328', 'ALG9-CDG', 1),
(17725, 'ORPHA:79328', 'CDG syndrome type IL', 1),
(17726, 'ORPHA:79328', 'CDG-IL', 1),
(17727, 'ORPHA:79328', 'CDG1L', 1),
(17728, 'ORPHA:79328', 'Carbohydrate deficient glycoprotein syndrome type IL', 1),
(17729, 'ORPHA:79328', 'Congenital disorder of glycosylation type 1L', 1),
(17730, 'ORPHA:79328', 'Mannosyltransferase 7-9 deficiency', 1),
(17731, 'ORPHA:79329', 'CDG syndrome type IIa', 1),
(17732, 'ORPHA:79329', 'CDG-IIa', 1),
(17733, 'ORPHA:79329', 'CDG2A', 1),
(17734, 'ORPHA:79329', 'Carbohydrate deficient glycoprotein syndrome type IIa', 1),
(17735, 'ORPHA:79329', 'Congenital disorder of glycosylation type 2a', 1),
(17736, 'ORPHA:79329', 'Congenital disorder of glycosylation type IIa', 1),
(17737, 'ORPHA:79329', 'MGAT2-CDG', 1),
(17738, 'ORPHA:79329', 'N-acetylglucosaminyltransferase 2 deficiency', 1),
(17739, 'ORPHA:79330', 'CDG syndrome type IIb', 1),
(17740, 'ORPHA:79330', 'CDG-IIb', 1),
(17741, 'ORPHA:79330', 'CDG2B', 1),
(17742, 'ORPHA:79330', 'Carbohydrate deficient glycoprotein syndrome type IIb', 1),
(17743, 'ORPHA:79330', 'Congenital disorder of glycosylation type 2b', 1),
(17744, 'ORPHA:79330', 'Congenital disorder of glycosylation type IIb', 1),
(17745, 'ORPHA:79330', 'Glucosidase 1 deficiency', 1),
(17746, 'ORPHA:79330', 'MOGS-CDG', 1),
(17747, 'ORPHA:79332', 'B4GALT1-CDG', 1),
(17748, 'ORPHA:79332', 'Beta-1,4-galactosyltransferase deficiency', 1),
(17749, 'ORPHA:79332', 'CDG syndrome type IId', 1),
(17750, 'ORPHA:79332', 'CDG-IId', 1),
(17751, 'ORPHA:79332', 'CDG2D', 1),
(17752, 'ORPHA:79332', 'Carbohydrate deficient glycoprotein syndrome type IId', 1),
(17753, 'ORPHA:79332', 'Congenital disorder of glycosylation type 2d', 1),
(17754, 'ORPHA:79332', 'Congenital disorder of glycosylation type IId', 1),
(17755, 'ORPHA:79333', 'CDG syndrome type IIe', 1),
(17756, 'ORPHA:79333', 'CDG-IIe', 1),
(17757, 'ORPHA:79333', 'CDG2E', 1),
(17758, 'ORPHA:79333', 'COG7-CDG', 1),
(17759, 'ORPHA:79333', 'Carbohydrate deficient glycoprotein syndrome type IIe', 1),
(17760, 'ORPHA:79333', 'Congenital disorder of glycosylation type 2e', 1),
(17761, 'ORPHA:79333', 'Congenital disorder of glycosylation type IIe', 1),
(17762, 'ORPHA:79345', 'Brachytelephalangic chondrodysplasia punctata', 1),
(17763, 'ORPHA:79346', 'Chondrodysplasia punctata, tibial-metacarpal type', 1),
(17764, 'ORPHA:79347', 'Chondrodysplasia punctata, Toriello type', 1),
(17765, 'ORPHA:79347', 'Toriello-Higgins-Miller syndrome', 1),
(17766, 'ORPHA:79350', '3-phosphoserine phosphatase deficiency, infantile/juvenile form', 2),
(17767, 'ORPHA:79350', 'PSPH deficiency, infantile/juvenile form', 2),
(17768, 'ORPHA:79351', '3-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form', 2),
(17769, 'ORPHA:79351', 'PHGDH deficiency, infantile/juvenile form', 2),
(17770, 'ORPHA:79353', 'Epidermal disease', 3),
(17771, 'ORPHA:79354', 'Ichthyosis', 3),
(17772, 'ORPHA:79355', 'Erythrokeratoderma', 3),
(17773, 'ORPHA:79356', 'Acrokeratoderma', 3),
(17774, 'ORPHA:79357', 'Hereditary PPK', 3),
(17775, 'ORPHA:79357', 'Hereditary keratosis palmoplantaris', 3),
(17776, 'ORPHA:79357', 'Hereditary palmoplantar hyperkeratosis', 3),
(17777, 'ORPHA:79357', 'Hereditary palmoplantar keratoderma', 3),
(17778, 'ORPHA:79358', 'Porokeratosis', 3),
(17779, 'ORPHA:79359', 'Other epidermal disorder', 3),
(17780, 'ORPHA:79360', 'Other genetic epidermal disease', 3),
(17781, 'ORPHA:79361', 'Epidermolysis bullosa hereditaria', 3),
(17782, 'ORPHA:79361', 'Hereditary epidermolysis bullosa', 3),
(17783, 'ORPHA:79361', 'Inherited epidermolysis bullosa', 3),
(17784, 'ORPHA:79362', 'Epidermal appendage anomaly', 3),
(17785, 'ORPHA:79363', 'Hair anomaly', 3),
(17786, 'ORPHA:79364', 'Alopecia', 3),
(17787, 'ORPHA:79365', 'Rare disorder with hypertrichosis', 3),
(17788, 'ORPHA:79366', 'Isolated hair shaft abnormality', 3),
(17789, 'ORPHA:79367', 'Syndromic hair shaft abnormality', 3),
(17790, 'ORPHA:79368', 'Nail anomaly', 3),
(17791, 'ORPHA:79369', 'Isolated nail anomaly', 3),
(17792, 'ORPHA:79370', 'Syndromic nail anomaly', 3),
(17793, 'ORPHA:79372', 'Sebaceous gland anomaly', 3),
(17794, 'ORPHA:79373', 'Ectodermal dysplasia', 3),
(17795, 'ORPHA:79373', 'Ectodermal dysplasia syndrome', 3),
(17796, 'ORPHA:79374', 'Pigmentation anomaly of the skin', 3),
(17797, 'ORPHA:79375', 'Hyperpigmentation of the skin', 3),
(17798, 'ORPHA:79376', 'Hypopigmentation of the skin', 3),
(17799, 'ORPHA:79377', 'Dermis disorder', 3),
(17800, 'ORPHA:79378', 'Dermis elastic tissue disorder', 3),
(17801, 'ORPHA:79379', 'Skin vascular disease', 3),
(17802, 'ORPHA:79380', 'Mixed dermis disorder', 3),
(17803, 'ORPHA:79381', 'Other dermis disorder', 3),
(17804, 'ORPHA:79382', 'Subcutaneous tissue disease', 3),
(17805, 'ORPHA:79384', 'Rare urticaria', 3),
(17806, 'ORPHA:79385', 'Unclassified genetic skin disorder', 3),
(17807, 'ORPHA:79386', 'Rare skin tumor or hamartoma', 3),
(17808, 'ORPHA:79387', 'Metabolic disease with skin involvement', 3),
(17809, 'ORPHA:79388', 'MPS with skin involvement', 3),
(17810, 'ORPHA:79388', 'Mucopolysaccharidosis with skin involvement', 3),
(17811, 'ORPHA:79389', 'Premature aging', 3),
(17812, 'ORPHA:79390', 'Rare photodermatosis', 3),
(17813, 'ORPHA:79390', 'Rare skin photosensitivity', 3),
(17814, 'ORPHA:79391', 'Immune deficiency with skin involvement', 3),
(17815, 'ORPHA:79394', 'CIE', 1),
(17816, 'ORPHA:79394', 'Congenital non-bullous ichthyosiform erythroderma', 1),
(17817, 'ORPHA:79394', 'Erythrodermic ichthyosis', 1),
(17818, 'ORPHA:79394', 'Non-bullous congenital ichthyosiform erythroderma', 1),
(17819, 'ORPHA:79395', 'Camisa disease', 1),
(17820, 'ORPHA:79395', 'Keratoderma hereditarium mutilans with ichthyosis', 1),
(17821, 'ORPHA:79395', 'Keratoderma-ichthyosiform dermatosis-elevated beta-glucuronidase syndrome', 1),
(17822, 'ORPHA:79395', 'Loricrin keratoderma', 1),
(17823, 'ORPHA:79395', 'Vohwinkel syndrome with ichthyosis', 1),
(17824, 'ORPHA:79396', 'EBS, generalized severe', 1),
(17825, 'ORPHA:79396', 'Epidermolysis bullosa simplex, Dowling-Meara type', 1),
(17826, 'ORPHA:79396', 'Epidermolysis bullosa simplex, generalized severe', 1),
(17827, 'ORPHA:79396', 'Epidermolysis bullosa simplex, herpetiformis', 1),
(17828, 'ORPHA:79397', 'EBS-MP', 1),
(17829, 'ORPHA:79397', 'Epidermolysis bullosa simplex with mottled pigmentation', 1),
(17830, 'ORPHA:79399', 'EBS, generalized intermediate', 1),
(17831, 'ORPHA:79399', 'Epidermolysis bullosa simplex, Koebner type', 1),
(17832, 'ORPHA:79399', 'Epidermolysis bullosa simplex, Köbner type', 1),
(17833, 'ORPHA:79399', 'Epidermolysis bullosa simplex, generalized intermediate', 1),
(17834, 'ORPHA:79399', 'Generalized EBS, non-Dowling-Meara type', 1),
(17835, 'ORPHA:79399', 'Generalized epidermolysis bullosa simplex, non-Dowling-Meara type', 1),
(17836, 'ORPHA:794', 'ACS3', 1),
(17837, 'ORPHA:794', 'Acrocephalosyndactyly type 3', 1),
(17838, 'ORPHA:794', 'SCS', 1),
(17839, 'ORPHA:794', 'Saethre-Chotzen syndrome', 1),
(17840, 'ORPHA:79400', 'EBS-loc', 1),
(17841, 'ORPHA:79400', 'Epidermolysis bullosa simplex of palms and soles', 1),
(17842, 'ORPHA:79400', 'Epidermolysis bullosa simplex, Weber-Cockayne type', 1),
(17843, 'ORPHA:79400', 'Localized epidermolysis bullosa simplex', 1),
(17844, 'ORPHA:79401', 'EBS-O', 1),
(17845, 'ORPHA:79401', 'Epidermolysis bullosa simplex, Ogna type', 1),
(17846, 'ORPHA:79402', 'GABEB', 2),
(17847, 'ORPHA:79402', 'Generalized atrophic benign epidermolysis bullosa', 2),
(17848, 'ORPHA:79402', 'Generalized junctional epidermolysis bullosa, non-Herlitz type', 2),
(17849, 'ORPHA:79402', 'JEB, generalized intermediate', 2),
(17850, 'ORPHA:79402', 'JEB-nH gen', 2),
(17851, 'ORPHA:79402', 'Junctional epidermolysis bullosa generalisata mitis', 2),
(17852, 'ORPHA:79402', 'Junctional epidermolysis bullosa, Disentis type', 2),
(17853, 'ORPHA:79402', 'Junctional epidermolysis bullosa, generalized intermediate', 2),
(17854, 'ORPHA:79403', 'Carmi syndrome', 1),
(17855, 'ORPHA:79403', 'JEB-PA', 1),
(17856, 'ORPHA:79403', 'Junctional epidermolysis bullosa-pyloric atresia syndrome', 1),
(17857, 'ORPHA:79404', 'Epidermolysis bullosa letalis', 1),
(17858, 'ORPHA:79404', 'JEB, generalized severe', 1),
(17859, 'ORPHA:79404', 'JEB-H', 1),
(17860, 'ORPHA:79404', 'Junctional epidermolysis bullosa generalisata gravis', 1),
(17861, 'ORPHA:79404', 'Junctional epidermolysis bullosa, Herlitz type', 1),
(17862, 'ORPHA:79404', 'Junctional epidermolysis bullosa, Herlitz-Pearson type', 1),
(17863, 'ORPHA:79404', 'Junctional epidermolysis bullosa, generalized severe', 1),
(17864, 'ORPHA:79405', 'EBJ-I', 1),
(17865, 'ORPHA:79405', 'Inverse JEB', 1),
(17866, 'ORPHA:79405', 'JEB-I', 1),
(17867, 'ORPHA:79405', 'Junctional epidermolysis bullosa inversa', 1),
(17868, 'ORPHA:79406', 'Epidermolysis bullosa progressiva', 1),
(17869, 'ORPHA:79406', 'JEB-lo', 1),
(17870, 'ORPHA:79406', 'Late-onset JEB', 1),
(17871, 'ORPHA:79406', 'Late-onset junctional epidermolysis bullosa', 1),
(17872, 'ORPHA:79408', 'Autosomal recessive dystrophic epidermolysis bullosa generalisata gravis', 1),
(17873, 'ORPHA:79408', 'Autosomal recessive dystrophic epidermolysis bullosa, Hallopeau-Siemens type', 1),
(17874, 'ORPHA:79408', 'RDEB generalisata gravis', 1),
(17875, 'ORPHA:79408', 'RDEB, Hallopeau-Siemens type', 1),
(17876, 'ORPHA:79408', 'RDEB-sev gen', 1),
(17877, 'ORPHA:79408', 'Severe generalized RDEB', 1),
(17878, 'ORPHA:79408', 'Severe generalized recessive dystrophic epidermolysis bullosa', 1),
(17879, 'ORPHA:79409', 'Dystrophic epidermolysis bullosa inversa', 1),
(17880, 'ORPHA:79409', 'Inverse RDEB', 1),
(17881, 'ORPHA:79409', 'Inverse recessive dystrophic epidermolysis bullosa', 1),
(17882, 'ORPHA:79409', 'RDEB-I', 1),
(17883, 'ORPHA:79409', 'Recessive dystrophic epidermolysis bullosa inversa', 1),
(17884, 'ORPHA:79410', 'DEB-Pt', 1),
(17885, 'ORPHA:79410', 'Pretibial DEB', 1),
(17886, 'ORPHA:79410', 'Pretibial dystrophic epidermolysis bullosa', 1),
(17887, 'ORPHA:79411', 'DEB, bullous dermolysis of the newborn', 1),
(17888, 'ORPHA:79411', 'DEB-BDN', 1),
(17889, 'ORPHA:79411', 'Transient bullous dermolysis of the newborn', 1),
(17890, 'ORPHA:79414', 'Woolly hair nevus', 1),
(17891, 'ORPHA:79414', 'Wooly hair nevus', 1),
(17892, 'ORPHA:79430', 'HPS', 1),
(17893, 'ORPHA:79430', 'Hermansky-Pudlak syndrome', 1),
(17894, 'ORPHA:79431', 'OCA1A', 2),
(17895, 'ORPHA:79431', 'Oculocutaneous albinism type 1A', 2),
(17896, 'ORPHA:79431', 'Tyrosinase-negative oculocutaneous albinism', 2),
(17897, 'ORPHA:79432', 'OCA2', 1),
(17898, 'ORPHA:79432', 'Oculocutaneous albinism type 2', 1),
(17899, 'ORPHA:79433', 'OCA3', 1),
(17900, 'ORPHA:79433', 'Oculocutaneous albinism type 3', 1),
(17901, 'ORPHA:79433', 'Red oculocutaneous albinism', 1),
(17902, 'ORPHA:79433', 'Rufous oculocutaneous albinism', 1),
(17903, 'ORPHA:79433', 'Xanthous oculocutaneous albinism', 1),
(17904, 'ORPHA:79434', 'OCA1B', 2),
(17905, 'ORPHA:79434', 'Oculocutaneous albinism type 1B', 2),
(17906, 'ORPHA:79434', 'Oculocutaneous albinism, Amish type', 2),
(17907, 'ORPHA:79434', 'Platinum oculocutaneous albinism', 2),
(17908, 'ORPHA:79434', 'Yellow oculocutaneous albinism', 2),
(17909, 'ORPHA:79435', 'OCA4', 1),
(17910, 'ORPHA:79435', 'Oculocutaneous albinism type 4', 1),
(17911, 'ORPHA:79443', 'AHO-PHP syndrome Ia', 1),
(17912, 'ORPHA:79443', 'Albright hereditary osteodystrophy-PHP syndrome Ia', 1),
(17913, 'ORPHA:79443', 'Pseudohypoparathyroidism type 1A', 1),
(17914, 'ORPHA:79444', 'Pseudohypoparathyroidism type 1C', 1),
(17915, 'ORPHA:79445', 'AHO-PPHP syndrome', 1),
(17916, 'ORPHA:79445', 'Albright hereditary osteodystrophy-PPHP syndrome', 1),
(17917, 'ORPHA:79445', 'Pseudopseudohypoparathyroidism', 1),
(17918, 'ORPHA:79447', 'X-linked lethal multiple pterygium syndrome', 1),
(17919, 'ORPHA:79452', 'Hereditary lymphedema type I', 1),
(17920, 'ORPHA:79452', 'Milroy disease', 1),
(17921, 'ORPHA:79452', 'Nonne-Milroy lymphedema', 1),
(17922, 'ORPHA:79455', 'Cutaneous local mastocytoma', 1),
(17923, 'ORPHA:79455', 'Cutaneous mastocytoma', 1),
(17924, 'ORPHA:79455', 'Multiple mastocytoma', 1),
(17925, 'ORPHA:79455', 'Solitary mastocytoma', 1),
(17926, 'ORPHA:79456', 'DCM', 1),
(17927, 'ORPHA:79456', 'Diffuse cutaneous maculopapulous mastocytosis', 1),
(17928, 'ORPHA:79456', 'Diffuse cutaneous mastocytosis', 1),
(17929, 'ORPHA:79457', 'Maculopapular cutaneous mastocytosis', 1),
(17930, 'ORPHA:79457', 'Urticaria pigmentosa', 1),
(17931, 'ORPHA:79459', 'Follicular atrophoderma-basal cell carcinoma', 2),
(17932, 'ORPHA:79466', 'ILVEN', 2),
(17933, 'ORPHA:79466', 'Inflammatory linear verrucous epidermal nevus', 2),
(17934, 'ORPHA:79467', 'Verrucous nevus', 2),
(17935, 'ORPHA:79468', 'Acanthokeratolytic verrucous nevus', 2),
(17936, 'ORPHA:79473', 'Porphyria variegata', 1),
(17937, 'ORPHA:79473', 'Protoporphyrinogen oxidase deficiency', 1),
(17938, 'ORPHA:79473', 'Variegate porphyria', 1),
(17939, 'ORPHA:79474', 'Atypical Werner syndrome', 1),
(17940, 'ORPHA:79474', 'Atypical progeroid syndrome', 1),
(17941, 'ORPHA:79476', 'Griscelli syndrome type 1', 2),
(17942, 'ORPHA:79476', 'Griscelli-Pruniéras syndrome type 1', 2),
(17943, 'ORPHA:79476', 'Hypopigmentation-neurologic impairment syndrome', 2),
(17944, 'ORPHA:79477', 'Griscelli syndrome type 2', 2),
(17945, 'ORPHA:79477', 'Griscelli-Pruniéras syndrome type 2', 2),
(17946, 'ORPHA:79477', 'Hypopigmentation-immunodeficiency with or without neurologic impairment syndrome', 2),
(17947, 'ORPHA:79478', 'Griscelli syndrome type 3', 2),
(17948, 'ORPHA:79478', 'Griscelli-Pruniéras syndrome type 3', 2),
(17949, 'ORPHA:79479', 'Pemphigus vegetans', 1),
(17950, 'ORPHA:79480', 'Pemphigus erythematosus', 1),
(17951, 'ORPHA:79480', 'Seborrheic pemphigus', 1),
(17952, 'ORPHA:79480', 'Senear-Usher syndrome', 1),
(17953, 'ORPHA:79481', 'Pemphigus foliaceus', 1),
(17954, 'ORPHA:79483', 'Phakomatosis cesioflammea', 2),
(17955, 'ORPHA:79483', 'Phakomatosis pigmentovascularis type 2', 2),
(17956, 'ORPHA:79484', 'Phakomatosis cesiomarmorata', 2),
(17957, 'ORPHA:79484', 'Phakomatosis pigmentovascularis type 5', 2),
(17958, 'ORPHA:79485', 'Phakomatosis pigmentovascularis type 3', 2),
(17959, 'ORPHA:79485', 'Phakomatosis spilorosea', 2),
(17960, 'ORPHA:79489', 'Cavernous lymphangioma', 1),
(17961, 'ORPHA:79489', 'Cavernous lymphatic malformation', 1),
(17962, 'ORPHA:79489', 'Macrocystic lymphangioma', 1),
(17963, 'ORPHA:79489', 'Macrocystic lymphatic malformation', 1),
(17964, 'ORPHA:79490', 'Capillary lymphangioma', 1),
(17965, 'ORPHA:79490', 'Capillary lymphatic malformation', 1),
(17966, 'ORPHA:79490', 'Cutaneous lymphangioma circumscriptum', 1),
(17967, 'ORPHA:79490', 'Microcystic infiltrating lymphatic malformation', 1),
(17968, 'ORPHA:79490', 'Microcystic lymphangioma', 1),
(17969, 'ORPHA:79490', 'Microcystic lymphatic malformation', 1),
(17970, 'ORPHA:79490', 'Superficial lymphangioma', 1),
(17971, 'ORPHA:79490', 'Superficial lymphatic malformation', 1),
(17972, 'ORPHA:79492', 'Pili gemini', 1),
(17973, 'ORPHA:79492', 'Pili multigemini', 1),
(17974, 'ORPHA:79493', 'Brooke-Spiegler syndrome', 1),
(17975, 'ORPHA:79493', 'CYLD cutaneous syndrome', 1),
(17976, 'ORPHA:79495', 'Congenital generalized hypertrichosis, Macias-Flores type', 2),
(17977, 'ORPHA:79495', 'Macias Flores-Garcia Cruz-Rivera syndrome', 2),
(17978, 'ORPHA:79495', 'X-linked congenital generalized hypertrichosis', 2),
(17979, 'ORPHA:79499', 'Autosomal dominant deafness-onychodystrophy syndrome', 1),
(17980, 'ORPHA:79499', 'Autosomal dominant hearing loss-onychodystrophy syndrome', 1),
(17981, 'ORPHA:79499', 'DDOD syndrome', 1),
(17982, 'ORPHA:795', 'Rare form of salmonellosis', 3),
(17983, 'ORPHA:79500', 'Autosomal recessive deafness-onychodystrophy syndrome', 1),
(17984, 'ORPHA:79500', 'Autosomal recessive hearing loss-onychodystrophy syndrome', 1),
(17985, 'ORPHA:79500', 'DOOR syndrome', 1),
(17986, 'ORPHA:79500', 'DOORS syndrome', 1),
(17987, 'ORPHA:79500', 'Deafness-onychodystrophy-osteodystrophy-intellectual disability syndrome', 1),
(17988, 'ORPHA:79500', 'Deafness-onychodystrophy-osteodystrophy-intellectual disability-seizures syndrome', 1),
(17989, 'ORPHA:79500', 'Deafness-onychoosteodystrophy-intellectual disability syndrome', 1),
(17990, 'ORPHA:79500', 'Hearing loss-onychodystrophy-osteodystrophy-intellectual disability syndrome', 1),
(17991, 'ORPHA:79500', 'Hearing loss-onychodystrophy-osteodystrophy-intellectual disability-seizures syndrome', 1),
(17992, 'ORPHA:79500', 'Hearing loss-onychoosteodystrophy-intellectual disability syndrome', 1),
(17993, 'ORPHA:79501', 'Buschke-Fischer-Brauer syndrome', 1),
(17994, 'ORPHA:79501', 'Keratodermia palmoplantaris papulosa, Buschke-Fischer-Brauer type', 1),
(17995, 'ORPHA:79501', 'PPKP1', 1),
(17996, 'ORPHA:79501', 'Punctate palmoplantar keratoderma type 1', 1),
(17997, 'ORPHA:79502', 'PPKP2', 1),
(17998, 'ORPHA:79502', 'PPPP', 1),
(17999, 'ORPHA:79502', 'Punctate palmoplantar hyperkeratosis type 2', 1),
(18000, 'ORPHA:79502', 'Punctate palmoplantar keratoderma type 2', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(18001, 'ORPHA:79503', 'Ichthyosis hystrix of Curth-Macklin', 1),
(18002, 'ORPHA:79503', 'Ichthyosis hystrix, Curth-Macklin type', 1),
(18003, 'ORPHA:79506', 'CEPT deficiency', 1),
(18004, 'ORPHA:79506', 'Cholesterol-ester transfer protein deficiency', 1),
(18005, 'ORPHA:79506', 'Familial hyperalphalipoproteinemia', 1),
(18006, 'ORPHA:79507', 'Hypotonia-failure to thrive-microcephaly syndrome', 1),
(18007, 'ORPHA:79507', 'LTC4 synthase deficiency', 1),
(18008, 'ORPHA:79507', 'Leukotriene C4 synthase deficiency', 1),
(18009, 'ORPHA:796', 'GM2 gangliosidosis 0 variant', 1),
(18010, 'ORPHA:796', 'Hexosaminidases A and B deficiency', 1),
(18011, 'ORPHA:796', 'Sandhoff disease', 1),
(18012, 'ORPHA:79643', 'Autosomal recessive hyperinsulinemic hypoglycemia due to SUR1 deficiency', 1),
(18013, 'ORPHA:79643', 'Autosomal recessive hyperinsulinism due to SUR1 deficiency', 1),
(18014, 'ORPHA:79644', 'Autosomal recessive hyperinsulinemic hypoglycemia due to Kir6.2 deficiency', 1),
(18015, 'ORPHA:79644', 'Autosomal recessive hyperinsulinism due to Kir6.2 deficiency', 1),
(18016, 'ORPHA:79651', 'Mild HPA', 2),
(18017, 'ORPHA:79651', 'Mild hyperphenylalaninemia', 2),
(18018, 'ORPHA:79651', 'Non-PKU HPA', 2),
(18019, 'ORPHA:79651', 'mHPA', 2),
(18020, 'ORPHA:79665', 'Gardner syndrome', 2),
(18021, 'ORPHA:79669', 'Autoimmune bullous skin disease', 3),
(18022, 'ORPHA:797', 'Besnier-Boeck-Schaumann disease', 1),
(18023, 'ORPHA:797', 'Boeck sarcoid', 1),
(18024, 'ORPHA:797', 'Sarcoidosis', 1),
(18025, 'ORPHA:798', 'SGS', 1),
(18026, 'ORPHA:798', 'Schinzel-Giedion syndrome', 1),
(18027, 'ORPHA:799', 'Schizencephaly', 1),
(18028, 'ORPHA:8', '47,XYY syndrome', 1),
(18029, 'ORPHA:8', 'Double Y syndrome', 1),
(18030, 'ORPHA:8', 'XYY syndrome', 1),
(18031, 'ORPHA:8', 'Y disomy', 1),
(18032, 'ORPHA:800', 'Aberfeld syndrome', 1),
(18033, 'ORPHA:800', 'Burton skeletal dysplasia', 1),
(18034, 'ORPHA:800', 'Burton syndrome', 1),
(18035, 'ORPHA:800', 'Catel-Hempel syndrome', 1),
(18036, 'ORPHA:800', 'Dysostosis enchondralis metaepiphysaria, Catel-Hempel type', 1),
(18037, 'ORPHA:800', 'Myotonic chondrodystrophy', 1),
(18038, 'ORPHA:800', 'Myotonic myopathy, dwarfism, chondrodystrophy, ocular and facial anomalies', 1),
(18039, 'ORPHA:800', 'Osteochondromuscular dystrophy', 1),
(18040, 'ORPHA:800', 'SJS', 1),
(18041, 'ORPHA:800', 'SJS1', 1),
(18042, 'ORPHA:800', 'Schwartz-Jampel syndrome', 1),
(18043, 'ORPHA:800', 'Schwartz-Jampel syndrome type 1', 1),
(18044, 'ORPHA:800', 'Schwartz-Jampel-Aberfeld syndrome', 1),
(18045, 'ORPHA:801', 'Scleroderma', 3),
(18046, 'ORPHA:803', 'ALS', 1),
(18047, 'ORPHA:803', 'Amyotrophic lateral sclerosis', 1),
(18048, 'ORPHA:803', 'Charcot disease', 1),
(18049, 'ORPHA:803', 'Lou Gehrig disease', 1),
(18050, 'ORPHA:805', 'Bourneville syndrome', 1),
(18051, 'ORPHA:805', 'Tuberous sclerosis', 1),
(18052, 'ORPHA:805', 'Tuberous sclerosis complex', 1),
(18053, 'ORPHA:806', 'Scott syndrome', 1),
(18054, 'ORPHA:808', 'Seckel syndrome', 1),
(18055, 'ORPHA:809', 'MCTD', 1),
(18056, 'ORPHA:809', 'Mixed connective tissue disease', 1),
(18057, 'ORPHA:809', 'Sharp syndrome', 1),
(18058, 'ORPHA:81', 'AS syndrome', 1),
(18059, 'ORPHA:81', 'Anti-Jo1 syndrome', 1),
(18060, 'ORPHA:81', 'Antisynthetase syndrome', 1),
(18061, 'ORPHA:810', 'Shigellosis', 1),
(18062, 'ORPHA:811', 'Pancreatic insufficiency and bone marrow dysfunction', 1),
(18063, 'ORPHA:811', 'SDS', 1),
(18064, 'ORPHA:811', 'Shwachman syndrome', 1),
(18065, 'ORPHA:811', 'Shwachman-Bodian-Diamond syndrome', 1),
(18066, 'ORPHA:811', 'Shwachman-Diamond syndrome', 1),
(18067, 'ORPHA:812', 'Cherry-red spot-myoclonus syndrome', 1),
(18068, 'ORPHA:812', 'Lipomucopolysaccharidosis', 1),
(18069, 'ORPHA:812', 'Normomorphic sialidosis', 1),
(18070, 'ORPHA:812', 'Sialidosis type 1', 1),
(18071, 'ORPHA:813', 'Silver-Russell dwarfism', 1),
(18072, 'ORPHA:813', 'Silver-Russell syndrome', 1),
(18073, 'ORPHA:816', 'Fatty acid alcohol oxidoreductase deficiency', 1),
(18074, 'ORPHA:816', 'Sjögren-Larsson syndrome', 1),
(18075, 'ORPHA:817', 'Deciduous skin', 3),
(18076, 'ORPHA:817', 'Familial continuous skin peeling syndrome', 3),
(18077, 'ORPHA:817', 'Idiopathic deciduous skin', 3),
(18078, 'ORPHA:817', 'Keratosis exfoliativa congenita', 3),
(18079, 'ORPHA:817', 'PSS', 3),
(18080, 'ORPHA:817', 'Peeling skin disease', 3),
(18081, 'ORPHA:817', 'Peeling skin syndrome', 3),
(18082, 'ORPHA:818', '7-dehydrocholesterol reductase deficiency', 1),
(18083, 'ORPHA:818', 'RSH syndrome', 1),
(18084, 'ORPHA:818', 'SLOS', 1),
(18085, 'ORPHA:818', 'Smith-Lemli-Opitz syndrome', 1),
(18086, 'ORPHA:819', '17p11.2 microdeletion syndrome', 1),
(18087, 'ORPHA:819', 'Smith-Magenis syndrome', 1),
(18088, 'ORPHA:82', 'Hereditary thrombophilia due to congenital antithrombin 3 deficiency', 1),
(18089, 'ORPHA:82', 'Hereditary thrombophilia due to congenital antithrombin deficiency', 1),
(18090, 'ORPHA:820', 'Ehrmann-Sneddon syndrome', 1),
(18091, 'ORPHA:820', 'Livedo racemosa-cerebrovascular accident syndrome', 1),
(18092, 'ORPHA:820', 'Livedo reticularis-cerebrovascular accident syndrome', 1),
(18093, 'ORPHA:820', 'Sneddon syndrome', 1),
(18094, 'ORPHA:821', 'Cerebral gigantism', 1),
(18095, 'ORPHA:821', 'Sotos syndrome', 1),
(18096, 'ORPHA:822', 'Hereditary spherocytosis', 1),
(18097, 'ORPHA:822', 'Minkowski-Chauffard disease', 1),
(18098, 'ORPHA:823', 'Isolated spina bifida', 3),
(18099, 'ORPHA:824', 'Agnogenic myeloid metaplasia', 1),
(18100, 'ORPHA:824', 'Idiopathic myelofibrosis', 1),
(18101, 'ORPHA:824', 'Myelofibrosis with myeloid metaplasia', 1),
(18102, 'ORPHA:824', 'Osteomyelofibrosis', 1),
(18103, 'ORPHA:824', 'Primary myelofibrosis', 1),
(18104, 'ORPHA:826', 'Sporotrichosis', 1),
(18105, 'ORPHA:827', 'Fundus flavimaculatus', 1),
(18106, 'ORPHA:827', 'Stargardt 1', 1),
(18107, 'ORPHA:827', 'Stargardt disease', 1),
(18108, 'ORPHA:828', 'Hereditary progressive arthroophthalmopathy', 1),
(18109, 'ORPHA:828', 'Stickler syndrome', 1),
(18110, 'ORPHA:829', 'AOSD', 1),
(18111, 'ORPHA:829', 'Adult-onset Still disease', 1),
(18112, 'ORPHA:829', 'Wissler-Fanconi syndrome', 1),
(18113, 'ORPHA:83', 'Antley-Bixler syndrome', 1),
(18114, 'ORPHA:83001', 'Urogenital tract malformation', 3),
(18115, 'ORPHA:831', 'Congenital cervical spinal stenosis', 1),
(18116, 'ORPHA:831', 'Congenital narrowing of cervical spinal canal', 1),
(18117, 'ORPHA:831', 'Congenital stenosis of the cervical spine', 1),
(18118, 'ORPHA:832', 'OXCT1 deficiency', 1),
(18119, 'ORPHA:832', 'SCOT deficiency', 1),
(18120, 'ORPHA:832', 'Succinyl-CoA acetoacetate transferase deficiency', 1),
(18121, 'ORPHA:832', 'Succinyl-CoA:3-ketoacid CoA transferase deficiency', 1),
(18122, 'ORPHA:832', 'Succinyl-CoA:3-oxoacid CoA transferase deficiency', 1),
(18123, 'ORPHA:833', 'Encephalopathy due to sulfite oxidase deficiency', 1),
(18124, 'ORPHA:83311', 'Rocky Mountain spotted fever', 1),
(18125, 'ORPHA:83312', 'Rickettsialpox', 1),
(18126, 'ORPHA:83313', 'Boutonneuse fever', 1),
(18127, 'ORPHA:83313', 'Mediterranean spotted fever', 1),
(18128, 'ORPHA:83314', 'Epidemic typhus', 1),
(18129, 'ORPHA:83315', 'Endemic typhus', 1),
(18130, 'ORPHA:83315', 'Flea-borne typhus', 1),
(18131, 'ORPHA:83315', 'Murine typhus', 1),
(18132, 'ORPHA:83316', 'Pseudotyphus of California', 1),
(18133, 'ORPHA:83317', 'Scrub typhus', 1),
(18134, 'ORPHA:83317', 'Tsutsugamushi disease', 1),
(18135, 'ORPHA:83317', 'Tsutsugamushi fever', 1),
(18136, 'ORPHA:83330', 'Infantile spinal muscular atrophy', 2),
(18137, 'ORPHA:83330', 'Proximal spinal muscular atrophy type 1', 2),
(18138, 'ORPHA:83330', 'SMA type 1', 2),
(18139, 'ORPHA:83330', 'SMA type I', 2),
(18140, 'ORPHA:83330', 'SMA-I', 2),
(18141, 'ORPHA:83330', 'SMA1', 2),
(18142, 'ORPHA:83330', 'Werdnig-Hoffmann disease', 2),
(18143, 'ORPHA:834', 'Free sialic acid storage disease', 1),
(18144, 'ORPHA:83418', 'Chronic infantile spinal muscular atrophy', 2),
(18145, 'ORPHA:83418', 'Chronic spinal muscular atrophy', 2),
(18146, 'ORPHA:83418', 'Intermediate spinal muscular atrophy', 2),
(18147, 'ORPHA:83418', 'Proximal spinal muscular atrophy type 2', 2),
(18148, 'ORPHA:83418', 'SMA type 2', 2),
(18149, 'ORPHA:83418', 'SMA type II', 2),
(18150, 'ORPHA:83418', 'SMA-II', 2),
(18151, 'ORPHA:83418', 'SMA2', 2),
(18152, 'ORPHA:83419', 'Juvenile spinal muscular atrophy', 2),
(18153, 'ORPHA:83419', 'Kugelberg-Welander disease', 2),
(18154, 'ORPHA:83419', 'Proximal spinal muscular atrophy type 3', 2),
(18155, 'ORPHA:83419', 'SMA type 3', 2),
(18156, 'ORPHA:83419', 'SMA type III', 2),
(18157, 'ORPHA:83419', 'SMA-III', 2),
(18158, 'ORPHA:83419', 'SMA3', 2),
(18159, 'ORPHA:83420', 'Proximal spinal muscular atrophy type 4', 2),
(18160, 'ORPHA:83420', 'SMA type 4', 2),
(18161, 'ORPHA:83420', 'SMA type IV', 2),
(18162, 'ORPHA:83420', 'SMA-IV', 2),
(18163, 'ORPHA:83420', 'SMA4', 2),
(18164, 'ORPHA:83420', 'Spinal muscular atrophy, adult form', 2),
(18165, 'ORPHA:83450', 'Ghost teeth', 1),
(18166, 'ORPHA:83450', 'Regional odontodysplasia', 1),
(18167, 'ORPHA:83451', 'Florid cemento-osseous dysplasia', 1),
(18168, 'ORPHA:83451', 'Florid osseous dysplasia', 1),
(18169, 'ORPHA:83451', 'Focal cemento-osseous dysplasia', 1),
(18170, 'ORPHA:83452', 'Complex regional pain syndrome', 1),
(18171, 'ORPHA:83453', 'Vulvovaginal gingival syndrome', 1),
(18172, 'ORPHA:83454', 'Glomangiomatosis', 1),
(18173, 'ORPHA:83454', 'Glomuvenous malformation', 1),
(18174, 'ORPHA:83454', 'Hereditary multiple glomangiomas', 1),
(18175, 'ORPHA:83454', 'Multiple glomus tumors', 1),
(18176, 'ORPHA:83454', 'VMGLOM', 1),
(18177, 'ORPHA:83454', 'Venous malformations with glomus cells', 1),
(18178, 'ORPHA:83461', 'Congenital primary aphakia', 1),
(18179, 'ORPHA:83463', 'Microtia', 1),
(18180, 'ORPHA:83465', 'Narcolepsy type 2', 1),
(18181, 'ORPHA:83465', 'Narcolepsy without cataplexy', 1),
(18182, 'ORPHA:83467', 'Limbic encephalitis-neuromyotonia-hyperhidrosis-polyneuropathy syndrome', 1),
(18183, 'ORPHA:83467', 'Morvan fibrillary chorea', 1),
(18184, 'ORPHA:83467', 'Morvan syndrome', 1),
(18185, 'ORPHA:83468', 'Solitary bone cyst', 1),
(18186, 'ORPHA:83468', 'Unicameral bone cyst', 1),
(18187, 'ORPHA:83469', 'DSRCT', 1),
(18188, 'ORPHA:83469', 'Desmoplastic small round cell tumor', 1),
(18189, 'ORPHA:83471', 'Nezelof syndrome', 1),
(18190, 'ORPHA:83471', 'Thymic aplasia', 1),
(18191, 'ORPHA:83472', 'CAMOS syndrome', 1),
(18192, 'ORPHA:83472', 'Cerebellar ataxia-intellectual disability-optic atrophy-skin abnormalities syndrome', 1),
(18193, 'ORPHA:83472', 'SCAR5', 1),
(18194, 'ORPHA:83473', 'MPPH syndrome', 1),
(18195, 'ORPHA:83473', 'Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome', 1),
(18196, 'ORPHA:83476', 'West-Nile encephalitis', 1),
(18197, 'ORPHA:83476', 'West-Nile fever', 1),
(18198, 'ORPHA:83482', 'Mycoplasma encephalitis', 1),
(18199, 'ORPHA:83483', 'Californian encephalitis', 1),
(18200, 'ORPHA:83483', 'La Crosse encephalitis', 1),
(18201, 'ORPHA:83484', 'Saint Louis encephalitis', 1),
(18202, 'ORPHA:83484', 'St. Louis encephalitis', 1),
(18203, 'ORPHA:83593', 'Western equine encephalitis', 1),
(18204, 'ORPHA:83593', 'Western equine encephalomyelitis', 1),
(18205, 'ORPHA:83594', 'Eastern equine encephalitis', 1),
(18206, 'ORPHA:83594', 'Eastern equine encephalomyelitis', 1),
(18207, 'ORPHA:83595', 'American mountain fever', 1),
(18208, 'ORPHA:83595', 'Colorado tick encephalitis', 1),
(18209, 'ORPHA:83595', 'Colorado tick fever', 1),
(18210, 'ORPHA:83595', 'Colorado tick-borne disease', 1),
(18211, 'ORPHA:83595', 'Mountain fever', 1),
(18212, 'ORPHA:83595', 'Mountain tick fever', 1),
(18213, 'ORPHA:83597', 'ADEM', 1),
(18214, 'ORPHA:83597', 'Acute disseminated encephalitis', 1),
(18215, 'ORPHA:83597', 'Acute disseminated encephalomyelitis', 1),
(18216, 'ORPHA:83600', 'Encephalitis lethargica', 1),
(18217, 'ORPHA:83600', 'Von Economo encephalitis', 1),
(18218, 'ORPHA:83601', 'Hashimoto encephalitis', 1),
(18219, 'ORPHA:83601', 'SREAT', 1),
(18220, 'ORPHA:83601', 'Steroid-responsive encephalopathy associated with autoimmune thyroiditis', 1),
(18221, 'ORPHA:83616', 'Rubella panencephalitis', 1),
(18222, 'ORPHA:83617', 'Agammaglobulinemia-microcephaly-craniosynostosis-severe dermatitis syndrome', 1),
(18223, 'ORPHA:83619', 'Macrostomia-preauricular tags-external ophthalmoplegia syndrome', 1),
(18224, 'ORPHA:83620', 'Congenital malabsorptive diarrhea due to paucity of enteroendocrine cells', 1),
(18225, 'ORPHA:83620', 'Enteric anendocrinosis', 1),
(18226, 'ORPHA:83628', 'LUMBAR syndrome', 1),
(18227, 'ORPHA:83628', 'Lower body hemangioma-urogenital anomalies-myelopathy-bony deformities-anorectal and arterial malformations-renal anomalies syndrome', 1),
(18228, 'ORPHA:83628', 'PELVIS syndrome', 1),
(18229, 'ORPHA:83628', 'Perineal hemangioma-external genitalia malformations-lipomyelomeningocele-vesicorenal abnormalities-imperforate anus-skin tag syndrome', 1),
(18230, 'ORPHA:83628', 'SACRAL syndrome', 1),
(18231, 'ORPHA:83629', 'H-SMD', 1),
(18232, 'ORPHA:83629', 'Hypomyelination-spondyloepimetaphyseal dysplasia syndrome', 1),
(18233, 'ORPHA:83629', 'Leukoencephalopathy-SEMD syndrome', 1),
(18234, 'ORPHA:83629', 'Leukoencephalopathy-metaphyseal chondrodysplasia syndrome', 1),
(18235, 'ORPHA:83629', 'Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome', 1),
(18236, 'ORPHA:83639', 'Congenital disorder of glycosylation due to PIGM deficiency', 1),
(18237, 'ORPHA:83639', 'Hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency', 1),
(18238, 'ORPHA:83639', 'PIGM-CDG', 1),
(18239, 'ORPHA:83642', 'Microcytic anemia with liver iron overload', 1),
(18240, 'ORPHA:838', 'RED-M', 1),
(18241, 'ORPHA:838', 'Retinocochleocerebral vasculopathy', 1),
(18242, 'ORPHA:838', 'Retinopathy-encephalopathy-deafness associated with microangiopathy', 1),
(18243, 'ORPHA:838', 'Retinopathy-encephalopathy-hearing loss associated with microangiopathy', 1),
(18244, 'ORPHA:838', 'SICRET syndrome', 1),
(18245, 'ORPHA:838', 'Small infarctions of cochlear, retinal and encephalic tissue', 1),
(18246, 'ORPHA:838', 'Susac syndrome', 1),
(18247, 'ORPHA:839', 'Congenital nephrotic syndrome, Finnish type', 1),
(18248, 'ORPHA:839', 'Finnish congenital nephrosis', 1),
(18249, 'ORPHA:84', 'Fanconi anemia', 1),
(18250, 'ORPHA:84', 'Fanconi pancytopenia', 1),
(18251, 'ORPHA:840', 'Fistulous vegetative verrucous hydradenoma', 1),
(18252, 'ORPHA:840', 'Naevus syringocystadenomatosus papilliferus', 1),
(18253, 'ORPHA:840', 'SCAP', 1),
(18254, 'ORPHA:840', 'Syringadenoma papilliferum', 1),
(18255, 'ORPHA:840', 'Syringocystadenoma papilliferum', 1),
(18256, 'ORPHA:84064', 'Phenotypic diarrhea', 1),
(18257, 'ORPHA:84064', 'SD/THE', 1),
(18258, 'ORPHA:84064', 'Syndromic diarrhea', 1),
(18259, 'ORPHA:84064', 'Syndromic diarrhea/Tricho-hepato-enteric syndrome', 1),
(18260, 'ORPHA:84064', 'Tricho-hepato-enteric syndrome', 1),
(18261, 'ORPHA:84064', 'Trichohepatoenteric syndrome', 1),
(18262, 'ORPHA:84065', 'Idiopathic bile acid malabsorption', 1),
(18263, 'ORPHA:84065', 'Idiopathic malabsorption due to bile acid synthesis defects', 1),
(18264, 'ORPHA:84081', 'Boichis disease', 1),
(18265, 'ORPHA:84081', 'Nephronophthisis-hepatic fibrosis syndrome', 1),
(18266, 'ORPHA:84081', 'Senior-Boichis syndrome', 1),
(18267, 'ORPHA:84085', 'HAS', 1),
(18268, 'ORPHA:84085', 'HS', 1),
(18269, 'ORPHA:84085', 'Hinman syndrome', 1),
(18270, 'ORPHA:84085', 'Hinman-Allen syndrome', 1),
(18271, 'ORPHA:84085', 'Non-neurogenic neurogenic bladder', 1),
(18272, 'ORPHA:84085', 'Occult neuropathic bladder', 1),
(18273, 'ORPHA:84087', 'Collagen type III glomerulopathy', 1),
(18274, 'ORPHA:84087', 'Collagenofibrotic glomerulopathy', 1),
(18275, 'ORPHA:84090', 'Fibronectin glomerulopathy', 1),
(18276, 'ORPHA:84090', 'GFND', 1),
(18277, 'ORPHA:84090', 'Glomerulopathy with fibronectin deposits', 1),
(18278, 'ORPHA:84093', 'Hereditary thermosensitive neuropathy', 1),
(18279, 'ORPHA:841', 'Sebocystomatosis', 1),
(18280, 'ORPHA:841', 'Steatocystoma multiplex', 1),
(18281, 'ORPHA:84132', 'Desmin-related myopathy with Mallory body-like inclusions', 1),
(18282, 'ORPHA:84132', 'Early-onset desmin-related myopathy', 1),
(18283, 'ORPHA:84142', 'Acquired neuromyotonia', 1),
(18284, 'ORPHA:84142', 'Continuous muscle fiber activity syndrome', 1),
(18285, 'ORPHA:84142', 'Isaac syndrome', 1),
(18286, 'ORPHA:84142', 'Isaac-Mertens syndrome', 1),
(18287, 'ORPHA:84142', 'Quantal squander syndrome', 1),
(18288, 'ORPHA:842', 'Seminoma of testis', 1),
(18289, 'ORPHA:842', 'Seminomatous germ cell tumor of testis', 1),
(18290, 'ORPHA:842', 'Testicular seminoma', 1),
(18291, 'ORPHA:842', 'Testicular seminomatous germ cell tumor', 1),
(18292, 'ORPHA:844', 'Atrial tachyarrhythmia with short PR interval', 1),
(18293, 'ORPHA:844', 'LGL syndrome', 1),
(18294, 'ORPHA:844', 'Lown-Ganong-Levine syndrome', 1),
(18295, 'ORPHA:845', 'GM2 gangliosidosis, B, B1 variant', 1),
(18296, 'ORPHA:845', 'Hexosaminidase A deficiency', 1),
(18297, 'ORPHA:845', 'Tay-Sachs disease', 1),
(18298, 'ORPHA:846', 'Alpha-thalassemia', 1),
(18299, 'ORPHA:847', 'ATR-X syndrome', 1),
(18300, 'ORPHA:847', 'Alpha-thalassemia-X-linked intellectual disability syndrome', 1),
(18301, 'ORPHA:848', 'Beta-thalassemia', 1),
(18302, 'ORPHA:849', 'Glanzmann thrombasthenia', 1),
(18303, 'ORPHA:85', 'CDA', 3),
(18304, 'ORPHA:85', 'Congenital dyserythropoietic anemia', 3),
(18305, 'ORPHA:851', 'Paris-Trousseau thrombocytopenia', 1),
(18306, 'ORPHA:85102', 'Perineurioma', 3),
(18307, 'ORPHA:85110', 'FENIB', 1),
(18308, 'ORPHA:85110', 'Familial encephalopathy with neuroserpin inclusion bodies', 1),
(18309, 'ORPHA:85112', 'Palmoplantar hyperkeratosis-XX sex reversal-predisposition to squamous cell carcinoma syndrome', 1),
(18310, 'ORPHA:85112', 'Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome', 1),
(18311, 'ORPHA:85128', 'Bothnia retinal dystrophy', 1),
(18312, 'ORPHA:85128', 'Västerbotten dystrophy', 1),
(18313, 'ORPHA:85136', 'CLWM', 1),
(18314, 'ORPHA:85136', 'Cystic leukoencephalopathy without megalencephaly', 1),
(18315, 'ORPHA:85138', 'Addison disease', 1),
(18316, 'ORPHA:85138', 'Autoimmune Addison disease', 1),
(18317, 'ORPHA:85138', 'Autoimmune adrenalitis', 1),
(18318, 'ORPHA:85138', 'Classic Addison disease', 1),
(18319, 'ORPHA:85138', 'Primary Addison disease', 1),
(18320, 'ORPHA:85146', 'Kaeser syndrome', 1),
(18321, 'ORPHA:85146', 'Neurogenic scapuloperoneal syndrome, Kaeser type', 1),
(18322, 'ORPHA:85146', 'Stark-Kaeser syndrome', 1),
(18323, 'ORPHA:85162', 'FOSMN syndrome', 1),
(18324, 'ORPHA:85162', 'Facial onset sensory and motor neuronopathy', 1),
(18325, 'ORPHA:85163', 'Hypomyelination-congenital cataract syndrome', 1),
(18326, 'ORPHA:85164', 'CATSHL syndrome', 1),
(18327, 'ORPHA:85164', 'Camptodactyly-tall stature-scoliosis-deafness syndrome', 1),
(18328, 'ORPHA:85164', 'Camptodactyly-tall stature-scoliosis-hearing loss syndrome', 1),
(18329, 'ORPHA:85165', 'SADDAN', 1),
(18330, 'ORPHA:85165', 'Severe achondroplasia-developmental delay-acanthosis nigricans syndrome', 1),
(18331, 'ORPHA:85166', 'PLSD-T', 1),
(18332, 'ORPHA:85166', 'Platyspondylic dysplasia, Torrance type', 1),
(18333, 'ORPHA:85166', 'Platyspondylic dysplasia, Torrance-Luton type', 1),
(18334, 'ORPHA:85166', 'Platyspondylic lethal skeletal dysplasia, Torrance type', 1),
(18335, 'ORPHA:85167', 'SMD-CRD', 1),
(18336, 'ORPHA:85167', 'Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome', 1),
(18337, 'ORPHA:85168', 'Craniofacial conodysplasia', 1),
(18338, 'ORPHA:85169', 'Familial digital arthropathy-brachydactyly', 1),
(18339, 'ORPHA:85170', 'Mesomelic dysplasia with absent fibulas and triangular tibias', 1),
(18340, 'ORPHA:85170', 'Mesomelic dysplasia, Savarirayan type', 1),
(18341, 'ORPHA:85170', 'Triangular tibia-fibular aplasia syndrome', 1),
(18342, 'ORPHA:85172', 'Microcephalic osteodysplastic dysplasia, Saul-Wilson type', 1),
(18343, 'ORPHA:85173', 'IMAGe syndrome', 1),
(18344, 'ORPHA:85173', 'Intrauterine growth retardation-metaphyseal dysplasia-adrenal hypoplasia congenita-genital anomalies syndrome', 1),
(18345, 'ORPHA:85174', 'Pseudodiastrophic dysplasia', 1),
(18346, 'ORPHA:85175', 'Astley-Kendall dysplasia', 1),
(18347, 'ORPHA:85179', 'Infantile osteopetrosis with neuroaxonal dysplasia', 1),
(18348, 'ORPHA:85182', 'Bone dysplasia-medullary fibrosarcoma syndrome', 1),
(18349, 'ORPHA:85182', 'Diaphyseal medullary stenosis-bone malignancy syndrome', 1),
(18350, 'ORPHA:85182', 'Diaphyseal medullary stenosis-malignant fibrous histiocytoma syndrome', 1),
(18351, 'ORPHA:85182', 'Hardcastle syndrome', 1),
(18352, 'ORPHA:85184', 'Craniometadiaphyseal dysplasia, wormian bone type', 1),
(18353, 'ORPHA:85186', 'Endosteal sclerosis-cerebellar hypoplasia syndrome', 1),
(18354, 'ORPHA:85188', 'Metaphyseal dysplasia, Braun-Tinschert type', 1),
(18355, 'ORPHA:85191', 'Singleton-Merten dysplasia', 1),
(18356, 'ORPHA:85191', 'Singleton-Merten syndrome', 1),
(18357, 'ORPHA:85192', 'Calvarial doughnut lesions-bone fragility syndrome', 1),
(18358, 'ORPHA:85192', 'Familial doughnut lesions of skull', 1),
(18359, 'ORPHA:85193', 'IJO', 1),
(18360, 'ORPHA:85193', 'Idiopathic juvenile osteoporosis', 1),
(18361, 'ORPHA:85193', 'Juvenile osteoporosis', 1),
(18362, 'ORPHA:85194', 'Spondylo-ocular syndrome', 1),
(18363, 'ORPHA:85195', 'Familial expansile osteolysis', 1),
(18364, 'ORPHA:85195', 'Hereditary expansile polyostotic osteolytic dysplasia', 1),
(18365, 'ORPHA:85195', 'McCabe disease', 1),
(18366, 'ORPHA:85197', 'Genochondromatosis type 1', 1),
(18367, 'ORPHA:85198', 'Dysspondyloenchondromatosis', 1),
(18368, 'ORPHA:85199', 'CAP syndrome', 1),
(18369, 'ORPHA:85199', 'CDAGS syndrome', 1),
(18370, 'ORPHA:85199', 'Craniosynostosis-anal anomalies-porokeratosis syndrome', 1),
(18371, 'ORPHA:852', 'X-linked thrombocytopenia with normal platelets', 2),
(18372, 'ORPHA:85200', 'Ischiospinal dysostosis', 1),
(18373, 'ORPHA:85200', 'Ischiovertebral dysplasia', 1),
(18374, 'ORPHA:85200', 'Ischiovertebral syndrome', 1),
(18375, 'ORPHA:85201', 'Absent patellae-scrotal hypoplasia-renal anomalies-facial dysmorphism-intellectual disability syndrome', 1),
(18376, 'ORPHA:85201', 'Genitopatellar syndrome', 1),
(18377, 'ORPHA:85202', 'Keutel syndrome', 1),
(18378, 'ORPHA:85202', 'Pulmonic stenosis-brachytelephalangism-calcification of cartilages syndrome', 1),
(18379, 'ORPHA:85203', 'ACRP syndrome', 1),
(18380, 'ORPHA:85203', 'Acropectoral syndrome', 1),
(18381, 'ORPHA:85203', 'Syndactyly-preaxial polydactyly-sternal deformity syndrome', 1),
(18382, 'ORPHA:85212', 'Fetal Gaucher disease', 2),
(18383, 'ORPHA:85212', 'Perinatal lethal Gaucher disease', 2),
(18384, 'ORPHA:85273', 'X-linked intellectual disability, Abidi type', 1),
(18385, 'ORPHA:85274', 'MRXS7', 1),
(18386, 'ORPHA:85274', 'Syndromic X-linked intellectual disability 7', 1),
(18387, 'ORPHA:85274', 'X-linked intellectual disability, Ahmad type', 1),
(18388, 'ORPHA:85275', 'MCOPS4', 1),
(18389, 'ORPHA:85275', 'Microphthalmia-ankyloblepharon-intellectual disability syndrome', 1),
(18390, 'ORPHA:85275', 'Syndromic microphthalmia type 4', 1),
(18391, 'ORPHA:85276', 'Armfield syndrome', 1),
(18392, 'ORPHA:85276', 'X-linked intellectual disability, Armfield type', 1),
(18393, 'ORPHA:85277', 'X-linked intellectual disability, Cantagrel type', 1),
(18394, 'ORPHA:85278', 'Christianson syndrome', 1),
(18395, 'ORPHA:85278', 'X-linked Angelman-like syndrome', 1),
(18396, 'ORPHA:85279', 'Syndromic X-linked intellectual disability due to JARID1C mutation', 1),
(18397, 'ORPHA:85280', 'X-linked intellectual disability-cubitus valgus-dysmorphism syndrome', 1),
(18398, 'ORPHA:85282', 'MEHMO syndrome', 1),
(18399, 'ORPHA:85282', 'X-linked intellectual disability-epileptic seizures-hypogenitalism-microcephaly-obesity syndrome', 1),
(18400, 'ORPHA:85283', 'X-linked intellectual disability, Miles-Carpenter type', 1),
(18401, 'ORPHA:85284', 'BRESEK syndrome', 1),
(18402, 'ORPHA:85284', 'BRESHECK syndrome', 1),
(18403, 'ORPHA:85285', 'X-linked intellectual disability, Schimke type', 1),
(18404, 'ORPHA:85286', 'Syndromic X-linked intellectual disability type 11', 1),
(18405, 'ORPHA:85286', 'X-linked intellectual disability, Shashi type', 1),
(18406, 'ORPHA:85287', 'X-linked intellectual disability, Siderius type', 1),
(18407, 'ORPHA:85288', 'X-linked intellectual disability, Stocco Dos Santos type', 1),
(18408, 'ORPHA:85290', 'X-linked intellectual disability, Wilson type', 1),
(18409, 'ORPHA:85292', 'SCAX4', 1),
(18410, 'ORPHA:85292', 'X-linked ataxia-dementia syndrome', 1),
(18411, 'ORPHA:85292', 'X-linked spinocerebellar ataxia type 4', 1),
(18412, 'ORPHA:85293', 'Cabezas syndrome', 1),
(18413, 'ORPHA:85293', 'X-linked intellectual disability, Cabezas type', 1),
(18414, 'ORPHA:85294', 'X-linked epilepsy-learning disabilities-behavior disorders syndrome', 1),
(18415, 'ORPHA:85295', 'HSD10 deficiency, atypical type', 2),
(18416, 'ORPHA:85295', 'HSD10 disease, atypical type', 2),
(18417, 'ORPHA:85295', 'Syndromic X-linked intellectual disability type 10', 2),
(18418, 'ORPHA:85295', 'X-linked intellectual disability-choreoathetosis-abnormal behavior syndrome', 2),
(18419, 'ORPHA:85297', 'SCAX3', 1),
(18420, 'ORPHA:85297', 'X-linked ataxia-deafness syndrome', 1),
(18421, 'ORPHA:85297', 'X-linked ataxia-hearing loss syndrome', 1),
(18422, 'ORPHA:85297', 'X-linked spinocerebellar ataxia type 3', 1),
(18423, 'ORPHA:853', 'FNAIT', 1),
(18424, 'ORPHA:853', 'Fetal and neonatal alloimmune thrombocytopenia', 1),
(18425, 'ORPHA:853', 'NAIT', 1),
(18426, 'ORPHA:85317', 'X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndrome', 1),
(18427, 'ORPHA:85319', 'X-linked intellectual disability-epilepsy-progressive joint contractures-dysmorphism syndrome', 1),
(18428, 'ORPHA:85320', 'Johnson syndrome', 1),
(18429, 'ORPHA:85320', 'X-linked intellectual disability-macrocephaly-macroorchidism syndrome', 1),
(18430, 'ORPHA:85321', 'Deafness-intellectual disability syndrome, Martin-Probst type', 1),
(18431, 'ORPHA:85321', 'Hearing loss-intellectual disability syndrome, Martin-Probst type', 1),
(18432, 'ORPHA:85321', 'Martin-Probst syndrome', 1),
(18433, 'ORPHA:85321', 'X-linked deafness-intellectual disability syndrome syndrome', 1),
(18434, 'ORPHA:85321', 'X-linked hearing loss-intellectual disability syndrome syndrome', 1),
(18435, 'ORPHA:85322', 'X-linked intellectual disability, Pai type', 1),
(18436, 'ORPHA:85323', 'X-linked intellectual disability, Seemanova type', 1),
(18437, 'ORPHA:85324', 'MRXS9', 1),
(18438, 'ORPHA:85324', 'X-linked intellectual disability, Shrimpton type', 1),
(18439, 'ORPHA:85325', 'X-linked intellectual disability, Stevenson type', 1),
(18440, 'ORPHA:85326', 'X-linked intellectual disability, Stoll type', 1),
(18441, 'ORPHA:85327', 'X-linked intellectual disability-acromegaly-hyperactivity syndrome', 1),
(18442, 'ORPHA:85328', 'X-linked intellectual disability, Turner type', 1),
(18443, 'ORPHA:85329', 'X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome', 1),
(18444, 'ORPHA:85332', 'Aldred syndrome', 1),
(18445, 'ORPHA:85332', 'Retinitis pigmentosa and intellectual disability due to Xp11.3 microdeletion', 1),
(18446, 'ORPHA:85332', 'Retinitis pigmentosa and intellectual disability due to del(X)(p11.3)', 1),
(18447, 'ORPHA:85332', 'Retinitis pigmentosa and intellectual disability due to monosomy Xp11.3', 1),
(18448, 'ORPHA:85332', 'X-linked intellectual disability-retinitis pigmentosa syndrome', 1),
(18449, 'ORPHA:85334', 'X-linked neurodegenerative syndrome, Bertini type', 1),
(18450, 'ORPHA:85335', 'Fried syndrome', 1),
(18451, 'ORPHA:85336', 'X-linked neurodegenerative syndrome, Hamel type', 1),
(18452, 'ORPHA:85338', 'X-linked intellectual disability-ataxia-apraxia syndrome', 1),
(18453, 'ORPHA:854', 'Non-cirrhotic portal vein thrombosis', 1),
(18454, 'ORPHA:854', 'Primitive portal vein thrombosis', 1),
(18455, 'ORPHA:85408', 'Juvenile polyarthritis without rheumatoid factor', 1),
(18456, 'ORPHA:85408', 'Juvenile rheumatoid factor-negative polyarthritis', 1),
(18457, 'ORPHA:85408', 'Rheumatoid factor-negative polyarticular JIA', 1),
(18458, 'ORPHA:85408', 'Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis', 1),
(18459, 'ORPHA:85410', 'Oligoarticular JIA', 1),
(18460, 'ORPHA:85410', 'Oligoarticular juvenile idiopathic arthritis', 1),
(18461, 'ORPHA:85410', 'Pauciarticular chronic arthritis', 1),
(18462, 'ORPHA:85414', 'Still disease', 1),
(18463, 'ORPHA:85414', 'Systemic-onset JIA', 1),
(18464, 'ORPHA:85414', 'Systemic-onset juvenile idiopathic arthritis', 1),
(18465, 'ORPHA:85435', 'Juvenile idiopathic rheumatoid factor-positive polyarthritis', 1),
(18466, 'ORPHA:85435', 'Juvenile polyarthritis with rheumatoid factor', 1),
(18467, 'ORPHA:85435', 'Rheumatoid factor-positive polyarticular JIA', 1),
(18468, 'ORPHA:85435', 'Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis', 1),
(18469, 'ORPHA:85436', 'Juvenile psoriatic arthritis', 1),
(18470, 'ORPHA:85436', 'Psoriasis-related JIA', 1),
(18471, 'ORPHA:85436', 'Psoriasis-related juvenile idiopathic arthritis', 1),
(18472, 'ORPHA:85438', 'Enthesitis-related JIA', 1),
(18473, 'ORPHA:85438', 'Enthesitis-related juvenile idiopathic arthritis', 1),
(18474, 'ORPHA:85438', 'Juvenile ERA', 1),
(18475, 'ORPHA:85442', 'Short stature-pituitary and cerebellar defects-small sella turcica syndrome', 1),
(18476, 'ORPHA:85443', 'AL amyloidosis', 1),
(18477, 'ORPHA:85443', 'Light-chain amyloidosis', 1),
(18478, 'ORPHA:85443', 'Primary amyloidosis', 1),
(18479, 'ORPHA:85445', 'AA amyloidosis', 1),
(18480, 'ORPHA:85445', 'Inflammatory amyloidosis', 1),
(18481, 'ORPHA:85445', 'Reactive amyloidosis', 1),
(18482, 'ORPHA:85445', 'Secondary amyloidosis', 1),
(18483, 'ORPHA:85446', 'ABeta2Mwt amyloidosis', 1),
(18484, 'ORPHA:85446', 'Dialysis-related amyloidosis', 1),
(18485, 'ORPHA:85446', 'Dialysis-related arthropathy', 1),
(18486, 'ORPHA:85446', 'Wild type ABeta2-microglobulinic amyloidosis', 1),
(18487, 'ORPHA:85446', 'Wild type ABeta2M amyloidosis', 1),
(18488, 'ORPHA:85447', 'ATTRV30M amyloidosis', 1),
(18489, 'ORPHA:85447', 'ATTRV30M-related amyloidosis', 1),
(18490, 'ORPHA:85447', 'Familial amyloid polyneuropathy type I', 1),
(18491, 'ORPHA:85447', 'Familial amyloid polyneuropathy, Portuguese-Swedish-Japanese type', 1),
(18492, 'ORPHA:85447', 'TTR amyloid neuropathy', 1),
(18493, 'ORPHA:85447', 'Transthyretin amyloid neuropathy', 1),
(18494, 'ORPHA:85447', 'Transthyretin amyloid polyneuropathy', 1),
(18495, 'ORPHA:85448', 'AGel amyloidosis', 1),
(18496, 'ORPHA:85448', 'Familial amyloid polyneuropathy type IV', 1),
(18497, 'ORPHA:85448', 'Familial amyloidosis, Finnish type', 1),
(18498, 'ORPHA:85448', 'Gelsolin amyloidosis', 1),
(18499, 'ORPHA:85448', 'Hereditary amyloidosis, Finnish type', 1),
(18500, 'ORPHA:85450', 'Amyloidosis, Ostertag type', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(18501, 'ORPHA:85450', 'Familial amyloid nephropathy', 1),
(18502, 'ORPHA:85450', 'Familial renal amyloidosis', 1),
(18503, 'ORPHA:85450', 'Hereditary amyloid nephropathy', 1),
(18504, 'ORPHA:85450', 'Hereditary amyloidosis with primary renal involvement', 1),
(18505, 'ORPHA:85450', 'Hereditary renal amyloidosis', 1),
(18506, 'ORPHA:85451', 'ATTR cardiomyopathy', 1),
(18507, 'ORPHA:85451', 'ATTRV122I amyloidosis', 1),
(18508, 'ORPHA:85451', 'ATTRV122I-related  amyloidosis', 1),
(18509, 'ORPHA:85451', 'TTR-related amyloid cardiomyopathy', 1),
(18510, 'ORPHA:85451', 'TTR-related cardiac amyloidosis', 1),
(18511, 'ORPHA:85451', 'Transthyretin amyloid cardiopathy', 1),
(18512, 'ORPHA:85451', 'Transthyretin-related familial amyloid cardiomyopathy', 1),
(18513, 'ORPHA:85453', 'Familial cutaneous amyloidosis', 1),
(18514, 'ORPHA:85453', 'PDR', 1),
(18515, 'ORPHA:85453', 'Partington disease', 1),
(18516, 'ORPHA:85453', 'X-linked cutaneous amyloidosis', 1),
(18517, 'ORPHA:85453', 'X-linked reticulate pigmentary disorder', 1),
(18518, 'ORPHA:85453', 'XLPDR', 1),
(18519, 'ORPHA:85458', 'HCHWA', 1),
(18520, 'ORPHA:85458', 'Hereditary cerebral hemorrhage with amyloidosis', 1),
(18521, 'ORPHA:857', 'Imperforate anus-hand, foot and ear anomalies syndrome', 1),
(18522, 'ORPHA:857', 'REAR syndrome', 1),
(18523, 'ORPHA:857', 'Renal-ear-anal-radial syndrome', 1),
(18524, 'ORPHA:857', 'Sensorineural deafness with imperforate anus and hypoplastic thumbs', 1),
(18525, 'ORPHA:857', 'Sensorineural hearing loss with imperforate anus and hypoplastic thumbs', 1),
(18526, 'ORPHA:857', 'TBS', 1),
(18527, 'ORPHA:857', 'Townes syndrome', 1),
(18528, 'ORPHA:857', 'Townes-Brocks syndrome', 1),
(18529, 'ORPHA:858', 'Congenital toxoplasmosis', 1),
(18530, 'ORPHA:858', 'Mother-to-child transmission of toxoplasmosis', 1),
(18531, 'ORPHA:858', 'Toxoplasma embryofetopathy', 1),
(18532, 'ORPHA:858', 'Toxoplasma embryopathy', 1),
(18533, 'ORPHA:859', 'Inherited deficiency of transcobalamin', 1),
(18534, 'ORPHA:859', 'Transcobalamin II deficiency', 1),
(18535, 'ORPHA:859', 'Transcobalamin deficiency', 1),
(18536, 'ORPHA:86', 'Familial abdominal aortic aneurysm', 1),
(18537, 'ORPHA:860', 'Congenitally uncorrected transposition of the great arteries', 1),
(18538, 'ORPHA:860', 'Congenitally uncorrected transposition of the great vessels', 1),
(18539, 'ORPHA:860', 'D-transposition of the great arteries', 1),
(18540, 'ORPHA:860', 'Dextro-transposition of the great arteries', 1),
(18541, 'ORPHA:860', 'Isolated ventriculoarterial discordance', 1),
(18542, 'ORPHA:860', 'Ventriculoarterial discordance with atrioventricular concordance', 1),
(18543, 'ORPHA:861', 'Franceschetti-Klein syndrome', 1),
(18544, 'ORPHA:861', 'Mandibulofacial dysostosis without limb anomalies', 1),
(18545, 'ORPHA:861', 'Treacher-Collins syndrome', 1),
(18546, 'ORPHA:863', 'Trichinellosis', 1),
(18547, 'ORPHA:863', 'Trichinosis', 1),
(18548, 'ORPHA:86309', 'CDG syndrome type Ij', 1),
(18549, 'ORPHA:86309', 'CDG-Ij', 1),
(18550, 'ORPHA:86309', 'CDG1J', 1),
(18551, 'ORPHA:86309', 'Carbohydrate deficient glycoprotein syndrome type Ij', 1),
(18552, 'ORPHA:86309', 'Congenital disorder of glycosylation type 1j', 1),
(18553, 'ORPHA:86309', 'Congenital disorder of glycosylation type Ij', 1),
(18554, 'ORPHA:86309', 'DPAGT1-CDG', 1),
(18555, 'ORPHA:86309', 'Dolichyl-phosphate N-acetylgalactosamine phosphotransferase deficiency', 1),
(18556, 'ORPHA:864', 'Trichofolliculoma', 1),
(18557, 'ORPHA:867', 'Familial multiple trichoepithelioma', 2),
(18558, 'ORPHA:86788', 'X-linked severe congenital neutropenia', 1),
(18559, 'ORPHA:86789', 'PTLAH', 1),
(18560, 'ORPHA:86789', 'Patella aplasia/hypoplasia', 1),
(18561, 'ORPHA:86795', 'Localized lichen myxedematosus', 3),
(18562, 'ORPHA:86795', 'Papular mucinosis', 3),
(18563, 'ORPHA:86797', 'Atypical lichen myxedematosus', 1),
(18564, 'ORPHA:86797', 'Intermediate lichen myxedematosus', 1),
(18565, 'ORPHA:868', 'Triose phosphate-isomerase deficiency', 1),
(18566, 'ORPHA:86812', 'Autosomal recessive limb-girdle muscular dystrophy type 2K', 1),
(18567, 'ORPHA:86812', 'LGMD type 2K', 1),
(18568, 'ORPHA:86812', 'LGMD2K', 1),
(18569, 'ORPHA:86812', 'Limb-girdle muscular dystrophy type 2K', 1),
(18570, 'ORPHA:86812', 'Limb-girdle muscular dystrophy-intellectual disability syndrome', 1),
(18571, 'ORPHA:86812', 'POMT1-related  limb-girdle muscular dystrophy R11', 1),
(18572, 'ORPHA:86812', 'POMT1-related LGMD R11', 1),
(18573, 'ORPHA:86813', 'Atrophia areata', 1),
(18574, 'ORPHA:86813', 'Helicoid peripapillary chorioretinal degeneration', 1),
(18575, 'ORPHA:86813', 'SCRA', 1),
(18576, 'ORPHA:86813', 'Sveinsson chorioretinal atrophy', 1),
(18577, 'ORPHA:86814', 'ADCME', 1),
(18578, 'ORPHA:86814', 'Autosomal dominant cortical myoclonus and epilepsy', 1),
(18579, 'ORPHA:86814', 'BAFME', 1),
(18580, 'ORPHA:86814', 'Benign adult familial myoclonic epilepsy', 1),
(18581, 'ORPHA:86814', 'Benign adult familial myoclonus epilepsy', 1),
(18582, 'ORPHA:86814', 'FAME', 1),
(18583, 'ORPHA:86814', 'FCMTE', 1),
(18584, 'ORPHA:86814', 'Familial adult myoclonic epilepsy', 1),
(18585, 'ORPHA:86814', 'Familial cortical myoclonic tremor and epilepsy', 1),
(18586, 'ORPHA:86815', 'ALSG', 1),
(18587, 'ORPHA:86815', 'Aplasia of lacrimal and salivary glands', 1),
(18588, 'ORPHA:86815', 'Congenital absence of lacrimal puncta and salivary glands', 1),
(18589, 'ORPHA:86816', 'Congenital analbuminemia', 1),
(18590, 'ORPHA:86817', 'Hemolytic anemia due to adenylate kinase deficiency', 1),
(18591, 'ORPHA:86818', 'AMME complex', 1),
(18592, 'ORPHA:86818', 'AMME syndrome', 1),
(18593, 'ORPHA:86818', 'ATS-MR', 1),
(18594, 'ORPHA:86818', 'Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome', 1),
(18595, 'ORPHA:86819', 'Atrichia with papular lesions', 1),
(18596, 'ORPHA:86819', 'Papular atrichia', 1),
(18597, 'ORPHA:86820', 'Familial avascular necrosis of femoral head', 1),
(18598, 'ORPHA:86820', 'Familial osteonecrosis of the femoral head', 1),
(18599, 'ORPHA:86821', 'Lissencephaly type 3-familial fetal akinesia sequence syndrome', 1),
(18600, 'ORPHA:86822', 'Lissencephaly type 3-metacarpal bone dysplasia syndrome', 1),
(18601, 'ORPHA:86823', 'LCH', 3),
(18602, 'ORPHA:86823', 'Lissencephaly with cerebellar hypoplasia', 3),
(18603, 'ORPHA:86829', 'Chronic neutrophilic leukemia', 1),
(18604, 'ORPHA:86830', 'CMPD-U', 1),
(18605, 'ORPHA:86830', 'Chronic myeloproliferative disease, unclassifiable', 1),
(18606, 'ORPHA:86830', 'Undifferentiated myeloproliferative disease', 1),
(18607, 'ORPHA:86834', 'JMML', 1),
(18608, 'ORPHA:86834', 'Juvenile chronic myelomonocytic leukemia', 1),
(18609, 'ORPHA:86834', 'Juvenile myelomonocytic leukemia', 1),
(18610, 'ORPHA:86836', 'Refractory cytopenia with multilineage dysplasia', 3),
(18611, 'ORPHA:86839', 'RAEB', 1),
(18612, 'ORPHA:86839', 'Refractory anemia with excess blasts', 1),
(18613, 'ORPHA:86841', '5q- syndrome', 1),
(18614, 'ORPHA:86841', 'Myelodysplastic syndrome associated with isolated del(5q) chromosome abnormality', 1),
(18615, 'ORPHA:86843', 'Acute myelodysplasia with myelofibrosis', 1),
(18616, 'ORPHA:86843', 'Acute myelofibrosis', 1),
(18617, 'ORPHA:86843', 'Acute myelosclerosis', 1),
(18618, 'ORPHA:86843', 'Acute panmyelosis with myelofibrosis', 1),
(18619, 'ORPHA:86845', 'AML with multilineage dysplasia', 1),
(18620, 'ORPHA:86845', 'AML with myelodysplasia-related features', 1),
(18621, 'ORPHA:86845', 'Acute myeloid leukaemia with myelodysplasia-related features', 1),
(18622, 'ORPHA:86845', 'Acute myeloid leukemia with multilineage dysplasia', 1),
(18623, 'ORPHA:86846', 'Secondary AML', 3),
(18624, 'ORPHA:86846', 'Secondary acute myeloid leukemia', 3),
(18625, 'ORPHA:86846', 'Therapy related acute myeloid leukemia and myelodysplastic syndrome', 3),
(18626, 'ORPHA:86846', 'Therapy-related AML and myelodysplastic syndrome', 3),
(18627, 'ORPHA:86849', 'Acute basophilic leukemia', 1),
(18628, 'ORPHA:86850', 'Chloroma', 1),
(18629, 'ORPHA:86850', 'Extramedullary myeloid tumor', 1),
(18630, 'ORPHA:86850', 'Granulocytic sarcoma', 1),
(18631, 'ORPHA:86850', 'Myeloid sarcoma', 1),
(18632, 'ORPHA:86851', 'Acute leukemia of ambiguous lineage', 3),
(18633, 'ORPHA:86851', 'Acute leukemia of indeterminate lineage', 3),
(18634, 'ORPHA:86851', 'Hybrid acute leukemia', 3),
(18635, 'ORPHA:86851', 'Mixed lineage acute leukemia', 3),
(18636, 'ORPHA:86852', 'B-PLL', 1),
(18637, 'ORPHA:86852', 'B-cell prolymphocytic leukemia', 1),
(18638, 'ORPHA:86854', 'SMZL', 1),
(18639, 'ORPHA:86854', 'Splenic marginal zone lymphoma', 1),
(18640, 'ORPHA:86855', 'Plasmacytoma', 1),
(18641, 'ORPHA:86855', 'Solitary plasmacytoma', 1),
(18642, 'ORPHA:86861', 'Non-amyloid MIDD', 1),
(18643, 'ORPHA:86861', 'Non-amyloid monoclonal immunoglobulin deposition disease', 1),
(18644, 'ORPHA:86861', 'Randall disease', 1),
(18645, 'ORPHA:86864', 'HCD', 1),
(18646, 'ORPHA:86864', 'Heavy chain disease', 1),
(18647, 'ORPHA:86867', 'NMZL', 1),
(18648, 'ORPHA:86867', 'Nodal marginal zone B-cell lymphoma', 1),
(18649, 'ORPHA:86869', 'LYG', 1),
(18650, 'ORPHA:86869', 'Lymphomatoid granulomatosis', 1),
(18651, 'ORPHA:86870', 'BPDCN', 1),
(18652, 'ORPHA:86870', 'Blastic NK-cell lymphoma', 1),
(18653, 'ORPHA:86870', 'Blastic plasmacytoid dendritic cell neoplasm', 1),
(18654, 'ORPHA:86870', 'CD4+/CD56+ hematodermic neoplasm', 1),
(18655, 'ORPHA:86870', 'Lymphoblastoid variant of NK-cell lymphoma', 1),
(18656, 'ORPHA:86870', 'Monomorphic NK-cell lymphoma', 1),
(18657, 'ORPHA:86871', 'T-PLL', 1),
(18658, 'ORPHA:86871', 'T-cell chronic lymphocytic leukemia', 1),
(18659, 'ORPHA:86871', 'T-cell prolymphocytic leukemia', 1),
(18660, 'ORPHA:86872', 'Proliferation of large granular lymphocytes', 1),
(18661, 'ORPHA:86872', 'T-LGL', 1),
(18662, 'ORPHA:86872', 'T-cell LGL leukemia', 1),
(18663, 'ORPHA:86872', 'T-cell large granular lymphocyte leukemia', 1),
(18664, 'ORPHA:86873', 'ANKCL', 1),
(18665, 'ORPHA:86873', 'Aggressive NK-cell leukemia', 1),
(18666, 'ORPHA:86873', 'Aggressive NK-cell lymphoma', 1),
(18667, 'ORPHA:86873', 'NK-cell LGL leukemia', 1),
(18668, 'ORPHA:86873', 'NK-cell large granular lymphocyte leukemia', 1),
(18669, 'ORPHA:86875', 'ATLL', 1),
(18670, 'ORPHA:86875', 'Adult T-cell leukemia/lymphoma', 1),
(18671, 'ORPHA:86879', 'Angiocentric T-cell lymphoma', 1),
(18672, 'ORPHA:86879', 'Extranodal nasal NK/T cell lymphoma', 1),
(18673, 'ORPHA:86879', 'Lethal midline granuloma', 1),
(18674, 'ORPHA:86879', 'NK/T-cell lymphoma', 1),
(18675, 'ORPHA:86879', 'NKTCL', 1),
(18676, 'ORPHA:86879', 'Nasal T/natural killer-cell lymphoma', 1),
(18677, 'ORPHA:86880', 'EATL', 1),
(18678, 'ORPHA:86880', 'ETTL', 1),
(18679, 'ORPHA:86880', 'Enteropathy-associated T-cell lymphoma', 1),
(18680, 'ORPHA:86880', 'Enteropathy-type T-cell lymphoma', 1),
(18681, 'ORPHA:86880', 'Intestinal T-cell lymphoma', 1),
(18682, 'ORPHA:86882', 'Hepatosplenic T-cell lymphoma', 1),
(18683, 'ORPHA:86884', 'SPTCL', 1),
(18684, 'ORPHA:86884', 'Subcutaneous panniculitic T-cell lymphoma', 1),
(18685, 'ORPHA:86884', 'Subcutaneous panniculitis-like T-cell lymphoma', 1),
(18686, 'ORPHA:86885', 'Primary cutaneous peripheral T-cell lymphoma NOS', 1),
(18687, 'ORPHA:86885', 'Primary cutaneous peripheral T-cell lymphoma not otherwise specified', 1),
(18688, 'ORPHA:86885', 'Primary cutaneous unspecified peripheral T-cell lymphoma', 1),
(18689, 'ORPHA:86886', 'AILT', 1),
(18690, 'ORPHA:86886', 'Angioimmunoblastic T-cell lymphoma', 1),
(18691, 'ORPHA:86886', 'Immunoblastic lymphadenopathy', 1),
(18692, 'ORPHA:86886', 'Lymphogranulomatosis X', 1),
(18693, 'ORPHA:86886', 'T-cell lymphoma, AILD type', 1),
(18694, 'ORPHA:86893', 'NLPHL', 1),
(18695, 'ORPHA:86893', 'Nodular lymphocyte predominant Hodgkin lymphoma', 1),
(18696, 'ORPHA:86896', 'Histiocytic sarcoma', 1),
(18697, 'ORPHA:86897', 'Langerhans cell sarcoma', 1),
(18698, 'ORPHA:869', '2A syndrome', 1),
(18699, 'ORPHA:869', '3A syndrome', 1),
(18700, 'ORPHA:869', '4A syndrome', 1),
(18701, 'ORPHA:869', 'AAA syndrome', 1),
(18702, 'ORPHA:869', 'Achalasia-addisonianism-alacrima syndrome', 1),
(18703, 'ORPHA:869', 'Adrenal insufficiency-achalasia-alacrima syndrome', 1),
(18704, 'ORPHA:869', 'Allgrove syndrome', 1),
(18705, 'ORPHA:869', 'Double A syndrome', 1),
(18706, 'ORPHA:869', 'Quaternary A syndrome', 1),
(18707, 'ORPHA:869', 'Triple A syndrome', 1),
(18708, 'ORPHA:86900', 'Interdigitating cell sarcoma', 1),
(18709, 'ORPHA:86900', 'Interdigitating dendritic cell sarcoma', 1),
(18710, 'ORPHA:86900', 'Reticulum cell sarcoma', 1),
(18711, 'ORPHA:86902', 'Follicular dendritic cell sarcoma', 1),
(18712, 'ORPHA:86903', 'Dendritic cell sarcoma not otherwise specified', 1),
(18713, 'ORPHA:86904', 'MTX-LPD', 1),
(18714, 'ORPHA:86904', 'MTX-associated lymphoproliferative disorders', 1),
(18715, 'ORPHA:86904', 'Methotrexate-associated lymphoproliferative disorders', 1),
(18716, 'ORPHA:86906', 'Hypothalamic hamartomas with gelastic seizures', 1),
(18717, 'ORPHA:86908', 'HHE syndrome', 1),
(18718, 'ORPHA:86908', 'Hemiconvulsion-hemiplegia-epilepsy syndrome', 1),
(18719, 'ORPHA:86908', 'IHHS', 1),
(18720, 'ORPHA:86908', 'Idiopathic hemiconvulsion-hemiplegia syndrome', 1),
(18721, 'ORPHA:86909', 'Benign myoclonic epilepsy of infancy', 1),
(18722, 'ORPHA:86909', 'Benign myoclonus epilepsy of infancy', 1),
(18723, 'ORPHA:86909', 'Myoclonic epilepsy of infancy', 1),
(18724, 'ORPHA:86911', 'Epilepsy with myoclonic absences', 1),
(18725, 'ORPHA:86913', 'Myoclonic epilepsy in non-progressive encephalopathies', 1),
(18726, 'ORPHA:86913', 'Myoclonic status in non-progressive encephalopathies', 1),
(18727, 'ORPHA:86913', 'Myoclonus epilepsy in non-progressive encephalopathies', 1),
(18728, 'ORPHA:86914', 'Lymphedema-cerebral arteriovenous anomaly syndrome', 1),
(18729, 'ORPHA:86915', 'Irons-Bhan syndrome', 1),
(18730, 'ORPHA:86915', 'Irons-Bianchi syndrome', 1),
(18731, 'ORPHA:86915', 'Lymphedema-atrial septal defects-facial changes syndrome', 1),
(18732, 'ORPHA:86918', 'Diffuse palmoplantar hyperkeratosis-acrocyanosis syndrome', 1),
(18733, 'ORPHA:86918', 'Diffuse palmoplantar keratoderma-acrocyanosis syndrome', 1),
(18734, 'ORPHA:86919', 'Keratosis palmaris et plantaris-clinodactyly syndrome', 1),
(18735, 'ORPHA:86919', 'Palmoplantar keratoderma-clinodactyly syndrome', 1),
(18736, 'ORPHA:86920', 'Dermatopathia pigmentosa reticularis', 1),
(18737, 'ORPHA:86923', 'Hereditary palmoplantar hyperkeratosis, Gamborg-Nielsen type', 1),
(18738, 'ORPHA:86923', 'Hereditary palmoplantar keratoderma, Gamborg-Nielsen type', 1),
(18739, 'ORPHA:86923', 'PPK, Gamborg-Nielsen type', 1),
(18740, 'ORPHA:87', 'ACS1', 1),
(18741, 'ORPHA:87', 'Acrocephalosyndactyly type 1', 1),
(18742, 'ORPHA:87', 'Apert syndrome', 1),
(18743, 'ORPHA:870', 'Down syndrome', 1),
(18744, 'ORPHA:870', 'Trisomy 21', 1),
(18745, 'ORPHA:871', 'Familial Lenègre disease', 1),
(18746, 'ORPHA:871', 'Familial Lev disease', 1),
(18747, 'ORPHA:871', 'Familial Lev-Lenègre disease', 1),
(18748, 'ORPHA:871', 'Familial PCCD', 1),
(18749, 'ORPHA:871', 'Familial progressive cardiac conduction defect', 1),
(18750, 'ORPHA:871', 'Familial progressive heart block', 1),
(18751, 'ORPHA:871', 'Hereditary bundle branch defect', 1),
(18752, 'ORPHA:87277', 'Rare intellectual disability', 3),
(18753, 'ORPHA:873', 'Aggressive fibromatosis', 1),
(18754, 'ORPHA:873', 'Desmoid tumor', 1),
(18755, 'ORPHA:873', 'Desmoid type fibromatosis', 1),
(18756, 'ORPHA:874', 'Adult cardiac tumor', 1),
(18757, 'ORPHA:874', 'Adult heart tumor', 1),
(18758, 'ORPHA:874', 'Primary adult heart tumor', 1),
(18759, 'ORPHA:875', 'Cardiac tumor of child', 1),
(18760, 'ORPHA:875', 'Heart tumor of child', 1),
(18761, 'ORPHA:875', 'Primary pediatric heart tumor', 1),
(18762, 'ORPHA:87503', 'Keratosis palmoplantaris transgrediens of Siemens', 1),
(18763, 'ORPHA:87503', 'Mal de Meleda', 1),
(18764, 'ORPHA:87503', 'Meleda disease', 1),
(18765, 'ORPHA:87503', 'Transgrediens palmoplantar keratoderma of Siemens', 1),
(18766, 'ORPHA:876', 'Endodermal sinus tumor', 1),
(18767, 'ORPHA:876', 'Yolk sac tumor', 1),
(18768, 'ORPHA:877', 'Neuroendocrine neoplasm', 3),
(18769, 'ORPHA:87876', 'Infantile dysmorphic sialidosis', 1),
(18770, 'ORPHA:87876', 'Sialidosis type 2', 1),
(18771, 'ORPHA:87884', 'Isolated genetic deafness', 1),
(18772, 'ORPHA:87884', 'Isolated genetic hearing loss', 1),
(18773, 'ORPHA:87884', 'Non-syndromic genetic deafness', 1),
(18774, 'ORPHA:87884', 'Non-syndromic genetic hearing loss', 1),
(18775, 'ORPHA:879', 'Tungiasis', 1),
(18776, 'ORPHA:88', 'Idiopathic aplastic anemia', 1),
(18777, 'ORPHA:88', 'Idiopathic bone marrow failure', 1),
(18778, 'ORPHA:881', '45,X syndrome', 1),
(18779, 'ORPHA:881', '45,X/46,XX syndrome', 1),
(18780, 'ORPHA:881', 'Turner syndrome', 1),
(18781, 'ORPHA:882', 'FAH deficiency', 1),
(18782, 'ORPHA:882', 'Fumarylacetoacetase deficiency', 1),
(18783, 'ORPHA:882', 'Fumarylacetoacetate hydrolase deficiency', 1),
(18784, 'ORPHA:882', 'Hepatorenal tyrosinemia', 1),
(18785, 'ORPHA:882', 'Tyrosinemia type 1', 1),
(18786, 'ORPHA:882', 'Tyrosinemia type I', 1),
(18787, 'ORPHA:883', 'Extragonadal teratoma', 1),
(18788, 'ORPHA:884', 'Isochromosome 12p mosaicism', 1),
(18789, 'ORPHA:884', 'Isochromosome 12p syndrome', 1),
(18790, 'ORPHA:884', 'Pallister-Killian syndrome', 1),
(18791, 'ORPHA:884', 'Tetrasomy 12p', 1),
(18792, 'ORPHA:886', 'Retinitis pigmentosa-deafness syndrome', 1),
(18793, 'ORPHA:886', 'Retinitis pigmentosa-hearing loss syndrome', 1),
(18794, 'ORPHA:886', 'USH', 1),
(18795, 'ORPHA:886', 'Usher syndrome', 1),
(18796, 'ORPHA:88616', 'AR-NSID', 2),
(18797, 'ORPHA:88616', 'Autosomal recessive non-syndromic intellectual disability', 2),
(18798, 'ORPHA:88616', 'NS-ARID', 2),
(18799, 'ORPHA:88618', 'S-adenosylhomocysteine hydrolase deficiency', 1),
(18800, 'ORPHA:88619', 'ADANE', 1),
(18801, 'ORPHA:88619', 'Familial acute necrotizing encephalopathy', 1),
(18802, 'ORPHA:88619', 'Recurrent acute necrotizing encephalopathy', 1),
(18803, 'ORPHA:88620', 'Isolated congenital anosmia', 1),
(18804, 'ORPHA:88621', 'Congenital ichthyosis type 4', 1),
(18805, 'ORPHA:88621', 'IPS', 1),
(18806, 'ORPHA:88621', 'Ichthyosis-prematurity syndrome', 1),
(18807, 'ORPHA:88628', 'Autosomal recessive posterior column ataxia and retinitis pigmentosa', 1),
(18808, 'ORPHA:88628', 'PCARP', 1),
(18809, 'ORPHA:88628', 'Posterior column ataxia-retinitis pigmentosa syndrome', 1),
(18810, 'ORPHA:88629', 'Blue colour blindness', 1),
(18811, 'ORPHA:88629', 'Congenital tritanopia', 1),
(18812, 'ORPHA:88629', 'Tritan colour blindness', 1),
(18813, 'ORPHA:88629', 'Tritanopia', 1),
(18814, 'ORPHA:88630', 'Terminal osseous dysplasia-pigmentary defects syndrome', 1),
(18815, 'ORPHA:88632', 'Anterior segment developmental anomaly', 3),
(18816, 'ORPHA:88632', 'Anterior segment dysgenesis', 3),
(18817, 'ORPHA:88633', 'SLK', 1),
(18818, 'ORPHA:88633', 'Superior limbic keratoconjunctivitis', 1),
(18819, 'ORPHA:88633', 'Theodore superior limbic keratoconjunctivitis', 1),
(18820, 'ORPHA:88633', 'Theodore syndrome', 1),
(18821, 'ORPHA:88635', 'Myopathy due to calsequestrin and SERCA1 protein overload', 1),
(18822, 'ORPHA:88635', 'Vacuolar aggregate myopathy', 1),
(18823, 'ORPHA:88635', 'Vacuolar myopathy with sarcoplasmic reticulum protein aggregates', 1),
(18824, 'ORPHA:88637', '4H syndrome', 2),
(18825, 'ORPHA:88637', 'Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome', 2),
(18826, 'ORPHA:88639', 'HIBCH deficiency', 1),
(18827, 'ORPHA:88639', 'Methacrylic aciduria', 1),
(18828, 'ORPHA:88639', 'Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency', 1),
(18829, 'ORPHA:88639', 'Valine metabolic defect', 1),
(18830, 'ORPHA:88642', 'Channelopathy-associated CIP', 1),
(18831, 'ORPHA:88642', 'Channelopathy-associated congenital insensitivity to pain', 1),
(18832, 'ORPHA:88643', 'Obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome', 1),
(18833, 'ORPHA:88644', 'ARCA1', 1),
(18834, 'ORPHA:88644', 'Autosomal recessive ataxia, Beauce type', 1),
(18835, 'ORPHA:88644', 'Autosomal recessive cerebellar ataxia type 1', 1),
(18836, 'ORPHA:88644', 'SCAR8', 1),
(18837, 'ORPHA:88659', 'Autosomal dominant progressive nephropathy with hypertension', 1),
(18838, 'ORPHA:88660', 'Early-onset hypertension with exacerbation in pregnancy', 1),
(18839, 'ORPHA:88660', 'Hypertension due to gain-of-function mutations in the mineralocorticoid receptor', 1),
(18840, 'ORPHA:88660', 'Pseudohyperaldosteronism type 2', 1),
(18841, 'ORPHA:88661', 'Amelogenesis imperfecta', 1),
(18842, 'ORPHA:88673', 'HCC', 3),
(18843, 'ORPHA:88673', 'Hepatocellular carcinoma', 3),
(18844, 'ORPHA:887', 'VACTERL association', 1),
(18845, 'ORPHA:887', 'VACTERL/VATER association', 1),
(18846, 'ORPHA:887', 'VATER association', 1),
(18847, 'ORPHA:888', 'Cleft lip/palate with mucous cysts of lower lip', 1),
(18848, 'ORPHA:888', 'Lip-pit syndrome', 1),
(18849, 'ORPHA:888', 'VWS', 1),
(18850, 'ORPHA:888', 'Van der Woude syndrome', 1),
(18851, 'ORPHA:889', 'Cutaneous hypersensitivity vasculitis', 1),
(18852, 'ORPHA:889', 'Cutaneous small vessel vasculitis', 1),
(18853, 'ORPHA:88917', 'X-linked Alport syndrome', 2),
(18854, 'ORPHA:88918', 'Autosomal dominant Alport syndrome', 2),
(18855, 'ORPHA:88919', 'Autosomal recessive Alport syndrome', 2),
(18856, 'ORPHA:88924', 'Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis', 1),
(18857, 'ORPHA:88924', 'PKDTS', 1),
(18858, 'ORPHA:88924', 'TSC2/PKD1 contiguous gene syndrome', 1),
(18859, 'ORPHA:88924', 'Tuberous sclerosis/polycystic kidney disease contiguous gene syndrome', 1),
(18860, 'ORPHA:88938', 'PHA2A', 2),
(18861, 'ORPHA:88938', 'Pseudohypoaldosteronism type 2A', 2),
(18862, 'ORPHA:88939', 'PHA2B', 2),
(18863, 'ORPHA:88939', 'Pseudohypoaldosteronism type 2B', 2),
(18864, 'ORPHA:88940', 'PHA2C', 2),
(18865, 'ORPHA:88940', 'Pseudohypoaldosteronism type 2C', 2),
(18866, 'ORPHA:88949', 'ADTKD-MUC1', 2),
(18867, 'ORPHA:88949', 'MCKD1', 2),
(18868, 'ORPHA:88949', 'MUC1-related autosomal dominant medullary cystic kidney disease', 2),
(18869, 'ORPHA:88949', 'MUC1-related autosomal dominant tubulointerstitial kidney disease', 2),
(18870, 'ORPHA:88949', 'MUCI-related ADTKD', 2),
(18871, 'ORPHA:88949', 'Medullary cystic kidney disease type 1', 2),
(18872, 'ORPHA:88950', 'ADTKD-UMOD', 2),
(18873, 'ORPHA:88950', 'Autosomal dominant medullary cystic kidney disease type 2', 2),
(18874, 'ORPHA:88950', 'Familial juvenile hyperuricemic nephropathy type 1', 2),
(18875, 'ORPHA:88950', 'MCKD2', 2),
(18876, 'ORPHA:88950', 'UMOD-related ADTKD', 2),
(18877, 'ORPHA:88950', 'UMOD-related autosomal dominant tubulointerstitial kidney disease', 2),
(18878, 'ORPHA:88950', 'Uromodulin kidney disease', 2),
(18879, 'ORPHA:88950', 'Uromodulin-associated kidney disease', 2),
(18880, 'ORPHA:88991', 'Rare congenital non-syndromic heart malformation', 3),
(18881, 'ORPHA:88993', 'Esophageal malformation', 3),
(18882, 'ORPHA:890', 'Hepatic veno-occlusive disease', 1),
(18883, 'ORPHA:890', 'Sinusoidal obstruction syndrome', 1),
(18884, 'ORPHA:89043', 'Rare dementia', 3),
(18885, 'ORPHA:891', 'Criswick-Schepens syndrome', 1),
(18886, 'ORPHA:891', 'FEVR', 1),
(18887, 'ORPHA:891', 'Familial exudative vitreoretinopathy', 1),
(18888, 'ORPHA:892', 'Familial cerebelloretinal angiomatosis', 1),
(18889, 'ORPHA:892', 'Lindau disease', 1),
(18890, 'ORPHA:892', 'VHL', 1),
(18891, 'ORPHA:892', 'Von Hippel-Lindau disease', 1),
(18892, 'ORPHA:892', 'Von Hippel-Lindau syndrome', 1),
(18893, 'ORPHA:893', 'Del(11)(p13)', 1),
(18894, 'ORPHA:893', 'Deletion 11p13', 1),
(18895, 'ORPHA:893', 'Monosomy 11p13', 1),
(18896, 'ORPHA:893', 'WAGR syndrome', 1),
(18897, 'ORPHA:893', 'Wilms tumor-aniridia-genitourinary anomalies-intellectual disability syndrome', 1),
(18898, 'ORPHA:894', 'WS1', 2),
(18899, 'ORPHA:894', 'Waardenburg syndrome type 1', 2),
(18900, 'ORPHA:894', 'Waardenburg syndrome type I', 2),
(18901, 'ORPHA:895', 'WS2', 2),
(18902, 'ORPHA:895', 'Waardenburg syndrome type 2', 2),
(18903, 'ORPHA:895', 'Waardenburg syndrome type II', 2),
(18904, 'ORPHA:896', 'Klein-Waardenburg syndrome', 2),
(18905, 'ORPHA:896', 'WS3', 2),
(18906, 'ORPHA:896', 'Waardenburg syndrome type 3', 2),
(18907, 'ORPHA:896', 'Waardenburg syndrome type III', 2),
(18908, 'ORPHA:896', 'Waardenburg syndrome with limb anomalies', 2),
(18909, 'ORPHA:897', 'Shah-Waardenburg syndrome', 1),
(18910, 'ORPHA:897', 'WS4', 1),
(18911, 'ORPHA:897', 'Waardenburg syndrome type 4', 1),
(18912, 'ORPHA:897', 'Waardenburg-Hirschsprung syndrome', 1),
(18913, 'ORPHA:897', 'Waardenburg-Shah syndrome', 1),
(18914, 'ORPHA:898', 'Dominant hyaloideoretinal dystrophy of Wagner', 1),
(18915, 'ORPHA:898', 'VCAN-related vitreoretinopathy', 1),
(18916, 'ORPHA:898', 'Vitreoretinal degeneration, Wagner type', 1),
(18917, 'ORPHA:898', 'Wagner disease', 1),
(18918, 'ORPHA:898', 'Wagner syndrome', 1),
(18919, 'ORPHA:89826', 'Rare skin disease', 3),
(18920, 'ORPHA:89838', 'EBS, autosomal recessive K14', 1),
(18921, 'ORPHA:89838', 'EBS-AR KRT14', 1),
(18922, 'ORPHA:89838', 'Epidermolysis bullosa simplex, autosomal recessive K14', 1),
(18923, 'ORPHA:89838', 'KRT14-related autosomal recessive EBS', 1),
(18924, 'ORPHA:89838', 'KRT14-related autosomal recessive epidermolysis bullosa simplex', 1),
(18925, 'ORPHA:89839', 'EBSS', 1),
(18926, 'ORPHA:89839', 'Epidermolysis bullosa simplex superficialis', 1),
(18927, 'ORPHA:89840', 'JEN-nH', 1),
(18928, 'ORPHA:89840', 'Junctional epidermolysis bullosa, non-Herlitz type', 1),
(18929, 'ORPHA:89841', 'Centripetal dystrophic epidermolysis bullosa', 1),
(18930, 'ORPHA:89841', 'Centripetal recessive dystrophic epidermolysis bullosa', 1),
(18931, 'ORPHA:89841', 'Centripetalis recessive dystrophic epidermolysis bullosa', 1),
(18932, 'ORPHA:89841', 'RDEB, centripetalis', 1),
(18933, 'ORPHA:89841', 'RDEB-Ce', 1),
(18934, 'ORPHA:89842', 'Autosomal recessive dystrophic epidermolysis bullosa generalisata mitis', 1),
(18935, 'ORPHA:89842', 'Autosomal recessive dystrophic epidermolysis bullosa, generalized other', 1),
(18936, 'ORPHA:89842', 'Generalized mitis RDEB', 1),
(18937, 'ORPHA:89842', 'RDEB generalisata mitis', 1),
(18938, 'ORPHA:89842', 'RDEB, generalized intermediate', 1),
(18939, 'ORPHA:89842', 'RDEB, non-Hallopeau-Siemens type', 1),
(18940, 'ORPHA:89842', 'RDEB-O', 1),
(18941, 'ORPHA:89842', 'RDEB-generalized other', 1),
(18942, 'ORPHA:89842', 'Recessive dystrophic epidermolysis bullosa, generalized intermediate', 1),
(18943, 'ORPHA:89842', 'Recessive dystrophic epidermolysis bullosa, non-Hallopeau-Siemens type', 1),
(18944, 'ORPHA:89842', 'Recessive dystrophic epidermolysis bullosa-generalized other', 1),
(18945, 'ORPHA:89843', 'DEB, pruriginosa', 1),
(18946, 'ORPHA:89843', 'DEB-Pr', 1),
(18947, 'ORPHA:89843', 'Dystrophic epidermolysis bullosa pruriginosa', 1),
(18948, 'ORPHA:89843', 'Pruriginous dystrophic epidermolysis bullosa', 1),
(18949, 'ORPHA:89844', 'Lissencephaly syndrome, Norman-Roberts type', 2),
(18950, 'ORPHA:89844', 'Microlissencephaly type A', 2),
(18951, 'ORPHA:899', 'HARD syndrome', 1),
(18952, 'ORPHA:899', 'Hydrocephalus-agyria-retinal dysplasia syndrome', 1),
(18953, 'ORPHA:899', 'WWS', 1),
(18954, 'ORPHA:899', 'Walker-Warburg syndrome', 1),
(18955, 'ORPHA:89936', 'X-linked hypophosphatemia', 1),
(18956, 'ORPHA:89936', 'X-linked hypophosphatemic rickets', 1),
(18957, 'ORPHA:89936', 'XLH', 1),
(18958, 'ORPHA:89937', 'ADHR', 1),
(18959, 'ORPHA:89937', 'Autosomal dominant hypophosphatemia', 1),
(18960, 'ORPHA:89937', 'Autosomal dominant hypophosphatemic rickets', 1),
(18961, 'ORPHA:89938', 'Bartter syndrome type 4', 2),
(18962, 'ORPHA:89938', 'Bartter syndrome type IV', 2),
(18963, 'ORPHA:89938', 'Infantile Bartter syndrome with sensorineural deafness', 2),
(18964, 'ORPHA:89938', 'Infantile Bartter syndrome with sensorineural hearing loss', 2),
(18965, 'ORPHA:9', '48,XXXX syndrome', 1),
(18966, 'ORPHA:9', 'Quadruple X', 1),
(18967, 'ORPHA:9', 'Tetra X', 1),
(18968, 'ORPHA:9', 'Tetrasomy X', 1),
(18969, 'ORPHA:90', 'Arginase deficiency', 1),
(18970, 'ORPHA:90', 'Argininemia', 1),
(18971, 'ORPHA:90', 'Hyperargininemia', 1),
(18972, 'ORPHA:900', 'GPA', 1),
(18973, 'ORPHA:900', 'Granulomatosis with polyangiitis', 1),
(18974, 'ORPHA:90000', 'Erythema elevatum diutinum', 1),
(18975, 'ORPHA:90001', 'Bornholm eye disease', 1),
(18976, 'ORPHA:90001', 'X-linked cone dysfunction syndrome with myopia', 1),
(18977, 'ORPHA:90002', 'UCTD', 1),
(18978, 'ORPHA:90002', 'Undifferentiated connective tissue syndrome', 1),
(18979, 'ORPHA:90003', 'Inflammatory pseudotumor of the liver', 1),
(18980, 'ORPHA:90020', 'Amyotrophic lateral sclerosis-parkinsonism-dementia complex', 1),
(18981, 'ORPHA:90020', 'Amyotrophic lateral sclerosis-parkinsonism-dementia of Guam syndrome', 1),
(18982, 'ORPHA:90020', 'Guam disease', 1),
(18983, 'ORPHA:90020', 'Lytico-Bodig disease', 1),
(18984, 'ORPHA:90020', 'PDALS', 1),
(18985, 'ORPHA:90020', 'Parkinsonism-dementia-ALS complex', 1),
(18986, 'ORPHA:90021', 'Radiation myelitis', 1),
(18987, 'ORPHA:90023', 'Primary immunodeficiency syndrome due to LAMTOR2 deficiency', 1),
(18988, 'ORPHA:90023', 'Primary immunodeficiency syndrome due to p14 deficiency', 1),
(18989, 'ORPHA:90023', 'Primary immunodeficiency syndrome with short stature', 1),
(18990, 'ORPHA:90024', 'Deafness with labyrinthine aplasia, microtia, and microdontia', 1),
(18991, 'ORPHA:90024', 'Hearing loss with labyrinthine aplasia, microtia, and microdontia', 1),
(18992, 'ORPHA:90024', 'LAMM syndrome', 1),
(18993, 'ORPHA:90024', 'Microdontia-type I microtia-deafness syndrome', 1),
(18994, 'ORPHA:90024', 'Microdontia-type I microtia-hearing loss syndrome', 1),
(18995, 'ORPHA:90025', 'Non-syndromic syndactyly', 3),
(18996, 'ORPHA:90026', 'Primary erythermalgia', 1),
(18997, 'ORPHA:90026', 'Primary erythromelalgia', 1),
(18998, 'ORPHA:90030', 'Hemolytic anemia due to glutathione reductase deficiency', 1),
(18999, 'ORPHA:90031', 'Non-spherocytic hemolytic anemia due to hexokinase deficiency', 1),
(19000, 'ORPHA:90033', 'Autoimmune hemolytic anemia, warm type', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(19001, 'ORPHA:90033', 'Warm AIHA', 1),
(19002, 'ORPHA:90033', 'wAHA', 1),
(19003, 'ORPHA:90033', 'wAIHA', 1),
(19004, 'ORPHA:90035', 'Donath-Landsteiner hemolytic anemia', 1),
(19005, 'ORPHA:90035', 'Donath-Landsteiner syndrome', 1),
(19006, 'ORPHA:90035', 'PCH', 1),
(19007, 'ORPHA:90035', 'Paroxysmal cold hemoglobinuria', 1),
(19008, 'ORPHA:90036', 'Mixed AIHA', 1),
(19009, 'ORPHA:90036', 'Mixed-type autoimmune hemolytic anemia', 1),
(19010, 'ORPHA:90037', 'Drug-induced AIHA', 1),
(19011, 'ORPHA:90037', 'Drug-induced autoimmune hemolytic anemia', 1),
(19012, 'ORPHA:90038', 'D+ HUS', 2),
(19013, 'ORPHA:90038', 'EHEC-HUS', 2),
(19014, 'ORPHA:90038', 'Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli', 2),
(19015, 'ORPHA:90038', 'Hemolytic uremic syndrome with diarrhea', 2),
(19016, 'ORPHA:90038', 'STEC-HUS', 2),
(19017, 'ORPHA:90038', 'Shiga toxin-associated hemolytic uremic syndrome', 2),
(19018, 'ORPHA:90038', 'Shiga-like toxin-associated HUS', 2),
(19019, 'ORPHA:90038', 'Stx-HUS', 2),
(19020, 'ORPHA:90038', 'Typical HUS', 2),
(19021, 'ORPHA:90038', 'Typical hemolytic uremic syndrome', 2),
(19022, 'ORPHA:90039', 'Hemoglobin D disease', 1),
(19023, 'ORPHA:90041', 'Gaisböck syndrome', 1),
(19024, 'ORPHA:90041', 'Stress erythrocytosis', 1),
(19025, 'ORPHA:90041', 'Stress polycythemia', 1),
(19026, 'ORPHA:90042', 'Congenital erythrocytosis due to erythropoietin receptor mutation', 1),
(19027, 'ORPHA:90042', 'Congenital polycythemia due to erythropoietin receptor mutation', 1),
(19028, 'ORPHA:90042', 'Familial erythrocytosis', 1),
(19029, 'ORPHA:90042', 'PFCP', 1),
(19030, 'ORPHA:90042', 'Primary congenital erythrocytosis', 1),
(19031, 'ORPHA:90042', 'Primary familial and congenital polycythemia', 1),
(19032, 'ORPHA:90042', 'Primary familial polycythemia', 1),
(19033, 'ORPHA:90044', 'Familial pseudohyperkalemia', 1),
(19034, 'ORPHA:90045', 'Congenital folate malabsorption', 1),
(19035, 'ORPHA:90045', 'Hereditary folate malabsorption', 1),
(19036, 'ORPHA:90050', 'ROP', 1),
(19037, 'ORPHA:90050', 'Retinopathy of prematurity', 1),
(19038, 'ORPHA:90050', 'Retrolental fibroplasia', 1),
(19039, 'ORPHA:90051', 'Sepsis in premature infants', 1),
(19040, 'ORPHA:90052', 'Recurrent hepatitis C virus induced liver disease in liver transplant recipients', 1),
(19041, 'ORPHA:90053', 'Complications after HSCT', 1),
(19042, 'ORPHA:90053', 'Complications after hematopoietic stem cell transplantation', 1),
(19043, 'ORPHA:90056', 'Moderate and severe traumatic brain injury', 1),
(19044, 'ORPHA:90058', 'Spinal cord injury', 1),
(19045, 'ORPHA:90059', 'Acute sensorineural hearing loss by acute acoustic trauma or sudden deafness or surgery induced acoustic trauma', 1),
(19046, 'ORPHA:90060', 'Diffuse alveolar hemorrhage', 1),
(19047, 'ORPHA:90061', 'Non-infectious choroiditis', 3),
(19048, 'ORPHA:90061', 'Non-infectious posterior uveitis', 3),
(19049, 'ORPHA:90062', 'Acute hepatic failure', 1),
(19050, 'ORPHA:90062', 'Acute liver failure', 1),
(19051, 'ORPHA:90062', 'Fulminant hepatic failure', 1),
(19052, 'ORPHA:90064', 'Acute peripheral arterial occlusion', 1),
(19053, 'ORPHA:90065', 'Acquired aneurysmal subarachnoid hemorrhage', 1),
(19054, 'ORPHA:90066', 'Pneumonia caused by Pseudomonas aeruginosa infection', 1),
(19055, 'ORPHA:90068', 'Cocaine intoxication', 1),
(19056, 'ORPHA:90069', 'Systemic monochloroacetate poisoning', 1),
(19057, 'ORPHA:90073', 'Hepatitis B reinfection following liver transplantation', 1),
(19058, 'ORPHA:90076', 'Partial deep dermal and full thickness burns', 1),
(19059, 'ORPHA:90077', 'Other acquired skin disease', 3),
(19060, 'ORPHA:90078', 'Invasive infections due to VRE', 1),
(19061, 'ORPHA:90078', 'Invasive infections due to vancomycin-resistant enterococci', 1),
(19062, 'ORPHA:90080', 'Scarring in glaucoma filtration surgical procedures', 1),
(19063, 'ORPHA:90081', 'AIDS wasting syndrome', 1),
(19064, 'ORPHA:901', 'Eosinophilic cellulitis', 1),
(19065, 'ORPHA:901', 'Wells syndrome', 1),
(19066, 'ORPHA:90103', 'CMT-deafness-intellectual disability syndrome', 1),
(19067, 'ORPHA:90103', 'Charcot-Marie-Tooth disease-deafness-intellectual disability syndrome', 1),
(19068, 'ORPHA:90103', 'Charcot-Marie-Tooth disease-hearing loss-intellectual disability syndrome', 1),
(19069, 'ORPHA:90103', 'Hereditary motor and sensory neuropathy with deafness, intellectual disability and absent sensory large myelinated fibers', 1),
(19070, 'ORPHA:90103', 'Hereditary motor and sensory neuropathy with hearing loss, intellectual disability and absent sensory large myelinated fibers', 1),
(19071, 'ORPHA:90114', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease', 3),
(19072, 'ORPHA:90114', 'CMTDI', 3),
(19073, 'ORPHA:90117', 'HMSNP', 1),
(19074, 'ORPHA:90117', 'Hereditary motor and sensory neuropathy, Okinawa type', 1),
(19075, 'ORPHA:90117', 'Hereditary motor and sensory neuropathy, proximal type', 1),
(19076, 'ORPHA:90118', 'AR-CMT2, Ouvrier type', 1),
(19077, 'ORPHA:90118', 'Autosomal recessive Charcot-Marie-Tooth disease, Ouvrier type', 1),
(19078, 'ORPHA:90118', 'SEOAN due to MFN2 deficiency', 1),
(19079, 'ORPHA:90118', 'Severe early-onset axonal neuropathy due to MFN2 deficiency', 1),
(19080, 'ORPHA:90119', 'AR-CMT2 with acrodystrophy', 1),
(19081, 'ORPHA:90119', 'Autosomal recessive Charcot-Marie-Tooth type 2 with acrodystrophy', 1),
(19082, 'ORPHA:90119', 'Autosomal recessive axonal Charcot-Marie-Tooth disease with acrodystrophy', 1),
(19083, 'ORPHA:90119', 'HMSN with acrodystrophy', 1),
(19084, 'ORPHA:90119', 'Hereditary motor and sensory neuropathy with acrodystrophy', 1),
(19085, 'ORPHA:90120', 'CMT6', 1),
(19086, 'ORPHA:90120', 'Charcot-Marie-Tooth disease type 6', 1),
(19087, 'ORPHA:90120', 'HMSN 6', 1),
(19088, 'ORPHA:90120', 'HMSN VI', 1),
(19089, 'ORPHA:90120', 'Hereditary motor and sensory neuropathy type 6', 1),
(19090, 'ORPHA:90120', 'Hereditary motor and sensory neuropathy type VI', 1),
(19091, 'ORPHA:90120', 'Peripheral neuropathy and optic atrophy', 1),
(19092, 'ORPHA:90153', 'Mandibuloacral dysplasia with type A lipodystrophy', 2),
(19093, 'ORPHA:90154', 'Mandibuloacral dysplasia with type B lipodystrophy', 2),
(19094, 'ORPHA:90156', 'Centrifugal lipodystrophy', 1),
(19095, 'ORPHA:90156', 'Lipodystrophia centrifugalis abdominalis infantilis', 1),
(19096, 'ORPHA:90157', 'Drug-induced localized lipodystrophy', 1),
(19097, 'ORPHA:90157', 'Lipoatrophy caused by injected drug', 1),
(19098, 'ORPHA:90158', 'Idiopathic localized lipodystrophy', 1),
(19099, 'ORPHA:90159', 'Panniculitis-induced localized lipodystrophy', 1),
(19100, 'ORPHA:90160', 'Lipoatrophia semicircularis', 1),
(19101, 'ORPHA:90160', 'Pressure-induced localized lipoatrophy', 1),
(19102, 'ORPHA:90160', 'Semicircular lipoatrophy', 1),
(19103, 'ORPHA:90186', 'Hereditary lymphedema type II', 1),
(19104, 'ORPHA:90186', 'Meige disease', 1),
(19105, 'ORPHA:90186', 'Meige lymphedema', 1),
(19106, 'ORPHA:902', 'Adult progeria', 1),
(19107, 'ORPHA:902', 'WS', 1),
(19108, 'ORPHA:902', 'Werner syndrome', 1),
(19109, 'ORPHA:90280', 'Chilblain lupus', 1),
(19110, 'ORPHA:90281', 'Discoid lupus erythematosus', 1),
(19111, 'ORPHA:90282', 'Hypertrophic or verrucous lupus erythematosus', 1),
(19112, 'ORPHA:90283', 'Intermittent cutaneous lupus', 1),
(19113, 'ORPHA:90283', 'Lupus erythematosus tumidus', 1),
(19114, 'ORPHA:90285', 'Lupus erythematosus panniculitis', 1),
(19115, 'ORPHA:90285', 'Lupus erythematosus profundus', 1),
(19116, 'ORPHA:90289', 'Localized fibrosing scleroderma', 1),
(19117, 'ORPHA:90289', 'Localized scleroderma', 1),
(19118, 'ORPHA:90291', 'Systemic scleroderma', 1),
(19119, 'ORPHA:90291', 'Systemic sclerosis', 1),
(19120, 'ORPHA:903', 'Hereditary von Willebrand disease', 1),
(19121, 'ORPHA:903', 'Von Willebrand disease', 1),
(19122, 'ORPHA:90301', 'Acanthosis nigricans-insulin resistance-muscle cramps-acral enlargement syndrome', 1),
(19123, 'ORPHA:90307', 'Parkes Weber syndrome', 2),
(19124, 'ORPHA:90308', 'Klippel-Trénaunay syndrome', 2),
(19125, 'ORPHA:90321', 'Cockayne syndrome type 1', 2),
(19126, 'ORPHA:90321', 'Cockayne syndrome type I', 2),
(19127, 'ORPHA:90322', 'Cockayne syndrome type 2', 2),
(19128, 'ORPHA:90322', 'Cockayne syndrome type II', 2),
(19129, 'ORPHA:90324', 'Cockayne syndrome type 3', 2),
(19130, 'ORPHA:90324', 'Cockayne syndrome type III', 2),
(19131, 'ORPHA:90340', 'Blau syndrome', 1),
(19132, 'ORPHA:90342', 'XPV', 1),
(19133, 'ORPHA:90342', 'Xeroderma pigmentosum variant', 1),
(19134, 'ORPHA:90348', 'ADCL', 1),
(19135, 'ORPHA:90348', 'Autosomal dominant cutis laxa', 1),
(19136, 'ORPHA:90349', 'ARCL1', 1),
(19137, 'ORPHA:90349', 'Autosomal recessive cutis laxa type 1', 1),
(19138, 'ORPHA:90349', 'Autosomal recessive cutis laxa with severe systemic involvement', 1),
(19139, 'ORPHA:90349', 'Autosomal recessive cutis laxa, pulmonary emphysema type', 1),
(19140, 'ORPHA:90350', 'ARCL2', 3),
(19141, 'ORPHA:90350', 'Autosomal recessive cutis laxa type 2', 3),
(19142, 'ORPHA:90350', 'Cutis laxa with joint laxity and developmental delay', 3),
(19143, 'ORPHA:90354', 'Brittle cornea syndrome', 1),
(19144, 'ORPHA:90362', 'Primary intestinal lymphangiectasia', 1),
(19145, 'ORPHA:90362', 'Waldmann disease', 1),
(19146, 'ORPHA:90363', 'Secondary intestinal lymphangiectasia', 1),
(19147, 'ORPHA:90368', 'Hereditary hypotrichosis simplex of the scalp', 1),
(19148, 'ORPHA:90368', 'Hypotrichosis simplex of the scalp', 1),
(19149, 'ORPHA:90389', 'Telangiectasia macularis eruptiva perstans', 2),
(19150, 'ORPHA:90390', 'Anonychia-onychodystrophy syndrome', 2),
(19151, 'ORPHA:90393', 'Atypical tuberous myxedema of Jadassohn-Dosseker', 1),
(19152, 'ORPHA:90393', 'Nodular lichen myxedematosus', 1),
(19153, 'ORPHA:90394', 'Discrete papular lichen myxedematosus', 1),
(19154, 'ORPHA:90395', 'Cutaneous mucinosis of infancy', 1),
(19155, 'ORPHA:90395', 'Papular mucinosis of infancy', 1),
(19156, 'ORPHA:90396', 'Acral persistent papular mucinosis', 1),
(19157, 'ORPHA:90397', 'Self-healing papular mucinosis', 1),
(19158, 'ORPHA:90398', 'Localized lichen myxedematosus with mixed features of different subtypes', 2),
(19159, 'ORPHA:90399', 'Localized lichen myxedematosus with monoclonal gammopathy or systemic symptoms', 2),
(19160, 'ORPHA:904', 'Deletion 7q11.23', 1),
(19161, 'ORPHA:904', 'Monosomy 7q11.23', 1),
(19162, 'ORPHA:904', 'Williams syndrome', 1),
(19163, 'ORPHA:904', 'Williams-Beuren syndrome', 1),
(19164, 'ORPHA:90400', 'Scleromyxedema without monoclonal gammopathy', 2),
(19165, 'ORPHA:905', 'Hepatolenticular degeneration', 1),
(19166, 'ORPHA:905', 'Wilson disease', 1),
(19167, 'ORPHA:906', 'Eczema-thrombocytopenia-immunodeficiency syndrome', 1),
(19168, 'ORPHA:906', 'WAS', 1),
(19169, 'ORPHA:906', 'Wiskott-Aldrich syndrome', 1),
(19170, 'ORPHA:90625', 'X-linked isolated neurosensory deafness type DFN', 2),
(19171, 'ORPHA:90625', 'X-linked isolated neurosensory hearing loss type DFN', 2),
(19172, 'ORPHA:90625', 'X-linked isolated sensorineural deafness type DFN', 2),
(19173, 'ORPHA:90625', 'X-linked isolated sensorineural hearing loss type DFN', 2),
(19174, 'ORPHA:90625', 'X-linked non-syndromic neurosensory deafness type DFN', 2),
(19175, 'ORPHA:90625', 'X-linked non-syndromic neurosensory hearing loss type DFN', 2),
(19176, 'ORPHA:90625', 'X-linked non-syndromic sensorineural deafness type DFN', 2),
(19177, 'ORPHA:90625', 'X-linked non-syndromic sensorineural hearing loss type DFN', 2),
(19178, 'ORPHA:90635', 'Autosomal dominant isolated neurosensory deafness type DFNA', 2),
(19179, 'ORPHA:90635', 'Autosomal dominant isolated neurosensory hearing loss type DFNA', 2),
(19180, 'ORPHA:90635', 'Autosomal dominant isolated sensorineural deafness type DFNA', 2),
(19181, 'ORPHA:90635', 'Autosomal dominant isolated sensorineural hearing loss type DFNA', 2),
(19182, 'ORPHA:90635', 'Autosomal dominant non-syndromic neurosensory deafness type DFNA', 2),
(19183, 'ORPHA:90635', 'Autosomal dominant non-syndromic neurosensory hearing loss type DFNA', 2),
(19184, 'ORPHA:90635', 'Autosomal dominant non-syndromic sensorineural deafness type DFNA', 2),
(19185, 'ORPHA:90635', 'Autosomal dominant non-syndromic sensorineural hearing loss type DFNA', 2),
(19186, 'ORPHA:90636', 'Autosomal recessive isolated neurosensory deafness type DFNB', 2),
(19187, 'ORPHA:90636', 'Autosomal recessive isolated neurosensory hearing loss type DFNB', 2),
(19188, 'ORPHA:90636', 'Autosomal recessive isolated sensorineural deafness type DFNB', 2),
(19189, 'ORPHA:90636', 'Autosomal recessive isolated sensorineural hearing loss type DFNB', 2),
(19190, 'ORPHA:90636', 'Autosomal recessive non-syndromic neurosensory deafness type DFNB', 2),
(19191, 'ORPHA:90636', 'Autosomal recessive non-syndromic neurosensory hearing loss type DFNB', 2),
(19192, 'ORPHA:90636', 'Autosomal recessive non-syndromic sensorineural deafness type DFNB', 2),
(19193, 'ORPHA:90636', 'Autosomal recessive non-syndromic sensorineural hearing loss type DFNB', 2),
(19194, 'ORPHA:90641', 'Isolated mitochondrial neurosensory deafness', 2),
(19195, 'ORPHA:90641', 'Isolated mitochondrial neurosensory hearing loss', 2),
(19196, 'ORPHA:90641', 'Isolated mitochondrial sensorineural deafness', 2),
(19197, 'ORPHA:90641', 'Isolated mitochondrial sensorineural hearing loss', 2),
(19198, 'ORPHA:90641', 'Mitochondrial non-syndromic neurosensory deafness', 2),
(19199, 'ORPHA:90641', 'Mitochondrial non-syndromic neurosensory hearing loss', 2),
(19200, 'ORPHA:90641', 'Mitochondrial non-syndromic sensorineural deafness', 2),
(19201, 'ORPHA:90641', 'Mitochondrial non-syndromic sensorineural hearing loss', 2),
(19202, 'ORPHA:90642', 'Syndromic genetic deafness', 3),
(19203, 'ORPHA:90642', 'Syndromic genetic hearing loss', 3),
(19204, 'ORPHA:90646', 'Deafness-hypogonadism syndrome', 1),
(19205, 'ORPHA:90646', 'Hearing loss-hypogonadism syndrome', 1),
(19206, 'ORPHA:90647', 'Jervell and Lange-Nielsen syndrome', 1),
(19207, 'ORPHA:90647', 'Long QT interval-deafness syndrome', 1),
(19208, 'ORPHA:90647', 'Long QT interval-hearing loss syndrome', 1),
(19209, 'ORPHA:90650', 'OPD I syndrome', 1),
(19210, 'ORPHA:90650', 'OPD syndrome 1', 1),
(19211, 'ORPHA:90650', 'Otopalatodigital syndrome type 1', 1),
(19212, 'ORPHA:90650', 'Taybi syndrome', 1),
(19213, 'ORPHA:90652', 'OPD II syndrome', 1),
(19214, 'ORPHA:90652', 'OPD syndrome 2', 1),
(19215, 'ORPHA:90652', 'Otopalatodigital syndrome type 2', 1),
(19216, 'ORPHA:90653', 'Stickler syndrome type 1', 2),
(19217, 'ORPHA:90654', 'Stickler syndrome type 2', 2),
(19218, 'ORPHA:90658', 'CMT1E', 1),
(19219, 'ORPHA:90658', 'Charcot-Marie-Tooth disease type 1E', 1),
(19220, 'ORPHA:90658', 'Charcot-Marie-Tooth disease-deafness syndrome', 1),
(19221, 'ORPHA:90658', 'Charcot-Marie-Tooth disease-hearing loss syndrome', 1),
(19222, 'ORPHA:90673', 'Hypothyroidism due to TSH receptor mutations', 1),
(19223, 'ORPHA:90674', 'Isolated TSH deficiency', 1),
(19224, 'ORPHA:90674', 'Isolated thyroid-stimulating hormone deficiency', 1),
(19225, 'ORPHA:90674', 'Isolated thyrotropin deficiency', 1),
(19226, 'ORPHA:90692', 'Rare endocrine growth disease', 3),
(19227, 'ORPHA:90695', 'Genetic panhypopituitarism', 1),
(19228, 'ORPHA:90695', 'Non-acquired panhypopituitarism', 1),
(19229, 'ORPHA:90771', 'DSD', 3),
(19230, 'ORPHA:90771', 'Disorder of sex development', 3),
(19231, 'ORPHA:90776', '46,XX DSD induced by fetal androgens excess', 3),
(19232, 'ORPHA:90776', '46,XX disorder of sex development induced by fetal androgens excess', 3),
(19233, 'ORPHA:90783', '46,XY DSD due to a testosterone synthesis defect', 3),
(19234, 'ORPHA:90783', '46,XY disorder of sex development due to a testosterone synthesis defect', 3),
(19235, 'ORPHA:90786', '46,XY DSD due to adrenal and testicular steroidogenesis defect', 3),
(19236, 'ORPHA:90786', '46,XY disorder of sex development due to adrenal and testicular steroidogenesis defect', 3),
(19237, 'ORPHA:90787', '46,XY DSD due to testicular steroidogenesis defect', 3),
(19238, 'ORPHA:90787', '46,XY disorder of sex development due to testicular steroidogenesis defect', 3),
(19239, 'ORPHA:90790', 'CLAH', 1),
(19240, 'ORPHA:90790', 'Congenital lipoid adrenal hyperplasia due to STAR deficency', 1),
(19241, 'ORPHA:90791', 'CAH due to 3-beta-hydroxysteroid dehydrogenase deficiency', 1),
(19242, 'ORPHA:90791', 'Congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency', 1),
(19243, 'ORPHA:90793', 'CAH due to 17-alpha-hydroxylase deficiency', 1),
(19244, 'ORPHA:90793', 'Combined 17-hydroxylase/17,20-lyase deficiency', 1),
(19245, 'ORPHA:90793', 'Congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency', 1),
(19246, 'ORPHA:90794', 'Classic 21-OHD CAH', 1),
(19247, 'ORPHA:90794', 'Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency', 1),
(19248, 'ORPHA:90795', 'CAH due to 11-beta-hydroxylase deficiency', 1),
(19249, 'ORPHA:90795', 'CYP11B1 deficiency', 1),
(19250, 'ORPHA:90795', 'Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency', 1),
(19251, 'ORPHA:90796', '46,XY disorder of sex development due to isolated 17,20-lyase deficiency', 1),
(19252, 'ORPHA:90797', 'PAIS', 1),
(19253, 'ORPHA:90797', 'Partial androgen insensitivity syndrome', 1),
(19254, 'ORPHA:90797', 'Partial androgen resistance syndrome', 1),
(19255, 'ORPHA:908', 'FRAXA syndrome', 1),
(19256, 'ORPHA:908', 'FXS', 1),
(19257, 'ORPHA:908', 'FraX syndrome', 1),
(19258, 'ORPHA:908', 'Fragile X syndrome', 1),
(19259, 'ORPHA:908', 'Martin-Bell syndrome', 1),
(19260, 'ORPHA:909', 'CTX', 1),
(19261, 'ORPHA:909', 'Cerebrotendinous xanthomatosis', 1),
(19262, 'ORPHA:909', 'Sterol 27-hydroxylase deficiency', 1),
(19263, 'ORPHA:90970', 'Primary lipodystrophy', 3),
(19264, 'ORPHA:91', 'Aromatase deficiency', 1),
(19265, 'ORPHA:91', 'Congenital estrogen deficiency', 1),
(19266, 'ORPHA:910', 'Xeroderma pigmentosum', 1),
(19267, 'ORPHA:91024', 'AR-CMT2', 3),
(19268, 'ORPHA:91024', 'Autosomal recessive axonal Charcot-Marie-Tooth disease type 2', 3),
(19269, 'ORPHA:91024', 'Autosomal recessive axonal hereditary motor and sensory neuropathy', 3),
(19270, 'ORPHA:91088', 'Other metabolic disease', 3),
(19271, 'ORPHA:911', 'Combined immunodeficiency due to ZAP70 deficiency', 1),
(19272, 'ORPHA:911', 'Zeta-associated-protein 70 deficiency', 1),
(19273, 'ORPHA:91127', 'Adenovirus infection in immunocompromised patients', 1),
(19274, 'ORPHA:91130', 'Cardiomyopathy-hypotonia-lactic acidosis syndrome', 1),
(19275, 'ORPHA:91131', 'CDG syndrome type Im', 1),
(19276, 'ORPHA:91131', 'CDG-Im', 1),
(19277, 'ORPHA:91131', 'CDG1M', 1),
(19278, 'ORPHA:91131', 'Carbohydrate deficient glycoprotein syndrome type Im', 1),
(19279, 'ORPHA:91131', 'Congenital disorder of glycosylation type 1m', 1),
(19280, 'ORPHA:91131', 'Congenital disorder of glycosylation type Im', 1),
(19281, 'ORPHA:91131', 'DK1-CDG', 1),
(19282, 'ORPHA:91131', 'Dolichol kinase deficiency', 1),
(19283, 'ORPHA:91131', 'Hypotonia and ichthyosis due to dolichol phosphate deficiency', 1),
(19284, 'ORPHA:91132', 'Hypotrichosis-congenital ichthyosis syndrome', 1),
(19285, 'ORPHA:91132', 'IFAH syndrome', 1),
(19286, 'ORPHA:91132', 'IHS', 1),
(19287, 'ORPHA:91132', 'Ichthyosis-follicular atrophoderma-hypotrichosis syndrome', 1),
(19288, 'ORPHA:91132', 'Ichthyosis-follicular atrophoderma-hypotrichosis-hypohidrosis syndrome', 1),
(19289, 'ORPHA:91132', 'Ichthyosis-hypotrichosis syndrome', 1),
(19290, 'ORPHA:91133', 'Osteopenia-myopia-deafness-intellectual disability-facial dysmorphism syndrome', 1),
(19291, 'ORPHA:91133', 'Osteopenia-myopia-hearing loss-intellectual disability-facial dysmorphism syndrome', 1),
(19292, 'ORPHA:91135', 'Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency', 1),
(19293, 'ORPHA:91135', 'PXE-like syndrome', 1),
(19294, 'ORPHA:91135', 'Pseudoxanthoma elasticum-like syndrome', 1),
(19295, 'ORPHA:91136', 'Acquired Fanconi syndrome secondary to monoclonal gammopathy', 1),
(19296, 'ORPHA:91136', 'Acquired monoclonal Ig light chain-associated Fanconi syndrome', 1),
(19297, 'ORPHA:91136', 'Acquired monoclonal immunoglobulin light chain-associated Fanconi syndrome', 1),
(19298, 'ORPHA:91137', 'Immunotactoid or fibrillary glomerulonephritis', 3),
(19299, 'ORPHA:91137', 'Immunotactoid or fibrillary glomerulopathy', 3),
(19300, 'ORPHA:91138', 'Cryoglobulinemic vasculitis', 1),
(19301, 'ORPHA:91138', 'Essential cryoglobulinemia', 1),
(19302, 'ORPHA:91138', 'Essential mixed cryoglobulinemia', 1),
(19303, 'ORPHA:91138', 'Mixed cryoglobulinemia', 1),
(19304, 'ORPHA:91138', 'Primary cryoglobulinemia', 1),
(19305, 'ORPHA:91139', 'Cryoglobulinemia type 1', 1),
(19306, 'ORPHA:91139', 'Simple cryoglobulinemia', 1),
(19307, 'ORPHA:91140', 'Unspecified JIA', 1),
(19308, 'ORPHA:91140', 'Unspecified juvenile idiopathic arthritis', 1),
(19309, 'ORPHA:91144', '46,XX DSD induced by maternal-derived androgen', 3),
(19310, 'ORPHA:91144', '46,XX disorder of sex development induced by maternal-derived androgen', 3),
(19311, 'ORPHA:912', 'Cerebrohepatorenal syndrome', 1),
(19312, 'ORPHA:912', 'ZS', 1),
(19313, 'ORPHA:912', 'Zellweger syndrome', 1),
(19314, 'ORPHA:913', 'Gastrinoma', 1),
(19315, 'ORPHA:913', 'Zollinger-Ellison syndrome', 1),
(19316, 'ORPHA:91347', 'Pituitary thyrotrophic adenoma', 1),
(19317, 'ORPHA:91347', 'TSH-oma', 1),
(19318, 'ORPHA:91347', 'TSH-secreting pituitary adenoma', 1),
(19319, 'ORPHA:91347', 'Thyroid stimulating hormone-secreting pituitary adenoma', 1),
(19320, 'ORPHA:91347', 'Thyrotroph adenoma', 1),
(19321, 'ORPHA:91348', 'Functioning gonadotropic adenoma', 1),
(19322, 'ORPHA:91348', 'Functioning pituitary gonadotropic adenoma', 1),
(19323, 'ORPHA:91348', 'Gonadotroph adenoma', 1),
(19324, 'ORPHA:91349', 'NFPA', 1),
(19325, 'ORPHA:91349', 'Non-functioning pituitary adenoma', 1),
(19326, 'ORPHA:91350', 'Pituitary deficiency due to Rathke cleft cysts', 1),
(19327, 'ORPHA:91351', 'Pituitary dermoid and epidermoid cysts', 1),
(19328, 'ORPHA:91352', 'Germinoma of the central nervous system', 2),
(19329, 'ORPHA:91354', 'Hypopituitarism due to empty sella turcica syndrome', 1),
(19330, 'ORPHA:91354', 'Pituitary deficiency due to empty sella turcica syndrome', 1),
(19331, 'ORPHA:91355', 'Sheehan syndrome', 1),
(19332, 'ORPHA:91357', 'Duplication of the esophagus', 3),
(19333, 'ORPHA:91358', 'Congenital esophageal diverticulum', 1),
(19334, 'ORPHA:91358', 'Congenital esophageal pouch', 1),
(19335, 'ORPHA:91359', 'CPI', 1),
(19336, 'ORPHA:91359', 'Chronic pneumonitis of infancy', 1),
(19337, 'ORPHA:91364', 'NSIP', 1),
(19338, 'ORPHA:91364', 'Non-specific idiopathic interstitial pneumonia', 1),
(19339, 'ORPHA:91364', 'Non-specific interstitial pneumonia', 1),
(19340, 'ORPHA:91378', 'Familial angioneurotic edema', 3),
(19341, 'ORPHA:91378', 'HAE', 3),
(19342, 'ORPHA:91378', 'Hereditary angioedema', 3),
(19343, 'ORPHA:91378', 'Hereditary angioneurotic edema', 3),
(19344, 'ORPHA:91378', 'Hereditary bradykinine-induced angioedema', 3),
(19345, 'ORPHA:91378', 'Hereditary non histamine-induced angioedema', 3),
(19346, 'ORPHA:91385', 'AAE', 3),
(19347, 'ORPHA:91385', 'Acquired C1 inhibitor deficiency', 3),
(19348, 'ORPHA:91385', 'Acquired angioedema', 3),
(19349, 'ORPHA:91385', 'Acquired angioneurotic edema', 3),
(19350, 'ORPHA:91385', 'Acquired bradykinine-induced angioedema', 3),
(19351, 'ORPHA:91385', 'Acquired non histamine-induced angioedema', 3),
(19352, 'ORPHA:91387', 'Familial TAAD', 1),
(19353, 'ORPHA:91387', 'Familial thoracic aortic aneurysm and aortic dissection', 1),
(19354, 'ORPHA:91396', 'Isolated cryptophthalmia', 1),
(19355, 'ORPHA:91397', 'Isolated ankyloblepharon filiforme adnatum', 1),
(19356, 'ORPHA:91411', 'Congenital ptosis', 1),
(19357, 'ORPHA:91412', 'Jaw-winking syndrome', 1),
(19358, 'ORPHA:91412', 'Mandibulo-palpebral synkinesis-ptosis syndrome', 1),
(19359, 'ORPHA:91412', 'Marcus-Gunn phenomenon', 1),
(19360, 'ORPHA:91412', 'Marcus-Gunn syndrome', 1),
(19361, 'ORPHA:91413', 'Congenital Claude-Bernard-Horner syndrome', 1),
(19362, 'ORPHA:91413', 'Congenital Horner syndrome', 1),
(19363, 'ORPHA:91414', 'Epithelioma calcificans of Malherbe', 1),
(19364, 'ORPHA:91414', 'Pilomatricoma', 1),
(19365, 'ORPHA:91414', 'Pilomatrixoma', 1),
(19366, 'ORPHA:91416', 'Isolated congenital alacrima', 1),
(19367, 'ORPHA:91481', 'Ring dermoid of cornea', 1),
(19368, 'ORPHA:91481', 'Ring dermoid syndrome', 1),
(19369, 'ORPHA:91483', 'Rieger anomaly', 1),
(19370, 'ORPHA:91489', 'Congenital anterior megalophthalmia', 1),
(19371, 'ORPHA:91489', 'Isolated congenital megalocornea', 1),
(19372, 'ORPHA:91490', 'Isolated congenital sclerocornea', 1),
(19373, 'ORPHA:91491', 'Congenital ectropion uveae', 1),
(19374, 'ORPHA:91492', 'Early-onset non-syndromic cataract', 1),
(19375, 'ORPHA:91494', 'Macular coloboma-cleft palate-hallux valgus syndrome', 1),
(19376, 'ORPHA:91495', 'Congenital retinal detachment', 1),
(19377, 'ORPHA:91495', 'NCRNA disease', 1),
(19378, 'ORPHA:91495', 'Non-syndromic congenital retinal non-attachment', 1),
(19379, 'ORPHA:91495', 'PFVS', 1),
(19380, 'ORPHA:91495', 'PHPV', 1),
(19381, 'ORPHA:91495', 'Persistent fetal vasculature syndrome', 1),
(19382, 'ORPHA:91495', 'Persistent hyperplastic primary vitreous', 1),
(19383, 'ORPHA:91496', 'Snowflake vitreoretinal degeneration', 1),
(19384, 'ORPHA:91498', 'Familial congenital palsy of trochlear nerve', 1),
(19385, 'ORPHA:915', 'Aarskog syndrome', 1),
(19386, 'ORPHA:915', 'Aarskog-Scott syndrome', 1),
(19387, 'ORPHA:915', 'Faciodigitogenital syndrome', 1),
(19388, 'ORPHA:915', 'Faciogenital dysplasia', 1),
(19389, 'ORPHA:91500', 'Acute tubulointerstitial nephritis and uveitis syndrome', 1),
(19390, 'ORPHA:91500', 'Dobrin syndrome', 1),
(19391, 'ORPHA:91500', 'TINU syndrome', 1),
(19392, 'ORPHA:91500', 'Tubulointerstitial nephritis and uveitis syndrome', 1),
(19393, 'ORPHA:91546', 'Lyme borreliosis', 1),
(19394, 'ORPHA:91546', 'Lyme disease', 1),
(19395, 'ORPHA:91547', 'Relapsing fever', 1),
(19396, 'ORPHA:916', 'Aase-Smith I syndrome', 1),
(19397, 'ORPHA:916', 'Aase-Smith syndrome', 1),
(19398, 'ORPHA:916', 'Hydrocephalus-cleft palate-joint contractures syndrome', 1),
(19399, 'ORPHA:92', 'Juvenile chronic arthritis', 3),
(19400, 'ORPHA:92', 'Juvenile idiopathic arthritis', 3),
(19401, 'ORPHA:92', 'Juvenile rheumatoid arthritis', 3),
(19402, 'ORPHA:920', 'Ablepharon macrostomia syndrome', 1),
(19403, 'ORPHA:92050', 'Congenital tufting enteropathy', 1),
(19404, 'ORPHA:92050', 'IED', 1),
(19405, 'ORPHA:92050', 'Intestinal epithelial dysplasia', 1),
(19406, 'ORPHA:92050', 'Non-syndromic congenital tufting enteropathy', 1),
(19407, 'ORPHA:921', 'Abruzzo-Erickson syndrome', 1),
(19408, 'ORPHA:921', 'CHARGE-like syndrome', 1),
(19409, 'ORPHA:921', 'Cleft palate-coloboma-deafness syndrome', 1),
(19410, 'ORPHA:921', 'Cleft palate-coloboma-hearing loss syndrome', 1),
(19411, 'ORPHA:922', 'Familial nasal acilia', 1),
(19412, 'ORPHA:926', 'Acatalasemia', 1),
(19413, 'ORPHA:926', 'Catalase deficiency', 1),
(19414, 'ORPHA:927', 'Hyperammonemia due to N-acetylglutamate synthase deficiency', 1),
(19415, 'ORPHA:927', 'NAGS deficiency', 1),
(19416, 'ORPHA:929', 'Achalasia-microcephaly syndrome', 1),
(19417, 'ORPHA:93', 'Aspartylglucosaminidase deficiency', 1),
(19418, 'ORPHA:93', 'Aspartylglucosaminuria', 1),
(19419, 'ORPHA:930', 'Achalasia cardia', 1),
(19420, 'ORPHA:930', 'Idiopathic achalasia', 1),
(19421, 'ORPHA:930', 'Idiopathic achalasia of esophagus', 1),
(19422, 'ORPHA:930', 'Primary achalasia', 1),
(19423, 'ORPHA:931', 'Acheiropodia', 1),
(19424, 'ORPHA:931', 'Acheiropody', 1),
(19425, 'ORPHA:93100', 'Renal agenesis, unilateral', 2),
(19426, 'ORPHA:93101', 'Renal hypoplasia', 1),
(19427, 'ORPHA:93108', 'Kidney dysplasia', 1),
(19428, 'ORPHA:93108', 'Renal dysplasia', 1),
(19429, 'ORPHA:93109', 'Congenital megacalycosis', 1),
(19430, 'ORPHA:93110', 'PUV', 1),
(19431, 'ORPHA:93110', 'Posterior urethral valve', 1),
(19432, 'ORPHA:93111', 'ADTKD-HNF1B', 2),
(19433, 'ORPHA:93111', 'HNF1B-MODY', 2),
(19434, 'ORPHA:93111', 'HNF1B-related autosomal dominant tubulointerstitial kidney disease', 2),
(19435, 'ORPHA:93111', 'MODY5', 2),
(19436, 'ORPHA:93111', 'Maturity-onset diabetes of the young type 5', 2),
(19437, 'ORPHA:93111', 'RCAD syndrome', 2),
(19438, 'ORPHA:93111', 'Renal cysts and diabetes syndrome', 2),
(19439, 'ORPHA:93111', 'Renal dysfunction-early-onset diabetes syndrome', 2),
(19440, 'ORPHA:93114', 'Autosomal dominant intermediate Charcot-Marie-Tooth disease type E', 1),
(19441, 'ORPHA:93114', 'CMTDIE', 1),
(19442, 'ORPHA:93114', 'Charcot-Marie-Tooth disease-nephropathy syndrome', 1),
(19443, 'ORPHA:93126', 'Pauci-immune glomerulonephritis', 1),
(19444, 'ORPHA:93160', 'HVDRR', 1),
(19445, 'ORPHA:93160', 'Hereditary vitamin D-resistant rickets', 1),
(19446, 'ORPHA:93160', 'Hypocalcemic vitamin D-resistant rickets', 1),
(19447, 'ORPHA:93160', 'VDDR II', 1),
(19448, 'ORPHA:93160', 'VDRR II', 1),
(19449, 'ORPHA:93160', 'Vitamin D-dependent rickets type II', 1),
(19450, 'ORPHA:93160', 'Vitamin D-resistant rickets type II', 1),
(19451, 'ORPHA:93164', 'Secondary pseudohypoaldosteronism', 1),
(19452, 'ORPHA:93164', 'TPHA', 1),
(19453, 'ORPHA:93164', 'Transient pseudohypoaldosteronism', 1),
(19454, 'ORPHA:93172', 'Kidney dysplasia, unilateral', 2),
(19455, 'ORPHA:93172', 'Renal dysplasia, unilateral', 2),
(19456, 'ORPHA:93173', 'Kidney dysplasia, bilateral', 2),
(19457, 'ORPHA:93173', 'Renal dysplasia, bilateral', 2),
(19458, 'ORPHA:93176', 'Unilateral congenital megacalycosis', 2),
(19459, 'ORPHA:93177', 'Congenital bilateral megacalycosis', 2),
(19460, 'ORPHA:932', 'Achondrogenesis', 1),
(19461, 'ORPHA:93256', 'FXTAS syndrome', 1),
(19462, 'ORPHA:93256', 'Fragile X-associated tremor/ataxia syndrome', 1),
(19463, 'ORPHA:93258', 'Classic Pfeiffer syndrome', 2),
(19464, 'ORPHA:93258', 'Pfeiffer syndrome type 1', 2),
(19465, 'ORPHA:93259', 'Pfeiffer syndrome type 2', 2),
(19466, 'ORPHA:93260', 'Pfeiffer syndrome type 3', 2),
(19467, 'ORPHA:93262', 'Crouzon syndrome-acanthosis nigricans syndrome', 1),
(19468, 'ORPHA:93262', 'Crouzon-dermoskeletal syndrome', 1),
(19469, 'ORPHA:93267', 'Cloverleaf skull-multiple congenital anomalies syndrome', 1),
(19470, 'ORPHA:93268', 'Short rib-polydactyly syndrome type 4', 1),
(19471, 'ORPHA:93268', 'Short rib-polydactyly syndrome, Beemer-Langer type', 1),
(19472, 'ORPHA:93269', 'Short rib-polydactyly syndrome type 2', 1),
(19473, 'ORPHA:93269', 'Short rib-polydactyly syndrome, Majewski type', 1),
(19474, 'ORPHA:93270', 'Short rib-polydactyly syndrome type 1', 1),
(19475, 'ORPHA:93270', 'Short rib-polydactyly syndrome, Saldino-Noonan type', 1),
(19476, 'ORPHA:93271', 'Short rib-polydactyly syndrome type 3', 1),
(19477, 'ORPHA:93271', 'Short rib-polydactyly syndrome, Verma-Naumoff type', 1),
(19478, 'ORPHA:93274', 'Cloverleaf skull-micromelic bone dysplasia syndrome', 2),
(19479, 'ORPHA:93274', 'TD2', 2),
(19480, 'ORPHA:93274', 'Thanatophoric dwarfism type 2', 2),
(19481, 'ORPHA:93274', 'Thanatophoric dwarfism-cloverleaf skull syndrome', 2),
(19482, 'ORPHA:93274', 'Thanatophoric dysplasia type 2', 2),
(19483, 'ORPHA:93276', 'Polyostotic fibrous dysplasia', 2),
(19484, 'ORPHA:93277', 'Jaffe-Lichtenstein disease', 2),
(19485, 'ORPHA:93277', 'Monostotic fibrous dysplasia', 2),
(19486, 'ORPHA:93279', 'Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis', 1),
(19487, 'ORPHA:93282', 'Spondyloepimetaphyseal dysplasia, PAPSS2 type', 1),
(19488, 'ORPHA:93282', 'Spondyloepimetaphyseal dysplasia, Pakistani type', 1),
(19489, 'ORPHA:93283', 'Spondyloepiphyseal dysplasia, Kimberley type', 1),
(19490, 'ORPHA:93284', 'Spondyloepiphyseal dysplasia tarda', 1),
(19491, 'ORPHA:93292', 'Adenoma of pancreas', 1),
(19492, 'ORPHA:93292', 'Pancreatic adenoma', 1),
(19493, 'ORPHA:93293', 'Duane-radial ray syndrome', 1),
(19494, 'ORPHA:93293', 'Okihiro syndrome', 1),
(19495, 'ORPHA:93296', 'Achondrogenesis type 2', 2),
(19496, 'ORPHA:93296', 'Achondrogenesis, Langer-Saldino type', 2),
(19497, 'ORPHA:93297', 'Hypochondrogenesis', 2),
(19498, 'ORPHA:93298', 'Achondrogenesis type 1B', 2),
(19499, 'ORPHA:93298', 'Achondrogenesis, Parenti-Fraccaro type', 2),
(19500, 'ORPHA:93299', 'Achondrogenesis type 1A', 2);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(19501, 'ORPHA:93299', 'Achondrogenesis, Houston-Harris type', 2),
(19502, 'ORPHA:93302', 'Brachyolmia type 2', 1),
(19503, 'ORPHA:93302', 'Brachyolmia, Maroteaux type', 1),
(19504, 'ORPHA:93304', 'Autosomal dominant brachyolmia', 1),
(19505, 'ORPHA:93304', 'Brachyolmia type 3', 1),
(19506, 'ORPHA:93307', 'Autosomal recessive multiple epiphyseal dysplasia', 1),
(19507, 'ORPHA:93307', 'EDM4', 1),
(19508, 'ORPHA:93307', 'MED4', 1),
(19509, 'ORPHA:93307', 'Multiple epiphyseal dysplasia type 4', 1),
(19510, 'ORPHA:93307', 'Polyepiphyseal dysplasia type 4', 1),
(19511, 'ORPHA:93307', 'rMED', 1),
(19512, 'ORPHA:93308', 'EDM1', 1),
(19513, 'ORPHA:93308', 'MED1', 1),
(19514, 'ORPHA:93308', 'Multiple epiphyseal dysplasia type 1', 1),
(19515, 'ORPHA:93308', 'Polyepiphyseal dysplasia type 1', 1),
(19516, 'ORPHA:93311', 'BHMED', 1),
(19517, 'ORPHA:93311', 'Bilateral hereditary micro-epiphyseal dysplasia', 1),
(19518, 'ORPHA:93311', 'EDM5', 1),
(19519, 'ORPHA:93311', 'MED5', 1),
(19520, 'ORPHA:93311', 'Multiple epiphyseal dysplasia type 5', 1),
(19521, 'ORPHA:93311', 'Polyepiphyseal dysplasia type 5', 1),
(19522, 'ORPHA:93314', 'Spondylometaphyseal dysplasia, Kozlowski type', 1),
(19523, 'ORPHA:93315', 'Spondylometaphyseal dysplasia, \'corner fracture\' type', 1),
(19524, 'ORPHA:93315', 'Spondylometaphyseal dysplasia, Sutcliffe type', 1),
(19525, 'ORPHA:93316', 'Spondylometaphyseal dysplasia with severe genu valgum', 1),
(19526, 'ORPHA:93316', 'Spondylometaphyseal dysplasia, Algerian type', 1),
(19527, 'ORPHA:93316', 'Spondylometaphyseal dysplasia, Schmidt type', 1),
(19528, 'ORPHA:93317', 'Spondylometaphyseal dysplasia, Sedaghatian type', 1),
(19529, 'ORPHA:93320', 'Congenital longitudinal deficiency of the ulna', 1),
(19530, 'ORPHA:93320', 'Ulnar clubhand', 1),
(19531, 'ORPHA:93320', 'Ulnar hemimelia', 1),
(19532, 'ORPHA:93320', 'Ulnar longitudinal meromelia', 1),
(19533, 'ORPHA:93321', 'Congenital longitudinal deficiency of the radius', 1),
(19534, 'ORPHA:93321', 'Radial clubhand', 1),
(19535, 'ORPHA:93321', 'Radial hemimelia', 1),
(19536, 'ORPHA:93321', 'Radial longitidinal meromelia', 1),
(19537, 'ORPHA:93321', 'Radial ray agenesis', 1),
(19538, 'ORPHA:93322', 'Congenital absence of tibia', 1),
(19539, 'ORPHA:93322', 'Congenital aplasia and dysplasia of the tibia with intact fibula', 1),
(19540, 'ORPHA:93322', 'Congenital longitudinal deficiency of the tibia', 1),
(19541, 'ORPHA:93322', 'Tibial hemimelia', 1),
(19542, 'ORPHA:93322', 'Tibial longitudinal meromelia', 1),
(19543, 'ORPHA:93323', 'Congenital longitudinal deficiency of the fibula', 1),
(19544, 'ORPHA:93323', 'Fibular hemimelia', 1),
(19545, 'ORPHA:93323', 'Fibular longitudinal meromelia', 1),
(19546, 'ORPHA:93324', 'Autosomal recessive Kenny-Caffey syndrome', 2),
(19547, 'ORPHA:93325', 'Autosomal dominant Kenny-Caffey syndrome', 2),
(19548, 'ORPHA:93328', 'Autosomal dominant omodysplasia', 2),
(19549, 'ORPHA:93329', 'Autosomal recessive omodysplasia', 2),
(19550, 'ORPHA:93329', 'Micromelic dysplasia-dislocation of radius syndrome', 2),
(19551, 'ORPHA:93333', 'Cousin syndrome', 1),
(19552, 'ORPHA:93333', 'Familial pelvis-scapular dysplasia', 1),
(19553, 'ORPHA:93333', 'Pelviscapular dysplasia', 1),
(19554, 'ORPHA:93334', 'Postaxial polydactyly type A', 1),
(19555, 'ORPHA:93335', 'Postaxial polydactyly type B', 1),
(19556, 'ORPHA:93336', 'PPD2', 1),
(19557, 'ORPHA:93336', 'Polydactyly of a triphalangeal thumb', 1),
(19558, 'ORPHA:93336', 'Preaxial polydactyly type 2', 1),
(19559, 'ORPHA:93337', 'PPD3', 1),
(19560, 'ORPHA:93337', 'Polydactyly of an index finger', 1),
(19561, 'ORPHA:93337', 'Preaxial polydactyly type 3', 1),
(19562, 'ORPHA:93338', 'PPD4', 1),
(19563, 'ORPHA:93338', 'Polysyndactyly', 1),
(19564, 'ORPHA:93338', 'Preaxial polydactyly type 4', 1),
(19565, 'ORPHA:93339', 'PPD1', 1),
(19566, 'ORPHA:93339', 'Polydactyly of a biphalangeal thumb', 1),
(19567, 'ORPHA:93339', 'Preaxial polydactyly type 1', 1),
(19568, 'ORPHA:93346', 'Spondyloepimetaphyseal dysplasia congenita, Strudwick type', 1),
(19569, 'ORPHA:93347', 'Anauxetic dysplasia', 1),
(19570, 'ORPHA:93347', 'Spondyloepimetaphyseal dysplasia, Menger type', 1),
(19571, 'ORPHA:93347', 'Spondyloepimetaphyseal dysplasia, anauxetic type', 1),
(19572, 'ORPHA:93349', 'X-linked spondyloepimetaphyseal dysplasia', 1),
(19573, 'ORPHA:93351', 'SEMD, Irapa type', 1),
(19574, 'ORPHA:93351', 'Spondyloepimetaphyseal dysplasia, Irapa type', 1),
(19575, 'ORPHA:93352', 'SEMD, Shohat type', 1),
(19576, 'ORPHA:93352', 'Spondyloepimetaphyseal dysplasia, Shohat type', 1),
(19577, 'ORPHA:93356', 'SEMD type 2', 1),
(19578, 'ORPHA:93356', 'SEMD, Missouri type', 1),
(19579, 'ORPHA:93356', 'Spondyloepimetaphyseal dysplasia type 2', 1),
(19580, 'ORPHA:93356', 'Spondyloepimetaphyseal dysplasia, Missouri type', 1),
(19581, 'ORPHA:93357', 'SPONASTRIME dysplasia', 1),
(19582, 'ORPHA:93357', 'Spondylar and nasal changes with striations of the metaphyses (SPONASTRIME) dysplasia', 1),
(19583, 'ORPHA:93357', 'Spondyloepimetaphyseal dysplasia, Sponastrime type', 1),
(19584, 'ORPHA:93358', 'Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome', 1),
(19585, 'ORPHA:93359', 'SEMD-JL', 1),
(19586, 'ORPHA:93359', 'SEMDJL1', 1),
(19587, 'ORPHA:93359', 'Spondyloepimetaphyseal dysplasia with joint laxity', 1),
(19588, 'ORPHA:93359', 'Spondyloepimetaphyseal dysplasia with joint laxity type 1', 1),
(19589, 'ORPHA:93359', 'Spondyloepimetaphyseal dysplasia with joint laxity, Beighton type', 1),
(19590, 'ORPHA:93360', 'SEMD-MD', 1),
(19591, 'ORPHA:93360', 'SEMDJL2', 1),
(19592, 'ORPHA:93360', 'Spondyloepimetaphyseal dysplasia with joint laxicity, Hall type', 1),
(19593, 'ORPHA:93360', 'Spondyloepimetaphyseal dysplasia with joint laxity type 2', 1),
(19594, 'ORPHA:93360', 'Spondyloepimetaphyseal dysplasia with joint laxity, leptodactylic type', 1),
(19595, 'ORPHA:93360', 'Spondyloepimetaphyseal dysplasia with multiple dislocations', 1),
(19596, 'ORPHA:93360', 'Spondyloepimetaphyseal dysplasia with multiple dislocations, Hall type', 1),
(19597, 'ORPHA:93372', 'FHH type 1', 2),
(19598, 'ORPHA:93372', 'Familial hypocalciuric hypercalcemia type 1', 2),
(19599, 'ORPHA:93382', 'Brachydactyly type A6', 1),
(19600, 'ORPHA:93382', 'Osebold-Remondini syndrome', 1),
(19601, 'ORPHA:93383', 'Brachydactyly type B', 1),
(19602, 'ORPHA:93384', 'Brachydactyly type C', 1),
(19603, 'ORPHA:93387', 'Brachydactyly type E', 1),
(19604, 'ORPHA:93388', 'Brachydactyly type A1', 1),
(19605, 'ORPHA:93388', 'Brachydactyly, Farabee type', 1),
(19606, 'ORPHA:93394', 'Brachydactyly type A4', 1),
(19607, 'ORPHA:93394', 'Brachydactyly, Temtamy type', 1),
(19608, 'ORPHA:93394', 'Brachymesophalangy II and V', 1),
(19609, 'ORPHA:93396', 'Brachydactyly type A2', 1),
(19610, 'ORPHA:93396', 'Brachydactyly, Mohr-Wriedt type', 1),
(19611, 'ORPHA:93397', 'Brachydactyly type A7', 1),
(19612, 'ORPHA:93397', 'Brachydactyly, Smorgasbord type', 1),
(19613, 'ORPHA:93398', 'Genochondromatosis type 2', 1),
(19614, 'ORPHA:93399', 'Juvenile sialidosis type 2', 2),
(19615, 'ORPHA:93400', 'Congenital sialidosis type 2', 2),
(19616, 'ORPHA:93402', 'Syndactyly type 1', 1),
(19617, 'ORPHA:93403', 'Syndactyly type 2', 1),
(19618, 'ORPHA:93403', 'Synpolydactyly', 1),
(19619, 'ORPHA:93404', 'SD3', 1),
(19620, 'ORPHA:93404', 'Syndactyly of fingers 4 and 5', 1),
(19621, 'ORPHA:93404', 'Syndactyly type 3', 1),
(19622, 'ORPHA:93405', 'Polysyndactyly, Haas type', 1),
(19623, 'ORPHA:93405', 'Syndactyly type 4', 1),
(19624, 'ORPHA:93406', 'Postaxial syndactyly with metacarpal synostosis', 1),
(19625, 'ORPHA:93406', 'SD5', 1),
(19626, 'ORPHA:93406', 'Syndactyly type 5', 1),
(19627, 'ORPHA:93409', 'Brachydactyly-syndactyly, Zhao type', 1),
(19628, 'ORPHA:93419', 'Rare bone disease', 3),
(19629, 'ORPHA:93420', 'FGFR3-related chondrodysplasia', 3),
(19630, 'ORPHA:93421', 'Type 2 collagen-related bone disorder', 3),
(19631, 'ORPHA:93422', 'Type 11 collagen-related bone disorder', 3),
(19632, 'ORPHA:93423', 'Sulfation-related bone disorder', 3),
(19633, 'ORPHA:93424', 'Perlecan-related bone disorder', 3),
(19634, 'ORPHA:93425', 'Bone filaminopathy', 3),
(19635, 'ORPHA:93425', 'Filamin-related bone disorder', 3),
(19636, 'ORPHA:93426', 'Ciliopathies with major skeletal involvement', 3),
(19637, 'ORPHA:93426', 'SRP', 3),
(19638, 'ORPHA:93426', 'Short rib dysplasia', 3),
(19639, 'ORPHA:93429', 'Multiple epiphyseal dysplasia and pseudoachondroplasia', 3),
(19640, 'ORPHA:93430', 'Multiple metaphyseal dysplasia', 3),
(19641, 'ORPHA:93434', 'Spondylodysplastic dysplasia', 3),
(19642, 'ORPHA:93436', 'Acromelic dysplasia', 3),
(19643, 'ORPHA:93437', 'Acromesomelic dysplasia', 3),
(19644, 'ORPHA:93438', 'Mesomelic and rhizo-mesomelic dysplasia', 3),
(19645, 'ORPHA:93439', 'Bent bone dysplasia', 3),
(19646, 'ORPHA:93439', 'Campomelic dysplasia and related disorders', 3),
(19647, 'ORPHA:93440', 'Slender bone dysplasia', 3),
(19648, 'ORPHA:93441', 'Primary bone dysplasia with multiple joint dislocations', 3),
(19649, 'ORPHA:93441', 'Primary osteodysplasia with multiple joint dislocations', 3),
(19650, 'ORPHA:93441', 'Primary skeletal dysplasia with multiple joint dislocations', 3),
(19651, 'ORPHA:93442', 'CDP', 3),
(19652, 'ORPHA:93442', 'Chondrodysplasia punctata', 3),
(19653, 'ORPHA:93443', 'Neonatal osteosclerotic dysplasia', 3),
(19654, 'ORPHA:93444', 'Primary bone dysplasia with increased bone density', 3),
(19655, 'ORPHA:93444', 'Primary osteodysplasia with increased bone density', 3),
(19656, 'ORPHA:93444', 'Primary skeletal dysplasia with increased bone density', 3),
(19657, 'ORPHA:93444', 'Sclerosing bone dysplasia', 3),
(19658, 'ORPHA:93446', 'Primary bone dysplasia with decreased bone density', 3),
(19659, 'ORPHA:93446', 'Primary osteodysplasia with decreased bone density', 3),
(19660, 'ORPHA:93446', 'Primary skeletal dysplasia with decreased bone density', 3),
(19661, 'ORPHA:93447', 'Primary bone dysplasia with defective bone mineralization', 3),
(19662, 'ORPHA:93447', 'Primary osteodysplasia with defective bone mineralization', 3),
(19663, 'ORPHA:93447', 'Primary skeletal dysplasia with defective bone mineralization', 3),
(19664, 'ORPHA:93448', 'Dysostosis multiplex', 3),
(19665, 'ORPHA:93448', 'Lysosomal storage disease with skeletal involvement', 3),
(19666, 'ORPHA:93449', 'Primary osteolysis', 3),
(19667, 'ORPHA:93450', 'Primary bone dysplasia with disorganized development of skeletal components', 3),
(19668, 'ORPHA:93450', 'Primary osteodysplasia with disorganized development of skeletal components', 3),
(19669, 'ORPHA:93450', 'Primary skeletal dysplasia with disorganized development of skeletal components', 3),
(19670, 'ORPHA:93451', 'Cleidocranial dysplasia and isolated cranial ossification defect', 3),
(19671, 'ORPHA:93453', 'Dysostosis with predominant craniofacial involvement', 3),
(19672, 'ORPHA:93454', 'Dysostosis with predominant vertebral and costal involvement', 3),
(19673, 'ORPHA:93455', 'Patellar dysostosis', 3),
(19674, 'ORPHA:93457', 'Non-syndromic limb hypoplasia', 3),
(19675, 'ORPHA:93457', 'Non-syndromic limb reduction defect', 3),
(19676, 'ORPHA:93458', 'Non-syndromic polydactyly, syndactyly and/or hyperphalangy', 3),
(19677, 'ORPHA:93459', 'Syndrome with synostosis or other joint formation defect', 3),
(19678, 'ORPHA:93460', 'Overgrowth syndrome', 3),
(19679, 'ORPHA:93461', 'Chromosomal disease with overgrowth', 3),
(19680, 'ORPHA:93465', 'Lethal chondrodysplasia', 3),
(19681, 'ORPHA:93473', 'Hurler disease', 2),
(19682, 'ORPHA:93473', 'Hurler syndrome', 2),
(19683, 'ORPHA:93473', 'MPS1H', 2),
(19684, 'ORPHA:93473', 'MPSIH', 2),
(19685, 'ORPHA:93473', 'Mucopolysaccharidosis type 1H', 2),
(19686, 'ORPHA:93473', 'Mucopolysaccharidosis type IH', 2),
(19687, 'ORPHA:93474', 'MPS1S', 2),
(19688, 'ORPHA:93474', 'MPSIS', 2),
(19689, 'ORPHA:93474', 'Mucopolysaccharidosis type 1S', 2),
(19690, 'ORPHA:93474', 'Mucopolysaccharidosis type IS', 2),
(19691, 'ORPHA:93474', 'Scheie syndrome', 2),
(19692, 'ORPHA:93476', 'Hurler-Scheie syndrome', 2),
(19693, 'ORPHA:93476', 'MPS1H/S', 2),
(19694, 'ORPHA:93476', 'MPSIH/S', 2),
(19695, 'ORPHA:93476', 'Mucopolysaccharidosis type 1H/S', 2),
(19696, 'ORPHA:93476', 'Mucopolysaccharidosis type IH/S', 2),
(19697, 'ORPHA:935', 'Achondroplasia-SCID syndrome', 1),
(19698, 'ORPHA:935', 'Achondroplasia-Swiss type agammaglobulinemia syndrome', 1),
(19699, 'ORPHA:935', 'Achondroplasia-severe combined immunodeficiency syndrome', 1),
(19700, 'ORPHA:935', 'Immunodeficiency-short limb dwarfism syndrome', 1),
(19701, 'ORPHA:935', 'Short limb skeletal dysplasia with SCID', 1),
(19702, 'ORPHA:935', 'Short-limb skeletal dysplasia with severe combined immunodeficiency', 1),
(19703, 'ORPHA:93545', 'CAKUT', 3),
(19704, 'ORPHA:93545', 'Congenital anomalies of kidney and urinary tract', 3),
(19705, 'ORPHA:93545', 'Renal or urinary tract malformation', 3),
(19706, 'ORPHA:93546', 'Non-syndromic renal or urinary tract malformation', 3),
(19707, 'ORPHA:93547', 'Syndromic renal or urinary tract malformation', 3),
(19708, 'ORPHA:93548', 'Glomerular disease', 3),
(19709, 'ORPHA:93552', 'Pediatric systemic lupus erythematosus', 1),
(19710, 'ORPHA:93552', 'SLE, pediatric onset', 1),
(19711, 'ORPHA:93554', 'MC type II', 2),
(19712, 'ORPHA:93554', 'Mixed cryoglobulinemia type II', 2),
(19713, 'ORPHA:93555', 'MC type III', 2),
(19714, 'ORPHA:93555', 'Mixed cryoglobulinemia type III', 2),
(19715, 'ORPHA:93556', 'HCDD', 2),
(19716, 'ORPHA:93556', 'Heavy chain deposition disease', 2),
(19717, 'ORPHA:93557', 'LHCDD', 2),
(19718, 'ORPHA:93557', 'Light and heavy chain deposition disease', 2),
(19719, 'ORPHA:93558', 'LCDD', 2),
(19720, 'ORPHA:93558', 'Light chain deposition disease', 2),
(19721, 'ORPHA:93560', 'AApoAI amyloidosis', 2),
(19722, 'ORPHA:93560', 'Apolipoprotein A-I amyloidosis', 2),
(19723, 'ORPHA:93560', 'Familial amyloid nephropathy due to apolipoprotein A-I variant', 2),
(19724, 'ORPHA:93560', 'Familial renal amyloidosis due to apolipoprotein A-I variant', 2),
(19725, 'ORPHA:93560', 'Hereditary amyloid nephropathy due to apolipoprotein A-I variant', 2),
(19726, 'ORPHA:93560', 'Hereditary renal amyloidosis due to apolipoprotein A-I variant', 2),
(19727, 'ORPHA:93561', 'ALys amyloidosis', 2),
(19728, 'ORPHA:93561', 'Familial amyloid nephropathy due to lysozyme variant', 2),
(19729, 'ORPHA:93561', 'Familial renal amyloidosis due to lysozyme variant', 2),
(19730, 'ORPHA:93561', 'Hereditary amyloid nephropathy due to lysozyme variant', 2),
(19731, 'ORPHA:93561', 'Hereditary renal amyloidosis due to lysozyme variant', 2),
(19732, 'ORPHA:93561', 'Lysozyme amyloidosis', 2),
(19733, 'ORPHA:93562', 'AFib amyloidosis', 2),
(19734, 'ORPHA:93562', 'Familial amyloid nephropathy due to fibrinogen A alpha-chain variant', 2),
(19735, 'ORPHA:93562', 'Fibrinogen A alpha-chain amyloidosis', 2),
(19736, 'ORPHA:93562', 'Hereditary amyloid nephropathy due to fibrinogen A alpha-chain variant', 2),
(19737, 'ORPHA:93562', 'Hereditary renal amyloidosis due to fibrinogen A alpha-chain variant', 2),
(19738, 'ORPHA:93568', 'Juvenile PM', 1),
(19739, 'ORPHA:93568', 'Juvenile polymyositis', 1),
(19740, 'ORPHA:93569', 'Polymyalgia rheumatica', 1),
(19741, 'ORPHA:93569', 'Rhizomelic pseudopolyarthritis', 1),
(19742, 'ORPHA:93571', 'Dense deposit disease', 2),
(19743, 'ORPHA:93571', 'Membranoproliferative glomerulonephritis type 2', 2),
(19744, 'ORPHA:93573', 'Thrombotic microangiopathy', 3),
(19745, 'ORPHA:93581', 'Atypical HUS with anti-factor H antibodies', 2),
(19746, 'ORPHA:93581', 'Atypical hemolytic uremic syndrome with anti-factor H antibodies', 2),
(19747, 'ORPHA:93581', 'aHUS with anti-factor H antibodies', 2),
(19748, 'ORPHA:93581', 'aHUS with neutralizing autoantibodies against factor H', 2),
(19749, 'ORPHA:93583', 'Congenital ADAMTS-13 deficiency', 2),
(19750, 'ORPHA:93583', 'Congenital TTP', 2),
(19751, 'ORPHA:93583', 'Congenital thrombotic thrombocytopenic purpura', 2),
(19752, 'ORPHA:93583', 'Familial TTP', 2),
(19753, 'ORPHA:93583', 'Upshaw-Schulman syndrome', 2),
(19754, 'ORPHA:93585', 'Acquired TTP', 2),
(19755, 'ORPHA:93585', 'Acquired thrombotic thrombocytopenic purpura', 2),
(19756, 'ORPHA:93585', 'Autoimmune thrombotic thrombocytopenic purpura', 2),
(19757, 'ORPHA:93585', 'Immune-mediated thrombotic thrombocytopenic purpura', 2),
(19758, 'ORPHA:93585', 'Thrombotic thrombocytopenic purpura due to anti-ADAMTS-13 antibodies', 2),
(19759, 'ORPHA:93585', 'aTTP', 2),
(19760, 'ORPHA:93585', 'iTTP', 2),
(19761, 'ORPHA:93587', 'Familial cystic renal disease', 3),
(19762, 'ORPHA:93589', 'Late-onset nephronophthisis', 2),
(19763, 'ORPHA:93591', 'Autosomal recessive infantile NPHP', 2),
(19764, 'ORPHA:93591', 'Autosomal recessive infantile nephronophthisis', 2),
(19765, 'ORPHA:93591', 'Infantile nephronophthisis', 2),
(19766, 'ORPHA:93592', 'Juvenile nephronophthisis', 2),
(19767, 'ORPHA:93593', 'Nephropathy secondary to a storage or other metabolic disease', 3),
(19768, 'ORPHA:93598', 'Glycolic aciduria', 2),
(19769, 'ORPHA:93598', 'Peroxisomal alanine-glyoxylate aminotransferase deficiency', 2),
(19770, 'ORPHA:93598', 'Primary hyperoxaluria type 1', 2),
(19771, 'ORPHA:93599', 'D-glycerate dehydrogenase deficiency', 2),
(19772, 'ORPHA:93599', 'L-glyceric aciduria', 2),
(19773, 'ORPHA:93599', 'Primary hyperoxaluria type 2', 2),
(19774, 'ORPHA:93600', 'Primary hyperoxaluria type 3', 2),
(19775, 'ORPHA:93601', 'XDH deficiency', 2),
(19776, 'ORPHA:93601', 'XO deficiency', 2),
(19777, 'ORPHA:93601', 'XOR deficiency', 2),
(19778, 'ORPHA:93601', 'Xanthine dehydrogenase deficiency', 2),
(19779, 'ORPHA:93601', 'Xanthine oxidase deficiency', 2),
(19780, 'ORPHA:93601', 'Xanthine oxidoreductase deficiency', 2),
(19781, 'ORPHA:93601', 'Xanthinuria type I', 2),
(19782, 'ORPHA:93602', 'XDH and AOX dual deficiency', 2),
(19783, 'ORPHA:93602', 'Xanthine dehydrogenase and xanthine aldehyde oxidase dual deficiency', 2),
(19784, 'ORPHA:93602', 'Xanthinuria type II', 2),
(19785, 'ORPHA:93603', 'Rare renal tubular disease', 3),
(19786, 'ORPHA:93604', 'Antenatal Bartter syndrome', 2),
(19787, 'ORPHA:93604', 'Bartter syndrome, furosemide type', 2),
(19788, 'ORPHA:93604', 'Bartter syndrome, furosemide-amiloride type', 2),
(19789, 'ORPHA:93604', 'Hyperprostaglandin E syndrome', 2),
(19790, 'ORPHA:93605', 'Adult Bartter syndrome', 2),
(19791, 'ORPHA:93605', 'Bartter syndrome type 3', 2),
(19792, 'ORPHA:93605', 'Bartter syndrome type III', 2),
(19793, 'ORPHA:93605', 'Classic Bartter syndrome', 2),
(19794, 'ORPHA:93606', 'NSIAD', 1),
(19795, 'ORPHA:93606', 'Nephrogenic syndrome of inappropriate antidiuresis', 1),
(19796, 'ORPHA:93607', 'AR pRTA', 2),
(19797, 'ORPHA:93607', 'Autosomal recessive proximal renal tubular acidosis', 2),
(19798, 'ORPHA:93607', 'Proximal renal tubular acidosis with ocular abnormalities and intellectual disability', 2),
(19799, 'ORPHA:93608', 'AD dRTA', 2),
(19800, 'ORPHA:93608', 'Autosomal dominant distal renal tubular acidosis', 2),
(19801, 'ORPHA:93610', 'Distal renal tubular acidosis with anemia', 2),
(19802, 'ORPHA:93610', 'dRTA with anemia', 2),
(19803, 'ORPHA:93612', 'Cystinuria type A', 2),
(19804, 'ORPHA:93613', 'Cystinuria type B', 2),
(19805, 'ORPHA:93614', 'Hematological disorder with renal involvement', 3),
(19806, 'ORPHA:93616', 'Alpha-thalassemia intermedia', 2),
(19807, 'ORPHA:93616', 'HbH disease', 2),
(19808, 'ORPHA:93616', 'Hemoglobin H disease', 2),
(19809, 'ORPHA:93618', 'Rare cause of hypertension', 3),
(19810, 'ORPHA:93619', 'Rare renal tumor', 3),
(19811, 'ORPHA:93622', 'Dent disease type 1', 2),
(19812, 'ORPHA:93622', 'Nephrolithiasis type 1', 2),
(19813, 'ORPHA:93623', 'Dent disease type 2', 2),
(19814, 'ORPHA:93623', 'Nephrolithiasis type 2', 2),
(19815, 'ORPHA:93626', 'Rare renal disease', 3),
(19816, 'ORPHA:93665', 'Autoinflammatory syndrome', 3),
(19817, 'ORPHA:93672', 'Juvenile DM', 1),
(19818, 'ORPHA:93672', 'Juvenile dermatomyositis', 1),
(19819, 'ORPHA:93685', 'Localized Castleman disease', 2),
(19820, 'ORPHA:93685', 'Unicentric Castleman disease', 2),
(19821, 'ORPHA:93890', 'Malformation syndrome', 3),
(19822, 'ORPHA:93890', 'Rare developmental defect during embryogenesis', 3),
(19823, 'ORPHA:939', '3-hydroxyisobutyric aciduria', 1),
(19824, 'ORPHA:93921', 'NF3', 1),
(19825, 'ORPHA:93921', 'Neurilemmomatosis', 1),
(19826, 'ORPHA:93921', 'Neurofibromatosis type 3', 1),
(19827, 'ORPHA:93921', 'Schwannomatosis', 1),
(19828, 'ORPHA:93924', 'Lobar holoprosencephaly', 2),
(19829, 'ORPHA:93925', 'Alobar holoprosencephaly', 2),
(19830, 'ORPHA:93926', 'MIH', 2),
(19831, 'ORPHA:93926', 'MIH type HPE', 2),
(19832, 'ORPHA:93926', 'MIHF', 2),
(19833, 'ORPHA:93926', 'MIHV', 2),
(19834, 'ORPHA:93926', 'Middle interhemispheric fusion variant', 2),
(19835, 'ORPHA:93926', 'Middle interhemispheric variant of holoprosencephaly', 2),
(19836, 'ORPHA:93926', 'Midline interhemispheric variant of holoprosencephaly', 2),
(19837, 'ORPHA:93926', 'Syntelencephaly', 2),
(19838, 'ORPHA:93928', 'Isolated epispadias', 2),
(19839, 'ORPHA:93929', 'Cloacal exstrophy', 2),
(19840, 'ORPHA:93929', 'OEIS complex', 2),
(19841, 'ORPHA:93929', 'Omphalocele-cloacal exstrophy-imperforate anus-spinal defect syndrome', 2),
(19842, 'ORPHA:93930', 'Bladder exstrophy', 2),
(19843, 'ORPHA:93930', 'Classic exstrophy of the bladder', 2),
(19844, 'ORPHA:93932', 'FG syndrome type 1', 1),
(19845, 'ORPHA:93932', 'Opitz-Kaveggia syndrome', 1),
(19846, 'ORPHA:93938', 'LTEC I', 2),
(19847, 'ORPHA:93938', 'LTEC1', 2),
(19848, 'ORPHA:93938', 'Laryngo-tracheo-esophageal cleft type 1', 2),
(19849, 'ORPHA:93938', 'Laryngotracheoesophageal cleft type 1', 2),
(19850, 'ORPHA:93939', 'LTEC II', 2),
(19851, 'ORPHA:93939', 'LTEC2', 2),
(19852, 'ORPHA:93939', 'Laryngo-tracheo-esophageal cleft type 2', 2),
(19853, 'ORPHA:93939', 'Laryngotracheoesophageal cleft type 2', 2),
(19854, 'ORPHA:93940', 'LTEC III', 2),
(19855, 'ORPHA:93940', 'LTEC3', 2),
(19856, 'ORPHA:93940', 'Laryngo-tracheo-esophageal cleft type 3', 2),
(19857, 'ORPHA:93940', 'Laryngotracheoesophageal cleft type 3', 2),
(19858, 'ORPHA:93941', 'LTEC IV', 2),
(19859, 'ORPHA:93941', 'LTEC4', 2),
(19860, 'ORPHA:93941', 'Laryngo-tracheo-esophageal cleft type 4', 2),
(19861, 'ORPHA:93941', 'Laryngotracheoesophageal cleft type 4', 2),
(19862, 'ORPHA:93945', 'X-linked intellectual disability, Porteous type', 2),
(19863, 'ORPHA:93946', 'Hamel cerebro-palato-cardiac syndrome', 2),
(19864, 'ORPHA:93947', 'X-linked intellectual disability, Golabi-Ito-Hall type', 2),
(19865, 'ORPHA:93950', 'X-linked intellectual disability, Sutherland-Haan type', 2),
(19866, 'ORPHA:93952', 'MRXSH', 1),
(19867, 'ORPHA:93952', 'X-linked intellectual disability, Hedera type', 1),
(19868, 'ORPHA:93953', 'Familial thyroglossal duct cyst', 1),
(19869, 'ORPHA:93958', 'Oromandibular dystonia', 1),
(19870, 'ORPHA:93964', 'Blepharospasm-oromandibular dystonia syndrome', 1),
(19871, 'ORPHA:93964', 'Meige dystonia', 1),
(19872, 'ORPHA:93964', 'Meige syndrome', 1),
(19873, 'ORPHA:93969', 'Myelomeningocele', 1),
(19874, 'ORPHA:93970', 'Holmes-Gang syndrome', 1),
(19875, 'ORPHA:93971', 'Chudley-Lowry syndrome', 1),
(19876, 'ORPHA:93971', 'Chudley-Lowry-Hoar syndrome', 1),
(19877, 'ORPHA:93972', 'Juberg-Marsidi syndrome', 1),
(19878, 'ORPHA:93973', 'Carpenter-Waziri syndrome', 1),
(19879, 'ORPHA:93974', 'Smith-Fineman-Myers syndrome', 1),
(19880, 'ORPHA:93975', 'Renier-Gabreels-Jasper syndrome', 1),
(19881, 'ORPHA:93976', 'Anotia', 1),
(19882, 'ORPHA:94', 'Astrocytic tumor', 3),
(19883, 'ORPHA:94', 'Astrocytoma', 3),
(19884, 'ORPHA:94056', 'Humero-ulnar fusion', 1),
(19885, 'ORPHA:94056', 'Humero-ulnar synostosis', 1),
(19886, 'ORPHA:94058', 'Neovascular glaucoma', 1),
(19887, 'ORPHA:94059', 'Uremic pruritus', 1),
(19888, 'ORPHA:94063', '12q14 microdeletion syndrome', 1),
(19889, 'ORPHA:94063', 'Del(12)(q14)', 1),
(19890, 'ORPHA:94063', 'Deletion 12q14', 1),
(19891, 'ORPHA:94063', 'Monosomy 12q14', 1),
(19892, 'ORPHA:94063', 'Osteopoikilosis-short stature-intellectual disability syndrome', 1),
(19893, 'ORPHA:94064', 'DIS', 1),
(19894, 'ORPHA:94064', 'Deafness-infertility syndrome', 1),
(19895, 'ORPHA:94064', 'Hearing loss-infertility syndrome', 1),
(19896, 'ORPHA:94065', '15q24 microdeletion syndrome', 2),
(19897, 'ORPHA:94065', 'Del(15)(q24)', 2),
(19898, 'ORPHA:94065', 'Monosomy 15q24', 2),
(19899, 'ORPHA:94066', 'Severe intellectual disability-epilepsy-anal anomalies-distal phalangeal hypoplasia', 1),
(19900, 'ORPHA:94068', 'Congenital spondyloepiphyseal dysplasia', 1),
(19901, 'ORPHA:94068', 'SEDC', 1),
(19902, 'ORPHA:94068', 'Spondyloepiphyseal dysplasia congenita', 1),
(19903, 'ORPHA:94068', 'Spranger-Wiedemann disease', 1),
(19904, 'ORPHA:94075', 'Autoimmune enteropathy', 3),
(19905, 'ORPHA:94075', 'Immune-mediated protracted diarrhea of infancy', 3),
(19906, 'ORPHA:94075', 'Severe immune-mediated enteropathy', 3),
(19907, 'ORPHA:94080', 'Non-functioning paraganglioma', 1),
(19908, 'ORPHA:94080', 'Non-secreting paraganglioma', 1),
(19909, 'ORPHA:94083', 'Partington syndrome', 1),
(19910, 'ORPHA:94083', 'Partington-Mulley syndrome', 1),
(19911, 'ORPHA:94083', 'X-linked intellectual disability-dystonia-dysarthria syndrome', 1),
(19912, 'ORPHA:94086', 'Blue diaper syndrome', 1),
(19913, 'ORPHA:94086', 'Drummond syndrome', 1),
(19914, 'ORPHA:94086', 'Familial hypercalcemia-nephrocalcinosis-indicanuria syndrome', 1),
(19915, 'ORPHA:94087', 'CHP', 1),
(19916, 'ORPHA:94087', 'Cytophagic histiocytic panniculitis', 1),
(19917, 'ORPHA:94087', 'Winkelmann cytophagic panniculitis', 1),
(19918, 'ORPHA:94088', 'Hereditary renal hypouricemia', 1),
(19919, 'ORPHA:94089', 'Pseudohypoparathyroidism type 1B', 1),
(19920, 'ORPHA:94090', 'Pseudohypoparathyroidism type 2', 1),
(19921, 'ORPHA:94091', 'Mills syndrome', 1),
(19922, 'ORPHA:94093', 'Neuroleptic malignant syndrome', 1),
(19923, 'ORPHA:94095', 'Casamassima-Morton-Nance syndrome', 1),
(19924, 'ORPHA:94095', 'Spondylocostal dysostosis-anal atresia-genitourinary malformation syndrome', 1),
(19925, 'ORPHA:941', 'D-glycerate kinase deficiency', 1),
(19926, 'ORPHA:941', 'D-glyceric acidemia', 1),
(19927, 'ORPHA:941', 'D-glyceric aciduria', 1),
(19928, 'ORPHA:94122', 'Cayman ataxia', 1),
(19929, 'ORPHA:94122', 'Cerebellar ataxia, Cayman type', 1),
(19930, 'ORPHA:94124', 'SCAN1', 1),
(19931, 'ORPHA:94124', 'Spinocerebellar ataxia with axonal neuropathy type 1', 1),
(19932, 'ORPHA:94125', 'MIRAS', 1),
(19933, 'ORPHA:94125', 'Recessive mitochondrial ataxia syndrome', 1),
(19934, 'ORPHA:94145', 'ADCA1', 3),
(19935, 'ORPHA:94145', 'ADCAI', 3),
(19936, 'ORPHA:94145', 'Autosomal dominant cerebellar ataxia type 1', 3),
(19937, 'ORPHA:94145', 'Autosomal dominant cerebellar ataxia type I', 3),
(19938, 'ORPHA:94145', 'Cerebellar plus syndrome', 3),
(19939, 'ORPHA:94147', 'Ataxia with pigmentary retinopathy', 1),
(19940, 'ORPHA:94147', 'Cerebellar syndrome-pigmentary maculopathy syndrome', 1),
(19941, 'ORPHA:94147', 'SCA7', 1),
(19942, 'ORPHA:94147', 'Spinocerebellar ataxia type 7', 1),
(19943, 'ORPHA:94148', 'ADCA3', 3),
(19944, 'ORPHA:94148', 'ADCAIII', 3),
(19945, 'ORPHA:94148', 'Autosomal dominant cerebellar ataxia type 3', 3),
(19946, 'ORPHA:94148', 'Autosomal dominant cerebellar ataxia type III', 3),
(19947, 'ORPHA:94148', 'Pure cerebellar syndrome-mild pyramidal signs syndrome', 3),
(19948, 'ORPHA:94149', 'ADCA4', 3),
(19949, 'ORPHA:94149', 'ADCAIV', 3),
(19950, 'ORPHA:94149', 'Autosomal dominant cerebellar ataxia type 4', 3),
(19951, 'ORPHA:94149', 'Autosomal dominant cerebellar ataxia type IV', 3),
(19952, 'ORPHA:94150', 'Anonychia congenita totalis', 2),
(19953, 'ORPHA:943', 'Malonic aciduria', 1),
(19954, 'ORPHA:943', 'Malonyl-CoA decarboxylase deficiency', 1),
(19955, 'ORPHA:945', 'Acalvaria', 1),
(19956, 'ORPHA:945', 'Primary acalvaria', 1),
(19957, 'ORPHA:946', 'ACS', 3),
(19958, 'ORPHA:946', 'Acrocephalosyndactylia', 3),
(19959, 'ORPHA:946', 'Acrocephalosyndactyly', 3),
(19960, 'ORPHA:949', 'Acrocraniofacial dysostosis', 1),
(19961, 'ORPHA:949', 'Kaplan-Plauchu-Fitch syndrome', 1),
(19962, 'ORPHA:95', 'FA', 1),
(19963, 'ORPHA:95', 'FRDA', 1),
(19964, 'ORPHA:95', 'Friedreich ataxia', 1),
(19965, 'ORPHA:950', 'Acrodysostosis', 1),
(19966, 'ORPHA:950', 'Acrodysplasia', 1),
(19967, 'ORPHA:950', 'Arkless-Graham syndrome', 1),
(19968, 'ORPHA:950', 'Maroteaux-Malamut syndrome', 1),
(19969, 'ORPHA:95157', 'Acute hepatic porphyria', 3),
(19970, 'ORPHA:95159', 'HEP', 1),
(19971, 'ORPHA:95159', 'Hepatoerythropoietic porphyria', 1),
(19972, 'ORPHA:95161', 'Chronic hepatic porphyria', 3),
(19973, 'ORPHA:952', 'Acrofacial dysostosis, Weyers type', 1),
(19974, 'ORPHA:952', 'Curry-Hall syndrome', 1),
(19975, 'ORPHA:952', 'Weyers acrodental dysostosis', 1),
(19976, 'ORPHA:952', 'Weyers acrofacial dysostosis', 1),
(19977, 'ORPHA:95232', 'Lissencephaly due to LIS1 mutation', 1),
(19978, 'ORPHA:95232', 'PAFAH1B1-related lissencephaly', 1),
(19979, 'ORPHA:95409', 'Acute adrenal failure', 1),
(19980, 'ORPHA:95409', 'Acute adrenal insufficiency', 1),
(19981, 'ORPHA:95409', 'Acute adrenocortical insufficiency', 1),
(19982, 'ORPHA:95409', 'Addisonian crisis', 1),
(19983, 'ORPHA:95409', 'Adrenal crisis', 1),
(19984, 'ORPHA:95409', 'Adrenocortical crisis', 1),
(19985, 'ORPHA:95427', 'Secondary short bowel syndrome', 1),
(19986, 'ORPHA:95428', 'CDG syndrome type IIh', 1),
(19987, 'ORPHA:95428', 'CDG-IIh', 1),
(19988, 'ORPHA:95428', 'CDG2H', 1),
(19989, 'ORPHA:95428', 'COG8-CDG', 1),
(19990, 'ORPHA:95428', 'Carbohydrate deficient glycoprotein syndrome type IIh', 1),
(19991, 'ORPHA:95428', 'Congenital disorder of glycosylation type 2h', 1),
(19992, 'ORPHA:95428', 'Congenital disorder of glycosylation type IIh', 1),
(19993, 'ORPHA:95429', 'Angioma serpiginosum', 1),
(19994, 'ORPHA:95430', 'Congenital major airway collapse', 1),
(19995, 'ORPHA:95430', 'Congenital tracheomalacia', 1),
(19996, 'ORPHA:95431', 'Feto-fetal transfusion syndrome', 1),
(19997, 'ORPHA:95431', 'Twin to twin transfusion syndrome', 1),
(19998, 'ORPHA:95432', 'Mesulam syndrome', 3),
(19999, 'ORPHA:95432', 'PPA', 3),
(20000, 'ORPHA:95432', 'Primary progressive aphasia', 3);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(20001, 'ORPHA:95433', 'Autosomal recessive spinocerebellar ataxia type 3', 1),
(20002, 'ORPHA:95433', 'Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome', 1),
(20003, 'ORPHA:95433', 'Autosomal recessive spinocerebellar ataxia-blindness-hearing loss syndrome', 1),
(20004, 'ORPHA:95433', 'SCABD', 1),
(20005, 'ORPHA:95433', 'SCAR3', 1),
(20006, 'ORPHA:95434', 'Autosomal recessive cerebellar ataxia-saccadic intrusion syndrome', 1),
(20007, 'ORPHA:95434', 'SCAR4', 1),
(20008, 'ORPHA:95434', 'SCASI', 1),
(20009, 'ORPHA:95443', 'Mesocardia', 1),
(20010, 'ORPHA:95443', 'Midline heart', 1),
(20011, 'ORPHA:95448', 'Congenital aortic valve atresia', 2),
(20012, 'ORPHA:95455', 'SJS-TEN', 1),
(20013, 'ORPHA:95455', 'Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum', 1),
(20014, 'ORPHA:95455', 'Toxic epidermolysis', 1),
(20015, 'ORPHA:95457', 'Congenital unguarded tricuspid orifice', 1),
(20016, 'ORPHA:95457', 'Tricuspid valve agenesis', 1),
(20017, 'ORPHA:95459', 'Congenital tricuspid stenosis', 1),
(20018, 'ORPHA:95461', 'Straddling or overriding tricuspid valve', 1),
(20019, 'ORPHA:95462', 'Accessory tricuspid valve tissue', 1),
(20020, 'ORPHA:95463', 'Anomaly of the tricuspid subvalvular apparatus', 3),
(20021, 'ORPHA:95464', 'Congenital mitral valve insufficiency and/or stenosis', 3),
(20022, 'ORPHA:95465', 'Cleft mitral valve', 1),
(20023, 'ORPHA:95474', 'Double-orifice mitral valve', 2),
(20024, 'ORPHA:95483', 'Univentricular cardiopathy', 3),
(20025, 'ORPHA:95485', 'Arterial duct anomaly', 3),
(20026, 'ORPHA:95485', 'Patent ductus arteriosus anomalies', 3),
(20027, 'ORPHA:95486', 'Premature closure of the arterial duct', 1),
(20028, 'ORPHA:95486', 'Premature closure of the patent ductus arteriosus', 1),
(20029, 'ORPHA:95488', 'Non-acquired pituitary hormone deficiency', 3),
(20030, 'ORPHA:95491', 'Congenital coronary aneurysm', 1),
(20031, 'ORPHA:95491', 'Congenital coronary artery aneurysm', 1),
(20032, 'ORPHA:95494', 'Combined pituitary hormone deficiencies, genetic forms', 1),
(20033, 'ORPHA:95494', 'Familial congenital hypopituitarism', 1),
(20034, 'ORPHA:95494', 'Multiple pituitary hormone deficiencies, genetic forms', 1),
(20035, 'ORPHA:95495', 'Disease associated with non-acquired combined pituitary hormone deficiency', 3),
(20036, 'ORPHA:95496', 'Ectopic neurohypophysis', 1),
(20037, 'ORPHA:95496', 'PSIS', 1),
(20038, 'ORPHA:95496', 'Pituitary stalk interruption syndrome', 1),
(20039, 'ORPHA:95498', 'Congenital anomaly of superior caval vein', 3),
(20040, 'ORPHA:95498', 'Congenital anomaly of superior vena cava', 3),
(20041, 'ORPHA:95498', 'Congenital anomaly of the SVC', 3),
(20042, 'ORPHA:95499', 'Congenital anomaly of the IVC', 3),
(20043, 'ORPHA:95499', 'Congenital anomaly of the inferior caval vein', 3),
(20044, 'ORPHA:95499', 'Congenital anomaly of the inferior vena cava', 3),
(20045, 'ORPHA:955', 'Acrodentoosteodysplasia', 1),
(20046, 'ORPHA:955', 'Acroosteolysis dominant type', 1),
(20047, 'ORPHA:955', 'Acroosteolysis with osteoporosis and changes in skull and mandible', 1),
(20048, 'ORPHA:955', 'Arthrodentoosteodysplasia', 1),
(20049, 'ORPHA:955', 'Cheney syndrome', 1),
(20050, 'ORPHA:955', 'Hajdu-Cheney syndrome', 1),
(20051, 'ORPHA:95500', 'Congenital anomaly of the coronary sinus', 3),
(20052, 'ORPHA:95502', 'Acquired pituitary hormone deficiency', 3),
(20053, 'ORPHA:95503', 'Pituitary hormone deficiency of tumoral origin', 3),
(20054, 'ORPHA:95505', 'Pituitary hormone deficiency of meningeal origin', 3),
(20055, 'ORPHA:95506', 'Autoimmune hypophysitis', 3),
(20056, 'ORPHA:95506', 'Primary hypophysitis', 3),
(20057, 'ORPHA:95507', 'Congenital anomaly of hepatic vein', 1),
(20058, 'ORPHA:95510', 'Atrial appendage anomaly', 3),
(20059, 'ORPHA:95510', 'Atrial auricle anomaly', 3),
(20060, 'ORPHA:95512', 'Adenohypophysitis', 1),
(20061, 'ORPHA:95512', 'Anterior pituitary hypophysitis', 1),
(20062, 'ORPHA:95513', 'Infundibulo-panhypophysitis', 1),
(20063, 'ORPHA:95513', 'Panhypophysitis', 1),
(20064, 'ORPHA:95611', 'Pituitary hormone deficiency of vascular origin', 3),
(20065, 'ORPHA:95613', 'Pituitary apoplexy', 1),
(20066, 'ORPHA:95613', 'Pituitary tumor apoplexy', 1),
(20067, 'ORPHA:95617', 'Pituitary hormone deficiency secondary to a granulomatous disease', 3),
(20068, 'ORPHA:95618', 'Pituitary hormone deficiency secondary to storage disease', 3),
(20069, 'ORPHA:95619', 'Post-traumatic pituitary deficiency', 1),
(20070, 'ORPHA:95626', 'Acquired CDI', 2),
(20071, 'ORPHA:95626', 'Acquired central diabetes insipidus', 2),
(20072, 'ORPHA:95626', 'Acquired neurogenic diabetes insipidus', 2),
(20073, 'ORPHA:95699', 'Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency', 1),
(20074, 'ORPHA:95699', 'Congenital adrenal hyperplasia due to cytochrome POR deficiency', 1),
(20075, 'ORPHA:95699', 'POR deficiency', 1),
(20076, 'ORPHA:95699', 'PORD', 1),
(20077, 'ORPHA:957', 'Acropectorovertebral dysplasia', 1),
(20078, 'ORPHA:957', 'F syndrome', 1),
(20079, 'ORPHA:95700', 'Familial adrenal hypoplasia with absent pituitary LH', 1),
(20080, 'ORPHA:95700', 'Familial adrenal hypoplasia with absent pituitary luteinizing hormone', 1),
(20081, 'ORPHA:95700', 'Familial adrenal hypoplasia, miniature type', 1),
(20082, 'ORPHA:95702', 'X-linked AHC', 1),
(20083, 'ORPHA:95702', 'X-linked adrenal hypoplasia congenita', 1),
(20084, 'ORPHA:95702', 'X-linked congenital adrenal hypoplasia', 1),
(20085, 'ORPHA:95706', 'Hypospadias, severe form', 1),
(20086, 'ORPHA:95706', 'Perineal, scrotal or penoscrotal hypospadias', 1),
(20087, 'ORPHA:95706', 'Posterior hypospadias', 1),
(20088, 'ORPHA:95707', 'Idiopathic isolated micropenis', 1),
(20089, 'ORPHA:95708', 'Rare precocious puberty', 3),
(20090, 'ORPHA:95709', 'Acquired premature ovarian failure', 3),
(20091, 'ORPHA:95710', 'Non-acquired premature ovarian failure', 3),
(20092, 'ORPHA:95711', 'Congenital hypothyroidism due to developmental anomaly', 3),
(20093, 'ORPHA:95711', 'Primary congenital hypothyroidism due to developmental anomaly', 3),
(20094, 'ORPHA:95712', 'Thyroid ectopia', 1),
(20095, 'ORPHA:95713', 'Athyreosis', 1),
(20096, 'ORPHA:95714', 'Primary congenital hypothyroidism without thyroid developmental anomaly', 3),
(20097, 'ORPHA:95715', 'Congenital hypothyroidism due to transplacental passage of TSH-binding inhibitory antibodies', 1),
(20098, 'ORPHA:95716', 'Familial thyroid dyshormonogenesis', 1),
(20099, 'ORPHA:95716', 'Thyroid dyshormonogenesis', 1),
(20100, 'ORPHA:95717', 'Idiopathic congenital hypothyroidism', 1),
(20101, 'ORPHA:95718', 'Congenital thyroid malformation without hypothyroidism', 3),
(20102, 'ORPHA:95719', 'Thyroid hemiagenesis', 1),
(20103, 'ORPHA:95720', 'Thyroid hypoplasia', 1),
(20104, 'ORPHA:958', 'Acro-renal-mandibular syndrome', 1),
(20105, 'ORPHA:958', 'Split hand/split foot-mandibular hypoplasia syndrome', 1),
(20106, 'ORPHA:95854', 'Isolated levocardia', 1),
(20107, 'ORPHA:95854', 'Levocardia', 1),
(20108, 'ORPHA:95854', 'Levocardia with situs inversus', 1),
(20109, 'ORPHA:959', 'Acro-renal-ocular syndrome', 1),
(20110, 'ORPHA:96', 'AVED', 1),
(20111, 'ORPHA:96', 'Ataxia with isolated vitamin E deficiency', 1),
(20112, 'ORPHA:96', 'Ataxia with vitamin E deficiency', 1),
(20113, 'ORPHA:96', 'Familial isolated vitamin E deficiency', 1),
(20114, 'ORPHA:96', 'Friedreich-like ataxia', 1),
(20115, 'ORPHA:96', 'Isolated vitamin E deficiency', 1),
(20116, 'ORPHA:96055', 'Isochromosome 21', 1),
(20117, 'ORPHA:96055', 'Tetrasomy 21', 1),
(20118, 'ORPHA:96059', 'Mosaic trisomy 4', 1),
(20119, 'ORPHA:96059', 'Mosaic trisomy chromosome 4', 1),
(20120, 'ORPHA:96059', 'Trisomy 4 mosaicism', 1),
(20121, 'ORPHA:96060', 'Mosaic trisomy 5', 1),
(20122, 'ORPHA:96060', 'Mosaic trisomy chromosome 5', 1),
(20123, 'ORPHA:96060', 'Trisomy 5 mosaicism', 1),
(20124, 'ORPHA:96061', 'Mosaic trisomy 8', 1),
(20125, 'ORPHA:96061', 'Mosaic trisomy chromosome 8', 1),
(20126, 'ORPHA:96061', 'Trisomy 8 mosaicism', 1),
(20127, 'ORPHA:96061', 'Warkany syndrome', 1),
(20128, 'ORPHA:96063', 'Mosaic trisomy 10', 1),
(20129, 'ORPHA:96063', 'Mosaic trisomy chromosome 10', 1),
(20130, 'ORPHA:96063', 'Trisomy 10 mosaicism', 1),
(20131, 'ORPHA:96068', 'Mosaic trisomy 22', 1),
(20132, 'ORPHA:96068', 'Mosaic trisomy chromosome 22', 1),
(20133, 'ORPHA:96068', 'Trisomy 22 mosaicism', 1),
(20134, 'ORPHA:96069', 'Distal duplication 1p36', 1),
(20135, 'ORPHA:96069', 'Distal trisomy 1p36', 1),
(20136, 'ORPHA:96069', 'Telomeric duplication 1p36', 1),
(20137, 'ORPHA:96069', 'Trisomy 1pter', 1),
(20138, 'ORPHA:96070', 'Distal duplication 2p', 1),
(20139, 'ORPHA:96070', 'Distal trisomy 2p', 1),
(20140, 'ORPHA:96070', 'Telomeric duplication 2p', 1),
(20141, 'ORPHA:96070', 'Trisomy 2pter', 1),
(20142, 'ORPHA:96071', 'Distal duplication 3p', 1),
(20143, 'ORPHA:96071', 'Distal trisomy 3p', 1),
(20144, 'ORPHA:96071', 'Telomeric duplication 3p', 1),
(20145, 'ORPHA:96071', 'Trisomy 3pter', 1),
(20146, 'ORPHA:96072', '4p16.3 microduplication syndrome', 1),
(20147, 'ORPHA:96072', 'Distal duplication 4p', 1),
(20148, 'ORPHA:96072', 'Distal trisomy 4p', 1),
(20149, 'ORPHA:96072', 'Telomeric duplication 4p', 1),
(20150, 'ORPHA:96072', 'Trisomy 4pter', 1),
(20151, 'ORPHA:96074', 'Distal duplication 7p', 1),
(20152, 'ORPHA:96074', 'Distal trisomy 7p', 1),
(20153, 'ORPHA:96074', 'Telomeric duplication 7p', 1),
(20154, 'ORPHA:96074', 'Trisomy 7pter', 1),
(20155, 'ORPHA:96076', 'Beckwith-Wiedemann syndrome due to 11p15 microduplication', 2),
(20156, 'ORPHA:96078', '16p13.3 microduplication syndrome', 1),
(20157, 'ORPHA:96078', 'Distal duplication 16p', 1),
(20158, 'ORPHA:96078', 'Distal trisomy 16p', 1),
(20159, 'ORPHA:96078', 'Dup(16)(p13.3)', 1),
(20160, 'ORPHA:96078', 'Telomeric duplication 16p', 1),
(20161, 'ORPHA:96078', 'Trisomy 16pter', 1),
(20162, 'ORPHA:96092', '8p inverted duplication/deletion syndrome', 1),
(20163, 'ORPHA:96092', 'Invdupdel(8p)', 1),
(20164, 'ORPHA:96092', 'Inverted 8p duplication/deletion syndrome', 1),
(20165, 'ORPHA:96094', 'Distal duplication 2q', 1),
(20166, 'ORPHA:96094', 'Distal trisomy 2q', 1),
(20167, 'ORPHA:96094', 'Telomeric duplication 2q', 1),
(20168, 'ORPHA:96094', 'Trisomy 2qter', 1),
(20169, 'ORPHA:96095', '3q26 microduplication syndrome', 1),
(20170, 'ORPHA:96095', 'Dup(3)(q26)', 1),
(20171, 'ORPHA:96095', 'Dup(3q) syndrome', 1),
(20172, 'ORPHA:96095', 'Trisomy 3q26', 1),
(20173, 'ORPHA:96096', 'Distal duplication 4q', 1),
(20174, 'ORPHA:96096', 'Distal trisomy 4q', 1),
(20175, 'ORPHA:96096', 'Telomeric duplication 4q', 1),
(20176, 'ORPHA:96096', 'Trisomy 4qter', 1),
(20177, 'ORPHA:96097', 'Distal duplication 5q', 1),
(20178, 'ORPHA:96097', 'Distal trisomy 5q', 1),
(20179, 'ORPHA:96097', 'Telomeric duplication 5q', 1),
(20180, 'ORPHA:96097', 'Trisomy 5qter', 1),
(20181, 'ORPHA:96098', 'Distal duplication 6q', 1),
(20182, 'ORPHA:96098', 'Distal trisomy 6q', 1),
(20183, 'ORPHA:96098', 'Telomeric duplication 6q', 1),
(20184, 'ORPHA:96098', 'Trisomy 6qter', 1),
(20185, 'ORPHA:96100', 'Distal duplication 8q', 1),
(20186, 'ORPHA:96100', 'Distal trisomy 8q', 1),
(20187, 'ORPHA:96100', 'Telomeric duplication 8q', 1),
(20188, 'ORPHA:96100', 'Trisomy 8qter', 1),
(20189, 'ORPHA:96101', 'Distal duplication 9q', 1),
(20190, 'ORPHA:96101', 'Distal trisomy 9q', 1),
(20191, 'ORPHA:96101', 'Telomeric duplication 9q', 1),
(20192, 'ORPHA:96101', 'Trisomy 9qter', 1),
(20193, 'ORPHA:96102', 'Distal duplication 10q', 1),
(20194, 'ORPHA:96102', 'Distal trisomy 10q', 1),
(20195, 'ORPHA:96102', 'Telomeric duplication 10q', 1),
(20196, 'ORPHA:96102', 'Trisomy 10qter', 1),
(20197, 'ORPHA:96103', 'Distal duplication 11q', 1),
(20198, 'ORPHA:96103', 'Distal trisomy 11q', 1),
(20199, 'ORPHA:96103', 'Telomeric duplication 11q', 1),
(20200, 'ORPHA:96103', 'Trisomy 11qter', 1),
(20201, 'ORPHA:96105', 'Distal duplication 13q', 1),
(20202, 'ORPHA:96105', 'Distal trisomy 13q', 1),
(20203, 'ORPHA:96105', 'Telomeric duplication 13q', 1),
(20204, 'ORPHA:96105', 'Trisomy 13qter', 1),
(20205, 'ORPHA:96106', 'Distal duplication 16q', 1),
(20206, 'ORPHA:96106', 'Distal trisomy 16q', 1),
(20207, 'ORPHA:96106', 'Telomeric duplication 16q', 1),
(20208, 'ORPHA:96106', 'Trisomy 16qter', 1),
(20209, 'ORPHA:96107', 'Distal duplication 20q', 1),
(20210, 'ORPHA:96107', 'Distal trisomy 20q', 1),
(20211, 'ORPHA:96107', 'Telomeric duplication 20q', 1),
(20212, 'ORPHA:96107', 'Trisomy 20qter', 1),
(20213, 'ORPHA:96109', 'Distal duplication 22q', 1),
(20214, 'ORPHA:96109', 'Distal trisomy 22q', 1),
(20215, 'ORPHA:96109', 'Telomeric duplication 22q', 1),
(20216, 'ORPHA:96109', 'Trisomy 22qter', 1),
(20217, 'ORPHA:96112', 'Non-distal duplication 9q', 1),
(20218, 'ORPHA:96112', 'Non-distal trisomy 9q', 1),
(20219, 'ORPHA:96112', 'Non-telomeric trisomy 9q', 1),
(20220, 'ORPHA:96121', '7q11.23 microduplication syndrome', 1),
(20221, 'ORPHA:96121', 'Dup(7)(q11.23)', 1),
(20222, 'ORPHA:96121', 'Trisomy 7q11.23', 1),
(20223, 'ORPHA:96123', 'Del(22)', 1),
(20224, 'ORPHA:96123', 'Deletion 22', 1),
(20225, 'ORPHA:96123', 'Monosomy 22', 1),
(20226, 'ORPHA:96125', '6p subtelomeric deletion syndrome', 1),
(20227, 'ORPHA:96125', '6p25 microdeletion syndrome', 1),
(20228, 'ORPHA:96125', 'Distal deletion 6p', 1),
(20229, 'ORPHA:96125', 'Distal monosomy 6p', 1),
(20230, 'ORPHA:96125', 'Monosomy 6p25', 1),
(20231, 'ORPHA:96126', 'Distal deletion 7p', 1),
(20232, 'ORPHA:96126', 'Distal monosomy 7p', 1),
(20233, 'ORPHA:96126', 'Monosomy 7pter', 1),
(20234, 'ORPHA:96126', 'Telomeric deletion 7p', 1),
(20235, 'ORPHA:96129', 'Distal deletion 19p', 1),
(20236, 'ORPHA:96129', 'Distal monosomy 19p13.3', 1),
(20237, 'ORPHA:96129', 'Telomeric deletion 19p', 1),
(20238, 'ORPHA:96145', 'Distal deletion 4q', 1),
(20239, 'ORPHA:96145', 'Distal monosomy 4q', 1),
(20240, 'ORPHA:96145', 'Monosomy 4qter', 1),
(20241, 'ORPHA:96145', 'Telomeric deletion 4q', 1),
(20242, 'ORPHA:96147', '9q subtelomeric deletion syndrome', 2),
(20243, 'ORPHA:96147', '9qSTDS', 2),
(20244, 'ORPHA:96147', 'Kleefstra syndrome due to 9q subtelomeric deletion', 2),
(20245, 'ORPHA:96147', 'Kleefstra syndrome due to 9q34 microdeletion', 2),
(20246, 'ORPHA:96147', 'Kleefstra syndrome due to del(9)(q34)', 2),
(20247, 'ORPHA:96147', 'Kleefstra syndrome due to monosomy 9q34', 2),
(20248, 'ORPHA:96148', 'Distal deletion 10q', 1),
(20249, 'ORPHA:96148', 'Distal monosomy 10q', 1),
(20250, 'ORPHA:96148', 'Monosomy 10qter', 1),
(20251, 'ORPHA:96148', 'Telomeric deletion 10q', 1),
(20252, 'ORPHA:96149', 'Distal deletion 12q', 1),
(20253, 'ORPHA:96149', 'Distal monosomy 12q', 1),
(20254, 'ORPHA:96149', 'Monosomy 12qter', 1),
(20255, 'ORPHA:96149', 'Telomeric deletion 12q', 1),
(20256, 'ORPHA:96150', 'Distal deletion 14q', 1),
(20257, 'ORPHA:96150', 'Distal monosomy 14q', 1),
(20258, 'ORPHA:96150', 'Telomeric deletion 14q', 1),
(20259, 'ORPHA:96152', 'Distal deletion 20q', 1),
(20260, 'ORPHA:96152', 'Distal monosomy 20q', 1),
(20261, 'ORPHA:96152', 'Monosomy 20qter', 1),
(20262, 'ORPHA:96152', 'Telomeric deletion 20q', 1),
(20263, 'ORPHA:96160', 'Non-distal deletion 12q', 1),
(20264, 'ORPHA:96160', 'Non-distal monosomy 12q', 1),
(20265, 'ORPHA:96160', 'Non-telomeric monosomy 12q', 1),
(20266, 'ORPHA:96164', 'Non-distal deletion 20q', 1),
(20267, 'ORPHA:96164', 'Non-distal monosomy 20q', 1),
(20268, 'ORPHA:96164', 'Non-telomeric monosomy 20q', 1),
(20269, 'ORPHA:96167', 'Duplication 8q/deletion 8p', 1),
(20270, 'ORPHA:96167', 'Rec(8) syndrome', 1),
(20271, 'ORPHA:96167', 'Rec8 syndrome', 1),
(20272, 'ORPHA:96167', 'Recombinant 8 syndrome', 1),
(20273, 'ORPHA:96167', 'Recombinant chromosome 8 syndrome', 1),
(20274, 'ORPHA:96167', 'San Luis Valley syndrome', 1),
(20275, 'ORPHA:96168', 'Del(13)(q34)', 1),
(20276, 'ORPHA:96168', 'Distal deletion 13q34', 1),
(20277, 'ORPHA:96168', 'Monosomy 13q34', 1),
(20278, 'ORPHA:96168', 'Subtelomeric deletion 13q34', 1),
(20279, 'ORPHA:96169', 'KdVS', 1),
(20280, 'ORPHA:96169', 'Koolen-De Vries syndrome', 1),
(20281, 'ORPHA:96170', 'Der(22)t(11;22) syndrome', 1),
(20282, 'ORPHA:96170', 'Emanuel syndrome', 1),
(20283, 'ORPHA:96170', 'Supernumerary der(22) syndrome', 1),
(20284, 'ORPHA:96171', 'Ring 2', 1),
(20285, 'ORPHA:96171', 'Ring chromosome 2', 1),
(20286, 'ORPHA:96171', 'Ring chromosome 2 syndrome', 1),
(20287, 'ORPHA:96172', 'Ring 3', 1),
(20288, 'ORPHA:96172', 'Ring chromosome 3', 1),
(20289, 'ORPHA:96172', 'Ring chromosome 3 syndrome', 1),
(20290, 'ORPHA:96173', 'Ring  9', 1),
(20291, 'ORPHA:96173', 'Ring chromosome 9', 1),
(20292, 'ORPHA:96173', 'Ring chromosome 9 syndrome', 1),
(20293, 'ORPHA:96175', 'RC11', 1),
(20294, 'ORPHA:96175', 'Ring 11', 1),
(20295, 'ORPHA:96175', 'Ring chromosome 11', 1),
(20296, 'ORPHA:96175', 'Ring chromosome 11 syndrome', 1),
(20297, 'ORPHA:96175', 'r(11) syndrome', 1),
(20298, 'ORPHA:96176', 'Ring 13', 1),
(20299, 'ORPHA:96176', 'Ring chromosome 13', 1),
(20300, 'ORPHA:96176', 'Ring chromosome 13 syndrome', 1),
(20301, 'ORPHA:96177', 'Ring 15', 1),
(20302, 'ORPHA:96177', 'Ring chromosome 15', 1),
(20303, 'ORPHA:96177', 'Ring chromosome 15 syndrome', 1),
(20304, 'ORPHA:96178', 'Ring 16', 1),
(20305, 'ORPHA:96178', 'Ring chromosome 16', 1),
(20306, 'ORPHA:96178', 'Ring chromosome 16 syndrome', 1),
(20307, 'ORPHA:96179', 'Maternal uniparental disomy of chromosome 2', 1),
(20308, 'ORPHA:96179', 'UPD(2)mat', 1),
(20309, 'ORPHA:96180', 'Maternal uniparental disomy of chromosome 4', 1),
(20310, 'ORPHA:96180', 'UPD(4)mat', 1),
(20311, 'ORPHA:96181', 'Maternal uniparental disomy of chromosome 6', 1),
(20312, 'ORPHA:96181', 'UPD(6)mat', 1),
(20313, 'ORPHA:96182', 'Silver-Russell syndrome due to maternal uniparental disomy of chromosome 7', 2),
(20314, 'ORPHA:96182', 'UPD(7)mat', 2),
(20315, 'ORPHA:96183', 'Maternal uniparental disomy of chromosome 9', 1),
(20316, 'ORPHA:96183', 'UPD(9)mat', 1),
(20317, 'ORPHA:96184', 'Temple syndrome due to maternal uniparental disomy of chromosome 14', 2),
(20318, 'ORPHA:96184', 'UPD(14)mat', 2),
(20319, 'ORPHA:96185', 'Maternal uniparental disomy of chromosome 16', 1),
(20320, 'ORPHA:96185', 'UPD(16)mat', 1),
(20321, 'ORPHA:96186', 'Maternal UPD(20)', 1),
(20322, 'ORPHA:96186', 'Maternal uniparental disomy of chromosome 20', 1),
(20323, 'ORPHA:96186', 'UPD(20)mat', 1),
(20324, 'ORPHA:96187', 'Maternal uniparental disomy of chromosome 21', 1),
(20325, 'ORPHA:96187', 'UPD(21)mat', 1),
(20326, 'ORPHA:96188', 'Maternal uniparental disomy of chromosome 22', 1),
(20327, 'ORPHA:96188', 'UPD(22)mat', 1),
(20328, 'ORPHA:96190', 'Paternal uniparental disomy of chromosome 5', 1),
(20329, 'ORPHA:96190', 'UPD(5)pat', 1),
(20330, 'ORPHA:96191', 'Paternal uniparental disomy of chromosome 6', 1),
(20331, 'ORPHA:96191', 'UPD(6)pat', 1),
(20332, 'ORPHA:96192', 'Paternal uniparental disomy of chromosome 7', 1),
(20333, 'ORPHA:96192', 'UPD(7)pat', 1),
(20334, 'ORPHA:96193', 'Beckwith-Wiedemann syndrome due to paternal uniparental disomy of chromosome 11', 2),
(20335, 'ORPHA:96193', 'Mosaic paternal uniparental disomy of chromosome 11', 2),
(20336, 'ORPHA:96193', 'UPD(11)pat', 2),
(20337, 'ORPHA:96194', 'Paternal UPD(20)', 1),
(20338, 'ORPHA:96194', 'Paternal uniparental disomy of chromosome 20', 1),
(20339, 'ORPHA:96194', 'UPD(20)pat', 1),
(20340, 'ORPHA:96195', 'Paternal uniparental disomy of chromosome 21', 1),
(20341, 'ORPHA:96195', 'UPD(21)pat', 1),
(20342, 'ORPHA:96201', 'X small rings', 1),
(20343, 'ORPHA:96210', 'Rare genetic deafness', 3),
(20344, 'ORPHA:96210', 'Rare genetic hearing loss', 3),
(20345, 'ORPHA:96253', 'Corticotroph pituitary adenoma', 1),
(20346, 'ORPHA:96253', 'Cushing disease', 1),
(20347, 'ORPHA:96253', 'Pituitary corticotroph micro-adenoma', 1),
(20348, 'ORPHA:96253', 'Pituitary-dependent Cushing syndrome', 1),
(20349, 'ORPHA:96256', 'Somatotropic adenoma', 3),
(20350, 'ORPHA:96256', 'Somatotropinoma', 3),
(20351, 'ORPHA:96263', '48,XXXY syndrome', 1),
(20352, 'ORPHA:96264', '49,XXXXY syndrome', 1),
(20353, 'ORPHA:96265', '46,XY DSD due to complete LH receptor inactivation', 2),
(20354, 'ORPHA:96265', '46,XY DSD due to complete LH resistance', 2),
(20355, 'ORPHA:96265', '46,XY DSD due to complete luteinizing hormone receptor inactivation', 2),
(20356, 'ORPHA:96265', '46,XY DSD due to complete luteinizing hormone resistance', 2),
(20357, 'ORPHA:96265', '46,XY disorder of sex development due to complete LH receptor inactivation', 2),
(20358, 'ORPHA:96265', '46,XY disorder of sex development due to complete LH resistance', 2),
(20359, 'ORPHA:96265', '46,XY disorder of sex development due to complete luteinizing hormone receptor inactivation', 2),
(20360, 'ORPHA:96265', '46,XY disorder of sex development due to complete luteinizing hormone resistance', 2),
(20361, 'ORPHA:96265', 'Leydig cell hypoplasia due to complete LH receptor inactivation', 2),
(20362, 'ORPHA:96265', 'Leydig cell hypoplasia due to complete LH resistance', 2),
(20363, 'ORPHA:96265', 'Leydig cell hypoplasia due to complete luteinizing hormone receptor inactivation', 2),
(20364, 'ORPHA:96265', 'Leydig cell hypoplasia due to complete luteinizing hormone resistance', 2),
(20365, 'ORPHA:96266', '46,XY DSD due to partial LH receptor inactivation', 2),
(20366, 'ORPHA:96266', '46,XY DSD due to partial LH resistance', 2),
(20367, 'ORPHA:96266', '46,XY DSD due to partial luteinizing hormone resistance', 2),
(20368, 'ORPHA:96266', '46,XY disorder of sex developement due to partial LH receptor inactivation', 2),
(20369, 'ORPHA:96266', '46,XY disorder of sex developement due to partial LH resistance', 2),
(20370, 'ORPHA:96266', '46,XY disorder of sex developement due to partial luteinizing hormone resistance', 2),
(20371, 'ORPHA:96266', 'Leydig cell hypoplasia due to partial LH receptor inactivation', 2),
(20372, 'ORPHA:96266', 'Leydig cell hypoplasia due to partial LH resistance', 2),
(20373, 'ORPHA:96266', 'Leydig cell hypoplasia due to partial luteinizing hormone receptor inactivation', 2),
(20374, 'ORPHA:96266', 'Leydig cell hypoplasia due to partial luteinizing hormone resistance', 2),
(20375, 'ORPHA:96269', 'Congenital absence of vagina', 1),
(20376, 'ORPHA:96269', 'Isolated partial vaginal agenesis', 1),
(20377, 'ORPHA:963', 'Acromegaly', 1),
(20378, 'ORPHA:96321', 'Polyploidy', 3),
(20379, 'ORPHA:96325', 'Isochromosome Y', 3),
(20380, 'ORPHA:96333', 'Rare otorhinolaryngological malformation', 3),
(20381, 'ORPHA:96334', 'Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14', 2),
(20382, 'ORPHA:96334', 'UPD(14)pat', 2),
(20383, 'ORPHA:96344', 'Rare gynecologic or obstetric disease', 3),
(20384, 'ORPHA:96346', 'Anorectal malformation', 3),
(20385, 'ORPHA:96369', 'Early-onset schizophrenia', 1),
(20386, 'ORPHA:965', 'Acromegaloid facial appearance syndrome', 1),
(20387, 'ORPHA:966', 'HAFF', 1),
(20388, 'ORPHA:966', 'Hypertrichosis-acromegaloid facial appearance syndrome', 1),
(20389, 'ORPHA:966', 'Hypertrichosis-acromegaloid facial features syndrome', 1),
(20390, 'ORPHA:966', 'Hypertrichosis-coarse face syndrome', 1),
(20391, 'ORPHA:968', 'Acromesomelic dwarfism', 1),
(20392, 'ORPHA:968', 'Acromesomelic dysplasia, Hunter-Thompson type', 1),
(20393, 'ORPHA:969', 'Acromicric dysplasia', 1),
(20394, 'ORPHA:97', 'Episodic ataxia type 2', 1),
(20395, 'ORPHA:97', 'Familial paroxysmal ataxia', 1),
(20396, 'ORPHA:970', 'Autosomal recessive sensory radicular neuropathy', 1),
(20397, 'ORPHA:970', 'HSAN2', 1),
(20398, 'ORPHA:970', 'Hereditary sensory and autonomic neuropathy type 2', 1),
(20399, 'ORPHA:970', 'Hereditary sensory and autonomic neuropathy type II', 1),
(20400, 'ORPHA:970', 'Neurogenic acroosteolysis', 1),
(20401, 'ORPHA:971', 'Acrorenal syndrome', 1),
(20402, 'ORPHA:97120', 'Distal arthrogryposis', 3),
(20403, 'ORPHA:972', 'Hereditary continuous muscle fiber activity', 1),
(20404, 'ORPHA:97214', 'Eisenmenger syndrome', 1),
(20405, 'ORPHA:97229', 'Brown-Vialetto-van Laere syndrome', 1),
(20406, 'ORPHA:97229', 'Riboflavin transporter deficiency', 1),
(20407, 'ORPHA:97229', 'Sensorineural deafness-pontobulbar palsy syndrome', 1),
(20408, 'ORPHA:97229', 'Sensorineural hearing loss-pontobulbar palsy syndrome', 1),
(20409, 'ORPHA:97230', 'Solar urticaria', 1),
(20410, 'ORPHA:97232', 'Fingerprint body myopathy', 1),
(20411, 'ORPHA:97234', 'GSD due to phosphoglycerate mutase deficiency', 1),
(20412, 'ORPHA:97234', 'GSD type 10', 1),
(20413, 'ORPHA:97234', 'Glycogen storage disease due to phosphoglycerate mutase deficiency', 1),
(20414, 'ORPHA:97234', 'Glycogenosis due to phosphoglycerate mutase deficiency', 1),
(20415, 'ORPHA:97234', 'Muscle phosphoglycerate mutase deficiency', 1),
(20416, 'ORPHA:97234', 'Myopathy due to phosphoglycerate mutase deficiency', 1),
(20417, 'ORPHA:97238', 'Rippling muscle disease', 1),
(20418, 'ORPHA:97239', 'Reducing body myopathy', 1),
(20419, 'ORPHA:97240', 'Zebra body myopathy', 1),
(20420, 'ORPHA:97242', 'CMD', 3),
(20421, 'ORPHA:97242', 'Congenital muscular dystrophy', 3),
(20422, 'ORPHA:97242', 'MDC', 3),
(20423, 'ORPHA:97244', 'Rigid spine congenital muscular dystrophy', 1),
(20424, 'ORPHA:97244', 'Rigid spine syndrome', 1),
(20425, 'ORPHA:97245', 'Congenital myopathy', 3),
(20426, 'ORPHA:97249', 'Cerebellar atrophy with progressive microcephaly', 1),
(20427, 'ORPHA:97249', 'PCH3', 1),
(20428, 'ORPHA:97249', 'Pontocerebellar hypoplasia type 3', 1),
(20429, 'ORPHA:97252', 'Mega-cisterna magna', 1),
(20430, 'ORPHA:97253', 'Neuroendocrine tumor of pancreas', 3),
(20431, 'ORPHA:97253', 'PNET', 3),
(20432, 'ORPHA:97253', 'Pancreatic NET', 3),
(20433, 'ORPHA:97253', 'Pancreatic neuroendocrine tumor', 3),
(20434, 'ORPHA:97253', 'Well-differentiated NEN of pancreas', 3),
(20435, 'ORPHA:97253', 'Well-differentiated neuroendocrine neoplasm of pancreas', 3),
(20436, 'ORPHA:97253', 'Well-differentiated pancreatic NEN', 3),
(20437, 'ORPHA:97253', 'Well-differentiated pancreatic neuroendocrine neoplasm', 3),
(20438, 'ORPHA:97261', 'GRF tumor', 1),
(20439, 'ORPHA:97261', 'GRFoma', 1),
(20440, 'ORPHA:97261', 'Growth hormone releasing factor tumor', 1),
(20441, 'ORPHA:97275', 'Encephalitis', 3),
(20442, 'ORPHA:97278', 'PPoma', 1),
(20443, 'ORPHA:97278', 'Pancreatic polypeptidoma', 1),
(20444, 'ORPHA:97279', 'Insulinoma', 1),
(20445, 'ORPHA:97280', 'Glucagonoma', 1),
(20446, 'ORPHA:97280', 'Glucagonoma syndrome', 1),
(20447, 'ORPHA:97282', 'Diarrheogenic islet cell tumor', 1),
(20448, 'ORPHA:97282', 'Pancreatic cholera', 1),
(20449, 'ORPHA:97282', 'VIP-secreting tumor', 1),
(20450, 'ORPHA:97282', 'VIPoma', 1),
(20451, 'ORPHA:97282', 'Verner-Morrison syndrome', 1),
(20452, 'ORPHA:97282', 'WDHA syndrome', 1),
(20453, 'ORPHA:97282', 'Watery diarrhea-hypokalemia-achlorhydria syndrome', 1),
(20454, 'ORPHA:97283', 'Somatostatinoma', 1),
(20455, 'ORPHA:97285', 'Thyroid lymphoma', 1),
(20456, 'ORPHA:97286', 'Carney dyad', 1),
(20457, 'ORPHA:97286', 'Carney-Stratakis dyad', 1),
(20458, 'ORPHA:97286', 'Carney-Stratakis syndrome', 1),
(20459, 'ORPHA:97286', 'GIST-paraganglioma dyad', 1),
(20460, 'ORPHA:97286', 'Paraganglioma and gastric stromal sarcoma', 1),
(20461, 'ORPHA:97287', 'Bronchial NET', 1),
(20462, 'ORPHA:97287', 'Bronchial neuroendocrine tumor', 1),
(20463, 'ORPHA:97289', 'Thymic neuroendocrine tumor', 1),
(20464, 'ORPHA:97290', 'Familial papillary thyroid carcinoma with renal papillary neoplasia', 1),
(20465, 'ORPHA:97290', 'PTC-RCC', 1),
(20466, 'ORPHA:97292', 'Cardiogenic shock', 1),
(20467, 'ORPHA:97293', 'Rare benign ovarian tumor', 3),
(20468, 'ORPHA:97297', 'BOS syndrome', 1),
(20469, 'ORPHA:97297', 'Bohring syndrome', 1),
(20470, 'ORPHA:97297', 'Bohring-Opitz syndrome', 1),
(20471, 'ORPHA:97297', 'C-like syndrome', 1),
(20472, 'ORPHA:97297', 'Oberklaid-Danks syndrome', 1),
(20473, 'ORPHA:97297', 'Opitz trigonocephaly-like syndrome', 1),
(20474, 'ORPHA:973', 'Adactyly of hand, unilateral', 1),
(20475, 'ORPHA:973', 'Congenital absence/hypoplasia of fingers excluding thumb, unilateral', 1),
(20476, 'ORPHA:973', 'Digits 2-5 hypodactyly, unilateral', 1),
(20477, 'ORPHA:973', 'Digits 2-5 oligodactyly, unilateral', 1),
(20478, 'ORPHA:97330', 'TOS', 1),
(20479, 'ORPHA:97330', 'Thoracic outlet compression syndrome', 1),
(20480, 'ORPHA:97330', 'Thoracic outlet syndrome', 1),
(20481, 'ORPHA:97332', 'Aseptic necrosis of the lunate bone', 1),
(20482, 'ORPHA:97332', 'Kienbock disease', 1),
(20483, 'ORPHA:97332', 'Lunatomalacia', 1),
(20484, 'ORPHA:97332', 'Osteochondrosis of the lunate bone', 1),
(20485, 'ORPHA:97332', 'Progressive avascular necrosis of the lunate bone', 1),
(20486, 'ORPHA:97335', 'Aseptic necrosis of the tibial tubercle', 1),
(20487, 'ORPHA:97335', 'Osgood-Schlatter disease', 1),
(20488, 'ORPHA:97335', 'Osteochondrosis of the tibial tubercle', 1),
(20489, 'ORPHA:97336', 'Aseptic necrosis of the capital humerus', 1),
(20490, 'ORPHA:97336', 'Osteochondrosis of the capital humerus', 1),
(20491, 'ORPHA:97336', 'Panner disease', 1),
(20492, 'ORPHA:97337', 'Aseptic necrosis of patella', 1),
(20493, 'ORPHA:97337', 'Osteochondrosis of patella', 1),
(20494, 'ORPHA:97337', 'Sinding-Larsen-Johansson disease', 1),
(20495, 'ORPHA:97338', 'Clear cell sarcoma of the tendons and aponeuroses', 1),
(20496, 'ORPHA:97338', 'Melanoma of soft tissue', 1),
(20497, 'ORPHA:97339', 'Cranial dural arteriovenous fistula', 1),
(20498, 'ORPHA:97339', 'Cranial dural arteriovenous malformations', 1),
(20499, 'ORPHA:97339', 'Dural sinus malformation', 1),
(20500, 'ORPHA:97340', 'Hunter-McAlpine craniosynostosis', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(20501, 'ORPHA:97341', 'Persistent placoid maculopathy', 1),
(20502, 'ORPHA:97345', 'ABri amyloidosis', 2),
(20503, 'ORPHA:97345', 'Familial dementia, British type', 2),
(20504, 'ORPHA:97346', 'ADan amyloidosis', 2),
(20505, 'ORPHA:97346', 'Familial dementia, Danish type', 2),
(20506, 'ORPHA:97349', 'Postencephalitic parkinsonism', 1),
(20507, 'ORPHA:97352', 'Pellagra', 1),
(20508, 'ORPHA:97353', 'Boxer\'s dementia', 1),
(20509, 'ORPHA:97353', 'Chronic traumatic encephalopathy', 1),
(20510, 'ORPHA:97353', 'Dementia pugilistica', 1),
(20511, 'ORPHA:97353', 'Punch-drunk syndrome', 1),
(20512, 'ORPHA:97355', 'Atypical parkinsonism in the Caribbean', 1),
(20513, 'ORPHA:97355', 'Caribbean parkinsonism', 1),
(20514, 'ORPHA:97360', 'Acral dysostosis with facial and genital abnormalities', 1),
(20515, 'ORPHA:97360', 'Fetal face syndrome', 1),
(20516, 'ORPHA:97360', 'Mesomelic dwarfism-small genitalia syndrome', 1),
(20517, 'ORPHA:97360', 'Robinow dwarfism', 1),
(20518, 'ORPHA:97360', 'Robinow syndrome', 1),
(20519, 'ORPHA:97360', 'Robinow-Silverman-Smith syndrome', 1),
(20520, 'ORPHA:97361', 'Renal hypoplasia, unilateral', 2),
(20521, 'ORPHA:97362', 'Renal hypoplasia, bilateral', 2),
(20522, 'ORPHA:97363', 'Unilateral MCDK', 2),
(20523, 'ORPHA:97363', 'Unilateral multicystic dysplastic kidney', 2),
(20524, 'ORPHA:97363', 'Unilateral multicystic renal dysplasia', 2),
(20525, 'ORPHA:97364', 'Bilateral MCDK', 2),
(20526, 'ORPHA:97364', 'Bilateral multicystic dysplastic kidney', 2),
(20527, 'ORPHA:97364', 'Bilateral multicystic renal dysplasia', 2),
(20528, 'ORPHA:97366', 'Multilocular cyst of the kidney', 1),
(20529, 'ORPHA:97366', 'Multilocular renal cyst', 1),
(20530, 'ORPHA:97366', 'Multiloculated renal cyst', 1),
(20531, 'ORPHA:97367', 'Renal tubular dysgenesis due to twin-twin transfusion', 2),
(20532, 'ORPHA:97368', 'Drug-related renal tubular dysgenesis', 2),
(20533, 'ORPHA:97369', 'Renal tubular dysgenesis of genetic origin', 2),
(20534, 'ORPHA:974', 'AOS', 1),
(20535, 'ORPHA:974', 'Adams-Oliver syndrome', 1),
(20536, 'ORPHA:974', 'Congenital scalp defects with distal limb anomalies', 1),
(20537, 'ORPHA:974', 'Congenital scalp defects with distal limb reduction anomalies', 1),
(20538, 'ORPHA:974', 'Limb, scalp and skull defects', 1),
(20539, 'ORPHA:97548', 'Isomerism of right atrial appendage', 1),
(20540, 'ORPHA:97548', 'Ivemark syndrome', 1),
(20541, 'ORPHA:97548', 'RAI', 1),
(20542, 'ORPHA:97548', 'Right sided atrial isomerism', 1),
(20543, 'ORPHA:97560', 'Idiopathic membranous glomerulonephritis', 1),
(20544, 'ORPHA:97560', 'Primary membranous glomerulonephritis', 1),
(20545, 'ORPHA:97560', 'Primary membranous nephropathy', 1),
(20546, 'ORPHA:97563', 'Pauci-immune glomerulonephritis with ANCA', 2),
(20547, 'ORPHA:97563', 'Pauci-immune glomerulonephritis with antineutrophil cytoplasmic antibody', 2),
(20548, 'ORPHA:97564', 'Antineutrophil cytoplasmic antibody-negative pauci-immune glomerulonephritis', 2),
(20549, 'ORPHA:97564', 'Pauci-immune glomerulonephritis without ANCA', 2),
(20550, 'ORPHA:97564', 'Pauci-immune glomerulonephritis without antineutrophil cytoplasmic antibody', 2),
(20551, 'ORPHA:97566', 'Congo red-negative amyloidosis-like glomerulopathy', 1),
(20552, 'ORPHA:97566', 'Non-amyloid fibrillary glomerulonephritis', 1),
(20553, 'ORPHA:97566', 'Non-amyloid fibrillary glomerulopathy', 1),
(20554, 'ORPHA:97567', 'Immunotactoid glomerulonephritis', 1),
(20555, 'ORPHA:97567', 'Immunotactoid glomerulopathy', 1),
(20556, 'ORPHA:97593', 'Pseudohypoparathyroidism', 3),
(20557, 'ORPHA:97598', 'Congenital renal artery stenosis', 1),
(20558, 'ORPHA:97598', 'Congenital renovascular hypoplasia', 1),
(20559, 'ORPHA:976', '2,8-dihydroxyadenine urolithiasis', 1),
(20560, 'ORPHA:976', 'APRT deficiency', 1),
(20561, 'ORPHA:976', 'Adenine phosphoribosyltransferase deficiency', 1),
(20562, 'ORPHA:97678', 'Maternal uniparental disomy of chromosome 13', 1),
(20563, 'ORPHA:97678', 'UPD(13)mat', 1),
(20564, 'ORPHA:97685', '17q11 microdeletion syndrome', 2),
(20565, 'ORPHA:97685', 'Del(17)(q11)', 2),
(20566, 'ORPHA:97685', 'Monosomy 17q11', 2),
(20567, 'ORPHA:97685', 'NF1 microdeletion syndrome', 2),
(20568, 'ORPHA:97685', 'Neurofibromatosis type 1 microdeletion syndrome', 2),
(20569, 'ORPHA:977', 'Adrenomyodystrophy', 1),
(20570, 'ORPHA:978', 'ADULT syndrome', 1),
(20571, 'ORPHA:978', 'Acro-dermato-ungual-lacrimal-tooth syndrome', 1),
(20572, 'ORPHA:978', 'Pigment anomaly-ectrodactyly-hypodontia syndrome', 1),
(20573, 'ORPHA:97929', 'Rare cardiac disease', 3),
(20574, 'ORPHA:97935', 'Rare gastroenterologic disease', 3),
(20575, 'ORPHA:97944', 'Gastroduodenal malformation', 3),
(20576, 'ORPHA:97945', 'Intestinal malformation', 3),
(20577, 'ORPHA:97955', 'Rare respiratory disease', 3),
(20578, 'ORPHA:97957', 'Respiratory or thoracic malformation', 3),
(20579, 'ORPHA:97962', 'Rare surgical thoracic disease', 3),
(20580, 'ORPHA:97965', 'Rare surgical cardiac disease', 3),
(20581, 'ORPHA:97966', 'Rare ophthalmic disorder', 3),
(20582, 'ORPHA:97978', 'Rare endocrine disease', 3),
(20583, 'ORPHA:97992', 'Rare hematologic disease', 3),
(20584, 'ORPHA:98', 'ARSACS', 1),
(20585, 'ORPHA:98', 'Autosomal recessive spastic ataxia of Charlevoix-Saguenay', 1),
(20586, 'ORPHA:98', 'Autosomal recessive spastic ataxia type 6', 1),
(20587, 'ORPHA:98', 'SPAX6', 1),
(20588, 'ORPHA:980', 'Absence of the pulmonary artery', 1),
(20589, 'ORPHA:980', 'Aplasia of pulmonary artery', 1),
(20590, 'ORPHA:980', 'UAPA', 1),
(20591, 'ORPHA:980', 'Unilateral Pulmonary Artery Absence', 1),
(20592, 'ORPHA:980', 'Unilateral pulmonary artery agenesis', 1),
(20593, 'ORPHA:98004', 'Rare immune disease', 3),
(20594, 'ORPHA:98006', 'Rare nervous system disease', 3),
(20595, 'ORPHA:98006', 'Rare neurologic disease', 3),
(20596, 'ORPHA:98010', 'Infectious disease of the nervous system', 3),
(20597, 'ORPHA:98022', 'Rare headache', 3),
(20598, 'ORPHA:98023', 'Rare systemic or rheumatologic disease', 3),
(20599, 'ORPHA:98026', 'Rare odontologic disease', 3),
(20600, 'ORPHA:98027', 'Rare disease with odontological manifestation', 3),
(20601, 'ORPHA:98028', 'Rare circulatory system disease', 3),
(20602, 'ORPHA:98033', 'Rare neurologic disease with psychiatric involvement', 3),
(20603, 'ORPHA:98036', 'Rare otorhinolaryngologic disease', 3),
(20604, 'ORPHA:98038', 'Cranial malformation', 3),
(20605, 'ORPHA:98039', 'Digestive tract malformation', 3),
(20606, 'ORPHA:98041', 'Visceral malformation of the liver, biliary tract, pancreas or spleen', 3),
(20607, 'ORPHA:98043', 'Diaphragmatic or abdominal wall malformation', 3),
(20608, 'ORPHA:98044', 'Central nervous system malformation', 3),
(20609, 'ORPHA:98045', 'Respiratory or mediastinal malformation', 3),
(20610, 'ORPHA:98047', 'Rare infertility', 3),
(20611, 'ORPHA:98048', 'Rare male infertility', 3),
(20612, 'ORPHA:98049', 'Rare female infertility', 3),
(20613, 'ORPHA:98050', 'Rare allergic disease', 3),
(20614, 'ORPHA:98050', 'Rare allergy', 3),
(20615, 'ORPHA:98052', 'Rare allergic respiratory disease', 3),
(20616, 'ORPHA:98052', 'Rare respiratory allergy', 3),
(20617, 'ORPHA:98053', 'Rare genetic disease', 3),
(20618, 'ORPHA:98054', 'Rare genetic cardiac disease', 3),
(20619, 'ORPHA:98056', 'Rare genetic renal disease', 3),
(20620, 'ORPHA:98057', 'Rare neoplasm', 3),
(20621, 'ORPHA:98057', 'Rare tumor', 3),
(20622, 'ORPHA:98058', 'Rare urinary tract cancer', 3),
(20623, 'ORPHA:98058', 'Rare urinary tract neoplasm', 3),
(20624, 'ORPHA:98058', 'Rare urinary tract tumor', 3),
(20625, 'ORPHA:98059', 'Rare digestive cancer', 3),
(20626, 'ORPHA:98059', 'Rare digestive neoplasm', 3),
(20627, 'ORPHA:98059', 'Rare digestive tumor', 3),
(20628, 'ORPHA:98060', 'Rare respiratory cancer', 3),
(20629, 'ORPHA:98060', 'Rare respiratory neoplasm', 3),
(20630, 'ORPHA:98060', 'Rare respiratory tumor', 3),
(20631, 'ORPHA:98061', 'Rare ORL cancer', 3),
(20632, 'ORPHA:98061', 'Rare ORL neoplasm', 3),
(20633, 'ORPHA:98061', 'Rare ORL tumor', 3),
(20634, 'ORPHA:98061', 'Rare otorhinolaryngologic tumor', 3),
(20635, 'ORPHA:98062', 'Rare nervous system neoplasm', 3),
(20636, 'ORPHA:98062', 'Rare nervous system tumor', 3),
(20637, 'ORPHA:98063', 'Rare gynaecological cancer', 3),
(20638, 'ORPHA:98063', 'Rare gynaecological neoplasm', 3),
(20639, 'ORPHA:98063', 'Rare gynecological tumor', 3),
(20640, 'ORPHA:98074', 'Gonadal dysgenesis of gynecological interest', 3),
(20641, 'ORPHA:98078', '46,XX DSD induced by androgens excess', 3),
(20642, 'ORPHA:98078', '46,XX disorder of sex development induced by androgens excess', 3),
(20643, 'ORPHA:98085', '46,XY DSD', 3),
(20644, 'ORPHA:98085', '46,XY disorder of sex development', 3),
(20645, 'ORPHA:98086', '46,XY disorder of sex development due to a defect in testosterone metabolism by peripheral tissue', 3),
(20646, 'ORPHA:98087', 'Syndrome with 46,XY DSD', 3),
(20647, 'ORPHA:98087', 'Syndrome with 46,XY disorder of sex development', 3),
(20648, 'ORPHA:98095', 'Autosomal recessive congenital cerebellar ataxia', 3),
(20649, 'ORPHA:98096', 'Autosomal recessive metabolic cerebellar ataxia', 3),
(20650, 'ORPHA:98097', 'Autosomal recessive cerebellar ataxia due to a DNA repair defect', 3),
(20651, 'ORPHA:98098', 'Autosomal recessive degenerative and progressive cerebellar ataxia', 3),
(20652, 'ORPHA:98099', 'Autosomal recessive syndromic cerebellar ataxia', 3),
(20653, 'ORPHA:981', 'Internal carotid absence', 1),
(20654, 'ORPHA:98127', 'Autosomal anomaly', 3),
(20655, 'ORPHA:98130', 'Autosomal duplication', 3),
(20656, 'ORPHA:98130', 'Autosomal trisomy', 3),
(20657, 'ORPHA:98131', 'Total autosomal trisomy', 3),
(20658, 'ORPHA:98132', 'Partial autosomal trisomy/tetrasomy', 3),
(20659, 'ORPHA:98141', 'Total autosomal monosomy', 3),
(20660, 'ORPHA:98142', 'Partial autosomal deletion', 3),
(20661, 'ORPHA:98142', 'Partial autosomal monosomy', 3),
(20662, 'ORPHA:98152', 'Autosomal uniparental disomy', 3),
(20663, 'ORPHA:98153', 'Maternal uniparental disomy', 3),
(20664, 'ORPHA:98154', 'Paternal uniparental disomy', 3),
(20665, 'ORPHA:98155', 'Allosome anomaly', 3),
(20666, 'ORPHA:98155', 'Sex-chromosome anomaly', 3),
(20667, 'ORPHA:98156', 'Allosome number anomaly', 3),
(20668, 'ORPHA:98156', 'Sex-chromosome number anomaly', 3),
(20669, 'ORPHA:98157', 'Allosome structural anomaly', 3),
(20670, 'ORPHA:98157', 'Sex-chromosome structural anomaly', 3),
(20671, 'ORPHA:98158', 'Chromosome Y structural anomaly', 3),
(20672, 'ORPHA:98159', 'Chromosome X structural anomaly', 3),
(20673, 'ORPHA:98196', 'Dysmorphologic diseases with phakomatosis', 3),
(20674, 'ORPHA:98196', 'Malformation syndrome with hamartosis', 3),
(20675, 'ORPHA:982', 'Absent pulmonary valve syndrome', 3),
(20676, 'ORPHA:982', 'Congenital absence of the pulmonary valve', 3),
(20677, 'ORPHA:982', 'PVA', 3),
(20678, 'ORPHA:982', 'Pulmonary valve agenesis', 3),
(20679, 'ORPHA:98203', 'Combined dystonia', 3),
(20680, 'ORPHA:98203', 'Dystonia-plus syndrome', 3),
(20681, 'ORPHA:98249', 'Ehlers-Danlos syndrome', 3),
(20682, 'ORPHA:98252', 'Infectious encephalitis', 3),
(20683, 'ORPHA:98253', 'Postinfectious encephalitis', 3),
(20684, 'ORPHA:98255', 'Chronic encephalitis', 3),
(20685, 'ORPHA:98257', 'Neonatal epilepsy syndrome', 3),
(20686, 'ORPHA:98258', 'Infantile epilepsy syndrome', 3),
(20687, 'ORPHA:98259', 'Childhood-onset epilepsy syndrome', 3),
(20688, 'ORPHA:98260', 'Adolescent-onset epilepsy syndrome', 3),
(20689, 'ORPHA:98261', 'PME', 3),
(20690, 'ORPHA:98261', 'Progressive myoclonic epilepsy', 3),
(20691, 'ORPHA:98261', 'Progressive myoclonus epilepsy', 3),
(20692, 'ORPHA:98267', 'Genetic non-syndromic obesity', 1),
(20693, 'ORPHA:98267', 'Monogenic obesity due to a leptin-melanocortin pathway anomaly', 1),
(20694, 'ORPHA:98274', 'MPD', 3),
(20695, 'ORPHA:98274', 'MPN', 3),
(20696, 'ORPHA:98274', 'Myeloproliferative disorder', 3),
(20697, 'ORPHA:98274', 'Myeloproliferative neoplasm', 3),
(20698, 'ORPHA:98275', 'Myelodysplastic/myeloproliferative disease', 3),
(20699, 'ORPHA:98277', 'AML with recurrent genetic anomaly', 3),
(20700, 'ORPHA:98277', 'Acute myeloid leukemia with recurrent genetic anomaly', 3),
(20701, 'ORPHA:98282', 'Plasma cell tumor', 3),
(20702, 'ORPHA:98287', 'Histiocytic and dendritic cell tumor', 3),
(20703, 'ORPHA:98288', 'Macrophage or histiocytic tumor', 3),
(20704, 'ORPHA:98289', 'Dendritic cell tumor', 3),
(20705, 'ORPHA:98290', 'Immunodeficiency-associated lymphoproliferative disease', 3),
(20706, 'ORPHA:98291', 'Lymphoproliferative disease associated with primary immune disease', 3),
(20707, 'ORPHA:98292', 'Mastocytosis', 3),
(20708, 'ORPHA:98293', 'Hodgkin lymphoma', 3),
(20709, 'ORPHA:983', 'ETRS', 1),
(20710, 'ORPHA:983', 'Embryonic testicular regression syndrome', 1),
(20711, 'ORPHA:983', 'TRS', 1),
(20712, 'ORPHA:983', 'Testicular regression syndrome', 1),
(20713, 'ORPHA:983', 'Vanishing testes syndrome', 1),
(20714, 'ORPHA:983', 'Vanishing testis syndrome', 1),
(20715, 'ORPHA:983', 'XY gonadal agenesis syndrome', 1),
(20716, 'ORPHA:98300', 'Idiopathic interstitial pneumonia', 3),
(20717, 'ORPHA:98301', 'Laminopathy', 3),
(20718, 'ORPHA:98305', 'Genetic lipodystrophy', 3),
(20719, 'ORPHA:98306', 'FPLD', 3),
(20720, 'ORPHA:98306', 'Familial partial lipodystrophy', 3),
(20721, 'ORPHA:98307', 'Acquired lipodystrophy', 3),
(20722, 'ORPHA:98313', 'Male infertility due to gonadal dysgenesis', 3),
(20723, 'ORPHA:98313', 'Male infertility due to testicular dysgenesis', 3),
(20724, 'ORPHA:98343', 'Male infertility due to impaired sperm transport', 3),
(20725, 'ORPHA:98343', 'Male infertility due to obstructive azoospermia', 3),
(20726, 'ORPHA:98345', 'Rare idiopathic male infertility', 1),
(20727, 'ORPHA:98349', 'Autosomal dominant isolated diffuse palmoplantar hyperkeratosis', 3),
(20728, 'ORPHA:98349', 'Autosomal dominant isolated diffuse palmoplantar keratoderma', 3),
(20729, 'ORPHA:98352', 'Autosomal dominant disease with diffuse palmoplantar hyperkeratosis as a major feature', 3),
(20730, 'ORPHA:98352', 'Autosomal dominant disease with diffuse palmoplantar keratoderma as a major feature', 3),
(20731, 'ORPHA:98353', 'Autosomal dominant disease associated with focal palmoplantar hyperkeratosis as a major feature', 3),
(20732, 'ORPHA:98353', 'Autosomal dominant disease associated with focal palmoplantar keratoderma as a major feature', 3),
(20733, 'ORPHA:98356', 'Autosomal recessive isolated diffuse palmoplantar hyperkeratosis', 3),
(20734, 'ORPHA:98356', 'Autosomal recessive isolated diffuse palmoplantar keratoderma', 3),
(20735, 'ORPHA:98357', 'Autosomal recessive disease with focal palmoplantar hyperkeratosis as a major feature', 3),
(20736, 'ORPHA:98357', 'Autosomal recessive disease with focal palmoplantar keratoderma as a major feature', 3),
(20737, 'ORPHA:98360', 'Constitutional anemia due to iron metabolism disorder', 3),
(20738, 'ORPHA:98362', 'Constitutional sideroblastic anemia', 3),
(20739, 'ORPHA:98363', 'Rare hemolytic anemia', 3),
(20740, 'ORPHA:98364', 'Rare constitutional hemolytic anemia due to a red cell membrane anomaly', 3),
(20741, 'ORPHA:98365', 'Hereditary stomatocytic disease', 3),
(20742, 'ORPHA:98365', 'Hereditary stomatocytosis', 3),
(20743, 'ORPHA:98366', 'Constitutional hemolytic anemia due to acanthocytic disorder', 3),
(20744, 'ORPHA:98366', 'Constitutional hemolytic anemia due to acanthocytosis', 3),
(20745, 'ORPHA:98369', 'Rare constitutional hemolytic anemia due to an enzyme disorder', 3),
(20746, 'ORPHA:98370', 'Hemolytic anemia due to hexose monophosphate shunt and glutathione metabolism anomalies', 3),
(20747, 'ORPHA:98372', 'Hemolytic anemia due to a disorder of glycolytic enzymes', 3),
(20748, 'ORPHA:98374', 'Hemolytic anemia due to an erythrocyte nucleotide metabolism disorder', 3),
(20749, 'ORPHA:98374', 'Hemolytic anemia due to an erythroenzymopathy', 3),
(20750, 'ORPHA:98375', 'AHA', 3),
(20751, 'ORPHA:98375', 'AIHA', 3),
(20752, 'ORPHA:98375', 'Autoimmune hemolytic anemia', 3),
(20753, 'ORPHA:98396', 'Constitutional megaloblastic anemia due to vitamin B12 metabolism disorder', 3),
(20754, 'ORPHA:984', 'Pulmonary agenesis', 1),
(20755, 'ORPHA:98408', 'Constitutional megaloblastic anemia due to folate metabolism disorder', 3),
(20756, 'ORPHA:98415', 'Vitamin B12- and folate-independent constitutional megaloblastic anemia', 3),
(20757, 'ORPHA:98421', 'Red cell aplasia', 3),
(20758, 'ORPHA:98427', 'Polycythemia', 3),
(20759, 'ORPHA:98428', 'Secondary erythrocytosis', 3),
(20760, 'ORPHA:98428', 'Secondary polycythemia', 3),
(20761, 'ORPHA:98429', 'Rare coagulation disorder', 3),
(20762, 'ORPHA:98434', 'Hereditary combined deficiency of factors II, VII, IX and X', 1),
(20763, 'ORPHA:98434', 'Hereditary combined deficiency of vitamin K-dependent clotting factors', 1),
(20764, 'ORPHA:98455', 'Alpha granule disease', 3),
(20765, 'ORPHA:98456', 'Delta granule disease', 3),
(20766, 'ORPHA:98456', 'Dense granule disease', 3),
(20767, 'ORPHA:98464', 'X-linked syndromic intellectual disability', 3),
(20768, 'ORPHA:98472', 'Skeletal muscle disease', 3),
(20769, 'ORPHA:98473', 'Muscular dystrophy', 3),
(20770, 'ORPHA:98482', 'IMM', 3),
(20771, 'ORPHA:98482', 'Idiopathic inflammatory myopathy', 3),
(20772, 'ORPHA:98482', 'Idiopathic inflammatory myositis', 3),
(20773, 'ORPHA:98486', 'Metabolic myopathy', 3),
(20774, 'ORPHA:98491', 'Neuromuscular junction disease', 3),
(20775, 'ORPHA:98494', 'Acquired neuromuscular junction disease', 3),
(20776, 'ORPHA:98495', 'Genetic neuromuscular junction disease', 3),
(20777, 'ORPHA:98496', 'Rare peripheral neuropathy', 3),
(20778, 'ORPHA:98497', 'Genetic peripheral neuropathy', 3),
(20779, 'ORPHA:98503', 'Anterior horn cell disease', 3),
(20780, 'ORPHA:98503', 'Motor neuron disease', 3),
(20781, 'ORPHA:98505', 'Genetic anterior horn cell disease', 3),
(20782, 'ORPHA:98505', 'Genetic motor neuron disease', 3),
(20783, 'ORPHA:98506', 'Acquired anterior horn cell disease', 3),
(20784, 'ORPHA:98506', 'Acquired motor neuron disease', 3),
(20785, 'ORPHA:98514', 'Malformation of the cerebellar vermis', 3),
(20786, 'ORPHA:98516', 'Malformation of the cerebellar hemispheres', 3),
(20787, 'ORPHA:98518', 'Cranial nerve and nuclear aplasia', 3),
(20788, 'ORPHA:98519', 'Posterior fossa malformation', 3),
(20789, 'ORPHA:98523', 'Non-syndromic pontocerebellar hypoplasia', 3),
(20790, 'ORPHA:98523', 'PCH', 3),
(20791, 'ORPHA:98523', 'Pontoneocerebellar atrophy', 3),
(20792, 'ORPHA:98523', 'Pontoneocerebllar hypoplasia', 3),
(20793, 'ORPHA:98534', 'Neurodegenerative disease with dementia', 3),
(20794, 'ORPHA:98535', 'Frontotemporal degeneration with dementia', 3),
(20795, 'ORPHA:98538', 'Ataxia with dementia', 3),
(20796, 'ORPHA:98539', 'Early-onset ataxia with dementia', 3),
(20797, 'ORPHA:98540', 'Late-onset ataxia with dementia', 3),
(20798, 'ORPHA:98542', 'Infectious disease with dementia', 3),
(20799, 'ORPHA:98543', 'Metabolic disease with dementia', 3),
(20800, 'ORPHA:98544', 'Cerebral lipidosis with dementia', 3),
(20801, 'ORPHA:98549', 'Rare cerebrovascular dementia', 3),
(20802, 'ORPHA:98553', 'Developmental defect of the eye', 3),
(20803, 'ORPHA:98555', 'Anophthalmia-microphthalmia syndrome', 3),
(20804, 'ORPHA:98555', 'Microphthalmia-anophthalmia-coloboma', 3),
(20805, 'ORPHA:98557', 'Syndromic aniridia', 3),
(20806, 'ORPHA:98560', 'Rare palpebral disorder', 3),
(20807, 'ORPHA:98561', 'Congenital malformation of the eyelid', 3),
(20808, 'ORPHA:98562', 'Cryptophthalmia', 3),
(20809, 'ORPHA:98563', 'Microblepharon-ablephara syndrome', 3),
(20810, 'ORPHA:98564', 'Eyelid border anomaly', 3),
(20811, 'ORPHA:98565', 'Syndromic ankyloblepharon', 3),
(20812, 'ORPHA:98565', 'Syndromic ankyloblepharon filiforme adnatum', 3),
(20813, 'ORPHA:98566', 'Syndromic eyelid coloboma', 3),
(20814, 'ORPHA:98566', 'Syndromic palpebral coloboma', 3),
(20815, 'ORPHA:98567', 'Eyelids malposition disorder', 3),
(20816, 'ORPHA:98567', 'Rare eyelid malposition disorder', 3),
(20817, 'ORPHA:98570', 'Congenital ectropion', 3),
(20818, 'ORPHA:98571', 'Secondary ectropion', 3),
(20819, 'ORPHA:98574', 'Syndromic epicanthus', 3),
(20820, 'ORPHA:98575', 'Syndromic telecanthus', 3),
(20821, 'ORPHA:98576', 'Malposition of external canthus', 3),
(20822, 'ORPHA:98576', 'Syndromic outer canthal malposition', 3),
(20823, 'ORPHA:98578', 'Rare disorder with ptosis', 3),
(20824, 'ORPHA:98594', 'Rare eyebrow/eyelash disorder', 3),
(20825, 'ORPHA:98594', 'Rare eyebrow/eyelashes anomaly', 3),
(20826, 'ORPHA:98602', 'Rare disorder of the lacrimal apparatus', 3),
(20827, 'ORPHA:98602', 'Rare lacrimal system disease', 3),
(20828, 'ORPHA:98604', 'Congenital alacrima', 3),
(20829, 'ORPHA:98605', 'Excretory apparatus of the lacrimal system anomaly', 3),
(20830, 'ORPHA:98605', 'Lacrimal drainage system anomaly', 3),
(20831, 'ORPHA:98606', 'Syndromic orbital border hypoplasia', 1),
(20832, 'ORPHA:98606', 'Urrets-Zavalia syndrome', 1),
(20833, 'ORPHA:98609', 'EEC syndrome and related disorders', 3),
(20834, 'ORPHA:98609', 'EEC syndrome and related syndrome', 3),
(20835, 'ORPHA:98610', 'Rare disorder with conjunctival involvement as a major feature', 3),
(20836, 'ORPHA:98618', 'Rare refraction anomaly', 3),
(20837, 'ORPHA:98619', 'Rare isolated myopia', 1),
(20838, 'ORPHA:98621', 'Rare hyperopia and astigmatism', 3),
(20839, 'ORPHA:98622', 'Syndromic hyperopia', 3),
(20840, 'ORPHA:98623', 'Syndromic keratoconus', 3),
(20841, 'ORPHA:98625', 'Anterior corneal dystrophy', 3),
(20842, 'ORPHA:98625', 'Superficial corneal dystrophy', 3),
(20843, 'ORPHA:98626', 'Stromal corneal dystrophy', 3),
(20844, 'ORPHA:98627', 'Posterior corneal dystrophy', 3),
(20845, 'ORPHA:98628', 'Syndromic corneal dystrophy', 3),
(20846, 'ORPHA:98631', 'Congenital malformation of the eye with glaucoma as a major feature', 3),
(20847, 'ORPHA:98634', 'Anterior segment developmental anomaly without extraocular manifestations', 3),
(20848, 'ORPHA:98635', 'Corneodysgenesis', 3),
(20849, 'ORPHA:98635', 'Corneogoniodysgenesis', 3),
(20850, 'ORPHA:98638', 'Rare disease with glaucoma as a major feature', 3),
(20851, 'ORPHA:98639', 'Rare lens disease', 3),
(20852, 'ORPHA:98640', 'Rare cataract', 3),
(20853, 'ORPHA:98640', 'Rare disorder with lens opacification', 3),
(20854, 'ORPHA:98641', 'Syndromic cataract', 3),
(20855, 'ORPHA:98642', 'Chromosomal anomaly with cataract', 3),
(20856, 'ORPHA:98644', 'Metabolic disease with cataract', 3),
(20857, 'ORPHA:98646', 'Renal disease with cataract', 3),
(20858, 'ORPHA:98648', 'Musculoskeletal disease with cataract', 3),
(20859, 'ORPHA:98649', 'Dentocutaneous disease with cataract', 3),
(20860, 'ORPHA:98650', 'Craniofacial anomaly with cataract', 3),
(20861, 'ORPHA:98652', 'Lens size anomaly', 3),
(20862, 'ORPHA:98653', 'Lens position anomaly', 3),
(20863, 'ORPHA:98655', 'Lens shape anomaly', 3),
(20864, 'ORPHA:98658', 'Color-vision disease', 3),
(20865, 'ORPHA:98661', 'Syndromic retinitis pigmentosa', 3),
(20866, 'ORPHA:98661', 'Syndromic rod-cone dystrophy', 3),
(20867, 'ORPHA:98668', 'Vitreoretinopathy', 3),
(20868, 'ORPHA:98671', 'Hereditary optic neuropathy', 3),
(20869, 'ORPHA:98672', 'ADOA', 3),
(20870, 'ORPHA:98672', 'Autosomal dominant optic atrophy', 3),
(20871, 'ORPHA:98672', 'DOA', 3),
(20872, 'ORPHA:98673', 'Autosomal dominant optic atrophy, Kjer type', 1),
(20873, 'ORPHA:98673', 'Autosomal dominant optic atrophy, classic form', 1),
(20874, 'ORPHA:98673', 'Kjer optic atrophy', 1),
(20875, 'ORPHA:98673', 'Optic atrophy type 1', 1),
(20876, 'ORPHA:98676', 'Autosomal recessive isolated optic atrophy', 1),
(20877, 'ORPHA:98676', 'Autosomal recessive non-syndromic optic atrophy', 1),
(20878, 'ORPHA:98681', 'Rare disorder with strabismus', 3),
(20879, 'ORPHA:98683', 'Syndrome with a symptomatic strabismus', 3),
(20880, 'ORPHA:98683', 'Syndromic disorder with strabismus', 3),
(20881, 'ORPHA:98684', 'Craniostenosis with strabismus', 3),
(20882, 'ORPHA:98685', 'Rare oculomotor nerve disorder', 3),
(20883, 'ORPHA:98686', 'Congenital CNIV palsy', 1),
(20884, 'ORPHA:98686', 'Congenital fourth cranial nerve palsy', 1),
(20885, 'ORPHA:98686', 'Congenital superior oblique palsy', 1),
(20886, 'ORPHA:98686', 'Congenital trochlear nerve palsy', 1),
(20887, 'ORPHA:98687', 'Supranuclear eye movement disorder', 3),
(20888, 'ORPHA:98688', 'Oculomotor apraxia', 3),
(20889, 'ORPHA:98706', 'Oculocutaneous or ocular albinism', 3),
(20890, 'ORPHA:98715', 'Uveitis', 3),
(20891, 'ORPHA:98716', 'Heart position anomaly', 3),
(20892, 'ORPHA:98717', 'Transposition of the great arteries and conotruncal cardiac anomaly', 3),
(20893, 'ORPHA:98718', 'Aortic malformation', 3),
(20894, 'ORPHA:98719', 'Pulmonary artery or pulmonary branch anomaly', 3),
(20895, 'ORPHA:98720', 'Atrioventricular valve anomaly', 3),
(20896, 'ORPHA:98721', 'Congenital tricuspid malformation', 3),
(20897, 'ORPHA:98722', 'AVSD', 3),
(20898, 'ORPHA:98722', 'Atrioventricular canal defect', 3),
(20899, 'ORPHA:98722', 'Atrioventricular septal defect', 3),
(20900, 'ORPHA:98723', 'Hypoplastic right heart syndrome', 3),
(20901, 'ORPHA:98724', 'Congenital anomaly of the great arteries', 3),
(20902, 'ORPHA:98724', 'Congenital aorta, aortic arch or  pulmonary arteries anomaly', 3),
(20903, 'ORPHA:98725', 'Ascending aorta anomaly', 3),
(20904, 'ORPHA:98727', 'Atrial defect and interauricular communication', 3),
(20905, 'ORPHA:98727', 'Rare atrial defect and interatrial communication', 3),
(20906, 'ORPHA:98729', 'Congenital pulmonary veins anomaly', 3),
(20907, 'ORPHA:98731', 'Congenital arteriovenous fistula', 3),
(20908, 'ORPHA:98733', 'Noonan syndrome and Noonan-related syndrome', 3),
(20909, 'ORPHA:98737', 'Genetic neurological muscular channelopathy', 3),
(20910, 'ORPHA:98738', 'Neurological muscular channelopathy due to a genetic sodium channel defect', 3),
(20911, 'ORPHA:98739', 'Neurological muscular channelopathy due to a genetic chloride channel defect', 3),
(20912, 'ORPHA:98740', 'Neurological muscular channelopathy due to a genetic calcium channel defect', 3),
(20913, 'ORPHA:98741', 'Neurological muscular channelopathy due to a genetic potassium channel defect', 3),
(20914, 'ORPHA:98742', 'Neurological muscular channelopathy due to a genetic ryanodine receptor defect', 3),
(20915, 'ORPHA:98743', 'Genetic neurological channelopathy of the central nervous system', 3),
(20916, 'ORPHA:98744', 'Neurological channelopathy of the central nervous system due to a genetic sodium channel defect', 3),
(20917, 'ORPHA:98745', 'Neurological channelopathy of the central nervous system due to a genetic calcium channel defect', 3),
(20918, 'ORPHA:98746', 'Neurological channelopathy of the central nervous system due to a genetic potassium channel defect', 3),
(20919, 'ORPHA:98747', 'Neurological channelopathy of the central nervous system due to a genetic glycine receptor defect', 3),
(20920, 'ORPHA:98748', 'Neurological channelopathy of the central nervous system due to a genetic acetylcholine receptor defect', 3),
(20921, 'ORPHA:98749', 'Neurological channelopathy of the central nervous system due to a genetic GABA receptor defect', 3),
(20922, 'ORPHA:98750', 'Autoimmune neurological channelopathy', 3),
(20923, 'ORPHA:98754', 'Prader-Willi syndrome due to maternal uniparental disomy of chromosome 15', 2),
(20924, 'ORPHA:98754', 'UPD(15)mat', 2),
(20925, 'ORPHA:98755', 'SCA1', 1),
(20926, 'ORPHA:98755', 'Spinocerebellar ataxia type 1', 1),
(20927, 'ORPHA:98756', 'SCA2', 1),
(20928, 'ORPHA:98756', 'Spinocerebellar ataxia type 2', 1),
(20929, 'ORPHA:98757', 'Azorean disease of the nervous system', 1),
(20930, 'ORPHA:98757', 'MJD', 1),
(20931, 'ORPHA:98757', 'Machado disease', 1),
(20932, 'ORPHA:98757', 'Machado-Joseph disease', 1),
(20933, 'ORPHA:98757', 'Nigro-spino-dentatal degeneration with nuclear ophthalmoplegia', 1),
(20934, 'ORPHA:98757', 'SCA3', 1),
(20935, 'ORPHA:98757', 'Spinocerebellar ataxia type 3', 1),
(20936, 'ORPHA:98758', 'SCA6', 1),
(20937, 'ORPHA:98758', 'Spinocerebellar ataxia type 6', 1),
(20938, 'ORPHA:98759', 'HDL4', 1),
(20939, 'ORPHA:98759', 'Huntington disease-like 4', 1),
(20940, 'ORPHA:98759', 'SCA17', 1),
(20941, 'ORPHA:98759', 'Spinocerebellar ataxia type 17', 1),
(20942, 'ORPHA:98760', 'SCA8', 1),
(20943, 'ORPHA:98760', 'Spinocerebellar ataxia type 8', 1),
(20944, 'ORPHA:98761', 'SCA10', 1),
(20945, 'ORPHA:98761', 'Spinocerebellar ataxia type 10', 1),
(20946, 'ORPHA:98762', 'SCA12', 1),
(20947, 'ORPHA:98762', 'Spinocerebellar ataxia type 12', 1),
(20948, 'ORPHA:98763', 'SCA14', 1),
(20949, 'ORPHA:98763', 'Spinocerebellar ataxia type 14', 1),
(20950, 'ORPHA:98764', 'SCA27', 1),
(20951, 'ORPHA:98764', 'Spinocerebellar ataxia type 27', 1),
(20952, 'ORPHA:98765', 'SCA4', 1),
(20953, 'ORPHA:98765', 'Spinocerebellar ataxia type 4', 1),
(20954, 'ORPHA:98766', 'SCA5', 1),
(20955, 'ORPHA:98766', 'Spinocerebellar ataxia type 5', 1),
(20956, 'ORPHA:98767', 'SCA11', 1),
(20957, 'ORPHA:98767', 'Spinocerebellar ataxia type 11', 1),
(20958, 'ORPHA:98768', 'SCA13', 1),
(20959, 'ORPHA:98768', 'Spinocerebellar ataxia type 13', 1),
(20960, 'ORPHA:98769', 'SCA15/16', 1),
(20961, 'ORPHA:98769', 'Spinocerebellar ataxia type 15/16', 1),
(20962, 'ORPHA:98771', 'SCA18', 1),
(20963, 'ORPHA:98771', 'Spinocerebellar ataxia type 18', 1),
(20964, 'ORPHA:98772', 'SCA19/22', 1),
(20965, 'ORPHA:98772', 'Spinocerebellar ataxia type 19/22', 1),
(20966, 'ORPHA:98773', 'SCA21', 1),
(20967, 'ORPHA:98773', 'Spinocerebellar ataxia type 21', 1),
(20968, 'ORPHA:98784', 'ADNFLE', 1),
(20969, 'ORPHA:98784', 'Autosomal dominant nocturnal frontal lobe epilepsy', 1),
(20970, 'ORPHA:98784', 'Autosomal dominant sleep-related hypermotor epilepsy', 1),
(20971, 'ORPHA:98791', 'ATR syndrome linked to chromosome 16', 1),
(20972, 'ORPHA:98791', 'ATR syndrome, deletion type', 1),
(20973, 'ORPHA:98791', 'ATR-16 syndrome', 1),
(20974, 'ORPHA:98791', 'Alpha thalassemia-intellectual disability syndrome, deletion type', 1),
(20975, 'ORPHA:98791', 'Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16', 1),
(20976, 'ORPHA:98793', 'Prader-Willi syndrome due to paternal 15q11q13 deletion', 2),
(20977, 'ORPHA:98794', 'Angelman syndrome due to maternal 15q11q13 deletion', 2),
(20978, 'ORPHA:98794', 'Angelman syndrome due to maternal monosomy 15q11q13', 2),
(20979, 'ORPHA:98795', 'Angelman syndrome due to paternal uniparental disomy of chromosome 15', 2),
(20980, 'ORPHA:98795', 'UPD(15)pat', 2),
(20981, 'ORPHA:98797', 'Isochromosomy Yp', 1),
(20982, 'ORPHA:98798', 'Isochromosomy Yq', 1),
(20983, 'ORPHA:988', 'Absent tibia-polydactyly syndrome', 1),
(20984, 'ORPHA:988', 'Tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome', 1),
(20985, 'ORPHA:98805', 'DYT4', 1),
(20986, 'ORPHA:98805', 'Hereditary whispering dysphonia', 1),
(20987, 'ORPHA:98805', 'Primary dystonia, DYT4 type', 1),
(20988, 'ORPHA:98806', 'DYT6', 1),
(20989, 'ORPHA:98806', 'Generalized cervical and upper-limb-onset dystonia', 1),
(20990, 'ORPHA:98806', 'Idiopathic torsion dystonia of mixed type', 1),
(20991, 'ORPHA:98806', 'Primary dystonia, DYT6 type', 1),
(20992, 'ORPHA:98807', 'DYT13', 1),
(20993, 'ORPHA:98807', 'Primary dystonia with mixed phenotype', 1),
(20994, 'ORPHA:98807', 'Primary dystonia, DYT13 type', 1),
(20995, 'ORPHA:98807', 'Primary torsion dystonia with predominant craniocervical or upper limb onset', 1),
(20996, 'ORPHA:98808', 'Autosomal dominant Segawa syndrome', 1),
(20997, 'ORPHA:98808', 'Autosomal dominant dopa-responsive dystonia', 1),
(20998, 'ORPHA:98808', 'DYT5a', 1),
(20999, 'ORPHA:98808', 'GTPCH1-deficient DRD', 1),
(21000, 'ORPHA:98808', 'GTPCH1-deficient dopa-responsive dystonia', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(21001, 'ORPHA:98808', 'HPD with marked diurnal fluctuation', 1),
(21002, 'ORPHA:98808', 'Hereditary progressive dystonia with marked diurnal fluctuation', 1),
(21003, 'ORPHA:98809', 'Familial PKD', 1),
(21004, 'ORPHA:98809', 'Familial paroxysmal kinesigenic dyskinesia', 1),
(21005, 'ORPHA:98809', 'Paroxysmal kinesigenic choreathetosis', 1),
(21006, 'ORPHA:98809', 'Paroxysmal kinesigenic dyskinesia', 1),
(21007, 'ORPHA:98810', 'Paroxysmal non-kinesigenic dyskinesia', 1),
(21008, 'ORPHA:98810', 'Paroxystic non-kinesigenic choreoathetosis', 1),
(21009, 'ORPHA:98811', 'DYT18', 1),
(21010, 'ORPHA:98811', 'Dystonia 18', 1),
(21011, 'ORPHA:98811', 'PED', 1),
(21012, 'ORPHA:98811', 'Paroxysmal exertion-induced dyskinesia', 1),
(21013, 'ORPHA:98813', 'Anhidrotic ectodermal dysplasia with immunodeficiency', 2),
(21014, 'ORPHA:98813', 'EDA-ID', 2),
(21015, 'ORPHA:98813', 'HED-ID', 2),
(21016, 'ORPHA:98813', 'Hypohidrotic ectodermal dysplasia with immunodeficiency', 2),
(21017, 'ORPHA:98815', 'Benign childhood occipital epilepsy, Panayiotopoulos type', 2),
(21018, 'ORPHA:98815', 'Early-onset benign childhood occipital epilepsy', 2),
(21019, 'ORPHA:98815', 'Panayiotopoulos syndrome', 2),
(21020, 'ORPHA:98816', 'Benign childhood occipital epilepsy, Gastaut type', 2),
(21021, 'ORPHA:98816', 'Late-onset benign childhood occipital epilepsy', 2),
(21022, 'ORPHA:98818', 'Acquired epileptic aphasia', 1),
(21023, 'ORPHA:98818', 'LKS', 1),
(21024, 'ORPHA:98818', 'Landau-Kleffner syndrome', 1),
(21025, 'ORPHA:98819', 'Familial temporal lobe epilepsy', 1),
(21026, 'ORPHA:98820', 'FFEVF', 1),
(21027, 'ORPHA:98820', 'Familial focal epilepsy with variable foci', 1),
(21028, 'ORPHA:98820', 'Familial partial epilepsy with variable foci', 1),
(21029, 'ORPHA:98823', 'CMML', 1),
(21030, 'ORPHA:98823', 'Chronic myelomonocytic leukemia', 1),
(21031, 'ORPHA:98824', 'Atypical chronic myeloid leukemia', 1),
(21032, 'ORPHA:98824', 'Subacute myeloid leukemia', 1),
(21033, 'ORPHA:98825', 'Unclassified mixed myelodysplastic/myeloproliferatic syndrome', 1),
(21034, 'ORPHA:98825', 'Unclassified myelodysplastic/myeloproliferative disease', 1),
(21035, 'ORPHA:98826', 'Refractory anemia', 1),
(21036, 'ORPHA:98827', 'Unclassified myelodysplastic syndrome', 1),
(21037, 'ORPHA:98829', 'AML with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)', 1),
(21038, 'ORPHA:98829', 'Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)', 1),
(21039, 'ORPHA:98831', 'AML with 11q23 abnormalities', 1),
(21040, 'ORPHA:98831', 'Acute myeloid leukemia with 11q23 abnormalities', 1),
(21041, 'ORPHA:98832', 'AML M0', 1),
(21042, 'ORPHA:98832', 'Acute myeloid leukemia with minimal differentiation', 1),
(21043, 'ORPHA:98832', 'Minimally differentiated acute myeloblastic leukemia', 1),
(21044, 'ORPHA:98833', 'AML M1', 1),
(21045, 'ORPHA:98833', 'Acute myeloblastic leukemia M1', 1),
(21046, 'ORPHA:98833', 'Acute myeloblastic leukemia without maturation', 1),
(21047, 'ORPHA:98834', 'AML M2', 1),
(21048, 'ORPHA:98834', 'Acute myeloblastic leukemia M2', 1),
(21049, 'ORPHA:98834', 'Acute myeloblastic leukemia with maturation', 1),
(21050, 'ORPHA:98835', 'Acute myeloid leukemia, minimal differentiation, FAB M0', 1),
(21051, 'ORPHA:98835', 'Acute undifferentiated leukemia', 1),
(21052, 'ORPHA:98838', 'Large cell lymphoma of the mediastinum', 1),
(21053, 'ORPHA:98838', 'Med-DLBCL', 1),
(21054, 'ORPHA:98838', 'Mediastinal diffuse large-cell lymphoma with sclerosis', 1),
(21055, 'ORPHA:98838', 'Primary mediastinal clear cell lymphoma of B-cell type', 1),
(21056, 'ORPHA:98838', 'Primary mediastinal large B-cell lymphoma', 1),
(21057, 'ORPHA:98839', 'Angioendotheliomatosis proliferans systemisata', 1),
(21058, 'ORPHA:98839', 'Angiotropic large cell lymphoma', 1),
(21059, 'ORPHA:98839', 'Intravascular large B-cell lymphoma', 1),
(21060, 'ORPHA:98839', 'Intravascular lymphomatosis', 1),
(21061, 'ORPHA:98839', 'Malignant angioendotheliomatosis', 1),
(21062, 'ORPHA:98839', 'Tappeiner-Pfleger disease', 1),
(21063, 'ORPHA:98841', 'ALCL', 1),
(21064, 'ORPHA:98841', 'Anaplastic large cell lymphoma', 1),
(21065, 'ORPHA:98841', 'CD30 positive anaplastic large cell lymphoma', 1),
(21066, 'ORPHA:98841', 'Ki-1 positive anaplastic large cell lymphoma', 1),
(21067, 'ORPHA:98841', 'Primary systemic ALCL', 1),
(21068, 'ORPHA:98841', 'sACL', 1),
(21069, 'ORPHA:98842', 'LyP', 1),
(21070, 'ORPHA:98842', 'Lymphomatoid papulosis', 1),
(21071, 'ORPHA:98843', 'Classic Hodgkin lymphoma, nodular sclerosis type', 2),
(21072, 'ORPHA:98844', 'Classic Hodgkin lymphoma, mixed cellularity type', 2),
(21073, 'ORPHA:98845', 'Classic Hodgkin lymphoma, lymphocyte-rich type', 2),
(21074, 'ORPHA:98846', 'Classic Hodgkin lymphoma, lymphocyte-depleted type', 2),
(21075, 'ORPHA:98848', 'Indolent systemic mastocytosis', 1),
(21076, 'ORPHA:98849', 'SM-AHN', 1),
(21077, 'ORPHA:98849', 'SM-AHNMD', 1),
(21078, 'ORPHA:98849', 'Systemic mastocytosis with an associated clonal hematologic non-mast cell lineage disease', 1),
(21079, 'ORPHA:98849', 'Systemic mastocytosis with associated hematologic neoplasm', 1),
(21080, 'ORPHA:98850', 'Aggressive systemic mastocytosis', 1),
(21081, 'ORPHA:98851', 'Mast cell leukemia', 1),
(21082, 'ORPHA:98852', 'Desquamative interstitial pneumonia', 1),
(21083, 'ORPHA:98853', 'Autosomal dominant Emery-Dreifuss muscular dystrophy', 2),
(21084, 'ORPHA:98853', 'EDMD2', 2),
(21085, 'ORPHA:98855', 'Autosomal recessive Emery-Dreifuss muscular dystrophy', 2),
(21086, 'ORPHA:98855', 'EDMD3', 2),
(21087, 'ORPHA:98856', 'AR-CMT2B1', 1),
(21088, 'ORPHA:98856', 'Autosomal recessive Charcot-Marie-Tooth disease type 2B1', 1),
(21089, 'ORPHA:98856', 'Autosomal recessive axonal CMT4C1', 1),
(21090, 'ORPHA:98856', 'Charcot-Marie-Tooth disease type 2B1', 1),
(21091, 'ORPHA:98863', 'X-linked Emery-Dreifuss muscular dystrophy', 2),
(21092, 'ORPHA:98868', 'Hereditary ovalocytosis', 1),
(21093, 'ORPHA:98868', 'Melanesian elliptocytosis', 1),
(21094, 'ORPHA:98868', 'Melanesian ovalocytosis', 1),
(21095, 'ORPHA:98868', 'SAO', 1),
(21096, 'ORPHA:98868', 'Southeast Asian ovalocytosis', 1),
(21097, 'ORPHA:98868', 'Stomatocytic elliptocytosis', 1),
(21098, 'ORPHA:98869', 'CDA I', 1),
(21099, 'ORPHA:98869', 'CDA type 1', 1),
(21100, 'ORPHA:98869', 'CDA type I', 1),
(21101, 'ORPHA:98869', 'Congenital dyserythropoietic anemia type 1', 1),
(21102, 'ORPHA:98869', 'Congenital dyserythropoietic anemia type I', 1),
(21103, 'ORPHA:98870', 'CDA III', 1),
(21104, 'ORPHA:98870', 'CDA type 3', 1),
(21105, 'ORPHA:98870', 'CDA type III', 1),
(21106, 'ORPHA:98870', 'Congenital dyserythropoietic anemia type 3', 1),
(21107, 'ORPHA:98870', 'Congenital dyserythropoietic anemia type III', 1),
(21108, 'ORPHA:98871', 'Transient acquired pure red cell aplasia', 1),
(21109, 'ORPHA:98871', 'Transient erythroblastopenia of childhood', 1),
(21110, 'ORPHA:98872', 'Adult pure red cell aplasia', 1),
(21111, 'ORPHA:98873', 'CDA II', 1),
(21112, 'ORPHA:98873', 'CDA type 2', 1),
(21113, 'ORPHA:98873', 'CDA type II', 1),
(21114, 'ORPHA:98873', 'Congenital dyserythropoietic anemia type 2', 1),
(21115, 'ORPHA:98873', 'Congenital dyserythropoietic anemia type II', 1),
(21116, 'ORPHA:98873', 'Hereditary erythroblastic multinuclearity with a positive acidified-serum test (hempas)', 1),
(21117, 'ORPHA:98873', 'SEC23B-CDG', 1),
(21118, 'ORPHA:98878', 'FVIII deficiency', 1),
(21119, 'ORPHA:98878', 'Factor VIII deficiency', 1),
(21120, 'ORPHA:98878', 'Hemophilia A', 1),
(21121, 'ORPHA:98879', 'Christmas disease', 1),
(21122, 'ORPHA:98879', 'Factor IX deficiency', 1),
(21123, 'ORPHA:98879', 'Hemophilia B', 1),
(21124, 'ORPHA:98880', 'Familial afibrinogenemia', 2),
(21125, 'ORPHA:98881', 'Familial dysfibrinogenemia', 2),
(21126, 'ORPHA:98885', 'Bleeding diathesis due to glycoprotein VI deficiency', 2),
(21127, 'ORPHA:98886', 'Bleeding diathesis due to integrin alpha2-beta1 deficiency', 2),
(21128, 'ORPHA:98888', 'Complex X-linked HSP', 3),
(21129, 'ORPHA:98888', 'Complex X-linked SPG', 3),
(21130, 'ORPHA:98888', 'Complicated X-linked HSP', 3),
(21131, 'ORPHA:98888', 'Complicated X-linked SPG', 3),
(21132, 'ORPHA:98888', 'X-linked complex spastic paraplegia', 3),
(21133, 'ORPHA:98888', 'X-linked complicated spastic paraplegia', 3),
(21134, 'ORPHA:98889', 'Bilateral perisylvian polymicrogyria', 2),
(21135, 'ORPHA:98890', 'Early-onset X-linked optic atrophy', 1),
(21136, 'ORPHA:98890', 'Non-Leber type optic atrophy with early-onset', 1),
(21137, 'ORPHA:98890', 'OPA2', 1),
(21138, 'ORPHA:98890', 'Optic atrophy type 2', 1),
(21139, 'ORPHA:98892', 'PVNH', 2),
(21140, 'ORPHA:98892', 'Periventricular nodular heterotopia', 2),
(21141, 'ORPHA:98893', 'CMD1B', 1),
(21142, 'ORPHA:98893', 'Congenital muscular dystrophy type 1B', 1),
(21143, 'ORPHA:98893', 'MDC1B', 1),
(21144, 'ORPHA:98895', 'BMD', 1),
(21145, 'ORPHA:98895', 'Becker dystrophinopathy', 1),
(21146, 'ORPHA:98895', 'Becker muscular dystrophy', 1),
(21147, 'ORPHA:98896', 'DMD', 1),
(21148, 'ORPHA:98896', 'Duchenne muscular dystrophy', 1),
(21149, 'ORPHA:98896', 'Severe dystrophinopathy, Duchenne type', 1),
(21150, 'ORPHA:98897', 'OPDM', 1),
(21151, 'ORPHA:98897', 'Oculopharyngeal distal myopathy', 1),
(21152, 'ORPHA:98897', 'Oculopharyngodistal myopathy', 1),
(21153, 'ORPHA:989', 'Aglossia-adactylia syndrome', 1),
(21154, 'ORPHA:989', 'Hanhart syndrome', 1),
(21155, 'ORPHA:989', 'Hypoglossia-hypodactyly syndrome', 1),
(21156, 'ORPHA:989', 'Jussieu syndrome', 1),
(21157, 'ORPHA:98902', 'Amish nemaline myopathy', 1),
(21158, 'ORPHA:98904', 'Actin myopathy', 1),
(21159, 'ORPHA:98904', 'Congenital myopathy with excess of thin filaments', 1),
(21160, 'ORPHA:98905', 'Congenital multicore myopathy with external ophthalmoplegia', 2),
(21161, 'ORPHA:98907', 'Dorfman-Chanarin disease', 1),
(21162, 'ORPHA:98907', 'NLSDI', 1),
(21163, 'ORPHA:98907', 'Neutral lipid storage disease with ichthyosis', 1),
(21164, 'ORPHA:98908', 'NLSDM', 1),
(21165, 'ORPHA:98908', 'Neutral lipid storage disease with myopathy without ichthyosis', 1),
(21166, 'ORPHA:98908', 'Neutral lipid storage myopathy', 1),
(21167, 'ORPHA:98909', 'Desmin-related myofibrillar myopathy', 1),
(21168, 'ORPHA:98909', 'Desminopathy', 1),
(21169, 'ORPHA:98910', 'Alpha-crystallinopathy', 3),
(21170, 'ORPHA:98910', 'CRYAB-related myofobrillar myopathy', 3),
(21171, 'ORPHA:98911', 'Distal myotilinopathy', 1),
(21172, 'ORPHA:98912', 'Late-onset distal myopathy, Markesbery-Griggs type', 1),
(21173, 'ORPHA:98912', 'ZASP-related myofibrillar myopathy', 1),
(21174, 'ORPHA:98913', 'Postsynaptic congenital myasthenic syndromes', 2),
(21175, 'ORPHA:98914', 'Presynaptic congenital myasthenic syndromes', 2),
(21176, 'ORPHA:98915', 'Synaptic congenital myasthenic syndromes', 2),
(21177, 'ORPHA:98916', 'AIDP', 1),
(21178, 'ORPHA:98916', 'Acute idiopathic demyelinating polyneuropathy', 1),
(21179, 'ORPHA:98916', 'Acute inflammatory demyelinating polyradiculoneuropathy', 1),
(21180, 'ORPHA:98916', 'Acute inflammatory polyneuropathy', 1),
(21181, 'ORPHA:98916', 'GBS, acute inflammatory demyelinating polyradiculoneuropathic form', 1),
(21182, 'ORPHA:98916', 'Guillain-Barré syndrome, acute inflammatory demyelinating polyradiculoneuropathic form', 1),
(21183, 'ORPHA:98917', 'AMSAN', 1),
(21184, 'ORPHA:98917', 'Acute motor and sensory axonal neuropathy', 1),
(21185, 'ORPHA:98917', 'Acute motor-sensory axonal GBS', 1),
(21186, 'ORPHA:98917', 'Acute motor-sensory axonal Guillain-Barré syndrome', 1),
(21187, 'ORPHA:98918', 'AMAN', 1),
(21188, 'ORPHA:98918', 'Acute motor axonal neuropathy', 1),
(21189, 'ORPHA:98918', 'Acute pure motor GBS', 1),
(21190, 'ORPHA:98918', 'Acute pure motor Guillain-Barré syndrome', 1),
(21191, 'ORPHA:98919', 'Cranial variant of GBS', 1),
(21192, 'ORPHA:98919', 'Cranial variant of Guillain-Barré syndrome', 1),
(21193, 'ORPHA:98919', 'Fisher syndrome', 1),
(21194, 'ORPHA:98919', 'Miller Fisher syndrome', 1),
(21195, 'ORPHA:98920', 'Autosomal recessive distal spinal muscular atrophy type 1', 1),
(21196, 'ORPHA:98920', 'Autosomal recessive spinal muscular atrophy with respiratory distress', 1),
(21197, 'ORPHA:98920', 'Diaphragmatic spinal muscular atrophy', 1),
(21198, 'ORPHA:98920', 'Distal hereditary motor neuropathy type 6', 1),
(21199, 'ORPHA:98920', 'Distal-HMN type 6', 1),
(21200, 'ORPHA:98920', 'SIANRF', 1),
(21201, 'ORPHA:98920', 'SMARD1', 1),
(21202, 'ORPHA:98920', 'Severe infantile axonal neuropathy with respiratory failure type 1', 1),
(21203, 'ORPHA:98920', 'Spinal muscular atrophy with respiratory distress type 1', 1),
(21204, 'ORPHA:98920', 'dHMN6', 1),
(21205, 'ORPHA:98920', 'dSMA1', 1),
(21206, 'ORPHA:98922', 'Blake pouch cyst', 1),
(21207, 'ORPHA:98933', 'MSA, parkinsonian type', 2),
(21208, 'ORPHA:98933', 'MSA-p', 2),
(21209, 'ORPHA:98933', 'Multiple system atrophy, parkinsonian type', 2),
(21210, 'ORPHA:98934', 'HDL2', 1),
(21211, 'ORPHA:98934', 'Huntington disease-like 2', 1),
(21212, 'ORPHA:98938', 'Colobomatous microphthalmia', 1),
(21213, 'ORPHA:98938', 'MAC', 1),
(21214, 'ORPHA:98938', 'Microphthalmia with colobomatous cyst', 1),
(21215, 'ORPHA:98938', 'Microphthalmia-anophthalmia-coloboma syndrome', 1),
(21216, 'ORPHA:98942', 'Coloboma of choroid and retina', 1),
(21217, 'ORPHA:98943', 'Coloboma of eye lens', 1),
(21218, 'ORPHA:98944', 'Coloboma of iris', 1),
(21219, 'ORPHA:98945', 'Coloboma of macula', 1),
(21220, 'ORPHA:98946', 'Coloboma of eyelid', 1),
(21221, 'ORPHA:98947', 'Coloboma of optic disc', 1),
(21222, 'ORPHA:98947', 'Coloboma of optic papilla', 1),
(21223, 'ORPHA:98948', 'Congenital symblepharon', 2),
(21224, 'ORPHA:98949', 'Complete cryptophthalmia', 2),
(21225, 'ORPHA:98950', 'Partial cryptophthalmia', 2),
(21226, 'ORPHA:98951', 'Inverse Marcus-Gunn phenomenon', 2),
(21227, 'ORPHA:98954', 'Juvenile hereditary epithelial dystrophy of Meesmann', 1),
(21228, 'ORPHA:98954', 'MECD', 1),
(21229, 'ORPHA:98954', 'Meesmann corneal dystrophy', 1),
(21230, 'ORPHA:98955', 'Band-shaped and whorled microcystic dystrophy of the corneal epithelium', 1),
(21231, 'ORPHA:98955', 'LECD', 1),
(21232, 'ORPHA:98955', 'Lisch epithelial corneal dystrophy', 1),
(21233, 'ORPHA:98956', 'Anterior basement membrane dystrophy', 1),
(21234, 'ORPHA:98956', 'Cogan microcystic epithelial dystrophy', 1),
(21235, 'ORPHA:98956', 'EBMD', 1),
(21236, 'ORPHA:98956', 'Epithelial basement membrane dystrophy', 1),
(21237, 'ORPHA:98956', 'Map-dot-fingerprint dystrophy', 1),
(21238, 'ORPHA:98957', 'GDCD', 1),
(21239, 'ORPHA:98957', 'Gelatinous drop-like corneal dystrophy', 1),
(21240, 'ORPHA:98957', 'Primary familial amyloidosis of the cornea', 1),
(21241, 'ORPHA:98957', 'Subepithelial amyloidosis of the cornea', 1),
(21242, 'ORPHA:98958', 'Climatic droplet keratopathy', 1),
(21243, 'ORPHA:98958', 'Honey-droplet corneal dystrophy', 1),
(21244, 'ORPHA:98959', 'SMCD', 1),
(21245, 'ORPHA:98959', 'Subepithelial mucinous corneal dystrophy', 1),
(21246, 'ORPHA:98960', 'Anterior limiting membrane dystrophy type 2', 1),
(21247, 'ORPHA:98960', 'Anterior limiting membrane dystrophy type II', 1),
(21248, 'ORPHA:98960', 'Corneal dystrophy of Bowman layer type 2', 1),
(21249, 'ORPHA:98960', 'Corneal dystrophy of Bowman layer type II', 1),
(21250, 'ORPHA:98960', 'Curly fiber corneal dystrophy', 1),
(21251, 'ORPHA:98960', 'Honeycomb corneal dystrophy', 1),
(21252, 'ORPHA:98960', 'TBCD', 1),
(21253, 'ORPHA:98960', 'Thiel-Behnke corneal dystrophy', 1),
(21254, 'ORPHA:98960', 'Waardenburg-Jonker corneal dystrophy', 1),
(21255, 'ORPHA:98961', 'Anterior limiting membrane dystrophy type 1', 1),
(21256, 'ORPHA:98961', 'Anterior limiting membrane dystrophy type I', 1),
(21257, 'ORPHA:98961', 'Atypical granular corneal dystrophy', 1),
(21258, 'ORPHA:98961', 'Corneal dystrophy of Bowman layer type 1', 1),
(21259, 'ORPHA:98961', 'Corneal dystrophy of Bowman layer type I', 1),
(21260, 'ORPHA:98961', 'Geographic corneal dystrophy', 1),
(21261, 'ORPHA:98961', 'Granular corneal dystrophy type 3', 1),
(21262, 'ORPHA:98961', 'Granular corneal dystrophy type III', 1),
(21263, 'ORPHA:98961', 'RBCD', 1),
(21264, 'ORPHA:98961', 'Reis-Bücklers corneal dystrophy', 1),
(21265, 'ORPHA:98961', 'Superficial granular corneal dystrophy', 1),
(21266, 'ORPHA:98962', 'Classic GCD', 1),
(21267, 'ORPHA:98962', 'Classic granular corneal dystrophy', 1),
(21268, 'ORPHA:98962', 'Corneal dystrophy Groenouw type I', 1),
(21269, 'ORPHA:98962', 'GCD1', 1),
(21270, 'ORPHA:98962', 'GCDI', 1),
(21271, 'ORPHA:98962', 'Granular corneal dystrophy type 1', 1),
(21272, 'ORPHA:98962', 'Granular corneal dystrophy type I', 1),
(21273, 'ORPHA:98963', 'Avellino corneal dystrophy', 1),
(21274, 'ORPHA:98963', 'GCD2', 1),
(21275, 'ORPHA:98963', 'GCDII', 1),
(21276, 'ORPHA:98963', 'Granular corneal dystrophy type 2', 1),
(21277, 'ORPHA:98963', 'Granular corneal dystrophy type II', 1),
(21278, 'ORPHA:98963', 'Granular-lattice corneal dystrophy', 1),
(21279, 'ORPHA:98964', 'Biber-Haab-Dimmer dystrophy', 1),
(21280, 'ORPHA:98964', 'Classic lattice corneal dystrophy', 1),
(21281, 'ORPHA:98964', 'LCD1', 1),
(21282, 'ORPHA:98964', 'LCDI', 1),
(21283, 'ORPHA:98964', 'Lattice corneal dystrophy type 1', 1),
(21284, 'ORPHA:98964', 'Lattice corneal dystrophy type I', 1),
(21285, 'ORPHA:98967', 'Crystalline stromal dystrophy', 1),
(21286, 'ORPHA:98967', 'Hereditary crystalline stromal dystrophy of Schnyder', 1),
(21287, 'ORPHA:98967', 'SCCD', 1),
(21288, 'ORPHA:98967', 'SCD', 1),
(21289, 'ORPHA:98967', 'Schnyder corneal dystrophy', 1),
(21290, 'ORPHA:98967', 'Schnyder crystalline corneal dystrophy', 1),
(21291, 'ORPHA:98967', 'Schnyder crystalline dystrophy sine crystals', 1),
(21292, 'ORPHA:98969', 'Corneal dystrophy Groenouw type II', 1),
(21293, 'ORPHA:98969', 'Fehr corneal dystrophy', 1),
(21294, 'ORPHA:98969', 'MCD', 1),
(21295, 'ORPHA:98969', 'Macular corneal dystrophy', 1),
(21296, 'ORPHA:98970', 'FCD', 1),
(21297, 'ORPHA:98970', 'Fleck corneal dystrophy', 1),
(21298, 'ORPHA:98970', 'François-Neetens speckled corneal dystrophy', 1),
(21299, 'ORPHA:98971', 'PACD', 1),
(21300, 'ORPHA:98971', 'Posterior amorphous corneal dystrophy', 1),
(21301, 'ORPHA:98971', 'Posterior amorphous stromal dystrophy', 1),
(21302, 'ORPHA:98972', 'CCDF', 1),
(21303, 'ORPHA:98972', 'Central cloudy corneal dystrophy of François', 1),
(21304, 'ORPHA:98972', 'Central cloudy dystrophy of François', 1),
(21305, 'ORPHA:98973', 'PPCD', 1),
(21306, 'ORPHA:98973', 'Posterior polymorphous corneal dystrophy', 1),
(21307, 'ORPHA:98973', 'Posterior polymorphous dystrophy', 1),
(21308, 'ORPHA:98973', 'Schlichting dystrophy', 1),
(21309, 'ORPHA:98974', 'Endoepithelial corneal dystrophy', 1),
(21310, 'ORPHA:98974', 'FECD', 1),
(21311, 'ORPHA:98974', 'Fuchs endothelial corneal dystrophy', 1),
(21312, 'ORPHA:98974', 'Late hereditary endothelial dystrophy', 1),
(21313, 'ORPHA:98975', 'Autosomal dominant CHED', 1),
(21314, 'ORPHA:98975', 'Autosomal dominant congenital hereditary endothelial dystrophy', 1),
(21315, 'ORPHA:98975', 'CHED1', 1),
(21316, 'ORPHA:98975', 'CHEDI', 1),
(21317, 'ORPHA:98975', 'Congenital hereditary endothelial dystrophy type 1', 1),
(21318, 'ORPHA:98975', 'Congenital hereditary endothelial dystrophy type I', 1),
(21319, 'ORPHA:98976', 'Buphthalmia', 1),
(21320, 'ORPHA:98976', 'Buphthalmos', 1),
(21321, 'ORPHA:98976', 'Buphthalmus', 1),
(21322, 'ORPHA:98976', 'Congenital glaucoma', 1),
(21323, 'ORPHA:98976', 'Primary congenital glaucoma', 1),
(21324, 'ORPHA:98977', 'Juvenile glaucoma', 1),
(21325, 'ORPHA:98978', 'Axenfeld anomaly', 1),
(21326, 'ORPHA:98979', 'Chandler syndrome', 2),
(21327, 'ORPHA:98980', 'Cogan-Reese syndrome', 2),
(21328, 'ORPHA:98981', 'Essential iris atrophy', 2),
(21329, 'ORPHA:98984', 'Coppock-like cataract', 2),
(21330, 'ORPHA:98984', 'Dusty cataract', 2),
(21331, 'ORPHA:98984', 'Pulverulent cataract', 2),
(21332, 'ORPHA:98985', 'Early-onset cataract with Y-shaped suture opacities', 2),
(21333, 'ORPHA:98985', 'Early-onset sutural cataract', 2),
(21334, 'ORPHA:98988', 'Early-onset anterior polar cataract', 2),
(21335, 'ORPHA:98988', 'Early-onset anterior subcapsular cataract', 2),
(21336, 'ORPHA:98989', 'Blue-dot cataract', 2),
(21337, 'ORPHA:98989', 'Cerulean cataract', 2),
(21338, 'ORPHA:98990', 'Coralliform cataract', 2),
(21339, 'ORPHA:98991', 'Early-onset nuclear cataract', 2),
(21340, 'ORPHA:98992', 'Early-onset partial cataract', 2),
(21341, 'ORPHA:98993', 'Early-onset posterior polar cataract', 2),
(21342, 'ORPHA:98994', 'Total early-onset cataract', 2),
(21343, 'ORPHA:98995', 'Early-onset zonular cataract', 2),
(21344, 'ORPHA:99', 'ADCA', 3),
(21345, 'ORPHA:99', 'Autosomal dominant cerebellar ataxia', 3),
(21346, 'ORPHA:99', 'Autosomal dominant spinocerebellar ataxia', 3),
(21347, 'ORPHA:990', 'Agnathia-holoprosencephaly-situs inversus syndrome', 1),
(21348, 'ORPHA:99000', 'AOFMD', 1),
(21349, 'ORPHA:99000', 'AVMD', 1),
(21350, 'ORPHA:99000', 'Adult-onset foveomacular dystrophy', 1),
(21351, 'ORPHA:99000', 'Adult-onset foveomacular dystrophy with choroidal neovascularization', 1),
(21352, 'ORPHA:99000', 'Adult-onset foveomacular vitelliform dystrophy', 1),
(21353, 'ORPHA:99000', 'Adult-onset vitelliform macular dystrophy', 1),
(21354, 'ORPHA:99000', 'Gass disease', 1),
(21355, 'ORPHA:99000', 'Pseudo-Best disease', 1),
(21356, 'ORPHA:99000', 'Pseudo-vitelliform macular dystrophy', 1),
(21357, 'ORPHA:99001', 'Butterfly-shaped pattern dystrophy', 1),
(21358, 'ORPHA:99001', 'Butterfly-shaped pigment dystrophy', 1),
(21359, 'ORPHA:99001', 'Butterfly-shaped pigmentary macular dystrophy', 1),
(21360, 'ORPHA:99002', 'Reticular dystrophy of the retinal pigment epithelium', 1),
(21361, 'ORPHA:99003', 'Multifocal pattern dystrophy simulating Stargardt disease', 1),
(21362, 'ORPHA:99003', 'Multifocal pattern dystrophy simulating fundus flavimaculatus', 1),
(21363, 'ORPHA:99004', 'Fundus pulverulentus', 1),
(21364, 'ORPHA:99013', 'SPG7', 1),
(21365, 'ORPHA:99013', 'Spastic paraplegia type 7', 1),
(21366, 'ORPHA:99014', 'CMT5X', 1),
(21367, 'ORPHA:99014', 'CMTX5', 1),
(21368, 'ORPHA:99014', 'X-linked Charcot-Marie-Tooth disease type 5', 1),
(21369, 'ORPHA:99015', 'SPG2', 1),
(21370, 'ORPHA:99015', 'Spastic gait type 2', 1),
(21371, 'ORPHA:99015', 'Spastic paraparesis type 2', 1),
(21372, 'ORPHA:99015', 'Spastic paraplegia type 2', 1),
(21373, 'ORPHA:99015', 'X-linked spastic paraplegia type 2', 1),
(21374, 'ORPHA:99027', 'ADLD', 1),
(21375, 'ORPHA:99027', 'Adult-onset autosomal dominant demyelinating leukodystrophy', 1),
(21376, 'ORPHA:99027', 'Adult-onset autosomal dominant leukodystrophy', 1),
(21377, 'ORPHA:99042', 'Congenitally uncorrected transposition of the great arteries with coarctation', 2),
(21378, 'ORPHA:99042', 'Congenitally uncorrected transposition of the great vessels with coarctation', 2),
(21379, 'ORPHA:99042', 'TGA with coarctation', 2),
(21380, 'ORPHA:99043', 'DORV with subaortic or doubly committed VSD with pulmonary stenosis', 2),
(21381, 'ORPHA:99043', 'DORV, Fallot type', 2),
(21382, 'ORPHA:99043', 'Double outlet right ventricle with subaortic or doubly committed ventricular septal defect with pulmonary stenosis', 2),
(21383, 'ORPHA:99043', 'Double outlet right ventricle, Fallot type', 2),
(21384, 'ORPHA:99045', 'DORV with subpulmonary VSD', 2),
(21385, 'ORPHA:99045', 'DORV-TGA', 2),
(21386, 'ORPHA:99045', 'Double outlet right ventricle with subpulmonary ventricular septal defect', 2),
(21387, 'ORPHA:99045', 'Double outlet right ventricle with transposition of the great arteries', 2),
(21388, 'ORPHA:99045', 'Taussig-Bing syndrome', 2),
(21389, 'ORPHA:99046', 'DORV with non-committed subpulmonary VSD', 2),
(21390, 'ORPHA:99046', 'Double outlet right ventricle with non-committed subpulmonary ventricular septal defect', 2),
(21391, 'ORPHA:99048', 'APV/PDA, non-Fallot type', 1),
(21392, 'ORPHA:99048', 'Pulmonary valve agenesis-intact ventricular septum-persistent ductus arteriosus syndrome', 1),
(21393, 'ORPHA:99049', 'Pulmonary artery coming from patent ductus arteriosus', 1),
(21394, 'ORPHA:99050', 'Abnormal origin of right or left pulmonary artery from the aorta', 1),
(21395, 'ORPHA:99050', 'Hemitruncus arteriosus', 1),
(21396, 'ORPHA:99050', 'Pulmonary artery coming from the aorta', 1),
(21397, 'ORPHA:99051', 'Discrete fixed membranous subaortic stenosis', 2),
(21398, 'ORPHA:99052', 'Discrete fibromuscular subaortic stenosis', 2),
(21399, 'ORPHA:99053', 'Tunnel subaortic stenosis', 2),
(21400, 'ORPHA:99054', 'Valvular pulmonary stenosis', 2),
(21401, 'ORPHA:99055', 'Congenital anomaly of the tricuspid valve chordae', 1),
(21402, 'ORPHA:99055', 'Congenital anomaly of tricuspid chordae tendineae', 1),
(21403, 'ORPHA:99055', 'Congenital anomaly of tricuspid tendinous chords', 1),
(21404, 'ORPHA:99056', 'Parachute tricuspid valve', 1),
(21405, 'ORPHA:99057', 'Congenital mitral stenosis', 1),
(21406, 'ORPHA:99058', 'Hypoplasia of the mitral valve annulus', 1),
(21407, 'ORPHA:99059', 'Congenital supravalvular mitral ring', 1),
(21408, 'ORPHA:99060', 'Congenital unguarded mitral orifice', 1),
(21409, 'ORPHA:99061', 'Accessory mitral valve tissue', 1),
(21410, 'ORPHA:99062', 'Mitral valve agenesis', 1),
(21411, 'ORPHA:99063', 'Shone complex', 1),
(21412, 'ORPHA:99064', 'Straddling and/or overriding mitral valve', 2),
(21413, 'ORPHA:99067', 'CAVC with ventricular hypoplasia', 2),
(21414, 'ORPHA:99067', 'Complete AVSD with ventricular hypoplasia', 2),
(21415, 'ORPHA:99067', 'Complete atrioventricular canal defect with ventricular hypoplasia', 2),
(21416, 'ORPHA:99067', 'Complete atrioventricular septal defect with ventricular hypoplasia', 2),
(21417, 'ORPHA:99067', 'Complete atrioventricular septal defect with ventricular imbalance', 2),
(21418, 'ORPHA:99067', 'Unbalanced complete atrioventricular canal', 2),
(21419, 'ORPHA:99068', 'CAVC-tetralogy of Fallot', 2),
(21420, 'ORPHA:99068', 'Complete AVSD-tetralogy of Fallot', 2),
(21421, 'ORPHA:99068', 'Complete atrioventricular canal defect-tetralogy of Fallot', 2),
(21422, 'ORPHA:99068', 'Complete atrioventricular septal defect-tetralogy of Fallot', 2),
(21423, 'ORPHA:99069', 'Univentricular heart with single atrio-ventricular valve', 2),
(21424, 'ORPHA:99070', 'Aorto-right ventricular tunnel', 2),
(21425, 'ORPHA:99071', 'Aorto-left ventricular tunnel', 2),
(21426, 'ORPHA:99072', 'Congenital patent ductus arteriosus aneurysm', 1),
(21427, 'ORPHA:99075', 'Encircling double aortic arch', 1),
(21428, 'ORPHA:99076', 'Persistent fifth aortic arch', 1),
(21429, 'ORPHA:99077', 'Kommerell diverticulum', 1),
(21430, 'ORPHA:99078', 'Neuhauser anomaly', 1),
(21431, 'ORPHA:99079', 'Cervical aortic arch', 1),
(21432, 'ORPHA:99081', 'Right aortic arch', 1),
(21433, 'ORPHA:99082', 'Dysphagia lusoria', 1),
(21434, 'ORPHA:99083', 'PAH', 1),
(21435, 'ORPHA:99083', 'Pulmonary artery hypoplasia', 1),
(21436, 'ORPHA:99083', 'Unilateral Pulmonary Artery Hypoplasia', 1),
(21437, 'ORPHA:99084', 'Branch pulmonary artery stenosis', 1),
(21438, 'ORPHA:99084', 'Peripheral pulmonary stenosis', 1),
(21439, 'ORPHA:99084', 'Pulmonary branch stenosis', 1),
(21440, 'ORPHA:99087', 'COSA', 1),
(21441, 'ORPHA:99087', 'Congenital coronary arterial orifice stenosis or atresia', 1),
(21442, 'ORPHA:99087', 'Congenital stenosis or atresia of a coronary ostium', 1),
(21443, 'ORPHA:99087', 'Coronary ostial stenosis or atresia', 1),
(21444, 'ORPHA:99089', 'Abnormal number of coronary ostia', 1),
(21445, 'ORPHA:99090', 'Malposition of a coronary ostium', 1),
(21446, 'ORPHA:99092', 'Interventricular septum aneurysm', 1),
(21447, 'ORPHA:99094', 'Laubry-Pezzi syndrome', 1),
(21448, 'ORPHA:99094', 'VSD with aortic insufficiency', 1),
(21449, 'ORPHA:99094', 'Ventricular septal defect with aortic insufficiency', 1),
(21450, 'ORPHA:99095', 'Congenital Gerbode defect', 1),
(21451, 'ORPHA:99095', 'Left ventricular-to-right atrial communication', 1),
(21452, 'ORPHA:99098', 'Cor triatriatum dexter', 1),
(21453, 'ORPHA:99098', 'Cor triatriatum dextrum', 1),
(21454, 'ORPHA:99098', 'Divided right atrium', 1),
(21455, 'ORPHA:99099', 'Cor triatriatum sinister', 1),
(21456, 'ORPHA:99099', 'Cor triatriatum sinistrum', 1),
(21457, 'ORPHA:99099', 'Divided left atrium', 1),
(21458, 'ORPHA:991', 'PAGOD syndrome', 1),
(21459, 'ORPHA:991', 'Pulmonary hypoplasia-agonadism-dextrocardia-diaphragmatic hernia syndrome', 1),
(21460, 'ORPHA:99100', 'Juxtaposition of the atrial appendages', 1),
(21461, 'ORPHA:99100', 'Juxtaposition of the atrial auricles', 1),
(21462, 'ORPHA:99101', 'Dilatation of the right atrial appendage', 1),
(21463, 'ORPHA:99101', 'Dilatation of the right atrial auricle', 1),
(21464, 'ORPHA:99101', 'Ectasia of the right atrial appendage', 1),
(21465, 'ORPHA:99101', 'Ectasia of the right atrial auricle', 1),
(21466, 'ORPHA:99102', 'Dilatation of the left atrial appendage', 1),
(21467, 'ORPHA:99102', 'Dilatation of the left auricle', 1),
(21468, 'ORPHA:99102', 'Ectasia of the left atrial appendage', 1),
(21469, 'ORPHA:99102', 'Ectasia of the left auricle', 1),
(21470, 'ORPHA:99103', 'ASD, ostium secundum type', 2),
(21471, 'ORPHA:99103', 'Atrial septal defect, ostium secundum type', 2),
(21472, 'ORPHA:99104', 'ASD, coronary sinus type', 2),
(21473, 'ORPHA:99104', 'Atrial septal defect, coronary sinus type', 2),
(21474, 'ORPHA:99104', 'Unroofed coronary sinus', 2),
(21475, 'ORPHA:99105', 'ASD, sinus venosus type', 2),
(21476, 'ORPHA:99105', 'Atrial septal defect, sinus venosus type', 2),
(21477, 'ORPHA:99106', 'ASD, ostium primum type', 2),
(21478, 'ORPHA:99106', 'Atrial septal defect, ostium primum type', 2),
(21479, 'ORPHA:99107', 'Atrial septal aneurysm', 1),
(21480, 'ORPHA:99109', 'Persistent left SVC connecting through coronary sinus to left-sided atrium', 1),
(21481, 'ORPHA:99109', 'Persistent left superior vena cava connecting through coronary sinus to left-sided atrium', 1),
(21482, 'ORPHA:99110', 'Right SVC connecting to left-sided atrium', 1),
(21483, 'ORPHA:99110', 'Right superior caval vein connecting to left-sided atrium', 1),
(21484, 'ORPHA:99110', 'Right superior vena cava connecting to left-sided atrium', 1),
(21485, 'ORPHA:99111', 'Persistent left SVC connecting to left-sided atrium', 1),
(21486, 'ORPHA:99111', 'Persistent left SVC connecting to the roof of left-sided atrium', 1),
(21487, 'ORPHA:99111', 'Persistent left superior vena cava connecting to left-sided atrium', 1),
(21488, 'ORPHA:99111', 'Persistent left superior vena cava connecting to the roof of left-sided atrium', 1),
(21489, 'ORPHA:99112', 'Absence of brachiocephalic vein', 1),
(21490, 'ORPHA:99112', 'Absence of innominate vein', 1),
(21491, 'ORPHA:99113', 'Subaortic course of brachiocephalic vein', 1),
(21492, 'ORPHA:99113', 'Subaortic course of innominate vein', 1),
(21493, 'ORPHA:99114', 'Absence of the SVC', 1),
(21494, 'ORPHA:99114', 'Absence of the superior caval vein', 1),
(21495, 'ORPHA:99114', 'Absence of the superior vena cava', 1),
(21496, 'ORPHA:99114', 'Agenesis of the SVC', 1),
(21497, 'ORPHA:99114', 'Agenesis of the superior caval vein', 1),
(21498, 'ORPHA:99114', 'Agenesis of the superior vena cava', 1),
(21499, 'ORPHA:99117', 'Coronary sinus stenosis', 1),
(21500, 'ORPHA:99118', 'Coronary sinus atresia', 1);

INSERT INTO `orpha_diagnostics` (`id`, `code`, `name`, `classification_level_id`) VALUES
(21501, 'ORPHA:99119', 'Right IVC connecting to left-sided atrium', 1),
(21502, 'ORPHA:99119', 'Right inferior caval vein connecting to left-sided atrium', 1),
(21503, 'ORPHA:99119', 'Right inferior vena cava connecting to left-sided atrium', 1),
(21504, 'ORPHA:99120', 'Persistent eustachian valve', 1),
(21505, 'ORPHA:99121', 'Azygos continuation of the IVC', 1),
(21506, 'ORPHA:99121', 'Azygos continuation of the inferior caval vein', 1),
(21507, 'ORPHA:99121', 'Azygos continuation of the inferior vena cava', 1),
(21508, 'ORPHA:99121', 'Inferior vena cava interruption with azygos continuation', 1),
(21509, 'ORPHA:99122', 'Congenital stenosis of the IVC', 1),
(21510, 'ORPHA:99122', 'Congenital stenosis of the inferior caval vein', 1),
(21511, 'ORPHA:99122', 'Congenital stenosis of the inferior vena cava', 1),
(21512, 'ORPHA:99123', 'IVC interruption', 1),
(21513, 'ORPHA:99123', 'Inferior caval vein interruption', 1),
(21514, 'ORPHA:99123', 'Inferior vena cava interruption without azygos continuation', 1),
(21515, 'ORPHA:99124', 'Congenital partial pulmonary venous return anomaly', 1),
(21516, 'ORPHA:99125', 'Congenital total pulmonary venous return anomaly', 1),
(21517, 'ORPHA:99129', 'Congenital complete agenesis of pericardium', 1),
(21518, 'ORPHA:99130', 'Congenital partial agenesis of pericardium', 1),
(21519, 'ORPHA:99131', 'Pleuro-pericardial cyst', 1),
(21520, 'ORPHA:99135', '6-phosphogluconate dehydrogenase deficiency', 1),
(21521, 'ORPHA:99138', 'Hemolytic anemia due to erythrocyte adenosine deaminase overproduction', 1),
(21522, 'ORPHA:99139', 'Unstable hemoglobin disease', 1),
(21523, 'ORPHA:99141', 'Lymphedema-posterior choanal atresia syndrome', 1),
(21524, 'ORPHA:99147', 'Acquired von Willebrand disease', 1),
(21525, 'ORPHA:99147', 'Acquired von Willebrand syndrome', 1),
(21526, 'ORPHA:99169', 'Epiblepharon', 1),
(21527, 'ORPHA:99170', 'Tarsal kink syndrome', 1),
(21528, 'ORPHA:99171', 'Isolated congenital ectropion', 1),
(21529, 'ORPHA:99172', 'Euryblepharon', 1),
(21530, 'ORPHA:99176', 'Congenital eyelid retraction', 1),
(21531, 'ORPHA:99177', 'Isolated distichiasis', 1),
(21532, 'ORPHA:99179', 'Kandori fleck retina', 1),
(21533, 'ORPHA:99226', 'Monosomy X', 2),
(21534, 'ORPHA:99228', 'Mosaic monosomy X', 2),
(21535, 'ORPHA:99324', 'Paternal uniparental disomy of chromosome 13', 1),
(21536, 'ORPHA:99324', 'UPD(13)pat', 1),
(21537, 'ORPHA:99329', '48,XYYY syndrome', 1),
(21538, 'ORPHA:99330', '49,XYYYY syndrome', 1),
(21539, 'ORPHA:99361', 'Familial MTC', 2),
(21540, 'ORPHA:99361', 'Familial medullary thyroid carcinoma', 2),
(21541, 'ORPHA:994', 'Arthrogryposis multiplex congenita-pulmonary hypoplasia syndrome', 1),
(21542, 'ORPHA:994', 'FADS', 1),
(21543, 'ORPHA:994', 'Fetal akinesia deformation sequence', 1),
(21544, 'ORPHA:994', 'Pena-Shokeir syndrome type 1', 1),
(21545, 'ORPHA:99408', 'Pituitary adenoma', 3),
(21546, 'ORPHA:99413', 'Turner syndrome due to structural X chromosome anomalies', 2),
(21547, 'ORPHA:99429', 'CAIS', 1),
(21548, 'ORPHA:99429', 'Complete androgen insensitivity syndrome', 1),
(21549, 'ORPHA:99429', 'Complete androgen resistance syndrome', 1),
(21550, 'ORPHA:99642', 'Spondyloepimetaphyseal dysplasia, Handigodu type', 1),
(21551, 'ORPHA:99646', 'Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria', 1),
(21552, 'ORPHA:99647', 'Cheirospondyloenchondromatosis', 1),
(21553, 'ORPHA:99647', 'Generalized enchondromatosis with platyspondyly', 1),
(21554, 'ORPHA:99657', 'DYT2', 1),
(21555, 'ORPHA:99657', 'Primary dystonia, DYT2 type', 1),
(21556, 'ORPHA:99672', 'Fried\'s tooth and nail syndrome', 1),
(21557, 'ORPHA:99688', 'Dermotrichic syndrome', 1),
(21558, 'ORPHA:99701', 'MTLE-HS', 1),
(21559, 'ORPHA:99701', 'Mesial temporal lobe epilepsy with hippocampal sclerosis', 1),
(21560, 'ORPHA:99710', 'Punctate acrokeratoderma freckle-like pigmentation', 1),
(21561, 'ORPHA:99718', 'LHON plus disease', 1),
(21562, 'ORPHA:99718', 'Leber plus disease', 1),
(21563, 'ORPHA:99725', 'Hypophyseal gigantism', 1),
(21564, 'ORPHA:99725', 'Infantile and juvenile forms of acromegaly', 1),
(21565, 'ORPHA:99725', 'Pituitary gigantism', 1),
(21566, 'ORPHA:99731', 'ISOD', 2),
(21567, 'ORPHA:99731', 'Isolated sulfite oxidase deficiency', 2),
(21568, 'ORPHA:99731', 'Sulfocysteinuria', 2),
(21569, 'ORPHA:99732', 'Combined deficiency of sulfite oxidase, xanthine dehydrogenase and aldehyde oxidase', 2),
(21570, 'ORPHA:99732', 'MOCOD', 2),
(21571, 'ORPHA:99732', 'Sulfite oxidase deficiency due to molybdenum cofactor deficiency', 2),
(21572, 'ORPHA:99734', 'Exercise-induced delayed-onset myotonia', 1),
(21573, 'ORPHA:99734', 'Fluctuating myotonia', 1),
(21574, 'ORPHA:99734', 'Myotonia fluctuans', 1),
(21575, 'ORPHA:99735', 'Myotonia permanens', 1),
(21576, 'ORPHA:99736', 'ACZ-responsive congenital myotonia', 1),
(21577, 'ORPHA:99736', 'ACZ-responsive myotonia', 1),
(21578, 'ORPHA:99736', 'Acetazolamide-responsive congenital myotonia', 1),
(21579, 'ORPHA:99736', 'Acetazolamide-responsive myotonia', 1),
(21580, 'ORPHA:99736', 'Myotonia-painful contractions syndrome', 1),
(21581, 'ORPHA:99736', 'Painful congenital myotonia', 1),
(21582, 'ORPHA:99736', 'Painful myotonia', 1),
(21583, 'ORPHA:99739', 'Rare familial disorder with hypertrophic cardiomyopathy', 3),
(21584, 'ORPHA:99739', 'Rare familial disorder with hypertrophic obstructive cardiomyopathy', 3),
(21585, 'ORPHA:99739', 'Rare familial disorder with hypertrophic subaortic stenosis', 3),
(21586, 'ORPHA:99741', 'King-Denborough syndrome', 1),
(21587, 'ORPHA:99741', 'Koussef-Nichols syndrome', 1),
(21588, 'ORPHA:99742', 'Amish lethal microcephaly', 1),
(21589, 'ORPHA:99745', 'Typhoid', 1),
(21590, 'ORPHA:99745', 'Typhoid fever', 1),
(21591, 'ORPHA:99745', 'Typhoidal salmonellosis', 1),
(21592, 'ORPHA:99748', 'Pontiac fever', 2),
(21593, 'ORPHA:99749', 'Infantile agranulocytosis', 1),
(21594, 'ORPHA:99749', 'Kostmann syndrome', 1),
(21595, 'ORPHA:99749', 'Severe congenital neutropenia type 3', 1),
(21596, 'ORPHA:99750', 'Atypical PSP syndrome', 2),
(21597, 'ORPHA:99750', 'Atypical progressive supranuclear palsy syndrome', 2),
(21598, 'ORPHA:99756', 'Alveolar rhabdomyosarcoma', 2),
(21599, 'ORPHA:99757', 'Embryonal rhabdomyosarcoma', 2),
(21600, 'ORPHA:99771', 'Bifid uvula', 1),
(21601, 'ORPHA:99771', 'Bifidity of the uvula', 1),
(21602, 'ORPHA:99771', 'Uvular cleft', 1),
(21603, 'ORPHA:99772', 'Cleft soft palate', 1),
(21604, 'ORPHA:99772', 'Cleft velum', 1),
(21605, 'ORPHA:99772', 'Cleft velum palatinum', 1),
(21606, 'ORPHA:99776', 'Mosaic trisomy 9', 1),
(21607, 'ORPHA:99776', 'Mosaic trisomy chromosome 9', 1),
(21608, 'ORPHA:99776', 'Trisomy 9 mosaicism', 1),
(21609, 'ORPHA:99789', 'DD-I', 2),
(21610, 'ORPHA:99789', 'DTDP1', 2),
(21611, 'ORPHA:99789', 'Dentin dysplasia type I', 2),
(21612, 'ORPHA:99789', 'Radicular dentin dysplasia', 2),
(21613, 'ORPHA:99791', 'DD-II', 2),
(21614, 'ORPHA:99791', 'DTDP2', 2),
(21615, 'ORPHA:99791', 'Dentin dysplasia type II', 2),
(21616, 'ORPHA:99792', 'Dentin dysplasia-sclerotic bones syndrome', 1),
(21617, 'ORPHA:99796', 'Subcortical band heterotopia', 1),
(21618, 'ORPHA:99796', 'Subcortical laminar heterotopia', 1),
(21619, 'ORPHA:99797', 'Anodontia', 1),
(21620, 'ORPHA:99798', 'Oligodontia', 1),
(21621, 'ORPHA:99798', 'Selective tooth agenesis', 1),
(21622, 'ORPHA:998', 'Albinism-deafness syndrome', 1),
(21623, 'ORPHA:998', 'Albinism-hearing loss syndrome', 1),
(21624, 'ORPHA:99802', 'Hemimegalencephaly', 1),
(21625, 'ORPHA:99802', 'Unilateral megalencephaly', 1),
(21626, 'ORPHA:99803', 'Congenital central alveolar hypoventilation-Hirschsprung disease syndrome', 1),
(21627, 'ORPHA:99803', 'Haddad syndrome', 1),
(21628, 'ORPHA:99803', 'Ondine-Hirschsprung disease', 1),
(21629, 'ORPHA:99803', 'Ondine-Hirschsprung syndrome', 1),
(21630, 'ORPHA:99806', 'OOD', 1),
(21631, 'ORPHA:99806', 'Oculootodental syndrome', 1),
(21632, 'ORPHA:99807', 'PEHO-like syndrome', 1),
(21633, 'ORPHA:99810', 'Familial porencephaly', 2),
(21634, 'ORPHA:99811', 'Neuronal intestinal pseudoobstruction', 2),
(21635, 'ORPHA:99812', 'DNA ligase IV deficiency', 1),
(21636, 'ORPHA:99812', 'LIG4 syndrome', 1),
(21637, 'ORPHA:99812', 'Ligase 4 syndrome', 1),
(21638, 'ORPHA:99818', 'Turcot syndrome with polyposis', 2),
(21639, 'ORPHA:99819', 'Familial gestational hyperthyroidism', 1),
(21640, 'ORPHA:99824', 'LF', 1),
(21641, 'ORPHA:99824', 'Lassa fever', 1),
(21642, 'ORPHA:99824', 'Lassa hemorrhagic fever', 1),
(21643, 'ORPHA:99825', 'Nipah encephalitis', 1),
(21644, 'ORPHA:99825', 'Nipah fever', 1),
(21645, 'ORPHA:99825', 'Nipah virus disease', 1),
(21646, 'ORPHA:99826', 'Green monkey disease', 1),
(21647, 'ORPHA:99826', 'MHF', 1),
(21648, 'ORPHA:99826', 'Marburg hemorrhagic fever', 1),
(21649, 'ORPHA:99826', 'Marburg virus disease', 1),
(21650, 'ORPHA:99827', 'CCHF', 1),
(21651, 'ORPHA:99827', 'Congo fever', 1),
(21652, 'ORPHA:99827', 'Congo hemorrhagic fever', 1),
(21653, 'ORPHA:99827', 'Crimean hemorrhagic fever', 1),
(21654, 'ORPHA:99827', 'Crimean-Congo hemorrhagic fever', 1),
(21655, 'ORPHA:99828', 'DF', 1),
(21656, 'ORPHA:99828', 'Dengue fever', 1),
(21657, 'ORPHA:99828', 'Dengue virus infection', 1),
(21658, 'ORPHA:99829', 'Bronze John', 1),
(21659, 'ORPHA:99829', 'YF', 1),
(21660, 'ORPHA:99829', 'Yellow Jack', 1),
(21661, 'ORPHA:99829', 'Yellow fever', 1),
(21662, 'ORPHA:99832', 'Central hypothyroidism due to TRH receptor deficiency', 1),
(21663, 'ORPHA:99832', 'Resistance to thyrotropin-releasing hormone syndrome', 1),
(21664, 'ORPHA:99832', 'TRH resistance syndrome', 1),
(21665, 'ORPHA:99842', 'LAD-I', 2),
(21666, 'ORPHA:99842', 'Leukocyte adhesion deficiency type I', 2),
(21667, 'ORPHA:99843', 'CDG syndrome type IIc', 2),
(21668, 'ORPHA:99843', 'CDG-IIc', 2),
(21669, 'ORPHA:99843', 'CDG2C', 2),
(21670, 'ORPHA:99843', 'LAD-II', 2),
(21671, 'ORPHA:99843', 'Leukocyte adhesion deficiency type II', 2),
(21672, 'ORPHA:99843', 'Rambam-Hasharon syndrome', 2),
(21673, 'ORPHA:99843', 'SLC35C1-CDG', 2),
(21674, 'ORPHA:99844', 'LAD-1 variant', 2),
(21675, 'ORPHA:99844', 'LAD-III', 2),
(21676, 'ORPHA:99844', 'Leukocyte adhesion deficiency type III', 2),
(21677, 'ORPHA:99844', 'Leukocyte adhesion deficiency-1 variant', 2),
(21678, 'ORPHA:99845', 'Genetic recurrent myoglobinuria', 1),
(21679, 'ORPHA:99846', 'Autosomal dominant myoglobinuria', 1),
(21680, 'ORPHA:99849', 'GSD due to muscle beta-enolase deficiency', 1),
(21681, 'ORPHA:99849', 'GSDXIII', 1),
(21682, 'ORPHA:99849', 'Glycogen storage disease due to muscle beta-enolase deficiency', 1),
(21683, 'ORPHA:99849', 'Glycogenosis due to muscle beta-enolase deficiency', 1),
(21684, 'ORPHA:99849', 'Glycogenosis type 13', 1),
(21685, 'ORPHA:99849', 'Muscle enolase deficiency', 1),
(21686, 'ORPHA:99849', 'Muscular enolase deficiency', 1),
(21687, 'ORPHA:99852', 'Progressive encephalopathy with severe infantile anorexia', 1),
(21688, 'ORPHA:99852', 'Ravine syndrome', 1),
(21689, 'ORPHA:99852', 'Reunion island-anorexia-vomiting which is irrepressible-neurological signs syndrome', 1),
(21690, 'ORPHA:99853', 'Ovarioleukodystrophy', 2),
(21691, 'ORPHA:99854', 'Cree leukoencephalopathy', 2),
(21692, 'ORPHA:99856', 'Congenital syringomyelia', 1),
(21693, 'ORPHA:99856', 'Primary syringomyelia', 1),
(21694, 'ORPHA:99857', 'Secondary syringomyelia', 1),
(21695, 'ORPHA:99858', 'Idiopathic syringomyelia', 2),
(21696, 'ORPHA:99860', 'B-ALL', 1),
(21697, 'ORPHA:99860', 'Precursor B-cell acute lymphoblastic leukemia', 1),
(21698, 'ORPHA:99860', 'Precursor B-cell acute lymphoblastic leukemia/lymphoma', 1),
(21699, 'ORPHA:99860', 'Precursor B-cell acute lymphocytic leukemia', 1),
(21700, 'ORPHA:99860', 'Precursor B-cell acute lymphocytic leukemia/lymphoma', 1),
(21701, 'ORPHA:99861', 'Precursor T-cell acute lymphoblastic leukemia', 1),
(21702, 'ORPHA:99861', 'Precursor T-cell acute lymphoblastic leukemia/lymphoma', 1),
(21703, 'ORPHA:99861', 'Precursor T-cell acute lymphocytic leukemia', 1),
(21704, 'ORPHA:99861', 'Precursor T-cell acute lymphocytic leukemia/lymphoma', 1),
(21705, 'ORPHA:99861', 'T-ALL', 1),
(21706, 'ORPHA:99865', 'Spermatocytic seminoma', 1),
(21707, 'ORPHA:99867', 'Primary thymic epithelial neoplasm', 1),
(21708, 'ORPHA:99867', 'Primary thymic epithelial tumor', 1),
(21709, 'ORPHA:99867', 'Thymoma', 1),
(21710, 'ORPHA:99868', 'Malignant thymoma', 1),
(21711, 'ORPHA:99868', 'Thymic carcinoma', 1),
(21712, 'ORPHA:99869', 'Thymic neuroendocrine carcinoma', 1),
(21713, 'ORPHA:99877', 'Familial parathyroid adenoma', 1),
(21714, 'ORPHA:99878', 'Familial parathyroids hyperplasia', 1),
(21715, 'ORPHA:99878', 'Hereditary parathyroids hyperplasia', 1),
(21716, 'ORPHA:99878', 'Primary parathyroid hyperplasia', 1),
(21717, 'ORPHA:99879', 'FIHPT', 1),
(21718, 'ORPHA:99879', 'Familial isolated hyperparathyroidism', 1),
(21719, 'ORPHA:99880', 'HPT-JT', 1),
(21720, 'ORPHA:99880', 'Hyperparathyroidism-jaw tumor syndrome', 1),
(21721, 'ORPHA:99885', 'Monogenic diabetes of infancy', 1),
(21722, 'ORPHA:99885', 'PNDM', 1),
(21723, 'ORPHA:99885', 'Permanent neonatal diabetes mellitus', 1),
(21724, 'ORPHA:99886', 'TNDM', 1),
(21725, 'ORPHA:99886', 'Transient neonatal diabetes mellitus', 1),
(21726, 'ORPHA:99887', 'Acute megakaryoblastic leukemia in Down syndrome', 2),
(21727, 'ORPHA:99887', 'DS-AMKL', 2),
(21728, 'ORPHA:99889', 'Adrenocorticotropic hormone secretion syndrome', 1),
(21729, 'ORPHA:99889', 'Cushing syndrome due to ectopic ACTH secretion', 1),
(21730, 'ORPHA:99889', 'Ectopic ACTH secreting tumor', 1),
(21731, 'ORPHA:99889', 'Ectopic Cushing syndrome', 1),
(21732, 'ORPHA:99889', 'Occult ectopic ACTH secretion', 1),
(21733, 'ORPHA:99889', 'Paraneoplastic Cushing syndrome', 1),
(21734, 'ORPHA:99892', 'ACTH-dependent CS', 3),
(21735, 'ORPHA:99892', 'ACTH-dependent Cushing syndrome', 3),
(21736, 'ORPHA:99892', 'Adrenocorticotropic hormone-dependent Cushing syndrome', 3),
(21737, 'ORPHA:99892', 'Corticotropin-dependent Cushing syndrome', 3),
(21738, 'ORPHA:99893', 'ACTH-independent Cushing syndrome', 3),
(21739, 'ORPHA:99893', 'Adrenal Cushing syndrome', 3),
(21740, 'ORPHA:99893', 'Adrenocorticotropic hormone-independent Cushing syndrome', 3),
(21741, 'ORPHA:99893', 'Corticotropin-independent Cushing syndrome', 3),
(21742, 'ORPHA:99898', 'MSMD due to complete IFNgammaR1 deficiency', 1),
(21743, 'ORPHA:99898', 'MSMD due to complete interferon gamma receptor 1 deficiency', 1),
(21744, 'ORPHA:99898', 'Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency', 1),
(21745, 'ORPHA:99898', 'Mendelian susceptibility to mycobacterial diseases due to complete interferon gamma receptor 1 deficiency', 1),
(21746, 'ORPHA:999', 'Ermine phenotype', 1),
(21747, 'ORPHA:999', 'O\'Doherty syndrome', 1),
(21748, 'ORPHA:999', 'Pigmentary disorder with deafness', 1),
(21749, 'ORPHA:999', 'Pigmentary disorder with hearing loss', 1),
(21750, 'ORPHA:99901', 'ACAD9 deficiency', 1),
(21751, 'ORPHA:99901', 'Acyl-CoA dehydrogenase 9 deficiency', 1),
(21752, 'ORPHA:99903', 'Sodoku', 2),
(21753, 'ORPHA:99903', 'Spirillary rat-bite fever', 2),
(21754, 'ORPHA:99905', 'Streptobacillary rat-bite fever', 2),
(21755, 'ORPHA:99906', 'Farmer\'s lung disease', 1),
(21756, 'ORPHA:99907', 'House allergic alveolitis', 1),
(21757, 'ORPHA:99908', 'Bird fancier lung', 1),
(21758, 'ORPHA:99908', 'Pigeon-breeder lung disease', 1),
(21759, 'ORPHA:99909', 'Occupational allergic alveolitis', 3),
(21760, 'ORPHA:99912', 'Dysgerminomatous germ cell cancer of the ovary', 1),
(21761, 'ORPHA:99912', 'Malignant dysgerminomatous germ cell tumor of the ovary', 1),
(21762, 'ORPHA:99912', 'Malignant ovarian dysgerminoma', 1),
(21763, 'ORPHA:99913', 'Extragonadal non-dysgerminomatous germ cell tumor', 3),
(21764, 'ORPHA:99914', 'Gynandroblastoma', 1),
(21765, 'ORPHA:99915', 'Granulosa cell cancer', 1),
(21766, 'ORPHA:99915', 'Granulosa cell malignant tumor', 1),
(21767, 'ORPHA:99915', 'Maligant granulosa cell tumor of the ovary', 1),
(21768, 'ORPHA:99916', 'Androblastoma', 1),
(21769, 'ORPHA:99916', 'Arrhenoblastoma', 1),
(21770, 'ORPHA:99916', 'Malignant Sertoli-Leydig cell tumor of the ovary', 1),
(21771, 'ORPHA:99916', 'Ovarian Sertoli-Leydig cell cancer', 1),
(21772, 'ORPHA:99916', 'Ovarian malignant Sertoli-Leydig cell tumor', 1),
(21773, 'ORPHA:99916', 'Virilizing ovarian tumor', 1),
(21774, 'ORPHA:99917', 'Theca (steroid-producing) cell cancer, not further specified', 1),
(21775, 'ORPHA:99917', 'Theca steroid-producing cell malignant tumor of ovary, not further specified', 1),
(21776, 'ORPHA:99918', 'Streptococcal TSS', 2),
(21777, 'ORPHA:99918', 'Streptococcal toxic-shock syndrome', 2),
(21778, 'ORPHA:99919', 'Staphylococcal TSS', 2),
(21779, 'ORPHA:99919', 'Staphylococcal toxic-shock syndrome', 2),
(21780, 'ORPHA:99920', 'Acute graft versus host disease', 2),
(21781, 'ORPHA:99921', 'Chronic graft versus host disease', 2),
(21782, 'ORPHA:99922', 'Ocular cicatricial pemphigoid', 1),
(21783, 'ORPHA:99925', 'Invasive mole', 1),
(21784, 'ORPHA:99926', 'Gestational choriocarcinoma', 1),
(21785, 'ORPHA:99927', 'Hydatidiform mole', 1),
(21786, 'ORPHA:99927', 'Molar pregnancy', 1),
(21787, 'ORPHA:99928', 'PSST', 1),
(21788, 'ORPHA:99928', 'Placental site trophoblastic tumor', 1),
(21789, 'ORPHA:99930', 'Secondary pulmonary hemosiderosis', 1),
(21790, 'ORPHA:99931', 'Idiopathic pulmonary hemosiderosis', 1),
(21791, 'ORPHA:99932', 'Cow\'s milk hypersensitivity', 2),
(21792, 'ORPHA:99932', 'Heiner syndrome', 2),
(21793, 'ORPHA:99933', 'Pleuropulmonary blastoma type 1', 2),
(21794, 'ORPHA:99934', 'Pleuropulmonary blastoma type 2', 2),
(21795, 'ORPHA:99935', 'Pleuropulmonary blastoma type 3', 2),
(21796, 'ORPHA:99936', 'Autosomal dominant Charcot-Marie-Tooth disease type 2B', 1),
(21797, 'ORPHA:99936', 'CMT2B', 1),
(21798, 'ORPHA:99937', 'Autosomal dominant Charcot-Marie-Tooth disease type 2C', 1),
(21799, 'ORPHA:99937', 'CMT2C', 1),
(21800, 'ORPHA:99938', 'Autosomal dominant Charcot-Marie-Tooth disease type 2D', 1),
(21801, 'ORPHA:99938', 'CMT2D', 1),
(21802, 'ORPHA:99939', 'Autosomal dominant Charcot-Marie-Tooth disease type 2E', 1),
(21803, 'ORPHA:99939', 'CMT2E', 1),
(21804, 'ORPHA:99940', 'Autosomal dominant Charcot-Marie-Tooth disease type 2F', 1),
(21805, 'ORPHA:99940', 'CMT2F', 1),
(21806, 'ORPHA:99941', 'Autosomal dominant Charcot-Marie-Tooth disease type 2G', 1),
(21807, 'ORPHA:99941', 'CMT2G', 1),
(21808, 'ORPHA:99942', 'Autosomal dominant Charcot-Marie-Tooth disease type 2I', 1),
(21809, 'ORPHA:99942', 'CMT2I', 1),
(21810, 'ORPHA:99943', 'Autosomal dominant Charcot-Marie-Tooth disease type 2J', 1),
(21811, 'ORPHA:99943', 'CMT2J', 1),
(21812, 'ORPHA:99944', 'Autosomal dominant Charcot-Marie-Tooth disease type 2K', 1),
(21813, 'ORPHA:99944', 'CMT2K', 1),
(21814, 'ORPHA:99945', 'Autosomal dominant Charcot-Marie-Tooth disease type 2L', 1),
(21815, 'ORPHA:99945', 'CMT2L', 1),
(21816, 'ORPHA:99946', 'Autosomal dominant Charcot-Marie-Tooth disease type 2A1', 1),
(21817, 'ORPHA:99946', 'CMT2A1', 1),
(21818, 'ORPHA:99947', 'Autosomal dominant Charcot-Marie-Tooth disease type 2A2', 1),
(21819, 'ORPHA:99947', 'CMT2A2', 1),
(21820, 'ORPHA:99948', 'CMT4A', 1),
(21821, 'ORPHA:99948', 'Charcot-Marie-Tooth disease type 4A', 1),
(21822, 'ORPHA:99949', 'CMT4C', 1),
(21823, 'ORPHA:99949', 'Charcot-Marie-Tooth disease type 4C', 1),
(21824, 'ORPHA:99950', 'CMT4D', 1),
(21825, 'ORPHA:99950', 'Charcot-Marie-Tooth disease type 4D', 1),
(21826, 'ORPHA:99950', 'HMSN, Lom type', 1),
(21827, 'ORPHA:99950', 'HMSN-Lom', 1),
(21828, 'ORPHA:99950', 'Hereditary motor and sensory neuropathy, Lom type', 1),
(21829, 'ORPHA:99951', 'Autosomal recessive congenital hypomyelinating neuropathy', 1),
(21830, 'ORPHA:99951', 'CMT4E', 1),
(21831, 'ORPHA:99951', 'Charcot-Marie-Tooth disease type 4E', 1),
(21832, 'ORPHA:99952', 'CMT4F', 1),
(21833, 'ORPHA:99952', 'Charcot-Marie-Tooth disease type 4F', 1),
(21834, 'ORPHA:99953', 'CMT4G', 1),
(21835, 'ORPHA:99953', 'Charcot-Marie-Tooth disease type 4G', 1),
(21836, 'ORPHA:99953', 'HMSNR', 1),
(21837, 'ORPHA:99953', 'Hereditary motor and sensory neuropathy, Russe Type', 1),
(21838, 'ORPHA:99954', 'CMT4H', 1),
(21839, 'ORPHA:99954', 'Charcot-Marie-Tooth disease type 4H', 1),
(21840, 'ORPHA:99955', 'CMT4B1', 1),
(21841, 'ORPHA:99955', 'Charcot-Marie-Tooth disease type 4B1', 1),
(21842, 'ORPHA:99956', 'CMT4B2', 1),
(21843, 'ORPHA:99956', 'Charcot-Marie-Tooth disease type 4B2', 1),
(21844, 'ORPHA:99960', 'BRIC type 1', 2),
(21845, 'ORPHA:99960', 'BRIC1', 2),
(21846, 'ORPHA:99960', 'Benign recurrent intrahepatic cholestasis type 1', 2),
(21847, 'ORPHA:99961', 'BRIC type 2', 2),
(21848, 'ORPHA:99961', 'BRIC2', 2),
(21849, 'ORPHA:99961', 'Benign recurrent intrahepatic cholestasis type 2', 2),
(21850, 'ORPHA:99965', 'O\'Sullivan-McLeod syndrome', 2),
(21851, 'ORPHA:99966', 'ATRT', 2),
(21852, 'ORPHA:99966', 'Atypical teratoid rhabdoid tumor', 2),
(21853, 'ORPHA:99967', 'MRCLS', 2),
(21854, 'ORPHA:99967', 'Myxoid/round cell liposarcoma', 2),
(21855, 'ORPHA:99969', 'PLS', 2),
(21856, 'ORPHA:99969', 'Pleomorphic liposarcoma', 2),
(21857, 'ORPHA:99970', 'DDLS', 2),
(21858, 'ORPHA:99970', 'Dedifferentiated liposarcoma', 2),
(21859, 'ORPHA:99971', 'ALT', 2),
(21860, 'ORPHA:99971', 'Atypical lipoma', 2),
(21861, 'ORPHA:99971', 'Atypical lipomatous tumor', 2),
(21862, 'ORPHA:99971', 'WDLS', 2),
(21863, 'ORPHA:99971', 'Well-differentiated liposarcoma', 2),
(21864, 'ORPHA:99976', 'Adenocarcinoma of the esophagus', 1),
(21865, 'ORPHA:99976', 'Esophageal adenocarcinoma', 1),
(21866, 'ORPHA:99977', 'ESCC', 1),
(21867, 'ORPHA:99977', 'Esophageal epidermoid carcinoma', 1),
(21868, 'ORPHA:99977', 'Esophageal squamous cell carcinoma', 1),
(21869, 'ORPHA:99977', 'Squamous cell carcinoma of the esophagus', 1),
(21870, 'ORPHA:99978', 'Hilar CCA', 1),
(21871, 'ORPHA:99978', 'Hilar cholangiocarcinoma', 1),
(21872, 'ORPHA:99978', 'Klatskin tumor', 1),
(21873, 'ORPHA:99981', 'Apnea of prematurity', 2),
(21874, 'ORPHA:99983', 'Cutaneous myiasis', 3),
(21875, 'ORPHA:99989', 'Developmental delay-epilepsy-neonatal diabetes syndrome, intermediate form', 2),
(21876, 'ORPHA:99989', 'Intermediate DEND syndrome', 2),
(21877, 'ORPHA:99990', 'Brill disease', 2),
(21878, 'ORPHA:99990', 'Brill-Zinsser disease', 2),
(21879, 'ORPHA:99990', 'Recrudescent typhus', 2),
(21880, 'ORPHA:99991', 'Relapsing epidemic typhus', 2),
(21881, 'ORPHA:99994', 'Causalgia', 2),
(21882, 'ORPHA:99994', 'Complex regional pain syndrome type 2', 2),
(21883, 'ORPHA:99995', 'Algodystrophy', 2),
(21884, 'ORPHA:99995', 'Complex regional pain syndrome type 1', 2),
(21885, 'ORPHA:99995', 'Reflex sympathetic dystrophy', 2);



/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;